<SEC-DOCUMENT>0001178913-22-001377.txt : 20220404
<SEC-HEADER>0001178913-22-001377.hdr.sgml : 20220404
<ACCEPTANCE-DATETIME>20220404080909
ACCESSION NUMBER:		0001178913-22-001377
CONFORMED SUBMISSION TYPE:	40-F
PUBLIC DOCUMENT COUNT:		151
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220404
DATE AS OF CHANGE:		20220404

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IM Cannabis Corp.
		CENTRAL INDEX KEY:			0001792030
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		40-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40065
		FILM NUMBER:		22800418

	BUSINESS ADDRESS:	
		STREET 1:		1 ADELAIDE STREET EAST, UNIT 801
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5C 2V9
		BUSINESS PHONE:		416-256-4202

	MAIL ADDRESS:	
		STREET 1:		1 ADELAIDE STREET EAST, UNIT 801
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5C 2V9
</SEC-HEADER>
<DOCUMENT>
<TYPE>40-F
<SEQUENCE>1
<FILENAME>zk2227544.htm
<DESCRIPTION>40-F
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:imc="http://www.imcannabis.com/20211231" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021q4"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>IM Cannabis Corp. - 1792030 - 2022</title></head><body style="font-size:10pt;font-family:Times New Roman;">
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20210101to20211231"  id="Fdei_AmendmentFlag20210428202814091" >false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20210101to20211231"  id="Fdei_DocumentFiscalPeriodFocus20210429051843186" >FY</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20210101to20211231"  id="Fdei_EntityCentralIndexKey20210429052436020" >0001792030</ix:nonNumeric></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="imc-20211231.xsd"/>
        </ix:references></ix:header></div><div>
  <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;width:100%;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;margin-bottom:0pt;text-align:center" />
  <p style="margin:0px 0pt 0pt">&#160;</p>
  <p style="margin-bottom:0pt;text-align:center;margin-top:8px"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>U</span></strong></span></span></span></span></span><span><span><span><span><span><strong><span>NITED STATES</span></strong></span></span></span></span></span></span></span></p>
  <p style="margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong><span>SECURITIES AND EXCHANGE COMMISSION</span></strong></span></span></span></span></span></span></p>
  <p style="margin-top:0pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><strong>Washington, D.C. 20549</strong></span></span></span></span></span></p>
  <p style="text-align:center"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong><span>FORM <ix:nonNumeric id="Fxbrl_20220127171057126" name="dei:DocumentType" contextRef="C_20210101to20211231">40-F</ix:nonNumeric></span></strong></span></span></span></span></span></span></p>
  <div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

        <tr>
          <td style="width:6.68%;vertical-align:top;white-space:nowrap">
            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20220127171446547" name="dei:DocumentRegistrationStatement" contextRef="C_20210101to20211231" format="ixt:booleanfalse">&#9744;</ix:nonNumeric></span></span></span></div>
          </td>
          <td style="width:93.32%;vertical-align:top">
            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>
            <div style="line-height:1.25;font-weight:bold">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width:6.68%;vertical-align:top;white-space:nowrap">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><ix:nonNumeric id="Fxbrl_20220127171502435" name="dei:DocumentAnnualReport" contextRef="C_20210101to20211231" format="ixt:booleantrue">&#9746;</ix:nonNumeric></span></span></span></div>
          </td>
          <td style="width:93.32%;vertical-align:top">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align:center;line-height:1.25">
      <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;color:#000000;width:100%">

          <tr>
            <td style="width:50.00%">
              <div style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span style="font-family:'Times New Roman',Times,serif;font-weight:bold">For the fiscal year ended <ix:nonNumeric id="Fxbrl_20220127174220165" name="dei:DocumentPeriodEndDate" contextRef="C_20210101to20211231" format="ixt:datemonthdayyearen"><ix:nonNumeric id="Fxbrl_20220127174238742" name="dei:CurrentFiscalYearEndDate" contextRef="C_20210101to20211231" format="ixt:datemonthdayen">December 31</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20220127174257693" name="dei:DocumentFiscalYearFocus" contextRef="C_20210101to20211231">2021</ix:nonNumeric></ix:nonNumeric></span></span></span></span></div>
            </td>
            <td style="width:50.00%">
              <div style="text-align:left"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span style="font-family:'Times New Roman',Times,serif;font-weight:bold">Commission File Number <ix:nonNumeric id="Fxbrl_20220127183253874" name="dei:EntityFileNumber" contextRef="C_20210101to20211231">001-40065</ix:nonNumeric></span></span></span></span></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:16pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none"><span style="font-size:16pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20220330004226495" name="dei:EntityRegistrantName" contextRef="C_20210101to20211231">IM CANNABIS CORP.</ix:nonNumeric></span></span></span></div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>(Exact name of Registrant as specified in its charter)</span></span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>British Columbia</span></span></span></span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(Province or other jurisdiction of incorporation or organization)</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>2833</span></span></span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(Primary Standard Industrial Classification Code Number (if applicable))</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Not Applicable</span></span></span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(I.R.S. Employer Identification Number (if applicable))</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127184823952" name="dei:EntityAddressAddressLine1" contextRef="C_20210101to20211231">Kibbutz</ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20220127184832100" name="dei:EntityAddressCityOrTown" contextRef="C_20210101to20211231">Glil Yam</ix:nonNumeric>,</span></span></span></span></div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127171721059" name="dei:EntityAddressAddressLine2" contextRef="C_20210101to20211231">Central District</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_202201271717500750" name="dei:EntityIncorporationStateCountryCode" contextRef="C_20210101to20211231" format="ixt-sec:edgarprovcountryen"><ix:nonNumeric id="Fxbrl_20220127171750075" name="dei:EntityAddressCountry" contextRef="C_20210101to20211231" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20220127171814154" name="dei:EntityAddressPostalZipCode" contextRef="C_20210101to20211231">4690500</ix:nonNumeric></span></span></span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">+</span> <span style="font-weight:bold"><ix:nonNumeric id="Fxbrl_20220127183540865" name="dei:CityAreaCode" contextRef="C_20210101to20211231">972</ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20220127183547075" name="dei:LocalPhoneNumber" contextRef="C_20210101to20211231">544331111</ix:nonNumeric></span></span></span></span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(Address and telephone number of Registrant&#8217;s principal executive offices)</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127171927497" name="dei:ContactPersonnelName" contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">CT Corporation System</ix:nonNumeric></span></span></span></span></div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127173042173" name="dei:EntityAddressAddressLine1" contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">1015 15th Street N.W.</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20220127173057817" name="dei:EntityAddressAddressLine2" contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Suite 1000</ix:nonNumeric></span></span></span></span></div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127173143201" name="dei:EntityAddressStateOrProvince" contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember" format="ixt-sec:stateprovnameen">Washington</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20220127183641142" name="dei:EntityAddressCityOrTown" contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">DC</ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20220127173211571" name="dei:EntityAddressPostalZipCode" contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">20005</ix:nonNumeric></span></span></span></span></div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(<ix:nonNumeric id="Fxbrl_20220127171957498" name="dei:CityAreaCode" contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">202</ix:nonNumeric>) <ix:nonNumeric id="Fxbrl_20220127172010394" name="dei:LocalPhoneNumber" contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">572-3133</ix:nonNumeric></span></span></span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>(Name, address (including zip code) and telephone number (including area code)</span></span></span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>of agent for service in the United States)</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Securities registered or to be registered pursuant to Section 12(b) of the Act:</span></span></span></span></div>
    <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

        <tr>
          <td style="width:39.51%;vertical-align:middle;border-bottom:#000000 2px solid">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Title of each class</span></span></span></span></div>
          </td>
          <td style="width:2.88%;vertical-align:top">&#160;</td>
          <td style="width:18.2%;vertical-align:middle;border-bottom:#000000 2px solid">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Trading Symbol(s)</span></span></span></span></div>
          </td>
          <td style="width:2.86%;vertical-align:top">&#160;</td>
          <td style="width:36.56%;vertical-align:middle;border-bottom:#000000 2px solid">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Name of each exchange on which registered</span></span></span></span></div>
          </td>
        </tr>
        <tr>
          <td style="width:39.51%;vertical-align:middle">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127173232257" name="dei:Security12bTitle" contextRef="C_20210101to20211231">Common Shares</ix:nonNumeric>, no par value</span></span></span></span></div>
          </td>
          <td style="width:2.88%;vertical-align:top">&#160;</td>
          <td style="width:18.2%;vertical-align:middle">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127173247903" name="dei:TradingSymbol" contextRef="C_20210101to20211231">IMCC</ix:nonNumeric></span></span></span></span></div>
          </td>
          <td style="width:2.86%;vertical-align:top">&#160;</td>
          <td style="width:36.56%;vertical-align:middle">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The <ix:nonNumeric id="Fxbrl_20220127173300401" name="dei:SecurityExchangeName" contextRef="C_20210101to20211231" format="ixt-sec:exchnameen">NASDAQ</ix:nonNumeric> Stock Market LLC</span></span></span></span></div>
          </td>
        </tr>

    </table>
    <div style="text-align:justify;line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Securities registered or to be registered pursuant to Section 12(g) of the Act: Not applicable.</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: Not applicable.</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>For annual reports, indicate by check mark the information filed with this Form:</span></span></span></span></div>
    <div style="text-align:justify;line-height:1.25">&#160;</div>
    <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

        <tr>
          <td style="width:20%;vertical-align:top">&#160;</td>
          <td style="width:35%;vertical-align:top">
            <div style="text-align:justify;line-height:1.25">
              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127172617316" name="dei:AnnualInformationForm" contextRef="C_20210101to20211231" format="ixt:booleantrue">&#9746;</ix:nonNumeric>&#160; &#160; &#160; &#160; &#160; Annual information form</span></span></span></span></div>
            </div>
          </td>
          <td style="width:45%;vertical-align:top">
            <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127172603175" name="dei:AuditedAnnualFinancialStatements" contextRef="C_20210101to20211231" format="ixt:booleantrue">&#9746;</ix:nonNumeric>&#160; &#160; &#160; &#160; &#160; &#160;Audited annual financial statements</span></span></span></span></div>
          </td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Number of outstanding shares of each of the issuer&#8217;s classes of</span></span></span></span></div>
    <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>capital or common stock as of December 31, 2021:</span></span></span></span></div>
    <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20220330182452069" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_20211231" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">68,217,894</ix:nonFraction>&#160;<span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Common Shares, no par value</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.</span></span></span></span></div>
    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127172155423" name="dei:EntityCurrentReportingStatus" contextRef="C_20210101to20211231">Yes </ix:nonNumeric> &#160;&#9746;&#160; &#160; No &#9744;</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></span></span></span></div>
    <div style="text-align:justify;line-height:1.25">&#160;</div>
    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220127173332170" name="dei:EntityInteractiveDataCurrent" contextRef="C_20210101to20211231">Yes </ix:nonNumeric> &#160;&#9746;&#160; &#160; No &#9744;</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company&#160;&#160;<ix:nonNumeric id="Fxbrl_20220127173417479" name="dei:EntityEmergingGrowthCompany" contextRef="C_20210101to20211231" format="ixt:booleantrue">&#9746;</ix:nonNumeric></span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>If an emerging growth company that prepares is financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric id="Fxbrl_20220329232541677" name="dei:EntityExTransitionPeriod" contextRef="C_20210101to20211231" format="ixt:booleanfalse">&#9744;</ix:nonNumeric></span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</span></span></span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.<ix:nonNumeric id="Fxbrl_20220127173751487" name="dei:IcfrAuditorAttestationFlag" contextRef="C_20210101to20211231" format="ixt:booleanfalse">&#9744;</ix:nonNumeric></span></span></span></span></div>
    <div style="text-align:justify;line-height:1.25">&#160;</div>
    <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
      <div style="page-break-after:always">
        <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
      </div>
    </div>
  </div>
<div style="line-height:1.25;font-weight:bold">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EXPLANATORY NOTE</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM Cannabis Corp. (the &#8220;<span style="font-weight:bold">Company</span>&#8221; or the &#8220;<span style="font-weight:bold">Registrant</span>&#8221;) is a Canadian issuer that is permitted, under the multijurisdictional disclosure system adopted in the United States, to prepare this Annual Report on Form 40-F (this &#8220;<span style="font-weight:bold">Annual Report</span>&#8221;) pursuant to Section 13 of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="font-weight:bold">Exchange Act</span>&#8221;), in accordance with Canadian disclosure requirements, which are different from those of the United States. The Company is a &#8220;foreign private issuer&#8221; as defined in Rule 3b-4 under the Exchange Act and Rule 405 under the Securities Act of 1933, as amended. Equity securities of the Company are accordingly exempt from Sections 14(a), 14(b), 14(c), 14(f) and 16 of the Exchange Act pursuant to Rule 3a12-3 thereunder.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FORWARD-LOOKING STATEMENTS</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">This Annual Report, including any documents incorporated by reference herein, contains &#8220;forward-looking information&#8221; and &#8220;forward-looking statements&#8221; within the meaning of applicable securities laws (collectively referred to herein as &#8220;<span style="font-weight:bold">forward-looking statements</span>&#8221;). All statements other than statements of fact may be deemed to be forward-looking statements, including statements with regard to expected financial performance, strategy and business conditions. The words &#8220;believe&#8221;, &#8220;plan&#8221;, &#8220;intend&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;continue&#8221;, or &#8220;potential&#8221;, and similar expressions, as well as future or conditional verbs such as &#8220;will&#8221;, &#8220;should&#8221;, &#8220;would&#8221;, and &#8220;could&#8221; often identify forward-looking statements. These statements reflect management&#8217;s current beliefs with respect to future events and are based on information currently available to management as of the date of this Annual Report on Form 40-F, or a document incorporated by reference therein, including reasonable assumptions, estimates, internal and external analysis and opinions of management considering its experience, perception of trends, current conditions and expected developments as well as other factors that management believes to be relevant as at the date such statements are made. Capitalized terms used in this section and not defined have the meanings ascribed to them in the Company&#8217;s Annual Information Form for the year ended December 31, 2021 (the &#8220;<span style="font-weight:bold">AIF</span>&#8221;), attached hereto as <span style="text-decoration:underline">Exhibit 99.1</span>.</span></span></div></div><div style="line-height:1.25"><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Without limitation, this Annual Report contains forward-looking statements pertaining to:</span></span></div><div style="text-align:justify;line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><div style="line-height:1.25"><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the expected performance of the Group&#8217;s&#160; business and operations;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the export of the Group&#8217;s cannabis products from Canada and import into Israel and Germany on a consistent basis or at all;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the import into Israel and Germany of cannabis from supply partners in Canada and elsewhere on a consistent basis or at all;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the ability to satisfy rapid growth in demand for imported high-THC premium and super-premium medical cannabis in Israel and Germany;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s expansion and development of its foreign operations and supply arrangements;</span></span></div><div style="font-family:'Times New Roman',Times,serif"><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expansion of cultivation capacity;</span></span></div></div></div></td></tr></table></div><div style="line-height:1.25"><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s intentions regarding leveraging its German operational platform and further developing its presence in Europe;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expectations regarding the Group&#8217;s revenues, expenses and profits;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expectations in the growth of demand in the medical cannabis industry, including without limitation, in Israel and Germany;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Company&#8217;s positioning as one of the largest distributors of medical cannabis in Israel after acquiring the Israeli Pharmacies and Rosen High Way, Panaxia GDP License and Panaxia-to-the-Home Operation;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the competitive conditions of the medical and recreational cannabis industry, including ancillary industries such as medical cannabis operations consulting;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the anticipated legalization and/or decriminalization of adult-use recreational cannabis in Israel and Germany and the Group&#8217;s business intentions in the event such legalization and/or decriminalization occurs;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Company&#8217;s expectations relating to the Canadian Facilities;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TJAC&#8217;s anticipated regulatory approval to sell its products in the Province of Quebec;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s anticipated obligations to comply with environmental and employee health and safety matters;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Company&#8217;s expectations relating to the Panxia Pharmacy Option;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s future product offerings and strategic plans of entering into new domestic and international markets;</span></span></div></td></tr></table><div>&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the effect of new or altered government regulations with respect to any cannabis related activity, including the marketing, acquisition, manufacture, management, transportation, storage, sale and disposal of cannabis and cannabis products;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the grant, maintenance or renewal of licenses or governmental approvals required to conduct activities related to cannabis;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the intentions of management of the Company;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s expectations to meet target production capacity;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the availability of raw materials and supplies at acceptable quantities, qualities and prices;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the scope of protection the Group is able to establish and maintain, if any, for intellectual property rights covering its products;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">future liquidity and financial capacity;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Company&#8217;s plan with respect to any payments of dividends;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the vertical integration of the Group&#8217;s business.</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the expansion of the Company&#8217;s business, operations and potential activities outside of the current markets, including but not limited to Europe and other international jurisdictions;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top"><div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s contractual obligations and commitments.</span></span></div></td></tr></table></div><div style="line-height:1.25"><div style="line-height:1.25">&#160;</div></div><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With respect to the forward looking-statements contained in this Annual Report, the Company has made assumptions regarding, among other things:</span></span></div><div style="line-height:1.25">&#160;</div><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the anticipated increase in demand for High-THC premium and super-premium medical cannabis in the markets in which the Group operates or is contemplating operations;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the anticipated demand for adult-use recreational cannabis in Canada;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the anticipated increase in liquidity for current investors and enhanced access for prospective investors in the Company&#8217;s Common Shares following its successful listing on NASDAQ;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the legalization and/or decriminalization of adult-use recreational cannabis and the demand for adult-use recreational cannabis products in the markets in which the Group operates;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to satisfy international demand for its products;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to export from its Canadian Facilities and import into Israel and Germany;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">future cannabis product pricing;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">cannabis production yields; and</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to market its brands and its services successfully to its anticipated patients and consumers.</span></span></div></td></tr></table><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Readers are cautioned that the above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include:</span></span></div><div style="line-height:1.25">&#160;</div><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Company&#8217;s ability to continue to meet the continued listing requirements of the Canadian Securities Exchange (the &#8220;<span style="font-weight:bold">CSE</span>&#8221;) and NASDAQ;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the failure of the Group to comply with applicable regulatory requirements in a highly regulated industry;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the failure of the Company to maintain &#8220;de facto&#8221; control over Focus in accordance with IFRS 10 and to consolidate its financial results;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the failure of the each of Pharm Yarok, Rosen High Way, Vironna, Oranim and IMC Pharma to maintain in good standing or renew its government-issued cannabis licenses;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the failure of Focus to maintain in good standing or renew its government-issued cannabis cultivation license;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the failure of TJAC to maintain in good standing or renew any of the TJAC Licenses or the MYM Licenses;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the failure of Adjupharm to maintain in good standing or renew any of its government-issued cannabis wholesale, narcotics handling or import/export licenses, permits, certificates or approvals;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Focus&#8217; reliance on the Focus Facility to conduct medical cannabis activities;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the failure of Focus to maintain the Focus Facility in good standing with all state and municipal Israeli regulations, including all required licenses and permits and under the Focus Lease Agreement;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">failure to maintain in good standing any of the Israeli Facilities, the Canadian Facilities and the Logistics Centre;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">compliance with the Cannabis Act, and provincial and territorial cannabis legislation;</span></span></div></td></tr></table><div>&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">reliance on the Canadian Facilities to conduct cannabis activities;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to maintain ancillary business licenses, permits and approvals required to operate effectively;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">regulatory authorities in Israel viewing the Company as the deemed owner of more than 5% of Focus in contravention of Israeli regulations;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">limitations on stockholdings of the Company in connection with its potential direct engagement in the Israeli medical cannabis market;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">unexpected changes in governmental policies and regulations affecting the production, distribution, manufacture import/export or use of cannabis in Canada, Israel and Germany, or any foreign jurisdictions in which the Company intends to operate;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the failure of the Company to attain the necessary regulatory approvals required for the successful acquisition of HW Shinua and the successful exercise of the Panaxia Pharmacy Option in a timely manner or at all;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group, including but not limited to the Construction Allegations, the MOH Allegations and the class action proceedings described herein;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the ability of the Group&#8217;s third-party cultivators, suppliers, distribution partners, and contracted pharmacies to fulfil their obligations to the Group;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to maintain partnerships with third-party cultivators, suppliers and distribution partners;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to secure new supply and distribution partners;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to fulfil obligations to third-party distribution partners;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to obtain or maintain sufficient insurance for its operations;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s possible exposure to additional liability for claims in excess of insurance coverage;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to implement effective product security and storage measures;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to conduct sales and marketing activities for its products;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to retain and attract key personnel and members of management;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to develop or facilitate introduction of new product offerings to the market;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s possible exposure to liability relating to product recalls;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Company&#8217;s ability to raise additional funds;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Company&#8217;s ability to manage cash flows;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">inflation risks.</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">anti-money laundering laws and regulation risks;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the Group&#8217;s ability to cope with the operational impacts of the COVID-19 pandemic;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the impact on the Group of any changes in global financial conditions, including those caused by geopolitical instability, catastrophic events, natural disasters, weather and disease;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Focus, TJAC and MYM&#8217;s ability to grow agricultural products effectively in light of natural elements;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the impact of increasing competition;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">inconsistent public opinion and perception regarding the use of cannabis;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">perceived effects of cannabis products;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">any change in the political environment which would negatively affect the decriminalization and/or legalization of adult-use recreational cannabis in Israel and Germany;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">engaging in activities considered illegal under relevant laws including U.S. federal law;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">political instability and conflict in the Middle East;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the conflict between Russia and Ukraine and any restrictive actions that have been and may further be taken by the U.S. and/or other countries in response thereto, including but not limited sanctions, export controls or conflict;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">adverse market conditions;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">competition from the illegal cannabis market;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">industry consolidation;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the inherent uncertainty of production and cost estimates and the potential for unexpected costs and expenses;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the potential for the Company to record future impairment losses;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">currency and interest rate fluctuations;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">global and local economic conditions;</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">the costs of inputs; and</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:18pt">&#160;</td><td style="width:18pt;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">reliance on management.</span></span></div></td></tr></table></div><div style="text-align:justify;line-height:1.25">&#160;</div></div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div style="line-height:1.25">&#160;<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The foregoing list of risk factors is not exhaustive. Additional information on these and other factors that could affect the business, operations or financial results of the Company are detailed under the heading &#8220;<span style="font-style:italic">Risk Factors</span>&#8221; in the AIF. Unless otherwise indicated, forward-looking statements in this Annual Report describe our expectations as of the date of this Annual Report. The Company and management caution readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. The Company and management assume no obligation to update or revise them to reflect new events or circumstances except as required by applicable securities laws.</span></span></div><div style="text-align:justify;line-height:1.25">&#160;</div></div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE TO UNITED STATES READERS - DIFFERENCES IN UNITED STATES AND CANADIAN REPORTING PRACTICES</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Registrant is permitted, under the multi-jurisdictional disclosure system adopted by the United States Securities and Exchange Commission (the &#8220;<span style="font-weight:bold">SEC</span>&#8221;), to prepare this Annual Report in accordance with Canadian disclosure requirements, which differ from those of the United States. The Company has prepared its financial statements, which are filed as <span style="text-decoration:underline">Exhibit 99.2</span> to this Annual Report and incorporated by reference herein, in accordance with International Financial Reporting Standards, as issued by the International Accounting Standards Board and they are not comparable to financial statements of United States companies.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ANNUAL INFORMATION FORM</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The audited consolidated financial statements of the Registrant for the years ended December 31, 2021, including the report of the independent registered public accounting firm thereon, are filed as <span style="text-decoration:underline">Exhibit 99.2</span> to this Annual Report and are incorporated by reference herein.</span></span></div></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AUDITED ANNUAL FINANCIAL STATEMENTS</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The audited consolidated financial statements of the Registrant for the years ended December 31, 2021, including the report of the independent registered public accounting firm thereon, are filed as <span style="text-decoration:underline">Exhibit 99.2</span> to this Annual Report and are incorporated by reference herein.</span></span></div></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Registrant&#8217;s management&#8217;s discussion and analysis for the year and three months ended December 31, 2021, is filed as <span style="text-decoration:underline">Exhibit 99.3</span>&#160;to this Annual Report and is incorporated by reference herein.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TAX MATTERS</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchasing, holding, or disposing of the Company's securities may have tax consequences under the laws of the United States and Canada that are not described in this Annual Report.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONTROLS AND PROCEDURES</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disclosure Controls and Procedures</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of the end of the period covered by this Annual Report, the Company carried out an evaluation, under the supervision of the Company&#8217;s Chief Executive Officer (&#8220;<span style="font-weight:bold">CEO</span>&#8221;) and Chief Financial Officer (&#8220;<span style="font-weight:bold">CFO</span>&#8221;), of the effectiveness of the Company&#8217;s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based upon that evaluation, the Company&#8217;s CEO and CFO have concluded that, as of the end of the period covered by this Annual Report, the Company&#8217;s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) accumulated and communicated to the Company&#8217;s management, including its principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.</span></span></div><div style="text-align:justify;line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">While the Company&#8217;s principal executive officer and principal financial officer believe that the Company&#8217;s disclosure controls and procedures provide a reasonable level of assurance that they are effective, they do not expect that the Company&#8217;s disclosure controls and procedures or internal control over financial reporting will prevent all errors or fraud. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.</span></span></div><div style="text-align:justify;line-height:1.25">&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div style="text-align:justify;line-height:1.25">&#160;</div><div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act. The Company's management has employed a framework consistent with Exchange Act Rule 13a-15(c), to evaluate the Company's internal control over financial reporting described below. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements. It should be noted that a control system, no matter how well conceived or operated, can only provide reasonable assurance, not absolute assurance, that the objectives of the control system are met. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies and procedures may deteriorate.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management, including the CEO and CFO, is responsible for establishing and maintaining adequate internal control over financial reporting, and has used the 2013 framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the "<span style="font-weight:bold">2013 COSO Framework</span>") to evaluate the effectiveness of the Company's controls in 2019. <span style="font-weight:bold">[</span>Based on this evaluation, management concluded that the Company's internal control over financial reporting was effective as at December 31, 2021, and provided a reasonable assurance of the reliability of the Company's financial reporting and preparation of financial statements.</span></span></div><div style="line-height:1.25">&#160;</div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 9 2021, the Company acquired MYM Nutraceuticals Inc. (&#8220;MYM&#8221;). The Company is in the process of integrating MYM into its internal controls and procedures. As a result, management&#8217;s evaluation of the Company&#8217;s internal control over financial reporting did not include an evaluation of the internal controls of MYM and management&#8217;s conclusion regarding the effectiveness of the Company&#8217;s internal control over financial reporting does not extend to the internal controls of MYM. Total assets of $5.7 million related to MYM are included in the consolidated financial statements of the Company as of and for the year ended December 31, 2021.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 18, 2021, the Company acquired Trichome Financial Corp (&#8220;Trichome&#8221;). The Company is in the process of integrating Trichome into its internal controls and procedures. As a result, management&#8217;s evaluation of the Company&#8217;s internal control over financial reporting did not include an evaluation of the internal controls of Trichome and management&#8217;s conclusion regarding the effectiveness of the Company&#8217;s internal control over financial reporting does not extend to the internal controls of Trichome. Total assets of $89.2 million related to Trichome and its consolidated subsidiaries are included in the consolidated financial statements of the Company as of and for the year ended December 31, 20121.</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Attestation Report of the Registered Public Accounting Firm</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">This Annual Report does not include an attestation report of the Company's registered public accounting firm&#160;because emerging growth companies are exempt from this requirement for so long as they remain emerging growth companies.</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in Internal Control over Financial Reporting</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the period covered by this Annual Report, no change occurred in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></span></div><div style="text-align:justify;line-height:1.25">&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CORPORATE GOVERNANCE</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s Board of Directors (the &#8220;<span style="font-weight:bold">Board of Directors</span>&#8221;) is responsible for the Company&#8217;s corporate governance and has a separately designated standing a Corporate Governance and Nomination Committee, a Compensation Committee and an Audit Committee. The Board of Directors has determined that all of the members of the Compensation Committee and the Audit Committee are independent, based on the criteria for independence prescribed by Section 5605(a)(2) of the NASDAQ Stock Market Rules.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate Governance and Nomination Committee</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Corporate Governance and Nomination Committee is responsible for, among other things: developing, recommending to the Board of Directors and maintaining corporate governance principles applicable to the Company; identifying and recommending qualified individuals for nomination to the Board of Directors; reviewing and evaluating the Board of Directors; and addressing any related matters required by applicable law.&#160; The Company&#8217;s Corporate Governance and Nomination Committee is comprised of Oren Shuster, Vivian Bercovici and Marc Lustig.&#160; Ms. Bercovici is independent based on the criteria for independence prescribed by Rule 5605(a)(2) of the NASDAQ Stock Market Rules.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation Committee</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation of the Company&#8217;s CEO and all other executive officers is recommended to the Board of Directors for determination by the Compensation Committee. The Compensation Committee is comprised of Brian Schinderle, Vivian Bercovici and Haleli Barath, all of whom are independent based on the criteria for independence prescribed by Rule 5605(a)(2) of the NASDAQ Stock Market Rules.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AUDIT COMMITTEE</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Board of Directors has a separately designated standing Audit Committee established for the purpose of overseeing the accounting and financial reporting processes of the Company and audits of the financial statements of the Company in accordance with Section&#160;3(a)(58)(A) of the Exchange Act and Rule 5602(c) of the NASDAQ Stock Market Rules. As of the date of this Annual Report, the Company&#8217;s Audit Committee is comprised of Haleli Barath, Vivian Bercovici and Brian Schinderle, all of whom are independent based on the criteria for independence prescribed by Rule 10A-3 of the Exchange Act and Rule 5605(a)(2) of the NASDAQ Stock Market Rules. The Audit Committee meets the composition requirements set forth by Section 5605(c)(2) of the NASDAQ Stock Market Rules.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Board of Directors has also determined that each member of the Audit Committee is financially literate, meaning each such member has the ability to read and understand a set of financial statements that present a breadth and level of complexity of the issues that can reasonably be expected to be raised by the Company&#8217;s financial statements.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Audit Committee Financial Expert</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Board of Directors has determined that Brian Schinderle qualifies as a financial expert (as defined in Item 407(d)(5)(ii) of Regulation&#160;S-K&#160;under the Exchange Act) and Rule 5605(c)(2)(A) of the NASDAQ Stock Market Rules; and (ii) is independent (as determined under Exchange Act Rule 10A-3 and Rule 5605(a)(2) of the NASDAQ Stock Market Rules).</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The SEC has indicated that the designation or identification of a person as an audit committee financial expert does not make such person an &#8220;expert&#8221; for any purpose, impose any duties, obligations or liability on such person that are greater than those imposed on members of the audit committee and the board of directors who do not carry this designation or identification, or affect the duties, obligations or liability of any other member of the audit committee or board of directors.</span></span></div><div style="text-align:justify;line-height:1.25">&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PRE-APPROVAL OF AUDIT AND NON-AUDIT SERVICES PROVIDED BY INDEPENDENT AUDITOR</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Audit Committee&#160;pre-approves&#160;all audit services to be provided to the Company by its independent auditors.&#160;Non-audit&#160;services that are prohibited to be provided to the Company by its independent auditors may not be&#160;pre-approved.&#160;In addition, prior to the granting of any&#160;pre-approval,&#160;the Audit Committee must be satisfied that the performance of the services in question will not compromise the independence of the independent auditors. All&#160;non-audit&#160;services performed by the Company&#8217;s auditor for the fiscal year ended December&#160;31, 2021 were&#160;pre-approved&#160;by the Audit Committee of the Company. No&#160;non-audit&#160;services were approved pursuant to the de minimis exemption to the&#160;pre-approval&#160;requirement set forth in Rule&#160;2-01(c)(7)(i)(C)&#160;of Regulation&#160;S-X.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><div style="line-height:1.25"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following lists the aggregate fees paid or payable to Kost Forer Gabbay &#38; Kasierer, a member of Ernst &#38; Young Global, Tel Aviv, Israel (PCAOB ID 1281) for the financial years ended December 31, 2021 and 2020.&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</span></span></div></div></div><div style="line-height:1.25">&#160;</div></div><table border="0" cellpadding="2" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"><tr><td style="width:33.13%;vertical-align:top;background-color:rgb(166, 166, 166);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)">&#160;</td><td style="width:33.43%;vertical-align:top;background-color:rgb(166, 166, 166);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December 31, 2021</span><sup style="vertical-align:text-top;line-height:1;font-size:smaller">(1)</sup></span></span></div></td><td style="width:33.43%;vertical-align:top;background-color:rgb(166, 166, 166);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December 31, 2020</span><sup style="vertical-align:text-top;line-height:1;font-size:smaller">(1)</sup></span></span></div></td></tr><tr><td style="width:33.13%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Audit fees<sup style="vertical-align:text-top;line-height:1;font-size:smaller">(2)</sup></span></span></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$894,039</span></span></div></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$239,308</span></span></div></td></tr><tr><td style="width:33.13%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Audit-related fees<sup style="vertical-align:text-top;line-height:1;font-size:smaller">(3)</sup></span></span></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div></td></tr><tr><td style="width:33.13%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax fees<sup style="vertical-align:text-top;line-height:1;font-size:smaller">(4)</sup></span></span></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$17,298</span></span></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$4,074</span></span></div></td></tr><tr><td style="width:33.13%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">All other fees<sup style="vertical-align:text-top;line-height:1;font-size:smaller">(5)</sup></span></span></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div></td></tr><tr><td style="width:33.13%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total fees</span></span></div></td><td style="width:33.43%;vertical-align:top;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$911,337</span></span></div></div></td><td style="width:33.43%;vertical-align:top;border-width:1px;border-style:solid;border-color:rgb(0, 0, 0)"><div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$243,382</span></span></div></td></tr></table><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Notes</span>:</span></span></div><div style="line-height:1.25">&#160;</div><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:36pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts are stated in USD.</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:36pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Audit fees consist of the aggregate fees billed for the audit or review of the Company&#8217;s annual financial statements that are normally provided in connection with statutory and regulatory filings or engagements.</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:36pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3)</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Audit-related fees consist of the aggregate fees billed for assurance and related services that are reasonably related to the performance of the audit or review of the Company&#8217;s financial statements and are not reported as audit fees.</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:36pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For tax compliance, tax advice and tax planning.</span></span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:36pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5)</span></span></td><td style="width:auto;vertical-align:top;text-align:justify"><div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For products and services other than the audit fees, audit-related fees and tax fees described above.</span></span></div></td></tr></table><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CODE OF ETHICS</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has adopted a Code of Business Conduct and Ethics that applies to directors, officers and employees of, and consultants to, the Company (the &#8220;<span style="font-weight:bold">Code</span>&#8221;). The Code is posted on the Company&#8217;s website at www.imcannabis.com.&#160;The Code meets the requirements for a &#8220;code of ethics&#8221; within the meaning of that term in General Instruction 9(b) of Form&#160;40-F.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">All waivers of the Code with respect to any of the employees, officers or directors covered by it will be promptly disclosed as required by applicable securities rules and regulations. During the fiscal year ended December 31, 2021, the Company did not waive or implicitly waive any provision of the Code with respect to any of the Company's principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.</span></span></div></div><div style="text-align:justify;line-height:1.25">&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTICES PURSUANT TO REGULATION BTR</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">There were no notices required by Rule 104 of Regulation BTR that the Company sent during the year ended December 31, 2021 concerning any equity security subject to a blackout period under Rule 101 of Regulation BTR.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MINE SAFETY DISCLOSURE</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Not Applicable.</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></span></div><div style="line-height:1.25">&#160;</div></div><div style="line-height:1.25"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Not applicable.</span></span></div><div style="line-height:1.25">&#160;</div></div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NASDAQ STATEMENT OF GOVERNANCE DIFFERENCES</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is a &#8220;foreign private issuer&#8221; as defined in Rule 3b-4 under Exchange Act and its Common Shares are listed on The NASDAQ Stock Market LLC (&#8220;<span style="font-weight:bold">NASDAQ</span>&#8221;) and the&#160;CSE. Rule 5615(a)(3) of NASDAQ Stock Market Rules permits foreign private issuers to follow home country practices in lieu of certain provisions of NASDAQ Stock Market Rules. A foreign private issuer that follows home country practices in lieu of certain provisions of NASDAQ Stock Market Rules must disclose ways in which its corporate governance practices differ from those followed by domestic companies either on its website or in the annual report that it distributes to shareholders in the United States. A description of the ways in which the Company&#8217;s governance practices differ from those followed by domestic companies pursuant to NASDAQ standards are as follows:</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Independent Nominating Committee</span>: NASDAQ Stock Market Rule 5605(e)(1) (&#8220;<span style="font-weight:bold">Rule 5605(e)(1)</span>&#8221;) requires having a Nominations Committee comprised solely of independent directors. In lieu of following Rule 5605(e)(1), has elected to follow Canadian practices consistent with the requirements of the CSE.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Shareholder Meeting Quorum Requirement</span>: NASDAQ Stock Market Rule 5620(c) (&#8220;<span style="font-weight:bold">Rule 5620(c)</span>&#8221;) requires that the minimum quorum requirement for a meeting of shareholders be 33&#160;1/3&#160;% of the outstanding common shares. In addition, Rule&#160;5620(c) requires that an issuer listed on NASDAQ state its quorum requirement in its by-laws.&#160; In lieu of following Rule 5620(c), has elected to follow Canadian practices consistent with the requirements of the CSE.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Shareholder Approval Requirements</span>: NASDAQ Stock Market Rule 5635(d) (&#8220;<span style="font-weight:bold">Rule 5635(d)</span>&#8221;) requires shareholder approval prior to a transaction involving the sale or issuance of a company&#8217;s common stock (or securities convertible into or exercisable for its common stock): (i) at a price below the greater of book value or market value; and (ii) which together with sales by officers, directors, or substantial stockholders, is equal to 20% or more of the company&#8217;s outstanding shares of common stock or 20% or more of the voting power prior to issuance.&#160; In lieu of following Rule 5620(c), has elected to follow Canadian practices consistent with the requirements of the CSE.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">UNDERTAKING</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company undertakes to make available, in person or by telephone, representatives to respond to inquiries made by SEC staff, and to furnish promptly, when requested to do so by SEC staff, information relating to: the securities registered pursuant to Form 40-F; the securities in relation to which the obligation to file an annual report on Form 40-F arises; or transactions in said securities.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSENT TO SERVICE OF PROCESS</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has previously filed with the SEC a written consent to service of process on Form F-X. Any change to the name or address of the Company&#8217;s agent for service shall be communicated promptly to the SEC by amendment to the Form F-X referencing the file number of the Company.</span></span><br />&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SIGNATURES</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this annual report to be signed on its behalf by the undersigned, thereto duly authorized.</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DATED this 31 day of March, 2022.</span></span></div></div><div style="line-height:1.25">&#160;</div><table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:100%"><tr><td style="width:56%;vertical-align:top">&#160;</td><td colspan="2" style="width:97.72%;vertical-align:top"><div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div></td><td style="width:2.28%;vertical-align:top">&#160;</td></tr><tr><td style="width:56%;vertical-align:top">&#160;</td><td style="width:20px;vertical-align:top"><div style="line-height:1.25">&#160;</div></td><td style="width:399px;vertical-align:top"><div style="text-align:right;line-height:1.25">&#160;</div></td><td style="width:2.28%;vertical-align:top">&#160;</td></tr><tr><td style="width:56%;vertical-align:top">&#160;</td><td style="width:20px;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">By:</span></span></div></td><td style="width:399px;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">/s/ Oren Shuster</span></span></div></td><td style="width:2.28%;vertical-align:top">&#160;</td></tr><tr><td style="width:56%;vertical-align:top">&#160;</td><td style="width:20px;vertical-align:top">&#160;</td><td style="width:399px;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name: Oren Shuster</span></span></div></td><td style="width:2.28%;vertical-align:top"><div style="text-align:right;line-height:1.25">&#160;</div></td></tr><tr><td style="width:56%;vertical-align:top">&#160;</td><td style="width:20px;vertical-align:top">&#160;</td><td style="width:399px;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Title:&#160; Chief Executive Officer and Director</span></span></div></td><td style="width:2.28%;vertical-align:top">&#160;</td></tr></table><div style="line-height:1.25;font-family:'Times New Roman',Times,serif;clear:both">&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div><div style="line-height:1.25">&#160;</div></div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EXHIBIT INDEX</span></span></div><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following documents are being filed with the SEC as Exhibits to this Form 40-F:&#160;</span></span></div><div style="line-height:1.25">&#160;</div><table border="0" cellpadding="2" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:11.92%;vertical-align:top"><div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exhibit Number</span></span></span></div></td><td style="width:88.08%;vertical-align:top"><div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Description</span></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-1.htm">99.1</a></span></span></div></td><td style="width:88.08%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-1.htm">Annual Information Form dated March 31, 2022 for the financial year ended December 31, 2021</a></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-2.htm">99.2</a></span></span></div></td><td style="width:88.08%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-2.htm">Audited Consolidated Financial Statements for the year ended December 31, 2021</a></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-3.htm">99.3</a></span></span></div></td><td style="width:88.08%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-3.htm">Management&#8217;s Discussion and Analysis for the year and three months ended December 31, 2021</a></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-4.htm">99.4</a></span></span></div></td><td style="width:88.08%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-4.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the U.S. Securities Exchange Act of 1934, as amended</a></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-5.htm">99.5</a></span></span></div></td><td style="width:88.08%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-5.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the U.S. Securities Exchange Act of 1934, as amended</a></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-6.htm">99.6</a></span></span></div></td><td style="width:88.08%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-6.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-7.htm">99.7</a></span></span></div></td><td style="width:88.08%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-7.htm">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-8.htm">99.8</a></span></span></div></td><td style="width:88.08%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-8.htm">Consent of Kost Forer Gabbay &#38; Kasierer, a member of Ernst &#38; Young Global</a></span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101</span></span></div></td><td style="width:88.08%;vertical-align:top"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interactive Data File (formatted as Inline XBRL)</span></span></div></td></tr><tr><td style="width:11.92%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">104</span></span></div></td><td style="width:88.08%;vertical-align:top;background-color:rgb(204, 238, 255)"><div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></span></div></td></tr></table><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" /></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;"><div style="font-size: 10pt;">
  <div>
    <div>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
    </div>
    <br>
    <div style="line-height: 1.25">
      <div style="border: #000000 2px solid; padding: 5px; width: 99%;">
        <div>&#160;</div>
        <div>
          <div style="text-align: center; text-indent: -0.5pt; margin-right: 0.35pt; margin-left: 0.5pt; line-height: 1.25;"><img width="203" height="127" src="image00003.jpg"></div>
          <div style="text-align: center; text-indent: -0.5pt; margin-right: 0.35pt; margin-left: 0.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">IM CANNABIS CORP.</div>
          <div style="line-height: 1.25; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          <div style="text-align: center; text-indent: -0.5pt; margin-right: 0.35pt; margin-left: 0.5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">ANNUAL INFORMATION FORM</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: center; text-indent: -0.5pt; margin-right: 0.35pt; margin-left: 0.5pt; line-height: 1.25;">For the Financial Year Ended December 31, 2021</div>
          <div style="text-align: center; text-indent: -0.5pt; margin-right: 0.35pt; margin-left: 0.5pt; line-height: 1.25;"><br>
            <div style="text-indent: -0.5pt; margin-right: 0.35pt; margin-left: 0.5pt; line-height: 1.25;">March 31, 2022</div>
            <br>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%- % -%-->
    <div style="line-height: 1.25">&#160;</div>
    <div >
      <div style="text-align: center; margin-right: 5.75pt; margin-left: 5.75pt; line-height: 1.25; font-weight: bold;">TABLE OF CONTENTS</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Page</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="zeaced2fda291438d9f3e9631f2b4c904">

          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#MARKETANDINDUSTRYDATA">MARKET AND INDUSTRY DATA</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">7<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#MARKETANDINDUSTRYDATA">NOTE REGARDING THE COMPANY&#8217;S ACCOUNTING PRACTICES</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">7<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#MARKETANDINDUSTRYDATA">CURRENCY AND EXCHANGE RATES</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">7<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#GLOSSARYOFKEYTERMS">GLOSSARY OF KEY TERMS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">8<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#CORPORATESTRUCTURE">CORPORATE STRUCTURE</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">17</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#GENERALDEVELOPMENTOFTHEBU">GENERAL DEVELOPMENT OF THE BUSINESS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">19</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#DESCRIPTIONOFTHEBUSINESS">DESCRIPTION OF THE BUSINESS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#RISKFACTORS">RISK FACTORS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">50<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#DIVIDENDS">DIVIDENDS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">82</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#DESCRIPTIONOFTHEBUSINESS">DESCRIPTION OF CAPITAL STRUCTURE</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">82</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#MARKETFORSECURITIES">MARKET FOR SECURITIES</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">84</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#ESCROWEDSECURITIESANDSECU">ESCROWED SECURITIES AND SECURITIES SUBJECT TO&#160; CONTRACTUAL RESTRICTIONS ON TRANSFER</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">87</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#ESCROWEDSECURITIESANDSECU">DIRECTORS AND EXECUTIVE OFFICERS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">87</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#PROMOTERS">PROMOTERS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">89</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#PROMOTERS">LEGAL PROCEEDINGS AND REGULATORY ACTIONS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">89</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#INTERESTOFMANAGEMENTANDOT">INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">93</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#INTERESTOFMANAGEMENTANDOT">TRANSFER AGENTS AND REGISTRARS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">93</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#INTERESTOFMANAGEMENTANDOT">MATERIAL CONTRACTS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">93</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#INTERESTSOFEXPERTS">INTERESTS OF EXPERTS</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">94</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#INTERESTSOFEXPERTS">AUDIT COMMITTEE INFORMATION</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">94</div>
            </td>
          </tr>
          <tr>
            <td style="width: 90%; vertical-align: top;">
              <div style="margin-right: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a href="#ADDITIONALINFORMATION">ADDITIONAL INFORMATION</a></div>
            </td>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: right; line-height: 1.25; font-weight: bold;">97</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><a href="#SCHEDULEA">SCHEDULE &#8220;A&#8221; &#8211; AUDIT COMMITTEE CHARTER</a></div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 2 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div >
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ANNUAL INFORMATION FORM</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In this annual information form (&#8220;<font style="font-weight: bold;">Annual Information Form</font>&#8221; or &#8220;<font style="font-weight: bold;">AIF</font>&#8221;), unless otherwise noted or the context indicates
      otherwise, the &#8220;<font style="font-weight: bold;">Company</font>&#8221; &#8220;<font style="font-weight: bold;">IMCC</font>&#8221;, &#8220;<font style="font-weight: bold;">IM Cannabis</font>&#8221;, &#8220;<font style="font-weight: bold;">we</font>&#8221;, &#8220;<font style="font-weight: bold;">us</font>&#8221;
      and &#8220;<font style="font-weight: bold;">our</font>&#8221; refer to IM Cannabis Corp., together with its subsidiaries, on a consolidated basis, and the &#8220;<font style="font-weight: bold;">Group</font>&#8221; refers to the Company, its subsidiaries and Focus, an
      Israeli private company over which IMC Holdings exercises &#8220;de facto control&#8221; under IFRS 10. All dollar amounts referred to in this Annual Information Form are stated in Canadian dollars unless otherwise indicated. IMCC prepares its financial
      statements in accordance with IFRS as issued by the International Accounting Standards Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The information in this Annual Information Form is presented as at December 31, 2021 unless otherwise indicated. All references to the Company&#8217;s Common Shares and securities issuable into Common
      Shares such as Warrants, Options, Broker Compensation Options, and RSUs are reflected on a post-Consolidation (each capitalized term as defined below) basis unless otherwise indicated or the context requires otherwise.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">FORWARD-LOOKING STATEMENTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Certain statements in this Annual Information Form may contain &#8220;forward-looking information&#8221; and &#8220;forward-looking statements&#8221; within the meaning of applicable securities laws (collectively referred
      to herein as &#8220;forward-looking statements&#8221;). All statements other than statements of fact may be deemed to be forward-looking statements, including statements with regard to expected financial performance, strategy and business conditions. The words
      &#8220;believe&#8221;, &#8220;plan&#8221;, &#8220;intend&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;continue&#8221;, or &#8220;potential&#8221;, and similar expressions, as well as future or conditional verbs such as &#8220;will&#8221;, &#8220;should&#8221;, &#8220;would&#8221;, and &#8220;could&#8221; often identify forward-looking statements.
      These statements reflect management&#8217;s current beliefs with respect to future events and are based on information currently available to management as of the date of this Annual Information Form including reasonable assumptions, estimates, internal
      and external analysis and opinions of management considering its experience, perception of trends, current conditions and expected developments as well as other factors that management believes to be relevant as at the date such statements are made.
      Capitalized terms used in this section and not defined have the meanings ascribed to them in &#8220;<font style="font-style: italic;">Glossary of Key Terms</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25;">Without limitation, this Annual Information Form contains forward-looking statements pertaining to:</div>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf7654b55d23a4343b84fb78b1ff5f5ae">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the expected performance of the Group&#8217;s business and operations;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z514c0e7d40da437fac02cf38d5a57399">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the export of the Group&#8217;s cannabis products from Canada and import into Israel and Germany on a consistent basis or at all;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcec188aa4cb84d7f9fe4556c63c01c50">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the import into Israel and Germany of cannabis from supply partners in Canada and elsewhere on a consistent basis or at all;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcb93bcd8fc9f417bba1b9aac5b0d1f42">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the ability to satisfy rapid growth in demand for imported High-THC premium and super-premium medical cannabis in Israel and Germany;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9e8427294bca4dac94ba56a8a20c1511">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s expansion and development of its foreign operations and supply arrangements; expansion of cultivation capacity;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z71cb4d4a85184999a3d2ba0b2356a476">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s intentions regarding leveraging its German operational platform and further developing its presence in Europe;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8a2c76ebe15640a5963c5c6a4ebd827b">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>expectations regarding the Group&#8217;s revenues, expenses and profits;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf1529e7c3b624989913b768f18c22219">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>expectations in the growth of demand in the medical cannabis industry, including without limitation, in Israel and Germany;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5bac2de1e49543a29b1e1c18eebcaa60">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Company&#8217;s positioning as one of the largest distributors of medical cannabis in Israel after acquiring the Israeli Pharmacies and Rosen High Way, Panxia GDP License and Panaxia-to-the-Home Operation;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z63d45c007ecb4914ae1d4e8d12345574">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the competitive conditions of the medical and recreational cannabis industry, including ancillary industries such as medical cannabis operations consulting;</div>
            </td>
          </tr>

      </table>
      <div> <br>
        <br>
        <br>
      </div>
      <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 3 -</font></div>
        <div  style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4ca261a0b9dc4a208846bfc1f77231a3">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the anticipated legalization and/or decriminalization of adult-use recreational cannabis in Israel and Germany and the Group&#8217;s business intentions in the event such legalization and/or decriminalization occurs;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd0f40a81c0e54b13a885891a7fa2553e">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Company&#8217;s expectations relating to the Canadian Facilities;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2224cb9146f74ac887b6dacd826aeb43">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>TJAC&#8217;s anticipated regulatory approval to sell its products in the Province of Quebec;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5175c970a26646a6af33f5efe3b5e5ad">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s anticipated obligations to comply with environmental and employee health and safety matters;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z83006842404743f8b2012748211c7dee">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Company&#8217;s expectations relating to the Panxia Pharmacy Option;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2815e19439aa4ee980163acf91a0f11a">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s future product offerings and strategic plans of entering into new domestic and international markets;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z44555efe1cd94541b4894714b88e2619">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the effect of new or altered government regulations with respect to any cannabis related activity, including the marketing, acquisition, manufacture, management, transportation, storage, sale and disposal of cannabis and cannabis
                products;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z87dcf86b11dc46e4b61de4132f72233e">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the grant, maintenance or renewal of licenses or governmental approvals required to conduct activities related to cannabis;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z28a3183e444846b2beacbadde081a93a">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the designation of Focus as an &#8220;essential service&#8221; in Israel;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9496b314771b442c8ff4d0ab01169ba5">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the intentions of management of the Company;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6270eb0194934d8195bbc6f01c7a735e">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s expectations to meet target production capacity;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdc932898b8954b26a5381107f783d2f5">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the availability of raw materials and supplies at acceptable quantities, qualities and prices;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5657b2154cee4937a2955d864d0dbfff">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the scope of protection the Group is able to establish and maintain, if any, for intellectual property rights covering its products;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf788a2cf903b4d4f82852ab41e4c215f">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>future liquidity and financial capacity;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z56a78a5f0d124c618166e71058a3437e">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Company&#8217;s plan with respect to any payments of dividends;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2103e0b9850b4150bd479750223829fa">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the vertical integration of the Group&#8217;s business.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zba048c3d87cc4bd8812146eed6217d52">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the expansion of the Company&#8217;s business, operations and potential activities outside of the current markets, including but not limited to Europe and other international jurisdictions;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd03a02d813de4f8f918c8f8e06050b16">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s contractual obligations and commitments.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">With respect to the forward looking-statements contained in this Annual Information Form, the Company has made assumptions regarding, among other things:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5cbb29ab8eaf4715ad65d438c3dec82a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the anticipated increase in demand for High-THC premium and super-premium medical cannabis in the markets in which the Group operates or is contemplating operations;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9b1cd0f2be1942f59e2ec7bcd1a38b18">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the anticipated demand for adult-use recreational cannabis in Canada;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2d78460ae4764571b7bbf49ca2505ea1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the anticipated increase in liquidity for current investors and enhanced access for prospective investors in the Company&#8217;s Common Shares following its successful listing on NASDAQ;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze34ad674adb14068b051917b775ea208">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the legalization and/or decriminalization of adult-use recreational cannabis and the demand for adult-use recreational cannabis products in the markets in which the Group operates;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0302f735cf6745fdbc8acb7f94602dfc">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s ability to satisfy international demand for its products;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z948b051dbfef44848a27e1b99a1b4b25">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s ability to export from its Canadian Facilities and import into Israel and Germany;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb33764aece5e4a9eba00d01b33f16903">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>future cannabis product pricing;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5afacedeef8346c58e26f4f04fe05c36">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>cannabis production yields; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf3649887b4d74f8cb13951491a4fb3b0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s ability to market its brands and its services successfully to its anticipated patients and consumers.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 4 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Readers are cautioned that the above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very
      nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z01224144619046aaa88c8c8413ecdaa3">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s ability to continue to meet the continued listing requirements of the CSE and NASDAQ;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zba12b61a4c9a436ea5f75bf4420c69aa">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of the Group to comply with applicable regulatory requirements in a highly regulated industry;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd13dde788b114ec1b567b72c08e8c9e8">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of the Company to maintain &#8220;de facto&#8221; control over Focus in accordance with IFRS 10 and to consolidate its financial results;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc12c1b5eb9942b18f315982ad233a0d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of the each of Pharm Yarok, Rosen High Way, Vironna, Oranim and IMC Pharma to maintain in good standing or renew its government-issued cannabis licenses;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zef53c314ccd8400e9faa2b42ca2ce81d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of Focus to maintain in good standing or renew its government-issued cannabis cultivation license;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze99bdd927270488798c81bdd993dd1b7">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of TJAC to maintain in good standing or renew any of the TJAC Licenses or the MYM Licenses;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbb56eb875873470b84d13052804ba321">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of Adjupharm to maintain in good standing or renew any of its government-issued cannabis wholesale, narcotics handling or import/export licenses, permits, certificates or approvals;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z46c8aa4dcf2a45a8ab4ce861bf15a2b1">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Focus&#8217; reliance on the Focus Facility to conduct medical cannabis activities;</div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79cbb5bc5d0c4d59b930f2b6d490ada2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of Focus to maintain the Focus Facility in good standing with all state and municipal Israeli regulations, including all required licenses and permits&#160;and under the Focus Lease Agreement;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7c22b6ac04f541e18bf8b4cab5fcbbe7">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>failure to maintain in good standing any of the Israeli Facilities, the Canadian Facilities and the Logistics Centre;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z26f0d42703a940d1a4c5c7f0d58a27ae">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>compliance with the Cannabis Act, and provincial and territorial cannabis legislation =;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z95f410160000421cbfea0ad7c97047ce">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>reliance on the Canadian Facilities to conduct cannabis activities;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za90b88d7d6c94a98bc5d8600ff752135">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to maintain ancillary business licenses, permits and approvals required to operate effectively;</div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z023a053e814d4b07811b512b114894a5">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>regulatory authorities in Israel viewing the Company as the deemed owner of more than 5% of Focus in contravention of Israeli regulations;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z69660bd55ab4456e9676540190962fbf">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>limitations on stockholdings of the Company in connection with its potential direct engagement in the Israeli medical cannabis market;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1e496768f1154c8c959acac933b1ab22">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>unexpected changes in governmental policies and regulations affecting the production, distribution, manufacture import/export or use of cannabis in Canada, Israel and Germany, or any foreign jurisdictions in which the Company intends to
              operate;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zebc88529c4a34683ac0ee27dd7e380d3">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of the Company to attain the necessary regulatory approvals required for the successful acquisition of HW Shinua and the successful exercise of the Panaxia Pharmacy Option in a timely manner or at all;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd13523bf5f9d4fb698e22df09425c476">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group, including but not limited to the
                Construction Allegations, the MOH Allegations (each as defined herein) and the class action proceedings described herein;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbfa9bfaa49e540b18436fcd0a9078907">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the ability of the Group&#8217;s third-party cultivators, suppliers, distribution partners, and contracted pharmacies to fulfil their obligations to the Group;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6b8a105199b94e69b3f6a4b7a2538ecd">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to maintain partnerships with third-party cultivators, suppliers and distribution partners;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc7d6e4f7cd9a41978065abdc7708e9c5">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to secure new supply and distribution partners;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd7154a33e76a4e079f2bd5095e312164">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to fulfil obligations to third-party distribution partners;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8b90539719fe40e5a3403e073c799873">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to obtain or maintain sufficient insurance for its operations;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z88454d09cb8b44c2a156ad57cc1c5d92">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s possible exposure to additional liability for claims in excess of insurance coverage;</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 5 -</font></div>
        <div  style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd55b98e64d414bcc9719277b158ee9bb">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to implement effective product security and storage measures;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b68bac675614a2cae054c200db1db20">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to conduct sales and marketing activities for its products;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2aa1b6d46aad4719b150da2be804f780">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to retain and attract key personnel and members of management;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f2946556e1a4bf0a04baa0c6e4f86e1">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to develop or facilitate introduction of new product offerings to the market;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0135efa2b75546c1b7a0ead9a9ad900a">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s possible exposure to liability relating to product recalls;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2bba3238737343fabd34f8f61b86fa68">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Company&#8217;s ability to raise additional funds;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z895239ea267f4888adfadc4cb5fa9305">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Company&#8217;s ability to manage cash flows;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaa9731424a25407080b94f233e62c65b">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>inflation risks.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeb09d37984da4a43b742d6284822dcd2">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>anti-money laundering laws and regulation risks;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z28c9482a3f58445cb6df464c8a85c7ed">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Group&#8217;s ability to cope with the operational impacts of the COVID-19 pandemic;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z68eb77962239445eb6cda6e8cd0fb2fb">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the impact on the Group of any changes in global financial conditions, including those caused by geopolitical instability, catastrophic events, natural disasters, weather and disease;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdbb17a515f2c48169d8c231ec6d489ee">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Focus, TJAC and MYM&#8217;s ability to grow agricultural products effectively in light of natural elements;</div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z81bd322e07a842d0b181876eca7b9d85">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the impact of increasing competition;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5cf301c3083d4b4f84f848fdac8ba2dd">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>inconsistent public opinion and perception regarding the use of cannabis;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z15756206102d4628912d6c70ade05e38">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>perceived effects of cannabis products;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zac7b986679884ca8b1607b2dcfbb1c22">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any change in the political environment which would negatively affect the decriminalization and/or legalization of adult-use recreational cannabis in Israel and Germany;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z98b8d1032eca4fe0a70e2f4d5a375f4e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>engaging in activities considered illegal under relevant laws including U.S. federal law;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z73f102bcd8294ceda67bcce700ef7bc5">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>political instability and conflict in the Middle East;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab30840b2a684f61bc6af67188218141">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>the conflict between Russia and Ukraine and any restrictive actions that have been and may further be taken by the U.S. and/or other countries in response thereto, including but not limited sanctions, export controls or conflict;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3bd17b05c49943b1a3700939bcf14cc4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>adverse market conditions;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0cdb2ed9b224497581abd00b0a6f515a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>competition from the illegal cannabis market;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1d3a72fc5fe0420b99099d509632d3f9">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>industry consolidation;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z57f697336e6f4bf7b7f66297fd28063b">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the inherent uncertainty of production and cost estimates and the potential for unexpected costs and expenses;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z94ac2d666d414590ae596fcd9573a8dd">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the potential for the Company to record future impairment losses;</div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf2201895c2e743f3b3e98faaead5d518">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>currency and interest rate fluctuations;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za1be64080fbb413d9d713c9c93c2d24a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>global and local economic conditions;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f39b8bd4a5e4ba9ad6aaa15722d7bbd">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the costs of inputs; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5b246e9622d44e7dbc3b0c06ede2edc6">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>reliance on management.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The foregoing list of risk factors is not exhaustive. Additional information on these and other factors that could affect the business, operations or financial results of the Company are detailed
      under the heading &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; of this Annual Information Form. Unless otherwise indicated, forward-looking statements in this Annual Information Form describe our expectations as of the date of this Annual
      Information Form. The Company and management caution readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. Although the Company believes that the expectations reflected in the forward-looking
      statements are reasonable, it can give no assurance that such expectations will prove to have been correct. The Company and management assume no obligation to update or revise them to reflect new events or circumstances except as required by
      applicable securities laws.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 6 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="MARKETANDINDUSTRYDATA"><!--Anchor--></a>MARKET AND INDUSTRY DATA</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">This Annual Information Form contains market and industry data and forecasts obtained from third-party sources, industry publications and publicly available information. The Company believes that the
      industry data is accurate and that its estimates and assumptions are reasonable, but there is no assurance as to the accuracy or completeness of this data. Third-party sources generally state that the information contained therein has been obtained
      from sources believed to be reliable, but there can be no assurance as to the accuracy or completeness of included information. Although management believes it to be reliable, the Company has not independently verified any of the data from
      third-party sources referred to in this Annual Information Form, or analyzed or verified the underlying information relied upon or referred to by such sources, or ascertained the underlying economic assumptions relied upon by such sources.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;">NOTE REGARDING THE COMPANY&#8217;S ACCOUNTING PRACTICES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company complies with IFRS 10, which applies a single consolidation model using a definition of &#8220;control&#8221; that requires an investor (as defined in IFRS 10) to consolidate an investee (as defined
      in IFRS 10) where: (i) the investor has power over the investee; (ii) the investor has exposure or rights to variable returns from involvement with the investee; and (iii) the investor can use its power over the investee to affect the amount of the
      investor&#8217;s returns.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Subsequent to the IMC Restructuring, the Company analyzed the terms of the contractual agreements with Focus (including the Commercial Agreements and the Focus Agreement) in accordance with IFRS 10
      and concluded that it is required to continue to consolidate the financial results of Focus in its financial statements. For additional information, please see &#8220;<font style="font-style: italic;">Risk Factors &#8211; Consolidation of Focus Financial Results
        under IFRS 10 and Maintenance of Common Control</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">For the period ended December 31, 2021, the Company analyzed the terms of the definitive agreements with each of Pharm Yarok, Rosen High Way, HW Shinua, Vironna and Oranim Plus (collectively, the &#8220;<font style="font-weight: bold;">Consolidated Entities</font>&#8221;) in accordance with IFRS 10 and concluded a requirement to consolidate the financial results of the Consolidated Entities as of the date of signing each such definitive agreement. Each of the
      definitive agreements for the Pharm Yarok Transaction, the Vironna Transaction and the Oranim Transaction provide the Company with the power to unilaterally make all decisions regarding the financial and operating policies of each of the Consolidated
      Entities and the right to obtain all related economic benefits. The Pharm Yarok Transaction, the Vironna Transaction and the Oranim Transaction were completed in the first quarter of 2022. The completion of the Pharm Yarok Transaction with respect to
      HW Shinua is still pending IMCA approval, therefore the Company continues to consolidate the financial results of HW Shinua in accordance with IFRS 10. For further information on the closing the transactions, please see<font style="font-style: italic;"> &#8220;General Development of Business &#8211; Developments During the Financial Year Ended December 31, 2021&#8221;</font>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;">CURRENCY AND EXCHANGE RATES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">References in this AIF to &#8220;<font style="font-weight: bold;">CAD</font>&#8221;, &#8220;<font style="font-weight: bold;">$</font>&#8221;, dollars or currency are to the lawful currency of Canada, unless otherwise
      indicated. In addition, this AIF includes references to (i) &#8220;<font style="font-weight: bold;">NIS</font>&#8221;<font style="font-weight: bold;">&#160;</font>which<font style="font-weight: bold;">&#160;</font>means the New Israeli Shekel, the lawful currency of the
      State of Israel. As of March 30, 2022, the value of one Canadian dollar expressed in NIS, based on the exchange rate available through the Bank of Israel, is NIS 2.5545, and (ii) &#8220;<font style="font-weight: bold;">USD</font>&#8221; or &#8220;<font style="font-weight: bold;">US$</font>&#8221; which means the United States Dollar, the lawful currency of the United States of America. As of March 25, 2022, the value of one Canadian dollar expressed in USD, based on the exchange rate available through
      the U.S. Federal Reserve, is US$0.799; (iii) &#8220;<font style="font-weight: bold;">EUR</font>&#8221; which means the Euro, the lawful currency of the European Union. As of March 30, 2022, the value of one Canadian dollar expressed in EUR, based on the exchange
      rate available through the European Central Bank, is EUR 0.7199.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 7 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="GLOSSARYOFKEYTERMS"><!--Anchor--></a>GLOSSARY OF KEY TERMS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">Unless otherwise indicated, the following terms used in this Annual Information Form shall have the meanings ascribed to them as set forth below:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">1961 Single Convention on Narcotic Drugs</font>&#8221; means the <font style="font-style: italic;">Single Convention on Narcotic Drugs, 1961</font>,
      an international treaty regarding the international control of narcotic drugs;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">2019 Broker Compensation Options</font>&#8221; means the 1,199,326 Common Share purchase warrants issued to certain agents who acted on the Company&#8217;s
      behalf in connection with the Reverse Takeover Transaction. Each four 2019 Broker Compensation Options are exercisable on an adjusted basis to acquire one unit consisting of one post-Consolidation Common Share and two pre-Consolidation 2019 Unlisted
      Warrants at an adjusted exercise price of $4.20 until August 30, 2022;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">2019</font>&#160;<font style="font-weight: bold;">Listed Warrants</font>&#8221; means the 9,730,258 Common Share purchase warrants issued in connection
      with the Reverse Takeover Transaction, with each four 2019 Listed Warrants being exercisable on an adjusted basis for one post-Consolidation Common Share at an exercise price of $5.20. The 2019 Listed Warrants were listed for trading on the CSE under
      the symbol &#8220;IMCC.WT&#8221; and expired on October 11, 2021;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">2019 Unlisted Warrants</font>&#8221; means the Common Share purchase warrants underlying the 2019 Broker Compensation Options upon exercise, with each
      four 2019 Unlisted Warrants being exercisable on an adjusted basis to acquire one post-Consolidation Common Share at an exercise price of $5.20 until August 30, 2022;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">2021 Broker Compensation Options</font>&#8221; means the 182,608 Common Share purchase warrants issued to certain agents who acted on the Company&#8217;s
      behalf in connection with the 2021 Offering. Each 2021 Broker Compensation Option is exercisable for one Common Share at an exercise price of US$6.61 until November 5, 2024.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">2021 Offered Shares</font>&#8221; means the 6,086,956 Common Shares issued in connection with the 2021 Offering at a price of US$5.75 per 2021 Offered
      Share;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">2021 Offered Warrants</font>&#8221; means the 3,043,478 Common Share purchase warrants issued in connection with the 2021 Offering, with each 2021
      Offered Warrant being exercisable to acquire one Common Share at an exercise price of US$7.20 until May 7, 2026;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">2021 Offering</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following
        the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">2021 Stock Option Plan</font>&#8221; means the &#8220;rolling&#8221; stock option plan approved by shareholders of the Company on July 28, 2021;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">ACMPR</font>&#8221;&#160;means <font style="font-style: italic;">Access to Cannabis for Medical Purposes Regulations</font>;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Adjupharm</font>&#8221; means Adjupharm GmbH, a company incorporated under the laws of Germany and a subsidiary of IMC Holdings;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 8 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Adjupharm Licenses</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Description of the Business &#8211; Production, Distribution
        and Sales in Principal Markets &#8211; Europe</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">AMG</font>&#8221; means <font style="font-style: italic;">German Medicines Act</font>;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">BCBCA</font>&#8221; means the <font style="font-style: italic;">Business Corporations Act</font> (British Columbia), as amended, including all
      regulations promulgated thereunder;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">BfArM</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and Germany &#8211;
        Germany &#8211; Cultivation in Germany and Distribution of Medical Cannabis Cultivated in Germany</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Board</font>&#8221; means the board of directors of the Company as presently constituted;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Broker Compensation Options</font>&#8221; means, collectively, the 2019 Broker Compensation Options and the 2021 Broker Compensation Options of the Company;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">BtMG</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and Germany &#8211; Germany</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">CAD</font>&#8221; means Canadian Dollars;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Canadian Facilities</font>&#8221; means, collectively, the TJAC Facilities and the MYM Facilities;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Canadian Licenses</font>&#8221; means, collectively, the TJAC Licenses and the MYM Licenses;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Cannabis Act</font>&#8221; means the <font style="font-style: italic;">Cannabis Act </font>(Canada), as amended, and the Cannabis Regulations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Cannabis Agency</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and Germany &#8211; Germany &#8211;
        Cultivation in Germany and Distribution of Medical Cannabis Cultivated in Germany</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Cannabis Regulations</font>&#8221; means the <font style="font-style: italic;">Cannabis Regulations</font> (Canada) made under the Cannabis Act;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">CBD</font>&#8221; means cannabidiol;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">cbdMD</font>&#8221; means cbdMD, Inc.;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">CBN</font>&#8221; means cannabinol;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">CEO</font>&#8221; means chief executive officer;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">CFO</font>&#8221; means chief financial officer;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Commercial Agreements&#8221; </font>has the meaning set out in &#8220;<font style="font-style: italic;">Corporate Structure &#8211; Intercorporate Relationships</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Common Shares</font>&#8221; means at any particular time the issued and outstanding common shares in the capital of the Company at that time;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Company</font>&#8221; means IM Cannabis Corp., a corporation continued under the BCBCA with its registered office located in Vancouver, British
      Columbia;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 9 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Consolidation</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211;</font>&#160;<font style="font-style: italic;">Developments Following the Reverse Takeover Transaction &#8211;</font>&#160;<font style="font-style: italic;">Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Consolidated Entities</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Note Regarding the Company&#8217;s Accounting Practices</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Construction Allegations</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Risk Factors &#8211; Reliance on Focus Facility</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">COVID-19</font>&#8221; means the COVID-19 novel coronavirus;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">CSA Staff Notice 51-352</font>&#8221; means Staff Notice 51-352 (Revised) &#8211; <font style="font-style: italic;">Issuers with U.S. Marijuana-related
        Activities</font> of the Canadian Securities Administrators.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">CSE</font>&#8221; means the Canadian Securities Exchange;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Dangerous Drugs Ordinance</font>&#8221; or &#8220;<font style="font-weight: bold;">DDO</font>&#8221; means the Dangerous Drugs Ordinance [New Version], 1973 [Hebrew];</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Directive 150</font>&#8221; means Directive 150/2016 &#8211; IMC-GSP certification, the IMCA directive that sets the standards for the security and
      protection measures that must be taken throughout the entire supply chain of medical cannabis;<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Directive 151</font>&#8221; means Directive 151/2016 &#8211; IMC-GAP certification, the IMCA directive that sets the norms and standards for growing medical
      cannabis in Israel;<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Directive 152</font>&#8221; means Directive 152/2016 &#8211; IMC-GMP certification, the IMCA directive that provides the IMC-GMP rules and standards for the
      creation and production of medical cannabis goods in Israel;<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Directive 153</font>&#8221; means Directive 153/20163 &#8211; IMC-GDP certification, the IMCA directive that sets the conditions for the proper storage and
      delivery of medical cannabis products in Israel;<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#160;&#8220;<font style="font-weight: bold;">EU</font>&#8221; means the European Union;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">EU-GACP Standard</font>&#8221; means the good agricultural and collection practice standard set out by the European Union and coordinated by the
      European Medicines Agency for companies that cultivate, harvest and collect cannabis to manufacture, process, package and store;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">EU-GMP Standard</font>&#8221; or &#8220;<font style="font-weight: bold;">EU-GMP</font>&#8221; means the good manufacturing practice standard set out by the
      European Union and coordinated by the European Medicines Agency for manufacturers of medical products intended for the European Union market;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">EUR</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Currency and Exchange Rates</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Export Guidelines</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and
        Germany &#8211; Israel &#8211; Medical Cannabis Exports</font>&#8221;;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
    </div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> Directive</div>
      <div style="line-height: 1.25;">150 [Hebrew] - <u>https://www.health.gov.il/hozer/mmk150_2016.pdf</u></div>
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> Directive 151 [Hebrew] - <u>https://www.health.gov.il/hozer/mmk151_2016.pdf</u></div>
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup> Directive 152 [Hebrew] - <u>https://www.health.gov.il/hozer/mmk152_2016.pdf</u></div>
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup> Directive 153 [Hebrew] - <u>https://www.health.gov.il/hozer/mmk153_2016.pdf</u></div>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 10 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Export Resolution</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and
        Germany &#8211; Israel &#8211; Medical Cannabis Exports</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Final Shelf Prospectus</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Focus</font>&#8221; means Focus Medical Herbs Ltd., a limited liability company existing under the laws of the State of Israel;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Focus Agreement</font>&#8221; means the option agreement between IMC Holdings and Focus dated April 2, 2019 whereby IMC Holdings has an option to
      purchase, at its sole discretion, all of the issued and outstanding ordinary shares of Focus at a price equal to NIS 765.67 per ordinary share for total consideration of NIS 2,756,500 for a period of 10 years following the date of the IMC
      Restructuring;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Focus Facility</font>&#8221; means the cultivation facility in Moshav Sde Avraham, Israel, operated by Focus pursuant to the Focus Lease Agreement;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Focus Lease Agreement</font>&#8221; means the long-term land lease agreements between Focus and the landowners on which the Focus Facility is built
      and operated;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Focus License</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Description of the Business &#8211; Production, Distribution and
        Sales in Principal Markets &#8211; Israel</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#160;&#8220;<font style="font-weight: bold;">GDPR</font>&#8221; means the General Data Protection Regulation<font style="font-style: italic;">&#160;</font>(EU) 2016/679;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">German Local Tender</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and
        Germany &#8211; Germany &#8211; Cultivation in Germany and Distribution of Medical Cannabis Cultivated in Germany</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Group</font>&#8221; means, collectively, the Company, its subsidiaries, and Focus, an Israeli private company over which IMC Holdings exercises &#8220;de
      facto control&#8221; under IFRS 10;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Highland Facility</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">HW Shinua</font>&#8221; means High Way Shinua Ltd.;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IFRS</font>&#8221; means International Financial Reporting Standards as issued by the International Accounting Standards Board applicable as at the
      relevant date;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IFRS 10</font>&#8221; means IFRS 10 <font style="font-style: italic;">Consolidated Financial Statements</font>, the reporting standard under IFRS
      outlining the requirements for the preparation and presentation of consolidated financial statements when an entity controls one or more other entities;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMC-GAP</font>&#8221; or &#8220;<font style="font-weight: bold;">GAP Standard</font>&#8221; means the good agricultural practices standard set out by the IMCA in
      Directive 151, and is required for Israeli cultivation licenses;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMC-GDP</font>&#8221; or &#8220;<font style="font-weight: bold;">GDP Standard</font>&#8221; means the good manufacturing practices standard set out by the IMCA in
      Directive 153, and is required for Israeli transportation, storage and distribution licenses;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 11 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMC-GMP</font>&#8221; or &#8220;<font style="font-weight: bold;">GMP Standard</font>&#8221; means the good manufacturing practices standard set out by the IMCA in
      Directive 152, and is required for Israeli manufacturing licenses;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMC-GSP</font>&#8221; or &#8220;<font style="font-weight: bold;">GSP Standard</font>&#8221; means the good security practices standard set out by the IMCA in
      Directive 150, and is required throughout the Israeli supply chain for cannabis-related activities;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMC Holdings</font>&#8221; means I.M.C. Holdings Ltd., a limited liability company existing under the laws of the State of Israel and a wholly-owned
      subsidiary of the Company;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMC Netherlands Holdco</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2020</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMC Pharma</font>&#8221; means I.M.C. Pharma Ltd., a limited liability company existing under the laws of the State of Israel and a wholly-owned
      subsidiary of IMC Holdings;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMC Restructuring</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Corporate Structure &#8211; Intercorporate Relationships</font>&#8221;;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IMCA</font>&#8221; means the Israeli Medical Cannabis Agency, an agency operated by the MOH;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IP Agreement</font>&#8221; means the License Agreement dated as of April 2, 2019 and as amended on January 1, 2021, by and between IMC Holdings and Focus, which provides,
      as further specified herein, Focus&#8217; obligation to exclusively use IMC Holdings&#8217; intellectual property, as further discussed in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse Takeover
        Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Israeli Facilities</font>&#8221; means, collectively, the facilities of the Israeli Pharmacies, and the facilities of Rosen High Way and IMC Pharma;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Israeli Licenses</font>&#8221; means, collectively, the licenses held by the Israeli Pharmacies, the license held by Rosen High Way, the Panaxia GDP
      License held by IMC Pharma and the Focus License;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Israeli Pharmacies</font>&#8221; means collectively, Pharm Yarok, Vironna and Oranim Pharm;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">IT systems</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Risk Factors &#8211; Information Technology</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">kg</font>&#8221; means a kilogram;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Licensed Producer</font>&#8221; has the meaning set out under the Cannabis Act;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Logistics Centre</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments during
        the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">MOH</font>&#8221; means the Israeli Ministry of Health;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">MOH Allegations</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Risk Factors &#8211; Reliance on Focus Facility</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">MOH Regulations</font>&#8221; means the Dangerous Drugs Ordinance, any amendments of the Dangerous Drugs Ordinance, any regulations enacted by virtue
      of the Dangerous Drugs Ordinance from time to time, and the regulatory regime introduced by the MOH with respect to the medical cannabis industry in Israel, including the Road Map, Procedure 106, Procedure 109, the Export Resolution and the Export
      Guidelines;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 12 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">MYM</font>&#8221; means MYM Nutraceuticals Inc., a company incorporated under the laws of the Province of British Columbia and a wholly-owned
      subsidiary of Trichome;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">MYM Facilities</font>&#8220; means, collectively, the Highland Facility and the Sublime Facility;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">MYM Licenses</font>&#8221; means the Standard Processing, Standard Cultivation and Sale for Medical Purposes licenses issued by Health Canada for the
      Highland Facility, and the Standard Cultivation license issued by Health Canada for the Sublime Facility;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">NASDAQ</font>&#8221; means the NASDAQ Capital Market;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">NGC</font>&#8221; means Northern Green Canada Inc.;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">NGC Supply Agreement&#8221;&#160;</font>has the meaning set out in <font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">NI 51-102</font>&#8221; means National Instrument 51-102 &#8211;&#160;<font style="font-style: italic;">Continuous Disclosure Obligations</font>;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">NI 52-110</font>&#8221; means National Instrument 52-110 &#8211; <font style="font-style: italic;">Audit Committees</font>;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">NIS</font>&#8221; means the New Israeli Shekel;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">NMCP</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and Germany &#8211; Israel</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">OBCA</font>&#8221; means the <font style="font-style: italic;">Business Corporations Act</font> (Ontario), as amended, including all regulations
      promulgated thereunder;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Option Cap</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Description of Capital Structure &#8211; Options</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Options</font>&#8221; means incentive stock options to purchase Common Shares granted to certain eligible participants of the Company in accordance
      with the terms of the 2021 Stock Option Plan and the Predecessor Option Plan;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Oranim Pharm</font>&#8221; means Oranim Pharm Partnership;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Oranim Plus</font>&#8221; means Oranim Plus Pharm Ltd., a limited liability company existing under the laws of the State of Israel and a subsidiary of
      IMC Holdings, holding 99.5% in Oranim Pharm;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Oranim Transaction</font>&#8221;&#160;has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Panaxia</font>&#8221; means, collectively, Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd., part of the Panaxia Labs Israel,
      Ltd. group of companies;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Panaxia GDP License</font>&#8221; means the trading house license acquired from Panaxia by IMC Pharma as part of the Panaxia Transaction and;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 13 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Panaxia Transaction</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual, partnership, unincorporated association, unincorporated syndicate, unincorporated organization, trust,
      trustee, executor, administrator or other legal representative;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Pharm Yarok</font>&#8221; means R.A. Yarok Pharm Ltd., a limited liability company existing under the laws of the State of Israel and a wholly-owned
      subsidiary of IMC Holdings;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Pharm Yarok Group</font>&#8221; means, collectively, Pharm Yarok, Rosen High Way and HW Shinua;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Pharm Yarok Transaction</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">PIPEDA</font>&#8221; means the <font style="font-style: italic;">Personal Information Protection and Electronic Documents Act </font>(Canada);</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Predecessor Stock Option Plan</font>&#8221; means the Company&#8217;s previous &#8220;rolling&#8221; stock option plan, as amended and restated on December 16, 2020,
      and replaced by the 2021 Stock Option Plan on July 28, 2021;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Preliminary Shelf Prospectus</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211;
        Developments Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Procedure 106</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and Germany
        &#8211; Israel &#8211; Patient Medical Use</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Procedure 109</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and Germany
        &#8211; Israel &#8211; Medical Cannabis Imports</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Qualified Securities</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Reverse Takeover Transaction</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; The
        Reverse Takeover Transaction</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Road Map</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Medical Cannabis Regulatory Framework in Israel and Germany &#8211;
        Israel &#8211; Licensing and Authorization for Commercial Activities in the Medical Cannabis Field</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Rosen High Way</font>&#8221; means Rosen High Way Ltd. a limited liability company existing under the laws of the State of Israel and a wholly-owned
      subsidiary of IMC Holdings;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RSU</font>&#8221; means a restricted share unit of the Company;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 14 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RSU Plan</font>&#8221; means the &#8220;rolling&#8221; restricted share unit plan approved by shareholders of the Company on December 16, 2020;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">SEC</font>&#8221; means the United States Securities and Exchange Commission;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Securities Commissions</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse
        Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Services Agreement</font>&#8221; means the services agreement dated as of April 2, 2019 and as amended on January 1, 2021, by and between IMC Holdings and Focus, requiring
      Focus to exclusively use IMC Holdings for the following services: (a) business development services, (b) marketing services, (c) strategic advisory services, (d) locating potential collaborations on a worldwide basis, and (e) financial analysis
      services, as further discussed in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Shiran</font>&#8221; means Shiran Single Member Societe Anonyme;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Sublime Lease</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Description of the Business</font> &#8211; <font style="font-style: italic;">Production,





        Distribution and Sales in Principal Markets &#8211; Canada&#8221;;</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Sublime Facility</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse
        Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;&#8220;<font style="font-weight: bold;">Subscription Receipts</font>&#8221; has the meaning set out in <font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse
        Takeover Transaction &#8211; The Reverse Takeover Transaction&#8221;</font>;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">THC</font>&#8221; means tetrahydrocannabinol;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">TJAC</font>&#8221; means Trichome JWC Acquisition Corp., a company incorporated under the laws of the Province of Ontario and a wholly-owned subsidiary of Trichome<font style="font-style: italic;">;</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">TJAC Facilities</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Production, Distribution and Sales in Principal Markets &#8211; Canada&#8221;;</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">TJAC Licenses</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Description of the Business &#8211; Production, Distribution and Sales in Principal
        Markets &#8211; Canada</font>&#8221;; &#8220;<font style="font-weight: bold;">TJAC Leases</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">Production, Distribution and Sales in Principal Markets &#8211; Canada&#8221;;</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Trichome</font>&#8221; means Trichome Financial Corp. a company incorporated under the laws of the Province of Ontario and a wholly-owned subsidiary of the Company;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Trichome Shares</font>&#8221; means all of the issued and outstanding shares of Trichome;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Trichome Transaction</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse
        Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;&#8220;<font style="font-weight: bold;">U.S.</font>&#8221; means the United States of America;</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 15 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">USD</font>&#8221; means United States Dollars;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Vironna</font>&#8221; means Revoly Trading and Marketing Ltd. dba Vironna Pharm a limited liability company existing under the laws of the State of
      Israel and a subsidiary of IMC Holdings;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Vironna Transaction</font>&#8221; has the meaning set out in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments
        Following the Reverse Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Warrants</font>&#8221; means collectively the 2019 Listed Warrants, the 2019 Unlisted Warrants and the 2021 Offered Warrants; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">Words importing the singular number only include the plural and vice versa, and words importing any gender include all genders.</div>
  </div>
  <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 16 -</font></div>
    <div  style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div style="text-align: center;"><br>
    <div style="text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="CORPORATESTRUCTURE"><!--Anchor--></a>CORPORATE STRUCTURE</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Name, Address and Incorporation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company was incorporated as &#8220;Nirvana Oil &amp; Gas Ltd.&#8221; pursuant to a Certificate of Incorporation issued under the BCBCA on March 7, 1980. Effective July 12, 2013, in connection with a share
      consolidation, the Company changed its name to &#8220;Navasota Resources Inc.&#8221;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On June 22, 2018, the Company completed a consolidation of its Common Shares on the basis of one (1) post-consolidation Common Share for every 5 pre-consolidation Common Shares.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On October 4, 2019, in connection with the Reverse Takeover Transaction, the Company effected a consolidation of its Common Shares on the basis of one (1) post-consolidation Common Share for every
      2.83 pre-consolidation Common Shares, changed its name to &#8220;IM Cannabis Corp.&#8221; and changed its business from mining to the international medical cannabis industry.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On February 12, 2021, in connection with its NASDAQ listing application, the Company effected the Consolidation on the basis of one (1) post-Consolidation Common Share for every four (4)
      pre-Consolidation Common Shares.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s head office is located at Kibbutz Glil Yam, Israel and its registered office is located at 550 Burrard Street, Suite 2300, Bentall 5, Vancouver, British Columbia, V6C 2B5, Canada. The
      Company is a reporting issuer under the laws of each of the provinces and territories of Canada.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Intercorporate Relationships</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The organizational chart of the Group, including the governing law or the jurisdiction of organization of the Company and each material subsidiary and the percentage of voting securities beneficially
      owned, or controlled or directed, directly or indirectly, by the Company, is set out below.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 17 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><img width="640" height="905" src="image1.jpg"></div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 18 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Notes:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5e8cc45f5dfb4edaa57eb8ccb7438460">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">(1)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Current Israeli law requires the prior approval by the IMCA of any shareholder owning 5% or more of an Israeli company licensed to engage in cannabis-related activities. For a number of reasons, including the opportunity to leverage a
              network of multiple Israeli licensed producers cultivating under the IMC brand, and in contemplation of a &#8220;go-public transaction&#8221; to geographically diversify the Company&#8217;s share ownership, IMC Holdings restructured its organization on April
              2, 2019 (the &#8220;<font style="font-weight: bold;">IMC Restructuring</font>&#8221;) resulting in the divestiture to Oren Shuster and Rafael Gabay of its interest in Focus, which is licensed by the IMCA to cultivate cannabis in Israel, while retaining
              an option with Messrs. Shuster and Gabay to re-acquire the sold interest in Focus under the Focus Agreement for consideration equal to the price paid by Messrs. Shuster and Gabay for the acquired interests at the time of the IMC
              Restructuring.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In addition, as part of the IMC Restructuring, IMC Holdings and Focus entered into the IP Agreement and the Services Agreement (collectively, the &#8220;<font style="font-weight: bold;">Commercial




        Agreements</font>&#8221;), which entitles the Company to a share of Focus&#8217; revenues from the sale by Focus of IMC-branded medical cannabis products. Although the Company does not hold any voting interests in Focus, the Company consolidates the financial
      results of Focus in its financial statements by virtue of its &#8220;de facto&#8221; control over Focus in accordance with IFRS 10. For more information on the Company&#8217;s corporate structure with respect to Focus and the Company&#8217;s accounting practices, please see
      &#8220;<font style="font-style: italic;">Note Regarding the Company&#8217;s Accounting Practices</font>&#8221;. For more information on the Commercial Agreements, please see &#8220;<font style="font-style: italic;">Description of the Business &#8211; Economic Dependence</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zadf0c9a690e84a37b4194a3eb66b262c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">(2)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>In March 2022, IMC Holdings received all requisite approvals, including the approval of the IMCA, to complete the acquisition of Pharm Yarok, Rosen High Way, Vironna and Oranim Pharm, each a licensed entity by the IMCA to carry on
              activities in the Israeli medical cannabis market. IMC Holdings is now a shareholder of licensed entities engaging in cannabis-related activities in Israel. The closing of HW Shinua is still pending the IMCA approval, and therefore its
              financial results continue to be consolidated according to IFRS 10. For more information on the acquisitions and closing of the Consolidated Entities, please see &#8220;<font style="font-style: italic;">General Development of the Business &#8211;
                Developments Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221; and &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse
                Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;. For more information on the Company&#8217;s corporate structure with respect to HW Shinua and the Company&#8217;s accounting practices, please see &#8220;<font style="font-style: italic;">Note Regarding the Company&#8217;s Accounting Practices</font>&#8221;.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za479d984aa114f8e9d9bdc88488b1b01">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">(3)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Highland Grow is 100% held by MYM through MYM International Brand Inc., a wholly owned subsidiary of MYM.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="GENERALDEVELOPMENTOFTHEBU"><!--Anchor--></a>GENERAL DEVELOPMENT OF THE BUSINESS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The following discussion covers key events during the Company&#8217;s historical development over the last three completed financial years, as well as certain subsequent events to the date of this Annual
      Information Form.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Introduction</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">IM Cannabis is a leading international cannabis company providing premium cannabis products to medical patients in Israel and Germany and adult-use recreational consumers in Canada.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;The Company&#8217;s Common Shares are listed on both the NASDAQ and the CSE under the ticker symbol &#8220;IMCC&#8221;. The Common Shares commenced trading on the NASDAQ as of March 1, 2021, and on the CSE as of
      November 5, 2019.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The business of the Company was formed following the Reverse Takeover Transaction, pursuant to which the Company changed its name from &#8220;Navasota Resources Inc.&#8221; to &#8220;IM Cannabis Corp.&#8221; and changed its
      business from mining to the international medical cannabis industry.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>The Reverse Takeover Transaction</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On October 11, 2019, the Company completed a business combination with IMC Holdings resulting in a reverse takeover of the Company by shareholders of IMC Holdings (the &#8220;<font style="font-weight: bold;">Reverse Takeover Transaction</font>&#8221;).<font style="font-weight: bold;">&#160;</font>The Reverse Takeover Transaction was effected by way of a &#8220;triangular merger&#8221; between the Company, IMC Holdings and a wholly-owned subsidiary of the Company
      pursuant to Israeli statutory law. The Board and management of the Company were reconstituted and subsequently led by Oren Shuster.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 19 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the Reverse Takeover Transaction, the Company completed a private placement offering of 19,460,527 subscription receipts (&#8220;<font style="font-weight: bold;">Subscription Receipts</font>&#8221;),




      on a pre-Consolidation (as defined below) basis, of a wholly-owned subsidiary of the Company at a price of $1.05 per Subscription Receipt for aggregate gross proceeds of approximately $20.4 million. Upon completion of the Reverse Takeover
      Transaction, each Subscription Receipt was exchanged for one unit comprised of one (1) Common Share and one-half of one (1/2) warrant (each whole warrant, a &#8220;<font style="font-weight: bold;">2019</font>&#160;<font style="font-weight: bold;">Listed Warrant</font>&#8221;).




      Each 2019 Listed Warrant was exercisable for one Common Share at an exercise price of $1.30 for a period of 24 months following the closing of the Reverse Takeover Transaction. A total of 9,730,258 2019 Listed Warrants were issued and listed for
      trading on the CSE under the ticker &#8220;IMCC.WT&#8221;. The 2019 Listed Warrants expired on October 11, 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Developments Following the Reverse Takeover Transaction</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Developments During the Financial Year Ended December 31, 2019</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On December 26, 2019, IMC Holdings entered into a share purchase agreement with Xinteza API Ltd. (&#8220;<font style="font-weight: bold;">Xinteza</font>&#8221;), a company with a unique biosynthesis technology,
      whereby the Company acquired, on an as-converted and fully diluted basis, 25.37% of Xinteza&#8217;s outstanding share capital, for consideration of US$1,700,000 (approximately $2,223,000, according to the December 24, 2019 exchange rate published by the
      Bank of Canada) paid in several installments (the &#8220;<font style="font-weight: bold;">Xinteza SPA</font>&#8221;). As of September 30, 2020, the Company has paid all outstanding installments pertaining to the Xinteza SPA, and as of the date of this AIF
      currently holds 23.35% of the outstanding share capital of Xinteza on an as-converted and fully diluted basis. Under an exclusive license from Yeda Research &amp; Development Company Ltd., the commercial division of the Weizmann Institute of Science,
      and based on disruptive plant genetics and metabolomics research led by Professor Asaph Aharoni, Xinteza has been developing advanced proprietary technologies related to the production of cannabinoid-based active pharmaceutical ingredients for the
      pharmaceutical and food industries using biosynthesis and bio-extraction technologies.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Developments During the Financial Year Ended December 31, 2020</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 30, 2020, Focus signed a three-year sales agreement for the sale of IMC-branded medical cannabis products with three pharmacies in Jerusalem operating under the Oranim Pharm and Medi Plus
      banners, under which Focus is to supply such pharmacies with a total of 800kg of medical cannabis products annually for a period of three years, commencing in 2021, for an aggregate of 2,400kg of medical cannabis products at a contracted price. On
      December 1, 2021, IMC Holdings entered into the Oranim Transaction to acquire 51% of the rights in Oranim Pharm. The Oranim Transaction completed in March 2022. For additional information, please see &#8220;<font style="font-style: italic;">General
        Development of the Business &#8211; Developments Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021&#8221; </font>and &#8220;<font style="font-style: italic;">Description of the Business &#8211; Israel&#8221;.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 31, 2020, Focus signed a supply agreement with Way of Life Ltd., an IMC-GAP certified cultivator (&#8220;<font style="font-weight: bold;">Way of Life</font>&#8221;), to purchase a total of approximately
      1,500kg of medical cannabis over three years. All finished products produced from the medical cannabis supplied under such supply agreement will be sold under the IMC brand to pharmacies in Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In April, 2020, Focus signed three binding agreements with licensed pharmacies in Israel for the sale of medical cannabis products under the IMC brand, including: (i) a two-year sales agreement with
      Shor Tabachnik pharmacies (&#8220;<font style="font-weight: bold;">Tabachnik</font>&#8221;), according to which Focus will sell Tabachnik 1,000kg of medical cannabis products beginning in 2021; (ii) a three-year sales agreement with Super-Pharm (Israel) Ltd. (&#8220;<font style="font-weight: bold;">Super-Pharm</font>&#8221;), according to which Focus will sell to Super-Pharm a total of 13,575kg of medical cannabis products; and (iii) a three-year sales agreement with Max Pharm Ltd. (&#8220;<font style="font-weight: bold;">Max
        Pharm</font>&#8221;), under which Max Pharm will purchase a total of 500kg of medical cannabis products annually. In 2021, the Group entered the distribution and retail segments of the Israeli medical cannabis market through agreements to acquire several
      Israeli pharmacies focused on the sale of medical cannabis to patients, and GDP licenses to enable the Group to store and distribute large quantities of medical cannabis and therefore to conduct effective procurement and optimize its margins. As a
      result, the Group is able to stream more of its IMC-branded products to its own retail companies, and accordingly adjusted, by mutual consent, the quantities to be sold under the aforementioned agreements with Tabachnik, Super Pharm and Max Pharm to
      be on an ongoing demand basis. For additional information, please see &#8220;&#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended
        December 31, 2021&#8221;&#160;</font>and &#8220;<font style="font-style: italic;">Description of the Business &#8211; Israel&#8221;.</font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;"> <br>
      </font></div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 20 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On April 13, 2020, Focus signed a one-year binding agreement for the sale of 1,000kg of medical cannabis products under the IMC brand to Panaxia Labs Israel, Ltd. at an agreed upon price.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On April 21, 2020, Focus signed a binding three-year agreement for the sale of 12,600kg of medical cannabis products under the IMC brand to Pharm Yarok, according to which, Focus will sell to Pharm
      Yarok a total of 12,600kg of medical cannabis products under the IMC brand between 2021 and 2023 at an agreed upon price, subject to Pharm Yarok meeting certain regulatory requirements. On July 28, 2021, IMC Holdings entered into the Pharm Yarok
      Transaction to acquire all of the issued and outstanding shares of the Pharm Yarok Group and subsequently completed the acquisition in March 2022.&#160;&#160; For additional information, please see &#8220;<font style="font-style: italic;">General Development of the
        Business &#8211; Developments Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221; and &#8220;<font style="font-style: italic;">Description of the Business &#8211; Israel</font>&#8221;.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On May 8, 2020, Adjupharm received regulatory confirmation for the import of up to 5,800kg of medical cannabis products into Germany from foreign suppliers under the Adjupharm Licenses within a
      12-month period. Such confirmation allows Adjupharm to import either bulk products, such as dried cannabis flowers and dronabinol, or extract products for end-products, at specified quantities set out in the confirmation.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On May 12, 2020, the Company announced that Adjupharm received a purchase commitment from a distributor in Germany for 465kg of IMC-branded medical cannabis products over a 12-month period.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On June 18, 2020, Focus received its first imported shipment of medical cannabis from a Canadian EU-GMP certified medical cannabis cultivator. The shipment was comprised of approximately 200kg of
      medical cannabis to be sold by Focus under the IMC brand to pharmacies in Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In July 2020, Adjupharm entered into several binding medical cannabis sales agreements with the following distributors in Germany: Zur Rose Pharma GmbH (&#8220;<font style="font-weight: bold;">Zur Rose</font>&#8221;),




      Axicorp Group, Canymed GmbH and Materia Deutschland GmbH. Focus and Zur Rose agreed to terminate the sales agreement on March 30, 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On July 24, 2020, Focus signed a supply agreement with Ever Green Solomon Pharma Ltd (&#8220;<font style="font-weight: bold;">Ever Green</font>&#8221;) (the &#8220;<font style="font-weight: bold;">Ever Green Supply
        Agreement</font>&#8221;), an IMC-GAP certified cultivator, for the purchase of all of the medical cannabis production cultivated by Ever Green in an 86,000 square feet area of its facility, over a period of five years, with an option for Focus to extend
      the term by an additional five years, for a total term of up to 10 years. The finished products created from medical cannabis delivered pursuant to the Ever Green Supply Agreement will be sold by Focus to pharmacies in Israel under the IMC brand.
      Under the Ever Green Supply Agreement the parties could terminate the agreement after one year of cultivation if the parties did not agree on the quality criteria of the cannabis flowers to be provided by Ever Green. On March 6, 2022, the parties
      amended the Ever Green Supply Agreement and ceased any future cultivation in the Ever Green Facility. Focus is obligated to purchase the current cannabis products cultivated by Ever Green but will not be required to purchase additional quantities.
      The Company does not expect any adverse effect of such termination due to its other quality sources of cannabis products, such as imported products from its Canadian Facilities and other supplier partners.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 21 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On September 8, 2020, Adjupharm signed distribution agreements for the sale of IMC-branded medical cannabis products with Cansativa GmbH and Ilios Sante GmbH.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On September 9, 2020, Adjupharm signed a distribution agreement for the sale of IMC-branded medical cannabis products with Farmako GmbH.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On September 15, 2020, the Company imported its first shipment of medical cannabis from its EU-GMP supply partner into Germany for distribution and sale through its German distributors, under the IMC
      brand.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On September 23, 2020, the Company officially launched the IMC brand in Germany as four of the Company&#8217;s German distribution partners received shipments of medical cannabis products for sale in the
      German medical cannabis market. The first product bearing the IMC brand available to customers was the High THC T20/1 medical cannabis inflorescences.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On December 29, 2020, Marc Lustig was appointed as Executive Chairman of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">Developments During the Financial Year Ended December 31, 2021</font>On January 1, 2021, the Company amended the terms of each of the IP Agreement and the Services
      Agreement to align the consideration with implementation of the Company&#8217;s transfer pricing framework. The amendments to these agreements constituted a &#8220;related party transaction&#8221; as such term is defined in Multilateral Instrument 61-101 - <font style="font-style: italic;">Protection of Minority Security Holders in Special Transactions</font> (&#8220;<font style="font-weight: bold;">MI 61-101</font>&#8221;).&#160; The Company was exempt from the formal valuation requirement under Section 5.5(a) and the
      minority approval requirement under Section 5.7(1)(a) of MI 61-101, respectively, as the fair market value of the amendments, as determined by the Board, did not exceed 25% of the Company's market capitalization on the date of such amendments.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On January 26, 2021, the Company announced that it received confirmation from The Depository Trust Company (&#8220;<font style="font-weight: bold;">DTC</font>&#8221;) that its Common Shares are eligible for
      electronic clearing and settlement through DTC in the U.S.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On February 12, 2021, the Company consolidated all of its issued and outstanding Common Shares on a four (4) to one (1) basis (the &#8220;<font style="font-weight: bold;">Consolidation</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On February 22, 2021, the Company appointed Brian Schinderle and Haleli Barath to the Board. Both Mr. Schinderle and Ms. Barath are independent directors under applicable Canadian and United States
      securities laws. Concurrently with these appointments, Rafael Gabay and Steven Mintz resigned from the Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 1, 2021, the Company&#8217;s Common Shares commenced trading on NASDAQ under the ticker symbol &#8220;IMCC&#8221;, making the Company the first Israeli medical cannabis operator to list its shares on NASDAQ.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 22 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 8, 2021, the Company announced that Focus signed a multi-year supply agreement with GTEC Holdings Ltd. (&#8220;<font style="font-weight: bold;">GTEC</font>&#8221;), a Canadian Licensed Producer of
      handcrafted and high quality cannabis (the &#8220;<font style="font-weight: bold;">GTEC Agreement</font>&#8221;). Pursuant to the GTEC Agreement, Focus will import GTEC&#8217;s high-THC medical cannabis inflorescence into Israel to be sold under the IMC brand. With
      the arrival of these commercial shipments, the Company will launch a new category of imported premium indoor medical cannabis products under its well-established brand. The first shipment of the Canadian-grown high-THC strains from GTEC&#8217;s subsidiary,
      Grey Bruce Farms Incorporated (&#8220;<font style="font-weight: bold;">GBF</font>&#8221;), arrived in Q2 2021 and the Company launched a new category of imported premium indoor medical cannabis products under its well-established brand.&#160; According to the GTEC
      Agreement, Focus will purchase a minimum quantity of 500kg of high-THC medical cannabis inflorescence from GBF and will be the exclusive recipient of GTEC cannabis products in the Israeli market for a period of 12 months from the date that the first
      shipment of GTEC products arrives in Israel (the &#8220;<font style="font-weight: bold;">Exclusive Term</font>&#8221;). The Exclusive Term can be extended under the terms of the GTEC Agreement by an additional 6 months.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 12, 2021, the Company filed a preliminary short form base shelf prospectus (the &#8220;<font style="font-weight: bold;">Preliminary Shelf Prospectus</font>&#8221;) with the securities commissions or
      similar securities regulatory authorities in each of the provinces and territories of Canada (the &#8220;<font style="font-weight: bold;">Securities Commissions</font>&#8221;), and on March 15, 2021, the Company filed a corresponding shelf registration statement
      on Form F-10, with the SEC under the Multijurisdictional Disclosure System (&#8220;<font style="font-weight: bold;">MJDS</font>&#8221;) established between Canada and the United States.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 12, 2021, Adjupharm entered into a supply agreement with NGC (the &#8220;<font style="font-weight: bold;">NGC Supply Agreement</font>&#8221;). Under the terms of the NGC Supply Agreement, NGC will
      provide Adjupharm with three new strains of medical cannabis products, to be distributed under the IMC brand to German pharmacies pursuant to Adjupharm&#8217;s distribution agreements with its German distribution partners. Shipments from NGC commenced in
      October 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 18, 2021, the Company acquired all of the issued and outstanding Trichome Shares in exchange for Common Shares through a statutory plan of arrangement under the OBCA pursuant to a definitive
      agreement entered into on December 30, 2020 (the &#8220;<font style="font-weight: bold;">Trichome Transaction</font>&#8221;). Trichome is the sole shareholder of TJAC, a wholly-owned subsidiary of Trichome and a Canadian Licensed Producer of cannabis products in
      the adult-use recreational cannabis market. Pursuant to the terms of the Trichome Transaction, former holders of Trichome Shares and former holders of Trichome convertible instruments (the &#8220;<font style="font-weight: bold;">Trichome Securityholders</font>&#8221;)




      received 0.24525 of a Common Share for each Trichome Share held and each in-the-money convertible instrument of Trichome. As a result of the Trichome Transaction, a total of 10,104,901 Common Shares were issued to the Trichome Securityholders,
      resulting in former Trichome Securityholders holding approximately 20.06% of the total number of issued and outstanding Common Shares immediately after closing. In addition, 100,916 Common Shares were issued to financial advisors for advisory fees in
      connection with the Trichome Transaction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Trichome Transaction constituted a &#8220;significant acquisition&#8221; for the Company under the significance tests set out in Part 8 of NI 51-102. As a result, the Company filed a business acquisition
      report in respect of the acquisition on April 28, 2021 which is available under the Company&#8217;s profile on SEDAR at <u>www.sedar.com</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 29, 2021, Adjupharm entered into a supply agreement with MediPharm Labs for certain medical cannabis extract products to be delivered by MediPharm Labs over an initial two-year term with an
      automatic two-year extension period (the &#8220;<font style="font-weight: bold;">MediPharm Supply Agreement</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 31, 2021, in connection with the Preliminary Shelf Prospectus, the Company filed a final short form base shelf prospectus (the &#8220;<font style="font-weight: bold;">Final Shelf Prospectus</font>&#8221;)




      with the Securities Commissions and a corresponding shelf registration statement on Form F-10 (the &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221;) with the SEC. The Final Shelf Prospectus and the Registration Statement enable the
      Company to offer up to US$250,000,000 (or its equivalent in other currencies) of Common Shares, warrants, subscription receipts, debt securities, units (collectively, the &#8220;<font style="font-weight: bold;">Qualified Securities</font>&#8221;), or any
      combination of such Qualified Securities from time to time, during the 25-month period that the Final Shelf Prospectus is effective. The specific terms of any offering under the Final Shelf Prospectus and the intended use of the net proceeds will be
      established in a prospectus supplement, which will be filed with the Securities Commissions and the SEC in connection with any such offering.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 23 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In March 2021, Adjupharm entered into two supply agreements with supply partners in China, under which Adjupharm purchased COVID-19 rapid antigen test kits. Concurrently, Adjupharm entered into
      several resale agreements with reseller partners in Germany, under which Adjupharm shall sell the COVID-19 antigen test kits supplied from the China-based suppliers, to be distributed to pharmacies and retailers in Germany.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On April 30, 2021, IMC Holdings signed a definitive agreement with Panaxia, pursuant to which IMC Holdings would acquire Panaxia&#8217;s home-delivery services online pharmacy business operating under the
      name <font style="font-style: italic;">Panaxia to the Home</font> and customer service centre (the &#8220;<font style="font-weight: bold;">Panaxia-to-the-Home Operation</font>&#8221;), the Panaxia GDP License and an option to purchase a pharmacy with licenses
      to sell medical cannabis directly to qualifying medical cannabis patients (the &#8220;<font style="font-weight: bold;">Panaxia Pharmacy Option</font>&#8221;), for an aggregate purchase price of $7,200,000 comprised of $2,900,000 in cash and $4,300,000 in Common
      Shares (the &#8220;<font style="font-weight: bold;">Panaxia Consideration Shares</font>&#8221;) to be issued in five instalments (the &#8220;<font style="font-weight: bold;">Panaxia Transaction</font>&#8221;).&#160; On March 14, 2022 the Company completed the acquisition of the
      Panaxia GDP License and concurrently exercised the Panaxia Pharmacy Option. For more information, please see &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On May 7, 2021, the Company completed the 2021 Offering of a total of 6,086,956 2021 Offered Shares at a price of US$5.75 per 2021 Offered Share for aggregate gross proceeds of approximately
      US$35,000,000. The Company also issued 3,043,478 2021 Offered Warrants for no additional consideration. In connection with the 2021 Offering, the Company entered into a best-efforts agency agreement (the &#8220;<font style="font-weight: bold;">2021</font>&#160;<font style="font-weight: bold;">Agency Agreement</font>&#8221;), in which A.G.P./Alliance Global Partners and Roth Capital Partners agreed to act as co-lead agents for the 2021 Offering. Roth Canada, ULC acted as the sole agent in Canada pursuant to the 2021
      Agency Agreement. Pursuant to the terms of the 2021 Offering, the agents held an over-allotment option to purchase up to an additional 913,044 2021 Offered Shares and 465,522 2021 Offered Warrants on the same terms and conditions for a period of 30
      days following the closing date, which was not exercised. The Company issued an aggregate of 182,608 2021 Broker Compensation Options to certain agents in connection with the 2021 Offering.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On May 14, 2021, the Company&#8217;s subsidiary, TJAC, entered into a revolving credit facility (the &#8220;<font style="font-weight: bold;">Revolver</font>&#8221;) for $5,000 with a private Canadian creditor. The
      Revolver has an initial term of 12 months that can be extended upon the mutual agreement of both parties. Per annum interest is equal to the greater of (i) 9.75% and, (ii) the Toronto Dominion Bank prime rate, plus 7.30%. The Revolver has a standby
      fee of 2.40% per annum, which is charged against the unused portion. Advanced amounts are secured against the assets of TJAC and Trichome, with Trichome providing a guarantee for the Revolver. To maintain the Revolver, TJAC must abide by certain
      financial covenants, such as the maintenance of a tangible net worth greater than $5,000 and a debt service coverage ratio of 2:1. On September 23, 2021, TJAC increased the limit on the Revolver from $5,000 to $7,500 and added Highland&#8217;s assets to
      the Revolver borrowing base. The increase will be used to finance TJAC and MYM&#8217;s receivables in order to manage the timing of cash flows. On October 18, 2021, TJAC and MYM increased the limit on the Revolver to $10,000. The increase will be used to
      finance TJAC and MYM&#8217;s receivables in order to manage the timing of cash flows.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 24 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">On May 30, 2021, the Company completed the first closing of the Panaxia Transaction, pursuant to which the Panaxia to the Home Operation and all intellectual property were transferred to IMC
      Holdings.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On July 9, 2021, pursuant to a plan of arrangement under the OBCA and a definitive agreement dated April 1, 2021, the Company, through Trichome, completed the acquisition of MYM and acquired all of
      the issued and outstanding MYM common shares (the &#8220;<font style="font-weight: bold;">MYM Shares</font>&#8221;) at an exchange ratio of 0.022 Common Shares for each MYM Share. MYM is a Canadian cultivator, processor, and distributor of premium cannabis via
      its two wholly owned subsidiaries, Highland Grow Inc. (&#8220;<font style="font-weight: bold;">Highland</font>&#8221;), with a facility in Antigonish, Nova Scotia (the &#8220;<font style="font-weight: bold;">Highland Facility</font>&#8221;) and SublimeCulture Inc. (&#8220;<font style="font-weight: bold;">Sublime</font>&#8221;), with a facility in Laval, Quebec (the &#8220;<font style="font-weight: bold;">Sublime Facility</font>&#8221;, and together with the Highland Facility, the &#8220;<font style="font-weight: bold;">MYM Facilities</font>&#8221;).
      In connection with the MYM Transaction, a total of 10,073,437 Common Shares have been issued to the former holders of MYM Shares, resulting in former MYM shareholders holding approximately 15% of the total number of Common Shares (based on 67,156,470
      Common Shares issued and outstanding immediately after closing).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In July, 2021, IMCC completed its new, state of-the-art logistics centre in Germany (the &#8220;<font style="font-weight: bold;">Logistics Centre</font>&#8221;) that will allow Adjupharm to internally manage all
      aspects of its supply chain including, the repackaging of bulk cannabis. IMCC expects that the Logistics Centre will strongly augment Adjupharm&#8217;s capabilities as a focal point for the Company&#8217;s European strategy. The Logistics Centre doubles
      Adjupharm&#8217;s footprint to approximately 8,000 square feet, upgrades the production facilities with state-of-the-art technology and increases cannabis storage capacity to seven tonnes.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On July 28, 2021, IMC Holdings entered into a definitive agreement in respect of the acquisition of the Pharm Yarok Group (the &#8220;<font style="font-weight: bold;">Pharm Yarok Transaction</font>&#8221;). The
      aggregate consideration for the Pharm Yarok Transaction is NIS 11,900,000 (approximately $4,600,000), of which NIS 3,500,000 (approximately $1,300,000) shall be invested in the Company at closing by the shareholders of Pharm Yarok Group in exchange
      for Common Shares. The closing of the Pharm Yarok Transaction was conditional upon receipt of all requisite approvals, including all requisite approval from the IMCA. Pharm Yarok is a leading medical cannabis pharmacy and trade company located in
      central Israel; Rosen High Way is a trade and distribution centre providing medical cannabis storage, distribution services and logistics solutions for cannabis companies and pharmacies in Israel; and HW Shinua is an applicant for a medical cannabis
      transportation license from the IMCA, the receipt of which would permit HW Shinua to transport large quantities of medical cannabis to and from Pharm Yarok&#8217;s pharmacy and Rosen High Way&#8217;s distribution centre and to and from third parties in the
      medical cannabis sector, including medical cannabis growing facilities, pharmacies, manufacturers and distribution centres across Israel. The Pharm Yarok Transaction was completed in March 2022. For more information, please see &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On August 3, 2021, IMC Holdings and cbdMD executed a binding letter of intent that will grant IMC Holdings an exclusive right to import, sell, distribute and market cbdMD products in Israel using the
      cbdMD brand name and trademark, subject to the legalization of hemp-derived CBD for non-medical purposes in Israel.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On August 16, 2021, IMC Holdings signed a definitive agreement to acquire 51% of the issued and outstanding ordinary shares of Vironna for total consideration of NIS 8,500,000 (approximately
      $3,330,000) comprised of NIS 5,000,000 (approximately $1,950,000) in cash and NIS 3,500,000 (approximately $1,350,000) in Common Shares to be issued on the closing date (the &#8220;<font style="font-weight: bold;">Vironna Transaction</font>&#8221;). Vironna is a
      leading pharmacy licensed to dispense and sell medical cannabis to licensed medical cannabis patients, located in central Israel and is one of the leading pharmacies in serving patients pertaining to the Arab population in Israel. The closing of the
      Vironna Transaction was conditional upon receipt of all requisite approvals, including from the IMCA. The Vironna Transaction was completed in March 2022.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 25 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On December 1, 2021, IMC Holdings signed a definitive agreement with Mr. Eitan Hevroni, Hevroni Entrepreneurship, Oranim Plus and Oranim Pharm, pursuant to which IMC Holdings will acquire 51.3% of
      the outstanding Oranim Plus common shares (the &#8220;<font style="font-weight: bold;">Oranim Transaction</font>&#8221;). Oranim Plus holds 99.5% of the rights in Oranim Pharm. The acquisition will result in IMC Holdings owning 51% of the rights in Oranim Pharm,
      which is one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area. As consideration for the Oranim Transaction, IMC&#160;Holdings will pay an aggregate purchase price of
      approximately NIS 11,940,000 (approximately $4,900,000), consisting of approximately NIS 10,400,000 (approximately $4,300,000) in cash (the &#8220;<font style="font-weight: bold;">Oranim Cash Consideration</font>&#8221;) and NIS 1,540,000 (approximately
      $630,000) payable in Common Shares (the &#8220;<font style="font-weight: bold;">Oranim Consideration Shares</font>&#8221;). The Oranim Cash Consideration will be paid in two instalments, with 50% paid at signing of the definitive agreement and the remaining 50%
      payable at the closing of the Oranim Transaction. The number of Oranim Consideration Shares issuable will be calculated based on the average closing price of the Common Shares on the NASDAQ over the 14 trading day period immediately preceding closing
      of the Oranim Transaction. The Oranim Transaction was completed in March 2022 upon receipt of all requisite approvals, including the required approval from the IMCA.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Developments Following the Financial Year Ended December 31, 2021</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On January 13, 2022, the Company announced that Yael Harrosh, previously IMCC&#8217;s General Counsel, Business Director and Corporate Secretary, had been promoted to global Chief Legal and Operations
      Officer, effective immediately. Rinat Efrima was appointed as the new Chief Executive Officer of IMC Holdings. Ms. Efrima joined IMC Holdings in the first quarter of 2022.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In January 2022, Focus imported approximately 399 kilograms of premium indoor-grown Canadian dried cannabis flowers from TJAC and an additional supply partner, marking an important milestone in the
      execution of the IM Cannabis&#8217; strategic objectives of vertical integration. The Group commenced the sale of imported cannabis flowers under its WAGNERS brand in the Israeli medical cannabis in Q1 2022.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In January 2022, Focus entered into a Revolving Credit Facility with Bank Mizrahi (the &#8220;<font style="font-weight: bold;">Focus Facility</font>&#8221;). The Focus Facility is guaranteed by Focus assets.
      Advances from the Focus Facility will be used for working capital needs. The Focus Facility has a total commitment of up to NIS 15,000,000 (approximately $6,000,000) and has a one-year term for ongoing needs and 6 month term for import and purchase
      needs. The Focus Facility is renewable upon mutual agreement by the parties on May 14, 2022 for up to two additional periods of 180 days. The borrowing base available for draw at any time throughout the Focus Facility and is subject to several
      covenants to be measured on a quarterly basis. The Focus Facility bears interest of Israeli prime interest plus 1.5% (approximately 3.3%) per annum</div>
    <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On February 1, 2022, the Company engaged international investor relations specialists MZ Group (&#8221;<font style="font-weight: bold;">MZ</font>&#8221;) to lead the Company's strategic investor relations and
      financial communications program across all key markets. The investor relations agreement between the Company and MZ (the &#8221;<font style="font-weight: bold;">MZ Agreement</font>&#8221;) commenced on February 1, 2022 for a term of three months until April 30,
      2022, and will automatically renew for an indefinite period, subject to termination by either party upon 30 days prior written notice. Pursuant to the MZ Agreement, MZ will be paid a fee of US$14,000 per month, plus applicable taxes. Subject to the
      terms of the MZ Agreement and if the MZ Agreement remains in effect as of August 1, 2022, the Company will issue to MZ 35,000 Common Shares at a price per share to be determined on the market price of the Common Shares on the CSE on the trading day
      prior to August 1, 2022, subject to applicable discounts permitted under CSE policies.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 26 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 14, 2022, the Company completed three strategic acquisitions previously announced in 2021: the Vironna Transaction, the Pharm Yarok Transaction and the Panaxia Transaction.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Vironna Transaction was completed for total consideration of NIS 8,500,000 (approximately $3,330,000), of which NIS 5,000,000 (approximately $1,950,000) was paid in cash and NIS 3,500,000
      (approximately $1,350,000) was paid in Common Shares. For satisfaction of the cash consideration component, NIS 3,750,000 (approximately $1,460,000) was paid at signing of the definitive agreement and the remaining NIS 1,250,000 (approximately
      $490,000) will be paid post-closing of the Vironna Transaction (the &#8220;<font style="font-weight: bold;">Vironna Closing Date</font>&#8221;). In satisfaction of the share consideration component, the Company issued 485,362 Common Shares at a deemed issue
      price of US$2.209 per share (approximately $2.8092), calculated based on the average closing price of the Common Shares on the Nasdaq for the 14 trading day period immediately preceding Vironna Closing Date. The shares issued to Vironna are subject
      to a staggered three-month lockup commencing on the Vironna Closing Date.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">IMC Holdings completed the acquisition of all the outstanding ordinary shares of Pharm Yarok, and Rosen High Way. The acquisition of the outstanding ordinary shares of High Way Shinua is pending
      receipt of the requisite approval from the IMCA. The aggregate cash consideration for the Pharm Yarok Transaction was NIS 11,900,000 (approximately $4,600,000), of which NIS 8,400,000 (approximately $3,300,000) was paid at signing of the definitive
      agreements and the remaining NIS 3,500,000 (approximately $1,300,000) paid at closing. In connection with closing of the Pharm Yarok Transaction, the Company completed a non-brokered private placement with former shareholders of Pharm Yarok and Rosen
      High Way. A total of 523,700 Common Shares were issued at a deemed price of $2.616 for aggregate proceeds of $1,369,999.20. The calculation of the deemed price was based on the average closing price of Common Shares on the CSE over the 8 trading day
      period immediately preceding March 14, 2022.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">IMC Holdings acquired the Panaxia GDP License following receipt of the requisite IMCA approval, and assigned the Panaxia GDP License to IMC Pharma in accordance with the terms of the Panaxia
      Transaction. The aggregate consideration for the Panaxia Transaction was NIS 18,700,000 (approximately $7,200,000), of which NIS 7,600,000 (approximately $2,900,000) was paid in two cash instalments and NIS 11,100,000 (approximately $4,300,000)
      payable in Common Shares (&#8220;<font style="font-weight: bold;">Panaxia Consideration Shares</font>&#8221;). To satisfy the share consideration component of the Panaxia Transaction, the Company issued four installments of an aggregate of 934,755 Panaxia
      Consideration Shares between August 9, 2021 and March 15, 2022, with the deemed price of each instalment of Panaxia Consideration Shares determined based on the average closing price of the Common Shares on Nasdaq during the 10 trading day period
      immediately prior to issuance. The fifth and final installment of Panaxia Consideration Shares will be issued following the Panaxia GDP License Closing. The Panaxia Transaction includes a further option to acquire, for no additional consideration, a
      pharmacy from Panaxia, including requisite licenses to dispense and sell medical cannabis to patients, that the Company has exercised (&#8220;<font style="font-weight: bold;">Panaxia Pharmacy Closing</font>&#8221;). The Panaxia Pharmacy Closing is expected to
      occur in Q3 2022.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 28, 2022, the Oranim Transaction closed upon receipt of all requisite approvals, including the approval of the IMCA. The Oranim Transaction was completed for total consideration of NIS
      11,940,000 (approximately $4,600,000), comprised of NIS 10,404,000 (approximately $4,000,000) and NIS 1,536,000 (approximately $600) in Common Shares issued on closing. In satisfaction of the cash consideration component, NIS&#160;5,202,000 (approximately
      $2,000,000) paid at signing of the definitive agreement and NIS 5,202,000 will be payable in the first quarter of 2023. In satisfaction of the share consideration component, the Company issued 251,001 Common Shares at a deemed issue price of US$1.899
      per share (approximately $2.37) per share, calculated based on the average closing price of the common shares of the Company on the Nasdaq Capital Market for the 14 trading day period immediately preceding March 28, 2022. The shares issued are
      subject to a staggered three-month lockup commencing on the date of issuance.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 27 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><img width="184" height="177" src="image00026.jpg"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="DESCRIPTIONOFTHEBUSINESS"><!--Anchor--></a>DESCRIPTION OF THE BUSINESS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Overview &#8211; Active Operation in Israel, Canada and Germany</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">IM Cannabis is a leading international cannabis company providing premium cannabis products to medical patients and adult-use recreational consumers. With operations in Israel, Canada, and Germany,
      the world&#8217;s three largest federally legal cannabis markets, the Company has developed its own proprietary import/export supply chain in order to efficiently deliver premium cannabis to patients and consumers under a uniform global branding umbrella.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company operates in Canada through Trichome and its subsidiaries TJAC and MYM, where it cultivates, processes and sells premium and super-premium cannabis at its own facilities under the WAGNERS
      and Highland Grow brands for the adult-use market in Canada and exports premium and super-premium medical cannabis to Israel and eventually to Germany. In Israel, the Company cultivates, imports, and distributes cannabis to local medical patients
      through its commercial relationship with Focus, with plans to import cannabis to supplement its operations of medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs operating through IMC Holdings. In Germany,
      the IM Cannabis ecosystem operates through Adjupharm importing and distributing cannabis to pharmacies for patients, acting as the Company&#8217;s entry point to a potential future Europe-wide distribution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israel</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Israel, the Group continues to expand IMC brand recognition and supply the growing Israeli medical cannabis market with its branded products. IMC Holdings developed the IMC brand of premium
      medical cannabis products, which has been cultivated over the last decade mainly by Focus, an Israeli licensed cultivator over which IMC Holdings exercises &#8220;de facto control&#8221; under IFRS 10, and its cultivation partners and then sold in the Israeli
      medical cannabis market. In addition to our locally grown medical cannabis by Focus and its cultivation partners, we are focused on importing premium indoor-grown dried cannabis from our Canadian Facilities as well as from world-leading cannabis
      suppliers. &#8217;In addition to the benefits of the Group&#8217;s long-term presence in Israel, we believe that with our globally integrated supply chain and coordinated team of compliance, regulatory and purchasing professionals, the Company is well-positioned
      to address the ongoing needs of medical cannabis patients in Israel.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 28 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In 2021, IMCC positioned itself to enter into the distribution and retail segments of the Israeli medical cannabis market by entering into agreements to acquire several leading pharmacies focused on
      medical cannabis in Israel, two licensed leading operating trading houses, along with a well-known nationwide home-delivery service, including call centre and online purchase activity, and customer service centre, which include:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4041bc96b0ea49b2b2ba912f45ecb5ed">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Vironna, a licensed pharmacy, which ranks among the top 10 single cannabis dispensing points in Israel and is one of the largest pharmacies in Israel serving the rapidly growing Arab consumer segment of the medical cannabis market;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z99c5b650764c40c38ec90849b24883f3">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Pharm Yarok, a licensed leading medical cannabis pharmacy located in central Israel;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z19c19fd832e846ac9022320e09bf838b">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Oranim Pharm, one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc9fcb9df4b6f4b34b52e9f75dc9e5c89">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Rosen High Way, a trade and distribution centre providing medical cannabis storage, distribution services and logistics solutions for cannabis companies and pharmacies in Israel; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1c426b729b414c2fbf38045d5723cdfd">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The acquisition of Panaxia&#8217;s GDP License together with its trading-house operation and the <font style="font-style: italic;">Panaxia-to-the-Home Operation</font>.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company believes that the above acquisitions positions IM Cannabis as one of the largest distributors of medical cannabis in Israel. The Company if focused on building a vertically-integrated
      retail chain, providing IM Cannabis products directly to patients, accessing and leveraging market data as well as providing a deeper understanding of consumer preferences. These acquisitions allow the Company to increase purchasing power with
      third-party product suppliers, offers potential synergies with its established call centre and online operations, achieves higher margins on direct to patient sales and creates the opportunity for up-sales across a growing range of products.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Through the acquisition of the Panaxia-to-the-Home Operation, the Company also plan to stay ahead of consumer trends and provide patients with accessible at-home delivery. The Company&#8217;s acquisition
      of the Rosen High Way, a trading house, and the Panaxia GDP License will expand its sales channels, distribution, delivery and storage capacity and strengthen the Groups&#8217; ability to reach its clients directly.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Following the acquisitions of the Israeli Pharmacies and trading houses, which closed in the first quarter of 2022, IMC Holdings has become, through its recently acquired subsidiaries, a licensed
      medical cannabis retailer in Israel, and is in the process vertically integrating its Israeli operations. The Company expects that these developments will increase revenue and margins from its Israeli medical cannabis market activities. For more
      information, see <font style="font-style: italic;">&#8220;General Development of the Business &#8211; Developments Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021&#8221; </font>and &#8220;<font style="font-style: italic;">&#8220;General Development of the Business &#8211; Developments Following the Financial Year Ended December 31, 2021&#8221;.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canada</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Following the successful completion of the Trichome Transaction and the MYM Transaction the Group&#8217;s global cannabis platform has evolved to now include the adult-use recreational cannabis market in
      Canada, in addition to its established medical cannabis operations in Israel and Germany.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 29 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Trichome is a Canadian subsidiary of IMCC, and through Trichome&#8217;s wholly-owned subsidiary, TJAC, operates as a Canadian Licensed Producer of cannabis products in the adult-use recreational cannabis
      market in Canada. TJAC operates two cultivation facilities in Ontario and sells products under the WAGNERS brand.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">MYM, acquired by the Company through Trichome, is a Canadian cultivator, processor, and distributor of premium cannabis through its two wholly-owned subsidiaries: Highland and Sublime. MYM&#8217;s flagship
      brand, Highland Grow, is an ultra-premium brand sold in most provinces and territories throughout Canada.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Germany</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Europe, the Company operates in Germany through Adjupharm, its German subsidiary and EU-GMP certified medical cannabis producer and distributor. The Company continues to lay its foundation in
      Germany, currently the largest medical cannabis market in the Europe.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup> Leveraging its global supply chain, IM Cannabis continues to focus on growing its business in Germany to be
      well-positioned through brand recognition in preparation for future regulatory reforms.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Similar to Israel, the Company&#8217;s focus in Germany is on importing premium indoor-grown dried cannabis from the Canadian Facilities, which we believe will satisfy the rapid growth in demand for
      premium Canadian cannabis across a variety of strains and qualities.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">While the Company does not currently distribute products in other European countries, the Company intends to leverage the foundation established by Adjupharm, its new state-of-the-art Logistics
      Centre and its network of distribution partners to expand into other jurisdictions across the continent. The Company expects that the Logistics Centre will allow the Company to execute all aspects of its supply chain, including the repackaging of
      bulk cannabis and distribution capabilities.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s operating track record, accumulation of and ability to source data, supply and existing brand reputation in Israel and Canada offers the Company a competitive advantage in the German
      and European markets to build brand and industry recognition and support from physicians who prescribe medical cannabis products. Adjupharm&#8217;s ability to produce and distribute cannabis through Adjupharm&#8217;s certification as an EU-GMP producer and
      distributor in Germany with wholesale, narcotics handling, manufacturing, procurement, storage and distribution authority is granted by German regulatory authorities. The quantities permitted for import under the Adjupharm Licenses were updated in
      March 2022.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Group does not currently have and is not in the process of developing marijuana-related activities in the U.S., even in U.S. states where such activity has been authorized within a state
      regulatory framework. As such, the Company is not and would not be considered in the future a &#8220;U.S. Marijuana Issuer&#8221; within the meaning set forth in CSA Staff Notice 51-352.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
    </div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup> The European Cannabis Report &#8211; Edition 6, p. 93 -&#160;&#160; https://prohibitionpartners.com/reports/</div>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 30 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25; font-weight: bold; text-align: left;"><u>Principal Products and Brands</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The IMC brand is well-known&#160;in the Israeli&#160;medical cannabis market. Leveraging its long-term success in the Israeli market, the Company launched the IMC brand in Germany in 2020.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Following the Company&#8217;s entry into the Canadian adult-use recreational cannabis market, the Company is now leveraging its vertical integration and applying a multi-country strategy and using its
      global platform and exporting its Canadian WAGNERS and Highland Grow brands to the Israeli and German medical cannabis markets. The Company believes that the sale of WAGNERS and Highland Grow into the Israeli and German markets can satisfy the
      increasing demand of both Israeli and German patients for indoor grown Canadian cannabis.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israeli Medical Cannabis Business</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company currently sells the IMC and WAGNERS brands in the Israeli market.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">IMC brand gained its reputation for quality and consistency in the Israeli medical cannabis market over the past 10 years. In August 2020, a survey of licensed medical cannabis patients showed that
      the IMC brand is one of the top four most popular medical cannabis brands in Israel.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In association with Focus, the Group maintains a portfolio of strains sold under the IMC umbrella that includes popular medical cannabis dried flowers and full-spectrum cannabis extracts.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In 2021, IMC was rebranded with a refreshed logo, packaging, design language and tone, with a bold new design to better position itself in the competitive Israeli medical cannabis market, creating a
      variety of available products for medical cannabis patients.&#160; The IMC brand launched four different product lines as part of its rebranding:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">The Signature Collection</font>&#160;&#8211; The IMC brand&#8217;s high-quality product line with greenhouse grown, high THC cannabis flowers. This collection of products currently
      includes well known cannabis dried flowers such as Roma, Tel Aviv and London as well as newer strains launched in 2021 such as Mango Mint.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">The Reserve Collection</font>&#160;&#8211; The IMC brand&#8217;s premium product line with indoor-grown, high THC cannabis&#160;flowers. Launched in February 2022 with BC Pink Kush.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">The Craft Collection</font>&#160;&#8211; The&#160;IMC brand&#8217;s ultra-premium product line with indoor-grown, hang-dried and hand-trimmed, high THC cannabis flowers. Including exotic
      and unique cannabis strains such as Peanut Butter MAC, Wedding Crasher and Alien Sin Mint Cookies.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">The Full Spectrum Extracts</font>&#160;&#8211; The IMC brand&#8217;s full spectrum, strain specific cannabis extracts including High THC Roma oil, balanced Paris oil and Super CBD.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u> </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup> According to a survey carried out by Cannabis Magazine among 519 patients licensed by the MOH to consume medical cannabis (Aug 2020, Israel).</div>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 31 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><img width="999" border="0" height="735" src="image00027.jpg"></div>
    <div style="text-align: justify; line-height: 1.25;">The WAGNERS brand launched in Israel during Q1 2022. For more information, please see &#8220;<font style="font-style: italic;">New Product Offering</font>&#8221;.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canadian Adult-Use Recreational Cannabis Business</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In Canada, the Company&#8217;s product portfolio consists of dried flower, pre-rolls and pressed hash offerings under the premium WAGNERS brand and ultra-premium Highland Grow brand. The WAGNERS brand was
      launched by TJAC in mid-2021, while the Highland Grow brand was acquired through the acquisition of MYM in July 2021.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The WAGNERS brand offers high-quality cannabis on a consistent basis at an approachable price point for consumers. The Highland Grow brand offers cannabis consumers ultra-premium product, curated to
      their tastes. Both the WAGNERS and Highland Grow brands have proven to be very popular with consumers, each holding a top 3 position in Ontario across their respective price segments (year-to-date in 2022).<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">WAGNERS and Highland Grow products are primarily sold in 3.5 gram flower and 3 x 0.5 gram flower pre-roll formats.&#160; Other flower formats are available in certain provinces, such as 7 or 14 gram
      units. Hash is typically sold in 1, 2 and 4 gram formats.<br>
      <br>
      <div><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
      </div>
      <div>
        <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup> Depletion and e-commerce sales data from Ontario Cannabis Store - Sale of Data report for period between January 1 &#8211; February 28, 2022 for dried flower product between $7.50 - $9.99/gram and above
          $12.99/gram.</div>
      </div>
      <br style="line-height: 1.25;">
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 32 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> Key WAGNERS flower and pre-roll strains include Cherry Jam, Pink Bubba, Blue Lime Pie, Purple Clementine, Dark Helmet and Silverback #4: <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <img width="616" height="138" src="image3.jpg"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Highland Grow brand portfolio includes six core flower strains: Gaelic Fire, White Lightning, Sensi Wizard, Cherry Burst, as well as two new strains added in Q4 2021, Gas Tank and Diamond Breath.</div>
    <div style="text-align: justify; line-height: 1.25;"><img width="618" height="133" src="image4.jpg"></div>
    <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">German Medical Cannabis Business</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In Germany, the Company sells IMC-branded dried flower products. The medical cannabis products sold in the German market are branded generically as IMC so as to rely on the Company&#8217;s brand
      recognition in establishing a foothold with German healthcare professionals. The Company&#8217;s IMC-branded cannabis products were launched in Germany with one high THC flower strain in 2020.&#160; In Q4 2021, Adjupharm launched a flower strain second high THC
      strain and two full spectrum extracts.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In July 2021, Adjupharm was recognized by the German Brand Institute with the &#8220;German Brand Award 2021&#8221;, recognizing its excellence in brand strategy and creation, communication and integrated
      marketing. The competitive advantage in Germany also lies in the Group&#8217;s track record, experience and brand reputation in Israel and proprietary data supporting the possible effectiveness of medical cannabis for the treatment of a variety of
      conditions.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 33 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><img width="575" border="0" height="322" src="image00028.jpg"></div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>New Products</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Between our various geographies, the strategy for new products varies given that each market is at a different stage of development with respect to regulatory regimes, patient and customer
      preferences and adoption rates.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israel</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">
      <table cellspacing="0" cellpadding="0" border="0" id="z4c34b8a55757468d89ca158c216572ac" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 80%; text-align: left; vertical-align: top;">
              <div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">In conjunction with Focus and its cultivation partners cultivating Israeli-grown cannabis, the Company is also importing premium cannabis from
                  the Canadian Facilities and from third-party supply partners. Canadian indoor-grown cannabis commands a premium to the Israeli consumer. The Company launched the BC Pink Kush cannabis flowers to its Reserve Collection during Q1 2022, and
                  is planning to launch another cannabis flower, Berlin, to its Signature Collection in the beginning of Q2 2022.</div>
              </div>
            </td>
            <td style="width: 20%; text-align: center; vertical-align: top;">
              <div><img width="170" height="128" src="image6.jpg"> </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The WAGNERS brand launched in Israel during Q1 2022, with premium indoor-grown cannabis from the Canadian Facilities. The WAGNERS brand in Israel offers premium, imported, indoor-grown flower at a
      competitive price point for the first time in the Israeli market, due to the Group&#8217;s vertically integrated global supply chain reducing costs across the chain.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The WAGNERS brand currently offers its Cherry Jam and Dark Helmet products in Israel with additional products expected to launch later in 2022.</div>
    <div style="line-height: 1.25;"><img width="445" height="171" src="image00029.jpg"></div>
    <div style="text-align: justify; line-height: 1.25;">We also plan to launch the Highland Grow brand in Israel later in 2022.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 34 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canada</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;">The Company has amassed a portfolio of more than 150 cannabis strains through the MYM Transaction, and we are regularly evaluating and bringing new strains to market. In Q4
      2021, we launched Pink Bubba and Blue Lime Pie under the WAGNERS brand. The market reception of Pink Bubba has been strong, rivaling sales of our flagship Canadian strain, Cherry Jam. We also plan to launch four new strains in Q2 2022; Tiki Rain,
      Rainforest Crunch, Golden Ghost OG and Turpy Slurpy:</div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;"> <br>
    </div>
    <div style="margin-right: 13.5pt; line-height: 1.25;"><img width="503" height="216" src="image00030.jpg"></div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;">We have introduced pre-rolls under the Highland Grow brand for cannabis connoisseurs who also value convenience. In addition, we have launched new strains Diamond Breath and Gas
      Tank under Highland Grow brand.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;">In Q1 2022, we commenced distribution of a new brand, Dymond Concentrates, which will offer high-quality concentrates such as THCA diamonds, caviar, live resin, badder and
      shatter:</div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;"><img width="574" height="273" src="image00025.jpg"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Germany</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">IM Cannabis started 2022 with the launch of a high CBD flower strain and is also currently in the process of launching its popular Canadian WAGNERS brand in the German medical cannabis market,
      importing cannabis flower from the Canadian Facilities. The expansion of our portfolio shows our commitment to providing German physicians and patients with the best available strains in the global cannabis market, giving them the opportunity to
      tailor their treatments to their patients&#8217; individual needs.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 35 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Revenue</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The following table shows the sales figures in thousands of dollars for each category of products that accounted for 15% or more of the total consolidated revenue of the Company for the financial
      years ended December 31, 2021 and 2020, derived from (a) sales to entities in which the Company maintains an investment accounted for by the equity method; (b) sales to customers, other than those referred to in (a); and (c) sales or transfers to
      controlling shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z8030a873d9494002bc21ef1e53eaf5bf" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

        <tr>
          <td valign="bottom" colspan="16" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">REVENUE BY PRODUCT TYPE</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
            <div style="line-height: 1.25; font-weight: bold;"> <br>
            </div>
            <div style="line-height: 1.25; font-weight: bold;"> <br>
            </div>
            <div style="line-height: 1.25; font-weight: bold;">FINANCIAL YEAR</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">MEDICAL CANNABIS PRODUCTS</div>
          </td>
          <td nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td class="cftguttercell" colspan="1" style="vertical-align: bottom; text-align: center; padding-bottom: 2px;">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">ADULT-USE RECREATIONAL CANNABIS PRODUCTS</div>
          </td>
          <td nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td class="cftguttercell" colspan="1" style="vertical-align: bottom; text-align: center; padding-bottom: 2px;">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">OTHER PRODUCTS</div>
          </td>
          <td nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td class="cftguttercell" colspan="1" style="vertical-align: bottom; text-align: center; padding-bottom: 2px;">&#160;</td>
          <td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">TOTAL</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">26,449</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">19,609</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">8,242</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">54,300</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">14,863</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">1,027</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">15,890</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Production, </u><u>Distribution and Sales in Principal Markets</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israel</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Over the last decade Focus was the main cultivator of cannabis products sold under the IMC brand in the Israeli market. To supplement the growing demand, Focus entered into supply agreements with
      third-party cultivators in Israel. Since 2021, the Company focused on securing additional supply from its supply partners from outside of Israel, leveraging its improved purchase capabilities and global presence, as well as facilitating the import of
      indoor-grown premium and super-premium cannabis products. Importing from the Canadian Facilities aligns with the Company&#8217;s strategy in acquiring Trichome and MYM to serve as a long term, reliable source of supply to the Israeli and German medical
      cannabis markets.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Following cultivation or import of medical cannabis, in accordance with Israeli regulations, the medical cannabis products are packed by contracted licensed producers of medical cannabis. The
      packaged medical cannabis products are then sold by the Group under the Company&#8217;s brands to local pharmacies in Israel through contracted distributors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Focus is licensed by the IMCA to cultivate medical cannabis in the State of Israel. The Focus cultivation license is valid until July 3, 2022 (the &#8220;<font style="font-weight: bold;">Focus License</font>&#8221;).




      Focus was one of the initial eight medical cannabis producers licensed by Israeli regulatory authorities and has over 10 years of experience growing high-quality medical cannabis products for the Israeli medical cannabis market, under the guidance
      and knowledge provided to it by the Company and its master grower in Israel. The propagation license held by Focus expired on January 3, 2022, however the Group continue to maintain its proprietary genetics, and any propagation services, if required,
      will be provided by contracted third parties. The Focus Facility has approximately 300,000 square feet of cultivation capacity and a current annual output of up to 5,000kg of medical cannabis, which is supplemented by additional supply from
      contracted third-party Israeli medical cannabis cultivators.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In the second quarter of 2021, the Company, through Focus, imported medical cannabis flowers from a Canadian supply partner, and sold the imported medical cannabis products in the Israeli market
      under the IMC brand. In January 2022, the Company completed the import of premium indoor-grown Canadian dried cannabis grown in TJAC&#8217;s own cultivation facility in Canada. The Company expects to import additional premium dried cannabis flowers from
      its Canadian Facilities and its supply partners in Canada and elsewhere on a consistent basis going forward.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 36 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In 2021, the Company expanded into the retail and distribution segments of the Israeli medical cannabis market by entering into each of the Panaxia Transaction, the Pharm Yarok Transaction, the
      Vironna Transaction and the Oranim Transaction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">All of the Israeli Pharmacies are licensed by the IMCA to sell finished medical cannabis products to licensed medical cannabis patients in Israel. The Israeli Pharmacies provide a variety of medical
      cannabis products. The Israeli Pharmacies source their medical cannabis product supply directly from licensed medical cannabis companies or through licensed distributors and suppliers.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s acquisition of the Rosen High Way and the Panaxia GDP License expand its sales channels, distribution, delivery and storage capacity and strengthen the Groups&#8217; ability to reach medical
      cannabis patients directly and efficiently.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canada</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Following the Trichome Transaction, the Company has been engaged in the cultivation and sale of cannabis products in the adult-use recreational cannabis market in Canada through TJAC. TJAC holds the
      Standard Processing, Standard Cultivation and Sale for Medical Purposes licenses (collectively the &#8220;<font style="font-weight: bold;">TJAC Licenses</font>&#8221;) issued by Health Canada, which permit it to cultivate, produce, extract and sell cannabis
      products in Canada.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">TJAC operates an approximately 32,050 square metre indoor cultivation facility (the &#8220;<font style="font-weight: bold;">Indoor Facility</font>&#8221;), with approximately 4,340 square metres of space for the
      cultivation of cannabis. All of TJAC&#8217;s cultivation occurs at this site, as well as certain processing activities, such as plant drying, bucking and trimming. Current cultivation capacity at the Indoor Facility is approximately 7,000kg per year, with
      the potential for approximately twice the amount of production in the next 12-24 months, subject to capital investment and procedural optimization. In addition, TJAC operates another facility of an approximately 1,400 square metres, which is the site
      where certain processing and all packaging, sales and shipping activities of the business occur (collectively with the Indoor Facility, the &#8220;<font style="font-weight: bold;">TJAC Facilities</font>&#8221;). The TJAC Facilities are located in Kitchener,
      Ontario and are operated pursuant to certain lease agreements (the &#8220;<font style="font-weight: bold;">TJAC Leases</font>&#8221;). The TJAC Licenses for the TJAC Facilities are valid until August 28, 2023.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Trichome was initially formed in 2017 as a specialty finance company focused on providing capital solutions to the global legal cannabis market. In August 2020, Trichome began winding down its loan
      portfolio to focus on operating TJAC as its sole line of business.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On July 9, 2021, following the acquisition of MYM, the Company furthered its presence in the Canadian adult-use recreational market with the addition of the ultra-premium Highland Grow brand.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">MYM operates two licensed facilities: the Highland Facility, which operates as a cultivation and processing facility that is home to the Highland Grow brand, holding of a Standard Cultivation Licence
      issued under the <font style="font-style: italic;">Cannabis Act</font> and <font style="font-style: italic;">Cannabis Regulations</font>; and the Sublime Facility, which<font style="font-style: italic;">&#160;</font>operates as an indoor growing
      facility, holding a Standard Cultivation Licence. The Highland Facility is currently built to approximately 530 square metres of cultivation and storage space. The Sublime Facility is currently built to 930 square metres and has the potential to be
      expanded upon proper licencing. The Sublime Facility is intended as a cutting edge, highly optimized facility to be used for genetics research and pheno-hunting, storage of dried cannabis, and the production of clones and seeds for sale. It includes
      a mothering and cloning area, allowing for exceptional genetic development and archiving. The Sublime Facility operates pursuant to a certain lease agreement (the &#8220;<font style="font-weight: bold;">Sublime Lease</font>&#8221;). The license for the Highland
      Facility is valid until November 27, 2023 and the license for the Sublime Facility is valid until January 31, 2023.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 37 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">TJAC and Highland Grow are currently authorized to sell into the provinces of Ontario, Alberta, British Columbia, Manitoba, Saskatchewan, New Brunswick, Newfoundland and Labrador, Prince Edward
      Island, the Yukon, the Northwest Territories, and Nunavut. Highland Grow is also authorized to sell into Nova Scotia.&#160; In each of the provinces, other than Saskatchewan and Manitoba, TJAC and Highland Grow sell their cannabis products to provincially
      owned wholesalers, who in turn sell and distribute directly to privately owned retailers or direct to consumers online. In Saskatchewan and Manitoba, TJAC and Highland Grow sell their products to a third-party, intermediary wholesaler who then sells
      and distributes TJAC&#8217;s and Highland Grow&#8217;s products to the province&#8217;s retail stores. In addition, TJAC expects to enter the Quebec market pending regulatory approval in the province.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In order to supplement their own cultivation, TJAC and Highland Grow regularly enter into one-time, business-to-business purchase and sale agreements with other Licensed Producers, on an as-needed
      basis, in order to back-fill its own purchase orders from the provinces.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Europe</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company replicated its Israeli business strategy and established its medical cannabis brand in the German market through Adjupharm, a certified EU-GMP producer and distributor in Germany with
      wholesale, narcotics handling, manufacturing, procurement, storage and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits (the &#8220;<font style="font-weight: bold;">Adjupharm
        Licenses</font>&#8221;). Adjupharm serves as the Company&#8217;s flagship European outpost for sales and distribution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">While the Company does not currently distribute products in any other European countries outside of Germany, the Company intends to leverage the platform established by Adjupharm in Germany and its
      network of distribution partners to expand to other jurisdictions across the continent in which medical cannabis is legal.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Germany</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s European strategy is centred in Germany, whose medical cannabis market is currently considered the largest in Europe.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup> Adjupharm serves as the Company&#8217;s principal operating
      hub in the German market.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company continues to develop Adjupharm as its European hub and to expand its presence in the German market by forging partnerships with pharmacies and distributors across the country. The
      Company&#8217;s objective is to capture a significant market share in Germany by working directly with distributors to increase market reach for products bearing the Company&#8217;s brands.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Adjupharm currently manufactures and distributes IMC-branded medical cannabis products to pharmacies and distribution partners in Germany pursuant to sales and distribution agreements. Adjupharm
      sources its medical cannabis products from strategic partners, including various Canadian and pan-European EU-GMP suppliers. In addition, the Company plans to export medical cannabis products to Germany from its Canadian cultivation facilities in
      2022, subject to regulatory approvals, to be sold and distributed by Adjupharm under the Company&#8217;s brands in the German medical cannabis market.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company currently has approximately 8,000 square feet of warehouse space and EU-GMP production capacity in Germany, following the completion of an expansion process at the state-of-the-art
      Logistics Centre, upgrading its production technology and increasing its storage capacity to seven tonnes of cannabis. The Company expects that the Logistics Centre will allow the Company to execute all aspects of its supply chain including the
      repackaging of bulk cannabis and distribution capabilities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Adjupharm relies on its sales and distribution agreements to supply and distribute IMC-branded products to distribution partners in Germany, which are then distributed to German pharmacies. There are
      approximately 19,000 community pharmacies in Germany, each of which is permitted to create and dispense medications, including medical cannabis, pursuant to physician prescriptions.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup> In 2021, Adjupharm expanded its internal and external
      sales department and focused on increasing physician awareness and engagement to drive sales of IMC-branded medical cannabis products. The competitive advantage in Germany lies in the Group&#8217;s track record and brand reputation in Israel and
      proprietary data supporting the effectiveness of medical cannabis for the treatment of a variety of conditions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
    </div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup> Health Europa, June 23, 2020. <u>https://www.healtheuropa.eu/exploring-growth-in-the-european-medical-cannabis-market/100849/</u></div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup> Federal Union of German Associations of Pharmacists: Figures Data Facts 2021</div>
        <u> </u></div>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 38 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Specialized Skill and Knowledge</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group relies on the expertise of its personnel to provide value to its clients. The Group has over 10 years of experience in cultivating, propagating and processing cannabis under the guidance of
      experienced master grower, Doron Reznik. Following the IMC Restructuring, IMC Holdings retained its master grower to continue providing cannabis cultivation and production advice exclusively to Focus and Focus&#8217; third-party cultivation partners. In
      Canada, Trichome and its subsidiaries employ teams of highly specialized individuals with significant backgrounds and experience in cultivation, plant health, operations planning, and processing at their Canadian Facilities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Competitive Conditions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The medical and recreational cannabis industries in which the Group operates is, and is expected to remain, very competitive. Cannabis companies compete primarily on a regional basis, and competition
      may vary significantly from region to region at any particular time. The cannabis sector is in a high growth phase, with market participants engaged in significant expansion across global legal jurisdictions. The Company is working to achieve a
      leadership position in the cannabis industry by taking advantage of IMC brand recognition, earning superior margins as a fully integrated business, and leveraging its vast know-how and experience.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group faces competition in Israel from similar established medical cannabis brands and manufacturers in the domestic market. The Company expects that its experience and track record, attained via
      the combination of Focus&#8217; operations over the past decade and IMC brand recognition, will distinguish its offerings from competitors in the Israeli market. In addition, the Company believes that with its integrated supply chain and indoor cultivation
      in Canada permitting the export of premium and super-premium cannabis products to Israel, following the successful acquisition of the Canadian Facilities, it is uniquely positioned to address the needs of medical cannabis patients and customers.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s European operations will face competition from other entities licensed to cultivate, produce and distribute medical cannabis products in each respective jurisdiction. In Germany,
      Adjupharm will compete with a number of licensed manufacturers and distributors including currently established entities, expected new market entrants, and domestic producers of cannabis. Competitors vary from well-capitalized businesses with
      substantial operations and revenues to smaller or newer market entrants.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 39 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Canadian adult-use cannabis market is highly competitive, with over 800 active Licensed Producers in the country selling cannabis products across multiple segments and various quality and price
      points.&#160; The Company believes that it is attractively positioned with WAGNERS and the Highland Grow brand, as evidenced by its market share growth, given product quality, which exceeds competitors at similar price points.&#160; As additional producers
      become licensed to sell product in the Canadian market, the Company believes that TJAC&#8217;s premium cultivation assets put the Company in a strong competitive position to continue to supply the premium and ultra-premium markets in Canada in a profitable
      manner, at current price points, or in the event the Canadian market saw price compression in the premium markets.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Components</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s ability to operate the business is dependent on its ability to source raw materials, skilled labour, and equipment from its supply partners around the world. In particular, required
      production inputs include but are not limited to biological assets, utilities, product packaging, and specialized equipment for propagating and cultivating cannabis. Although the Group does not foresee an issue with the availability of these inputs
      as needed, the Group is wary of any increases in pricing for such inputs. If prices of inputs were to significantly increase, this may cause a material adverse effect on the Group&#8217;s business operations and financial condition. See &#8220;<font style="font-style: italic;">Risk Factors &#8211; Reliance on Key Business Inputs</font>&#8221; below for additional details.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Intangible Properties</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company relies on the licensing of its brand in Israel to widen its reach and offer branding, marketing and other related services to participants in the Israeli medical cannabis industry. The
      Group also plans to rely on the IMC brand to facilitate the distribution of cannabis products in international markets. The Group owns trademarks and trade secrets that allow it to serve a range of cannabis industry participants.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;IMC&#8221; is a registered trade name and trademark valid in Israel through May 2027, in Germany and in Portugal through the World Intellectual Property Organization through November 2027. In Canada, the
      Company applied for registration of the IMC name for use in connection with various food supplements, vitamins, minerals and proteins and is awaiting a response to its submissions. As of the date of this AIF, the pending trademark application has
      been examined by Canada Patent and Trademark Office. The opposition period ended on 19 March 2022 and the Company is waiting for registration.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In February 2022, the Company successfully completed the registration of its well-known medical cannabis brand strain &#8220;ROMA&#8221; as a trade name in Israel and is valid through July 2031. In addition, the
      Company commenced trademark applications for its new branding and the name &#8220;I AM Cannabis&#8221; in Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">TJAC has also commenced a trademark application for the name &#8220;WAGNERS&#8221; in Canada.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 40 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Cycles</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The demand for both medical cannabis products and recreational cannabis products is not materially influenced by seasonal or cyclical trends, and subject to the continued increase in demand in the
      medical cannabis market<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup> in Israel is consistent year-round. In Canada<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">11</sup>, some seasonality is noticeable in terms of sales volumes,
      whereby Q4 is typically the highest selling quarter in terms of volume due to the holiday season. Q1 is typically the lowest selling quarter in terms of volume as a result of increased stocking by the provinces in Q4 to meet the increased demand
      during the holiday season. Overall, the impact is relatively marginal. In addition, the Company&#8217;s cultivation strategy, as well as its globally integrated supply chain and its ability to secure additional supply from its cultivation and supply
      partners, allow it to provide consistent supply of cannabis products to its customers in all jurisdictions all year-round.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Economic Dependence</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Israel, the Company is substantially dependent on several categories of commercial agreements to ensure the continuity of its operations and maintain its revenues, including:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4ae23cb7164646d08e4c3fce492c9235">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Commercial Agreements, whereby IMC Holdings derives economic benefit from Focus and whereby Focus (i) uses the IMC brand on an exclusive basis for the sale of cannabis products; and (ii) engages IMC Holdings to provide certain
              management and consulting services. As a result of the Company&#8217;s commercial relationship with Focus, it is dependent on Focus maintaining the Focus License, the Focus Lease Agreement and the Focus Facility in good standing, as well as any
              ancillary licenses required to carry on its operations in the Israeli medical cannabis industry.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">On January 1, 2021, the Company amended the terms of each of the Commercial Agreements to align the consideration with implementation of the Company&#8217;s transfer pricing framework.
      The amendments to these agreements constituted a &#8220;related party transaction&#8221; as such term is defined in Multilateral Instrument 61-101 - <font style="font-style: italic;">Protection of Minority Security Holders in Special Transactions</font> (&#8220;<font style="font-weight: bold;">MI 61-101</font>&#8221;).&#160; The Company was exempt from the formal valuation requirement under Section 5.5(a) and the minority approval requirement under Section 5.7(1)(a) of MI 61-101, respectively, as the fair market value of
      the amendments, as determined by the Board, did not exceed 25% of the Company's market capitalization on the date of such amendment.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8206843c15434b2e881d026ea7ab5c7b">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Supply agreements with third party cannabis cultivators and suppliers to meet the Israeli market&#8217;s demand for the Company&#8217;s products.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7be3c541ba8049128c646606f5cdddef">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Purchase orders received from time to time for the sale of the Company&#8217;s products to pharmacies or distributors, either in association with Focus or through the Company&#8217;s direct trading house operations.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14c2ed840e9a4a0bae4af47d9857a584">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Ongoing retail purchases of the Company&#8217;s products sold at the Israeli Pharmacies by Israeli medical cannabis patients.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup><br>
        <u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u></div>
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><br>
          10</sup> IMCA - Up-to-date data from patient licenses (December 2021). P. 2 [Hebrew] https://www.health.gov.il/Subjects/cannabis/Documents/licenses-status-december-2021.pdf</div>
      <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">11</sup><u>https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=2010000801&amp;pickMembers%5B0%5D=2.30&amp;pickMembers%5B1%5D=3.1&amp;cubeTimeFrame.startMonth=01&amp;cubeTimeFrame.startYear=2020&amp;cubeTimeFrame.endMonth=02&amp;cubeTimeFrame.endYear=2021&amp;referencePeriods=20200101%2C20210201</u></div>
      <div><br>
      </div>
      <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 41 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">For additional information on potential risks arising from the Company&#8217;s economic dependence on Focus, its commercial and supply agreements with third parties and its pharmacy operations, see &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; below.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Germany, Adjupharm is substantially dependent on the supply, sales and distribution agreements with suppliers and German distributors, as listed and described under &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse Takeover Transaction</font>&#8221;. Any failure to maintain the Adjupharm License in good standing could have a material adverse effect on the Group. For additional
      information on potential risks arising from the Company&#8217;s dependence on Adjupharm&#8217;s operations, see &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; below.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Canada, TJAC and Highland Grow rely on and are substantially dependent on supply agreements for the sale of its products with certain provinces in Canada, with particular concentration in Ontario,
      Alberta, and Manitoba, in order to maintain revenues. A loss of one or a number of such supply agreements could materially impact TJAC&#8217;s and/or Highland Grow&#8217;s profit margins for the foreseeable future by requiring TJAC and/or Highland Grow to sell
      at lower margins through alternative sales channels, unless more suitable sales arrangements could be secured. Furthermore, in light of this dependence, any failure to maintain the TJAC Licenses or the TJAC Leases or the MYM Licenses or the Sublime
      Lease in good standing could have a material adverse effect on the Group. For additional information on potential risks arising from the Company&#8217;s dependence on its Canadian operations, see &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221;
      below.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Changes to Contracts</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There were no changes to contracts that materially affected the Company&#8217;s financial year ended December 31, 2021. As of the date of this Annual Information Form, the Company does not anticipate being
      materially affected by the renegotiation or termination of any material contracts or sub-contracts in the current financial year.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Environmental Protection</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s operations are subject to local environmental and safety laws and regulations concerning, among other things, emissions and discharges to water, air and land, the handling and disposal of
      hazardous and nonhazardous materials and wastes, and employee health and safety. The Company will incur ongoing costs and obligations related to compliance with environmental and employee health and safety matters. Failure to comply with
      environmental and safety laws and regulations may result in additional costs for corrective measures, penalties or in restrictions on the Company&#8217;s manufacturing operations. In addition, changes in environmental, employee health and safety or other
      laws, more vigorous enforcement thereof or other unanticipated events could require extensive changes to the Company&#8217;s operations or give rise to material liabilities, which could have a material adverse effect on the business, results of operations
      and financial condition of the Company. The Company places great importance on being a constructive and responsible contributor to the environment and incurs ongoing costs and obligations to ensure compliance with all applicable environmental and
      employee health and safety matters.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 42 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold; text-align: left;"><u>Employees</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of December 31, 2021, the Company and its subsidiaries employed approximately 283 employees and Focus employed approximately 56 employees.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of the date of this Annual Information Form, the Company and its subsidiaries employ approximately 336 employees and Focus employs approximately 50 employees.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Regulatory Framework</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">To operate its business, the Company must abide by applicable medical cannabis laws in those countries in which it operates, namely Israel, Germany and Canada. Each jurisdiction has unique laws and
      regulations on the propagation, cultivation, production, distribution, use, import and export of medical cannabis products and the current regulatory frameworks continue to evolve. The Company cooperates with the regulatory authorities in those
      jurisdictions in which it operates to ensure that it is at all times in full compliance with applicable laws, rules and regulations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israel</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In Israel, cannabis is currently defined as a &#8220;dangerous drug&#8221; according to the Dangerous Drugs Ordinance<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">12</sup> and the 1961 Single Convention on
      Narcotic Drugs (&#8220;<font style="font-weight: bold;">Narcotics Convention</font>&#8221;), to which Israel is a signatory. However, both the DDO and the Narcotics Convention allow for the use of cannabis for medical or research purposes under a supervised and
      controlled regime. The competent regulatory authority in Israel in all matters concerning the oversight, control and regulation of cannabis for medical production, consumption, and research in Israel is the IMCA, established by Government Res. No.
      3069.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">13</sup> The production, distribution and consumption of adult-use recreational cannabis products is currently illegal in Israel.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><u>Patient Medical Consumption</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The use of cannabis is allowed for patients and for medical purposes, in respect of certain medical conditions, under a special approval of the MOH. Procedure 106<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">14</sup> of the IMCA sets out a
      list of medical conditions that are allowed to be treated with medical cannabis products. Such authorized medical conditions are examined and updated from time to time, and include, among others, cancer, pain, nausea, seizures, muscle spasms,
      epilepsy, Tourette syndrome, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and post-traumatic stress disorder (PTSD).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Licensing and Authorization for Commercial Activities in the Medical Cannabis Field</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In December 2017, the IMCA issued regulations that standardized the licensing process for any cannabis related activity (the &#8220;<font style="font-weight: bold;">Road Map</font>&#8221;).<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">15</sup> Pursuant
      to the Road Map, each operation in the medical cannabis field, including the propagation, cultivation, products manufacturing, storage and distribution to licensed pharmacies, and distribution from licensed pharmacies to licensed patients, requires
      compliance with the provisions of applicable laws, including the procurement of an appropriate license under the DDO from the IMCA and the maintenance of such license in good standing. Cannabis licenses may not be transferred, exchanged or assigned
      without the prior approval of the IMCA. The licenses are valid for a period of up to 3 years and can be renewed with the approval of the IMCA only.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
    </div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">12</sup> Cannabis is listed in schedule 1 of the Dangerous Drugs Ordinance [New Version], 1973 [Hebrew]</div>
      <div style="text-align: justify; line-height: 1.25;">https://www.health.gov.il/LegislationLibrary/Samim_01_EN.pdf</div>
      <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">13</sup> Israeli Government Res. No. 3609 [Hebrew], August 7th, 2011 <u>https://www.gov.il/he/Departments/policies/2011_des3609</u></div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">14</sup> Ministry of Health Pharmaceutical Division Policy Number 106 &#8211; Licenses for Use of Cannabis</div>
        <div style="text-align: justify; line-height: 1.25;"><u>https://www.health.gov.il/hozer/CN_106_2019.pdf</u>&#160; (in Hebrew)</div>
        <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">15</sup> Directive 107 - Guidelines for the process of licensing the practice of cannabis for medical use, as amended on October 2020 [Hebrew] - <u>https://www.health.gov.il/hozer/CN_107_2019.pdf</u></div>
      </div>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 43 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">The MOH has issued a set of directives containing procedures and requirements for applicants for cannabis related activity licenses and has authorized certain entities to issue official certificates
      upon compliance with such directives. These directives include (i) Directive 150 (GSP Standard certification); (ii) Directive 151 (GAP Standard certification); (iii) Directive 152 (GMP Standard certification); and (iv) Directive 153 (GDP Standard
      certification).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Regular and periodic examinations are conducted for licensed entities, in order to ensure compliance with the analytical standards and the level of quality required during each of the phases of
      production and distribution of medical cannabis.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><u>Medical Cannabis Imports and Exports</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Narcotics Convention governs the import and export of cannabis between member countries. Since Israel is a member country, any export and import of cannabis is subject to the Narcotic Convention.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">In October 2020, the IMCA issued an updated procedure, titled &#8220;Guidelines for Approval of Applications for Importation of Dangerous Drug of Cannabis Type for Medical Use and for
      Research&#8221; (&#8220;<font style="font-weight: bold;">Procedure 109</font>&#8221;), describing the application requirements for cannabis import licenses for medical and research purposes. Therefore, each import of medical cannabis is to be approved by the IMCA
      issuing a specific import permit for each imported shipment, rather than a general license for import. An application for import of medical cannabis can be submitted by an entity licensed by the IMCA for the conduct of medical cannabis related
      activity.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">The Israeli government approved the export of pharmaceutical-grade cannabis and cannabis-based products on January 27, 2019,<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">16</sup> and in December 2020, the IMCA published
      guidelines for the medical cannabis export permit application process.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">17</sup></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Legalization of Adult-Use Recreational Cannabis and CBD for Non-Medical Purposes in Israel</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">As of the date of this Annual Information Form, adult-use recreational cannabis use in Israel and CBD for non-medical use is illegal. In November 2020, an Israeli government
      committee responsible for advancing the cannabis market reform published a report supporting and recommending the legalization of adult-use recreational cannabis in Israel. The Israeli parliament dissolved since then without applying the committee&#8217;s
      recommendations and all legislative initiatives were suspended. However, the new government, formed on June 13, 2021, declared, and settled in the coalition agreement, its commitment to legalization of adult-use recreational cannabis. Since the
      formation of the new government, several legislative initiatives were filed, including for the decriminalization of the possession of cannabis for individual recreational adult-use and the legalization of CBD for non-medical use. These initiatives
      were not accepted; however they are viewed as first steps towards more comprehensive legislation towards the legalization of adult-use recreational cannabis. Members of the Israeli government continue to affirm their commitment to the legalization of
      adult-use recreational cannabis.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif; text-align: left;">
      <div><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup></div>
      <div><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
        </u>
        <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">16</sup> Directive 4490 [Hebrew] - <u>https://www.gov.il/he/departments/policies/dec4490_2019</u></div>
        <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">17</sup> Directive 110, December 2020 [Hebrew] - <u>https://www.health.gov.il/hozer/CN_110.pdf</u></div>
        <div><br>
        </div>
      </div>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div ><font  style="font-weight: normal; font-style: normal;">- 44 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><u>Previous Regime and Price Control</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Until September 2019, under the previous regime, patients licensed for consumption of medical cannabis products by the IMCA received all of their medical cannabis products authorized under their
      respective licenses at a fixed monthly price of NIS 370, regardless of each patient&#8217;s authorized amount.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Since September 2019, under the new regime, licenses to patients were no longer entitling them for such fixed monthly price. However, some medical cannabis patient licenses granted under the previous
      regime remain valid, entitling their holders to receive medical cannabis products pursuant to the price controls and supplier restrictions of the former regime. All licenses under the previous regime expired in Q1 2022. For more information, please
      see <font style="font-style: italic;">&#8220;Legal Proceedings and Regulatory Actions &#8211; Legal Proceedings &#8211; Supreme Court of Justice 2335/19&#8221;</font>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Germany</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">On March 10, 2017, the German federal government enacted bill Bundestag-Drucksache 18/8965 &#8211; <font style="font-style: italic;">Law amending narcotics and other regulations </font>that




      amended existing narcotics legislation to recognize cannabis as a form of medicine and allow for the importation and domestic cultivation of medical cannabis products. Under the updated legislation, cannabis is listed in Annex 3 to the <font style="font-style: italic;">Federal Narcotics Act</font> (&#8220;<font style="font-weight: bold;">BtMG</font>&#8221;) as a &#8220;marketable narcotic suitable for prescription&#8221;. Legalization in Germany applies only to cannabis for medicinal purposes under state
      control in accordance with the Narcotic Convention. Currently, the production, distribution, exportation and importation of medical cannabis products in Germany is legal, subject to regulations and licensing requirements, while operations involving
      adult-use recreational cannabis products remain illegal. Nevertheless, current German government has declared in the coalition agreement its intention to open up the German market also in the recreational market. So far, however, there have been no
      visible further developments in this regard. Medical cannabis in Germany must comply with the corresponding monographs of the German and European pharmacopoeia. All BtMG permit applications must specify the strains and estimated quantities of medical
      cannabis involved and any subsequent changes must be reported to the Federal Opium Agency of Germany.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">Unlike cannabis, CBD is not subject to German narcotics laws and may or may not be subject to German drug laws, depending on its use and dosage. Annex 1 of the Ordinance on the
      Prescription of Medicinal Products stipulates that CBD is in principle subject to prescription but does not specify a minimum quantity or a specific dosage form. However, a distinction must be made between consumable products that naturally contain
      CBD and those that are infused with CBD extract; the European Commission considers the latter to be a type of &#8220;food&#8221;. In light of the above, various products containing CBD can be found in the German market.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><u>Cultivation in Germany and Distribution of Medical Cannabis Cultivated in Germany</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">The Federal Opium Agency of Germany&#8217;s Federal Institute for Drugs and Medical Devices (&#8220;<font style="font-weight: bold;">BfArM</font>&#8221;) formed a cannabis division (the &#8220;<font style="font-weight: bold;">Cannabis Agency</font>&#8221;) to oversee cultivation, harvesting, processing, quality control, storage, packaging and distribution to wholesalers, pharmacists and manufacturers. The Cannabis Agency also regulates pricing of
      German-produced medical cannabis products and serves as an intermediary of medical cannabis product sales between manufacturers, wholesalers and pharmacies on a non-profit basis.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">18</sup> In late
      2018, the Cannabis Agency issued a call for tenders to award licenses for local medical cannabis cultivation and distribution of German-cultivated medical cannabis products (the &#8220;<font style="font-weight: bold;">German Local Tender</font>&#8221;). The
      Cannabis Agency would serve as an intermediary in the supply chain between such cultivation and distribution. In April 2019, three licenses for local cultivation were granted. In consequence three companies in Germany cultivate on behalf of the
      Cannabis Agency of the BfArM. Each license permitted the holder to grow up to 200kg per year for total production of 2,600kg per year collectively from the 13 cultivation lots and 10,400kg over the four-year license period. In July 2021, the BfArM
      launched the state sale of cannabis grown in Germany. Since then, pharmacies have been able to purchase medical cannabis in pharmaceutical drug quality for the supply of patients from the BfArM via the portal www.cannabisagentur.de. The sale from the
      BfArM to pharmacies is at a price of 4.30 euros per gram.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">19</sup></div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> <br>
      </sup></div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> <br>
      </sup></div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">
      <div style="line-height: 1.25;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u>
        <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">18</sup> <u>www.bfarm.de/DE/Bundesopiumstelle/Cannabis/Cannabisagentur/_node.html</u></div>
        <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">19</sup> <u>www.bfarm.de/DE/Bundesopiumstelle/Cannabis/Cannabisagentur/_node.html</u></div>
      </div>
      <sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup></div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> <br>
      </sup></div>
    - 45 -<br>
  </div>
  <div> </div>
  <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div  style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div><br>
    <div style="line-height: 1.25"><br>
    </div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">The Cannabis Agency has no influence on the actual retail price of medical cannabis products, and is not responsible for the import of medical cannabis products and will
      therefore neither purchase nor distribute imported medical cannabis products. As a wholesaler, the Cannabis Agency sells German-based medical cannabis products in its own name.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><u>Import Volumes and Procedures</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">The current regime permits the importation of cannabis plants and plant parts for medicinal purposes under state control subject to the requirements under the Narcotic
      Convention, according to which, Germany must estimate the expected demand of medical cannabis products for medical and research purposes for the following year and report such estimates to the International Narcotics Control Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">As a prerequisite to obtaining a German import license, the supplier must grow and harvest in compliance with EU-GACP Standard Guidelines and manufacture in compliance with
      EU-GMP Standard Guidelines<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">20</sup> and certifications.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">21</sup><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"></sup> All medical cannabis products imported to Germany must derive from plant
      material cultivated in a country whose regulations comply with the Narcotic Convention, and must comply with the relevant monographs described in the German and European pharmacopeias. While these requirements also apply to the exportation of medical
      cannabis products, the current German regime does not allow domestically cultivated medical cannabis products to be directly sold to commercial entities other than the Cannabis Agency.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><u>Dispensing Exclusively via Pharmacies</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Medical cannabis products imported pursuant to an import license under the BtMG and AMG/BtMG permits are sold exclusively to pharmacies for final dispensing to patients on a prescription basis as
      &#8216;magistral preparations&#8217;, a term used in Europe to refer to medical products prepared in a pharmacy in accordance to a medical prescription for an individual patient. Magistral preparations require certain manufacturing steps in the pharmacy. Such
      manufacturing steps of the pharmacist typically include the testing and dosing of pre-packaged cannabis inflorescences (typically referred to as &#8220;floss&#8221;), medical cannabis products for oral administration (dronabinol), medical cannabis products for
      inhalation upon evaporation, and medical cannabis-infused teas. In addition to magistral preparations, medical cannabis products are also&#160;marketable as pre-packaged, licensed drugs (e.g. Sativex&#174;).</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u> </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">20</sup> The point at which GACP ends and GMP begins differs for flowers and extracts.</div>
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">21</sup> The certificates may usually be a maximum of 2-3 years old and must come from a European authority, unless there are facilitations based on an MRA/ACAA.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <br>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 46 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-style: italic;">Canada</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Cannabis Act and the Cannabis Regulations came into force on October 17, 2018, legalizing the sale of adult-use recreational cannabis. The Cannabis Act and Cannabis Regulations establish a
      licensing and permitting scheme for the production, importation, exportation, testing, packaging, labelling, sending, delivery, transportation, sale, possession and disposal of adult-use recreational cannabis.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On October 17, 2019, amending regulations titled the <font style="font-style: italic;">Regulations Amending the Cannabis Regulations </font>came into force that, among other things, expanded the
      scope of the Cannabis Act and Cannabis Regulations to enable the sale of certain categories of cannabis, including cannabis extracts, topicals and edibles, and set THC content limits for certain categories of cannabis products.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Licensing</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Cannabis Regulations establish six classes of licenses under the Cannabis Act: (i) cultivation licences, including standard cultivation, micro-cultivation and nursery sub-classes; (ii) processing
      licences, including standard processing and micro-processing sub-classes; (iii) analytical testing licences; (iv) sales for medical purposes licences; (v) research licences; and (vi) cannabis drug licences. These licences are valid for a period of up
      to five years. Licence requirements and rules differ depending on the class and/or sub-class of the licence.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Security Clearances</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Certain people associated with cannabis licensees must hold a valid security clearance issued by Canada&#8217;s Minister of Health. For example, in the case of corporations that hold licences for
      cultivation, processing or sale, directors, officers and other individuals who exercise, or are in positions to exercise, direct control over the corporation are required to hold such a security clearance. Under the Cannabis Regulations, the Minister
      may refuse to grant security clearances to individuals with organized crime associations or past convictions for, or in association with, drug trafficking, corruption or violent offences. Individuals who have a history of nonviolent, lower-risk
      criminal activity (for example, simple possession of cannabis or small-scale cultivation of cannabis plants) are not precluded by legislation from participating in the legal cannabis industry, and the granting of security clearance to such
      individuals is at the discretion of the Minister.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Cannabis Tracking System</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Under the Cannabis Act, the Minister is authorized to establish and maintain a national cannabis tracking system. Accordingly, Health Canada introduced the Cannabis Tracking and Licensing System,
      whereby licence holders are required to use this online system to submit monthly tracking reports, new license applications and licence renewal requests, among other things. The purpose of this system is to track cannabis throughout the supply chain
      to help prevent diversion of cannabis into, and out of, the legal market. The Cannabis Act provides the Minister with the authority to make a ministerial order that would require licensees to report specific information about their authorized
      activities with cannabis, in the form and manner specified by the Minister.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Cannabis Products</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Cannabis Act and Cannabis Regulations, as amended, set out the requirements for the sale of dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis edibles, cannabis extracts
      and cannabis topicals. Among other requirements, THC content limits are prescribed depending on the product category.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 47 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Packaging &amp; Labelling</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Cannabis Regulations set out detailed requirements pertaining to the packaging and labelling of cannabis products that seek to promote informed consumer choice and allow for the safe handling and
      transportation of cannabis, while also reducing the appeal of cannabis to youth and promoting safe consumption. These requirements include plain packaging for cannabis products and packaging that is tamper-proof and child-resistant. The Cannabis
      Regulations further require package labels to include, among other information, the class of cannabis and the name, phone number and email of the licensed cultivator or processor, the standardized cannabis symbol and information pertaining to the THC
      and CBD content. Specific requirements vary depending on the product category of cannabis.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Promotion</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Cannabis Act prohibits the promotion of cannabis, cannabis accessories and cannabis-related services unless authorized by the Cannabis Act through certain exceptions prescribed in the Cannabis
      Act and the Cannabis Regulations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Medical Cannabis</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition to governance of recreational cannabis activities, the Cannabis Regulations also govern the regulatory framework associated with medical cannabis in Canada. Prior to the coming into force
      of the Cannabis Act and Cannabis Regulations, the sale of medical cannabis was permitted under the ACMPR. Although the ACMPR was replaced by the Cannabis Act and Cannabis Regulations, the new rules were not significantly different from the previous
      rules; changes were made to improve patient access, ensure consistency with recreational cannabis rules, and reduce the risk of abuse within the medical access system.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><u>Provincial and Territorial Regulatory Framework</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">While the Cannabis Act provides for the regulation of adult-use cannabis production by the federal government, provincial and territorial governments maintain authority to regulate other aspects of
      adult-use recreational cannabis activities such as sale and distribution, minimum age requirements, and places where cannabis can be consumed.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 48 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The following chart summarizes the basic recreational cannabis regimes in place as of the date of this Annual Information Form:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z7f1662a3efb94d8a8e691c2f234548d8">

        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Province or Territory</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Minimum Age to Purchase Recreational Cannabis Products</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Private and/or Public Operated Retailers</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Online Sales</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Alberta</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">18</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">British Columbia</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Manitoba</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">New Brunswick</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Newfoundland and Labrador</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Nova Scotia</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Ontario</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Prince Edward Island</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Quebec</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">21</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Saskatchewan</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Northwest Territories</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Nunavut</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yukon</div>
          </td>
          <td style="width: 26.9%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
          </td>
          <td style="width: 25.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
          </td>
          <td style="width: 22.16%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Bankruptcy</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">No voluntary or involuntary bankruptcy, receivership or similar proceedings have been engaged against the Group during the financial years ended December 31, 2021, December 31, 2020, December 31,
      2019. No proceedings have been engaged against Focus, the Company or any of the Company&#8217;s subsidiaries as of the date of this Annual Information Form.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Reorganizations</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Other than as described below, no material reorganizations of the Company or any of its subsidiaries have taken place within the financial years ended December 31, 2021, December 31, 2020, December
      31, 2019, or as of the date of this Annual Information Form, and there are no proposed reorganizations as of the date of this Annual Information Form.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On October 11, 2019, the Company completed the Reverse Takeover Transaction.<font style="font-weight: bold;">&#160;</font>The Reverse Takeover Transaction was effected by way of a &#8220;triangular merger&#8221;
      between the Company, IMC Holdings and a wholly-owned subsidiary of the Company pursuant to Israeli statutory law. The Board and management of the Company were reconstituted and subsequently led by Oren Shuster. As a result of the Reverse Takeover
      Transaction, the Company changed its business from mining to the international medical cannabis industry. Upon the completion of the Trichome Transaction, the Company expanded its activities to the Canadian recreational cannabis industry.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 49 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Social or Environmental Policies</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company has not implemented any specific social or environmental policies that are fundamental to the Company&#8217;s operations, other than as stated below. However, the Company consults with local
      advisors to ensure that the Group is in compliance with local environmental laws in each of the Group&#8217;s operational jurisdictions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">TJAC and MYM have drafted and implemented very strict health and safety policies governing employee operations regarding hearing protection, eye protection and respiratory protection that supersedes
      minimum levels suggested by the Canadian Ministry of Labour.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="RISKFACTORS"><!--Anchor--></a>RISK FACTORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There are certain risks associated with owning securities of the Company that holders should carefully consider. The risks and uncertainties below are not the only risks and uncertainties facing the
      Company. Additional risks and uncertainties not presently known to the Company or that the Company currently considers immaterial may also impair the business, operations and future prospects of the Company, cause the price of its securities to
      decline and cause future results to differ materially from those described herein. If any of the following risks actually occur, the business of the Company may be harmed and its financial condition and results of operations may suffer significantly.
      In that event, the trading price of the Company&#8217;s securities could decline, and holders may lose all or part of their investment. In addition to the risks described elsewhere in the Company&#8217;s filings on SEDAR at <u>www.sedar.com</u>, holders of
      securities should carefully consider each of, and the cumulative effect of all of, the following risk factors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The cannabis-related business and activities of the Group are heavily regulated in all jurisdictions where it carries on business. The Group&#8217;s operations are subject to various laws, regulations and
      guidelines by governmental authorities, particularly the MOH in Israel, Health Canada in Canada and BfArM in Germany, relating to the grow, propagate, manufacture, marketing, management, transportation, storage, distribution, sale, pricing and
      disposal of dried and fresh cannabis, cannabis plants and seeds, edible cannabis, cannabis extracts and cannabis topicals, in Canada and dried and fresh cannabis, cannabis seeds, clones and plants and cannabis extracts in Israel and in Germany. The
      Group&#8217;s operations are also subject to laws and regulations relating to health and safety, insurance coverage, the conduct of operations and the protection of the environment.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Consolidation of Certain Financial Results under IFRS 10 and Maintenance of Common Control</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company complies with IFRS 10, which applies a single consolidation model using a definition of &#8220;control&#8221; that requires an investor (as defined in IFRS 10) to consolidate an investee (as defined
      in IFRS 10) where: (i) the investor has power over the investee; (ii) the investor has exposure or rights to variable returns from involvement with the investee; and (iii) the investor can use its power over the investee to affect the amount of the
      investor&#8217;s returns.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Subsequent to the IMC Restructuring, the Company analyzed the terms of the contractual agreements with Focus (including the Commercial Agreements and the Focus Agreement) in accordance with IFRS 10
      to conclude whether it should continue to consolidate the accounts of Focus in its financial statements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Under IFRS 10, consolidation occurs when an investor can exercise control over an investee. Control is achieved through voting rights or other evidence of power. Where there are no direct holdings,
      under IFRS 10, an investor (as defined in IFRS 10) should consider other evidence of power and ability to unilaterally direct an investee&#8217;s (as defined in IFRS 10) relevant activities. In view of the contractual agreements and the guidance in IFRS
      10, notwithstanding that the Company has no direct or indirect ownership of Focus, it has sufficient rights to unilaterally direct the relevant activities (a concept known as &#8220;de facto control&#8221;), mainly due to the following:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4c27fd05ff464468ba91a942168d36de">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company receiving economic benefits from Focus (and the terms of the Commercial Agreements cannot be changed without the approval of the Company);</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 50 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z01aa354294b543eb96f02437f14a971a">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company having the option to purchase the divested 74% interest in Focus held by Oren Shuster, the CEO, director and a promoter of the Company, and Rafael Gabay, a former consultant director, a former consultant and a promoter of the
              Company;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf6421b36a48e4c49b96e8e5087582609">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Messrs. Shuster and Gabay each being a director of Focus (while Mr. Shuster concurrently being a director, officer and substantial shareholder of the Company and Mr. Gabay concurrently being a substantial shareholder of the Company); and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfc0b0c0e30fb4cb1952c12150e8dfa33">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(d)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company providing management and support activities to Focus through the Services Agreement.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Accordingly, under IFRS 10, the Company has &#8220;de facto control&#8221; over Focus, and therefore consolidates the financial results of Focus in the Company&#8217;s financial statements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Any failure of the Company or Messrs. Oren Shuster and Rafael Gabay to maintain &#8220;de facto control&#8221; over Focus as defined under IFRS 10 could alter the Company&#8217;s consolidation model, potentially
      resulting in a material adverse effect on the business, results of operations and financial condition of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">For the period ended December 31, 2021, the Company analyzed the terms of the definitive agreements with each of its Consolidated Entities in accordance with accounting criteria IFRS 10. Viewed as
      effectively exercising control over these Consolidated Entities, the Company&#160;consolidate the financial results of the Consolidated Entities as of the date of signing each such definitive agreement. Each of the definitive agreements for the Panaxia
      Transaction, the Pharm Yarok Transaction, the Vironna Transaction and the Oranim Transaction provide the Company with the power to unilaterally make all decisions regarding the financial and operating policies of each of the Consolidated Entities and
      the right to obtain all related economic benefits. The Panaxia Transaction, the Pharm Yarok Transaction, the Vironna Transaction and the Oranim Transaction were completed in the first quarter of 2022. For further information on the closing the
      transactions, please see &#8220;<font style="font-style: italic;">General Development of the Business &#8211;</font>&#160;<font style="font-style: italic;">Developments Following the Reverse Takeover Transaction &#8211;</font>&#160;<font style="font-style: italic;">Developments
        Following the Financial Year Ended December 31, 2021</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Ownership of Focus</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There is a risk that regulatory authorities in Israel may view the Company as the deemed owner of more than 5% of Focus and/or determine that the Company is in contravention of Israeli cannabis
      regulations. Namely, prior approval of the IMCA is required for any shareholder owning 5% or more of an Israeli company licensed to engage in cannabis-related activities. Any contravention of Israeli cannabis regulations could jeopardize the good
      standing of the Focus License. Such a determination may adversely affect the Company&#8217;s ability to conduct sales and marketing activities and could have a material adverse effect on the Company&#8217;s business, operating results or financial condition.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Involvement in the Israeli Cannabis Industry</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Following the completion of the Panaxia Transaction, the Pharm Yarok Transaction, the Vironna Transaction and the Oranim Transaction (as described in &#8220;<font style="font-style: italic;">General
        Development of the Business &#8211; Developments Following the Reverse Takeover Transaction &#8211; Developments Following the Financial Year Ended December 31, 2021</font>&#8221;), the Company, through IMC Holdings, is now licensed to directly engage in the
      storage, distribution, transportation and sale of medical cannabis products in Israel (the &#8220;<font style="font-weight: bold;">Israeli</font>&#160;<font style="font-weight: bold;">Cannabis Activities</font>&#8221;) in accordance with the current Israeli
      regulatory medical cannabis framework, which requires, among other things, pre-approvals by the IMCA of all directors, officers and shareholders holding over 5% of the &#160;license applicant and applies limitations on future securityholdings.
      Furthermore, due to the uncertainty related to the broad administrative discretion of the IMCA over the activities in the medical cannabis industry in Israel, the aforementioned approvals and restrictions may apply to the Company and its shareholders
      by virtue of a subsidiary engaging in Israeli Cannabis Activities. Any inability of the Company or any of its subsidiaries to comply with IMCA regulations could lead to enforcement action by the IMCA that impacts the ability of the Company to operate
      the Israeli Cannabis Activities, resulting in a material adverse effect on the business, results of operations, financial condition and prospects of the Company.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 51 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Governmental Regulation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israel &#8211; MOH Regulation</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Laws and regulations, applied generally, grant government agencies and self-regulatory bodies broad administrative discretion over the activities of Focus and of the Israeli Pharmacies, Rosen High
      Way and IMC Pharma (the Israeli Pharmacies, Rosen High Way and IMC Pharma are collectively, the &#8220;<font style="font-weight: bold;">Israeli</font>&#160;<font style="font-weight: bold;">Licensed Companies</font>&#8221;), which can include the power to limit or
      restrict business activities, the import and export of cannabis products and the imposition of additional quality criteria and disclosure requirements on the products and services provided by Israeli Licensed Companies and Focus. Achievement of the
      Israeli Licensed Companies<font style="font-weight: bold;">&#160;</font>and Focus business objectives are contingent, in part, upon compliance with regulatory requirements enacted by these governmental authorities and obtaining all regulatory approvals,
      where necessary, for the production and sale of its products.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company cannot predict the time required for the Israeli Licensed Companies or Focus to secure all appropriate regulatory approvals for the products and activity, or the extent of testing and
      documentation that may be required by governmental authorities. Any delays in obtaining, or failure to obtain regulatory approvals would significantly delay the development of markets and products and could have a material adverse effect on the
      business, results of operations, financial condition and prospects of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Failure to comply with the laws and regulations applicable to its operations may lead to possible sanctions including the revocation or imposition of additional conditions on licenses to operate the
      Israeli Licensed Companies<font style="font-weight: bold;">&#160;</font>and/or the<font style="font-weight: bold;">&#160;</font>Focus business, the suspension or expulsion from a particular market or jurisdiction or of its key personnel, and the imposition of
      fines and censures. To the extent that there are changes to the existing laws and regulations or the enactment of future laws and regulations that affect the sale or offering of the Israeli Licensed Companies<font style="font-weight: bold;">&#160;</font>and/or<font style="font-weight: bold;">&#160;</font>Focus products or services in any way, this could have a material adverse effect on the business, results of operations, financial condition and prospects of the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canada &#8211; Health Canada Regulation</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Canadian cannabis market is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations, which include a licensing and regulatory scheme governing the production, importation,
      exportation, testing, packaging, labelling, delivery, transportation, sale, possession and disposal of cannabis for adult use recreational and medical use.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On October 17, 2019, targeted amendments to the Cannabis Act and Cannabis Regulations came into force, adding three new authorized classes of cannabis for sale: edibles, extracts and topicals. The
      amendments introduced new regulatory controls to address sale of the new product classes, content and product specifications, packaging and licensing requirements. The effect of Health Canada&#8217;s administration, application and enforcement of this new
      regulatory regime on the Company is unknown and the interpretation and application of the regulations may change at any time, or their implementation may be delayed. There is no assurance that the Company will be able to comply with these new
      regulations.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 52 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In addition, the governments of every Canadian province and territory have enacted and implemented their respective regulatory regimes for the distribution and sale of adult-use recreational cannabis
      within those jurisdictions. Various different models for distribution and sale have been implemented in each jurisdiction across Canada including government-operated retail and/or distribution models, privately operated retail and/or distribution
      models and hybrid approaches. These provincial and/or territorial legislation and regulatory regimes may change in ways that impact our ability to continue our business as currently conducted or proposed to be conducted. There is no guarantee that
      provincial or territorial regulatory regimes governing the distribution and sale of adult-use recreational cannabis in each jurisdiction will remain as currently enacted or that any such legislation and regulation will create the growth opportunities
      that the Companycurrently anticipates. The federal and provincial or territorial legislation and regulatory regimes for cannabis products also include excise duties payable by licenced cannabis producers on adult-use recreational cannabis products,
      in addition to goods and services tax/harmonized sales tax in certain provinces and territories. The rate of the excise duties for cannabis products varies by province and territory. Any significant increase in the rate of excise duties on cannabis
      products in the future could reduce consumer demands for cannabis products and adversely impact the adult-use recreational cannabis industry and market in general. In addition, any increase in the rate of excise duties on cannabis products in the
      future could reduce the Company&#8217;s margins and profitability in the event that the Company could not or chose not to pass along such increases to consumers. Any of the foregoing could result in a material adverse effect of the Company&#8217;s business,
      financial condition, results of operations and prospects.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The adult-use recreational cannabis industry and market in Canada is also subject to certain risks that are unique to this industry, as well as the risks that are currently applicable to the
      adult-use recreational and medical cannabis markets which are described elsewhere in this section. If any of these shared risks occur, the Company&#8217;s business, financial condition, results of operations and prospects could be adversely affected in a
      number of ways, including by not being able to successfully compete in the adult-use recreational cannabis industry and by being subject to fines, damage awards and other penalties as a result of regulatory infractions or other claims brought against
      the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Germany &#8211; BfArM Regulation</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">Legalization in Germany applies only to cannabis stemming from cultivation for medicinal purposes under state control and in preparations as finished medicinal products, in
      accordance with the Narcotic Convention. Currently, the production, distribution, exportation and importation of medical cannabis products in Germany is legal, subject to regulations and licensing requirements. Medical cannabis in Germany must comply
      with the corresponding monographs of the German and European pharmacopoeia.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">The import, export and distribution of medical cannabis currently requires a wholesale permit pursuant to the AMG and a distribution permit for narcotics pursuant to the BtMG.
      Manufacturing operations require authorizations pursuant to AMG. All BtMG permit applications must specify the strains and estimated quantities of medical cannabis involved and any subsequent changes must be reported to the BfArM. The import of
      medical cannabis from other EU and non-EU countries requires quantity-based import licenses pursuant to the BtMG. In addition, for imports from a non-EU country, an import certificate pursuant to the AMG is required and in certain circumstances,
      depending on the import source, a general import permit may also be required under the AMG.</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 53 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">The Cannabis Agency, a cannabis division of the BfArM is overseeing the cultivation, harvesting, processing, quality control, storage, packaging and distribution to wholesalers,
      pharmacists and manufacturers. The Cannabis Agency also regulates pricing of German-produced medical cannabis products and serves as an intermediary of medical cannabis product sales between manufacturers, wholesalers and pharmacies on a non-profit
      basis. The Cannabis Agency has no influence on the actual retail price of medical cannabis products. The responsibilities of the Cannabis Agency are based on the requirements of the Narcotic Convention. The Cannabis Agency is not responsible for the
      import of medical cannabis products and will therefore neither purchase nor distribute imported medical cannabis products. As a wholesaler, the Cannabis Agency sells German-based medical cannabis products in its own name. The Cannabis Agency
      contracted with a distributor that was selected in a Europe-wide tender procedure and commissioned it to carry out the distribution of medical cannabis products in accordance with all pharmaceutical and narcotic legal requirements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">The current regime permits the importation of cannabis plants and plant parts for medicinal purposes under state control subject to the requirements under the Narcotic
      Convention. Pursuant to Narcotic Convention, Germany must estimate the expected demand of medical cannabis products for medical and research purposes for the following year and report such estimates to the International Narcotics Control Board. The
      estimates are also required to be reported by the BfArM by June 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of each year.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As a prerequisite to obtaining a German import license, the supplier must grow and harvest in compliance with EU-GACP-Guidelines and manufacture in compliance with EU-GMP-Guidelines and
      certifications. All medical cannabis products imported to Germany must derive from plant material cultivated in a country whose regulations comply with the Narcotic Convention and must comply with the relevant monographs described in the German and
      European pharmacopeias. While these requirements also apply to the exportation of medical cannabis products, the current German regime does not allow domestically cultivated medical cannabis products to be directly sold to commercial entities other
      than the Cannabis Agency. Medical cannabis products imported pursuant to an import license under the BtMG and AMG permits are sold exclusively to pharmacies for final dispensing to patients on a prescription basis as &#8216;magistral preparations&#8217;, a term
      used in Europe to refer to medical products prepared in a pharmacy in accordance to a medical prescription for an individual patient. In addition to magistral preparations, medical cannabis products are also&#160;marketable as pre-packaged, licensed
      drugs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Failure to comply with the laws and regulations applicable to the Company's operations may lead to possible sanctions, including revocation or suspension of licences (and thus the Company's inability
      to operate), recalls and withdrawals (both regulatory and as a result of competition law proceedings), the loss of eligibility as a corporate body of a corporation or as a medicinal product or narcotics law functionary (and thus the Company's
      inability to operate), flanked by administrative fines for regulatory offences, fines and imprisonment for criminal offences as well as administrative orders (requirements, prohibitions, etc.) as well as competition law warnings and proceedings (such
      as injunctions).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Reliance on Licensing</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israel &#8211; Reliance on the Israeli Licenses</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s ability to produce, store, import, distribute and sell cannabis in Israel is dependent on the Israeli Licensed Companies and Focus maintaining the Israeli Licenses with the IMCA.
      Failure to comply with the requirements or any failure to maintain the Israeli Licenses would have a material adverse impact on the business, financial condition and operating results of the Company. There can be no guarantees that the IMCA&#160;will
      extend or renew any of Israeli Licenses as necessary or, if it extended or renewed, that any of the Israeli Licenses will be extended or renewed on the same or similar terms. Should the IMCA&#160;not extend or renew any of Israeli Licenses or should it
      renew any of the Israeli Licenses on different terms, the business, financial condition and results of the operations of the Companywould be materially adversely affected.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 54 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canada &#8211; Reliance on the Canadian Licenses</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s ability to produce, store and sell cannabis and derivate products in Canada is dependent on TJAC and MYM maintaining the Canadian Licenses. Failure to comply with the requirements of
      the Health Canada issued licenses or any failure to maintain their respective licenses would have a material adverse impact on the business, financial condition and operating results of the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Although management believes it will continue to meet the requirements of the Cannabis Act for extension of the Canadian Licenses, there can be no guarantee that Health Canada will extend or renew
      the applicable licences or, if it is extended or renewed, that it will be extended or renewed on the same or similar terms. Should Health Canada not extend or renew each of the Canadian Licenses, or should it renew the Canadian Licenses on different
      terms or not provide the amendments as requested for anticipated capacity increases, the business, financial condition and results of the operations of the Companywill be materially adversely affected. TJAC and MYM have also each been issued a
      cannabis license under the <font style="font-style: italic;">Excise Act</font> which is required to package and distribute cannabis as described herein.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Prior to the expiry of each licence, TJAC and MYM must submit to Health Canada an application for renewal of the licence containing information prescribed by the Cannabis Act. Failure to comply with
      the requirements of the licence or any failure to renew the licence would have a material adverse impact on the business, financial condition, results of operations and prospects of the Company. The Company is not currently aware of any circumstances
      that would impede the renewal of any of its Canadian Licences.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Germany &#8211; Reliance on the Adjupharm Licenses</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s ability to produce and distribute cannabis through Adjupharm&#8217;s certification as a EU-GMP and EU-GDP producer and distributor in Germany with wholesale, narcotics handling,
      manufacturing, procurement, storage and distribution authority is granted by German regulatory authorities.&#160; As of the date of this Annual Information Form, the quantities for import under the Adjupharm Licenses were updated on March 4, 2022. Failure
      to comply with the requirements of the BfArM issued licenses or any failure to maintain their respective licenses would have a material adverse impact on the business, financial condition and operating results of the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Reliance on Licensed Facilities</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israel &#8211; Reliance on the Company&#8217;s Facilities</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">The Focus Facility</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Focus License is specific to the Focus Facility and both must remain in good standing for Focus to conduct the medical cannabis activities authorized thereunder. Adverse changes or developments
      affecting the Focus Facility, including but not limited to the failure to maintain all requisite regulatory and ancillary permits and licenses, the failure to comply with state or municipal regulations, or a breach of security, could have a material
      adverse effect on the Company&#8217;s business, financial condition, results of operations and prospects.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 55 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Any breach of the Focus Lease Agreement or any failure to renew the Focus Lease Agreement, on materially similar or more favorable terms, may also have a material adverse effect on the Company&#8217;s
      business, financial condition, results of operations and prospects, and could also have an impact on Focus&#8217; ability to continue operating the Focus Facility under the Focus License or to renew the Focus License.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Focus Facility is subject to state and municipal regulation and oversight, including the acquisition of all required regulatory and ancillary permits to conduct operations or undertake any
      construction. Any breach of regulatory requirements, security measures or other facility requirements, including any failure to comply with recommendations or requirements arising from inspections by government regulators at all levels, could also
      have an impact on Focus&#8217; ability to maintain the Focus Lease Agreement and/or keep the Focus Facility in good standing, and to continue operating under the Focus License or the prospect of renewing the Focus License.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In December 2020, the municipal committee presiding over planning and construction in southern Israel (the &#8220;<font style="font-weight: bold;">Construction</font>&#160;<font style="font-weight: bold;">Committee</font>&#8221;)




      advised Focus that it was the subject of certain allegations regarding inadequate permitting for construction relating to the Focus Facility (the &#8220;<font style="font-weight: bold;">Construction Allegations</font>&#8221;). Focus&#8217; shareholders, officers and
      directors, including Oren Shuster and Rafael Gabay, received a summons and have testified before the Construction Committee. In January 2021, the MOH advised Focus that it had received a complaint of the same nature as the Construction Allegations
      (the &#8220;<font style="font-weight: bold;">MOH Allegations</font>&#8221;).&#160; On July 11, 2021, the Company was informed that a claim was filed by Construction committee against Focus, Focus&#8217; directors, shareholder, officers, and certain landowners, including
      Oren Shuster and Rafael Gabay, claiming for inadequate permitting for construction relating to the Focus Facility (the &#8220;<font style="font-weight: bold;">Construction Proceedings</font>&#8221;). A hearing is set to June 13, 2022. At this preliminary stage,
      based on the opinion of its legal counsel, Focus&#8217; management cannot assess the chances of the claim advancing or the potential outcome of the Construction Proceedings.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Potential consequences of any negative outcome of the Construction Proceedings may include, but are not limited to: (i) criminal charges against defendants; (ii) monetary penalties or fines; (iii)
      temporary or permanent suspension of the Focus License; and (iv) other consequences that may limit, in part or as a whole, Focus&#8217; operations under the Focus License. A negative outcome to the Construction Proceedings or the MOH Allegations may have a
      material adverse effect on the business, results of operations and financial conditions of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">The Israeli Facilities</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Israeli Licenses are specific to each respective Israeli Facility holding such license and therefore both the license and the facility must remain in good standing for each the Israeli Pharmacies
      and the Company&#8217;s trading houses to be able to conduct the Israeli Cannabis Activities authorized thereunder. Adverse changes or developments affecting the Israeli Facilities, including but not limited to the failure to maintain all requisite
      regulatory and ancillary permits and licenses, the failure to comply with state or municipal regulations, or a breach of security, could have a material adverse effect on the Company&#8217;s business, financial condition, results of operations and
      prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Any breach of any lease agreement relevant to the operations of the Israeli Facilities or any failure to renew such lease agreements, on materially similar or more favorable terms, may also have a
      material adverse effect on the Company&#8217;s business, financial condition, results of operations and prospects.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 56 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canada &#8211; Reliance on Canadian Facilities</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s Canadian cultivation and harvesting, drying, curing, processing, extraction, packaging and sale activities are carried out at the Canadian Facilities. Adverse changes or developments
      affecting the Canadian Facilities, including but not limited to changes to municipal laws regarding zoning, facility design errors, environmental pollution, non-performance by third party contractors, increases in materials or labour costs, labour
      disputes or disruptions, inability to attract sufficient numbers of qualified workers, productivity inefficiencies, equipment or process failures, production errors, disruption in the supply of energy and utilities and major incidents and/or
      catastrophic events such as fires, explosions, earthquakes or storms, would have a material and adverse effect on the Company&#8217;s business, financial condition, results of operations and prospects. The Company&#8217;s operations and financial performance may
      be adversely affected if it is unable to keep up with maintenance requirements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The TJAC Licenses and the MYM Licenses are specific to each of their respective licensed sites. As such, the TJAC Licenses and the MYM Licenses must remain in good standing to conduct the cannabis
      cultivation, processing and sales activities authorized thereunder. Adverse changes or developments affecting the Canadian sites or facilities, including but not limited to the failure to maintain all requisite regulatory and ancillary permits and
      licenses, the failure to comply with provincial or municipal regulations, or a breach of security, could have a material adverse effect on the Company&#8217;s business, financial condition, results of operations and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, any breach of either of the TJAC Leases or the Sublime Lease or failure to renew any of them on materially similar or more favorable terms, may have a material adverse effect on the
      Company&#8217;s business, financial condition, results of operations and prospects, and could also have an impact on TJAC and Sublime&#8217;s abilities to continue operating under their respective licenses or to renew any of their respective licenses.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The TJAC Facilities and the Sublime Facility are leased facilities. Any breach of regulatory requirements, security measures or other facility requirements, including any failure to comply with
      recommendations or requirements arising from inspections by government regulators at all levels, could also have an impact on (i) TJAC&#8217;s ability to maintain the TJAC Leases and/or keep the TJAC Facilities in good standing, and to continue operating
      under the TJAC Licenses or the prospect of renewing one or both of the TJAC Licenses or (ii) Sublime&#8217;s ability to maintain the Sublime Lease and/or keep the Sublime Facility in good standing, and to continue operating under the Sublime License or the
      prospect of renewing the Sublime Licenses.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The TJAC Facilities and the MYM Facilities continue to operate with routine maintenance. TJAC and Sublime will bear some of the costs of maintenance and upkeep of the TJAC Facilities and the Sublime
      Facility in accordance with the terms of the respective TJAC and Sublime Leases, including replacement of components over time. Highland will bear all of the costs of maintenance and upkeep of the Highland Facility, which Highland owns.&#160; TJAC&#8217;s,
      Highland&#8217;s and Sublime&#8217;s operations and the Company&#8217;s financial performance may be adversely affected if each entity is unable to keep up with such maintenance requirements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Germany &#8211; Reliance on Logistics Centre</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s state of-the-art Logistics Centre in Germany allows Adjupharm to manage all aspects of its supply chain including the production, the repackaging and distribution of bulk medical
      cannabis. Any breach of regulatory requirements, including any failure to comply with recommendations or requirements arising from inspections by government regulators, could also have an impact on Adjupharm&#8217;s ability to maintain the licenses and/or
      keep the Logistics Centre in good standing, and to continue operating it under the licenses, could have a material adverse effect on the Company&#8217;s business, financial condition, results of operations and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 57 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><br>
      <u>Reliance on Supply and Distribution Agreements</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">Israel &#8211; Supply, </font>manufacture<font style="font-style: italic;"> and Distribution Agreements</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Focus and the Israeli Licensed<font style="font-weight: bold;">&#160;</font>Companies rely on and are substantially dependent on various supply agreements with third-party cannabis cultivators, imported
      cannabis products manufacture agreements and distribution agreements to fulfill the supply requirements of its distribution and sales agreements with pharmacies in the Israeli medical cannabis market. The Israeli Licensed<font style="font-weight: bold;">&#160;</font>Companies and Focus acquire cannabis from third parties in amounts sufficient to operate its business. However, there can be no assurance that there will continue to be a supply of cannabis available for the Companyto purchase in
      order to operate or expand. Additionally, the price of cannabis and other inputs may rise which would increase the cost of goods. If any suppliers fail to supply any contracted materials to Focus or the Israeli Licensed<font style="font-weight: bold;">&#160;</font>Companies, the Israeli Licensed<font style="font-weight: bold;">&#160;</font>Companies and Focus may fail to meet purchase commitments from their distribution partners. If the Companywere unable to acquire the cannabis or other inputs
      required to operate or expand or to do so on favourable terms, or fail to maintain the manufacture agreements with IMC-GMP manufacture companies, it could have a material adverse impact on the Company&#8217;s business, financial condition and results of
      operations. If any of the Company&#8217;s suppliers fails to provide inputs meeting the Company&#8217;s quality standards, it may need to source cannabis or other inputs from other suppliers, which may result in additional costs and delay in the delivery of its
      products and services to distributors, pharmacies and patients. There is no assurance that suppliers will be able to supply and deliver the required materials to the Company in a timely manner or that the materials they supply to the Companywill not
      be defective or substandard. Any delay in the delivery of materials, or any defect in the materials, supplied to the Companymay materially and adversely affect or delay its production schedule and affect its product quality. Consequently, the
      Companyrelies on the suppliers of such supply agreements to provide necessary cannabis products to Focus and the Israeli Licensed<font style="font-weight: bold;">&#160;</font>Ccompanies. If the Companycannot secure cannabis of similar quality and at
      reasonable prices from alternative suppliers in a timely manner, or at all, Focus or the Israeli Licensed<font style="font-weight: bold;">&#160;</font>may not be able to deliver its products to distributors, pharmacies or patients on time with the
      required quality. The various suppliers and distributors may elect, at any time, to breach or otherwise cease to participate in supply, service or distribution agreements, or other relationships, upon which the Company&#8217;s operations rely. Loss of its
      suppliers, service providers or distributors or their timely service would have a material adverse effect on the Company&#8217;s business and operational results.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canada &#8211; Reliance on Provincial Supply Agreements in Canada</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">TJAC and MYM expect to derive a significant portion of their future revenues from the adult-use cannabis industry and market in Canada, through its provincial supply agreements. A loss of one or a
      number of such provincial supply agreements could materially impact TJAC or MYM&#8217;s profit margins for the foreseeable future by requiring TJAC or MYM to sell at lower margins through alternative sales channels (such as business-to-business sales
      agreements with intermediary Licensed Producers), unless more suitable sales arrangements could be secured. A loss of one or more of TJAC or MYM&#8217;s provincial supply agreements may ultimately lead to a material adverse effect on the business, results
      of operations and financial conditions of the Company.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 58 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Germany &#8211; Reliance on Supply and Distribution Agreements in Germany</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Adjupharm relies on its sales and distribution agreements to supply IMC-branded products to distribution partners in Germany, which are then distributed to German pharmacies for sales to medical
      cannabis patients and also on direct sales by Adjupharm of IMC-branded products to German pharmacies.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Adjupharm relies on supply agreements with cannabis cultivators and producers in order to meet the demands of their respective sales agreements with distribution partners and pharmacies.
      Consequently, the Companyrelies on the suppliers of such supply agreements to provide necessary cannabis products to Adjupharm. If any suppliers fail to supply any contracted materials to Adjupharm, Adjupharm may fail to meet purchase commitments
      from their distribution partners and this could result a material adverse effect on the Company&#8217;s business, financial and operational results.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Tax Remittance</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company is subject to the provisions of the ITA12 and to review by CRA13. The Company files its annual tax compliance based on its interpretation of the ITA and CRA&#8217;s guidance. There is no
      certainty that the returns and tax position of the Company will be accepted by CRA as filed. Any difference between the Company&#8217;s tax filings and CRA&#8217;s final assessment could impact the Company&#8217;s results and financial position.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As at December 31, 2021, the Company&#8217;s financial statements included a tax liability of $9,060 and a tax indemnification asset of $8,835. The indemnification asset, intended to cover certain
      statutory tax obligations arising from the Trichome Transaction to the CRA, consists of: (1) 927,463 Common Shares; (2) The Company is a party to an indemnification agreement with certain directors and officers of the Company and Trichome to cover
      certain tax liabilities, interest and penalties arising from the Trichome Transaction; (3) a director of the Company has entered into a security pledge agreements with the Company to secure the obligations under the indemnification agreement. The
      director has pledged an aggregate of 833,508 Common Shares and 275,125 vested RSU&#8217;s in favour of the Company.; (4) the director has transferred the Company cash in the amount of $3,250 (the &#8220;Indemnification Asset&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There can be no assurance that the Indemnification Asset will be sufficient to satisfy the requisite payments to the CRA. Additionally, there can be no assurance that the directors and officers whom
      are party to the indemnification agreement will make sufficient payments to the Company and/or CRA, or make the payments at all.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There can be no assurance that income tax laws or the interpretation thereof in any of the jurisdictions in which the Company operates will not be changed or interpreted or administered in a manner
      which adversely affects the Company and its shareholders. In addition, there is no assurance that CRA will agree with the manner in which the Company calculates taxes payable or that any of the other tax agencies will not change their administrative
      practices to the detriment of the Company or its shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Negative Cash Flow from Operations</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">During the year ended December 31, 2021, the Company had negative cash flows from operating activities. Although the Company expects to generate positive cash flows from its future operating
      activities, there is no assurance that it will achieve this objective. If operational cash flows continue to be negative, the Company may be required to fund future operations with alternative financing options such as offerings of shares.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 59 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Additional Financing</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There is no assurance that the Company will be able to secure the funds necessary to implement its strategies. Additional debt incurred by the Company from engagements such as major acquisitions may
      cause the Company&#8217;s debt level to increase and result in difficulties in completing or negotiating future debt financings. Any triggering of credit defaults or failure to raise capital by the Company may cause significant delays in carrying out
      business objectives or result in a material adverse effect on the Company&#8217;s business, financial condition, operational results and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Evolving Market Competition</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There is potential that the Group will face intense competition from other companies or groups of companies, some of which can be expected to have more financial resources, industry, manufacturing
      and marketing experience than the Group. Because of the early stage of the industry in which the Group operates, as well as evolving legislation and governmental initiatives in a number of jurisdictions, the Group expects to face additional
      competition from new entrants in the jurisdictions in which it currently operates or is contemplating operations. If the number of users of medical cannabis products in Israel and Europe increases, the demand for products in such areas will increase
      and the Company expects that competition will become more intense, as current and future competitors begin to offer an increasing number of diversified products and pricing strategies. Similarly, as the adult-use recreational cannabis market matures
      in Canada, there is potential that the Company may face intense competition from other domestic and international cannabis brands, cultivators and distributors operating in Canada that are more established or may have access to greater financial
      resources. Increased competition by larger and better-financed competitors could materially and adversely affect the business, financial condition and results of operations of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Constraints on Marketing Products under Cannabis Laws</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The development of the Group&#8217;s business and operating results may be hindered by applicable restriction on promotion marketing and advertising activities imposed by the MOH, Health Canada or BfArM.
      If the Group is unable to effectively market its products and compete for market share, or if the costs of compliance with government legislation and regulation cannot be absorbed through the selling price for its products, the Group&#8217;s sales and
      operating results could be adversely affected.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Industry Consolidation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The cannabis industry is undergoing rapid growth and substantial change, which has resulted in an increase in competitors, consolidation and formation of strategic relationships. It is possible that
      industry maturation could create larger companies that may have increased geographic scope. Such acquisitions or other consolidating transactions could harm the Group in a number of ways, including the loss of strategic partners (if they are acquired
      by or enter into relationships with a competitor), customers, or revenue and market share, all of which could harm the Group&#8217;s operating results. The Group&#8217;s operating results could also be harmed if the Group was forced to expend greater resources
      to meet new or additional competitive threats. Additional competition from larger, better-financed competitors with geographic advantages could outcompete the Group by placing downward pressure on retail prices for products and services. This could
      ultimately cause a material adverse effect on the business, financial condition, results of operations and prospects of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 60 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Conditions in Israel</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group is vulnerable to the political, economic, legal, regulatory, and military conditions affecting Israel and the Middle East. Armed conflicts between Israel and its neighbouring countries and
      territories occur periodically in the region and may adversely affect the Group&#8217;s business, results of operations and financial condition. In addition, the Group may be adversely affected by other events or factors affecting Israel such as the
      interruption or curtailment of trade between Israel and its trading partners, or any restrictions or pressure on the Group&#8217;s partners or customers or others to prevent or discourage them from doing business activities with Israel or Israeli
      businesses, a significant downturn in the economic or financial condition of Israel, a significant downgrading of Israel&#8217;s internal credit rating, labour disputes and political instability, including riots, uprisings and government failures.
      Restrictive laws or policies directed towards Israel or Israeli businesses could have a material adverse effect on the Group&#8217;s business, results of operations, financial condition and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Furthermore, under Israeli law, citizens and permanent residents of Israel are obligated to perform military reserve duty for extended periods of time and are subject to being called to active duty
      at any time under emergency circumstances. In response to increased hostilities, there have been periods of significant call-ups of military reservists. It is possible that there will be additional call-ups in the future, which may include officers
      and key personnel of the Company, which could disrupt business operations for a significant period of time.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Conflict and Political Instability in Eastern Europe</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The first part of 2022 has seen significantly higher levels of volatility in global markets due to market participants' reactions to, and uncertainty surrounding, the magnitude and timing of
      government and central bank action to be taken in response to heightened inflation, as well as Russia's invasion of Ukraine. This volatility has resulted in a decline in the level of activity in the financial markets. Continued market volatility or
      uncertainty related to actions taken or to be taken by central banks, a decline in the global macroeconomic outlook, including as a result of Russia's invasion of Ukraine and the threat, or outbreak of more widespread armed conflict in Eastern Europe
      would cause financial market activity to continue to decrease, which would negatively affect the Group&#8217;s revenues and capital markets activity.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Political Risk</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As discussed further below under &#8220;<font style="font-style: italic;">Foreign Market Participation</font>&#8221;, political risk is an additional risk that the Group may be exposed to when operating in a
      foreign market. Examples of political risk include without limitation social unrest, threats or occurrences of war, organized crime, political instability, changes of government and changes in taxation policies in domestic and international markets
      and jurisdictions in which the Group operates.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">While the Group actively analyzes risks and developments in foreign markets that it currently or will participate in, there is no assurance that unpredicted impacts will not occur. Depending on the
      magnitude of such unpredicted impacts, there may be a material adverse effect on the Group&#8217;s business, financial condition, operating results and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Inflation Risk</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Global economies are currently experiencing elevated inflation which could curtail levels of economic activity, including in our primary production markets. This inflation is predominantly driven by
      costs of goods as input costs continue to increase with the overall increase in costs caused by several external factors including but not limited to general uncertainties caused by global supply chain constrictions, rising energy prices and the
      global COVID-19 pandemic. As such, delivery and distribution costs, utility costs and other necessary supplies at an economic cost cannot be assured. These are integral requirements for the Group&#8217;s business and it is reasonable to expect that
      inflation, supply shortages or increases in demand could impact the Group&#8217;s future economic performance and competitiveness, as it may entail a meaningful increase in costs for various goods and services that the Group may not be able to pass onto
      patients or customers. In addition, the operations of the Group could be affected by the economic context should interest rates, inflation or unemployment levels reach levels that consumer trends and spending and, consequently, impact the sales and
      profitability of the Group. The Group may not be able to effectively or successfully address such risks and uncertainties or successfully implement operating strategies to mitigate the impact of such risks and uncertainties. In the event that the
      Group fails to do so, such failure could materially harm the Group&#8217;s business.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 61 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Product Security and Storage</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Due to the nature of the Group&#8217;s products and the limited legal channels for distribution, the Israeli Facilities the Canadian Facilities and the Logistics Centre of the Group is subject to the risk
      of theft of its product and other security breaches. A security breach in any one of the Group&#8217;s facilities could result in a significant loss of available product, revocation of cannabis licenses, exposure to additional liability under applicable
      regulations and to potentially costly litigation or increased expenses relating to insurance premiums and other resolutions and future prevention of security breaches, any of which could have an adverse effect on the Group&#8217;s business, financial
      condition, results of operations and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group stores products in the Focus Facility, the Israeli Facilities, the Logistics Centre and the Canadian Facilities before distribution. Pursuant to the applicable Israeli, German and Canadian
      licensing requirements, Focus, the Israeli Licensed<font style="font-weight: bold;">&#160;</font>Companies, Adjupharm, TJAC and MYM are required to maintain certain standards of storage for cannabis products. The risk of inventory theft from these
      facilities is mitigated by Focus, the Israeli Licensed<font style="font-weight: bold;">&#160;</font>Companies, Adjupharm, TJAC and MYM through the implementation of the security measures required under applicable laws, such as usage of qualified storage
      units, designated storage locations, locked storage vaults, access control, security cameras, and alert systems. Notwithstanding such security measures, any breaches of security may result in losses of inventory, potential litigation, and increased
      costs to bolster security and insurance.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Reliance on Other Business Licenses, Permits and Approvals</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group is dependent on ancillary business licenses, permits and approvals granted by government authorities or other third parties in order to operate effectively including, without limitation,
      building permits, municipal permits, third-party licenses including distributors and suppliers, and foreign trade licenses. Should the Group fail to maintain any of these licenses, permits and approvals, or should it fail to renew any of such
      licenses, permits and approvals on materially similar or more favorable terms, the business, financial condition and results of the operations of the Group may be subject to a material adverse effect.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Shareholder Risk and Liability</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Given the nature of the Group&#8217;s business, it may from time to time be subject to claims or complaints from investors or others in the normal course of business. The legal risks facing the Group, its
      directors, officers, employees or agents in this respect include potential liability for violations of securities laws, breach of fiduciary duty or misuse of investors&#8217; funds. Violations of securities laws and breach of fiduciary duty could result in
      civil liability, fines, sanctions, or the suspension or revocation of the Group&#8217;s right to carry on its existing business. The Group may incur significant costs in connection with such potential liabilities.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 62 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Compliance with Laws</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group and its investees&#8217; operations are subject to various laws, regulations and guidelines. The Group endeavours to and cause its investees to comply with all relevant laws, regulations and
      guidelines. However, there is a risk that the Group&#8217;s and its investees&#8217; interpretation of laws, regulations and guidelines, including, but not limited to applicable stock exchange rules and regulations, may differ from each other, and the Group and
      its investees&#8217; operations may not be in compliance with such laws, regulations and guidelines. Any potential noncompliance could cause the business, financial condition and results of operations of the Group to be adversely affected. Further, any
      amendment to or replacement of cannabis legislations and applicable rules and regulations governing the activities of the investees may cause adverse effects to the Group&#8217;s operations. The risks to the business of the Group associated with the
      decision to amend or replace cannabis legislation and regulation, could reduce the addressable market for the Group&#8217;s products and could materially and adversely affect the business, financial condition and results of operations of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group and its investees incur ongoing costs and obligations related to regulatory compliance. Failure to comply with applicable laws and regulations may result in enforcement actions thereunder,
      including orders issued by regulatory or judicial authorities causing operations to cease or be curtailed, and may include corrective measures requiring capital expenditures or remedial actions. Parties may be liable for civil or criminal fines or
      penalties imposed for violations of applicable laws or regulations. Amendments to current laws, regulations and permitting requirements, or more stringent application of existing laws or regulations, may have a material adverse impact on the Group&#8217;s
      and/or its investees, resulting in increased capital expenditures or production costs, reduced levels of cannabis production or abandonment or delays in the development of facilities which could have a material adverse effect on the business, results
      of operations and financial condition of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The introduction of new tax laws, regulations or rules, or changes to, or differing interpretations of, or application of, existing tax laws, regulations or rules in any of the countries in which the
      Group invests could result in an increase in the Group&#8217;s taxes, or other governmental charges, duties or impositions. No assurance can be given that new tax laws, regulations or rules will not be enacted or that existing tax laws, regulations or
      rules will not be changed, interpreted or applied in a manner which could result in the Group&#8217;s profits being subject to additional taxation or which could otherwise have a material adverse effect on the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Changes in Laws, Regulations and Other Guidelines</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s operations are subject to a variety of laws, regulations, and guidelines relating to the marketing, acquisition, manufacture, management, distribution (including import and export),
      transportation, storage, sale and disposal of cannabis products. The Group&#8217;s operations are also subject to laws and regulations relating to health and safety, insurance coverage, the conduct of operations and the protection of the environment. Any
      changes to such laws and regulations that are beyond the control of the Group could have a material adverse effect on the business, results of operations, financial condition and prospects of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Management of Growth and Acquisition Integration</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company may be subject to growth related risks including capacity constraints and pressure on its internal systems and controls. The ability of the Company to manage growth effectively will
      require it to continue to implement and improve its operational and financial systems and to expand, train and manage its employee base. If the Company is unable to deal with this growth, any negative impact may have a material adverse effect on the
      Company&#8217;s business, financial condition, results of operation and prospects.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 63 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, the realization of the benefits of acquisitions made by the Company, including the acquisition of Trichome, MYM, certain operations from Panaxia, the Israeli Pharmacies and the trading
      house of Rosen High Way, depend in part on successfully consolidating functions and integrating and leveraging operations, procedures and personnel in a timely and efficient manner as well as the Company&#8217;s ability to share knowledge and realize
      revenues, synergies and other growth opportunities from combining the acquired businesses and operations with those of the Company. The integration of acquired businesses may depend on a number of factors, including without limitation: (i) the input
      of substantial management effort, time and resources; (ii) the successful incorporation of key personnel from acquired companies for post-acquisition periods; and (iii) the execution of effective non-competition agreements with certain employees or
      ex-employees of the acquired companies. Any failure in successfully integrating acquired businesses may result in a material adverse effect on the Company&#8217;s business, financial condition, operating results and prospects. The risks we face in
      connection with an acquisition include:<br>
      <br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z55ddf92703ec41789402e9ac37264653">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>diversion of management time and focus from operating our business to addressing acquisition integration challenges;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3cfbbc1bebd74ca5b9f3339c2deb4b67">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>coordination of research and development and sales and marketing functions;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4859f97610664439b81ea10897a61d39">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>retention of employees from the acquired company;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7e39d181c196469fa0c44cd7170e6275">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>cultural challenges associated with integrating employees from the acquired company into our organization;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z361a23150ca544e49348c8316a27b55d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>integration of the acquired company's accounting, management information, human resources, and other administrative systems;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze8e198efaa3845018a2ee99aeb1eafd1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the need to implement or improve controls, procedures, and policies at a business that prior to the acquisition may have lacked effective controls, procedures, and policies;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6b1f21c40164e51bbebb61f2386aafc">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>potential write-offs of intangible assets or other assets acquired in transactions that may have an adverse effect on our operating results in a given period;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z87cbffe0ff6a43e5bb2a61a731a21c16">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>liability for activities of the acquired company before the acquisition, including patent and trademark infringement claims, violations of laws, commercial disputes, tax liabilities, and other known and unknown liabilities; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1dcfb871319245548c056872b0d4b299">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>litigation or other claims in connection with the acquired company, including claims from terminated employees, consumers, former stockholders, or other third parties.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Environmental and Employee Health and Safety Regulations</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s operations are subject to environmental and occupational safety laws and regulations in certain jurisdictions, concerning, among other things, emissions and discharges to water, air and
      land, the handling and disposal of hazardous and nonhazardous materials and wastes, and employee health and safety. The Group incurs ongoing costs and obligations related to compliance with environmental and employee health and safety matters. Any
      failure to comply or maintain compliance with environmental and occupational safety laws and regulations may result in additional costs for corrective measures, penalties or restrictions on manufacturing operations and could have a material adverse
      effect on the business, results of operations and financial condition of the Group.</div>
    <div style="line-height: 1.25">&#160;<br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 64 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Ability to Meet Target Production Capacity</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s sales agreements are subject to estimates in target production capacity at the time of such agreement. These estimates may prove to be inaccurate due to uncontrollable external factors
      such as genetic drifts in strain of plants grown and general difficulties in estimating growth of cannabis plants. Any adverse misalignments between the target production capacity and actual production capacity may result in a material adverse effect
      on the Group&#8217;s business, financial condition.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Ability to Secure New Suppliers and Distribution Partners</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s success depends on its ability to secure suppliers and distribution partners. There are many factors which could impact the Group&#8217;s ability to secure suppliers and distribution partners,
      including but not limited to IMC and other brand awareness, the Group&#8217;s ability to continually produce desirable and effective cannabis products, compliance with regulatory requirements in connection with import and export of cannabis products, and
      the successful implementation of new partnership plans. The failure to secure suppliers or distribution partners could have a material adverse effect on the Group&#8217;s business, financial condition, results of operations and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Reliance on Key Business Inputs</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s business is dependent on a number of key inputs and their related costs including raw materials and supplies related to its growing and distribution operations as well as electricity,
      water, and other utilities. Any significant interruption or negative change in the availability or economics of the supply chain for key inputs (e.g. rising energy costs) could cause a material adverse effect on the business, financial condition, and
      operating results of the Group. Any failure to secure required supplies and services or to do so on appropriate terms could also have a material adverse effect on the business, financial condition, and operating results of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Competition and Innovation to Achieve Strategic Objectives</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition to being subject to general business risks applicable to a business involving an agricultural product and a regulated consumer product, the Group will need to make investments in its
      business strategy. These investments include the procurement of raw material, new cannabis strains supplier and distributor outreach projects, marketing efforts and research and development projects. The Group expects that competitors will undertake
      similar investments to compete with it. Competitive conditions, third-party partner preferences, patient requirements and spending patterns in this industry and market are relatively unknown and may have unique circumstances that differ from other
      existing industries and markets and contribute to unsuccessful future business development or expansion efforts by the Group or other undesirable consequences. As a result, the Group may not be successful in its efforts to secure suppliers or
      distribution partners or to develop new cannabis products and produce and distribute these cannabis products. In addition, these activities may require significantly more resources than the Company currently anticipates in order to be successful.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Any new cannabis products that the Group develops or distributes may be subject to time-intensive regulatory approval procedures that might delay any release schedules or lead to adverse market
      conditions that might affect product profitability. The Group may ultimately fail to effectively bring new product offerings to market for reasons that include, but are not limited to, stringent regulatory approval procedures. Any inability to
      introduce new product offerings may cause a material adverse effect on the Group&#8217;s business, results of operations, financial condition and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Reliance on Third Party Transportation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group relies on international third-party transportation services to deliver and receive product-related shipments. In the process of the deliveries, time delays, labor strikes, COVID-19-related
      issues, product storage issues or other logistical problems may occur and force late delivery or receipt of items or receipt of damaged items. Such delays, receipt of damaged items or other logistical problems may cause a material adverse effect on
      the Group&#8217;s business, operations or financial condition. Rising costs associated with courier services used by the Group may also adversely impact the business of the Group and its ability to operate profitably.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 65 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, any breach of security of the package during the possession of the third-party transportation service may result in violations of regulations regarding possession of cannabis products
      and thus may have a material adverse effect on the Group&#8217;s business, financial condition and operating results.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Investment Business Strategy</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As part of the Company&#8217;s business strategy, it seeks new opportunities in the cannabis industry. In pursuit of such opportunities, the Company may fail to select appropriate investment candidates and
      negotiate acceptable arrangements. The Company cannot provide assurance that it can complete any investment that it pursues or is pursuing, on favourable terms, or that any investment completed will ultimately benefit the Company. In addition, the
      Company&#8217;s capital solutions may not attract a following in the cannabis industry. In the event that the Company chooses to raise debt capital to finance any acquisition or other arrangement, the Company&#8217;s leverage will be increased. In addition, the
      introduction of new tax laws or regulations, or accounting rules or policies, or rating agency policies, or changes to, or differing interpretations of, or application of, existing tax laws or regulations or accounting rules or policies or rating
      agency policies, could make the productivity and services offered by the Company less attractive to investees. Such changes could adversely affect the Company&#8217;s ability to enter into new investments.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Risks Inherent in Strategic Alliances</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group may enter into further strategic alliances with third parties that it believes will complement or augment its existing business. The Group&#8217;s ability to complete strategic alliances is
      dependent upon, and may be limited by, the availability of suitable candidates and capital. In addition, strategic alliances could present unforeseen integration obstacles or costs, may not enhance the Group&#8217;s business, and may involve risks that
      could adversely affect the Group, including significant amounts of management time that may be diverted from investment activities operations to pursue and complete such transactions or maintain such strategic alliances. Future strategic alliances
      could result in the incurrence of additional debt, costs and contingent liabilities, and there can be no assurance that future strategic alliances will achieve the expected benefits to the Group&#8217;s business or that the Group will be able to consummate
      future strategic alliances on satisfactory terms, or at all.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">While the Company conducts due diligence with respect to investees, there are risks inherent in any investment. Specifically, there could be unknown or undisclosed risks or liabilities of investees
      for which the Company is not or will not be sufficiently indemnified. Any such unknown, undisclosed or unmitigated risks or liabilities could materially and adversely affect the Company&#8217;s financial performance and results of operations. The Company
      could encounter additional transaction and enforcement related costs or other factors such as the failure to realize all of the benefits from its investments. Any of the foregoing risks and uncertainties could have a material adverse effect on
      Group&#8217;s business, financial condition and results of operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Risks Associated with Divestment</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In certain circumstances, the Company may decide, or be required, to divest any of its direct or indirect interests in certain investees. In particular, if any of the investees violate any applicable
      laws and regulations, the Company may be required to divest its indirect or direct interest in such investee or risk significant fines, penalties, administrative sanctions, convictions or settlements. There is no assurance that these divestitures
      will be completed on terms favourable to the Company, or at all. Any opportunities resulting from these divestitures, and the anticipated effects of these divestitures on the Company may never be realized, or may not be realized to the extent the
      Company anticipates. Any required divestiture or an actual or perceived violation of applicable laws or regulations could have a material adverse effect on the Company, including its reputation and ability to conduct business, its holdings (directly
      or indirectly) in the investees, the listing of its securities on applicable stock exchanges, its financial position, operating results, profitability or liquidity or the market price of its publicly traded shares. In addition, it is difficult for
      the Company to estimate the time or resources that may be required for the investigation of any such matters or its final resolution because, in part, the time and resources that may be needed are dependent on the nature and extent of any information
      requested by the applicable authorities involved, and such time or resources could be substantial.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 66 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Reliance on Key Personnel</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company has relied upon the ability, judgment, discretion and good faith of its executive management team. The Company&#8217;s future success depends on its continuing ability to attract, develop,
      motivate and retain highly qualified employees, especially its key personnel. If the Company were to lose any members of the executive management or key employees, any inability to find suitable replacements at reasonable costs may have a material
      adverse effect on the Company&#8217;s business, financial condition and results of operations. Further, as designated individuals of a licensee under the Cannabis Act, certain key personnel of the Company are subject to a security clearance by Health
      Canada. There is no assurance that any of the Company&#8217;s key personnel who presently or may in the future require a security clearance will be able to obtain or renew such clearances or that new personnel who require a security clearance will be able
      to obtain one. A failure by any of those individuals to maintain or renew his or her security clearance, could result in a material adverse effect on the Company&#8217;s business, financial condition and results of operations. In addition, if any such
      individual leaves the Company, and the Company is unable to find a suitable replacement that has a security clearance required by applicable law, or at all, there could occur a material adverse effect on the Company&#8217;s business, financial condition
      and results of operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Reliance on International Advisors and Consultants</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The legal and regulatory requirements in the foreign countries in which the Group may invest or operate in with respect to the cultivation and sale of cannabis, banking systems and controls, as well
      as local business culture and practices are different from those in Canada. The Group&#8217;s officers and directors must rely, to a great extent, on local legal counsel and consultants in order to keep abreast of material legal, regulatory and
      governmental developments as they pertain to and affect the Group&#8217;s business operations, and to assist with governmental relations. The Group must rely, to some extent, on those members of management and the Board who have previous experience working
      and conducting business in these countries, if any, in order to enhance the Group&#8217;s understanding of and appreciation for the local business culture and practices. The Group also relies on the advice of local experts and professionals in connection
      with current and new regulations that develop in respect of the cultivation and sale of cannabis as well as in respect of banking, financing, labour, litigation and tax matters in these jurisdictions. Any developments or changes in such legal,
      regulatory or governmental requirements or in local business practices are beyond the Group&#8217;s control. The impact of any such changes may cause a material adverse effect to the Group&#8217;s business, financial condition, operating results and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 67 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Foreign Market Participation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Global capital markets have also recently experienced extreme volatility which may, in conjunction with the factors set out above and despite the actions of government authorities, contribute to a
      worsening of general economic conditions including, rising interest rates, high levels of inflation and unemployment in Canada and other economies, the unavailability of credit or the devaluation of currencies. Unexpected changes in these factors and
      financial market and economic conditions Group&#8217;s financial condition, profitability and cash flows, and may also have a negative effect on the valuation of, and the ability of the Groupto exit or partially divest from, investment positions. Depending
      on conditions, the Groupmay incur substantial realized and unrealized losses in future periods, all of which may materially adversely affect its results of operations and the value of any investment in the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Groupcontinues to monitor developments and policies in the foreign markets in which it operates or invests and assess the impact thereof to its operations; however, such developments cannot be
      accurately predicted. The realization of any of these risks may significantly impair the Group&#8217;s local operations and have a material adverse effect on the Group&#8217;s business, financial condition and results of operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">These risks may also limit or disrupt the Group&#8217;s strategic alliances or investments, restrict the movement of funds, increase the Group&#8217;s costs, or result in the deprivation of contract rights or
      the taking of property by nationalization or expropriation without fair compensation, and may have a material adverse effect on the Group&#8217;s financial position and/or results of operations. In addition, the enforcement by the Group of its legal rights
      in foreign countries, including rights to exploit properties or utilize permits and licenses and contractual rights may not be recognized by the court systems in such foreign countries or enforced in accordance with the rule of law.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Future Acquisitions or Dispositions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Material acquisitions, dispositions and other strategic transactions involve a number of risks, including but not limited to the potential disruption of the Group&#8217;s ongoing business, distraction of
      management, the Company may become more financially leveraged, the failure to realize anticipated benefits of those transactions fully or at all, or may take longer to realize than expected, and loss or reduction of control over certain Group assets.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Despite the Company&#8217;s due diligence efforts, the presence of one or more material liabilities of an acquired company that are unknown to the Company at the time of acquisition could have a material
      adverse effect on the business, results of operations, prospects and financial condition of the Company. A strategic transaction may result in a significant change in the nature of the Company&#8217;s business, operations and strategy. In addition, the
      Company may encounter unforeseen obstacles or costs in implementing a strategic transaction or integrating any acquired business into the Company&#8217;s operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, the Company&#8217;s strategic transaction decisions are based on the economic assessments made by the Company and its external advisors. Such economic assessments involve a series of
      assumptions regarding factors such as future cannabis prices, production requirements, expected revenue growth, cash flow and financing requirements, future capital expenditures and operating costs. Many of these factors are subject to change and are
      beyond the control of the Company. In addition, future acquisition or international expansion could require the Group to incur a number of up-front expenses, including those associated with obtaining regulatory approvals, as well as additional
      ongoing expenses, including those associated with infrastructure, buildout, staff and regulatory compliance. If there is any significant negative change in any of these factors, the Group may experience a material adverse effect on its business,
      financial condition, operating results and prospects.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 68 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Foreign Expansion Efforts and Operations</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s expansion into foreign jurisdictions is subject to additional business risks, including new or unexpected risks or could significantly increase the Group&#8217;s exposure to one or more
      existing risk factors, including economic instability, changes in laws and regulations, and the effects of competition, as well as operational, regulatory, compliance and reputational and foreign exchange rate risk. The failure of the Group&#8217;s
      operating infrastructure to support such expansions could result in operational failures and regulatory fines or sanctions. Additionally, there is no guarantee that the Group will be able to realize any of the anticipated benefits of any transactions
      related to the Group expansion strategy.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>No U.S. Operations</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company and, to its knowledge, its&#160; subsidiaries do not currently engage in any U.S. cannabis-related activities as defined in CSA Staff Notice 51-352. To date, the Company has caused its
      investees to only conduct business and invest in entities in federally-legal jurisdictions by including appropriate representations, warranties and covenants in its agreements with investees. However, an investee may breach such obligations. Any such
      violation of such obligation would result in a breach of the applicable agreement and, accordingly, may have a material adverse effect on the business, operations and financial condition of Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Risks Inherent in the Agricultural Business</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s business, specifically as it pertains to, TJAC, MYM and the Company&#8217;s relationship with Focus, involves the growing of cannabis products, which are agricultural products. As such, the
      business is subject to the risks inherent in the agricultural business, such as pests, plant diseases and similar agricultural risks. Although, TJAC, MYM and Focus and their respective third-party cultivators carefully monitor the growing conditions
      with trained personnel and applicable equipment, there can be no assurance that natural elements will not have a material adverse effect on the production of its products and results of operations. Any decline in production by, TJAC, MYM and Focus or
      could have a material adverse effect on the Group&#8217;s business, operating results or financial condition.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Illegal Market Competition</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As a participant of the cannabis market in international jurisdictions with varying regulations, the Group may be subject to competition from entities that conduct illegal cannabis business
      operations. Such entities may resort to competitive measures such as producing products with prohibited concentrations of THC and CBD or producing imitations of the Group&#8217;s products without the authorization or endorsement of the Group. If demand for
      these illegal products increases and local governments fail to regulate markets accordingly, the Group may experience a material adverse effect on its business, operating results and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Publicity and Consumer Perception</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group believes the medical cannabis industry is highly dependent upon consumer perception regarding the safety, efficiency and quality of the medical cannabis products produced. Consumer
      perception of the Group&#8217;s products can be significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention and other publicity regarding the consumption of medical cannabis products.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 69 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There can be no assurance that future scientific research, findings, regulatory proceedings, litigation, media attention or other research findings or publicity will be favorable to the medical
      cannabis market or any particular product, or consistent with earlier publicity.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Future research reports, findings, regulatory proceedings, litigation, media attention or other publicity that are perceived as less favorable than, or that question, earlier research reports,
      findings or publicity could have a material adverse effect on the demand for products bearing the brands marketed and sold by the Group and the business, results of operations, financial condition, prospects and the Group&#8217;s cash flows.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Further, adverse publicity reports or other media attention regarding the safety, efficacy and quality of medical cannabis products in general, or the Group&#8217;s products specifically, or associating
      the consumption of medical cannabis products with illness or other negative effects or events, could have a material adverse effect. Such adverse publicity reports or other media attention could arise even if the adverse effects associated with such
      products resulted from consumers&#8217; failure to consume such products appropriately or as directed.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Perceived Effects of Products</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">If the products the Group sells are not perceived to have the effects intended by the end user, its business may suffer. There is little long-term data with respect to efficacy, unknown side effects
      and/or interaction with individual human biochemistry of various cannabis products. As a result, the Group&#8217;s products could have certain side effects if not taken as directed or if taken by an end user that has certain known or unknown medical
      conditions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Reputational Risk to Third Parties</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The parties outside of the cannabis industry with which the Group does business may perceive that they are exposed to reputational risk as a result of the Group&#8217;s cannabis business activities.
      Failure to establish or maintain business relationships could have a material adverse effect on the Group&#8217;s business, financial condition, results of operations and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Information Technology</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s operations will depend, in part, on how well it and its supply and distribution partners protect networks, equipment, information technology systems (&#8220;<font style="font-weight: bold;">IT
        systems</font>&#8221;) and software against damage from a number of threats, including, but not limited to, cable cuts, damage to physical plants, natural disasters, intentional damage and destruction, fire, power loss, hacking, computer viruses,
      vandalism and theft. The Group&#8217;s operations also will depend on the timely maintenance, upgrade and replacement of networks, equipment, IT systems and software, as well as pre-emptive expenses to mitigate the risks of failures. Any of these and other
      events could result in information system failures, delays and/or increase in capital expenses. The failure of IT systems or a component of IT systems could, depending on the nature of any such failure, adversely impact the Group&#8217;s financial
      condition, operating results and reputation.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Cybersecurity</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s information systems and its third-party service providers and vendors are vulnerable to increasing threat of continually evolving cybersecurity risks, resulting in data breaches and data
      losses. These risks arising from events including without limitation malware, computer viruses, employee error, extortion, malfeasance, system errors, and hacking. In order to minimize the risk of these events from occurring, the Group is performing
      timely maintenance, upgrade and replacement of networks, equipment, IT systems and software and other protective measures. However, any failure or delay in maintaining, upgrading or replacing such systems and software could materially increase the
      risk of cybersecurity incident and data breach or data loss, and the Group may experience operational delays, information system failures, and/or increases in capital expenses. Ultimately, the Group&#8217;s business, financial condition, operating results
      and reputation may be impacted adversely by such occurrences.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 70 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group has not experienced any material losses to date relating to cybersecurity-attacks or other information security breaches, but there can be no assurance that the Group will not incur such
      losses in the future. The Group&#8217;s risk and exposure to these matters cannot be fully mitigated because of, among other things, the evolving nature of these threats. As a result, cyber security and the continued development and enhancement of
      controls, processes and practices designed to protect systems, computers, software, data and networks from attack, damage or unauthorized access is a priority. As cyber threats continue to evolve, the Group may be required to expend additional
      resources to modify or enhance protective measures or to investigate and remediate any security vulnerabilities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Privacy</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group collects and stores certain personal information about its patients and customers, and is responsible for protecting that information from privacy breaches. A privacy breach may occur
      through certain threats, including, without limitation, procedural or process failure, information technology malfunction, or deliberate unauthorized intrusions, computer viruses, and cyber-attacks. Theft of data for competitive purposes is an
      ongoing risk whether perpetrated via employee collusion or negligence or through deliberate cyber-attack. Any such theft or privacy breach would have a material adverse effect on the Group&#8217;s business, financial condition and results of operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, there are a number of Israeli, German, European, and Canadian federal and provincial laws, rules and regulations protecting the privacy and confidentiality of certain patient health
      information, and private information including patient records, and employee information, and restricting the collection, use transfer, storage, disposal and disclosure of that protected information. The interpretation and enforcement of such laws
      and regulations are uncertain, are subject to change and may require the Group to incur substantial costs to monitor and implement compliance with any additional requirements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Canada, the privacy rules under PIPEDA and provincial statutes regulating the collection, use and disclosure of personal information, protect medical records and other personal health information
      by limiting their use and disclosure of health information to the minimum level reasonably necessary to accomplish the intended purpose. If the Group was found to be in violation of the privacy or security rules under PIPEDA or other failure to
      comply with the applicable privacy or security rules, laws, regulations protecting the privacy data and confidentiality of patient health information in the jurisdictions in which the Group operates could result in sanctions and civil or criminal
      penalties, litigation, adverse publicity, which could increase its liabilities, harm its reputation and have a material adverse effect on the business, financial condition and operating results of the Group.&#160;In addition, the EU&#8217;s GDPR governs the
      collection and use of personal data in the European Union. The GDPR, which is wide-ranging in scope, will impose several requirements relating to the consent of the individuals to whom the personal data relates, the information provided to the
      individuals, the security and confidentiality of the personal data, data breach notification and the use of third-party processors in connection with the processing of the personal data. The GDPR also imposes strict rules on the transfer of personal
      data out of the EU to the U.S., enhances enforcement authority and imposes large penalties for noncompliance, including the potential for fines of up to EUR 20 million or four percent of the annual global revenues of the infringer, whichever is
      greater. In addition, certain breaches of the GDPR may result in regulatory investigations, reputational damage and civil lawsuits including class action lawsuits. In the State of Israel, privacy rights and obligations are mainly regulated under the
      <font style="font-style: italic;">Protection of Privacy Law, 5741-1981</font> (the &#8220;<font style="font-weight: bold;">Israeli Privacy Law</font>&#8221;) and the regulations promulgated thereunder (mainly the <font style="font-style: italic;">Protection of
        Privacy (Data Security) Regulations, 5777-2017</font> and the <font style="font-style: italic;">Protection of Privacy (Transfer of Data Abroad) Regulations, 5761-2001</font>) (the &#8220;<font style="font-weight: bold;">Israeli Privacy Regulations</font>&#8221;).




      Under the Israeli Privacy Law, &#8216;information&#8217; and &#8216;sensitive information&#8217; includes information such as those related to a person&#8217;s health, personality, intimate affairs, financial condition, faith and opinions. The Israeli Privacy Law impose
      obligations related to database registration, notice, disclosure and use restrictions on an &#8216;owner&#8217; of a database, and the Israeli Privacy Regulations set forth the security measurements to be implemented and the rules related to the transfer of
      personal information. Violation of the Israeli Privacy Law could lead to a criminal investigation or an administrative enforcement procedure on behalf of the Israeli Privacy Protection Authority, as well as an administrative fine imposed pursuant to
      the <font style="font-style: italic;">Administrative Offenses Law, 5746-1985</font>. In addition, legal remedies such as statutory compensation of up to NIS 50,000 are available to successful claimants of privacy violations.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 71 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Additional jurisdictions in which the Group operates or in which it may enter in the future, also have data privacy and security laws and regulations that govern the collection, use, disclosure,
      transfer, storage, disposal, and protection of sensitive personal information. The interpretation and enforcement of such laws and regulations are uncertain, are subject to change and may require the Group to incur substantial costs to monitor and
      implement compliance with any additional requirements. Failure to comply with data protection laws and regulations could result in government enforcement actions, litigation and/or adverse publicity and could negatively affect the Group&#8217;s operating
      results, business and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Wholesale Price Volatility</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The cannabis industry is a margin-based business in which gross profits depend on the excess of sales prices over costs. Consequently, profitability is sensitive to fluctuations in wholesale and
      retail prices caused by changes in supply (which itself depends on other factors such as weather, fuel, equipment and labour costs, shipping costs, economic situation, government regulations and demand), taxes, government programs and policies for
      the cannabis industry (including price controls and wholesale price restrictions that may be imposed by government agencies responsible for the sale of cannabis), and other market conditions, all of which are factors beyond the control of the Group.
      The Group&#8217;s operating incomes may be significantly and adversely affected by a decline in the price of cannabis products and will be sensitive to changes in the price of cannabis products and the overall condition of the cannabis industry, as the
      Group&#8217;s profitability is directly related to the price of cannabis products. The price of cannabis products is affected by numerous factors beyond the Group&#8217;s control. Any price decline may have a material adverse effect on the Group&#8217;s business,
      financial condition and results of operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Fraudulent or Illegal Activity</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s employees, independent contractors and consultants may expose the Group to additional risk if they engage in fraudulent or other illegal activity prohibited by relevant laws. Although the
      Group has set preventative measures in place to minimize such fraud or illegal activities from occurring, there is no guarantee that the measures will be effective. If the measures fail and fraud or illegal activities take place, the Group may be
      subject to lawsuits for failure to comply with regulations and be ordered to pay such penalties as prescribed by the court if found to be in violation. Thus, the occurrence of fraud or illegal activities may cause a material adverse effect on the
      Group&#8217;s business, reputation, financial condition and results of operations.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 72 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Corruption and Anti-Bribery Law Violations</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s business is subject to Canadian laws, as well as any other applicable domestic or foreign anti-corruption or anti-bribery laws to which the Group is or may become subject, which generally
      prohibit companies and employees from engaging in bribery or other prohibited payments to foreign officials for the purpose of obtaining or retaining business. In addition, the Group is subject to the anti-bribery laws of any other countries in which
      it conducts business now or in the future. The Group&#8217;s employees or other agents may, without its knowledge and despite its efforts, engage in prohibited conduct under the Group&#8217;s policies and procedures and anti-bribery laws for which the Group may
      be held responsible. The Group&#8217;s policies mandate compliance with these anti-corruption and anti-bribery laws. However, there can be no assurance that the Group&#8217;s internal control policies and procedures will always protect it from recklessness,
      fraudulent behaviour, dishonesty or other inappropriate acts committed by its affiliates, employees, contractors or agents. If the Group&#8217;s employees or other agents are found to have engaged in such practices, the Group could suffer severe penalties
      and other consequences that may have a material adverse effect on its business, reputation, financial condition and results of operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Intellectual Property</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group uses intellectual property protections such as trademarks, trade secrets and contractual confidentiality obligations in order to protect its products, brands and technologies. The
      administrative task of maintaining such protections across multiple jurisdictions can result in high costs to the Group. The Group would also be required to pay for any costs attributed to the enforcement of intellectual property protections. In
      addition, in any infringement proceeding, some or all of the Group&#8217;s intellectual property rights or other proprietary know-how, may be found invalid, unenforceable, anti-competitive or not infringed. An adverse result in any litigation or defense
      proceedings could create the risk of invalidation or narrow interpretation of the Group&#8217;s affected intellectual property rights. Such results could cause a material adverse effect on the Group&#8217;s business, financial condition, results of operations
      and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Furthermore, the possession of intellectual property protections does not completely eliminate the risk of litigation. Even with such protections properly registered, the Group is still vulnerable to
      infringement claims and would be liable for the costs of defending such claims. If the claims succeed, the Group would be liable for the costs of the resulting court orders and may need to negotiate licensing of the intellectual property rights from
      third-party owners.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, despite any intellectual property protections in place, unauthorized parties may attempt to replicate or otherwise obtain and use the Group&#8217;s trademarks, know-how, trade secrets,
      products or technology. Identifying unauthorized use of intellectual property rights is difficult as the Group may be unable to effectively monitor and evaluate the products being distributed by its competitors, including parties such as illegal
      distributers, and the processes used to produce such products. The Group makes no assurance that it will successfully identify unauthorized replication, acquisition or use of the Group&#8217;s trademarks, know-how, trade secrets, products, or technology
      before the effects of such actions cause a material adverse effect on the Group&#8217;s business, financial condition, results of operation and prospects.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>CSE and NASDAQ Continued Listing Requirements</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Common Shares and Warrants began trading on the CSE on November 5, 2019 and November 19, 2019, respectively. The Common Shares began trading on NASDAQ on March 1, 2021.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 73 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company is subject to the rules and regulations of NASDAQ and the CSE. Further, in order to maintain compliance with all continued listing requirements, the Company pays legal, accounting and
      compliance fees to advisors and regulatory organizations and will have to continue to pay additional fees if its Common Shares remain listed on NASDAQ. Any changes to rules, regulations policies or guidelines issued by regulatory authorities may
      impact any such fees paid and increase the risk of non-compliance. There is no assurance that the Company will be able to comply with the applicable NASDAQ or CSE continued listing standards within any projected timeframes, or at all, and maintain
      listing status on either NASDAQ or CSE.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Any failure to comply with applicable continued listing requirements and regulations may result in the delisting of the Company&#8217;s Common Shares and/or Warrants from the CSE and/or the Company&#8217;s
      Common Shares from NASDAQ. Such events may have material adverse effects on the Company&#8217;s business and financial condition.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Significant Sales of Listed Securities</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Sales of a substantial number of Common Shares or other equity-related securities in the public markets by the Company or its shareholders could depress the market price of the Company&#8217;s securities
      and impair the Company&#8217;s ability to raise capital through the sale of additional equity securities. The Company cannot predict the effect that future sales of Common Shares or other equity-related securities would have on the market price of the
      Common Shares. The price of the Common Shares could be affected by possible sales of the Common Shares by hedging or arbitrage trading activity.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Dilution</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company may issue additional securities in the future, which may dilute a shareholder&#8217;s holdings, or a holder of a convertible security&#8217;s underlying relative interest, in the Company. The
      Company&#8217;s articles permit the issuance of an unlimited number of Common Shares, and shareholders will have no pre-emptive rights in connection with any such further issuance. The directors of the Company have discretion to determine the price and the
      terms of further issuances, subject to applicable stock exchange policies. Moreover, additional Common Shares will be issued by the Company on the full exercise of Options, Broker Compensation Options, RSUs and Warrants, issued or to be issued by the
      Company in the future, and the exercise of any resulting convertible securities of such as applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of the date of this Annual Information Form, the issuances of Options are limited by the Option Cap. Subject to shareholder approval, the Option Cap may be increased to a higher percentage of
      Common Shares issued and outstanding. As a result, additional dilution may occur if more options are issued under an increased Option Cap.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Additionally, on March 31, 2021, the Company filed the Final Shelf Prospectus, which allows the Company to offer for sale up to US$250,000,000 in Qualified Securities of the Company for an effective
      period of 25 months. Any issuances of Qualified Securities under a supplement to the Final Shelf Prospectus may dilute a shareholder&#8217;s holdings or a holder of a convertible security&#8217;s underlying relative interest, in the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Holding Company Status</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">IMCC is a holding company. Substantially all of the Company&#8217;s operating assets are the capital stock of its subsidiaries and arrangements with investees. Substantially all of the Company&#8217;s business
      is conducted through subsidiaries or investees, which are separate legal entities. Consequently, the Company&#8217;s cash flows and ability to pursue future business and expansion opportunities are dependent on the earnings of its subsidiaries and
      investees and the distribution of those earnings to the Company. The ability of these entities to pay dividends and other distributions will depend on their operating results and will be subject to applicable laws and regulations which require that
      solvency and capital standards be maintained by such companies and contractual restrictions contained in the instruments governing their debt. In the event of a bankruptcy, liquidation or reorganization of any of the Company&#8217;s subsidiaries, holders
      of indebtedness and trade creditors will generally be entitled to payment of their claims from the assets of those subsidiaries before any assets are made available for distribution to the Company.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 74 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Dividends</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company has not paid any dividends on the outstanding Common Shares, and the Company maintains no current intention to declare dividends on the Common Shares in the foreseeable future. Any
      decision to pay dividends on the Common Shares in the future will be at the discretion of the Board and will depend on, among other things, the Company&#8217;s results of operations, current and anticipated cash requirements and surplus, financial
      condition, any future contractual restrictions and financing agreement covenants, solvency tests imposed by corporate law and other factors that the Board may deem relevant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Securities Price Volatility</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The market price of the Common Shares and Warrants may fluctuate to a wide degree as a result of a number of factors, including without limitation market conditions, financial analyst predictions,
      changes in law, press releases and public filings of the Company, operational activity and results and competitor activity. In particular, the dual-listing of the Common Shares on the CSE and the NASDAQ may result in higher volatility as a result of
      the exposure to both U.S. and Canadian financial market conditions. Overall, such factors, whether related or unrelated to operational performance of the Company, may cause a temporary or non-temporary negative pressure on prices of the Company&#8217;s
      securities or assets. If the negative pressure on prices arising from these factors persist, impairment losses may be recorded and the Company could experience a material adverse effect on its operations, financial condition and operating results.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Internal Controls</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Effective internal controls are required for the Company to provide reasonable assurance that its financial results and other financial information are accurate and reliable. Any failure to design,
      develop or maintain effective controls, or difficulties encountered in implementing, improving or remediation lapses in internal controls may affect the Company&#8217;s ability to prevent fraud, detect material misstatements, and fulfill our reporting
      obligations. As a result, investors may lose confidence in the Company&#8217;s ability to report timely, accurate and reliable financial and other information, which may expose the Company to certain legal or regulatory actions, thus negatively impacting
      its business and financial condition, including the liquidity and/or market value of its securities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Liquidity of Securities</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Despite the listing of the Common Shares and Warrants on public exchanges, there is no guarantee to security holders that the securities will be sufficiently liquid to any degree without a
      substantial decrease in price, particularly if selling significant quantities within a short time frame. Accordingly, there is a possibility that a lack of liquidity may cause difficulty for security holders to re-sell securities at desired prices.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 75 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Credit Risk</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group may be owed current or long-term debts such as accounts receivables over the course of its operations. As a result, the Group may be exposed to the risk of debtor defaults on payments as
      they come due. The Company makes no guarantee on the level of credit risk that it will hold at any given time but intends to minimize this risk as determined by the Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Liquidity Risk</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group is subject to the inherent risk that it will not be able to pay its financial obligations as they become due. In light of its recent negative cash flows, the Company intends to monitor
      liquidity risk carefully and plan its liquid holdings strategically to avoid any payment defaults.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Market Risk</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk includes exchange rate risk and interest
      rate risk.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Exchange rate risk is the risk of loss arising from changes to foreign exchange rates. As the Group is a party to certain international contracts that require the Group to make or receive payments in
      foreign currencies, there is a risk that losses will be incurred if there is an adverse shift in exchange rates.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Interest rate risk pertains to the risk of loss arising from changes in prevailing interest rates. Any increases in prevailing interest rates may increase interest expenses paid by the Group on any
      long-term debt.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Global Economy Risk</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">An economic downturn of global capital markets has been shown to make the raising of capital by equity or debt financing more difficult. The Company will be dependent upon the capital markets to
      raise additional financing in the future, while it continues to develop its operations. As such, the Company is subject to liquidity risks in meeting its development and future operating cost requirements in instances where cash positions are unable
      to be maintained or appropriate financing is unavailable. These factors may impact the Company&#8217;s ability to raise equity or obtain loans and other credit facilities in the future and on terms favorable to the Company and its management. If uncertain
      market conditions persist, the Company&#8217;s ability to raise capital could be jeopardized, which could have an adverse impact on the Company&#8217;s operations and the trading price of the Company&#8217;s securities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Future crises may be precipitated by any number of causes, including natural disasters, public health crises, geopolitical instability, war, natural disasters, changes to energy prices or sovereign
      defaults. These factors may impact the ability of the Company to obtain equity or debt financing in the future and, if obtained, on terms favorable to the Company. Increased levels of volatility and market turmoil can adversely impact the Group&#8217;s
      operations and the value, and the price of the Common Shares and/or Warrants could be adversely affected.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, there is a risk that one or more of the Group&#8217;s current service providers may themselves be adversely impacted by difficult economic circumstances, which could have a material adverse
      effect on the Group&#8217;s business, financial condition, results of operations and prospects.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 76 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Sufficiency of Insurance</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group maintains various types of insurance which may include product liability insurance (see &#8220;<font style="font-style: italic;">Potential Product Liability</font>&#8221; below), errors and omission
      insurance, directors and officers insurance, trustees&#8217; insurance, property coverage and general commercial insurance. There is no assurance that claims will not exceed the limits of available coverage, that any insurer will remain solvent or willing
      to continue providing insurance coverage with sufficient limits or at a reasonable cost; or, that any insurer will not dispute coverage of certain claims due to ambiguities in the policies. A judgment against any member of the Group in excess of
      available coverage could have a material adverse effect on the Group in terms of damages awarded and negatively impact the reputation of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Uninsured or Uninsurable Risks</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The insurance purchased by the Group cannot cover all risks that the Group is exposed to. Additionally, some insurance policies are outside of budget limitations and are therefore elected to be
      excluded. There is no guarantee that any insurance coverage maintained by any member(s) of the Group will sufficiently cover any or all liabilities incurred by that Group member. Any uninsured amounts of liabilities incurred by member(s) of the Group
      may be paid directly by such members. Accordingly, such direct payments may have a material adverse effect on the Group&#8217;s business, results of operations, and financial condition.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Potential Product Liability</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">TJAC, MYM, Focus, Adjupharm and the Israeli Licensed Companies are producers and/or distributors and/or sellers of products designed to be ingested or inhaled by humans. Such products face an
      inherent risk of exposure to product liability claims, regulatory action and litigation if such products are alleged to have caused significant loss or injury. In addition, the manufacture and sale of such products involve the risk of injury or loss
      to consumers or patients due to tampering by unauthorized third parties, product contamination, unauthorized use by consumers or patients or other third parties. Previously unknown adverse reactions resulting from human consumption of cannabis
      products alone or in combination with other medications or substances could occur.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group may be subject to various product liability claims, including, among others, that products manufactured, distributed, stored or sold by the Group or bearing one of the Group&#8217;s brands caused
      injury, illness or loss, include inadequate instructions for use or include inadequate warnings concerning possible side effects or interactions with other substances. A product liability claim or regulatory action against the Group could result in
      increased costs, could adversely affect the Group&#8217;s reputation with its clients, patients and consumers generally, and could have a material adverse effect on the Group&#8217;s results of operations and financial condition.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There can be no assurances that the Group will be able to obtain or maintain product liability insurance on acceptable terms or with adequate coverage against potential liabilities. Such insurance is
      expensive and may not be available in the future on acceptable terms, or at all. The inability to obtain sufficient insurance coverage on reasonable terms or to otherwise protect against potential product liability claims could prevent or inhibit the
      commercialization of the Group&#8217;s products.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Current and Potential General Litigation</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Certain members and/or representatives of the Group are parties to certain legal proceedings or investigations, including the Construction Allegations and Proceedings, the MOH Allegations and certain
      legal proceedings as described in &#8220;<font style="font-style: italic;">Legal Proceedings and Regulatory Actions</font> &#8211; <font style="font-style: italic;">Legal Proceedings</font>&#8221; below.<font style="font-style: italic;">&#160;</font>Should such Group
      members and/or representatives fail to receive favorable decisions at the conclusion of these legal proceedings or incur significant costs in litigation thereof, the Group&#8217;s business, financial condition or operating results may be subject to a
      material adverse effect.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 77 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Members and/or representatives of the Group are or may become parties to litigation from time to time in the ordinary course of business that could adversely affect its business. Should any
      litigation in which the Group members and/or representatives become involved be determined against such Group members and/or representatives, such a decision could adversely affect the Group&#8217;s ability to continue operating and the market price for
      the Common Shares and/or Warrants. Even if such Group members and/or representatives are involved in litigation and win, the litigation process can consume significant resources of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Quality Control Systems</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The quality and safety of the Group&#8217;s products and products purchased from third party suppliers are critical to the success of the Group&#8217;s business and operations. As such, it is imperative that the
      Group&#8217;s (and its service providers&#8217;) quality control systems operate effectively and successfully. Quality control systems can be negatively impacted by the design of the quality control systems, the quality training program, and adherence by
      employees to quality control guidelines. Although the Group strives to ensure that it and all of its service providers have implemented and adhere to high calibre quality control systems, the Group could experience a significant failure or
      deterioration of such quality control systems. A failure of the Group&#8217;s quality control systems could result in significant costs incurred in replacing, destroying or repurposing defective inventory, providing replacement products to its customers or
      recalling such products. The Group may be unable to meet customer demand and may lose customers who have to purchase alternative brands or products. In addition, consumers may lose confidence in the Group&#8217;s brands whether affected or not and such
      brand reputation may be materially damaged. Any loss of sales volume from a contamination event may affect the Group&#8217;s ability to fulfill its contractual obligations. During this time, the Group&#8217;s competitors may benefit from an increased market
      share that could be difficult and costly to regain.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Potential Product Recalls</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Manufacturers and distributors of products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, such as contamination, unintended
      harmful side effects or interactions with other substances, packaging safety and inadequate or inaccurate labeling disclosure. If products are recalled due to an alleged product defect or for any other reason, the Group could be required to incur the
      unexpected expense of the recall and any legal proceedings that might arise in connection with the recall.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group may lose a significant amount of sales and may not be able to replace those sales at an acceptable margin or at all. In addition, a product recall may require significant management
      attention.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Although the Group has detailed procedures in place for testing finished products, there can be no assurance that any quality, potency or contamination problems will be detected in time to avoid
      unforeseen product recalls, regulatory action or lawsuits. Additionally, if one of the Group&#8217;s significant brands were subject to recall, the image of that brand and the Group could be harmed. A recall for any one of the foregoing reasons could lead
      to decreased demand for the Group&#8217;s products and could have a material adverse effect on the results of operations and financial condition of the Group. Additionally, product recalls may lead to increased scrutiny of the Group&#8217;s operations by the
      applicable regulatory body, including but not limited to Health Canada, MOH or BfArM or other regulatory agencies, requiring further management attention and potential legal fees and other expenses.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 78 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Difficulty in Forecasts</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s sales forecasts are largely dependent on the Group&#8217;s own market research. There is no assurance pertaining to the accuracy of the Group&#8217;s predictions regarding the cannabis industry. Any
      assumptions made in producing forecasts may be inaccurate as a result of external factors that are unpredictable to the Group. Such inaccuracies could have a material adverse effect on the Group&#8217;s business, financial condition and results of
      operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Catastrophic Events, Natural Disasters, Severe Weather and Disease</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s business may be negatively impacted by a number of events that are beyond its control, including cyber-attacks, energy blackouts, pandemics, terrorist attacks, acts of war, earthquakes,
      hurricanes, tornados, fires, floods, ice storms or other catastrophic events. Further, the Group relies on certain suppliers and distribution partners whose businesses may be impacted by the occurrence of any of the foregoing events. Catastrophic
      events can evolve rapidly and their impacts can be difficult to predict. There can be no assurance that the occurrence of a catastrophic event or the associated consequences will not disrupt the Group&#8217;s operations, ability to carry on business or
      supply and distribution chains. In addition, liquidity and volatility, credit availability, market and financial conditions and cannabis cultivation, supply and distribution conditions, among other critical factors to the Group&#8217;s business, could
      change at any time as a result. These events and any associated consequences may cause a material adverse effect on the business, financial condition and results of operations of the Group. A catastrophic event, including an outbreak of infectious
      disease, a pandemic or a similar health threat, such as the COVID-19 pandemic, or fear of any of the foregoing, could adversely impact the Group and its ability to maintain normal operations. Although the Group has taken proactive measures throughout
      the COVID-19 pandemic to protect the health and safety of its employees, to continue delivering high quality cannabis products to patients and to maintain its balance sheet, the current global uncertainty with respect to the spread of the COVID-19,
      the rapidly evolving nature of the pandemic and local and international developments related thereto and its effect on the broader global economy and capital markets may impact the Group&#8217;s business in the coming months.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Anti-Money Laundering Laws and Regulation Risks</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group is subject to a variety of laws and regulations domestically and internationally that involve money laundering, financial recordkeeping and proceeds of crime, including the <font style="font-style: italic;">Proceeds of Crime (Money Laundering) and Terrorist Financing Act</font> (Canada), as amended and the rules and regulations thereunder, the <font style="font-style: italic;">Criminal Code</font> (Canada) and any related
      or similar rules, regulations or guidelines, issued, administered or enforced by governmental authorities internationally. In the event that any of the Group&#8217;s investments, or any proceeds thereof, any dividends or distributions therefrom, or any
      profits or revenues accruing from such investments were found to be contrary to money laundering legislation, such transactions may be viewed as proceeds of crime under one or more of the statutes noted above or any other applicable legislation. This
      could restrict or otherwise jeopardize the ability of the Company to declare or pay dividends, effect other distributions or subsequently repatriate such funds back to Canada. Furthermore, while the Company has no current intention to declare or pay
      dividends in the foreseeable future, in the event that Company determines to declare or pay dividends but a determination was made that the investments in Company&#8217;s investees could reasonably be shown to constitute proceeds of crime, the Company may
      subsequently decide or be required to suspend declaring or paying dividends without advance notice and for an indefinite period of time.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 79 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Security over Underlying Assets</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There is no guarantee that the Group will be able to effectively enforce any guarantees, indemnities or other security interests it may have. Should a bankruptcy or other similar event occur that
      precludes an investee from performing its obligations under an agreement with any member of the Group, the Group would have to enforce its security interest. In the event that the investee has insufficient assets to pay its liabilities, it is
      possible that other liabilities will be satisfied prior to the liabilities owed to the Group. In addition, bankruptcy or other similar proceedings are often a complex, lengthy and expensive process, the outcome of which may be uncertain and could
      result in a material adverse effect on the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">If the Group is unable to enforce its security interests due to any reasons including regulatory reasons related to its cannabis activity, there may be a material adverse effect on the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Conflicts of Interest</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company may be subject to various potential conflicts of interest because of the fact that some of its officers and directors may be engaged in a range of business activities. In some cases, the
      executive officers and directors may have fiduciary obligations associated with these business interests that interfere with their ability to devote time to the Company and its affairs, and that could adversely affect Company operations. These
      business interests could require significant time and attention of the Company&#8217;s executive officers and directors. In addition, the Company may also become involved in other transactions which conflict with the interests of the Company&#8217;s directors
      and officers who may from time to time deal with persons, firms, institutions or corporations with which the Company may be dealing, or which may be seeking investments similar to those the Company desires. The interests of these persons could
      conflict with the Company&#8217;s interests.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, from time to time, these persons may be competing with the Company for available investment opportunities. Conflicts of interest, if any, will be subject to the procedures and remedies
      provided under applicable laws. In particular, in the event that such a conflict of interest arises at a meeting of directors, a director who has such a conflict will abstain from voting for or against the approval of such participation or such
      terms. In accordance with applicable laws, directors are required to act honestly, in good faith and in the Company&#8217;s best interests.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Foreign Private Issuer Status under U.S. Securities Laws</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company is a &#8220;foreign private issuer&#8221;, as defined in Rule 405 under the U.S. Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold;">U.S. Securities Act</font>&#8221;), and Rule 3b-4
      under the U.S. Securities and Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">U.S. Exchange Act</font>&#8221;). It is therefore not subject to the same requirements that are imposed upon U.S. domestic issuers by the SEC. Under the
      U.S. Exchange Act, the Company is subject to reporting obligations that, in certain respects, are less detailed and less frequent than those of U.S. domestic reporting companies. As a result, the Company does not file the same reports that a U.S.
      domestic issuer would file with the SEC, although the Company is required to file with or furnish to the SEC the continuous disclosure documents that it is required to file in Canada under Canadian securities laws. In addition, the Company&#8217;s
      officers, directors, and principal shareholders are exempt from the reporting and short-swing profit recovery provisions of Section 16 of the Exchange Act. Therefore, the Company&#8217;s shareholders may not know on as timely a basis when the Company&#8217;s
      officers, directors and principal shareholders purchase or sell Common Shares, as the reporting periods under the corresponding Canadian insider reporting requirements are longer.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 80 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As a foreign private issuer, the Company is exempt from the rules and regulations under the Exchange Act related to the furnishing and content of proxy statements. The Company is also exempt from
      Regulation FD, which prohibits issuers from making selective disclosures of material non-public information. While the Company complies with the corresponding requirements relating to proxy statements and disclosure of material non-public information
      under Canadian securities laws, these requirements differ from those under the Exchange Act and Regulation FD and shareholders should not expect to receive the same information at the same time as such information is provided by U.S. domestic
      companies. In addition, the Company may not be required under the Exchange Act to file annual and quarterly reports with the SEC as promptly as U.S. domestic companies whose securities are registered under the Exchange Act.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In addition, as a foreign private issuer, the Company has the option to follow certain Canadian corporate governance practices, except to the extent that such laws would be contrary to U.S.
      securities laws, and provided that the Company disclose the requirements it is not following and describe the Canadian practices it follows instead. The Company may in the future elect to follow home country practices in Canada with regard to certain
      corporate governance matters. As a result, the Company&#8217;s shareholders may not have the same protections afforded to shareholders of U.S. domestic companies that are subject to all corporate governance requirements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Loss of Foreign Private Issuer Status under U.S. Securities Laws</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In order to maintain its status as a foreign private issuer, a majority of the Company&#8217;s Common Shares must be either directly or indirectly owned by non-residents of the U.S. unless the Company also
      satisfies one of the additional requirements necessary to preserve this status. The Company may in the future lose its foreign private issuer status if a majority of its Common Shares are held in the U.S. and if the Company fails to meet the
      additional requirements necessary to avoid loss of its foreign private issuer status. The regulatory and compliance costs under U.S. federal securities laws as a U.S. domestic issuer may be significantly more than the costs incurred as a Canadian
      foreign private issuer eligible to use MJDS. If the Company is not a foreign private issuer, it would not be eligible to use the MJDS or other foreign issuer forms and would be required to file periodic and current reports and registration statements
      on U.S. domestic issuer forms with the SEC, which are more detailed and extensive than the forms available to a foreign private issuer. In addition, the Company may lose the ability to rely upon exemptions from NASDAQ corporate governance
      requirements that are available to foreign private issuers.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Emerging Growth Company Status under U.S. Securities Laws</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company is an &#8220;emerging growth company&#8221; as defined in section 3(a) of the Exchange Act (as amended by the JOBS Act, enacted on April 5, 2012), and the Company will continue to qualify as an
      emerging growth company until the earliest to occur of: (a) the last day of the fiscal year during which the Company has total annual gross revenues of US$1,070,000,000 (as such amount is indexed for inflation every five years by the SEC) or more;
      (b) the last day of the fiscal year of the Company following the fifth anniversary of the date of the first sale of common equity securities of the Company pursuant to an effective registration statement under the U.S. Securities Act; (c) the date on
      which the Company has, during the previous three year period, issued more than US$1,000,000,000 in non-convertible debt; and (d) the date on which the Company is deemed to be a &#8220;large accelerated filer&#8221;, as defined in Rule 12b&#8211;2 under the Exchange
      Act. The Company will qualify as a large accelerated filer (and would cease to be an emerging growth company) at such time when on the last business day of its second fiscal quarter of such year the aggregate worldwide market value of its common
      equity held by non-affiliates will be US$700,000,000 or more.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 81 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">For so long as the Company remains an emerging growth company, it is permitted to and intends to rely upon exemptions from certain disclosure requirements that are applicable to other public
      companies that are not emerging growth companies. These exemptions include not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. The Company cannot predict whether investors will find the
      Common Shares less attractive because the Company relies upon certain of these exemptions. If some investors find the Common Shares less attractive as a result, there may be a less active trading market for the Common Shares and the Common Share
      price may be more volatile. On the other hand, if the Company no longer qualifies as an emerging growth company, the Company would be required to divert additional management time and attention from the Company&#8217;s development and other business
      activities and incur increased legal and financial costs to comply with the additional associated reporting requirements, which could negatively impact the Company&#8217;s business, financial condition and results of operations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="DIVIDENDS"><!--Anchor--></a>DIVIDENDS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of the date of this Annual Information Form, the Company has not declared dividends on its Common Shares and has no intention to declare dividends on its Common Shares in the immediate or
      foreseeable future. There are no restrictions in the Company&#8217;s articles or by-laws that prevent the Company from paying dividends. Any future dividends declared will made at the discretion of the Board and will depend on circumstances at the time of
      contemplation, including financial status of the Company, contractual or regulatory obligations, and other conditions existing at such future time.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;">DESCRIPTION OF CAPITAL STRUCTURE</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Common Shares</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The authorized capital of the Company consists of an unlimited number of Common Shares issuable in series, which may contain the rights, privileges and restrictions as determined by the Board.
      Holders of Common Shares are entitled to dividends, if, as and when declared by the Board, to one vote per share at meetings of shareholders of the Company and, upon dissolution, to share equally in such assets of the Company as are distributable to
      the holders of Common Shares.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There are 69,690,151<font style="font-weight: bold;">&#160;</font>Common Shares issued and outstanding as of the date of this Annual Information Form.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Warrants</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the Reverse Takeover Transaction, and prior to the Consolidation, the Company issued an aggregate of 9,730,258 2019 Listed Warrants. Following the Consolidation, the 2019 Listed
      Warrants were adjusted to require four 2019 Listed Warrants to be exercised for one Common Share at an adjusted exercise price of $5.20. The 2019 Listed Warrants were listed on the CSE under the symbol &#8220;IMCC.WT&#8221; until their expiry on October 11,
      2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Certain 2019 Unlisted Warrants are outstanding and issuable upon exercise of 2019 Broker Compensation Options. Following the Consolidation, the 2019 Unlisted Warrants were adjusted to require four
      2019 Unlisted Warrants to be exercised for one Common Share at an adjusted exercise price of $5.20. All 2019 Unlisted Warrants expire on August 30, 2022 and are not listed for trading on any stock exchange.&#160; As of the date of this Annual Information
      Form, there are 134,924 2019 Unlisted Warrants outstanding.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 82 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As part of the 2021 Offering, the Company issued a total of 3,043,478 2021 Offered Warrants to the purchasers of the 2021 Offered Shares. Each 2021 Warrant is exercisable for one Common Share at an
      exercise price of US$7.20. The 2021 Offered Warrants expire on May 7, 2026. As of the date of this Annual Information Form, there are 3,043,478 2021 Offered Warrants outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Broker Compensation Options</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the Reverse Takeover Transaction, and prior to the Consolidation, the Company issued to the agents who acted on its behalf a total of 1,199,326 2019 Broker Compensation Options.
      Following the Consolidation, the 2019 Broker Compensation Options were adjusted to require four 2019 Broker Compensation Options to be exercised for one underlying unit at an adjusted exercise price of $4.20, with each unit exercisable into one
      Common Share and one-half of one 2019 Unlisted Warrant. The 2019 Broker Compensation Options expire on August 30, 2022. As of the date of this Annual Information Form, there are 539,488 2019 Broker Compensation Options.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the 2021 Offering, the Company issued to the agents who acted on its behalf a total of 182,609 2021 Broker Compensation Options. The 2021 Broker Compensation Options expire on
      November 5, 2024. As of the date of this Annual Information Form, there are 182,609 2021 Broker Compensation Options outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Incentive Stock Options</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On July 28, 2021, the shareholders approved the 2021 Stock Option Plan at the Company&#8217;s annual general meeting. All Options granted by the Company following the date of such approval are governed by
      the 2021 Stock Option Plan.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The maximum number of Common Shares that may be reserved for issuance under the 2021 Stock Option Plan and any other security based compensation arrangements (such as the RSU Plan and the Predecessor
      Stock Option Plan) is 10% of the issued and outstanding Common Shares, on a non-diluted basis, on each date of grant (the &#8220;<font style="font-weight: bold;">Option Cap</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">All Options granted by the Company prior to July 28, 2021, are governed by the Predecessor Stock Option Plan. The 2021 Stock Option Plan has replaced the Predecessor Stock Option Plan and no
      additional Options will be issued under the Predecessor Stock Option Plan. As at the date of this Annual Information Form, the Company had an aggregate of 4,639,431 Options outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Restricted Share Units</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On December 16, 2020, the Company&#8217;s shareholders approved a &#8220;rolling&#8221; restricted share unit plan (&#8220;<font style="font-weight: bold;">RSU Plan</font>&#8221;) whereby the Company may issue RSUs. The maximum
      number of Common Shares that may be reserved for issuance under the RSU Plan and any other security based compensation arrangements (such as the 2021 Stock Option Plan and the Predecessor Stock Option Plan) is 10% of the issued and outstanding Common
      Shares, on a non-diluted basis, on each date of grant. The RSU Plan supplements the 2021 Stock Option Plan by providing the Board with an alternative to issuing Options if it determines that a full value share plan provides an attractive form of
      long-term incentive for key personnel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of the date of this Annual Information Form, the Company had an aggregate of 550,000 RSUs outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 83 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="MARKETFORSECURITIES"><!--Anchor--></a>MARKET FOR SECURITIES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Trading Price nd Volume</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Common Shares</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Common Shares have been listed for trading under the symbol &#8220;IMCC&#8221; on the CSE since November 5, 2019, following the completion of the Reverse Takeover Transaction, and on the NASDAQ since March
      1, 2021. The chart below sets forth the reported high and low prices and the monthly trading volume history of the Common Shares on the CSE for the financial year ended December 31, 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left;" id="z8238c4fca30e4264a90525afa45522e3">

        <tr>
          <td colspan="4" style="width: 100%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Common Share Historic Trading Prices and Volumes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Month</div>
          </td>
          <td style="width: 21.35%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">High</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(CAD)</div>
          </td>
          <td style="width: 19.94%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Low</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(CAD)</div>
          </td>
          <td style="width: 23.37%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Volume</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">December 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$6.00</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$3.86</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">751,097</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">November 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$5.65</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$2.84</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,818,757</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">October 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$4.75</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$3.34</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">725,118</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">September 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$4.83</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$3.39</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">790,694</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">August 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$6.49</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$4.31</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">463,233</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">July 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$6.71</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$5.76</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">695,807</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">June 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$7.60</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$5.15</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,314,235</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$8.31</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$4.84</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">990,498</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">April 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$10.00</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$6.14</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">940,921</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">March 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$14.40</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$8.72</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">863,987</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">February 12-28, 2021<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$12.00</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$8.51</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">268,791</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">February 1-11, 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$3.00</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$2.21</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1,263,989</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">January 2021</div>
          </td>
          <td style="width: 21.35%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$2.85</div>
          </td>
          <td style="width: 19.94%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$2.32</div>
          </td>
          <td style="width: 23.37%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">812,869</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 126pt; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 126pt; line-height: 1.25; font-weight: bold;"><u>Notes:</u></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z16d770ebaa5e4b1f93f2bf90c4aaac45">

        <tr>
          <td style="width: 90pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;"><u>(1)</u></td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company effected the Consolidation as of February 12, 2021.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <br>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 84 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">Warrants</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The 2019 Listed Warrants were listed for trading on the CSE under the symbol &#8220;IMCC.WT&#8221; until their expiry date of October 11, 2021. The below trading information chart sets out the monthly trading
        history of the 2019 Listed Warrants on the CSE for the financial year ended December 31, 2021.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 80%; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left;" id="z93119f8c051d4d31bdea2079dfb445ff">

        <tr>
          <td colspan="4" style="width: 100%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Listed Warrants Historic Trading Prices and Volumes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Month</div>
          </td>
          <td style="width: 19.45%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">High</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(CAD)</div>
          </td>
          <td style="width: 25%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Low</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(CAD)</div>
          </td>
          <td style="width: 25.01%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Share Volume</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">October 1 to October 11, 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.01</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.005</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">250,258</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">September 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.15</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.01</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">321,047</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">August 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.56</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.15</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">52,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">July 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.45</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.15</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">26,762</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">June 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.45</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.30</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">53,220</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.38</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.37</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">20,880</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">April 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$1.01</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$0.38</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">10,325</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">March 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$1.80</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$1.01</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">70,302</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">February 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$4.20</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$1.10</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">155,687</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.54%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">January 2021</div>
          </td>
          <td style="width: 19.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$1.70</div>
          </td>
          <td style="width: 25%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$1.00</div>
          </td>
          <td style="width: 25.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">83,518</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <br>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 85 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Prior Sales</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The table below summarizes details of securities of the Company that were not listed or quoted on a marketplace and issued by the Company during the financial year ended December 31, 2021. For a
        list of all outstanding options granted as of the date of this Annual Information Form, please see &#8220;<font style="font-style: italic;">Description of Capital Structure &#8211; Options</font>&#8221; above.</div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="2" border="0" align="center" style="width: 80%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="z6baddc2fa58d4d51be288f429e78a63b">

          <tr>
            <td colspan="4" style="border-bottom: #000000; border-left: 2px solid #000000; border-right: 2px solid; border-top: 2px solid #000000; vertical-align: middle; width: 100%;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Prior Sales of Unlisted or Unquoted Securities</div>
            </td>
          </tr>
          <tr>
            <td style="border-bottom: #000000; border-left: 2px solid #000000; border-top: 2px solid #000000; vertical-align: middle; width: 24.99%;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Date of Issuance</div>
            </td>
            <td style="border-bottom: #000000; border-left: 2px solid #000000; border-top: 2px solid #000000; vertical-align: middle; width: 24.99%;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Security</div>
            </td>
            <td style="border-bottom: #000000; border-left: 2px solid #000000; border-top: 2px solid #000000; vertical-align: middle; width: 25.01%;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Issuance/Exercise Price Per Security</div>
              <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">(CAD)</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td style="border-bottom: #000000; border-left: 2px solid #000000; border-right: 2px solid; border-top: 2px solid #000000; vertical-align: middle; width: 25.01%;">
              <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">Number of Securities</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">January 7, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">2019 Unlisted Warrants<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">5.20</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">16,864</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">February 8, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(3)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">10.00</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">5,500</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">February 23, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">2019 Unlisted Warrants<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)(4)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">5.20</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">7,838</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">March 18, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">10.02</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">700,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">May 7, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">2021 Offered Warrants<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">US$7.20</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">3,043,478</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">May 7, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">2021 Broker Compensation Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">US$6.61</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">182,609</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">May 19, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">5.87</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">1,471,465</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">May 19, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">RSUs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">-</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">550,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">July 9, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">34.55</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">19,800</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">September 27, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">4.50</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">29,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">December 20, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">2019 Unlisted Warrants<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)(12)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">5.20</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25;">16,865</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">December 27, 2021</div>
            </td>
            <td style="width: 24.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(13)</sup></div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">4.62</div>
            </td>
            <td style="width: 25.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">8,500</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Notes</font>:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z71ceb24c9cd64e639f3a65d0b76207d7">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(1)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Figures are reported on a post-Consolidation basis. Following the Consolidation, all Options outstanding issued prior to February 12, 2021 were consolidated on the basis of four (4) pre-Consolidation Options to one (1) post-Consolidation
              Option (a &#8220;<font style="font-weight: bold;">Post-Consolidation Option</font>&#8221;), with respective exercise prices adjusted by a factor of four (4). Each Post-Consolidation Option is exercisable for one Common Share at the adjusted exercise
              price. All 2019 Listed Warrants, 2019 Broker Compensation Options and 2019 Unlisted Warrants were adjusted such that four of each respective security was required to acquire one post-Consolidation Common Share.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f2d62f4934a4bcf9f6f9f0001d6375c">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(2)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>During the financial year ended December 31, 2021, the Company issued an aggregate of 166,272 2019 Unlisted Warrants pursuant to exercises of 2019 Broker Compensation Options. Each 2019 Unlisted Warrant is exercisable at the exercise price
              until August 30, 2022.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z13fc725712b3462b9209a16eb85b7611">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(3)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Each Option is exercisable at the exercise price for one Common Share and expires on February 8, 2026. As of the date of this Annual Information Form, all 5,500 of these Options, remain outstanding.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z363e7ffb966e4c5cb0fe00512d26a7bd">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(4)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Issued as a result of a 2019 Broker Compensation Option exercise on February 23, 2021 and immediately exercised into Common Shares.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbbea851f4c644a60982cb9a255281df9">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(5)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Each Option is exercisable at the exercise price for one Common Share and expires on March 18, 2026. As of the date of this Annual Information Form, 675,000 of these Options remain outstanding.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z65a0282959784c7b8ccb6d11f6d76b0a">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(6)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Issued in connection of the 2021 Offering. Each 2021 Offered Warrant exercisable at the exercise price for one Common Share and expires on May 7, 2026.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z70b19172a1be4c7cbbceff953d4a6222">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(7)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Issued in connection with the 2021 Offering. Each 2021 Broker Compensation Option is exercisable at the exercise price for one Common Share, at any time following November 5, 2021 until November 5, 2024.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z752d093a818c46aaa8978ba4c57fca2b">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(8)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Each Option is exercisable at the exercise price for one Common Share and expires on May 19, 2026. As of the date of this Annual Information Form, 1,466,215 of these Options remain outstanding.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf1612499abfd412aa42f1ed50cd675e6">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(9)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Each RSU entitles it holder to receive: (i) one Common Share; or (ii) a cash payment calculated under the terms of the RSU Plan; or (iii) a combination of (i) and (ii), as determined by the Board in its sole discretion, on the date when
              the RSU granted is fully vested.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za5cc1a5a5bd648558f2ad5ad3109c0de">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(10)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Each Option is exercisable at the exercise price for one Common Share. 16,500 of the Options granted on July 9, 2021 expired on February 11, 2022; however as the Company was in a quarterly blackout period on February 11, 2022, these
              Options may be exercised for a period following the end of such quarterly blackout. 3,300 Options granted on July 9, 2021 expire on September 27, 2022.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeeacd59f8deb490bb0713cd2e4c0ffe1">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(11)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Each Option is exercisable at the exercise price for one Common Share and expires on September 27, 2026. As of the date of this Annual Information Form, 24,000 of these Options, remain outstanding.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0b56a56274a9446ab19c9217f5ea8ae5">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(12)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Issued as a result of a 2019 Broker Compensation Option exercise on December 20, 2021.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z827f51b8560649a19da749df92283c67">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(13)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Each Option is exercisable at the exercise price for one Common Share and expires on December 27, 2026. As of the date of this Annual Information Form, 8,500 of these Options remain outstanding.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ESCROWED SECURITIES AND SECURITIES SUBJECT TO<br>
        CONTRACTUAL RESTRICTIONS ON TRANSFER</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">As of December 31, 2020, none of the Company&#8217;s securities of any class are subject to a contractual restriction or are being held in escrow.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 86 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">DIRECTORS AND EXECUTIVE OFFICERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The following table sets out the name, province or state, and country of residence, positions and offices held with the Company, the period during which each director has served as a director and the
      principal occupations of each of the directors and executive officers as of the date hereof. Directors of the Company hold office until the next annual meeting of shareholders or until their successors are duly elected or appointed, unless his office
      is earlier vacated in accordance with the Company&#8217;s articles or by-laws:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="zb0fd7366e8044c7dbb51fb989107c947">

          <tr>
            <td colspan="4" style="background-color: #FFFFFF; border-bottom: #000000; border-left: 2px solid #000000; border-right: 2px solid; border-top: 2px solid #000000; vertical-align: top; width: 100%;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Director and Executive Officer Information</div>
            </td>
          </tr>
          <tr>
            <td style="background-color: #FFFFFF; border-bottom: #000000; border-left: 2px solid #000000; border-top: 2px solid #000000; vertical-align: top; width: 21.78%;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
              </div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Name and Residence</div>
            </td>
            <td style="background-color: #FFFFFF; border-bottom: #000000; border-left: 2px solid #000000; border-top: 2px solid #000000; vertical-align: top; width: 16.01%;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
              </div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Office with Company</div>
            </td>
            <td style="background-color: #FFFFFF; border-bottom: #000000; border-left: 2px solid #000000; border-top: 2px solid #000000; vertical-align: top; width: 37.5%;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Principal Occupation and Positions </div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Held During the Last 5 Years</div>
            </td>
            <td style="background-color: #FFFFFF; border-bottom: #000000; border-left: 2px solid #000000; border-right: 2px solid; border-top: 2px solid #000000; vertical-align: top; width: 24.7%;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Number and Percentage of Common Shares Owned, Beneficially Held or Controlled<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)(3)</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 21.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Oren Shuster<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;">Ra&#8217;anana, Israel</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
            <td style="width: 16.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Chief Executive Officer and Director since October 2019</div>
            </td>
            <td style="width: 37.5%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CEO of IMC Holdings since 2018 to 2022; founder of Ewave Group Ltd. since 1999.</div>
            </td>
            <td style="width: 24.7%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">9,135,137<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(13.10%)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 21.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Shai Shemesh</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;">Petach-Tikva, Israel</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
            <td style="width: 16.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Chief Financial Officer since October 2019</div>
            </td>
            <td style="width: 37.5%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CFO of IMC Holdings since 2019; CFO of Sadyt Israel and IVM Minrav-Sadyt from 2011 to 2019.</div>
            </td>
            <td style="width: 24.7%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">11,905</div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(&lt;1%)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 21.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yael Harrosh</div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;">Tel Aviv, Israel</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
            <td style="width: 16.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Chief Legal and Operations Officer as of January 2022; General Counsel and Corporate Secretary from October 2019 to January 2022</div>
            </td>
            <td style="width: 37.5%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">General Counsel, Corporate Secretary and Business and Compliance Manager of IMC Holdings since 2018; Legal Counsel and Deputy CEO at ProMarket
                Group from 2016 to 2018; Advocate at AYR Law Firm, Israel from 2015 to 2016.</div>
            </td>
            <td style="width: 24.7%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Nil</div>
            </td>
          </tr>
          <tr>
            <td style="width: 21.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Haleli Barath<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)(5)</sup></div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;">Tel Aviv, Israel</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
            <td style="width: 16.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director since February 2021</div>
            </td>
            <td style="width: 37.5%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Partner of Bfp &amp; Co. since 2009.</div>
            </td>
            <td style="width: 24.7%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">166,682<br>
                (&lt;1%)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 21.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Vivian Bercovici<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> (4)(5)(6)</sup></div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;">Tel Aviv, Israel</div>
            </td>
            <td style="width: 16.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director since March 2020</div>
            </td>
            <td style="width: 37.5%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Independent consultant and columnist, Managing Director, Europe and Israel at Nuuvera Inc. from 2017 to 2018; Canadian Ambassador to Israel
                from 2014 to 2016.</div>
            </td>
            <td style="width: 24.7%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19,980</div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(&lt;1%)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 21.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Brian Schinderle<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)(5)</sup></div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;">Illinois, USA</div>
            </td>
            <td style="width: 16.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director since February 2021</div>
            </td>
            <td style="width: 37.5%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Founder and Manager of Solidum Capital Advisors LLC since 2017; EVP-Finance of GR Companies Inc., (DBA Grassroots Cannabis) from 2018 to 2020;
                Portfolio Manager of Balyasny Asset Management from 2009 to 2017.</div>
            </td>
            <td style="width: 24.7%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Nil</div>
            </td>
          </tr>
          <tr>
            <td style="width: 21.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Marc Lustig<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;">West Vancouver, British Columbia</div>
            </td>
            <td style="width: 16.01%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director since October 2019, Executive Chairman since December 2020 and Chairman from October 2019 to December 2020</div>
            </td>
            <td style="width: 37.5%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director of Pharmacielo Ltd. since November 2020; Director of Cresco Labs Inc. since June 2020; Director of Trichome Financial Corp. since
                October 2019; Founder, Chairman and Chief Executive Officer of CannaRoyalty Corp. (dba Origin House) from 2016 to 2020.</div>
            </td>
            <td style="width: 24.7%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">833,508</div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(1.19%)</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Notes</font>:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zabeaeb99a45b4c87a029862b9de4c150">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(1)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Assumes 69,690,151 Common Shares issued and outstanding.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z858563e42b284ab9875d3b4895734938">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(2)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Does not include the 8,067,825&#160; Common Shares issuable on the full exercise of 4,639,431 outstanding Options, 67,435 outstanding 2019 Unlisted Warrants, 3,043,478 2021 Offered Warrants, 182,609 2021 Broker Compensation Options, and 134,872
              2019 Broker Compensation Options, including the Common Shares issuable upon exercise of the underlying 2019 Unlisted Warrants issued upon exercise of such 2019 Broker Compensation Options.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf8129f138c2d405cb702c7234f490dcf">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(3)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>As of the date hereof, all directors and executive officers noted above of the Company, as a group, beneficially own, directly or indirectly, or exercise control or direction over 10,147,232 Common Shares of the Company, representing
              14.56%&#160; of the Company&#8217;s outstanding Common Shares.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z22b238ad131643aaafe7bef15b228dad">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(4)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Member of the Audit Committee.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9e674745d58b45efb3d699881cc84984">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(5)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Member of the Compensation Committee.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f2fd5dc678449e888199067451859bf">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(6)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Member of the Governance and Nomination Committee.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbf6601643d7f43b6a275fc4d70a427a8">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(7)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>9,133,602 shares are held directly by Oren Shuster and 1,535 shares are held by Ewave Group Ltd., an entity of which Mr. Shuster owns and controls 50% of the outstanding ordinary shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 87 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Cease Trade Orders, Bankruptcies, Penalties or Sanctions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">To the knowledge of the Company, no director or executive officer of the Company is, as at the date of this Annual Information Form, or has been, within the 10 years before the date of this Annual
      Information Form, a director, chief executive officer or chief financial officer of any company (including the Company) that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za2a37d8b769c48c3b3b65ad6ed236004">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>was the subject of a cease trade or similar order or an order that denied the relevant company access to any exemption under securities legislation, for a period of more than 30 consecutive days that was issued while the director or
              executive officer was acting in the capacity as director, chief executive officer or chief financial officer; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z84de39221e394178ab4bef4246e18834">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>was subject to a cease trade or similar order or an order that denied the relevant company access to any exemption under securities legislation, for a period of more than 30 consecutive days that was issued after the director or executive
              officer ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer,</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">To the knowledge of the Company, no director or executive officer of the Company, or a shareholder holding a sufficient number of securities of the Company to affect materially the control of the
      Company:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z873bfc0a7d52460c989b46a82cf4a414">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>is, as at the date of this Annual Information Form, or has been within the 10 years before the date of the Annual Information Form, a director or executive officer of any company (including the Company) that, while that person was acting
              in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or
              compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z517ce1b6ad7d412286e18d95440d08ab">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>has, within the 10 years before the date of this Annual Information Form, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or
              compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold the assets of the director, executive officer or shareholder.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">To the knowledge of the Company, no director or executive officer of the Company, or a shareholder holding a sufficient number of securities of the Company to affect materially the control of the
      Company, has been subject to:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf45443f1d00041659cb3a85b98c770ea">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79dd2d1616fa4edcb6583fe89ed0256b">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable investor in making an investment decision.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 88 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Conflicts of Interest</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There are potential conflicts of interest to which the directors, officers and promoters of the Company will be subject with respect to the operations of the Company. Certain directors and/or
      officers serve as directors and/or officers of other companies or have significant shareholdings in other companies. Situations may arise where the directors, officers and promoters of the Company will be engaged in direct competition with the
      Company. Any conflicts of interest will be subject to and governed by the law applicable to directors and officers conflicts of interest, including the procedures prescribed by the BCBCA. The BCBCA requires that directors and officers of the Company,
      who are also directors or officers of a party which enters into a material contract with the Company or otherwise have a material interest in a material contract entered into by the Company, must disclose their interest and, in certain instances,
      refrain from voting on any resolution of the Company&#8217;s directors to approve the contract.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="PROMOTERS"><!--Anchor--></a>PROMOTERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Oren Shuster, CEO and director of the Company and Rafael Gabay, a former director of the Company, may be considered to be promoters because they founded and organized the business of IMC Holdings
      prior to the Reverse Takeover Transaction. Mr. Shuster is a resident of Ra&#8217;anana, Israel and controls 9,135,137 Common Shares, representing 13.1% of the issued and outstanding Common Shares on a non-diluted basis. Mr. Gabay is a resident of Ganot,
      Israel and controls 8,090,720 Common Shares, representing 11.6% of the issued and outstanding Common Shares on a non-diluted basis. 9,133,602 Common Shares and 8,089,185 Common Shares are held directly by Oren Shuster and Rafael Gabay, respectively,
      and 1,535 Common Shares are owned by Ewave Group Ltd., an entity which is jointly owned and controlled by Messrs. Shuster and Gabay.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Under the IMC Restructuring, IMC Holdings sold its interest in Focus to Messrs. Shuster and Gabay and retained options to re-acquire these entities pursuant to the Focus Agreement as described above
      in &#8220;<font style="font-style: italic;">Corporate Structure &#8211; Intercorporate Relationships</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;">LEGAL PROCEEDINGS AND REGULATORY ACTIONS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Legal Proceedings</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Except for the proceedings disclosed below pertaining to Focus, there are no actual or pending material legal proceedings to which the Group or any of its subsidiaries or affiliates are a party or of
      which any of their assets are subject. Management of the Company is not aware of any such material legal proceedings contemplated.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Class Action T.Z. 35676-08-19 Tel Aviv - Jaffa District Court</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On August 19, 2019, a Cannabis consumer (the &#8220;Applicant&#8221;) filed a motion for approval of a class action to Tel Aviv - Jaffa District Court (the &#8220;<font style="font-weight: bold;">Motion</font>&#8221;)
      against 17 companies (the &#8220;<font style="font-weight: bold;">Parties</font>&#8221;) operating in the field of medical cannabis in Israel, including Focus. The Applicant&#8217;s argument is that the Parties did not accurately mark the concentration of active
      ingredients in their products. The personal suit sum for each class member stands at NIS 15,585 and the total amount of the class action suit is estimated at NIS 685,740,000. On June 2, 2020, the Parties submitted their response to the Motion. The
      Parties argue in their response that the threshold conditions for approval of a class action were not met, since there is no reasonable possibility that the causes of action in the Motion will be decided in favor of the class group. On July 3, 2020
      the Applicant submitted his response to the Parties&#8217; response. On July 5, 2020 the Applicant was absent from the hearing. As a result, on July 23, 2020 the Parties filed an application for a ruling of expenses which received a response from the
      Applicant on August 12, 2020, asking to decline this request. On September 29, 2020 the court ruled that the Applicant would pay the Parties&#8217; expenses amount of NIS 750. On July 14, 2021 a prehearing was held. The court recommended the parties
      negotiate independently to avoid litigation, and if negotiations fail, then to begin mediation proceedings. The parties agreed to follow the court&#8217;s recommendations. Negotiations between the parties have not yet commenced. On November 3, 2021 the
      court ruled the parties will file an update regarding the mediation procedure, in 30 days. The parties conducted unsuccessful negotiations and are now waiting for a court decision regarding the continuation of the proceedings.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 89 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of the date of this Annual Information Form, due to the current preliminary state of the litigation process and based on the opinion of legal counsel to Focus, the Company&#8217;s management believes
      that it is not reasonably possible to assess the outcome of the proceeding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Supreme Court of Justice 2335/19</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 2019 a petition was filed to the Supreme Court of Israel by the Medical Cannabis Association against MOH regarding the new regulatory framework of the cannabis market (the &#8220;<font style="font-weight: bold;">Petition</font>&#8221;). Subsequently, additional 10 respondents joined the Petition.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On October 6, 2019, Focus received a decision regarding the Petition, concerning the new regulatory framework of the cannabis market and demanding that the court resolve as follows:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za7fccb1d63dd4cbb91e98f9a0b61b98e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>that the MOH immediately suspend the implementation of the new regulation that harms, disproportionally, the medical cannabis patients;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z430bcb082d0049d6928bf7fa03a2994e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>that the implementation of the new regulation, as is, would cause violation of constitutional rights of the medical cannabis patients; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z58e2b1979a98443db7221ed5586b3b6f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>that the MOH amends the flaws of the new regulation, prior to becoming effective, and to establish new regulations regarding labeling and use of pesticides.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The decision provided for an interim injunction, extending the validity of patient licenses until the earlier of March 31, 2020 or 10 days after the date the MOH reaches a conclusion regarding the
      price control of medical cannabis products.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">According to the decision, Focus was attached to the proceedings as a respondent. Accordingly, Focus filed its response to the petition on November 12, 2019.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 8, 2020, the court decided to extend the validity of the interim injunction, so that the medical cannabis use licenses, which were extended under the decision, would continue to be valid
      until May 15, 2020, or 10 days after the price committee&#8217;s decision on the matter before it, whichever comes first, subject to another court decision.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The court also decided that if a further extension of the period of the interim injunction is granted beyond May 15, 2020, to the extent required, it would be subject to medical surveillance by the
      attending physician, the details of which were to be included in the patient&#8217;s existing use license.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In light of several applications by the respondent represented by the state attorney&#8217;s office, for extension to file updated notice to the court, the interim injunction was extended on July 30, 2020,
      until and subject to other decision of the court.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 90 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On October 29, 2020, the respondents represented by the state attorney&#8217;s office filed an update notice stating that the appeals committee unanimously decided against imposing price controls on
      medical cannabis products and that the prices committee would hold a follow-up hearing in four months. The respondents also requested to update the court again in two months.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On November 25, 2020, the petitioner submitted their response to the respondents&#8217; update.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 25, 2021, the respondents represented by the State Attorney&#8217;s Office filed an updating notice stating that the Prices Committee had come to a decision against imposing price controls on
      medical cannabis products. However, the Prices Committee announced that it will issue an RFI to the corporations engaged in the medical cannabis market and assess the market every six months. Following the aforementioned, the respondents represented
      by the State Attorney&#8217;s Office believe that the appeal should be rejected and the interim injunction should be canceled. On April 13, 2021, three of the respondents filed a response to the court, requesting to reject the appeal and to cancel the
      interim injunction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On April 25, 2021, the petitioner filed a response to the update notice from March 25, 2021, objecting to the position of the respondents represented by the State Attorney&#8217;s Office, requesting the
      court to resolve as requested in the petition and grant the requested remedies to the petitioner. On July 6, 2021, the petitioner filed an urgent request to the court, to issue orders to the respondents represented by the State Attorney&#8217;s Office, to
      request information from corporations engaged in the medical cannabis market in order to continue the examination of the market, according to the Prices Committee&#8217;s announcement mentioned above, and requested the court reschedule the September 19,
      2021 hearing date to an earlier date. The petitioner&#8217;s request was rejected by the court on July 7, 2021, and on September 19, 2021, a hearing was held.&#160; On November 16, 2021 the court ruled the motion will delete, and the interim injunction will be
      cancelled in 10 days. Following a request submitted by the petitioner, on November 15, 2021 the court determined the interim injunction will extend until 1.3.22. Additional requests submitted for an extension of the interim order were denied.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Supreme Court of Justice 8249/2</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On December 1, 2021 the Medical Cannabis Association filed a motion to Supreme Court of Justice of Israel for further hearing regarding the court ruling on 2335/19 as detailed above. The petitioner
      also submitted a request for an exemption from the obligation to pay a fee or deposit a deposit. On February 9, 2022 the petitioner submitted an urgent request for a ruling by the court as well as a request to extend the validity of the interim
      injunction, for at least three additional months. On February 24, 2022 the court overruled the request for a further hearing in the petition, as well as the request to extend the validity of the interim injunction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Planning and Construction 66813-06-21 Beer Sheva Magistrate Court</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On July 11, 2021 the Company was informed that on June 30, 2021, a claim was filed to Beer Sheva Magistrate Court (the &#8220;<font style="font-weight: bold;">Construction Proceedings</font>&#8221;), by the
      municipal committee presiding over planning and construction in southern Israel (the &#8220;Construction Committee&#8221;) against Focus, Focus&#8217; directors and officers, including Oren Shuster and Rafael Gabay, and certain landowners, claiming for inadequate
      permitting for construction relating to the Focus Facility (&#8220;Construction Allegations&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On December 6, 2021 the defendants filed a motion Request for dismissal the indictment on the ground of defense of justice. The municipal committee filed her response and after that the defendants
      filed a response to the municipal committee's response. As of the date of this letter no decision has yet been made on the application.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 91 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">A hearing was initially set to December 1, 2021 but has been postponed to June 13, 2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">At this preliminary stage, based on the opinion of Focus&#8217; legal counsel, Company management cannot assess the chances of the claim advancing or the potential outcome of the Construction Proceedings.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">COVID-19 Test Kits Claim</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On November 19, 2021, Adjupharm filed a Statement of Claim (the &#8220;Claim&#8221;) to the District Court of Stuttgart (the &#8220;Court&#8221;) against Stroakmont &amp; Atton Trading GmbH (&#8220;Stroakmont &amp; Atton&#8221;), its
      shareholders and managing directors regarding a debt owed by Stroakmont &amp; Atton to Adjupharm in an amount of approximately EUR 947,563 for COVID-19 test kits purchased by Stroakmont &amp; Atton from Adjupharm in May 2021. The Claim was accepted
      on December 2, 2021. In January 2022, Stroakmont &amp; Atton filed its Statement of Defence to the Court in which they essentially stated two main arguments for their defense:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z88c1c40c402944cfa105434ed27c972e">

        <tr>
          <td style="width: 28.2pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>They stated that the contractual partner of the Company is not the defendant, Stroakmont &amp; Atton is not the real rather its is a company named Uniclaro GmbH.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z027ebf875bc541dcae100d4390d3f1ff">

        <tr>
          <td style="width: 28.2pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>They stated furthermore that the Company allegedly placed an order with Uniclaro GmbH for a total of 4.3 million Clongene Covid-19 tests, of which Uniclaro GmbH claims to have a payment claim against the Company for a partial delivery of
              380,400 Clongene tests in the total amount of <font style="font-weight: bold;">EUR&#160;941,897.20</font>. Uniclaro GmbH has assigned this alleged claim against the Company to Stroakmont &amp; Atton Trading GmbH, and Stroakmont &amp; Atton
              Trading GmbH has precautionary declared a <font style="font-weight: bold;">set-off</font> against the Company's claim.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 22, 2022 Adjupharm filed a response to Stroakmont &amp; Atton&#8217;s Statement of Defence and rejected both allegations with a variety of legal arguments and facts and also offered evidence to
      the contrary in the form of testimony from the witnesses in question.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The burden of proof for both allegations lies with the opponents and they offered evidences to the court in the form of testimony from certain witnesses. If the opponents succeed in proving both
      allegations to the court, the chances of winning the lawsuit will be considerably reduced. However, it will not be easy for the opponents to present evidence of these allegations.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Regional Court of Stuttgart set the date for the conciliation hearing (<font style="font-style: italic;">G&#252;teverhandlung</font>) and the main hearing (<font style="font-style: italic;">Hauptverhandlung</font>)
      for May 27, 2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Regulatory Actions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There have not been any penalties or sanctions imposed against the Company by a court relating to provincial or territorial securities legislation or by a securities regulatory authority, nor have
      there been any other penalties or sanctions imposed by a court or regulatory body against the Company that would likely be considered important to a reasonable investor in making an investment decision, and the Company has not entered into any
      settlement agreements before a court relating to provincial or territorial securities legislation or with a securities regulatory authority.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 92 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="INTERESTOFMANAGEMENTANDOT"><!--Anchor--></a>INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Except as described below and otherwise disclosed in this Annual Information Form, to the Company&#8217;s knowledge, no director or executive officer of the Company or any person or company that is the
      direct or indirect beneficial owners of, or who exercises control or direction over, more than 10% of any class of the Company&#8217;s outstanding voting securities, or an associate or affiliate of any persons or companies referred to in this paragraph,
      has any material interest, direct or indirect, in any transaction within the financial years ended December 31, 2021, December 31, 2020, December 31, 2019 or as of the date of this Annual Information Form, or in any proposed transaction, that has
      materially affected or will materially affect the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">At the time of voting for the Trichome Transaction by the Company&#8217;s board of directors, Marc Lustig, the executive chairman and a director of the Company, was also a director of Trichome.
      Accordingly, Mr. Lustig had a disclosable interest with respect to the Trichome Transaction and, in accordance with Canadian corporate law requirements, he declared the nature and extent of his interest in the Trichome Transaction and recused himself
      from consideration and voting on the Trichome Transaction as a director. As of the date of this Annual Information Form, Mr. Lustig continues to serve as executive chairman and director of the Company and as a director of Trichome.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">At the time of voting for the MYM Transaction by the Company&#8217;s board of directors, Howard Steinberg, a director of Trichome, was also a director of MYM. Accordingly, Mr. Steinberg had a disclosable
      interest with respect to the MYM Transaction and, in accordance with Canadian corporate law requirements, he declared the nature and extent of his interest in the MYM Transaction and recused himself from consideration and voting on the MYM
      Transaction as a director of Trichome. As of the date of this Annual Information Form, Mr. Steinberg serves as CEO of MYM, Highland and Sublime and is a director of Trichome.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;">TRANSFER AGENTS AND REGISTRARS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The transfer agent and registrar for the Common Shares is Computershare Investor Services Inc., located at 510 Burrard Street, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor, Vancouver, British Columbia V6C 3B9. The United
      States co-transfer agent of the Company is Continental Stock Transfer &amp; Trust Company, located at 1 State Street, 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, New York, NY 10004-1561.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;">MATERIAL CONTRACTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Except for contracts entered into in the ordinary course of business, the only material contracts the Company or a subsidiary is a party to as the date of this Annual Information Form are the
      following:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfcbecd083ec44e4e9ca8ac000e62e3bf">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the IP Agreement dated April 2, 2019 and as amended on January 1, 2021, between IMC Holdings and Focus, as further described in &#8220;<font style="font-style: italic;">Corporate Structure &#8211; Intercorporate Relationships</font>&#8221;;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1a4b1af6eda149bf91d3ec5ec77a0a7b">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Services Agreement dated April 2, 2019 and as amended on January 1, 2021, between IMC Holdings and Focus, as further described in &#8220;<font style="font-style: italic;">Corporate Structure &#8211; Intercorporate Relationships</font>&#8221;;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z06ed8b7c74024b7b91c542366ac2fc47">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Focus Agreement dated April 2, 2019, between IMC Holdings, Oren Shuster and Rafael Gabay, as further described in &#8220;<font style="font-style: italic;">Corporate Structure &#8211; Intercorporate Relationships</font>&#8221;;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zea49f7c85bbc4287ad3b2443771034ce">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the arrangement agreement dated December 30, 2020, as subsequently amended on January 22, 2021 and March 14, 2021, between the Company and Trichome entered into in connection with the Trichome Transaction as further described in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 93 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d20a5b5c6e84bd68b9eefc729b94ef7">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the arrangement agreement dated March 31, 2021 between the Company, Trichome and MYM entered into in connection with the MYM Transaction, as further described in &#8220;<font style="font-style: italic;">General Development of the Business &#8211;
                Developments Following the Reverse Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc54f6fcce7bb4d7c8fa7945f75b230d2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Agency Agreement dated May 5, 2021 with A.G.P./Alliance Global Partners and Roth Capital Partners, as further described in &#8220;<font style="font-style: italic;">General Development of the Business &#8211; Developments Following the Reverse
                Takeover Transaction &#8211; Developments During the Financial Year Ended December 31, 2021</font>&#8221;;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Copies of the above material contracts are available on the Company&#8217;s SEDAR profile at <u>www.sedar.com</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="INTERESTSOFEXPERTS"><!--Anchor--></a>INTERESTS OF EXPERTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Names of Experts</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The following are the persons or companies who were named as having prepared or certified a statement, report, opinion or valuation described or included in a filing, or referred to in a filing, made
      under NI 51-102 by the Company during, or relating to, the financial year ended December 31, 2021, and whose profession or business gives authority to the statement, report, valuation, or opinion made by the person or company:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25;">The annual consolidated financial statements as of December 31, 2021, audited by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, an independent registered public accounting
        firm, have been included in reliance on their report given on their authority as experts in accounting and auditing.&#160;</div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Interests of Experts</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, have confirmed that they are independent with respect to the Company within the meaning of the U.S. Securities Act and the
      applicable rules and regulations thereunder adopted by the SEC and the Public Company Accounting Oversight Board (United States).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;">AUDIT COMMITTEE INFORMATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Audit Committee Charter</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The charter of the Company&#8217;s Audit Committee is attached to this Annual Information Form as Schedule &#8220;A&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Composition of Audit Committee</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of the date of this Annual Information Form, the members of the Audit Committee are Haleli Barath, Brian Schinderle (Chair) and Vivian Bercovici, all of whom are &#8220;independent&#8221;, and all of whom are
      &#8220;financially literate&#8221; as such terms are defined in NI 52-110.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Each of the Audit Committee members has an understanding of the accounting principles used to prepare the Company&#8217;s financial statements, experience preparing, auditing, analyzing or evaluating
      comparable financial statements and experience as to the general application of relevant accounting principles, as well as an understanding of the internal controls and procedures necessary for financial reporting.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 94 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Audit Committee has the primary function of fulfilling its responsibilities in relation to reviewing the integrity of the Company&#8217;s financial statements, financial disclosures and internal
      controls over financial reporting; monitoring the system of internal control; monitoring the Company&#8217;s compliance with legal and regulatory requirements, selecting the external auditor for shareholder approval; reviewing the qualifications,
      independence and performance of the external auditor; and reviewing the qualifications, independence and performance of the Company&#8217;s internal auditors. The Audit Committee has specific responsibilities relating to the Company&#8217;s financial reports;
      the external auditor; the internal audit function; internal controls; regulatory reports and returns; legal or compliance matters that have a material impact on the Company; and the Company&#8217;s whistleblowing procedures. In fulfilling its
      responsibilities, the Audit Committee meets regularly with the internal and external auditor and key management members. The full text of the Audit Committee&#8217;s charter is disclosed in Appendix &#8220;A&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;"><u>Relevant Experience and Education</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Brian Schinderle</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Mr. Schinderle is the Founder and Managing Partner of Solidum Capital Advisors LLC (&#8220;<font style="font-weight: bold;">Solidum</font>&#8221;). Solidum invests its own capital and works in a merchant banking
      and advisory capacity with a select group of companies in the cannabis sector. In addition, from 2018 to 2020, Mr. Schinderle served as Executive Vice President -Finance of GR Companies Inc. (dba Grassroots Cannabis) (&#8220;<font style="font-weight: bold;">Grassroots</font>&#8221;), focusing on finance, strategy, capital markets, investor relations, mergers and acquisitions. In July 2020, Grassroots merged with Curaleaf Holdings, Inc. (CSE: CURA) in a transaction valued at approximately US$850
      million. Prior to forming Solidum in 2017, Mr. Schinderle spent over 20 years in investment management, primarily investing in fixed income and equity assets via hedge funds, private equity and discretely managed funds. Mr. Schinderle currently
      serves on the advisory boards of Altitude Investments Inc. and AIM PLC, Greenlight Cannabis and Curio Wellness.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Haleli Barath</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Ms. Barath is the Co-founder and Senior Partner at BFP &amp; Co., an Israel-based law firm. Ms. Barath has over 20 years&#8217; experience advising Israeli and international corporations on a wide range of
      sophisticated cross-border and domestic transactions. Ms. Barath advises Fortune 500 international corporations, funds and prominent early-stage start-ups and growth companies in Israel on a range of sectors including enterprise software,
      cybersecurity, fintech, biotech, cannabis and digital health and is an active partner in their development and growth. Ms. Barath is also the Co-founder and General Partner of Cerca Partners, a venture capital firm that invests in Israeli technology
      companies. Ms. Barath holds an LLB degree from the Hebrew University in Israel, is a member of the Israeli bar and lectures at universities and various business forums on topics ranging from corporate and business law to technology and regulatory
      matters.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Vivian Bercovici</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Ms. Bercovici is a consultant to various medical cannabis and medical device entities regarding operational issues and market opportunities in Israel, Europe and Canada. In addition, Ms. Bercoviciis
      writing regularly for print media and also launching an independent publication in the coming months.From March 2017 to March 2018, Ms. Bercovici was the Managing Director, Israel and Europe operation at Nuuvera Inc., a Toronto-based medical cannabis
      company that was acquired by Aphria Inc. Also, Ms. Bercovici served as Canadian Ambassador to Israel from 2014 to 2016, having been appointed by then Prime Minister Stephen Harper. Ms. Bercovici has vast experience of over 20 years practicing law in
      Toronto, specializing in media defence and financial services regulatory law. Ms. Bercovici holds a Bachelor of Arts from York University, a Postgraduate Diploma in International Relations from the London School of Economics and Political Science and
      a Bachelor of Laws from the University of Toronto.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 95 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Audit Committee Oversight</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">At no time since the commencement of the financial year ended December 31, 2021 was a recommendation of the Audit Committee to nominate or compensate an external auditor not adopted by the Board.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Reliance on Certain Exemptions</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">At no time since the commencement of the financial year ended December 31, 2021 has the Company relied any of the exemptions set forth in Section 2.4, Section 3.2, Section 3.3(2), Section 3.4,
      Section 3.5, Section 3.6 or Section 3.8 of NI 52-110. The Corporation has also not relied on any exemptions from NI 52-110 granted under Part 8 of NI 52-110.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Pre-Approval Policies and Procedures</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Audit Committee has adopted specific policies and procedures for the engagement of non-audit services as described in Schedule &#8220;A&#8221; attached hereto.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>External Auditor Service Fees (by Category)</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Audit Fees</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global are the Company&#8217;s external auditors since January, 2020. The following table lists the aggregate fees paid or payable to all
      external auditors, by category, for the financial years ended December 31, 2021 and December 31, 2020:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="zb6d05d282a9a4086802e32ce9e4ac942">

        <tr>
          <td style="width: 33.33%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;">December 31, 2021</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;">December 31, 2020</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Audit fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$894</div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$239</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Audit-related fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Tax fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$17</div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">All other fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total fees</div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$911</div>
          </td>
          <td style="width: 33.34%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$243</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Notes</font>:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4de49e45eb5942aeb0fca26cd95a0168">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(1)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Amounts are stated in thousands USD.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zac8e20bc27074d6aaa7d9a9b2bb59496">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(2)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Audit fees consist of the aggregate fees billed for the audit or review of the Company&#8217;s annual and quarterly financial statements that are normally provided in connection with statutory and regulatory filings or engagements.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z408b72bd1fa44d5ba13810833e8745c6">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(3)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Audit-related fees consist of the aggregate fees billed for assurance and related services that are reasonably related to the performance of the audit or review of the Company&#8217;s financial statements and are not reported as audit fees.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a75a3c99fd84c249a08d4e4ab069a36">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(4)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>For tax compliance, tax advice and tax planning.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3f91abb95d714dd1b293c03174d170bb">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">(5)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>For products and services other than the audit fees, audit-related fees and tax fees described above.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">- 96 -</font></div>
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; line-height: 1.25; font-weight: bold;"><a name="ADDITIONALINFORMATION"><!--Anchor--></a>ADDITIONAL INFORMATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Additional information relating to the Company may be found on SEDAR at <u>www.sedar.com</u>. Additional information, including directors&#8217; and officers&#8217; remuneration and indebtedness, principal
      holders of the Company&#8217;s securities and securities authorized for issuance under equity compensation plans are contained in the Company&#8217;s information circular for its most recent annual meeting of shareholders held on July 28, 2021. Additional
      information is also provided in the Company&#8217;s financial statements and MD&amp;A for the financial year ended December 31, 2021.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25;">- 97 -<br>
    </div>
    <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div  style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>&#160;<br>
      <br>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="SCHEDULEA"><!--Anchor--></a>SCHEDULE &#8220;A&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; margin-right: 0.4pt; line-height: 1.25; font-weight: bold;">IM CANNABIS CORP.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; margin-right: 0.4pt; line-height: 1.25; font-weight: bold;">AUDIT COMMITTEE CHARTER</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">PURPOSE OF THE COMMITTEE</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The purpose of the Audit Committee (the &#8220;<font style="font-weight: bold;">Committee</font>&#8221;) of the Board of Directors (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;) of IM Cannabis Corp.
        (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) is to provide an open avenue of communication between management, the Company&#8217;s independent auditor and the Board and to assist the Board in its oversight of:<br>
        <br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3497ad2e942f420e9f166ce5b8030a21">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the integrity, adequacy and timeliness of the Company&#8217;s financial reporting and disclosure practices;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z60343e3ebcee4cb69ccf599c24bd24b4">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the Company&#8217;s compliance with legal and regulatory requirements related to financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcd302bed7c3b4804b59c17de2867e90c">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the independence and performance of the Company&#8217;s independent auditor.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The Committee shall also perform any other activities consistent with this audit committee charter (the &#8220;<font style="font-weight: bold;">Charter</font>&#8221;), the Company&#8217;s articles, the rules and
        regulations of all exchanges on which the securities of the Company are listed for trading, National Instrument 52-110 &#8211;&#160;<font style="font-style: italic;">Audit Committees</font>, as amended from time to time (&#8220;<font style="font-weight: bold;">NI
          52-110</font>&#8221;), the <font style="font-style: italic;">Business Corporations Act </font>(British Columbia), the United States Securities Exchange Act of 1934 (the &#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221;), as amended for issuers
        listed on the NASDAQ Capital Market (&#8220;<font style="font-weight: bold;">NASDAQ</font>&#8221;) and any other applicable laws as required or deemed necessary or appropriate by the Committee or Board (collectively, the &#8220;<font style="font-weight: bold;">Applicable




          Laws</font>&#8221;).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Committee&#8217;s role is one of oversight of the conduct of those activities by the Company&#8217;s management and external auditors, including oversight of the accounting and financial reporting
        processes of the Company and the audits of the financial statements of the Company. Management is responsible for preparing the Company&#8217;s financial statements and other financial information and for the fair presentation of the information set
        forth in the financial statements in accordance with international financial reporting standards (&#8220;<font style="font-weight: bold;">IFRS</font>&#8221;). Management is also responsible for establishing internal controls and procedures and for maintaining
        the appropriate accounting and financial reporting principles and policies designed to assure compliance with accounting standards and all Applicable Laws.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The independent auditor&#8217;s responsibility is to audit the Company&#8217;s financial statements and provide its opinion, based on its audit conducted in accordance with generally accepted auditing
        standards, that the financial statements present fairly, in all material respects, the financial position, results of operations and cash flows of the Company in accordance with IFRS.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Committee is responsible for recommending to the Board the independent auditor to be nominated for the purpose of auditing the Company&#8217;s financial statements, preparing or issuing an auditor&#8217;s
        report or performing other audit, review or attest services for the Company, and for reviewing and recommending the compensation of the independent auditor. The Committee is also directly responsible for the evaluation of and oversight of the work
        of the independent auditor.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The independent auditor shall report directly to the Committee.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%A - %%-->
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">COMMITTEE RESPONSIBILITIES</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">In addition to the foregoing, in performing its oversight responsibilities the Committee shall:<br>
        <br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5aa9892388bc4439a04f6a9d5d42fc97">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Have the funding and authority to discharge its duties and responsibilities.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb07cad684f9941f386c6b55e699f3692">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Monitor the adequacy of this Charter on an annual basis and recommend any proposed changes to the Board.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3bc211d5c3144a638ac852483bf827e8">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Review the appointments of the Company&#8217;s Chief Financial Officer and any other key financial executives involved in the financial reporting process.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za5a1e3662bd94bc686cdc3399fab01df">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Review with management and the independent auditor the adequacy and effectiveness of the Company&#8217;s accounting and financial controls and the adequacy and timeliness of its financial reporting processes.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8aa23aa995054d01a34e68813a7f1eb9">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Review with management and the independent auditor the annual financial statements and related documents and review with management the unaudited quarterly financial statements and related documents, prior to filing or distribution,
                including matters required to be reviewed under applicable legal or regulatory requirements.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf0d02742ac344cd2bd7ba912cf8e121e">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Where appropriate and prior to release, review with management any news releases that disclose annual or interim financial results or contain other significant financial information that has not previously been released to the public.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43143f1e9df140adb76cef568d4a1d96">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Review the Company&#8217;s financial reporting and accounting standards and principles and significant changes in such standards or principles or in their application, including key accounting decisions affecting the financial statements,
                alternatives thereto and the rationale for decisions made.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za914b0c4217a4115a6d1deec616c6bdc">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Review the quality and appropriateness of the accounting policies and the clarity of financial information and disclosure practices adopted by the Company, including consideration of the independent auditor&#8217;s judgment about the quality
                and appropriateness of the Company&#8217;s accounting policies. This review may include discussions with the independent auditor without the presence of management.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3fa0bd580174413390bdcf56c1e24e42">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">9.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Review with management and the independent auditor significant related party transactions and potential conflicts of interest.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4858396554ed4752b7e468f3f5030381">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">10.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Pre-approve all non-audit services to be provided to the Company by the independent auditor.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb9028e3e23064b24a47697d1e154ffe3">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">11.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Ensure receipt from the independent auditors of a formal written statement delineating all relationships between the auditor and the Company, and monitor the independence of the independent auditor by reviewing all relationships between
                the independent auditor and the Company and all non-audit work performed for the Company by the independent auditor and to engage in a dialogue with the independent auditors with respect to any disclosed relationships or services that may
                impact the objectivity and independence of the external auditors.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80cf479eb70643658f1699974b5d474a">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">12.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Establish and review the Company&#8217;s procedures for the:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za013932380f641b38537507d4d8047e1">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>receipt, retention and treatment of complaints regarding accounting, financial disclosure, internal controls or auditing matters; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >A - 2</font></div>
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6ca6d2c0d3af4bdf9147f37a50971722">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>confidential, anonymous submission by employees regarding questionable accounting, auditing and financial reporting and disclosure matters.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z577df05ed13144f3b09e6263c85def91">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">13.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Conduct or authorize investigations into any matters that the Committee believes is within the scope of its responsibilities.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd5522ac73cf64940a244af732f3f5454">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">14.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Perform such other functions and exercise such other powers as are prescribed or required by the articles of the Company or pursuant to Applicable Laws as set out for the audit committee of a reporting issuer under NI 52-110, section 224
                of the <font style="font-style: italic;">Business Corporations Act </font>(British Columbia) and the Exchange Act.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">DIRECTORS MAY REQUEST MEETING</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Any Director of the Company may request the chair of the Committee (the &#8220;<font style="font-weight: bold;">Chair</font>&#8221;) to call a meeting of the Committee and may attend at such meeting or inform
        the Committee of a specific matter of concern to such Director, and may participate in such meeting to the extent permitted by the Chair.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The times of and places where the meetings of the Committee shall be held and the calling of and procedure at such meetings shall be determined from time to time by the Committee.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">COMMITTEE STRUCTURE AND AUTHORITY<br>
        </font><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zed99646a46e14fcf9eeeda6af6fc56ba">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Composition</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Committee shall consist of at least three directors as determined by the Board, all of whom shall qualify as independent directors pursuant to (i) NI 52-110; (ii) Rule 5605
        of the NASDAQ Stock Market Rules; (iii) Rule10A-3(b)(1) under the Exchange Act; and (iv) any additional requirements or guidelines for audit committee service under applicable securities laws and the rules of any stock exchange on which the shares
        of the Company are listed for trading.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">All members of the Committee shall be financially literate, as defined in NI 52-110, and at least one member shall have &#8220;accounting or related financial management expertise&#8221;. In
        particular, at least one member shall have: (i) education and experience as a principal financial officer, principal accounting officer, controller, public accountant or auditor or experience in one or more positions that involve the performance of
        similar functions; (ii) experience actively supervising a principal financial officer, principal accounting officer, controller, public accountant, auditor or person performing similar functions; (iii) experience overseeing or assessing the
        performance of companies or public accountants with respect to the preparation, auditing or evaluation of financial statements; or (iv) other relevant experience:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z53e92d2e334f4cac8def206e3c4ad26b">

          <tr>
            <td style="width: 53.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>an understanding of generally accepted accounting principles and financial statements;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf20a9fada970400ba2459a2f7870b2cc">

          <tr>
            <td style="width: 53.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the ability to assess the general application of such principles in connection with the accounting for estimates, accruals and provisions;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6eab5a1e681346aa821ca6965dd33593">

          <tr>
            <td style="width: 53.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>expertise preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be
                expected to be raised by the Company&#8217;s financial statements, or experience actively supervising one or more persons engaged in such activities;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1f5c238265534cf5b37275b73de9019a">

          <tr>
            <td style="width: 53.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>an understanding of internal controls and procedures for financial reporting; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >A - 3</font></div>
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb83888f1d0364900a566a1ae47eb75a0">

          <tr>
            <td style="width: 53.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>an understanding of audit committee functions.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 35.5pt; line-height: 1.25;">Committee members may not, other than in their respective capacities as members of the Committee, the Board or any other committee of the Board, accept directly or indirectly
        any consulting, advisory or other compensatory fee from the Company or any subsidiary of the Company, or be an &#8220;affiliated person&#8221; (as such term is defined in the Exchange Act and the rules adopted by the U.S. Securities and Exchange Commission
        thereunder) of the Company or any subsidiary of the Company. For greater certainty, directors&#8217; fees and fixed amounts of compensation under a retirement plan (including deferred compensation) for prior service with the Company that are not
        contingent on continued service should be the only compensation an audit committee member may receive from the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">No Committee member shall serve on the audit committees of more than three other issuers without prior determination by the Board that such simultaneous service would not impair
        the ability of such member to serve effectively on the Committee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd29f2feb1eae469593521f3ab6b5ee6b">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Appointment of Replacement Committee Members</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Each member of the Committee shall serve at the pleasure of the Board. Any member of the Committee may be removed or replaced at any time by the Board and shall automatically
        cease to be a member of the Committee upon ceasing to be a Director of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Board may fill vacancies on the Committee by appointment from amongst its number. The Board shall fill any vacancy if the membership of the Committee is less than three
        directors. If and whenever a vacancy shall exist on the Committee, the remaining members may exercise all their power so long as a quorum remains in office.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Subject to the foregoing, the members of the Committee shall be appointed by the Board annually and each member of the Committee shall hold office until the next annual meeting
        of the shareholders of the Company after his or her election or until his or her successor shall be duly qualified and appointed.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3db33ce6c82c4990a955a5474477005c">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Quorum</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">A majority of the Committee present in person or by telephone or other telecommunication device that permits all persons participating in the meeting to speak to each other shall
        constitute a quorum.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z88aa6b123a2341779e45ce34e74c8919">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Review of Charter</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Committee shall review and reassess the adequacy of this Charter at least annually and otherwise as it deems appropriate, and recommend changes to the Board of Directors. The
        Committee shall reference this Charter in establishing its annual goals and meeting objectives.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze348d82c580546a0997fe252c038bd18">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Delegation</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Committee may delegate from time to time to any person or committee of persons any of the Committee&#8217;s responsibilities that lawfully may be delegated.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >A - 4</font></div>
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za727df27da7c43fe93ece760f5f51674">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Reporting to the Board</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Committee will report through the Chair to the Board on matters considered by the Committee, its recommendations and performance relative to annual objectives and its
        Charter.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8f71de3ae394bfda75299fe279c7b83">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Chair</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Chair shall be appointed by the Board from among the members of the Committee, and if not appointed by the Board, then shall be appointed by the members of the Committee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z960b0ed27f0643f6affa10df3ebe07ad">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(h)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Absence of Chair</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">If the Chair is not present at any meeting of the Committee, one of the other members of the Committee present at the meeting shall be chosen by the Committee to preside at the
        meeting.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5ddb20c360ae45c7a99d74b1eb401405">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Calling of Meetings</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Any Director, the Chairman of the Board, the Corporate Secretary of the Company or the independent auditor of the Company may call a meeting. The Committee shall meet at least
        four times per year and as many additional times as needed to carry out its duties effectively.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb96ace6f87a34fa5b9db340c8a79a071">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(j)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Notice of Meetings</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Notice of the time and place of every meeting shall be given in writing or electronic communication to each member of the Committee at least 48 hours prior to the time fixed for
        such meeting. Notice of each meeting shall also be given to the independent auditors of the Company. A member of the Committee and the independent auditors may in any manner waive notice of a Committee meeting. Attendance of a member of the
        Committee at a meeting is a waiver of notice of the meeting except where a member attends a meeting for the express purpose of objecting to the transaction of any business on the grounds that the meeting was not lawfully called.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7e88ac0259e44c818e867dc771932839">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(k)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Procedure, Records and Reporting</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Subject to any statute or articles or by-laws of the Company, the Committee shall fix its own procedures at meetings, keep records of its proceedings and report to the Board,
        generally not later than the next scheduled meeting of the Board that follows the Committee meeting. In discharging its responsibilities, the Committee shall have full access to any relevant records of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbde746f2ac1f4ee1914a76ba19ef97cf">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(l)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Attendance of Others at Meetings</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Committee shall have the right to determine who shall, and who shall not, be present at any time during a meeting of the Committee. The Committee may request any officer or
        employee of the Company, the Company&#8217;s legal counsel, or any external auditor, to attend a meeting of the Committee or to meet with any members of, or consultants to the Committee. The Committee shall also have the authority to communicate directly
        with the independent auditor.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z194f2ded8dec4a1e9b93697d6b26c3c7">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">(m)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Outside Experts and Advisors</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Committee may retain, and set and pay the compensation to, any outside expert or advisor, including but not limited to, legal, accounting, financial or other consultants, at
        the Company&#8217;s expense, as it determines necessary to carry out its duties. The Committee will assure itself as to the independence of any outside expert or advisor.</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >A - 5</font></div>
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">CURRENCY OF THIS CHARTER</div>
      <div style="text-align: justify; line-height: 1.25;">This Charter was last approved by the Board on November 26, 2020.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25;">A - 6<br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;"></div>
    </div>
  </div>
  <br>
</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:imc="http://www.imcannabis.com/20211231" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021q4"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>IM Cannabis Corp. - 1792030 - 2022</title></head><body style="font-size:10pt;font-family:Times New Roman;">
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonFraction name="imc:FairValueOfWarrants" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"  id="Fxbrl_20220307151218509" unitRef="CAD"  xsi:nil="true"></ix:nonFraction><ix:footnote id="FN20220308122848898" xml:lang="en-US">Includes payments to shareholders for the years ended 2021 and 2020 of $455 and $534, respectively.</ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="imc-20211231.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20210101to20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:OvernightMarketedOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-05-10</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:OvernightMarketedOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2021-05-10</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-18</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-18</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210331_imcEquityTransactionAxis_imcPreliminaryShelfProspectusMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:PreliminaryShelfProspectusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-05-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-07-09</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210701to20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-08-16</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imc:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imc:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imc:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MizrahiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imc:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MizrahiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211101to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-12-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-28</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-28</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:OvernightMarketedOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:OvernightMarketedOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCPointHoldingsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCPointHoldingsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcFocusMedicalHerbsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcFocusMedicalHerbsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCFarmsIsraelLtdPointMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCFarmsIsraelLtdPointMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCFarmsIsraelLtdPointMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCFarmsIsraelLtdPointMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCVenturesLtdPointMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCVenturesLtdPointMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCVenturesLtdPointMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCVenturesLtdPointMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:AdjupharmGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:AdjupharmGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRayarokPharmLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:RayarokPharmLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRosenHighWayLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:RosenHighWayLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcHighWayShinuaLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:HighWayShinuaLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRevolyTradingAndMarketingLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:RevolyTradingAndMarketingLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcOranimPlusPharmLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:OranimPlusPharmLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCannabisGpIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeFinancialCannabisGpIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCannabisManagerIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeFinancialCannabisManagerIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeAssetFundingCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeAssetFundingCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeJwcAcquisitionCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeJwcAcquisitionCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeRetailCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeRetailCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcMymNutraceuticalsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcSublimecultureIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:SublimecultureIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcCannacanadaIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:CannacanadaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcMymInternationalBrandsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:MymInternationalBrandsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcHighlandGrowIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:HighlandGrowIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcOranimPharmMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:OranimPharmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20220106_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-18</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-09-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-09-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-07-28</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210701to20210731_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPlusPharmLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPlusPharmLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220228_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_srtStatementScenarioAxis_srtProFormaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_srtStatementScenarioAxis_srtProFormaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220329_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-29</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-09-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220228_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211130to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPlusPharmLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPlusPharmLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-11-30</xbrli:startDate>
        <xbrli:endDate>2021-12-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:WholesalesAndPharmaciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:WholesalesAndPharmaciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:ForeignCountriesTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">imc:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:ForeignCountriesTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">imc:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullMajorCustomersAxis_imcCustomerThreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">imc:CustomerThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullMajorCustomersAxis_imcCustomerThreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">imc:CustomerThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByTypeAxis">imc:CannabisPlantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByTypeAxis">imc:CannabisPlantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByTypeAxis">imc:CannabisPlantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:UnobservableInputAxis">imc:ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByTypeAxis">imc:CannabisPlantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:UnobservableInputAxis">imc:ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:WorkInProgressMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:BulkCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:PackagedDriedCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:OtherCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:WorkInProgressMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:BulkCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:PackagedDriedCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:OtherCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:WorkInProgressMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:OtherCannabisProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:OtherCannabisProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrants2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrants2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrants2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrants2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyEUR"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyILS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2021-05-10</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-05-10</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_imcListedWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imc:ListedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2021-05-10</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2021-05-10</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyUSD"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyGBP"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190819"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-08-19</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200901to20200921"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-09-01</xbrli:startDate>
        <xbrli:endDate>2020-09-21</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imc:IntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imc:IntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imc:IntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imc:IntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_countryCA"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_srtStatementGeographicalAxis_countryCA"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_srtStatementGeographicalAxis_countryCA"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember_srtStatementGeographicalAxis_countryDE"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:AdjupharmGmbhMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:CurrentBiologicalAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:CurrentBiologicalAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:CurrentBiologicalAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:CurrentBiologicalAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imc:OtherDeferredTaxAssestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imc:OtherDeferredTaxAssestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imc:OtherDeferredTaxAssestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imc:OtherDeferredTaxAssestsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210212"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-02-12</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember_imcVestingAxis_imcFirstAnniversaryOfApplicableVestingCommencementDateMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:VestingAxis">imc:FirstAnniversaryOfApplicableVestingCommencementDateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember_imcVestingAxis_imcVestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:VestingAxis">imc:VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210201to20210212"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-02-01</xbrli:startDate>
        <xbrli:endDate>2021-02-12</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imc:RestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imc:RestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imc:RestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:ShareholdersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:ShareholdersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:OtherOperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:ForeignCountriesTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:OtherOperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:ForeignCountriesTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:OtherOperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:OtherOperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-14</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-14</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-15</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220224_ifrsfullBusinessCombinationsAxis_imcXintezaApiLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember_imcAgreementAxis_imcSimpleAgreementForFutureEquityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:XintezaApiLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="imc:AgreementAxis">imc:SimpleAgreementForFutureEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-02-24</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-14</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-28</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-14</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792030</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-28</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:unit id="CAD"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit>
<xbrli:unit id="CAD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="CAD_per_gram"><xbrli:measure>imc:CAD_per_gram</xbrli:measure></xbrli:unit>
<xbrli:unit id="Euro"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit>
<xbrli:unit id="GBP"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit>
<xbrli:unit id="Gram"><xbrli:measure>imc:Gram</xbrli:measure></xbrli:unit>
<xbrli:unit id="NIS"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit>
<xbrli:unit id="Percentage"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Share"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="Shares"><xbrli:measure>imc:Shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="Year"><xbrli:measure>imc:Year</xbrli:measure></xbrli:unit>
<ix:relationship fromRefs="Fxbrl_20210428001641289" toRefs="FN20220329225335286"/><ix:relationship fromRefs="Fxbrl_20210428001652437" toRefs="FN20220329225335286"/><ix:relationship fromRefs="Fxbrl_20220307105144170_73" toRefs="FN20220308122848898"/><ix:relationship fromRefs="Fxbrl_20220307105144170_77" toRefs="FN20220308122848898"/></ix:resources></ix:header></div><div>
  <div style="text-align:right;line-height:1.25">
    <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;width:100%;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" /><span style="text-decoration:underline"><span style="font-weight:bold">Exhibit 99.2</span></span>
  </div>
  <p style="margin:0pt">&#160;</p>
  <p style="text-align:center"><img src="imc_img01.jpg" style="width:920px;height:1301px" alt=" " /></p>
  <p style="text-align:center">&#160;</p>
  <hr style="border-top:2px solid #000000;page-break-after:always" />
  <p style="margin:0pt">&#160;</p>
  <p style="text-align:center;margin-top:10px;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>IM CANNABIS CORP.</strong></span></span></span></span></span></span></p>
  <p style="text-align:center;margin-top:0px;margin-bottom:0px">&#160;</p>
  <p style="text-align:center;margin-top:0px;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>CONSOLIDATED FINANCIAL STATEMENTS </strong></span></span></span></span></span></span></p>
  <p style="text-align:center;margin-top:0px;margin-bottom:0px">&#160;</p>
  <p style="margin-left:0.3pt;text-align:center;margin-top:0px;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>AS OF DECEMBER 31, 2021</strong></span></span></span></span></span></span></span></p>
  <p style="margin-left:0.3pt;text-align:center;margin-top:0px;margin-bottom:0px">&#160;</p>
  <p style="text-align:center;margin-top:0px;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>CANADIAN DOLLARS IN THOUSANDS</strong></span></span></span></span></span></span></span></p>
  <p style="text-align:center;margin-top:0px;margin-bottom:0px">&#160;</p>
  <p style="text-align:center;margin-top:0px;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>INDEX</strong></span></span></span></span></span></span></p>
  <p style="text-align:center;margin-top:0px;margin-bottom:0px">&#160;</p>
  <div dir="ltr">
    <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%">

        <tr>
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Page</strong></span></span></span></p>
          </td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span><span><span><span><span><strong><span><span><span><span><span><strong><span><span><span><span><span><strong><a href="#REPORTOFINDEPENDENTREGISTEREDPUBLICACCOUNTINGFIRM"><span><span><span><span><span><strong><span><span><span><span><span><strong><span><span><span><span><span><strong><span><span><span><span><span><strong>Report of Independent Registered Public Accounting Firm</strong></span></span></span></span></span></strong></span></span></span></span></span></strong></span></span></span></span></span></strong></span></span></span></span></span></a></strong></span></span></span></span></span></strong></span></span></span></span></span></strong></span></span></span></span></span>&#160;(PCAOB ID: <ix:nonNumeric id="Fxbrl_20220307182718716" name="dei:AuditorFirmId" contextRef="C_20210101to20211231">1281</ix:nonNumeric>) </strong></span></span></span></span></span></span></span></td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>F - 2</strong></span></span></span></span></span></span></span></td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><a href="#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"><span><span><span><span><span><strong>Consolidated Statements of Financial Position</strong></span></span></span></span></span></a></strong></span></span></span></span></span></span></span></td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>F - 3 &#8211; F - 4</strong></span></span></span></span></span></span></span></td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><a href="#CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"><span><span><span><span><span><strong>Consolidated Statements of Profit or Loss and Other Comprehensive Income</strong></span></span></span></span></span></a></strong></span></span></span></span></span></span></span></td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>F - 5 &#8211; F - 6</strong></span></span></span></span></span></span></span></td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong><a href="#CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"><span><span><span><span><strong>Consolidated Statements of Changes in Equity</strong></span></span></span></span></a></strong></span></span></span></span></span></span></td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong>F - 7</strong></span></span></span></span></span></span></td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><a href="#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"><span><span><span><span><span><strong>Consolidated Statements of Cash Flows</strong></span></span></span></span></span></a></strong></span></span></span></span></span></span></span></td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>F - 8 - F - 11</strong></span></span></span></span></span></span></span></td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="width:85%;vertical-align:top;text-align:justify;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong><span><span><span><span><strong><span><span><span><span><strong><span><span><span><span><strong><a href="#NOTESTOCONSOLIDATEDFINANCIALSTATEMENTS"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong><span><span><span><span><strong><span><span><span><span><strong><span><span><span><span><strong>Notes to Consolidated Financial Statements</strong></span></span></span></span></strong></span></span></span></span></strong></span></span></span></span></strong></span></span></span></span></span></span></a></strong></span></span></span></span></strong></span></span></span></span></strong></span></span></span></span> </strong></span></span></span></span></span></span></td>
          <td style="width:14%;vertical-align:top;text-align:center;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>F - 12 - F - 79</strong></span></span></span></span></span></span></span></td>
        </tr>

    </table>
  </div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
  <hr style="border-top:2px solid #000000;page-break-after:always" />
  <div>&#160;</div>
  <div dir="ltr"><a id="REPORTOFINDEPENDENTREGISTEREDPUBLICACCOUNTINGFIRM"></a>
    <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%">

        <tr>
          <td style="width:32%;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><img src="imc_img02.jpg" style="width:102px;height:116px" alt=" " /></span></span></span></span></span></span></td>
          <td style="width:35%;vertical-align:top">
            <p style="margin-bottom:0pt;text-align:left"><span style="color:#000000"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span style="font-size:10pt"><strong>Kost Forer Gabbay &#38; Kasierer</strong></span></span></span></span></span></span></span></span></span></span></p>
            <p style="margin-top:0pt;margin-bottom:0pt;text-align:left"><span style="color:#000000"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span style="font-size:10pt">144 Menachem Begin Road, Building A,</span></span></span></span></span></span></span></span></span></span></p>
            <p style="margin-top:0pt;text-align:left"><span style="color:#000000"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span style="font-size:10pt">Tel-Aviv 6492102, Israel</span></span></span></span></span></span></span></span></span></span></p>
          </td>
          <td style="vertical-align:top;width:33%">
            <p style="margin-bottom:0pt;text-align:left"><span style="color:#000000"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span style="font-size:10pt"><span>Tel: +972-3-6232525</span></span></span></span></span></span></span></span></span></span></span></p>
            <p style="margin-top:0pt;margin-bottom:0pt;text-align:left"><span style="color:#000000"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span style="font-size:10pt"><span>Fax: +972-3-5622555</span></span></span></span></span></span></span></span></span></span></span></p>
            <p style="margin-top:0pt;text-align:left"><span style="color:#000000"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span style="font-size:10pt">ey.com</span></span></span></span></span></span></span></span></span></span></p>
          </td>
        </tr>

    </table>
  </div>
  <p style="margin:0pt">&#160;</p>
  <p style="text-align:center;background-color:rgb(255, 255, 255);margin-top:0px;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</strong></span></span></p>
  <p style="margin:0pt">&#160;</p>
  <p style="text-align:center;background-color:rgb(255, 255, 255);margin-top:0px;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>to the Shareholders and Board of directors of</strong></span></span></span></span></span></span></span></span></p>
  <p style="margin:0pt">&#160;</p>
  <p style="text-align:center;margin-top:0px;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><strong>IM CANNABIS CORP. and its subsidiaries</strong></span></span></span></span></span></span></span></span></p>
  <p style="margin:0pt">&#160;</p>
  <div>
    <div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Opinion on the consolidated financial statements</span></span>
        <p style="margin:0pt">&#160;</p>
      </div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have audited the accompanying consolidated statements of financial position of IM Cannabis Corp. (the &#8220;Company&#8221;) and its subsidiaries (collectively, the "Group"), as of December 31, 2021 and 2020 and the related consolidated statements of profit or loss and other comprehensive income, changes in equity and cash flows for the years then ended and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;).</span></span>
        <p style="margin:0pt">&#160;</p>
      </div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Group as of December 31, 2021 and 2020 and the results of its operations and its cash flows for the years then ended, in conformity with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis for Opinion</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements are the responsibility of the Group's management. Our responsibility is to express an opinion on the Group&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Group in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Group is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Group&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></span>
        <p style="margin:0pt">&#160;</p>
      </div>
    </div>
  </div>
  <div>
    <div>
      <div>
        <div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:58.39%;vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220331114820452" name="dei:AuditorName" contextRef="C_20210101to20211231">KOST FORER GABBAY &#38; KASIERER</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:41.61%;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="width:58.39%;vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A Member of Ernst &#38; Young Global</span></span></div>
                  </td>
                  <td style="width:41.61%;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="width:58.39%;vertical-align:bottom">&#160;</td>
                  <td style="width:41.61%;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="width:58.39%;vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have served as the Company's auditor since 2018.</span></span></div>
                  </td>
                  <td style="width:41.61%;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="width:58.39%;vertical-align:bottom">&#160;</td>
                  <td style="width:41.61%;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="width:58.39%;vertical-align:bottom">
                    <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220331114812741" name="dei:AuditorLocation" contextRef="C_20210101to20211231">Tel-Aviv, Israel</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:41.61%;vertical-align:bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="width:58.39%;vertical-align:bottom">
                    <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 31, 2022</span></span></div>
                  </td>
                  <td style="width:41.61%;vertical-align:bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
  <p style="text-align:center;margin-top:10pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span><span><span><span><span>F - 2</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></p>
  <hr style="border-top:2px solid #000000;page-break-after:always" />
  <div style="margin-top:10pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>

  <div>
    <div>
      <div>
        <div style="line-height:1.25">
          <div>
            <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
            <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
          </div>
        </div>
      </div>
      <div style="line-height:1.25">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><a id="CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"></a></div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</span></span></div>
            <div style="text-align:justify;line-height:1.25;font-weight:bold">
              <hr style="height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);text-align:center;margin-left:auto;margin-right:auto;border:medium none;text-align:center" />
            </div>
          </div>
          <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

              <tr>
                <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASSETS</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CURRENT ASSETS:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"><ix:nonFraction id="Fxbrl_20210426233757561" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,903</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"><ix:nonFraction id="Fxbrl_20210426233800468" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,885</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted deposit</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460496" name="ifrs-full:CurrentRestrictedCashAndCashEquivalents" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460498" name="ifrs-full:CurrentRestrictedCashAndCashEquivalents" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">18</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivables</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619460500" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,711</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619460502" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,501</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances to suppliers</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426234249914" name="ifrs-full:CurrentAdvancesToSuppliers" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,300</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460506" name="ifrs-full:CurrentAdvancesToSuppliers" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,602</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts receivable</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619460508" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,481</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619460510" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">689</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments and financial instruments</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220304221017303_1619460508" name="ifrs-full:CurrentInvestments" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,129</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329160641034" name="ifrs-full:CurrentInvestments" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loans receivable</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15e</span></span></div>
                  </div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220304221019540_1619460508" name="ifrs-full:LoansAndReceivables" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,708</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220304221019540_1619460510" name="ifrs-full:LoansAndReceivables" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biological assets</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460512" name="ifrs-full:CurrentBiologicalAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,687</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460514" name="ifrs-full:CurrentBiologicalAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">78</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F1619460516" name="ifrs-full:Inventories" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,391</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F1619460518" name="ifrs-full:Inventories" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,370</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426234123886" name="ifrs-full:CurrentAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">84,311</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426234133919" name="ifrs-full:CurrentAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,143</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NON-CURRENT ASSETS:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment, net</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619460520" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,268</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619460521" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,532</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15c</span></span></div>
                  </div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460523" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,429</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460525" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,341</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative assets</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220304221411676_1619460523" name="ifrs-full:DerivativeFinancialAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220304221411676_1619460525" name="ifrs-full:DerivativeFinancialAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use assets, net</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460527" name="ifrs-full:RightofuseAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,162</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460529" name="ifrs-full:RightofuseAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">935</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets, net</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220329160437531" name="ifrs-full:DeferredTaxAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619460533" name="ifrs-full:DeferredTaxAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">769</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets, net</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5, 11</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460535" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,885</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619460537" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,092</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5, 11</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F1619460539" name="ifrs-full:Goodwill" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">121,303</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F1619460541" name="ifrs-full:Goodwill" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">304</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426234204773" name="ifrs-full:NoncurrentAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">203,077</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426234215841" name="ifrs-full:NoncurrentAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,973</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:4px" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total assets</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F1619460543" name="ifrs-full:Assets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">287,388</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F1619460544" name="ifrs-full:Assets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,116</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
        </div>
      </div>
      <div>
        <div>
          <div style="text-align:justify;line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:normal;font-style:normal">F - 3</span></span></span></div>
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0)" />
            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div>
              <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">IM CANNABIS CORP.</span></span></div>
              <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">and its subsidiaries</span></span></div>
            </div>
          </div>
          <div style="line-height:1.25">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</span></span></div>
            <div style="text-align:justify;line-height:1.25;font-weight:bold">
              <hr style="height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);text-align:center;margin-left:auto;margin-right:auto;border:medium none;text-align:center" />
            </div>
          </div>
          <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Canadian Dollars in thousands</span></span></div>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LIABILITIES AND EQUITY</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CURRENT LIABILITIES:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade payables</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313044_xbrl_20210426233921125" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,989</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313044_xbrl_20210426233933872" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,605</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank loans</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1a</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313048_xbrl_20220304221731619_xbrl_20210426233921125" name="ifrs-full:ShorttermBorrowings" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,502</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313048_xbrl_20220304221731619_xbrl_20210426233933872" name="ifrs-full:ShorttermBorrowings" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts payable and accrued expenses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313051_xbrl_20210427033851578_xbrl_20210426233921125" name="ifrs-full:OtherCurrentPayables" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,143</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313051_xbrl_20210427033851578_xbrl_20210426233933872" name="ifrs-full:OtherCurrentPayables" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,497</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued purchase consideration liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313056_xbrl_20220329160505098_xbrl_20210427033851578_xbrl_20210426233921125" name="ifrs-full:NoncurrentPayablesForPurchaseOfNoncurrentAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,039</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313056_xbrl_20220329160505098_xbrl_20210427033851578_xbrl_20210426233933872" name="ifrs-full:NoncurrentPayablesForPurchaseOfNoncurrentAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of operating lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313060_xbrl_20210427033854332_xbrl_20210426233921125" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,554</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313060_xbrl_20210427033854332_xbrl_20210426233933872" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">167</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313064_xbrl_20210427033931366_xbrl_20210426233921125" name="ifrs-full:CurrentLiabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">51,227</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313064_xbrl_20210427033931366_xbrl_20210426233933872" name="ifrs-full:CurrentLiabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,269</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NON-CURRENT LIABILITIES:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants measured at fair value</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313067_xbrl_20210427033920380_xbrl_20210426233921125" name="imc:WarrantsMeasuredAtFairValue" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,022</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313067_xbrl_20210427033920380_xbrl_20210426233933872" name="imc:WarrantsMeasuredAtFairValue" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,540</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313072_xbrl_20210427033922448_xbrl_20210426233921125" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,820</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313072_xbrl_20210427033922448_xbrl_20210426233933872" name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">823</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term loans</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313077_xbrl_20220304221737546_xbrl_20210426233921125" name="ifrs-full:LongtermBorrowings" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">392</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313077_xbrl_20220329160537332" name="ifrs-full:LongtermBorrowings" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employee benefit liabilities, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313082_xbrl_20210427033924518_xbrl_20210426233921125" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">391</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313082_xbrl_20210427033924518_xbrl_20210426233933872" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">371</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liability</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313088_xbrl_20210427033927355_xbrl_20210426233921125" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,591</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313088_xbrl_20210427033927355_xbrl_20210426233933872" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,503</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313091_xbrl_20210427033933320_xbrl_20210426233921125" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,216</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313091_xbrl_20210427033933320_xbrl_20210426233933872" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,237</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313094_xbrl_20210427033935883_xbrl_20210426233921125" name="ifrs-full:Liabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">82,443</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313094_xbrl_20210427033935883_xbrl_20210426233933872" name="ifrs-full:Liabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,506</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share capital and premium</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313097_xbrl_20210427033938627_xbrl_20210426233921125" name="ifrs-full:IssuedCapital" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">237,677</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313097_xbrl_20210427033938627_xbrl_20210426233933872" name="ifrs-full:IssuedCapital" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">37,040</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury Stock</span></span></div>
                    </td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331133126667_xbrl_20220331115313100_xbrl_20210427033941066_xbrl_20210426233921125" name="ifrs-full:TreasuryShares" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">660</ix:nonFraction></td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">) </span></span></td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331133126667_xbrl_20220331115313100_xbrl_20210427033941066_xbrl_20210426233933872" name="ifrs-full:TreasuryShares" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Translation reserve</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313100_xbrl_20210427033941066_xbrl_20210426233921125" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,614</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313100_xbrl_20210427033941066_xbrl_20210426233933872" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,229</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reserve from share-based payment transactions</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313104_xbrl_20210427033942879_xbrl_20210426233921125" name="ifrs-full:ReserveOfSharebasedPayments" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,348</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313104_xbrl_20210427033942879_xbrl_20210426233933872" name="ifrs-full:ReserveOfSharebasedPayments" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,829</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated deficit</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331115313110_xbrl_20220329160657991" name="ifrs-full:RetainedEarnings" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">50,743</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331115313110_xbrl_20210427033946850_xbrl_20210426233933872" name="ifrs-full:RetainedEarnings" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">33,001</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total equity attributable to shareholders of the Company</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313114_xbrl_20210427033951810_xbrl_20210426233921125" name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">201,236</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313114_xbrl_20210427033951810_xbrl_20210426233933872" name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,097</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-controlling interests</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313117_xbrl_20210427033953741_xbrl_20210426233921125" name="ifrs-full:NoncontrollingInterests" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,709</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313117_xbrl_20210427033953741_xbrl_20210426233933872" name="ifrs-full:NoncontrollingInterests" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,513</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total equity</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313120_xbrl_20210427033956310_xbrl_20210426233921125" name="ifrs-full:Equity" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">204,945</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313120_xbrl_20210427033956310_xbrl_20210426233933872" name="ifrs-full:Equity" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,610</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total equity and liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313126_xbrl_20210427033958391_xbrl_20210426233921125" name="ifrs-full:EquityAndLiabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">287,388</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331115313126_xbrl_20210427033958391_xbrl_20210426233933872" name="ifrs-full:EquityAndLiabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,116</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
            </div>
          </div>
          <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:22.35%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">March 31, 2022</span></span></div>
                </td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
              </tr>
              <tr>
                <td style="width:22.35%;vertical-align:top">
                  <div style="text-align:center;margin-left:2.85pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Date of approval of the</span></span></div>
                </td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top">
                  <div style="text-align:center;margin-left:2.85pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Marc Lustig</span></span></div>
                </td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top">
                  <div style="text-align:center;margin-left:2.85pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Oren Shuster</span></span></div>
                </td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top">
                  <div style="text-align:center;margin-left:2.85pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Shai Shemesh</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="width:22.35%;vertical-align:top">
                  <div style="text-align:center;margin-left:2.85pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">financial statements</span></span></div>
                </td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top">
                  <div style="text-align:center;margin-left:2.85pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Chairman of the Board</span></span></div>
                </td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top">
                  <div style="text-align:center;margin-left:2.85pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Chief Executive Officer</span></span></div>
                </td>
                <td style="width:2.35%;vertical-align:top">&#160;</td>
                <td style="width:23.53%;vertical-align:top">
                  <div style="text-align:center;margin-left:2.85pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Chief Financial Officer</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
        </div>
      </div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 4</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
        </div>
      </div>
    </div>
  </div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>

  <div>
    <div>
      <div style="line-height:1.25">
        <div>
          <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
          <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
        </div>
      </div>
      <div style="line-height:1.25;font-weight:bold"><a id="CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF PROFIT OR LOSS</span></span></div>
      <div style="line-height:1.25">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AND OTHER COMPREHENSIVE INCOME</span></span></div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" />
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands</span></span></div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                <tr>
                  <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440911_0" name="ifrs-full:Revenue" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,300</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440912_1" name="ifrs-full:Revenue" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,890</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440913_2" name="ifrs-full:CostOfSales" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,418</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440914_4" name="ifrs-full:CostOfSales" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,081</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross profit before fair value adjustments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440913_3" name="imc:GrossProfitBeforeFairValueAdjustments" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,882</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440914_5" name="imc:GrossProfitBeforeFairValueAdjustments" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,809</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments:</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrealized change in fair value of biological assets</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440915_6" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">7,210</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440915_7" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">11,781</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Realized fair value adjustments on inventory sold in the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="F20220330051440916_8" name="imc:RealizedFairValueAdjustmentOnInventorySold" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">8,796</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="F20220330051440916_9" name="imc:RealizedFairValueAdjustmentOnInventorySold" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">10,122</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total fair value adjustments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="F20220330051440938_59" name="ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,586</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440935_58" name="ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,659</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross profit after fair value adjustments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440917_10" name="ifrs-full:GrossProfit" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,296</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440917_11" name="ifrs-full:GrossProfit" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,468</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"><ix:nonFraction id="F20220330051440918_12" name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,219</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"><ix:nonFraction id="F20220330051440918_13" name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,549</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing expenses</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440918_14" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,995</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440919_15" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,782</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440919_16" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,471</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440920_17" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,382</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating expenses</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440920_18" name="ifrs-full:OperatingExpense" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,685</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440923_19" name="ifrs-full:OperatingExpense" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,713</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating loss</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="F20220330051440923_20" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">38,389</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="F20220330051440924_21" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">8,245</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance income</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F20220330051440924_22" name="ifrs-full:FinanceIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,024</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F20220330051440925_23" name="ifrs-full:FinanceIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">277</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance expenses</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440925_24" name="ifrs-full:FinanceCosts" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,648</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440925_25" name="ifrs-full:FinanceCosts" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,504</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance income (expense), net</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440939_63" name="ifrs-full:FinanceIncomeCost" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,376</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440939_62" name="ifrs-full:FinanceIncomeCost" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">20,227</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income taxes</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440926_26" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">18,013</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440926_27" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,472</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440938_61" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">505</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440938_60" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">262</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net Loss</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="F20220330051440933_50" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">18,518</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="F20220330051440926_28" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,734</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income that will not be reclassified to profit or loss in subsequent periods:</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remeasurement gain (loss) on defined benefit plans</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440927_29" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">21</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440927_30" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">30</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange differences on translation to presentation currency</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440928_31" name="imc:OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">858</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440928_32" name="imc:OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,144</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330105653040" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">879</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="F20220330051440930_36" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,114</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income that will be reclassified to profit or loss in subsequent periods:</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments arising from translating financial statements of foreign operation</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440928_33" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">530</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330104957708" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">124</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other comprehensive income that will be reclassified to profit or loss in subsequent periods</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330105030452" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">530</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220329161258158_20220330051440929_34" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">124</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other comprehensive income</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440934_54" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,409</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F20220330051440930_37" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">990</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive loss</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440934_53" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,109</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440931_38" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">27,744</ix:nonFraction></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="text-align:justify;line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
          <div style="text-align:justify;line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 5</span></span></span></div>
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0)" />
            </div>
          </div>
          <div style="text-align:justify;line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25">
            <div>
              <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
              <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
            </div>
          </div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF PROFIT OR LOSS</span></span></div>
          <div style="line-height:1.25">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AND OTHER COMPREHENSIVE INCOME</span></span></div>
            <div style="text-align:justify;line-height:1.25;font-weight:bold">
              <hr style="height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);text-align:center;margin-left:auto;margin-right:auto;border:medium none;text-align:center" />
            </div>
          </div>
          <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands, except per share data</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

              <tr>
                <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity holders of the Company</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="F20220330051440931_41" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,763</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20210429031558975_20220330051440931_38" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,698</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-controlling interests</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440932_43" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">755</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210429031601577_20220330051440931_38" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">36</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440932_45" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">18,518</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210429031603982_20220330051440931_38" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,734</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive income (loss) attributable to:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity holders of the Company</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="F20220330051440933_47" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">16,357</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20210429031606217_20220330051440931_38" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">27,808</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-controlling interests</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440935_57" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">752</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220305001358684_xbrl_20210429031608567_20220330051440931_38" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">64</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="F20220330051440935_55" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,109</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210429031555262_20220330051440931_38" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">27,744</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per share attributable to equity holders of the Company:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="F20220330051440933_49" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20210101to20211231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal" sign="-">0.31</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20210429031610940_20220330051440931_38" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20200101to20201231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal" sign="-">0.74</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220304225246562_20220330051440933_49" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20210101to20211231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal" sign="-">0.66</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220304225246562_xbrl_20210429031610940_20220330051440931_38" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20200101to20201231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal" sign="-">0.74</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 6</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
        </div>
      </div>
    </div>
  </div>

  <div>
    <div>
      <div>
        <div>
          <div>
            <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
            <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
          </div>
          <div style="line-height:1.25">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><a id="CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</span></span>
              <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" />
            </div>
          </div>
          <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands</span></span></div>
          <div>
            <div>
              <div>
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25">
                    <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px;width:28%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share Capital and premium</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury Stock</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reserve from share-based payment transactions</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Translation reserve</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated deficit</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-controlling interests</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">equity</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:28%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427043804777" name="ifrs-full:Equity" contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,947</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331152938637" name="ifrs-full:Equity" contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427043835299" name="ifrs-full:Equity" contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,677</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427043847996" name="ifrs-full:Equity" contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">309</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427044150767" name="ifrs-full:Equity" contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">4,273</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427044209998" name="ifrs-full:Equity" contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,660</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427044222698" name="ifrs-full:Equity" contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,449</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427044236232" name="ifrs-full:Equity" contextRef="C_20191231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,109</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20220307164315736" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331152957756" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20220307164334470" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20220307164346894" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,698</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,698</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">36</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,734</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other comprehensive income (loss)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20220307164433814" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153012074" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20220307164735655" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043847996" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">920</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">30</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">890</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">100</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210518144954610" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">990</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive income (loss)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20220307165502005" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153017953" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20220307165521053" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043847996" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">920</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,728</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">27,808</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">64</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210518145022467" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">27,744</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of warrants and compensation options</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043804777" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,251</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153024528" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20220307163751023" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20220307163815415" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20220307163818710" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,251</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20220307163821464" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,251</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20210427050437231_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043804777" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">834</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153030687" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20210427050437231_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043835299" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">222</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20220307163940519" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20220307164007256" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20210427050437231_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">612</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20220307164019521" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20210427050437231_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">612</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20220307164035856" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153036705" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20210427050439933_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043835299" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,382</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20220307164102449" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20220307164107463" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20210427050439933_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,382</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20220307164111616" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20210427050439933_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,382</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited options</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20210427050443077_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043804777" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153044624" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20210427050443077_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043835299" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">8</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164153527" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164156983" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164202520" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164205648" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164209239" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043804777" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">37,040</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153050313" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043835299" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,829</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043847996" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,229</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044150767" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">33,001</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044209998" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,097</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044222698" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,513</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044236232" name="ifrs-full:Equity" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,610</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307170312581" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153058296" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307170315877" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307170321197" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307155902102_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,763</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307155902102_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,763</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307155902102_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">755</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307155902102_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">18,518</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total other comprehensive income (loss)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307170444933" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153107256" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307170447637" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307155930775_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,385</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307155930775_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">21</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307155930775_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,406</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307170450660" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307155930775_xbrl_20210518144954610" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,409</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive income (loss)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307170532133" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153117672" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307170536180" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043847996" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,385</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,742</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">16,357</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">752</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210518145022467" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,109</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of common shares, net of issuance costs of $3,800</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307163134704" name="ifrs-full:IssueOfEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">195,259</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153126080" name="ifrs-full:IssueOfEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307165902694" name="ifrs-full:IssueOfEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307165905614" name="ifrs-full:IssueOfEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307165908173" name="ifrs-full:IssueOfEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307163140520" name="ifrs-full:IssueOfEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">195,259</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307163150688" name="ifrs-full:IssueOfEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,948</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307163146144" name="ifrs-full:IssueOfEquity" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">198,207</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of treasury common shares</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163134704" name="imc:AmountOfPurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220331153132886" name="imc:AmountOfPurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">660</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165902694" name="imc:AmountOfPurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165905614" name="imc:AmountOfPurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165908173" name="imc:AmountOfPurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163140520" name="imc:AmountOfPurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">660</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163150688" name="imc:AmountOfPurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163146144" name="imc:AmountOfPurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">660</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of warrants and compensation options</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163134704" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,293</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153139767" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165902694" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165905614" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165908173" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163140520" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,293</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163150688" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163146144" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,293</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307163240807" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,053</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153148112" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307163301903" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">920</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307165946701" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307165951582" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307163252383" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">133</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307165954221" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307163257391" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">133</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307170100045" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153159871" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307163358129" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,471</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307170106621" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307170109341" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307163406296" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,471</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307170112750" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307163411209" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,471</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited options</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307163448120" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">32</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331153206792" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307163454584" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">32</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170207069" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170209869" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170213973" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170217605" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170219764" name="imc:IncreaseDecreaseThroughForfeitedOptions" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043804777" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">237,677</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220331153221850" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">660</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043835299" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,348</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043847996" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,614</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044150767" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">50,743</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044209998" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">201,236</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044222698" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,709</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:6%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044236232" name="ifrs-full:Equity" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">204,945</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
                </div>
              </div>
            </div>
          </div>
          <div style="text-align:justify;line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 7</span></span></span></div>
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="margin-top:10pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>

  <div>
    <div>
      <div>
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
      </div>
      <div style="line-height:1.25">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><a id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" />
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands</span></span></div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
    </div>
  </div>
  <div>
    <div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

          <tr>
            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cash provided from operating activities:</span></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325714_xbrl_20210427212508026_42" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">18,518</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325714_xbrl_20210427212508026_45" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,734</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments for non-cash items:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrealized gain on changes in fair value of biological assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325717_xbrl_20210427212508026_82" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,210</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325717_xbrl_20210427212508026_85" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,781</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustment on sale of inventory</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325719_xbrl_20210427212508026_92" name="imc:FairValueAdjustmentOnSaleOfInventory" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,796</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325719_xbrl_20210427212508026_95" name="imc:FairValueAdjustmentOnSaleOfInventory" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,122</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustment on Warrants, Investments, and Accounts Receivable</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325721_xbrl_20210427212508026_102" name="imc:FairValueAdjustmentOnWarrantsMeasuredAtFairValue" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">21,638</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325721_xbrl_20210427212508026_105" name="imc:FairValueAdjustmentOnWarrantsMeasuredAtFairValue" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,155</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation of property, plant and equipment</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325722_xbrl_20210427212508026_112" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,021</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325722_xbrl_20210427220705525" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">690</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization of intangible assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325725_xbrl_20210427212508026_122" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,158</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325725_xbrl_20210427212508026_125" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">31</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation of right-of-use assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325727_xbrl_20210427212508026_132" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,550</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325727_xbrl_20210427212508026_135" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">209</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of goodwill</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173028847_xbrl_20220307153325727_xbrl_20210427212508026_132" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">275</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173028847_xbrl_20220307153325727_xbrl_20210427212508026_135" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance income, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325732_xbrl_20210427212508026_152" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,262</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325732_xbrl_20210427212508026_155" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">72</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax benefit</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325737_xbrl_20210427212508026_172" name="ifrs-full:AdjustmentsForDeferredTaxExpense" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">278</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325737_xbrl_20210427212508026_175" name="ifrs-full:AdjustmentsForDeferredTaxExpense" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">66</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based payments expenses</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325740_xbrl_20210427212508026_182" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,471</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325740_xbrl_20210427212508026_185" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,382</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based acquisition costs related to business combination</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307171622635_xbrl_20220307153325740_xbrl_20210427212508026_182" name="imc:AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">807</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307171622635_xbrl_20220307153325740_xbrl_20210427212508026_185" name="imc:AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220330111711599" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">4,230</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307171810554" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,814</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in non-cash working capital:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in trade receivables, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325743_xbrl_20210427212508026_232" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">6,602</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325743_xbrl_20210427212508026_235" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">3,534</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in other accounts receivable and advances to suppliers</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325745_xbrl_20210427212508026_242" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">845</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325745_xbrl_20210427212508026_245" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,029</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease in biological assets, net of fair value adjustments</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325747_xbrl_20210427212508026_252" name="ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,412</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325747_xbrl_20210427212508026_255" name="ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,771</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in inventories, net of fair value adjustments</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325749_xbrl_20210427212508026_262" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">19,707</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325749_xbrl_20210427212508026_265" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">12,729</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in trade payables</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325751_xbrl_20210427212508026_272" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,573</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325751_xbrl_20210427212508026_275" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,135</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in employee benefit liabilities, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173032872_xbrl_20220307153325727_xbrl_20210427212508026_132" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">28</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173032872_xbrl_20220307153325727_xbrl_20210427212508026_135" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">59</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase in other accounts payable and accrued expenses</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325753_xbrl_20210427212508026_282" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,661</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307153325753_xbrl_20210427212508026_285" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,929</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220330111727799" name="ifrs-full:IncreaseDecreaseInWorkingCapital" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,790</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220307171854245" name="ifrs-full:IncreaseDecreaseInWorkingCapital" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,398</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes paid</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325756_xbrl_20210427212508026_322" name="ifrs-full:IncomeTaxesPaidClassifiedAsOperatingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">834</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325756_xbrl_20210427212508026_325" name="ifrs-full:IncomeTaxesPaidClassifiedAsOperatingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">601</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in operating activities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325758_xbrl_20210427212508026_342" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">34,372</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325758_xbrl_20210427212508026_345" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">7,919</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cash flows from investing activities:</span></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property, plant and equipment</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325760_xbrl_20210427212508026_382" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,578</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325760_xbrl_20210427212508026_385" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,617</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from loans receivable</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173036345_xbrl_20220307153325727_xbrl_20210427212508026_132" name="ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,796</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173036345_xbrl_20220307153325727_xbrl_20210427212508026_135" name="ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of intangible assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307171952934" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325762_xbrl_20210427212508026_392" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">93</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition of subsidiaries</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220329173043305_xbrl_20220307153325727_xbrl_20210427212508026_132" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,536</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173043305_xbrl_20220307153325727_xbrl_20210427212508026_135" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments in associates</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325764_xbrl_20210427212508026_412" name="ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325764_xbrl_20210427212508026_415" name="ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,347</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from sale of investment</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173040761_xbrl_20220307153325727_xbrl_20210427212508026_132" name="ifrs-full:ProceedsFromSalesOfInvestmentProperty" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">319</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173040761_xbrl_20220307153325727_xbrl_20210427212508026_135" name="ifrs-full:ProceedsFromSalesOfInvestmentProperty" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from (investment in) restricted deposits</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172134302" name="imc:ProceedsFromInvestmentInRestrictedDeposits" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325767_xbrl_20210427212508026_422" name="imc:ProceedsFromInvestmentInRestrictedDeposits" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">18</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in investing activities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325768_xbrl_20210427212508026_442" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">9,012</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307153325768_xbrl_20210427212508026_445" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">4,075</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>

      </table>
      <div style="text-align:justify;line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
      <div style="text-align:justify;line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 8</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0)" />
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25">
        <div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
          </div>
        </div>
      </div>
      <div style="line-height:1.25">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <hr style="height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);text-align:center;margin-left:auto;margin-right:auto;border:medium none;text-align:center" />
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands</span></span></div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
      <div style="line-height:1.25">
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

            <tr>
              <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cash provided by financing activities:</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from issuance of share capital, net of issuance costs</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172743523" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,131</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729012_xbrl_20210427215700978_45" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from issuance of warrants measured at fair value</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172754354" name="imc:ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,222</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729012_xbrl_20210427215700978_55" name="imc:ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from exercise of warrants and compensation options</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172807316" name="imc:ProceedsFromExerciseOfWarrantsAndCompensationOptions" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,682</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729014_xbrl_20210427215700978_62" name="imc:ProceedsFromExerciseOfWarrantsAndCompensationOptions" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,378</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from exercise of options</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172825275" name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">133</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729015_xbrl_20210427215700978_72" name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">612</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of lease liability</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307172729016_xbrl_20210427215700978_82" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">633</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307172729016_xbrl_20210427215700978_85" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">182</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment of lease liability interest</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307172729018_xbrl_20210427215700978_92" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,347</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307172729018_xbrl_20210427215700978_95" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">68</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from bank loan</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173046962_xbrl_20220307153325727_xbrl_20210427212508026_132" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,804</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173046962_xbrl_20220307153325727_xbrl_20210427212508026_135" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest paid in respect of loans</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220329173048705_xbrl_20220307153325727_xbrl_20210427212508026_132" name="imc:InterestPaidInRespectOfLoans" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">261</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329173048705_xbrl_20220307153325727_xbrl_20210427212508026_135" name="imc:InterestPaidInRespectOfLoans" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by financing activities</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729020_xbrl_20210427215700978_122" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,731</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729020_xbrl_20210427215700978_125" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,740</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of foreign exchange on cash and cash equivalents</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307172729023_xbrl_20210427215700978_142" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">329</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729023_xbrl_20210427215700978_145" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">213</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in cash and cash equivalents</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729026_xbrl_20210427215700978_162" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,018</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307172729026_xbrl_20210427215700978_165" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">5,041</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents at beginning of year</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729028_xbrl_20210427215700978_172" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,885</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729028_xbrl_20210427215700978_175" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20191231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,926</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents at end of year</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729029_xbrl_20210427215700978_192" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,903</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172729029_xbrl_20210427215700978_195" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,885</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Supplemental disclosure of non-cash activities:</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use asset recognized with corresponding lease liability</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172905854" name="imc:RightOfUseAssetRecognizedWithCorrespondingLeaseLiability" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,678</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307172910627" name="imc:RightOfUseAssetRecognizedWithCorrespondingLeaseLiability" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">107</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Conversion of warrant and compensation options into common shares</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330111757801_xbrl_20220307172905854" name="imc:ConversionOfWarrantAndCompensationOptionsIntoCommonShares" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">611</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330111757801_xbrl_20220307172910627" name="imc:ConversionOfWarrantAndCompensationOptionsIntoCommonShares" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,873</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height:1.25">&#160;</div>
    </div>
  </div>

  <p style="text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Schedule A - Acquisition of TFC:</span></span></span></p>
  <div>
    <div>
      <div style="line-height:1.25">
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

            <tr>
              <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The subsidiary's assets and liabilities at date of acquisition:</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Working capital (excluding cash and cash equivalents)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307192044218" name="imc:WorkingCapital" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,427</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307192100237" name="imc:InvestmentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">319</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307192110027" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,193</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right of use assets</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307192141446" name="imc:RightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,037</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307192154487" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,037</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307192211517" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,458</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307192430436" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">67,269</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common shares issued upon the acquisition</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307192639580" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">99,028</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:top;width:88%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$ </span></span></td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307192702047" name="imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">362</ix:nonFraction></td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">) </span></span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align:justify;line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the consolidated financial statements.</span></span></div>
      <div style="text-align:justify;line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 9</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0)" />
        </div>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25">
        <div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
          </div>
        </div>
      </div>
      <div style="line-height:1.25">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <hr style="height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);text-align:center;margin-left:auto;margin-right:auto;border:medium none;text-align:center" />
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands</span></span></div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
      <div style="line-height:1.25">
        <div style="line-height:1.25">
          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Schedule B - Acquisition of Panaxia:</span></span></span></div>
          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

              <tr>
                <td style="vertical-align:top" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The assets and liabilities at date of acquisition:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307192806702" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued purchase consideration liability</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220330113651881" name="imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">126</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307193013323" name="imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,837</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307193039391" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">88</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329174843710" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">776</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329174840742" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,240</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307193122971" name="imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,834</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>

          </table>
          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25">&#160;</div>
          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Schedule C - Acquisition of MYM:</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

              <tr>
                <td style="vertical-align:top" valign="bottom">
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The subsidiary's assets and liabilities at date of acquisition:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Working capital (excluding cash and cash equivalents)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307193456660" name="imc:WorkingCapital" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,471</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loan payables</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220329204248256" name="imc:LoansPayableAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">915</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment and right of use assets</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307193740554" name="imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,735</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307193816797" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">873</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liability</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307193849545" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,061</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307193933291" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,200</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307193944864" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,932</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common shares issued upon the acquisition</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307193955745" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,620</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194049791" name="imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">131</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">) </span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Schedule D - Acquisition of Pharm Yarok:</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

              <tr>
                <td style="vertical-align:top" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The subsidiary's assets and liabilities at date of acquisition:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Working capital deficit (excluding cash and cash equivalents)</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194121487" name="imc:WorkingCapital" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">646</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued purchase consideration liability</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194236629" name="imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,332</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194257463" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,145</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term loans</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194320592" name="imc:LongTermBorrowingsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,042</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liability</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194401824" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">224</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194344048" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">974</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194415736" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,294</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194436762" name="imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,169</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>

          </table>
          <div style="text-align:justify;line-height:1.25"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Schedule E - Acquisition of Vironna:</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

              <tr>
                <td style="vertical-align:top" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The subsidiary's assets and liabilities at date of acquisition:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Working capital (excluding cash and cash equivalents)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194451648" name="imc:WorkingCapital" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">44</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued purchase consideration liability</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194515521" name="imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,855</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194530593" name="imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">210</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liability</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194555258" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">532</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194543835" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,316</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194624324" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,250</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                  <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-controlling interest</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194638374" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,026</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194655155" name="imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,407</ix:nonFraction></td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
      </div>
      <div style="line-height:1.25">
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 10</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0)" />
          </div>
        </div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">
            <div>
              <div style="line-height:1.25;font-weight:bold">&#160;</div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
            </div>
          </div>
        </div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <hr style="height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);text-align:center;margin-left:auto;margin-right:auto;border:medium none;text-align:center" />
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Schedule F - Acquisition of Oranim:</span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;color:rgb(0, 0, 0);width:100%">

          <tr>
            <td style="vertical-align:top" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The subsidiary's assets and liabilities at date of acquisition:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Working capital deficit (excluding cash and cash equivalents)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329175339862" name="imc:WorkingCapital" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">595</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued purchase consideration liability</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307194732438" name="imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,726</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307194836563" name="imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">389</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right of use assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307195057774" name="imc:RightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,312</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307195108937" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,312</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307195122194" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,991</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liability</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307195315301" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">688</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307195328601" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,907</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-controlling interest</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307195339713" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,849</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307195352650" name="imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,619</ix:nonFraction></td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>

      </table>
      <div>
        <div style="text-align:center;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-weight:bold">&#160;</div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 11</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0)" />
          </div>
        </div>
        <div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM CANNABIS CORP.</span></span></div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and its subsidiaries</span></span></div>
          </div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;line-height:1.25;font-weight:bold"><a id="NOTESTOCONSOLIDATEDFINANCIALSTATEMENTS"></a><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></div>
          <div style="text-align:justify;line-height:1.25;font-weight:bold">
            <hr style="height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);text-align:center;margin-left:auto;margin-right:auto;border:medium none;text-align:center" />
          </div>
        </div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollars in thousands, except share and per share data</span></span></div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
      </div>
    </div>
  </div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220307183747880" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <div>
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1:-</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GENERAL</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate information:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM Cannabis Corp. (the "Company" or "IMCC") is listed for trading on the Canadian Securities Exchange (&#8220;CSE&#8221;) and, commencing from March 1, 2021, on NASDAQ under the ticker symbol &#8220;IMCC&#8221;. IMCC&#8217;s main office is located in Kibutz Glil-Yam, Israel.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IMCC operates in the field of medical cannabis, through Focus Medical Herbs Ltd. ("Focus"), which is licensed under the regulations of medical cannabis by the Israeli Ministry of Health ("MOH") through its Israel Medical Cannabis Agency ("IMCA") to breed, grow and supply medical cannabis product in Israel and all of its operations are performed pursuant to the Israeli Dangerous Drugs Ordinance (New Version), 1973 (the "Dangerous Drugs Ordinance"), and the related regulations issued by IMCA. During 2021 IMCC entered to the retail market using pharmacies selling medical cannabis and other pharma products.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In Europe, IMCC operates through Adjupharm, a German-based subsidiary acquired by IMC Holdings on March 15, 2019. Adjupharm is an EU-GMP certified medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In Canada, IMCC operates through Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;) d/b/a JWC and MYM, both Canadian federally licensed producer of cannabis products in the adult-use recreational cannabis market in Canada.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company and its subsidiaries do not engage in any U.S. cannabis-related activities as defined in Canadian Securities Administrators Staff Notice 51-352.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company, its subsidiaries and Focus (collectively: the "Group"), operate in geographical reporting segments (note 23). The majority of the Group&#8217;s revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">COVID-19:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Since March 31, 2020, the outbreak of the novel strain of coronavirus ("COVID-19") and the ongoing pandemic, has resulted in governments worldwide enacting various emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods, closing of non-essential businesses and social distancing, have caused material disruption to businesses globally resulting in an economic slowdown.</span></span></div>
                </div>
              </div>
              <div><ix:exclude>
                <p style="margin:0pt">&#160;</p>
                <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>12</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold">&#160;</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 1:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">GENERAL </span><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group has taken proactive measures to protect the health and safety of its employees in order to continue delivering high quality medical cannabis products to its patients and to maintain its financial health, including postponed planned investments in certain jurisdictions until global economic risks subside.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To date, the Group&#8217;s cannabis operations, results and financial position have not been materially impacted by COVID-19 related issues. Apart for temporary delays in Canada, the Group has not experienced material disruptions in its labor inputs and cultivation and processing activities, there have been no indicators of material issues to the Group&#8217;s supply chain, and on the consumer side, product demand has remained stable and medical cannabis has been declared an essential service across Israel, Germany and Canada, as such, the Group's overall distribution remains relatively unimpacted.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">While the precise impact of the COVID-19 outbreak on the Group remains unknown, the rapid spread of COVID-19 and declaration of the outbreak as a global pandemic have resulted in travel advisories and restrictions, certain restrictions on business operations, social distancing precautions and restrictions on group gatherings which are having direct impacts on businesses in Canada, Israel, Germany and elsewhere in the world. Such additional precautionary measures could also impact the Group&#8217;s business. The spread of COVID-19 may also have a material adverse effect on global economic activity and could result in volatility and disruption to global supply chains and the financial and capital markets. These disruptions could cause interruptions in supplies and other services from third parties upon which the Group relies; decrease demand for products; and cause staff shortages, reduced customer traffic, and increased government regulation, all of which may materially and negatively impact the business, financial condition and results of operations of the Group.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity and capital resources:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 10, 2021, the Company completed an overnight marketed offering (the &#8220;Offering&#8221;) of <ix:nonFraction id="Fxbrl_20220307170913338" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">6,086,956</ix:nonFraction> Common Shares (each an &#8220;Offered Share&#8221;) at a price of US$<ix:nonFraction id="Fxbrl_20220307170948470" name="ifrs-full:ParValuePerShare" contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="USD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">5.75</ix:nonFraction> per Offered Share for aggregate gross proceeds of approximately US$<ix:nonFraction id="Fxbrl_20220307171019742" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="USD" scale="6" decimals="-6" format="ixt:numdotdecimal">35</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20220307171043027" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,502</ix:nonFraction>) (see Note 15d).</span></span></div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021, the Company's cash position (cash and cash equivalents) totaled $<ix:nonFraction id="Fxbrl_20220331182715214" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,903</ix:nonFraction> and the Company's working capital (current assets less current liabilities) amounted to $<ix:nonFraction id="Fxbrl_20220331182724959" name="imc:WorkingCapitalOfBusinessAcquisition" contextRef="C_20210101to20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,084</ix:nonFraction>. In the year ended December 31, 2021, the Company had an operating loss of ($<ix:nonFraction id="Fxbrl_20220331182734077" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,389</ix:nonFraction>) and negative cash flows from operating activities of ($<ix:nonFraction id="Fxbrl_20220331182741710" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20210101to20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,372</ix:nonFraction>). The Company&#8217;s current operating budget includes various assumptions concerning the level and timing of cash receipts from sales and cash outlays for operating expenses and capital expenditures, including a cost saving plan. The Company is planning to finance its operations from its existing and future working capital resources and to continue to evaluate additional sources of capital and financing. However, there is no assurance that additional capital and or financing will be available to the Company, and even if available, whether it will be on terms acceptable to the Company or in amounts required. Accordingly, the Company&#8217;s board of directors approved a cost saving plan, to be implemented if needed, in whole or in part, at its discretion, to allow the Company to continue its operations and meet its cash obligations. The cost saving plan consist of cost reduction due to efficiencies and synergies, which include mainly the following steps: reduction in payroll and headcount, reduction in compensation paid to key management personnel, operational efficiencies and reduced capital expenditures. The Company and the board of directors believe that its existing financial resources and its operating plans, including the effects of the costs saving plan, will be adequate to satisfy its expected liquidity requirements for a period of at least twelve months from the end of the reporting period.</span></span></div>
                  <div style="line-height:1.25">
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <div>
                            <div style="line-height:1.25">&#160;</div>
                          </div>
                        </div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year, TJAC and certain MYM subsidiaries entered into a revolving credit facility (the &#8220;Facility&#8221;) with a private Canadian creditor. The Facility is guaranteed by Trichome Financial Corp. Advances from the Facility is used for working capital needs.</span></span></div>
                      </div>
                    </div>
                  </div>
                  <div style="line-height:1.25">
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Facility has a total commitment of up to $<ix:nonFraction id="Fxbrl_20220329205334515" name="imc:Commitment" contextRef="C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,000</ix:nonFraction> and has a one-year term, renewable upon mutual agreement by the parties on May 14, 2022 for up to two additional periods of 180 days. The borrowing base available for draw at any time throughout the Facility is a function of the trade receivable and inventory balances at the time of drawdown. The Facility bears interest at the higher of <ix:nonFraction id="Fxbrl_20220329205347563" name="ifrs-full:BorrowingsInterestRate" contextRef="C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">9.75</ix:nonFraction>% and the Toronto Dominion Bank <ix:nonNumeric id="Fxbrl_20220329205408971" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20210101to20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">Prime Rate plus 7.30% per annum</ix:nonNumeric>. The balance as at December 31, 2021 was $<ix:nonFraction id="Fxbrl_20220329205433115" name="ifrs-full:Borrowings" contextRef="C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,582</ix:nonFraction>.</span></span></div>
                  </div>
                </div>
              </div>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>13</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                </div>
                <div style="text-align:justify;line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 1:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">GENERAL </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In January 2022, Focus entered into a Revolving Credit Facility with Bank Mizrahi (the &#8220;Mizrahi Facility&#8221;). The Mizrahi Facility is guaranteed by Focus assets. Advances from the Mizrahi Facility will be used for working capital needs.</span></span></div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Mizrahi Facility has a total commitment of up to NIS <ix:nonFraction id="Fxbrl_20220329205922485" name="imc:Commitment" contextRef="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">15,000</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220329205932629" name="imc:Commitment" contextRef="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,000</ix:nonFraction>) and has a one-year term for on-going needs and 6 months term for imports and purchases needs. The Mizrahi Facility is renewable upon mutual agreement by the parties. The borrowing base available for draw at any time throughout the Mizrahi Facility and is subject to several covenants to be measured on a quarterly basis. The Mizrahi Facility bears interest of Israeli <ix:nonNumeric id="Fxbrl_20220329210005703" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20220101to20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">Prime interest plus 1.5% (approximately 3.3%) per annum</ix:nonNumeric>.</span></span></div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Strategic developments:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:14.15pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 2, 2019, IMC undertook a restructuring process (the "IMC Restructuring") to divest its holdings in Focus, I.M.C Pharma Ltd and I.M.C.C. Ltd. (the "Licensed Entities") and sold its interest to the two Principal Shareholders of the Company. In the process, IMC restructured its connection to the Government Issued License, from Direct Ownership to a Business Agreement relationship, according to which IMC will still gain most of the economic values generated from the License, without directly owning it. Furthermore, IMC has the option to buy back the ownership of the license from the two Principal Shareholders. The restructuring process was subject to the prior approval of the Ministry of Health (the "MOH") and became effective on June 24, 2019.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;text-indent:0pt;margin-left:92.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following the IMC Restructuring of the Licensed Entities, the Company does not currently hold, directly or indirectly, any licenses to engage in the cultivation, production, processing, distribution or sale of medical cannabis in Israel.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;text-indent:0pt;margin-left:92.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent to the IMC Restructuring, according to accounting criteria in IFRS 10, the Company is still viewed as effectively exercising control over Focus, and therefore, the accounts of Focus continue to be consolidated with those of the Company.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:14.15pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 8, 2021, the Company announced that Focus signed a multi-year supply agreement with GTEC Holdings Ltd. (&#8220;GTEC&#8221;), a Canadian licensed producer of handcrafted and high-quality cannabis (the &#8220;GTEC Agreement&#8221;). According to the GTEC Agreement, Focus will import GTEC&#8217;s high-THC medical cannabis inflorescence into Israel to be sold under the IMC brand. With the arrival of these commercial shipments, the Company will launch a new category of imported premium indoor medical cannabis products under its well-established brand.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:92.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The first import of the Canadian-grown high-THC strains from GTEC&#8217;s subsidiary, Grey Bruce Farms Incorporated (&#8220;GBF&#8221;), arrived during September 2021. According to the GTEC Agreement, Focus will purchase a minimum quantity of 500kg of high-THC medical cannabis inflorescence from GBF and will be the exclusive recipient of GTEC cannabis products in the Israeli market for a period of 12 months from the date that the first shipment of GTEC products arrives in Israel (the &#8220;Exclusive Term&#8221;). The Exclusive Term can be extended under the terms of the GTEC Agreement by an additional 6 months.</span></span></div>
                </div>
              </div>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>14</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="text-align:justify;line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 1:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">GENERAL </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">3.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 12, 2021, the Company filed a preliminary short form base shelf prospectus (the &#8220;Preliminary Shelf Prospectus&#8221;) with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada (the &#8220;Securities Commissions&#8221;), and on March 15, 2021, the Company filed a corresponding shelf registration statement on Form F-10 with the SEC, under the Multijurisdictional Disclosure System (&#8220;MJDS&#8221;) established between Canada and the United States.</div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:96pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 31, 2021, in connection with the Preliminary Shelf Prospectus, the Company filed a final short form base shelf prospectus (the &#8220;Final Shelf Prospectus&#8221;) with the Securities Commissions and a corresponding shelf registration statement on Form F-10 (the &#8220;Registration Statement&#8221;) with the SEC. The Final Shelf Prospectus and the Registration Statement enable the Company to offer up to US$<ix:nonFraction id="Fxbrl_20220307194534506" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20210301to20210331_imcEquityTransactionAxis_imcPreliminaryShelfProspectusMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">250</ix:nonFraction> million (or its equivalent in other currencies) of Common Shares, warrants, subscription receipts, debt securities, units (collectively, the &#8220;Qualified Securities&#8221;), or any combination of such Qualified Securities from time to time, during the 25-month period that the Final Shelf Prospectus is effective. The specific terms of any offering under the Final Shelf Prospectus and the intended use of the net proceeds will be established in a prospectus supplement, which will be filed with the Securities Commissions and the SEC in connection with any such offering.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">4.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 12, 2021, Adjupharm entered into a supply agreement with Northern Green Canada Inc. (&#8220;NGC&#8221;) (the &#8220;NGC Supply Agreement&#8221;). Under the terms of the NGC Supply Agreement, NGC will provide Adjupharm with three new strains of medical cannabis products, to be distributed under the IMC brand to German pharmacies pursuant to Adjupharm&#8217;s distribution agreements with its German distribution partners. Shipments from NGC commenced in October 2021.</div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">5.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 18, 2021, the Company acquired all of Trichome Financial Corp.&#8217;s ("Trichome" or "TFC") issued and outstanding shares (the &#8220;Trichome Shares&#8221;). Pursuant to the terms of the Trichome Transaction, former holders of Trichome Shares and former holders of Trichome convertible instruments (the &#8220;Trichome Securityholders&#8221;) received <ix:nonFraction id="Fxbrl_20220307194135003" name="imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree" contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Share" scale="0" decimals="5" format="ixt:numdotdecimal">0.24525</ix:nonFraction> of a Common Share for each Trichome Share held and each in-the-money convertible instrument of Trichome. As a result of the Trichome Transaction, a total of <ix:nonFraction id="Fxbrl_20220307194151562" name="ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable" contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Shares" decimals="INF" format="ixt:numdotdecimal">10,104,901</ix:nonFraction> Common Shares were issued to the Trichome Securityholders. In addition, <ix:nonFraction id="Fxbrl_20220307195240886" name="ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Shares" decimals="INF" format="ixt:numdotdecimal">100,916</ix:nonFraction> Common Shares were issued to financial advisors for advisory fees in connection with the Trichome Transaction.</div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">6.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 29, 2021, Adjupharm entered into a supply agreement with MediPharm Labs Corp. (&#8220;MediPharm Labs&#8221;) for certain medical cannabis extract products to be delivered by MediPharm Labs over an initial two-year term with an automatic two-year extension period. Shipments from MediPharm Labs commenced in October 2021.</div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">7.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 30, 2021, Zur Rose Pharma GmbH (&#8220;Zur Rose&#8221;) and the Company entered into a termination settlement agreement in connection with the sales agreements announced in July 2020 according to Zur Rose's request, and under which Adjupharm received a termination fee. According to the termination agreement, no inventory will be transferred from Zur Rose to Adjupharm or vice versa.</div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>15</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="text-align:justify;line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 1:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">GENERAL </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="text-align:justify;margin-left:74.7pt;line-height:1.25">&#160;</div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During March 2021, Adjupharm entered into two supply agreements with supply partners in China, under which Adjupharm bought COVID-19 rapid antigen test kits. Concurrently, Adjupharm entered into several resale agreements with reseller partners in Germany, under which Adjupharm sold the COVID-19 antigen test kits to pharmacies and retailers in Germany.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="text-align:justify;margin-left:74.7pt;line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>
                            <div>
                              <div>
                                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 30, 2021, the Company announced that its wholly-owned Israeli subsidiary, IMC Holdings, signed a definitive agreement (the &#8220;Panaxia Agreement&#8221;) with Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd. (collectively &#8220;Panaxia&#8221;) (the &#8220;Panaxia Transaction&#8221;). Pursuant to the Panaxia Agreement, IMC Holdings will acquire Panaxia&#8217;s trading house license and in-house pharmacy activities, certain distribution assets and an option to purchase a pharmacy with licenses to sell medical cannabis to patients, for an aggregate purchase price of NIS <ix:nonFraction id="Fxbrl_20220307200014261" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="NIS" scale="6" decimals="-5" format="ixt:numdotdecimal">18.7</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20220307200046653" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,000</ix:nonFraction>), comprised of NIS <ix:nonFraction id="Fxbrl_20220307200107493" name="ifrs-full:CashTransferred" contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="NIS" scale="6" decimals="-5" format="ixt:numdotdecimal">7.6</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20220307200134508" name="ifrs-full:CashTransferred" contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,800</ix:nonFraction>) in cash and NIS <ix:nonFraction id="Fxbrl_20220307200206030" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="NIS" scale="6" decimals="-5" format="ixt:numdotdecimal">11.1</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20220307200228576" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,200</ix:nonFraction>) in Common Shares (the &#8220;Panaxia Consideration Shares&#8221;). As of December 31, 2021, all of the cash consideration was paid and all of the common shares consideration were issued.</span></span></div>
                              </div>
                              <div style="text-align:justify">&#160;</div>
                              <div>
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia Transaction will be finalized in two stages, with an option of a third stage. Upon the initial closing, on May 30, 2021, all online-related activities and intellectual property will be transferred to IMC Holdings. The second stage requires that Panaxia will transfer its IMC-GDP license, which allows the holder to store and distribute medical cannabis in Israel, to IMC Holdings or its subsidiary (the &#8220;Panaxia IMC-GDP License&#8221;). The second stage was subject to MOH approval, which granted its approval subsequent to December 31, 2021, on February 15, 2022. Panaxia Transaction includes an option to acquire Panaxia&#8217;s pharmacy (the &#8220;Panaxia Option&#8221;), including licenses to dispense and sell products to cannabis patients (the &#8220;Panaxia Pharmacy Licenses&#8221;) for additional payment in the amount equal to the medical cannabis inventory of the pharmacy at the time of exercise. The option was exercised on February 1, 2022.</span></span></div>
                                </div>
                              </div>
                            </div>
                          </div>
                          <div>
                            <div style="line-height:1.25">&#160;</div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Panaxia Agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of all of the abovementioned acquired assets and activities and the rights to obtain all economic benefits from those assets and activities. Accordingly, the Company has concluded that it exercises control over the acquired assets and activities as of the date of the definitive agreement, which is the date from which the assets are included in these consolidated financial statements.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 9, 2021, the Company acquired all the issued and outstanding shares of MYM Nutraceuticals Inc. and closed the MYM transaction (the &#8220;MYM Transaction&#8220;). The Company acquired MYM's licensed producer subsidiary Highland Grow Inc., pursuant to a plan of arrangement to be completed under the Business Corporations Act in British Columbia. MYM operates two licensed, craft cultivation facilities in Canada; SublimeCulture Inc. in Laval, Quebec, and Highland Grow Inc., in Antigonish, Nova Scotia. MYM&#8217;s flagship brand, Highland, is an ultra-premium brand sold in most provinces throughout Canada. Under the terms of the MYM Transaction, the shareholders of MYM will receive <ix:nonFraction id="Fxbrl_20220307200834899" name="imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree" contextRef="C_20210701to20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="Share" scale="0" decimals="3" format="ixt:numdotdecimal">0.022</ix:nonFraction> Common Shares of IMCC for each common share of MYM. As a result of the MYM transaction, a total of <ix:nonFraction id="Fxbrl_20220307200817040" name="ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable" contextRef="C_20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="Shares" decimals="INF" format="ixt:numdotdecimal">10,073,437</ix:nonFraction> Common shares were issued to the MYM former shareholders (including 49,802 Common Shares issued to a financial advisor of MYM).</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>16</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 1:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">GENERAL </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>
                            <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 28, 2021, IMC Holdings entered into a definitive agreement to acquire all of the issued and outstanding share of R.A. Yarok Pharm Ltd., Rosen High Way Ltd. and High Way Shinua Ltd. (collectively "Pharm Yarok Group"). The aggregate consideration for the Pharm Yarok Group acquisition is NIS <ix:nonFraction id="Fxbrl_20220307201725524" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">11,900</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307201758765" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,600</ix:nonFraction>), of which NIS <ix:nonFraction id="Fxbrl_20220307201821101" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,500</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307202056453" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,300</ix:nonFraction>) shall be in the form of issuance of Common Shares of the Company at closing to the former shareholders. The closing of the Pharm Yarok Group acquisition is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022. As of December 31, 2021, the Company has not transferred the Common Share consideration. Pharm Yarok Group is a leading medical cannabis pharmacy and trading company located in central Israel, Rosen High Way, a trade and distribution center providing medical cannabis storage, distribution services and logistics solutions for cannabis companies and pharmacies in Israel and High Way Shinua, an applicant for a medical cannabis transportation license from the IMCA, the receipt of which would permit High Way Shinua to transport large quantities of medical cannabis to and from Pharm Yarok&#8217;s pharmacy and Rosen High Way&#8217;s distribution center and to and from third parties in the medical cannabis sector, including medical cannabis growing facilities, pharmacies, manufacturers and distribution centers across Israel.</span></span></div>
                          </div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of the Pharm Yarok Group and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over the Pharm Yarok Group as of the date of the definitive agreement, which is the date from which the accounts of the Pharm Yarok Group are included in these consolidated financial statements.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 16, 2021, IMC Holdings signed a definitive agreement to acquire <ix:nonFraction id="Fxbrl_20220307202117552" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">51</ix:nonFraction>% of the outstanding ordinary shares of Revoly Trading and Marketing Ltd. ("Vironna") for a total consideration of NIS <ix:nonFraction id="Fxbrl_20220307202222452" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">8,500</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307202242557" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,300</ix:nonFraction>), of which NIS <ix:nonFraction id="Fxbrl_20220307202311207" name="ifrs-full:CashTransferred" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,000</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307202330181" name="ifrs-full:CashTransferred" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,950</ix:nonFraction>) in cash and NIS <ix:nonFraction id="Fxbrl_20220307202357538" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,500</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307202352263" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,350</ix:nonFraction>) is in Common Shares of the Company to be issued at closing of Vironna transaction. The closing is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022. As of December 31, 2021, the Company paid a consideration amounted to NIS <ix:nonFraction id="Fxbrl_20220331212128675" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,750</ix:nonFraction> (approximately <ix:nonFraction id="Fxbrl_20220331212312579" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,400</ix:nonFraction>) to the former shareholders of Virrona. Vironna is a leading pharmacy licensed to dispense and sell medical cannabis to licensed medical cannabis patients, located in central Israel.</span></span></div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021 the Company paid a consideration amounted to NIS <ix:nonFraction id="Fxbrl_20220330115934890" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,750</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330120001545" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,400</ix:nonFraction>) to the former shareholders of Vironna.</span></span></div>
                          </div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of Vironna and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over Vironna as of the date of the definitive agreement, which is the date from which the accounts of Vironna are included in these consolidated financial statements.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 1, 2021, IMC Holdings signed a definitive agreement to acquire <ix:nonFraction id="Fxbrl_20220329210049470" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">51</ix:nonFraction>% of the rights in Oranim Pharm, one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area, by acquiring <ix:nonFraction id="Fxbrl_20220329212025165" name="imc:PercentageOfOutstandingSharesAcquired" contextRef="C_20211101to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">51.3</ix:nonFraction>% of the outstanding shares of Oranim Plus, which holds <ix:nonFraction id="Fxbrl_20220329212039013" name="imc:PercentageOfRightsHold" contextRef="C_20211101to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">99.5</ix:nonFraction>% of the rights in Oranim Pharm (the &#8220;Oranim Transaction&#8221;).</span></span></div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Oranim Transaction closed on March 28, 2022, upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS <ix:nonFraction id="Fxbrl_20220330051544769" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">11,940</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330051718080" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,900</ix:nonFraction>), consisting of NIS <ix:nonFraction id="Fxbrl_20220330052411078" name="ifrs-full:CashTransferred" contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,202</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330052442122" name="ifrs-full:CashTransferred" contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,104</ix:nonFraction>) paid in cash upon signing, NIS <ix:nonFraction id="Fxbrl_20220330052520089" name="ifrs-full:CashTransferred" contextRef="C_20230331_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,202</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330052537340" name="ifrs-full:CashTransferred" contextRef="C_20230331_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,104</ix:nonFraction>) which will be paid in cash on the first quarter of 2023 and NIS <ix:nonFraction id="Fxbrl_20220330052615545" name="ifrs-full:CashTransferred" contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">1,536</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330052633479" name="ifrs-full:CashTransferred" contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">630</ix:nonFraction>) paid in <ix:nonFraction id="Fxbrl_20220330052707919" name="imc:IssuanceOfCommonShares" contextRef="C_20220301to20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">251,001</ix:nonFraction> Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#8217;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.</span></span></div>
                              <div style="line-height:1.25">&#160;</div>
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of Oranim and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over Oranim as of the date of the definitive agreement, which is the date from which the accounts of Oranim are included in these consolidated financial statements.</span></span></div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>17</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 1:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">GENERAL </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Approval of consolidated financial statements:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements of the Group were authorized for issue by the board of directors on March 31, 2022.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Definitions:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In these financial statements:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:95pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;float:left">

                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company, or IMCC</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM Cannabis Corp.</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM Cannabis Corp., its Subsidiaries and Focus</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Companies that are controlled by the Company (as defined in IFRS 10) and whose accounts are consolidated with those of the Company</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25;clear:both">&#160;</div>
                  <div style="margin-left:95pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;float:left">

                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAD or $</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollar</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NIS</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New Israeli Shekel</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">USD or US$</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States Dollar</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EURO or &#8364;</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25;clear:both">&#160;</div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>18</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
    </div>
  </div>
  <div>&#160;</div>

      <div>
        <ix:nonNumeric id="Fxbrl_20220329180805473" name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" contextRef="C_20210101to20211231" escape="true">
          <div>
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>NOTE 2:-</span></span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>SIGNIFICANT ACCOUNTING POLICIES</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
            <div>
              <div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following accounting policies have been applied consistently in the financial statements for all periods presented, unless otherwise stated.</span></span></span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <ix:nonNumeric id="Fxbrl_20220329175807659" name="imc:DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Basis of presentation:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB").</span></span></span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Group's financial statements have been prepared on a cost basis, except for:</span></span></span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Financial instruments which are presented at fair value through profit or loss.</span></span></span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Biological assets which are presented at fair value less cost to sell up to the point of harvest.</span></span></span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Group has elected to present the profit or loss items using the function of expense method.</span></span></span></span></span></span>
                    </div>
                  </div>
                </ix:nonNumeric>
                <p style="margin:0pt">&#160;</p>
                <ix:nonNumeric id="Fxbrl_20220329175822403" name="imc:DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Consolidated financial statements:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The consolidated financial statements comprise the financial statements of companies that are controlled by the Company (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Potential voting rights are considered when assessing whether an entity has control. The consolidation of the financial statements commences on the date on which control is obtained and ends when such control ceases.</span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>19</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, and 2020, major subsidiaries over which the Company has control, directly or indirectly, include<span style="font-weight:bold">:</span></span></span></span></span>
                    </div>
                    <ix:nonNumeric id="Fxbrl_20220329175848956" name="ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" contextRef="C_20210101to20211231" escape="true">
                      <div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="1" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left">

                              <tr>
                                <td rowspan="2" style="width:67.71%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subsidiaries</span></span></span></span></div>
                                </td>
                                <td colspan="3" style="width:32.29%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Percentage ownership</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:14.18%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2020</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C. Holdings Ltd (&#8221;IMC&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001615262" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001631987" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Focus Medical Herbs Ltd. ("Focus") *)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001641289" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcFocusMedicalHerbsLtdMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">74</ix:nonFraction>%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001652437" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcFocusMedicalHerbsLtdMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">74</ix:nonFraction>%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C Farms Israel Ltd. ("IMC Farms")</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001659914" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCFarmsIsraelLtdPointMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001713337" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCFarmsIsraelLtdPointMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C Ventures Ltd. ("IMC Ventures")</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001722758" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCVenturesLtdPointMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">75</ix:nonFraction>%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001736856" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCVenturesLtdPointMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">75</ix:nonFraction>%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C - International Medical Cannabis Portugal Unipessoal Lda</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001743430" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001754308" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Adjupharm GmbH (&#8220;Adjupharm&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001801659" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">90.02</ix:nonFraction>%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428001814769" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">92.5</ix:nonFraction>%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>R.A. Yarok Pharm Ltd. (&#8220;Pharm Yarok&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032351336" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRayarokPharmLtdMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Rosen High Way Ltd. (&#8220;Rosen High Way&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032435671" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRosenHighWayLtdMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>High Way Shinua Ltd. (&#8220;HW Shinua&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032441119" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcHighWayShinuaLtdMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revoly Trading and Marketing Ltd. (&#8220;Vironna&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032443758" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRevolyTradingAndMarketingLtdMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">51</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oranim Plus Pharm LTD.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032446574" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcOranimPlusPharmLtdMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">51.3</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oranim Pharm</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220329174636210" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcOranimPharmMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">51</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Corp. (&#8220;Trichome&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032451591" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Cannabis GP Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032454600" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCannabisGpIncMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Cannabis Manager Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032457516" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCannabisManagerIncMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Asset Funding Corp.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032500270" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeAssetFundingCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032503012" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeJwcAcquisitionCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Retail Corp.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032505302" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeRetailCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MYM Nutraceuticals Inc. (&#8220;MYM&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032509141" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcMymNutraceuticalsIncMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SublimeCulture Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032511796" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcSublimecultureIncMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CannaCanada Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032514444" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcCannacanadaIncMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MYM International Brands Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032516853" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcMymInternationalBrandsIncMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Highland Grow Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305032520965" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcHighlandGrowIncMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-width:2px;border-style:solid;border-color:rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25;clear:both">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>*) <ix:footnote id="FN20220329225335286" xml:lang="en-US">See also Note 1b(1)</ix:footnote></span></span></span></span></div>
                      </div>
                    </ix:nonNumeric>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The financial statements of the Company and of the subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all companies in the Group. Significant intragroup balances and transactions and gains or losses resulting from intragroup transactions are eliminated in full in the consolidated financial statements.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-controlling interests in subsidiaries represent the equity in subsidiaries not attributable, directly or indirectly, to a parent. Non-controlling interests are presented in equity separately from the equity attributable to the equity holders of the Company. Profit or loss and components of other comprehensive income are attributed to the Company and to non-controlling interests. Losses are attributed to non-controlling interests even if they result in a negative balance of non-controlling interests in the consolidated statement of financial position.</span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>20</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                      <div style="line-height:1.25">
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The disposal of a subsidiary that does not result in a loss of control is recognized as a change in equity. Upon the disposal of a subsidiary resulting in loss of control, the Company:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the subsidiary's assets (including goodwill) and liabilities.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the carrying amount of non-controlling interests.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the adjustments arising from translating financial statements carried to equity.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes the fair value of the consideration received.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes the fair value of any remaining investment.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Reclassifies the components previously recognized in other comprehensive income (loss) on the same basis as would be required if the subsidiary had directly disposed of the related assets or liabilities.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes any resulting difference (surplus or deficit) as gain or loss.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329175911648" name="ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Business combinations and goodwill:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Business combinations are accounted for by applying the acquisition method. The cost of the acquisition is measured at the fair value of the consideration transferred on the acquisition date with the addition of non-controlling interests in the acquiree. In each business combination, the Company chooses whether to measure the non-controlling interests in the acquiree based on their fair value on the acquisition date or at their proportionate share in the fair value of the acquiree's net identifiable assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Direct acquisition costs are carried to the statement of profit or loss as incurred.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In a business combination achieved in stages, equity interests in the acquiree that had been held by the acquirer prior to obtaining control are measured at the acquisition date fair value while recognizing a gain or loss resulting from the revaluation of the prior investment on the date of achieving control.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Contingent consideration is recognized at fair value on the acquisition date and classified as a financial asset or liability in accordance with IFRS 9. Subsequent changes in the fair value of the contingent consideration are recognized in profit or loss. If the contingent consideration is classified as an equity instrument, it is measured at fair value on the acquisition date without subsequent remeasurement.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill is initially measured at cost which represents the excess of the acquisition consideration and the amount of non-controlling interests over the net identifiable assets acquired and liabilities assumed. If the resulting amount is negative, the acquirer recognizes the resulting gain on the acquisition date.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div><ix:exclude>
                  <div style="line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>21</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <div style="line-height:1.25">
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </ix:exclude></div>
                <div>
                  <p style="margin:0pt">&#160;</p>
                  <ix:nonNumeric id="Fxbrl_20220329175927408" name="ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" contextRef="C_20210101to20211231" escape="true">
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Functional currency, presentation currency and foreign currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Functional currency and presentation currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The functional currency of the Company is the Canadian dollar ("CAD"). The Group determines the functional currency of each Group entity.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Assets, including fair value adjustments upon acquisition, and liabilities of an investee which is a foreign operation, and of each Group entity for which the functional currency is not the presentation currency are translated at the closing rate at each reporting date. Profit or loss items are translated at average exchange rates for all periods presented. The resulting translation differences are recognized in other comprehensive income (loss).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Upon the full or partial disposal of a foreign operation resulting in loss of control in the foreign operation, the cumulative gain (loss) from the foreign operation which had been recognized in other comprehensive income is transferred to profit or loss. Upon the partial disposal of a foreign operation which results in the retention of control in the subsidiary, the relative portion of the amount recognized in other comprehensive income is reattributed to non-controlling interests.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Transactions, assets and liabilities in foreign currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Transactions denominated in foreign currency are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at each reporting date into the functional currency at the exchange rate at that date. Exchange rate differences, other than those capitalized to qualifying assets or accounted for as hedging transactions in equity, are recognized in profit or loss.</span></span></span></span></div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <p style="margin:0pt">&#160;</p>
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>22</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="text-align:justify;line-height:1.25;font-weight:bold">
                            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                                <tr>
                                  <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                                  <td style="width:auto;vertical-align:top;text-align:justify">
                                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                                  </td>
                                </tr>

                            </table>
                          </div>
                        </div>
                      </div>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-monetary assets and liabilities denominated in foreign currency and measured at cost are translated at the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currency and measured at fair value are translated into the functional currency using the exchange rate prevailing at the date when the fair value was determined.</span></span></span></span>
                    </div>
                  </ix:nonNumeric>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329175940657" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash equivalents:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash equivalents are considered as highly liquid investments, including unrestricted short-term bank deposits with an original maturity of three months or less from the date of investment or with a maturity of more than three months, but which are redeemable on demand without penalty and which form part of the Group's cash management.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329175952040" name="imc:DescriptionOfAccountingPolicyForShortTermDepositsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>f.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term deposits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term bank deposits are deposits with an original maturity of more than three months from the date of investment and which do not meet the definition of cash equivalents. The deposits are presented according to their terms of deposit.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180045498" name="ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt">&#160;</td>
                            <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>g.</span></span></span></span></td>
                            <td style="width:auto;vertical-align:top;text-align:justify">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement:</span></span></span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></span></span></span></div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></span></span></span></div>
                      <div><ix:exclude>
                        <div style="line-height:1.25">
                          <p style="margin:0pt">&#160;</p>
                          <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>23</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                          <p style="margin:0pt">&#160;</p>
                        </div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </ix:exclude></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>All assets and liabilities measured at fair value or for which fair value is disclosed are categorized into levels within the fair value hierarchy based on the lowest level input that is significant to the entire fair value measurement:</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="margin-left:95pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left">

                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 1</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">&#160;</td>
                              <td style="width:3.58%;vertical-align:top">&#160;</td>
                              <td style="width:82.14%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 2</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>inputs other than quoted prices included within Level 1 that are observable directly or indirectly.</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">&#160;</td>
                              <td style="width:3.58%;vertical-align:top">&#160;</td>
                              <td style="width:82.14%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 3</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25;clear:both">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180104000" name="ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>h.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Biological assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s biological assets consist of cannabis plants.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2, Inventories. These costs include the direct cost of planting and growing materials as well as other indirect costs such as utilities and supplies used in the cultivation process.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Indirect labor for individuals involved in the cultivation and quality control process is also included, as well as depreciation on growing equipment and overhead costs such as rent to the extent it is associated with the growing space. All direct and indirect costs of biological assets are capitalized as they are incurred, and they are all subsequently recorded within the line item cost of revenues on the Group&#8217;s statements of profit or loss and other comprehensive income in the period that the related product is sold.</span></span></span></span></div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <p style="margin:0pt">&#160;</p>
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>24</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventories after harvest. The fair value is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred (e.g., post-harvest costs). The net unrealized gains or losses arising from changes in fair value less cost to sell during the period are included in the gross profit for the related period and are recorded in a separate line on the face of the Group&#8217;s statements of profit or loss and other comprehensive income.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Determination of the fair values of the biological assets requires the Group to make assumptions about how market participants assign fair values to these assets. These assumptions primarily relate to the level of effort required to bring the cannabis up to the point of harvest, costs to convert the harvested cannabis to finished goods, sales price, risk of loss, expected future yields from the cannabis plants and estimating values during the growth cycle.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group accretes fair value on a straight-line basis according to stage of growth (e.g., a cannabis plant that is 50% through its growing cycle would be ascribed approximately 50% of its harvest date expected fair value, subject to wastage adjustments).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The fair value of biological assets is categorized within Level 3 of the fair value hierarchy. For the inputs and assumptions used in determining the fair value of biological assets, see Note 8.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s estimates are, by their nature, subject to change and differences from the anticipated yield will be reflected in the gain or loss on biological assets in future periods.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180123766" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>i.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories are measured at the lower of cost and net realizable value. The cost of inventories comprises costs of purchase and costs incurred in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and estimated costs necessary to make the sale. The Group reviews inventory for obsolete, redundant and slow-moving goods and any such inventory are written-down to net realizable value.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories of purchased finished goods and packing materials are initially valued at cost and subsequently at the lower of cost and net realizable value.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The direct and indirect costs of inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labor and depreciation expense on equipment involved in packaging, labeling and inspection.</span></span></span></span></div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <p style="margin:0pt">&#160;</p>
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>25</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">
                            <div>
                              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                                  <tr>
                                    <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                                    <td style="width:auto;vertical-align:top;text-align:justify">
                                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                                    </td>
                                  </tr>

                              </table>
                            </div>
                          </div>
                        </div>
                      </div>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of revenues on the Group&#8217;s statements of profit or loss and other comprehensive income at the time cannabis is sold, except for realized fair value amounts included in inventory sold which are recorded as a separate line item on the face of the statements of profit or loss and other comprehensive income.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has otherwise been damaged.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180143529" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>j.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property, plant and equipment:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation, accumulated impairment losses and excluding day-to-day servicing expenses. Cost includes spare parts and auxiliary equipment that are used in connection with plant and equipment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is depreciated separately using the component method.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values which are determined through the exercise of judgement and calculated on a straight-line basis over the useful lives of the assets at annual rates as follows:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <ix:nonNumeric id="Fxbrl_20220329180155278" name="imc:DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory" contextRef="C_20210101to20211231" escape="true">
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr>
                                <td style="width:49.99%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Mainly %</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Buildings</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428114838689" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428114857761" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Greenhouse production equipment</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220329173228210" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">7</ix:nonFraction> - <ix:nonFraction id="Fxbrl_20210428115020727" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428115024767" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Greenhouse structure</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428115125656" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">12.5</ix:nonFraction></span></span></td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428115209711" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">12.5</ix:nonFraction></span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Motor vehicles</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305025214234" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">15</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20220305025221411" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428115232296" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Computer, software and equipment</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20210428115240783" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">20</ix:nonFraction> - <ix:nonFraction id="Fxbrl_20210428115300225" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">50</ix:nonFraction></span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428115304297" name="ifrs-full:DepreciationRatePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leasehold improvements</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>See below</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>See below</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>
                      </ix:nonNumeric>
                    </div>
                    <div style="line-height:1.25;clear:both">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leasehold improvements are depreciated on a straight-line basis over the shorter of the lease term and the useful life of the improvement.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate. Depreciation of an asset ceases at the earlier of the date that the asset is classified as held for sale and the date that the asset is derecognized.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div><ix:exclude>
                  <div style="line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>26</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180214735" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>k.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Impairment of non-financial assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group evaluates the need to record an impairment of non-financial assets whenever events or changes in circumstances indicate that the carrying amount is not recoverable. If the carrying amount of non-financial assets exceeds their recoverable amount, the assets are reduced to their recoverable amount. The recoverable amount is the higher of fair value less costs of sale and value in use. In measuring value in use, the expected future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the asset. The recoverable amount of an asset that does not generate independent cash flows is determined for the cash-generating unit to which the asset belongs. Impairment losses are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>An impairment loss of an asset, other than goodwill, is reversed only if there have been changes in the estimates used to determine the asset's recoverable amount since the last impairment loss was recognized. Reversal of an impairment loss, as above, shall not be increased above the lower of the carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized for the asset in prior years and its recoverable amount. The reversal of impairment loss of an asset presented at cost is recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following criteria are applied in assessing impairment of these specific assets:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill in respect of subsidiaries:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company reviews goodwill for impairment once a year, on December 31, or more frequently if events or changes in circumstances indicate that there is an impairment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit (or group of cash-generating units) to which the goodwill has been allocated. The Company identified the operations and Israel, Canada and Europe as three separate cash-generating units.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>An impairment loss is recognized if the recoverable amount of the cash-generating unit (or group of cash-generating units) to which goodwill has been allocated is less than the carrying amount of the cash-generating unit (or group of cash-generating units). Any impairment loss is allocated first to goodwill. Impairment losses recognized for goodwill cannot be reversed in subsequent periods. During the year ended December 31, 2021, the Company recorded goodwill impairment in the amount of $<ix:nonFraction id="Fxbrl_20220329175750854" name="ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">275</ix:nonFraction> with respect to the cash generating unit in Germany.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div><ix:exclude>
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>27</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                  <div style="line-height:1.25">
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </ix:exclude></div>
                <div>
                  <p style="margin:0pt">&#160;</p>
                  <ix:nonNumeric id="Fxbrl_20220329180239966" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" contextRef="C_20210101to20211231" escape="true">
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>l.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue recognition:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from contracts with customers is recognized when the control over the goods or services is transferred to the customer. The transaction price is the amount of the consideration that is expected to be received based on the contract terms, excluding amounts collected on behalf of third parties (such as taxes).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In determining the amount of revenue from contracts with customers, the Group evaluates whether it is a principal or an agent in the arrangement. The Group is a principal when the Group controls the promised goods or services before transferring&#160;</span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>them to the customer. In these circumstances, the Group recognizes revenue for the gross amount of the consideration. When the Group is an agent, it recognizes revenue for the net amount of the consideration, after deducting the amount due to the principal.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from the sale of goods:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from the sale of cannabis products is generally recognized at a point in time when control over the goods have been transferred to the customer. Payment is typically due prior to or upon delivery and revenue is recognized upon the satisfaction of the performance obligation. The Group satisfies its performance obligation and transfers control upon delivery and acceptance by the customer.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Variable consideration:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group determines the transaction price separately for each contract with a customer. When exercising this judgment, the Group evaluates the effect of each variable amount in the contract, taking into consideration discounts, penalties, variations, claims, and non-cash consideration. In determining the effect of the variable consideration, the Group normally uses the "most likely amount" method described in the Standard. Pursuant to this method, the amount of the consideration is determined as the single most likely amount in the range of possible consideration amounts in the contract. According to the Standard, variable consideration is included in the transaction price only to the extent that it is highly probable that a significant reversal in the amount of revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span></span></span></span></div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <p style="margin:0pt">&#160;</p>
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>28</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                      <div style="line-height:1.25">
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </ix:exclude></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Bill-and-hold arrangements:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Due to strict regulations of storage and handling large quantities of cannabis products, the Group's customer may request the Group to retain physical possession of a sold product until it is delivered to the customer at a future point in time. Revenue from bill-and-hold sales is recognized before the product is physically delivered to the customer when all of the following criteria are met:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a) The reason for the bill-and-hold arrangement is substantive (for example, the customer has requested the arrangement);</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b)</span></span><span> </span><span><span>The product is identified separately as belonging to the customer;</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c)</span></span><span> </span><span><span>The product currently is ready for physical delivery to the customer;</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d)</span></span><span> </span><span><span>The Group does not have the ability to use the product by selling it or delivering it to another customer.</span></span></span></span></div>
                  </ix:nonNumeric>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180258174" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>m.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leases:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For leases in which the Group is the lessee, the Group recognizes on the commencement date of the lease a right-of-use asset and a lease liability, excluding leases whose term is up to 12 months and leases for which the underlying asset is of low value. For these excluded leases, the Group has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Group has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the lease liability includes all unpaid lease payments discounted at the interest rate implicit in the lease, if that rate can be readily determined, or otherwise using the Group's incremental borrowing rate. After the commencement date, the Group measures the lease liability using the effective interest rate method.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the right-of-use asset is recognized in an amount equal to the lease liability plus lease payments already made on or before the commencement date and initial direct costs incurred. The right-of-use asset is measured applying the cost model and amortized over the shorter of its useful life and the lease term. The periods of amortization are: Land and buildings &#8211; <ix:nonNumeric id="Fxbrl_20210428003310749" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" format="ixt-sec:duryear">5</ix:nonNumeric>-<ix:nonNumeric id="Fxbrl_20220329174340454" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" format="ixt-sec:duryear">12</ix:nonNumeric> years; Motor vehicles &#8211; <ix:nonNumeric id="Fxbrl_20210428003342464" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" format="ixt-sec:duryear">3</ix:nonNumeric> years.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div><ix:exclude>
                        <div style="line-height:1.25">
                          <p style="margin:0pt">&#160;</p>
                          <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>29</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                          <p style="margin:0pt">&#160;</p>
                        </div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </ix:exclude></div>
                    </div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Variable lease payments that depend on an index:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the Group uses the index rate prevailing on the commencement date to calculate the future lease payments.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For leases in which the Group is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the right-of-use asset, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease extension and termination options:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In the event of any change in the expected exercise of the lease extension option or in the expected non-exercise of the lease termination option, the Group remeasures the lease liability based on the revised lease term using a revised discount rate as of the date of the change in expectations. The total change is recognized in the carrying amount of the right-of-use asset until it is reduced to zero, and any further reductions are recognized in profit or loss.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <p style="margin:0pt">&#160;</p>
                <ix:nonNumeric id="Fxbrl_20220329180321864" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>n.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research and development expenditures:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research expenditures are recognized in profit or loss when incurred.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">
                  <div><ix:exclude>
                    <div style="line-height:1.25">
                      <p style="margin:0pt">&#160;</p>
                      <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>30</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </ix:exclude></div>
                </div>
                <div>
                  <p style="margin:0pt">&#160;</p>
                  <ix:nonNumeric id="Fxbrl_20220329180346271" name="ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" contextRef="C_20210101to20211231" escape="true">
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>o.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial instruments:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group apply the provisions of IFRS 9, "Financial Instruments".</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial assets are measured upon initial recognition at fair value plus transaction costs that are directly attributable to the acquisition of the financial assets, except for financial assets measured at fair value through profit or loss in respect of which transaction costs are recorded in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group classifies and measures debt instruments in the financial statements based on the following criteria:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s business model for managing financial assets; and</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The contractual cash flow terms of the financial asset.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Debt instruments are measured at amortized cost when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s business model is to hold the financial assets in order to collect their contractual cash flows, and the contractual terms of the financial assets give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. After initial recognition, the instruments in this category are measured according to their terms at amortized cost using the effective interest rate method, less any provision for impairment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Debt instruments are measured at fair value through profit or loss when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial asset which is a debt instrument does not meet the criteria for measurement at amortized cost or at fair value through other comprehensive income. After initial recognition, the financial asset is measured at fair value and gains or losses from fair value adjustments are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Equity instruments:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Investments in equity instruments do not meet the above criteria and accordingly are measured at fair value through profit or loss. Dividends from investments in equity instruments are recognized in profit or loss when the right to receive the dividends is established.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div><ix:exclude>
                        <div style="line-height:1.25">
                          <p style="margin:0pt">&#160;</p>
                          <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>31</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                          <p style="margin:0pt">&#160;</p>
                        </div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </ix:exclude></div>
                    </div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Impairment of financial assets:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group evaluates at the end of each reporting period the loss allowance for financial debt instruments measured at amortized cost. The Group has short-term financial assets, principally trade receivables, in respect of which the Group applies a simplified approach and measures the loss allowance in an amount equal to the lifetime expected credit losses. The impairment loss, if any, is recognized in profit or loss with a corresponding allowance that is offset from the carrying amount of the assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognition of financial assets:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial asset is derecognized only when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The contractual rights to the cash flows from the financial asset has expired; or</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has transferred substantially all the risks and rewards deriving from the contractual rights to receive cash flows from the financial asset or has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset; or</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has retained its contractual rights to receive cash flows from the financial asset but has assumed a contractual obligation to pay the cash flows in full without material delay to a third party.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities measured at amortized cost:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities measured at fair value through profit or loss:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>At initial recognition, the Group measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs incurred at initial recognition are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>After initial recognition, changes in fair value are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div><ix:exclude>
                        <div style="line-height:1.25">
                          <p style="margin:0pt">&#160;</p>
                          <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>32</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                          <p style="margin:0pt">&#160;</p>
                        </div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </ix:exclude></div>
                    </div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognition of financial liabilities:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial liability is derecognized only when it is extinguished, that is when the obligation specified in the contract is discharged or cancelled or expires. A financial liability is extinguished when the debtor discharges the liability by paying in cash, other financial assets, goods or services; or is legally released from the liability.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issue of a unit of securities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The issue of a unit of securities involves the allocation of the proceeds received (before issue expenses) to the securities issued in the unit based on the following order: financial derivatives and other financial instruments measured at fair value in each period. Then fair value is determined for financial liabilities that are measured at amortized cost. The proceeds allocated to equity instruments are determined to be the residual amount. Issue costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></span></span></span></div>
                  </ix:nonNumeric>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180423129" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>p.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Employee benefit liabilities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has several employee benefit plans:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term employee benefits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term employee benefits are benefits that are expected to be settled wholly before twelve months after the end of the annual reporting period in which the employees render the related services. These benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Post-employment benefits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has defined contribution plans pursuant to section 14 to the Israeli Severance Pay Law under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods. Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense when contributed concurrently with performance of the employee's services.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div><ix:exclude>
                        <div style="line-height:1.25">
                          <p style="margin:0pt">&#160;</p>
                          <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>33</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                          <p style="margin:0pt">&#160;</p>
                        </div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </ix:exclude></div>
                    </div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group also operates a defined benefit plan in respect of severance pay pursuant to the Israeli Severance Pay Law. According to the Severance Pay Law, employees are entitled to severance pay upon dismissal or retirement. The liability for termination of employment is measured using the projected unit credit method. The actuarial assumptions include expected salary increases and rates of employee turnover based on the estimated timing of payment. The amounts are presented based on discounted expected future cash flows using a discount rate determined by reference to market yields at the reporting date on high quality corporate bonds that are linked to the Consumer Price Index with a term that is consistent with the estimated term of the severance pay obligation.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In respect of its severance pay obligation to certain of its employees, the Group makes current deposits in pension funds and insurance companies (the "plan assets"). Plan assets comprise assets held by a long-term employee benefit fund or qualifying insurance policies. Plan assets are not available to the Group&#8217;s own creditors and cannot be returned directly to the Group.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The liability for employee benefits shown in the statement of financial position reflects the present value of the defined benefit obligation less the fair value of the plan assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remeasurements of the net liability are recognized in other comprehensive income in the period in which they occur.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180444112" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>q.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based payment transactions:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group's employees and service providers are entitled to remuneration in the form of equity-settled share-based payments.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Equity-settled transactions:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The cost of equity-settled transactions with employees is measured at the fair value of the equity instruments granted at grant date. The fair value is determined using an acceptable option pricing model.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As for other service providers, the cost of the transactions is measured at the fair value of the goods or services received as consideration for equity instruments granted.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The cost of equity-settled transactions is recognized in profit or loss together with a corresponding increase in equity during the period which the performance and/or service conditions are to be satisfied ending on the date on which the relevant employees become entitled to the award (the "vesting period"). The cumulative expense recognized for equity-settled transactions at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group's best estimate of the number of equity instruments that will ultimately vest.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div><ix:exclude>
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>34</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180502044" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>r.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Provisions:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A provision in accordance with IAS 37 is recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. When the Group expects part or all of the expense to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense is recognized in the statement of profit or loss net of any reimbursement.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180515843" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>s.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Taxes on income:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current or deferred taxes are recognized in profit or loss, except to the extent that they relate to items which are recognized in other comprehensive income or equity.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current taxes:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The current tax liability is measured using the tax rates and tax laws that have been enacted or substantively enacted by the reporting date as well as adjustments required in connection with the tax liability in respect of previous years.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are computed in respect of temporary differences between the carrying amounts in the financial statements and the amounts attributed for tax purposes.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are measured at the tax rate that is expected to apply when the asset is realized, or the liability is settled, based on tax laws that have been enacted or substantively enacted by the reporting date.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred tax assets are reviewed at each reporting date and reduced to the extent that it is not probable that they will be utilized. Deductible carryforward losses and temporary differences for which deferred tax assets had not been recognized are reviewed at each reporting date and a respective deferred tax asset is recognized to the extent that their utilization is probable.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are offset if there is a legally enforceable right to offset a current tax asset against a current tax liability and the deferred taxes relate to the same taxpayer and the same taxation authority.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div><ix:exclude>
                  <div style="line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>35</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 2:-</span></span></span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180531964" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>t.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Earnings per share:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Earnings per share are calculated by dividing the net income attributable to equity holders of the Group by the weighted number of Common Shares outstanding during the period.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Potential Common Shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share from continuing operations. Potential Common Shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share. The Company's share of earnings of investees is included based on its share of earnings per share of the investees multiplied by the number of shares held by the Company.</span></span></span></span></div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329180552397" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>u.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Expenditures relating to internally generated intangible assets, excluding capitalized development costs, are recognized in profit or loss when incurred.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company acquired brand with indefinite life. The Company believes that it will use the asset perpetually, with no intention of discontinuing the brand in the future. Intangible assets with indefinite useful lives are not systematically amortized and are tested for impairment annually or whenever there is an indication that the intangible asset may be impaired. The useful life of these assets is reviewed annually to determine whether their indefinite life assessment continues to be supportable. If the events and circumstances do not continue to support the assessment, the change in the useful life assessment from indefinite to finite is accounted for prospectively as a change in accounting estimate and on that date the asset is tested for impairment. Commencing from that date, the asset is amortized systematically over its useful life.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible assets with a finite useful life are amortized over their useful life and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for an intangible asset are reviewed at least at each year end.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortization is calculated on a straight-line basis over the useful life of the assets as follows:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <ix:nonNumeric id="Fxbrl_20220329180600739" name="imc:DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

                            <tr>
                              <td style="width:76.8%;vertical-align:top">&#160;</td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Years</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">&#160;</td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cultivations and processing license</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20210428001001956" name="ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">6</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20220330223227617" name="ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationships</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305030257948" name="ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">5</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20220305030251804" name="ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Brand</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220305030301699" name="ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">9</ix:nonFraction> - indefinite</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other intangibles</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20210428001115825" name="ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20210428001141104" name="ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </ix:nonNumeric>
                  </div>
                </ix:nonNumeric>
                <p style="margin:0pt">&#160;</p>
                <ix:nonNumeric id="Fxbrl_20220331163201761" name="imc:DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>v.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Government grants:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A government grant is recorded as a reduction of expenses or the cost of a related asset when there is reasonable assurance that the entity will comply with the relevant conditions and the grant will be received. When a government grant is for the purchase of an asset, the cost of the asset is reduced by the value of the grant on acquisition if all conditions for the grant are met and it is reasonably certain to be received, resulting in a reduction of depreciation expense over the useful life of the asset in the statement of profit and loss.</span></span></span></span></div>
                        </div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div>
                  <div>
                    <div style="line-height:1.25">
                      <div style="line-height:1.25">&#160;</div>
                      <ix:nonNumeric id="Fxbrl_20220331163659981" name="ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory" contextRef="C_20210101to20211231" escape="true">
                        <div>
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>w.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Treasury shares:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="margin-left:85.05pt;text-align:justify;line-height:1.25">&#160;</div>
                          <div style="margin-left:85.05pt;text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Company shares held by the Company and/or subsidiaries are recognized at cost of purchase and presented as a deduction from equity. Any gain or loss arising from a purchase, sale, issue or cancellation of treasury shares is recognized directly in equity.</span></span></span></div>
                        </div>
                      </ix:nonNumeric>
                      <div style="line-height:1.25">&#160;</div>
                    </div>
                  </div>
                </div>
                <ix:nonNumeric id="Fxbrl_20220331163640497" name="ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>x.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating segments:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                          <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker ("CODM"), who is responsible for allocating resources and assessing performance of the operating segments. The Company's Chief Executive Officer is the CODM. The Company has determined that it operates in three operating segments (see Note 23).</span></span></span></span></div>
                        </div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
        <div>
          <div>
            <div style="line-height:1.25">
              <p style="margin:0pt">&#160;</p>
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>36</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
              <p style="margin:0pt">&#160;</p>
            </div>
          </div>
        </div>
      </div>

  <div style="margin-top:0pt">
    <div>
      <div>
        <div>
          <div>
            <ix:nonNumeric id="Fxbrl_20220329181026512" name="imc:DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 3:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements:</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                </div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">a.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Judgments:</span></span></div>
                      </td>
                    </tr>

                </table>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Determining the fair value of share-based payment transactions:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The fair value of share-based payment transactions is determined upon initial recognition by an acceptable option pricing model. The inputs to the model include share price, exercise price and assumptions regarding expected volatility, expected life of share option and expected dividend yield.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Discount rate for a lease liability:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">When the Group is unable to readily determine the discount rate implicit in a lease in order to measure the lease liability, the Group uses an incremental borrowing rate. That rate represents the rate of interest that the Group would have to pay to borrow over a similar term and with similar security, the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment. When there are no financing transactions that can serve as a basis, the Group determines the incremental borrowing rate based on its credit risk, the lease term and other economic variables deriving from the lease contract's conditions and restrictions. In certain situations, the Group is assisted by an external valuation expert in determining the incremental borrowing rate.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">b.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Estimates and assumptions:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The key assumptions made in the financial statements concerning uncertainties at the reporting date and the critical estimates computed by the Group that may result in a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Assessment of going concern:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The use of the going concern basis of preparation of the financial statements. At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Group will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.</span></span></div>
                <div><ix:exclude>
                  <div style="line-height:1.25">
                    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>37</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 3:-</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS (Cont.)</span></span></div>
                        </td>
                      </tr>

                  </table>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In arriving at this determination, the Group has undertaken a thorough review of the Group&#8217;s cash flow forecast and potential liquidity risks. Cash flow projections have been prepared which show that the Group&#8217;s operations will be cash generative during the period of at least 12 months from the date of approval of the consolidated financial statements.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Biological assets and inventory:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In calculating the value of the biological assets and inventory, management is required to make several estimates, including estimating the stage of growth of the cannabis up to the point of harvest, harvesting costs, selling costs, average or expected selling prices and list prices, expected yields for the cannabis plants, and oil conversion factors. The valuation of work-in-process and finished goods also requires the estimate of conversion costs incurred, which become part of the carrying amount for the inventory. The Group must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has otherwise been damaged. See Note 9 for further information.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Legal claims:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In estimating the likelihood of legal claims filed against the Group entities, the Group management rely on the opinion of its legal counsel. These estimates are based on the legal counsel's best professional judgment, taking into account the stage of proceedings and legal precedents in respect of the different issues. Since the outcome of the claims may be determined in courts, the results could differ from these estimates.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Deferred tax assets:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Deferred tax assets are recognized for unused carryforward tax losses and deductible temporary differences to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgment is required to determine the amount of deferred tax assets that can be recognized, based upon the timing and level of future taxable profits, its source and the tax planning strategy.</span></span></div>
                <div><ix:exclude>
                  <div style="line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>38</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 3:-</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS (Cont.)</span></span></div>
                        </td>
                      </tr>

                  </table>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Impairment of goodwill:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Group reviews goodwill for impairment at least once a year. This requires management to make an estimate of the projected future cash flows from the continuing use of the cash-generating unit (or a group of cash-generating units) to which the goodwill is allocated and also to choose a suitable discount rate for those cash flows.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Determining the fair value of an unquoted financial assets and liabilities:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The fair value of unquoted financial assets in Level 3 of the fair value hierarchy is determined using valuation techniques, generally using future cash flows discounted at current rates applicable for items with similar terms and risk characteristics. Changes in estimated future cash flows and estimated discount rates, after consideration of risks such as liquidity risk, credit risk and volatility, are liable to affect the fair value of these assets.</span></span></div>
              </div>
            </ix:nonNumeric>
            <p style="margin:0pt">&#160;</p>
          </div>
        </div>
      </div>
    </div>
  </div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220329181612814" name="ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" contextRef="C_20210101to20211231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 4:-</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION</span></span></div>
                </td>
              </tr>

          </table>
          <div style="text-align:justify;line-height:1.25;font-style:italic">
            <p style="margin:0pt">&#160;</p>
            <p style="margin-left:56.7pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">a. Amendment to IAS 1, "Presentation of Financial Statements":</span></span></p>
          </div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In January 2020, the IASB issued an amendment to IAS 1, "Presentation of Financial Statements" ("the Amendment") regarding the criteria for determining the classification of liabilities as current or non-current.</span></span>
            <p style="margin:0pt">&#160;</p>
          </div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendment includes the following clarifications:</span></span></div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">What is meant by a right to defer settlement;</span></span></div>
                </td>
              </tr>

          </table>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">That a right to defer must exist at the end of the reporting period;</span></span></div>
                </td>
              </tr>

          </table>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">That classification is unaffected by the likelihood that an entity will exercise its deferral right;</span></span></div>
                </td>
              </tr>

          </table>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">That only if an embedded derivative in a convertible liability is itself an equity instrument would the terms of a liability not impact its classification.</span></span></div>
                </td>
              </tr>

          </table>
          <div><ix:exclude>
            <div style="line-height:1.25">
              <p style="margin:0pt">&#160;</p>
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>39</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
              <p style="margin:0pt">&#160;</p>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 4:-</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION (Cont.)</span></span></div>
                  </td>
                </tr>

            </table>
          </ix:exclude></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendment is effective for annual periods beginning on or after January 1, 2023 and must be applied retrospectively.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Group is evaluating the possible impact of the Amendment on its current loan agreements.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">b. Amendments to IFRS 3, "Business Combinations":</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In May 2020, the IASB issued Amendments to IFRS 3 Business Combinations &#8211; Reference to the Conceptual Framework which are intended to replace a reference to the Framework for the Preparation and Presentation of Financial Statements with a reference to the Conceptual Framework for Financial Reporting, that was issued in March 2018, without significantly changing its requirements.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The IASB added an exception to the recognition principle of IFRS 3 to avoid the issue of potential &#8216;day 2&#8217; gains or losses arising for liabilities and contingent liabilities that would be within the scope of IAS 37 Provisions, Contingent Liabilities and Contingent Assets or IFRIC 21 Levies, if incurred separately</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">According to the exception, liabilities and contingent liabilities within the scope of IAS 37 or IFRIC 21 will be recognized on the acquisition date according to the criteria in IAS 37 or IFRIC 21 and not according to the Conceptual Framework.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendments also clarify that contingent assets do not qualify for recognition at the acquisition date.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendments are effective for annual reporting periods beginning on or after January 1, 2022 and apply prospectively.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">c. Amendment to IAS 8, "Accounting Policies, Changes to Accounting Estimates and Errors":</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In February 2021, the IASB issued an amendment to IAS 8, "Accounting Policies, Changes to Accounting Estimates and Errors" ("the Amendment"), in which it introduces a new definition of "accounting estimates".</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Accounting estimates are defined as "monetary amounts in financial statements that are subject to measurement uncertainty". The Amendment clarifies the distinction between changes in accounting estimates and changes in accounting policies and the correction of errors.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendment is to be applied prospectively for annual reporting periods beginning on or after January 1, 2023 and is applicable to changes in accounting policies and changes in accounting estimates that occur on or after the start of that period. Early application is permitted.</span></span></div>
          <div><ix:exclude>
            <div style="line-height:1.25">
              <p style="margin:0pt">&#160;</p>
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>40</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
              <p style="margin:0pt">&#160;</p>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 4:-</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION (Cont.)</span></span></div>
                  </td>
                </tr>

            </table>
          </ix:exclude></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Group is evaluating the effects of the Amendment on its financial statements.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">d. Amendment to IAS 12, "Income Taxes":</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In May 2021, the IASB issued an amendment to IAS 12, "Income Taxes" ("IAS 12"), which narrows the scope of the initial recognition exception under IAS 12.15 and IAS 12.24 ("the Amendment").</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">According to the recognition guidelines of deferred tax assets and liabilities, IAS 12 excludes recognition of deferred tax assets and liabilities in respect of certain temporary differences arising from the initial recognition of certain transactions. This exception is referred to as the "initial recognition exception". The Amendment narrows the scope of the initial recognition exception and clarifies that it does not apply to the recognition of deferred tax assets and liabilities arising from transactions that are not a business combination and that give rise to equal taxable and deductible temporary differences, even if they meet the other criteria of the initial recognition exception.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.5pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendment applies for annual reporting periods beginning on or after January 1, 2023, with earlier application permitted. In relation to leases and decommissioning obligations, the Amendment is to be applied commencing from the earliest reporting period presented in the financial statements in which the Amendment is initially applied. The cumulative effect of the initial application of the Amendment should be recognized as an adjustment to the opening balance of retained earnings (or another component of equity, as appropriate) at that date.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.5pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Group estimates that the initial application of the Amendment is not expected to have a material impact on its financial statements.</span></span></div>
        </div>
      </ix:nonNumeric>
    </div>
  </div>
  <p style="margin:0pt">&#160;</p>
  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>41</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
  <p style="margin:0pt">&#160;</p>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220329194521699" name="ifrs-full:DisclosureOfBusinessCombinationsExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <div>
            <div>
              <div style="text-align:justify;line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman, Times, serif;font-size:10pt">NOTE 5:-</span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">BUSINESS COMBINATIONS</span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trichome Financial Corp.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 18, 2021, the Company acquired Trichome Financial Corp. (&#8220;Trichome&#8221; or "TFC"), a Canadian adult-use recreational cannabis producer (the "Trichome Transaction").</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Trichome Transaction was completed pursuant to the terms and subject to the conditions of arrangement agreement dated December 30, 2020 (the "Arrangement Agreement"), whereby the Company agreed to acquire all of the issued and outstanding Trichome Shares under a statutory plan of arrangement under the <span style="font-style:italic">Business Corporations Act </span>(Ontario) ("OBCA").</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the terms of the Arrangement Agreement, former holders of Trichome Shares received <ix:nonFraction id="Fxbrl_20220307110902344" name="imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree" contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">0.24525</ix:nonFraction> IMC Common Shares for each Trichome Share previously held (the &#8220;Exchange Ratio&#8221;) and former holders of Trichome in-the-money convertible instruments received a net payment of IMC Shares based on the Exchange Ratio (the &#8220;Consideration&#8221;).</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon completion of the Trichome Transaction, the total Consideration paid to former holders of Trichome Shares and in-the-money convertible instruments equaled to the issuance of <ix:nonFraction id="Fxbrl_20220307111239473" name="ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable" contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Shares" decimals="INF" format="ixt:numdotdecimal">10,104,901</ix:nonFraction> Common Shares, valued at approximately $<ix:nonFraction id="Fxbrl_20220307111656470" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">99,028</ix:nonFraction> at the market price per share of $<ix:nonFraction id="Fxbrl_20220307112139590" name="ifrs-full:WeightedAverageSharePrice2019" contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">9.8</ix:nonFraction> on the date of the acquisition. The results of operations of Trichome were consolidated in the Company's consolidated financial statements commencing on the date of acquisition.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a valuation study prepared by management with the assistance of an external valuation specialist.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon acquisition, other payables of Trichome include approximately $<ix:nonFraction id="Fxbrl_20220307113337443" name="imc:AmountOfSettlementOfWithholdingTaxLiabilities" contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,131</ix:nonFraction> to settle withholding tax liabilities to Canada Revenue Agency (&#8220;CRA&#8221;), with a corresponding indemnification asset comprised of <ix:nonFraction id="Fxbrl_20220307113737321" name="imc:NumberOfCommonSharesComprisedToCoverTaxLiabilities" contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">927,463</ix:nonFraction> IMCC&#8217;s Common Shares withheld to cover the tax liabilities (the "Purchaser Balance Shares"). In addition, in connection with the Trichome Transaction, certain directors and officers of Trichome and TJAC, one of which is currently serving as chairman of the board of directors of the Company, agreed to indemnify and hold harmless the Company, Trichome, and TJAC against <ix:nonFraction id="Fxbrl_20220307114138552" name="imc:PercentageOfWithholdingTaxLiabilities" contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">75</ix:nonFraction>% of the withholding tax liabilities to CRA. Each indemnifying director or officer agreed to indemnify for: (a) <ix:nonFraction id="Fxbrl_20220307115015063" name="imc:PercentageOfIncomeTaxLiabilityOfKeyPersonnel" contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">75</ix:nonFraction>% of such liability that is on account of such director or officer&#8217;s personal Canadian income tax liability, plus (b) jointly and severally indemnify <ix:nonFraction id="Fxbrl_20220307115543699" name="imc:PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">75</ix:nonFraction>% of any liability for penalties and interest in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a)).</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, subsequent to the reporting period, on January 6, 2022, the Company and certain former Trichome directors, one of which is currently serving as chairman of the Company's board of directors, signed an amendment to the tax indemnification agreement, and agreed to indemnify and hold harmless the Company and pay the Company the following amounts in cash as soon as practicable and in no event no later than February 28, 2022: <ix:nonNumeric id="Fxbrl_20220330191719220" name="ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">(a). any portion of remittance to the CRA on account of any non-residence Canadian estimated at approximately $<ix:nonFraction id="Fxbrl_20220330124011350" name="imc:AmountOfSettlementOfWithholdingTaxLiabilities" contextRef="C_20220228_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,886</ix:nonFraction>, plus (b) <ix:nonFraction id="Fxbrl_20220330193642073" name="imc:PercentageOfWithholdingTaxLiabilities" contextRef="C_20220228_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">75</ix:nonFraction>% of any liabilities for penalties up to December 31, 2021 and 100% of any penalties from January 1, 2022 onward (estimated at approximately $<ix:nonFraction id="Fxbrl_20220307115900761" name="imc:ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" contextRef="C_20210101to20220106_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">604</ix:nonFraction>), and indemnify 75% of any liabilities for interest through December 31, 2021 and 100% of any interest from January 1, 2022 (estimated at approximately $<ix:nonFraction id="Fxbrl_20220330124114735" name="imc:ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">342</ix:nonFraction>), in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a) above), plus (c) To the extent not captured above in sections (a) and (b), 100% of the withholding taxes tax liabilities, <span style="text-decoration:underline">subtracting</span> all cash proceeds received by Trichome or IMC from the sale of the Purchaser Balance Shares</ix:nonNumeric>.</span></span></div>
                <div><ix:exclude>
                  <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                  <div style="text-align:justify;line-height:1.25">
                    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>42</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                    <p style="margin:0pt">&#160;</p>
                    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 5:-</span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">BUSINESS COMBINATIONS </span><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">(Cont.)</span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;margin-left:50.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of the date of the issuance of these consolidated financial statements, the former Trichome director and current chairman of the Company's board of director, transferred the Company cash in the amount of $<ix:nonFraction id="Fxbrl_20220330192028586" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220101to20220329_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,250</ix:nonFraction>. Further, on March 30, 2022, the Company and the former Trichome director and current chairman of the Company's board of director, entered into several security agreements under which the former Trichome director and current chairman of the Company's board of director pledged <ix:nonFraction id="Fxbrl_20220330192102646" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20220101to20220329_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="Shares" decimals="INF" format="ixt:numdotdecimal">833,508</ix:nonFraction> Common Shares and <ix:nonFraction id="Fxbrl_20220330192110530" name="imc:NumberOfShareOptionsShareVestedRsu" contextRef="C_20220101to20220329_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">275,125</ix:nonFraction> vested RSU&#8217;s in favor of the Company to secure the indemnification asset for the remaining tax withholding liability. Such pledge of securities was registered in Ontario and British Columbia.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                    </div>
                    <div style="text-align:justify;margin-left:49.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 18, 2021, <ix:nonFraction id="Fxbrl_20220307120624587" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="Shares" decimals="INF" format="ixt:numdotdecimal">700,000</ix:nonFraction> options were granted to Trichome&#8217;s employees under the 2018 Plan (see Note 18).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:50.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition costs of Trichome include the issuance of <ix:nonFraction id="Fxbrl_20220330192011641" name="imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">50,525</ix:nonFraction> Common Shares, valued at $<ix:nonFraction id="Fxbrl_20220330192148479" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">495</ix:nonFraction> to financial advisors for advisory fees in connection with the Trichome Transactions.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:50.85pt;line-height:1.25">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trichome's revenue and net loss included in the Company&#8217;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $<ix:nonFraction id="Fxbrl_20220331214307369" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,223</ix:nonFraction> and $(<ix:nonFraction id="Fxbrl_20220331214325044" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,983</ix:nonFraction>), respectively.</span></span></p>
                      <div style="margin-left:50.85pt;line-height:1.25">&#160;</div>
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the Trichome Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                    </div>
                  </div>
                </div>
                <ix:nonNumeric id="Fxbrl_20220330123723483" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" escape="true">
                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="text-align:justify;margin-left:63pt;line-height:1.25">
                            <div>
                              <div>
                                <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                    <tr>
                                      <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330190134706" name="ifrs-full:RevenueOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">55,563</ix:nonFraction></td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330190144416" name="ifrs-full:ProfitLossOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,372</ix:nonFraction></td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                      </td>
                                    </tr>

                                </table>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
              </div>
              <p style="margin:0pt">&#160;</p>
              <p style="margin-left:56.7pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and TFC been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></p>
              <div><ix:exclude>
                <div style="text-align:justify;line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>43</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="text-align:justify;line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 5:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">BUSINESS COMBINATIONS </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MYM Nutraceuticals Inc.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 9, 2021, the Company, through its wholly owned subsidiary, Trichome, completed the acquisition of MYM Nutraceuticals (&#8220;MYM&#8221;). MYM is a Canadian cultivator, processor, and distributor of premium cannabis via its two wholly owned subsidiaries; SublimeCulture Inc. (&#8220;Sublime&#8221;) located near Montreal, Quebec, and Highland Grow Inc. (&#8220;Highland&#8221;), located in Antigonish, Nova Scotia. MYM&#8217;s flagship brand, Highland, is an ultra-premium brand sold in most provinces throughout Canada.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company acquired all the issued and outstanding shares of MYM. The Company acquired MYM's licensed producer subsidiary Highland Grow Inc., pursuant to a plan of arrangement under the Business Corporations Act in British Columbia. Under the terms of the MYM Transaction, the shareholders of MYM received <ix:nonFraction id="Fxbrl_20220307120720781" name="ifrs-full:WeightedAverageSharePrice2019" contextRef="C_20210701to20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD_per_Share" scale="0" decimals="3" format="ixt:numdotdecimal">0.022</ix:nonFraction> Common Shares of IMCC for each common share of MYM. As a result of the MYM transaction, a total of <ix:nonFraction id="Fxbrl_20220307120937114" name="ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable" contextRef="C_20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">10,073,437</ix:nonFraction> Common Shares were issued to the MYM former shareholders and financial advisors, resulting in former MYM shareholders holding approximately <ix:nonFraction id="Fxbrl_20220307121350539" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">15</ix:nonFraction>% of the total number of issued and outstanding Common Shares immediately after closing. Total consideration of the issued shares, warrants and stock options valued at approximately $<ix:nonFraction id="Fxbrl_20220329192615920" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20210701to20210731_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,620</ix:nonFraction>.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management with the assistance of an external valuation specialist.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition costs of MYM include the issuance of <ix:nonFraction id="Fxbrl_20220307122913529" name="ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">49,802</ix:nonFraction> Common Shares, valued at $<ix:nonFraction id="Fxbrl_20220307122555337" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">312</ix:nonFraction> to financial advisors for advisory fees in connection with the MYM Transactions.</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MYM's revenue and net profit included in the Company&#8217;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $<ix:nonFraction id="Fxbrl_20220331215450232" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,024</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220331215520463" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">130</ix:nonFraction>, respectively.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group including Trichome and MYM.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the MYM Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                <div style="text-align:justify;margin-left:0pt;line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220330123735576" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" escape="true">
                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25">
                            <div style="margin-left:63pt">
                              <div>
                                <div>
                                  <div style="line-height:1.25">&#160;</div>
                                  <div style="line-height:1.25">
                                    <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                        <tr>
                                          <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330190211970_xbrl_20220330190134706" name="ifrs-full:RevenueOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">61,639</ix:nonFraction></span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330190211971_xbrl_20220330190144416" name="ifrs-full:ProfitLossOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,132</ix:nonFraction></td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                          </td>
                                        </tr>

                                    </table>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and MYM been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia's Assets and Operations</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 30, 2021, the Company acquired all Panaxia's online-related activities and intellectual property. The aggregate purchase price of NIS <ix:nonFraction id="Fxbrl_20220307125230132" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="NIS" scale="6" decimals="-5" format="ixt:numdotdecimal">18.7</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20220307125345805" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,000</ix:nonFraction>). In order to complete the acquisition, the Company will issue Common Shares in the aggregate amount of NIS <ix:nonFraction id="Fxbrl_20220330122217153" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="NIS" scale="6" decimals="-5" format="ixt:numdotdecimal">11.1</ix:nonFraction> million (approximately $<ix:nonFraction id="Fxbrl_20220307125608129" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,200</ix:nonFraction>).</span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;text-indent:0pt;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2021, the Company issued the four installments of the Panaxia Consideration Shares, in the aggregate amount of <ix:nonFraction id="Fxbrl_20220307131926196" name="ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">934,755</ix:nonFraction>, at a various of share price ranging between US$<ix:nonFraction id="Fxbrl_20220307132023182" name="ifrs-full:WeightedAverageSharePrice2019" contextRef="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">5.01</ix:nonFraction> to US$<ix:nonFraction id="Fxbrl_20220330192212149" name="ifrs-full:WeightedAverageSharePrice2019" contextRef="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">3.1</ix:nonFraction>. The total consideration represents an aggregate amount of US$<ix:nonFraction id="Fxbrl_20220307132039714" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,397</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307132056716" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,290</ix:nonFraction>). The fifth and final installment of Panaxia Consideration Shares will be issued following the Panaxia GDP License Closing.</span></span></div>
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <div><ix:exclude>
                    <div style="text-align:justify;line-height:1.25;font-weight:normal">
                      <p style="margin:0pt">&#160;</p>
                      <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>44</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div style="text-align:justify;line-height:1.25;font-weight:normal">
                      <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                          <tr>
                            <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 5:-</span></td>
                            <td style="width:auto;vertical-align:top;text-align:justify">
                              <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">BUSINESS COMBINATIONS </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </ix:exclude></div>
                </div>
              </div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Group recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by an external valuation specialist.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As part of the acquisition, the Company purchased an option to purchase the Panaxia pharmacy, including cannabis-related licenses (see Note 1 (9)). As the exercise price of the option relates only to the medical cannabis inventory at the date of exercise, the Company has allocated $<ix:nonFraction id="Fxbrl_20220307132441448" name="imc:AmountOfNonCancellablePurchasePrice" contextRef="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,837</ix:nonFraction> of the non-cancellable purchase price to effectively reflect the Company&#8217;s advance payment for the estimated fair value of the licenses and other assets of the Panaxia pharmacy that will be acquired upon exercise of the option.</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group and Panaxia's acquired assets.</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia's results of operation for the acquisition date through December 31, 2021, were immaterial to the consolidated financial statements.</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              </div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharm Yarok pharmacy</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 28, 2021, IMC Holdings entered into a definitive agreement to acquire all of the issued and outstanding share of R.A. Yarok Pharm Ltd., Rosen High Way Ltd. and High Way Shinua Ltd. (collectively "Pharm Yarok Group"). The aggregate consideration for the Pharm Yarok Group acquisition was NIS <ix:nonFraction id="Fxbrl_20220307133023192" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">11,900</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307133051776" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,600</ix:nonFraction>), of which approximately NIS <ix:nonFraction id="Fxbrl_20220307133203826" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,500</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307133222265" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,300</ix:nonFraction>) shall be invested by the shareholders of Pharm Yarok Group in the Company at closing in consideration for Common Shares. The closing of the Pharm Yarok Group acquisition is conditional upon receipt of all requisite approvals, including from the MOH<span style="font-weight:bold">, </span>which granted its approval subsequent to December 31, 2021, on February 15, 2022.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharm Yarok Group's revenue and net profit included in the Company&#8217;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $<ix:nonFraction id="Fxbrl_20220331220521372" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,897</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220331220540248" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction>, respectively.</span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                <div><ix:exclude>
                  <div style="text-align:justify;line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>45</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <div style="text-align:justify;line-height:1.25">
                    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 5:-</span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">BUSINESS COMBINATIONS </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the Pharm Yarok Group Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                <div style="text-align:justify;margin-left:0pt;line-height:1.25;font-family:'Times New Roman', Times, serif">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220330123743649" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" escape="true">
                  <div>
                    <div style="margin-left:0t">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330190224662_xbrl_20220330190134706" name="ifrs-full:RevenueOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,345</ix:nonFraction></span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330190224663_xbrl_20220330190144416" name="ifrs-full:ProfitLossOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,986</ix:nonFraction></td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Pharm Yarok Group been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></div>
              </div>
              <div><ix:exclude>
                <div style="text-align:justify;line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>46</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="text-align:justify;line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 5:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">BUSINESS COMBINATIONS </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vironna pharmacy</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 16, 2021, IMC Holdings has signed a definitive agreement to acquire <ix:nonFraction id="Fxbrl_20220307133736844" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">51</ix:nonFraction>% of the outstanding ordinary shares of Revoly Trading and Marketing Ltd. ("Vironna") for a total consideration of NIS <ix:nonFraction id="Fxbrl_20220307133928334" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">8,500</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307133953098" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,300</ix:nonFraction>), of which NIS <ix:nonFraction id="Fxbrl_20220307134020187" name="ifrs-full:CashTransferred" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,000</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307134036725" name="ifrs-full:CashTransferred" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,950</ix:nonFraction>) in cash and NIS <ix:nonFraction id="Fxbrl_20220307134113504" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,500</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307134154458" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,350</ix:nonFraction>) is in common shares of the Company to be issued at closing of Vironna transaction. The closing is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group and the pharmacies. The Group has elected to measure the non-controlling interest in this business combination based on the fair value of the identifiable net assets acquired (excluding goodwill).</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the Vironna Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                <div style="text-align:justify;margin-left:0pt;line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220330123749662" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" escape="true">
                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma profit or loss for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330190228697_xbrl_20220330190134706" name="ifrs-full:RevenueOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">56,816</ix:nonFraction></span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330190228698_xbrl_20220330190144416" name="ifrs-full:ProfitLossOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,180</ix:nonFraction></td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Vironna been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></div>
              </div>
              <div><ix:exclude>
                <div style="text-align:justify;line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>47</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="text-align:justify;line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 5:-</span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">BUSINESS COMBINATIONS </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oranim pharmacy</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 1, 2021, IMC Holdings signed a definitive agreement to acquire <ix:nonFraction id="Fxbrl_20220329195853626" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">51</ix:nonFraction>% of the rights in Oranim Pharm, one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area, by acquiring <ix:nonFraction id="Fxbrl_20220329200250557" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPlusPharmLtdMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">51.3</ix:nonFraction>% of the outstanding shares of Oranim Plus, which holds <ix:nonFraction id="Fxbrl_20220330194335276" name="imc:PercentageOfAcquisition" contextRef="C_20211130to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPlusPharmLtdMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">99.5</ix:nonFraction>% of the rights in Oranim Pharm (the &#8220;Oranim Transaction&#8221;).</span></span></div>
                <div style="line-height:1.25">&#160;</div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Oranim Transaction closed on March 28, 2022, upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS <ix:nonFraction id="Fxbrl_20220330194524953" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">11,940</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330194533750" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,900</ix:nonFraction>), consisting of NIS <ix:nonFraction id="Fxbrl_20220330194704101" name="ifrs-full:CashTransferred" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,202</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330194720950" name="ifrs-full:CashTransferred" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,104</ix:nonFraction>) paid in cash upon signing, NIS <ix:nonFraction id="Fxbrl_20220330194734087" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,202</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330194743991" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,104</ix:nonFraction>) which will be paid in cash on the first quarter of 2023 and NIS <ix:nonFraction id="Fxbrl_20220330195227206" name="ifrs-full:CashTransferred" contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">1,536</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330195403469" name="ifrs-full:CashTransferred" contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">630</ix:nonFraction>) paid in <ix:nonFraction id="Fxbrl_20220330195039123" name="ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable" contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">251,001</ix:nonFraction> Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#8217;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oranim's revenue and net profit included in the Company&#8217;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $<ix:nonFraction id="Fxbrl_20220331221005776" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,410</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220331221022416" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">46</ix:nonFraction>, respectively.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the Oranim Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                <div style="text-align:justify;margin-left:0pt;line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220330123755549" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" escape="true">
                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma profit or loss for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330190234189_xbrl_20220330190134706" name="ifrs-full:RevenueOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">67,589</ix:nonFraction></td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330190234192_xbrl_20220330190144416" name="ifrs-full:ProfitLossOfAcquiree" contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_srtStatementScenarioAxis_srtProFormaMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,870</ix:nonFraction></td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                                <div style="line-height:1.25">&#160;</div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Oranim been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></div>
              </div>
              <div style="line-height:1.25">
                <div><ix:exclude>
                  <div style="text-align:justify;line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>48</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <div style="text-align:justify;line-height:1.25">
                    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 5:-</span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">BUSINESS COMBINATIONS </span><span style="font-size:10pt;font-weight:bold;font-family:Times New Roman, Times, serif">(Cont.)</span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
              </div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the identifiable assets acquired and liabilities assumed on the acquisition date:</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <ix:nonNumeric id="Fxbrl_20220330123331378" name="imc:DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory" contextRef="C_20210101to20211231" escape="true">
                <div>
                  <div style="line-height:1.25;margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value</span></span></div>
                          </td>
                          <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TFC</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MYM</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vironna</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharm Yarok</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oranim</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320385_xbrl_20220307141209947" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">362</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320385_xbrl_20220307141550820" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">131</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320385_xbrl_20220307141553693" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">57</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320385_xbrl_20220307141558414" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">105</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320385_xbrl_20220307141604824" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">485</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320385_xbrl_20220329194053618_xbrl_20220307141604824" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,240</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,548</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">259</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">456</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,329</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320401_xbrl_20220329194053619_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indemnification asset</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,131</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320416_xbrl_20220329194053622_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biological assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:BiologicalAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">785</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:BiologicalAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">63</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:BiologicalAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:BiologicalAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:BiologicalAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320432_xbrl_20220329194053624_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:BiologicalAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,883</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,180</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">639</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">346</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,043</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320447_xbrl_20220329194053627_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loan receivable</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:LoanReceivableRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,470</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:LoanReceivableRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,122</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:LoanReceivableRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:LoanReceivableRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:LoanReceivableRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320464_xbrl_20220329194053630_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:LoanReceivableRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320479_xbrl_20220329194053633_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,837</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,193</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,105</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">210</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,145</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">389</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320496_xbrl_20220329194053636_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">88</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:DerivativeAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">114</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:DerivativeAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:DerivativeAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:DerivativeAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:DerivativeAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320512_xbrl_20220329194053639_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:DerivativeAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right of use assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:RightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,037</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:RightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">630</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:RightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:RightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:RightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,312</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320528_xbrl_20220329194053642_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:RightOfUseAssetsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:InvestmentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">319</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:InvestmentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:InvestmentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:InvestmentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:InvestmentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320544_xbrl_20220329194053644_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:InvestmentsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,458</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,200</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,316</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">974</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,991</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320559_xbrl_20220329194053647_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">776</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">61,992</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,979</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,481</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,026</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,549</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320575_xbrl_20220329194053651_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,720</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,196</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,442</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">854</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,448</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,777</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320595_xbrl_20220329194053654_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank loans</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">915</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320616_xbrl_20220329194053657_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,037</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">873</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,312</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320634_xbrl_20220329194053660_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:LeaseLiabilityAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long term loans</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:LongTermBorrowingsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:LongTermBorrowingsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:LongTermBorrowingsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:LongTermBorrowingsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,042</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:LongTermBorrowingsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320653_xbrl_20220329194053663_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:LongTermBorrowingsAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax, net</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,061</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">532</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">224</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">688</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320672_xbrl_20220329194053667_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,233</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,291</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,386</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,714</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,777</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320691_xbrl_20220329194053670_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable assets, net</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,759</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,688</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,095</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">312</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,772</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320712_xbrl_20220329194053674_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,720</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill arising on acquisition</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">67,269</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,932</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,250</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,294</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,907</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320730_xbrl_20220329194053678_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,240</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Controlling interest</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,026</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,849</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320746_xbrl_20220329194053681_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total purchase price</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">99,028</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,620</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,319</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,606</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,830</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330122320762_xbrl_20220329194053685_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,960</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <div>
        <div>
          <div style="line-height:1.25">
            <p style="margin:0pt">&#160;</p>
            <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>49</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
            <p style="margin:0pt">&#160;</p>
          </div>
        </div>
      </div>
    </div>
  </div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20210426191039932" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt">NOTE 6:-</span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt">TRADE RECEIVABLES</span></div>
                </td>
              </tr>

          </table>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <ix:nonNumeric id="Fxbrl_20210426191155044" name="imc:DisclosureOfTradeReceivablesExplanatory" contextRef="C_20210101to20211231" escape="true">
                <div>
                  <div style="margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wholesalers and pharmacies</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426190339676" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,711</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426190345555" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,501</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivables are non-interest bearing and are generally on terms of <ix:nonNumeric id="Fxbrl_20210426191849044" name="imc:TermOfNonInterestBearingTradeReceivables" contextRef="C_20210101to20211231">30 to 90 days</ix:nonNumeric>. As of December 31, 2021 and 2020, there were no material past-due receivables.</span></span></div>
              <div>
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Major customers data as a percentage of total revenues:</span></span></div>
                  <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                </div>
              </div>
              <ix:nonNumeric id="Fxbrl_20220331172019313" name="ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory" contextRef="C_20210101to20211231" escape="true">
                <div>
                  <div>
                    <div>
                      <div style="line-height:1.25;margin-left:63pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Reporting segment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Customer A</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Canada</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331165550704_xbrl_20210426191350509" name="ifrs-full:PercentageOfEntitysRevenue" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">17</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331165550704_xbrl_20210426191400900" name="ifrs-full:PercentageOfEntitysRevenue" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:zerodash">-</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Customer B</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:9%;text-align:center" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Israel</span></span></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331165550709_xbrl_20220305042416894_xbrl_20210426191357662" name="ifrs-full:PercentageOfEntitysRevenue" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullMajorCustomersAxis_imcCustomerThreeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">8</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220331165550709_xbrl_20220305042416894_xbrl_20210426191404650" name="ifrs-full:PercentageOfEntitysRevenue" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullMajorCustomersAxis_imcCustomerThreeMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">35</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20210426231213664" name="imc:DisclosureOfOtherAccountsReceivablesExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 7:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OTHER ACCOUNTS RECEIVABLE</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:63pt">
                  <ix:nonNumeric id="Fxbrl_20220329180126756" name="imc:DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory" contextRef="C_20210101to20211231" escape="true">
                    <div>
                      <div>
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426231559629" name="ifrs-full:CurrentPrepaidExpenses" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,716</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426231605028" name="ifrs-full:CurrentPrepaidExpenses" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">472</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government authorities</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619459180" name="imc:ReceivablesFromGovernmentAuthorities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,338</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="F1619459182" name="imc:ReceivablesFromGovernmentAuthorities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">75</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties (see Note 21)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619459184" name="ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="F1619459186" name="ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">36</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indemnification assets (see Note 5)</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329180514111_1619459184" name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,112</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331221427744" name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other receivables (including related parties - see Note 5)</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F1619459188" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,304</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F1619459190" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">106</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426231654374" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,481</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426231703888" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">689</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </ix:nonNumeric>
                </div>
              </div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
    </div>
  </div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">
    <div style="margin:0pt">&#160;</div>
    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>50</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
  </div>
  <div>&#160;</div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220305053941977" name="ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt">NOTE 8:-</span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt">BIOLOGICAL ASSETS</span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group&#8217;s biological assets consist of cannabis plants. The changes in the carrying value of biological assets are as follows:</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="margin-left:63pt">
                <ix:nonNumeric id="Fxbrl_20220329181608492" name="ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of January 1, 2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_02" name="ifrs-full:BiologicalAssets" contextRef="C_20191231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">52</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production costs capitalized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_22" name="imc:ProductionCostsCapitalizedBiologicalAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,717</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value less cost to sell due to biological transformation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_32" name="ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,782</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transferred to inventory upon harvest</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427143031968_42" name="ifrs-full:DecreaseDueToHarvestBiologicalAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,478</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange translation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_52" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of December 31, 2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_72" name="ifrs-full:BiologicalAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">78</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions related to acquisitions of Trichome and MYM</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220305053519199" name="ifrs-full:AcquisitionsThroughBusinessCombinationsBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">848</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production costs capitalized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_92" name="imc:ProductionCostsCapitalizedBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,454</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value less cost to sell due to biological transformation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_102" name="ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,210</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transferred to inventory upon harvest</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427143031968_112" name="ifrs-full:DecreaseDueToHarvestBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,977</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange translation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_122" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">74</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of December 31, 2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143031968_142" name="ifrs-full:BiologicalAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,687</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </ix:nonNumeric>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021, the weighted average fair value less cost to sell was $<ix:nonFraction id="Fxbrl_20210427144456174" name="imc:WeightedAverageFairValueLessCostToSellOfBiologicalAssets" contextRef="C_20210101to20211231" unitRef="CAD_per_gram" scale="0" decimals="2" format="ixt:numdotdecimal">2.48</ix:nonFraction> per gram.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of biological assets is categorized within Level 3 of the fair value hierarchy.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The inputs and assumptions used in determining the fair value of biological assets include:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling price per gram - calculated as the weighted average historical selling price for all strains of cannabis sold by the Group, which is expected to approximate future selling prices.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post-harvest costs - calculated as the cost per gram of harvested cannabis to complete the sale of cannabis plants post-harvest, consisting of the cost of direct and indirect materials, depreciation and labor as well as labelling and packaging costs.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Attrition rate - represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average yield per plant - represents the expected number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Stage of growth - represents the weighted average number of weeks out of the average weeks growing cycle that biological assets have reached as of the measurement date.<span style="font-weight:bold"> </span>The growing cycle is approximately 12 weeks.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>51</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 8:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BIOLOGICAL ASSETS (Cont.)</span></span></div>
                      </td>
                    </tr>

                </table>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table quantifies each significant unobservable input, and also provides the impact a 10% increase/decrease in each input would have on the fair value of biological assets:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:63pt">
                <ix:nonNumeric id="Fxbrl_20220329181632284" name="imc:DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10% change as at</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average selling price per gram of dried cannabis (in CAD)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_32" name="imc:AverageSellingPricePerGramOfDriedCannabis" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="CAD_per_gram" scale="0" decimals="2" format="ixt:numdotdecimal">3.64</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_35" name="imc:AverageSellingPricePerGramOfDriedCannabis" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="CAD_per_gram" scale="0" decimals="2" format="ixt:numdotdecimal">6.01</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_38" name="imc:AverageSellingPricePerGramOfDriedCannabis" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="CAD_per_gram" scale="0" decimals="0" format="ixt:numdotdecimal">296</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_311" name="imc:AverageSellingPricePerGramOfDriedCannabis" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="CAD_per_gram" scale="0" decimals="2" format="ixt:numdotdecimal">8.86</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average post-harvest costs per gram of dried cannabis (in CAD)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_42" name="imc:AveragePostHarvestCostsPerGramOfDriedCannabis" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="CAD_per_gram" scale="0" decimals="2" format="ixt:numdotdecimal">1.16</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_45" name="imc:AveragePostHarvestCostsPerGramOfDriedCannabis" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="CAD_per_gram" scale="0" decimals="2" format="ixt:numdotdecimal">0.83</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_48" name="imc:AveragePostHarvestCostsPerGramOfDriedCannabis" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="CAD_per_gram" scale="0" decimals="0" format="ixt:numdotdecimal">140</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_411" name="imc:AveragePostHarvestCostsPerGramOfDriedCannabis" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="CAD_per_gram" scale="0" decimals="2" format="ixt:numdotdecimal">0.23</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Attrition rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143924034" name="imc:AttritionRate" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">27</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143932866" name="imc:AttritionRate" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">5</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_58" name="imc:AttritionRate" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">100</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_511" name="imc:AttritionRate" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">0.43</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average yield per plant (in grams)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_62" name="imc:AverageYieldPerPlant" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="Gram" scale="0" decimals="0" format="ixt:numdotdecimal">47</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_65" name="imc:AverageYieldPerPlant" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="Gram" scale="0" decimals="0" format="ixt:numdotdecimal">54</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_68" name="imc:AverageYieldPerPlant" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="Gram" scale="0" decimals="0" format="ixt:numdotdecimal">228</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_611" name="imc:AverageYieldPerPlant" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="Gram" scale="0" decimals="2" format="ixt:numdotdecimal">7.64</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average stage of growth</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427144405650" name="imc:AverageStageOfGrowth" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">47</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427144416600" name="imc:AverageStageOfGrowth" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">4</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_78" name="imc:AverageStageOfGrowth" contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">212</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427143313240_711" name="imc:AverageStageOfGrowth" contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">7.64</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </ix:nonNumeric>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These estimates are subject to volatility in market prices and a number of uncontrollable factors, which could significantly affect the fair value of biological assets in future periods.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group&#8217;s estimates are, by their nature, subject to change including differences in the anticipated yield. These changes will be reflected in the gain or loss on biological assets in future periods.</span></span></div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20220329182238572" name="ifrs-full:DisclosureOfInventoriesExplanatory" contextRef="C_20210101to20211231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt">NOTE 9:-</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt">INVENTORIES</span></div>
                  </td>
                </tr>

            </table>
            <div>
              <div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220329182411079" name="imc:DisclosureOfDetailedInformationAboutInventoriesExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <div style="margin-left:63pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized costs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair valuation adjustment, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying value</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work in progress:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bulk cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_32" name="imc:CapitalizedCostsOfInventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,113</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_35" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,336</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_38" name="ifrs-full:Inventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,449</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other cannabis products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220305055723308_xbrl_20210427170247861_32" name="imc:CapitalizedCostsOfInventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,074</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220305055723308_xbrl_20210427170247861_35" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220305055723308_xbrl_20210427170247861_38" name="ifrs-full:Inventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,074</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Packaged dried cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_62" name="imc:CapitalizedCostsOfInventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,974</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_65" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">270</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_68" name="ifrs-full:Inventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,244</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other cannabis products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220305055726052_xbrl_20210427170247861_32" name="imc:CapitalizedCostsOfInventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">744</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220305055726052_xbrl_20210427170247861_35" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220305055726052_xbrl_20210427170247861_38" name="ifrs-full:Inventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">744</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_72" name="imc:CapitalizedCostsOfInventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">880</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_75" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_78" name="ifrs-full:Inventories" contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">880</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_92" name="imc:CapitalizedCostsOfInventories" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,785</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_95" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,606</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170247861_98" name="ifrs-full:Inventories" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,391</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>52</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                      </div>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 9:-</span></span></td>
                            <td style="width:auto;vertical-align:top;text-align:justify">
                              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INVENTORIES (Cont.)</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </ix:exclude></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:63pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized costs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair valuation adjustment, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying value</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work in progress:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bulk cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170825076_xbrl_20210427170247861_32" name="imc:CapitalizedCostsOfInventories" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,130</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170825076_xbrl_20210427170247861_35" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,728</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427170825076_xbrl_20210427170247861_38" name="ifrs-full:Inventories" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,858</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Packaged dried cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427171142473_xbrl_20210427170825076_xbrl_20210427170247861_32" name="imc:CapitalizedCostsOfInventories" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">363</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427171142473_xbrl_20210427170825076_xbrl_20210427170247861_35" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">603</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427171142473_xbrl_20210427170825076_xbrl_20210427170247861_38" name="ifrs-full:Inventories" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">966</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427171147303_xbrl_20210427170825076_xbrl_20210427170247861_32" name="imc:CapitalizedCostsOfInventories" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">546</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427171147303_xbrl_20210427170825076_xbrl_20210427170247861_35" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427171147303_xbrl_20210427170825076_xbrl_20210427170247861_38" name="ifrs-full:Inventories" contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">546</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427170825095_xbrl_20210427170247861_92" name="imc:CapitalizedCostsOfInventories" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,039</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427170825095_xbrl_20210427170247861_95" name="ifrs-full:InventoriesAtFairValueLessCostsToSell" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,331</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427170825095_xbrl_20210427170247861_98" name="ifrs-full:Inventories" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,370</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the years ended December 31, 2021 and 2020, inventory expensed to cost of revenue of cannabis products was $<ix:nonFraction id="Fxbrl_20220305060115471" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">43,720</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220305060123021" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,203</ix:nonFraction>, respectively, which included $<ix:nonFraction id="Fxbrl_20220305060132060" name="imc:NonCashExpenseRelatedToChangesInFairValueOfInventorySold" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,796</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220305060137861" name="imc:NonCashExpenseRelatedToChangesInFairValueOfInventorySold" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,122</ix:nonFraction> of non-cash expense, respectively, related to the changes in fair value of inventory sold.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, during the years ended December 31, 2021 and 2020, write-downs of inventories recognized in cost of revenue amounted to $<ix:nonFraction id="Fxbrl_20220305060148238" name="ifrs-full:InventoryWritedown2011" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt-sec:numwordsen">nil</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220305060156909" name="ifrs-full:InventoryWritedown2011" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">291</ix:nonFraction>, respectively.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues in 2021 and 2020, also include production overhead not allocated to costs of inventories produced and recognized as an expense as incurred.</span></span></div>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
        <p style="margin:0pt">&#160;</p>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>53</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
      </div>
    </div>
  </div>
  <div>&#160;</div>

  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20220307122814376" name="imc:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory" contextRef="C_20210101to20211231" escape="true">
          <div>
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 10:-</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:63pt">
                    <ix:nonNumeric id="Fxbrl_20220329184043140" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" contextRef="C_20210101to20211231" escape="true">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings and improvements</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greenhouse production equipment</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greenhouse structure</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer, software and equipment</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113510514_xbrl_20210427131155081_32" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,675</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113510514_xbrl_20210427131155081_35" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,534</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113510514_xbrl_20210427131155081_38" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">884</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113510514_xbrl_20210427131155081_311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">174</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113510514_xbrl_20210427131155081_314" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113510514_xbrl_20210427131155081_317" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,286</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_32" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">705</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_35" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,123</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_38" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">648</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_311" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">95</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_314" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">44</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_317" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,615</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_32" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">97</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_35" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">104</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_38" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">63</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_311" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_314" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_317" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">276</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_32" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,477</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_35" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,761</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_38" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,595</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">279</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_314" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">65</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_317" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,177</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_32" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,932</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_35" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,846</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_38" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">508</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_311" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">261</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_314" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">31</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_317" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,578</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions related to acquisitions</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_32" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,828</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_35" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,584</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_38" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_311" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">455</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_314" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">263</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_317" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,130</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_32" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">81</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_35" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">79</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_38" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">79</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_311" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">44</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_314" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_317" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">132</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance December as of 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_32" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,156</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_35" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,270</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_38" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,182</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,039</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_314" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">370</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_317" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,017</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">46</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">534</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">280</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">26</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">8</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">894</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">132</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">350</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">147</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">52</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">690</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">61</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">184</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">919</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">444</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">81</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,645</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,554</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">993</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">206</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">241</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,021</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">40</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">26</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">83</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,742</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,952</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">676</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">333</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">46</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">4,749</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,414</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,318</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,506</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">706</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">324</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,268</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_32" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,293</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_35" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,842</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_38" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,151</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">198</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_314" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">48</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_317" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,532</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </ix:nonNumeric>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </div>
  <div>
    <div>&#160;</div>
    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>54</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
  </div>
  <div>&#160;</div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220307140548178" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 11:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span>INTANGIBLE ASSETS, NET</span></span></div>
                      </td>
                    </tr>

                </table>
                <div>
                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <ix:nonNumeric id="Fxbrl_20220330130355466" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
                      <div>
                        <div style="line-height:1.25;margin-left:63pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                              <tr>
                                <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cultivations and processing license *)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer relationships</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Brand</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost:</span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439090_xbrl_20220307141937626_32" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">831</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439090_xbrl_20220307141937626_35" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">58</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439090_xbrl_20220307141937626_38" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">63</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439090_xbrl_20220307141937626_311" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">62</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439090_xbrl_20220307141937626_314" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,014</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchases</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439096_xbrl_20220307141937626_52" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">93</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439096_xbrl_20220307141937626_55" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439096_xbrl_20220307141937626_58" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439096_xbrl_20220307141937626_511" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439096_xbrl_20220307141937626_514" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">93</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustment derived from purchase price allocation</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439103_xbrl_20220307141937626_72" name="imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">110</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439103_xbrl_20220307141937626_75" name="imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439103_xbrl_20220307141937626_78" name="imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439103_xbrl_20220307141937626_711" name="imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439103_xbrl_20220307141937626_714" name="imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">110</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439110_xbrl_20220307141937626_82" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">26</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439110_xbrl_20220307141937626_85" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439110_xbrl_20220307141937626_88" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439110_xbrl_20220307141937626_811" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439110_xbrl_20220307141937626_814" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">32</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439135_xbrl_20220307141937626_172" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,060</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439135_xbrl_20220307141937626_175" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">58</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439135_xbrl_20220307141937626_178" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">63</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439135_xbrl_20220307141937626_1711" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">68</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439135_xbrl_20220307141937626_1714" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,249</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:middle;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial consolidations</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439123_xbrl_20220307141937626_132" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,950</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439123_xbrl_20220307141937626_135" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,337</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439123_xbrl_20220307141937626_138" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,300</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439123_xbrl_20220307141937626_1311" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">128</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439123_xbrl_20220307141937626_1314" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,715</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330125439130_xbrl_20220307141937626_152" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">49</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439130_xbrl_20220307141937626_155" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">279</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439130_xbrl_20220307141937626_158" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439130_xbrl_20220307141937626_1511" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439130_xbrl_20220307141937626_1514" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">236</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_172" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,961</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_175" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,674</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_178" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,363</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_1711" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">202</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_1714" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,200</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated amortization and impairment:</span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439146_xbrl_20220307141937626_212" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">125</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439146_xbrl_20220307141937626_215" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439146_xbrl_20220307141937626_218" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439146_xbrl_20220307141937626_2111" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439146_xbrl_20220307141937626_2114" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">125</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization recognized in the year</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439152_xbrl_20220307141937626_232" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">31</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439152_xbrl_20220307141937626_235" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439152_xbrl_20220307141937626_238" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439152_xbrl_20220307141937626_2311" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439152_xbrl_20220307141937626_2314" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">31</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_152" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_155" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_158" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_1511" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_1514" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_212" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">156</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_215" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_218" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_2111" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_2114" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">157</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization recognized in the year</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439171_xbrl_20220307141937626_282" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">618</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439171_xbrl_20220307141937626_285" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">469</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439171_xbrl_20220307141937626_288" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439171_xbrl_20220307141937626_2811" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">63</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439171_xbrl_20220307141937626_2814" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,158</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_212" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">774</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_215" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">469</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_218" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">8</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_2111" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">64</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_2114" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,315</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:4px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost at December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439199_xbrl_20220307141937626_332" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,187</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439199_xbrl_20220307141937626_335" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,205</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439199_xbrl_20220307141937626_338" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,355</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439199_xbrl_20220307141937626_3311" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">138</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125439199_xbrl_20220307141937626_3314" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,885</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost at December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_332" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">904</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_335" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">58</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_338" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">63</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_3311" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">67</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_3314" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,092</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:45pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*) The licenses consist of GMP and GDP licenses. </span></span></div>
                      </div>
                    </ix:nonNumeric>
                    <div><ix:exclude>
                      <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:45pt">&#160;</div>
                      <div style="line-height:1.25">
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>55</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        <p style="margin:0pt">&#160;</p>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 11:-</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTANGIBLE ASSETS, NET</span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </ix:exclude></div>
                    <div>
                      <div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">
                          <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of goodwill and intangible assets:</span></span>
                        </div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Adjupahrm's</span> recoverable <span>amounts</span> of the intangible assets and the goodwill <span>were</span> determined based on the value in use which is calculated at the expected estimated future cash flows, as determined according to the budget for the next three years and approved by the Company&#8217;s management. The pre-tax discount rate of the cash flows is <ix:nonFraction id="Fxbrl_20220330155201027" name="imc:PreTaxDiscountRateOfCashFlows" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">13.06</ix:nonFraction>%. The projected cash flows for the period exceeding three years was estimated using a fixed growth rate of <ix:nonFraction id="Fxbrl_20220330155206614" name="imc:FixedGrowthRate" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction>%, representing the long-term average growth rate as customary in Adjupharm&#8217;s business.<span> For the year ended December 31, 2021, the Company recorded a goodwill impairment in the amount of $275 with respect to Adjupharm.</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Trichome's</span> recoverable <span>amounts</span> of the intangible assets and the goodwill <span>were</span> determined based on the value in use which is calculated at the expected estimated future cash flows, as determined according to the budget for the next three years and approved by the Company&#8217;s management. The pre-tax discount rate of the cash flows is <ix:nonFraction id="Fxbrl_20220330155214030" name="imc:PreTaxDiscountRateOfCashFlows" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCorpMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">11.78</ix:nonFraction>%. The projected cash flows for the period exceeding <span>three</span> years was estimated using a fixed growth rate of <ix:nonFraction id="Fxbrl_20220330155228366" name="imc:FixedGrowthRate" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCorpMember" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">4</ix:nonFraction>%, representing the long-term average growth rate as customary in Trichome's business.<span> Based on the analysis performed the Company did not record goodwill impairment.</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisitions during the year:</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2021, the Group entered into several business combination transactions. As part of these acquisitions, the Group identified cultivations and processing licenses, customer relationship, brand and others. The intangible assets identified have finite life and are being amortized on a straight-line basis over the useful life of the assets. During the year ended on December 31, 2021 and 2020, the Group recorded amortization expenses in the amount of $<ix:nonFraction id="Fxbrl_20220329191726094" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,158</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220329191733000" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">31</ix:nonFraction>, respectively. The amortization expenses are included in the <span>cost of revenues</span> and in the selling and marketing expenses.</span></span></div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>56</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <div>
    <ix:nonNumeric id="Fxbrl_20220307141811709" name="imc:DisclosureOfRightOfUseAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt">NOTE 12:-</span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt">RIGHT-OF-USE ASSETS</span></div>
              </td>
            </tr>

        </table>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20220329194217051" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Land and buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428014246210" name="ifrs-full:RightofuseAssets" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">955</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428022230797" name="ifrs-full:RightofuseAssets" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">195</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428022421203" name="ifrs-full:RightofuseAssets" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,150</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428014424092" name="ifrs-full:AdditionsToRightofuseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428022537849" name="ifrs-full:AdditionsToRightofuseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">107</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428022621021" name="ifrs-full:AdditionsToRightofuseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">107</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428014325451" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428022836982" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428022847986" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">62</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428014527242" name="imc:DisposalsOfRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428023002933" name="imc:DisposalsOfRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">73</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428023006679" name="imc:DisposalsOfRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">73</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428014547381" name="ifrs-full:RightofuseAssets" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,005</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023017413" name="ifrs-full:RightofuseAssets" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">241</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023025786" name="ifrs-full:RightofuseAssets" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,246</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307122947840_xbrl_20210428014006957" name="ifrs-full:AdditionsToRightofuseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,408</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307122947840_xbrl_20210428021124387" name="ifrs-full:AdditionsToRightofuseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">270</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307122947840_xbrl_20210428021147875" name="ifrs-full:AdditionsToRightofuseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,678</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial consolidations</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123710791_xbrl_20220307123031391_xbrl_20210428014124845" name="imc:InitialConsolidationsRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,956</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123710791_xbrl_20220307123031391_xbrl_20210428021302764" name="imc:InitialConsolidationsRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">23</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123710791_xbrl_20220307123031391_xbrl_20210428021307406" name="imc:InitialConsolidationsRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,979</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123031391_xbrl_20210428014124845" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">145</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123031391_xbrl_20210428021302764" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123031391_xbrl_20210428021307406" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">157</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123129951_xbrl_20210428014547381" name="ifrs-full:RightofuseAssets" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,514</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123129951_xbrl_20210428023017413" name="ifrs-full:RightofuseAssets" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">546</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307123129951_xbrl_20210428023025786" name="ifrs-full:RightofuseAssets" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,060</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated depreciation:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307135007912_xbrl_20210428020341467" name="ifrs-full:RightofuseAssets" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307135007912_xbrl_20210428023603385" name="ifrs-full:RightofuseAssets" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307135007912_xbrl_20210428023612922" name="ifrs-full:RightofuseAssets" contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428020734633" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">80</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023713580" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">47</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023717794" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">127</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428020742540" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">107</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023727834" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">102</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023741739" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">209</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307132720695_xbrl_20210428020742540" name="imc:DisposalsOfRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">7</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307132720695_xbrl_20210428023727834" name="imc:DisposalsOfRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">3</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307132720695_xbrl_20210428023741739" name="imc:DisposalsOfRightOfUseAssets" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">10</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428020806401" name="imc:DisposalOfTerminationOfLeases" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428023804125" name="imc:DisposalOfTerminationOfLeases" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428023808004" name="imc:DisposalOfTerminationOfLeases" contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428020408668" name="ifrs-full:RightofuseAssets" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">194</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023815203" name="ifrs-full:RightofuseAssets" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">117</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023819149" name="ifrs-full:RightofuseAssets" contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">311</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307131754692_xbrl_20210428020734633" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,438</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307131754692_xbrl_20210428023713580" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">112</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307131754692_xbrl_20210428023717794" name="ifrs-full:DepreciationRightofuseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,550</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329195505515" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307131805140_xbrl_20210428023727834" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307131805140_xbrl_20210428023741739" name="imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">37</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307131824811_xbrl_20210428020408668" name="ifrs-full:RightofuseAssets" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,659</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307131824811_xbrl_20210428023815203" name="ifrs-full:RightofuseAssets" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">239</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307131824811_xbrl_20210428023819149" name="ifrs-full:RightofuseAssets" contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,898</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost at December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428020854390" name="ifrs-full:RightofuseAssets" contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,855</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023827416" name="ifrs-full:RightofuseAssets" contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">307</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023839804" name="ifrs-full:RightofuseAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,162</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost at December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428020927004" name="ifrs-full:RightofuseAssets" contextRef="C_20201231_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">811</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023851484" name="ifrs-full:RightofuseAssets" contextRef="C_20201231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">124</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023855676" name="ifrs-full:RightofuseAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">935</ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group has entered into leases of land, buildings and motor vehicles which are used for the Group's operations.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases of buildings have lease terms of between <ix:nonNumeric id="Fxbrl_20220329201032463" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" format="ixt-sec:duryear">5</ix:nonNumeric> and <ix:nonNumeric id="Fxbrl_20220329201049706" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" format="ixt-sec:duryear">12</ix:nonNumeric> years, whereas leases of motor vehicles usually have lease terms of <ix:nonNumeric id="Fxbrl_20220329201112618" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember" format="ixt-sec:duryear">3</ix:nonNumeric> years.</span></span></div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>57</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
    <p style="margin:0pt">&#160;</p>
  </div>

  <div>
    <ix:nonNumeric id="Fxbrl_20220329201131360" name="ifrs-full:DisclosureOfEmployeeBenefitsExplanatory" contextRef="C_20210101to20211231" escape="true">
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 13:-</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span>EMPLOYEE BENEFIT ASSETS AND LIABILITIES</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employee benefits consist of short-term benefits and post-employment benefits.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:-28.35pt;margin-left:80pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Post-employment benefits:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">According to the labor laws and Severance Pay Law in Israel, the Group is required to pay compensation to an employee upon dismissal or retirement or to make current contributions in defined contribution plans pursuant to Section 14 to the Severance Pay Law, as specified below. The Group&#8217;s liability is accounted for as a post-employment benefit only for employees not under Section 14. The computation of the Group&#8217;s employee benefit liability is made in accordance with a valid employment contract or a collective employees agreement based on the employee's salary and employment term which establish the entitlement to receive the compensation.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The post-employment employee benefits are normally financed by contributions classified as defined benefit plans, as detailed below:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Defined benefit plans:</p>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group accounts for the payment of compensation, that is not covered by contributions in defined contribution plans, as above, as a defined benefit plan for which an employee benefit liability is recognized and for which the Group deposits amounts in a long-term employee benefit fund and in qualifying insurance policies.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expenses recognized in the consolidated statements of profit or loss and other comprehensive income:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20220307103530609" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current service cost</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220308141108822_32" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">146</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220308141108822_35" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">166</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220308141108822_42" name="ifrs-full:InterestExpenseDefinedBenefitPlans" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220308141108822_45" name="ifrs-full:InterestExpenseDefinedBenefitPlans" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total employee benefit expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220308141108822_62" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">160</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220308141108822_65" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">176</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income on plan assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220308141108822_82" name="imc:InterestIncomeOnPlanAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220308141108822_85" name="imc:InterestIncomeOnPlanAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The defined benefit liability (asset), net:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20210428001049579" name="ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Defined benefit obligation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428001118428_32" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">668</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428001118428_35" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">588</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value of plan assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428001118428_42" name="ifrs-full:PlanAssetsAtFairValue" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">277</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428001118428_45" name="ifrs-full:PlanAssetsAtFairValue" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">217</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net defined benefit liability</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428001118428_62" name="ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">391</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428001118428_65" name="ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">371</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div><ix:exclude>
              <div style="line-height:1.25">
                <p style="margin:0pt">&#160;</p>
                <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>58</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                <p style="margin:0pt">&#160;</p>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 13:-</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EMPLOYEE BENEFIT ASSETS AND LIABILITIES (Cont.)</span></span></div>
                    </td>
                  </tr>

              </table>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in the present value of defined benefit liabilities:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20210428021526510" name="imc:DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_22" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">588</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_25" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" contextRef="C_20191231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">390</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current service cost</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_42" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">146</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_45" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">166</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_52" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_55" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">10</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits paid</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428002251218_62" name="ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428002251218_65" name="ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">23</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Re-measurement loss on defined benefit plans</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307101447477" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">33</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_75" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">32</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation effect</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_82" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_85" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_102" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">668</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428002251218_105" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">588</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in the fair value of plan assets:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Plan assets comprise assets held by a long-term employee benefit funds and qualifying insurance policies.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20210428011816903" name="ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_22" name="ifrs-full:PlanAssetsAtFairValue" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">217</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_25" name="ifrs-full:PlanAssetsAtFairValue" contextRef="C_20191231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">128</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_42" name="imc:InterestIncomeOnPlanAssets" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_45" name="imc:InterestIncomeOnPlanAssets" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Return, net of interest income - remeasurement gain (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307102836883" name="imc:ReturnNetOfInterestIncomeReMeasurementGainLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">12</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_55" name="imc:ReturnNetOfInterestIncomeReMeasurementGainLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits paid</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428011902333_62" name="ifrs-full:BenefitsPaidOrPayable" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428011902333_65" name="ifrs-full:BenefitsPaidOrPayable" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">23</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts deposited</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_72" name="imc:PlanAssetsAmountsDeposited" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">116</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_75" name="imc:PlanAssetsAmountsDeposited" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">101</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation effect</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307102903475" name="imc:PlanAssetsForeignCurrencyTranslationEffect" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_85" name="imc:PlanAssetsForeignCurrencyTranslationEffect" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_102" name="ifrs-full:PlanAssetsAtFairValue" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">277</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428011902333_105" name="ifrs-full:PlanAssetsAtFairValue" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">217</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The principal assumptions underlying the defined benefit plan:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div>
              <div style="margin-left:90pt">
                <ix:nonNumeric id="Fxbrl_20220329201156328" name="ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:85%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428012929372" name="ifrs-full:ActuarialAssumptionOfDiscountRates" contextRef="C_20211231" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">3.5</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428013107936" name="ifrs-full:ActuarialAssumptionOfDiscountRates" contextRef="C_20201231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">2.58</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salary growth</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428012940683" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" contextRef="C_20211231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">4.64</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210428013001589" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" contextRef="C_20201231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">3.37</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </ix:nonNumeric>
              </div>
            </div>
            <div style="line-height:1.25;clear:both">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Based on reasonably possible changes of the principal assumptions underlying the defined benefit plan as mentioned above, occurring at the end of the reporting period, the changes would have an immaterial effect on the consolidated financial statements.</span></span></div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>59</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
    <p style="margin:0pt">&#160;</p>
  </div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20210426222203301" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 14:-</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span>OTHER PAYABLES</span></span></div>
                </td>
              </tr>

          </table>
          <div>
            <div>
              <div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20210426223553105" name="imc:DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div style="margin-left:63pt">
                    <div>
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_32" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,146</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_35" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">407</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and payroll accruals</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_42" name="imc:EmployeesAndPayrollAccruals" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,267</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_45" name="imc:EmployeesAndPayrollAccruals" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,545</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government authorities</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_52" name="imc:OtherCurrentPayablesToGovernmentAuthorities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,002</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_55" name="imc:OtherCurrentPayablesToGovernmentAuthorities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">642</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307110310848_xbrl_20210426222226328_52" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">875</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307110310848_xbrl_20210426222226328_55" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances from customers</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_62" name="ifrs-full:CurrentDepositsFromCustomers" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">137</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_65" name="ifrs-full:CurrentDepositsFromCustomers" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">741</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other payables</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_72" name="imc:OtherMiscellaneousCurrentPayables" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">716</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_75" name="imc:OtherMiscellaneousCurrentPayables" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">162</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_92" name="ifrs-full:OtherCurrentPayables" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,143</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210426222226328_95" name="ifrs-full:OtherCurrentPayables" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,497</ix:nonFraction></td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </ix:nonNumeric>
              </div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <div>
    <ix:nonNumeric id="Fxbrl_20220127180958259" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory" contextRef="C_20210101to20211231" escape="true">
      <div>
        <div>
          <div>
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>NOTE 15:-</span></span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">FINANCIAL INSTRUMENTS</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div>
          <div>
            <div style="text-align:justify;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The carrying values of the financial instruments which are measured at fair value through profit and loss as of December 31, 2021, and 2020, summarized in the following table:</span></span></span></span></div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
            <div style="line-height:1.25;margin-left:56.7pt">
              <ix:nonNumeric id="Fxbrl_20220330172624864" name="ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" contextRef="C_20210101to20211231" escape="true">
                <div>
                  <div>
                    <div>
                      <div style="line-height:1.25">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets:</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329223311547" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,429</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329223315071" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,341</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c,e</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative assets</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329223237105" name="ifrs-full:DerivativeFinancialAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329223240586" name="ifrs-full:DerivativeFinancialAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:64%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities:</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329223347812" name="imc:WarrantsMeasuredAtFairValue" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,022</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329223351533" name="imc:WarrantsMeasuredAtFairValue" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,540</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b,d</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:74.7pt;vertical-align:top;align:right">
                        <div style="margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></div>
                      </td>
                      <td style="width:auto;vertical-align:top">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management believes that the carrying amount of cash and cash equivalents, restricted bank deposit, trade receivables, other accounts receivable, loans receivables, trade payables, bank loans, other account payables and accrued expenses and purchase consideration payable, and approximate their fair value due to the short-term maturities of these instruments.</span></span></p>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:74.7pt;vertical-align:top;align:right">
                        <div style="margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></div>
                      </td>
                      <td style="width:auto;vertical-align:top">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021 and 2020, there were <ix:nonFraction id="Fxbrl_20220307151139626" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member" unitRef="Shares" scale="0" decimals="0" format="ixt-sec:numwordsen">nil</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20220307151154183" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" contextRef="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">9,729,264</ix:nonFraction> 2019 Warrants outstanding from private placements in 2019 (2019 Warrants). The Company re-measured the warrants, according to their trading price in the market, in the amount of $<span style="-sec-ix-hidden:Fxbrl_20220307151218509">nil</span> and $<ix:nonFraction id="Fxbrl_20220307151235866" name="imc:FairValueOfWarrants" contextRef="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,540</ix:nonFraction>, respectively (level 1 in fair value hierarchy). As a result, for the year ended December 31, 2021 and 2020, the Company recognized a revaluation gain (loss) of $<ix:nonFraction id="Fxbrl_20220307151251929" name="imc:GainLossOnRevaluationOfFinancialInstruments" contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,929</ix:nonFraction> and $(<ix:nonFraction id="Fxbrl_20220307151302587" name="imc:GainLossOnRevaluationOfFinancialInstruments" contextRef="C_20200101to20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">16,283</ix:nonFraction>), respectively, in the consolidated statement of profit or loss and other comprehensive income, which unrealized gain is included in finance income (expense). During 2021, amount&#160;of $<ix:nonFraction id="Fxbrl_20220330165537653" name="imc:AmountOfWarrantTransferredInEquityDuringPeriod" contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">611</ix:nonFraction> of the 2019 Warrants transferred to equity and the rest expired.</span></span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div><ix:exclude>
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
                <div>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>60</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                </div>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 15:-</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FINANCIAL INSTRUMENTS (Cont.)</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On December 26, 2019, IMC entered into a share purchase agreement (the &#8220;SPA&#8221;) with Xinteza API Ltd. ("Xinteza"), a company with a unique biosynthesis technology.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The investment in the investee is accounted for as financial asset measured at fair value through profit or loss. The fair value of the investment as of December 31, 2021 and 2020, was $<ix:nonFraction id="Fxbrl_20220307152515478" name="imc:FairValueOfInvestment" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,429</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20220307152523843" name="imc:FairValueOfInvestment" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,341</ix:nonFraction>, respectively.</span></span></span></span></div>
            <div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021 and 2020, the fair value of the Xinteza was categorized within Level 3 of the fair value hierarchy. The fair value was based on financing rounds for the purchase of preferred shares during 2020 (see Note 24).</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:74.7pt;vertical-align:top;align:right">
                      <div style="margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></div>
                    </td>
                    <td style="width:auto;vertical-align:top">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On May 10, 2021, the Company completed an overnight marketed offering (the &#8220;Offering&#8221;)&#160;of&#160;<ix:nonFraction id="Fxbrl_20220307163118507" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">6,086,956</ix:nonFraction> Common Shares (each an &#8220;Offered Share&#8221;) at a price of US$<ix:nonFraction id="Fxbrl_20220307163417937" name="ifrs-full:ParValuePerShare" contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="USD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">5.75</ix:nonFraction> per Offered Share for aggregate gross proceeds of approximately US$<ix:nonFraction id="Fxbrl_20220307163443857" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="USD" scale="6" decimals="-6" format="ixt:numdotdecimal">35</ix:nonFraction> million ($<ix:nonFraction id="Fxbrl_20220307163523146" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,502</ix:nonFraction>). The Company also issued <ix:nonFraction id="Fxbrl_20220307163702422" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Shares" decimals="INF" format="ixt:numdotdecimal">3,043,478</ix:nonFraction> Common Share purchase warrants (each an &#8220;2021 Warrant&#8221;) to the purchasers of Offered Shares, for no additional consideration, that entitle the holders to purchase <ix:nonFraction id="Fxbrl_20220307163754895" name="imc:NumberOfCommonSharesCalledByWarrants" contextRef="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">3,043,478</ix:nonFraction> Common Shares of the Company at an exercise price of US$<ix:nonFraction id="Fxbrl_20220307163844033" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="USD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">7.2</ix:nonFraction> per Common Share for a term of <ix:nonNumeric id="Fxbrl_20220307163948158" name="imc:TermOfWarrantsFromDateOfIssuance" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" format="ixt-sec:duryear">5</ix:nonNumeric> years from the closing date.</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As the exercise price of the 2021 Warrants is denominated in US dollars, which is not the functional currency of the Company, the 2021 Warrants are accounted for as a derivative liability, which is measured at fair value. Gross proceeds in the amount of $<ix:nonFraction id="Fxbrl_20220330205829057" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,670</ix:nonFraction> were recorded as Share capital and premium, and $<ix:nonFraction id="Fxbrl_20220307164106252" name="ifrs-full:WarrantLiability" contextRef="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,832</ix:nonFraction> were recorded as a Warrant liability, based on a valuation using the Black &#38; Scholes option pricing model. The transaction costs incurred as a result of the Common Shares issuance amounted to approximately $<ix:nonFraction id="Fxbrl_20220307164212467" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,800</ix:nonFraction>, of which approximately $<ix:nonFraction id="Fxbrl_20220307164249420" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_imcListedWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,296</ix:nonFraction> (attributed to the issuance of the Warrants classified as liabilities) were recorded as an expense in the Company's consolidated statements of profit or loss and approximately $<ix:nonFraction id="Fxbrl_20220307164323867" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,539</ix:nonFraction> (attributed to the issuance of share capital) as a deduction from Share capital and premium.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, there were <ix:nonFraction id="Fxbrl_20220307164958756" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">3,043,478</ix:nonFraction> of 2021 Warrants outstanding and the Company re-measured the 2021 Warrants, according to Black &#38; Scholes model, in the amount of $<ix:nonFraction id="Fxbrl_20220307165020147" name="imc:FairValueOfWarrants" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,022</ix:nonFraction>. As a result, for the year ended December 31, 2021, the Company recognized a revaluation gain of $<ix:nonFraction id="Fxbrl_20220307165113616" name="imc:GainLossOnRevaluationOfFinancialInstruments" contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,810</ix:nonFraction> in the consolidated statement of profit or loss and other comprehensive income, which unrealized gain is included in finance income (expense).</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div><ix:exclude>
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
                <div>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>61</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                </div>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 15:-</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FINANCIAL INSTRUMENTS (Cont.)</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The 2021 warrants fair value was measured using the Black &#38; Scholes model with the following key assumptions:</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20220329223154529" name="imc:DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="margin-left:81pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td style="width:15.97%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31,</span></span></span></span></div>
                        </td>
                        <td style="width:1.11%;vertical-align:top">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                        </td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Sensitivity</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected volatility</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329223021813" name="imc:ExpectedVolatilityOfWarrants" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">83 </ix:nonFraction>%</span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td rowspan="2" style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Increase (decrease) in key assumptions would</span></span></span></span></div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>result in increase (decrease) in fair value.</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life (in years)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329223013508" name="imc:ExpectedLifeOfWarrants" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Year" decimals="INF" format="ixt:numdotdecimal">4.342</ix:nonFraction></span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk-free interest rate</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329222952838" name="imc:RiskFreeInterestRateOfWarrants" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">0.85</ix:nonFraction>%</span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td rowspan="2" style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Increase (decrease) in key assumptions would</span></span></span></span></div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>result in decrease (increase) in fair value.</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected dividend yield</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329222933423" name="imc:ExpectedDividendYieldOfWarrants" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction>%</span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value:</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Per Warrant (Canadian Dollar)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="Fxbrl_20220329222915365" name="imc:FairValuePerWarrant" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD_per_Share" scale="0" decimals="3" format="ixt:numdotdecimal">1.979</ix:nonFraction></span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Warrants (Canadian Dollar in thousands)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="Fxbrl_20220329222904812" name="imc:FairValueOfWarrants" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,022</ix:nonFraction></span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Financial risk management:</span></span></span></p>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has exposure to the following risks from its use of financial instruments:</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share price risk:</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group's investments in unlisted shares are sensitive to market price risk arising from uncertainties about future value of these investments. The Group manages the price risk through diversification and by placing limits on individual and total investment in shares.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company's Board of directors reviews and approves all decisions related to investments in shares.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>At the reporting date, the Group's exposure to investments in unlisted shares measured at fair value was $<ix:nonFraction id="Fxbrl_20210427224020199" name="imc:InvestmentsInUnlistedSharesMeasuredAtFairValue" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,429</ix:nonFraction>.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div><ix:exclude>
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
                <div>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>62</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                </div>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 15:-</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FINANCIAL INSTRUMENTS (Cont.)</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Credit risk:</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The maximum credit exposure as of December 31, 2021, is the carrying amount of cash and cash equivalents, accounts receivable and other current assets. The Group does not have significant credit risk with respect to customers. All cash and cash equivalents are placed with major Israeli financial institutions.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loan receivable credit risk is managed by each loan separately according to the Group&#8217;s policy, procedures and control relating to the borrower&#8217;s credit risk management. At the end of each period, the individual loan values are assessed based on a credit risk analysis. As of December 31, 2021, the Group had 2 loans outstanding (2020: <ix:nonFraction id="Fxbrl_20220330172537567" name="ifrs-full:CurrentPortionOfLongtermBorrowings" contextRef="C_20201231" unitRef="CAD" scale="6" decimals="-6" format="ixt-sec:numwordsen">nil</ix:nonFraction> loans) with a total balance of approximately $<ix:nonFraction id="Fxbrl_20220330172516049" name="ifrs-full:CurrentPortionOfLongtermBorrowings" contextRef="C_20211231" unitRef="CAD" scale="6" decimals="-4" format="ixt:numdotdecimal">2.71</ix:nonFraction> million.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The expected credit loss analysis is generally based on Management&#8217;s understanding of the borrower&#8217;s experience/integrity, financial health, business plans, capacity, products, customers, contracts, competitive advantages/disadvantages, and other pertinent factors when assessing credit risk. This would also include the assessment of the borrower&#8217;s forecasts as well as taking into consideration any security and/or collateral the Company has on the outstanding balance.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As security on the loan receivable to Biome Grow Inc., the borrower holds approximately 744,000 IM Cannabis Corp. common shares, on December 31, 2021. These shares cannot be sold without the proceeds from any sale being provided to the Company as repayment for the loan until the balance is fully discharged.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, the Company assessed the overall risk of the loan receivable balance and concluded that no expected credit loss under IFRS 9 was required.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Liquidity risk:</span></span></span></span></div>
            <div style="line-height:1.25">
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, the Group's financial liabilities with liquidity risk consist of trade payables and other accounts payable which have contractual maturity dates within one year, bank loans and lease liabilities. The Group manages its liquidity risk by reviewing its capital requirements on an ongoing basis. Based on the Group's working capital position at December 31, 2021, management considers liquidity risk to be low. The table below summarizes the maturity profile of the Group&#8217;s bank loans and lease liabilities based on contractual undiscounted payments (including interest payments):</span></span></span></span></div>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20220330172643568" name="ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2021:</span></span></span></span></div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="line-height:1.25;font-weight:400;font-family:'Times New Roman',Times,serif;margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less than one year</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1 to 5 years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6 to 10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&gt;10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212619375_xbrl_20210427163720349" name="ifrs-full:LeaseLiabilities" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,130</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212619375_xbrl_20210427163723287" name="ifrs-full:LeaseLiabilities" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,781</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212619375_xbrl_20210427163727563" name="ifrs-full:LeaseLiabilities" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,760</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212619375_xbrl_20210427163734208" name="ifrs-full:LeaseLiabilities" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,620</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Bank Loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163720349" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,502</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163723287" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163727563" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330172035221" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330172101460_xbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163720349" name="imc:BankLoanAndLeaseLiabilities" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,632</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330172101460_xbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163723287" name="imc:BankLoanAndLeaseLiabilities" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,781</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330172101460_xbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163727563" name="imc:BankLoanAndLeaseLiabilities" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,760</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330172101460_xbrl_20220330172035221" name="imc:BankLoanAndLeaseLiabilities" contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,620</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2020:</span></span></span></span></div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less than one year</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1 to 5 years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6 to 10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&gt;10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220329212624036_xbrl_20210427163720349" name="ifrs-full:LeaseLiabilities" contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">232</ix:nonFraction></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220329212624036_xbrl_20210427163723287" name="ifrs-full:LeaseLiabilities" contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">547</ix:nonFraction></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220329212624036_xbrl_20210427163727563" name="ifrs-full:LeaseLiabilities" contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">515</ix:nonFraction></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220330172705239" name="ifrs-full:LeaseLiabilities" contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <div><ix:exclude>
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
                <div>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>63</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                </div>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 15:-</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FINANCIAL INSTRUMENTS (Cont.)</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The maturity profile of the Group's other financial liabilities with liquidity risk (trade payables, other account payable and accrued expenses) as of December 31, 2021 and 2020, are less than one year.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Currency rate risk<span style="font-weight:bold">:</span></span></span></span></span></div>
            <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25;font-style:italic">&#160;</div>
            <div style="line-height:1.25">
              <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, a portion of the Group's financial assets and liabilities held in Euro, NIS, USD and GBP consist of cash and cash equivalents in the amount of EUR <ix:nonFraction id="Fxbrl_20220307162554779" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyEUR" unitRef="Euro" scale="3" decimals="-3" format="ixt:numdotdecimal">742</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220330170051458" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyEUR" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,069</ix:nonFraction>), NIS <ix:nonFraction id="Fxbrl_20220330170247232" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyILS" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">16,718</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220307162836343" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyILS" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,845</ix:nonFraction>), USD <ix:nonFraction id="Fxbrl_20220308025139279" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyUSD" unitRef="USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,136</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220330171444278" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyUSD" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,447</ix:nonFraction>) and GBP <ix:nonFraction id="Fxbrl_20220329223709214" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyGBP" unitRef="GBP" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220330171518133" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyGBP" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction>) respectively. The Group's objective in managing its foreign currency risk is to minimize its net exposure to foreign currency cash flows by transacting, to the greatest extent possible, with third parties in NIS. The Group does not currently use foreign exchange contracts to hedge its exposure of its foreign currency cash flows as management has determined that this risk is not significant at this point of time.</span></span></span></span></div>
              <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25">&#160;</div>
            </div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:27.75pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Changes in liabilities arising from financing activities:</span></span></span></p>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">
              <ix:nonNumeric id="Fxbrl_20220330172731189" name="ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" contextRef="C_20210101to20211231" escape="true">
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total liabilities arising from financing activities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1, 2020</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102110_xbrl_20210427191805093_22" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102110_xbrl_20210427191805093_25" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,050</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102110_xbrl_20210427191805093_28" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">197</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102110_xbrl_20210427191805093_211" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20191231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,247</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new leases</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102117_xbrl_20210427191805093_72" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102117_xbrl_20210427191805093_75" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">107</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102117_xbrl_20210427191805093_78" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102117_xbrl_20210427191805093_711" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">107</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash flows</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102122_xbrl_20210427191805093_82" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102122_xbrl_20210427191805093_85" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">250</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102122_xbrl_20210427191805093_88" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102122_xbrl_20210428131426043" name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">250</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Conversion of warrant</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102128_xbrl_20220307143134242_xbrl_20210427191805093_82" name="imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102128_xbrl_20220307143134242_xbrl_20210427191805093_85" name="imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102128_xbrl_20220307143134242_xbrl_20210427191805093_88" name="imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">3,873</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102128_xbrl_20220307143134242_xbrl_20210428131426043" name="imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">3,873</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other changes</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102134_xbrl_20210427191805093_92" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102134_xbrl_20210427191805093_95" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">83</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102134_xbrl_20210427191805093_98" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">61</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102134_xbrl_20210427191805093_911" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">144</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effect of changes in fair value</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102144_xbrl_20210427191805093_102" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102144_xbrl_20210427191805093_105" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102144_xbrl_20210427191805093_108" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,155</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102144_xbrl_20210427191805093_1011" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,155</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31, 2020</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212124535_xbrl_20210427191805093_202" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212124535_xbrl_20210427191805093_205" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">990</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212124535_xbrl_20210427191805093_208" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,540</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212124535_xbrl_20210427191805093_2011" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,530</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issuance of new warrants</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102165_xbrl_20220307144239893_xbrl_20210427191805093_142" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102165_xbrl_20220307144239893_xbrl_20210427191805093_145" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102165_xbrl_20220307144239893_xbrl_20210427191805093_148" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,832</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102165_xbrl_20220307144239893_xbrl_20210427191805093_1411" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,832</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_142" name="imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,504</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_145" name="imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_148" name="imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_1411" name="imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,504</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new leases</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102182_xbrl_20210427191805093_142" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102182_xbrl_20210427191805093_145" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,678</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102182_xbrl_20210427191805093_148" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102182_xbrl_20210427191805093_1411" name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,678</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions related to acquisitions</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_142" name="imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,957</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_145" name="imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,222</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_148" name="imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_1411" name="imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,179</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayments</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102188_xbrl_20220308020126882" name="imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">700</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102188_xbrl_20220308020527303" name="imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,980</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102188_xbrl_20220308020559808" name="imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102188_xbrl_20220308020714179" name="imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">2,680</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effective interest</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174504470_xbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_142" name="imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174504470_xbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_145" name="imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,347</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174504470_xbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_148" name="imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174504470_xbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_1411" name="imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,347</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other changes</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102194_xbrl_20210427191805093_172" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">133</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102194_xbrl_20210427191805093_175" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">117</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102194_xbrl_20210427191805093_178" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">611</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102194_xbrl_20210427191805093_1711" name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">361</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effect of changes in fair value</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102199_xbrl_20210427191805093_182" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329212102199_xbrl_20210427191805093_185" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102199_xbrl_20220308014213241" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">21,739</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329212102199_xbrl_20220308014228650" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">21,739</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31, 2021</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330171822805_xbrl_20220329212124535_xbrl_20210427191805093_202" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,894</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330171822805_xbrl_20220329212124535_xbrl_20210427191805093_205" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,374</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330171822805_xbrl_20220329212124535_xbrl_20210427191805093_208" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,022</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330171822805_xbrl_20220329212124535_xbrl_20210427191805093_2011" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,290</ix:nonFraction></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
        <div>
          <div>
            <div>
              <div>
                <div>
                  <div style="margin-left:90pt">&#160;</div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>64</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
  </div>
  <div>&#160;</div>

  <div>
    <div>
      <div>
        <div>
          <div>
            <div>
              <div>
                <ix:nonNumeric id="Fxbrl_20220329201614038" name="ifrs-full:DisclosureOfContingentLiabilitiesExplanatory" contextRef="C_20210101to20211231" escape="true">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 16:-</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Legal proceedings:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:27.75pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">a.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">On August 19, 2019, a motion was filed for approval of a class action (the &#8220;Motion&#8221;) against 17 companies (the &#8220;Companies&#8221;) operating in the field of medical cannabis in Israel, including Focus. The applicant&#8217;s argument is that the Companies did not accurately mark the concentration of active ingredients in their products. The personal suit sum for every class member stands at NIS <ix:nonFraction id="Fxbrl_20220307111845176" name="imc:AmountOfPersonalSuit" contextRef="C_20190819" unitRef="NIS" scale="0" decimals="0" format="ixt:numdotdecimal">15,585</ix:nonFraction> ($<ix:nonFraction id="Fxbrl_20220307111901359" name="imc:AmountOfPersonalSuit" contextRef="C_20190819" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,900</ix:nonFraction>) and the total amount of the class action suit is estimated at NIS <ix:nonFraction id="Fxbrl_20220307111912751" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" contextRef="C_20190819" unitRef="NIS" scale="0" decimals="0" format="ixt:numdotdecimal">686,000</ix:nonFraction> ($<ix:nonFraction id="Fxbrl_20220307111939958" name="ifrs-full:EstimatedFinancialEffectOfContingentLiabilities" contextRef="C_20190819" unitRef="CAD" scale="0" decimals="0" format="ixt:numdotdecimal">259,000</ix:nonFraction>). On June 2, 2020, the Companies submitted their response to the Motion. The Companies argue in their response that the threshold conditions for approval of a class action were not met, since there is no reasonable possibility that the causes of action in the Motion will be decided in favor of the class group. On July 3, 2020, the applicant submitted his response to the Companies&#8217; response. On July 5, 2020 the applicant was absent from the hearing. As a result, on July 23, 2020, the Companies filed an application for a ruling of expenses, which received a response from the applicant on August 12, 2020, asking to decline this request. On September 21, 2020, the court ruled that the applicant would pay the Companies&#8217; expenses amount of NIS <ix:nonFraction id="Fxbrl_20220307120511602" name="imc:AmountOfExpensesPaidByApplicant" contextRef="C_20200901to20200921" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">750</ix:nonFraction>. On July 14, 2021 a hearing was held. The court recommended the parties to negotiate independently to avoid litigation, and if negotiations fail, then to begin mediation proceedings. The parties agreed to follow the court&#8217;s recommendations, though the negotiations between the parties have not yet begun. On November 3, 2021 the court ruled the parties will file an update regarding the mediation procedure, in 30 days. The parties conducted unsuccessful negotiations and are now waiting for a court decision regarding the continuation of the proceedings.</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">At this preliminary stage, based on the opinion of its legal counsel, Focus&#8217; management cannot assess the chances of approval of the Motion nor the chances of the claims under the Motion being accepted if the Motion is approved. Therefore, no provision has been recorded in respect thereof.</span></span></div>
                    <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">b.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">On October 6, 2019, Focus received a decision regarding a petition that was filed against the MOH, concerning the new regulatory framework of the cannabis market and demanding that the court resolve as follows:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:103.05pt">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">that the MOH immediately suspend the implementation of the new regulation that harms, disproportionally, the medical cannabis patients;</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">that the implementation of the new regulation, as is, would cause violation of constitutional rights of the medical cannabis patients; and</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">that the MOH amend the flaws of the new regulation, prior to becoming effective, and to establish new regulations regarding labeling and use of pesticides.</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">According to the decision, Focus was attached to the proceedings and filed its response on November 12, 2019.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">On March 8, 2020, the court decided to extend the validity of the interim injunction, so that the medical cannabis use licenses, which were extended under the decision, would continue to be valid until May 15, 2020, or 10 days after the date the MOH comes to a conclusion regarding the price control of medical cannabis products, whichever comes first, subject to another court decision.</span></span></div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <p style="margin:0pt">&#160;</p>
                        <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>65</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 16:-</span></span></td>
                            <td style="width:auto;vertical-align:top;text-align:justify">
                              <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Cont.)</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </ix:exclude></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The court also decided that if a further extension of the period of the interim injunction is granted beyond May 15, 2020, to the extent required, it would be subject to medical surveillance by the attending physician, that his details of which were included in the patient&#8217;s existing use license.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 29, 2020, the respondents represented by the State Attorney&#8217;s Office filed an update notice stating that the Appeals Committee unanimously decided against imposing price controls on medical cannabis products and that the Prices Committee would hold a follow-up hearing in four months. The respondents also requested to update the Court again in two months.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 25, 2020, the petitioner submitted their response to the respondents&#8217; update notice.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 25, 2021, the respondents represented by the State Attorney&#8217;s Office filed an updating notice stating that the Prices Committee had come to a decision against imposing price controls on medical cannabis products. However, the Prices Committee announced that it will issue a request for information to the corporations engaged in the medical cannabis market and assess the market every six months. Following the aforementioned, the respondents represented by the State Attorney&#8217;s Office believe that the appeal should be rejected and the interim injunction should be canceled. On April 13, 2021, three of the respondents filed a response to the court, requesting to reject the appeal and to cancel the interim injunction.</span></span></div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;</span></span></div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 25, 2021, the petitioner filed a response to the update notice to the court, objecting to the position of the respondents represented by the State Attorney&#8217;s Office, requesting the court to resolve as requested in the petition and grant the requested remedies to the petitioner. On July 6, 2021, the petitioner filed an urgent request to the court, to issue orders to the respondents represented by the State Attorney&#8217;s Office, to request information from corporations engaged in the medical cannabis market in order to continue the examination of the market, according to the Prices Committee&#8217;s announcement mentioned above, and requested the court to reschedule the hearing set to occur on September 19, 2021, to an earlier date. The petitioner&#8217;s request was rejected by the court on July 7, 2021, and on September 19, 2021, a hearing was held. On November 16, 2021 the Supreme court of Israel ruled that motion will be deleted and interim injunction will be expired after 10 days. Following a request submitted by the petitioner on November 15, 2021, the Supreme court of Israel determined that the interim injunction will extend until March 1, 2022. Further requests submitted for an extension of the interim injunction were denied.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                            <tr>
                              <td style="width:56.7pt">&#160;</td>
                              <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 11, 2021, the Company was informed that a claim (the &#8220;Construction Proceedings&#8221;) was filed by the municipal committee presiding over planning and construction in southern Israel (the &#8220;Construction Committee&#8221;) against Focus, Focus&#8217; directors and officers, and certain landowners, including Oren Shuster and Rafael Gabay, claiming for inadequate permitting for construction relating to the Focus Facility (&#8220;Construction Allegations&#8221;). A hearing was set to June 13, 2022.</span></span></div>
                              </td>
                            </tr>

                        </table>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At this preliminary stage, based on the opinion of its legal counsel, Focus&#8217; management cannot assess the chances of the claim advancing or the potential outcome of the Construction Proceedings.</span></span></div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
                <p style="margin:0pt">&#160;</p>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>66</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
  <div>&#160;</div>

  <ix:nonNumeric id="Fxbrl_20220307102745883" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" contextRef="C_20210101to20211231" escape="true">
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 17:-</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TAXES ON INCOME</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax rates applicable to the Group:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company and its Canadian subsidiaries are subject to tax rates applicable in Canada. The combined federal and provincial rate for 2021 and 2020 is <ix:nonFraction id="Fxbrl_202104280257057420" name="ifrs-full:ApplicableTaxRate" contextRef="C_20200101to20201231_srtStatementGeographicalAxis_countryCA" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal"><ix:nonFraction id="Fxbrl_20210428025705742" name="ifrs-full:ApplicableTaxRate" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryCA" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">26.5</ix:nonFraction></ix:nonFraction>%.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Israeli subsidiaries are subject to Israeli corporate income tax rate of <ix:nonFraction id="Fxbrl_202104280257290750" name="ifrs-full:ApplicableTaxRate" contextRef="C_20200101to20201231_srtStatementGeographicalAxis_countryIL" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal"><ix:nonFraction id="Fxbrl_20210428025729075" name="ifrs-full:ApplicableTaxRate" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryIL" unitRef="Percentage" scale="-2" decimals="2" format="ixt:numdotdecimal">23</ix:nonFraction></ix:nonFraction>% in 2021 and 2020.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The German subsidiary is subject to weighted tax rate of approximately <ix:nonFraction id="Fxbrl_20210428030550834" name="ifrs-full:ApplicableTaxRate" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">29.1</ix:nonFraction>% (composed of Federal and Municipal tax).</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Carryforward losses for tax purposes:</p>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward operating tax losses of the Israeli subsidiaries total approximately $<ix:nonFraction id="Fxbrl_20220307095851065" name="imc:CarryforwardOperatingTaxLosses" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryIL" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,153</ix:nonFraction>, as of December 31, 2021. These losses can be carried forward to future years and offset against taxable income in the future without any time limitation. No deferred tax assets were recorded with regards to IMC Holdings ltd. since the Company does not anticipate to utilize the net operating losses in the foreseeable future.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward operating tax losses of the German subsidiary as of December 31, 2021, amounted to approximately $<ix:nonFraction id="Fxbrl_20220307095908173" name="imc:CarryforwardOperatingTaxLosses" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember_srtStatementGeographicalAxis_countryDE" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,964</ix:nonFraction>. <ix:nonNumeric id="Fxbrl_20220307095922900" name="imc:CarryforwardLossesForTaxPurposesDescription" contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember_srtStatementGeographicalAxis_countryDE">Accumulated tax losses can be carried forward without time restrictions and can be deducted from future profits and capital gains unless they exceed &#8364;1,000 thousand (approximately $1,441). Any excess of such amount will be limited to 60% of the profits or capital gains</ix:nonNumeric>. Unused carried forward losses will be subject to such limitation in the future. No deferred tax assets were recorded with regards to the German subsidiary since the Company does not anticipate to utilize the net operating losses in the foreseeable future.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward operating tax losses of Canadian subsidiaries as of December 31, 2021, amounted to approximately $<ix:nonFraction id="Fxbrl_20220329211452593" name="imc:CarryforwardOperatingTaxLosses" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryCA" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,218</ix:nonFraction>. These losses can be carried forward to future years and offset against taxable income in the future without any time limitation. Deferred tax assets of approximately $<ix:nonFraction id="Fxbrl_20220307095858151" name="ifrs-full:DeferredTaxAssets" contextRef="C_20211231_srtStatementGeographicalAxis_countryCA" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,542</ix:nonFraction>, relating to these losses were recognized in the financial statements.</span></span></div>
        <div><ix:exclude>
          <div style="line-height:1.25">
            <p style="margin:0pt">&#160;</p>
            <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>67</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
            <p style="margin:0pt">&#160;</p>
          </div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 17:-</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TAXES ON INCOME (Cont.)</span></span></div>
                </td>
              </tr>

          </table>
        </ix:exclude></div>
        <p style="margin:0pt">&#160;</p>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Income tax expense (benefit):</p>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">
          <p style="margin:0pt">&#160;</p>
        </div>
        <ix:nonNumeric id="Fxbrl_20210428060043799" name="imc:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory" contextRef="C_20210101to20211231" escape="true">
          <div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427094354029_32" name="ifrs-full:CurrentTaxExpenseIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">248</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427094354029_35" name="ifrs-full:CurrentTaxExpenseIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427094354029_42" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">278</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210427094354029_45" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">66</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax from previous years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220307100344404_xbrl_20210427094354029_52" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">21</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307100344404_xbrl_20210427094354029_55" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">303</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307100354540_xbrl_20210427094354029_72" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">505</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307100354540_xbrl_20210427094354029_75" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">262</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Deferred taxes:</p>
              </td>
            </tr>

        </table>
        <div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20210428104409367" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory" contextRef="C_20210101to20211231" escape="true">
            <div style="margin-left:90pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statements of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">financial position</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statements of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">profit or loss</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward tax losses and other</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307103151334_xbrl_20210427112936081" name="ifrs-full:DeferredTaxAssets" contextRef="C_20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,542</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307103151334_xbrl_20210427113018999" name="ifrs-full:DeferredTaxAssets" contextRef="C_20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">769</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307103151334_xbrl_20210427113140287" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20210101to20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">892</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307103151334_xbrl_20210427113201752" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20200101to20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">440</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other deferred tax assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329210821784_xbrl_20220307103151334_xbrl_20210427112936081" name="ifrs-full:DeferredTaxAssets" contextRef="C_20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329210821784_xbrl_20220307103151334_xbrl_20210427113018999" name="ifrs-full:DeferredTaxAssets" contextRef="C_20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220329210821784_xbrl_20220307103151334_xbrl_20210427113140287" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20210101to20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329210821784_xbrl_20220307103151334_xbrl_20210427113201752" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20200101to20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331171524784" name="ifrs-full:DeferredTaxAssets" contextRef="C_20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,556</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329210826079_xbrl_20220307103151334_xbrl_20210427113018999" name="ifrs-full:DeferredTaxAssets" contextRef="C_20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">769</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331192929580" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20210101to20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">891</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329210826079_xbrl_20220307103151334_xbrl_20210427113201752" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20200101to20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">440</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory and biological assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307103207524_xbrl_20210427113257053" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">863</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307103207524_xbrl_20210427113323428" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,239</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307103207524_xbrl_20210427113423549" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">431</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307103207524_xbrl_20210427113603540" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">385</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427113340299" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,261</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427113406244" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">264</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427113633253" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">189</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427113654579" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">11</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307112741861_xbrl_20210427113340299" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307112741861_xbrl_20210427113406244" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307112741861_xbrl_20210427113633253" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307112741861_xbrl_20210427113654579" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331171931145_xbrl_20220307112741861_xbrl_20210427113340299" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,131</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331171931145_xbrl_20220307112741861_xbrl_20210427113406244" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,503</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331171931145_xbrl_20220307112741861_xbrl_20210427113633253" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20210101to20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">613</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331171931145_xbrl_20220307112741861_xbrl_20210427113654579" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20200101to20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">374</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Translation differences</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427113820707" name="imc:TranslationDifferencesOfDefferedTaxes" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">54</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427113843779" name="imc:TranslationDifferencesOfDefferedTaxes" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">63</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax expenses, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307103227012_xbrl_20210427113935230" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">278</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307103227012_xbrl_20210427114000622" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">66</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427114021277" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,575</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427114130511" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">734</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The deferred taxes are reflected in the statements of financial position as follows:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20210428104428889" name="imc:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" contextRef="C_20210101to20211231" escape="true">
          <div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427142712404" name="ifrs-full:DeferredTaxAssets" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427142717641" name="ifrs-full:DeferredTaxAssets" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">769</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427142728434_xbrl_20210427142712404" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,591</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427142728434_xbrl_20210427142717641" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,503</ix:nonFraction></span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The deferred taxes are computed based on the tax rates that are expected to apply upon realization.</span></span></div>
        <div><ix:exclude>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>68</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
              <p style="margin:0pt">&#160;</p>
            </div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 17:-</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TAXES ON INCOME (Cont.)</span></span></div>
                </td>
              </tr>

          </table>
        </ix:exclude></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of tax expense and the accounting profit multiplied by the Company's domestic tax rate for 2021 and 2020:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20210428172327161" name="imc:DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory" contextRef="C_20210101to20211231" escape="true">
          <div>
            <div style="margin-left:90pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income tax</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307113918000_xbrl_20210428023705327_32" name="ifrs-full:AccountingProfit" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">18,013</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307113918000_xbrl_20210428023705327_35" name="ifrs-full:AccountingProfit" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,472</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate in Canada <ix:nonFraction id="Fxbrl_202203292102487510" name="ifrs-full:ApplicableTaxRate" contextRef="C_20200101to20201231" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal"><ix:nonFraction id="Fxbrl_20220329210248751" name="ifrs-full:ApplicableTaxRate" contextRef="C_20210101to20211231" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">26.5</ix:nonFraction></ix:nonFraction>%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428023705327_52" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">4,773</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210428023705327_55" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">7,545</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in income tax due to:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses (non-taxable income), net for tax purposes</span></span></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220307113927129_xbrl_20210428023705327_92" name="imc:NonDeductibleIncomeExpenseNetForTaxPurposes" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">3,447</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307113927129_xbrl_20210428023705327_95" name="imc:NonDeductibleIncomeExpenseNetForTaxPurposes" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,306</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of different tax rate of subsidiaries</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023705327_102" name="imc:TaxEffectOfDifferentTaxRateOfSubsidiaries" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">310</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023705327_105" name="imc:TaxEffectOfDifferentTaxRateOfSubsidiaries" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">161</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments in respect of current income tax of previous years</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307113934767_xbrl_20210428023705327_112" name="imc:TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">21</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113934767_xbrl_20210428023705327_115" name="imc:TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">303</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognition (derecognition) of tax benefit in respect of losses of previous years</span></span></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307113941983_xbrl_20210428023705327_122" name="imc:TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">846</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220307113941983_xbrl_20210428023705327_125" name="imc:TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">830</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrecognized tax benefit in respect of loss for the year</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023705327_132" name="imc:TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,093</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210428023705327_135" name="imc:TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,771</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Utilization of losses not previously recognized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307114620089_xbrl_20210428023705327_132" name="imc:UtilizationOfLossesNotPreviouslyRecognized" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,466</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20220307114620089_xbrl_20210428023705327_135" name="imc:UtilizationOfLossesNotPreviouslyRecognized" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in tax benefits not recognized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329211130030" name="imc:ChangeInTaxBenefitsNotRecognized" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,252</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220330193418718" name="imc:ChangeInTaxBenefitsNotRecognized" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other adjustments</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307113950203_xbrl_20210428023705327_142" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">289</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113950203_xbrl_20210428023705327_145" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">96</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113956196_xbrl_20210428023705327_162" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">505</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307113956196_xbrl_20210428023705327_165" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">262</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>

  <ix:nonNumeric id="Fxbrl_20220307121844648" name="ifrs-full:DisclosureOfIssuedCapitalExplanatory" contextRef="C_20210101to20211231" escape="true">
    <div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 18:-</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span>EQUITY</span></span></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition of share capital:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20210427121410409" name="imc:DisclosureOfCompositionOfShareCapitalExplanatory" contextRef="C_20210101to20211231" escape="true">
            <div>
              <div style="line-height:1.25;margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Authorized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued and outstanding</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Authorized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued and outstanding</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="14" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares without par value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unlimited</span></span></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_202104271329324710" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20211231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fxbrl_20210427132932471" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20211231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">68,217,894</ix:nonFraction></ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unlimited</span></span></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_202104271330424370" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20201231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fxbrl_20210427133042437" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20201231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">39,765,799</ix:nonFraction></ix:nonFraction></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares confer upon their holders the right to participate in the general meeting where each Ordinary share has one voting right in all matters, receive dividends if and when declared and to participate in the distribution of surplus assets in case of liquidation of the Company.</span></span></div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
          <div><ix:exclude>
            <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
              <div>
                <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>69</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 18:-</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EQUITY (Cont.)</span></span></div>
                  </td>
                </tr>

            </table>
          </ix:exclude></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 12, 2021, <ix:nonNumeric id="Fxbrl_20210507094522618" name="imc:DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" contextRef="C_20210201to20210212">the Company's shareholders general meeting resolved to consolidated all of its issued and outstanding Ordinary shares on a four (4) to one (1) basis (the &#8220;Share Consolidation&#8221;)</ix:nonNumeric>. Following the Share Consolidation, the number of Listed Warrants outstanding was not altered; however, the exercise terms were adjusted such that four Listed Warrants are exercisable for one Ordinary Share following the payment of an adjusted exercise price of $<ix:nonFraction id="Fxbrl_20210428025124509" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20210212" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">5.20</ix:nonFraction>. The earnings per share, in these consolidated financial statements, give effect to the Share Consolidation for all periods presented.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital issuance during the reporting period:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 10, 2021, the Company completed an overnight marketed offering (the &#8220;Offering&#8221;) of <ix:nonFraction id="Fxbrl_20220307134209235" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">6,086,956</ix:nonFraction> Common Shares (each an &#8220;Offered Share&#8221;) at a price of US$<ix:nonFraction id="Fxbrl_20220307134216792" name="ifrs-full:ParValuePerShare" contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="USD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">5.75</ix:nonFraction> per Offered Share for aggregate gross proceeds of approximately US$<ix:nonFraction id="Fxbrl_20220307134221776" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="USD" scale="6" decimals="-6" format="ixt:numdotdecimal">35</ix:nonFraction> million ($<ix:nonFraction id="Fxbrl_20220307134525529" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,502</ix:nonFraction>). The Company also issued <ix:nonFraction id="Fxbrl_20220307135057180" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">3,043,478</ix:nonFraction> Common Share purchase warrants (each an &#8220;2021 Warrant&#8221;) to the purchasers of Offered Shares, for no additional consideration, that entitle the holders to purchase <ix:nonFraction id="Fxbrl_20220307135100170" name="imc:NumberOfCommonSharesCalledByWarrants" contextRef="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">3,043,478</ix:nonFraction> Common Shares of the Company at an exercise price of US$<ix:nonFraction id="Fxbrl_20220307135107559" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="USD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">7.2</ix:nonFraction> per Common Share for a term of <ix:nonNumeric id="Fxbrl_20220307135111415" name="imc:TermOfWarrantsFromDateOfIssuance" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" format="ixt-sec:duryear">5</ix:nonNumeric> years from the closing date.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As the exercise price of the 2021 Warrants is denominated in US dollars, which is not the functional currency of the Company, the 2021 Warrants are accounted for as a derivative liability, which is measured at fair value. Gross proceeds in the amount of $<ix:nonFraction id="Fxbrl_20220330214546764" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,670</ix:nonFraction> were recorded as Share capital and premium, and $<ix:nonFraction id="Fxbrl_20220307140626252" name="ifrs-full:WarrantLiability" contextRef="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,832</ix:nonFraction> were recorded as a Warrant liability, based on a valuation using the Black &#38; Scholes option pricing model. The transaction costs incurred as a result of the Common Shares issuance amounted to approximately $<ix:nonFraction id="Fxbrl_20220307142301551" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,800</ix:nonFraction>, of which approximately $<ix:nonFraction id="Fxbrl_20220307142339609" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_imcListedWarrantsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,296</ix:nonFraction> (attributed to the issuance of the Warrants classified as liabilities) were recorded as an expense in the Company's consolidated statements of profit or loss and approximately $<ix:nonFraction id="Fxbrl_20220307142409945" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,539</ix:nonFraction> (attributed to the issuance of share capital) as a deduction from Share capital and premium.</span></span></div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to the terms of the Offering, the placement agents held an over-allotment option to purchase up to an additional <ix:nonFraction id="Fxbrl_20220307143348504" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">913,044</ix:nonFraction> Offered Shares and <ix:nonFraction id="Fxbrl_20220308030459847" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">456,522</ix:nonFraction> 2021 Warrants on the same terms and conditions for a period of 30 days following the closing date. The over- allotment option was not exercised by the placement agents and expired as of June 30, 2021. The Company recorded expenses in the amount of approximately $<ix:nonFraction id="Fxbrl_20220307143408530" name="imc:ShareBasedCompensation" contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">800</ix:nonFraction> under share-based compensation expenses with respect to the Offering.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Offering was conducted pursuant to the Company's effective shelf registration statement on Form F-10 filed with the U.S. Securities and Exchange Commission and a corresponding Canadian shelf prospectus filed with the Securities Regulatory Authority in each of the provinces and territories of Canada and a final prospectus supplement which was filed with the SEC on May 5, 2021.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div><ix:exclude>
            <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
              <div>
                <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>70</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 18:-</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EQUITY (Cont.)</span></span></div>
                  </td>
                </tr>

            </table>
          </ix:exclude></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in issued and outstanding share capital:</span></span></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <ix:nonNumeric id="Fxbrl_20210427121439324" name="imc:DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory" contextRef="C_20210101to20211231" escape="true">
            <div>
              <div style="margin-left:90pt">
                <div>
                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427133123064" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20191231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">36,435,837</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of Warrants and Compensation options exercised</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307144224467" name="imc:OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" contextRef="C_20200101to20201231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">3,169,769</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of options exercises</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307144242882" name="imc:OrdinarySharesIssuedOptionsExercises" contextRef="C_20200101to20201231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">160,193</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329204938286" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20201231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">39,765,799</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of Warrants and Compensation options exercised</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427133401725" name="imc:OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" contextRef="C_20210101to20211231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">633,784</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of options exercises</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427133438825" name="imc:OrdinarySharesIssuedOptionsExercises" contextRef="C_20210101to20211231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">517,346</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of treasury common shares</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220331132832770_xbrl_20210427133438825" name="imc:PurchaseOfTreasuryCommonShares" contextRef="C_20210101to20211231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal" sign="-">101,649</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued related secondary transaction and business combinations</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329204930433" name="imc:NumberOfSharesIssuedInBusinessCombinationTransaction" contextRef="C_20210101to20211231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">27,402,614</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331132628095_xbrl_20220329204938286" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20211231" unitRef="Share" scale="0" decimals="0" format="ixt:numdotdecimal">68,217,894</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
          <div>&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share option plan:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="text-align:justify;margin-right:28.35pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Awards granted under the company&#8217;s current plan which was approved by the board of directors on December 19, 2018 (&#8220;2018 Plan&#8221;) are subject to vesting schedules and unless determined otherwise by the administrator of the 2018 Plan, generally vest following a period of three years from the applicable vesting commencement date, such that <ix:nonFraction id="Fxbrl_20210428045024529" name="imc:PercentageOfAwardsVest" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember_imcVestingAxis_imcFirstAnniversaryOfApplicableVestingCommencementDateMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">33.3</ix:nonFraction>% of the awards vest on the first anniversary of the applicable vesting commencement date and <ix:nonFraction id="Fxbrl_20210428045112168" name="imc:PercentageOfAwardsVest" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember_imcVestingAxis_imcVestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">66.7</ix:nonFraction>% of the awards vest in eight equal installments upon the lapse of each three-month period thereafter. Subject to the discretion of the 2018 Plan administrator, if an award has not been exercised within seven years after the date of the grant, the award expires. As of December 31, 2021, <ix:nonFraction id="Fxbrl_20210428045403965" name="imc:NumberOfSharesAvailableForFutureGrants" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">1,607,550</ix:nonFraction> Ordinary shares are available for future grants under the 2018 Plan.</span></span></div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div><ix:exclude>
            <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
              <div>
                <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>71</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 18:-</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EQUITY (Cont.)</span></span></div>
                  </td>
                </tr>

            </table>
          </ix:exclude></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value for options granted during the years ended December 31, 2021 and 2020, to the Group's employees, directors and advisors was estimated using the Black &#38; Scholes option pricing model with the following assumptions:</span></span></div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
          <div style="margin-left:90pt">
            <ix:nonNumeric id="Fxbrl_20220330181507214" name="imc:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div>
                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price (in CAD)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="Fxbrl_20220331133104084" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Year" scale="0" decimals="1" format="ixt:numdotdecimal">4.5</ix:nonFraction> - $<ix:nonFraction id="Fxbrl_20210427160732853" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">10.12</ix:nonFraction></span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="Fxbrl_20220330181149385" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">1.6</ix:nonFraction> - $<ix:nonFraction id="Fxbrl_20220307161038207" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">8.56</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428121057426" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="C_20210101to20211231" unitRef="Percentage" scale="-2" decimals="2" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210428121113706" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="C_20200101to20201231" unitRef="Percentage" scale="-2" decimals="2" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected life of share options (Years)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331133137764" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Year" scale="0" decimals="0" format="ixt:numdotdecimal">3</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20220331133141244" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Year" scale="0" decimals="0" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307161708165" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Year" scale="0" decimals="2" format="ixt:numdotdecimal">2.77</ix:nonFraction> - <ix:nonFraction id="Fxbrl_20220330200053762" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Year" scale="0" decimals="0" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Volatility (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427160903917" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">80.61</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20210427160936839" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">83.68</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307162031008" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="3" format="ixt:numdotdecimal">74.8</ix:nonFraction> - <ix:nonFraction id="Fxbrl_20220307161318878" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">80.39</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Annual risk-free rate (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210427160915068" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">0.52</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20210427160941503" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">0.77</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307162108015" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">0.25</ix:nonFraction> &#8211; <ix:nonFraction id="Fxbrl_20210427161034953" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Percentage" scale="-2" decimals="4" format="ixt:numdotdecimal">0.37</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share price (in CAD)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">$<ix:nonFraction id="Fxbrl_20210427160921239" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20210101to20211231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">10.02</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="Fxbrl_20220307161914661" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">1.48</ix:nonFraction> &#8211; $<ix:nonFraction id="Fxbrl_20220307161919055" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">8.56</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </ix:nonNumeric>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div>
            <div>
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The weighted average fair value of each option on the grant date amounted to $<ix:nonFraction id="Fxbrl_20210428045752591" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember" unitRef="CAD" scale="0" decimals="2" format="ixt:numdotdecimal">4.16</ix:nonFraction>.</span></span></div>
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                <p style="margin:0pt">&#160;</p>
              </div>
            </div>
          </div>
        </div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table lists the number of share options and the weighted average exercise prices of share options in the 2018 Plan:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20220330181524286" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" contextRef="C_20210101to20211231" escape="true">
          <div>
            <div style="line-height:1.25;margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in CAD</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427151729421" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20201231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">3,154,870</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20201231" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">2.2</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152243944_xbrl_20210427151729421" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">2,964,265</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152243944_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20210101to20211231" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">6.2</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercised during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427152252702_xbrl_20210427151729421" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">517,346</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152252702_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20210101to20211231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">2.43</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options forfeited during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427152314692_xbrl_20210427151729421" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20210101to20211231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">158,544</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152314692_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20210101to20211231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">4.08</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152318936_xbrl_20210427151729421" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20211231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">5,443,245</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152318936_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">3.91</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152329288_xbrl_20210427151729421" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20211231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">1,888,480</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152329288_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20211231" unitRef="CAD_per_Share" scale="0" decimals="0" format="ixt:numdotdecimal">2</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
              <p style="margin:0pt">&#160;</p>
            </div>
            <div><ix:exclude>
              <div style="line-height:1.25">
                <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>72</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                <p style="margin:0pt">&#160;</p>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 18:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EQUITY (Cont.)</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </ix:exclude></div>
            <div style="margin-left:90pt">&#160;</div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in CAD</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152819985_xbrl_20210427151729421" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20191231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">2,940,000</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152819985_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20191231" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">1.6</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152847303_xbrl_20210427152252702_xbrl_20210427151729421" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20200101to20201231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">905,000</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152847303_xbrl_20210427152252702_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20200101to20201231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">4.24</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercised during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307162905758" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20200101to20201231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">160,193</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152923934_xbrl_20210427152252702_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20200101to20201231" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">1.8</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options forfeited during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427152954396_xbrl_20210427152314692_xbrl_20210427151729421" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20200101to20201231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">529,937</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152954396_xbrl_20210427152314692_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20200101to20201231" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">1.8</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152737742_xbrl_20210427151729421" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20201231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">3,154,870</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152737742_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20201231" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">2.2</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152755407_xbrl_20210427152329288_xbrl_20210427151729421" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20201231" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">1,328,770</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427152755407_xbrl_20210427152329288_xbrl_20210427151739167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20201231" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">1.8</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The weighted average remaining contractual life for the share options outstanding as of December 31, 2021, and 2020 was <ix:nonNumeric id="Fxbrl_20210428050338427" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember" format="ixt-sec:duryear">5.37</ix:nonNumeric> and <ix:nonNumeric id="Fxbrl_20210428050423397" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember" format="ixt-sec:duryear">7.32</ix:nonNumeric> years respectively.</span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The share-based payment expenses for the year ended December 31, 2021 and 2020, amounted to $<ix:nonFraction id="Fxbrl_20210428050534423" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,471</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20210428050553662" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,382</ix:nonFraction>, respectively.</span></span>
            <p style="margin:0pt">&#160;</p>
          </div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table lists the number of restricted share units (&#8220;RSUs&#8221;) as of December 31, 2021:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:90pt">
            <ix:nonNumeric id="Fxbrl_20220331142049125" name="imc:DisclosureOfRestrictedShareUnitsTableTextBlock" contextRef="C_20210101to20211231" escape="true">
              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of RSU</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331142205906" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember" unitRef="Shares" scale="0" decimals="0" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331142240032_xbrl_20220331142226473" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">550,000</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the end of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220331142238345_xbrl_20220331142226473" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">550,000</ix:nonFraction></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331142226473" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember" unitRef="Shares" scale="0" decimals="0" format="ixt:numdotdecimal">229,006</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </ix:nonNumeric>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other convertible securities:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021, there are <ix:nonFraction id="Fxbrl_20210428052830824" name="imc:NumberOfCompensationUnitsIssued" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">134,872</ix:nonFraction>, 2019 Compensation Units Options to acquire Compensation Units at a price of $<ix:nonFraction id="Fxbrl_20210428052914309" name="imc:CompensationUnitPerShare" contextRef="C_20210101to20211231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">1.05</ix:nonFraction> per unit. Each Compensation Unit consists of one IMCC Ordinary Share and one half IMCC Warrant, with each whole IMCC Warrant exercisable for one IMC Ordinary Share at an exercise price of $<ix:nonFraction id="Fxbrl_20210428221901063" name="ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20211231" unitRef="CAD_per_Share" scale="0" decimals="1" format="ixt:numdotdecimal">1.3</ix:nonFraction>. These Units are exercisable at any time until August 2022.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021, there are <ix:nonFraction id="Fxbrl_20220307164205426" name="imc:NumberOfCompensationWarrantsToAcquired" contextRef="C_20211231" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">182,609</ix:nonFraction> compensation warrants. Each Compensation Warrant is exercisable for one Common Share at an exercise price of US$<ix:nonFraction id="Fxbrl_20220307164229262" name="imc:WarrantPricePerShare" contextRef="C_20210101to20211231" unitRef="USD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">6.61</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220307164249110" name="imc:WarrantPricePerShare" contextRef="C_20210101to20211231" unitRef="CAD_per_Share" scale="0" decimals="2" format="ixt:numdotdecimal">8.42</ix:nonFraction>). These Warrants are exercisable at any time following the date that is six months after the date of the Compensation warrants agency agreement until the date that is the three and one half year anniversary of the agency agreement.</span></span></div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20210427100445784" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt">NOTE 19:-</span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt">SELECTED STATEMENTS OF PROFIT OR LOSS DATA</span></div>
                </td>
              </tr>

          </table>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <ix:nonNumeric id="Fxbrl_20210427100708194" name="ifrs-full:DisclosureOfExpensesByNatureExplanatory" contextRef="C_20210101to20211231" escape="true">
                <div>
                  <div style="margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427100925380" name="ifrs-full:WagesAndSalaries" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,718</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427100933315" name="ifrs-full:WagesAndSalaries" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,897</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427100940703" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,004</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427100945493" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">930</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <div>&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>73</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
    </div>
  </div>
  <div>&#160;</div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20210427205249017" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 20:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NET EARNINGS (LOSS) PER SHARE</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Details of the number of shares and income (loss) used in the computation of earnings per share:</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:63pt">
                  <ix:nonNumeric id="Fxbrl_20220329202427967" name="ifrs-full:EarningsPerShareExplanatory" contextRef="C_20210101to20211231" escape="true">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted number of shares (in thousands)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to equity holders of the Company</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted number of shares (in thousands)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to equity holders of the Company</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the computation of basic net earnings</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427205400026" name="ifrs-full:WeightedAverageShares" contextRef="C_20210101to20211231" unitRef="Share" scale="3" decimals="-3" format="ixt:numdotdecimal">57,963</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427205437082" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">17,763</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427205536092" name="ifrs-full:WeightedAverageShares" contextRef="C_20200101to20201231" unitRef="Share" scale="3" decimals="-3" format="ixt:numdotdecimal">38,565</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427205617852" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,698</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of potential dilutive Ordinary shares&#160;- Warrants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307121716390_xbrl_20210427205407010" name="ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" contextRef="C_20210101to20211231" unitRef="Share" scale="3" decimals="-3" format="ixt:numdotdecimal">1,810</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307121716390_xbrl_20210427205455173" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">21,739</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307121716390_xbrl_20210427205556085" name="ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" contextRef="C_20200101to20201231" unitRef="Share" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307121716390_xbrl_20210427205635597" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the computation of diluted net earnings</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427205423040" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20210101to20211231" unitRef="Share" scale="3" decimals="-3" format="ixt:numdotdecimal">59,773</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427205511938" name="imc:ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">39,502</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427205605821" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20200101to20201231" unitRef="Share" scale="3" decimals="-3" format="ixt:numdotdecimal">38,565</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427205710012" name="imc:ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">28,698</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </ix:nonNumeric>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">For 2021, and 2020, potentially dilutive securities (share options) were excluded from the calculation of diluted earnings per share as they are antidilutive.</p>
                      </td>
                    </tr>
                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">**)</p>
                      </td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Including the effect of Share Consolidation (See Note 18a).</p>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <div>
    <div>
      <div>
        <div>
          <ix:nonNumeric id="Fxbrl_20220329202733485" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" contextRef="C_20210101to20211231" escape="true">
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 21:-</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span>RELATED PARTY BALANCES AND TRANSACTIONS</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div>
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balances and transactions:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes balances with related parties in the statements of financial position:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <ix:nonNumeric id="Fxbrl_20210427131318809" name="imc:DisclosureOfBalancesWithRelatedPartiesExplanatory" contextRef="C_20210101to20211231" escape="true">
                    <div>
                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts receivables</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307104833531" name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307104845316" name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">36</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts payables</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307104839541" name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="C_20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">875</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307104859580" name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="C_20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </ix:nonNumeric>
                  <div><ix:exclude>
                    <div style="line-height:1.25">
                      <p style="margin:0pt">&#160;</p>
                      <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>74</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 21:-</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RELATED PARTY BALANCES AND TRANSACTIONS (Cont.)</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </ix:exclude></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes the transactions with related parties in the consolidated statements of profit or loss and other comprehensive income:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <ix:nonNumeric id="Fxbrl_20210427131331015" name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" contextRef="C_20210101to20211231" escape="true">
                    <div>
                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307104908732" name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,116</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220307104917251" name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">617</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </ix:nonNumeric>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions with related parties mainly includes compensation for management services and bonus in the ordinary course of business and short-term lease payments.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation of key management personnel of the Group:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's key management personnel are the directors, senior executives and a managing company which provides the Company with key management personnel services.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div>
                    <ix:nonNumeric id="Fxbrl_20220329202746014" name="ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" contextRef="C_20210101to20211231" escape="true">
                      <div>
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payroll and related expenses</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307105144170_33" name="imc:KeyManagementPersonnelCompensationPayrollAndRelatedExpenses" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,377</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307105144170_37" name="imc:KeyManagementPersonnelCompensationPayrollAndRelatedExpenses" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,005</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307105144170_53" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,700</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307105144170_57" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,791</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees *)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307105144170_73" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,029</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220307105144170_77" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,391</ix:nonFraction></td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25">&#160;</div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:85.05pt">&#160;</td>
                              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Includes payments to shareholders for the years ended 2021 and 2020 of $<ix:nonFraction id="Fxbrl_20210428150056331" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">455</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20210428150102383" name="ifrs-full:ProfessionalFeesExpense" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">534</ix:nonFraction>, respectively.</span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </ix:nonNumeric>
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25">
                            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                                <tr>
                                  <td style="width:56.7pt">&#160;</td>
                                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif">c.</td>
                                  <td style="width:auto;vertical-align:top;text-align:justify">
                                    <div>See Note 5 for indemnification agreement with a former director of TFC, currently serving as the Company's chairman of the board of directors.</div>
                                  </td>
                                </tr>

                            </table>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
          <div>
            <div>
              <div>
                <div>
                  <p style="margin:0pt">&#160;</p>
                  <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>75</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                  <p style="margin:0pt">&#160;</p>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>

  <div>
    <ix:nonNumeric id="Fxbrl_20220329203000331" name="imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory" contextRef="C_20210101to20211231" escape="true">
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span><span style="font-size:10pt">NOTE 22:-</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span><span style="font-size:10pt">SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Summarized financial information for Focus as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20211101180453497" name="imc:DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Statement of financial position at reporting date (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Current assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191133109" name="ifrs-full:CurrentAssets" contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,913</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191144582" name="ifrs-full:CurrentAssets" contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,531</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Non-current assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191158221" name="ifrs-full:NoncurrentAssets" contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,473</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191226933" name="ifrs-full:NoncurrentAssets" contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,226</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Current liabilities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427191326124" name="ifrs-full:CurrentLiabilities" contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,616</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427191406056" name="ifrs-full:CurrentLiabilities" contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,341</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Non-current liabilities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427191417856" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,883</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427191429475" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,274</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total equity</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191635902" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,887</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191646280" name="ifrs-full:Equity" contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,142</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20210427192610728" name="imc:DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Operating results (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Revenues</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191726984" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,747</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191745209" name="ifrs-full:Revenue" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,823</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net income (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307114024627" name="ifrs-full:ProfitLoss" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,524</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191809544" name="ifrs-full:ProfitLoss" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">968</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Other comprehensive income</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191832288" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">37</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427191842488" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">22</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total comprehensive income (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220307114037336" name="ifrs-full:ComprehensiveIncome" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,487</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191908793" name="ifrs-full:ComprehensiveIncome" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">946</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20211101180440768" name="ifrs-full:DisclosureOfCashFlowStatementExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Cash flows (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From operating activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191937819" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,346</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427191954835" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,882</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From investing activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427192003002" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">783</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427192021497" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,656</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From financing activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427192037922" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">560</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20210427192055898" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">184</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Effect of foreign exchange on cash and cash equivalents</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427192111522" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">169</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427192126179" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">39</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net increase in cash and cash equivalents</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427192135939" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,292</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><ix:nonFraction id="Fxbrl_20210427192146811" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">81</ix:nonFraction></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>76</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
    <p style="margin:0pt">&#160;</p>
  </div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220329215029228" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory" contextRef="C_20210101to20211231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 23:-</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OPERATING SEGMENTS</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Reporting operating segments:</p>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20220329215112392" name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" contextRef="C_20210101to20211231" escape="true">
            <div>
              <div style="margin-left:90pt">&#160;</div>
              <div>
                <div>
                  <div style="line-height:1.25;margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2021:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329214608778_xbrl_20220329214324071_33" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,431</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329214608778_xbrl_20220329214324071_37" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,247</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329214608778_xbrl_20220329214324071_311" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,622</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329214608778_xbrl_20220329214324071_315" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329214608778_xbrl_20220329214324071_319" name="ifrs-full:Revenue" contextRef="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,300</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329214612834_xbrl_20220329214324071_33" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">10,654</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329214612834_xbrl_20220329214324071_37" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">15,353</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329214612834_xbrl_20220329214324071_311" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">5,142</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220330174842986" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329214612834_xbrl_20220329214324071_319" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">31,149</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated corporate expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330175419300_xbrl_20220330174842986" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">7,240</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330175419300_xbrl_20220329214612834_xbrl_20220329214324071_319" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">7,240</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220330175616814_xbrl_20220330175419300_xbrl_20220329214612834_xbrl_20220329214324071_319" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20210101to20211231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">38,389</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation, amortization and impairment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214614963_xbrl_20220329214324071_33" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,424</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214614963_xbrl_20220329214324071_37" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,879</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214614963_xbrl_20220329214324071_311" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">701</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214614963_xbrl_20220329214324071_315" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214614963_xbrl_20220329214324071_319" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,004</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                    <div>&#160;</div>
                  </div>
                  <div style="line-height:1.25;margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2020:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_33" name="ifrs-full:Revenue" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,826</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_37" name="ifrs-full:Revenue" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_311" name="ifrs-full:Revenue" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,064</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_315" name="ifrs-full:Revenue" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_319" name="ifrs-full:Revenue" contextRef="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,890</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220331234028017" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">2,090</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220331234158016" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329214843707_xbrl_20220329214612834_xbrl_20220329214324071_311" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">3,744</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214843707_xbrl_20220329214612834_xbrl_20220329214324071_315" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220329214843707_xbrl_20220329214612834_xbrl_20220329214324071_319" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">5,834</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated corporate expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330175700057_xbrl_20220330175419300_xbrl_20220330174842986" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">2,411</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(<ix:nonFraction id="Fxbrl_20220330175700057_xbrl_20220330175419300_xbrl_20220329214612834_xbrl_20220329214324071_319" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">2,411</ix:nonFraction></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220330175717885_xbrl_20220330175616814_xbrl_20220330175419300_xbrl_20220329214612834_xbrl_20220329214324071_319" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20200101to20201231" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">8,245</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation, amortization and impairment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_33" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">617</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_37" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_311" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">73</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_315" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_319" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">690</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
              <div>
                <div>
                  <div style="line-height:1.25;margin-left:90pt">&#160;</div>
                </div>
              </div>
            </div>
          </ix:nonNumeric>
        </div>
      </ix:nonNumeric>
      <p style="margin:0pt">&#160;</p>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>77</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <div>
    <div>
      <div>
        <div>
          <div>
            <ix:nonNumeric id="Fxbrl_20220329213127264" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" contextRef="C_20210101to20211231" escape="true">
              <div>
                <div>
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 24:-</span></span></td>
                          <td style="width:auto;vertical-align:top">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SUBSEQUENT EVENTS</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revolving Credit</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In January 2022, Focus entered into a Revolving Credit Facility with Bank Mizrahi (the &#8220;Mizrahi Facility&#8221;). The Mizrahi Facility is guaranteed by Focus assets. Advances from the Mizrahi Facility will be used for working capital needs.</span></span></div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Mizrahi Facility has a total commitment of up to NIS <ix:nonFraction id="Fxbrl_20220329223134208" name="imc:Commitment" contextRef="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">15,000</ix:nonFraction> thousand (approximately $<ix:nonFraction id="Fxbrl_20220329223153627" name="imc:Commitment" contextRef="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,000</ix:nonFraction>) and has a one-year term for on-going needs and 6 months term for imports and purchases needs. The Mizrahi Facility is renewable upon mutual agreement by the parties. The borrowing base available for draw at any time throughout the Mizrahi Facility and is subject to several covenants to be measured on a quarterly basis. The Mizrahi Facility bears interest of Israeli <ix:nonNumeric id="Fxbrl_20220329223218739" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20220101to20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">Prime interest plus 1.5% (approximately 3.3%) per annum</ix:nonNumeric>.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Xinteza</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 24, 2022, IMC Holdings entered into a Simple Agreement for Future Equity (SAFE) with Xinteza, under which IMC Holdings invested US$<ix:nonFraction id="Fxbrl_20220329223259937" name="ifrs-full:CashTransferred" contextRef="C_20220224_ifrsfullBusinessCombinationsAxis_imcXintezaApiLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember_imcAgreementAxis_imcSimpleAgreementForFutureEquityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:numdotdecimal">100,000</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329223315604" name="ifrs-full:CashTransferred" contextRef="C_20220224_ifrsfullBusinessCombinationsAxis_imcXintezaApiLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember_imcAgreementAxis_imcSimpleAgreementForFutureEquityMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">125</ix:nonFraction>), in exchange for additional future shares of Xinteza.</span></span></div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing of Pharm Yarok Transaction</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 14, 2022, the Pharm Yarok Transaction closed upon receipt of all requisite approvals, including the IMCA approval, for an aggregate consideration of NIS <ix:nonFraction id="Fxbrl_20220329221439771" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">11,900</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329221602829" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,600</ix:nonFraction>), of which NIS <ix:nonFraction id="Fxbrl_20220329221622189" name="ifrs-full:CashTransferred" contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">8,400</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329221639196" name="ifrs-full:CashTransferred" contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,300</ix:nonFraction>) was paid in cash upon signing the definitive agreement, and NIS <ix:nonFraction id="Fxbrl_20220329221659019" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,500</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329221729021" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,300</ix:nonFraction>) paid upon closing. The acquisition of the outstanding ordinary shares of HW Shinua is pending receipt of the requisite approval from the IMCA. In connection with closing of the Pharm Yarok Transaction, the Company completed a non-brokered private placement with former shareholders of Pharm Yarok and Rosen High Way on March 14, 2022. A total of <ix:nonFraction id="Fxbrl_20220329222245289" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">523,700</ix:nonFraction> Common Shares were issued at a deemed price of $<ix:nonFraction id="Fxbrl_20220329222303937" name="imc:DeemedPricePerShare" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD_per_Share" scale="0" decimals="3" format="ixt:numdotdecimal">2.616</ix:nonFraction> for aggregate proceeds of $<ix:nonFraction id="Fxbrl_20220329222335449" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,370</ix:nonFraction>. The calculation of the deemed price was based on the average closing price of Common Shares on the CSE over the 8 trading day period immediately preceding March 14, 2022.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing of Vironna Transaction</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 14, 2022, the Vironna Transaction closed upon receipt of all requisite approvals, including the approval of the IMCA in consideration of NIS <ix:nonFraction id="Fxbrl_20220329222443158" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">8,500</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329222455333" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,330</ix:nonFraction>), comprised of NIS <ix:nonFraction id="Fxbrl_20220329222524996" name="ifrs-full:CashTransferred" contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,000</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329222532217" name="ifrs-full:CashTransferred" contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,960</ix:nonFraction>) in cash and NIS <ix:nonFraction id="Fxbrl_20220329222635077" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,500</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329222731001" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,700</ix:nonFraction>) in Common Shares issued on closing. In satisfaction of the cash consideration component, NIS <ix:nonFraction id="Fxbrl_20220329222850576" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">3,750</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329222905170" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,470</ix:nonFraction>) was paid at signing of the definitive agreement and the remaining NIS <ix:nonFraction id="Fxbrl_20220329223724818" name="imc:RemainingAmountOfCashPaid" contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">1,250</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220329223758083" name="imc:RemainingAmountOfCashPaid" contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">490</ix:nonFraction>) will be paid post-closing of the Vironna Transaction. In satisfaction of the share consideration component, the Company issued <ix:nonFraction id="Fxbrl_20220329222929291" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">485,362</ix:nonFraction> Common Shares at a deemed issue price of US$<ix:nonFraction id="Fxbrl_20220329222959892" name="imc:DeemedPricePerShare" contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="USD_per_Share" scale="0" decimals="3" format="ixt:numdotdecimal">2.209</ix:nonFraction> per share (approximately $<ix:nonFraction id="Fxbrl_20220329223024923" name="imc:DeemedPricePerShare" contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD_per_Share" scale="0" decimals="4" format="ixt:numdotdecimal">2.8092</ix:nonFraction>), calculated based on the average closing price of the Common Shares of on the NASDAQ for the 14 trading day period immediately preceding closing. The shares issued are subject to a staggered three-month lockup commencing on the date of issuance.</span></span>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                    </div>
                    <div><ix:exclude>
                      <div style="line-height:1.25">
                        <div style="text-align:justify;line-height:1.25">
                          <div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>F - </span>78</span></span></div><div style="break-after:page"><div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div><div style="line-height:1.25"><div style="text-align:right;text-indent:18.25pt;margin-left:350.3pt;line-height:1.25;font-family:Times New Roman, Times, serif"><div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>IM CANNABIS CORP.</strong></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>and its subsidiaries</strong></span></span></span></div></div></div><div style="line-height:1.25"><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</strong></span></span></span></div><div style="text-align:justify;line-height:1.25"><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Canadian Dollars in thousands, except share and per share data</strong></span></span></span></div></div>
                        </div>
                        <p style="margin:0pt">&#160;</p>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 24:-</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SUBSEQUENT EVENTS (Cont.)</span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </ix:exclude></div>
                    <div style="line-height:1.25">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold">&#160;</div>
                          <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing of Panaxia Transaction</span></span></div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 14, 2022, IMC Holdings acquired the Panaxia GDP License following receipt of the requisite IMCA approval and assigned it to IMC Pharma in accordance with the terms of the Panaxia Transaction (the &#8220;<span style="font-weight:bold">Panaxia GDP License Closing</span>&#8221;). The aggregate consideration for the Panaxia Transaction was NIS <ix:nonFraction id="Fxbrl_20220330134550268" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">18,700</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330134609277" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,200</ix:nonFraction>), of which NIS <ix:nonFraction id="Fxbrl_20220330164414250" name="ifrs-full:CashTransferred" contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">7,600</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330164432661" name="ifrs-full:CashTransferred" contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,900</ix:nonFraction>) was paid in two cash instalments and NIS <ix:nonFraction id="Fxbrl_20220330164507219" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">11,100</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330164533802" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,300</ix:nonFraction>) payable in Common Shares (&#8220;<span style="font-weight:bold">Panaxia Consideration Shares</span>&#8221;). To satisfy the share consideration component of the Panaxia Transaction, the Company issued four instalments of an aggregate of <ix:nonFraction id="Fxbrl_20220330164604289" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">93,755</ix:nonFraction> Panaxia Consideration Shares between August 9, 2021 and March 14, 2022, with the deemed price of each instalment of Panaxia Consideration Shares determined based on the average closing price of the Common Shares on Nasdaq during the 10 trading day period immediately prior to issuance. The fifth and final instalment of Panaxia Consideration Shares will be issued following the Panaxia GDP License Closing. The Panaxia Transaction includes a further option to acquire, for no additional consideration, a pharmacy from Panaxia, including requisite licenses to dispense and sell medical cannabis to patients, that the Company has exercised (&#8220;<span style="font-weight:bold">Panaxia Pharmacy Closing</span>&#8221;). The Panaxia Pharmacy Closing is expected to occur during the third quarter of 2022.</span></span></div>
                          <div style="text-align:justify;margin-left:33.9pt;line-height:1.25">&#160;</div>
                        </div>
                      </div>
                      <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing of Oranim Transaction</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25">
                        <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 28, 2022, the Oranim Transaction closed upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS <ix:nonFraction id="Fxbrl_20220330134555740" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">11,940</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330134613556" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,900</ix:nonFraction>), consisting of NIS <ix:nonFraction id="Fxbrl_20220330164420263" name="ifrs-full:CashTransferred" contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,202</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330164438402" name="ifrs-full:CashTransferred" contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,104</ix:nonFraction>) paid in cash upon signing, NIS <ix:nonFraction id="Fxbrl_20220330164457290" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">5,202</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330164539832" name="imc:CashConsiderationOfBusinessCombination" contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,104</ix:nonFraction>) which will be paid in cash on the first quarter of 2023 and NIS <ix:nonFraction id="Fxbrl_20220330164654292" name="imc:RemainingAmountOfCashPaid" contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:numdotdecimal">1,536</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20220330164712477" name="imc:RemainingAmountOfCashPaid" contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="CAD" scale="3" decimals="-3" format="ixt:numdotdecimal">630</ix:nonFraction>) paid in <ix:nonFraction id="Fxbrl_20220330164611928" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember" unitRef="Share" decimals="INF" format="ixt:numdotdecimal">251,001</ix:nonFraction> Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#8217;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.</span></span></div>
                      </div>
                    </div>
                  </div>
                </div>
                <div>
                  <div>
                    <div style="text-align:justify;margin-left:33.9pt;line-height:1.25">&#160;</div>
                  </div>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F - 79</span></span></div>
            <div style="line-height:1.25">
              <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit_99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;"><div style="font-size: 10pt;">
  <div>
    <div >
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div>
            <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
            <div>
              <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.3</font></u><br>
              </div>
              <br>
              <br>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;">&#160; <img width="570" border="0" height="785" src="image00016.jpg">
      <div><br>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <br>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
        <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
        <div style="line-height: 1.25; font-weight: bold;">
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">TABLE OF CONTENTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="2" border="0" id="z7f9688f47d534bb78149d588fc47961b" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><br>
            </div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#EXECUTIVESUMMARY">EXECUTIVE SUMMARY</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#STRATEGYINDETAIL">STRATEGY IN DETAIL</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; margin-left: 9pt;"><a href="#STRATEGYINDETAIL">GEOGRAPHIES AND NEW MARKETS</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; margin-left: 9pt;"><a href="#BRANDS">BRANDS</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">8</div>
          </td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; margin-left: 9pt;"><a href="#HIGH-QUALITYRELIABLESUPPL">HIGH-QUALITY, RELIABLE SUPPLY</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">11</div>
          </td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; margin-left: 9pt;"><a href="#NEWPRODUCTOFFERINGS">NEW PRODUCT OFFERINGS</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">12</div>
          </td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#CORPORATEHIGHLIGHTSANDEVE">CORPORATE HIGHLIGHTS AND EVENTS</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">14</div>
          </td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#REVIEWOFFINANCIALPERFORMA">REVIEW OF FINANCIAL PERFORMANCE</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">20</div>
          </td>
        </tr>
        <tr>
          <td style="width: 89.3%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#LEGALANDREGULATORY">LEGAL AND REGULATORY</a></div>
          </td>
          <td style="width: 10.7%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;">47</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >2</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: #7030A0; font-family: Calibri, sans-serif; font-size: 11pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">IM Cannabis Corp. (&#8220;<font style="font-weight: bold;">IM Cannabis</font>&#8221; or the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) is a British Columbia company whose business formed on October 11,
      2019 as the result of a reverse takeover with IMC Holdings Ltd. (the &#8220;<font style="font-weight: bold;">Reverse Takeover Transaction</font>&#8221;), pursuant to which the Company changed its name from &#8220;Navasota Resources Inc.&#8221; to &#8220;IM Cannabis Corp.&#8221; and
      changed its business from mining to the international medical cannabis industry. The Company&#8217;s common shares (the &#8220;<font style="font-weight: bold;">Common Shares</font>&#8221;) trade under the ticker symbol &#8220;IMCC&#8221; on both the NASDAQ Capital Market (&#8220;<font style="font-weight: bold;">NASDAQ</font>&#8221;) and the Canadian Securities Exchange (&#8220;<font style="font-weight: bold;">CSE</font>&#8221;) as of March 1, 2021, and November 5, 2019, respectively. The Reverse Takeover Transaction is more fully described under
      &#8220;<font style="font-style: italic;">Review of Financial Performance &#8211; Share Capital &#8211; Financial Background</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">This Management&#8217;s Discussion and Analysis (&#8220;<font style="font-weight: bold;">MD&amp;A</font>&#8221;) reports on the consolidated financial condition and operating results of IM Cannabis for the year and
      three months ended December 31, 2021. Throughout this MD&amp;A, unless otherwise specified, references to &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or similar terms, as well as the &#8220;Company&#8221; and &#8220;IM Cannabis&#8221; refer to IM Cannabis Corp., together with its subsidiaries, on a
      consolidated basis, and the &#8220;Group&#8221; refers to the Company, its subsidiaries and Focus Medical Herbs Ltd.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">This MD&amp;A should be read in conjunction with the audited consolidated financial statements of the Company and the notes thereto for the years ended December 31, 2021 and 2020, (the &#8220;<font style="font-weight: bold;">Annual Financial Statements</font>&#8221;). References in the below discussion to &#8220;Q4 2021&#8221; and &#8220;Q4 2020&#8221; refer to the three months ended December 31, 2021 and December 31, 2020, respectively, and references to &#8220;2020&#8221; refer to
      the year ended December 31, 2020.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Annual Financial Statements have been prepared by management in accordance with the International Financial Reporting Standards (&#8220;<font style="font-weight: bold;">IFRS</font>&#8221;) as issued by the
      International Accounting Standards Board (&#8220;<font style="font-weight: bold;">IASB</font>&#8221;). IFRS requires management to make certain judgments, estimates and assumptions that affect the reported amount of assets and liabilities at the date of the
      Annual Financial Statements and the amount of revenue and expenses incurred during the reporting period. The results of operations for the periods reflected herein are not necessarily indicative of results that may be expected for future periods. The
      Annual Financial Statements include the accounts of the Group, which includes, among others, the following entities:</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <table cellspacing="0" cellpadding="2" border="0" id="zc99f359d8db74f978371e5749f926219" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 39.24%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Legal Entity</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Jurisdiction</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Relationship with the Company</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">IMC Holdings Ltd. (&#8220;<font style="font-weight: bold;">IMC Holdings</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">I.M.C. Pharma Ltd. (&#8220;<font style="font-weight: bold;">IMC Pharma</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary of IMC Holdings</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Focus Medical Herbs Ltd. (&#8220;<font style="font-weight: bold;">Focus</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Private company over which IMC Holdings exercises &#8220;de facto control&#8221; under IFRS 10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">R.A. Yarok Pharm Ltd. (&#8220;<font style="font-weight: bold;">Pharm Yarok</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary of IMC Holdings</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Rosen High Way Ltd. (&#8220;<font style="font-weight: bold;">Rosen High Way</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary of IMC Holdings</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">High Way Shinua Ltd. (&#8220;<font style="font-weight: bold;">HW Shinua</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Private company over which IMC Holdings exercises &#8220;de facto&#8221; control under IFRS 10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Revoly Trading and Marketing Ltd. dba Vironna Pharm (&#8220;<font style="font-weight: bold;">Vironna</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Subsidiary of IMC Holdings</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Oranim Plus Pharm Ltd. (&#8220;<font style="font-weight: bold;">Oranim Plus</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Israel</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Subsidiary of IMC Holdings</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Trichome Financial Corp. (&#8220;<font style="font-weight: bold;">Trichome</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Canada</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Trichome JWC Acquisition Corp. (&#8220;<font style="font-weight: bold;">TJAC</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Canada</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary of Trichome</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">MYM Nutraceuticals Inc. (&#8220;<font style="font-weight: bold;">MYM</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Canada</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary of Trichome</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">SublimeCulture Inc. (&#8220;<font style="font-weight: bold;">Sublime</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Canada</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary of MYM</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Highland Grow Inc. (&#8220;<font style="font-weight: bold;">Highland</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25;">Canada</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25;">Wholly-owned subsidiary of MYM International Brands Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 39.24%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',serif;">Adjupharm GmbH (&#8220;<font style="font-weight: bold;">Adjupharm</font>&#8221;)</div>
            </td>
            <td style="width: 11.59%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',serif;">Germany</div>
            </td>
            <td style="width: 49.17%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',serif;">Subsidiary of IMC Holdings</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"> </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >3</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;">All intercompany balances and transactions were eliminated on consolidation.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">All dollar figures in this MD&amp;A are expressed in thousands of Canadian Dollars ($), except per share data and unless otherwise noted. All references to &#8220;NIS&#8221; are to New Israeli Shekels. All
      references to &#8220;&#8364;&#8221; or to &#8220;Euros&#8221; are to Euros. All references to &#8220;US$&#8221; or to &#8220;U.S. Dollars&#8221; are to United States Dollars. The Company&#8217;s shares, options, units and warrants are not expressed in thousands. Prices are not expressed in thousands.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">NON&#8209;IFRS FINANCIAL MEASURES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Certain non-IFRS financial measures are referenced in this MD&amp;A that do not have any standardized meaning under IFRS, including &#8220;Gross Margin&#8221;, &#8220;EBITDA&#8221; and &#8220;Adjusted EBITDA&#8221;. The Company
      believes that these non-IFRS financial measures and operational performance measures, in addition to conventional measures prepared in accordance with IFRS, enable readers to evaluate the Company&#8217;s operating results, underlying performance and
      prospects in a similar manner to the Company&#8217;s management. For a reconciliation of these non-IFRS financial measures to the most comparable IFRS financial measures, as applicable, see the &#8220;<font style="font-style: italic;">Metrics and Non-IFRS
        Financial Measures</font>&#8221; section of the MD&amp;A.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">NOTE REGARDING THE COMPANY&#8217;S ACCOUNTING PRACTICES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company complies with IFRS 10 to consolidate the financial results of Focus, an Israeli licensed cultivator on the basis of which IMC Holdings exercises &#8220;de facto control&#8221;. For a full explanation
      of the Company&#8217;s application of IFRS 10, see &#8220;<font style="font-style: italic;">Legal and Regulatory &#8211; &#8220;Restructuring&#8221; </font>and &#8220;<font style="font-style: italic;">Legal and Regulatory &#8211; Risk Factors - Consolidation of Focus Financial Results under
        IFRS 10 and Maintenance of Common Control</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">For the period ended December 31, 2021, the Company analyzed the terms of the definitive agreements with each of Pharm Yarok, Rosen High Way, HW Shinua, Vironna and Oranim
          Plus (collectively, the &#8220;<font style="font-weight: bold;">Consolidated Entities</font>&#8221;) in accordance with IFRS 10 and concluded a requirement to consolidate the financial results as of the Consolidated Entities as of the date of signing each
          such definitive agreement. Each of such definitive agreements provide the Company with the power to unilaterally make all decisions regarding the financial and operating policies of each of the Consolidated Entities and the right to obtain all
          related economic benefits. The Pharm Yarok Transaction, the Vironna Transaction and the Oranim Transaction (as each are further defined herein) were completed in the first quarter of 2022. <font style="color: rgb(0, 0, 0);">The completion of the
            Pharm Yarok Transaction with respect to HW Shinua remains subject to the IMCA approval, and accordingly the financial results of HW Shinua continue to be consolidated in compliance with IFRS 10. </font>For further information on the closing of
          the above transactions, please see <font style="font-style: italic;">&#8220;Corporate Highlights and Events</font>&#8221;.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >4</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160);">EXECUTIVE SUMMARY</div>
    </div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160); font-family: 'Times New Roman',Times,serif;">OVERVIEW &#8211; CURRENT OPERATIONS IN ISRAEL, CANADA AND GERMANY</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; color: rgb(34, 34, 34); font-family: 'Times New Roman',serif;">IM Cannabis is a leading international cannabis company providing premium cannabis products to medical patients and adult-use recreational consumers. With
        operations in Israel, Canada, and Germany, the world&#8217;s three largest federally legal cannabis markets, the Company has developed its own proprietary import/export supply chain in order to efficiently deliver premium cannabis to patients and
        consumers under a uniform global branding umbrella.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; color: #222222; font-family: 'Times New Roman', serif; font-size: 11pt;">
          <div style="line-height: 1.25; color: #222222;"><font style="font-family: 'Times New Roman',serif; font-size: 10pt;">The Company operates in Canada through Trichome and its subsidiaries TJAC and MYM, where it cultivates, processes and sells
              premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada and exports premium and ultra-premium medical cannabis to Israel and eventually to Germany.</font></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; color: #222222; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',serif; font-size: 10pt;">In Israel, the Company cultivates, imports, and distributes cannabis to
            local medical patients through its commercial relationship with Focus, with plans to import cannabis to supplement its operations of medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs operating
            through IMC Holdings.</font></div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25; color: rgb(34, 34, 34); font-family: 'Times New Roman',serif;">In Germany, the IM Cannabis ecosystem operates through Adjupharm importing and distributing cannabis to pharmacies for patients, acting as the Company&#8217;s
            entry point to a potential future Europe-wide distribution.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160); font-family: 'Times New Roman',Times,serif;">OUR GOAL - DRIVE PROFITABLE REVENUE GROWTH</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Our primary goal is to sustainably increase revenue in each of our core markets in order to build long term shareholder value. By focusing on sustainable revenue growth, while actively managing costs
      and margins, we believe we can achieve positive EBITDA.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160); font-family: 'Times New Roman',Times,serif;">HOW WE PLAN TO ACHIEVE OUR GOAL &#8211; FOUR CORE STRATEGIES</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Our strategy to grow sustainable revenues consists of:</div>
    <div style="line-height: 1.25">&#160;<font style="font-family: 'Times New Roman',Times,serif;"><br>
      </font></div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <table cellspacing="0" cellpadding="0" id="z513c851e188c4924b4f2f5ff5d51c86d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Geographic diversification and preparing to target new legal cannabis markets in Germany and Israel, while leveraging the cultivation excellence and consumer insights and experienced team in the mature Canadian
                market.</div>
            </div>
          </td>
        </tr>

    </table>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <table cellspacing="0" cellpadding="0" id="z8ff2ae1d83f94523b4fc2a61899d9b89" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Properly positioned brands with respect to target-market, price, potency and quality, such as the successful mid-2021 launch of WAGNERS in Canada. By Q4 2021, both WAGNERS and Highland Grow were among the top
                premium and ultra-premium cannabis brands in Ontario (Canada&#8217;s largest province) by retail market share<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>.</div>
            </div>
          </td>
        </tr>

    </table>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <table cellspacing="0" cellpadding="0" id="zee9cf2e03a394890bbf046e2731afdea" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">High-quality, reliable supply to our customers and patients, leading to recurring sales.</div>
            </div>
          </td>
        </tr>

    </table>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <table cellspacing="0" cellpadding="0" id="z2dbc8ffe617c488ba473402381f4e7c2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Ongoing introduction of new SKUs to keep customers and patients engaged.</div>
            </div>
          </td>
        </tr>

    </table>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">In order to turn increased revenues into positive EBITDA, we plan to focus on spending discipline and cost efficiencies through vertical integration throughout 2022.</div>
    </div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;"><font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> Depletion and e-commerce sales data from Ontario Cannabis Store - Sale of Data report for period between October 1 &#8211; December 31, 2021 for dried flower
        product between $7.50 - $9.99/gram and above $12.99/gram.</div>
    </div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >5</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br>
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25; color: rgb(112, 48, 160); font-family: 'Times New Roman',Times,serif;">RESULTS &#8211; SIGNIFICANT REVENUE GROWTH IN 2021</div>
      <div style="line-height: 1.25; text-align: center;">&#160;<img src="image00017.jpg"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; color: rgb(112, 48, 160); font-family: 'Times New Roman',Times,serif;">STRATEGY IN DETAIL</div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160); font-family: 'Times New Roman',Times,serif;">GEOGRAPHIES AND NEW MARKETS</div>
      <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company operates in the Israeli and German medical markets and the Canadian recreational market.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Israel</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In Israel, we continue to expand IMC brand recognition and supply the growing Israeli medical cannabis market with our branded products. In addition to our locally grown
          medical cannabis by Focus and its cultivation partners, we are focused on importing premium indoor-grown dried cannabis from our Canadian Facilities (defined below) as well as from world-leading cannabis suppliers. In addition to the benefits of
          the Group&#8217;s long-term presence in Israel, we believe that with our globally integrated supply chain and coordinated team of compliance, regulatory and purchasing professionals, the Company is well-positioned to address the ongoing needs of
          medical cannabis patients in Israel.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Since the beginning of 2021, the Company has focused on entering additional segments of the medical cannabis market in Israel, including the distribution and retail segments. The acquisitions of
      Israeli pharmacies Pharm Yarok, Vironna and Oranim Pharm (collectively, the &#8220;<font style="font-weight: bold;">Israeli Pharmacies</font>&#8221;) positions IM Cannabis as one of the largest distributors of medical cannabis in Israel. We are focused on
      building a vertically-integrated retail chain, providing IM Cannabis products directly to patients, accessing and leveraging market data as well as providing a deeper understanding of consumer preferences. These acquisitions allow the Company to
      increase purchasing power with third-party product suppliers, offers potential synergies with our established call centre and online operations, achieves higher margins on direct to patient sales and creates the opportunity for up-sales across a
      growing range of products.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Through the acquisition of the home-delivery services and online pharmacy business operating under the name <font style="font-style: italic;">&#8220;Panaxia-to-the-Home</font>&#8221; and customer service center
      (&#8220;<font style="font-weight: bold;">Panaxia-to-the-Home Operation</font>&#8221;), we plan to stay ahead of consumer trends and provide patients with accessible, at-home delivery. The Company&#8217;s acquisition of Rosen High Way, a trading house, and the Panaxia
      trading house license (the &#8220;<font style="font-weight: bold;">Panaxia GDP License</font>&#8221;) will expand its sales channels, distribution, delivery and storage capacity and strengthen the Groups&#8217; ability to reach its clients directly. Following the
      completion of these transactions in the first quarter of 2022, IMC Holdings has become, through its recently acquired subsidiaries, a licensed medical cannabis retailer in Israel, in the process vertically integrating its Israeli operations. The
      Company expects that these developments will increase revenue and margins from its Israeli medical cannabis market activities. For more information, see <font style="font-style: italic;">&#8220;Corporate Highlights and Events&#8221;.</font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >6</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><br>
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="text-align: left; line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="text-align: left; line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Canada</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Following the completion of the Trichome Transaction and the MYM Transaction, each acquisition further discussed below in &#8220;<font style="font-style: italic;">Corporate Highlights and Events</font>&#8221;,
      the Company&#8217;s global cannabis platform has evolved to include operations in the adult-use recreational cannabis market in Canada, in addition to its established medical cannabis operations in Israel and Germany. Through its wholly-owned subsidiary,
      TJAC, Trichome operates as a Canadian Licensed Producer (defined below) of cannabis products in the Canadian cannabis market and sells adult-use recreational cannabis products under the WAGNERS brand.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">MYM operates through its wholly-owned subsidiaries, Highland and Sublime, Canadian Licensed Producers. Each of Highland and Sublime produce cannabis products for the adult-use recreational cannabis
      market under the Highland Grow brand.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The MYM and Trichome acquisitions are complementary to each other and the larger IM Cannabis ecosystem. The WAGNERS brand operates in the premium cannabis market segment ($7.50-$9.99 per gram at the
      consumer level), while Highland operates in the ultra-premium market segment ($12.99+ per gram at the consumer level). In addition, the acquisitions provide an efficient, vertically integrated avenue to provide product to the Israeli and German
      markets.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Canadian cannabis market is more mature than the other jurisdictions in which we operate, yet market growth is still expected to continue to grow in the coming years,
        with estimated market growth from $1.07 billion in Q4 2021 ($4.3 billion annualized)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2 </sup>to $8 billion in annual sales by 2026<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup>. The Company continues to capitalize on numerous opportunities to grow its market share within
        Canada, including:</div>
      <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z56055d73c4804eb9ab16d6ee1a6ba835" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Expanding into new provinces, particularly Quebec, which accounts for approximately 23% of Canada&#8217;s population.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zb9ebcf58e73f41e0a94291e02fa472ee" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Launching new SKUs, products, and formats to meet consumer demand.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zee79c5bb0cff48ef98c8b1ca652d012f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Continuing to expand our competitive market share in key markets;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z18e0663b9bd04d92989190c005ea1718" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>In Ontario, Wagners has increased from 0% market share in January 2021 to over 6% in the premium dried flower segment for the first two months of 2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup></div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z3b25060ca8be46c7b6d829bf38225d95" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Highland now holds over 10% market share in the ultra-premium segment in Ontario in the first two months of 2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup></div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z26f10ae022ee4a3f9bea1a3314893141" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Engaging directly with current and prospective customers, retailers, and consumers to educate them on our high-quality brands.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-style: italic;"> <br>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Germany</div>
    <div style="line-height: 1.25; font-style: italic;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">In Europe, the Company operates in Germany through Adjupharm, its German subsidiary and EU-GMP certified medical cannabis producer and distributor. We continue to lay our foundation in Germany,
      currently the largest medical cannabis markets in Europe<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup>. Leveraging our global supply chain, IM Cannabis continues to focus on growing its business in Germany to be well-positioned through
      brand recognition in preparation for future regulatory reforms.</div>
    <div style="line-height: 1.25">&#160;
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="line-height: 1.25;">Similar to Israel, the Company&#8217;s focus in Germany is on importing premium indoor-grown dried cannabis from its Canadian Facilities, which we believe will satisfy the rapid growth in demand for high-THC premium
            cannabis across a variety of strains and qualities.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">While the Company does not currently distribute products in other European countries, the Company intends to leverage the foundation established by Adjupharm, its new state-of-the-art, approximately
      8,000 square foot warehouse space and EU-GMP production facility in Germany, completed in July 2021 (the &#8220;<font style="font-weight: bold;">Logistics Centre</font>&#8221;) and its network of distribution partners to expand into other jurisdictions across
      the continent. The Company expects that the Logistics Centre will allow the Company to execute all aspects of its supply chain, including the repackaging of bulk cannabis and distribution capabilities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> Based on HiFyre Data for period between October 1 &#8211; December 31, 2021.</div>
      <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup> BDSA,
        https://www.globenewswire.com/news-release/2021/09/21/2300624/0/en/BDSA-Reports-Global-Cannabis-Sales-Surge-41-YoY-in-2021-Will-Surpass-62-Billion-by-2026.html</div>
      <div style="line-height: 1.25;"><font style="font-size: 8pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><font style="font-family: 'Times New Roman',Times,serif;">4</font></sup> </font>Depletion and e-commerce sales data from Ontario Cannabis Store - Sale of Data report for period
        between January 1 &#8211; February 28, 2022 for dried flower product between $7.50 - $9.99/gram.</div>
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup> <font style="font-style: italic;">Ibid</font>.</div>
      <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup> The European Cannabis Report &#8211; Edition 6, p. 93 -&#160;&#160; https://prohibitionpartners.com/reports/</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br>
        </div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >7</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160);">BRANDS</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The IMC brand is well-known&#160;in the Israeli&#160;medical cannabis market. Leveraging its long-term success in the Israeli market, the Company launched the IMC brand in Germany in 2020.</div>
    <div style="line-height: 1.25">&#160;
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Following the Company&#8217;s entry into the Canadian adult-use recreational cannabis market, the Company is now leveraging its vertical integration and applying a multi-country
          strategy and using its global platform and exporting its Canadian WAGNERS and Highland Grow brands to the Israeli and German medical cannabis markets. The Company believes that the sale of WAGNERS and Highland Grow into the Israeli and German
          markets can satisfy the increasing demand of both Israeli and German patients for indoor grown high-THC premium cannabis.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Israeli Medical Cannabis Business</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The Company currently sells the IMC and WAGNERS brands in the Israeli market.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The IMC brand established its reputation in Israel for quality and consistency over the past 10 years. In August 2020, a survey of licensed medical cannabis patients showed that the IMC brand is one
      of the top four most popular medical cannabis brands in Israel.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In association with Focus, the Group maintains a portfolio of strains sold under the IMC umbrella that includes popular medical cannabis dried flowers and full-spectrum cannabis extracts.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In 2021, IMC was rebranded with a refreshed logo, packaging, design language and tone, with a bold new design to better position itself in the competitive Israeli medical cannabis market, creating a
      variety of available products for medical cannabis patients. The IMC brand launched four different product lines as part of its rebranding:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">The Signature Collection</font> &#8211; The IMC brand&#8217;s high-quality product line with greenhouse grown, high THC cannabis flowers. This collection of products currently
      includes well known cannabis dried flowers such as Roma, Tel Aviv and London as well as newer strains launched in 2021 such as Mango Mint.<br>
      <div><br>
      </div>
      <div><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u></div>
      <div>
        <div style="text-align: left; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup> According to a survey carried out by Cannabis Magazine among 519 patients licensed by the MOH to consume medical cannabis (Aug 2020, Israel).</div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >8</font></div>
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="text-align: left; line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="text-align: left; line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">The Reserve Collection</font> &#8211; The IMC brand&#8217;s premium product line with indoor-grown, high THC cannabis&#160;flowers. Launched in Q1 2022 with BC Pink Kush.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">The Craft Collection</font> &#8211; The&#160;IMC brand&#8217;s ultra-premium product line with indoor-grown, hang-dried and hand-trimmed, high THC cannabis flowers. Including exotic and unique cannabis
      strains such as Peanut Butter MAC, Wedding Crasher and Alien Sin Mint Cookies.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">The Full Spectrum Extracts</font> &#8211; The IMC brand&#8217;s full spectrum, strain specific cannabis extracts including High THC Roma oil, balanced Paris oil and Super CBD.</div>
    <div style="line-height: 1.25; text-align: center;"><img src="image00018.jpg"> </div>
    <div style="text-align: justify; line-height: 1.25;">The WAGNERS brand launched in Israel during Q1 2022. For more information, please see &#8220;<font style="font-style: italic;">New Product Offering</font>&#8221;.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Canadian Adult-Use Recreational Cannabis Business</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Canada, the Company&#8217;s product portfolio consists of dried flower, pre-rolls and pressed hash offerings under the premium WAGNERS brand and ultra-premium Highland Grow brand. The WAGNERS brand was
      launched by TJAC in mid-2021, while the Highland Grow brand was acquired through the acquisition of MYM in July 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The WAGNERS brand offers high-quality cannabis on a consistent basis at an approachable price point for consumers. The Highland Grow brand offers cannabis consumers ultra-premium product, curated to
      their tastes. Both the WAGNERS and Highland Grow brands have proven to be very popular with consumers, each holding a top 3 position in Ontario across their respective price segments (year-to-date in 2022).<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup></div>
    <div style="text-align: justify; line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> <br>
      </sup></div>
    <div style="text-align: justify; line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> <br>
      </sup></div>
    <div style="text-align: justify; line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
      </sup></div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup> Depletion and e-commerce sales data from Ontario Cannabis Store - Sale of Data report for period between January 1 &#8211; February 28, 2022 for dried flower product between $7.50 - $9.99/gram
        and above $12.99/gram.</div>
      <div style="line-height: 1.25">&#160;</div>
      <sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >9</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">WAGNERS and Highland Grow products are primarily sold in 3.5 gram flower and 3 x 0.5 gram flower pre-roll formats.&#160; Other flower formats are available in certain provinces, such as 7 or 14 gram
      units. Hash is typically sold in 1, 2 and 4 gram formats.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Key WAGNERS flower and pre-roll strains include Cherry Jam, Pink Bubba, Blue Lime Pie, Purple Clementine, Dark Helmet and Silverback #4:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><img src="image00019.jpg"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Highland Grow brand portfolio includes six core flower strains: Gaelic Fire, White Lightning, Sensi Wizard, Cherry Burst, as well as two new strains added in Q4 2021, Gas Tank and Diamond Breath.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><img src="image00020.jpg"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">German Medical Cannabis Business</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Germany, the Company sells IMC-branded dried flower products. The medical cannabis products sold in the German market are branded generically as IMC so as to rely on the Company&#8217;s brand
      recognition in establishing a foothold with German healthcare professionals. The Company&#8217;s IMC-branded cannabis products were launched in Germany with one high THC flower strain in 2020.&#160; In Q4 2021, Adjupharm launched a flower strain second high THC
      strain and two full spectrum extracts.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In July 2021, Adjupharm was recognized by the German Brand Institute with the &#8220;German Brand Award 2021&#8221;, recognizing its excellence in brand strategy and creation, communication and integrated
      marketing. The competitive advantage in Germany also lies in the Group&#8217;s track record, experience and brand reputation in Israel and proprietary data supporting the possible effectiveness of medical cannabis for the treatment of a variety of
      conditions.</div>
    <div style="line-height: 1.25">&#160;&#160; </div>
    <div style="text-align: center; line-height: 1.25;"><img src="image00021.jpg"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >10</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
          <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
          <div style="line-height: 1.25; font-weight: bold;">
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160); font-family: 'Times New Roman',Times,serif;">HIGH-QUALITY, RELIABLE SUPPLY</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Israel</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Over the last decade, Focus was the primary cultivator of medical cannabis products sold under the IMC brand in the Israeli market, as an Israeli IMCA licensee permitted to
        cultivate medical cannabis in Israel (the &#8220;<font style="font-weight: bold;">Focus License</font>&#8221;) at the Focus cultivation facility (the &#8220;<font style="font-weight: bold;">Focus Facility</font>&#8221;). To supplement growing demand, Focus entered into
        supply agreements with third-party Israeli cultivators. Since 2021, the Company has focused on securing additional supply from its supply partners from outside of Israel, leveraging its improved purchasing capabilities and global presence, as well
        as facilitating the import of indoor-grown premium and ultra-premium cannabis from the Canadian Facilities. Importing from the Canadian Facilities aligns with the Company&#8217;s strategy in acquiring the Trichome and MYM to serve as a long term,
        reliable source of supply to both the Israeli and German markets.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Following cultivation in Israel or import of medical cannabis, in accordance with Israeli regulations, the medical cannabis products are then packed by contracted licensed producers of medical
      cannabis. The packaged medical cannabis products are then sold by the Group under the Company&#8217;s brands to local Israeli pharmacies directly or through contracted distributors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Canada</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In Canada, our primary customers are provincially-owned cannabis wholesalers who in turn sell to private and public retail locations where the consumer ultimately purchases cannabis products.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company supplies the WAGNERS and Highland Grow brands through a combination of internally cultivated production from the Canadian Facilities in Ontario, Quebec, and Nova Scotia. To diversify our
      supply lines, we also purchase carefully curated cannabis to match our consumers&#8217; demands and expectations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The Company operates four facilities in Canada (the &#8220;<font style="font-weight: bold;">Canadian Facilities</font>&#8221;):</div>
    <div style="line-height: 1.25;"><br>
      <table cellspacing="0" cellpadding="2" border="0" id="z3a61fe6e56e04b13b0a737f66fbfe0c9" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 18.14%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt; font-weight: bold;">Facility</div>
            </td>
            <td style="width: 13.64%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt; font-weight: bold;">Location</div>
            </td>
            <td style="width: 68.22%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt; font-weight: bold;">Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.14%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Manitou Facility</div>
            </td>
            <td style="width: 13.64%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Ontario</div>
            </td>
            <td style="width: 68.22%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Flagship 32,050 square metre facility, with approximately 4,340 square metre of cultivation space</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.14%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Trillium Facility</div>
            </td>
            <td style="width: 13.64%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Ontario</div>
            </td>
            <td style="width: 68.22%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Approximately 1,400 square metre processing and cultivation facility</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.14%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Sublime Facility</div>
            </td>
            <td style="width: 13.64%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Quebec</div>
            </td>
            <td style="width: 68.22%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Approximately 930 square metre cultivation and storage facility</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.14%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Highland Facility</div>
            </td>
            <td style="width: 13.64%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Nova Scotia</div>
            </td>
            <td style="width: 68.22%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">Approximately 530 square metre cultivation and storage facility</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Manitou Facility and Trillium Facility (together, the &#8220;<font style="font-weight: bold;">TJAC Facilities</font>&#8221;) are operated by TJAC, and the Sublime Facility and
        Highland Facility (together, the &#8220;<font style="font-weight: bold;">MYM Facilities</font>&#8221;) are operated by Sublime and Highland, respectively. The TJAC Facilities, and the MYM Facilities, pursuant to their Health Canada issued licenses (the &#8220;<font style="font-weight: bold;">TJAC Licenses</font>&#8221; and the &#8220;<font style="font-weight: bold;">MYM Licenses</font>&#8221;, respectively) are authorized to cultivate, process and sell cannabis (only the Trillium Facility and the Highland Facility hold a
        license to sell).</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Germany</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company continues to expand its presence in the German market by forging partnerships with pharmacies and distributors across the country and developing Adjupharm and the Logistics Centre as the
      Company&#8217;s European hub. Adjupharm sources its supply of medical cannabis for the German market from various EU-GMP certified European and Canadian suppliers. The completion of the Logistics Centre upgraded Adjupharm&#8217;s production technology and
      increased its storage capacity to accommodate its anticipated growth. The Company is also focused on exporting products into Germany from its Canadian Facilities, securing a reliable long term source of supply and minimizing the risks inherent in the
      supply chain.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >11</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Adjuharm currently holds wholesale, narcotics handling, manufacturing, procurement, storage, distribution and import/export licenses granted to it by the applicable German regulatory authorities (the
      &#8220;<font style="font-weight: bold;">Adjupharm Licenses</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160); font-family: 'Times New Roman',Times,serif;">NEW PRODUCT OFFERINGS</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Between our various geographies, the strategy for new products varies given that each market is at a different stage of development with respect to regulatory regimes, patient and customer
      preferences and adoption rates.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Israel</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" border="0" id="z7342cf525edc48f5a8993ab5de9dd19d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 80%; text-align: left; vertical-align: top;">
              <div>
                <div style="line-height: 1.25;">In conjunction with Focus and its cultivation partners cultivating Israeli-grown cannabis, the Company is also importing premium cannabis from its Canadian Facilities and from third-party supply partners.
                  Canadian indoor-grown cannabis commands a premium to the Israeli consumer. The Company launched the BC Pink Kush cannabis flowers to its Reserve Collection during Q1 2022, and is planning to launch another cannabis flower, Berlin, to its
                  Signature Collection in the beginning of Q2 2022.</div>
              </div>
            </td>
            <td style="width: 20%; text-align: left; vertical-align: top;">
              <div>&#160;<img src="image00014.jpg"></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;"></div>
    <div style="text-align: justify; line-height: 1.25;">The WAGNERS brand launched in Israel during Q1 2022, with premium indoor-grown cannabis from the Canadian Facilities. The WAGNERS brand in Israel offers premium, imported, indoor-grown flower at a
      competitive price point for the first time in the Israeli market, due to the Group&#8217;s vertically integrated global supply chain reducing costs across the chain.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The WAGNERS brand currently offers its Cherry Jam and Dark Helmet products in Israel with additional products expected to launch later in 2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; text-align: center;"> <img src="image00013.jpg"></div>
    <br>
    <div style="text-align: justify; line-height: 1.25;">We also plan to launch the Highland Grow brand in Israel later in 2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >12</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Canada</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;">The Company has amassed a portfolio of more than 150 cannabis strains through the MYM Transaction, and we are regularly evaluating and bringing new strains to market. In Q4
      2021, we launched Pink Bubba and Blue Lime Pie under the WAGNERS brand. The market reception of Pink Bubba has been strong, rivaling sales of our flagship Canadian strain, Cherry Jam in key markets. We also plan to launch four new strains in Q2 2022;
      Tiki Rain, Rainforest Crunch, Golden Ghost OG and Turpy Slurpy:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; margin-right: 13.5pt; line-height: 1.25;"><img src="image00022.jpg"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;">We have introduced pre-rolls under the Highland Grow brand for cannabis connoisseurs who also value convenience. In addition, we have launched new strains: Diamond Breath and
      Gas Tank under Highland Grow brand.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;">In Q1 2022, we commenced distribution of a new brand, Dymond Concentrates, which will offer high-quality concentrates such as THCA diamonds, caviar, live resin, badder and
      shatter:</div>
    <div style="text-align: justify; margin-right: 13.5pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25;"><img src="image00023.jpg"></div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Germany</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">IM Cannabis started 2022 with the launch of a high CBD flower strain and is also currently in the process of launching its popular Canadian WAGNERS brand in the German medical cannabis market,
      importing cannabis flower from the Canadian Facilities. The expansion of our portfolio shows our commitment to providing German physicians and patients with the best available strains in the global cannabis market, giving them the opportunity to
      tailor their treatments to their patients&#8217; individual needs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >13</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160);">CORPORATE HIGHLIGHTS AND EVENTS</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">KEY HIGHLIGHTS FOR THE QUARTER AND YEAR ENDED DECEMBER 31, 2021</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In 2021 the Company executed on its strategy to expand its business operations through several strategic acquisitions to enter the Canadian adult-use recreational cannabis market and the retail and
      distribution segments of the medical cannabis market in Israel. The Company&#8217;s key highlights and events for the year ended December 31, 2021 include:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Amendment of Focus&#8217; Commercial Agreements</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">On January 1, 2021, the Company amended the terms of each of the IP Agreement and the Services Agreement to align the consideration with implementation of the Company&#8217;s transfer pricing framework. The amendments to
          these agreements constituted a &#8220;related party transaction&#8221; as such term is defined in Multilateral Instrument 61-101 - <font style="font-style: italic;">Protection of Minority Security Holders in Special Transactions</font> (&#8220;<font style="font-weight: bold;">MI 61-101</font>&#8221;).&#160; The Company was exempt from the formal valuation requirement under Section 5.5(a) and the minority approval requirement under Section 5.7(1)(a) of MI 61-101, respectively, as the fair market value
          of the amendments, as determined by the Board, did not exceed 25% of the Company's market capitalization on the date of such amendments.</div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">DTC Eligibility</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On January 26, 2021, the Company announced that it received confirmation from The Depository Trust Company (&#8220;<font style="font-weight: bold;">DTC</font>&#8221;) that its Common Shares are eligible for
      electronic clearing and settlement through DTC in the United States (&#8220;<font style="font-weight: bold;">U.S.</font>&#8221;)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Share Consolidation </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;"></font></div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">On February 12, 2021, IM Cannabis consolidated all of its issued and outstanding Common Shares on the basis of one (1) post-consolidation Common Share for each four (4) pre-consolidation Common
      Shares (the &#8220;<font style="font-weight: bold;">Share Consolidation</font>&#8221;) to meet the NASDAQ minimum share price requirement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Changes to Board of Directors</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On February 22, 2021, IM Cannabis appointed Brian Schinderle and Haleli Barath to its board of directors (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;). Both Mr. Schinderle and Ms. Barath are
      independent directors under applicable Canadian and United States securities laws. Concurrently with the foregoing appointments, Rafael Gabay and Steven Mintz resigned from the Board.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Listing on NASDAQ</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 1, 2021, the Common Shares commenced trading on the NASDAQ under the ticker symbol&#160;&#8220;IMCC&#8221;, making IM Cannabis the first Israeli medical cannabis operator to list its shares on the NASDAQ.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">First Supply Partnership for Import of Premium Medical Cannabis to Israel</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 8, 2021, the Company announced that Focus signed a multi-year supply agreement with GTEC Holdings Ltd. (&#8220;<font style="font-weight: bold;">GTEC</font>&#8221;), a Canadian Licensed Producer of
      handcrafted and high quality cannabis, under which Focus will import GTEC&#8217;s high-THC medical cannabis flowers into Israel to be sold under the IMC brand. By committing to purchase a minimum quantity of 500 kg of high-THC medical cannabis flower from
      GTEC&#8217;s subsidiary, Grey Bruce Farms Incorporated, Focus is the exclusive recipient of GTEC cannabis products in the Israeli market for a period of 12 months commencing on the date the first shipment of GTEC products arrives in Israel, with an option
      to extend the term of exclusivity by an additional 6 months. The first shipment arrived in Q3 2021 and the Group launched a new category of imported premium indoor medical cannabis products under its well-established brand.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >14</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">On June 7, 2021, the Group continued to execute on its strategy of importing premium product and growing its network of strategic supply partners by Focus entering into a three-year supply agreement
      with Flowr Corporation (&#8220;<font style="font-weight: bold;">Flowr</font>&#8221;), a Canadian Licensed Producer of ultra-premium adult-use recreational and medical cannabis products. The first shipment from Flowr arrived in Q4 2021. The Group launched the
      medical cannabis products from this shipment in Q1 2022.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Entering the Canadian Adult-Use Recreational Market</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 18, 2021, the Company acquired all of the issued and outstanding shares of Trichome(the &#8220;<font style="font-weight: bold;">Trichome Transaction</font>&#8221;), becoming the first Israeli medical
      cannabis operator with established operation in Israel, Germany and Canada, securing its supply of premium indoor cannabis with the objective of exporting into the Israeli medical market and competing in the premium segment of Canada&#8217;s adult-use
      recreational cannabis market. Trichome is the sole shareholder of TJAC (then doing business as JWC), and is a Canadian Licensed Producer of cannabis products in the adult-use recreational cannabis market. The Trichome Transaction completed pursuant
      to a statutory plan of arrangement under the <font style="font-style: italic;">Business Corporations Act</font> (Ontario) in accordance with a definitive agreement entered into on December 30, 2020.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">Pursuant to the terms of the Trichome Transaction, former holders of common shares of Trichome (the &#8220;<font style="font-weight: bold;">Trichome Shares</font>&#8221;) and former holders of Trichome convertible instruments
          (collectively, the &#8220;<font style="font-weight: bold;">Trichome Securityholders</font>&#8221;) received 0.24525 of a Common Share for each Trichome Share held and each in-the-money convertible instrument of Trichome. Pursuant to the Trichome Transaction,
          a total of 10,104,901 Common Shares were issued to the Trichome Securityholders, resulting in former Trichome Securityholders holding approximately 20.06% of the total number of Common Shares (based on 50,370,027 Common Shares issued and
          outstanding immediately after closing of the Trichome Transaction). In addition, 100,916 Common Shares were issued to financial advisors in connection with the Trichome Transaction.</div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Entering the Retail Segment in Israel by Acquiring Panaxia&#8217;s Largest Retail and Online Pharmacy Business</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On April 30, 2021, IMC Holdings signed a definitive agreement with Panaxia to acquire the Panaxia-to-the-Home Operation, and the Panaxia GDP License from Panaxia Pharmaceutical Industries Israel Ltd.
      and Panaxia Logistics Ltd., part of the Panaxia Labs Israel, Ltd. group of companies (the &#8220;<font style="font-weight: bold;">Panaxia Transaction</font>&#8221;). Panaxia-to-the-Home offers medical cannabis patients across Israel the largest selection of
      medical cannabis products in Israel through an online platform with temperature-controlled home delivery, along with a call centre for patient support.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On May 30, 2021, the Company completed the first closing of the Panaxia Transaction, pursuant to which the Panaxia-to-the-Home Operation and all intellectual property were transferred to IMC
      Holdings., and on March 14, 2022 the Company completed the acquisition of the Panaxia GDP License. For more information, please see &#8220;<font style="font-style: italic;">Subsequent Events</font>&#8221;.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >15</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Closing of US$35 Million Equity Financing by Overnight Marketed Offering</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">On May 7, 2021, IM Cannabis closed an overnight marketed offering (the &#8220;<font style="font-weight: bold;">2021 Offering</font>&#8221;) of its Common Shares (&#8220;<font style="font-weight: bold;">Offered
          Shares</font>&#8221;) and Common Share purchase warrants (&#8220;<font style="font-weight: bold;">2021 Offered Warrants</font>&#8221;). A total of 6,086,956 Offered Shares at a price of US$5.75 per Offered Share were sold and issued for aggregate gross proceeds of
        approximately US$35,000 ($42,502). IM Cannabis also issued 3,043,478 2021 Offered Warrants to purchasers of Offered Shares, for no additional consideration, with each 2021 Offered Warrant exercisable for one Common Share at an exercise price of
        US$7.20 for a term of 5 years from the date of closing of the 2021 Offering. The 2021 Offering was completed by way of a final prospectus supplement filed on May 5, 2021. Pursuant to the terms of the 2021 Offering, the agents who acted on the
        Company&#8217;s behalf in connection with the 2021 Offering, held an over-allotment option to purchase up to an additional 913,044 Offered Shares and 465,522 2021 Offered Warrants on the same terms and conditions for a period of 30 days following the
        date of closing of the 2021 Offering which was not exercised.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company also issued a total of 182,609 broker compensation options (the &#8220;<font style="font-weight: bold;">2021 Broker Compensation Options</font>&#8221;) to the agents who acted on its behalf in
      connection with the 2021 Offering. Each 2021 Broker Compensation Options is exercisable for one (1) Common Share at an exercise price of US$6.61, at any time following November 5, 2021 until November 5, 2024.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The 2021 Offering was conducted pursuant to a prospectus supplement under the Company&#8217;s final base shelf prospectus receipted by the applicable Canadian securities commissions on March 31, 2021 (the
      &#8220;<font style="font-weight: bold;">Base Shelf Prospectus</font>&#8221;) and its Registration Statement on Form F-10, which was declared effective on March 31, 2021by the United States Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">TJAC Revolving Credit Facility</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; text-align: justify; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">On May 14, 2021, the Company&#8217;s subsidiary, TJAC, entered into a revolving credit facility (the &#8220;<font style="font-weight: bold;">Revolver</font>&#8221;) for $5,000 with a private Canadian creditor. The Revolver has an
        initial term of 12 months that can be extended upon the mutual agreement of both parties. Per annum interest is equal to the greater of (i) 9.75% and, (ii) the Toronto Dominion Bank prime rate, plus 7.30%. The Facility has a standby fee of 2.40%
        per annum, which is charged against the unused portion. Advanced amounts are secured against the assets of TJAC and Trichome, with Trichome providing a guarantee for the Facility.<font style="font-weight: bold;">&#160;</font>To maintain the Facility,
        TJAC must abide by certain financial covenants, such as the maintenance of a tangible net worth greater than $5,000 and a debt service coverage ratio of 2:1. On September 23, 2021, TJAC increased the limit on the Revolver from $5,000 to $7,500 and
        added Highland&#8217;s assets to the Revolver borrowing base. The increase will be used to finance TJAC and MYM&#8217;s receivables in order to manage the timing of cash flows. On October 18, 2021, TJAC and MYM increased the limit on the Revolver to $10,000.
        The increase will be used to finance TJAC and MYM&#8217;s receivables in order to manage the timing of cash flows.&#160; On March 29, 2022, the limit on the Revolver increased from $10,000 to $15,000 and was renewed for an additional 12 months.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >16</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Acquisition of MYM Nutraceuticals Inc.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On July 9, 2021, the Company, through Trichome, acquired all of the issued and outstanding shares of MYM on July 9 2021 (the &#8220;<font style="font-weight: bold;">MYM Transaction</font>&#8221;). In addition to
      acquiring the rights to the Highland Grow brand, a widely-available ultra-premium cannabis brand in Canada with a proven track record, the Company also acquired over 150 strains in its product portfolio that the Company plans to selectively release
      to market. The MYM Transaction was completed pursuant to a statutory plan of arrangement under the <font style="font-style: italic;">Business Corporations Act</font> (British Columbia) in accordance with a definitive agreement entered into on March
      31, 2021. Pursuant to the terms of the MYM Transaction, former holders of common shares of MYM (the &#8220;<font style="font-weight: bold;">MYM Shares</font>&#8221;) received 0.022 of a Common Share for each MYM Share held. In connection with the MYM
      Transaction, a total of 10,073,437 Common Shares were issued to the former holders of MYM Shares, resulting in former MYM shareholders holding approximately 15% of the total number of Common Shares (based on 67,156,470 Common Shares issued and
      outstanding immediately after closing of the MYM Transaction).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Completion of German Logistics Centre</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In July 2021, the Company completed the Logistics Centre that allows Adjupharm to internally manage all aspects of its supply chain including, the repackaging of bulk cannabis. IM Cannabis expects
      that the Logistics Centre will strongly augment Adjupharm&#8217;s capabilities as a focal point for the Company&#8217;s European strategy. The Logistics Centre doubles Adjupharm&#8217;s footprint to approximately 8,000 square feet, upgrades the production facilities
      with state-of-the-art technology and increases cannabis storage capacity to seven tonnes.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Acquisition of Leading Israeli Retailer and Distributor - Pharm Yarok Group</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On July 28, 2021, IMC Holdings entered into a definitive agreement to acquire100% of the issued and outstanding shares of (i) Pharm Yarok, a leading medical cannabis pharmacy located in central
      Israel; (ii) Rosen High Way, a trade and distribution centre providing medical cannabis storage, distribution services and logistics solutions for cannabis companies and pharmacies in Israel; and (iii) HW Shinua, an applicant for a medical cannabis
      transportation license (collectively, the &#8220;<font style="font-weight: bold;">Pharm Yarok Transaction</font>&#8221;). The Pharm Yarok Transaction aligns with the Company&#8217;s execution of its vertical integration strategy within the Israeli medical cannabis
      retail market. The Pharm Yarok Transaction closed in March 2022. For more information, please see &#8220;<font style="font-style: italic;">Subsequent Events</font>&#8221;.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Acquisition of Leading Israeli Pharmacy &#8211; Vironna</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On August 16, 2021, IMC Holdings entered into definitive agreement to acquire 51% of the issued and outstanding ordinary shares of Vironna (the &#8220;<font style="font-weight: bold;">Vironna Transaction</font>&#8221;),









      a pharmacy licensed to dispense and sell medical cannabis and is one of the leading pharmacies serving patients in the Arab population in Israel. The Vironna Transaction closed in March 2022. For more information, please see &#8220;<font style="font-style: italic;">Subsequent Events</font>&#8221;.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Acquisition of Jerusalem&#8217;s Leading Medical Cannabis Pharmacy- Oranim Pharm</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On December 1, 2021, IMC Holdings signed a definitive agreement to acquire 51.3% of the outstanding ordinary shares of Oranim Plus. Oranim Plus holds 99.5% of the rights in Oranim Pharm Partnership
      (&#8220;<font style="font-weight: bold;">Oranim Pharm</font>&#8221;). The acquisition will result in IMC Holdings owning 51% of the rights in Oranim Pharm, which is one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling
      medical cannabis in the Jerusalem area (the &#8220;<font style="font-weight: bold;">Oranim Transaction</font>&#8221;). The Oranim Transaction closed in March 2022. For more information, please see &#8220;<font style="font-style: italic;">Subsequent Events</font>&#8221;.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >17</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Executive Changes to Subsidiaries</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Effective December 2021, Howard Steinberg was appointed Chief Executive Officer of the following wholly-owned Canadian subsidiaries of IM Cannabis: MYM, Highland and Sublime. Karl Grywacheski was
      appointed Chief Financial Officer of Highland.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">SUBSEQUENT EVENTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Strategic Executive Management Changes</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On January 13, 2022, the Company announced the following changes to its management team: Yael Harrosh, previously IM Cannabis&#8217;s General Counsel, Business Director and Corporate Secretary, was
      promoted to global Chief Legal and Operations Officer, effective immediately. Rinat Efrima was appointed the new Chief Executive Officer of IMC Holdings and joined the Company in Q1 2022.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">First Import to Israel of Cannabis from the Company&#8217;s Canadian Facility</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On January 19, 2022, Focus imported premium indoor-grown Canadian cannabis flowers from TJAC, and an additional supply partner, marking an important milestone in the execution of the IM Cannabis&#8217;
      strategic objectives of vertical integration. The Group commenced the sale of imported cannabis flowers under its WAGNERS brand in the Israeli medical cannabis market as of February 2021.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Focus Revolving Credit Facility</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In January 2022, Focus entered into a revolving credit facility with Bank Mizrahi (the &#8220;<font style="font-weight: bold;">Mizrahi Facility</font>&#8221;).&#160; The Mizrahi Facility is guaranteed by Focus
      assets. Advances from the Mizrahi Facility will be used for working capital needs. The Mizrahi Facility has a total commitment of up to NIS 15,000 (approximately $6,000) and has a one-year term for on-going needs and 6 month term for imports and
      purchases needs. The Mizrahi Facility is renewable upon mutual agreement by the parties. The borrowing base available for draw at any time throughout the Mizrahi Facility and is subject to several covenants to be measured on a quarterly basis. The
      Mizrahi Facility bears interest of Israeli prime interest plus 1.5% (approximately 3.3%) per annum.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Closing of Pharm Yarok Transaction</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 14, 2022, the Pharm Yarok Transaction closed upon receipt of all requisite approvals, including the IMCA approval, for an aggregate consideration of NIS 11,900 (approximately $4,600), of
      which NIS 8,400 (approximately $3,300) was paid in cash upon signing the definitive agreement, and NIS 3,500 (approximately $1,300) paid upon closing. The acquisition of the outstanding ordinary shares of HW Shinua is pending receipt of the requisite
      approval from the IMCA. In connection with closing of the Pharm Yarok Transaction, the Company completed a non-brokered private placement with former shareholders of Pharm Yarok and Rosen High Way on March 14, 2022. A total of 523,700 Common Shares
      were issued at a deemed price of $2.616 for aggregate proceeds of approximately $1,370. The calculation of the deemed price was based on the average closing price of Common Shares on the CSE over the 8 trading day period immediately preceding March
      14, 2022.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >18</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Closing of Vironna Transaction</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 14, 2022, the Vironna Transaction closed upon receipt of all requisite approvals, including the approval of the IMCA. The Vironna Transaction was completed for total consideration of NIS
      8,500 (approximately $3,330), comprised of NIS 5,000 (approximately $1,950) in cash and NIS 3,500 (approximately $1,350) in Common Shares issued on closing. In satisfaction of the cash consideration component, NIS 3,750 (approximately $1,470) was
      paid at signing of the definitive agreement and the remaining NIS 1,250 (approximately $490) will be paid post-closing of the Vironna Transaction. In satisfaction of the share consideration component, the Company issued 485,362 Common Shares at a
      deemed issue price of US$2.209 per share (approximately $2.8092), calculated based on the average closing price of the Common Shares of on the NASDAQ for the 14 trading day period immediately preceding closing. The shares issued are subject to a
      staggered three-month lockup commencing on the date of issuance.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Closing of Panaxia Transaction</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On March 14, 2022, IMC Holdings acquired the Panaxia GDP License following receipt of the requisite IMCA approval, and assigned it to IMC Pharma in accordance with the
          terms of the Panaxia Transaction (the &#8220;<font style="font-weight: bold;">Panaxia GDP License Closing</font>&#8221;). The aggregate consideration for the Panaxia Transaction was NIS 18,700 (approximately $7,200), of which NIS 7,600 (approximately $2,900)
          was paid in two cash instalments and NIS 11,100 (approximately $4,300) payable in Common Shares (&#8220;<font style="font-weight: bold;">Panaxia Consideration Shares</font>&#8221;). To satisfy the share consideration component of the Panaxia Transaction, the
          Company issued four installments of an aggregate of 934,755 Panaxia Consideration Shares between August 9, 2021 and March 14, 2022, with the deemed price of each instalment of Panaxia Consideration Shares determined based on the average closing
          price of the Common Shares on Nasdaq during the 10 trading day period immediately prior to issuance. The fifth and final installment of Panaxia Consideration Shares will be issued following the Panaxia GDP License Closing. The Panaxia Transaction
          includes a further option to acquire, for no additional consideration, a pharmacy from Panaxia, including requisite licenses to dispense and sell medical cannabis to patients, that the Company has exercised (&#8220;<font style="font-weight: bold;">Panaxia



            Pharmacy Closing</font>&#8221;). The Panaxia Pharmacy Closing is expected to occur in Q3 2022.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Closing of Oranim Transaction</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 28, 2022, the Oranim Transaction closed upon receipt of all requisite approvals, including the approval of the IMCA. The Oranim Transaction was completed for total consideration of NIS
      11,940 (approximately $4,600), comprised of NIS 10,404 (approximately $4,000) and NIS 1,536 (approximately $600) in Common Shares issued on closing. In satisfaction of the cash consideration component, NIS&#160;5,202 (approximately $2,000) paid at signing
      of the definitive agreement and NIS 5,202 will be payable in the first quarter of 2023. In satisfaction of the share consideration component, the Company issued 251,001 Common Shares at a deemed issue price of US$1.9 per share (approximately $2.37)
      per share, calculated based on the average closing price of the common shares of the Company on the Nasdaq Capital Market for the 14 trading day period immediately preceding March 28, 2022. The shares issued are subject to a staggered three-month
      lockup commencing on the date of issuance.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >19</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
            <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
            <div style="line-height: 1.25; font-weight: bold;">
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="line-height: 1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; color: rgb(112, 48, 160);">REVIEW OF FINANCIAL PERFORMANCE</div>
    </div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Financial Highlights</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Below is the analysis of the changes that occurred for the year and three months ended December 31, 2021 and 2020. Commentary is provided below.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z31d13e8694c845cb88b97c3d39cd0dc9" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the year ended December 31</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6" rowspan="1">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the three months ended December 31</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Revenues</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">54,300</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">15,890</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">20,028</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,900</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Gross profit before fair value impacts in cost of sales</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">11,882</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">8,809</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3,773</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,791</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Gross margin before fair value impacts in cost of sales (%)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">55</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">19</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">57</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Operating Loss</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(38,389</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(8,245</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(11,722</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(6,383</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="margin-right: 0.9pt; line-height: 1.25;">Loss</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(18,518</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(28,734</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(12,488</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(19,976</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Loss per share attributable to equity holders of the Company - Basic</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.31</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.74 <br>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">) <br>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.19 <br>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.125</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Loss per share attributable to equity holders of the Company - Diluted</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.66</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.74 <br>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">)<br>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.19 <br>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">) <br>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.125</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z7c558ccc2ffd48de8e2c366d7d37cb4f" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the year ended December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the three months ended December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Average net selling price of dried flower (per Gram)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> 1</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4.90</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">5.75</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">5.52</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">5.51</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Average net selling price of other cannabis products (per Gram)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4.70</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4.07</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Quantity harvested and trimmed (in Kilograms)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,770</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,564</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,998</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,610</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Quantity of other cannabis products sold (in Kilograms)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,033</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">503</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Quantity of dried flower sold (in Kilograms)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">8,410</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,586</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,949</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,079</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">Notes:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Cannabis selling prices in the Canadian market are characterized with lower selling prices than dried flowers the Israeli and German market.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Including other cannabis products such as Kief, Hash and Pre-rolls.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Harvested flowers, after trimming and ready for manufacturing.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Overview of Financial Performance includes reference to non-IFRS financial measure, &#8220;gross margin&#8221;, which the Company defines as the difference between revenue and cost of revenues divided by
      revenue (expressed as a percentage), prior to the effect of a fair value adjustment for inventory and biological assets. For more information on non-IFRS financial measures, see the &#8220;<font style="font-style: italic;">Non-IFRS Financial Measures</font>&#8221;
      and &#8220;<font style="font-style: italic;">Metrics and Non-IFRS Financial Measures</font>&#8221; sections of the MD&amp;A.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >20</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">OPERATIONAL RESULTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company remains positive on the cannabis markets in Israel, Canada and Germany.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company believes that there a number of key factors creating tailwinds to facilitate further industry growth.&#160; In Israel, the number of licensed medical patients has
          increased by&#160;36% in 2021 and is expected to further grow in the next years and may further benefit from regulatory change liberalizing the cannabis market in Israel. Moreover, the acquisitions of Israeli pharmacies Pharm Yarok, Vironna and Oranim
          Pharm (collectively, the &#8220;Israeli Pharmacies&#8221;) positions IM Cannabis as one of the largest distributors of medical cannabis in Israel. In Canada, the recreational cannabis market is expected to grow from $1.07 billion in Q4 2021 ($4.3 billion
          annualized)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup> to $8 billion in annual sales by 2026<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup>. In Germany, the newly elected coalition government has endorsed the legalization of adult-use cannabis.&#160; While no specific legislation has yet been tabled and any
          implementation will take time, the Company believes that Germany will be the second largest federally legal, adult-use market in the world.&#160; Moreover, in Germany, the Company has seen an increase in the number of private payors of medical
          cannabis products, which the Company believes is supportive of its business plan as it relies less on the need for insurance re-imbursement.&#160; The outlook for the Company is further supported by its focus on the cultivation and distribution of
          premium cannabis products only, which the Company believes to be in the greatest demand in all of its markets, faces less competition, and therefore is less likely to face significant price competition.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Notwithstanding the above, the Israeli cannabis market has become increasingly competitive and the ability to import premium cannabis from Canada is a key determinant of success in Israel.&#160; The
      cannabis industry in Canada remains highly competitive and generally oversupplied, particularly in value products, and the ongoing viability of the illicit market.&#160; The German has been slower to develop due to the difficulty in medical patients
      accessing prescriptions and insurance re-imbursements.&#160; In each of the Company&#8217;s markets, the Company must navigate evolving customer and patient trends in order to be competitive with other suppliers of cannabis products.</div>
    <div style="line-height: 1.25"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u><u><font style="font-family: 'Times New Roman',Times,serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></u><font style="font-family: 'Times New Roman',Times,serif;"><br>
      </font>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup> Based on HiFyre Data for period between October 1 &#8211; December 31, 2021.</div>
      <font style="font-family: 'Times New Roman',Times,serif;"> </font>
      <div style="line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup> <font style="font-size: 9pt;">BDSA, </font><font style="font-size: 9pt; color: rgb(5, 99, 193);"><u>https://www.globenewswire.com/news-release/2021/09/21/2300624/0/en/BDSA-Reports-Global-Cannabis-Sales-Surge-41-YoY-in-2021-Will-Surpass-62-Billion-by-2026.html</u></font></font></div>
      <u></u>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >21</font></div>
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">REVENUES AND GROSS MARGINS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Revenues</div>
    <div style="line-height: 1.25">&#160;
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The main revenues of the Group are generated from sales of medical cannabis products to customers in Israel and Germany as well as products to the recreational market in
          Canada. The three reportable geographical segments in which the Company operates are Israel,&#160;Canada and Germany.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="line-height: 1.25;">For the year ended December 31:</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z7c51a8f5bb1c4deeb54c688d13f257ce" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Israel</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Canada</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Germany</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Adjustments</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Total</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Total revenue</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">25,431</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">13,826</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">20,247</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">8,622</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,064</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">54,300</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">15,890</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%;">
            <div style="line-height: 1.25;">Segment income (loss)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(10,654</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,090</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(15,353</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,142</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(3,744</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(31,149</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,834</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Unallocated corporate expenses</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(7,240</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,411</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(7,240</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,411</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%;">
            <div style="line-height: 1.25;">Total operating (loss) income</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(10,654</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,090</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(15,353</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,142</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(3,744</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(7,240</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,411</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(38,389</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(8,245</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Depreciation and amortization</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,424</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">617</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3,879</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">701</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">73</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">6,004</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">690</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">For the three months ended December 31:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z7133a5e89ac24cd7a01bdcbcc4cb70b7" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Israel</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Canada</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Germany</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Adjustments</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Total</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Total revenue</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">8,472</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">5,541</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">10,116</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,440</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(641</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">20,028</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,900</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%;">
            <div style="line-height: 1.25;">Segment income (loss)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(4,451</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,559</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,983</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,725</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">264</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(10,159</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,295</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Unallocated corporate expenses</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(1,563</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(1,088</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(1,563</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(1,088</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%;">
            <div style="line-height: 1.25;">Total operating (loss) income</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(4,451</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,559</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,983</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,725</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">264</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(1,563</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(1,088</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(11,722</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(6,383</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 20%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Depreciation and amortization</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">405</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(1</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,378</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">617</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">20</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,400</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">19</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">The consolidated revenues of the Group for the three and twelve months ended December 31, 2021 was attributed to the sale of medical cannabis products in Israel and Germany. After the acquisition of
      Trichome and MYM, the consolidated revenues included revenues from the sale of adult-use recreational cannabis in Canada increasing the consolidated revenue of the Group.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfe10d4a1916644e095efc3046d88c844" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><font style="font-family: 'Times New Roman',Times,serif;"><br>
            </font> </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Revenues for the year ended December 31, 2021 and 2020 were $54,300 and $15,890, respectively, representing an increase of $38,410 or 242%. The increase in revenues was mainly due to the Company&#8217;s new
                acquisitions done through the year. These acquisitions led to the consolidation of the new subsidiaries both in the Canadian and Israeli market.</div>
            </div>
          </td>
        </tr>

    </table>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25"><font style="font-family: 'Times New Roman',Times,serif;">&#160;</font>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><font style="font-family: 'Times New Roman',Times,serif;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>
                <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Revenues from the Israeli operation were attributed to the sale of medical
                    cannabis through company agreement with Focus and the consolidation of revenues from company new purchasing of pharmacies.</font></div>
              </div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25"><font style="font-family: 'Times New Roman',Times,serif;">&#160;</font>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><font style="font-family: 'Times New Roman',Times,serif;"><br>
                </font> </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif;">
                  <div style="line-height: 1.25;">Revenues from Company Canadian operation are including revenues from the sale of adult-use recreational cannabis in Canada through Company acquisitions of TJAC and MYM.</div>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25"><font style="font-family: 'Times New Roman',Times,serif;">&#160;</font>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt;"><font style="font-family: 'Times New Roman',Times,serif;"><br>
                  </font> </td>
                <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>
                    <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">In Germany Company revenues were attributed to the sale of medical cannabis
                        through company subsidiary Adjupharm.</font></div>
                  </div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
        </div>
      </div>
    </div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font> <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <table cellspacing="0" cellpadding="0" id="z8d5662a7c0e34ef0b897e610ba2e58ce" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;"><font style="font-family: 'Times New Roman',Times,serif;"> </font>
            <div style="font-family: 'Times New Roman',Times,serif;">Revenues for the three months ended December 31, 2021 and 2020 were $20,028 and $4,900, respectively, representing an increase of $15,128 or 309%.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z355ac30bbef3402ca5d6cfe4e5f7c10b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Total dried flower sold for the year ended December 31, 2021 was 8,410kg at an average selling price of $4.90 per gram compared to 2,586kg for the same period in 2020 at an average selling price of $5.75 per gram, derived mainly from the
              lower average selling price per gram the Company benefited from through its Canadian acquisitions of Trichome and MYM.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >22</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zb62a1fb95664498080b11866c849f7af" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Total dried flower sold for the three months ended December 31, 2021 was 2,949 kg at an average selling price of $5.52 per gram compared to 1,079kg for the same period in 2020&#160;at an average selling price of $5.51 per gram.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zb610871f08d64dc096b72b85bb0a8aa3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The increase in revenues related to dried flower in 2021 is attributable to deliveries made under the Focus&#8217; sales agreements to pharmacies, revenues generated from Adjupharm, the consolidation of Trichome, MYM, and the Consolidated
              Entities according to the definitive agreement dates for each of the Consolidated Entities.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5fd04b95729642318a81c3cf2650e4a1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Total other cannabis product sold for the year ended December 31, 2021 was 1,033kg at an average selling price of $4.70 per gram. Other cannabis products include keef, hash, pre-rolls and more cannabis related products and are.
              attributable to the acquisitions of Trichome and MYM during 2021.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5dfeb253717d4df1b042aba6b610e3f4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Total other cannabis product sold for the three months ended December 31, 2021 was 503kg at an average selling price of $4.07 per gram. The increase in revenues related to other cannabis products for the twelve and three month ended
              December 31, 2021 is attributable to the acquisitions of MYM and Trichome and the sales of the WAGNERS, Highland and Sublime brands during 2021.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Cost of Revenues</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Cost of revenues is comprised of cultivation costs, purchase of materials and finished goods, utilities, salary expenses and import costs, including the purchase of raw materials, production, product
      testing, shipping and sales related costs. At harvest, the biological assets are transferred to inventory at their fair value which becomes the deemed cost for the inventory. Inventory is later expensed to the cost of sales when sold. Direct
      production costs are expensed through the cost of sales.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The fair value of biological assets is categorized within Level 3 of the fair value hierarchy. The inputs and assumptions used in determining the fair value of biological assets include:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zcafc8a39a4e24611875681c56734355f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.55pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Selling price per gram - calculated as the weighted average historical selling price for all strains of cannabis sold by the Group, which is expected to approximate future selling prices.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z3ee86b3e3a844cd8a0f187db060fde1f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.55pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Post-harvest costs - calculated as the cost per gram of harvested cannabis to complete the sale of cannabis plants post-harvest, consisting of the cost of direct and indirect materials, depreciation and labor as well as labelling and
              packaging costs.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zcae0959089a0467684859ed7587662e9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.55pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Attrition rate - represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z099b7db44baf4d6daa2e40bdf9b5cfb6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.55pt; vertical-align: top; align: right;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Average yield per plant - represents the expected number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z35666758851e4a2b9a6aa95c4574191e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.55pt; vertical-align: top; align: right;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Stage of growth - represents the weighted average number of weeks out of the average weeks growing cycle that biological assets have reached as of the measurement date.<font style="font-weight: bold;">&#160;</font>The growing cycle is
              approximately 12 weeks.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >23</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">The following table quantifies each significant unobservable input, and also provides the impact that a 10% increase/decrease in each input would have on the fair value of biological assets grown by
      the Company:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z59cd5d7dd0ef4931b3fe1dc3efa1ebe7" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the year ended December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">10% change in thousands as at</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Average selling price per gram of dried cannabis (in CAD)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3.64</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">6.01</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">296</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">8.86</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Average post-harvest costs per gram of dried cannabis (in CAD)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1.16</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">0.83</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">140</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">0.23</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Attrition rate</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">27</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">5</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">100</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">0.4 3</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Average yield per plant (in grams)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">47</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">54</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">228</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">7.64</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Average stage of growth</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">47</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">212</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">7.64</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z669c4a90a63d4b22b909e9e0d27092f5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The cost of revenues for the year ended December 31, 2021 and 2020 were $42,418 and $7,081, respectively, representing an increase of $35,337 or 499%.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2c517ea23306400187d2013cf6cdb11b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Cost of revenues for the three months ended December 31, 2021 and 2020 were $16,255 and $2,109, respectively, representing an increase of $14,146 or 671%.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Focus, Highland and TJAC expect net cost of sales to vary from quarter to quarter based on the number of pre-harvest plants, after harvest plants, the strains being grown and technological progress in the trimming
      machines.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Gross Profit</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The Company&#8217;s formula for calculating gross profit includes:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z748b193e739741dbb394b5c11285bbd2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>production costs (current period costs that are directly attributable to the cannabis growing and harvesting process);</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3bd592113c504ac6936b0057415afde7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>materials and finished goods purchase costs;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z73638e1706d84d5b89b67df465334d1c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a fair value adjustment on sale of inventory (the change in fair value associated with biological assets that were transferred to inventory upon harvest); and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfd0d6c575e1a41d48e33bbd5b2e62f53" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a fair value adjustment on growth of biological assets (the estimated fair value less cost to sell of biological assets as at the reporting date).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;<br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >24</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Gross profit also includes the net change in fair value of biological assets, inventory expensed and production costs. Biological assets consist of cannabis plants at various after-harvest stages
      which are recorded at fair value less costs to sell after harvest.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Gross profit in 2021 was $10,296 representing a decrease of $172 or 2% over the one year period when compared to 2020.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Gross profit for the three months ended December 31, 2021 and 2020 gross profit was $4,311 and $507, respectively, representing an increase of $3,804 or 750%.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Gross profit included gains (losses) from unrealized changes in fair value of biological assets and realized fair value adjustments on inventory sold of $(1,586) and $1,659 for the year ended
      December 31, 2021 and 2020, respectively. Fair value adjustments were impacted primarily due to less valuation to unrealized biological assets during the twelve months ended 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Gains (losses) from unrealized changes in fair value of biological assets and realized fair value adjustments on inventory sold for the three months ended December 31, 2021 and 2020 were $538 and
      $(2,284), respectively.&#160;Fair value adjustments were impacted primarily due to higher realization of biological assets during the three months ended 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">EXPENSES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">General and Administrative</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There was an increase in the general and administrative expense which is mainly attributable to the growing corporate activities in Israel, Canada, and Germany, professional services derived from
      legal fees and other consulting services,&#160;among others, in relation to the NASDAQ listing, the 2021 Offering and acquisitions in the amount of $11,814, including share-based expenses to financial advisors of approximately $807, salaries to employees
      in the amount of $9,900, depreciation and amortization in the amount of $2,827 and insurance costs in the amount of $2,871.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">General and administrative expenses for the year ended December 31, 2021 and 2020 were $32,219 and $11,549, respectively, representing an increase of $20,670 or 179%.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">For the three months ended December 31, 2021 and 2020, general and administrative expenses were $9,575 and $4,191, respectively, representing an increase of $5,384 or 128%.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Selling and Marketing</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Selling and marketing expenses for the year ended December 31, 2021 and 2020 were $8,995 and $3,782, respectively, representing an increase of $5,213 or 138%. For the three months ended December 31,
      2021, selling and marketing expenses were $4,341, compared to $1,448 for the three months ended December 31, 2020, representing an increase of $2,893 or 200%. The increase in the selling and marketing expenses was due mainly to the Company&#8217;s
      increased marketing efforts in Israel, brand launch in Germany, and increased distribution expenses relating to the increase in sales and consolidation of selling and marketing expenses of entities acquired in 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >25</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Share-Based Compensation</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Share-based compensation expense for the year ended December 31, 2021 and 2020 was $7,471 and $3,382, respectively, representing an increase $4,089 or 121%. For the three months ended December 31,
      2021 and 2020, share-based compensation expense was $2,117 and $1,251, respectively, representing an increase of $866 or 69%. The increase was mainly due to the grant of new incentive stock options (&#8220;<font style="font-weight: bold;">Options</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Financing</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Financing income (expense), net, for the year ended December 31, 2021 and 2020 was $20,376 and $(20,227), respectively, representing an increase of $40,603 or 201%. For the three months ended
      December 31, 2021 and 2020, financing income was $436 and $14,252, respectively, representing an decrease of $13,816 or 97%. The change for the year was mainly due to $21,638 finance income arising mainly from the updated valuation of the Company&#8217;s
      Warrants (defined below) and other financial instruments affected by the Company&#8217;s decreased share price.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">NET INCOME/LOSS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Net loss for the year ended December 31, 2021 and 2020 was $(18,518) and $(28,734), respectively, representing a net loss decrease of $10,216 or 36%. For the three months ended December 31, 2021 and
      2020, Net loss was $(12,488) and $(19,976) respectively, representing a net loss increase of $7,488 or 37%. The net income decrease related to factors impacting net income from operations described above, and finance income driven by revaluation of
      warrants and other financial instruments in the amount of $21,638, which were recorded against liability on the grant day and were re-evaluated at December 31, 2021 through profit or loss.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">NET INCOME (LOSS) PER SHARE BASIC AND DILUTED</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Basic loss per share is calculated by dividing the net profit attributable to holders of Common Shares by the weighted average number of Common Shares outstanding during the
        period. Diluted profit per Common Share is calculated by adjusting the earnings and number of Common Shares for the effects of dilutive warrants and other potentially dilutive securities. The weighted average number of Common Shares used as the
        denominator in calculating diluted profit per Common Share excludes unissued Common Shares related to Options as they are antidilutive. Basic Income (Loss) per Common Share for the year ended December 31, 2021 and 2020 were $(0.31) and $(0.74) per
        Common Share, respectively. For the three months ended December 31, 2021 and 2020 were $(0.19) and $(0.13) respectively.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Diluted Income (Loss) per Common Share for the year ended December 31, 2021 and 2020 were $(0.66) and $(0.74) per Common Share, respectively. Diluted Income (Loss) per Common Share for the three
      months ended December 31, 2021 and 2020 were $(0.19) and $(0.13), respectively.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">TOTAL ASSETS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Total assets as at December 31, 2021 were $287,388, compared to $38,116 as at December 31, 2020, representing an increase of $249,272 or 654%. This increase was primarily due to the consolidation of
      Trichome, MYM and the Israeli subsidiaries. The acquisitions resulted in the recognition of goodwill and intangible assets of an aggregate amount of approximately $150,607, property plant and equipment of approximately $23,130, increase in
      right-of-use assets of approximately $16,979 and approximately $13,891 of working capital.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >26</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Intangible Assets</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 18, 2021, the Trichome Transaction was completed whereby the Company acquired all of the issued and outstanding securities of Trichome for a total Common Share consideration valued at
      approximately $99,028. Upon completion of the Trichome Transaction, the businesses of IM Cannabis and Trichome have been combined.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z303557b420444d11af81dc8700e6d0af" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Through the Trichome Transaction, the Company recognized goodwill of approximately $67,269 and intangible assets, primarily attributed to the cultivation license, worth approximately $6,458 (based on a preliminary purchase price allocation
              study). The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Company and Trichome, as well as value attributed to the assembled workforce, which is included
              in goodwill. The goodwill recognized is not expected to be deductible for income tax purposes.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z49c38ec512344188bf43c51d6e826d8a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company recognized the fair value of the assets acquired and liabilities assumed in the business combination according to a provisional measurement. The purchase consideration and the fair value of the acquired assets and liabilities
              may be adjusted within 12 months from the acquisition date. At the date of final measurement, adjustments are generally made by restating comparative information previously determined provisionally. As of the date of the approval of the
              Annual Financial Statements, a preliminary valuation for the fair value of the identifiable assets acquired and liabilities assumed by an external valuation specialist was obtained.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On July 9, 2021, the Company completed the MYM Transaction. As a result, the company recognized goodwill of approximately $39,932 and intangible assets consisting of brand name and customer
      relationships worth approximately $17,200 (based on a preliminary purchase price allocation study). The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Company and
      MYM, as well as value attributed to the assembled workforce, which is included in goodwill. The goodwill recognized is not expected to be deductible for income tax purposes.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5140110d1406448e9ad9000a3f6ff9c2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company recognized the fair value of the assets acquired and liabilities assumed in the business combination according to a provisional measurement. As of the date of the approval of the Annual Financial Statements, a final valuation
              for the fair value of the identifiable assets acquired and liabilities assumed by an external valuation specialist has not been obtained. The purchase consideration and the fair value of the acquired assets and liabilities may be adjusted
              within 12 months from the acquisition date. At the date of final measurement, adjustments are generally made by restating comparative information previously determined provisionally.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Investment in Xinteza</div>
    <div style="line-height: 1.25; font-style: italic;"> <br>
    </div>
    <div style="line-height: 1.25; font-style: italic; text-align: justify;"><font style="font-style: normal;">On December 26, 2019, IMC Holdings entered into a share purchase agreement with Xinteza API Ltd. (&#8220;<font style="font-weight: bold;">Xinteza</font>&#8221;),





        a company with a unique biosynthesis technology, whereby the Company acquired, on an as-converted and fully diluted basis, 25.37% of Xinteza&#8217;s outstanding share capital, for consideration of US$1,700 (approximately $2,165 as of December 31, 2021)
        paid in several installments (the &#8220;Xinteza SPA&#8221;). As of December 31, 2021, the Company has paid all outstanding installments pertaining to the Xinteza SPA and currently holds 23.35% of the outstanding share capital of Xinteza on an as-converted and
        fully diluted basis. On February 24, 2022, IMC Holdings entered into a Simple Agreement for Future Equity (SAFE) with Xinteza, under which IMC Holdings paid US$100,000 (approximately $125), in exchange for right to certain shares of Xinteza</font>
    </div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >27</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">TOTAL LIABILITIES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Total liabilities as at December 31, 2021 were $82,443, compared to $25,506 at December 31, 2020, representing an increase of $56,937 or 223%. The increase was primarily due to an increase of $16,646
      in other accounts payable and accrued expenses, an increase of $6,039 in purchase consideration payable and an increase of $18,384 in lease liabilities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">LIQUIDITY AND CAPITAL RESOURCES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">For the year ended December 31, 2021, the Company generated revenues of $54,300, received $39,622 in net proceeds from issuance of share capital at the Company&#8217;s financing round in May 2021, and $3,815 in proceeds
          from the exercises of warrants and 2019 Compensation Options (defined below) issued to certain agents who acted on the Company&#8217;s behalf in connection with the Reverse Takeover Transaction, and exercises of Options.</div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In the plan for use of available funds mentioned in the Company&#8217;s Base Shelf Prospectus, the Company have provided the following information:<br>
      <div><br>
      </div>
      <br>
      <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 80%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="zb54c20727f8f445eb59c4ddb723e65cc" class="cfttable">

          <tr>
            <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Uses of Available Funds (Net)</div>
            </td>
            <td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">Amount ($)</div>
            </td>
            <td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">Actual amount used ($)</div>
            </td>
            <td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">Variances</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">CAPEX Activities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">4,340</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2,758</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$&#160;</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(1,582</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
              <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">M&amp;A and investments</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">14,880</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">16,510</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1,630</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Working capital</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">11,750</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">11,750</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">General corporate activities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">8,652</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">8,604</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">48</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">TOTAL</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">39,622</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">$</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">39,622</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">0</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>Variances in use of proceeds:</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">CAPEX Activities &#8211; The Company made an analysis process regarding its CAPEX activities in Israel at the end of 2021. Due to its strategic review the
        company lowered its CAPEX investments in Israel.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">M&amp;A activities &#8211; Following the two acquisitions in Canada the
          company started on execution of a M&amp;A strategy also in Israel. The Company paid an additional $1,630 KCAD due to Israel M&amp;A&#8217;s.</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>Additional Liquidity:</u></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">On May 14, 2021, the Company&#8217;s subsidiary, TJAC, entered into the Revolver for $5,000 with a private Canadian creditor. The Revolver has an initial term of 12 months that can be extended upon the mutual agreement of
          both parties. Per annum interest is equal to the greater of (i) 9.75% and, (ii) the Toronto Dominion Bank prime rate, plus 7.30%. The Facility has a standby fee of 2.40% per annum, which is charged against the unused portion. Advanced amounts are
          secured against the assets of TJAC and Trichome, with Trichome providing a guarantee for the Facility.<font style="font-weight: bold;">&#160;</font>To maintain the Facility, TJAC must abide by certain financial covenants, such as the maintenance of a
          tangible net worth greater than $5,000 and a debt service coverage ratio of 2:1. On September 23, 2021, TJAC increased the limit on the Revolver from $5,000 to $7,500 and added Highland&#8217;s assets to the Revolver borrowing base. The increase will
          be used to finance TJAC and MYM&#8217;s receivables in order to manage the timing of cash flows. On October 18, 2021, TJAC and MYM increased the limit on the Revolver to $10,000. The increase will be used to finance TJAC and MYM&#8217;s receivables in order
          to manage the timing of cash flows.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">In January 2022, Focus entered into the Mizrahi Facility.&#160; The Mizrahi Facility is guaranteed by Focus assets. Advances from the Mizrahi Facility will be used for working capital needs. The Mizrahi Facility has a
          total commitment of up to NIS 15,000 (approximately $6,000) and has a one-year term for on-going needs and 6 month term for imports and purchases needs. The Mizrahi Facility is renewable upon mutual agreement by the parties. The borrowing base
          available for draw at any time throughout the Mizrahi Facility and is subject to several covenants to be measured on a quarterly basis. The Mizrahi Facility bears interest of Israeli prime interest plus 1.5% (approximately 3.3%) per annum.</div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >28</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company believes that the generated cash flow from working capital in the different jurisdictions in which it operates, as well as future financing rounds and debt raises will meet all of its
      future requirements. In evaluating its capital requirements, including the impact, if any, on the Company from the COVID-19 pandemic and the ability to fund the execution of its strategy, the Company believes it has adequate availability to meet its
      working capital and other operating requirements, fund growth initiatives and capital expenditures, settle its liabilities, and repay scheduled principal and interest payments on debt for at least the next twelve months.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company has ensured that it has access to public capital markets through its CSE and NASDAQ listings and continues to review and pursue selected external financing sources to ensure adequate
      financial resources. These potential sources include, but are not limited to (i) obtaining financing from traditional or non-traditional investment capital organizations and (ii) obtaining funding from the sale of the Company&#8217;s securities. There can
      be no assurance that we will gain adequate market acceptance for our products or be able to generate sufficient positive cash flow to achieve our business plans. We expect to continue funding these purchases with our available cash, cash equivalents
      and short-term investments. Therefore, we are subject to risks including, but not limited to, our inability to raise additional funds through financings to support our continued development, including capital expenditure requirements, operating
      requirements and to meet our liabilities and commitments as they come due.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">As at December 31, 2021, the Company had a working capital surplus of $33,084, compared to working capital of $20,874 as at December 31, 2020. The increase in working capital of $12,210 or 58% was
      primarily due to increase in inventory, trade and other receivables, offset by trade and other payables including purchase consideration payable. As of December 31, 2021, the Company had a cash balance of $13,903.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">As at December 31, 2021, the Group&#8217;s financial liabilities consisted of accounts payable and other accounts payable which have contractual maturity dates within one year. The Group manages its
      liquidity risk by reviewing its capital requirements on an ongoing basis. Based on the Group&#8217;s working capital position at December 31, 2021, management considers liquidity risk to be low.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">As at December 31, 2021, the Group has identified the following liquidity risks related to financial liabilities (undiscounted):</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 80%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="z90c85e7d829d40b9bcfb17668c861d21" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Less than one year</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">1 to 5 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">6 to 10 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">&gt; 10 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25;">Contractual Obligation</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">21,683</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">12,236</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">12,759</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,620</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The maturity profile of the Company&#8217;s other financial liabilities (trade payables, other account payable and accrued expenses, and warrants) as of December 31, 2021 are less than one year.</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >29</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" id="zc34b65b1ab8745048ef8b8e303043ba7" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="1"><br>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="18">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Payments Due by Period</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="1">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Contractual Obligations</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Less than one year</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">1 to 3 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">4 to 5 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">After 5 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Debt</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">18,814</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">18,422</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">392</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 40%;">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Finance Lease Obligations</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">30,291</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">3,068</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6,247</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">5,597</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">15,379</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Operating Leases</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">193</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">193</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 40%;">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Purchase Obligations<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 40%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Other Obligations<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 40%;">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total Contractual Obligations</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">49,298</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">21,683</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6,639</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">5,597</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">15,379</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Notes:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1 </sup>&#8220;Purchase Obligation&#8221; means an agreement to purchase goods or services that is enforceable and legally binding on the Company that specifies all significant terms, including: fixed or
      minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> &#8220;Other Obligations&#8221; means other financial liabilities reflected on the Company&#8217;s statement of financial position.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Annual Financial Statements have been prepared on the basis of accounting&#160;principles applicable to a going concern, which assumes that the Company will continue in operation for the foreseeable
      future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The Annual Financial Statements do not include any adjustments to the amounts and classification of assets and liabilities that would be
      necessary should the Company be unable to continue as a going concern. Such adjustments could be material.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">SHARE CAPITAL</div>
    <div style="line-height: 1.25">&#160;
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',serif;">The Company&#8217;s authorized share capital consists of an unlimited number of Common Shares without par value, 69,690,151 of which were issued and outstanding as at the date hereof.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Common Shares confer upon their holders the right to participate in the general meeting with each Common Share carrying the right to one vote on all matters. The Common Shares also allow holders
      to receive dividends if and when declared and to participate in the distribution of surplus assets in the case of liquidation of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Other Securities</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',serif;">As of December 31, 2021, the Company also has the following outstanding securities which are convertible into, or exercisable or exchangeable for, voting or
        equity securities of the Company: 4,893,245 Incentive Stock Options, 550,000 RSU&#8217;s, 236,039 2019 Broker Compensation Options, 3,043,478 2021 Offered Warrants, and 182,609 2021 Broker Compensation Options. See below <font style="font-style: italic;">&#8220;Financial Background&#8221;</font> for more information.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >30</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">
            <div style="line-height: 1.25;">
              <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
              <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
              <div style="line-height: 1.25; font-weight: bold;">
                <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;"><br>
      Financial Background</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On October 11, 2019, the Company completed the Reverse Takeover Transaction, effected by way of a &#8220;triangular merger&#8221; between the Company, IMC Holdings and a wholly-owned subsidiary of the Company
      pursuant to Israeli statutory law.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the Reverse Takeover Transaction, the Company completed a private placement offering of 19,460,527 subscription receipts (each a &#8220;<font style="font-weight: bold;">Subscription
        Receipt</font>&#8221;) (on a pre-Share Consolidation (as defined below) basis) of a wholly-owned subsidiary of the Company at a price of $1.05 per Subscription Receipt for aggregate gross proceeds of $20,433. Upon completion of the Reverse Takeover
      Transaction, each Subscription Receipt was exchanged for one unit comprised of one (1) common share and one-half of one (1/2) warrant (each whole warrant, a &#8220;<font style="font-weight: bold;">2019 Listed Warrant</font>&#8221;). Each Listed Warrant was
      exercisable for one Common Share at an exercise price of $1.30 until October 11, 2021. A total of 9,730,258 2019 Listed Warrants were issued and listed for trading on the CSE under the ticker &#8220;IMCC.WT&#8221;. The Listed Warrants expired on October 11,
      2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company also issued the agent who acted on its behalf in connection with the Reverse Takeover Transaction, a total of 1,199,326 2019 Broker Compensation Options (the &#8220;<font style="font-weight: bold;">2019 Broker Compensation Options</font>&#8221;). Following the Consolidation, the 2019 Broker Compensation Options were adjusted to require four 2019 Broker Compensation Options to be exercised for one underlying unit at an adjusted exercise price
      of $4.20, with each unit exercisable into one Common Share and one-half of one Common Share purchase warrant (the &#8220;<font style="font-weight: bold;">2019 Unlisted Warrant</font>&#8221;). Following the Consolidation, the 2019 Unlisted Warrants were adjusted
      to require four 2019 Unlisted Warrants to be exercised for one Common Share at an adjusted exercise price of $5.20. The 2019 Broker Compensation Options and the 2019 Unlisted Warrants will expire on August 30, 2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As part of the 2021 Offering, the Company issued a total of 3,043,478 2021 Offered Warrants to the purchasers of the 2021 Offered Shares. Each 2021 Warrant exercisable for one (1) Common Share at an
      exercise price of US$7.20 for a term of 5 years from the date of closing of the 2021 Offering.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company also issued a total of 182,609 2021 Broker Compensation Options to the agents who acted on its behalf in connection with the 2021 Offering. Each 2021 Broker
        Compensation Option is exercisable for one (1) Common Share at an exercise price of US$6.61, at any time following November 5, 2021 until November 5, 2024.&#160; As of the date of this Annual Information Form, there are 182,609 2021 Broker Compensation
        Options outstanding.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">For the year ended December 31, 2021 and 2020, the Company recognized a revaluation gain (loss) of $15,928 and $(16,540), respectively. For the three months ended December 31, 2021 and 2020, the
      Company recognized a revaluation gain (loss) of $72 and $(14,107) in the consolidated statement of profit or loss and other comprehensive income, in which the unrealized gain is included in finance income (expense).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of December 31, 2021, and 2020, there were 3,043,478 and nil Unlisted Warrants outstanding, respectively, re-measured by the Company, using the Black-Scholes pricing model, in the amount of $6,022
      and $nil, respectively. For the year ended December 31, 2021 and 2020, the Company recognized a revaluation gain (loss) of $5,810 and $nil, respectively. For the three months ended December 31, 2021 and 2020, the Company recognized a revaluation gain
      (loss) of $428 and $nil in the consolidated statement of profit or loss and other comprehensive income, in which the unrealized gain is included in finance income (expense).</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >31</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">During the year ended December 31, 2021, a total of 2,367,876 2019 Listed Warrants were exercised for 591,969 Common Shares at an adjusted&#160;exercise price of $5.20 per Common Share. As a result, the
      Company received a total amount of $3,078. Remaining 2019 Listed Warrants expired on October 21, 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">During the year ended December 31, 2021, a total of 194,992 2019 Unlisted Warrants were exercised for 48,748 Common Shares at an adjusted&#160;exercise price of $5.20 per Common Share. As a result, the
      Company received a total amount of $255.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">During the year ended December 31, 2021, a total of 332,556 2019 Compensation Options were exercised on an adjusted basis for 83,139 Common Shares and 41,568 2019 Unlisted
        Warrants. Consequently, the Company received an aggregate adjusted exercise amount of $349.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">OPERATING, FINANCING AND INVESTING ACTIVITIES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The following table highlights the Company&#8217;s cash flow activities for the twelve and three months ended December 31, 2021 and 2020 and year ended December 31, 2020:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z31cf72b3c83a4ac8bc35c53b034780b9" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the year ended December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the three months ended December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">
            <div style="line-height: 1.25;"><br>
            </div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);" rowspan="1">
            <div style="line-height: 1.25;">Net cash provided by (used in):</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">&#160;&#160;&#160;Operating activities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(34,372</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(7,919</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,762</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(535</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">&#160;&#160;&#160;Investing activities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(9,012</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(4,075</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(7,082</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(838</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">&#160;&#160;&#160;Financing activities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">48,731</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">6,740</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,794</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">502</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">&#160;&#160;&#160;Effect of foreign exchange</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(329</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">213</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(3,687</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">19</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 4px;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Increase (Decrease) in cash</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">5,018</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,041</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(3,213</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); padding-bottom: 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(852</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Operating activities used cash of $34,372 and $7,919 for the year ended December 31, 2021 and 2020, respectively. For the three months ended December 31, 2021 and 2020, operating activities used
      (provided by) cash of $(4,762) and $535, respectively. This variance is primarily due to increase in the business activities of the Company including corporate expenses for salaries, professional fees and marketing expenses in Israel, Germany and
      Canada as well as costs related to the NASDAQ listing, the 2021 Offering and M&amp;A processes. In the twelve months ended December 31, 2021, cash was predominantly used to expand the Company&#8217;s Canadian operations, facilitate the Company&#8217;s NASDAQ
      listing, the 2021 Offering and M&amp;A processes.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Investing activities used cash of $9,012 and $4,075 for the year ended December 31, 2021 and 2020, respectively. For the three months ended December 31, 2021 and 2020, investing activities used cash
      of $7,082 and $838, respectively. Cash was used primarily as consideration for M&amp;A transactions in the amount of $13,023 balanced by repayment of loan receivable of $7,796. Cash was also used to enhance production through the purchase of
      equipment for Focus, Adjupharm, Highland and TJAC in the amount of $4,578.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Financing activities used cash of $48,731 and $6,740 for the year ended December 31, 2021 and 2020, respectively. For the three months ended December 31, 2021 and 2020, financing activities used cash
      of $2,794 and $502, respectively. Most of the cash was derived from the Company&#8217;s financing round in May 2021 in the amount of $39,622.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >32</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">SELECTED ANNUAL INFORMATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z55b768ac09924727a95fae9fe03fa8a5" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-weight: bold;">For the year ended</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31, 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31, 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Revenues</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">54,300</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">15,890</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="line-height: 1.25;">Net Loss</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(18,518</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(28,734</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Basic net income (Loss) per share:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.31</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.74</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="line-height: 1.25;">Diluted net income (Loss) per share:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.66</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.74</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Total assets</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">287,388</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">38,116</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="line-height: 1.25;">Total non-current financial liabilities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">31,216</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">19,237</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zc4a2f6ad314644fdb519aeb6c7e62cc2" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-weight: bold;">For the three months ended</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;" colspan="2">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">December 31, 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">September 30, 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">June 30, 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">March 31, 2021</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Revenues</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">20,028</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">14,393</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">11,112</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">8,767</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="line-height: 1.25;">Net income (Loss)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(12,488</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,656</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5,089</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,715</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Basic net income (Loss) per share:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.19</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.06</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.10</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">0.11</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="line-height: 1.25;">Diluted net loss per share:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.19</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.18</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.23</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.06</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z4b31a5b9a91147cda6b9248d9a04274e" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-weight: bold;">For the three months ended</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31, 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">September 30, 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">June 30, 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">March 31, 2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Revenues</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,900</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">5,893</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3,757</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,340</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="line-height: 1.25;">Net income (Loss)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(19,976</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">738</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(9,696</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">200</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Basic net income (Loss) per share:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.13</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">0.004</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.52</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.003</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%;">
            <div style="line-height: 1.25;">Diluted net income (Loss) per share:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.13</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">0.004</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.52</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(0.003</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As it can be shown, on a nearly quarterly basis, the Company has consistently increased revenues, which reflects the Group&#8217;s expansion strategy.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-style: italic;">METRICS AND NON-IFRS FINANCIAL MEASURES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">This MD&amp;A makes reference to certain non&#8209;IFRS financial measures including &#8220;Gross Margin&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">11</sup>, &#8220;EBITDA&#8221;, and &#8220;Adjusted EBITDA&#8221;. These measures are not recognized measures under IFRS and
      do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by
      providing further understanding of our results of operations from management&#8217;s perspective. Accordingly, these measures should neither be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. For
      more information on non-IFRS financial measures, see the &#8220;<font style="font-style: italic;">Non-IFRS Financial Measures</font>&#8221;</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >33</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Management defines EBITDA as income earned or lost from operations, as reported, before interest, tax, depreciation and amortization. Adjusted EBITDA is defined as EBITDA, adjusted by removing other
      non-recurring or non-cash items, including the unrealized change in fair value of biological assets, realized fair value adjustments on inventory sold in the period, share-based compensation expenses, and revaluation adjustments of financial assets
      and liabilities measured on a fair value basis. Management believes that Adjusted EBITDA is a useful financial metric to assess its operating performance on a cash adjusted basis before the impact of non-recurring or non-cash items. Management
      defines gross margin as the difference between revenue and cost of goods sold divided by revenue (expressed as a percentage), prior to the effect of a fair value adjustment for inventory and biological assets.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The non-IFRS financial measures can provide investors with supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when
      relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers. Our management also uses these non-IFRS financial measures in
      order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. As required by Canadian securities laws, we reconcile these
      non-IFRS financial measures to the most comparable IFRS measures.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zfc119a623be84672b7a51ca955d962dc" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the year ended December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the three months ended December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">2021*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25; font-weight: bold;"><br>
            </div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">2021*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25; font-weight: bold;"><br>
            </div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">2020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Operating Loss</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(38,389</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(8,245</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(11,722</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(6,383</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Depreciation &amp; Amortization</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">6,004</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">930</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,400</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">258</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25; font-weight: bold;">EBITDA</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(32,385</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(7,315</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(9,322</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(6,125</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">IFRS Biological assets fair value adjustments, net</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,586</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(1,659</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(538</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,284</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Share-based payments</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">7,471</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3,382</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,117</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,251</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Non-recurring costs related to the RTO</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Costs related to the NASDAQ listing</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,296</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">175</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">35</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">175</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25;">Other Non-recurring costs</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">520</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(570</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(5</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -11.35pt; margin-left: 11.35pt; line-height: 1.25; font-weight: bold;">Adjusted EBITDA (Non-IFRS)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(22,032</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(4,897</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(8,278</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(2,420</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">* Acquisition costs, in the amount of $4,359 and $32 for the twelve and three months ended December 31, 2021, respectively, have not been adjusted in the above-mentioned table. Had these
      non-operational acquisition costs been adjusted, the Company&#8217;s Adjusted EBITDA for the twelve and three months ended December 31, 2021 would have been $(17,673) and $(8,246), respectively.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Adjusted EBITDA for the year ended December 31, 2021 and 2020 was $(22,032) and $(4,897), respectively, representing a decrease of $17,135. Adjusted EBITDA for the three months ended December 31,
      2021, and 2020 was $(8,278) and $(2,420), respectively, representing a decrease of $5,858. The Company&#8217;s Adjusted EBITDA for the year ended December 31, 2021 decreased primarily due to the previously disclosed delays in contracted shipments to
      Germany from its primary supply partner as well as labour and shipping disruptions caused by COVID-19 in Canada in last month of the fourth quarter of 2021&#160;and integration costs for acquisitions in Canada and Israel. Additional impact on the Adjusted
      EBITDA derived from general and administrative costs mainly attributable to the growing corporate activities in Israel, Germany, and Canada, professional services derived from legal fees and other consulting services, M&amp;A transaction costs,
      salaries to employees and increased insurance costs upon listing on NASDAQ. Adjusted EBITDA is expected to climb with the full integration of Trichome and MYM as well as the consolidation of the newly acquired retail activities in Israel.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >34</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">CONTINGENT LIABILITIES AND COMMITMENTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 0.2pt; line-height: 1.25; font-style: italic;">Rental Liabilities</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The table below summarizes the maturity profile of the Group&#8217;s lease liabilities based on contractual undiscounted payments (including interest payments):</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">December 31, 2021<font style="font-weight: bold;">:</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z42d1a2110b9a4fabbfcadeb2ae209138" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Less than one year</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">1 to 5 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">6 to 10 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">&gt;10 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25;">Lease liabilities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3,068</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">11,844</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">15,379</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">December 31, 2020<font style="font-weight: bold;">:</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z9ddfc1a697044c53acbb49e96120347a" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Less than one year</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">1 to 5 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">6 to 10 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">&gt;10 years</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -8.5pt; margin-left: 8.5pt; line-height: 1.25;">Lease liabilities</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">172</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">312</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">534</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The maturity profile of the Company&#8217;s other financial liabilities with liquidity risk (trade payables, other account payable and accrued expenses) as of December 31, 2021 and
        2020, are less than one year.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">LITIGATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Class Action T.Z. 35676-08-19 Tel Aviv - Jaffa District Court</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">On August 19, 2019, a cannabis consumer (the &#8220;<font style="font-weight: bold;">Applicant</font>&#8221;) filed a motion for approval of a class action to Tel Aviv - Jaffa District Court (the &#8220;<font style="font-weight: bold;">Motion</font>&#8221;) against 17 companies (the &#8220;<font style="font-weight: bold;">Parties</font>&#8221;) operating in the field of medical cannabis in Israel, including Focus. The Applicant&#8217;s argument is that the Parties did not accurately mark the
          concentration of active ingredients in their products. The personal suit sum for each class member stands at NIS 15,585 and the total amount of the class action suit is estimated at NIS 685,740,000. On June 2, 2020, the Parties submitted their
          response to the Motion. The Parties argue in their response that the threshold conditions for approval of a class action were not met, since there is no reasonable possibility that the causes of action in the Motion will be decided in favor of
          the class group. On July 3, 2020 the Applicant submitted his response to the Parties&#8217; response. On July 5, 2020 the Applicant was absent from the hearing. As a result, on July 23, 2020 the Parties filed an application for a ruling of expenses
          which received a response from the Applicant on August 12, 2020, asking to decline this request. On September 29, 2020 the court ruled that the Applicant would pay the Parties&#8217; expenses amount of NIS 750. On July 14, 2021 a prehearing was held.
          The court recommended the parties negotiate independently to avoid litigation, and if negotiations fail, then to begin mediation proceedings. The parties agreed to follow the court&#8217;s recommendations. Negotiations between the parties have not yet
          commenced. On November 3, 2021 the court ruled the parties will file an update regarding the mediation procedure, in 30 days. The parties conducted unsuccessful negotiations and are now waiting for a court decision regarding the continuation of
          the proceedings.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >35</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">As of the date of this Annual Information Form, due to the current preliminary state of the litigation process and based on the opinion of legal counsel to Focus, the
        Company&#8217;s management believes that it is not reasonably possible to assess the outcome of the proceeding. Therefore, no provision has been recorded in respect thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Supreme Court of Justice 2335/19</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On March 2019 a petition was filed to the Supreme Court of Israel by the Medical Cannabis Association against MOH regarding the new regulatory framework of the cannabis
          market (the &#8220;<font style="font-weight: bold;">Petition</font>&#8221;). Subsequently, additional 10 respondents joined the Petition.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="line-height: 1.25">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="line-height: 1.25;">On October 6, 2019, Focus received a decision regarding the Petition, concerning the new regulatory framework of the cannabis market and demanding that the court resolve as follows:</div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;that the MOH immediately suspend the implementation of the new regulation that harms, disproportionally, the medical cannabis patients;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;that the implementation of the new regulation, as is, would cause violation of constitutional rights of the medical cannabis patients; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; margin-left: 18pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;that the MOH amends the flaws of the new regulation, prior to becoming effective, and to establish new regulations regarding labeling and use of pesticides.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The decision provided for an interim injunction, extending the validity of patient licenses until the earlier of March 31, 2020 or 10 days after the date the MOH reaches a
        conclusion regarding the price control of medical cannabis products.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">According to the decision, Focus was attached to the proceedings as a respondent. Accordingly, Focus filed its response to the petition on November 12, 2019.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On March 8, 2020, the court decided to extend the validity of the interim injunction, so that the medical cannabis use licenses, which were extended under the decision, would
        continue to be valid until May 15, 2020, or 10 days after the price committee&#8217;s decision on the matter before it, whichever comes first, subject to another court decision.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >36</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The court also decided that if a further extension of the period of the interim injunction is granted beyond May 15, 2020, to the extent required, it would be subject to
        medical surveillance by the attending physician, the details of which were to be included in the patient&#8217;s existing use license.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In light of several applications by the respondent represented by the state attorney&#8217;s office, for extension to file updated notice to the court, the interim injunction was
        extended on July 30, 2020, until and subject to other decision of the court.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On October 29, 2020, the respondents represented by the state attorney&#8217;s office filed an update notice stating that the appeals committee unanimously decided against imposing
        price controls on medical cannabis products and that the prices committee would hold a follow-up hearing in four months. The respondents also requested to update the court again in two months.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">On November 25, 2020, the petitioner submitted their response to the respondents&#8217; update.</div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On March 25, 2021, the respondents represented by the State Attorney&#8217;s Office filed an updating notice stating that the Prices Committee had come to a decision against
          imposing price controls on medical cannabis products. However, the Prices Committee announced that it will issue an RFI to the corporations engaged in the medical cannabis market and assess the market every six months. Following the
          aforementioned, the respondents represented by the State Attorney&#8217;s Office believe that the appeal should be rejected and the interim injunction should be canceled. On April 13, 2021, three of the respondents filed a response to the court,
          requesting to reject the appeal and to cancel the interim injunction.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On April 25, 2021, the petitioner filed a response to the update notice from March 25, 2021, objecting to the position of the respondents represented by the State
          Attorney&#8217;s Office, requesting the court to resolve as requested in the petition and grant the requested remedies to the petitioner. On July 6, 2021, the petitioner filed an urgent request to the court, to issue orders to the respondents
          represented by the State Attorney&#8217;s Office, to request information from corporations engaged in the medical cannabis market in order to continue the examination of the market, according to the Prices Committee&#8217;s announcement mentioned above, and
          requested the court reschedule the September 19, 2021 hearing date to an earlier date. The petitioner&#8217;s request was rejected by the court on July 7, 2021, and on September 19, 2021, a hearing was held.&#160; On November 16, 2021 the court ruled the
          motion will delete, and the interim injunction will be cancelled in 10 days. Following a request submitted by the petitioner, on November 15, 2021 the court determined the interim injunction will extend until 1.3.22. Additional requests submitted
          for an extension of the interim order were denied.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Supreme Court of Justice 8249/2</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On December 1, 2021 the Medical Cannabis Association filed a motion to Supreme Court of Justice of Israel for further hearing regarding the court ruling
        on 2335/19 as detailed above. The petitioner also submitted a request for an exemption from the obligation to pay a fee or deposit a deposit. On February 9, 2022 the petitioner submitted an urgent request for a ruling by the court as well as a
        request to extend the validity of the interim injunction, for at least three additional months. On February 24, 2022 the court overruled the request for a further hearing in the petition, as well as the request to extend the validity of the interim
        injunction.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">37<br>
      </div>
      <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div  style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25">
                  <div style="line-height: 1.25;">
                    <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                    <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                    <div style="line-height: 1.25; font-weight: bold;">
                      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                  </div>
                </div>
              </div>
            </div>
          </div>
          <div style="line-height: 1.25; font-style: italic;"><br>
          </div>
        </div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-style: italic;">Planning and Construction 66813-06-21 Beer Sheva Magistrate Court</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On July 11, 2021 the Company was informed that on June 30, 2021, a claim was filed to Beer Sheva Magistrate Court (the &#8220;<font style="font-weight: bold;">Construction
            Proceedings</font>&#8221;), by the municipal committee presiding over planning and construction in southern Israel (the &#8220;Construction Committee&#8221;) against Focus, Focus&#8217; directors and officers, including Oren Shuster and Rafael Gabay, and certain
          landowners, claiming for inadequate permitting for construction relating to the Focus Facility (&#8220;Construction Allegations&#8221;).</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On December 6, 2021 the defendants filed a motion Request for dismissal the indictment on the ground of defense of justice. The municipal committee filed her response and
          after that the defendants filed a response to the municipal committee's response. As of the date of this letter no decision has yet been made on the application.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">A hearing was initially set to December 1, 2021 but has been postponed to June 13, 2022.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">At this preliminary stage, based on the opinion of Focus&#8217; legal counsel, Company management cannot assess the chances of the claim advancing or the potential outcome of the
          Construction Proceedings. Therefore, no provision has been recorded in respect thereof.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: italic;">COVID-19 Test Kits Claim, </font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">District Court of Stuttgart</font></div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">On November 19, 2021, Adjupharm filed a Statement of Claim (the &#8220;Claim&#8221;) to the District Court of Stuttgart (the &#8220;Court&#8221;) against Stroakmont &amp; Atton Trading GmbH (&#8220;Stroakmont &amp; Atton&#8221;), its
        shareholders and managing directors regarding a debt owed by Stroakmont &amp; Atton to Adjupharm in an amount of approximately EUR 947,563 for COVID-19 test kits purchased by Stroakmont &amp; Atton from Adjupharm in May 2021. The Claim was accepted
        on December 2, 2021. In January 2022, Stroakmont &amp; Atton filed its Statement of Defence to the Court in which they essentially stated two main arguments for their defense:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman',Times,serif;"> <br>
        </font></div>
      <div style="text-align: justify; line-height: 1.25;"> </div>
      <font style="font-family: 'Times New Roman',Times,serif;"> </font>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3b200b9b0e444820b42748477e3efbf2">

            <tr>
              <td style="width: 46.35pt; vertical-align: top; align: right;">
                <div style="margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1.</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                  <div style="line-height: 1.25;">that the contractual partner of the Company is not the defendant, Stroakmont &amp; Atton is not the real purchaser rather rather a company named Uniclaro GmbH.</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <font style="font-family: 'Times New Roman',Times,serif;"> </font>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <font style="font-family: 'Times New Roman',Times,serif;"> </font>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z40ff7d91e27942c3af3b597e1f05c00c">

            <tr>
              <td style="width: 46.35pt; vertical-align: top; align: right;">
                <div style="margin-left: 28.35pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2.</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                  <div style="line-height: 1.25;">that the Company allegedly placed an order with Uniclaro GmbH for a total of 4.3 million Clongene Covid-19 tests, of which Uniclaro GmbH claims to have a payment claim against the Company for a partial
                    delivery of 380,400 Clongene tests in the total amount of EUR&#160;941,897.20. Uniclaro GmbH has assigned this alleged claim against the Company to Stroakmont &amp; Atton Trading GmbH, and Stroakmont &amp; Atton Trading GmbH has
                    precautionary declared a set-off against the Company's claim.</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <font style="font-family: 'Times New Roman',Times,serif;"> </font>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <font style="font-family: 'Times New Roman',Times,serif;"> </font>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">On March 22, 2022 Adjupharm filed a response to Stroakmont &amp; Atton&#8217;s Statement of Defence and rejected both allegations with a variety of legal arguments and facts and also offered evidence to the contrary in the
          form of testimony from the witnesses in question.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The burden of proof for both allegations lies with the opponents and they offered evidences to the court in the form of testimony from certain witnesses. If the opponents
          succeed in proving both allegations to the court, the chances of winning the lawsuit will be considerably reduced. However, it will not be easy for the opponents to present evidence of these allegations.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Regional Court of Stuttgart set the date for the conciliation hearing (<font style="font-style: italic;">G&#252;teverhandlung</font>) and the main hearing (<font style="font-style: italic;">Hauptverhandlung</font>) for May 27, 2022.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">At this stage, the Company management cannot assess the chances of the claim advancing or the potential outcome of this Proceedings.</div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">38<br>
      </div>
      <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div  style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;
        <div style="line-height: 1.25">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25">
                  <div style="line-height: 1.25;">
                    <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                    <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                    <div style="line-height: 1.25; font-weight: bold;">
                      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                  </div>
                </div>
              </div>
            </div>
          </div>
          <div style="line-height: 1.25; font-style: italic;"><br>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;">OFF-BALANCE SHEET ARRANGEMENTS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">IM Cannabis had no off-balance sheet arrangements as at December 31, 2021.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">TRANSACTIONS WITH RELATED PARTIES</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Trichome, through a management service agreement, provided investment management services to the Fund during the year ended December 31, 2021. Under IFRS 10, the Fund is an equity accounted
        investment and therefore is not consolidated with the results of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">On January 1, 2021, the Company amended the terms of each of the IP Agreement and the Services Agreement to align the consideration with implementation of the Company&#8217;s transfer pricing framework. The amendments to
          these agreements constituted a &#8220;related party transaction&#8221; as such term is defined in MI 61-101.&#160; The Company was exempt from the formal valuation requirement under Section 5.5(a) and the minority approval requirement under Section 5.7(1)(a) of
          MI 61-101, respectively, as the fair market value of the amendments, as determined by the Board, did not exceed 25% of the Company's market capitalization on the date of such amendments.</div>
      </div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Other than the investment management activities noted above, the Company had no other transactions with related parties outside of the Group except those pertaining to transactions with key
      management personnel and shareholders in the ordinary course of their employment or directorship. Transactions with related parties for the sale of Focus due to the restructuring process were adjusted in the Company&#8217;s consolidated financial
      statements following the application of IFRS 10. See the &#8220;<font style="font-style: italic;">Legal and Regulatory &#8211; Restructuring</font>&#8221; section of the MD&amp;A.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">PROPOSED TRANSACTIONS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">There are no proposed transactions as at the date of this MD&amp;A that have not been disclosed.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">CRITICAL ACCOUNTING ESTIMATES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial
      statements:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 28.35pt; line-height: 1.25;">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Judgments</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Determining the fair value of share-based payment transactions</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The fair value of share-based payment transactions is determined upon initial recognition by an acceptable option pricing model. The inputs to the model include share price, exercise price and
      assumptions regarding expected volatility, expected life of the share options and expected dividend yield.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Discount rate for a lease liability</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">When the Company is unable to readily determine the discount rate implicit in a lease in order to measure the lease liability, the Company uses an incremental borrowing rate. That rate represents the
      rate of interest that the Company would have to pay to borrow over a similar term and with similar security, the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment. When there are no
      financing transactions that can serve as a basis, the Company determines the incremental borrowing rate based on its credit risk, the lease term and other economic variables deriving from the lease contract&#8217;s conditions and restrictions. The rates at
      which the Company can borrow will also vary based on the jurisdiction of the leased property, whether it be Israel, Germany, or Canada. In certain situations, the Company is assisted by an external valuation expert in determining the incremental
      borrowing rate.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >39</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;">&#160;</div>
    </div>
    <div style="margin-left: 28.35pt; line-height: 1.25;">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Estimates and assumptions</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of
      assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The key assumptions made in the financial statements concerning uncertainties at the reporting date and the critical estimates computed by the Group that may result in a material adjustment to the
      carrying amounts of assets and liabilities within the next financial year are discussed below.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Assessment of going concern</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The use of the going concern basis of preparation of the financial statements. At each reporting period, management assesses the basis of preparation of the financial statements. These financial
      statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Company will continue its operations for the foreseeable future and be able to realize its assets and discharge
      its liabilities and commitments in the normal course of business.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In arriving at this determination, the Company has undertaken a thorough review of the Group&#8217;s cash flow forecast and potential liquidity risks. Cash flow projections have been prepared which show
      that the Group&#8217;s operations will be cash generative during the period of at least 12 months from the date of approval of the consolidated financial statements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Biological assets and inventory</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In calculating the value of the biological assets and inventory, management is required to make several estimates, including estimating the stage of growth of the cannabis up to the point of harvest,
      harvesting costs, selling costs, average or expected selling prices and list prices, expected yields for the cannabis plants, and oil conversion factors. The valuation of work-in-process and finished goods also requires the estimate of conversion
      costs incurred, which become part of the carrying amount for the inventory. The Company must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has
      otherwise been damaged. See Note 4 of the Annual Financial Statements for further information.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Business combinations</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In determining the fair value of all identifiable assets acquired and liabilities assumed, the most significant estimates generally relate to contingent consideration and intangible assets.
      Management exercises judgment in estimating the probability and timing of when earn-outs are expected to be achieved, which is used as the basis for estimating fair value. Identified intangible assets are fair valued using appropriate valuation
      techniques which are generally based on a forecast of the total expected future net cash flows of the acquiree. Valuations are highly dependent on the inputs used and assumptions made by management regarding the future performance of these assets and
      any changes in the discount rate applied.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >40</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Impairment of property, plant and equipment and finite life intangible assets</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company assesses impairment of property, plant and equipment and finite life intangible assets when an impairment indicator arises (e.g., change in use or discontinued use, obsolescence or
      physical damage). When the asset does not generate cash inflows that are largely independent of those from other assets or group of assets, the asset is tested at the cash generating unit (&#8220;<font style="font-weight: bold;">CGU</font>&#8221;) level. In
      assessing impairment, the Company compares the carrying amount of the asset or CGU to the recoverable amount, which is determined as the higher of the asset or CGU&#8217;s fair value less costs of disposal and its value-in-use. Value-in-use is assessed
      based on the estimated future cash flows, discounted to their present value using a pre-tax discount rate that reflects applicable market and economic conditions, the time value of money and the risks specific to the asset. An impairment loss is
      recognized whenever the carrying amount of the asset or CGU exceeds its recoverable amount and is recorded in the consolidated statements of comprehensive loss.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Impairment of intangible assets with indefinite life and goodwill</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Goodwill and intangible assets with an indefinite life or not yet available for use are tested for impairment annually, and whenever events or circumstances that make it more likely than not that an
      impairment may have occurred, such as a significant adverse change in the business climate or a decision to sell or dispose all or a portion of a reporting unit. Finite life intangible assets are tested whenever there is an indication of impairment.
      Goodwill and indefinite life intangible assets are tested for impairment by comparing the carrying value of each CGU containing the assets to its recoverable amount. Goodwill is allocated to CGUs or groups of CGU&#8217;s for impairment testing based on the
      level at which it is monitored by management, and not at a level higher than an operating segment. Goodwill is allocated to those CGUs or groups of CGUs expected to benefit from the business combination from which the goodwill arose, which requires
      the use of judgment. An impairment loss is recognized for the amount by which the CGU&#8217;s carrying amount exceeds it recoverable amount. The recoverable amounts of the CGUs&#8217; assets have been determined based on either fair value less costs of disposal
      or value-in-use method. There is a material degree of uncertainty with respect to the estimates of the recoverable amounts of the CGU, given the necessity of making key economic assumptions about the future. Impairment losses recognized in respect of
      a CGU are first allocated to the carrying value of goodwill and any excess is allocated to the carrying value of assets in the CGU. Any impairment is recorded in profit and loss in the period in which the impairment is identified. A reversal of an
      asset impairment loss is allocated to the assets of the CGU on a pro rata basis. In allocating a reversal of an impairment loss, the carrying amount of an asset shall not be increased above the lower of its recoverable amount and the carrying amount
      that would have been determined had no impairment loss been recognized for the asset in prior period. Impairment losses on goodwill are not subsequently reversed.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >41</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">Legal claims</div>
    <div style="line-height: 1.25; font-style: italic;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">In estimating the likelihood of legal claims filed against certain entities of the Group, the Company&#8217;s management rely on the opinions of the respective legal counsel of each relevant entity of the
      Group. These estimations are based on each legal counsel&#8217;s best professional judgment, taking into account the stage of proceedings and legal precedents in respect of the different issues. Since the outcome of the claims may be determined in courts,
      the results could differ from these estimations.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Deferred tax assets</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Deferred tax assets are recognized for unused carry-forward tax losses and deductible temporary differences to the extent that it is probable that taxable profit will be available against which the
      losses can be utilized. Significant management judgment is required to determine the amount of deferred tax assets that can be recognized, based upon the timing and level of future taxable profits, its source and the tax planning strategy.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Valuation of loans receivable</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">For loans receivable measured at amortized cost or at Fair Value Through Profit or Loss (&#8220;<font style="font-weight: bold;">FVTPL</font>&#8221;) under IFRS 9 <font style="font-style: italic;">Financial
        Instruments </font>(&#8220;<font style="font-weight: bold;">IFRS 9</font>&#8221;), judgment is used by the Company in determining the fair value of the loan at inception of the lending arrangement and at each reporting period. The fair value of the loan at
      any given point in time is calculated based on the present value of estimated future loan payments, discounted using an interest rate that would be charged by another market participant for a financing arrangement with similar characteristics.
      Judgment is used by the Company in determining what the interest rate would be for sourcing a similar financing arrangement in the market. This can lead to material fair value gains or losses on loans held at FVTPL.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Derecognition and modification of loans receivable</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company uses judgment in determining whether the change in the terms of the lending arrangement qualifies as a derecognition of the loan or a modification of the loan under IFRS 9. Depending on
      the Company&#8217;s judgment, the manner in which the loan is treated, be it a modification or a settlement, can result in materially different results in interest revenue or other income. If there is a modification in a lending arrangement subsequent to
      initial recognition, the Company also reassesses the need to modify the expected credit loss associated with the loan.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Share-based payments</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company uses the Black-Scholes option pricing model in determining the fair value of Options issued to employees. In estimating fair value, the Company is required to make certain assumptions and
      estimates such as the expected life of the options, volatility of the Company&#8217;s future share price, the risk-free rate, future dividend yields and estimated forfeiture rates at the initial grant date.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Equity accounted investees</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Significant judgment is used by the Company in assessing control of the Company&#8217;s investment in its equity accounted investee &#8211; the Fund. Although not holding more than a 20% stake in the Fund, the
      Company concluded that significant influence exists under IFRS 10 based on the Company&#8217;s management of day-to-day operations of the business and overall investment management.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >42</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Estimated useful lives and depreciation/amortization of property and equipment, as well as intangible assets</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Depreciation and amortization of property and equipment, as well as intangible assets, are dependent upon estimated useful lives which are determined through the exercise of judgment. Estimated
      useful lives are assessed at the end of each reporting period for any changes in the expected life of the asset and consumption of economic benefits from the use of the asset. Amortization as well as depreciation commences when the asset is first put
      into use. The expected life of any intangible assets with a finite life are assessed at the end of each reporting period.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Leases</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Judgment is used in determining the value of the Company&#8217;s right-of-use assets and lease liabilities. The value determined for the Company&#8217;s right-of-use assets and lease liabilities can be
      materially different based on the discount rate selected to present value the future lease payments as well as the likelihood of the Company exercising extensions, termination, and/or purchase options. The discount rate used to present value the
      future lease payments over the life of the lease is based on the Company&#8217;s incremental borrowing rate at inception of the lease. This rate is determined by the Company using judgment.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In determining the value of the Company&#8217;s right-of-use assets and lease liabilities, the Company assesses future business plans to determine whether to include certain extension options noted in the
      lease agreement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">If there is no interest rate implicit in the lease agreement, the Company uses a discount rate that would be charged to a similar borrower, with similar risk characteristics, in a mortgage loan to
      purchase the leased facility. This discount rate is used to present value the future lease payments in determining the right-of-use asset and lease liability values at inception of the leases.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Revenue recognition</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Under IFRS 15 Revenue from Contracts with Customers, judgment is required in recognizing revenue when variable consideration is present in a contract. In certain supply agreements, the Company stands
      ready to accept returns on cannabis sales, indicating the possibility of variable consideration.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Judgment is used by the Company in determining which of the above two methods of revenue recognition should be used when recognizing revenue from cannabis sales. Moreover, estimates are used by the
      Company in determining the amount of revenue to recognize upon delivery and acceptance of cannabis inventory to a customer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Changes in Accounting Policies Including Initial Adoption</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s significant accounting policies under IFRS are contained in the Annual Financial Statements (refer to Note 2 to the Annual Financial Statements). Certain of these policies involve
      critical accounting estimates as they require management to make particularly subjective or complex judgments, estimates and assumptions about matters that are inherently uncertain and because of the likelihood that materially different amounts could
      be reported under different conditions or using different assumptions.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >43</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">The following new accounting standards applied or adopted during the twelve months ended December 31, 2021, had impact on the Annual&#160;Financial Statements:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">IFRS 3, &#8220;Business Combinations&#8221;:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">In October 2018, the IASB issued an amendment to the definition of a &#8220;business&#8221; in IFRS 3, &#8220;Business Combinations&#8221; (the &#8220;<font style="font-weight: bold;">2018 Amendment</font>&#8221;).









      The 2018 Amendment is intended to assist entities in determining whether a transaction should be accounted for as a business combination or as an acquisition of an asset.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">The 2018 Amendment consists of the following:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 54pt; line-height: 1.25;">1. Clarification that to meet the definition of a business, an integrated set of activities and assets must include, as a minimum, an input and a substantive process that together
      significantly contribute to the ability to create output.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 54pt; line-height: 1.25;">2. Removal of the reference to the assessment whether market participants are capable of acquiring the business and continuing to operate it and produce outputs by integrating the
      business with their own inputs and processes.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 54pt; line-height: 1.25;">3. Introduction of additional guidance and examples to assist entities in assessing whether the acquired processes are substantive.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 54pt; line-height: 1.25;">4. Narrowing the definitions of &#8220;outputs&#8221; and &#8220;business&#8221; by focusing on goods and services provided to customers.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 54pt; line-height: 1.25;">5. Introducing an optional concentration test that permits a simplified assessment of whether an acquired set of activities and assets is not a business.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">The 2018 Amendment is to be applied prospectively to all business combinations and asset acquisitions for which the acquisition date is on or after the beginning of the first
      annual reporting period beginning on or after January 1, 2020, with earlier application permitted. The 2018 Amendment is not expected to have a material impact on the Company in the current or future reporting periods.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Amendment to IAS 1, &#8220;Presentation of Financial Statements&#8221;:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25;">In January 2020, the IASB issued an amendment to IAS 1, &#8220;Presentation of Financial Statements&#8221; (the &#8220;<font style="font-weight: bold;">2020 Amendment</font>&#8221;) regarding the
      criteria for determining the classification of liabilities as current or non-current.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25;">The 2020 Amendment includes the following clarifications:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9bae601bd43e4eb7b4aa2769a37a0744" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.7pt;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>What is meant by a right to defer settlement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="ze08d6dda0d9e4e368b3bf005dcd3b183" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.7pt;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>That a right to defer must exist at the end of the reporting period;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zd45824d50d5f4a9e8a9096f402337c00" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.7pt;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>That classification is unaffected by the likelihood that an entity will exercise its deferral right.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zad4ed65ca29344ff87a1c894efa6e793" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.7pt;"><br>
          </td>
          <td style="width: 28.35pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>That only if an embedded derivative in a convertible liability is itself an equity instrument would the terms of a liability not impact its classification.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >44</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25;">The 2020 Amendment is effective for annual periods beginning on or after January 1, 2023 and must be applied retrospectively.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25;">The Company is evaluating the possible impact of the 2020 Amendment on its current loan agreements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">FINANCIAL INSTRUMENTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 56.7pt; line-height: 1.25;">Financial instruments are measured either at fair value or at amortized cost. The table below lists the valuation methods used to determine fair value of each financial
      instrument.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" align="right" id="ze6361b2a01374d669432ba2e291c161e" style="width: 88%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

        <tr>
          <td style="width: 44.61%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Financial Instruments Measured at Fair Value</div>
          </td>
          <td style="width: 3.31%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Fair Value Method</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top;">&#160;</td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top;">
            <div style="line-height: 1.25;">Derivative assets<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top;">
            <div style="line-height: 1.25;">Black &amp; Scholes model (Level 3 category)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top;">
            <div style="line-height: 1.25;">Unlisted Warrants<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top;">
            <div style="line-height: 1.25;">Black &amp; Scholes model (Level 3 category)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top;">
            <div style="line-height: 1.25;">Listed Warrants<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top;">
            <div style="line-height: 1.25;">Market price (Level 1 category)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">Loans receivable</div>
          </td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">Discounted Cashflow Method (Level 3 category)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top;">
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Financial Instruments Measured at<br>
              Amortized Cost</div>
          </td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top;">
            <div style="line-height: 1.25;">Cash and cash equivalents, Trade receivables and other account receivables</div>
          </td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top;">
            <div style="line-height: 1.25;">Carrying amount (approximates fair value due to short-term nature)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top;">
            <div style="line-height: 1.25;">Loans receivable</div>
          </td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top;">
            <div style="line-height: 1.25;">Amortized Cost (effective interest method)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 44.61%; vertical-align: top;">
            <div style="line-height: 1.25;">Trade Payables, other accounts payable and accrued expenses</div>
          </td>
          <td style="width: 3.31%; vertical-align: top;">&#160;</td>
          <td style="width: 52.08%; vertical-align: top;">
            <div style="line-height: 1.25;">Carrying amount (approximates fair value due to short-term nature)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; clear: both;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Notes:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0f636648616b491caa0b995e1fa3db4f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Finance expense (income) include fair value adjustment of Warrants, Investments, and Derivative assets measured at fair value, for the year ended December 31, 2021 and 2020, amounted to $21,638 and $(20,155), respectively.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Finance expense (income) include fair value adjustment of Warrants, Investments, and Accounts Receivable measured at fair value, for the three months ended December 31, 2021 and
      2020, amounted to $469 and $(14,107), respectively.</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >45</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="line-height: 1.25;">The Group has exposure to the following risks from its use of financial instruments:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Share price risk</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Group&#8217;s investments in unlisted shares are sensitive to the market price risk arising from uncertainties about the future value of these investments. The Group manages the price risk through
      diversification and by placing limits on individual and total investment in shares.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The Company&#8217;s board of directors reviews and approves all decisions related to investments in shares.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">At the reporting date, the Group&#8217;s exposure to investments in unlisted shares measured at fair value was $2,165.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Credit risk</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The maximum credit exposure at December 31, 2021, is the carrying amount of cash and cash equivalents, accounts receivable and other current assets. The Group does not have significant credit risk
      with respect to customers. All cash and cash equivalents are placed with major Israeli financial institutions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Liquidity risk</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As at December 31, 2021, the Group&#8217;s financial liabilities with liquidity risk consist of trade payables and other accounts payable, which have contractual maturity dates within one year, and lease
      liabilities. The Group manages its liquidity risk by reviewing its capital requirements on an ongoing basis. Based on the Group&#8217;s working capital position as at December 31, 2021, management considers liquidity risk to be low.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Currency rate risk</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As at December 31, 2021, a portion of the Group&#8217;s financial assets and liabilities held in Euros, Canadian dollars and U.S. dollars consist of cash and cash equivalents. The Group&#8217;s objective in
      managing its foreign currency risk is to minimize its net exposure to foreign currency cash flows by transacting, to the greatest extent possible, with third parties as applicable. The Group does not currently use foreign exchange contracts to hedge
      its exposure of its foreign currency cash flows, as management has determined that this risk is not significant at this point of time.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Procedures and Internal Control over Financial Reporting</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
      external purposes in accordance with applicable IFRS. Internal control over financial reporting should include those policies and procedures that establish the following:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd27ce936a895497093b6a684c0d35053" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>maintenance of records in reasonable detail, that accurately and fairly reflect the transactions and dispositions of assets;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7bdcd6a98db548c780855b1c7ec86e36" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with applicable IFRS;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z72d441900ab94882954fb45d6c511899" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>receipts and expenditures are only being made in accordance with authorizations of management or the board of directors; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0ca961cd311042b9839422b34a2a134d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on the financial instruments.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >46</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s management, with the participation of the Chief Financial Officer, assessed the effectiveness of the Company&#8217;s internal controls over financial reporting and concluded that as at
      December 31, 2021, the Company&#8217;s internal control over financial reporting was effective and yet constantly seek to improve it.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As of December 31, 2021, the Company did not make any significant changes to its internal controls over financial reporting that would have materially affected, or reasonably likely to materially
      affect, its internal controls over financial reporting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Limitations of Disclosure Controls and Procedures and Internal Control over Financial Reporting</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s management, including the Chief Executive Officer and Chief Financial Officer, believe that due to inherent limitations, any disclosure controls and procedures or internal control over
      financial reporting, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. Further, the design of a control system must reflect the fact that there are resource
      constraints, and the benefits of controls must be considered relative to their costs. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that any design will not succeed in achieving its stated goals under
      all potential future conditions. Accordingly, because of the inherent limitations in a cost- effective control system, misstatements due to error or fraud may occur and not be detected. Additionally, management is required to use judgment in
      evaluating controls and procedures.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">LIMITATION ON SCOPE OF DESIGN</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company is considering all its entities as subject to its controls, policies and procedures. In the first year post-acquisition, each subsidiary goes through an
        implementation phase, through which the newly acquired subsidiary implements the Company&#8217;s procedures.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;"><a name="LEGALANDREGULATORY"><!--Anchor--></a>LEGAL AND REGULATORY</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25; font-style: italic;">RESTRUCTURING</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Current Israeli law requires prior approval by the IMCA, a unit of the MOH, of the identity of any shareholder owning 5% or more of an Israeli company licensed by the IMCA to engage in
      cannabis-related activities in Israel. For a number of reasons, including the opportunity to leverage a network of multiple Israeli licensed producers cultivating under the IMC brand, and in contemplation of a &#8220;go-public transaction&#8221; to
      geographically diversify the Company&#8217;s share ownership, IMC Holdings restructured its organization on April 2, 2019 (the &#8220;<font style="font-weight: bold;">IMC Restructuring</font>&#8221;) resulting in the divestiture to Oren Shuster and Rafael Gabay of its
      interest in Focus, which is licensed by the IMCA to engage in cannabis-related activity in Israel.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >47</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;"><br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">IMC Holdings retains an option with Messrs. Shuster and Gabay to re-acquire the sold interest in Focus at its sole discretion and in accordance with Israeli cannabis regulations, within 10 years of
      the date of the IMC Restructuring (the &#8220;<font style="font-weight: bold;">Focus Agreement</font>&#8221;). The Focus Agreement sets an aggregate exercise price equal to NIS&#160;765.67 per share of Focus for a total consideration of NIS&#160;2,756,500, that being
      equal to the price paid by Messrs. Shuster and Gabay for the acquired interests in Focus at the time of the IMC Restructuring.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As part of the IMC Restructuring, IMC Holdings and Focus entered into an agreement in which Focus shall use the IMC brand on an exclusive basis for the sale of any cannabis plant and/or cannabis
      product produced by Focus, either alone or together with other sub-contractors engaged by Focus through the IP Agreement. Focus is also obligated to exclusively use IMC Holdings for certain management and consulting services including: (a)&#160;business
      development services; (b)&#160;marketing services; (c)&#160;strategic advisory services; (d)&#160;locating potential collaborations on a worldwide basis; and (e)&#160;financial analysis services through the Services Agreement&#8221; and Commercial Agreements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Under the IP Agreement, IMC Holdings charges Focus an amount equal to 25% of its revenues on a quarterly basis, which may be adjusted by mutual consent from time to time, as consideration for Focus&#8217;
      use of certain trademarks, know-how, technology and maintenance services provided by IMC Holdings.</div>
    <div style="line-height: 1.25">&#160;
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Under the Services Agreement, IMC Holdings charges Focus an amount equal to IMC Holdings&#8217;
            cost of providing certain services to Focus plus a 25% mark-up, which may be adjusted by mutual consent from time to time, as consideration for the provision of such services. On January 1, 2021, the Company amended the terms of each of the IP
            Agreement and the Services Agreement. For more information see &#8220;<font style="font-style: italic;">Corporate Highlights and Events</font>&#8221;.</font></div>
        <div style="line-height: 1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Subsequent to the IMC Restructuring, according to accounting criteria in IFRS 10, the Company is viewed as effectively exercising control over Focus, and therefore, the financial statements of Focus
      continue to be consolidated with those of the Company, despite the fact that the Company does not own Focus.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;"><u>ISRAELI MARKET DEVELOPMENT 2012-2021</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">According to Israeli Ministry of Health, as of December 2021, there are 109,352 medical cannabis licensed patients in Israel. A monthly prescription of 4,220,000 grams of cannabis were recorded in
      December 2021 an increase of 1,013,000 grams of cannabis from December 2020.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">11</sup></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">The chart below reflects the growth in licensed medical cannabis patients in Israel between 2012 to December 2021.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">12</sup></div>
    <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> <br>
      </sup></div>
    <div style="line-height: 1.25;"><br>
      <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
      <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">11</sup> Israel Ministry of Health &#8211; licensed patients&#8217; data as of December 2021 -
        https://www.health.gov.il/Subjects/cannabis/Documents/licenses-status-december-2021.pdf</div>
      <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">12</sup> Ministry of Health &#8211; licensed patients&#8217; data as of February 2022 -
        https://www.gov.il/BlobFolder/reports/licenses-status-february-2022/he/licenses-status-february-2022.pdf</div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >48</font></div>
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;"><br>
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;
        <div><img src="image00024.jpg"> </div>
        <div><br>
        </div>
        <div>
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;">REGULATORY FRAMEWORK IN ISRAEL</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">In Israel, cannabis is currently defined as a &#8220;dangerous drug&#8221; according to the Dangerous Drugs Ordinance<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">13</sup> and the 1961 Single Convention on Narcotic Drugs (&#8220;<font style="font-weight: bold;">Narcotics Convention</font>&#8221;), to which Israel is a signatory. However, both the DDO and the Narcotics Convention allow for the use
            of cannabis for medical or research purposes under a supervised and controlled regime. The competent regulatory authority in Israel in all matters concerning the oversight, control and regulation of cannabis for medical production, consumption,
            and research in Israel is the IMCA, established by Government Res. No. 3069<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">14</sup>. The production, distribution and consumption of adult-use recreational cannabis products is currently
            illegal in Israel.</div>
          <br>
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;">Patient Medical Consumption.</font> The use of cannabis is allowed for patients and for medical purposes, in
            respect of certain medical conditions, under a special approval of the MOH. Procedure 106<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> of the IMCA sets out a list of medical conditions that are allowed to be treated with medical cannabis products. Such authorized medical
            conditions are examined and updated from time to time, and include, among others, cancer, pain, nausea, seizures, muscle spasms, epilepsy, Tourette syndrome, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and post-traumatic
            stress disorder (PTSD).</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;">Licensing and Authorization for Commercial Activities in the Medical Cannabis Field.</font> In December 2017, the
            IMCA issued regulations that standardized the licensing process for any cannabis related activity (the &#8220;<font style="font-weight: bold;">Road Map</font>&#8221;).<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">16</sup> Pursuant to the Road Map, each operation in the medical cannabis field,
            including the propagation, cultivation, products manufacturing, storage and distribution to licensed pharmacies, and distribution from licensed pharmacies to licensed patients, requires compliance with the provisions of applicable laws,
            including the procurement of an appropriate license under the DDO from the IMCA and the maintenance of such license in good standing. Cannabis licenses may not be transferred, exchanged or assigned without the prior approval of the IMCA. The
            licenses are valid for a period of up to 3 years and can be renewed with the approval of the IMCA only.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: left;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u><br>
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">13</sup> Cannabis is listed in schedule 1 of the Dangerous Drugs Ordinance [New Version], 1973 [Hebrew]</div>
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>https://www.health.gov.il/LegislationLibrary/Samim_01_EN.pdf</u></div>
          <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">14</sup> Israeli Government Res. No. 3609 [Hebrew], August 7th, 2011 <u>https://www.gov.il/he/Departments/policies/2011_des3609</u></div>
          <div><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">15</sup> Ministry of Health Pharmaceutical Division Policy Number 106 &#8211; Licenses for Use of Cannabis<font style="font-family: 'Times New Roman', Times, serif;"><u>
                https://www.health.gov.il/hozer/DR_106.pdf</u></font> (in Hebrew)</div>
          <div>
            <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">16</sup> Directive 107 - Guidelines for the process of licensing the practice of cannabis for medical use, as amended on October 2020 [Hebrew] - <u>https://www.health.gov.il/hozer/CN_107_2019.pdf</u></div>
          </div>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
          <div ><font style="font-family: 'Times New Roman', Times, serif; font-weight: normal; font-style: normal;" >49</font></div>
          <div style="page-break-after: always;" >
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <br>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="text-align: left; line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25">
                  <div style="line-height: 1.25;">
                    <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                    <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                    <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
                      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                  </div>
                </div>
              </div>
            </div>
          </div>
          <br>
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">The MOH has issued a set of directives containing procedures and requirements for applicants for cannabis related activity licenses and has
            authorized certain entities to issue official certificates upon compliance with such directives. These directives include (i) Directive 150 (GSP Standard certification); (ii) Directive 151 (GAP Standard certification); (iii) Directive 152 (GMP
            Standard certification); and (iv) Directive 153 (GDP Standard certification). Regular and periodic examinations are conducted for licensed entities, in order to ensure compliance with the analytical standards and the level of quality required
            during each of the phases of production and distribution of medical cannabis.</div>
          <br>
          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;">Medical Cannabis Imports and Exports.</font> The Narcotics Convention governs the import and export of cannabis
            between member countries. Since Israel is a member country, any export and import of cannabis is subject to the Narcotic Convention.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;">In October 2020, the IMCA issued an updated procedure, titled &#8220;Guidelines for Approval of Applications for Importation of Dangerous Drug of Cannabis Type for Medical Use and for
      Research&#8221; (&#8220;<font style="font-weight: bold;">Procedure 109</font>&#8221;), describing the application requirements for cannabis import licenses for medical and research purposes. Therefore, each import of medical cannabis is to be approved by the IMCA
      issuing a specific import permit for each imported shipment, rather than a general license for import. An application for import of medical cannabis can be submitted by an entity licensed by the IMCA for the conduct of medical cannabis related
      activity. The Israeli government approved the export of pharmaceutical-grade cannabis and cannabis-based products on January 27, 2019<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">17</sup>, and in December 2020, the IMCA published guidelines for
      the medical cannabis export permit application process.<sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">18</sup><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">.</sup> </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Legalization of Adult-Use Recreational Cannabis and CBD for non-medical purposes in Israel. </font>As of the date of this Annual Information Form, adult-use
      recreational cannabis use in Israel and CBD for non-medical use is illegal. In November 2020, an Israeli government committee responsible for advancing the cannabis market reform published a report supporting and recommending the legalization of
      adult-use recreational cannabis in Israel. The Israeli parliament dissolved since then without applying the committee&#8217;s&#8217; recommendations and all legislative initiatives were suspended. However, the new government, formed on June 13, 2021, declared,
      and settled in the coalition agreement, its commitment to legalization of adult-use recreational cannabis. Since the formation of the new government, several legislative initiatives were filed, including for the decriminalization of the possession of
      cannabis for individual recreational adult-use and the legalization of CBD for non-medical use. These initiatives were not accepted; however they are viewed as first steps towards more comprehensive legislation towards the legalization of adult-use
      recreational cannabis. Members of the Israeli government continue to affirm their commitment to the legalization of adult-use recreational cannabis.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"></div>
    <div style="line-height: 1.25">&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u></div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">17</sup> Directive 4490 [Hebrew] - <u>https://www.gov.il/he/departments/policies/dec4490_2019</u></div>
      <div style="line-height: 1.25;"><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;">18</sup> Directive 110, December 2020 [Hebrew] - <u>https://www.health.gov.il/hozer/CN_110.pdf</u></div>
      <div style="line-height: 1.25;"><u> <br>
        </u></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
        <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal;" >50</font></div>
        <div style="page-break-after: always;" >
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%51%%%--> </div>
    <div style="line-height: 1.25">
      <div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;"><br>
        </div>
        <div style="line-height: 1.25; font-style: italic;">
          <div style="text-align: justify; margin-right: 3.6pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold; font-style: normal;">Previous Regime and Price Control.</font><font style="font-style: normal;">
              Until September 2019, under the previous regime, patients licensed for consumption of medical cannabis products by the IMCA received all of their medical cannabis products authorized under their respective licenses at a fixed monthly price of
              NIS 370, regardless of each patient&#8217;s authorized amount. Since September 2019, under the new regime, licenses to patients were no longer entitling them for such fixed monthly price. However, some medical cannabis patient licenses granted
              under the previous regime remain valid, entitling their holders to receive medical cannabis products pursuant to the price controls and supplier restrictions of the former regime. All licenses under the previous regime expired in Q1 2022. For
              more information, please see &#8220;Legal Proceedings and Regulatory Actions &#8211; Legal Proceedings &#8211; Supreme Court of Justice 2335/19&#8221;.</font></div>
          <div style="line-height: 1.25; font-style: normal;">&#160;</div>
          <div style="line-height: 1.25; font-style: normal;">REGULATORY FRAMEWORK IN CANADA</div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25; font-style: italic;">Canada</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">
          <div style="text-align: justify; line-height: 1.25;">The Cannabis Act and the Cannabis Regulations came into force on October 17, 2018, legalizing the sale of adult-use recreational cannabis. The Cannabis Act and Cannabis Regulations establish a
            licensing and permitting scheme for the production, importation, exportation, testing, packaging, labelling, sending, delivery, transportation, sale, possession and disposal of adult-use recreational cannabis.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">On October 17, 2019, amending regulations titled the <font style="font-style: italic;">Regulations Amending the Cannabis Regulations </font>came into force that, among other things, expanded
            the scope of the Cannabis Act and Cannabis Regulations to enable the sale of certain categories of cannabis, including cannabis extracts, topicals and edibles, and set THC content limits for certain categories of cannabis products.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Licensing.</font> The Cannabis Regulations establish six classes of licenses under the Cannabis Act: (i) cultivation licences, including standard cultivation,
            micro-cultivation and nursery sub-classes; (ii) processing licences, including standard processing and micro-processing sub-classes; (iii) analytical testing licences; (iv) sales for medical purposes licences; (v) research licences; and (vi)
            cannabis drug licences. These licences are valid for a period of up to five years. Licence requirements and rules differ depending on the class and/or sub-class of the licence.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Security Clearances.</font> Certain people associated with cannabis licensees must hold a valid security clearance issued by Canada&#8217;s Minister of Health. For
            example, in the case of corporations that hold licences for cultivation, processing or sale, directors, officers and other individuals who exercise, or are in positions to exercise, direct control over the corporation are required to hold such
            a security clearance. Under the Cannabis Regulations, the Minister may refuse to grant security clearances to individuals with organized crime associations or past convictions for, or in association with, drug trafficking, corruption or violent
            offences. Individuals who have a history of nonviolent, lower-risk criminal activity (for example, simple possession of cannabis or small-scale cultivation of cannabis plants) are not precluded by legislation from participating in the legal
            cannabis industry, and the granting of security clearance to such individuals is at the discretion of the Minister.</div>
          <div style="text-align: justify; line-height: 1.25;"> <br>
          </div>
          <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">51</font></div>
            <div  style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25">&#160;
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25">
                    <div style="line-height: 1.25;">
                      <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                      <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                      <div style="line-height: 1.25; font-weight: bold;">
                        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
            <div style="line-height: 1.25; font-style: italic;"><br>
            </div>
          </div>
          <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Cannabis Tracking System. </font>Under the Cannabis Act, the Minister is authorized to establish and maintain a national cannabis tracking system. Accordingly,
            Health Canada introduced the Cannabis Tracking and Licensing System, whereby licence holders are required to use this online system to submit monthly tracking reports, new license applications and licence renewal requests, among other things.
            The purpose of this system is to track cannabis throughout the supply chain to help prevent diversion of cannabis into, and out of, the legal market. The Cannabis Act provides the Minister with the authority to make a ministerial order that
            would require licensees to report specific information about their authorized activities with cannabis, in the form and manner specified by the Minister.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Cannabis Products.</font> The Cannabis Act and Cannabis Regulations, as amended, set out the requirements for the sale of dried cannabis, fresh cannabis,
            cannabis plants, cannabis seeds, cannabis edibles, cannabis extracts and cannabis topicals. Among other requirements, THC content limits are prescribed depending on the product category.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Packaging &amp; Labelling. </font>The Cannabis Regulations set out detailed requirements pertaining to the packaging and labelling of cannabis products that
            seek to promote informed consumer choice and allow for the safe handling and transportation of cannabis, while also reducing the appeal of cannabis to youth and promoting safe consumption. These requirements include plain packaging for cannabis
            products and packaging that is tamper-proof and child-resistant. The Cannabis Regulations further require package labels to include, among other information, the class of cannabis and the name, phone number and email of the licensed cultivator
            or processor, the standardized cannabis symbol and information pertaining to the THC and CBD content. Specific requirements vary depending on the product category of cannabis.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Promotion.</font> The Cannabis Act prohibits the promotion of cannabis, cannabis accessories and cannabis-related services unless authorized by the Cannabis Act
            through certain exceptions prescribed in the Cannabis Act and the Cannabis Regulations.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Medical Cannabis. </font>In addition to governance of recreational cannabis activities, the Cannabis Regulations also govern the regulatory framework
            associated with medical cannabis in Canada. Prior to the coming into force of the Cannabis Act and Cannabis Regulations, the sale of medical cannabis was permitted under the ACMPR. Although the ACMPR was replaced by the Cannabis Act and
            Cannabis Regulations, the new rules were not significantly different from the previous rules; changes were made to improve patient access, ensure consistency with recreational cannabis rules, and reduce the risk of abuse within the medical
            access system.</div>
          <div style="text-align: justify; line-height: 1.25;"> <br>
          </div>
          <div  style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div  style="text-align: center;"><font  style="font-weight: normal; font-style: normal;">52</font></div>
            <div  style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25">&#160;
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">
                  <div style="line-height: 1.25">
                    <div style="line-height: 1.25;">
                      <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                      <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                      <div style="line-height: 1.25; font-weight: bold;">
                        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
            <div style="line-height: 1.25; font-style: italic;"><br>
            </div>
          </div>
          <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Provincial and Territorial Regulatory Framework. </font>While the Cannabis Act provides for the regulation of adult-use cannabis production by the federal
            government, provincial and territorial governments maintain authority to regulate other aspects of adult-use recreational cannabis activities such as sale and distribution, minimum age requirements, and places where cannabis can be consumed.<font style="font-weight: bold;">&#160;</font>The following chart summarizes the basic recreational cannabis regimes in place as of the date of this Annual Information Form:</div>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="za7d8dc2d540b40d78cdbcb5b8a4c24b8">

              <tr>
                <td style="width: 25.78%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Province or Territory</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">Minimum Age to Purchase Recreational Cannabis Products</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Private and/or Public Operated Retailers</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; background-color: rgb(242, 242, 242); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Online Sales</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Alberta</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">18</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">British Columbia</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Manitoba</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">New Brunswick</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Newfoundland and Labrador</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Nova Scotia</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Ontario</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Prince Edward Island</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Quebec</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">21</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Saskatchewan</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Northwest Territories</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Nunavut</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25.78%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yukon</div>
                </td>
                <td style="width: 26.99%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">19</div>
                </td>
                <td style="width: 25.27%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Private and Public</div>
                </td>
                <td style="width: 21.96%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Yes (Public only)</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
  </div>
  <div><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> <br>
    </sup></div>
  <sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"></sup><sup style="font-family: 'Times New Roman', serif; vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup>
  <div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >53</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;"><br>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">REGULATORY FRAMEWORK IN GERMANY</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">On March 10, 2017, the German federal government enacted bill Bundestag-Drucksache 18/8965 &#8211; Law amending narcotics and other regulations that amended existing narcotics legislation to recognize
      cannabis as a form of medicine and allow for the importation and domestic cultivation of medical cannabis products. Under the updated legislation, cannabis is listed in Annex 3 to the Federal Narcotics Act (&#8220;BtMG&#8221;) as a &#8220;marketable narcotic suitable
      for prescription&#8221;. Legalization in Germany applies only to cannabis for medicinal purposes under state control in accordance with the Narcotic Convention.&#160; Currently, the production, distribution, exportation and importation of medical cannabis
      products in Germany is legal, subject to regulations and licensing requirements, while operations involving adult-use recreational cannabis products remain illegal. Nevertheless, current German government has declared in the coalition agreement its
      intention to open up the German market also in the recreational market. So far, however, there have been no visible further developments in this regard. Medical cannabis in Germany must comply with the corresponding monographs of the German and
      European pharmacopoeia. All BtMG permit applications must specify the strains and estimated quantities of medical cannabis involved and any subsequent changes must be reported to the Federal Opium Agency of Germany.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Unlike cannabis, CBD is not subject to German narcotics laws and may or may not be subject to German drug laws, depending on its use and dosage. Annex 1 of the Ordinance on the Prescription of
      Medicinal Products stipulates that CBD is in principle subject to prescription but does not specify a minimum quantity or a specific dosage form. However, a distinction must be made between consumable products that naturally contain CBD and those
      that are infused with CBD extract; the European Commission considers the latter to be a type of &#8220;food&#8221;. In light of the above, various products containing CBD can be found in the German market.</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Cultivation in Germany and Distribution of Medical Cannabis Cultivated in Germany.&#160; </font>The Federal Opium Agency of Germany&#8217;s Federal Institute for Drugs and
        Medical Devices (&#8220;BfArM&#8221;) formed a cannabis division (the &#8220;Cannabis Agency&#8221;) to oversee cultivation, harvesting, processing, quality control, storage, packaging and distribution to wholesalers, pharmacists and manufacturers. The Cannabis Agency
        also regulates pricing of German-produced medical cannabis products and serves as an intermediary of medical cannabis product sales between manufacturers, wholesalers and pharmacies on a non-profit basis. In late 2018, the Cannabis Agency issued a
        call for tenders to award licenses for local medical cannabis cultivation and distribution of German-cultivated medical cannabis products (the &#8220;<font style="font-weight: bold;">German Local Tender</font>&#8221;). The Cannabis Agency would serve as an
        intermediary in the supply chain between such cultivation and distribution. In April 2019, three licences for local cultivation were granted. In consequence three companies in Germany cultivate on behalf of the Cannabis Agency of the BfArM. Each
        license permitted the holder to grow up to 200kg per year for total production of 2,600kg per year collectively from the 13 cultivation lots and 10,400kg over the four-year license period. In July 2021, the BfArM launched the state sale of cannabis
        grown in Germany. Since then, pharmacies have been able to purchase medical cannabis in pharmaceutical drug quality for the supply of patients from the BfArM via the portal www.cannabisagentur.de. The sale from the BfArM to pharmacies is at a price
        of 4.30 euros per gram.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Cannabis Agency has no influence on the actual retail price of medical cannabis products, and is not responsible for the import of medical cannabis products and will therefore neither purchase
        nor distribute imported medical cannabis products. As a wholesaler, the Cannabis Agency sells German-based medical cannabis products in its own name.</div>
      <div style="text-align: justify; line-height: 1.25;"> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >54</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;"><br>
        </div>
      </div>
    </div>
    <div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Import volumes and procedures.&#160; </font>The current regime permits the importation of cannabis plants and plant parts for medicinal purposes under state control
        subject to the requirements under the Narcotic Convention, according to which, Germany must estimate the expected demand of medical cannabis products for medical and research purposes for the following year and report such estimates to the
        International Narcotics Control Board.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">As a prerequisite to obtaining a German import license, the supplier must grow and harvest in compliance with EU-GACP-Guidelines and manufacture in compliance with EU-GMP-Guidelines and
        certifications. All medical cannabis products imported to Germany must derive from plant material cultivated in a country whose regulations comply with the Narcotic Convention, and must comply with the relevant monographs described in the German
        and European pharmacopeias. While these requirements also apply to the exportation of medical cannabis products, the current German regime does not allow domestically cultivated medical cannabis products to be directly sold to commercial entities
        other than the Cannabis Agency.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Dispensing Exclusively via Pharmacies. </font>Medical cannabis products imported pursuant to an import license under the BtMG and AMG/BtMG permits are sold
        exclusively to pharmacies for final dispensing to patients on a prescription basis as &#8216;magistral preparations&#8217;, a term used in Europe to refer to medical products prepared in a pharmacy in accordance to a medical prescription for an individual
        patient. Magistral preparations require certain manufacturing steps in the pharmacy. Such manufacturing steps of the pharmacist typically include the testing and dosing of pre-packaged cannabis inflorescences (typically referred to as &#8220;floss&#8221;),
        medical cannabis products for oral administration (dronabinol), medical cannabis products for inhalation upon evaporation, and medical cannabis-infused teas. In addition to magistral preparations, medical cannabis products are also marketable as
        pre-packaged, licensed drugs (e.g. Sativex&#174;).</div>
    </div>
    <div><br>
    </div>
    <div style="line-height: 1.25;"><font style="font-style: italic;">No U.S. Cannabis-Related Activities<br>
      </font><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Group does not engage in any U.S. cannabis-related activities as defined in Canadian Securities Administrators Staff Notice 51-352 (Revised) &#8211; <font style="font-style: italic;">Issuers with U.S.
        Marijuana-Related Activities</font>&#8220;.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-style: italic;">RISK FACTORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company has implemented risk management governance processes that are led by the board of directors, with the active participation of management, and updates its assessment of its business risks
      on an annual basis. Notwithstanding, it is possible that the Company may not be able to foresee all the risks that it may have to face. The market in which IM Cannabis currently competes is complex, competitive and changing rapidly, and its business
      is subject to risks inherent in a high growth, heavily regulated enterprise, and the Company has identified certain risks pertinent to the Group&#8217;s business that may have affected or may affect the Group&#8217;s business, financial conditions, results of
      operations and cash flows, as further described throughout this MD&amp;A and under &#8220;Risk Factors&#8221; in the Annual Information Form. For additional risk factors, readers are directed to the Company&#8217;s most recent Annual Information Form, which is (a)
      available under the Company&#8217;s issuer profile on SEDAR at www.sedar.com, and (b) incorporated into and forms part of the Company's annual report on Form-40F filed on EDGAR at www.sec.gov. Sometimes new risks emerge, and management may not be able to
      predict all of them or be able to predict how they may cause actual results to be different from those contained in forward looking statements. Readers of this MD&amp;A should not rely upon forward looking statements as a prediction of future
      results.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >55</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;"><br>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;">Credit Risk</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The maximum credit exposure as of December 31, 2021, is the carrying amount of cash and cash equivalents, accounts receivable and other current assets. The Group does not have significant credit risk
      with respect to customers. All cash and cash equivalents are placed with major Israeli financial institutions.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Loan receivable credit risk is managed by each loan separately according to the Group&#8217;s policy, procedures and control relating to the borrower&#8217;s credit risk management. At the end of each period,
      the individual loan values are assessed based on a credit risk analysis. As of December 31, 2021, the Group had 2 loans outstanding (2020: nil loans) with a total balance of approximately $2.71 million.</div>
    <div style="line-height: 1.25;"><br>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">The expected credit loss analysis is generally based on Management&#8217;s understanding of the borrower&#8217;s experience/integrity, financial health, business plans, capacity, products, customers, contracts, competitive
          advantages/disadvantages, and other pertinent factors when assessing credit risk. This would also include the assessment of the borrower&#8217;s forecasts as well as taking into consideration any security and/or collateral the Company has on the
          outstanding balance.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <div style="line-height: 1.25;">As security on the loan receivable to Biome Grow Inc., the borrower holds approximately 744,000 Common Shares, on December 31, 2021. These shares cannot be sold without the proceeds from any sale being provided to
          the Company as repayment for the loan until the balance is fully discharged</div>
      </div>
      <br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"></div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;">As of December 31, 2021, the Company assessed the overall risk of the loan receivable balance and concluded that no expected credit loss under IFRS 9 was required.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >56</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <br>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                <div style="line-height: 1.25; font-weight: bold;">
                  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">Liquidity Risk</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. As of December 31, 2021, the Group's financial liabilities with
      liquidity risk consist of trade payables and other accounts payable which have contractual maturity dates within one year, and lease liabilities. The Group manages its liquidity risk by reviewing its capital requirements on an ongoing basis. Based on
      the Group's working capital position at December 31, 2021, management considers liquidity risk to be low.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 0.2pt; line-height: 1.25; font-style: italic;">
      <div style="text-indent: 0.2pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Currency rate risk</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 0.2pt; line-height: 1.25;">As at December 31, 2021, a portion of the Group&#8217;s financial assets and liabilities held in NIS, Euros, Canadian dollars and U.S. dollars consist of cash and cash equivalents. The
      Group&#8217;s objective in managing its foreign currency risk is to minimize its net exposure to foreign currency cash flows by transacting, to the greatest extent possible, with third parties as applicable. The Group does not currently use foreign
      exchange contracts to hedge its exposure of its foreign currency cash flows, as management has determined that this risk is not significant at this point of time.</div>
    <div style="text-align: justify; text-indent: 0.2pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 0.2pt; line-height: 1.25;">
      <div style="text-align: left; text-indent: 0.2pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Tax Remittance</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Company is subject to the provisions of the ITA12 and to review by CRA13. The Company files its annual tax compliance based on its interpretation of the ITA and CRA&#8217;s
        guidance. There is no certainty that the returns and tax position of the Company will be accepted by CRA as filed. Any difference between the Company&#8217;s tax filings and CRA&#8217;s final assessment could impact the Company&#8217;s results and financial
        position.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-family: Calibri, sans-serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">As at December 31, 2021, the Company&#8217;s financial statements included a tax liability of
          $9,060 and a tax indemnification asset of $8,835. The indemnification asset, intended to cover certain statutory tax obligations arising from the Trichome Transaction to the CRA, consists of: (1) 927,463 Common Shares; (2) The Company is a party
          to an indemnification agreement with certain directors and officers of the Company and Trichome to cover certain tax liabilities, interest and penalties arising from the Trichome Transaction; (3) a director of the Company has entered into a
          security pledge agreements with the Company to secure the obligations under the indemnification agreement. The director has pledged an aggregate of 833,508 Common Shares and 275,125 vested RSU&#8217;s in favour of the Company.; (4) the director has
          transferred the Company cash in the amount of $3,250 (the &#8220;</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Indemnification Asset</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#8221;).</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">There can be no assurance that the Indemnification Asset will be sufficient to satisfy the requisite payments to the CRA. Additionally, there can be no assurance that the
        directors and officers whom are party to the indemnification agreement will make sufficient payments to the Company and/or CRA, or make the payments at all.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">There can be no assurance that income tax laws or the interpretation thereof in any of the jurisdictions in which the Company operates will not be changed or interpreted or
        administered in a manner which adversely affects the Company and its shareholders. In addition, there is no assurance that CRA will agree with the manner in which the Company calculates taxes payable or that any of the other tax agencies will not
        change their administrative practices to the detriment of the Company or its shareholders.</div>
    </div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-style: italic; font-family: 'Times New Roman',Times,serif;">CAUTION CONCERNING FORWARD-LOOKING INFORMATION</div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <font style="font-family: 'Times New Roman',Times,serif;"> </font>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">Certain statements in this MD&amp;A may contain &#8220;forward-looking statements&#8221; or &#8220;forward-looking information,&#8221; within the meaning of
        applicable Canadian securities legislation (collectively referred to herein as &#8220;forward-looking statements&#8221; or &#8220;forward-looking information&#8221;). All statements other than statements of fact may be deemed to be forward-looking statements, including
        statements with regard to expected financial performance, strategy and business conditions. The words &#8220;believe&#8221;, &#8220;plan&#8221;, &#8220;intend&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;continue&#8221;, or &#8220;potential&#8221;, and similar expressions, as well as future or
        conditional verbs such as &#8220;will&#8221;, &#8220;should&#8221;, &#8220;would&#8221;, and &#8220;could&#8221; often identify forward-looking statements. These statements reflect management&#8217;s current expectations and plans with respect to future events and are based on information currently
        available to management including based on reasonable assumptions, estimates, internal and external analysis and opinions of management considering its experience, perception of trends, current conditions and expected developments as well as other
        factors that management believes to be relevant as at the date such statements are made. No assurance can be given that the expectations in any forward looking statement will prove to be correct and, as such, the forward-looking statements included
        in this MD&amp;A should not be unduly relied upon. Forward-looking information is by its nature prospective and requires IM Cannabis to make certain assumptions and is subje</font>ct to inherent risks and uncertainties. All forward-looking
      information is provided as of the date of this MD&amp;A. The Company does not undertake to update any such forward-looking information whether as a result of new information, future events or otherwise, except as required by law.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >57</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;">&#160;</div>
      </div>
    </div>
    <div style="line-height: 1.25;">FORWARD LOOKING STATEMENTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">This MD&amp;A and the documents incorporated by reference herein contain certain statements which contain &#8220;forward-looking information&#8221; within the meaning of Canadian securities legislation (each a
      &#8220;forward-looking statement&#8221;). All statements, other than statements of historical fact included in this MD&amp;A, including information that address activities, events or developments that the Company expects or anticipates will or may occur in the
      future, are forward-looking statements. The use of any of the words &#8220;anticipates&#8221;, &#8220;plans&#8221;, &#8220;contemplates&#8221;, &#8220;continues&#8221;, &#8220;estimates&#8221;, &#8220;expects&#8221;, &#8220;intends&#8221;, &#8220;proposes&#8221;, &#8220;might&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;shall&#8221;, &#8220;projects&#8221;, &#8220;should&#8221;, &#8220;could&#8221;, &#8220;would&#8221;,
      &#8220;believe&#8221;, &#8220;predict&#8221;, &#8220;forecast&#8221;, &#8220;pursue&#8221;, &#8220;potential&#8221;, &#8220;capable&#8221;, &#8220;budget&#8221; and similar expressions are intended to identify forward-looking statements. Forward-looking statements in this MD&amp;A may include,&#160;without limitation, forward-looking
      statements pertaining to:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z72124567342f4b5986293d72f1c01ddb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s business objectives and milestones and the anticipated timing of execution;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za07e76cd73424db0bbe150d573827e51" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the performance of the Company&#8217;s business, strategies and operations;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze0ee3bd07f874383834aecc7f063ade2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the intention to expand the business, operations and potential activities of the Company;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z67dbdfe27bfc44bf816cfc99712827e7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>expectations relating to the number of patients in Israel licensed by the MOH to consume medical cannabis;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z86067997a3a040138a80ebddd459b89c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>expectations of Focus, TJAC and MYM on variations of net cost of sales based on the number of pre-harvest plants, after harvest plants, the strains being grown and technological progress in the trimming machines;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5ae3897ffadb4093a363a9a61eb883f4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">the future impact of the Oranim Transaction, Panaxia Transaction, Pharm Yarok Transaction and the Vironna Transaction;</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z57ae999523b941b484739ff7e69789e0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company&#8217;s proposed acquisition of the HW Shinua and the Panaxia Pharmacy Option and the future impact thereof;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3b1646d09f2f41508fda72d1f7fc3da7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the future product portfolios of the Group and the Company&#8217;s ability to export its products, strains and genetics from Canada to Israel and Germany;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7bf8d9fa4cf24e1fbd873fb79ac9acb8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the competitive conditions of the cannabis industry and the growth of medical or recreational cannabis markets in the jurisdictions in which the Company operates;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z6226a40a39de44a69fc9693e0bff6ac6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the growth of the Company&#8217;s brands in the respective jurisdictions;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z632c1794bc0e43a3aa73e272c00cd9ed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s retail presence, distribution capabilities and data-driven insights;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z213af274aedb41488947bd791a82c072" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the competitive conditions of the industry, including the Company&#8217;s ability to maintain or grow its market share;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd89dca17f2b946f698ec050da47cf808" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>cannabis licensing in Israel, Germany and Canada, including the anticipated decriminalization or legalization of recreational cannabis in Israel and Germany;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z6035e62030f94d10a8cdc86b62a2e040" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>expectations regarding the renewal and/or extension of the Group&#8217;s licenses;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2e15cf4f6e2b40469a8cfe540ca61d82" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s anticipated operating cash requirements and future financing needs;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze27a9d6ef08343498375b8999638c5e1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s expectations regarding its revenue, expenses, profit margins and operations;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfd423df2d5d24ba7b3b434042aa419a9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the anticipated gross margins, EBITDA and adjusted EBITDA from the Company&#8217;s operations</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z74dc8e57022e4ff7af09f2a26f277041" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>future opportunities for the Company in Canada, particularly in the premium and ultra-premium segments;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0407feb2efab4bb39ca9c8e06e1f4cb0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>future opportunities for the Company in Israel, particularly in the retail and distribution segments of the cannabis market; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4e23459e48444507820a2282f4d133a9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>contractual obligations and commitments.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >58</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;"><br>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">With respect to the forward looking-statements contained in this MD&amp;A, the Company has made assumptions regarding, among other things:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z17a59e8b8d444700b570a49537df2cdc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the anticipated increase in demand for medical and recreational cannabis in the markets in which the Company operates;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zffb964b765e64d77abaa0d3cfd4ac949" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s satisfaction of international demand for its products;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zaad500f6eed74e8e8ce6a1c50e12cfc0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s ability to implement its growth strategies;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8013cfc96f9341408e1a76b6b6d65add" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the development and introduction of new products;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z78fac75d05da48debc975065015d43fa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the changes and trends in the cannabis industry;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zeb06bf2b08eb41e2a7d1228b6ad6585e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s ability to maintain and renew required licenses;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3d9117b47ccc4894b56db7ced873a264" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">the Company&#8217;s ability to rely on the export of, creation and maintenance of and maintain a consistent supply of imported cannabis from the Canadian Facilities;</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0e2ba0b8eecc458897d780b3bb3b90cc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the effectiveness of its products for medical cannabis patients and recreational consumers;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf34ac8ed1774400b8a703005b11e4aba" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>future cannabis pricing and input costs;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z067054661435479ba09852f7575f0ca6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>cannabis production yields;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8af1702bd3b2406182cee60540cdda63" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company being able to continue to drive organic growth from Canadian operations; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zebe9722f367243309dd0d4bd15aca114" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s ability to market its brands and services successfully to its anticipated customers.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;<br>
      Readers are cautioned that the above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties.
      Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd12c8279b58c4ba49bee3368716dd06f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>general business risk and liability, including claims or complaints in the normal course of business;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb6faddd914e14aaf9bf8c916bff49786" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any failure of the Company to maintain &#8220;de facto&#8221; control over Focus in accordance with IFRS 10 <font style="font-style: italic;">Consolidated Financial Statements</font> (&#8220;IFRS 10&#8221;);</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze4ad98de478f45cb81129082679e9027" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>regulatory authorities in Israel viewing the Company as the deemed owner of more than 5% of Focus in contravention of Israeli regulations;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za140c09019e64e9badb88600d6d49ad9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>limitations on stockholdings of the Company in connection with its potential direct engagement in the Israeli medical cannabis market;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z09d12083185f49069cc9853fdebb966b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the ability and/or need to obtain additional financing for continued operations;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8e7705f4afad485fb04042294ce46c39" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the lack of control over the Company&#8217;s investees;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4c5c4b540e5e4e64a2bb8f171fd2e5f1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zaecd525d8d77425693b2ed911dd0f253" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>unexpected changes in governmental policies and regulations affecting the production, distribution, manufacture or use of medial cannabis in Israel, Germany, Canada, Portugal, Greece, or any jurisdictions in which the Company intends to
              operate;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z00435e1e3d7f4edf9c64b3b3ca3f5ea7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s ability to continue to meet the listing requirements of the CSE and the NASDAQ;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z117ca5e4a9f04a6e9e54958b7d9cb8d7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Israeli government deciding to abandon the decriminalization or legalization of recreational cannabis;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0e03b076f4da4161b726a827167fd0af" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any change in the political environment which would negatively affect the prospect of decriminalization or legalization of recreational cannabis in Israel;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >59</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;"><br>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" id="z587ff8da758c4928a0a44e5c5ddf95bd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>any unexpected failure of Focus to maintain in good standing or renew the Focus License;</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z80bd2a5484a0441688e01dd7669dbe7c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Focus&#8217; reliance on the Focus Facility to conduct medical cannabis activities in Israel;</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" id="zda603a48b8ba46029b6b9285e753119d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any unexpected failure of Focus to maintain the Focus Facility in good standing with all state and municipal Israeli regulations, including all required licenses and permits&#160;and under the Focus Leases;</div>
            <div> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z29089076fe38421197c98cf976f6bdd0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any adverse outcome of the Construction Proceedings;</div>
            <div> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="za561a135f3f745358e9858ce31ad9333" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any unexpected failure of Adjupharm to maintain in good standing or renew any of its Adjupharm Licenses;<br>
              <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zdab622ad2ca845ab9d644f298d89109c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any unexpected failure of TJAC to maintain in good standing or renew any of the TJAC Licenses or MYM Licenses;<br>
              <br>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" id="z74df93e0e2d6429e975a9817346736e7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the reliance on the Canadian Facilities to conduct medical cannabis activities;</div>
              <div> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" id="z7916181e91974557962b3403486367d1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any unexpected failure of TJAC and/or MYM to maintain their facilities in good standing with all applicable regulations, including all required licenses and permits&#160;and under the TJAC Leases and the Sublime Lease;</div>
            <div> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z4e9b7aec6b7246fa8eb4bce20114737c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s ability to maintain ancillary business licenses, permits and approvals required to operate effectively;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8f6abc18fd5d45058549c51f1dd1bab7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the ability of the Company, following the Trichome Transaction, the MYM Transaction, the Panaxia Transaction, the Pharm Yarok Transaction, the Oranim Transaction and the Vironna Transaction to integrate each entity into the Company&#8217;s
              operations and realize the anticipated benefits and synergies of each such transaction and the timing thereof and the focus of management on such integration;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zba8e3edae75443899e1f810e20fa2adf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any potential undisclosed liabilities of Trichome, MYM, Pharm Yarok, Rosen High Way, Oranim Pharm, and Vironna or other entities acquired by the Company that were unidentified during the due diligence process;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4840b16e66b64067a1a36aaf66c4898e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the interpretation of Company&#8217;s acquisitions of companies or assets by tax authorities or regulatory bodies, including but not limited to the change of control of licensed entities;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zbb0548a3b1d849568f3e8249ff32e982" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the ability of the Group to deliver on their sales commitments or growth objectives;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8f936cc14ef54ebc8f8b31297f83a65e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s reliance on third-party supply agreements and its ability to enter into additional supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group&#8217;s obligations;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8b20930063854ccf8e5dd26e5dae8c2e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group, including but not limited to the
              Construction Proceedings, the MOH Allegations and the class action proceedings described herein;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z98bfb8f27b4b4610b465ff985e424194" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the impact of increasing competition;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0d3ad3dff4fb4d57adec2e61dacb166c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any lack of merger and acquisition opportunities;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zac71401a4e624b76ba64e4c7bc81a553" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>inconsistent public opinion and perception regarding the use of cannabis;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zcd5fa5c7d3ef425698fa07a0ad9ba5f4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>engaging in activities considered illegal under US federal law related to cannabis;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd54bf6428b2844ffab7263dc6f058e2e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>political instability and conflict in the Middle East, Eastern Europe and Ukraine;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zee84f9b4f25843f08c2ba431406a3451" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>adverse market conditions;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zdd59c118d8c04e2c983f33f425c61820" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>unexpected disruptions to the operations and businesses of the Group as a result of the COVID-19 global pandemic or other disease outbreaks including a resurgence in the cases of COVID-19;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zc980f1537a324199a6925a577b7c2898" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" >
      <div style="text-align: center;" ><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >60</font></div>
      <div style="page-break-after: always;" >
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25">
                <div style="line-height: 1.25;">
                  <div style="text-align: right; line-height: 1.25;"><img width="46" height="29" src="image00003.jpg"></div>
                  <div style="line-height: 1.25; font-weight: bold;">Management&#8217;s Discussion and Analysis</div>
                  <div style="line-height: 1.25; font-weight: bold;">
                    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div style="line-height: 1.25; font-style: italic;"><br>
        </div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zced8dcf80a2547bf887493851b1689b4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Group&#8217;s ability to sell its products</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfe09f564cb2e491488d588832ec0a245" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>currency fluctuations;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5527f31516f142b3a9a0faa1bc91f125" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any change in accounting practices or treatment affecting the consolidation of financial results;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z70cfadc24b464003982f1c0555e01537" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the costs of inputs;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf59a7b10703a49c68694cd826a10b118" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>reliance on management; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0392d23506d046a09b55ed0bb935003f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the loss of key management and/or employees.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;<br>
      Readers are cautioned that the foregoing list of risk factors is not exhaustive. Additional information on these and other factors that could affect the business, operations or financial results of the Company are detailed under the headings &#8220;Risks
      Factors&#8221; and &#8220;Contingent Liabilities and Commitments&#8221; of this MD&amp;A. The Company and management caution readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. Although the Company believes that
      the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. The Company and management assume no obligation to update or revise them to reflect new
      events or circumstances except as required by applicable securities laws.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Additional information about the assumptions, risks and uncertainties of the Company&#8217;s business and material factors or assumptions on which information contained in forward-looking information is
      based is provided in the Company&#8217;s disclosure materials, including in this MD&amp;A under &#8220;<font style="font-style: italic;">Legal and Regulatory &#8211; Risk Factors</font>&#8221; and the Company&#8217;s current annual information form under &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221;, filed with the securities regulatory authorities in Canada and which can be viewed online under the Company&#8217;s profile on the System for Electronic Document Analysis and Retrieval (&#8220;SEDAR&#8221;) at www.sedar.com.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">All forward-looking information in this MD&amp;A is qualified by these cautionary statements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">FINANCIAL OUTLOOK</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',serif;">The forward-looking information in this MD&amp;A contain statements in respect of estimated revenues. The Company and its management believe that the estimated revenues are
        reasonable as of the date hereof and are based on management&#8217;s current views, strategies, expectations, assumptions and forecasts, and have been calculated using accounting policies that are generally consistent with the Company&#8217;s current
        accounting policies. These estimates are considered financial outlooks under applicable securities legislation. These estimates and any other financial outlooks or future-oriented financial information included herein have been approved by
        management of the Company as of the date hereof. Such financial outlooks or future-oriented financial information are provided for the purposes of presenting information about management&#8217;s current expectations and goals relating to the sales
        agreements described in the &#8220;Corporate Highlights and Events&#8221; section of this MD&amp;A and other previously announced Focus sales agreements and the future business of the Company. The Company disclaims any intention or obligation to update or
        revise any future-oriented financial information, whether as a result of new information, future events or otherwise, except as required by securities legislation. Readers are cautioned that actual results may vary materially as a result of a
        number of risks, uncertainties, and other factors, many of which are beyond the Group&#8217;s control. See the risks and uncertainties discussed in the &#8220;Risk Factors&#8221; section and elsewhere in this MD&amp;A and other risks detailed from time to time in
        the publicly filed disclosure documents of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">ADDITIONAL INFORMATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Additional information relating to the Company, including the Company&#8217;s Annual Information Form, is available on SEDAR at www.sedar.com.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; text-align: center;"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" >61</font>
      <hr style="border-width: 1px medium 4px; border-style: solid none; border-color: black -moz-use-text-color; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; height: 10px; color: rgb(255, 255, 255); background-color: rgb(255, 255, 255); margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>exhibit_99-4.htm
<DESCRIPTION>EXHIBIT 99.4
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 99.4</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">I, Oren Shuster, certify that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>I have reviewed this annual report on Form 40-F of IM Cannabis Corp.;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
              misleading with respect to the period covered by this report;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for,
              the periods presented in this report;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The issuer&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
              defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries,
              is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">b)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
              the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">c)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Evaluated the effectiveness of the issuer&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
              report based on such evaluation; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">d)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Disclosed in this report any change in the issuer&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the
              issuer&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The issuer&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer&#8217;s auditors and the audit committee of the issuer&#8217;s board of directors (or
              persons performing the equivalent functions):</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer&#8217;s ability to record, process, summarize and report
              financial information; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">b)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zf66e8a991247474692f04cbec3047e47">

          <tr>
            <td style="width: 50%; text-align: left; vertical-align: top;">
              <div>
                <div style="line-height: 1.25;">Date: March 31, 2022</div>
              </div>
            </td>
            <td style="width: 5%; text-align: left; vertical-align: top;">
              <div><font style="font-family: 'Times New Roman',Times,serif;">By:</font></div>
            </td>
            <td style="width: 45%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-style: normal;"><u>/s/ Oren Shuster</u></div>
                Oren Shuster<br>
                Chief Executive Officer<br>
                (Principal Executive Officer)</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>6
<FILENAME>exhibit_99-5.htm
<DESCRIPTION>EXHIBIT 99.5
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 99.5</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">I, Shai Shemesh, certify that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>I have reviewed this annual report on Form 40-F of IM Cannabis Corp.;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
              misleading with respect to the period covered by this report;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for,
              the periods presented in this report;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The issuer&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
              defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries,
              is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">b)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
              the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">c)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Evaluated the effectiveness of the issuer&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
              report based on such evaluation; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">d)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Disclosed in this report any change in the issuer&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the
              issuer&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 20.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The issuer&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer&#8217;s auditors and the audit committee of the issuer&#8217;s board of directors (or
              persons performing the equivalent functions):</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer&#8217;s ability to record, process, summarize and report
              financial information; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

        <tr>
          <td style="width: 56.3pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">b)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="line-height: 1.25;">Date: March 31, 2022</div>
              </td>
              <td style="width: 5%; vertical-align: top;">By:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic;"><font style="font-style: normal;"><u> /s/ Shai Shemesh</u></font><br>
                  </div>
                Shai Shemesh<font style="font-family: 'Times New Roman', Times, serif;"><br>
                </font>Chief Financial Officer<font style="font-family: 'Times New Roman', Times, serif;"><br>
                </font>(Principal Financial and Accounting Officer)</td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>7
<FILENAME>exhibit_99-6.htm
<DESCRIPTION>EXHIBIT 99.6
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 99.6</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">CERTIFICATION PURSUANT TO<br>
      18 U.S.C. &#167;1350,<br>
      AS ADOPTED PURSUANT TO<br>
      SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">In connection with the Annual Report of IM Cannabis Corp. (the &#8220;Company&#8221;) on Form 40-F for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof
      (the &#8220;Report&#8221;), I, Oren Shuster, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 10.5pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 10.5pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50%; text-align: left; vertical-align: top;">
                <div>
                  <div style="line-height: 1.25;">Date: March 31, 2022</div>
                </div>
              </td>
              <td style="width: 5%; text-align: left; vertical-align: top;">
                <div><font style="font-family: 'Times New Roman',Times,serif;">BY:</font></div>
              </td>
              <td style="width: 45%;">
                <div>
                  <div style="text-align: left; line-height: 1.25; font-style: normal;"><u>/s/ Oren Shuster</u></div>
                  Oren Shuster<br>
                  Chief Executive Officer<br>
                  (Principal Executive Officer)</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A signed original of this written statement required by Section 906 has been provided to IM Cannabis Corp. and will be retained by IM Cannabis Corp. and furnished to the Securities
      and Exchange Commission or its staff upon request.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>8
<FILENAME>exhibit_99-7.htm
<DESCRIPTION>EXHIBIT 99.7
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <br>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 99.7</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">CERTIFICATION PURSUANT TO<br>
      18 U.S.C. &#167;1350,<br>
      AS ADOPTED PURSUANT TO<br>
      SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">In connection with the Annual Report of IM Cannabis Corp. (the &#8220;Company&#8221;) on Form 40-F for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof
      (the &#8220;Report&#8221;), I, Shai Shemesh, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 10.5pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 10.5pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: -288pt; margin-left: 288pt; line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">March 31, 2022</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-style: italic;"><u><font style="font-style: normal;"> /s/ Shai Shemesh</font></u><font style="font-family: 'Times New Roman',Times,serif;"><br>
                  </font></div>
                Shai Shemesh<font style="font-family: 'Times New Roman',Times,serif;"><br>
                </font>Chief Financial Officer<font style="font-family: 'Times New Roman',Times,serif;"><br>
                </font>(Principal Financial and Accounting Officer)</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A signed original of this written statement required by Section 906 has been provided to IM Cannabis Corp. and will be retained by IM Cannabis Corp. and furnished to the Securities
      and Exchange Commission or its staff upon request.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.8
<SEQUENCE>9
<FILENAME>exhibit_99-8.htm
<DESCRIPTION>EXHIBIT 99.8
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u> Exhibit 99.8</u><br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Consent&#160;of&#160;Independent&#160;Registered&#160;Public&#160;Accounting&#160;Firm</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">We&#160;consent&#160;to the incorporation by reference in the Registration Statement (Form F-10 No. 333-254255) of IM Cannabis Corp. and in the
      related Prospectus of our report dated March 31, 2022, with respect to the consolidated financial statements of IM Cannabis Corp. included in this Annual Report (Form 40-F) for the year ended December 31, 2021.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z58a03a0abd79477babebfd64be428584" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.47%; vertical-align: middle;">
            <div style="line-height: 1.25;"> <u>/s/ KOST FORER GABBAY &amp; KASIERER</u></div>
            <div style="line-height: 1.25;">KOST FORER GABBAY &amp; KASIERER</div>
          </td>
          <td style="width: 50.53%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.47%; vertical-align: middle;">
            <div style="line-height: 1.25;">A Member of Ernst &amp; Young Global</div>
          </td>
          <td style="width: 50.53%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.47%; vertical-align: middle;">&#160;</td>
          <td style="width: 50.53%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.47%; vertical-align: middle;">
            <div style="line-height: 1.25;">Tel-Aviv, Israel</div>
          </td>
          <td style="width: 50.53%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.47%; vertical-align: middle;">
            <div style="line-height: 1.25;">March 31, 2022</div>
          </td>
          <td style="width: 50.53%; vertical-align: middle;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25">&#160;
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>imc-20211231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:imc="http://www.imcannabis.com/20211231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" targetNamespace="http://www.imcannabis.com/20211231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
  <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
  <import namespace="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.imcannabis.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" id="CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
        <link:definition>0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME" id="CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME">
        <link:definition>0003 - Statement - CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" id="CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY">
        <link:definition>0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals" id="CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals">
        <link:definition>0005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation" id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation">
        <link:definition>0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Additional information)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/GENERAL" id="GENERAL">
        <link:definition>0008 - Disclosure - GENERAL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIES" id="SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGESTIMATESANDASSUMPTIONSUSEDINTHEPREPARATIONOFTHEFINANCIALSTATEMENTS" id="SIGNIFICANTACCOUNTINGESTIMATESANDASSUMPTIONSUSEDINTHEPREPARATIONOFTHEFINANCIALSTATEMENTS">
        <link:definition>0010 - Disclosure - SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/DISCLOSUREOFNEWSTANDARDSINTHEPERIODPRIORTOTHEIRADOPTION" id="DISCLOSUREOFNEWSTANDARDSINTHEPERIODPRIORTOTHEIRADOPTION">
        <link:definition>0011 - Disclosure - DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONS" id="BUSINESSCOMBINATIONS">
        <link:definition>0012 - Disclosure - BUSINESS COMBINATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TRADERECEIVABLES" id="TRADERECEIVABLES">
        <link:definition>0013 - Disclosure - TRADE RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLE" id="OTHERACCOUNTSRECEIVABLE">
        <link:definition>0014 - Disclosure - OTHER ACCOUNTS RECEIVABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETS" id="BIOLOGICALASSETS">
        <link:definition>0015 - Disclosure - BIOLOGICAL ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/INVENTORIES" id="INVENTORIES">
        <link:definition>0016 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET" id="PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET">
        <link:definition>0017 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNET" id="INTANGIBLEASSETSNET">
        <link:definition>0018 - Disclosure - INTANGIBLE ASSETS, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETS" id="RIGHTOFUSEASSETS">
        <link:definition>0019 - Disclosure - RIGHT-OF-USE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIES" id="EMPLOYEEBENEFITASSETSANDLIABILITIES">
        <link:definition>0020 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OTHERPAYABLES" id="OTHERPAYABLES">
        <link:definition>0021 - Disclosure - OTHER PAYABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTS" id="FINANCIALINSTRUMENTS">
        <link:definition>0022 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES" id="CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES">
        <link:definition>0023 - Disclosure - CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TAXESONINCOME" id="TAXESONINCOME">
        <link:definition>0024 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EQUITY" id="EQUITY">
        <link:definition>0025 - Disclosure - EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATA" id="SELECTEDSTATEMENTSOFPROFITORLOSSDATA">
        <link:definition>0026 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARE" id="NETEARNINGSLOSSPERSHARE">
        <link:definition>0027 - Disclosure - NET EARNINGS (LOSS) PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONS" id="RELATEDPARTYBALANCESANDTRANSACTIONS">
        <link:definition>0028 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY" id="SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY">
        <link:definition>0029 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OPERATINGSEGMENTS" id="OPERATINGSEGMENTS">
        <link:definition>0030 - Disclosure - OPERATING SEGMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SUBSEQUENTEVENTS" id="SUBSEQUENTEVENTS">
        <link:definition>0031 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" id="SIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" id="SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables" id="BUSINESSCOMBINATIONSTables">
        <link:definition>0034 - Disclosure - BUSINESS COMBINATIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESTables" id="TRADERECEIVABLESTables">
        <link:definition>0035 - Disclosure - TRADE RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLETables" id="OTHERACCOUNTSRECEIVABLETables">
        <link:definition>0036 - Disclosure - OTHER ACCOUNTS RECEIVABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSTables" id="BIOLOGICALASSETSTables">
        <link:definition>0037 - Disclosure - BIOLOGICAL ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/INVENTORIESTables" id="INVENTORIESTables">
        <link:definition>0038 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETTables" id="PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETTables">
        <link:definition>0039 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNETTables" id="INTANGIBLEASSETSNETTables">
        <link:definition>0040 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETSTables" id="RIGHTOFUSEASSETSTables">
        <link:definition>0041 - Disclosure - RIGHT-OF-USE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables" id="EMPLOYEEBENEFITASSETSANDLIABILITIESTables">
        <link:definition>0042 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OTHERPAYABLESTables" id="OTHERPAYABLESTables">
        <link:definition>0043 - Disclosure - OTHER PAYABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables" id="FINANCIALINSTRUMENTSTables">
        <link:definition>0044 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TAXESONINCOMETables" id="TAXESONINCOMETables">
        <link:definition>0045 - Disclosure - TAXES ON INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EQUITYTables" id="EQUITYTables">
        <link:definition>0046 - Disclosure - EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATATables" id="SELECTEDSTATEMENTSOFPROFITORLOSSDATATables">
        <link:definition>0047 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARETables" id="NETEARNINGSLOSSPERSHARETables">
        <link:definition>0048 - Disclosure - NET EARNINGS (LOSS) PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables" id="RELATEDPARTYBALANCESANDTRANSACTIONSTables">
        <link:definition>0049 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables" id="SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables">
        <link:definition>0050 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OPERATINGSEGMENTSTables" id="OPERATINGSEGMENTSTables">
        <link:definition>0051 - Disclosure - OPERATING SEGMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/GENERALDetailTextuals" id="GENERALDetailTextuals">
        <link:definition>0052 - Disclosure - GENERAL (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals" id="SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals">
        <link:definition>0053 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails" id="SIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>0054 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1" id="SIGNIFICANTACCOUNTINGPOLICIESDetails1">
        <link:definition>0055 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2" id="SIGNIFICANTACCOUNTINGPOLICIESDetails2">
        <link:definition>0056 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals" id="BUSINESSCOMBINATIONSDetailTextuals">
        <link:definition>0057 - Disclosure - BUSINESS COMBINATIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails" id="BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails">
        <link:definition>0058 - Disclosure - BUSINESS COMBINATIONS - Disclosure of detailed information about proforma acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails" id="BUSINESSCOMBINATIONSDetails">
        <link:definition>0059 - Disclosure - BUSINESS COMBINATIONS - Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1" id="BUSINESSCOMBINATIONSDetails1">
        <link:definition>0060 - Disclosure - BUSINESS COMBINATIONS - Disclosure of detailed information about cash outflow/inflow on the acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESDetailTextuals" id="TRADERECEIVABLESDetailTextuals">
        <link:definition>0061 - Disclosure - TRADE RECEIVABLES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESDetails" id="TRADERECEIVABLESDetails">
        <link:definition>0062 - Disclosure - TRADE RECEIVABLES - Disclosure of trade receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESDetails1" id="TRADERECEIVABLESDetails1">
        <link:definition>0063 - Disclosure - TRADE RECEIVABLES - Disclosure of major customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails" id="OTHERACCOUNTSRECEIVABLEDetails">
        <link:definition>0064 - Disclosure - OTHER ACCOUNTS RECEIVABLE - Disclosure of detailed information about other accounts receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSDetailTextuals" id="BIOLOGICALASSETSDetailTextuals">
        <link:definition>0065 - Disclosure - BIOLOGICAL ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSDetails" id="BIOLOGICALASSETSDetails">
        <link:definition>0066 - Disclosure - BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1" id="BIOLOGICALASSETSDetails1">
        <link:definition>0067 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about Impact on fair value if 10% increase decrease in each input (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/INVENTORIESDetailTextuals" id="INVENTORIESDetailTextuals">
        <link:definition>0068 - Disclosure - INVENTORIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/INVENTORIESDetails" id="INVENTORIESDetails">
        <link:definition>0069 - Disclosure - INVENTORIES - Disclosure of detailed information about inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails" id="PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails">
        <link:definition>0070 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET - Disclosure of detailed information about property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals" id="INTANGIBLEASSETSNETDetailTextuals">
        <link:definition>0071 - Disclosure - INTANGIBLE ASSETS, NET (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails" id="INTANGIBLEASSETSNETDetails">
        <link:definition>0072 - Disclosure - INTANGIBLE ASSETS, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals" id="RIGHTOFUSEASSETSDetailTextuals">
        <link:definition>0073 - Disclosure - RIGHT-OF-USE ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails" id="RIGHTOFUSEASSETSDetails">
        <link:definition>0074 - Disclosure - RIGHT-OF-USE ASSETS - Disclosure of detailed information about right-of-use assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails" id="EMPLOYEEBENEFITASSETSANDLIABILITIESDetails">
        <link:definition>0075 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about expenses recognized in consolidated statements of profit or loss and other comprehensive income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1" id="EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1">
        <link:definition>0076 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about defined benefit liability (asset) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2" id="EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2">
        <link:definition>0077 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in present value of defined benefit liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3" id="EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3">
        <link:definition>0078 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in the fair value of plan assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4" id="EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4">
        <link:definition>0079 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about principal assumptions underlying the defined benefit plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OTHERPAYABLESDetails" id="OTHERPAYABLESDetails">
        <link:definition>0080 - Disclosure - OTHER PAYABLES - Disclosure of detailed information of other current payables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals" id="FINANCIALINSTRUMENTSDetailTextuals">
        <link:definition>0081 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails" id="FINANCIALINSTRUMENTSDetails">
        <link:definition>0082 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of carrying values of financial instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1" id="FINANCIALINSTRUMENTSDetails1">
        <link:definition>0083 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of information about key assumptions to measure fair value of warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2" id="FINANCIALINSTRUMENTSDetails2">
        <link:definition>0084 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of maturity analysis for lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3" id="FINANCIALINSTRUMENTSDetails3">
        <link:definition>0085 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of changes in liabilities arising from financing activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals" id="CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals">
        <link:definition>0086 - Disclosure - CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals" id="TAXESONINCOMEDetailTextuals">
        <link:definition>0087 - Disclosure - TAXES ON INCOME (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails" id="TAXESONINCOMEDetails">
        <link:definition>0088 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about income tax expense (benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails1" id="TAXESONINCOMEDetails1">
        <link:definition>0089 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about deferred taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails2" id="TAXESONINCOMEDetails2">
        <link:definition>0090 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about statements of financial position deferred taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails3" id="TAXESONINCOMEDetails3">
        <link:definition>0091 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about reconciliation of tax expense and accounting profit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EQUITYDetailTextuals" id="EQUITYDetailTextuals">
        <link:definition>0092 - Disclosure - EQUITY (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EQUITYDetails" id="EQUITYDetails">
        <link:definition>0093 - Disclosure - EQUITY - Disclosure of composition of share capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EQUITYDetails1" id="EQUITYDetails1">
        <link:definition>0094 - Disclosure - EQUITY - Disclosure of changes in issued and outstanding share capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EQUITYDetails2" id="EQUITYDetails2">
        <link:definition>0095 - Disclosure - EQUITY - Disclosure of detailed information about options, valuation assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails" id="EQUITYNumberOfRestrictedShareUnitsRSUDetails">
        <link:definition>0096 - Disclosure - EQUITY - Disclosure of number of restricted share units ("RSU") (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/EQUITYDetails3" id="EQUITYDetails3">
        <link:definition>0097 - Disclosure - EQUITY - Disclosure of number and weighted average exercise prices of share options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails" id="SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails">
        <link:definition>0098 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA - Disclosure of statement of profit and loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails" id="NETEARNINGSLOSSPERSHAREDetails">
        <link:definition>0099 - Disclosure - NET EARNINGS (LOSS) PER SHARE - Disclosure of earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals" id="RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals">
        <link:definition>0100 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails" id="RELATEDPARTYBALANCESANDTRANSACTIONSDetails">
        <link:definition>0101 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of financial position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1" id="RELATEDPARTYBALANCESANDTRANSACTIONSDetails1">
        <link:definition>0102 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of profit or loss and other comprehensive income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails2" id="RELATEDPARTYBALANCESANDTRANSACTIONSDetails2">
        <link:definition>0103 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about key management personnel (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails" id="SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails">
        <link:definition>0104 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement of financial position for partly owned subsidiary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1" id="SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1">
        <link:definition>0105 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of operating results for partly owned subsidiary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2" id="SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2">
        <link:definition>0106 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails" id="OPERATINGSEGMENTSDetails">
        <link:definition>0107 - Disclosure - OPERATING SEGMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals" id="SUBSEQUENTEVENTSDetailTextuals">
        <link:definition>0108 - Disclosure - SUBSEQUENT EVENTS  (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="imc-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="imc-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="imc-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="imc-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" id="imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AcquisitionCostsForProfessionalFees" id="imc_AcquisitionCostsForProfessionalFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AcquisitionCostsOfCommonShares" id="imc_AcquisitionCostsOfCommonShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AcquisitionOfSubsidiaryAbstract" id="imc_AcquisitionOfSubsidiaryAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AcquisitionOfTrichomeFinancialCorpMember" id="imc_AcquisitionOfTrichomeFinancialCorpMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AcquisitionTransactionCosts" id="imc_AcquisitionTransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionsToDisposalsRightOfUseAssets" id="imc_AdditionsToDisposalsRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjupharmGmbhMember" id="imc_AdjupharmGmbhMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjupharmsCeoMember" id="imc_AdjupharmsCeoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustedExercisePrice" id="imc_AdjustedExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent" id="imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentsForNonCashInterestIncomeOnLoansReceivable" id="imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentsForRevaluationOfOtherReceivable" id="imc_AdjustmentsForRevaluationOfOtherReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" id="imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateGrossProceedsOfSubscriptionReceipts" id="imc_AggregateGrossProceedsOfSubscriptionReceipts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregatePurchasePriceOfBusinessAcquisition" id="imc_AggregatePurchasePriceOfBusinessAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AgreementAxis" id="imc_AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="AgreementDomain" id="imc_AgreementDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AgreementWithFarmerMember" id="imc_AgreementWithFarmerMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AllocatedPercentageOfShareCapital" id="imc_AllocatedPercentageOfShareCapital" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountDepositedInEscrow" id="imc_AmountDepositedInEscrow" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfClassActionGroupIncurredDamages" id="imc_AmountOfClassActionGroupIncurredDamages" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfExpensesPaidByApplicant" id="imc_AmountOfExpensesPaidByApplicant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfNonCancellablePurchasePrice" id="imc_AmountOfNonCancellablePurchasePrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfPersonalSuit" id="imc_AmountOfPersonalSuit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfPurchaseOfTreasuryCommonShares" id="imc_AmountOfPurchaseOfTreasuryCommonShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfSettlementOfWithholdingTaxLiabilities" id="imc_AmountOfSettlementOfWithholdingTaxLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfSharesGranted" id="imc_AmountOfSharesGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfTranslationTransaction" id="imc_AmountOfTranslationTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfVotingEquityInterestsAcquired" id="imc_AmountOfVotingEquityInterestsAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfWarrantTransferredInEquityDuringPeriod" id="imc_AmountOfWarrantTransferredInEquityDuringPeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountToBeDeliveredOverTermOfSalesAgreements" id="imc_AmountToBeDeliveredOverTermOfSalesAgreements" type="dtr-types:massItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountToReleaseSecurityProvidedForBankLoanAndBankCredit" id="imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ApproximatelyCashAndCashEquivalents" id="imc_ApproximatelyCashAndCashEquivalents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AreaOfCultivationAndProcessing" id="imc_AreaOfCultivationAndProcessing" type="dtr-types:areaItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ArrangementAgreementMember" id="imc_ArrangementAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AssetsLocationMember" id="imc_AssetsLocationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AttritionRate" id="imc_AttritionRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AutomaticExtensionPeriodOfAgreement" id="imc_AutomaticExtensionPeriodOfAgreement" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AveragePostHarvestCostsPerGramOfDriedCannabis" id="imc_AveragePostHarvestCostsPerGramOfDriedCannabis" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageSellingPricePerGramOfDriedCannabis" id="imc_AverageSellingPricePerGramOfDriedCannabis" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageStageOfGrowth" id="imc_AverageStageOfGrowth" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageYieldPerPlant" id="imc_AverageYieldPerPlant" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankCreditRecognisedAsOfAcquisitionDate" id="imc_BankCreditRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BankLoanAndLeaseLiabilities" id="imc_BankLoanAndLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BaseShelfProspectusMember" id="imc_BaseShelfProspectusMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasicDilutedEarningsLossPerShare" id="imc_BasicDilutedEarningsLossPerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiologicalAssetsRecognisedAsOfAcquisitionDate" id="imc_BiologicalAssetsRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BorrowingRecognisedAsOfAcquisitionDate" id="imc_BorrowingRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BulkCannabisMember" id="imc_BulkCannabisMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CannabisPlantsMember" id="imc_CannabisPlantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CannacanadaIncMember" id="imc_CannacanadaIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CapitalExpenditures" id="imc_CapitalExpenditures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CapitalizedCostsOfInventories" id="imc_CapitalizedCostsOfInventories" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CarryforwardLossesForTaxPurposesDescription" id="imc_CarryforwardLossesForTaxPurposesDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CarryforwardOperatingTaxLosses" id="imc_CarryforwardOperatingTaxLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashAndCashEquivalentMember" id="imc_CashAndCashEquivalentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CashConsiderationOfBusinessCombination" id="imc_CashConsiderationOfBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ChangeInRestrictedBankDeposits" id="imc_ChangeInRestrictedBankDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ChangeInTaxBenefitsNotRecognized" id="imc_ChangeInTaxBenefitsNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ChangesInNonCashWorkingCapitalAbstract" id="imc_ChangesInNonCashWorkingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassesOfInventoriesAxis" id="imc_ClassesOfInventoriesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ClassesOfInventoriesDomain" id="imc_ClassesOfInventoriesDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Commitment" id="imc_Commitment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CompensationOptionPricePerShare" id="imc_CompensationOptionPricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CompensationOptions2019Member" id="imc_CompensationOptions2019Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CompensationUnitPerShare" id="imc_CompensationUnitPerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CompensationUnitsMember" id="imc_CompensationUnitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConversionOfWarrantAndCompensationOptionsIntoCommonShares" id="imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConversionPricePerWarrant" id="imc_ConversionPricePerWarrant" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CostOfGoodsSoldInventory" id="imc_CostOfGoodsSoldInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CultivationsAndProcessingLicenseMember" id="imc_CultivationsAndProcessingLicenseMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerOneMember" id="imc_CustomerOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerRelationshipsMember" id="imc_CustomerRelationshipsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerThreeMember" id="imc_CustomerThreeMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerTwoMember" id="imc_CustomerTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeemedIssuance" id="imc_DeemedIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeemedPricePerShare" id="imc_DeemedPricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxAssetsAbstract" id="imc_DeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxAssetsAndLiabilitiesAxis" id="imc_DeferredTaxAssetsAndLiabilitiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="DeferredTaxAssetsAndLiabilitiesDomain" id="imc_DeferredTaxAssetsAndLiabilitiesDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxAssetsMember" id="imc_DeferredTaxAssetsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxLiabilitiesMember" id="imc_DeferredTaxLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DerivativeAssetsAsOfAcquisitionDate" id="imc_DerivativeAssetsAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory" id="imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory" id="imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory" id="imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock" id="imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForShortTermDepositsExplanatory" id="imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover" id="imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfExpectedDividendYieldOptionsGranted" id="imc_DescriptionOfExpectedDividendYieldOptionsGranted" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfOtherConvertibleSecritiesConversion" id="imc_DescriptionOfOtherConvertibleSecritiesConversion" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" id="imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfSharesAndWarrantsExchangedForPostConsolidation" id="imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureForSignificantAccountingPoliciesAbstract" id="imc_DisclosureForSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfBalancesWithRelatedPartiesExplanatory" id="imc_DisclosureOfBalancesWithRelatedPartiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory" id="imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCompositionOfShareCapitalExplanatory" id="imc_DisclosureOfCompositionOfShareCapitalExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems" id="imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable" id="imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory" id="imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory" id="imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" id="imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory" id="imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory" id="imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" id="imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory" id="imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory" id="imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory" id="imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInventoriesExplanatory" id="imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory" id="imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory" id="imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory" id="imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory" id="imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract" id="imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory" id="imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" id="imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory" id="imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGeneralInformationAboutFinancialStatementsAbstract" id="imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGeographicAllocationOfAssetsExplanatory" id="imc_DisclosureOfGeographicAllocationOfAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGeographicAllocationOfRevenuesExplanatory" id="imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" id="imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory" id="imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherAccountsReceivableAbstract" id="imc_DisclosureOfOtherAccountsReceivableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherAccountsReceivablesExplanatory" id="imc_DisclosureOfOtherAccountsReceivablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory" id="imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfRestrictedShareUnitsTableTextBlock" id="imc_DisclosureOfRestrictedShareUnitsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfReverseTakeoverExplanatory" id="imc_DisclosureOfReverseTakeoverExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfReverseTakeoverLineItems" id="imc_DisclosureOfReverseTakeoverLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfReverseTakeoverTable" id="imc_DisclosureOfReverseTakeoverTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfRightOfUseAssetsExplanatory" id="imc_DisclosureOfRightOfUseAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfRightOfUseAssetsExplanatoryExplanatory" id="imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory" id="imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory" id="imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfStatementOfProfitAndLossExplanatory" id="imc_DisclosureOfStatementOfProfitAndLossExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory" id="imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" id="imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfTradeReceivablesExplanatory" id="imc_DisclosureOfTradeReceivablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisposalOfTerminationOfLeases" id="imc_DisposalOfTerminationOfLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DisposalsOfRightOfUseAssets" id="imc_DisposalsOfRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DocumentAndEntityAbstract" id="imc_DocumentAndEntityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DocumentAndEntityInformationAbstract" id="imc_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeeBenefitAssetsAndLiabilitiesAbstract" id="imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesAndPayrollAccruals" id="imc_EmployeesAndPayrollAccruals" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EmployeesDirectorsAndAdvisorsMember" id="imc_EmployeesDirectorsAndAdvisorsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityIssuancePricePerShare" id="imc_EquityIssuancePricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityTransactionAxis" id="imc_EquityTransactionAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="EquityTransactionDomain" id="imc_EquityTransactionDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedTotalAmountOfClassActionSuit" id="imc_EstimatedTotalAmountOfClassActionSuit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExercisePriceOfWarrant" id="imc_ExercisePriceOfWarrant" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedDividendYieldOfWarrants" id="imc_ExpectedDividendYieldOfWarrants" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedLifeOfWarrants" id="imc_ExpectedLifeOfWarrants" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedVolatilityOfWarrants" id="imc_ExpectedVolatilityOfWarrants" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExternalCustomersRevenues" id="imc_ExternalCustomersRevenues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" id="imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueAdjustmentOnSaleOfInventory" id="imc_FairValueAdjustmentOnSaleOfInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueAdjustmentOnWarrantsMeasuredAtFairValue" id="imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueAdjustmentsAbstract" id="imc_FairValueAdjustmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueOfCompensationUnits" id="imc_FairValueOfCompensationUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfInvestment" id="imc_FairValueOfInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueOfUnitsIssued" id="imc_FairValueOfUnitsIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfWarrants" id="imc_FairValueOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValuePerWarrant" id="imc_FairValuePerWarrant" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialAdvisorsMember" id="imc_FinancialAdvisorsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialInstrumentsAtAmortizedCostMember" id="imc_FinancialInstrumentsAtAmortizedCostMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialInstrumentsAtFairValueThroughProfitOrLossMember" id="imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinishedGoodsMember" id="imc_FinishedGoodsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FirstAnniversaryOfApplicableVestingCommencementDateMember" id="imc_FirstAnniversaryOfApplicableVestingCommencementDateMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FirstInstallmentMember" id="imc_FirstInstallmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FixedGrowthRate" id="imc_FixedGrowthRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FocusMedicalHerbsLtdMember" id="imc_FocusMedicalHerbsLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignCountriesTwoMember" id="imc_ForeignCountriesTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GainLossOnRevaluationOfFinancialInstruments" id="imc_GainLossOnRevaluationOfFinancialInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GalenIndustriesSingleMemberSocieteAnonymeMember" id="imc_GalenIndustriesSingleMemberSocieteAnonymeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GoodwillAndIntangibleAssetsAsOfAcquisitionDate" id="imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GreenhouseProductionEquipmentMember" id="imc_GreenhouseProductionEquipmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GreenhouseStructureMember" id="imc_GreenhouseStructureMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrossProceedsFromIssuanceOfUnits" id="imc_GrossProceedsFromIssuanceOfUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GrossProfitBeforeFairValueAdjustments" id="imc_GrossProfitBeforeFairValueAdjustments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="HighlandGrowIncMember" id="imc_HighlandGrowIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HighWayShinuaLtdMember" id="imc_HighWayShinuaLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IdentifiableAssetsRecognisedAsOfAcquisitionDate" id="imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" id="imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ImcHoldingsLtdMember" id="imc_ImcHoldingsLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IMCOrdinaryShareholderMember" id="imc_IMCOrdinaryShareholderMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" id="imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" id="imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxFromPreviousYears" id="imc_IncomeTaxFromPreviousYears" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxLiabilityOfKeyPersonnel" id="imc_IncomeTaxLiabilityOfKeyPersonnel" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16" id="imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" id="imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" id="imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughForfeitedOptions" id="imc_IncreaseDecreaseThroughForfeitedOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment" id="imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" id="imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" id="imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary" id="imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" id="imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseThroughInitialConsolidationsArisingFromFinancingActivities" id="imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" id="imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InitialCapitalExpenditures" id="imc_InitialCapitalExpenditures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InitialConsolidationsRightOfUseAssets" id="imc_InitialConsolidationsRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InitialTermOfAgreement" id="imc_InitialTermOfAgreement" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IntangibleAssetsMember" id="imc_IntangibleAssetsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestIncomeOnPlanAssets" id="imc_InterestIncomeOnPlanAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InterestPaidInRespectOfLoans" id="imc_InterestPaidInRespectOfLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InterSegmentRevenues" id="imc_InterSegmentRevenues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InventoriesLineItems" id="imc_InventoriesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InventoriesTable" id="imc_InventoriesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" id="imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate" id="imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentsAsOfAcquisitionDate" id="imc_InvestmentsAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InvestmentsInUnlistedSharesMeasuredAtFairValue" id="imc_InvestmentsInUnlistedSharesMeasuredAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IPointMPointCFarmsIsraelLtdPointMember" id="imc_IPointMPointCFarmsIsraelLtdPointMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" id="imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IPointMPointCPointHoldingsLtdMember" id="imc_IPointMPointCPointHoldingsLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IPointMPointCVenturesLtdPointMember" id="imc_IPointMPointCVenturesLtdPointMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IsraelAndGermanyAndCanadaMember" id="imc_IsraelAndGermanyAndCanadaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IsraelMember" id="imc_IsraelMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfCommonShares" id="imc_IssuanceOfCommonShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfCommonSharesAmount" id="imc_IssuanceOfCommonSharesAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfEquityOnReverseAcquisition" id="imc_IssuanceOfEquityOnReverseAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IssuanceOfSharesInConnectionWithReverseAcquisition" id="imc_IssuanceOfSharesInConnectionWithReverseAcquisition" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesWithPrivatePlacement" id="imc_IssuanceOfSharesWithPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssueOfEquity1" id="imc_IssueOfEquity1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IssueOfEquity2" id="imc_IssueOfEquity2" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IssuePricePerSubscriptionReceipt" id="imc_IssuePricePerSubscriptionReceipt" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KeyManagementPersonnelCompensationPayrollAndRelatedExpenses" id="imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LeaseLiabilityAsOfAcquisitionDate" id="imc_LeaseLiabilityAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LicensesWithIndefiniteLifeMember" id="imc_LicensesWithIndefiniteLifeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ListedWarrantsMember" id="imc_ListedWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ListingBeforeCost" id="imc_ListingBeforeCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ListingCostOfReverseAcquisition" id="imc_ListingCostOfReverseAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ListingExpenseInReverseTakeover" id="imc_ListingExpenseInReverseTakeover" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LoanReceivableRecognisedAsOfAcquisitionDate" id="imc_LoanReceivableRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LoansPayableAsOfAcquisitionDate" id="imc_LoansPayableAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LongTermBorrowingsAsOfAcquisitionDate" id="imc_LongTermBorrowingsAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MajorComponentsOfIncomeTaxExpenseLineItems" id="imc_MajorComponentsOfIncomeTaxExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MajorComponentsOfIncomeTaxExpenseTable" id="imc_MajorComponentsOfIncomeTaxExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="MarketPriceOfCommonShares" id="imc_MarketPriceOfCommonShares" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MedipharmLabsCorpMember" id="imc_MedipharmLabsCorpMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MizrahiMember" id="imc_MizrahiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MymInternationalBrandsIncMember" id="imc_MymInternationalBrandsIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MymNutraceuticalsIncMember" id="imc_MymNutraceuticalsIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MymNutraceuticalsMember" id="imc_MymNutraceuticalsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NavasotaFincoMember" id="imc_NavasotaFincoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NavasotaMember" id="imc_NavasotaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NavasotaShareholdersMember" id="imc_NavasotaShareholdersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetCashTransferred" id="imc_NetCashTransferred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NetIdentifiableAssetsAcquiredLiabilitiesAssumed" id="imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NetLiabilitiesOnDateOfReverseAcquisition" id="imc_NetLiabilitiesOnDateOfReverseAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NonCashExpenseRelatedToChangesInFairValueOfInventorySold" id="imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonDeductibleIncomeExpenseNetForTaxPurposes" id="imc_NonDeductibleIncomeExpenseNetForTaxPurposes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NumberOfCommonSharesCalledByWarrants" id="imc_NumberOfCommonSharesCalledByWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCommonSharesComprisedToCoverTaxLiabilities" id="imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCommonSharesIssuedForEachShareOfAcquiree" id="imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism" id="imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCommonSharesReceived" id="imc_NumberOfCommonSharesReceived" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCommonSharesReceivedOfConvertibleInstrument" id="imc_NumberOfCommonSharesReceivedOfConvertibleInstrument" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCompensationUnitsConvertedToOrdinaryShares" id="imc_NumberOfCompensationUnitsConvertedToOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCompensationUnitsIssued" id="imc_NumberOfCompensationUnitsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCompensationWarrantsGrantedToAgents" id="imc_NumberOfCompensationWarrantsGrantedToAgents" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfCompensationWarrantsToAcquired" id="imc_NumberOfCompensationWarrantsToAcquired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOptionsExercisedUnderCashlessMechanism" id="imc_NumberOfOptionsExercisedUnderCashlessMechanism" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOptionsGranted" id="imc_NumberOfOptionsGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesIssuedUponConversion" id="imc_NumberOfOrdinarySharesIssuedUponConversion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfPreferredSharesCommittedToBeAcquired" id="imc_NumberOfPreferredSharesCommittedToBeAcquired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfShareOptionsShareVestedRsu" id="imc_NumberOfShareOptionsShareVestedRsu" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesAvailableForFutureGrants" id="imc_NumberOfSharesAvailableForFutureGrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedInBusinessCombinationTransaction" id="imc_NumberOfSharesIssuedInBusinessCombinationTransaction" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedInReverseTakeover" id="imc_NumberOfSharesIssuedInReverseTakeover" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesRaisedInUSD" id="imc_NumberOfSharesRaisedInUSD" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSubscriptionReceiptsIssuedInPrivatePlacement" id="imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfUnitsIssued" id="imc_NumberOfUnitsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfUnitsIssuedPricePerShare" id="imc_NumberOfUnitsIssuedPricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantExercised" id="imc_NumberOfWarrantExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsAndCompensationOptionsExercised" id="imc_NumberOfWarrantsAndCompensationOptionsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsConvertedToOrdinaryShares" id="imc_NumberOfWarrantsConvertedToOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsIssuedInReverseTakeover" id="imc_NumberOfWarrantsIssuedInReverseTakeover" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsIssuedUponConversion" id="imc_NumberOfWarrantsIssuedUponConversion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsIssuedUponConversionOfUnits" id="imc_NumberOfWarrantsIssuedUponConversionOfUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OranimPharmacyMember" id="imc_OranimPharmacyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OranimPharmMember" id="imc_OranimPharmMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OranimPlusPharmLtdMember" id="imc_OranimPlusPharmLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharedListedInStockExchangeMarket" id="imc_OrdinarySharedListedInStockExchangeMarket" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld" id="imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" id="imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesIssuedOptionsExercises" id="imc_OrdinarySharesIssuedOptionsExercises" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesIssuedToShareholdersForEachCommonShare" id="imc_OrdinarySharesIssuedToShareholdersForEachCommonShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesReservedForIssuance" id="imc_OrdinarySharesReservedForIssuance" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCannabisMember" id="imc_OtherCannabisMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCannabisProductsMember" id="imc_OtherCannabisProductsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" id="imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OtherCurrentPayablesToGovernmentAuthorities" id="imc_OtherCurrentPayablesToGovernmentAuthorities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OtherDeferredTaxAssestsMember" id="imc_OtherDeferredTaxAssestsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherMiscellaneousCurrentPayables" id="imc_OtherMiscellaneousCurrentPayables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OtherOperatingSegmentsMember" id="imc_OtherOperatingSegmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherPayablesRecognisedAsOfAcquisitionDate" id="imc_OtherPayablesRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OvernightMarketedOfferingMember" id="imc_OvernightMarketedOfferingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PackagedDriedCannabisMember" id="imc_PackagedDriedCannabisMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PanaxiaLogisticsLtdMember" id="imc_PanaxiaLogisticsLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentsToShareholdersRelatedPartyTransactions" id="imc_PaymentsToShareholdersRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PercentageOfAcquisition" id="imc_PercentageOfAcquisition" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfAcquisitionOfOutstandingOrdinaryShares" id="imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfAwardsVest" id="imc_PercentageOfAwardsVest" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfIncomeTaxLiabilityOfKeyPersonnel" id="imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOptionsExercised" id="imc_PercentageOfOptionsExercised" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOrdinarySharesHeld" id="imc_PercentageOfOrdinarySharesHeld" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired" id="imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOutstandingSharesAcquired" id="imc_PercentageOfOutstandingSharesAcquired" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOwnershipInterest" id="imc_PercentageOfOwnershipInterest" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfRestrictedSharesGranted" id="imc_PercentageOfRestrictedSharesGranted" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne" id="imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero" id="imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfRightsHold" id="imc_PercentageOfRightsHold" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfSharesGranted" id="imc_PercentageOfSharesGranted" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfWarrantsAndCompensationOptionsExercised" id="imc_PercentageOfWarrantsAndCompensationOptionsExercised" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfWarrantsExercised" id="imc_PercentageOfWarrantsExercised" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfWithholdingTaxLiabilities" id="imc_PercentageOfWithholdingTaxLiabilities" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest" id="imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageRightToPurchaseOfTotalProduction" id="imc_PercentageRightToPurchaseOfTotalProduction" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentagesOfWarrantQuantityHeld" id="imc_PercentagesOfWarrantQuantityHeld" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PeriodicPaymentInstallmentAxis" id="imc_PeriodicPaymentInstallmentAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="PeriodicPaymentInstallmentDomain" id="imc_PeriodicPaymentInstallmentDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PharmYarokPharmacyMember" id="imc_PharmYarokPharmacyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PlanAssetsAmountsDeposited" id="imc_PlanAssetsAmountsDeposited" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PlanAssetsForeignCurrencyTranslationEffect" id="imc_PlanAssetsForeignCurrencyTranslationEffect" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PreliminaryShelfProspectusMember" id="imc_PreliminaryShelfProspectusMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreTaxDiscountRateOfCashFlows" id="imc_PreTaxDiscountRateOfCashFlows" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivatePlacementsMember" id="imc_PrivatePlacementsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsFromExerciseOfWarrantsAndCompensationOptions" id="imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromInvestmentInRestrictedDeposits" id="imc_ProceedsFromInvestmentInRestrictedDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" id="imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromSaleOfInvestment" id="imc_ProceedsFromSaleOfInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromWarrantsAndCompensationOptionsExercised" id="imc_ProceedsFromWarrantsAndCompensationOptionsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductionCostsCapitalizedBiologicalAssets" id="imc_ProductionCostsCapitalizedBiologicalAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings" id="imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ProFormaAdjustmentsMember" id="imc_ProFormaAdjustmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PropertyPlantAndEquipmentAndIntangibleAssetsAbstract" id="imc_PropertyPlantAndEquipmentAndIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" id="imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PropertyPlantAndEquipmentUsingShares" id="imc_PropertyPlantAndEquipmentUsingShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PurchaseConsiderationPayable" id="imc_PurchaseConsiderationPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PurchaseOfInterestsInSubsidiary" id="imc_PurchaseOfInterestsInSubsidiary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PurchaseOfTreasuryCommonShares" id="imc_PurchaseOfTreasuryCommonShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PurchasePriceOfBusinessAcquisitionInCommonShares" id="imc_PurchasePriceOfBusinessAcquisitionInCommonShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RayarokPharmLtdMember" id="imc_RayarokPharmLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RealizedFairValueAdjustmentOnInventorySold" id="imc_RealizedFairValueAdjustmentOnInventorySold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReceivablesFromGovernmentAuthorities" id="imc_ReceivablesFromGovernmentAuthorities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReductionOfSharePremiumCostAllocatedToOrdinaryShares" id="imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RemainingAmountOfCashPaid" id="imc_RemainingAmountOfCashPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RemainingInstallmentMember" id="imc_RemainingInstallmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RepaymentOfAforementionedBankLoan" id="imc_RepaymentOfAforementionedBankLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RestrictedShareUnitsMember" id="imc_RestrictedShareUnitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReturnNetOfInterestIncomeReMeasurementGainLoss" id="imc_ReturnNetOfInterestIncomeReMeasurementGainLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RevaluationOfExercisedWarrants" id="imc_RevaluationOfExercisedWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReverseAcquisitionAcquirerAxis" id="imc_ReverseAcquisitionAcquirerAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="ReverseAcquisitionAcquirerDomain" id="imc_ReverseAcquisitionAcquirerDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReverseTakeoverAbstract" id="imc_ReverseTakeoverAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RevolvingCreditFacilityMember" id="imc_RevolvingCreditFacilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RevolyTradingAndMarketingLtdMember" id="imc_RevolyTradingAndMarketingLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RightOfUseAssetRecognizedWithCorrespondingLeaseLiability" id="imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RightOfUseAssetsAsOfAcquisitionDate" id="imc_RightOfUseAssetsAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RiskFreeInterestRateOfWarrants" id="imc_RiskFreeInterestRateOfWarrants" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RosenHighWayLtdMember" id="imc_RosenHighWayLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensation" id="imc_ShareBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareBasedCompensations" id="imc_ShareBasedCompensations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareholdersMember" id="imc_ShareholdersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareIncentivePlanMember" id="imc_ShareIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePurchaseAgreementMember" id="imc_SharePurchaseAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareSplitRatio" id="imc_ShareSplitRatio" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract" id="imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsAbstract" id="imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SimpleAgreementForFutureEquityMember" id="imc_SimpleAgreementForFutureEquityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StatementOfBalanceSheetLocationAxis" id="imc_StatementOfBalanceSheetLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="StatementOfBalanceSheetLocationDomain" id="imc_StatementOfBalanceSheetLocationDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SublimecultureIncMember" id="imc_SublimecultureIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubscriptionReceiptsHoldersMember" id="imc_SubscriptionReceiptsHoldersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsequentEventMember" id="imc_SubsequentEventMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract" id="imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract" id="imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplementalDisclosureOfNonCashActivitiesAbstract" id="imc_SupplementalDisclosureOfNonCashActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplyAgreementMember" id="imc_SupplyAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" id="imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TaxEffectOfDifferentTaxRateOfSubsidiaries" id="imc_TaxEffectOfDifferentTaxRateOfSubsidiaries" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" id="imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" id="imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TermOfNonInterestBearingTradeReceivables" id="imc_TermOfNonInterestBearingTradeReceivables" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TermOfWarrantsFromDateOfIssuance" id="imc_TermOfWarrantsFromDateOfIssuance" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThresholdLimitOfOfferingPriceOfSecurities" id="imc_ThresholdLimitOfOfferingPriceOfSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TotalAcquisitionSubsidiary" id="imc_TotalAcquisitionSubsidiary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TotalAllocatedAmountTranslationTransaction" id="imc_TotalAllocatedAmountTranslationTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" id="imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TradeReceivablesLineItems" id="imc_TradeReceivablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TradeReceivablesTable" id="imc_TradeReceivablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="TranslationDifferencesOfDefferedTaxes" id="imc_TranslationDifferencesOfDefferedTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TrichomeAssetFundingCorpMember" id="imc_TrichomeAssetFundingCorpMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrichomeFinancialCannabisGpIncMember" id="imc_TrichomeFinancialCannabisGpIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrichomeFinancialCannabisManagerIncMember" id="imc_TrichomeFinancialCannabisManagerIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrichomeFinancialCorpMember" id="imc_TrichomeFinancialCorpMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrichomeJwcAcquisitionCorpMember" id="imc_TrichomeJwcAcquisitionCorpMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrichomeRetailCorpMember" id="imc_TrichomeRetailCorpMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrichomeSecurityholdersMember" id="imc_TrichomeSecurityholdersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TypeOfCannabisAxis" id="imc_TypeOfCannabisAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="TypeOfCannabisDomain" id="imc_TypeOfCannabisDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnobservableInputAxis" id="imc_UnobservableInputAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="UnobservableInputDomain" id="imc_UnobservableInputDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UtilizationOfLossesNotPreviouslyRecognized" id="imc_UtilizationOfLossesNotPreviouslyRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants" id="imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ValueOfWarrantsConvertedToOrdinaryShares" id="imc_ValueOfWarrantsConvertedToOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember" id="imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VestingAxis" id="imc_VestingAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="VestingDomain" id="imc_VestingDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VestingPercentageOfShareBasedArrangement" id="imc_VestingPercentageOfShareBasedArrangement" type="num:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VironnaPharmacyMember" id="imc_VironnaPharmacyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Warrant2021Member" id="imc_Warrant2021Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantPricePerShare" id="imc_WarrantPricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Warrants2018Member" id="imc_Warrants2018Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Warrants2019Member" id="imc_Warrants2019Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsAndCompensationOptions2019Member" id="imc_WarrantsAndCompensationOptions2019Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsAndCompensationOptionsMember" id="imc_WarrantsAndCompensationOptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsMeasuredAtFairValue" id="imc_WarrantsMeasuredAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WarrantsMember" id="imc_WarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageFairValueLessCostToSellOfBiologicalAssets" id="imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedTaxRateComposedOfFederalAndMunicipalTax" id="imc_WeightedTaxRateComposedOfFederalAndMunicipalTax" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WholesalesAndPharmaciesMember" id="imc_WholesalesAndPharmaciesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WhollyOwnedSubsidiaryOfNavasotaFincoMember" id="imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WithholdingTaxLiabilities" id="imc_WithholdingTaxLiabilities" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WorkingCapital" id="imc_WorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="WorkingCapitalOfBusinessAcquisition" id="imc_WorkingCapitalOfBusinessAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WorkInProgressMember" id="imc_WorkInProgressMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WriteDownsOfInventoriesRecognizedCostOfSales" id="imc_WriteDownsOfInventoriesRecognizedCostOfSales" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="XintezaApiLtdMember" id="imc_XintezaApiLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>imc-20211231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDetails" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDetails1" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetails" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetails3" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails3"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OTHERPAYABLESDetails" roleURI="http://www.imcannabis.com/role/OTHERPAYABLESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OTHERACCOUNTSRECEIVABLEDetails" roleURI="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIESDetails" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BiologicalAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoanReceivableRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DerivativeAssetsAsOfAcquisitionDate" xlink:label="loc_imc_DerivativeAssetsAsOfAcquisitionDate_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAsOfAcquisitionDate_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankCreditRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_20"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0" xlink:to="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_imc_DerivativeAssetsAsOfAcquisitionDate_9" order="80" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_10" order="90" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_imc_InvestmentsAsOfAcquisitionDate_11" order="100" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xlink:to="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_12" order="110" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0" xlink:to="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14" xlink:to="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_16" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14" xlink:to="loc_imc_LeaseLiabilityAsOfAcquisitionDate_17" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14" xlink:to="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_18" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14" xlink:to="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_19" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_14" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_20" order="60" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetCashTransferred" xlink:label="loc_imc_NetCashTransferred_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_NetCashTransferred_0" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_NetCashTransferred_0" xlink:to="loc_ifrs-full_CashTransferred_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_3" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetails3">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonDeductibleIncomeExpenseNetForTaxPurposes" xlink:label="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" xlink:label="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfDifferentTaxRateOfSubsidiaries" xlink:label="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" xlink:label="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UtilizationOfLossesNotPreviouslyRecognized" xlink:label="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInTaxBenefitsNotRecognized" xlink:label="loc_imc_ChangeInTaxBenefitsNotRecognized_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" xlink:label="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_9"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_imc_ChangeInTaxBenefitsNotRecognized_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_9" order="80" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LoansAndReceivables" xlink:label="loc_ifrs-full_LoansAndReceivables_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAdvancesToSuppliers" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMeasuredAtFairValue" xlink:label="loc_imc_WarrantsMeasuredAtFairValue_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-full_ShorttermBorrowings_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_39"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_CurrentAssets_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CashAndCashEquivalents_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_Inventories_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentTradeReceivables_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentInvestments_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_LoansAndReceivables_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentAdvancesToSuppliers_9" order="80" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_NoncurrentAssets_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_11" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_11" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_11" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_12" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_11" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_13" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_11" xlink:to="loc_ifrs-full_RightofuseAssets_14" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_11" xlink:to="loc_ifrs-full_Goodwill_15" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_11" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_16" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_11" xlink:to="loc_ifrs-full_DeferredTaxAssets_17" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_19" xlink:to="loc_ifrs-full_Liabilities_20" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_20" xlink:to="loc_ifrs-full_NoncurrentLiabilities_20" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_20" xlink:to="loc_imc_WarrantsMeasuredAtFairValue_20" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_20" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_21" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_20" xlink:to="loc_ifrs-full_LongtermBorrowings_22" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_20" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_23" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_20" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_24" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_20" xlink:to="loc_ifrs-full_CurrentLiabilities_26" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_26" xlink:to="loc_ifrs-full_OtherCurrentPayables_26" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_26" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_27" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_26" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_28" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_26" xlink:to="loc_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_29" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_26" xlink:to="loc_ifrs-full_ShorttermBorrowings_30" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_19" xlink:to="loc_ifrs-full_Equity_33" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_33" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_33" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_33" xlink:to="loc_ifrs-full_ReserveOfSharebasedPayments_33" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_33" xlink:to="loc_ifrs-full_TreasuryShares_34" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_33" xlink:to="loc_ifrs-full_RetainedEarnings_35" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_33" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_36" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_33" xlink:to="loc_ifrs-full_IssuedCapital_37" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_33" xlink:to="loc_ifrs-full_NoncontrollingInterests_39" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RealizedFairValueAdjustmentOnInventorySold" xlink:label="loc_imc_RealizedFairValueAdjustmentOnInventorySold_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProfitBeforeFairValueAdjustments" xlink:label="loc_imc_GrossProfitBeforeFairValueAdjustments_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_20"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_1" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1" xlink:to="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_1" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_4" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_4" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_4" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_ProfitLoss_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_7" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_7" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_7" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_8" xlink:to="loc_ifrs-full_FinanceIncomeCost_8" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_8" xlink:to="loc_ifrs-full_FinanceIncome_8" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_8" xlink:to="loc_ifrs-full_FinanceCosts_9" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_8" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_11" xlink:to="loc_ifrs-full_OperatingExpense_11" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_11" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_11" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_11" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_12" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_11" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_13" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_11" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_14" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_11" xlink:to="loc_ifrs-full_GrossProfit_16" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_16" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_16" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_16" xlink:to="loc_imc_RealizedFairValueAdjustmentOnInventorySold_16" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_16" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_17" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_16" xlink:to="loc_imc_GrossProfitBeforeFairValueAdjustments_19" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_GrossProfitBeforeFairValueAdjustments_19" xlink:to="loc_ifrs-full_CostOfSales_19" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_GrossProfitBeforeFairValueAdjustments_19" xlink:to="loc_ifrs-full_Revenue_20" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OTHERPAYABLESDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesAndPayrollAccruals" xlink:label="loc_imc_EmployeesAndPayrollAccruals_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCurrentPayablesToGovernmentAuthorities" xlink:label="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-full_CurrentDepositsFromCustomers_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherMiscellaneousCurrentPayables" xlink:label="loc_imc_OtherMiscellaneousCurrentPayables_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_imc_EmployeesAndPayrollAccruals_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_ifrs-full_CurrentDepositsFromCustomers_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentPayables_0" xlink:to="loc_imc_OtherMiscellaneousCurrentPayables_6" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReceivablesFromGovernmentAuthorities" xlink:label="loc_imc_ReceivablesFromGovernmentAuthorities_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_OtherCurrentReceivables_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_imc_ReceivablesFromGovernmentAuthorities_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_5" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForRevaluationOfOtherReceivable" xlink:label="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable" xlink:label="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" xlink:label="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingCostOfReverseAcquisition" xlink:label="loc_imc_ListingCostOfReverseAcquisition_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue" xlink:label="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnSaleOfInventory" xlink:label="loc_imc_FairValueAdjustmentOnSaleOfInventory_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInRestrictedBankDeposits" xlink:label="loc_imc_ChangeInRestrictedBankDeposits_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentProperty" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_32"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromInvestmentInRestrictedDeposits" xlink:label="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" xlink:label="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_36"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions" xlink:label="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_42"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestPaidInRespectOfLoans" xlink:label="loc_imc_InterestPaidInRespectOfLoans_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_46"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAcquisitionSubsidiary" xlink:label="loc_imc_TotalAcquisitionSubsidiary_47"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapital" xlink:label="loc_imc_WorkingCapital_48"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankCreditRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_51"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_53"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_54"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_3" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_4" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_5" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_6" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_1" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_7" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_9" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_ProfitLoss_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_11" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_12" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_13" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_imc_ListingCostOfReverseAcquisition_14" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_15" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_imc_FairValueAdjustmentOnSaleOfInventory_16" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_17" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_18" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_19" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_20" order="90" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_21" order="100" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_22" order="110" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_23" order="120" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_11" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_24" order="130" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" xlink:to="loc_imc_ChangeInRestrictedBankDeposits_27" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" xlink:to="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_28" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_29" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" xlink:to="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_30" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_31" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_32" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" xlink:to="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_33" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_27" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_34" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_36" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_37" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_38" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_39" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_40" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_41" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_42" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_imc_InterestPaidInRespectOfLoans_43" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_36" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_44" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_46" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_TotalAcquisitionSubsidiary_47" xlink:to="loc_imc_WorkingCapital_48" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_TotalAcquisitionSubsidiary_47" xlink:to="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_49" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_TotalAcquisitionSubsidiary_47" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_50" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_TotalAcquisitionSubsidiary_47" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_51" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_TotalAcquisitionSubsidiary_47" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_52" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_TotalAcquisitionSubsidiary_47" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_53" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_imc_TotalAcquisitionSubsidiary_47" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_54" order="60" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:label="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_0" xlink:to="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_0" xlink:to="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_0" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2" order="10" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>imc-20211231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails" roleURI="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDetails" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDetailTextuals" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSTables" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDetails1" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetails1" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetailTextuals" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TRADERECEIVABLESDetails1" roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TRADERECEIVABLESDetails" roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails" roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1" roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2" roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYDetails2" roleURI="http://www.imcannabis.com/role/EQUITYDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYDetailTextuals" roleURI="http://www.imcannabis.com/role/EQUITYDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BIOLOGICALASSETSDetails1" roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RELATEDPARTYBALANCESANDTRANSACTIONSDetails1" roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetails" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetails1" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetails2" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetails3" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetailTextuals" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INVENTORIESDetails" roleURI="http://www.imcannabis.com/role/INVENTORIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails1" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails2" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUBSEQUENTEVENTSDetailTextuals" roleURI="http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#GENERALDetailTextuals" roleURI="http://www.imcannabis.com/role/GENERALDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RIGHTOFUSEASSETSDetails" roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#DocumentAndEntityInformation" roleURI="http://www.imcannabis.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RIGHTOFUSEASSETSDetailTextuals" roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals" roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INTANGIBLEASSETSNETDetailTextuals" roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INTANGIBLEASSETSNETDetails" roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OPERATINGSEGMENTSDetails" roleURI="http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYNumberOfRestrictedShareUnitsRSUDetails" roleURI="http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseProductionEquipmentMember" xlink:label="loc_imc_GreenhouseProductionEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseStructureMember" xlink:label="loc_imc_GreenhouseStructureMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment" xlink:label="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_imc_GreenhouseProductionEquipmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_imc_GreenhouseStructureMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" xlink:to="loc_ifrs-full_CarryingAmountMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_19" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_20" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BiologicalAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoanReceivableRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DerivativeAssetsAsOfAcquisitionDate" xlink:label="loc_imc_DerivativeAssetsAsOfAcquisitionDate_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAsOfAcquisitionDate_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_22"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_26"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_27"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_29"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_35"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmacyMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AssetsAbstract_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_15" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_16" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_17" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_18" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_imc_DerivativeAssetsAsOfAcquisitionDate_19" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_20" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_imc_InvestmentsAsOfAcquisitionDate_21" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_22" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAbstract_11" xlink:to="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_23" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_LiabilitiesAbstract_25" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_25" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_25" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_25" xlink:to="loc_imc_LeaseLiabilityAsOfAcquisitionDate_27" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_25" xlink:to="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_28" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_25" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_29" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesAbstract_25" xlink:to="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_30" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_32" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_33" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_34" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_35" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmMember" xlink:label="loc_imc_OranimPharmMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPlusPharmLtdMember" xlink:label="loc_imc_OranimPlusPharmLtdMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmsCeoMember" xlink:label="loc_imc_AdjupharmsCeoMember_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsequentEventMember" xlink:label="loc_imc_SubsequentEventMember_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesReceivedOfConvertibleInstrument" xlink:label="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_29"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfSettlementOfWithholdingTaxLiabilities" xlink:label="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_30"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities" xlink:label="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_31"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilities" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilities_32"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel" xlink:label="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_33"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_34"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" xlink:label="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_36"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfShareOptionsShareVestedRsu" xlink:label="loc_imc_NumberOfShareOptionsShareVestedRsu_37"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree" xlink:label="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_38"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAcquisition" xlink:label="loc_imc_PercentageOfAcquisition_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_42"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_43"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_44"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfNonCancellablePurchasePrice" xlink:label="loc_imc_AmountOfNonCancellablePurchasePrice_45"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapitalOfBusinessAcquisition" xlink:label="loc_imc_WorkingCapitalOfBusinessAcquisition_46"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_47"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit" xlink:label="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_48"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountDepositedInEscrow" xlink:label="loc_imc_AmountDepositedInEscrow_49"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfSharesGranted" xlink:label="loc_imc_PercentageOfSharesGranted_50"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesGranted" xlink:label="loc_imc_PercentageOfRestrictedSharesGranted_51"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingPercentageOfShareBasedArrangement" xlink:label="loc_imc_VestingPercentageOfShareBasedArrangement_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_53"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_54"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_55"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_56"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPlusPharmLtdMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_12" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_12" xlink:to="loc_imc_AdjupharmsCeoMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_12" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_RangeAxis_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_16" xlink:to="loc_ifrs-full_RangesMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_16" xlink:to="loc_ifrs-full_BottomOfRangeMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_16" xlink:to="loc_ifrs-full_TopOfRangeMember_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_16" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_21" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_21" xlink:to="loc_ifrs-full_NonadjustingEventsMember_21" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_21" xlink:to="loc_imc_SubsequentEventMember_21" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_21" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_27" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_28" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_29" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_30" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_31" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_PercentageOfWithholdingTaxLiabilities_32" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_33" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_34" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_35" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_36" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_NumberOfShareOptionsShareVestedRsu_37" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_38" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_PercentageOfAcquisition_39" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_40" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_41" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_42" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CashTransferred_43" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_CashConsiderationOfBusinessCombination_44" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_AmountOfNonCancellablePurchasePrice_45" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_WorkingCapitalOfBusinessAcquisition_46" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_47" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_48" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_AmountDepositedInEscrow_49" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_PercentageOfSharesGranted_50" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_PercentageOfRestrictedSharesGranted_51" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_VestingPercentageOfShareBasedArrangement_52" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_53" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_54" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_Revenue_55" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_56" order="310" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmacyMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_12" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetCashTransferred" xlink:label="loc_imc_NetCashTransferred_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CashTransferred_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_imc_NetCashTransferred_8" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAndLiabilitiesAxis" xlink:label="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAndLiabilitiesDomain" xlink:label="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsMember" xlink:label="loc_imc_DeferredTaxAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxLiabilitiesMember" xlink:label="loc_imc_DeferredTaxLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAndLiabilitiesDomain" xlink:label="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherDeferredTaxAssestsMember" xlink:label="loc_imc_OtherDeferredTaxAssestsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBiologicalAssetsMember" xlink:label="loc_ifrs-full_CurrentBiologicalAssetsMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IntangibleAssetsMember" xlink:label="loc_imc_IntangibleAssetsMember_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TranslationDifferencesOfDefferedTaxes" xlink:label="loc_imc_TranslationDifferencesOfDefferedTaxes_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1" xlink:to="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1" xlink:to="loc_imc_DeferredTaxAssetsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1" xlink:to="loc_imc_DeferredTaxLiabilitiesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1" xlink:to="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_6" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_6" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_6" xlink:to="loc_imc_OtherDeferredTaxAssestsMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_6" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_11" xlink:to="loc_ifrs-full_FinancialAssetsMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_11" xlink:to="loc_ifrs-full_CurrentBiologicalAssetsMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_11" xlink:to="loc_imc_IntangibleAssetsMember_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_11" xlink:to="loc_ifrs-full_OtherAssetsMember_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_11" xlink:to="loc_ifrs-full_FinancialAssetsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxAssets_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_imc_TranslationDifferencesOfDefferedTaxes_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_21" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_22" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MajorComponentsOfIncomeTaxExpenseLineItems" xlink:label="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MajorComponentsOfIncomeTaxExpenseTable" xlink:label="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="loc_country_IL_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="loc_country_DE_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="loc_country_CA_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardOperatingTaxLosses" xlink:label="loc_imc_CarryforwardOperatingTaxLosses_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardLossesForTaxPurposesDescription" xlink:label="loc_imc_CarryforwardLossesForTaxPurposesDescription_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_0" xlink:to="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1" xlink:to="loc_srt_StatementGeographicalAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5" xlink:to="loc_srt_SegmentGeographicalDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5" xlink:to="loc_country_IL_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5" xlink:to="loc_country_DE_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5" xlink:to="loc_country_CA_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5" xlink:to="loc_srt_SegmentGeographicalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_0" xlink:to="loc_ifrs-full_ApplicableTaxRate_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_0" xlink:to="loc_imc_CarryforwardOperatingTaxLosses_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxAssets_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_0" xlink:to="loc_imc_CarryforwardLossesForTaxPurposesDescription_15" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TRADERECEIVABLESDetails1">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeReceivablesLineItems" xlink:label="loc_imc_TradeReceivablesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeReceivablesTable" xlink:label="loc_imc_TradeReceivablesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerOneMember" xlink:label="loc_imc_CustomerOneMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerTwoMember" xlink:label="loc_imc_CustomerTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerThreeMember" xlink:label="loc_imc_CustomerThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ForeignCountriesTwoMember" xlink:label="loc_imc_ForeignCountriesTwoMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imc_TradeReceivablesLineItems_0" xlink:to="loc_imc_TradeReceivablesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_TradeReceivablesTable_1" xlink:to="loc_ifrs-full_MajorCustomersAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MajorCustomersAxis_1" xlink:to="loc_ifrs-full_MajorCustomersMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_1" xlink:to="loc_imc_CustomerOneMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_1" xlink:to="loc_imc_CustomerTwoMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersMember_1" xlink:to="loc_imc_CustomerThreeMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MajorCustomersAxis_1" xlink:to="loc_ifrs-full_MajorCustomersMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_TradeReceivablesTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_7" xlink:to="loc_ifrs-full_GeographicalAreasMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_7" xlink:to="loc_ifrs-full_CountryOfDomicileMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_7" xlink:to="loc_imc_ForeignCountriesTwoMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_7" xlink:to="loc_ifrs-full_GeographicalAreasMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_TradeReceivablesLineItems_0" xlink:to="loc_ifrs-full_PercentageOfEntitysRevenue_13" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TRADERECEIVABLESDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WholesalesAndPharmaciesMember" xlink:label="loc_imc_WholesalesAndPharmaciesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_imc_WholesalesAndPharmaciesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CurrentTradeReceivables_6" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity1" xlink:label="loc_imc_IssueOfEquity1_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity2" xlink:label="loc_imc_IssueOfEquity2_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPurchaseOfTreasuryCommonShares" xlink:label="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughForfeitedOptions" xlink:label="loc_imc_IncreaseDecreaseThroughForfeitedOptions_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_24"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_TreasurySharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_Equity_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_imc_IssueOfEquity1_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_imc_IssueOfEquity2_15" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_16" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_17" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_18" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_19" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_20" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_imc_IncreaseDecreaseThroughForfeitedOptions_21" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_22" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_23" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_24" order="130" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_imc_FocusMedicalHerbsLtdMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_CurrentAssets_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_NoncurrentAssets_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_CurrentLiabilities_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_NoncurrentLiabilities_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_Equity_10" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_imc_FocusMedicalHerbsLtdMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_Revenue_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_9" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_imc_FocusMedicalHerbsLtdMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_10" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_12" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareIncentivePlanMember" xlink:label="loc_imc_ShareIncentivePlanMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesDirectorsAndAdvisorsMember" xlink:label="loc_imc_EmployeesDirectorsAndAdvisorsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingAxis" xlink:label="loc_imc_VestingAxis_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingDomain" xlink:label="loc_imc_VestingDomain_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstAnniversaryOfApplicableVestingCommencementDateMember" xlink:label="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember" xlink:label="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingDomain" xlink:label="loc_imc_VestingDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2018Member" xlink:label="loc_imc_Warrants2018Member_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2019Member" xlink:label="loc_imc_Warrants2019Member_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptions2019Member" xlink:label="loc_imc_CompensationOptions2019Member_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptions2019Member" xlink:label="loc_imc_WarrantsAndCompensationOptions2019Member_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionAxis" xlink:label="loc_imc_EquityTransactionAxis_26"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_26"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PrivatePlacementsMember" xlink:label="loc_imc_PrivatePlacementsMember_26"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OvernightMarketedOfferingMember" xlink:label="loc_imc_OvernightMarketedOfferingMember_27"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_35"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListedWarrantsMember" xlink:label="loc_imc_ListedWarrantsMember_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" xlink:label="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_42"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_46"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesCalledByWarrants" xlink:label="loc_imc_NumberOfCommonSharesCalledByWarrants_47"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfWarrantsFromDateOfIssuance" xlink:label="loc_imc_TermOfWarrantsFromDateOfIssuance_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WarrantLiability" xlink:label="loc_ifrs-full_WarrantLiability_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_51"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensation" xlink:label="loc_imc_ShareBasedCompensation_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_53"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssued" xlink:label="loc_imc_NumberOfUnitsIssued_54"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesWithPrivatePlacement" xlink:label="loc_imc_IssuanceOfSharesWithPrivatePlacement_55"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssuedPricePerShare" xlink:label="loc_imc_NumberOfUnitsIssuedPricePerShare_56"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProceedsFromIssuanceOfUnits" xlink:label="loc_imc_GrossProceedsFromIssuanceOfUnits_57"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfSharesIssuedInReverseTakeover_58"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions" xlink:label="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_59"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesReservedForIssuance" xlink:label="loc_imc_OrdinarySharesReservedForIssuance_60"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_61"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsExercised" xlink:label="loc_imc_PercentageOfWarrantsExercised_62"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_63"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_64"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_65"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOptionsExercised" xlink:label="loc_imc_PercentageOfOptionsExercised_66"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_67"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_68"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_69"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantExercised" xlink:label="loc_imc_NumberOfWarrantExercised_70"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevaluationOfExercisedWarrants" xlink:label="loc_imc_RevaluationOfExercisedWarrants_71"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_72"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAwardsVest" xlink:label="loc_imc_PercentageOfAwardsVest_73"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesAvailableForFutureGrants" xlink:label="loc_imc_NumberOfSharesAvailableForFutureGrants_74"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_75"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_76"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsIssued" xlink:label="loc_imc_NumberOfCompensationUnitsIssued_77"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitPerShare" xlink:label="loc_imc_CompensationUnitPerShare_78"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfOtherConvertibleSecritiesConversion" xlink:label="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_79"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsToAcquired" xlink:label="loc_imc_NumberOfCompensationWarrantsToAcquired_80"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantPricePerShare" xlink:label="loc_imc_WarrantPricePerShare_81"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptionPricePerShare" xlink:label="loc_imc_CompensationOptionPricePerShare_82"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_imc_ShareIncentivePlanMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_imc_EmployeesDirectorsAndAdvisorsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_9" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_9" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_9" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_imc_VestingAxis_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_VestingAxis_13" xlink:to="loc_imc_VestingDomain_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_VestingDomain_13" xlink:to="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_VestingDomain_13" xlink:to="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_VestingAxis_13" xlink:to="loc_imc_VestingDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_18" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_18" xlink:to="loc_imc_Warrants2018Member_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_18" xlink:to="loc_imc_Warrants2019Member_19" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_18" xlink:to="loc_imc_CompensationOptions2019Member_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_18" xlink:to="loc_imc_WarrantsAndCompensationOptions2019Member_21" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_18" xlink:to="loc_imc_Warrant2021Member_22" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_18" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_imc_EquityTransactionAxis_26" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_EquityTransactionAxis_26" xlink:to="loc_imc_EquityTransactionDomain_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_EquityTransactionDomain_26" xlink:to="loc_imc_PrivatePlacementsMember_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_EquityTransactionDomain_26" xlink:to="loc_imc_OvernightMarketedOfferingMember_27" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_EquityTransactionAxis_26" xlink:to="loc_imc_EquityTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_31" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_31" xlink:to="loc_ifrs-full_NonadjustingEventsMember_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_31" xlink:to="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_31" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_35" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_35" xlink:to="loc_ifrs-full_EquityMember_35" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_35" xlink:to="loc_imc_ListedWarrantsMember_35" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_35" xlink:to="loc_ifrs-full_IssuedCapitalMember_36" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_35" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_41" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_42" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ParValuePerShare_43" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_44" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_45" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_46" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_NumberOfCommonSharesCalledByWarrants_47" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_TermOfWarrantsFromDateOfIssuance_48" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_49" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WarrantLiability_50" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_51" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_ShareBasedCompensation_52" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_53" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_NumberOfUnitsIssued_54" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_IssuanceOfSharesWithPrivatePlacement_55" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_NumberOfUnitsIssuedPricePerShare_56" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_GrossProceedsFromIssuanceOfUnits_57" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_NumberOfSharesIssuedInReverseTakeover_58" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_59" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_OrdinarySharesReservedForIssuance_60" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_61" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_PercentageOfWarrantsExercised_62" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_63" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_64" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_65" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_PercentageOfOptionsExercised_66" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_67" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_68" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_69" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_NumberOfWarrantExercised_70" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_RevaluationOfExercisedWarrants_71" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_72" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_PercentageOfAwardsVest_73" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_NumberOfSharesAvailableForFutureGrants_74" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_75" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_76" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_NumberOfCompensationUnitsIssued_77" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_CompensationUnitPerShare_78" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_79" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_NumberOfCompensationWarrantsToAcquired_80" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_WarrantPricePerShare_81" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_imc_CompensationOptionPricePerShare_82" order="420" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssetsByTypeAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssetsTypeMember" xlink:label="loc_ifrs-full_BiologicalAssetsTypeMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannabisPlantsMember" xlink:label="loc_imc_CannabisPlantsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssetsTypeMember" xlink:label="loc_ifrs-full_BiologicalAssetsTypeMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputAxis" xlink:label="loc_imc_UnobservableInputAxis_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputDomain" xlink:label="loc_imc_UnobservableInputDomain_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" xlink:label="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputDomain" xlink:label="loc_imc_UnobservableInputDomain_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageSellingPricePerGramOfDriedCannabis" xlink:label="loc_imc_AverageSellingPricePerGramOfDriedCannabis_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AveragePostHarvestCostsPerGramOfDriedCannabis" xlink:label="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AttritionRate" xlink:label="loc_imc_AttritionRate_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageYieldPerPlant" xlink:label="loc_imc_AverageYieldPerPlant_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageStageOfGrowth" xlink:label="loc_imc_AverageStageOfGrowth_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" xlink:to="loc_ifrs-full_BiologicalAssetsByTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BiologicalAssetsByTypeAxis_1" xlink:to="loc_ifrs-full_BiologicalAssetsTypeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BiologicalAssetsTypeMember_1" xlink:to="loc_imc_CannabisPlantsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BiologicalAssetsByTypeAxis_1" xlink:to="loc_ifrs-full_BiologicalAssetsTypeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" xlink:to="loc_imc_UnobservableInputAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_UnobservableInputAxis_5" xlink:to="loc_imc_UnobservableInputDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_UnobservableInputDomain_5" xlink:to="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_UnobservableInputAxis_5" xlink:to="loc_imc_UnobservableInputDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xlink:to="loc_imc_AverageSellingPricePerGramOfDriedCannabis_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xlink:to="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xlink:to="loc_imc_AttritionRate_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xlink:to="loc_imc_AverageYieldPerPlant_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xlink:to="loc_imc_AverageStageOfGrowth_14" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_RelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_6" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtAmortizedCostMember" xlink:label="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember" xlink:label="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMeasuredAtFairValue" xlink:label="loc_imc_WarrantsMeasuredAtFairValue_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_7" xlink:to="loc_ifrs-full_CurrentInvestments_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_7" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_7" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_11" xlink:to="loc_imc_WarrantsMeasuredAtFairValue_11" order="0" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedVolatilityOfWarrants" xlink:label="loc_imc_ExpectedVolatilityOfWarrants_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedLifeOfWarrants" xlink:label="loc_imc_ExpectedLifeOfWarrants_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RiskFreeInterestRateOfWarrants" xlink:label="loc_imc_RiskFreeInterestRateOfWarrants_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedDividendYieldOfWarrants" xlink:label="loc_imc_ExpectedDividendYieldOfWarrants_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValuePerWarrant" xlink:label="loc_imc_FairValuePerWarrant_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfWarrants" xlink:label="loc_imc_FairValueOfWarrants_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_imc_Warrant2021Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ExpectedVolatilityOfWarrants_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ExpectedLifeOfWarrants_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_RiskFreeInterestRateOfWarrants_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ExpectedDividendYieldOfWarrants_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_FairValuePerWarrant_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_FairValueOfWarrants_11" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTenYearsMember" xlink:label="loc_ifrs-full_LaterThanTenYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankLoanAndLeaseLiabilities" xlink:label="loc_imc_BankLoanAndLeaseLiabilities_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanTenYearsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_LeaseLiabilities_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_BankLoanAndLeaseLiabilities_11" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMember" xlink:label="loc_imc_WarrantsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16" xlink:label="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_imc_WarrantsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_13" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_14" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_15" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_16" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_17" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_18" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_19" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_20" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_21" order="140" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-full_CurrencyRiskMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_XintezaApiLtdMember" xlink:label="loc_imc_XintezaApiLtdMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentAxis" xlink:label="loc_imc_PeriodicPaymentInstallmentAxis_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentDomain" xlink:label="loc_imc_PeriodicPaymentInstallmentDomain_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstInstallmentMember" xlink:label="loc_imc_FirstInstallmentMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingInstallmentMember" xlink:label="loc_imc_RemainingInstallmentMember_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentDomain" xlink:label="loc_imc_PeriodicPaymentInstallmentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParentMember" xlink:label="loc_ifrs-full_ParentMember_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaShareholdersMember" xlink:label="loc_imc_NavasotaShareholdersMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionAxis" xlink:label="loc_imc_EquityTransactionAxis_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PrivatePlacementsMember" xlink:label="loc_imc_PrivatePlacementsMember_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SharePurchaseAgreementMember" xlink:label="loc_imc_SharePurchaseAgreementMember_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OvernightMarketedOfferingMember" xlink:label="loc_imc_OvernightMarketedOfferingMember_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptionsMember" xlink:label="loc_imc_WarrantsAndCompensationOptionsMember_25"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2018Member" xlink:label="loc_imc_Warrants2018Member_26"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitsMember" xlink:label="loc_imc_CompensationUnitsMember_27"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2019Member" xlink:label="loc_imc_Warrants2019Member_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PreferenceSharesMember" xlink:label="loc_ifrs-full_PreferenceSharesMember_29"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_30"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashAndCashEquivalentMember" xlink:label="loc_imc_CashAndCashEquivalentMember_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_35"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListedWarrantsMember" xlink:label="loc_imc_ListedWarrantsMember_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="loc_currency_EUR_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="loc_currency_ILS_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="loc_currency_USD_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP" xlink:label="loc_currency_GBP_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssued" xlink:label="loc_imc_NumberOfUnitsIssued_48"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssuedPricePerShare" xlink:label="loc_imc_NumberOfUnitsIssuedPricePerShare_49"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProceedsFromIssuanceOfUnits" xlink:label="loc_imc_GrossProceedsFromIssuanceOfUnits_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_51"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfWarrantsFromDateOfIssuance" xlink:label="loc_imc_TermOfWarrantsFromDateOfIssuance_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_53"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_54"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfWarrants" xlink:label="loc_imc_FairValueOfWarrants_55"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfWarrantTransferredInEquityDuringPeriod" xlink:label="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_56"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_57"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsGrantedToAgents" xlink:label="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_58"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_59"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_60"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares" xlink:label="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_61"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_62"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_63"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_64"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_65"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_66"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_67"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GainLossOnRevaluationOfFinancialInstruments" xlink:label="loc_imc_GainLossOnRevaluationOfFinancialInstruments_68"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_69"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_70"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfCompensationUnits" xlink:label="loc_imc_FairValueOfCompensationUnits_71"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_72"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_73"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_74"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_75"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversion" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversion_76"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionPricePerWarrant" xlink:label="loc_imc_ConversionPricePerWarrant_77"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversionOfUnits" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_78"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants" xlink:label="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_79"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfPreferredSharesCommittedToBeAcquired" xlink:label="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_80"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_81"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired" xlink:label="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_82"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_83"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfNonCancellablePurchasePrice" xlink:label="loc_imc_AmountOfNonCancellablePurchasePrice_84"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfTranslationTransaction" xlink:label="loc_imc_AmountOfTranslationTransaction_85"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAllocatedAmountTranslationTransaction" xlink:label="loc_imc_TotalAllocatedAmountTranslationTransaction_86"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsInUnlistedSharesMeasuredAtFairValue" xlink:label="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_87"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_88"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_89"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ApproximatelyCashAndCashEquivalents" xlink:label="loc_imc_ApproximatelyCashAndCashEquivalents_90"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities_91"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_92"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_93"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_94"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesCalledByWarrants" xlink:label="loc_imc_NumberOfCommonSharesCalledByWarrants_95"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_96"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_97"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WarrantLiability" xlink:label="loc_ifrs-full_WarrantLiability_98"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensation" xlink:label="loc_imc_ShareBasedCompensation_99"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfInvestment" xlink:label="loc_imc_FairValueOfInvestment_100"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1" xlink:to="loc_ifrs-full_TypesOfRisksMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_1" xlink:to="loc_ifrs-full_CurrencyRiskMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1" xlink:to="loc_ifrs-full_TypesOfRisksMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_dei_LegalEntityAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5" xlink:to="loc_dei_EntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5" xlink:to="loc_imc_XintezaApiLtdMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_imc_PeriodicPaymentInstallmentAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_PeriodicPaymentInstallmentAxis_9" xlink:to="loc_imc_PeriodicPaymentInstallmentDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_PeriodicPaymentInstallmentDomain_9" xlink:to="loc_imc_FirstInstallmentMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_PeriodicPaymentInstallmentDomain_9" xlink:to="loc_imc_RemainingInstallmentMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_PeriodicPaymentInstallmentAxis_9" xlink:to="loc_imc_PeriodicPaymentInstallmentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_14" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_14" xlink:to="loc_ifrs-full_ParentMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_14" xlink:to="loc_imc_NavasotaShareholdersMember_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_14" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_imc_EquityTransactionAxis_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_EquityTransactionAxis_19" xlink:to="loc_imc_EquityTransactionDomain_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_EquityTransactionDomain_19" xlink:to="loc_imc_PrivatePlacementsMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_EquityTransactionDomain_19" xlink:to="loc_imc_SharePurchaseAgreementMember_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_EquityTransactionDomain_19" xlink:to="loc_imc_OvernightMarketedOfferingMember_21" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_EquityTransactionAxis_19" xlink:to="loc_imc_EquityTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_25" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25" xlink:to="loc_imc_WarrantsAndCompensationOptionsMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25" xlink:to="loc_imc_Warrants2018Member_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25" xlink:to="loc_imc_CompensationUnitsMember_27" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25" xlink:to="loc_imc_Warrants2019Member_28" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25" xlink:to="loc_ifrs-full_PreferenceSharesMember_29" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25" xlink:to="loc_imc_Warrant2021Member_30" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_25" xlink:to="loc_imc_CashAndCashEquivalentMember_31" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_25" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_35" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_35" xlink:to="loc_ifrs-full_EquityMember_35" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_35" xlink:to="loc_imc_ListedWarrantsMember_35" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_35" xlink:to="loc_ifrs-full_IssuedCapitalMember_36" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_35" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_srt_CurrencyAxis_40" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_40" xlink:to="loc_currency_AllCurrenciesDomain_40" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_40" xlink:to="loc_currency_EUR_40" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_40" xlink:to="loc_currency_ILS_41" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_40" xlink:to="loc_currency_USD_42" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_40" xlink:to="loc_currency_GBP_43" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_40" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfUnitsIssued_48" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfUnitsIssuedPricePerShare_49" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_GrossProceedsFromIssuanceOfUnits_50" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_51" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_TermOfWarrantsFromDateOfIssuance_52" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_53" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_54" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_FairValueOfWarrants_55" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_56" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_57" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_58" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_59" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_FinanceCosts_60" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_61" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_62" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_63" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_64" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_65" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_66" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_67" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_GainLossOnRevaluationOfFinancialInstruments_68" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_69" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_70" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_FairValueOfCompensationUnits_71" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_72" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_73" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_74" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_75" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfWarrantsIssuedUponConversion_76" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ConversionPricePerWarrant_77" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_78" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_79" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_80" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_81" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_82" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_83" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_AmountOfNonCancellablePurchasePrice_84" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_AmountOfTranslationTransaction_85" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_TotalAllocatedAmountTranslationTransaction_86" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_87" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_88" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_89" order="420" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ApproximatelyCashAndCashEquivalents_90" order="430" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_FinancialLiabilities_91" order="440" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_92" order="450" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_ParValuePerShare_93" order="460" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_94" order="470" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_NumberOfCommonSharesCalledByWarrants_95" order="480" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_96" order="490" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_97" order="500" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_WarrantLiability_98" order="510" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_ShareBasedCompensation_99" order="520" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_imc_FairValueOfInvestment_100" order="530" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INVENTORIESDetails">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InventoriesLineItems" xlink:label="loc_imc_InventoriesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InventoriesTable" xlink:label="loc_imc_InventoriesTable_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesAxis" xlink:label="loc_imc_ClassesOfInventoriesAxis_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesDomain" xlink:label="loc_imc_ClassesOfInventoriesDomain_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkInProgressMember" xlink:label="loc_imc_WorkInProgressMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinishedGoodsMember" xlink:label="loc_imc_FinishedGoodsMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesDomain" xlink:label="loc_imc_ClassesOfInventoriesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisAxis" xlink:label="loc_imc_TypeOfCannabisAxis_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisDomain" xlink:label="loc_imc_TypeOfCannabisDomain_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BulkCannabisMember" xlink:label="loc_imc_BulkCannabisMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PackagedDriedCannabisMember" xlink:label="loc_imc_PackagedDriedCannabisMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisProductsMember" xlink:label="loc_imc_OtherCannabisProductsMember_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisMember" xlink:label="loc_imc_OtherCannabisMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisDomain" xlink:label="loc_imc_TypeOfCannabisDomain_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CapitalizedCostsOfInventories" xlink:label="loc_imc_CapitalizedCostsOfInventories_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoriesAtFairValueLessCostsToSell" xlink:label="loc_ifrs-full_InventoriesAtFairValueLessCostsToSell_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imc_InventoriesLineItems_0" xlink:to="loc_imc_InventoriesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_InventoriesTable_1" xlink:to="loc_imc_ClassesOfInventoriesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_ClassesOfInventoriesAxis_1" xlink:to="loc_imc_ClassesOfInventoriesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_ClassesOfInventoriesDomain_1" xlink:to="loc_imc_WorkInProgressMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_ClassesOfInventoriesDomain_1" xlink:to="loc_imc_FinishedGoodsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_ClassesOfInventoriesAxis_1" xlink:to="loc_imc_ClassesOfInventoriesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_InventoriesTable_1" xlink:to="loc_imc_TypeOfCannabisAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_TypeOfCannabisAxis_6" xlink:to="loc_imc_TypeOfCannabisDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_TypeOfCannabisDomain_6" xlink:to="loc_imc_BulkCannabisMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_TypeOfCannabisDomain_6" xlink:to="loc_imc_PackagedDriedCannabisMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_TypeOfCannabisDomain_6" xlink:to="loc_imc_OtherCannabisProductsMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_TypeOfCannabisDomain_6" xlink:to="loc_imc_OtherCannabisMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_TypeOfCannabisAxis_6" xlink:to="loc_imc_TypeOfCannabisDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_InventoriesLineItems_0" xlink:to="loc_imc_CapitalizedCostsOfInventories_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_InventoriesLineItems_0" xlink:to="loc_ifrs-full_InventoriesAtFairValueLessCostsToSell_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_InventoriesLineItems_0" xlink:to="loc_ifrs-full_Inventories_16" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCPointHoldingsLtdMember" xlink:label="loc_imc_IPointMPointCPointHoldingsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCFarmsIsraelLtdPointMember" xlink:label="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCVenturesLtdPointMember" xlink:label="loc_imc_IPointMPointCVenturesLtdPointMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" xlink:label="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RayarokPharmLtdMember" xlink:label="loc_imc_RayarokPharmLtdMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RosenHighWayLtdMember" xlink:label="loc_imc_RosenHighWayLtdMember_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighWayShinuaLtdMember" xlink:label="loc_imc_HighWayShinuaLtdMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolyTradingAndMarketingLtdMember" xlink:label="loc_imc_RevolyTradingAndMarketingLtdMember_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPlusPharmLtdMember" xlink:label="loc_imc_OranimPlusPharmLtdMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmMember" xlink:label="loc_imc_OranimPharmMember_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisGpIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisGpIncMember_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisManagerIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisManagerIncMember_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeAssetFundingCorpMember" xlink:label="loc_imc_TrichomeAssetFundingCorpMember_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeJwcAcquisitionCorpMember" xlink:label="loc_imc_TrichomeJwcAcquisitionCorpMember_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeRetailCorpMember" xlink:label="loc_imc_TrichomeRetailCorpMember_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SublimecultureIncMember" xlink:label="loc_imc_SublimecultureIncMember_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannacanadaIncMember" xlink:label="loc_imc_CannacanadaIncMember_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymInternationalBrandsIncMember" xlink:label="loc_imc_MymInternationalBrandsIncMember_22"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighlandGrowIncMember" xlink:label="loc_imc_HighlandGrowIncMember_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_28"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_IPointMPointCPointHoldingsLtdMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_FocusMedicalHerbsLtdMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_IPointMPointCVenturesLtdPointMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_RayarokPharmLtdMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_RosenHighWayLtdMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_HighWayShinuaLtdMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_RevolyTradingAndMarketingLtdMember_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_OranimPlusPharmLtdMember_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_OranimPharmMember_12" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_13" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeFinancialCannabisGpIncMember_14" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeFinancialCannabisManagerIncMember_15" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeAssetFundingCorpMember_16" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeJwcAcquisitionCorpMember_17" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeRetailCorpMember_18" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_19" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_SublimecultureIncMember_20" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_CannacanadaIncMember_21" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_MymInternationalBrandsIncMember_22" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_HighlandGrowIncMember_23" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_28" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseProductionEquipmentMember" xlink:label="loc_imc_GreenhouseProductionEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseStructureMember" xlink:label="loc_imc_GreenhouseStructureMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageMember" xlink:label="loc_ifrs-full_WeightedAverageMember_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRatePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationRatePropertyPlantAndEquipment_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_imc_GreenhouseProductionEquipmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_imc_GreenhouseStructureMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_RangeAxis_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_10" xlink:to="loc_ifrs-full_RangesMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_10" xlink:to="loc_ifrs-full_BottomOfRangeMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_10" xlink:to="loc_ifrs-full_TopOfRangeMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_10" xlink:to="loc_ifrs-full_WeightedAverageMember_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_10" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DepreciationRatePropertyPlantAndEquipment_17" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_6" xlink:to="loc_ifrs-full_BuildingsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_6" xlink:to="loc_ifrs-full_MotorVehiclesMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_11" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_11" xlink:to="loc_ifrs-full_RightofuseAssetsMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_11" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_17" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-full_CustomerrelatedIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_LicencesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_CustomerrelatedIntangibleAssetsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_BrandNamesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_RangeAxis_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_8" xlink:to="loc_ifrs-full_RangesMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_8" xlink:to="loc_ifrs-full_BottomOfRangeMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_8" xlink:to="loc_ifrs-full_TopOfRangeMember_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_8" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_15" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsequentEventMember" xlink:label="loc_imc_SubsequentEventMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementAxis" xlink:label="loc_imc_AgreementAxis_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementDomain" xlink:label="loc_imc_AgreementDomain_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SimpleAgreementForFutureEquityMember" xlink:label="loc_imc_SimpleAgreementForFutureEquityMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementDomain" xlink:label="loc_imc_AgreementDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MizrahiMember" xlink:label="loc_imc_MizrahiMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_XintezaApiLtdMember" xlink:label="loc_imc_XintezaApiLtdMember_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolvingCreditFacilityMember" xlink:label="loc_imc_RevolvingCreditFacilityMember_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_24"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingAmountOfCashPaid" xlink:label="loc_imc_RemainingAmountOfCashPaid_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_27"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_29"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeemedPricePerShare" xlink:label="loc_imc_DeemedPricePerShare_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_31"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Commitment" xlink:label="loc_imc_Commitment_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_33"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_imc_SubsequentEventMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_imc_AgreementAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_AgreementAxis_5" xlink:to="loc_imc_AgreementDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_AgreementDomain_5" xlink:to="loc_imc_SimpleAgreementForFutureEquityMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_AgreementAxis_5" xlink:to="loc_imc_AgreementDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_9" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9" xlink:to="loc_imc_PharmYarokPharmacyMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9" xlink:to="loc_imc_VironnaPharmacyMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9" xlink:to="loc_imc_MizrahiMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9" xlink:to="loc_imc_XintezaApiLtdMember_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9" xlink:to="loc_imc_OranimPharmacyMember_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_9" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_9" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_18" xlink:to="loc_ifrs-full_BorrowingsByNameMember_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_18" xlink:to="loc_imc_RevolvingCreditFacilityMember_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_18" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_23" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_24" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_imc_RemainingAmountOfCashPaid_25" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_CashTransferred_26" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_27" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_imc_CashConsiderationOfBusinessCombination_28" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_29" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_imc_DeemedPricePerShare_30" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_31" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_imc_Commitment_32" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_33" order="110" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/GENERALDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionAxis" xlink:label="loc_imc_EquityTransactionAxis_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OvernightMarketedOfferingMember" xlink:label="loc_imc_OvernightMarketedOfferingMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreliminaryShelfProspectusMember" xlink:label="loc_imc_PreliminaryShelfProspectusMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MizrahiMember" xlink:label="loc_imc_MizrahiMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmMember" xlink:label="loc_imc_OranimPharmMember_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolvingCreditFacilityMember" xlink:label="loc_imc_RevolvingCreditFacilityMember_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsequentEventMember" xlink:label="loc_imc_SubsequentEventMember_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" xlink:label="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_31"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Commitment" xlink:label="loc_imc_Commitment_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_35"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionCostsOfCommonShares" xlink:label="loc_imc_AcquisitionCostsOfCommonShares_36"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfCommonShares" xlink:label="loc_imc_IssuanceOfCommonShares_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_39"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree" xlink:label="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_40"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_42"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_45"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingSharesAcquired" xlink:label="loc_imc_PercentageOfOutstandingSharesAcquired_46"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRightsHold" xlink:label="loc_imc_PercentageOfRightsHold_47"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapitalOfBusinessAcquisition" xlink:label="loc_imc_WorkingCapitalOfBusinessAcquisition_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_50"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_imc_EquityTransactionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_EquityTransactionAxis_1" xlink:to="loc_imc_EquityTransactionDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_EquityTransactionDomain_1" xlink:to="loc_imc_OvernightMarketedOfferingMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_EquityTransactionDomain_1" xlink:to="loc_imc_PreliminaryShelfProspectusMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_EquityTransactionAxis_1" xlink:to="loc_imc_EquityTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_6" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6" xlink:to="loc_imc_TrichomeFinancialCorpMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6" xlink:to="loc_imc_MymNutraceuticalsIncMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6" xlink:to="loc_imc_PharmYarokPharmacyMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6" xlink:to="loc_imc_VironnaPharmacyMember_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6" xlink:to="loc_imc_MizrahiMember_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_6" xlink:to="loc_imc_OranimPharmMember_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_6" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_16" xlink:to="loc_ifrs-full_BorrowingsByNameMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_16" xlink:to="loc_imc_RevolvingCreditFacilityMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_16" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_20" xlink:to="loc_ifrs-full_NonadjustingEventsMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_20" xlink:to="loc_imc_SubsequentEventMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_20" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_ParValuePerShare_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_27" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_28" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_29" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_30" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_31" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_Commitment_32" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRate_33" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_34" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_Borrowings_35" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_AcquisitionCostsOfCommonShares_36" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_IssuanceOfCommonShares_37" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_38" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_39" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_40" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_CashConsiderationOfBusinessCombination_41" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_42" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_CashTransferred_43" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_44" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_45" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_PercentageOfOutstandingSharesAcquired_46" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_PercentageOfRightsHold_47" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_WorkingCapitalOfBusinessAcquisition_48" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_49" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_50" order="260" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandAndBuildingsMember" xlink:label="loc_ifrs-full_LandAndBuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialConsolidationsRightOfUseAssets" xlink:label="loc_imc_InitialConsolidationsRightOfUseAssets_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" xlink:label="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalsOfRightOfUseAssets" xlink:label="loc_imc_DisposalsOfRightOfUseAssets_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalOfTerminationOfLeases" xlink:label="loc_imc_DisposalOfTerminationOfLeases_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_LandAndBuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" xlink:to="loc_ifrs-full_CarryingAmountMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_6" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_6" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_RightofuseAssets_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_AdditionsToRightofuseAssets_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_imc_InitialConsolidationsRightOfUseAssets_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_15" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_16" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_imc_DisposalsOfRightOfUseAssets_17" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_imc_DisposalOfTerminationOfLeases_18" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_dei_AuditedAnnualFinancialStatements_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_dei_AnnualInformationForm_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_47"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentInformationTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityRegistrantName_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentType_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AmendmentFlag_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AmendmentDescription_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityFilerCategory_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityVoluntaryFilers_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_16" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_17" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_18" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_19" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_20" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_21" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityExTransitionPeriod_22" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityFileNumber_23" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentRegistrationStatement_24" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_25" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentAnnualReport_26" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentShellCompanyReport_27" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_28" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_ContactPersonnelName_29" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_CityAreaCode_30" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_31" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_32" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressCountry_33" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_34" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine2_35" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_36" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine3_37" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressStateOrProvince_38" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AuditedAnnualFinancialStatements_39" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AnnualInformationForm_40" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_Security12bTitle_41" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_TradingSymbol_42" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_SecurityExchangeName_43" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_44" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AuditorName_45" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AuditorLocation_46" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AuditorFirmId_47" order="420" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementAxis" xlink:label="loc_imc_AgreementAxis_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementDomain" xlink:label="loc_imc_AgreementDomain_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementWithFarmerMember" xlink:label="loc_imc_AgreementWithFarmerMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementDomain" xlink:label="loc_imc_AgreementDomain_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AreaOfCultivationAndProcessing" xlink:label="loc_imc_AreaOfCultivationAndProcessing_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AllocatedPercentageOfShareCapital" xlink:label="loc_imc_AllocatedPercentageOfShareCapital_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_RangeAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_6" xlink:to="loc_ifrs-full_BottomOfRangeMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_6" xlink:to="loc_ifrs-full_TopOfRangeMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_imc_AgreementAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imc_AgreementAxis_11" xlink:to="loc_imc_AgreementDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_AgreementDomain_11" xlink:to="loc_imc_AgreementWithFarmerMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imc_AgreementAxis_11" xlink:to="loc_imc_AgreementDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_imc_AreaOfCultivationAndProcessing_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_imc_AllocatedPercentageOfShareCapital_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_18" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareholdersMember" xlink:label="loc_imc_ShareholdersMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_imc_ShareholdersMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_6" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreTaxDiscountRateOfCashFlows" xlink:label="loc_imc_PreTaxDiscountRateOfCashFlows_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FixedGrowthRate" xlink:label="loc_imc_FixedGrowthRate_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_PreTaxDiscountRateOfCashFlows_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_imc_FixedGrowthRate_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_9" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CultivationsAndProcessingLicenseMember" xlink:label="loc_imc_CultivationsAndProcessingLicenseMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerRelationshipsMember" xlink:label="loc_imc_CustomerRelationshipsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_imc_CultivationsAndProcessingLicenseMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_imc_CustomerRelationshipsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_BrandNamesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" xlink:to="loc_ifrs-full_CarryingAmountMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_18" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_19" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_20" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasTable" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ForeignCountriesTwoMember" xlink:label="loc_imc_ForeignCountriesTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignCountriesMember" xlink:label="loc_ifrs-full_ForeignCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherOperatingSegmentsMember" xlink:label="loc_imc_OtherOperatingSegmentsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-full_OperatingSegmentsMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExternalCustomersRevenues" xlink:label="loc_imc_ExternalCustomersRevenues_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterSegmentRevenues" xlink:label="loc_imc_InterSegmentRevenues_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_ifrs-full_CountryOfDomicileMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_imc_ForeignCountriesTwoMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_ifrs-full_ForeignCountriesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_imc_OtherOperatingSegmentsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_8" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_8" xlink:to="loc_ifrs-full_OperatingSegmentsMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_8" xlink:to="loc_ifrs-full_UnallocatedAmountsMember_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_8" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_0" xlink:to="loc_imc_ExternalCustomersRevenues_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_0" xlink:to="loc_imc_InterSegmentRevenues_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_0" xlink:to="loc_ifrs-full_Revenue_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_0" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_18" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapital" xlink:label="loc_imc_WorkingCapital_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoansPayableAsOfAcquisitionDate" xlink:label="loc_imc_LoansPayableAsOfAcquisitionDate_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAsOfAcquisitionDate_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate" xlink:label="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_23"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankCreditRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_25"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_30"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_31"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmacyMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_WorkingCapital_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_LoansPayableAsOfAcquisitionDate_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_InvestmentsAsOfAcquisitionDate_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_16" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_17" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_18" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_19" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_20" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_LeaseLiabilityAsOfAcquisitionDate_21" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_22" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_23" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_24" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_25" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_26" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_27" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_28" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_29" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_30" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xlink:to="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_31" order="210" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProFormaAdjustmentsMember" xlink:label="loc_imc_ProFormaAdjustmentsMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember" xlink:label="loc_srt_ProFormaMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="loc_ifrs-full_RevenueOfAcquiree_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-full_ProfitLossOfAcquiree_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmacyMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_srt_StatementScenarioAxis_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_10" xlink:to="loc_srt_ScenarioUnspecifiedDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_10" xlink:to="loc_imc_ProFormaAdjustmentsMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_10" xlink:to="loc_srt_ProFormaMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_10" xlink:to="loc_srt_ScenarioUnspecifiedDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_RevenueOfAcquiree_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_ProfitLossOfAcquiree_17" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RestrictedShareUnitsMember" xlink:label="loc_imc_RestrictedShareUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_imc_RestrictedShareUnitsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_8" order="30" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>imc-20211231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="loc_country_CA_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="loc_country_CA_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="loc_country_DE_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="loc_country_DE_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="loc_country_IL_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="loc_country_IL_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="loc_currency_EUR_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="loc_currency_EUR_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP" xlink:label="loc_currency_GBP_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP" xlink:label="loc_currency_GBP_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="loc_currency_ILS_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="loc_currency_ILS_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="loc_currency_USD_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="loc_currency_USD_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AdrMember" xlink:label="loc_dei_AdrMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AdrMember" xlink:label="loc_dei_AdrMember_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_dei_AnnualInformationForm_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_dei_AuditedAnnualFinancialStatements_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_53"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_56"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_57"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_62"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_64"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_65"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_66"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_67"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_68"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_69"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_70"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccrualsClassifiedAsCurrent" xlink:label="loc_ifrs-full_AccrualsClassifiedAsCurrent_71"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_72"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_73"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_74"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_75"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_76"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_77"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_78"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_79"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_80"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_81"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_82"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_83"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_84"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_85"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_86"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_87"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_88"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_89"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_90"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_91"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_92"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_93"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_94"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_95"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_96"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_97"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_98"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_99"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_100"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_101"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_102"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_103"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_104"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_105"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_106"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_107"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_108"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_109"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_110"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_111"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_112"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_113"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_114"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_115"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_116"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_117"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_118"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncome" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_119"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncome" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_120"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncome" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_121"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_122"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_123"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_124"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_125"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_126"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_127"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_128"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_129"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_130"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_131"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_132"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_133"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_134"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_135"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_136"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_137"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_138"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_139"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_140"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_141"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_142"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_143"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_144"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_145"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_146"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_147"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_148"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_149"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_150"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_151"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_152"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_153"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_154"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_155"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_156"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_157"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_158"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_159"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_160"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_161"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_162"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_163"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_164"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_165"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_166"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_167"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_168"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_169"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BenefitsPaidOrPayable" xlink:label="loc_ifrs-full_BenefitsPaidOrPayable_170"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BenefitsPaidOrPayable" xlink:label="loc_ifrs-full_BenefitsPaidOrPayable_171"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BenefitsPaidOrPayable" xlink:label="loc_ifrs-full_BenefitsPaidOrPayable_172"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_173"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_174"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_175"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssetsByTypeAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByTypeAxis_176"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssetsTypeMember" xlink:label="loc_ifrs-full_BiologicalAssetsTypeMember_177"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_178"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsAbstract" xlink:label="loc_ifrs-full_BorrowingsAbstract_179"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_180"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_181"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_182"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_183"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_184"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_185"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_186"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_187"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_188"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_189"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_190"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_191"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_192"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_193"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_194"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_195"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_196"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_197"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_198"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_199"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_200"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_201"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_202"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_203"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_204"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_205"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_206"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_207"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_208"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_209"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_210"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_211"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_212"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_213"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_214"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_215"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_216"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_217"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_218"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_219"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_220"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_221"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_222"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_223"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_224"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_225"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_226"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_227"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_228"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_229"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_230"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_231"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_232"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_233"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_234"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_235"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_236"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_237"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_238"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_239"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_240"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_241"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_242"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_243"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_244"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_245"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_246"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_247"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_248"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_249"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_250"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_251"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_252"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_253"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_254"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_255"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_256"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_257"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_258"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_259"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_260"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_261"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_262"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_263"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_264"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_265"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_266"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_267"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_268"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_269"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_270"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_271"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_272"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_273"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_274"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_275"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_276"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_277"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-full_CurrencyRiskMember_278"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_279"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_280"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAdvancesToSuppliers" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers_281"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAdvancesToSuppliers" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers_282"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_283"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_284"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_285"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_286"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_287"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_288"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_289"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBiologicalAssetsMember" xlink:label="loc_ifrs-full_CurrentBiologicalAssetsMember_290"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBiologicalAssetsMember" xlink:label="loc_ifrs-full_CurrentBiologicalAssetsMember_291"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-full_CurrentDepositsFromCustomers_292"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-full_CurrentDepositsFromCustomers_293"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="loc_ifrs-full_CurrentGovernmentGrants_294"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentGovernmentGrants" xlink:label="loc_ifrs-full_CurrentGovernmentGrants_295"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_296"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_297"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_298"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_299"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_300"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_301"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_302"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_303"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_304"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_305"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_306"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_307"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_308"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_309"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_310"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_311"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_312"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_313"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:label="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_314"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:label="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_315"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_316"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_317"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_318"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_319"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_320"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_321"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_322"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_323"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_324"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_325"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-full_CustomerrelatedIntangibleAssetsMember_326"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-full_CustomerrelatedIntangibleAssetsMember_327"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_328"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_329"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_330"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_331"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_332"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_333"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_334"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_335"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_336"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_337"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_338"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_339"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_340"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_341"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_342"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_343"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_344"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_345"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_346"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_347"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_348"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_349"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_350"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_351"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_352"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_353"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_354"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_355"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_356"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_357"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRatePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationRatePropertyPlantAndEquipment_358"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_359"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_360"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_361"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_362"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_363"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_364"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_365"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_366"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_367"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_368"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_369"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_370"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_371"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_372"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_373"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_374"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_375"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_376"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_377"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_378"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_379"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_380"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_381"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_382"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_383"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_384"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_385"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_386"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_387"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_388"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_389"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_390"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_391"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_392"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_393"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_394"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_395"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_396"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_397"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_398"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_399"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_400"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_401"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_402"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_403"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_404"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_405"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_406"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_407"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_408"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_409"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_410"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_411"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_412"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_413"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_414"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_415"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_416"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_417"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_418"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_419"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_420"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_421"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_422"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_423"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_424"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_425"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_426"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_427"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_428"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_429"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_430"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_431"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_432"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_433"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_434"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_435"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_436"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_437"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_438"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_439"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_440"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_441"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_442"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_443"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_444"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_445"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_446"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_447"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_448"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_449"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_450"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_451"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_452"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_453"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_454"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_455"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_456"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_457"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_458"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_459"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_460"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_461"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_462"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_463"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_464"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_465"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_466"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_467"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_468"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_469"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_470"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_471"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_472"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasTable" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_473"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_474"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_475"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_476"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_477"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory_478"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory_479"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_480"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_481"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_482"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_483"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_484"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_485"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_486"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_487"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_488"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_489"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_490"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_491"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_492"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_493"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_494"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_495"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_496"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_497"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_498"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_499"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_500"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_501"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_502"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_503"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_504"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_505"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_506"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_507"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_508"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_509"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_510"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_511"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_512"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_513"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_514"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_515"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_516"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_517"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_518"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_519"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_520"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_521"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_522"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_523"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_524"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_525"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_526"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_527"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_528"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_529"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_530"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_531"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_532"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_533"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_534"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_535"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_536"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_537"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_538"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_539"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_540"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_541"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_542"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_543"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_544"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_545"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_546"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_547"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_548"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_549"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_550"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_551"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_552"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_553"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_554"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_555"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_556"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_557"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_558"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_559"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_560"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_561"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_562"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_563"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_564"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_565"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_566"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_567"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_568"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_569"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_570"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_571"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_572"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_573"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_574"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_575"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_576"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_577"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_578"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_579"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_580"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_581"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_582"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_583"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_584"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_585"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_586"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_587"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_588"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_589"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_590"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_591"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities_592"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignCountriesMember" xlink:label="loc_ifrs-full_ForeignCountriesMember_593"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignCountriesMember" xlink:label="loc_ifrs-full_ForeignCountriesMember_594"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_595"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_596"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_597"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_598"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_599"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_600"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_601"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_602"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_603"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_604"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_605"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_606"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_607"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_608"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_609"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_610"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_611"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_612"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_613"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_614"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_615"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_616"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_617"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_618"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_619"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_620"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_621"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_622"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_623"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_624"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_625"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_626"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_627"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_628"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_629"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_630"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_631"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_632"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_633"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_634"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_635"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_636"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_637"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_638"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_639"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_640"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_641"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_642"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_643"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_644"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_645"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_646"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_647"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_648"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_649"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_650"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_651"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_652"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_653"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_654"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_655"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_656"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_657"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_658"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_659"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_660"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_661"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_662"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill_663"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill_664"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_665"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_666"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_667"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_668"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_669"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_670"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_671"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_672"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_673"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_674"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_675"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_676"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_677"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_678"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_679"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_680"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_681"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_682"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_683"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_684"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_685"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_686"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_687"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoriesAtFairValueLessCostsToSell" xlink:label="loc_ifrs-full_InventoriesAtFairValueLessCostsToSell_688"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoriesAtFairValueLessCostsToSell" xlink:label="loc_ifrs-full_InventoriesAtFairValueLessCostsToSell_689"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_690"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_691"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_692"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_693"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_694"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_695"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_696"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_697"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_698"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_699"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_700"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_701"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_702"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_703"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_704"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_705"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_706"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_707"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandAndBuildingsMember" xlink:label="loc_ifrs-full_LandAndBuildingsMember_708"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandAndBuildingsMember" xlink:label="loc_ifrs-full_LandAndBuildingsMember_709"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_710"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_711"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_712"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_713"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTenYearsMember" xlink:label="loc_ifrs-full_LaterThanTenYearsMember_714"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTenYearsMember" xlink:label="loc_ifrs-full_LaterThanTenYearsMember_715"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_716"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_717"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_718"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_719"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_720"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_721"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_722"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_723"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_724"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_725"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_726"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_727"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_728"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_729"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_730"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_731"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_732"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_733"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_734"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember_735"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember_736"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-full_LicencesAndFranchisesMember_737"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_738"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_739"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_740"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LoansAndReceivables" xlink:label="loc_ifrs-full_LoansAndReceivables_741"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LoansAndReceivables" xlink:label="loc_ifrs-full_LoansAndReceivables_742"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_743"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_744"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_745"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowingsMember" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_746"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_747"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_748"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_749"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_750"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_751"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_752"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_753"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_754"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_755"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_756"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_757"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_758"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_759"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_760"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_761"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_762"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_763"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_764"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_765"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_766"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_767"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_768"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_769"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_770"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_771"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_772"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_773"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_774"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_775"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_776"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_777"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_778"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_779"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_780"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_781"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_782"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_783"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_784"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_785"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_786"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_787"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_788"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_789"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_790"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_791"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_792"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_793"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_794"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_795"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_796"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_797"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_798"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_799"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_800"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_801"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_802"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_803"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_804"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_805"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_806"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_807"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_808"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_809"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_810"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_811"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_812"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_813"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_814"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_815"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_816"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_817"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_818"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_819"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_820"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_821"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_822"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_823"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_824"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_825"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-full_OperatingSegmentsMember_826"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-full_OperatingSegmentsMember_827"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_828"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_829"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember_830"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember_831"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_832"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_833"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_834"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_835"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_836"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_837"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_838"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_839"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_840"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_841"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_842"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_843"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_844"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_845"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_846"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_847"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_848"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_849"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_850"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_851"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_852"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_853"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_854"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_855"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_856"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_857"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-full_OtherExpenseByNature_858"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-full_OtherExpenseByNature_859"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-full_OtherExpenseByNature_860"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-full_OtherExpenseByNature_861"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherGainsLosses" xlink:label="loc_ifrs-full_OtherGainsLosses_862"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherGainsLosses" xlink:label="loc_ifrs-full_OtherGainsLosses_863"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_864"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_865"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_866"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_867"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_868"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_869"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_870"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParentMember" xlink:label="loc_ifrs-full_ParentMember_871"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParentMember" xlink:label="loc_ifrs-full_ParentMember_872"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_873"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_874"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_875"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_876"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_877"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_878"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_879"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_880"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfOtherEquityInstruments" xlink:label="loc_ifrs-full_PaymentsOfOtherEquityInstruments_881"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfOtherEquityInstruments" xlink:label="loc_ifrs-full_PaymentsOfOtherEquityInstruments_882"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfOtherEquityInstruments" xlink:label="loc_ifrs-full_PaymentsOfOtherEquityInstruments_883"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_884"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_885"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_886"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_887"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_888"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_889"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_890"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_891"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_892"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_893"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_894"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_895"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_896"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PreferenceSharesMember" xlink:label="loc_ifrs-full_PreferenceSharesMember_897"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PreferenceSharesMember" xlink:label="loc_ifrs-full_PreferenceSharesMember_898"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_899"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_900"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_901"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_902"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_903"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_904"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_905"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_906"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_907"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_908"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_909"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentProperty" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_910"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentProperty" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_911"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_912"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_913"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_914"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_915"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_916"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_917"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_918"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_919"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="loc_ifrs-full_ProfitLossAttributableToAbstract_920"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="loc_ifrs-full_ProfitLossAttributableToAbstract_921"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_922"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_923"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_924"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_925"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_926"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_927"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_928"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_929"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_930"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_931"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_932"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_933"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_934"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_935"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_936"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_937"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_938"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-full_ProfitLossOfAcquiree_939"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-full_ProfitLossOfAcquiree_940"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-full_ProfitLossOfAcquiree_941"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_942"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_943"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_944"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_945"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_946"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_947"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_948"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_949"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_950"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_951"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_952"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_953"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfInvestmentProperty" xlink:label="loc_ifrs-full_PurchaseOfInvestmentProperty_954"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfInvestmentProperty" xlink:label="loc_ifrs-full_PurchaseOfInvestmentProperty_955"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_956"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_957"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_958"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_959"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_960"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_961"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_962"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:label="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_963"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:label="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_964"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_965"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_966"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_967"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_968"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_969"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_970"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_971"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_972"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_973"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_974"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_975"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_976"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_977"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_978"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_979"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_980"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_981"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_982"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_983"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_984"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_985"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="loc_ifrs-full_RevenueOfAcquiree_986"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="loc_ifrs-full_RevenueOfAcquiree_987"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_988"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_989"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_990"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_991"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_992"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_993"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_994"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_995"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_996"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_997"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_998"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_999"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_1000"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-full_SegmentsMember_1001"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingExpense" xlink:label="loc_ifrs-full_SellingExpense_1002"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1003"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_1004"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_1005"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_1006"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_1007"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_1008"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_1009"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-full_ShorttermBorrowings_1010"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-full_ShorttermBorrowings_1011"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-full_ShorttermBorrowings_1012"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_1013"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_1014"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_1015"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_1016"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1017"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_1018"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_1019"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_1020"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1021"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_1022"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1023"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1024"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1025"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_1026"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_1027"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="loc_ifrs-full_TaxEffectOfTaxLosses_1028"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="loc_ifrs-full_TaxEffectOfTaxLosses_1029"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1030"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1031"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1032"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1033"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1034"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_1035"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_1036"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_1037"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_1038"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_1039"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1040"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1041"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_1042"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_1043"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_1044"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_1045"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_1046"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherPayablesAbstract_1047"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1048"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1049"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1050"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_1051"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_1052"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_1053"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember_1054"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1055"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_1056"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1057"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_1058"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_1059"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_1060"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1061"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1062"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_1063"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_1064"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_1065"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WarrantLiability" xlink:label="loc_ifrs-full_WarrantLiability_1066"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_1067"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_1068"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_1069"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_1070"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_1071"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_1072"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1073"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1074"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1075"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1076"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1077"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1078"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1079"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1080"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1081"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1082"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1083"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1084"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1085"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1086"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1087"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageMember" xlink:label="loc_ifrs-full_WeightedAverageMember_1088"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageMember" xlink:label="loc_ifrs-full_WeightedAverageMember_1089"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1090"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1091"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_1092"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_1093"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1094"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1095"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_1096"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_1097"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_1098"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_1099"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_1100"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionCostsForProfessionalFees" xlink:label="loc_imc_AcquisitionCostsForProfessionalFees_1101"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionCostsForProfessionalFees" xlink:label="loc_imc_AcquisitionCostsForProfessionalFees_1102"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionCostsForProfessionalFees" xlink:label="loc_imc_AcquisitionCostsForProfessionalFees_1103"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionCostsOfCommonShares" xlink:label="loc_imc_AcquisitionCostsOfCommonShares_1104"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionCostsOfCommonShares" xlink:label="loc_imc_AcquisitionCostsOfCommonShares_1105"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionCostsOfCommonShares" xlink:label="loc_imc_AcquisitionCostsOfCommonShares_1106"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionOfSubsidiaryAbstract" xlink:label="loc_imc_AcquisitionOfSubsidiaryAbstract_1107"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionOfSubsidiaryAbstract" xlink:label="loc_imc_AcquisitionOfSubsidiaryAbstract_1108"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionOfTrichomeFinancialCorpMember" xlink:label="loc_imc_AcquisitionOfTrichomeFinancialCorpMember_1109"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionOfTrichomeFinancialCorpMember" xlink:label="loc_imc_AcquisitionOfTrichomeFinancialCorpMember_1110"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionOfTrichomeFinancialCorpMember" xlink:label="loc_imc_AcquisitionOfTrichomeFinancialCorpMember_1111"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionTransactionCosts" xlink:label="loc_imc_AcquisitionTransactionCosts_1112"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionTransactionCosts" xlink:label="loc_imc_AcquisitionTransactionCosts_1113"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionTransactionCosts" xlink:label="loc_imc_AcquisitionTransactionCosts_1114"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdditionsToDisposalsRightOfUseAssets" xlink:label="loc_imc_AdditionsToDisposalsRightOfUseAssets_1115"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdditionsToDisposalsRightOfUseAssets" xlink:label="loc_imc_AdditionsToDisposalsRightOfUseAssets_1116"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdditionsToDisposalsRightOfUseAssets" xlink:label="loc_imc_AdditionsToDisposalsRightOfUseAssets_1117"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1118"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1119"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1120"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmsCeoMember" xlink:label="loc_imc_AdjupharmsCeoMember_1121"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmsCeoMember" xlink:label="loc_imc_AdjupharmsCeoMember_1122"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmsCeoMember" xlink:label="loc_imc_AdjupharmsCeoMember_1123"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustedExercisePrice" xlink:label="loc_imc_AdjustedExercisePrice_1124"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustedExercisePrice" xlink:label="loc_imc_AdjustedExercisePrice_1125"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustedExercisePrice" xlink:label="loc_imc_AdjustedExercisePrice_1126"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent" xlink:label="loc_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_1127"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent" xlink:label="loc_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_1128"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent" xlink:label="loc_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_1129"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable" xlink:label="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1130"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable" xlink:label="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1131"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable" xlink:label="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1132"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable" xlink:label="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1133"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForRevaluationOfOtherReceivable" xlink:label="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_1134"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForRevaluationOfOtherReceivable" xlink:label="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_1135"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForRevaluationOfOtherReceivable" xlink:label="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_1136"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" xlink:label="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1137"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" xlink:label="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1138"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" xlink:label="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1139"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" xlink:label="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1140"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AggregateGrossProceedsOfSubscriptionReceipts" xlink:label="loc_imc_AggregateGrossProceedsOfSubscriptionReceipts_1141"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AggregateGrossProceedsOfSubscriptionReceipts" xlink:label="loc_imc_AggregateGrossProceedsOfSubscriptionReceipts_1142"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AggregateGrossProceedsOfSubscriptionReceipts" xlink:label="loc_imc_AggregateGrossProceedsOfSubscriptionReceipts_1143"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AggregatePurchasePriceOfBusinessAcquisition" xlink:label="loc_imc_AggregatePurchasePriceOfBusinessAcquisition_1144"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AggregatePurchasePriceOfBusinessAcquisition" xlink:label="loc_imc_AggregatePurchasePriceOfBusinessAcquisition_1145"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AggregatePurchasePriceOfBusinessAcquisition" xlink:label="loc_imc_AggregatePurchasePriceOfBusinessAcquisition_1146"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementAxis" xlink:label="loc_imc_AgreementAxis_1147"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementAxis" xlink:label="loc_imc_AgreementAxis_1148"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementDomain" xlink:label="loc_imc_AgreementDomain_1149"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementDomain" xlink:label="loc_imc_AgreementDomain_1150"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementWithFarmerMember" xlink:label="loc_imc_AgreementWithFarmerMember_1151"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementWithFarmerMember" xlink:label="loc_imc_AgreementWithFarmerMember_1152"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AllocatedPercentageOfShareCapital" xlink:label="loc_imc_AllocatedPercentageOfShareCapital_1153"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AllocatedPercentageOfShareCapital" xlink:label="loc_imc_AllocatedPercentageOfShareCapital_1154"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AllocatedPercentageOfShareCapital" xlink:label="loc_imc_AllocatedPercentageOfShareCapital_1155"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountDepositedInEscrow" xlink:label="loc_imc_AmountDepositedInEscrow_1156"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountDepositedInEscrow" xlink:label="loc_imc_AmountDepositedInEscrow_1157"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountDepositedInEscrow" xlink:label="loc_imc_AmountDepositedInEscrow_1158"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfClassActionGroupIncurredDamages" xlink:label="loc_imc_AmountOfClassActionGroupIncurredDamages_1159"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfClassActionGroupIncurredDamages" xlink:label="loc_imc_AmountOfClassActionGroupIncurredDamages_1160"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfClassActionGroupIncurredDamages" xlink:label="loc_imc_AmountOfClassActionGroupIncurredDamages_1161"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfExpensesPaidByApplicant" xlink:label="loc_imc_AmountOfExpensesPaidByApplicant_1162"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfExpensesPaidByApplicant" xlink:label="loc_imc_AmountOfExpensesPaidByApplicant_1163"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfExpensesPaidByApplicant" xlink:label="loc_imc_AmountOfExpensesPaidByApplicant_1164"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfNonCancellablePurchasePrice" xlink:label="loc_imc_AmountOfNonCancellablePurchasePrice_1165"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfNonCancellablePurchasePrice" xlink:label="loc_imc_AmountOfNonCancellablePurchasePrice_1166"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfNonCancellablePurchasePrice" xlink:label="loc_imc_AmountOfNonCancellablePurchasePrice_1167"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPersonalSuit" xlink:label="loc_imc_AmountOfPersonalSuit_1168"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPersonalSuit" xlink:label="loc_imc_AmountOfPersonalSuit_1169"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPersonalSuit" xlink:label="loc_imc_AmountOfPersonalSuit_1170"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPurchaseOfTreasuryCommonShares" xlink:label="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_1171"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPurchaseOfTreasuryCommonShares" xlink:label="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_1172"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPurchaseOfTreasuryCommonShares" xlink:label="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_1173"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPurchaseOfTreasuryCommonShares" xlink:label="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_1174"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfSettlementOfWithholdingTaxLiabilities" xlink:label="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_1175"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfSettlementOfWithholdingTaxLiabilities" xlink:label="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_1176"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfSettlementOfWithholdingTaxLiabilities" xlink:label="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_1177"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfSharesGranted" xlink:label="loc_imc_AmountOfSharesGranted_1178"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfSharesGranted" xlink:label="loc_imc_AmountOfSharesGranted_1179"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfSharesGranted" xlink:label="loc_imc_AmountOfSharesGranted_1180"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfTranslationTransaction" xlink:label="loc_imc_AmountOfTranslationTransaction_1181"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfTranslationTransaction" xlink:label="loc_imc_AmountOfTranslationTransaction_1182"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfTranslationTransaction" xlink:label="loc_imc_AmountOfTranslationTransaction_1183"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfVotingEquityInterestsAcquired" xlink:label="loc_imc_AmountOfVotingEquityInterestsAcquired_1184"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfVotingEquityInterestsAcquired" xlink:label="loc_imc_AmountOfVotingEquityInterestsAcquired_1185"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfVotingEquityInterestsAcquired" xlink:label="loc_imc_AmountOfVotingEquityInterestsAcquired_1186"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfWarrantTransferredInEquityDuringPeriod" xlink:label="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_1187"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfWarrantTransferredInEquityDuringPeriod" xlink:label="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_1188"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfWarrantTransferredInEquityDuringPeriod" xlink:label="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_1189"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountToBeDeliveredOverTermOfSalesAgreements" xlink:label="loc_imc_AmountToBeDeliveredOverTermOfSalesAgreements_1190"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountToBeDeliveredOverTermOfSalesAgreements" xlink:label="loc_imc_AmountToBeDeliveredOverTermOfSalesAgreements_1191"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountToBeDeliveredOverTermOfSalesAgreements" xlink:label="loc_imc_AmountToBeDeliveredOverTermOfSalesAgreements_1192"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit" xlink:label="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_1193"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit" xlink:label="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_1194"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit" xlink:label="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_1195"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ApproximatelyCashAndCashEquivalents" xlink:label="loc_imc_ApproximatelyCashAndCashEquivalents_1196"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ApproximatelyCashAndCashEquivalents" xlink:label="loc_imc_ApproximatelyCashAndCashEquivalents_1197"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ApproximatelyCashAndCashEquivalents" xlink:label="loc_imc_ApproximatelyCashAndCashEquivalents_1198"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AreaOfCultivationAndProcessing" xlink:label="loc_imc_AreaOfCultivationAndProcessing_1199"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AreaOfCultivationAndProcessing" xlink:label="loc_imc_AreaOfCultivationAndProcessing_1200"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AreaOfCultivationAndProcessing" xlink:label="loc_imc_AreaOfCultivationAndProcessing_1201"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ArrangementAgreementMember" xlink:label="loc_imc_ArrangementAgreementMember_1202"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ArrangementAgreementMember" xlink:label="loc_imc_ArrangementAgreementMember_1203"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ArrangementAgreementMember" xlink:label="loc_imc_ArrangementAgreementMember_1204"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AssetsLocationMember" xlink:label="loc_imc_AssetsLocationMember_1205"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AssetsLocationMember" xlink:label="loc_imc_AssetsLocationMember_1206"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AssetsLocationMember" xlink:label="loc_imc_AssetsLocationMember_1207"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AttritionRate" xlink:label="loc_imc_AttritionRate_1208"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AttritionRate" xlink:label="loc_imc_AttritionRate_1209"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AttritionRate" xlink:label="loc_imc_AttritionRate_1210"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AutomaticExtensionPeriodOfAgreement" xlink:label="loc_imc_AutomaticExtensionPeriodOfAgreement_1211"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AutomaticExtensionPeriodOfAgreement" xlink:label="loc_imc_AutomaticExtensionPeriodOfAgreement_1212"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AutomaticExtensionPeriodOfAgreement" xlink:label="loc_imc_AutomaticExtensionPeriodOfAgreement_1213"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AveragePostHarvestCostsPerGramOfDriedCannabis" xlink:label="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_1214"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AveragePostHarvestCostsPerGramOfDriedCannabis" xlink:label="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_1215"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AveragePostHarvestCostsPerGramOfDriedCannabis" xlink:label="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_1216"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageSellingPricePerGramOfDriedCannabis" xlink:label="loc_imc_AverageSellingPricePerGramOfDriedCannabis_1217"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageSellingPricePerGramOfDriedCannabis" xlink:label="loc_imc_AverageSellingPricePerGramOfDriedCannabis_1218"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageSellingPricePerGramOfDriedCannabis" xlink:label="loc_imc_AverageSellingPricePerGramOfDriedCannabis_1219"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageStageOfGrowth" xlink:label="loc_imc_AverageStageOfGrowth_1220"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageStageOfGrowth" xlink:label="loc_imc_AverageStageOfGrowth_1221"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageStageOfGrowth" xlink:label="loc_imc_AverageStageOfGrowth_1222"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageYieldPerPlant" xlink:label="loc_imc_AverageYieldPerPlant_1223"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageYieldPerPlant" xlink:label="loc_imc_AverageYieldPerPlant_1224"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageYieldPerPlant" xlink:label="loc_imc_AverageYieldPerPlant_1225"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankCreditRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_1226"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankCreditRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_1227"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankCreditRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_1228"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankCreditRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_1229"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankLoanAndLeaseLiabilities" xlink:label="loc_imc_BankLoanAndLeaseLiabilities_1230"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankLoanAndLeaseLiabilities" xlink:label="loc_imc_BankLoanAndLeaseLiabilities_1231"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankLoanAndLeaseLiabilities" xlink:label="loc_imc_BankLoanAndLeaseLiabilities_1232"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BaseShelfProspectusMember" xlink:label="loc_imc_BaseShelfProspectusMember_1233"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BaseShelfProspectusMember" xlink:label="loc_imc_BaseShelfProspectusMember_1234"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BaseShelfProspectusMember" xlink:label="loc_imc_BaseShelfProspectusMember_1235"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BasicDilutedEarningsLossPerShare" xlink:label="loc_imc_BasicDilutedEarningsLossPerShare_1236"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BasicDilutedEarningsLossPerShare" xlink:label="loc_imc_BasicDilutedEarningsLossPerShare_1237"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BasicDilutedEarningsLossPerShare" xlink:label="loc_imc_BasicDilutedEarningsLossPerShare_1238"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BiologicalAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_1239"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BiologicalAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_1240"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BiologicalAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_1241"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BorrowingRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BorrowingRecognisedAsOfAcquisitionDate_1242"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BorrowingRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BorrowingRecognisedAsOfAcquisitionDate_1243"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BorrowingRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BorrowingRecognisedAsOfAcquisitionDate_1244"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BulkCannabisMember" xlink:label="loc_imc_BulkCannabisMember_1245"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BulkCannabisMember" xlink:label="loc_imc_BulkCannabisMember_1246"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BulkCannabisMember" xlink:label="loc_imc_BulkCannabisMember_1247"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannabisPlantsMember" xlink:label="loc_imc_CannabisPlantsMember_1248"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannabisPlantsMember" xlink:label="loc_imc_CannabisPlantsMember_1249"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannabisPlantsMember" xlink:label="loc_imc_CannabisPlantsMember_1250"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannacanadaIncMember" xlink:label="loc_imc_CannacanadaIncMember_1251"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannacanadaIncMember" xlink:label="loc_imc_CannacanadaIncMember_1252"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannacanadaIncMember" xlink:label="loc_imc_CannacanadaIncMember_1253"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CapitalExpenditures" xlink:label="loc_imc_CapitalExpenditures_1254"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CapitalExpenditures" xlink:label="loc_imc_CapitalExpenditures_1255"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CapitalExpenditures" xlink:label="loc_imc_CapitalExpenditures_1256"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CapitalizedCostsOfInventories" xlink:label="loc_imc_CapitalizedCostsOfInventories_1257"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CapitalizedCostsOfInventories" xlink:label="loc_imc_CapitalizedCostsOfInventories_1258"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CapitalizedCostsOfInventories" xlink:label="loc_imc_CapitalizedCostsOfInventories_1259"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardLossesForTaxPurposesDescription" xlink:label="loc_imc_CarryforwardLossesForTaxPurposesDescription_1260"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardLossesForTaxPurposesDescription" xlink:label="loc_imc_CarryforwardLossesForTaxPurposesDescription_1261"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardLossesForTaxPurposesDescription" xlink:label="loc_imc_CarryforwardLossesForTaxPurposesDescription_1262"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardOperatingTaxLosses" xlink:label="loc_imc_CarryforwardOperatingTaxLosses_1263"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardOperatingTaxLosses" xlink:label="loc_imc_CarryforwardOperatingTaxLosses_1264"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardOperatingTaxLosses" xlink:label="loc_imc_CarryforwardOperatingTaxLosses_1265"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashAndCashEquivalentMember" xlink:label="loc_imc_CashAndCashEquivalentMember_1266"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashAndCashEquivalentMember" xlink:label="loc_imc_CashAndCashEquivalentMember_1267"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_1268"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_1269"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_1270"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInRestrictedBankDeposits" xlink:label="loc_imc_ChangeInRestrictedBankDeposits_1271"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInRestrictedBankDeposits" xlink:label="loc_imc_ChangeInRestrictedBankDeposits_1272"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInRestrictedBankDeposits" xlink:label="loc_imc_ChangeInRestrictedBankDeposits_1273"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInTaxBenefitsNotRecognized" xlink:label="loc_imc_ChangeInTaxBenefitsNotRecognized_1274"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInTaxBenefitsNotRecognized" xlink:label="loc_imc_ChangeInTaxBenefitsNotRecognized_1275"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInTaxBenefitsNotRecognized" xlink:label="loc_imc_ChangeInTaxBenefitsNotRecognized_1276"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangesInNonCashWorkingCapitalAbstract" xlink:label="loc_imc_ChangesInNonCashWorkingCapitalAbstract_1277"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangesInNonCashWorkingCapitalAbstract" xlink:label="loc_imc_ChangesInNonCashWorkingCapitalAbstract_1278"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesAxis" xlink:label="loc_imc_ClassesOfInventoriesAxis_1279"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesAxis" xlink:label="loc_imc_ClassesOfInventoriesAxis_1280"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesDomain" xlink:label="loc_imc_ClassesOfInventoriesDomain_1281"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesDomain" xlink:label="loc_imc_ClassesOfInventoriesDomain_1282"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Commitment" xlink:label="loc_imc_Commitment_1283"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Commitment" xlink:label="loc_imc_Commitment_1284"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Commitment" xlink:label="loc_imc_Commitment_1285"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptionPricePerShare" xlink:label="loc_imc_CompensationOptionPricePerShare_1286"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptionPricePerShare" xlink:label="loc_imc_CompensationOptionPricePerShare_1287"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptionPricePerShare" xlink:label="loc_imc_CompensationOptionPricePerShare_1288"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptions2019Member" xlink:label="loc_imc_CompensationOptions2019Member_1289"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptions2019Member" xlink:label="loc_imc_CompensationOptions2019Member_1290"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptions2019Member" xlink:label="loc_imc_CompensationOptions2019Member_1291"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitPerShare" xlink:label="loc_imc_CompensationUnitPerShare_1292"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitPerShare" xlink:label="loc_imc_CompensationUnitPerShare_1293"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitPerShare" xlink:label="loc_imc_CompensationUnitPerShare_1294"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitsMember" xlink:label="loc_imc_CompensationUnitsMember_1295"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitsMember" xlink:label="loc_imc_CompensationUnitsMember_1296"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitsMember" xlink:label="loc_imc_CompensationUnitsMember_1297"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares" xlink:label="loc_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_1298"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares" xlink:label="loc_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_1299"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares" xlink:label="loc_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_1300"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionPricePerWarrant" xlink:label="loc_imc_ConversionPricePerWarrant_1301"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionPricePerWarrant" xlink:label="loc_imc_ConversionPricePerWarrant_1302"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionPricePerWarrant" xlink:label="loc_imc_ConversionPricePerWarrant_1303"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CostOfGoodsSoldInventory" xlink:label="loc_imc_CostOfGoodsSoldInventory_1304"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CostOfGoodsSoldInventory" xlink:label="loc_imc_CostOfGoodsSoldInventory_1305"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CostOfGoodsSoldInventory" xlink:label="loc_imc_CostOfGoodsSoldInventory_1306"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CultivationsAndProcessingLicenseMember" xlink:label="loc_imc_CultivationsAndProcessingLicenseMember_1307"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CultivationsAndProcessingLicenseMember" xlink:label="loc_imc_CultivationsAndProcessingLicenseMember_1308"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CultivationsAndProcessingLicenseMember" xlink:label="loc_imc_CultivationsAndProcessingLicenseMember_1309"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerOneMember" xlink:label="loc_imc_CustomerOneMember_1310"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerOneMember" xlink:label="loc_imc_CustomerOneMember_1311"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerOneMember" xlink:label="loc_imc_CustomerOneMember_1312"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerRelationshipsMember" xlink:label="loc_imc_CustomerRelationshipsMember_1313"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerRelationshipsMember" xlink:label="loc_imc_CustomerRelationshipsMember_1314"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerRelationshipsMember" xlink:label="loc_imc_CustomerRelationshipsMember_1315"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerThreeMember" xlink:label="loc_imc_CustomerThreeMember_1316"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerThreeMember" xlink:label="loc_imc_CustomerThreeMember_1317"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerThreeMember" xlink:label="loc_imc_CustomerThreeMember_1318"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerTwoMember" xlink:label="loc_imc_CustomerTwoMember_1319"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerTwoMember" xlink:label="loc_imc_CustomerTwoMember_1320"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerTwoMember" xlink:label="loc_imc_CustomerTwoMember_1321"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeemedIssuance" xlink:label="loc_imc_DeemedIssuance_1322"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeemedIssuance" xlink:label="loc_imc_DeemedIssuance_1323"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeemedIssuance" xlink:label="loc_imc_DeemedIssuance_1324"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeemedPricePerShare" xlink:label="loc_imc_DeemedPricePerShare_1325"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeemedPricePerShare" xlink:label="loc_imc_DeemedPricePerShare_1326"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeemedPricePerShare" xlink:label="loc_imc_DeemedPricePerShare_1327"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAbstract" xlink:label="loc_imc_DeferredTaxAssetsAbstract_1328"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAbstract" xlink:label="loc_imc_DeferredTaxAssetsAbstract_1329"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAndLiabilitiesAxis" xlink:label="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1330"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAndLiabilitiesAxis" xlink:label="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1331"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAndLiabilitiesDomain" xlink:label="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1332"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsMember" xlink:label="loc_imc_DeferredTaxAssetsMember_1333"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsMember" xlink:label="loc_imc_DeferredTaxAssetsMember_1334"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsMember" xlink:label="loc_imc_DeferredTaxAssetsMember_1335"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxLiabilitiesMember" xlink:label="loc_imc_DeferredTaxLiabilitiesMember_1336"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxLiabilitiesMember" xlink:label="loc_imc_DeferredTaxLiabilitiesMember_1337"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxLiabilitiesMember" xlink:label="loc_imc_DeferredTaxLiabilitiesMember_1338"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DerivativeAssetsAsOfAcquisitionDate" xlink:label="loc_imc_DerivativeAssetsAsOfAcquisitionDate_1339"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DerivativeAssetsAsOfAcquisitionDate" xlink:label="loc_imc_DerivativeAssetsAsOfAcquisitionDate_1340"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DerivativeAssetsAsOfAcquisitionDate" xlink:label="loc_imc_DerivativeAssetsAsOfAcquisitionDate_1341"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1342"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1343"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1344"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_1345"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_1346"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_1347"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_1348"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_1349"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_1350"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock" xlink:label="loc_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_1351"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock" xlink:label="loc_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_1352"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock" xlink:label="loc_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_1353"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_1354"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_1355"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_1356"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover" xlink:label="loc_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_1357"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover" xlink:label="loc_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_1358"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover" xlink:label="loc_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_1359"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfExpectedDividendYieldOptionsGranted" xlink:label="loc_imc_DescriptionOfExpectedDividendYieldOptionsGranted_1360"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfExpectedDividendYieldOptionsGranted" xlink:label="loc_imc_DescriptionOfExpectedDividendYieldOptionsGranted_1361"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfExpectedDividendYieldOptionsGranted" xlink:label="loc_imc_DescriptionOfExpectedDividendYieldOptionsGranted_1362"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfOtherConvertibleSecritiesConversion" xlink:label="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_1363"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfOtherConvertibleSecritiesConversion" xlink:label="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_1364"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfOtherConvertibleSecritiesConversion" xlink:label="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_1365"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" xlink:label="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_1366"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" xlink:label="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_1367"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" xlink:label="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_1368"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation" xlink:label="loc_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_1369"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation" xlink:label="loc_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_1370"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation" xlink:label="loc_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_1371"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureForSignificantAccountingPoliciesAbstract" xlink:label="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_1372"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfBalancesWithRelatedPartiesExplanatory" xlink:label="loc_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1373"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfBalancesWithRelatedPartiesExplanatory" xlink:label="loc_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1374"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfBalancesWithRelatedPartiesExplanatory" xlink:label="loc_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1375"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory" xlink:label="loc_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_1376"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory" xlink:label="loc_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_1377"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory" xlink:label="loc_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_1378"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfCompositionOfShareCapitalExplanatory" xlink:label="loc_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1379"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfCompositionOfShareCapitalExplanatory" xlink:label="loc_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1380"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfCompositionOfShareCapitalExplanatory" xlink:label="loc_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1381"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_1382"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_1383"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1384"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1385"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_1386"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_1387"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_1388"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_1389"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_1390"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_1391"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1392"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1393"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1394"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_1395"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_1396"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_1397"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_1398"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_1399"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_1400"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1401"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1402"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1403"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_1404"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_1405"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_1406"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_1407"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_1408"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_1409"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1410"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1411"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1412"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1413"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1414"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1415"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_1416"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_1417"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_1418"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_1419"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_1420"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_1421"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1422"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1423"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1424"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_1425"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_1426"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_1427"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_1428"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_1429"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_1430"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_1431"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1432"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1433"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1434"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1435"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1436"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract" xlink:label="loc_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_1437"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract" xlink:label="loc_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_1438"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeographicAllocationOfAssetsExplanatory" xlink:label="loc_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_1439"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeographicAllocationOfAssetsExplanatory" xlink:label="loc_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_1440"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeographicAllocationOfAssetsExplanatory" xlink:label="loc_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_1441"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory" xlink:label="loc_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_1442"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory" xlink:label="loc_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_1443"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory" xlink:label="loc_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_1444"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" xlink:label="loc_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1445"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" xlink:label="loc_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1446"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory" xlink:label="loc_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1447"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_1448"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_1449"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_1450"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOtherAccountsReceivableAbstract" xlink:label="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_1451"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOtherAccountsReceivablesExplanatory" xlink:label="loc_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1452"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOtherAccountsReceivablesExplanatory" xlink:label="loc_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1453"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOtherAccountsReceivablesExplanatory" xlink:label="loc_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1454"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory" xlink:label="loc_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1455"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory" xlink:label="loc_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1456"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory" xlink:label="loc_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1457"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRestrictedShareUnitsTableTextBlock" xlink:label="loc_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_1458"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRestrictedShareUnitsTableTextBlock" xlink:label="loc_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_1459"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRestrictedShareUnitsTableTextBlock" xlink:label="loc_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_1460"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfReverseTakeoverExplanatory" xlink:label="loc_imc_DisclosureOfReverseTakeoverExplanatory_1461"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfReverseTakeoverExplanatory" xlink:label="loc_imc_DisclosureOfReverseTakeoverExplanatory_1462"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfReverseTakeoverExplanatory" xlink:label="loc_imc_DisclosureOfReverseTakeoverExplanatory_1463"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfReverseTakeoverLineItems" xlink:label="loc_imc_DisclosureOfReverseTakeoverLineItems_1464"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfReverseTakeoverTable" xlink:label="loc_imc_DisclosureOfReverseTakeoverTable_1465"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfReverseTakeoverTable" xlink:label="loc_imc_DisclosureOfReverseTakeoverTable_1466"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRightOfUseAssetsExplanatory" xlink:label="loc_imc_DisclosureOfRightOfUseAssetsExplanatory_1467"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRightOfUseAssetsExplanatory" xlink:label="loc_imc_DisclosureOfRightOfUseAssetsExplanatory_1468"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRightOfUseAssetsExplanatory" xlink:label="loc_imc_DisclosureOfRightOfUseAssetsExplanatory_1469"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory" xlink:label="loc_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_1470"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory" xlink:label="loc_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_1471"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory" xlink:label="loc_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_1472"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory" xlink:label="loc_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1473"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory" xlink:label="loc_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1474"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory" xlink:label="loc_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1475"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1476"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1477"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1478"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfStatementOfProfitAndLossExplanatory" xlink:label="loc_imc_DisclosureOfStatementOfProfitAndLossExplanatory_1479"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfStatementOfProfitAndLossExplanatory" xlink:label="loc_imc_DisclosureOfStatementOfProfitAndLossExplanatory_1480"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfStatementOfProfitAndLossExplanatory" xlink:label="loc_imc_DisclosureOfStatementOfProfitAndLossExplanatory_1481"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_1482"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_1483"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_1484"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_1485"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfTradeReceivablesExplanatory" xlink:label="loc_imc_DisclosureOfTradeReceivablesExplanatory_1486"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfTradeReceivablesExplanatory" xlink:label="loc_imc_DisclosureOfTradeReceivablesExplanatory_1487"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfTradeReceivablesExplanatory" xlink:label="loc_imc_DisclosureOfTradeReceivablesExplanatory_1488"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalOfTerminationOfLeases" xlink:label="loc_imc_DisposalOfTerminationOfLeases_1489"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalOfTerminationOfLeases" xlink:label="loc_imc_DisposalOfTerminationOfLeases_1490"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalOfTerminationOfLeases" xlink:label="loc_imc_DisposalOfTerminationOfLeases_1491"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalsOfRightOfUseAssets" xlink:label="loc_imc_DisposalsOfRightOfUseAssets_1492"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalsOfRightOfUseAssets" xlink:label="loc_imc_DisposalsOfRightOfUseAssets_1493"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalsOfRightOfUseAssets" xlink:label="loc_imc_DisposalsOfRightOfUseAssets_1494"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DocumentAndEntityAbstract" xlink:label="loc_imc_DocumentAndEntityAbstract_1495"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DocumentAndEntityInformationAbstract" xlink:label="loc_imc_DocumentAndEntityInformationAbstract_1496"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" xlink:label="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_1497"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesAndPayrollAccruals" xlink:label="loc_imc_EmployeesAndPayrollAccruals_1498"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesAndPayrollAccruals" xlink:label="loc_imc_EmployeesAndPayrollAccruals_1499"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesAndPayrollAccruals" xlink:label="loc_imc_EmployeesAndPayrollAccruals_1500"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesDirectorsAndAdvisorsMember" xlink:label="loc_imc_EmployeesDirectorsAndAdvisorsMember_1501"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesDirectorsAndAdvisorsMember" xlink:label="loc_imc_EmployeesDirectorsAndAdvisorsMember_1502"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesDirectorsAndAdvisorsMember" xlink:label="loc_imc_EmployeesDirectorsAndAdvisorsMember_1503"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityIssuancePricePerShare" xlink:label="loc_imc_EquityIssuancePricePerShare_1504"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityIssuancePricePerShare" xlink:label="loc_imc_EquityIssuancePricePerShare_1505"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityIssuancePricePerShare" xlink:label="loc_imc_EquityIssuancePricePerShare_1506"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionAxis" xlink:label="loc_imc_EquityTransactionAxis_1507"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionAxis" xlink:label="loc_imc_EquityTransactionAxis_1508"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_1509"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_1510"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EstimatedTotalAmountOfClassActionSuit" xlink:label="loc_imc_EstimatedTotalAmountOfClassActionSuit_1511"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EstimatedTotalAmountOfClassActionSuit" xlink:label="loc_imc_EstimatedTotalAmountOfClassActionSuit_1512"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EstimatedTotalAmountOfClassActionSuit" xlink:label="loc_imc_EstimatedTotalAmountOfClassActionSuit_1513"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExercisePriceOfWarrant" xlink:label="loc_imc_ExercisePriceOfWarrant_1514"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExercisePriceOfWarrant" xlink:label="loc_imc_ExercisePriceOfWarrant_1515"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExercisePriceOfWarrant" xlink:label="loc_imc_ExercisePriceOfWarrant_1516"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedDividendYieldOfWarrants" xlink:label="loc_imc_ExpectedDividendYieldOfWarrants_1517"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedDividendYieldOfWarrants" xlink:label="loc_imc_ExpectedDividendYieldOfWarrants_1518"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedDividendYieldOfWarrants" xlink:label="loc_imc_ExpectedDividendYieldOfWarrants_1519"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedLifeOfWarrants" xlink:label="loc_imc_ExpectedLifeOfWarrants_1520"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedLifeOfWarrants" xlink:label="loc_imc_ExpectedLifeOfWarrants_1521"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedLifeOfWarrants" xlink:label="loc_imc_ExpectedLifeOfWarrants_1522"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedVolatilityOfWarrants" xlink:label="loc_imc_ExpectedVolatilityOfWarrants_1523"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedVolatilityOfWarrants" xlink:label="loc_imc_ExpectedVolatilityOfWarrants_1524"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedVolatilityOfWarrants" xlink:label="loc_imc_ExpectedVolatilityOfWarrants_1525"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExternalCustomersRevenues" xlink:label="loc_imc_ExternalCustomersRevenues_1526"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExternalCustomersRevenues" xlink:label="loc_imc_ExternalCustomersRevenues_1527"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExternalCustomersRevenues" xlink:label="loc_imc_ExternalCustomersRevenues_1528"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_1529"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_1530"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_1531"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnSaleOfInventory" xlink:label="loc_imc_FairValueAdjustmentOnSaleOfInventory_1532"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnSaleOfInventory" xlink:label="loc_imc_FairValueAdjustmentOnSaleOfInventory_1533"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnSaleOfInventory" xlink:label="loc_imc_FairValueAdjustmentOnSaleOfInventory_1534"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnSaleOfInventory" xlink:label="loc_imc_FairValueAdjustmentOnSaleOfInventory_1535"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnSaleOfInventory" xlink:label="loc_imc_FairValueAdjustmentOnSaleOfInventory_1536"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue" xlink:label="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1537"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue" xlink:label="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1538"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue" xlink:label="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1539"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue" xlink:label="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1540"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentsAbstract" xlink:label="loc_imc_FairValueAdjustmentsAbstract_1541"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentsAbstract" xlink:label="loc_imc_FairValueAdjustmentsAbstract_1542"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfCompensationUnits" xlink:label="loc_imc_FairValueOfCompensationUnits_1543"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfCompensationUnits" xlink:label="loc_imc_FairValueOfCompensationUnits_1544"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfCompensationUnits" xlink:label="loc_imc_FairValueOfCompensationUnits_1545"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfInvestment" xlink:label="loc_imc_FairValueOfInvestment_1546"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfInvestment" xlink:label="loc_imc_FairValueOfInvestment_1547"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfInvestment" xlink:label="loc_imc_FairValueOfInvestment_1548"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfUnitsIssued" xlink:label="loc_imc_FairValueOfUnitsIssued_1549"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfUnitsIssued" xlink:label="loc_imc_FairValueOfUnitsIssued_1550"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfUnitsIssued" xlink:label="loc_imc_FairValueOfUnitsIssued_1551"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfWarrants" xlink:label="loc_imc_FairValueOfWarrants_1552"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfWarrants" xlink:label="loc_imc_FairValueOfWarrants_1553"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfWarrants" xlink:label="loc_imc_FairValueOfWarrants_1554"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfWarrants" xlink:label="loc_imc_FairValueOfWarrants_1555"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValuePerWarrant" xlink:label="loc_imc_FairValuePerWarrant_1556"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValuePerWarrant" xlink:label="loc_imc_FairValuePerWarrant_1557"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValuePerWarrant" xlink:label="loc_imc_FairValuePerWarrant_1558"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialAdvisorsMember" xlink:label="loc_imc_FinancialAdvisorsMember_1559"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialAdvisorsMember" xlink:label="loc_imc_FinancialAdvisorsMember_1560"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialAdvisorsMember" xlink:label="loc_imc_FinancialAdvisorsMember_1561"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtAmortizedCostMember" xlink:label="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1562"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtAmortizedCostMember" xlink:label="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1563"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtAmortizedCostMember" xlink:label="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1564"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember" xlink:label="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_1565"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember" xlink:label="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_1566"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember" xlink:label="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_1567"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinishedGoodsMember" xlink:label="loc_imc_FinishedGoodsMember_1568"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinishedGoodsMember" xlink:label="loc_imc_FinishedGoodsMember_1569"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinishedGoodsMember" xlink:label="loc_imc_FinishedGoodsMember_1570"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstAnniversaryOfApplicableVestingCommencementDateMember" xlink:label="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_1571"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstAnniversaryOfApplicableVestingCommencementDateMember" xlink:label="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_1572"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstAnniversaryOfApplicableVestingCommencementDateMember" xlink:label="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_1573"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstInstallmentMember" xlink:label="loc_imc_FirstInstallmentMember_1574"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstInstallmentMember" xlink:label="loc_imc_FirstInstallmentMember_1575"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstInstallmentMember" xlink:label="loc_imc_FirstInstallmentMember_1576"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FixedGrowthRate" xlink:label="loc_imc_FixedGrowthRate_1577"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FixedGrowthRate" xlink:label="loc_imc_FixedGrowthRate_1578"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FixedGrowthRate" xlink:label="loc_imc_FixedGrowthRate_1579"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1580"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1581"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1582"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1583"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ForeignCountriesTwoMember" xlink:label="loc_imc_ForeignCountriesTwoMember_1584"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ForeignCountriesTwoMember" xlink:label="loc_imc_ForeignCountriesTwoMember_1585"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ForeignCountriesTwoMember" xlink:label="loc_imc_ForeignCountriesTwoMember_1586"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GainLossOnRevaluationOfFinancialInstruments" xlink:label="loc_imc_GainLossOnRevaluationOfFinancialInstruments_1587"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GainLossOnRevaluationOfFinancialInstruments" xlink:label="loc_imc_GainLossOnRevaluationOfFinancialInstruments_1588"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GainLossOnRevaluationOfFinancialInstruments" xlink:label="loc_imc_GainLossOnRevaluationOfFinancialInstruments_1589"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GalenIndustriesSingleMemberSocieteAnonymeMember" xlink:label="loc_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_1590"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GalenIndustriesSingleMemberSocieteAnonymeMember" xlink:label="loc_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_1591"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GalenIndustriesSingleMemberSocieteAnonymeMember" xlink:label="loc_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_1592"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate" xlink:label="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_1593"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate" xlink:label="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_1594"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate" xlink:label="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_1595"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseProductionEquipmentMember" xlink:label="loc_imc_GreenhouseProductionEquipmentMember_1596"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseProductionEquipmentMember" xlink:label="loc_imc_GreenhouseProductionEquipmentMember_1597"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseProductionEquipmentMember" xlink:label="loc_imc_GreenhouseProductionEquipmentMember_1598"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseStructureMember" xlink:label="loc_imc_GreenhouseStructureMember_1599"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseStructureMember" xlink:label="loc_imc_GreenhouseStructureMember_1600"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseStructureMember" xlink:label="loc_imc_GreenhouseStructureMember_1601"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProceedsFromIssuanceOfUnits" xlink:label="loc_imc_GrossProceedsFromIssuanceOfUnits_1602"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProceedsFromIssuanceOfUnits" xlink:label="loc_imc_GrossProceedsFromIssuanceOfUnits_1603"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProceedsFromIssuanceOfUnits" xlink:label="loc_imc_GrossProceedsFromIssuanceOfUnits_1604"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProfitBeforeFairValueAdjustments" xlink:label="loc_imc_GrossProfitBeforeFairValueAdjustments_1605"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProfitBeforeFairValueAdjustments" xlink:label="loc_imc_GrossProfitBeforeFairValueAdjustments_1606"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProfitBeforeFairValueAdjustments" xlink:label="loc_imc_GrossProfitBeforeFairValueAdjustments_1607"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighlandGrowIncMember" xlink:label="loc_imc_HighlandGrowIncMember_1608"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighlandGrowIncMember" xlink:label="loc_imc_HighlandGrowIncMember_1609"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighlandGrowIncMember" xlink:label="loc_imc_HighlandGrowIncMember_1610"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighWayShinuaLtdMember" xlink:label="loc_imc_HighWayShinuaLtdMember_1611"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighWayShinuaLtdMember" xlink:label="loc_imc_HighWayShinuaLtdMember_1612"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighWayShinuaLtdMember" xlink:label="loc_imc_HighWayShinuaLtdMember_1613"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1614"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1615"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1616"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1617"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1618"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1619"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1620"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImcHoldingsLtdMember" xlink:label="loc_imc_ImcHoldingsLtdMember_1621"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImcHoldingsLtdMember" xlink:label="loc_imc_ImcHoldingsLtdMember_1622"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImcHoldingsLtdMember" xlink:label="loc_imc_ImcHoldingsLtdMember_1623"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IMCOrdinaryShareholderMember" xlink:label="loc_imc_IMCOrdinaryShareholderMember_1624"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IMCOrdinaryShareholderMember" xlink:label="loc_imc_IMCOrdinaryShareholderMember_1625"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IMCOrdinaryShareholderMember" xlink:label="loc_imc_IMCOrdinaryShareholderMember_1626"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" xlink:label="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_1627"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" xlink:label="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_1628"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" xlink:label="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_1629"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" xlink:label="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_1630"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" xlink:label="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_1631"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" xlink:label="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_1632"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncomeTaxFromPreviousYears" xlink:label="loc_imc_IncomeTaxFromPreviousYears_1633"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncomeTaxFromPreviousYears" xlink:label="loc_imc_IncomeTaxFromPreviousYears_1634"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncomeTaxFromPreviousYears" xlink:label="loc_imc_IncomeTaxFromPreviousYears_1635"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncomeTaxLiabilityOfKeyPersonnel" xlink:label="loc_imc_IncomeTaxLiabilityOfKeyPersonnel_1636"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncomeTaxLiabilityOfKeyPersonnel" xlink:label="loc_imc_IncomeTaxLiabilityOfKeyPersonnel_1637"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncomeTaxLiabilityOfKeyPersonnel" xlink:label="loc_imc_IncomeTaxLiabilityOfKeyPersonnel_1638"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16" xlink:label="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_1639"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16" xlink:label="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_1640"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16" xlink:label="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_1641"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_1642"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_1643"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_1644"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_1645"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_1646"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_1647"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughForfeitedOptions" xlink:label="loc_imc_IncreaseDecreaseThroughForfeitedOptions_1648"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughForfeitedOptions" xlink:label="loc_imc_IncreaseDecreaseThroughForfeitedOptions_1649"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughForfeitedOptions" xlink:label="loc_imc_IncreaseDecreaseThroughForfeitedOptions_1650"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment" xlink:label="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_1651"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment" xlink:label="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_1652"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment" xlink:label="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_1653"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" xlink:label="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_1654"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" xlink:label="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_1655"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" xlink:label="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_1656"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_1657"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_1658"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_1659"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary" xlink:label="loc_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_1660"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary" xlink:label="loc_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_1661"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary" xlink:label="loc_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_1662"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1663"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1664"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1665"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1666"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_1667"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_1668"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_1669"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_1670"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_1671"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_1672"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialCapitalExpenditures" xlink:label="loc_imc_InitialCapitalExpenditures_1673"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialCapitalExpenditures" xlink:label="loc_imc_InitialCapitalExpenditures_1674"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialCapitalExpenditures" xlink:label="loc_imc_InitialCapitalExpenditures_1675"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialConsolidationsRightOfUseAssets" xlink:label="loc_imc_InitialConsolidationsRightOfUseAssets_1676"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialConsolidationsRightOfUseAssets" xlink:label="loc_imc_InitialConsolidationsRightOfUseAssets_1677"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialConsolidationsRightOfUseAssets" xlink:label="loc_imc_InitialConsolidationsRightOfUseAssets_1678"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialTermOfAgreement" xlink:label="loc_imc_InitialTermOfAgreement_1679"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialTermOfAgreement" xlink:label="loc_imc_InitialTermOfAgreement_1680"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialTermOfAgreement" xlink:label="loc_imc_InitialTermOfAgreement_1681"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IntangibleAssetsMember" xlink:label="loc_imc_IntangibleAssetsMember_1682"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IntangibleAssetsMember" xlink:label="loc_imc_IntangibleAssetsMember_1683"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IntangibleAssetsMember" xlink:label="loc_imc_IntangibleAssetsMember_1684"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestIncomeOnPlanAssets" xlink:label="loc_imc_InterestIncomeOnPlanAssets_1685"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestIncomeOnPlanAssets" xlink:label="loc_imc_InterestIncomeOnPlanAssets_1686"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestIncomeOnPlanAssets" xlink:label="loc_imc_InterestIncomeOnPlanAssets_1687"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestIncomeOnPlanAssets" xlink:label="loc_imc_InterestIncomeOnPlanAssets_1688"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestPaidInRespectOfLoans" xlink:label="loc_imc_InterestPaidInRespectOfLoans_1689"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestPaidInRespectOfLoans" xlink:label="loc_imc_InterestPaidInRespectOfLoans_1690"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestPaidInRespectOfLoans" xlink:label="loc_imc_InterestPaidInRespectOfLoans_1691"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterSegmentRevenues" xlink:label="loc_imc_InterSegmentRevenues_1692"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterSegmentRevenues" xlink:label="loc_imc_InterSegmentRevenues_1693"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterSegmentRevenues" xlink:label="loc_imc_InterSegmentRevenues_1694"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InventoriesLineItems" xlink:label="loc_imc_InventoriesLineItems_1695"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InventoriesLineItems" xlink:label="loc_imc_InventoriesLineItems_1696"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InventoriesTable" xlink:label="loc_imc_InventoriesTable_1697"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InventoriesTable" xlink:label="loc_imc_InventoriesTable_1698"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1699"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1700"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1701"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1702"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate_1703"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate_1704"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAsOfAcquisitionDate_1705"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAsOfAcquisitionDate_1706"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAsOfAcquisitionDate_1707"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsInUnlistedSharesMeasuredAtFairValue" xlink:label="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_1708"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsInUnlistedSharesMeasuredAtFairValue" xlink:label="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_1709"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsInUnlistedSharesMeasuredAtFairValue" xlink:label="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_1710"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCFarmsIsraelLtdPointMember" xlink:label="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_1711"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCFarmsIsraelLtdPointMember" xlink:label="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_1712"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCFarmsIsraelLtdPointMember" xlink:label="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_1713"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" xlink:label="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_1714"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" xlink:label="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_1715"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" xlink:label="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_1716"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCPointHoldingsLtdMember" xlink:label="loc_imc_IPointMPointCPointHoldingsLtdMember_1717"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCPointHoldingsLtdMember" xlink:label="loc_imc_IPointMPointCPointHoldingsLtdMember_1718"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCPointHoldingsLtdMember" xlink:label="loc_imc_IPointMPointCPointHoldingsLtdMember_1719"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCVenturesLtdPointMember" xlink:label="loc_imc_IPointMPointCVenturesLtdPointMember_1720"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCVenturesLtdPointMember" xlink:label="loc_imc_IPointMPointCVenturesLtdPointMember_1721"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCVenturesLtdPointMember" xlink:label="loc_imc_IPointMPointCVenturesLtdPointMember_1722"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IsraelAndGermanyAndCanadaMember" xlink:label="loc_imc_IsraelAndGermanyAndCanadaMember_1723"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IsraelAndGermanyAndCanadaMember" xlink:label="loc_imc_IsraelAndGermanyAndCanadaMember_1724"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IsraelAndGermanyAndCanadaMember" xlink:label="loc_imc_IsraelAndGermanyAndCanadaMember_1725"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IsraelMember" xlink:label="loc_imc_IsraelMember_1726"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IsraelMember" xlink:label="loc_imc_IsraelMember_1727"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfCommonShares" xlink:label="loc_imc_IssuanceOfCommonShares_1728"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfCommonShares" xlink:label="loc_imc_IssuanceOfCommonShares_1729"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfCommonShares" xlink:label="loc_imc_IssuanceOfCommonShares_1730"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfCommonSharesAmount" xlink:label="loc_imc_IssuanceOfCommonSharesAmount_1731"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfCommonSharesAmount" xlink:label="loc_imc_IssuanceOfCommonSharesAmount_1732"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfCommonSharesAmount" xlink:label="loc_imc_IssuanceOfCommonSharesAmount_1733"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfEquityOnReverseAcquisition" xlink:label="loc_imc_IssuanceOfEquityOnReverseAcquisition_1734"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfEquityOnReverseAcquisition" xlink:label="loc_imc_IssuanceOfEquityOnReverseAcquisition_1735"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfEquityOnReverseAcquisition" xlink:label="loc_imc_IssuanceOfEquityOnReverseAcquisition_1736"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesInConnectionWithReverseAcquisition" xlink:label="loc_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_1737"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesInConnectionWithReverseAcquisition" xlink:label="loc_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_1738"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesInConnectionWithReverseAcquisition" xlink:label="loc_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_1739"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesWithPrivatePlacement" xlink:label="loc_imc_IssuanceOfSharesWithPrivatePlacement_1740"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesWithPrivatePlacement" xlink:label="loc_imc_IssuanceOfSharesWithPrivatePlacement_1741"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesWithPrivatePlacement" xlink:label="loc_imc_IssuanceOfSharesWithPrivatePlacement_1742"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesWithPrivatePlacement" xlink:label="loc_imc_IssuanceOfSharesWithPrivatePlacement_1743"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity1" xlink:label="loc_imc_IssueOfEquity1_1744"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity1" xlink:label="loc_imc_IssueOfEquity1_1745"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity1" xlink:label="loc_imc_IssueOfEquity1_1746"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity2" xlink:label="loc_imc_IssueOfEquity2_1747"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity2" xlink:label="loc_imc_IssueOfEquity2_1748"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity2" xlink:label="loc_imc_IssueOfEquity2_1749"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuePricePerSubscriptionReceipt" xlink:label="loc_imc_IssuePricePerSubscriptionReceipt_1750"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuePricePerSubscriptionReceipt" xlink:label="loc_imc_IssuePricePerSubscriptionReceipt_1751"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuePricePerSubscriptionReceipt" xlink:label="loc_imc_IssuePricePerSubscriptionReceipt_1752"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses" xlink:label="loc_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1753"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses" xlink:label="loc_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1754"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses" xlink:label="loc_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1755"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_1756"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_1757"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_1758"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_1759"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LicensesWithIndefiniteLifeMember" xlink:label="loc_imc_LicensesWithIndefiniteLifeMember_1760"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LicensesWithIndefiniteLifeMember" xlink:label="loc_imc_LicensesWithIndefiniteLifeMember_1761"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LicensesWithIndefiniteLifeMember" xlink:label="loc_imc_LicensesWithIndefiniteLifeMember_1762"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LicensesWithIndefiniteLifeMember" xlink:label="loc_imc_LicensesWithIndefiniteLifeMember_1763"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListedWarrantsMember" xlink:label="loc_imc_ListedWarrantsMember_1764"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListedWarrantsMember" xlink:label="loc_imc_ListedWarrantsMember_1765"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingBeforeCost" xlink:label="loc_imc_ListingBeforeCost_1766"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingBeforeCost" xlink:label="loc_imc_ListingBeforeCost_1767"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingBeforeCost" xlink:label="loc_imc_ListingBeforeCost_1768"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingCostOfReverseAcquisition" xlink:label="loc_imc_ListingCostOfReverseAcquisition_1769"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingCostOfReverseAcquisition" xlink:label="loc_imc_ListingCostOfReverseAcquisition_1770"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingCostOfReverseAcquisition" xlink:label="loc_imc_ListingCostOfReverseAcquisition_1771"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingExpenseInReverseTakeover" xlink:label="loc_imc_ListingExpenseInReverseTakeover_1772"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingExpenseInReverseTakeover" xlink:label="loc_imc_ListingExpenseInReverseTakeover_1773"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingExpenseInReverseTakeover" xlink:label="loc_imc_ListingExpenseInReverseTakeover_1774"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoanReceivableRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_1775"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoanReceivableRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_1776"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoanReceivableRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_1777"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoansPayableAsOfAcquisitionDate" xlink:label="loc_imc_LoansPayableAsOfAcquisitionDate_1778"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoansPayableAsOfAcquisitionDate" xlink:label="loc_imc_LoansPayableAsOfAcquisitionDate_1779"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoansPayableAsOfAcquisitionDate" xlink:label="loc_imc_LoansPayableAsOfAcquisitionDate_1780"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_1781"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_1782"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_1783"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_1784"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MajorComponentsOfIncomeTaxExpenseLineItems" xlink:label="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_1785"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MajorComponentsOfIncomeTaxExpenseLineItems" xlink:label="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_1786"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MajorComponentsOfIncomeTaxExpenseTable" xlink:label="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1787"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MajorComponentsOfIncomeTaxExpenseTable" xlink:label="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1788"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MarketPriceOfCommonShares" xlink:label="loc_imc_MarketPriceOfCommonShares_1789"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MarketPriceOfCommonShares" xlink:label="loc_imc_MarketPriceOfCommonShares_1790"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MarketPriceOfCommonShares" xlink:label="loc_imc_MarketPriceOfCommonShares_1791"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MedipharmLabsCorpMember" xlink:label="loc_imc_MedipharmLabsCorpMember_1792"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MedipharmLabsCorpMember" xlink:label="loc_imc_MedipharmLabsCorpMember_1793"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MedipharmLabsCorpMember" xlink:label="loc_imc_MedipharmLabsCorpMember_1794"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MizrahiMember" xlink:label="loc_imc_MizrahiMember_1795"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MizrahiMember" xlink:label="loc_imc_MizrahiMember_1796"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymInternationalBrandsIncMember" xlink:label="loc_imc_MymInternationalBrandsIncMember_1797"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymInternationalBrandsIncMember" xlink:label="loc_imc_MymInternationalBrandsIncMember_1798"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymInternationalBrandsIncMember" xlink:label="loc_imc_MymInternationalBrandsIncMember_1799"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_1800"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_1801"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_1802"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_1803"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsMember" xlink:label="loc_imc_MymNutraceuticalsMember_1804"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsMember" xlink:label="loc_imc_MymNutraceuticalsMember_1805"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsMember" xlink:label="loc_imc_MymNutraceuticalsMember_1806"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaFincoMember" xlink:label="loc_imc_NavasotaFincoMember_1807"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaFincoMember" xlink:label="loc_imc_NavasotaFincoMember_1808"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaMember" xlink:label="loc_imc_NavasotaMember_1809"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaMember" xlink:label="loc_imc_NavasotaMember_1810"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaMember" xlink:label="loc_imc_NavasotaMember_1811"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaShareholdersMember" xlink:label="loc_imc_NavasotaShareholdersMember_1812"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaShareholdersMember" xlink:label="loc_imc_NavasotaShareholdersMember_1813"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaShareholdersMember" xlink:label="loc_imc_NavasotaShareholdersMember_1814"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetCashTransferred" xlink:label="loc_imc_NetCashTransferred_1815"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetCashTransferred" xlink:label="loc_imc_NetCashTransferred_1816"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetCashTransferred" xlink:label="loc_imc_NetCashTransferred_1817"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetCashTransferred" xlink:label="loc_imc_NetCashTransferred_1818"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_1819"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_1820"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_1821"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetLiabilitiesOnDateOfReverseAcquisition" xlink:label="loc_imc_NetLiabilitiesOnDateOfReverseAcquisition_1822"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetLiabilitiesOnDateOfReverseAcquisition" xlink:label="loc_imc_NetLiabilitiesOnDateOfReverseAcquisition_1823"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetLiabilitiesOnDateOfReverseAcquisition" xlink:label="loc_imc_NetLiabilitiesOnDateOfReverseAcquisition_1824"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold" xlink:label="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1825"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold" xlink:label="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1826"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold" xlink:label="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1827"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold" xlink:label="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1828"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold" xlink:label="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1829"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonDeductibleIncomeExpenseNetForTaxPurposes" xlink:label="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1830"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonDeductibleIncomeExpenseNetForTaxPurposes" xlink:label="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1831"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonDeductibleIncomeExpenseNetForTaxPurposes" xlink:label="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1832"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonDeductibleIncomeExpenseNetForTaxPurposes" xlink:label="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1833"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesCalledByWarrants" xlink:label="loc_imc_NumberOfCommonSharesCalledByWarrants_1834"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesCalledByWarrants" xlink:label="loc_imc_NumberOfCommonSharesCalledByWarrants_1835"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesCalledByWarrants" xlink:label="loc_imc_NumberOfCommonSharesCalledByWarrants_1836"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities" xlink:label="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_1837"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities" xlink:label="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_1838"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities" xlink:label="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_1839"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree" xlink:label="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_1840"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree" xlink:label="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_1841"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree" xlink:label="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_1842"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism" xlink:label="loc_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_1843"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism" xlink:label="loc_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_1844"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism" xlink:label="loc_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_1845"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesReceived" xlink:label="loc_imc_NumberOfCommonSharesReceived_1846"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesReceived" xlink:label="loc_imc_NumberOfCommonSharesReceived_1847"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesReceived" xlink:label="loc_imc_NumberOfCommonSharesReceived_1848"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesReceivedOfConvertibleInstrument" xlink:label="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_1849"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesReceivedOfConvertibleInstrument" xlink:label="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_1850"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesReceivedOfConvertibleInstrument" xlink:label="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_1851"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_1852"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_1853"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_1854"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsIssued" xlink:label="loc_imc_NumberOfCompensationUnitsIssued_1855"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsIssued" xlink:label="loc_imc_NumberOfCompensationUnitsIssued_1856"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsIssued" xlink:label="loc_imc_NumberOfCompensationUnitsIssued_1857"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsGrantedToAgents" xlink:label="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_1858"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsGrantedToAgents" xlink:label="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_1859"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsGrantedToAgents" xlink:label="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_1860"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsToAcquired" xlink:label="loc_imc_NumberOfCompensationWarrantsToAcquired_1861"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsToAcquired" xlink:label="loc_imc_NumberOfCompensationWarrantsToAcquired_1862"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsToAcquired" xlink:label="loc_imc_NumberOfCompensationWarrantsToAcquired_1863"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOptionsExercisedUnderCashlessMechanism" xlink:label="loc_imc_NumberOfOptionsExercisedUnderCashlessMechanism_1864"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOptionsExercisedUnderCashlessMechanism" xlink:label="loc_imc_NumberOfOptionsExercisedUnderCashlessMechanism_1865"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOptionsExercisedUnderCashlessMechanism" xlink:label="loc_imc_NumberOfOptionsExercisedUnderCashlessMechanism_1866"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOptionsGranted" xlink:label="loc_imc_NumberOfOptionsGranted_1867"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOptionsGranted" xlink:label="loc_imc_NumberOfOptionsGranted_1868"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOptionsGranted" xlink:label="loc_imc_NumberOfOptionsGranted_1869"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOrdinarySharesIssuedUponConversion" xlink:label="loc_imc_NumberOfOrdinarySharesIssuedUponConversion_1870"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOrdinarySharesIssuedUponConversion" xlink:label="loc_imc_NumberOfOrdinarySharesIssuedUponConversion_1871"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOrdinarySharesIssuedUponConversion" xlink:label="loc_imc_NumberOfOrdinarySharesIssuedUponConversion_1872"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfPreferredSharesCommittedToBeAcquired" xlink:label="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_1873"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfPreferredSharesCommittedToBeAcquired" xlink:label="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_1874"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfPreferredSharesCommittedToBeAcquired" xlink:label="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_1875"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfShareOptionsShareVestedRsu" xlink:label="loc_imc_NumberOfShareOptionsShareVestedRsu_1876"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfShareOptionsShareVestedRsu" xlink:label="loc_imc_NumberOfShareOptionsShareVestedRsu_1877"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfShareOptionsShareVestedRsu" xlink:label="loc_imc_NumberOfShareOptionsShareVestedRsu_1878"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesAvailableForFutureGrants" xlink:label="loc_imc_NumberOfSharesAvailableForFutureGrants_1879"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesAvailableForFutureGrants" xlink:label="loc_imc_NumberOfSharesAvailableForFutureGrants_1880"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesAvailableForFutureGrants" xlink:label="loc_imc_NumberOfSharesAvailableForFutureGrants_1881"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInBusinessCombinationTransaction" xlink:label="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1882"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInBusinessCombinationTransaction" xlink:label="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1883"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInBusinessCombinationTransaction" xlink:label="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1884"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInBusinessCombinationTransaction" xlink:label="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1885"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfSharesIssuedInReverseTakeover_1886"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfSharesIssuedInReverseTakeover_1887"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfSharesIssuedInReverseTakeover_1888"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfSharesIssuedInReverseTakeover_1889"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesRaisedInUSD" xlink:label="loc_imc_NumberOfSharesRaisedInUSD_1890"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesRaisedInUSD" xlink:label="loc_imc_NumberOfSharesRaisedInUSD_1891"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesRaisedInUSD" xlink:label="loc_imc_NumberOfSharesRaisedInUSD_1892"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement" xlink:label="loc_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_1893"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement" xlink:label="loc_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_1894"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement" xlink:label="loc_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_1895"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssued" xlink:label="loc_imc_NumberOfUnitsIssued_1896"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssued" xlink:label="loc_imc_NumberOfUnitsIssued_1897"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssued" xlink:label="loc_imc_NumberOfUnitsIssued_1898"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssuedPricePerShare" xlink:label="loc_imc_NumberOfUnitsIssuedPricePerShare_1899"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssuedPricePerShare" xlink:label="loc_imc_NumberOfUnitsIssuedPricePerShare_1900"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssuedPricePerShare" xlink:label="loc_imc_NumberOfUnitsIssuedPricePerShare_1901"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantExercised" xlink:label="loc_imc_NumberOfWarrantExercised_1902"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantExercised" xlink:label="loc_imc_NumberOfWarrantExercised_1903"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantExercised" xlink:label="loc_imc_NumberOfWarrantExercised_1904"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_1905"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_1906"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_1907"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_1908"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_1909"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_1910"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfWarrantsIssuedInReverseTakeover_1911"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfWarrantsIssuedInReverseTakeover_1912"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfWarrantsIssuedInReverseTakeover_1913"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversion" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversion_1914"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversion" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversion_1915"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversion" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversion_1916"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversionOfUnits" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_1917"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversionOfUnits" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_1918"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversionOfUnits" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_1919"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_1920"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_1921"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_1922"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmMember" xlink:label="loc_imc_OranimPharmMember_1923"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmMember" xlink:label="loc_imc_OranimPharmMember_1924"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPlusPharmLtdMember" xlink:label="loc_imc_OranimPlusPharmLtdMember_1925"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPlusPharmLtdMember" xlink:label="loc_imc_OranimPlusPharmLtdMember_1926"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPlusPharmLtdMember" xlink:label="loc_imc_OranimPlusPharmLtdMember_1927"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharedListedInStockExchangeMarket" xlink:label="loc_imc_OrdinarySharedListedInStockExchangeMarket_1928"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharedListedInStockExchangeMarket" xlink:label="loc_imc_OrdinarySharedListedInStockExchangeMarket_1929"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharedListedInStockExchangeMarket" xlink:label="loc_imc_OrdinarySharedListedInStockExchangeMarket_1930"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld" xlink:label="loc_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_1931"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld" xlink:label="loc_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_1932"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld" xlink:label="loc_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_1933"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" xlink:label="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1934"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" xlink:label="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1935"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" xlink:label="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1936"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" xlink:label="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1937"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedOptionsExercises" xlink:label="loc_imc_OrdinarySharesIssuedOptionsExercises_1938"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedOptionsExercises" xlink:label="loc_imc_OrdinarySharesIssuedOptionsExercises_1939"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedOptionsExercises" xlink:label="loc_imc_OrdinarySharesIssuedOptionsExercises_1940"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedOptionsExercises" xlink:label="loc_imc_OrdinarySharesIssuedOptionsExercises_1941"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedToShareholdersForEachCommonShare" xlink:label="loc_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_1942"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedToShareholdersForEachCommonShare" xlink:label="loc_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_1943"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedToShareholdersForEachCommonShare" xlink:label="loc_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_1944"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesReservedForIssuance" xlink:label="loc_imc_OrdinarySharesReservedForIssuance_1945"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesReservedForIssuance" xlink:label="loc_imc_OrdinarySharesReservedForIssuance_1946"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesReservedForIssuance" xlink:label="loc_imc_OrdinarySharesReservedForIssuance_1947"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisMember" xlink:label="loc_imc_OtherCannabisMember_1948"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisMember" xlink:label="loc_imc_OtherCannabisMember_1949"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisMember" xlink:label="loc_imc_OtherCannabisMember_1950"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisProductsMember" xlink:label="loc_imc_OtherCannabisProductsMember_1951"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisProductsMember" xlink:label="loc_imc_OtherCannabisProductsMember_1952"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisProductsMember" xlink:label="loc_imc_OtherCannabisProductsMember_1953"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1954"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1955"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1956"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCurrentPayablesToGovernmentAuthorities" xlink:label="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_1957"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCurrentPayablesToGovernmentAuthorities" xlink:label="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_1958"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCurrentPayablesToGovernmentAuthorities" xlink:label="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_1959"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherDeferredTaxAssestsMember" xlink:label="loc_imc_OtherDeferredTaxAssestsMember_1960"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherDeferredTaxAssestsMember" xlink:label="loc_imc_OtherDeferredTaxAssestsMember_1961"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherDeferredTaxAssestsMember" xlink:label="loc_imc_OtherDeferredTaxAssestsMember_1962"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherMiscellaneousCurrentPayables" xlink:label="loc_imc_OtherMiscellaneousCurrentPayables_1963"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherMiscellaneousCurrentPayables" xlink:label="loc_imc_OtherMiscellaneousCurrentPayables_1964"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherMiscellaneousCurrentPayables" xlink:label="loc_imc_OtherMiscellaneousCurrentPayables_1965"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherOperatingSegmentsMember" xlink:label="loc_imc_OtherOperatingSegmentsMember_1966"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherOperatingSegmentsMember" xlink:label="loc_imc_OtherOperatingSegmentsMember_1967"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherOperatingSegmentsMember" xlink:label="loc_imc_OtherOperatingSegmentsMember_1968"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1969"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1970"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1971"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1972"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OvernightMarketedOfferingMember" xlink:label="loc_imc_OvernightMarketedOfferingMember_1973"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OvernightMarketedOfferingMember" xlink:label="loc_imc_OvernightMarketedOfferingMember_1974"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PackagedDriedCannabisMember" xlink:label="loc_imc_PackagedDriedCannabisMember_1975"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PackagedDriedCannabisMember" xlink:label="loc_imc_PackagedDriedCannabisMember_1976"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PackagedDriedCannabisMember" xlink:label="loc_imc_PackagedDriedCannabisMember_1977"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_1978"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_1979"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_1980"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_1981"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PaymentsToShareholdersRelatedPartyTransactions" xlink:label="loc_imc_PaymentsToShareholdersRelatedPartyTransactions_1982"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PaymentsToShareholdersRelatedPartyTransactions" xlink:label="loc_imc_PaymentsToShareholdersRelatedPartyTransactions_1983"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PaymentsToShareholdersRelatedPartyTransactions" xlink:label="loc_imc_PaymentsToShareholdersRelatedPartyTransactions_1984"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAcquisition" xlink:label="loc_imc_PercentageOfAcquisition_1985"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAcquisition" xlink:label="loc_imc_PercentageOfAcquisition_1986"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAcquisition" xlink:label="loc_imc_PercentageOfAcquisition_1987"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares" xlink:label="loc_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_1988"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares" xlink:label="loc_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_1989"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares" xlink:label="loc_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_1990"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAwardsVest" xlink:label="loc_imc_PercentageOfAwardsVest_1991"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAwardsVest" xlink:label="loc_imc_PercentageOfAwardsVest_1992"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAwardsVest" xlink:label="loc_imc_PercentageOfAwardsVest_1993"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel" xlink:label="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_1994"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel" xlink:label="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_1995"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel" xlink:label="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_1996"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOptionsExercised" xlink:label="loc_imc_PercentageOfOptionsExercised_1997"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOptionsExercised" xlink:label="loc_imc_PercentageOfOptionsExercised_1998"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOptionsExercised" xlink:label="loc_imc_PercentageOfOptionsExercised_1999"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOrdinarySharesHeld" xlink:label="loc_imc_PercentageOfOrdinarySharesHeld_2000"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOrdinarySharesHeld" xlink:label="loc_imc_PercentageOfOrdinarySharesHeld_2001"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired" xlink:label="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_2002"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired" xlink:label="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_2003"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired" xlink:label="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_2004"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingSharesAcquired" xlink:label="loc_imc_PercentageOfOutstandingSharesAcquired_2005"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingSharesAcquired" xlink:label="loc_imc_PercentageOfOutstandingSharesAcquired_2006"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingSharesAcquired" xlink:label="loc_imc_PercentageOfOutstandingSharesAcquired_2007"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOwnershipInterest" xlink:label="loc_imc_PercentageOfOwnershipInterest_2008"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOwnershipInterest" xlink:label="loc_imc_PercentageOfOwnershipInterest_2009"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOwnershipInterest" xlink:label="loc_imc_PercentageOfOwnershipInterest_2010"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesGranted" xlink:label="loc_imc_PercentageOfRestrictedSharesGranted_2011"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesGranted" xlink:label="loc_imc_PercentageOfRestrictedSharesGranted_2012"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesGranted" xlink:label="loc_imc_PercentageOfRestrictedSharesGranted_2013"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne" xlink:label="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_2014"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne" xlink:label="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_2015"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne" xlink:label="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_2016"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero" xlink:label="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_2017"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero" xlink:label="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_2018"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero" xlink:label="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_2019"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRightsHold" xlink:label="loc_imc_PercentageOfRightsHold_2020"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRightsHold" xlink:label="loc_imc_PercentageOfRightsHold_2021"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRightsHold" xlink:label="loc_imc_PercentageOfRightsHold_2022"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfSharesGranted" xlink:label="loc_imc_PercentageOfSharesGranted_2023"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfSharesGranted" xlink:label="loc_imc_PercentageOfSharesGranted_2024"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfSharesGranted" xlink:label="loc_imc_PercentageOfSharesGranted_2025"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_2026"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_2027"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_2028"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsExercised" xlink:label="loc_imc_PercentageOfWarrantsExercised_2029"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsExercised" xlink:label="loc_imc_PercentageOfWarrantsExercised_2030"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsExercised" xlink:label="loc_imc_PercentageOfWarrantsExercised_2031"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilities" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilities_2032"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilities" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilities_2033"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilities" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilities_2034"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_2035"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_2036"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_2037"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageRightToPurchaseOfTotalProduction" xlink:label="loc_imc_PercentageRightToPurchaseOfTotalProduction_2038"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageRightToPurchaseOfTotalProduction" xlink:label="loc_imc_PercentageRightToPurchaseOfTotalProduction_2039"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageRightToPurchaseOfTotalProduction" xlink:label="loc_imc_PercentageRightToPurchaseOfTotalProduction_2040"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentagesOfWarrantQuantityHeld" xlink:label="loc_imc_PercentagesOfWarrantQuantityHeld_2041"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentagesOfWarrantQuantityHeld" xlink:label="loc_imc_PercentagesOfWarrantQuantityHeld_2042"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentagesOfWarrantQuantityHeld" xlink:label="loc_imc_PercentagesOfWarrantQuantityHeld_2043"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentAxis" xlink:label="loc_imc_PeriodicPaymentInstallmentAxis_2044"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentAxis" xlink:label="loc_imc_PeriodicPaymentInstallmentAxis_2045"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentDomain" xlink:label="loc_imc_PeriodicPaymentInstallmentDomain_2046"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentDomain" xlink:label="loc_imc_PeriodicPaymentInstallmentDomain_2047"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_2048"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_2049"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_2050"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PlanAssetsAmountsDeposited" xlink:label="loc_imc_PlanAssetsAmountsDeposited_2051"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PlanAssetsAmountsDeposited" xlink:label="loc_imc_PlanAssetsAmountsDeposited_2052"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PlanAssetsAmountsDeposited" xlink:label="loc_imc_PlanAssetsAmountsDeposited_2053"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PlanAssetsForeignCurrencyTranslationEffect" xlink:label="loc_imc_PlanAssetsForeignCurrencyTranslationEffect_2054"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PlanAssetsForeignCurrencyTranslationEffect" xlink:label="loc_imc_PlanAssetsForeignCurrencyTranslationEffect_2055"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PlanAssetsForeignCurrencyTranslationEffect" xlink:label="loc_imc_PlanAssetsForeignCurrencyTranslationEffect_2056"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreliminaryShelfProspectusMember" xlink:label="loc_imc_PreliminaryShelfProspectusMember_2057"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreliminaryShelfProspectusMember" xlink:label="loc_imc_PreliminaryShelfProspectusMember_2058"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreliminaryShelfProspectusMember" xlink:label="loc_imc_PreliminaryShelfProspectusMember_2059"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreTaxDiscountRateOfCashFlows" xlink:label="loc_imc_PreTaxDiscountRateOfCashFlows_2060"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreTaxDiscountRateOfCashFlows" xlink:label="loc_imc_PreTaxDiscountRateOfCashFlows_2061"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreTaxDiscountRateOfCashFlows" xlink:label="loc_imc_PreTaxDiscountRateOfCashFlows_2062"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PrivatePlacementsMember" xlink:label="loc_imc_PrivatePlacementsMember_2063"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PrivatePlacementsMember" xlink:label="loc_imc_PrivatePlacementsMember_2064"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PrivatePlacementsMember" xlink:label="loc_imc_PrivatePlacementsMember_2065"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions" xlink:label="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_2066"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions" xlink:label="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_2067"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions" xlink:label="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_2068"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromInvestmentInRestrictedDeposits" xlink:label="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_2069"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromInvestmentInRestrictedDeposits" xlink:label="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_2070"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromInvestmentInRestrictedDeposits" xlink:label="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_2071"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" xlink:label="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_2072"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" xlink:label="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_2073"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" xlink:label="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_2074"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromSaleOfInvestment" xlink:label="loc_imc_ProceedsFromSaleOfInvestment_2075"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromSaleOfInvestment" xlink:label="loc_imc_ProceedsFromSaleOfInvestment_2076"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromSaleOfInvestment" xlink:label="loc_imc_ProceedsFromSaleOfInvestment_2077"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_2078"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_2079"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_2080"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProductionCostsCapitalizedBiologicalAssets" xlink:label="loc_imc_ProductionCostsCapitalizedBiologicalAssets_2081"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProductionCostsCapitalizedBiologicalAssets" xlink:label="loc_imc_ProductionCostsCapitalizedBiologicalAssets_2082"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProductionCostsCapitalizedBiologicalAssets" xlink:label="loc_imc_ProductionCostsCapitalizedBiologicalAssets_2083"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings" xlink:label="loc_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_2084"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings" xlink:label="loc_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_2085"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings" xlink:label="loc_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_2086"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProFormaAdjustmentsMember" xlink:label="loc_imc_ProFormaAdjustmentsMember_2087"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProFormaAdjustmentsMember" xlink:label="loc_imc_ProFormaAdjustmentsMember_2088"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentAndIntangibleAssetsAbstract" xlink:label="loc_imc_PropertyPlantAndEquipmentAndIntangibleAssetsAbstract_2089"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_2090"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_2091"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_2092"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentUsingShares" xlink:label="loc_imc_PropertyPlantAndEquipmentUsingShares_2093"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentUsingShares" xlink:label="loc_imc_PropertyPlantAndEquipmentUsingShares_2094"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentUsingShares" xlink:label="loc_imc_PropertyPlantAndEquipmentUsingShares_2095"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseConsiderationPayable" xlink:label="loc_imc_PurchaseConsiderationPayable_2096"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseConsiderationPayable" xlink:label="loc_imc_PurchaseConsiderationPayable_2097"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseConsiderationPayable" xlink:label="loc_imc_PurchaseConsiderationPayable_2098"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseOfInterestsInSubsidiary" xlink:label="loc_imc_PurchaseOfInterestsInSubsidiary_2099"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseOfInterestsInSubsidiary" xlink:label="loc_imc_PurchaseOfInterestsInSubsidiary_2100"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseOfInterestsInSubsidiary" xlink:label="loc_imc_PurchaseOfInterestsInSubsidiary_2101"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseOfTreasuryCommonShares" xlink:label="loc_imc_PurchaseOfTreasuryCommonShares_2102"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseOfTreasuryCommonShares" xlink:label="loc_imc_PurchaseOfTreasuryCommonShares_2103"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseOfTreasuryCommonShares" xlink:label="loc_imc_PurchaseOfTreasuryCommonShares_2104"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchasePriceOfBusinessAcquisitionInCommonShares" xlink:label="loc_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_2105"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchasePriceOfBusinessAcquisitionInCommonShares" xlink:label="loc_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_2106"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchasePriceOfBusinessAcquisitionInCommonShares" xlink:label="loc_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_2107"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RayarokPharmLtdMember" xlink:label="loc_imc_RayarokPharmLtdMember_2108"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RayarokPharmLtdMember" xlink:label="loc_imc_RayarokPharmLtdMember_2109"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RayarokPharmLtdMember" xlink:label="loc_imc_RayarokPharmLtdMember_2110"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RealizedFairValueAdjustmentOnInventorySold" xlink:label="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2111"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RealizedFairValueAdjustmentOnInventorySold" xlink:label="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2112"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RealizedFairValueAdjustmentOnInventorySold" xlink:label="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2113"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RealizedFairValueAdjustmentOnInventorySold" xlink:label="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2114"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RealizedFairValueAdjustmentOnInventorySold" xlink:label="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2115"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RealizedFairValueAdjustmentOnInventorySold" xlink:label="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2116"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReceivablesFromGovernmentAuthorities" xlink:label="loc_imc_ReceivablesFromGovernmentAuthorities_2117"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReceivablesFromGovernmentAuthorities" xlink:label="loc_imc_ReceivablesFromGovernmentAuthorities_2118"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReceivablesFromGovernmentAuthorities" xlink:label="loc_imc_ReceivablesFromGovernmentAuthorities_2119"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares" xlink:label="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_2120"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares" xlink:label="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_2121"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares" xlink:label="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_2122"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingAmountOfCashPaid" xlink:label="loc_imc_RemainingAmountOfCashPaid_2123"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingAmountOfCashPaid" xlink:label="loc_imc_RemainingAmountOfCashPaid_2124"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingAmountOfCashPaid" xlink:label="loc_imc_RemainingAmountOfCashPaid_2125"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingInstallmentMember" xlink:label="loc_imc_RemainingInstallmentMember_2126"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingInstallmentMember" xlink:label="loc_imc_RemainingInstallmentMember_2127"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingInstallmentMember" xlink:label="loc_imc_RemainingInstallmentMember_2128"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RepaymentOfAforementionedBankLoan" xlink:label="loc_imc_RepaymentOfAforementionedBankLoan_2129"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RepaymentOfAforementionedBankLoan" xlink:label="loc_imc_RepaymentOfAforementionedBankLoan_2130"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RepaymentOfAforementionedBankLoan" xlink:label="loc_imc_RepaymentOfAforementionedBankLoan_2131"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RestrictedShareUnitsMember" xlink:label="loc_imc_RestrictedShareUnitsMember_2132"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RestrictedShareUnitsMember" xlink:label="loc_imc_RestrictedShareUnitsMember_2133"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReturnNetOfInterestIncomeReMeasurementGainLoss" xlink:label="loc_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_2134"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReturnNetOfInterestIncomeReMeasurementGainLoss" xlink:label="loc_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_2135"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReturnNetOfInterestIncomeReMeasurementGainLoss" xlink:label="loc_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_2136"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevaluationOfExercisedWarrants" xlink:label="loc_imc_RevaluationOfExercisedWarrants_2137"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevaluationOfExercisedWarrants" xlink:label="loc_imc_RevaluationOfExercisedWarrants_2138"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevaluationOfExercisedWarrants" xlink:label="loc_imc_RevaluationOfExercisedWarrants_2139"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReverseAcquisitionAcquirerAxis" xlink:label="loc_imc_ReverseAcquisitionAcquirerAxis_2140"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReverseAcquisitionAcquirerAxis" xlink:label="loc_imc_ReverseAcquisitionAcquirerAxis_2141"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReverseAcquisitionAcquirerDomain" xlink:label="loc_imc_ReverseAcquisitionAcquirerDomain_2142"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReverseAcquisitionAcquirerDomain" xlink:label="loc_imc_ReverseAcquisitionAcquirerDomain_2143"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReverseTakeoverAbstract" xlink:label="loc_imc_ReverseTakeoverAbstract_2144"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolvingCreditFacilityMember" xlink:label="loc_imc_RevolvingCreditFacilityMember_2145"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolvingCreditFacilityMember" xlink:label="loc_imc_RevolvingCreditFacilityMember_2146"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolyTradingAndMarketingLtdMember" xlink:label="loc_imc_RevolyTradingAndMarketingLtdMember_2147"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolyTradingAndMarketingLtdMember" xlink:label="loc_imc_RevolyTradingAndMarketingLtdMember_2148"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolyTradingAndMarketingLtdMember" xlink:label="loc_imc_RevolyTradingAndMarketingLtdMember_2149"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability" xlink:label="loc_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_2150"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability" xlink:label="loc_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_2151"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability" xlink:label="loc_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_2152"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_2153"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_2154"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_2155"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RiskFreeInterestRateOfWarrants" xlink:label="loc_imc_RiskFreeInterestRateOfWarrants_2156"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RiskFreeInterestRateOfWarrants" xlink:label="loc_imc_RiskFreeInterestRateOfWarrants_2157"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RiskFreeInterestRateOfWarrants" xlink:label="loc_imc_RiskFreeInterestRateOfWarrants_2158"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RosenHighWayLtdMember" xlink:label="loc_imc_RosenHighWayLtdMember_2159"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RosenHighWayLtdMember" xlink:label="loc_imc_RosenHighWayLtdMember_2160"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RosenHighWayLtdMember" xlink:label="loc_imc_RosenHighWayLtdMember_2161"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensation" xlink:label="loc_imc_ShareBasedCompensation_2162"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensation" xlink:label="loc_imc_ShareBasedCompensation_2163"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensation" xlink:label="loc_imc_ShareBasedCompensation_2164"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensation" xlink:label="loc_imc_ShareBasedCompensation_2165"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensations" xlink:label="loc_imc_ShareBasedCompensations_2166"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensations" xlink:label="loc_imc_ShareBasedCompensations_2167"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensations" xlink:label="loc_imc_ShareBasedCompensations_2168"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareholdersMember" xlink:label="loc_imc_ShareholdersMember_2169"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareholdersMember" xlink:label="loc_imc_ShareholdersMember_2170"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareIncentivePlanMember" xlink:label="loc_imc_ShareIncentivePlanMember_2171"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareIncentivePlanMember" xlink:label="loc_imc_ShareIncentivePlanMember_2172"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareIncentivePlanMember" xlink:label="loc_imc_ShareIncentivePlanMember_2173"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SharePurchaseAgreementMember" xlink:label="loc_imc_SharePurchaseAgreementMember_2174"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SharePurchaseAgreementMember" xlink:label="loc_imc_SharePurchaseAgreementMember_2175"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareSplitRatio" xlink:label="loc_imc_ShareSplitRatio_2176"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareSplitRatio" xlink:label="loc_imc_ShareSplitRatio_2177"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareSplitRatio" xlink:label="loc_imc_ShareSplitRatio_2178"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract" xlink:label="loc_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract_2179"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsAbstract" xlink:label="loc_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsAbstract_2180"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SimpleAgreementForFutureEquityMember" xlink:label="loc_imc_SimpleAgreementForFutureEquityMember_2181"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SimpleAgreementForFutureEquityMember" xlink:label="loc_imc_SimpleAgreementForFutureEquityMember_2182"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_StatementOfBalanceSheetLocationAxis" xlink:label="loc_imc_StatementOfBalanceSheetLocationAxis_2183"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_StatementOfBalanceSheetLocationDomain" xlink:label="loc_imc_StatementOfBalanceSheetLocationDomain_2184"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SublimecultureIncMember" xlink:label="loc_imc_SublimecultureIncMember_2185"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SublimecultureIncMember" xlink:label="loc_imc_SublimecultureIncMember_2186"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SublimecultureIncMember" xlink:label="loc_imc_SublimecultureIncMember_2187"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubscriptionReceiptsHoldersMember" xlink:label="loc_imc_SubscriptionReceiptsHoldersMember_2188"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubscriptionReceiptsHoldersMember" xlink:label="loc_imc_SubscriptionReceiptsHoldersMember_2189"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubscriptionReceiptsHoldersMember" xlink:label="loc_imc_SubscriptionReceiptsHoldersMember_2190"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsequentEventMember" xlink:label="loc_imc_SubsequentEventMember_2191"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsequentEventMember" xlink:label="loc_imc_SubsequentEventMember_2192"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract" xlink:label="loc_imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract_2193"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract" xlink:label="loc_imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract_2194"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract" xlink:label="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_2195"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SupplementalDisclosureOfNonCashActivitiesAbstract" xlink:label="loc_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_2196"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SupplementalDisclosureOfNonCashActivitiesAbstract" xlink:label="loc_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_2197"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SupplyAgreementMember" xlink:label="loc_imc_SupplyAgreementMember_2198"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SupplyAgreementMember" xlink:label="loc_imc_SupplyAgreementMember_2199"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SupplyAgreementMember" xlink:label="loc_imc_SupplyAgreementMember_2200"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" xlink:label="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2201"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" xlink:label="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2202"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" xlink:label="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2203"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfDifferentTaxRateOfSubsidiaries" xlink:label="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_2204"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfDifferentTaxRateOfSubsidiaries" xlink:label="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_2205"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfDifferentTaxRateOfSubsidiaries" xlink:label="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_2206"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" xlink:label="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2207"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" xlink:label="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2208"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" xlink:label="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2209"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" xlink:label="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2210"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" xlink:label="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_2211"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" xlink:label="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_2212"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" xlink:label="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_2213"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfNonInterestBearingTradeReceivables" xlink:label="loc_imc_TermOfNonInterestBearingTradeReceivables_2214"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfNonInterestBearingTradeReceivables" xlink:label="loc_imc_TermOfNonInterestBearingTradeReceivables_2215"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfNonInterestBearingTradeReceivables" xlink:label="loc_imc_TermOfNonInterestBearingTradeReceivables_2216"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfWarrantsFromDateOfIssuance" xlink:label="loc_imc_TermOfWarrantsFromDateOfIssuance_2217"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfWarrantsFromDateOfIssuance" xlink:label="loc_imc_TermOfWarrantsFromDateOfIssuance_2218"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfWarrantsFromDateOfIssuance" xlink:label="loc_imc_TermOfWarrantsFromDateOfIssuance_2219"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfWarrantsFromDateOfIssuance" xlink:label="loc_imc_TermOfWarrantsFromDateOfIssuance_2220"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ThresholdLimitOfOfferingPriceOfSecurities" xlink:label="loc_imc_ThresholdLimitOfOfferingPriceOfSecurities_2221"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ThresholdLimitOfOfferingPriceOfSecurities" xlink:label="loc_imc_ThresholdLimitOfOfferingPriceOfSecurities_2222"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ThresholdLimitOfOfferingPriceOfSecurities" xlink:label="loc_imc_ThresholdLimitOfOfferingPriceOfSecurities_2223"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAcquisitionSubsidiary" xlink:label="loc_imc_TotalAcquisitionSubsidiary_2224"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAcquisitionSubsidiary" xlink:label="loc_imc_TotalAcquisitionSubsidiary_2225"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAcquisitionSubsidiary" xlink:label="loc_imc_TotalAcquisitionSubsidiary_2226"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAllocatedAmountTranslationTransaction" xlink:label="loc_imc_TotalAllocatedAmountTranslationTransaction_2227"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAllocatedAmountTranslationTransaction" xlink:label="loc_imc_TotalAllocatedAmountTranslationTransaction_2228"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAllocatedAmountTranslationTransaction" xlink:label="loc_imc_TotalAllocatedAmountTranslationTransaction_2229"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2230"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2231"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2232"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeReceivablesLineItems" xlink:label="loc_imc_TradeReceivablesLineItems_2233"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeReceivablesLineItems" xlink:label="loc_imc_TradeReceivablesLineItems_2234"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeReceivablesTable" xlink:label="loc_imc_TradeReceivablesTable_2235"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeReceivablesTable" xlink:label="loc_imc_TradeReceivablesTable_2236"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TranslationDifferencesOfDefferedTaxes" xlink:label="loc_imc_TranslationDifferencesOfDefferedTaxes_2237"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TranslationDifferencesOfDefferedTaxes" xlink:label="loc_imc_TranslationDifferencesOfDefferedTaxes_2238"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TranslationDifferencesOfDefferedTaxes" xlink:label="loc_imc_TranslationDifferencesOfDefferedTaxes_2239"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeAssetFundingCorpMember" xlink:label="loc_imc_TrichomeAssetFundingCorpMember_2240"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeAssetFundingCorpMember" xlink:label="loc_imc_TrichomeAssetFundingCorpMember_2241"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeAssetFundingCorpMember" xlink:label="loc_imc_TrichomeAssetFundingCorpMember_2242"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisGpIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisGpIncMember_2243"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisGpIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisGpIncMember_2244"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisGpIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisGpIncMember_2245"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisManagerIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisManagerIncMember_2246"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisManagerIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisManagerIncMember_2247"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisManagerIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisManagerIncMember_2248"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_2249"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_2250"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_2251"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_2252"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeJwcAcquisitionCorpMember" xlink:label="loc_imc_TrichomeJwcAcquisitionCorpMember_2253"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeJwcAcquisitionCorpMember" xlink:label="loc_imc_TrichomeJwcAcquisitionCorpMember_2254"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeJwcAcquisitionCorpMember" xlink:label="loc_imc_TrichomeJwcAcquisitionCorpMember_2255"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeRetailCorpMember" xlink:label="loc_imc_TrichomeRetailCorpMember_2256"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeRetailCorpMember" xlink:label="loc_imc_TrichomeRetailCorpMember_2257"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeRetailCorpMember" xlink:label="loc_imc_TrichomeRetailCorpMember_2258"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeSecurityholdersMember" xlink:label="loc_imc_TrichomeSecurityholdersMember_2259"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeSecurityholdersMember" xlink:label="loc_imc_TrichomeSecurityholdersMember_2260"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeSecurityholdersMember" xlink:label="loc_imc_TrichomeSecurityholdersMember_2261"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisAxis" xlink:label="loc_imc_TypeOfCannabisAxis_2262"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisAxis" xlink:label="loc_imc_TypeOfCannabisAxis_2263"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisDomain" xlink:label="loc_imc_TypeOfCannabisDomain_2264"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisDomain" xlink:label="loc_imc_TypeOfCannabisDomain_2265"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputAxis" xlink:label="loc_imc_UnobservableInputAxis_2266"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputAxis" xlink:label="loc_imc_UnobservableInputAxis_2267"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputDomain" xlink:label="loc_imc_UnobservableInputDomain_2268"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputDomain" xlink:label="loc_imc_UnobservableInputDomain_2269"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UtilizationOfLossesNotPreviouslyRecognized" xlink:label="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_2270"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UtilizationOfLossesNotPreviouslyRecognized" xlink:label="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_2271"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UtilizationOfLossesNotPreviouslyRecognized" xlink:label="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_2272"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants" xlink:label="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_2273"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants" xlink:label="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_2274"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants" xlink:label="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_2275"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_2276"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_2277"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_2278"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember" xlink:label="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_2279"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember" xlink:label="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_2280"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember" xlink:label="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_2281"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingAxis" xlink:label="loc_imc_VestingAxis_2282"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingAxis" xlink:label="loc_imc_VestingAxis_2283"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingDomain" xlink:label="loc_imc_VestingDomain_2284"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingDomain" xlink:label="loc_imc_VestingDomain_2285"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingPercentageOfShareBasedArrangement" xlink:label="loc_imc_VestingPercentageOfShareBasedArrangement_2286"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingPercentageOfShareBasedArrangement" xlink:label="loc_imc_VestingPercentageOfShareBasedArrangement_2287"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingPercentageOfShareBasedArrangement" xlink:label="loc_imc_VestingPercentageOfShareBasedArrangement_2288"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_2289"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_2290"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_2291"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_2292"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_2293"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_2294"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantPricePerShare" xlink:label="loc_imc_WarrantPricePerShare_2295"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantPricePerShare" xlink:label="loc_imc_WarrantPricePerShare_2296"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantPricePerShare" xlink:label="loc_imc_WarrantPricePerShare_2297"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2018Member" xlink:label="loc_imc_Warrants2018Member_2298"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2018Member" xlink:label="loc_imc_Warrants2018Member_2299"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2018Member" xlink:label="loc_imc_Warrants2018Member_2300"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2019Member" xlink:label="loc_imc_Warrants2019Member_2301"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2019Member" xlink:label="loc_imc_Warrants2019Member_2302"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2019Member" xlink:label="loc_imc_Warrants2019Member_2303"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptions2019Member" xlink:label="loc_imc_WarrantsAndCompensationOptions2019Member_2304"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptions2019Member" xlink:label="loc_imc_WarrantsAndCompensationOptions2019Member_2305"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptions2019Member" xlink:label="loc_imc_WarrantsAndCompensationOptions2019Member_2306"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptionsMember" xlink:label="loc_imc_WarrantsAndCompensationOptionsMember_2307"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptionsMember" xlink:label="loc_imc_WarrantsAndCompensationOptionsMember_2308"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMeasuredAtFairValue" xlink:label="loc_imc_WarrantsMeasuredAtFairValue_2309"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMeasuredAtFairValue" xlink:label="loc_imc_WarrantsMeasuredAtFairValue_2310"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMeasuredAtFairValue" xlink:label="loc_imc_WarrantsMeasuredAtFairValue_2311"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMeasuredAtFairValue" xlink:label="loc_imc_WarrantsMeasuredAtFairValue_2312"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMember" xlink:label="loc_imc_WarrantsMember_2313"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMember" xlink:label="loc_imc_WarrantsMember_2314"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMember" xlink:label="loc_imc_WarrantsMember_2315"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets" xlink:label="loc_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_2316"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets" xlink:label="loc_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_2317"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets" xlink:label="loc_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_2318"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WeightedTaxRateComposedOfFederalAndMunicipalTax" xlink:label="loc_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_2319"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WeightedTaxRateComposedOfFederalAndMunicipalTax" xlink:label="loc_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_2320"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WeightedTaxRateComposedOfFederalAndMunicipalTax" xlink:label="loc_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_2321"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WholesalesAndPharmaciesMember" xlink:label="loc_imc_WholesalesAndPharmaciesMember_2322"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WholesalesAndPharmaciesMember" xlink:label="loc_imc_WholesalesAndPharmaciesMember_2323"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WholesalesAndPharmaciesMember" xlink:label="loc_imc_WholesalesAndPharmaciesMember_2324"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember" xlink:label="loc_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_2325"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember" xlink:label="loc_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_2326"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember" xlink:label="loc_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_2327"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WithholdingTaxLiabilities" xlink:label="loc_imc_WithholdingTaxLiabilities_2328"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WithholdingTaxLiabilities" xlink:label="loc_imc_WithholdingTaxLiabilities_2329"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapital" xlink:label="loc_imc_WorkingCapital_2330"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapital" xlink:label="loc_imc_WorkingCapital_2331"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapital" xlink:label="loc_imc_WorkingCapital_2332"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapitalOfBusinessAcquisition" xlink:label="loc_imc_WorkingCapitalOfBusinessAcquisition_2333"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapitalOfBusinessAcquisition" xlink:label="loc_imc_WorkingCapitalOfBusinessAcquisition_2334"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapitalOfBusinessAcquisition" xlink:label="loc_imc_WorkingCapitalOfBusinessAcquisition_2335"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkInProgressMember" xlink:label="loc_imc_WorkInProgressMember_2336"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkInProgressMember" xlink:label="loc_imc_WorkInProgressMember_2337"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkInProgressMember" xlink:label="loc_imc_WorkInProgressMember_2338"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WriteDownsOfInventoriesRecognizedCostOfSales" xlink:label="loc_imc_WriteDownsOfInventoriesRecognizedCostOfSales_2339"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WriteDownsOfInventoriesRecognizedCostOfSales" xlink:label="loc_imc_WriteDownsOfInventoriesRecognizedCostOfSales_2340"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WriteDownsOfInventoriesRecognizedCostOfSales" xlink:label="loc_imc_WriteDownsOfInventoriesRecognizedCostOfSales_2341"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_XintezaApiLtdMember" xlink:label="loc_imc_XintezaApiLtdMember_2342"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_XintezaApiLtdMember" xlink:label="loc_imc_XintezaApiLtdMember_2343"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_2344"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember" xlink:label="loc_srt_ProFormaMember_2345"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2346"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_2347"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_2349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_2350"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2351"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_CA_0" xml:lang="en-US">CANADA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_CA_1" xml:lang="en-US">Canada [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_DE_0" xml:lang="en-US">GERMANY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_DE_1" xml:lang="en-US">German [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_IL_0" xml:lang="en-US">ISRAEL</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_IL_1" xml:lang="en-US">Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_AllCurrenciesDomain_0" xml:lang="en-US">All Currencies [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_EUR_0" xml:lang="en-US">Euro Member Countries, Euro</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_currency_EUR_1" xml:lang="en-US">EUR [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_GBP_0" xml:lang="en-US">United Kingdom, Pounds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_currency_GBP_1" xml:lang="en-US">GBP [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_ILS_0" xml:lang="en-US">Israel, New Shekels</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_currency_ILS_1" xml:lang="en-US">NIS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_USD_0" xml:lang="en-US">United States of America, Dollars</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_currency_USD_1" xml:lang="en-US">USD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AddressTypeDomain_0" xml:lang="en-US">Address Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AdrMember_0" xml:lang="en-US">ADR [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_AdrMember_1" xml:lang="en-US">Cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentDescription_0" xml:lang="en-US">Amendment Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AnnualInformationForm_0" xml:lang="en-US">Annual Information Form</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditedAnnualFinancialStatements_0" xml:lang="en-US">Audited Annual Financial Statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorFirmId_0" xml:lang="en-US">Auditor Firm ID</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorLocation_0" xml:lang="en-US">Auditor Location</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorName_0" xml:lang="en-US">Auditor Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_BusinessContactMember_0" xml:lang="en-US">Business Contact [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelName_0" xml:lang="en-US">Contact Personnel Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract_0" xml:lang="en-US">Cover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAnnualReport_0" xml:lang="en-US">Document Annual Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems_0" xml:lang="en-US">Document Information [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable_0" xml:lang="en-US">Document Information [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentRegistrationStatement_0" xml:lang="en-US">Document Registration Statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentShellCompanyReport_0" xml:lang="en-US">Document Shell Company Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine3_0" xml:lang="en-US">Entity Address, Address Line Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesAddressTypeAxis_0" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressStateOrProvince_0" xml:lang="en-US">Entity Address, State or Province</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain_0" xml:lang="en-US">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers_0" xml:lang="en-US">Entity Voluntary Filers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_IcfrAuditorAttestationFlag_0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis_0" xml:lang="en-US">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Security Exchange Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccountingProfit_0" xml:lang="en-US">Accounting profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccountingProfit_1" xml:lang="en-US">Income (loss) before income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccountingProfit_2" xml:lang="en-US">Loss before income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccrualsClassifiedAsCurrent_0" xml:lang="en-US">Accruals classified as current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_0" xml:lang="en-US">Accumulated depreciation, amortisation and impairment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_1" xml:lang="en-US">Accumulated depreciation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_2" xml:lang="en-US">Accumulated amortization and impairment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1" xml:lang="en-US">Total purchase price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2" xml:lang="en-US">Total purchase price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_3" xml:lang="en-US">Common shares issued upon the acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_4" xml:lang="en-US">Total consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_5" xml:lang="en-US">Common shares issued upon the acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0" xml:lang="en-US">Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1" xml:lang="en-US">Acquisition costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2" xml:lang="en-US">Aggregate consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_0" xml:lang="en-US">Acquisitions through business combinations, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_1" xml:lang="en-US">Additions related to acquisitions of Trichome and MYM</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Acquisitions through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Initially consolidated company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_0" xml:lang="en-US">Acquisitions through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1" xml:lang="en-US">Additions related to acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_0" xml:lang="en-US">Actuarial assumption of discount rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_1" xml:lang="en-US">Discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_0" xml:lang="en-US">Actuarial assumption of expected rates of salary increases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_1" xml:lang="en-US">Salary growth</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Purchases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1" xml:lang="en-US">Additions during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsToRightofuseAssets_0" xml:lang="en-US">Additions to right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsToRightofuseAssets_1" xml:lang="en-US">Additions during the year: New leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_0" xml:lang="en-US">Adjusted weighted average number of ordinary shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_1" xml:lang="en-US">For the computation of diluted net earnings, Weighted number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_0" xml:lang="en-US">Adjustments for current tax of prior periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_1" xml:lang="en-US">Income tax from previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_0" xml:lang="en-US">Adjustments for decrease (increase) in biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1" xml:lang="en-US">Decrease in biological assets, net of fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0" xml:lang="en-US">Adjustments for decrease (increase) in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1" xml:lang="en-US">Increase in inventories, net of fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_0" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_1" xml:lang="en-US">Increase in other accounts receivable and advances to suppliers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0" xml:lang="en-US">Adjustments for decrease (increase) in trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1" xml:lang="en-US">Increase in trade receivables, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_0" xml:lang="en-US">Adjustments for deferred tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_1" xml:lang="en-US">Deferred tax expense (benefit), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_2" xml:lang="en-US">Deferred tax benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense_0" xml:lang="en-US">Adjustments for depreciation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_0" xml:lang="en-US">Adjustments for fair value losses (gains)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_1" xml:lang="en-US">Total fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_2" xml:lang="en-US">Total fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncome_0" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncome_1" xml:lang="en-US">Adjustments for finance income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncome_2" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_0" xml:lang="en-US">Adjustments for finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_1" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_2" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_0" xml:lang="en-US">Unrealized gain on changes in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1" xml:lang="en-US">Adjustments for gains (losses) on change in fair value less costs to sell, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2" xml:lang="en-US">Unrealized change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_0" xml:lang="en-US">Adjustments for impairment loss recognised in profit or loss, goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_1" xml:lang="en-US">Goodwill impairment with respect to the cash generating unit in Europe</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0" xml:lang="en-US">Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1" xml:lang="en-US">Impairment of goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_0" xml:lang="en-US">Adjustments for increase (decrease) in employee benefit liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_1" xml:lang="en-US">Changes in employee benefit liabilities, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_0" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_1" xml:lang="en-US">Increase in trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1" xml:lang="en-US">Increase in other accounts payable and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_0" xml:lang="en-US">Adjustments to reconcile profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_1" xml:lang="en-US">Total adjustments for non-cash items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_2" xml:lang="en-US">Total adjustments for non-cash items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0" xml:lang="en-US">Adjustments for non-cash items:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_0" xml:lang="en-US">Adjustments for share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_1" xml:lang="en-US">Share-based payments expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedTimeBandsMember_0" xml:lang="en-US">Aggregated time bands [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Amortization recognized in the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Amortization of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_3" xml:lang="en-US">Amortization expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Amortisation method, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Amortization method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Amortisation rate, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Amortization rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_0" xml:lang="en-US">Amounts payable, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_1" xml:lang="en-US">Other accounts payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions_0" xml:lang="en-US">Amounts receivable, related party transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions_1" xml:lang="en-US">Other accounts receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ApplicableTaxRate_0" xml:lang="en-US">Applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ApplicableTaxRate_1" xml:lang="en-US">Statutory tax rate in Canada</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Assets_2" xml:lang="en-US">Segment assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAbstract_0" xml:lang="en-US">Assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AssetsAbstract_1" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AssetsAbstract_2" xml:lang="en-US">ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_0" xml:lang="en-US">Bank borrowings, undiscounted cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_1" xml:lang="en-US">Bank Loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_1" xml:lang="en-US">Basic (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BenefitsPaidOrPayable_0" xml:lang="en-US">Benefits paid or payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BenefitsPaidOrPayable_1" xml:lang="en-US">Benefits paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_BenefitsPaidOrPayable_2" xml:lang="en-US">Benefits paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_BiologicalAssets_0" xml:lang="en-US">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_BiologicalAssets_1" xml:lang="en-US">Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssets_2" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssetsByTypeAxis_0" xml:lang="en-US">Biological assets by type [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BiologicalAssetsTypeMember_0" xml:lang="en-US">Biological assets, type [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Borrowings_0" xml:lang="en-US">Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsAbstract_0" xml:lang="en-US">Borrowings [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameAxis_0" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameMember_0" xml:lang="en-US">Borrowings by name [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsInterestRate_0" xml:lang="en-US">Borrowings, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsInterestRateBasis_0" xml:lang="en-US">Borrowings, interest rate basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Bank Loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Borrowings recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Bank loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember_0" xml:lang="en-US">Bottom of range [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BottomOfRangeMember_1" xml:lang="en-US">Bottom of range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BrandNamesMember_0" xml:lang="en-US">Brand names [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BrandNamesMember_1" xml:lang="en-US">Brand [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BuildingsMember_0" xml:lang="en-US">Buildings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BuildingsMember_1" xml:lang="en-US">Buildings and improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BuildingsMember_2" xml:lang="en-US">Land and buildings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsAxis_0" xml:lang="en-US">Business combinations [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountMember_0" xml:lang="en-US">Carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_0" xml:lang="en-US">Cash and cash equivalents at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_1" xml:lang="en-US">Cash and cash equivalents at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalents_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_3" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Cash and cash equivalents acquired with the acquiree at the acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2" xml:lang="en-US">From financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1" xml:lang="en-US">Cash provided by financing activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1" xml:lang="en-US">Net cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_2" xml:lang="en-US">From investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1" xml:lang="en-US">Cash flows from investing activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_2" xml:lang="en-US">From operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_3" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xml:lang="en-US">Cash provided from operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_0" xml:lang="en-US">Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_1" xml:lang="en-US">Acquisition of subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_2" xml:lang="en-US">Acquisition of subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/negativeTerseLabel" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_3" xml:lang="en-US">Acquisition of subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_0" xml:lang="en-US">Cash receipts from repayment of advances and loans made to other parties, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_1" xml:lang="en-US">Repayment of loan receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_2" xml:lang="en-US">Proceeds from loans receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_0" xml:lang="en-US">Cash repayments of advances and loans from related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_1" xml:lang="en-US">Payments to shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashTransferred_0" xml:lang="en-US">Cash transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashTransferred_1" xml:lang="en-US">Cash paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_CashTransferred_2" xml:lang="en-US">Cash paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAbstract_0" xml:lang="en-US">Categories of financial assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAbstract_1" xml:lang="en-US">Financial assets:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_0" xml:lang="en-US">Categories of financial liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_1" xml:lang="en-US">Financial liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis_0" xml:lang="en-US">Classes of assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsMember_0" xml:lang="en-US">Assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis_0" xml:lang="en-US">Classes of financial assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_0" xml:lang="en-US">Financial instruments, class [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract_0" xml:lang="en-US">Classes of current inventories [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis_0" xml:lang="en-US">Classes of share capital [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalMember_0" xml:lang="en-US">Share capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_0" xml:lang="en-US">Components of equity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_0" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_1" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss in subsequent periods:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_0" xml:lang="en-US">Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_1" xml:lang="en-US">Other comprehensive income (loss) that will not be reclassified to profit or loss in subsequent periods:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_2" xml:lang="en-US">Other comprehensive income that will not be reclassified to profit or loss in subsequent periods:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncome_0" xml:lang="en-US">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_1" xml:lang="en-US">Total comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_2" xml:lang="en-US">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_3" xml:lang="en-US">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract_0" xml:lang="en-US">Comprehensive income attributable to [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract_1" xml:lang="en-US">Total comprehensive income (loss) attributable to:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_0" xml:lang="en-US">Comprehensive income, attributable to non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_1" xml:lang="en-US">Non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_0" xml:lang="en-US">Comprehensive income, attributable to owners of parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_1" xml:lang="en-US">Equity holders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComputerEquipmentMember_0" xml:lang="en-US">Computer, software and equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComputerEquipmentMember_1" xml:lang="en-US">Computer, software and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_0" xml:lang="en-US">Cost of inventories recognised as expense during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_1" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_2" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_3" xml:lang="en-US">Non-cash expense related to the changes in fair value of inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfMerchandiseSold_0" xml:lang="en-US">Cost of merchandise sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfMerchandiseSold_1" xml:lang="en-US">Inventory expensed to cost of goods sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CostOfSales_0" xml:lang="en-US">Cost of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfSales_1" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfSales_2" xml:lang="en-US">Cost of goods sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CostOfSales_3" xml:lang="en-US">Cost of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesMember_0" xml:lang="en-US">Counterparties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CountryOfDomicileMember_0" xml:lang="en-US">Country of domicile [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CountryOfDomicileMember_1" xml:lang="en-US">Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrencyRiskMember_0" xml:lang="en-US">Currency risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_0" xml:lang="en-US">Current accrued expenses and other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_1" xml:lang="en-US">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAdvancesToSuppliers_0" xml:lang="en-US">Current advances to suppliers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentAdvancesToSuppliers_1" xml:lang="en-US">Advances to suppliers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentAssets_2" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_0" xml:lang="en-US">Current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_1" xml:lang="en-US">CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_0" xml:lang="en-US">Current biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentBiologicalAssets_1" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentBiologicalAssetsMember_0" xml:lang="en-US">Current biological assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentBiologicalAssetsMember_1" xml:lang="en-US">Inventory and biological assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentDepositsFromCustomers_0" xml:lang="en-US">Current deposits from customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentDepositsFromCustomers_1" xml:lang="en-US">Advances from customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentGovernmentGrants_0" xml:lang="en-US">Current government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentGovernmentGrants_1" xml:lang="en-US">Government authorities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentInvestments_0" xml:lang="en-US">Current investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentInvestments_1" xml:lang="en-US">Investments and Financial Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentInvestments_2" xml:lang="en-US">Investments and financial instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_0" xml:lang="en-US">Current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_1" xml:lang="en-US">Current maturities of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities_1" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_2" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_3" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_0" xml:lang="en-US">Current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_1" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_0" xml:lang="en-US">Current portion of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_1" xml:lang="en-US">Outstanding balance of 2 loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_0" xml:lang="en-US">Current prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentPrepaidExpenses_1" xml:lang="en-US">Prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentRestrictedCashAndCashEquivalents_0" xml:lang="en-US">Current restricted cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentRestrictedCashAndCashEquivalents_1" xml:lang="en-US">Restricted bank deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentRestrictedCashAndCashEquivalents_2" xml:lang="en-US">Restricted deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans_0" xml:lang="en-US">Current service cost, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans_1" xml:lang="en-US">Current service cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_0" xml:lang="en-US">Current service cost, net defined benefit liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_1" xml:lang="en-US">Current service cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome_0" xml:lang="en-US">Current tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome_1" xml:lang="en-US">Total current tax expense (income) and adjustments for current tax of prior periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome_2" xml:lang="en-US">Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_0" xml:lang="en-US">Current tax expense (income) and adjustments for current tax of prior periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_1" xml:lang="en-US">Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTradeReceivables_0" xml:lang="en-US">Current trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables_1" xml:lang="en-US">Wholesalers and pharmacies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables_2" xml:lang="en-US">Trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CustomerrelatedIntangibleAssetsMember_0" xml:lang="en-US">Customer-related intangible assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CustomerrelatedIntangibleAssetsMember_1" xml:lang="en-US">Customer relationships [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_0" xml:lang="en-US">Decrease due to harvest, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_1" xml:lang="en-US">Transferred to inventory upon harvest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2" xml:lang="en-US">Transferred to inventory upon harvest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxAssets_0" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeferredTaxAssets_1" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxAssets_2" xml:lang="en-US">Deferred tax assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_0" xml:lang="en-US">Deferred tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_1" xml:lang="en-US">Deferred, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_0" xml:lang="en-US">Deferred tax expense (income) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_1" xml:lang="en-US">Deferred tax expenses, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_1" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_2" xml:lang="en-US">Deferred tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_3" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Deferred tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Deferred tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Deferred tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_4" xml:lang="en-US">Deferred tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_0" xml:lang="en-US">Deferred tax liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_1" xml:lang="en-US">Deferred tax assets (liabilities), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_2" xml:lang="en-US">Deferred tax liabilities, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_1" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_2" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_3" xml:lang="en-US">Depreciation, amortization and impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0" xml:lang="en-US">Depreciation, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_1" xml:lang="en-US">Depreciation, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_2" xml:lang="en-US">Depreciation during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_3" xml:lang="en-US">Depreciation of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationRatePropertyPlantAndEquipment_0" xml:lang="en-US">Depreciation rate, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_0" xml:lang="en-US">Depreciation, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_1" xml:lang="en-US">Additions during the year: Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_2" xml:lang="en-US">Depreciation of right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DerivativeFinancialAssets_0" xml:lang="en-US">Derivative financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DerivativeFinancialAssets_1" xml:lang="en-US">Derivative assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_0" xml:lang="en-US">Description of accounting policy for biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_1" xml:lang="en-US">Biological assets [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for business combinations and goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_1" xml:lang="en-US">Business combinations and goodwill [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Description of accounting policy for derecognition of financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_1" xml:lang="en-US">Financial instruments [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0" xml:lang="en-US">Description of accounting policy for earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1" xml:lang="en-US">Earnings per share [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0" xml:lang="en-US">Description of accounting policy for employee benefits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_1" xml:lang="en-US">Employee benefit liabilities [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_0" xml:lang="en-US">Description of accounting policy for fair value measurement [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_1" xml:lang="en-US">Fair value measurement [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_0" xml:lang="en-US">Description of accounting policy for functional currency [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_1" xml:lang="en-US">Functional currency, presentation currency and foreign currency [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0" xml:lang="en-US">Description of accounting policy for impairment of non-financial assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_1" xml:lang="en-US">Impairment of non-financial assets [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_0" xml:lang="en-US">Description of accounting policy for income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_1" xml:lang="en-US">Taxes on income [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1" xml:lang="en-US">Intangible assets [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_0" xml:lang="en-US">Description of accounting policy for leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_1" xml:lang="en-US">Leases [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1" xml:lang="en-US">Inventories [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, plant and equipment [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0" xml:lang="en-US">Description of accounting policy for provisions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_1" xml:lang="en-US">Provisions [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1" xml:lang="en-US">Revenue recognition [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_0" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_1" xml:lang="en-US">Research and development expenditures [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_0" xml:lang="en-US">Description of accounting policy for segment reporting [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_1" xml:lang="en-US">Operating segments [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1" xml:lang="en-US">Share-based payment transactions [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_0" xml:lang="en-US">Description of accounting policy for treasury shares [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_1" xml:lang="en-US">Treasury shares [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1" xml:lang="en-US">Cash equivalents [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_0" xml:lang="en-US">Description of arrangement for contingent consideration arrangements and indemnification assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_1" xml:lang="en-US">Description of contingent consideration of acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_0" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_1" xml:lang="en-US">DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_0" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0" xml:lang="en-US">Expected volatility, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1" xml:lang="en-US">Volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0" xml:lang="en-US">Option life, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_1" xml:lang="en-US">Expected life of share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_1" xml:lang="en-US">Annual risk-free rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_0" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_1" xml:lang="en-US">Diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_0" xml:lang="en-US">Dilutive effect of convertible instruments on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1" xml:lang="en-US">Effect of potential dilutive Ordinary shares - Warrants, Weighted number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_0" xml:lang="en-US">Disclosure of business combinations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1" xml:lang="en-US">BUSINESS COMBINATIONS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0" xml:lang="en-US">Disclosure of detailed information about business combination [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory_0" xml:lang="en-US">Disclosure of cash flow statement [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory_1" xml:lang="en-US">Disclosure of statement cash flows for partly owned subsidiary [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xml:lang="en-US">Disclosure of classes of share capital [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xml:lang="en-US">Disclosure of contingent liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure of contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1" xml:lang="en-US">CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0" xml:lang="en-US">Disclosure of deferred taxes [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1" xml:lang="en-US">Disclosure of detailed information about deferred taxes [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_0" xml:lang="en-US">Disclosure of defined benefit plans [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_1" xml:lang="en-US">Disclosure of detailed information about defined benefit plans [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xml:lang="en-US">Disclosure of detailed information about biological assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1" xml:lang="en-US">BIOLOGICAL ASSETS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0" xml:lang="en-US">Disclosure of detailed information about biological assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_0" xml:lang="en-US">Disclosure of detailed information about biological assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about business combination [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about business combinations [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_1" xml:lang="en-US">Disclosure of carrying values of financial instruments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about intangible assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" xml:lang="en-US">NET EARNINGS (LOSS) PER SHARE [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_0" xml:lang="en-US">Disclosure of employee benefits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_1" xml:lang="en-US">EMPLOYEE BENEFIT ASSETS AND LIABILITIES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_0" xml:lang="en-US">Disclosure of entity's operating segments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_1" xml:lang="en-US">SELECTED STATEMENTS OF PROFIT OR LOSS DATA [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_0" xml:lang="en-US">Disclosure of events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1" xml:lang="en-US">SUBSEQUENT EVENTS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory_0" xml:lang="en-US">Disclosure of expenses by nature [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory_1" xml:lang="en-US">Disclosure of statement of profit and loss [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_0" xml:lang="en-US">Disclosure of fair value of plan assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about changes in the fair value of plan assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xml:lang="en-US">Disclosure of financial assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsTable_0" xml:lang="en-US">Disclosure of financial assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1" xml:lang="en-US">FINANCIAL INSTRUMENTS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_0" xml:lang="en-US">Disclosure of general information about financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1" xml:lang="en-US">GENERAL [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_0" xml:lang="en-US">Disclosure of geographical areas [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_1" xml:lang="en-US">Disclosure of operating segments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems_0" xml:lang="en-US">Disclosure of geographical areas [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasTable_0" xml:lang="en-US">Disclosure of geographical areas [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" xml:lang="en-US">TAXES ON INCOME [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0" xml:lang="en-US">Disclosure of information about key management personnel [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1" xml:lang="en-US">Disclosure of information about key management personnel [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory_0" xml:lang="en-US">Disclosure of information about unconsolidated subsidiaries [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory_1" xml:lang="en-US">Disclosure of detailed information about subsidiaries [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0" xml:lang="en-US">Disclosure of intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" xml:lang="en-US">INTANGIBLE ASSETS, NET [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0" xml:lang="en-US">Disclosure of inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1" xml:lang="en-US">INVENTORIES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIssuedCapitalExplanatory_0" xml:lang="en-US">Disclosure of issued capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIssuedCapitalExplanatory_1" xml:lang="en-US">EQUITY [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_0" xml:lang="en-US">Disclosure of leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_1" xml:lang="en-US">RIGHT-OF-USE ASSETS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_0" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_1" xml:lang="en-US">Disclosure of detailed information about defined benefit liability (asset) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xml:lang="en-US">Disclosure of operating segments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0" xml:lang="en-US">Disclosure of operating segments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1" xml:lang="en-US">OPERATING SEGMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_1" xml:lang="en-US">Acquisition of a subsidiary:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about right-of-use assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_0" xml:lang="en-US">Disclosure of reconciliation of changes in biological assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_1" xml:lang="en-US">Disclosure of reconciliation of changes in biological assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_1" xml:lang="en-US">Disclosure of changes in liabilities arising from financing activities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0" xml:lang="en-US">Disclosure of related party [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" xml:lang="en-US">RELATED PARTY BALANCES AND TRANSACTIONS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_0" xml:lang="en-US">Disclosure of major customers [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_1" xml:lang="en-US">Disclosure of major customers [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_0" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_1" xml:lang="en-US">Disclosure of detailed information about principal assumptions underlying the defined benefit plan [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_0" xml:lang="en-US">Disclosure of subsidiaries [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1" xml:lang="en-US">Disclosure of detailed information about subsidiaries [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0" xml:lang="en-US">Disclosure of subsidiaries [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_0" xml:lang="en-US">Disclosure of subsidiaries [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0" xml:lang="en-US">Disclosure of significant accounting policies [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_0" xml:lang="en-US">Disclosure of trade and other payables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1" xml:lang="en-US">OTHER PAYABLES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">Disclosure of trade and other receivables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">TRADE RECEIVABLES [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_0" xml:lang="en-US">Disclosure of transactions between related parties [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_1" xml:lang="en-US">Disclosure of transactions between related parties [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xml:lang="en-US">Disclosure of transactions between related parties [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0" xml:lang="en-US">Disclosure of transactions between related parties [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Disposals, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_1" xml:lang="en-US">Net loss per share attributable to equity holders of the Company:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_2" xml:lang="en-US">Net loss per share attributable to equity holders of the Company:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_0" xml:lang="en-US">Earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory_1" xml:lang="en-US">Disclosure of earnings per share [Table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_1" xml:lang="en-US">Effect of foreign exchange on cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense_0" xml:lang="en-US">Employee benefits expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense_1" xml:lang="en-US">Total employee benefit expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_0" xml:lang="en-US">Entity's total for business combinations [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0" xml:lang="en-US">Entity's total for related parties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_0" xml:lang="en-US">Entity's total for segment consolidation items [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForSubsidiariesMember_0" xml:lang="en-US">Entity's total for subsidiaries [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity_2" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity_3" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Equity_4" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAbstract_0" xml:lang="en-US">Equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAbstract_1" xml:lang="en-US">EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY :</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EquityAbstract_2" xml:lang="en-US">EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities_0" xml:lang="en-US">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities_1" xml:lang="en-US">Total equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract_0" xml:lang="en-US">Equity and liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract_1" xml:lang="en-US">LIABILITIES AND EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent_0" xml:lang="en-US">Equity attributable to owners of parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent_1" xml:lang="en-US">Total equity attributable to shareholders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParentMember_0" xml:lang="en-US">Equity attributable to owners of parent [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParentMember_1" xml:lang="en-US">Equity attributable to owners of parent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_0" xml:lang="en-US">Equity interests of acquirer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_1" xml:lang="en-US">Value of common shares issued in business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityMember_0" xml:lang="en-US">Equity [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_0" xml:lang="en-US">Estimated financial effect of contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_1" xml:lang="en-US">Estimated total amount of class action suit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0" xml:lang="en-US">Exercise price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_1" xml:lang="en-US">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0" xml:lang="en-US">Expected dividend as percentage, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1" xml:lang="en-US">Dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0" xml:lang="en-US">Expense from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_0" xml:lang="en-US">Expense from share-based payment transactions with employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts_0" xml:lang="en-US">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinanceCosts_1" xml:lang="en-US">Finance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceCosts_2" xml:lang="en-US">Finance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncome_0" xml:lang="en-US">Finance income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinanceIncome_1" xml:lang="en-US">Finance income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncomeCost_0" xml:lang="en-US">Finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_FinanceIncomeCost_1" xml:lang="en-US">Finance income (expense), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_0" xml:lang="en-US">Total financial assets at fair value through profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_1" xml:lang="en-US">Financial assets at fair value through profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_2" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsMember_0" xml:lang="en-US">Financial assets, class [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialLiabilities_0" xml:lang="en-US">Financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ForeignCountriesMember_0" xml:lang="en-US">Foreign countries [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ForeignCountriesMember_1" xml:lang="en-US">Germany [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_0" xml:lang="en-US">Gain (loss) on remeasurement, net defined benefit liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_1" xml:lang="en-US">Re-measurement loss on defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment attributable to physical changes, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_1" xml:lang="en-US">Changes in fair value less cost to sell due to biological transformation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0" xml:lang="en-US">Gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_1" xml:lang="en-US">A positive or negative XBRL value can be entered for this element. Refer to the standard element label to determine the correct sign. Use a negative value for terms in brackets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2" xml:lang="en-US">Total gains (losses) on fair value adjustment, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_3" xml:lang="en-US">Unrealized change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_4" xml:lang="en-US">Unrealized change in fair value of biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_0" xml:lang="en-US">Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_1" xml:lang="en-US">A positive or negative XBRL value can be entered for this element. Refer to the standard element label to determine the correct sign. Use a negative value for terms in brackets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_2" xml:lang="en-US">Total fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_3" xml:lang="en-US">Total fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense_1" xml:lang="en-US">General and administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasAxis_0" xml:lang="en-US">Geographical areas [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasMember_0" xml:lang="en-US">Geographical areas [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Goodwill_0" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Goodwill_1" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Goodwill recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Goodwill arising on acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_0" xml:lang="en-US">Gross carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_1" xml:lang="en-US">Cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossProfit_0" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GrossProfit_1" xml:lang="en-US">Gross profit after fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_1" xml:lang="en-US">Total identifiable assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xml:lang="en-US">Total identifiable assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeStatementAbstract_0" xml:lang="en-US">Profit or loss [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_0" xml:lang="en-US">Taxes paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_1" xml:lang="en-US">Income taxes paid, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_2" xml:lang="en-US">Taxes paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xml:lang="en-US">Tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1" xml:lang="en-US">Income tax expense (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2" xml:lang="en-US">Income tax expense (recovery), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_3" xml:lang="en-US">Income tax expense (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_4" xml:lang="en-US">Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2" xml:lang="en-US">Net increase in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_0" xml:lang="en-US">Increase (decrease) in working capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_1" xml:lang="en-US">Changes in non-cash working capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_2" xml:lang="en-US">Changes in non-cash working capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_3" xml:lang="en-US">Changes in non-cash working capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_0" xml:lang="en-US">Increase (decrease) through acquisition of subsidiary, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_1" xml:lang="en-US">Issuance of shares related to acquisitions in Israel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase (decrease) through changes in fair values, liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Effect of changes in fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_0" xml:lang="en-US">Increase (decrease) through changes in foreign exchange rates, net defined benefit liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_1" xml:lang="en-US">Foreign currency translation effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0" xml:lang="en-US">Increase (decrease) through exercise of options, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0" xml:lang="en-US">Increase (decrease) through exercise of warrants, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1" xml:lang="en-US">Exercise of warrants and compensation options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Increase (decrease) through financing cash flows, liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_0" xml:lang="en-US">Increase (decrease) through net exchange differences, biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_1" xml:lang="en-US">Foreign exchange translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Currency translation adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_0" xml:lang="en-US">Increase (decrease) through net exchange differences, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_1" xml:lang="en-US">Foreign currency translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Additions due to acquisition of subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Increase (decrease) through other changes, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Purchases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase (decrease) through other changes, liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Other changes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase through new leases, liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Additions for new leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Indemnification assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Indemnification asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_3" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0" xml:lang="en-US">Intangible assets other than goodwill [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseDefinedBenefitPlans_0" xml:lang="en-US">Interest expense, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_ifrs-full_InterestExpenseDefinedBenefitPlans_1" xml:lang="en-US">Interest expense on the defined benefit obligation represents an increase in net defined benefit liability and should be tagged with a positive value. Interest income on the plan assets represents a decrease in net defined benefit liability (equivalent to an increase in a net defined benefit asset) and should be tagged with a negative value. Interest on the effect of the asset ceiling represents an increase in net defined benefit liability and should be tagged with a positive value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestExpenseDefinedBenefitPlans_2" xml:lang="en-US">Interest expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_0" xml:lang="en-US">Interest expense (income), net defined benefit liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_1" xml:lang="en-US">Interest expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_0" xml:lang="en-US">Repayment of lease liability interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_1" xml:lang="en-US">Interest paid, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Inventories_0" xml:lang="en-US">Current inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Inventories_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Inventories_2" xml:lang="en-US">Carrying value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoriesAtFairValueLessCostsToSell_0" xml:lang="en-US">Inventories, at fair value less costs to sell</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InventoriesAtFairValueLessCostsToSell_1" xml:lang="en-US">Fair valuation adjustment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Inventory recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoryWritedown2011_0" xml:lang="en-US">Inventory write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InventoryWritedown2011_1" xml:lang="en-US">Write downs of inventories recognized cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_0" xml:lang="en-US">Investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_1" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital_0" xml:lang="en-US">Issued capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssuedCapital_1" xml:lang="en-US">Share capital and premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapitalMember_0" xml:lang="en-US">Issued capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssuedCapitalMember_1" xml:lang="en-US">Share Capital and premium [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssuedCapitalMember_2" xml:lang="en-US">Share Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfEquity_0" xml:lang="en-US">Issue of equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssueOfEquity_1" xml:lang="en-US">Issuance of common shares, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0" xml:lang="en-US">Key management personnel compensation, share-based payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0" xml:lang="en-US">Key management personnel of entity or parent [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_1" xml:lang="en-US">Key management personnel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LandAndBuildingsMember_0" xml:lang="en-US">Land and buildings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LandAndBuildingsMember_1" xml:lang="en-US">Land and buildings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_0" xml:lang="en-US">Later than five years and not later than ten years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_1" xml:lang="en-US">6 to 10 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">Later than one year and not later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1" xml:lang="en-US">1 to 5 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanTenYearsMember_0" xml:lang="en-US">Later than ten years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanTenYearsMember_1" xml:lang="en-US">&gt;10 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember_0" xml:lang="en-US">Leasehold improvements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember_1" xml:lang="en-US">Leasehold improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities_0" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember_0" xml:lang="en-US">Lease liabilities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember_1" xml:lang="en-US">Lease liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Liabilities_2" xml:lang="en-US">Segment liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesAbstract_0" xml:lang="en-US">Liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LiabilitiesAbstract_1" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Liabilities arising from financing activities, ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Liabilities arising from financing activities, beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0" xml:lang="en-US">Liabilities arising from financing activities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_0" xml:lang="en-US">Liabilities arising from financing activities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_0" xml:lang="en-US">Balance at December 31,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_1" xml:lang="en-US">Balance at January 1,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2" xml:lang="en-US">Net defined benefit liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_3" xml:lang="en-US">Defined benefit obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LicencesAndFranchisesMember_0" xml:lang="en-US">Licences and franchises [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LicencesAndFranchisesMember_1" xml:lang="en-US">Licences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LicencesAndFranchisesMember_2" xml:lang="en-US">Licenses arose from acquisition of subsidiary [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LicencesMember_0" xml:lang="en-US">Licences [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LicencesMember_1" xml:lang="en-US">Licences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LicencesMember_2" xml:lang="en-US">Cultivations and processing license [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LoansAndReceivables_0" xml:lang="en-US">Loans and receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LoansAndReceivables_1" xml:lang="en-US">Loans receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LongtermBorrowings_0" xml:lang="en-US">Non-current portion of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_1" xml:lang="en-US">Long term loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_2" xml:lang="en-US">Long-term loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LongtermBorrowingsMember_0" xml:lang="en-US">Long-term borrowings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xml:lang="en-US">Major components of tax expense (income) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorCustomersAxis_0" xml:lang="en-US">Major customers [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorCustomersMember_0" xml:lang="en-US">Customers [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorOrdinaryShareTransactionsMember_0" xml:lang="en-US">Major ordinary share transactions [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_MajorOrdinaryShareTransactionsMember_1" xml:lang="en-US">Event after reporting period [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_0" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_1" xml:lang="en-US">Disclosure of maturity analysis for lease liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAxis_0" xml:lang="en-US">Maturity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MotorVehiclesMember_0" xml:lang="en-US">Motor vehicles [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MotorVehiclesMember_1" xml:lang="en-US">Motor vehicles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsMember_0" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_0" xml:lang="en-US">Non-controlling interest in acquiree recognised at acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_1" xml:lang="en-US">Non-controlling interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncontrollingInterests_0" xml:lang="en-US">Non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncontrollingInterests_1" xml:lang="en-US">Non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncontrollingInterestsMember_0" xml:lang="en-US">Non-controlling interests [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncontrollingInterestsMember_1" xml:lang="en-US">Non-controlling interests [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssets_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_2" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_3" xml:lang="en-US">Carrying amounts of non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_0" xml:lang="en-US">Non-current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_1" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_0" xml:lang="en-US">Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_1" xml:lang="en-US">Carrying amounts of non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_0" xml:lang="en-US">Non-current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_1" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities_2" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities_1" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_2" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_3" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0" xml:lang="en-US">Non-current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_1" xml:lang="en-US">NON-CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_0" xml:lang="en-US">Non-current payables for purchase of non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_1" xml:lang="en-US">Accrued purchase consideration liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_0" xml:lang="en-US">Non-current net defined benefit liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_1" xml:lang="en-US">Employee benefit liabilities, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_0" xml:lang="en-US">Not later than one year [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_1" xml:lang="en-US">Less than one year [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_0" xml:lang="en-US">Number of instruments or interests issued or issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_1" xml:lang="en-US">Number of common shares issued in business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1" xml:lang="en-US">Number of warrants issued for common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2" xml:lang="en-US">RSU granted during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of other equity instruments exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_1" xml:lang="en-US">RSU exercisable at the end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2" xml:lang="en-US">RSU outstanding at the beginning</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_3" xml:lang="en-US">RSU outstanding at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_0" xml:lang="en-US">Options outstanding at the end of year - Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_1" xml:lang="en-US">Options outstanding at the beginning of the year - Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_2" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0" xml:lang="en-US">Options exercisable at the end of year - Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2" xml:lang="en-US">RSU exercisable at the end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1" xml:lang="en-US">Options exercised during the year - Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2" xml:lang="en-US">Number of share options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3" xml:lang="en-US">Options exercised during the year - Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1" xml:lang="en-US">Options forfeited during the year - Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2" xml:lang="en-US">Options forfeited during the year - Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1" xml:lang="en-US">Options granted during the year - Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2" xml:lang="en-US">Number of share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_3" xml:lang="en-US">RSU granted during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesIssued_0" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_0" xml:lang="en-US">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_1" xml:lang="en-US">Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_2" xml:lang="en-US">Number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OperatingExpense_0" xml:lang="en-US">Operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_OperatingExpense_1" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OperatingExpense_2" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OperatingExpense_3" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OperatingSegmentsMember_0" xml:lang="en-US">Operating segments [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OperatingSegmentsMember_1" xml:lang="en-US">Operating segments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OrdinarySharesMember_0" xml:lang="en-US">Ordinary shares [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OrdinarySharesMember_1" xml:lang="en-US">Ordinary shares without par value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherAssetsMember_0" xml:lang="en-US">Other assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherAssetsMember_1" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_0" xml:lang="en-US">Other cash payments to acquire equity or debt instruments of other entities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_1" xml:lang="en-US">Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_2" xml:lang="en-US">Investments in associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_3" xml:lang="en-US">Aggregate consideration to acquire preferred shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_0" xml:lang="en-US">Other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_1" xml:lang="en-US">Total other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_2" xml:lang="en-US">Other comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_3" xml:lang="en-US">Other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2" xml:lang="en-US">Adjustments arising from translating financial statements of foreign operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_0" xml:lang="en-US">Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_1" xml:lang="en-US">Re-measurement loss on defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_2" xml:lang="en-US">Remeasurement gain (loss) on defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_0" xml:lang="en-US">Other comprehensive income, net of tax, hedges of net investments in foreign operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_1" xml:lang="en-US">Adjustments arising from translating financial statements of foreign operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_0" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_1" xml:lang="en-US">Total other comprehensive income that will be reclassified to profit or loss in subsequent periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_0" xml:lang="en-US">Other comprehensive income that will not be reclassified to profit or loss, net of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1" xml:lang="en-US">Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentPayables_0" xml:lang="en-US">Other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherCurrentPayables_1" xml:lang="en-US">Other accounts payable and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherCurrentPayables_2" xml:lang="en-US">Total other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentReceivables_0" xml:lang="en-US">Other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherCurrentReceivables_1" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherCurrentReceivables_2" xml:lang="en-US">Other accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_OtherExpenseByNature_0" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherExpenseByNature_1" xml:lang="en-US">Other expenses, by nature</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherExpenseByNature_2" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherExpenseByNature_3" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherGainsLosses_0" xml:lang="en-US">Other gains (losses)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherGainsLosses_1" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember_0" xml:lang="en-US">Other intangible assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember_1" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember_2" xml:lang="en-US">Other intangibles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherReceivables_0" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherReceivables_1" xml:lang="en-US">Other accounts receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_0" xml:lang="en-US">Other tax effects for reconciliation between accounting profit and tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_1" xml:lang="en-US">Other adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ParentMember_0" xml:lang="en-US">Parent [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ParentMember_1" xml:lang="en-US">IMC [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ParValuePerShare_0" xml:lang="en-US">Par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_0" xml:lang="en-US">Payments for share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_1" xml:lang="en-US">Fees and other issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_0" xml:lang="en-US">Payments in respect of settlements, net defined benefit liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_1" xml:lang="en-US">Benefits paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_2" xml:lang="en-US">Benefits paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0" xml:lang="en-US">Repayment of lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfOtherEquityInstruments_0" xml:lang="en-US">Conversion of warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfOtherEquityInstruments_1" xml:lang="en-US">Payments of other equity instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PaymentsOfOtherEquityInstruments_2" xml:lang="en-US">Conversion of warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfEntitysRevenue_0" xml:lang="en-US">Percentage of entity's revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PercentageOfEntitysRevenue_1" xml:lang="en-US">Percentage of total revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_0" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1" xml:lang="en-US">Percentage of issued and outstanding shares acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue_0" xml:lang="en-US">Balance at December 31,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue_1" xml:lang="en-US">Balance at January 1,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue_2" xml:lang="en-US">Plan assets, at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue_3" xml:lang="en-US">Fair value of plan assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue_4" xml:lang="en-US">Fair value of plan assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_0" xml:lang="en-US">Post-employment benefit expense in profit or loss, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_1" xml:lang="en-US">Total employee benefit expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_2" xml:lang="en-US">Use this line item to tag employee benefits expenses including expenses from share-based payment transactions with employees (or when expenses from share-based payment transactions with employees are zero). Do NOT use this line item to tag employee benefits expenses excluding expenses from share-based payment transactions with employees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_3" xml:lang="en-US">Employee benefits expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PreferenceSharesMember_0" xml:lang="en-US">Preference shares [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PreferenceSharesMember_1" xml:lang="en-US">Convertible preferred shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_0" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1" xml:lang="en-US">Proceeds from bank loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_0" xml:lang="en-US">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_1" xml:lang="en-US">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0" xml:lang="en-US">Proceeds from issue of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_0" xml:lang="en-US">Proceeds from issuing other equity instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_1" xml:lang="en-US">Issuance of new warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2" xml:lang="en-US">Gross proceeds from warrants recorded as Share capital and premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_0" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_1" xml:lang="en-US">Net proceeds from private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_2" xml:lang="en-US">Proceeds from issuance of share capital, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentProperty_0" xml:lang="en-US">Proceeds from sales of investment property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentProperty_1" xml:lang="en-US">Proceeds from sale of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_0" xml:lang="en-US">Professional fees expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_1" xml:lang="en-US">Professional fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfessionalFeesExpense_2" xml:lang="en-US">Payments to shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss_0" xml:lang="en-US">Profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLoss_1" xml:lang="en-US">Segment income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss_2" xml:lang="en-US">Net Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLoss_3" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_ProfitLoss_4" xml:lang="en-US">Net Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToAbstract_0" xml:lang="en-US">Profit (loss), attributable to [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToAbstract_1" xml:lang="en-US">Net loss attributable to:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_0" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_1" xml:lang="en-US">Non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_0" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_1" xml:lang="en-US">For the computation of basic net earnings, Net loss attributable to equity holders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_0" xml:lang="en-US">Profit (loss), attributable to owners of parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_1" xml:lang="en-US">For the computation of basic net earnings, Net loss attributable to equity holders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_2" xml:lang="en-US">Equity holders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_3" xml:lang="en-US">For the computation of diluted net earnings, Net loss attributable to equity holders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_0" xml:lang="en-US">Profit (loss) before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_1" xml:lang="en-US">Loss before income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0" xml:lang="en-US">Profit (loss) from continuing operations attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1" xml:lang="en-US">Effect of potential dilutive Ordinary shares - Warrants, Net loss attributable to equity holders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_1" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_2" xml:lang="en-US">Segment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_3" xml:lang="en-US">Net loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_4" xml:lang="en-US">Net Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossOfAcquiree_0" xml:lang="en-US">Profit (loss) of acquiree since acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossOfAcquiree_1" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ProfitLossOfAcquiree_2" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_0" xml:lang="en-US">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_1" xml:lang="en-US">Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_3" xml:lang="en-US">Property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentMember_0" xml:lang="en-US">Property, plant and equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0" xml:lang="en-US">Proportion of ownership interest in subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1" xml:lang="en-US">Percentage ownership</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfInvestmentProperty_0" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfInvestmentProperty_1" xml:lang="en-US">Purchase of investment property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis_0" xml:lang="en-US">Range [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesMember_0" xml:lang="en-US">Ranges [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_0" xml:lang="en-US">Net defined benefit liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_1" xml:lang="en-US">Net defined benefit liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_0" xml:lang="en-US">Reconciliation of average effective tax rate and applicable tax rate [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_1" xml:lang="en-US">Increase (decrease) in income tax due to:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RelatedPartiesMember_0" xml:lang="en-US">Related parties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RelatedPartyTransactionsAbstract_0" xml:lang="en-US">Related party transactions [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_0" xml:lang="en-US">Repayment of bank loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1" xml:lang="en-US">Repayments of borrowings, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Research and development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_0" xml:lang="en-US">Reserve of exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_1" xml:lang="en-US">Translation reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_0" xml:lang="en-US">Reserve of exchange differences on translation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_1" xml:lang="en-US">Translation reserve [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfSharebasedPayments_0" xml:lang="en-US">Reserve of share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfSharebasedPayments_1" xml:lang="en-US">Reserve from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_0" xml:lang="en-US">Reserve of share-based payments [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_1" xml:lang="en-US">Reserve from share-based payment transactions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarnings_0" xml:lang="en-US">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_1" xml:lang="en-US">Retained earnings (accumulated deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_2" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember_0" xml:lang="en-US">Retained earnings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarningsMember_1" xml:lang="en-US">Retained earnings (deficit) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Revenue_0" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Revenue_1" xml:lang="en-US">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueOfAcquiree_0" xml:lang="en-US">Revenue of acquiree since acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RevenueOfAcquiree_1" xml:lang="en-US">Net revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_RightofuseAssets_0" xml:lang="en-US">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_RightofuseAssets_1" xml:lang="en-US">Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssets_2" xml:lang="en-US">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RightofuseAssets_3" xml:lang="en-US">Right-of-use assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssetsMember_0" xml:lang="en-US">Right-of-use assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_0" xml:lang="en-US">Risk exposure associated with instruments sharing characteristic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_1" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_2" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_3" xml:lang="en-US">Total cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_4" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SalesAndMarketingExpense_0" xml:lang="en-US">Sales and marketing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_SalesAndMarketingExpense_1" xml:lang="en-US">Selling and marketing expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SegmentConsolidationItemsAxis_0" xml:lang="en-US">Segment consolidation items [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SegmentsMember_0" xml:lang="en-US">Segments [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingExpense_0" xml:lang="en-US">Selling expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember_0" xml:lang="en-US">Share-based payment arrangements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_0" xml:lang="en-US">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_1" xml:lang="en-US">Share capital issuance cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_2" xml:lang="en-US">Issuance expenses including FV of compensation units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_3" xml:lang="en-US">Transaction costs incurred for common share issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_0" xml:lang="en-US">Number of shares reserved for issue under options and contracts for sale of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_1" xml:lang="en-US">Ordinary shares reserved for issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermBorrowings_0" xml:lang="en-US">Current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ShorttermBorrowings_1" xml:lang="en-US">Total borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermBorrowings_2" xml:lang="en-US">Bank Loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermBorrowingsMember_0" xml:lang="en-US">Short-term borrowings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermBorrowingsMember_1" xml:lang="en-US">Short-term loans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_0" xml:lang="en-US">Short-term employee benefits accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_1" xml:lang="en-US">Employees and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0" xml:lang="en-US">Subsidiaries [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract_0" xml:lang="en-US">Statement of changes in equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems_0" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable_0" xml:lang="en-US">Statement of changes in equity [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of financial position [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_0" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1" xml:lang="en-US">Non-deductible (income) expense, net for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2" xml:lang="en-US">Non-deductible (income) expense, net for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates_0" xml:lang="en-US">Tax effect of foreign tax rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates_1" xml:lang="en-US">Statutory tax rate in Canada 26.5%</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxEffectOfTaxLosses_0" xml:lang="en-US">Tax effect of tax losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxEffectOfTaxLosses_1" xml:lang="en-US">Adjustments in respect of current income tax of previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_0" xml:lang="en-US">Tax expense (income) at applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1" xml:lang="en-US">Adjustments in respect of current income tax of previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_2" xml:lang="en-US">Statutory tax rate in Canada</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember_0" xml:lang="en-US">Top of range [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TopOfRangeMember_1" xml:lang="en-US">Top of range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xml:lang="en-US">Trade and other current payables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_0" xml:lang="en-US">Current payables to related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_1" xml:lang="en-US">Related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_0" xml:lang="en-US">Current trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_0" xml:lang="en-US">Trade and other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_1" xml:lang="en-US">Total other accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_2" xml:lang="en-US">Other accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_0" xml:lang="en-US">Current receivables due from related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_1" xml:lang="en-US">Related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherPayablesAbstract_0" xml:lang="en-US">Trade and other payables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Trade and other payables recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract_0" xml:lang="en-US">Trade and other receivables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TreasuryShares_0" xml:lang="en-US">Treasury Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TreasuryShares_1" xml:lang="en-US">Treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TreasurySharesMember_0" xml:lang="en-US">Treasury shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfRisksAxis_0" xml:lang="en-US">Types of risks [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfRisksMember_0" xml:lang="en-US">Risks [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UnallocatedAmountsMember_0" xml:lang="en-US">Unallocated amounts [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UnusedTaxLossesMember_0" xml:lang="en-US">Unused tax losses [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UnusedTaxLossesMember_1" xml:lang="en-US">Carryforward tax losses and other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Amortization of intangible assets on straight-line basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_0" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WagesAndSalaries_0" xml:lang="en-US">Wages and salaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WagesAndSalaries_1" xml:lang="en-US">Salaries and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WarrantLiability_0" xml:lang="en-US">Warrant liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Exercise price of warrants exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Exercise price of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Exercise price of warrants issued per common share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Options exercisable at the end of year - Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Options exercised during the year - Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Exercise price of compensation option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Options forfeited during the year - Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Options granted during the year - Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Weighted average value of each option grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Options outstanding at the end of year - Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Options outstanding at the beginning of the year - Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0" xml:lang="en-US">Weighted average fair value at measurement date, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1" xml:lang="en-US">Weighted average fair value of each option grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageMember_0" xml:lang="en-US">Weighted average [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageMember_1" xml:lang="en-US">Mainly [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1" xml:lang="en-US">Weighted average remaining contractual life for the share options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019_0" xml:lang="en-US">Weighted average share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019_1" xml:lang="en-US">Market price of common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0" xml:lang="en-US">Weighted average share price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1" xml:lang="en-US">Share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares_0" xml:lang="en-US">Weighted average number of ordinary shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares_1" xml:lang="en-US">For the computation of basic net earnings, Weighted number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_0" xml:lang="en-US">Accrued Purchase Consideration Liability As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_1" xml:lang="en-US">It represents accrued purchase consideration liability as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_2" xml:lang="en-US">Accrued purchase consideration liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AcquisitionCostsForProfessionalFees_0" xml:lang="en-US">Acquisition Costs For Professional Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AcquisitionCostsForProfessionalFees_1" xml:lang="en-US">It represents acquisition costs for professional fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AcquisitionCostsForProfessionalFees_2" xml:lang="en-US">Acquisition costs for professional fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AcquisitionCostsOfCommonShares_0" xml:lang="en-US">Acquisition Costs Of Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AcquisitionCostsOfCommonShares_1" xml:lang="en-US">It represents acquisition costs of common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AcquisitionCostsOfCommonShares_2" xml:lang="en-US">Acquisition costs of common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AcquisitionOfSubsidiaryAbstract_0" xml:lang="en-US">Acquisition Of Subsidiary [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AcquisitionOfSubsidiaryAbstract_1" xml:lang="en-US">Schedule A - Acquisition of TFC</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AcquisitionOfTrichomeFinancialCorpMember_0" xml:lang="en-US">Acquisition Of Trichome Financial Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AcquisitionOfTrichomeFinancialCorpMember_1" xml:lang="en-US">Acquisition of Trichome Financial Corp. ("Trichome").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AcquisitionOfTrichomeFinancialCorpMember_2" xml:lang="en-US">Acquisition of Trichome Financial Corp. ("Trichome")</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AcquisitionTransactionCosts_0" xml:lang="en-US">Represent the amount of acquisition transaction costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AcquisitionTransactionCosts_1" xml:lang="en-US">Acquisition Transaction Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AcquisitionTransactionCosts_2" xml:lang="en-US">Acquisition costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AdditionsToDisposalsRightOfUseAssets_0" xml:lang="en-US">Additions To Disposals Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AdditionsToDisposalsRightOfUseAssets_1" xml:lang="en-US">Represents the amount of additions to the disposals of right of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AdditionsToDisposalsRightOfUseAssets_2" xml:lang="en-US">Additions during the year: Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AdjupharmGmbhMember_0" xml:lang="en-US">This member stands for Adjupharm Gmbh.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AdjupharmGmbhMember_1" xml:lang="en-US">Adjupharm Gmbh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AdjupharmGmbhMember_2" xml:lang="en-US">Adjupharm GmbH ("Adjupharm") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AdjupharmsCeoMember_0" xml:lang="en-US">This member stands for Adjupharm's CEO.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AdjupharmsCeoMember_1" xml:lang="en-US">Adjupharms Ceo [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AdjupharmsCeoMember_2" xml:lang="en-US">Adjupharm's CEO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AdjustedExercisePrice_0" xml:lang="en-US">Information about adjusted exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AdjustedExercisePrice_1" xml:lang="en-US">Adjusted Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AdjustedExercisePrice_2" xml:lang="en-US">Adjusted exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_0" xml:lang="en-US">Adjusted Weighted Average Shares Profit Loss Attributable To Owners Of Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_1" xml:lang="en-US">Adjusted Weighted Average Shares Profit Loss Attributable To Owners Of Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_2" xml:lang="en-US">For the computation of diluted net earnings, Net loss attributable to equity holders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_0" xml:lang="en-US">Adjustments For Non Cash Interest Income On Loans Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1" xml:lang="en-US">It represents adjustments for non cash interest income on loans receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_2" xml:lang="en-US">Non-cash interest income on loans receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_3" xml:lang="en-US">Non-cash interest income on loans receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AdjustmentsForRevaluationOfOtherReceivable_0" xml:lang="en-US">Adjustments For Revaluation Of Other Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AdjustmentsForRevaluationOfOtherReceivable_1" xml:lang="en-US">It represents adjustments for revaluation of other receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AdjustmentsForRevaluationOfOtherReceivable_2" xml:lang="en-US">Revaluation of other receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_0" xml:lang="en-US">Adjustments For Share Based Acquisiotion Costs Related To Business Comintation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1" xml:lang="en-US">It represents adjustments for share based acquisiotion costs related to business comintation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_2" xml:lang="en-US">Share based acquisiotion costs related to business comintation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_3" xml:lang="en-US">Share based acquisition costs related to business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AggregateGrossProceedsOfSubscriptionReceipts_0" xml:lang="en-US">Represents the aggregate gross proceeds of subscription receipts issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AggregateGrossProceedsOfSubscriptionReceipts_1" xml:lang="en-US">Aggregate Gross Proceeds Of Subscription Receipts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AggregateGrossProceedsOfSubscriptionReceipts_2" xml:lang="en-US">Aggregate gross proceeds of subscription receipts issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AggregatePurchasePriceOfBusinessAcquisition_0" xml:lang="en-US">Aggregate Purchase Price Of Business Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AggregatePurchasePriceOfBusinessAcquisition_1" xml:lang="en-US">It represents aggregate purchase price of business acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AggregatePurchasePriceOfBusinessAcquisition_2" xml:lang="en-US">Aggregate purchase price of business acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AgreementAxis_0" xml:lang="en-US">Agreement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AgreementAxis_1" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AgreementDomain_0" xml:lang="en-US">Agreement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AgreementDomain_1" xml:lang="en-US">Represents domain information related to agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AgreementWithFarmerMember_0" xml:lang="en-US">Agreement With Farmer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AgreementWithFarmerMember_1" xml:lang="en-US">Represents member information related to farmer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AllocatedPercentageOfShareCapital_0" xml:lang="en-US">Allocated Percentage Of Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AllocatedPercentageOfShareCapital_1" xml:lang="en-US">Allocated percentage of share capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AllocatedPercentageOfShareCapital_2" xml:lang="en-US">Allocated percentage of share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountDepositedInEscrow_0" xml:lang="en-US">Amount Deposited In Escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountDepositedInEscrow_1" xml:lang="en-US">It represents amount deposited in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountDepositedInEscrow_2" xml:lang="en-US">Amount deposited in escrow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfClassActionGroupIncurredDamages_0" xml:lang="en-US">Represents the amount of class action group incurred damages.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfClassActionGroupIncurredDamages_1" xml:lang="en-US">Amount Of Class Action Group Incurred Damages</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AmountOfClassActionGroupIncurredDamages_2" xml:lang="en-US">Amount of class action group incurred damages</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfExpensesPaidByApplicant_0" xml:lang="en-US">Amount Of Expenses Paid By Applicant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfExpensesPaidByApplicant_1" xml:lang="en-US">Represents the amount of Companies&#8217; expenses paid by applicant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountOfExpensesPaidByApplicant_2" xml:lang="en-US">Amount of expenses paid by applicant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfNonCancellablePurchasePrice_0" xml:lang="en-US">Amount Of Non Cancellable Purchase Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfNonCancellablePurchasePrice_1" xml:lang="en-US">It represents amount of non cancellable purchase price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AmountOfNonCancellablePurchasePrice_2" xml:lang="en-US">Amount of non cancellable purchase price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfPersonalSuit_0" xml:lang="en-US">Represents the amount of personal suit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfPersonalSuit_1" xml:lang="en-US">Amount Of Personal Suit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountOfPersonalSuit_2" xml:lang="en-US">Amount of personal suit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfPurchaseOfTreasuryCommonShares_0" xml:lang="en-US">Amount Of Purchase Of Treasury Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfPurchaseOfTreasuryCommonShares_1" xml:lang="en-US">Amount of purchase of treasury common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountOfPurchaseOfTreasuryCommonShares_2" xml:lang="en-US">Purchase of treasury common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_AmountOfPurchaseOfTreasuryCommonShares_3" xml:lang="en-US">Purchase of treasury common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfSettlementOfWithholdingTaxLiabilities_0" xml:lang="en-US">Amount Of Settlement Of Withholding Tax Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfSettlementOfWithholdingTaxLiabilities_1" xml:lang="en-US">It represents amount of settlement of withholding tax liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AmountOfSettlementOfWithholdingTaxLiabilities_2" xml:lang="en-US">Amount of settlement of withholding tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfSharesGranted_0" xml:lang="en-US">Represent the amount Of shares granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfSharesGranted_1" xml:lang="en-US">Amount Of Shares Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountOfSharesGranted_2" xml:lang="en-US">Amount of shares granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfTranslationTransaction_0" xml:lang="en-US">Amount Of Translation Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfTranslationTransaction_1" xml:lang="en-US">Amount of translation transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountOfTranslationTransaction_2" xml:lang="en-US">Amount of translation transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfVotingEquityInterestsAcquired_0" xml:lang="en-US">The amount of voting equity interests acquired in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfVotingEquityInterestsAcquired_1" xml:lang="en-US">Amount Of Voting Equity Interests Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountOfVotingEquityInterestsAcquired_2" xml:lang="en-US">Amount of issued and outstanding shares acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountOfWarrantTransferredInEquityDuringPeriod_0" xml:lang="en-US">Amount Of Warrant Transferred In Equity During Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountOfWarrantTransferredInEquityDuringPeriod_1" xml:lang="en-US">Represents the amount of warrant transferred in equity during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AmountOfWarrantTransferredInEquityDuringPeriod_2" xml:lang="en-US">Amount of warrant transferred in equity during the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountToBeDeliveredOverTermOfSalesAgreements_0" xml:lang="en-US">Amount To Be Delivered Over Term Of Sales Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountToBeDeliveredOverTermOfSalesAgreements_1" xml:lang="en-US">Amounts to be delivered over the terms of several binding medical cannabis sales agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountToBeDeliveredOverTermOfSalesAgreements_2" xml:lang="en-US">Amounts to be delivered over the terms of several binding medical cannabis sales agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_0" xml:lang="en-US">Represent the amount for release of security provided for bank loan and bank credit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_1" xml:lang="en-US">Amount To Release Security Provided For Bank Loan And Bank Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_2" xml:lang="en-US">Amount to release security provided for bank loan and bank credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ApproximatelyCashAndCashEquivalents_0" xml:lang="en-US">Approximately Cash And Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ApproximatelyCashAndCashEquivalents_1" xml:lang="en-US">Amount of approximately cash and cash equivalents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ApproximatelyCashAndCashEquivalents_2" xml:lang="en-US">Approximately cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AreaOfCultivationAndProcessing_0" xml:lang="en-US">Area Of Cultivation And Processing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AreaOfCultivationAndProcessing_1" xml:lang="en-US">Represents information related to the area of cultivation and processing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AreaOfCultivationAndProcessing_2" xml:lang="en-US">Area of cultivation and processing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ArrangementAgreementMember_0" xml:lang="en-US">Arrangement agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ArrangementAgreementMember_1" xml:lang="en-US">Arrangement Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ArrangementAgreementMember_2" xml:lang="en-US">Arrangement agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AssetsLocationMember_0" xml:lang="en-US">Assets Location [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AssetsLocationMember_1" xml:lang="en-US">Represents assets location member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_AssetsLocationMember_2" xml:lang="en-US">Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AttritionRate_0" xml:lang="en-US">Represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AttritionRate_1" xml:lang="en-US">Attrition Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AttritionRate_2" xml:lang="en-US">Attrition rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AutomaticExtensionPeriodOfAgreement_0" xml:lang="en-US">Represents automatic extension period of agreement during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AutomaticExtensionPeriodOfAgreement_1" xml:lang="en-US">Automatic Extension Period Of Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AutomaticExtensionPeriodOfAgreement_2" xml:lang="en-US">Automatic extension period of agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_0" xml:lang="en-US">Represent the average post-harvest costs per gram of dried cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_1" xml:lang="en-US">Average Post Harvest Costs Per Gram Of Dried Cannabis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_2" xml:lang="en-US">Average post-harvest costs per gram of dried cannabis (in CAD)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AverageSellingPricePerGramOfDriedCannabis_0" xml:lang="en-US">Represent the average selling price per gram of dried cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AverageSellingPricePerGramOfDriedCannabis_1" xml:lang="en-US">Average Selling Price Per Gram Of Dried Cannabis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AverageSellingPricePerGramOfDriedCannabis_2" xml:lang="en-US">Average selling price per gram of dried cannabis (in CAD)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AverageStageOfGrowth_0" xml:lang="en-US">Represents percentage for average stage of growth.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AverageStageOfGrowth_1" xml:lang="en-US">Average Stage Of Growth</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AverageStageOfGrowth_2" xml:lang="en-US">Average stage of growth</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_AverageYieldPerPlant_0" xml:lang="en-US">Represents the expected number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_AverageYieldPerPlant_1" xml:lang="en-US">Average Yield Per Plant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_AverageYieldPerPlant_2" xml:lang="en-US">Average yield per plant (in grams)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_BankCreditRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount recognised as of the acquisition date for bank credit assumed in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_BankCreditRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Bank Credit Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_BankCreditRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Bank credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_BankCreditRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Bank credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_BankLoanAndLeaseLiabilities_0" xml:lang="en-US">Bank Loan And Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_BankLoanAndLeaseLiabilities_1" xml:lang="en-US">Represents the total amount of bank loan and lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_BankLoanAndLeaseLiabilities_2" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_BaseShelfProspectusMember_0" xml:lang="en-US">base shelf prospectus [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_BaseShelfProspectusMember_1" xml:lang="en-US">Base Shelf Prospectus [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_BaseShelfProspectusMember_2" xml:lang="en-US">Base shelf prospectus [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_BasicDilutedEarningsLossPerShare_0" xml:lang="en-US">Basic Diluted Earnings Loss Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_BasicDilutedEarningsLossPerShare_1" xml:lang="en-US">Represents the amount of basic diluted earnings loss per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_BasicDilutedEarningsLossPerShare_2" xml:lang="en-US">Basic and diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Biological Assets Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">It represents biological assets recognised as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Biological assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_BorrowingRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Borrowing Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_BorrowingRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">It represents borrowings recognised as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_BorrowingRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Loan receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_BulkCannabisMember_0" xml:lang="en-US">Represents member information related to Bulk cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_BulkCannabisMember_1" xml:lang="en-US">Bulk Cannabis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_BulkCannabisMember_2" xml:lang="en-US">Bulk cannabis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CannabisPlantsMember_0" xml:lang="en-US">This member stands for cannabis plants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CannabisPlantsMember_1" xml:lang="en-US">Cannabis Plants [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CannabisPlantsMember_2" xml:lang="en-US">Cannabis Plants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CannacanadaIncMember_0" xml:lang="en-US">Cannacanada Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CannacanadaIncMember_1" xml:lang="en-US">This member stands for CannaCanada Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_CannacanadaIncMember_2" xml:lang="en-US">CannaCanada Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CapitalExpenditures_0" xml:lang="en-US">Capital Expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CapitalExpenditures_1" xml:lang="en-US">Information about capital expenditures.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_CapitalExpenditures_2" xml:lang="en-US">Capital expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CapitalizedCostsOfInventories_0" xml:lang="en-US">Represents the amount of capitalized costs of inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CapitalizedCostsOfInventories_1" xml:lang="en-US">Capitalized Costs Of Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CapitalizedCostsOfInventories_2" xml:lang="en-US">Capitalized costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CarryforwardLossesForTaxPurposesDescription_0" xml:lang="en-US">Carryforward losses for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CarryforwardLossesForTaxPurposesDescription_1" xml:lang="en-US">Carryforward Losses For Tax Purposes Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_CarryforwardLossesForTaxPurposesDescription_2" xml:lang="en-US">Description of carryforward losses for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CarryforwardOperatingTaxLosses_0" xml:lang="en-US">Represents Carryforward operating tax losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CarryforwardOperatingTaxLosses_1" xml:lang="en-US">Carryforward Operating Tax Losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_CarryforwardOperatingTaxLosses_2" xml:lang="en-US">Carryforward operating tax losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CashAndCashEquivalentMember_0" xml:lang="en-US">Cash And Cash Equivalent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CashAndCashEquivalentMember_1" xml:lang="en-US">Cash and cash equivalent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CashConsiderationOfBusinessCombination_0" xml:lang="en-US">Cash Consideration Of Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CashConsiderationOfBusinessCombination_1" xml:lang="en-US">It represents cash consideration of business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CashConsiderationOfBusinessCombination_2" xml:lang="en-US">Cash consideration of business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ChangeInRestrictedBankDeposits_0" xml:lang="en-US">Represents amount related to change in restricted bank deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_ChangeInRestrictedBankDeposits_1" xml:lang="en-US">Change in restricted bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ChangeInRestrictedBankDeposits_2" xml:lang="en-US">Change In Restricted Bank Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ChangeInTaxBenefitsNotRecognized_0" xml:lang="en-US">Change In Tax Benefits Not Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ChangeInTaxBenefitsNotRecognized_1" xml:lang="en-US">The amount of change in tax benefits not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_ChangeInTaxBenefitsNotRecognized_2" xml:lang="en-US">Change in tax benefits not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ChangesInNonCashWorkingCapitalAbstract_0" xml:lang="en-US">Changes In Non Cash Working Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ChangesInNonCashWorkingCapitalAbstract_1" xml:lang="en-US">Changes in non-cash working capital:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ClassesOfInventoriesAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ClassesOfInventoriesAxis_1" xml:lang="en-US">Classes Of Inventories [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ClassesOfInventoriesDomain_0" xml:lang="en-US">This member stands for the standard value for the Inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ClassesOfInventoriesDomain_1" xml:lang="en-US">Classes Of Inventories [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_Commitment_0" xml:lang="en-US">Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_Commitment_1" xml:lang="en-US">Represents amount of commitment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_Commitment_2" xml:lang="en-US">Total Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CompensationOptionPricePerShare_0" xml:lang="en-US">Represents amount related to compensation option price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CompensationOptionPricePerShare_1" xml:lang="en-US">Compensation Option Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CompensationOptionPricePerShare_2" xml:lang="en-US">Compensation option price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CompensationOptions2019Member_0" xml:lang="en-US">Compensation Options 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CompensationOptions2019Member_1" xml:lang="en-US">Compensation options 2019.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CompensationOptions2019Member_2" xml:lang="en-US">2019 Compensation Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CompensationUnitPerShare_0" xml:lang="en-US">Represents the compensation unit per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CompensationUnitPerShare_1" xml:lang="en-US">Compensation Unit Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CompensationUnitPerShare_2" xml:lang="en-US">Compensation unit per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CompensationUnitsMember_0" xml:lang="en-US">Compensation units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CompensationUnitsMember_1" xml:lang="en-US">Compensation Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_CompensationUnitsMember_2" xml:lang="en-US">Compensation units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_0" xml:lang="en-US">Conversion Of Warrant And Compensation Options Into Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_1" xml:lang="en-US">Information about conversion of warrant and compensation options into common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_2" xml:lang="en-US">Conversion of warrant and compensation options into common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ConversionPricePerWarrant_0" xml:lang="en-US">Conversion price per warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ConversionPricePerWarrant_1" xml:lang="en-US">Conversion Price Per Warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ConversionPricePerWarrant_2" xml:lang="en-US">Conversion price per warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CostOfGoodsSoldInventory_0" xml:lang="en-US">Cost Of Goods Sold Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CostOfGoodsSoldInventory_1" xml:lang="en-US">It represents cost of inventory sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CostOfGoodsSoldInventory_2" xml:lang="en-US">Cost of goods sold Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CultivationsAndProcessingLicenseMember_0" xml:lang="en-US">Cultivations And Processing License [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CultivationsAndProcessingLicenseMember_1" xml:lang="en-US">This member stands for cultivations and processing license.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CultivationsAndProcessingLicenseMember_2" xml:lang="en-US">Cultivations and processing license [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CustomerOneMember_0" xml:lang="en-US">Represents member information related to Customer one.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CustomerOneMember_1" xml:lang="en-US">Customer One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_CustomerOneMember_2" xml:lang="en-US">Customer A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CustomerRelationshipsMember_0" xml:lang="en-US">Customer Relationships [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CustomerRelationshipsMember_1" xml:lang="en-US">This member stands for a class of intangible assets representing assets related to customer relationships.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_CustomerRelationshipsMember_2" xml:lang="en-US">Customer relationships [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CustomerThreeMember_0" xml:lang="en-US">Customer Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CustomerThreeMember_1" xml:lang="en-US">Represents member information related to Customer B.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_CustomerThreeMember_2" xml:lang="en-US">Customer C [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_CustomerTwoMember_0" xml:lang="en-US">Represents member information related to Customer B.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_CustomerTwoMember_1" xml:lang="en-US">Customer Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_CustomerTwoMember_2" xml:lang="en-US">Customer B [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DeemedIssuance_0" xml:lang="en-US">Information about deemed issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DeemedIssuance_1" xml:lang="en-US">Deemed Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DeemedIssuance_2" xml:lang="en-US">Deemed issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DeemedPricePerShare_0" xml:lang="en-US">Deemed Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DeemedPricePerShare_1" xml:lang="en-US">Represents share issued at deemed price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DeemedPricePerShare_2" xml:lang="en-US">Deemed price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DeferredTaxAssetsAbstract_0" xml:lang="en-US">Deferred Tax Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DeferredTaxAssetsAbstract_1" xml:lang="en-US">Deferred tax assets:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DeferredTaxAssetsAndLiabilitiesAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DeferredTaxAssetsAndLiabilitiesAxis_1" xml:lang="en-US">Deferred Tax Assets And Liabilities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DeferredTaxAssetsAndLiabilitiesDomain_0" xml:lang="en-US">Deferred Tax Assets And Liabilities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DeferredTaxAssetsMember_0" xml:lang="en-US">This member stands for deferred tax assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DeferredTaxAssetsMember_1" xml:lang="en-US">Deferred Tax Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DeferredTaxAssetsMember_2" xml:lang="en-US">Deferred tax assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DeferredTaxLiabilitiesMember_0" xml:lang="en-US">This member stands for deferred tax liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DeferredTaxLiabilitiesMember_1" xml:lang="en-US">Deferred Tax Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DeferredTaxLiabilitiesMember_2" xml:lang="en-US">Deferred tax liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DerivativeAssetsAsOfAcquisitionDate_0" xml:lang="en-US">Derivative Assets As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DerivativeAssetsAsOfAcquisitionDate_1" xml:lang="en-US">It represents derivative assets as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DerivativeAssetsAsOfAcquisitionDate_2" xml:lang="en-US">Derivative assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for basis of presentation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Basis Of Presentation Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_2" xml:lang="en-US">Basis of presentation [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for changes in accounting policies new financial reporting accounting standards and amendments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Changes In Accounting Policies New Financial Reporting Accounting Standards And Amendments Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_2" xml:lang="en-US">Changes in accounting policies - initial application of new financial reporting and accounting standards and amendments to existing financial reporting and accounting standards [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for consolidated financial statements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Consolidated Financial Statements Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_2" xml:lang="en-US">Consolidated financial statements [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_0" xml:lang="en-US">Description Of Accounting Policy For Government Grant Explanatory [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_1" xml:lang="en-US">The description of the entity's accounting policy for government grant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_2" xml:lang="en-US">Government grants [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for short term deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Short Term Deposits Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_2" xml:lang="en-US">Short-term deposits [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_0" xml:lang="en-US">Represents the description of exchange of subscription receipts after completion of reverse takeover.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_1" xml:lang="en-US">Description Of Exchange Of Subscription Receipt After Completion Of Reverse Takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_2" xml:lang="en-US">Description of exchange of subscription receipts after completion of reverse takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfExpectedDividendYieldOptionsGranted_0" xml:lang="en-US">Description of expected dividend yield options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfExpectedDividendYieldOptionsGranted_1" xml:lang="en-US">Description Of Expected Dividend Yield Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DescriptionOfExpectedDividendYieldOptionsGranted_2" xml:lang="en-US">Dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfOtherConvertibleSecritiesConversion_0" xml:lang="en-US">Represents the description of other convertible secrities conversion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfOtherConvertibleSecritiesConversion_1" xml:lang="en-US">Description Of Other Convertible Secrities Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DescriptionOfOtherConvertibleSecritiesConversion_2" xml:lang="en-US">Description of other convertible secrities conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_0" xml:lang="en-US">Information about description of share consolidation of issued and outstanding ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_1" xml:lang="en-US">Description Of Share Consolidation Of Issued And Outstanding Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_2" xml:lang="en-US">Description of share consolidation of issued and outstanding ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_0" xml:lang="en-US">Description of shares and warrants exchanged for post consolidation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_1" xml:lang="en-US">Description Of Shares And Warrants Exchanged For Post Consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_2" xml:lang="en-US">Description of shares and warrants exchanged for post consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xml:lang="en-US">Disclosure For Significant Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_0" xml:lang="en-US">Disclosure of information about balances with related parties in statements of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1" xml:lang="en-US">Disclosure Of Balances With Related Parties Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_2" xml:lang="en-US">Disclosure of balances with related parties [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_0" xml:lang="en-US">Disclosure of changes in issued and outstanding share capital explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_1" xml:lang="en-US">Disclosure Of Changes In Issued And Outstanding Share Capital Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_2" xml:lang="en-US">Disclosure of changes in issued and outstanding share capital [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfCompositionOfShareCapitalExplanatory_0" xml:lang="en-US">Disclosure Of Composition Of Share Capital Explanatory [Table Text Block].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1" xml:lang="en-US">Disclosure Of Composition Of Share Capital Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfCompositionOfShareCapitalExplanatory_2" xml:lang="en-US">Disclosure of composition of share capital [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0" xml:lang="en-US">Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_1" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_0" xml:lang="en-US">Disclosure Of Detailed Information About Additional Cash Flow Information [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1" xml:lang="en-US">Schedule disclosing information related to additional cash flow information.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about amortization calculated on straight-line basis over useful life of intangible assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Amortization Calculated On Straight Line Basis Over Useful Life Of Intangible Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_0" xml:lang="en-US">The disclosure of detailed information about Cash outflow/inflow on the acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Cash Outflow Inflow From Acquisition Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_2" xml:lang="en-US">Disclosure of detailed information about cash outflow/inflow on the acquisition [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About Deferred Tax Assets And Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure of detailed information about deferred tax assets and liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about deferred tax assets and liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About Deferred Taxes Explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Deferred Taxes Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about deferred taxes [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">The disclosure of detailed information about depreciation rate calculated on straight line basis over useful lives of property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Depreciation Rate Calculated On Straight Line Basis Over Useful Lives Of Property, Plant And Equipment Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_2" xml:lang="en-US">Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_0" xml:lang="en-US">Represents information of expenses recognized in consolidated statements of profit or loss and other comprehensive income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Expenses Recognized In Consolidated Statements Of Profit Or Loss And Other Comprehensive Income Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_2" xml:lang="en-US">Disclosure of detailed information about expenses recognized in consolidated statements of profit or loss and other comprehensive income [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_0" xml:lang="en-US">The disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Fair Value Of Identifiable Assets Acquired And Liabilities Assumed On Acquisition Date Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_2" xml:lang="en-US">Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_0" xml:lang="en-US">The disclosure of detailed information about Impact on fair value of 10% increase/decrease in each input.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Impact On Fair Value Of Ten Percent Increase Decrease In Each Input Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_2" xml:lang="en-US">Disclosure of detailed information about Impact on fair value of 10% increase/decrease in each input [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About Income Tax Expense Benefits Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Income Tax Expense Benefits Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about Income tax expense (benefit) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0" xml:lang="en-US">Disclosure of detailed information about inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Inventories Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about inventories [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_0" xml:lang="en-US">The disclosure of information about key assumptions to measure fair value of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Key Assumptions To Measure Fair Value Of Warrants Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_2" xml:lang="en-US">Disclosure of information about key assumptions to measure fair value of warrants [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about options, valuation assumptions [Table Text Block].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Options Valuation Assumptions Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_2" xml:lang="en-US">Disclosure of detailed information about options, valuation assumptions [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_0" xml:lang="en-US">The disclosure of detailed information about other accounts receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Other Accounts Receivable Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_2" xml:lang="en-US">Disclosure of detailed information about other accounts receivable [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_0" xml:lang="en-US">Represents information of present value of defined benefit liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Present Value Of Defined Benefit Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_2" xml:lang="en-US">Disclosure of detailed information about changes in present value of defined benefit liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0" xml:lang="en-US">Disclosure Of Detailed Information About Property Plant And Equipment And Intangible Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_0" xml:lang="en-US">Disclosure Of Detailed Information About Reconciliation of tax expense and the accounting profit Explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Reconciliation Of Tax Expense And Accounting Profit Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_2" xml:lang="en-US">Disclosure of detailed information about reconciliation of tax expense and accounting profit [Table text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_0" xml:lang="en-US">Schedule disclosing information related to details of Summarized financial information for partly owned subsidiary.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xml:lang="en-US">Disclosure Of Detailed Information About Summarized Financial Information For Partly Owned Subsidiary [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_0" xml:lang="en-US">Disclosure of detailed information of other current payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information Of Other Current Payables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_2" xml:lang="en-US">Disclosure of detailed information of other current payables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_0" xml:lang="en-US">Disclosure of general information about financial statements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_1" xml:lang="en-US">Disclosure Of General Information About Financial Statements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_0" xml:lang="en-US">Disclosure of geographic allocation of total assets explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Geographic Allocation Of Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_2" xml:lang="en-US">Disclosure of geographic allocation of assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_0" xml:lang="en-US">Disclosure of geographic allocation of revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_1" xml:lang="en-US">Disclosure Of Geographic Allocation Of Revenues Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_2" xml:lang="en-US">Disclosure of geographic allocation of revenues [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_0" xml:lang="en-US">Disclosure of information about balances with related parties in statements of profit or loss and other comprehensive income explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1" xml:lang="en-US">Disclosure Of Information About Balances With Related Parties In Statements Of Profit Or Loss And Other Comprehensive Income Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_2" xml:lang="en-US">Disclosure of information about balances with related parties in statements of profit or loss and other comprehensive income [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_0" xml:lang="en-US">Tabular disclosure of operating results for partly owned subsidiary explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_1" xml:lang="en-US">Disclosure Of Operating Results For Partly Owned Subsidiary Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_2" xml:lang="en-US">Disclosure of operating results for partly owned subsidiary [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xml:lang="en-US">Disclosure of other accounts receivable [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfOtherAccountsReceivablesExplanatory_0" xml:lang="en-US">The disclosure of other accounts receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Other Accounts Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfOtherAccountsReceivablesExplanatory_2" xml:lang="en-US">OTHER ACCOUNTS RECEIVABLE [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_0" xml:lang="en-US">The entire disclosure for property, plant and equipment and intangible assets, net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1" xml:lang="en-US">Disclosure Of Property, Plant And Equipment And Intangible Assets, Net Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_2" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_0" xml:lang="en-US">Disclosure Of Restricted Share Units [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_1" xml:lang="en-US">Disclosure of restricted share units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_2" xml:lang="en-US">Disclosure of restricted share units [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfReverseTakeoverExplanatory_0" xml:lang="en-US">Represents the entire disclosure of reverse takeover.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfReverseTakeoverExplanatory_1" xml:lang="en-US">Disclosure Of Reverse Takeover Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfReverseTakeoverExplanatory_2" xml:lang="en-US">REVERSE TAKEOVER [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfReverseTakeoverLineItems_0" xml:lang="en-US">Disclosure Of Reverse Takeover [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfReverseTakeoverTable_0" xml:lang="en-US">Represents the tabular information associated to reverse takeover.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfReverseTakeoverTable_1" xml:lang="en-US">Disclosure Of Reverse Takeover [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfRightOfUseAssetsExplanatory_0" xml:lang="en-US">Entire disclosure related to right of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfRightOfUseAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Right Of Use Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfRightOfUseAssetsExplanatory_2" xml:lang="en-US">RIGHT-OF-USE ASSETS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_0" xml:lang="en-US">Disclosure Of Right Of Use Assets Explanatory Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_1" xml:lang="en-US">The entire disclosure for right of use assets explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_2" xml:lang="en-US">RIGHT-OF-USE ASSETS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_0" xml:lang="en-US">Disclosure of significant accounting estimates and assumptions used in the preparation of the financial statements explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1" xml:lang="en-US">Disclosure Of Significant Accounting Estimates And Assumptions Used In Preparation Of Financial Statements Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_2" xml:lang="en-US">SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_0" xml:lang="en-US">Tabular disclosure of statement of financial position for partly owned subsidiary explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1" xml:lang="en-US">Disclosure Of Statement Of Financial Position For Partly Owned Subsidiary Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_2" xml:lang="en-US">Disclosure of statement of financial position for partly owned subsidiary [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfStatementOfProfitAndLossExplanatory_0" xml:lang="en-US">Disclosure of statement of profit and loss explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfStatementOfProfitAndLossExplanatory_1" xml:lang="en-US">Disclosure Of Statement Of Profit And Loss Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfStatementOfProfitAndLossExplanatory_2" xml:lang="en-US">Disclosure of statement of profit and loss [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_0" xml:lang="en-US">Disclosure Of Summarized Financial Information For Partly Owned Subsidiary Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_1" xml:lang="en-US">SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_1" xml:lang="en-US">Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisclosureOfTradeReceivablesExplanatory_0" xml:lang="en-US">Disclosure of Table information related to trade receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisclosureOfTradeReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Trade Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_DisclosureOfTradeReceivablesExplanatory_2" xml:lang="en-US">Disclosure of trade receivables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisposalOfTerminationOfLeases_0" xml:lang="en-US">Disposal Of Termination Of Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisposalOfTerminationOfLeases_1" xml:lang="en-US">Represents amount related to disposal of termination of leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_DisposalOfTerminationOfLeases_2" xml:lang="en-US">Disposals during the year: Termination of leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_DisposalsOfRightOfUseAssets_0" xml:lang="en-US">Represents amount related to disposal of right-of-use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_DisposalsOfRightOfUseAssets_1" xml:lang="en-US">Disposals during the year:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DisposalsOfRightOfUseAssets_2" xml:lang="en-US">Disposals Of Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DocumentAndEntityAbstract_0" xml:lang="en-US">Document And Entity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_DocumentAndEntityInformationAbstract_0" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xml:lang="en-US">Employee Benefit Assets And Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_EmployeesAndPayrollAccruals_0" xml:lang="en-US">Employees And Payroll Accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_EmployeesAndPayrollAccruals_1" xml:lang="en-US">Represents the amount of employees and payroll accruals including salaries and other salaries related costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_EmployeesAndPayrollAccruals_2" xml:lang="en-US">Employees and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_EmployeesDirectorsAndAdvisorsMember_0" xml:lang="en-US">Information about employees directors and advisors.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_EmployeesDirectorsAndAdvisorsMember_1" xml:lang="en-US">Employees Directors And Advisors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_EmployeesDirectorsAndAdvisorsMember_2" xml:lang="en-US">Employees directors and advisors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_EquityIssuancePricePerShare_0" xml:lang="en-US">Equity Issuance, Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_EquityIssuancePricePerShare_1" xml:lang="en-US">Represents the amount of equity issuance, price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_EquityIssuancePricePerShare_2" xml:lang="en-US">Par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_EquityTransactionAxis_0" xml:lang="en-US">Information about equity transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_EquityTransactionAxis_1" xml:lang="en-US">Equity Transaction [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_EquityTransactionDomain_0" xml:lang="en-US">Equity Transaction [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_EquityTransactionDomain_1" xml:lang="en-US">Equity Transaction [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_EstimatedTotalAmountOfClassActionSuit_0" xml:lang="en-US">Represents the amount of estimated total amount of class action suit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_EstimatedTotalAmountOfClassActionSuit_1" xml:lang="en-US">Estimated Total Amount Of Class Action Suit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_EstimatedTotalAmountOfClassActionSuit_2" xml:lang="en-US">Estimated total amount of class action suit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ExercisePriceOfWarrant_0" xml:lang="en-US">Represents the exercise price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ExercisePriceOfWarrant_1" xml:lang="en-US">Exercise Price Of Warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ExercisePriceOfWarrant_2" xml:lang="en-US">Exercise price of warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ExpectedDividendYieldOfWarrants_0" xml:lang="en-US">Expected dividend yield of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ExpectedDividendYieldOfWarrants_1" xml:lang="en-US">Expected Dividend Yield Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ExpectedDividendYieldOfWarrants_2" xml:lang="en-US">Expected dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ExpectedLifeOfWarrants_0" xml:lang="en-US">Expected life of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ExpectedLifeOfWarrants_1" xml:lang="en-US">Expected Life Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ExpectedLifeOfWarrants_2" xml:lang="en-US">Expected life (in years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ExpectedVolatilityOfWarrants_0" xml:lang="en-US">Expected volatility of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ExpectedVolatilityOfWarrants_1" xml:lang="en-US">Expected Volatility Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ExpectedVolatilityOfWarrants_2" xml:lang="en-US">Expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ExternalCustomersRevenues_0" xml:lang="en-US">External Customers Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ExternalCustomersRevenues_1" xml:lang="en-US">Information about external customers revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ExternalCustomersRevenues_2" xml:lang="en-US">External customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">The amount of fair value adjustment derived from final purchase price allocation, intangible assets other than goodwill.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Fair Value Adjustment Derived From Final Purchase Price Allocation, Intangible Assets Other Than Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Fair value adjustment derived from final purchase price allocation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValueAdjustmentOnSaleOfInventory_0" xml:lang="en-US">Fair Value Adjustment On Sale Of Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FairValueAdjustmentOnSaleOfInventory_1" xml:lang="en-US">Fair value adjustment on sale of inventory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_FairValueAdjustmentOnSaleOfInventory_2" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FairValueAdjustmentOnSaleOfInventory_3" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_FairValueAdjustmentOnSaleOfInventory_4" xml:lang="en-US">Fair value adjustment on sale of inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_0" xml:lang="en-US">Represents amount related to fair value adjustment on warrants measured at fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1" xml:lang="en-US">Fair Value Adjustment On Warrants Measured At Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_2" xml:lang="en-US">Fair value adjustment on warrants measured at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_3" xml:lang="en-US">Fair value adjustment on Warrants, Investments, and Accounts Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValueAdjustmentsAbstract_0" xml:lang="en-US">Fair Value Adjustments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FairValueAdjustmentsAbstract_1" xml:lang="en-US">Fair value adjustments:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FairValueOfCompensationUnits_0" xml:lang="en-US">Fair value of compensation units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValueOfCompensationUnits_1" xml:lang="en-US">Fair Value Of Compensation Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FairValueOfCompensationUnits_2" xml:lang="en-US">Fair value of compensation units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValueOfInvestment_0" xml:lang="en-US">Fair Value Of Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FairValueOfInvestment_1" xml:lang="en-US">The fair value of the investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FairValueOfInvestment_2" xml:lang="en-US">Fair value of the investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FairValueOfUnitsIssued_0" xml:lang="en-US">Represents the fair value of units issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValueOfUnitsIssued_1" xml:lang="en-US">Fair Value Of Units Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_FairValueOfUnitsIssued_2" xml:lang="en-US">Fair value of units issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FairValueOfWarrants_0" xml:lang="en-US">Fair value of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValueOfWarrants_1" xml:lang="en-US">Fair Value Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FairValueOfWarrants_2" xml:lang="en-US">Total Warrants (Canadian Dollar in thousands)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_FairValueOfWarrants_3" xml:lang="en-US">Fair value of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FairValuePerWarrant_0" xml:lang="en-US">Fair value per warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FairValuePerWarrant_1" xml:lang="en-US">Fair Value Per Warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FairValuePerWarrant_2" xml:lang="en-US">Fair value: Per Warrant (Canadian Dollar)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FinancialAdvisorsMember_0" xml:lang="en-US">Financial advisors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FinancialAdvisorsMember_1" xml:lang="en-US">Financial Advisors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FinancialAdvisorsMember_2" xml:lang="en-US">Financial advisors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FinancialInstrumentsAtAmortizedCostMember_0" xml:lang="en-US">This member stands for the financial instruments at amortised cost category.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FinancialInstrumentsAtAmortizedCostMember_1" xml:lang="en-US">Financial Instruments At Amortized Cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FinancialInstrumentsAtAmortizedCostMember_2" xml:lang="en-US">Amortized cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_0" xml:lang="en-US">This member stands for the financial instruments at fair value through profit or loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_1" xml:lang="en-US">Financial Instruments At Fair Value Through Profit Or Loss [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_2" xml:lang="en-US">FVTPL [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FinishedGoodsMember_0" xml:lang="en-US">Represents information related to Finished goods.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FinishedGoodsMember_1" xml:lang="en-US">Finished Goods [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_FinishedGoodsMember_2" xml:lang="en-US">Finished goods [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_0" xml:lang="en-US">This member stands for first anniversary of applicable vesting commencement date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_1" xml:lang="en-US">First Anniversary Of Applicable Vesting Commencement Date [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_2" xml:lang="en-US">Vest on the first anniversary of the applicable vesting commencement date [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FirstInstallmentMember_0" xml:lang="en-US">First installment of payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FirstInstallmentMember_1" xml:lang="en-US">First Installment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FirstInstallmentMember_2" xml:lang="en-US">First installment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FixedGrowthRate_0" xml:lang="en-US">Represents the fixed growth rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FixedGrowthRate_1" xml:lang="en-US">Fixed Growth Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FixedGrowthRate_2" xml:lang="en-US">Fixed growth rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_FocusMedicalHerbsLtdMember_0" xml:lang="en-US">Focus Medical Herbs Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_FocusMedicalHerbsLtdMember_1" xml:lang="en-US">Focus Medical Herbs Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_FocusMedicalHerbsLtdMember_2" xml:lang="en-US">Focus Medical Herbs Ltd. ("Focus") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_FocusMedicalHerbsLtdMember_3" xml:lang="en-US">Focus Medical Herbs Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ForeignCountriesTwoMember_0" xml:lang="en-US">Foreign Countries Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ForeignCountriesTwoMember_1" xml:lang="en-US">This member stands for countries outside the entity's country of domicile. [Refer: Country of domicile [member]]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ForeignCountriesTwoMember_2" xml:lang="en-US">Canada [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_GainLossOnRevaluationOfFinancialInstruments_0" xml:lang="en-US">gain loss on revaluation of financial instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_GainLossOnRevaluationOfFinancialInstruments_1" xml:lang="en-US">Gain Loss On Revaluation Of Financial Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_GainLossOnRevaluationOfFinancialInstruments_2" xml:lang="en-US">(Gain) loss on revaluation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_0" xml:lang="en-US">Galen Industries Single Member Societe Anonyme.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_1" xml:lang="en-US">Galen Industries Single Member Societe Anonyme [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_2" xml:lang="en-US">Galen Industries Single Member Societe Anonyme [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_0" xml:lang="en-US">Goodwill And Intangible Assets As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_1" xml:lang="en-US">It represents goodwill and intangible assets as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_2" xml:lang="en-US">Goodwill and intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_GreenhouseProductionEquipmentMember_0" xml:lang="en-US">This member stands for greenhouse production equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_GreenhouseProductionEquipmentMember_1" xml:lang="en-US">Greenhouse Production Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_GreenhouseProductionEquipmentMember_2" xml:lang="en-US">Greenhouse production equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_GreenhouseStructureMember_0" xml:lang="en-US">This member stands for greenhouse structure.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_GreenhouseStructureMember_1" xml:lang="en-US">Greenhouse Structure [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_GreenhouseStructureMember_2" xml:lang="en-US">Greenhouse structure [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_GrossProceedsFromIssuanceOfUnits_0" xml:lang="en-US">Information about gross proceeds from issuance of units under private placements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_GrossProceedsFromIssuanceOfUnits_1" xml:lang="en-US">Gross Proceeds From Issuance Of Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_GrossProceedsFromIssuanceOfUnits_2" xml:lang="en-US">Gross proceeds from issuance of units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_GrossProfitBeforeFairValueAdjustments_0" xml:lang="en-US">Represents amount related to gross profit before fair value adjustment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_GrossProfitBeforeFairValueAdjustments_1" xml:lang="en-US">Gross Profit Before Fair Value Adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_imc_GrossProfitBeforeFairValueAdjustments_2" xml:lang="en-US">Gross profit before fair value adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_HighlandGrowIncMember_0" xml:lang="en-US">Highland Grow Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_HighlandGrowIncMember_1" xml:lang="en-US">This member stands for Highland Grow Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_HighlandGrowIncMember_2" xml:lang="en-US">Highland Grow Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_HighWayShinuaLtdMember_0" xml:lang="en-US">High Way Shinua Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_HighWayShinuaLtdMember_1" xml:lang="en-US">This member stands for High Way Shinua Ltd. (&#8220;HW Shinua&#8221;).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_HighWayShinuaLtdMember_2" xml:lang="en-US">High Way Shinua Ltd. (&#8220;HW Shinua&#8221;) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount recognised as of the acquisition date for identifiable assets acquired in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Identifiable Assets Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Total identifiable assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount recognised as of the acquisition date for liabilities assumed in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Identifiable Liabilities Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Total identifiable liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Total identifiable liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ImcHoldingsLtdMember_0" xml:lang="en-US">I.M.C. Holdings Ltd.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ImcHoldingsLtdMember_1" xml:lang="en-US">Imc Holdings Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ImcHoldingsLtdMember_2" xml:lang="en-US">I.M.C. Holdings Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IMCOrdinaryShareholderMember_0" xml:lang="en-US">IMC Ordinary shareholder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IMCOrdinaryShareholderMember_1" xml:lang="en-US">I M C Ordinary Shareholder [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IMCOrdinaryShareholderMember_2" xml:lang="en-US">IMC ordinary shareholder [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_0" xml:lang="en-US">Impact On Fair Value Ten Percent Increase Decrease In Each Input [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_1" xml:lang="en-US">Impact On Fair Value Ten Percent Increase Decrease In Each Input [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_2" xml:lang="en-US">10% change [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_0" xml:lang="en-US">Impairment Loss Of Indemnification Asset And Penalty And Interest Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_1" xml:lang="en-US">It represents impairment loss of indemnification asset and penalty and interest expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_2" xml:lang="en-US">Impairment loss of indemnification asset and penalty and interest expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncomeTaxFromPreviousYears_0" xml:lang="en-US">It represents income tax from previous years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncomeTaxFromPreviousYears_1" xml:lang="en-US">Income Tax From Previous Years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IncomeTaxFromPreviousYears_2" xml:lang="en-US">Income tax from previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncomeTaxLiabilityOfKeyPersonnel_0" xml:lang="en-US">Income Tax Liability Of Key Personnel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncomeTaxLiabilityOfKeyPersonnel_1" xml:lang="en-US">It represents income tax liability of key personnel.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IncomeTaxLiabilityOfKeyPersonnel_2" xml:lang="en-US">Income tax liability of key personnel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_0" xml:lang="en-US">The increase (decrease) in financial liabilities on the basis of their measurement categories in accordance with IFRS 16.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_1" xml:lang="en-US">Increase Decrease In Financial Liabilities On Basis Of Initial Application Of I F R S 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_2" xml:lang="en-US">Initial application of IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase Decrease Through Acquisitions, Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">The increase (decrease) in liabilities arising from financing activities resulting from related to acquisitions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Additions related to acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase Decrease Through Effective Interest, Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Increase decrease through effective interest, liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Effective interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseThroughForfeitedOptions_0" xml:lang="en-US">The increase (decrease) in equity resulting from forfeited options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseThroughForfeitedOptions_1" xml:lang="en-US">Increase Decrease Through Forfeited Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IncreaseDecreaseThroughForfeitedOptions_2" xml:lang="en-US">Forfeited Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_0" xml:lang="en-US">Increase (Decrease) Through Initial Consolidations, Property, Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_1" xml:lang="en-US">The increase (decrease) in property, plant and equipment resulting from changes through initial consolidations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_2" xml:lang="en-US">Initial consolidations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_0" xml:lang="en-US">Represents amount related to adjustments arising from translating financial statements from functional currency to presentation currency.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_1" xml:lang="en-US">Increase Decrease Through Net Exchange Differences Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_2" xml:lang="en-US">Additions during the year: Adjustments arising from translating financial statements from functional currency to presentation currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase Decrease Through Repayments Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">The increase (decrease) in liabilities arising from financing activities resulting from changes in repayments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Repayments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_0" xml:lang="en-US">The increase (decrease) in equity resulting from share-based payment transactions of subsidiary.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_1" xml:lang="en-US">Increase Decrease Through Share Based Payment Transactions Of Subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_2" xml:lang="en-US">Share based compensation of subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase Decrease Through Warrant Conversions Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Represents the cash outflow for payments for warrant conversions liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Payments of other equity instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_3" xml:lang="en-US">Conversion of warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_0" xml:lang="en-US">Increase Through Initial Consolidations Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_1" xml:lang="en-US">The increase in liabilities arising from financing activities resulting from Initial consolidations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_2" xml:lang="en-US">Initial consolidations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Increase Through New Loans, Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">The increase in liabilities arising from financing activities resulting from new loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Additions for new loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InitialCapitalExpenditures_0" xml:lang="en-US">Represents initial capital expenditures during the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InitialCapitalExpenditures_1" xml:lang="en-US">Initial Capital Expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_InitialCapitalExpenditures_2" xml:lang="en-US">Initial capital expenditures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InitialConsolidationsRightOfUseAssets_0" xml:lang="en-US">Initial Consolidations Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InitialConsolidationsRightOfUseAssets_1" xml:lang="en-US">Represents the amount of initial consolidations of right of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_InitialConsolidationsRightOfUseAssets_2" xml:lang="en-US">Additions during the year: Initial consolidations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InitialTermOfAgreement_0" xml:lang="en-US">Represents initial term of agreement during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InitialTermOfAgreement_1" xml:lang="en-US">Initial Term Of Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_InitialTermOfAgreement_2" xml:lang="en-US">Initial term of agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IntangibleAssetsMember_0" xml:lang="en-US">This member stands for Intangible assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IntangibleAssetsMember_1" xml:lang="en-US">Intangible Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IntangibleAssetsMember_2" xml:lang="en-US">Intangible assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InterestIncomeOnPlanAssets_0" xml:lang="en-US">Represents amount of interest income on plan assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InterestIncomeOnPlanAssets_1" xml:lang="en-US">Interest Income On Plan Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_InterestIncomeOnPlanAssets_2" xml:lang="en-US">Interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_InterestIncomeOnPlanAssets_3" xml:lang="en-US">Interest income on plan assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InterestPaidInRespectOfLoans_0" xml:lang="en-US">Interest Paid In Respect Of Loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InterestPaidInRespectOfLoans_1" xml:lang="en-US">The cash outflow for interest paid in respect of loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_InterestPaidInRespectOfLoans_2" xml:lang="en-US">Interest paid in respect of loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InterSegmentRevenues_0" xml:lang="en-US">Inter Segment Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InterSegmentRevenues_1" xml:lang="en-US">Information about inter segment revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_InterSegmentRevenues_2" xml:lang="en-US">Inter-segment revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InventoriesLineItems_0" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InventoriesLineItems_1" xml:lang="en-US">Inventories [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InventoriesTable_0" xml:lang="en-US">Schedule disclosing information related to inventories.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InventoriesTable_1" xml:lang="en-US">Inventories [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_0" xml:lang="en-US">Investment And Financial Instruments As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1" xml:lang="en-US">Represents the amount Investment and financial instruments as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_2" xml:lang="en-US">Investments and financial Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_3" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate_0" xml:lang="en-US">Investments And Financial Instruments As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate_1" xml:lang="en-US">Represents the amount of investments and financial instruments as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InvestmentsAsOfAcquisitionDate_0" xml:lang="en-US">Investments As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InvestmentsAsOfAcquisitionDate_1" xml:lang="en-US">It represents investments as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_InvestmentsAsOfAcquisitionDate_2" xml:lang="en-US">Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_0" xml:lang="en-US">Investments in unlisted shares measured at fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_1" xml:lang="en-US">Investments In Unlisted Shares Measured At Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_2" xml:lang="en-US">Investments in unlisted shares measured at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IPointMPointCFarmsIsraelLtdPointMember_0" xml:lang="en-US">This member stands for I.M.C Farms Israel Ltd. ("IMC Farms").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IPointMPointCFarmsIsraelLtdPointMember_1" xml:lang="en-US">I Point M Point C Farms Israel Ltd Point [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IPointMPointCFarmsIsraelLtdPointMember_2" xml:lang="en-US">I.M.C Farms Israel Ltd. ("IMC Farms") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_0" xml:lang="en-US">This member stands for i point m point c international medical cannabis portugal unipessoal lda.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_1" xml:lang="en-US">I Point M Point C International Medical Cannabis Portugal Unipessoal Lda [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_2" xml:lang="en-US">I.M.C - International Medical Cannabis Portugal Unipessoal Lda [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IPointMPointCPointHoldingsLtdMember_0" xml:lang="en-US">This member stands for I.M.C. Holdings Ltd ("IMC").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IPointMPointCPointHoldingsLtdMember_1" xml:lang="en-US">I Point M Point C Point Holdings Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IPointMPointCPointHoldingsLtdMember_2" xml:lang="en-US">I.M.C. Holdings Ltd ("IMC") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IPointMPointCVenturesLtdPointMember_0" xml:lang="en-US">This member stands for i point m point c ventures ltd point ("imc ventures").</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IPointMPointCVenturesLtdPointMember_1" xml:lang="en-US">I Point M Point C Ventures Ltd Point [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IPointMPointCVenturesLtdPointMember_2" xml:lang="en-US">I.M.C Ventures Ltd. ("IMC Ventures") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IsraelAndGermanyAndCanadaMember_0" xml:lang="en-US">Israel And Germany And Canada [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IsraelAndGermanyAndCanadaMember_1" xml:lang="en-US">Represents member information related to Israel and Germany and Canada.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IsraelAndGermanyAndCanadaMember_2" xml:lang="en-US">Total [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IsraelMember_0" xml:lang="en-US">Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IsraelMember_1" xml:lang="en-US">Israel.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IssuanceOfCommonShares_0" xml:lang="en-US">Issuance Of Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IssuanceOfCommonShares_1" xml:lang="en-US">It represents issuance of common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IssuanceOfCommonShares_2" xml:lang="en-US">Issuance of common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IssuanceOfCommonSharesAmount_0" xml:lang="en-US">Issuance Of Common Shares Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IssuanceOfCommonSharesAmount_1" xml:lang="en-US">It represents issuance of common shares amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IssuanceOfCommonSharesAmount_2" xml:lang="en-US">Issuance of common shares amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IssuanceOfEquityOnReverseAcquisition_0" xml:lang="en-US">The increase in equity through the issue of equity instruments on the reverse acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IssuanceOfEquityOnReverseAcquisition_1" xml:lang="en-US">Issuance Of Equity On Reverse Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IssuanceOfEquityOnReverseAcquisition_2" xml:lang="en-US">Issuance of share capital on the reverse acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_0" xml:lang="en-US">Information about Issuance of shares in connection with reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_1" xml:lang="en-US">Issuance Of Shares In Connection With Reverse Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_2" xml:lang="en-US">Issuance of shares in connection with reverse acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IssuanceOfSharesWithPrivatePlacement_0" xml:lang="en-US">Information about issuance of shares in connection with 2019 private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IssuanceOfSharesWithPrivatePlacement_1" xml:lang="en-US">Issuance Of Shares With Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IssuanceOfSharesWithPrivatePlacement_2" xml:lang="en-US">Issuance of shares in connection with 2019 private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IssuanceOfSharesWithPrivatePlacement_3" xml:lang="en-US">Issuance of shares in private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IssueOfEquity1_0" xml:lang="en-US">Issue Of Equity 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IssueOfEquity1_1" xml:lang="en-US">The increase in equity through the issue of equity instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_IssueOfEquity1_2" xml:lang="en-US">Issuance of shares related to MYM</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IssueOfEquity2_0" xml:lang="en-US">Issue Of Equity 2</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IssueOfEquity2_1" xml:lang="en-US">The increase in equity through the issue of equity instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IssueOfEquity2_2" xml:lang="en-US">Issuance of shares in Nasdaq</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_IssuePricePerSubscriptionReceipt_0" xml:lang="en-US">Represents the issue price per per subscription receipt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_IssuePricePerSubscriptionReceipt_1" xml:lang="en-US">Issue Price Per Subscription Receipt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_IssuePricePerSubscriptionReceipt_2" xml:lang="en-US">Issue price per per subscription receipt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_0" xml:lang="en-US">Key management personnel compensation payroll and related expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1" xml:lang="en-US">Key Management Personnel Compensation Payroll And Related Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_2" xml:lang="en-US">Payroll and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_LeaseLiabilityAsOfAcquisitionDate_0" xml:lang="en-US">Lease Liability As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_LeaseLiabilityAsOfAcquisitionDate_1" xml:lang="en-US">It represents lease liability as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_LeaseLiabilityAsOfAcquisitionDate_2" xml:lang="en-US">Lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_LeaseLiabilityAsOfAcquisitionDate_3" xml:lang="en-US">Lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_LicensesWithIndefiniteLifeMember_0" xml:lang="en-US">Licenses With Indefinite Life [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_LicensesWithIndefiniteLifeMember_1" xml:lang="en-US">Licenses With Indefinite Life.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_LicensesWithIndefiniteLifeMember_2" xml:lang="en-US">Licences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_LicensesWithIndefiniteLifeMember_3" xml:lang="en-US">Licenses arose from acquisition of subsidiary [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ListedWarrantsMember_0" xml:lang="en-US">Listed Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ListedWarrantsMember_1" xml:lang="en-US">Listed Warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ListingBeforeCost_0" xml:lang="en-US">Represents amount related to Listing Before Cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ListingBeforeCost_1" xml:lang="en-US">Listing Before Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_ListingBeforeCost_2" xml:lang="en-US">Listing cost of reverse acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ListingCostOfReverseAcquisition_0" xml:lang="en-US">Listing Cost Of Reverse Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ListingCostOfReverseAcquisition_1" xml:lang="en-US">Information about listing cost of reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_ListingCostOfReverseAcquisition_2" xml:lang="en-US">Listing cost of reverse acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ListingExpenseInReverseTakeover_0" xml:lang="en-US">Represents the amount of listing expense in reverse takeover.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ListingExpenseInReverseTakeover_1" xml:lang="en-US">Listing Expense In Reverse Takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_ListingExpenseInReverseTakeover_2" xml:lang="en-US">Listing expense in reverse takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_LoanReceivableRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Loan Receivable Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_LoanReceivableRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">The amount recognised as of the acquisition date for loan receivable acquired in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_LoanReceivableRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Loan receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_LoansPayableAsOfAcquisitionDate_0" xml:lang="en-US">Loans Payable As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_LoansPayableAsOfAcquisitionDate_1" xml:lang="en-US">The amount of loans payable recognised as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_LoansPayableAsOfAcquisitionDate_2" xml:lang="en-US">Loans payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_LongTermBorrowingsAsOfAcquisitionDate_0" xml:lang="en-US">Long Term Borrowings As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_LongTermBorrowingsAsOfAcquisitionDate_1" xml:lang="en-US">It represents long term borrowings as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_LongTermBorrowingsAsOfAcquisitionDate_2" xml:lang="en-US">Long term loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_LongTermBorrowingsAsOfAcquisitionDate_3" xml:lang="en-US">Long term loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_MajorComponentsOfIncomeTaxExpenseLineItems_0" xml:lang="en-US">Major components Of Income Tax Expense [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_MajorComponentsOfIncomeTaxExpenseLineItems_1" xml:lang="en-US">Major Components Of Income Tax Expense [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_MajorComponentsOfIncomeTaxExpenseTable_0" xml:lang="en-US">Major Components Of Income Tax Expense [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_MajorComponentsOfIncomeTaxExpenseTable_1" xml:lang="en-US">Major Components Of Income Tax Expense [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_MarketPriceOfCommonShares_0" xml:lang="en-US">Market Price Of Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_MarketPriceOfCommonShares_1" xml:lang="en-US">It represents market price of common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_MarketPriceOfCommonShares_2" xml:lang="en-US">Market price of common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_MedipharmLabsCorpMember_0" xml:lang="en-US">MediPharm Labs Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_MedipharmLabsCorpMember_1" xml:lang="en-US">Medipharm Labs Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_MedipharmLabsCorpMember_2" xml:lang="en-US">MediPharm Labs Corp. ("MediPharm Labs") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_MizrahiMember_0" xml:lang="en-US">Mizrahi [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_MizrahiMember_1" xml:lang="en-US">This member stands for Mizrahi.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_MymInternationalBrandsIncMember_0" xml:lang="en-US">Mym International Brands Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_MymInternationalBrandsIncMember_1" xml:lang="en-US">This member stands for MYM International Brands Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_MymInternationalBrandsIncMember_2" xml:lang="en-US">MYM International Brands Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_MymNutraceuticalsIncMember_0" xml:lang="en-US">Mym Nutraceuticals Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_MymNutraceuticalsIncMember_1" xml:lang="en-US">This member stands for MYM Nutraceuticals Inc. (&#8220;MYM&#8221;).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_MymNutraceuticalsIncMember_2" xml:lang="en-US">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_MymNutraceuticalsIncMember_3" xml:lang="en-US">MYM transaction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_MymNutraceuticalsMember_0" xml:lang="en-US">MYM Nutraceuticals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_MymNutraceuticalsMember_1" xml:lang="en-US">Mym Nutraceuticals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_MymNutraceuticalsMember_2" xml:lang="en-US">MYM Nutraceuticals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NavasotaFincoMember_0" xml:lang="en-US">Navasota Finco</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NavasotaFincoMember_1" xml:lang="en-US">Navasota Finco [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NavasotaMember_0" xml:lang="en-US">Navasota</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NavasotaMember_1" xml:lang="en-US">Navasota [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NavasotaMember_2" xml:lang="en-US">Description of shares and warrants exchanged for post consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NavasotaShareholdersMember_0" xml:lang="en-US">Navasota shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NavasotaShareholdersMember_1" xml:lang="en-US">Navasota Shareholders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NavasotaShareholdersMember_2" xml:lang="en-US">Navasota shareholders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NetCashTransferred_0" xml:lang="en-US">The fair value, at acquisition date, of net cash transferred as consideration in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NetCashTransferred_1" xml:lang="en-US">Net Cash Transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_imc_NetCashTransferred_2" xml:lang="en-US">Net cash outflow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_imc_NetCashTransferred_3" xml:lang="en-US">Net cash outflow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_0" xml:lang="en-US">Net Identifiable Assets Acquired (Liabilities Assumed)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_1" xml:lang="en-US">The amount recognized as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_2" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NetLiabilitiesOnDateOfReverseAcquisition_0" xml:lang="en-US">Represents the amount of net liabilities on the date of the reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NetLiabilitiesOnDateOfReverseAcquisition_1" xml:lang="en-US">Net Liabilities On Date Of Reverse Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NetLiabilitiesOnDateOfReverseAcquisition_2" xml:lang="en-US">Net liabilities on the date of reverse takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_0" xml:lang="en-US">Non Cash Expense Related To Changes In Fair Value Of Inventory Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1" xml:lang="en-US">Represents the amount of non cash expense related to the changes in fair value of inventory sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_2" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_3" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_4" xml:lang="en-US">Non-cash expense related to the changes in fair value of inventory sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_0" xml:lang="en-US">Non Deductible (Income) Expense, Net For Tax Purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1" xml:lang="en-US">Non deductible (income) expense, net for tax purposes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_2" xml:lang="en-US">Non-deductible (income) expense, net for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_3" xml:lang="en-US">Non-deductible expenses (non-taxable income), net for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCommonSharesCalledByWarrants_0" xml:lang="en-US">Number Of Common Shares Called By Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCommonSharesCalledByWarrants_1" xml:lang="en-US">Number of common shares called by warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfCommonSharesCalledByWarrants_2" xml:lang="en-US">Number of common shares called by warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_0" xml:lang="en-US">Number Of Common Shares Comprised To Cover Tax Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_1" xml:lang="en-US">It represents number of common shares comprised to cover tax liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_2" xml:lang="en-US">Number of common shares comprised to cover tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_0" xml:lang="en-US">Number Of Common Shares Issued For Each Share Of Acquiree</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_1" xml:lang="en-US">Number of common shares issued for each share of acquiree.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_2" xml:lang="en-US">Number of common shares issued for each share of acquiree</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_0" xml:lang="en-US">Number Of Common Shares Issued For Exercised Of Options Under Cashless Mechanism</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_1" xml:lang="en-US">Number of common shares issued for exercised of options under cashless mechanism.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_2" xml:lang="en-US">Number of common shares issued for exercised of options under cashless mechanism</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCommonSharesReceived_0" xml:lang="en-US">Number Of Common Shares Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCommonSharesReceived_1" xml:lang="en-US">It represents number of common shares received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfCommonSharesReceived_2" xml:lang="en-US">Number of common shares received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_0" xml:lang="en-US">Number Of Common Shares Received Of Convertible Instrument</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_1" xml:lang="en-US">It represents number of common shares received of convertible instrument.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_2" xml:lang="en-US">Number of common shares received of convertible instrument</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_0" xml:lang="en-US">Number of compensation units converted to ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_1" xml:lang="en-US">Number Of Compensation Units Converted To Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_2" xml:lang="en-US">Number of compensation units converted to ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCompensationUnitsIssued_0" xml:lang="en-US">Number of compensation unit issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCompensationUnitsIssued_1" xml:lang="en-US">Number Of Compensation Units Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfCompensationUnitsIssued_2" xml:lang="en-US">Number of compensation unit issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCompensationWarrantsGrantedToAgents_0" xml:lang="en-US">Number of compensation warrants granted to agents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCompensationWarrantsGrantedToAgents_1" xml:lang="en-US">Number Of Compensation Warrants Granted To Agents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfCompensationWarrantsGrantedToAgents_2" xml:lang="en-US">Number of compensation warrants granted to agents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfCompensationWarrantsToAcquired_0" xml:lang="en-US">Number Of Compensation Warrants To Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfCompensationWarrantsToAcquired_1" xml:lang="en-US">Number of compensation warrants to acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfCompensationWarrantsToAcquired_2" xml:lang="en-US">Number of compensation warrants to acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfOptionsExercisedUnderCashlessMechanism_0" xml:lang="en-US">Number Of Options Exercised Under Cashless Mechanism</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfOptionsExercisedUnderCashlessMechanism_1" xml:lang="en-US">Number of options exercised under cashless mechanism.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfOptionsExercisedUnderCashlessMechanism_2" xml:lang="en-US">Number of options exercised under cashless mechanism</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfOptionsGranted_0" xml:lang="en-US">Number Of Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfOptionsGranted_1" xml:lang="en-US">It represents number of options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfOptionsGranted_2" xml:lang="en-US">Number of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfOrdinarySharesIssuedUponConversion_0" xml:lang="en-US">Number of ordinary shares issued upon conversion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfOrdinarySharesIssuedUponConversion_1" xml:lang="en-US">Number Of Ordinary Shares Issued Upon Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfOrdinarySharesIssuedUponConversion_2" xml:lang="en-US">Number of ordinary shares issued upon conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfPreferredSharesCommittedToBeAcquired_0" xml:lang="en-US">Number of preferred shares committed to acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfPreferredSharesCommittedToBeAcquired_1" xml:lang="en-US">Number Of Preferred Shares Committed To Be Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfPreferredSharesCommittedToBeAcquired_2" xml:lang="en-US">Number of preferred shares committed to acquire</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfShareOptionsShareVestedRsu_0" xml:lang="en-US">Number Of Share Options Share Vested Rsu</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfShareOptionsShareVestedRsu_1" xml:lang="en-US">Number of share options granted in share vested RSU.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfShareOptionsShareVestedRsu_2" xml:lang="en-US">Number of RSU vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfSharesAvailableForFutureGrants_0" xml:lang="en-US">Number of shares available for future grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfSharesAvailableForFutureGrants_1" xml:lang="en-US">Number Of Shares Available For Future Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfSharesAvailableForFutureGrants_2" xml:lang="en-US">Number of shares available for future grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_0" xml:lang="en-US">Number Of Shares Issued In Business Combination Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1" xml:lang="en-US">Number of shares issued in business combination transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_2" xml:lang="en-US">New shares from Issuance of business acquisition transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_3" xml:lang="en-US">Common Shares issued related secondary transaction and business combinations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfSharesIssuedInReverseTakeover_0" xml:lang="en-US">Number of shares issued in reverse takeover.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfSharesIssuedInReverseTakeover_1" xml:lang="en-US">Number Of Shares Issued In Reverse Takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfSharesIssuedInReverseTakeover_2" xml:lang="en-US">Number of Finco shares issued in reverse takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfSharesIssuedInReverseTakeover_3" xml:lang="en-US">Number of shares issued in Reverse Takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfSharesRaisedInUSD_0" xml:lang="en-US">Number Of Shares Raised In U S D</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfSharesRaisedInUSD_1" xml:lang="en-US">Number of shares raised in USD.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfSharesRaisedInUSD_2" xml:lang="en-US">Number of shares raised in USD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_0" xml:lang="en-US">Represents the number of subscription receipts issued in private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_1" xml:lang="en-US">Number Of Subscription Receipts Issued In Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_2" xml:lang="en-US">Number of subscription receipts issued in private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfUnitsIssued_0" xml:lang="en-US">Information about number of units issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfUnitsIssued_1" xml:lang="en-US">Number Of Units Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfUnitsIssued_2" xml:lang="en-US">Number of units issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfUnitsIssuedPricePerShare_0" xml:lang="en-US">Information about the number of units issued per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfUnitsIssuedPricePerShare_1" xml:lang="en-US">Number Of Units Issued Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfUnitsIssuedPricePerShare_2" xml:lang="en-US">Number of units issued, price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfWarrantExercised_0" xml:lang="en-US">Represents number of warrant exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfWarrantExercised_1" xml:lang="en-US">Number Of Warrant Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfWarrantExercised_2" xml:lang="en-US">Number of warrant exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfWarrantsAndCompensationOptionsExercised_0" xml:lang="en-US">Number of Warrants and Compensation options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfWarrantsAndCompensationOptionsExercised_1" xml:lang="en-US">Number Of Warrants And Compensation Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfWarrantsAndCompensationOptionsExercised_2" xml:lang="en-US">Number of warrants and compensation options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfWarrantsConvertedToOrdinaryShares_0" xml:lang="en-US">Number of warrants converted to Ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfWarrantsConvertedToOrdinaryShares_1" xml:lang="en-US">Number Of Warrants Converted To Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfWarrantsConvertedToOrdinaryShares_2" xml:lang="en-US">Number of warrants converted to ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfWarrantsIssuedInReverseTakeover_0" xml:lang="en-US">Number of warrants issued in reverse takeover.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfWarrantsIssuedInReverseTakeover_1" xml:lang="en-US">Number Of Warrants Issued In Reverse Takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_NumberOfWarrantsIssuedInReverseTakeover_2" xml:lang="en-US">Number of Finco warrants issued in reverse takeover</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfWarrantsIssuedUponConversion_0" xml:lang="en-US">Number Of Warrants Issued Upon Conversion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfWarrantsIssuedUponConversion_1" xml:lang="en-US">Number of warrants  issued upon conversion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfWarrantsIssuedUponConversion_2" xml:lang="en-US">Number of warrants issued upon conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_NumberOfWarrantsIssuedUponConversionOfUnits_0" xml:lang="en-US">Number of warrants issued upon conversion of units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_NumberOfWarrantsIssuedUponConversionOfUnits_1" xml:lang="en-US">Number Of Warrants Issued Upon Conversion Of Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_NumberOfWarrantsIssuedUponConversionOfUnits_2" xml:lang="en-US">Number of warrants issued upon conversion of units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OranimPharmacyMember_0" xml:lang="en-US">Oranim Pharmacy [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OranimPharmacyMember_1" xml:lang="en-US">This member represents information about Oranim pharmacy entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_OranimPharmacyMember_2" xml:lang="en-US">Oranim pharmacy [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OranimPharmMember_0" xml:lang="en-US">Oranim Pharm [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OranimPharmMember_1" xml:lang="en-US">This member stands for Oranim Pharm.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OranimPlusPharmLtdMember_0" xml:lang="en-US">Oranim Plus Pharm Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OranimPlusPharmLtdMember_1" xml:lang="en-US">This member stands for Oranim Plus Pharm LTD.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OranimPlusPharmLtdMember_2" xml:lang="en-US">Oranim Plus Pharm LTD. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OrdinarySharedListedInStockExchangeMarket_0" xml:lang="en-US">Ordinary Shared Listed In Stock Exchange Market</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OrdinarySharedListedInStockExchangeMarket_1" xml:lang="en-US">Ordinary shared listed in stock exchange market.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OrdinarySharedListedInStockExchangeMarket_2" xml:lang="en-US">Ordinary shared listed in nasdaq (issued during raising 35M USD)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_0" xml:lang="en-US">Ordinary Shares Issued For Each Share And Each Convertible Instrument Held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_1" xml:lang="en-US">Ordinary shares issued for each Share held and each in-the-money convertible instrument held.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_2" xml:lang="en-US">Ordinary shares issued for each Trichome Share and convertible instrument held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_0" xml:lang="en-US">Information about Ordinary shares issued as a result of Warrants and Compensation options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1" xml:lang="en-US">Ordinary Shares Issued For Warrants Compensation Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_2" xml:lang="en-US">Ordinary shares issued as a result of Warrants and Compensation options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_3" xml:lang="en-US">Common Shares issued as a result of Warrants and Compensation options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OrdinarySharesIssuedOptionsExercises_0" xml:lang="en-US">Information about ordinary shares issued as a result of options exercises.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OrdinarySharesIssuedOptionsExercises_1" xml:lang="en-US">Ordinary Shares Issued Options Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OrdinarySharesIssuedOptionsExercises_2" xml:lang="en-US">Ordinary shares issued as a result of options exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_OrdinarySharesIssuedOptionsExercises_3" xml:lang="en-US">Common Shares issued as a result of options exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_0" xml:lang="en-US">Ordinary Shares Issued To Shareholders For Each Common Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_1" xml:lang="en-US">Ordinary shares issued to shareholders for each common share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_2" xml:lang="en-US">Ordinary shares issued to shareholders for each common share of MYM</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OrdinarySharesReservedForIssuance_0" xml:lang="en-US">Represents the ordinary shares reserved for issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OrdinarySharesReservedForIssuance_1" xml:lang="en-US">Ordinary Shares Reserved For Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_OrdinarySharesReservedForIssuance_2" xml:lang="en-US">Percentage of ordinary shares reserved for issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OtherCannabisMember_0" xml:lang="en-US">Represents information related to other cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OtherCannabisMember_1" xml:lang="en-US">Other Cannabis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_OtherCannabisMember_2" xml:lang="en-US">Other products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OtherCannabisProductsMember_0" xml:lang="en-US">Other Cannabis Products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OtherCannabisProductsMember_1" xml:lang="en-US">This member stands for other cannabis products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OtherCannabisProductsMember_2" xml:lang="en-US">Other cannabis products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_0" xml:lang="en-US">The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1" xml:lang="en-US">Other Comprehensive Income That Will Not Be Reclassified Net Of Tax Exchange Differences On Translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_2" xml:lang="en-US">Exchange differences on translation to presentation currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OtherCurrentPayablesToGovernmentAuthorities_0" xml:lang="en-US">Amount of other current payables to government authorities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OtherCurrentPayablesToGovernmentAuthorities_1" xml:lang="en-US">Other Current Payables To Government Authorities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OtherCurrentPayablesToGovernmentAuthorities_2" xml:lang="en-US">Government authorities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OtherDeferredTaxAssestsMember_0" xml:lang="en-US">Other Deferred Tax Assests [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OtherDeferredTaxAssestsMember_1" xml:lang="en-US">This member stands for Other deferred tax assests.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_OtherDeferredTaxAssestsMember_2" xml:lang="en-US">Other deferred tax assests [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OtherMiscellaneousCurrentPayables_0" xml:lang="en-US">Amount of other miscellaneous current payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OtherMiscellaneousCurrentPayables_1" xml:lang="en-US">Other Miscellaneous Current Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OtherMiscellaneousCurrentPayables_2" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OtherOperatingSegmentsMember_0" xml:lang="en-US">Other Operating Segments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OtherOperatingSegmentsMember_1" xml:lang="en-US">Information about other operating segments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OtherOperatingSegmentsMember_2" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OtherPayablesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount recognised as of the acquisition date for other payables assumed in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Other Payables Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_OtherPayablesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_OtherPayablesRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_OvernightMarketedOfferingMember_0" xml:lang="en-US">Overnight Marketed Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_OvernightMarketedOfferingMember_1" xml:lang="en-US">Information of overnight marketed offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PackagedDriedCannabisMember_0" xml:lang="en-US">Represents member information releated to Packaged dried cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PackagedDriedCannabisMember_1" xml:lang="en-US">Packaged Dried Cannabis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PackagedDriedCannabisMember_2" xml:lang="en-US">Packaged dried cannabis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PanaxiaLogisticsLtdMember_0" xml:lang="en-US">Panaxia Logistics Ltd. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PanaxiaLogisticsLtdMember_1" xml:lang="en-US">This member stands for Panaxia Logistics Ltd. entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PanaxiaLogisticsLtdMember_2" xml:lang="en-US">Panaxia Logistics Ltd. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PanaxiaLogisticsLtdMember_3" xml:lang="en-US">Panaxia transaction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PaymentsToShareholdersRelatedPartyTransactions_0" xml:lang="en-US">Payments To Shareholders Related Party Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PaymentsToShareholdersRelatedPartyTransactions_1" xml:lang="en-US">Represent the payments to shareholders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PaymentsToShareholdersRelatedPartyTransactions_2" xml:lang="en-US">Payments to shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfAcquisition_0" xml:lang="en-US">Percentage Of Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfAcquisition_1" xml:lang="en-US">Information about percentage of acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfAcquisition_2" xml:lang="en-US">Percentage of acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_0" xml:lang="en-US">Percentage Of Acquisition Of Outstanding Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_1" xml:lang="en-US">It represents percentage of acquisition of outstanding ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_2" xml:lang="en-US">Percentage of acquisition of outstanding ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfAwardsVest_0" xml:lang="en-US">Represents the percentage of awards vest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfAwardsVest_1" xml:lang="en-US">Percentage Of Awards Vest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfAwardsVest_2" xml:lang="en-US">Awards vest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_0" xml:lang="en-US">Percentage Of Income Tax Liability Of Key Personnel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_1" xml:lang="en-US">Percentage of income tax liability of Key Personnel.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_2" xml:lang="en-US">Percentage of income tax liability of key personnel</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfOptionsExercised_0" xml:lang="en-US">Represents the percentage of options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfOptionsExercised_1" xml:lang="en-US">Percentage Of Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentageOfOptionsExercised_2" xml:lang="en-US">Percentage of options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfOrdinarySharesHeld_0" xml:lang="en-US">Represents the percentage of ordinary shares held.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfOrdinarySharesHeld_1" xml:lang="en-US">Percentage Of Ordinary Shares Held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_0" xml:lang="en-US">Percentage of outstanding share capital for Preferred Shares to be acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_1" xml:lang="en-US">Percentage Of Outstanding Share Capital For Preferred Shares To Be Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_2" xml:lang="en-US">Percentage of outstanding share capital for preferred shares to be acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfOutstandingSharesAcquired_0" xml:lang="en-US">Percentage Of Outstanding Shares Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfOutstandingSharesAcquired_1" xml:lang="en-US">Represents percentage of outstanding shares acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentageOfOutstandingSharesAcquired_2" xml:lang="en-US">Percentage of outstanding shares acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfOwnershipInterest_0" xml:lang="en-US">Represents the percentage of ownership interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfOwnershipInterest_1" xml:lang="en-US">Percentage Of Ownership Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentageOfOwnershipInterest_2" xml:lang="en-US">Ownership interest of Resulting Issuer shares held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfRestrictedSharesGranted_0" xml:lang="en-US">Represent the percentage of restricted shares granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfRestrictedSharesGranted_1" xml:lang="en-US">Percentage Of Restricted Shares Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfRestrictedSharesGranted_2" xml:lang="en-US">Percentage of restricted shares granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_0" xml:lang="en-US">Represent the percentage of restricted shares vest on March 1, 2021.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_1" xml:lang="en-US">Percentage Of Restricted Shares Vest On March One Two Zero Two One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_2" xml:lang="en-US">Percentage of restricted shares vest on March 1, 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_0" xml:lang="en-US">Represent the Percentage of restricted shares vest on March 1, 2020.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_1" xml:lang="en-US">Percentage Of Restricted Shares Vest On March One Two Zero Two Zero</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_2" xml:lang="en-US">Percentage of restricted shares vest on March 1, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfRightsHold_0" xml:lang="en-US">Percentage Of Rights Hold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfRightsHold_1" xml:lang="en-US">Represents percentage of rights hold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfRightsHold_2" xml:lang="en-US">Percentage of rights hold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfSharesGranted_0" xml:lang="en-US">Represent the percentage of shares granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfSharesGranted_1" xml:lang="en-US">Percentage Of Shares Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfSharesGranted_2" xml:lang="en-US">Percentage of shares granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfWarrantsAndCompensationOptionsExercised_0" xml:lang="en-US">Percentage of warrants and Compensation options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfWarrantsAndCompensationOptionsExercised_1" xml:lang="en-US">Percentage Of Warrants And Compensation Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageOfWarrantsAndCompensationOptionsExercised_2" xml:lang="en-US">Percentage of warrants and Compensation options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfWarrantsExercised_0" xml:lang="en-US">Percentage Of Warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfWarrantsExercised_1" xml:lang="en-US">Represents percentage of warrants exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentageOfWarrantsExercised_2" xml:lang="en-US">Percentage of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfWithholdingTaxLiabilities_0" xml:lang="en-US">Percentage Of Withholding Tax Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfWithholdingTaxLiabilities_1" xml:lang="en-US">It represents percentage of withholding tax liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentageOfWithholdingTaxLiabilities_2" xml:lang="en-US">Percentage of withholding tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_0" xml:lang="en-US">Percentage Of Withholding Tax Liabilities Of Penalties And Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_1" xml:lang="en-US">It represents percentage of withholding tax liabilities of penalties and interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_2" xml:lang="en-US">Percentage of withholding tax liabilities of penalties and interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentageRightToPurchaseOfTotalProduction_0" xml:lang="en-US">Represents percentage of right to purchase of total production from the Joint Venture at a preferred price as determined in the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentageRightToPurchaseOfTotalProduction_1" xml:lang="en-US">Percentage Right To Purchase Of Total Production</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PercentageRightToPurchaseOfTotalProduction_2" xml:lang="en-US">Percentage of total production from Joint Venture at preferred price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PercentagesOfWarrantQuantityHeld_0" xml:lang="en-US">Represents percentages of warrant quantity held.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PercentagesOfWarrantQuantityHeld_1" xml:lang="en-US">Percentages Of Warrant Quantity Held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PercentagesOfWarrantQuantityHeld_2" xml:lang="en-US">Percentages of warrant quantity held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PeriodicPaymentInstallmentAxis_0" xml:lang="en-US">Periodic payment installment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PeriodicPaymentInstallmentAxis_1" xml:lang="en-US">Periodic Payment Installment [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PeriodicPaymentInstallmentDomain_0" xml:lang="en-US">Periodic payment installment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PeriodicPaymentInstallmentDomain_1" xml:lang="en-US">Periodic Payment Installment [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PharmYarokPharmacyMember_0" xml:lang="en-US">Pharm Yarok Pharmacy [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PharmYarokPharmacyMember_1" xml:lang="en-US">This member stands for Pharm Yarok pharmacy entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PharmYarokPharmacyMember_2" xml:lang="en-US">Pharm Yarok pharmacy [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PlanAssetsAmountsDeposited_0" xml:lang="en-US">Represents amount of plan assets amount deposited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PlanAssetsAmountsDeposited_1" xml:lang="en-US">Plan Assets Amounts Deposited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PlanAssetsAmountsDeposited_2" xml:lang="en-US">Amounts deposited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PlanAssetsForeignCurrencyTranslationEffect_0" xml:lang="en-US">Represents amount of foreign currency translation effect.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PlanAssetsForeignCurrencyTranslationEffect_1" xml:lang="en-US">Plan Assets Foreign Currency Translation Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PlanAssetsForeignCurrencyTranslationEffect_2" xml:lang="en-US">Foreign currency translation effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PreliminaryShelfProspectusMember_0" xml:lang="en-US">Preliminary Shelf Prospectus [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PreliminaryShelfProspectusMember_1" xml:lang="en-US">Information about preliminary shelf prospectus.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PreliminaryShelfProspectusMember_2" xml:lang="en-US">Preliminary Shelf Prospectus [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PreTaxDiscountRateOfCashFlows_0" xml:lang="en-US">Represents the pre tax discount rate of cash flows.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PreTaxDiscountRateOfCashFlows_1" xml:lang="en-US">Pre Tax Discount Rate Of Cash Flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PreTaxDiscountRateOfCashFlows_2" xml:lang="en-US">Pre-tax discount rate of cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PrivatePlacementsMember_0" xml:lang="en-US">Information about private placements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PrivatePlacementsMember_1" xml:lang="en-US">Private Placements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PrivatePlacementsMember_2" xml:lang="en-US">2019 Private Placements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_0" xml:lang="en-US">Represents amount related to proceeds from exercise of warrants and compensation options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_1" xml:lang="en-US">Proceeds From Exercise Of Warrants And Compensation Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_2" xml:lang="en-US">Proceeds from exercise of warrants and compensation options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ProceedsFromInvestmentInRestrictedDeposits_0" xml:lang="en-US">Proceeds From Investment In Restricted Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ProceedsFromInvestmentInRestrictedDeposits_1" xml:lang="en-US">Represents cash inflow from investments in restricted deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ProceedsFromInvestmentInRestrictedDeposits_2" xml:lang="en-US">Proceeds from (investment in) restricted deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_0" xml:lang="en-US">Represents amount related to proceeds from issuance of warrants measured at fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_1" xml:lang="en-US">Proceeds From Issuance Of Warrants Measured At Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_2" xml:lang="en-US">Proceeds from issuance of warrants measured at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ProceedsFromSaleOfInvestment_0" xml:lang="en-US">Proceeds From Sale Of Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ProceedsFromSaleOfInvestment_1" xml:lang="en-US">Represents proceeds from sale of investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ProceedsFromSaleOfInvestment_2" xml:lang="en-US">Proceeds from sale of investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_0" xml:lang="en-US">Proceeds from Warrants and Compensation options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_1" xml:lang="en-US">Proceeds From Warrants And Compensation Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_2" xml:lang="en-US">Proceeds from warrants and compensation options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ProductionCostsCapitalizedBiologicalAssets_0" xml:lang="en-US">The amount of production costs capitalized on biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ProductionCostsCapitalizedBiologicalAssets_1" xml:lang="en-US">Production Costs Capitalized Biological Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ProductionCostsCapitalizedBiologicalAssets_2" xml:lang="en-US">Production costs capitalized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_0" xml:lang="en-US">Profit Loss Attributable To Owners Of Parent Computation Of Diluted Net Earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_1" xml:lang="en-US">The profit (loss) from continuing and discontinued operations attributable to owners of the parent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_2" xml:lang="en-US">For the computation of diluted net earnings, Net loss attributable to equity holders of the Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ProFormaAdjustmentsMember_0" xml:lang="en-US">Pro Forma Adjustments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ProFormaAdjustmentsMember_1" xml:lang="en-US">Information reported based on historical fact adjusted for potential activity. Includes, but is not limited to, information expected to be reported in future period for effect on historical fact. Excludes forecast information.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0" xml:lang="en-US">Property, Plant And Equipment And Intangible Assets [Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_0" xml:lang="en-US">Property Plant And Equipment And Right Of Use Assets As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_1" xml:lang="en-US">It represents property, plant and equipment and right of use assets as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_2" xml:lang="en-US">Property, plant and equipment and right of use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PropertyPlantAndEquipmentUsingShares_0" xml:lang="en-US">Property Plant And Equipment Using Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PropertyPlantAndEquipmentUsingShares_1" xml:lang="en-US">It represents property plant and equipment using shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PropertyPlantAndEquipmentUsingShares_2" xml:lang="en-US">PP&amp;E using shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PurchaseConsiderationPayable_0" xml:lang="en-US">Purchase Consideration Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PurchaseConsiderationPayable_1" xml:lang="en-US">Represents the purchase consideration payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_PurchaseConsiderationPayable_2" xml:lang="en-US">Purchase considiration payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PurchaseOfInterestsInSubsidiary_0" xml:lang="en-US">Represents amount related to purchase of interest in subsidiary.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_PurchaseOfInterestsInSubsidiary_1" xml:lang="en-US">Acquisition of subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PurchaseOfInterestsInSubsidiary_2" xml:lang="en-US">Purchase Of Interests In Subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PurchaseOfTreasuryCommonShares_0" xml:lang="en-US">Purchase Of Treasury Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PurchaseOfTreasuryCommonShares_1" xml:lang="en-US">Represents number of purchase of treasury common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PurchaseOfTreasuryCommonShares_2" xml:lang="en-US">Purchase of treasury common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_0" xml:lang="en-US">Purchase Price Of Business Acquisition In Common Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_1" xml:lang="en-US">It represents purchase price of business acquisition in common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_2" xml:lang="en-US">Purchase price of business acquisition in common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RayarokPharmLtdMember_0" xml:lang="en-US">Rayarok Pharm Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RayarokPharmLtdMember_1" xml:lang="en-US">This member stands for R.A. Yarok Pharm Ltd. (&#8220;Pharm Yarok&#8221;).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_RayarokPharmLtdMember_2" xml:lang="en-US">R.A. Yarok Pharm Ltd. (&#8220;Pharm Yarok&#8221;) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RealizedFairValueAdjustmentOnInventorySold_0" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_RealizedFairValueAdjustmentOnInventorySold_1" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RealizedFairValueAdjustmentOnInventorySold_2" xml:lang="en-US">Realized Fair Value Adjustment On Inventory Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_RealizedFairValueAdjustmentOnInventorySold_3" xml:lang="en-US">Realized fair value adjustments on inventory sold in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_RealizedFairValueAdjustmentOnInventorySold_4" xml:lang="en-US">Fair value adjustment on sale of inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_imc_RealizedFairValueAdjustmentOnInventorySold_5" xml:lang="en-US">Realized fair value adjustments on inventory sold in the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ReceivablesFromGovernmentAuthorities_0" xml:lang="en-US">Amount receivables from government authorities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ReceivablesFromGovernmentAuthorities_1" xml:lang="en-US">Receivables From Government Authorities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ReceivablesFromGovernmentAuthorities_2" xml:lang="en-US">Government authorities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_0" xml:lang="en-US">Reduction of share premium cost allocated to the Ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_1" xml:lang="en-US">Reduction Of Share Premium Cost Allocated To Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_2" xml:lang="en-US">Reduction of share premium, cost allocated to Ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RemainingAmountOfCashPaid_0" xml:lang="en-US">Remaining Amount Of Cash Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RemainingAmountOfCashPaid_1" xml:lang="en-US">Represents remaining amount of cash paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_RemainingAmountOfCashPaid_2" xml:lang="en-US">Remaining amount of cash paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RemainingInstallmentMember_0" xml:lang="en-US">Remaining installment of payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RemainingInstallmentMember_1" xml:lang="en-US">Remaining Installment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_RemainingInstallmentMember_2" xml:lang="en-US">Remaining installment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RepaymentOfAforementionedBankLoan_0" xml:lang="en-US">Represent the repayment amount of aforementioned bank loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RepaymentOfAforementionedBankLoan_1" xml:lang="en-US">Repayment Of Aforementioned Bank Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_RepaymentOfAforementionedBankLoan_2" xml:lang="en-US">Repayment of aforementioned bank loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RestrictedShareUnitsMember_0" xml:lang="en-US">Restricted Share Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RestrictedShareUnitsMember_1" xml:lang="en-US">Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_0" xml:lang="en-US">Represents information Return net of interest income re measurement gain loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_1" xml:lang="en-US">Return Net Of Interest Income Re Measurement Gain Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_2" xml:lang="en-US">Return, net of interest income - remeasurement gain (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RevaluationOfExercisedWarrants_0" xml:lang="en-US">Represents the revaluation of exercised warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RevaluationOfExercisedWarrants_1" xml:lang="en-US">Revaluation Of Exercised Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_RevaluationOfExercisedWarrants_2" xml:lang="en-US">Revaluation of exercised Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ReverseAcquisitionAcquirerAxis_0" xml:lang="en-US">Name of acquirer in reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ReverseAcquisitionAcquirerAxis_1" xml:lang="en-US">Reverse Acquisition, Acquirer [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ReverseAcquisitionAcquirerDomain_0" xml:lang="en-US">Name of acquirer in reverse acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ReverseAcquisitionAcquirerDomain_1" xml:lang="en-US">Reverse Acquisition, Acquirer [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ReverseTakeoverAbstract_0" xml:lang="en-US">Reverse Takeover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RevolvingCreditFacilityMember_0" xml:lang="en-US">Revolving Credit Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RevolvingCreditFacilityMember_1" xml:lang="en-US">This member stand for revolving credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RevolyTradingAndMarketingLtdMember_0" xml:lang="en-US">Revoly Trading And Marketing Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RevolyTradingAndMarketingLtdMember_1" xml:lang="en-US">This member stands for Revoly Trading and Marketing Ltd. (&#8220;Vironna&#8221;).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_RevolyTradingAndMarketingLtdMember_2" xml:lang="en-US">Revoly Trading and Marketing Ltd. (&#8220;Vironna&#8221;) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_0" xml:lang="en-US">Represents amount related to right-of-use asset recognized with corresponding lease liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_1" xml:lang="en-US">Right Of Use Asset Recognized With Corresponding Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_2" xml:lang="en-US">Right-of-use asset recognized with corresponding lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RightOfUseAssetsAsOfAcquisitionDate_0" xml:lang="en-US">Right Of Use Assets As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RightOfUseAssetsAsOfAcquisitionDate_1" xml:lang="en-US">It represents right of use assets as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_RightOfUseAssetsAsOfAcquisitionDate_2" xml:lang="en-US">Right of use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RiskFreeInterestRateOfWarrants_0" xml:lang="en-US">Risk free interest rate of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RiskFreeInterestRateOfWarrants_1" xml:lang="en-US">Risk Free Interest Rate Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_RiskFreeInterestRateOfWarrants_2" xml:lang="en-US">Risk-free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_RosenHighWayLtdMember_0" xml:lang="en-US">Rosen High Way Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_RosenHighWayLtdMember_1" xml:lang="en-US">This member stands for Rosen High Way Ltd. (&#8220;Rosen High Way&#8221;).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_RosenHighWayLtdMember_2" xml:lang="en-US">Rosen High Way Ltd. (&#8220;Rosen High Way&#8221;) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ShareBasedCompensation_0" xml:lang="en-US">Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ShareBasedCompensation_1" xml:lang="en-US">Represents amount related to share based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_ShareBasedCompensation_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ShareBasedCompensation_3" xml:lang="en-US">Expenses for share based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ShareBasedCompensations_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ShareBasedCompensations_1" xml:lang="en-US">Share Based Compensations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ShareBasedCompensations_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ShareholdersMember_0" xml:lang="en-US">Shareholders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ShareholdersMember_1" xml:lang="en-US">Represents member information related to Shareholders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ShareIncentivePlanMember_0" xml:lang="en-US">Information about share incentive plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ShareIncentivePlanMember_1" xml:lang="en-US">Share Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ShareIncentivePlanMember_2" xml:lang="en-US">2018 Share Incentive Plan" (the "2018 Plan") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_SharePurchaseAgreementMember_0" xml:lang="en-US">Share purchase agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SharePurchaseAgreementMember_1" xml:lang="en-US">Share Purchase Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ShareSplitRatio_0" xml:lang="en-US">Represents ratio applied to the conversion of stock split.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ShareSplitRatio_1" xml:lang="en-US">Share Split Ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ShareSplitRatio_2" xml:lang="en-US">Share split ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract_0" xml:lang="en-US">Significant Accounting Estimates And Assumptions Used In Preparation Of Financial Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsAbstract_0" xml:lang="en-US">Significant Accounting Estimates And Assumptions Used In Preparation Of Financial Statements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SimpleAgreementForFutureEquityMember_0" xml:lang="en-US">Simple Agreement For Future Equity [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_SimpleAgreementForFutureEquityMember_1" xml:lang="en-US">This member stands for Simple Agreement for Future Equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_StatementOfBalanceSheetLocationAxis_0" xml:lang="en-US">Statement Of Balance Sheet Location [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_StatementOfBalanceSheetLocationDomain_0" xml:lang="en-US">Statement Of Balance Sheet Location [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SublimecultureIncMember_0" xml:lang="en-US">Sublimeculture Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_SublimecultureIncMember_1" xml:lang="en-US">This member stands for SublimeCulture Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_SublimecultureIncMember_2" xml:lang="en-US">SublimeCulture Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_SubscriptionReceiptsHoldersMember_0" xml:lang="en-US">Subscription receipts holders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SubscriptionReceiptsHoldersMember_1" xml:lang="en-US">Subscription Receipts Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_SubscriptionReceiptsHoldersMember_2" xml:lang="en-US">Subscription receipts holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SubsequentEventMember_0" xml:lang="en-US">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_SubsequentEventMember_1" xml:lang="en-US">Subsequent event.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract_0" xml:lang="en-US">Subsidiaries Assets And Liabilities At Date Of Acquisition [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract_1" xml:lang="en-US">The subsidiary's assets and liabilities at date of acquisition:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0" xml:lang="en-US">Summarized Financial Information For Partly Owned Subsidiary [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_0" xml:lang="en-US">Supplemental Disclosure Of Non Cash Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_1" xml:lang="en-US">Supplemental disclosure of non-cash activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_SupplyAgreementMember_0" xml:lang="en-US">Supply Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_SupplyAgreementMember_1" xml:lang="en-US">Supply Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_SupplyAgreementMember_2" xml:lang="en-US">Supply agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_0" xml:lang="en-US">Tax Effect Of Adjustments In Respect Of Current Income Tax Of Previous Years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_1" xml:lang="en-US">Represents amount of tax effect of adjustments in respect of current Income tax of previous years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2" xml:lang="en-US">Adjustments in respect of current income tax of previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_0" xml:lang="en-US">The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to different tax rates of subsidiaries.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_1" xml:lang="en-US">Tax Effect Of Different Tax Rate Of Subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_2" xml:lang="en-US">Effect of different tax rate of subsidiaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_0" xml:lang="en-US">Recognition of tax benefit in respect of losses of previous years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_1" xml:lang="en-US">Tax Effect Of Recognition Of Tax Benefit In Respect Of Losses Of Previous Years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2" xml:lang="en-US">Recognition (derecognition) of tax benefit in respect of losses of previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_3" xml:lang="en-US">Recognition of tax benefit in respect of losses of previous years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_0" xml:lang="en-US">Unrecognized tax benefit in respect of loss for the year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_1" xml:lang="en-US">Tax Effect Of Unrecognized Tax Benefit In Respect Of Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_2" xml:lang="en-US">Unrecognized tax benefit in respect of loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TermOfNonInterestBearingTradeReceivables_0" xml:lang="en-US">Represents term of non interest bearing trade receivables .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TermOfNonInterestBearingTradeReceivables_1" xml:lang="en-US">Term Of Non Interest Bearing Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_TermOfNonInterestBearingTradeReceivables_2" xml:lang="en-US">Term of non interest bearing trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TermOfWarrantsFromDateOfIssuance_0" xml:lang="en-US">Term of warrants from date of issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TermOfWarrantsFromDateOfIssuance_1" xml:lang="en-US">Term Of Warrants From Date Of Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TermOfWarrantsFromDateOfIssuance_2" xml:lang="en-US">Term of warrants from date of issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_TermOfWarrantsFromDateOfIssuance_3" xml:lang="en-US">Term of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ThresholdLimitOfOfferingPriceOfSecurities_0" xml:lang="en-US">Represents threshold limit of offering price of securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ThresholdLimitOfOfferingPriceOfSecurities_1" xml:lang="en-US">Threshold Limit Of Offering Price Of Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ThresholdLimitOfOfferingPriceOfSecurities_2" xml:lang="en-US">Threshold limit of offering price of securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TotalAcquisitionSubsidiary_0" xml:lang="en-US">Represents amount related to acquisition of subsidiary.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TotalAcquisitionSubsidiary_1" xml:lang="en-US">Total Acquisition Subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_imc_TotalAcquisitionSubsidiary_2" xml:lang="en-US">Acquisition of a subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TotalAllocatedAmountTranslationTransaction_0" xml:lang="en-US">Total Allocated Amount Translation Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TotalAllocatedAmountTranslationTransaction_1" xml:lang="en-US">Total allocated amount translation transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TotalAllocatedAmountTranslationTransaction_2" xml:lang="en-US">Total allocated amount translation transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount recognised as of the acquisition date for trade and other receivables acquired in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Trade And Other Receivables Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TradeReceivablesLineItems_0" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TradeReceivablesLineItems_1" xml:lang="en-US">Trade Receivables [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TradeReceivablesTable_0" xml:lang="en-US">Disclosure of trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TradeReceivablesTable_1" xml:lang="en-US">Trade Receivables [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TranslationDifferencesOfDefferedTaxes_0" xml:lang="en-US">It represents translation differences of deffered taxes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TranslationDifferencesOfDefferedTaxes_1" xml:lang="en-US">Translation Differences Of Deffered Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_TranslationDifferencesOfDefferedTaxes_2" xml:lang="en-US">Translation differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TrichomeAssetFundingCorpMember_0" xml:lang="en-US">Trichome Asset Funding Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TrichomeAssetFundingCorpMember_1" xml:lang="en-US">This member stands for Trichome Asset Funding Corp.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TrichomeAssetFundingCorpMember_2" xml:lang="en-US">Trichome Asset Funding Corp. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TrichomeFinancialCannabisGpIncMember_0" xml:lang="en-US">Trichome Financial Cannabis Gp Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TrichomeFinancialCannabisGpIncMember_1" xml:lang="en-US">This member stands for Trichome Financial Cannabis GP Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TrichomeFinancialCannabisGpIncMember_2" xml:lang="en-US">Trichome Financial Cannabis GP Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TrichomeFinancialCannabisManagerIncMember_0" xml:lang="en-US">Trichome Financial Cannabis Manager Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TrichomeFinancialCannabisManagerIncMember_1" xml:lang="en-US">This member stands for Trichome Financial Cannabis Manager Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TrichomeFinancialCannabisManagerIncMember_2" xml:lang="en-US">Trichome Financial Cannabis Manager Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TrichomeFinancialCorpMember_0" xml:lang="en-US">Trichome Financial Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TrichomeFinancialCorpMember_1" xml:lang="en-US">This member stands for Trichome Financial Corp. (&#8220;Trichome&#8221;).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TrichomeFinancialCorpMember_2" xml:lang="en-US">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_TrichomeFinancialCorpMember_3" xml:lang="en-US">Trichome transaction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TrichomeJwcAcquisitionCorpMember_0" xml:lang="en-US">Trichome Jwc Acquisition Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TrichomeJwcAcquisitionCorpMember_1" xml:lang="en-US">This member stands for Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TrichomeJwcAcquisitionCorpMember_2" xml:lang="en-US">Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TrichomeRetailCorpMember_0" xml:lang="en-US">Trichome Retail Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TrichomeRetailCorpMember_1" xml:lang="en-US">This member stands for Trichome Retail Corp.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TrichomeRetailCorpMember_2" xml:lang="en-US">Trichome Retail Corp. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TrichomeSecurityholdersMember_0" xml:lang="en-US">Trichome securityholders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TrichomeSecurityholdersMember_1" xml:lang="en-US">Trichome Securityholders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_TrichomeSecurityholdersMember_2" xml:lang="en-US">Trichome Securityholders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TypeOfCannabisAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TypeOfCannabisAxis_1" xml:lang="en-US">Type Of Cannabis [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_TypeOfCannabisDomain_0" xml:lang="en-US">This member stands for the type of cannabis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_TypeOfCannabisDomain_1" xml:lang="en-US">Type Of Cannabis [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_UnobservableInputAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_UnobservableInputAxis_1" xml:lang="en-US">Unobservable Input [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_UnobservableInputDomain_0" xml:lang="en-US">This member stands for unobservable input.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_UnobservableInputDomain_1" xml:lang="en-US">Unobservable Input [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_UtilizationOfLossesNotPreviouslyRecognized_0" xml:lang="en-US">Utilization Of Losses Not Previously Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_UtilizationOfLossesNotPreviouslyRecognized_1" xml:lang="en-US">The amount of utilization of losses not previously recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_UtilizationOfLossesNotPreviouslyRecognized_2" xml:lang="en-US">Utilization of losses not previously recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_0" xml:lang="en-US">Value of compensation units converted to ordinary shares and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_1" xml:lang="en-US">Value Of Compensation Units Converted To Ordinary Shares And Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_2" xml:lang="en-US">Value of compensation units converted to ordinary shares and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_ValueOfWarrantsConvertedToOrdinaryShares_0" xml:lang="en-US">Value of warrants converted to Ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_ValueOfWarrantsConvertedToOrdinaryShares_1" xml:lang="en-US">Value Of Warrants Converted To Ordinary Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_ValueOfWarrantsConvertedToOrdinaryShares_2" xml:lang="en-US">Value of warrants converted to ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_0" xml:lang="en-US">This member stands for vest in eight equal installments upon lapse of each three month period thereafter.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_1" xml:lang="en-US">Vest In Eight Equal Installments Upon Lapse Of Each Three Month Period Thereafter [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_2" xml:lang="en-US">Vest in eight equal installments upon the lapse of each three-month period thereafter [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_VestingAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_VestingAxis_1" xml:lang="en-US">Vesting [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_VestingDomain_0" xml:lang="en-US">It's represents the vesting.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_VestingDomain_1" xml:lang="en-US">Vesting [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_VestingPercentageOfShareBasedArrangement_0" xml:lang="en-US">Vesting Percentage Of Share Based Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_VestingPercentageOfShareBasedArrangement_1" xml:lang="en-US">The vesting percentage of share-based arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_VestingPercentageOfShareBasedArrangement_2" xml:lang="en-US">Vesting percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_VironnaPharmacyMember_0" xml:lang="en-US">Vironna Pharmacy [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_VironnaPharmacyMember_1" xml:lang="en-US">This member stands for Vironna pharmacy entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_VironnaPharmacyMember_2" xml:lang="en-US">Vironna pharmacy [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_Warrant2021Member_0" xml:lang="en-US">Warrant 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_Warrant2021Member_1" xml:lang="en-US">Information of 2021 Warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_Warrant2021Member_2" xml:lang="en-US">2021 Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WarrantPricePerShare_0" xml:lang="en-US">Represents warrant price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WarrantPricePerShare_1" xml:lang="en-US">Warrant Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_WarrantPricePerShare_2" xml:lang="en-US">Warrant price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_Warrants2018Member_0" xml:lang="en-US">2018 Warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_Warrants2018Member_1" xml:lang="en-US">Warrants 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_Warrants2018Member_2" xml:lang="en-US">2018 Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_Warrants2019Member_0" xml:lang="en-US">The 2019 Warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_Warrants2019Member_1" xml:lang="en-US">Warrants 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_Warrants2019Member_2" xml:lang="en-US">2019 Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WarrantsAndCompensationOptions2019Member_0" xml:lang="en-US">Warrants And Compensation Options 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WarrantsAndCompensationOptions2019Member_1" xml:lang="en-US">2019 Warrants and Compensation Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_WarrantsAndCompensationOptions2019Member_2" xml:lang="en-US">2019 Warrants and Compensation Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WarrantsAndCompensationOptionsMember_0" xml:lang="en-US">Warrants and Compensation options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WarrantsAndCompensationOptionsMember_1" xml:lang="en-US">Warrants And Compensation Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WarrantsMeasuredAtFairValue_0" xml:lang="en-US">The amounts of warrants measured at fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WarrantsMeasuredAtFairValue_1" xml:lang="en-US">Warrants Measured At Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_WarrantsMeasuredAtFairValue_2" xml:lang="en-US">Warrants measured at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_WarrantsMeasuredAtFairValue_3" xml:lang="en-US">Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WarrantsMember_0" xml:lang="en-US">Information of the warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WarrantsMember_1" xml:lang="en-US">Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_WarrantsMember_2" xml:lang="en-US">2018 Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_0" xml:lang="en-US">Represent the weighted average fair value less cost to sell of biological assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_1" xml:lang="en-US">Weighted Average Fair Value Less Cost To Sell Of Biological Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_2" xml:lang="en-US">Weighted average fair value less cost to sell</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_0" xml:lang="en-US">Represents weighted tax rate composed of federal and municipal tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_1" xml:lang="en-US">Weighted Tax Rate Composed Of Federal And Municipal Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_2" xml:lang="en-US">Weighted tax rate composed of Federal and Municipal tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WholesalesAndPharmaciesMember_0" xml:lang="en-US">Wholesales And Pharmacies [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WholesalesAndPharmaciesMember_1" xml:lang="en-US">This member stands for wholesales and pharmacies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_WholesalesAndPharmaciesMember_2" xml:lang="en-US">Wholesalers and pharmacies [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_0" xml:lang="en-US">Wholly owned subsidiary of Navasota Finco</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_1" xml:lang="en-US">Wholly Owned Subsidiary Of Navasota Finco [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_2" xml:lang="en-US">Wholly owned subsidiary of Navasota ("Finco") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WithholdingTaxLiabilities_0" xml:lang="en-US">Withholding Tax Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WithholdingTaxLiabilities_1" xml:lang="en-US">It represents percentage of withholding tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WorkingCapital_0" xml:lang="en-US">Represents amount related to working capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WorkingCapital_1" xml:lang="en-US">Working Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_imc_WorkingCapital_2" xml:lang="en-US">Working capital (excluding cash and cash equivalents)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WorkingCapitalOfBusinessAcquisition_0" xml:lang="en-US">Working Capital Of Business Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WorkingCapitalOfBusinessAcquisition_1" xml:lang="en-US">It represents working capital of business acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_WorkingCapitalOfBusinessAcquisition_2" xml:lang="en-US">Working capital of business acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WorkInProgressMember_0" xml:lang="en-US">Represents member information related to work in progress.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WorkInProgressMember_1" xml:lang="en-US">Work In Progress [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_WorkInProgressMember_2" xml:lang="en-US">Work in progress [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_WriteDownsOfInventoriesRecognizedCostOfSales_0" xml:lang="en-US">Represents the amount of write downs of inventories recognized cost of sales.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_WriteDownsOfInventoriesRecognizedCostOfSales_1" xml:lang="en-US">Write Downs Of Inventories Recognized Cost Of Sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_imc_WriteDownsOfInventoriesRecognizedCostOfSales_2" xml:lang="en-US">Write downs of inventories recognized cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_imc_XintezaApiLtdMember_0" xml:lang="en-US">Xinteza API Ltd.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_imc_XintezaApiLtdMember_1" xml:lang="en-US">Xinteza Api Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CurrencyAxis_0" xml:lang="en-US">Currency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProFormaMember_0" xml:lang="en-US">Pro Forma [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioUnspecifiedDomain_0" xml:lang="en-US">Scenario [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_SegmentGeographicalDomain_0" xml:lang="en-US">Geographical [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementGeographicalAxis_0" xml:lang="en-US">Geographical [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementScenarioAxis_0" xml:lang="en-US">Scenario [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA_1" xlink:to="lab_country_CA_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA_2" xlink:to="lab_country_CA_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE_3" xlink:to="lab_country_DE_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE_4" xlink:to="lab_country_DE_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL_5" xlink:to="lab_country_IL_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL_6" xlink:to="lab_country_IL_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain_7" xlink:to="lab_currency_AllCurrenciesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR_8" xlink:to="lab_currency_EUR_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR_9" xlink:to="lab_currency_EUR_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP_10" xlink:to="lab_currency_GBP_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP_11" xlink:to="lab_currency_GBP_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_12" xlink:to="lab_currency_ILS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_13" xlink:to="lab_currency_ILS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD_14" xlink:to="lab_currency_USD_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD_15" xlink:to="lab_currency_USD_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain_16" xlink:to="lab_dei_AddressTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AdrMember_17" xlink:to="lab_dei_AdrMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AdrMember_18" xlink:to="lab_dei_AdrMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentDescription_19" xlink:to="lab_dei_AmendmentDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_20" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AnnualInformationForm_21" xlink:to="lab_dei_AnnualInformationForm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditedAnnualFinancialStatements_22" xlink:to="lab_dei_AuditedAnnualFinancialStatements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId_23" xlink:to="lab_dei_AuditorFirmId_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation_24" xlink:to="lab_dei_AuditorLocation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName_25" xlink:to="lab_dei_AuditorName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember_26" xlink:to="lab_dei_BusinessContactMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_27" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName_28" xlink:to="lab_dei_ContactPersonnelName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_29" xlink:to="lab_dei_CoverAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_30" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_31" xlink:to="lab_dei_DocumentAnnualReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_32" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_33" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems_34" xlink:to="lab_dei_DocumentInformationLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable_35" xlink:to="lab_dei_DocumentInformationTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_36" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement_37" xlink:to="lab_dei_DocumentRegistrationStatement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport_38" xlink:to="lab_dei_DocumentShellCompanyReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_39" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_40" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_41" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_42" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3_43" xlink:to="lab_dei_EntityAddressAddressLine3_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_44" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_45" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_46" xlink:to="lab_dei_EntityAddressesAddressTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_47" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_48" xlink:to="lab_dei_EntityAddressStateOrProvince_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_49" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_50" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_51" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_52" xlink:to="lab_dei_EntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_53" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_54" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_55" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_56" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_57" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_58" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_59" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_60" xlink:to="lab_dei_EntityVoluntaryFilers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_61" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag_62" xlink:to="lab_dei_IcfrAuditorAttestationFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_63" xlink:to="lab_dei_LegalEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_64" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_65" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_66" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_67" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit_68" xlink:to="lab_ifrs-full_AccountingProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit_69" xlink:to="lab_ifrs-full_AccountingProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit_70" xlink:to="lab_ifrs-full_AccountingProfit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccrualsClassifiedAsCurrent_71" xlink:to="lab_ifrs-full_AccrualsClassifiedAsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_72" xlink:to="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_73" xlink:to="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_74" xlink:to="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_75" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_76" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_77" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_78" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_79" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_80" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_81" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_82" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_83" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_84" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_85" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_86" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_87" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_88" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_89" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_90" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_91" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_92" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_93" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_94" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_95" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_96" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_97" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsToRightofuseAssets_98" xlink:to="lab_ifrs-full_AdditionsToRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsToRightofuseAssets_99" xlink:to="lab_ifrs-full_AdditionsToRightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_100" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_101" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_102" xlink:to="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_103" xlink:to="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_104" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_105" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_106" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_107" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_108" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_109" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_110" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_111" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_112" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_113" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_114" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationExpense_115" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_116" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_117" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_118" xlink:to="lab_ifrs-full_AdjustmentsForFairValueGainsLosses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncome_119" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncome_120" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncome_121" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_122" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_123" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_124" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_125" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_126" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_127" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_128" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_129" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_130" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_131" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_132" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_133" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_134" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_135" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_136" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_137" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_138" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_139" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_140" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_141" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_142" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_143" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_144" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_145" xlink:to="lab_ifrs-full_AggregatedTimeBandsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_146" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_147" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_148" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_149" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_150" xlink:to="lab_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_151" xlink:to="lab_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_152" xlink:to="lab_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_153" xlink:to="lab_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_154" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_155" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_156" xlink:to="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_157" xlink:to="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_158" xlink:to="lab_ifrs-full_ApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_159" xlink:to="lab_ifrs-full_ApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_160" xlink:to="lab_ifrs-full_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_161" xlink:to="lab_ifrs-full_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_162" xlink:to="lab_ifrs-full_Assets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract_163" xlink:to="lab_ifrs-full_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract_164" xlink:to="lab_ifrs-full_AssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract_165" xlink:to="lab_ifrs-full_AssetsAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_166" xlink:to="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_167" xlink:to="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_168" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_169" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BenefitsPaidOrPayable_170" xlink:to="lab_ifrs-full_BenefitsPaidOrPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BenefitsPaidOrPayable_171" xlink:to="lab_ifrs-full_BenefitsPaidOrPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BenefitsPaidOrPayable_172" xlink:to="lab_ifrs-full_BenefitsPaidOrPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_173" xlink:to="lab_ifrs-full_BiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_174" xlink:to="lab_ifrs-full_BiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssets_175" xlink:to="lab_ifrs-full_BiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssetsByTypeAxis_176" xlink:to="lab_ifrs-full_BiologicalAssetsByTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BiologicalAssetsTypeMember_177" xlink:to="lab_ifrs-full_BiologicalAssetsTypeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_178" xlink:to="lab_ifrs-full_Borrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsAbstract_179" xlink:to="lab_ifrs-full_BorrowingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_180" xlink:to="lab_ifrs-full_BorrowingsByNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameMember_181" xlink:to="lab_ifrs-full_BorrowingsByNameMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_182" xlink:to="lab_ifrs-full_BorrowingsInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRateBasis_183" xlink:to="lab_ifrs-full_BorrowingsInterestRateBasis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_184" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_185" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_186" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_187" xlink:to="lab_ifrs-full_BottomOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_188" xlink:to="lab_ifrs-full_BottomOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BrandNamesMember_189" xlink:to="lab_ifrs-full_BrandNamesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BrandNamesMember_190" xlink:to="lab_ifrs-full_BrandNamesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_191" xlink:to="lab_ifrs-full_BuildingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_192" xlink:to="lab_ifrs-full_BuildingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_193" xlink:to="lab_ifrs-full_BuildingsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_194" xlink:to="lab_ifrs-full_BusinessCombinationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_195" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember_196" xlink:to="lab_ifrs-full_CarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_197" xlink:to="lab_ifrs-full_CashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_198" xlink:to="lab_ifrs-full_CashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_199" xlink:to="lab_ifrs-full_CashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_200" xlink:to="lab_ifrs-full_CashAndCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_201" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_202" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_203" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_204" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_205" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_206" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_207" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_208" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_209" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_210" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_211" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_212" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_213" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_214" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_215" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_216" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_217" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_218" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_219" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_220" xlink:to="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_221" xlink:to="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_222" xlink:to="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_223" xlink:to="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_224" xlink:to="lab_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_225" xlink:to="lab_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_226" xlink:to="lab_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_227" xlink:to="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_228" xlink:to="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred_229" xlink:to="lab_ifrs-full_CashTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred_230" xlink:to="lab_ifrs-full_CashTransferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred_231" xlink:to="lab_ifrs-full_CashTransferred_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_232" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_233" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_234" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_235" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_236" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_237" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_238" xlink:to="lab_ifrs-full_ClassesOfAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_239" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_240" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_241" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_242" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_243" xlink:to="lab_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_244" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_245" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_246" xlink:to="lab_ifrs-full_ClassesOfShareCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_247" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_248" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_249" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_250" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_251" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_252" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_253" xlink:to="lab_ifrs-full_ComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_254" xlink:to="lab_ifrs-full_ComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_255" xlink:to="lab_ifrs-full_ComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_256" xlink:to="lab_ifrs-full_ComprehensiveIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_257" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_258" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_259" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_260" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_261" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_262" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_263" xlink:to="lab_ifrs-full_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_264" xlink:to="lab_ifrs-full_ComputerEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_265" xlink:to="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_266" xlink:to="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_267" xlink:to="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_268" xlink:to="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfMerchandiseSold_269" xlink:to="lab_ifrs-full_CostOfMerchandiseSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfMerchandiseSold_270" xlink:to="lab_ifrs-full_CostOfMerchandiseSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_271" xlink:to="lab_ifrs-full_CostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_272" xlink:to="lab_ifrs-full_CostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_273" xlink:to="lab_ifrs-full_CostOfSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_274" xlink:to="lab_ifrs-full_CostOfSales_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesMember_275" xlink:to="lab_ifrs-full_CounterpartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CountryOfDomicileMember_276" xlink:to="lab_ifrs-full_CountryOfDomicileMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CountryOfDomicileMember_277" xlink:to="lab_ifrs-full_CountryOfDomicileMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrencyRiskMember_278" xlink:to="lab_ifrs-full_CurrencyRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_279" xlink:to="lab_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_280" xlink:to="lab_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAdvancesToSuppliers_281" xlink:to="lab_ifrs-full_CurrentAdvancesToSuppliers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAdvancesToSuppliers_282" xlink:to="lab_ifrs-full_CurrentAdvancesToSuppliers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_283" xlink:to="lab_ifrs-full_CurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_284" xlink:to="lab_ifrs-full_CurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_285" xlink:to="lab_ifrs-full_CurrentAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_286" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_287" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_288" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssets_289" xlink:to="lab_ifrs-full_CurrentBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssetsMember_290" xlink:to="lab_ifrs-full_CurrentBiologicalAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBiologicalAssetsMember_291" xlink:to="lab_ifrs-full_CurrentBiologicalAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDepositsFromCustomers_292" xlink:to="lab_ifrs-full_CurrentDepositsFromCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDepositsFromCustomers_293" xlink:to="lab_ifrs-full_CurrentDepositsFromCustomers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentGovernmentGrants_294" xlink:to="lab_ifrs-full_CurrentGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentGovernmentGrants_295" xlink:to="lab_ifrs-full_CurrentGovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentInvestments_296" xlink:to="lab_ifrs-full_CurrentInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentInvestments_297" xlink:to="lab_ifrs-full_CurrentInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentInvestments_298" xlink:to="lab_ifrs-full_CurrentInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_299" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_300" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_301" xlink:to="lab_ifrs-full_CurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_302" xlink:to="lab_ifrs-full_CurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_303" xlink:to="lab_ifrs-full_CurrentLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_304" xlink:to="lab_ifrs-full_CurrentLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_305" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_306" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_307" xlink:to="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_308" xlink:to="lab_ifrs-full_CurrentPortionOfLongtermBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_309" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses_310" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_311" xlink:to="lab_ifrs-full_CurrentRestrictedCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_312" xlink:to="lab_ifrs-full_CurrentRestrictedCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_313" xlink:to="lab_ifrs-full_CurrentRestrictedCashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_314" xlink:to="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_315" xlink:to="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_316" xlink:to="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_317" xlink:to="lab_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome_318" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome_319" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome_320" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_321" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_322" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_323" xlink:to="lab_ifrs-full_CurrentTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_324" xlink:to="lab_ifrs-full_CurrentTradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_325" xlink:to="lab_ifrs-full_CurrentTradeReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CustomerrelatedIntangibleAssetsMember_326" xlink:to="lab_ifrs-full_CustomerrelatedIntangibleAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CustomerrelatedIntangibleAssetsMember_327" xlink:to="lab_ifrs-full_CustomerrelatedIntangibleAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_328" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_329" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_330" xlink:to="lab_ifrs-full_DecreaseDueToHarvestBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_331" xlink:to="lab_ifrs-full_DeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_332" xlink:to="lab_ifrs-full_DeferredTaxAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_333" xlink:to="lab_ifrs-full_DeferredTaxAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_334" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_335" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_336" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_337" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_338" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_339" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_340" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_341" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_342" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_343" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_344" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_345" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_346" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_347" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_348" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_349" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_350" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_351" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_352" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_353" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_354" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_355" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_356" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_357" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRatePropertyPlantAndEquipment_358" xlink:to="lab_ifrs-full_DepreciationRatePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_359" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_360" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_361" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialAssets_362" xlink:to="lab_ifrs-full_DerivativeFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialAssets_363" xlink:to="lab_ifrs-full_DerivativeFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_364" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_365" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_366" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_367" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_368" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_369" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_370" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_371" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_372" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_373" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_374" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_375" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_376" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_377" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_378" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_379" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_380" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_381" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_382" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_383" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_384" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_385" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_386" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_387" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_388" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_389" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_390" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_391" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_392" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_393" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_394" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_395" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_396" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_397" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_398" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_399" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_400" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_401" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_402" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_403" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_404" xlink:to="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_405" xlink:to="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_406" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_407" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_408" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_409" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_410" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_411" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_412" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_413" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_414" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_415" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_416" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_417" xlink:to="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_418" xlink:to="lab_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_419" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_420" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_421" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_422" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_423" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_424" xlink:to="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_425" xlink:to="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_426" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_427" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_428" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_429" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_430" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_431" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_432" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_433" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_434" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_435" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_436" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_437" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_438" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_439" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_440" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_441" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_442" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_443" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_444" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_445" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_446" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_447" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_448" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_449" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_450" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_451" xlink:to="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_452" xlink:to="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_453" xlink:to="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_454" xlink:to="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_455" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_456" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_457" xlink:to="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_458" xlink:to="lab_ifrs-full_DisclosureOfExpensesByNatureExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_459" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_460" xlink:to="lab_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_461" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_462" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_463" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_464" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_465" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_466" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_467" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_468" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_469" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_470" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_471" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_472" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_473" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_474" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_475" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_476" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_477" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory_478" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory_479" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutUnconsolidatedSubsidiariesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_480" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_481" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_482" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_483" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_484" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_485" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_486" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_487" xlink:to="lab_ifrs-full_DisclosureOfIssuedCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_488" xlink:to="lab_ifrs-full_DisclosureOfIssuedCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_489" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_490" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_491" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_492" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_493" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_494" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_495" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_496" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_497" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_498" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_499" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_500" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_501" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_502" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_503" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_504" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_505" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_506" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_507" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_508" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_509" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_510" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_511" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_512" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_513" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_514" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_515" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_516" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_517" xlink:to="lab_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_518" xlink:to="lab_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_519" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_520" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_521" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_522" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_523" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_524" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_525" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_526" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_527" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_528" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_529" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_530" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_531" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_532" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_533" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_534" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_535" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_536" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_537" xlink:to="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_538" xlink:to="lab_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_539" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_540" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_541" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_542" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory_543" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_544" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_545" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_546" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_547" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_548" xlink:to="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_549" xlink:to="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_550" xlink:to="lab_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_551" xlink:to="lab_ifrs-full_EntitysTotalForSubsidiariesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_552" xlink:to="lab_ifrs-full_Equity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_553" xlink:to="lab_ifrs-full_Equity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_554" xlink:to="lab_ifrs-full_Equity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_555" xlink:to="lab_ifrs-full_Equity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_556" xlink:to="lab_ifrs-full_Equity_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_557" xlink:to="lab_ifrs-full_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_558" xlink:to="lab_ifrs-full_EquityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_559" xlink:to="lab_ifrs-full_EquityAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_560" xlink:to="lab_ifrs-full_EquityAndLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_561" xlink:to="lab_ifrs-full_EquityAndLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_562" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_563" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_564" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent_565" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_566" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_567" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_568" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_569" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityMember_570" xlink:to="lab_ifrs-full_EquityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_571" xlink:to="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_572" xlink:to="lab_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_573" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_574" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_575" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_576" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_577" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_578" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_579" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_580" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_581" xlink:to="lab_ifrs-full_FinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_582" xlink:to="lab_ifrs-full_FinanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_583" xlink:to="lab_ifrs-full_FinanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_584" xlink:to="lab_ifrs-full_FinanceIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_585" xlink:to="lab_ifrs-full_FinanceIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost_586" xlink:to="lab_ifrs-full_FinanceIncomeCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost_587" xlink:to="lab_ifrs-full_FinanceIncomeCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_588" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_589" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_590" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsMember_591" xlink:to="lab_ifrs-full_FinancialAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilities_592" xlink:to="lab_ifrs-full_FinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ForeignCountriesMember_593" xlink:to="lab_ifrs-full_ForeignCountriesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ForeignCountriesMember_594" xlink:to="lab_ifrs-full_ForeignCountriesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_595" xlink:to="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_596" xlink:to="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_597" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_598" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_599" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_600" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_601" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_602" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_603" xlink:to="lab_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_604" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_605" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_606" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_607" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_608" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense_609" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis_610" xlink:to="lab_ifrs-full_GeographicalAreasAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasMember_611" xlink:to="lab_ifrs-full_GeographicalAreasMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Goodwill_612" xlink:to="lab_ifrs-full_Goodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Goodwill_613" xlink:to="lab_ifrs-full_Goodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_614" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_615" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_616" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_617" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_618" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_619" xlink:to="lab_ifrs-full_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_620" xlink:to="lab_ifrs-full_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_621" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_622" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_623" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_624" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_625" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract_626" xlink:to="lab_ifrs-full_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_627" xlink:to="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_628" xlink:to="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_629" xlink:to="lab_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_630" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_631" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_632" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_633" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_634" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_635" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_636" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_637" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_638" xlink:to="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_639" xlink:to="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_640" xlink:to="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_641" xlink:to="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_642" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_643" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_644" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_645" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_646" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_647" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_648" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_649" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_650" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_651" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_652" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_653" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_654" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_655" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_656" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_657" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_658" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_659" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_660" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_661" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_662" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill_663" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill_664" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_665" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_666" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_667" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_668" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_669" xlink:to="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_670" xlink:to="lab_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_671" xlink:to="lab_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_672" xlink:to="lab_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_673" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_674" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_675" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_676" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_677" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_678" xlink:to="lab_ifrs-full_InterestExpenseDefinedBenefitPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_679" xlink:to="lab_ifrs-full_InterestExpenseDefinedBenefitPlans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_680" xlink:to="lab_ifrs-full_InterestExpenseDefinedBenefitPlans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_681" xlink:to="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_682" xlink:to="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_683" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_684" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_685" xlink:to="lab_ifrs-full_Inventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_686" xlink:to="lab_ifrs-full_Inventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_687" xlink:to="lab_ifrs-full_Inventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoriesAtFairValueLessCostsToSell_688" xlink:to="lab_ifrs-full_InventoriesAtFairValueLessCostsToSell_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoriesAtFairValueLessCostsToSell_689" xlink:to="lab_ifrs-full_InventoriesAtFairValueLessCostsToSell_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_690" xlink:to="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_691" xlink:to="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_692" xlink:to="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_693" xlink:to="lab_ifrs-full_InventoryWritedown2011_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011_694" xlink:to="lab_ifrs-full_InventoryWritedown2011_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_695" xlink:to="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_696" xlink:to="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_697" xlink:to="lab_ifrs-full_IssuedCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_698" xlink:to="lab_ifrs-full_IssuedCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_699" xlink:to="lab_ifrs-full_IssuedCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_700" xlink:to="lab_ifrs-full_IssuedCapitalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_701" xlink:to="lab_ifrs-full_IssuedCapitalMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_702" xlink:to="lab_ifrs-full_IssueOfEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_703" xlink:to="lab_ifrs-full_IssueOfEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_704" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_705" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_706" xlink:to="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_707" xlink:to="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandAndBuildingsMember_708" xlink:to="lab_ifrs-full_LandAndBuildingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandAndBuildingsMember_709" xlink:to="lab_ifrs-full_LandAndBuildingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_710" xlink:to="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_711" xlink:to="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_712" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_713" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTenYearsMember_714" xlink:to="lab_ifrs-full_LaterThanTenYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTenYearsMember_715" xlink:to="lab_ifrs-full_LaterThanTenYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseholdImprovementsMember_716" xlink:to="lab_ifrs-full_LeaseholdImprovementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseholdImprovementsMember_717" xlink:to="lab_ifrs-full_LeaseholdImprovementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_718" xlink:to="lab_ifrs-full_LeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember_719" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember_720" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_721" xlink:to="lab_ifrs-full_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_722" xlink:to="lab_ifrs-full_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_723" xlink:to="lab_ifrs-full_Liabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract_724" xlink:to="lab_ifrs-full_LiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesAbstract_725" xlink:to="lab_ifrs-full_LiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_726" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_727" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_728" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_729" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_730" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_731" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_732" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_733" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_734" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesAndFranchisesMember_735" xlink:to="lab_ifrs-full_LicencesAndFranchisesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesAndFranchisesMember_736" xlink:to="lab_ifrs-full_LicencesAndFranchisesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesAndFranchisesMember_737" xlink:to="lab_ifrs-full_LicencesAndFranchisesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesMember_738" xlink:to="lab_ifrs-full_LicencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesMember_739" xlink:to="lab_ifrs-full_LicencesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesMember_740" xlink:to="lab_ifrs-full_LicencesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansAndReceivables_741" xlink:to="lab_ifrs-full_LoansAndReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansAndReceivables_742" xlink:to="lab_ifrs-full_LoansAndReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_743" xlink:to="lab_ifrs-full_LongtermBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_744" xlink:to="lab_ifrs-full_LongtermBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_745" xlink:to="lab_ifrs-full_LongtermBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowingsMember_746" xlink:to="lab_ifrs-full_LongtermBorrowingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_747" xlink:to="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersAxis_748" xlink:to="lab_ifrs-full_MajorCustomersAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersMember_749" xlink:to="lab_ifrs-full_MajorCustomersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_750" xlink:to="lab_ifrs-full_MajorOrdinaryShareTransactionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_751" xlink:to="lab_ifrs-full_MajorOrdinaryShareTransactionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_752" xlink:to="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_753" xlink:to="lab_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis_754" xlink:to="lab_ifrs-full_MaturityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MotorVehiclesMember_755" xlink:to="lab_ifrs-full_MotorVehiclesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MotorVehiclesMember_756" xlink:to="lab_ifrs-full_MotorVehiclesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_757" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember_758" xlink:to="lab_ifrs-full_NonadjustingEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_759" xlink:to="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_760" xlink:to="lab_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterests_761" xlink:to="lab_ifrs-full_NoncontrollingInterests_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterests_762" xlink:to="lab_ifrs-full_NoncontrollingInterests_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterestsMember_763" xlink:to="lab_ifrs-full_NoncontrollingInterestsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterestsMember_764" xlink:to="lab_ifrs-full_NoncontrollingInterestsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_765" xlink:to="lab_ifrs-full_NoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_766" xlink:to="lab_ifrs-full_NoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_767" xlink:to="lab_ifrs-full_NoncurrentAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_768" xlink:to="lab_ifrs-full_NoncurrentAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_769" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_770" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_771" xlink:to="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_772" xlink:to="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_773" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_774" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities_775" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_776" xlink:to="lab_ifrs-full_NoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_777" xlink:to="lab_ifrs-full_NoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_778" xlink:to="lab_ifrs-full_NoncurrentLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_779" xlink:to="lab_ifrs-full_NoncurrentLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_780" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_781" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_782" xlink:to="lab_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_783" xlink:to="lab_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_784" xlink:to="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_785" xlink:to="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_786" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_787" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_788" xlink:to="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_789" xlink:to="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_790" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_791" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_792" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_793" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_794" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_795" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_796" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_797" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_798" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_799" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_800" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_801" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_802" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_803" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_804" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_805" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_806" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_807" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_808" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_809" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_810" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_811" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_812" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_813" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_814" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_815" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_816" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_817" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_818" xlink:to="lab_ifrs-full_NumberOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_819" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_820" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_821" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_822" xlink:to="lab_ifrs-full_OperatingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_823" xlink:to="lab_ifrs-full_OperatingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_824" xlink:to="lab_ifrs-full_OperatingExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_825" xlink:to="lab_ifrs-full_OperatingExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingSegmentsMember_826" xlink:to="lab_ifrs-full_OperatingSegmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingSegmentsMember_827" xlink:to="lab_ifrs-full_OperatingSegmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember_828" xlink:to="lab_ifrs-full_OrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember_829" xlink:to="lab_ifrs-full_OrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAssetsMember_830" xlink:to="lab_ifrs-full_OtherAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAssetsMember_831" xlink:to="lab_ifrs-full_OtherAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_832" xlink:to="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_833" xlink:to="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_834" xlink:to="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_835" xlink:to="lab_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_836" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_837" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_838" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_839" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_840" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_841" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_842" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_843" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_844" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_845" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_846" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_847" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_848" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_849" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_850" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_851" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables_852" xlink:to="lab_ifrs-full_OtherCurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables_853" xlink:to="lab_ifrs-full_OtherCurrentPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables_854" xlink:to="lab_ifrs-full_OtherCurrentPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables_855" xlink:to="lab_ifrs-full_OtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables_856" xlink:to="lab_ifrs-full_OtherCurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables_857" xlink:to="lab_ifrs-full_OtherCurrentReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherExpenseByNature_858" xlink:to="lab_ifrs-full_OtherExpenseByNature_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherExpenseByNature_859" xlink:to="lab_ifrs-full_OtherExpenseByNature_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherExpenseByNature_860" xlink:to="lab_ifrs-full_OtherExpenseByNature_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherExpenseByNature_861" xlink:to="lab_ifrs-full_OtherExpenseByNature_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherGainsLosses_862" xlink:to="lab_ifrs-full_OtherGainsLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherGainsLosses_863" xlink:to="lab_ifrs-full_OtherGainsLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember_864" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember_865" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember_866" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_867" xlink:to="lab_ifrs-full_OtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_868" xlink:to="lab_ifrs-full_OtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_869" xlink:to="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_870" xlink:to="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParentMember_871" xlink:to="lab_ifrs-full_ParentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParentMember_872" xlink:to="lab_ifrs-full_ParentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare_873" xlink:to="lab_ifrs-full_ParValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_874" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_875" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_876" xlink:to="lab_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_877" xlink:to="lab_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_878" xlink:to="lab_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_879" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_880" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfOtherEquityInstruments_881" xlink:to="lab_ifrs-full_PaymentsOfOtherEquityInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfOtherEquityInstruments_882" xlink:to="lab_ifrs-full_PaymentsOfOtherEquityInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfOtherEquityInstruments_883" xlink:to="lab_ifrs-full_PaymentsOfOtherEquityInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfEntitysRevenue_884" xlink:to="lab_ifrs-full_PercentageOfEntitysRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfEntitysRevenue_885" xlink:to="lab_ifrs-full_PercentageOfEntitysRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_886" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_887" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue_888" xlink:to="lab_ifrs-full_PlanAssetsAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue_889" xlink:to="lab_ifrs-full_PlanAssetsAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue_890" xlink:to="lab_ifrs-full_PlanAssetsAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue_891" xlink:to="lab_ifrs-full_PlanAssetsAtFairValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue_892" xlink:to="lab_ifrs-full_PlanAssetsAtFairValue_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_893" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_894" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_895" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_896" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PreferenceSharesMember_897" xlink:to="lab_ifrs-full_PreferenceSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PreferenceSharesMember_898" xlink:to="lab_ifrs-full_PreferenceSharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_899" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_900" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_901" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_902" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_903" xlink:to="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_904" xlink:to="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_905" xlink:to="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_906" xlink:to="lab_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_907" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_908" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_909" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_910" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentProperty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_911" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentProperty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_912" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_913" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfessionalFeesExpense_914" xlink:to="lab_ifrs-full_ProfessionalFeesExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_915" xlink:to="lab_ifrs-full_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_916" xlink:to="lab_ifrs-full_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_917" xlink:to="lab_ifrs-full_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_918" xlink:to="lab_ifrs-full_ProfitLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_919" xlink:to="lab_ifrs-full_ProfitLoss_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_920" xlink:to="lab_ifrs-full_ProfitLossAttributableToAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_921" xlink:to="lab_ifrs-full_ProfitLossAttributableToAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_922" xlink:to="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_923" xlink:to="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_924" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_925" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_926" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_927" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_928" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_929" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_930" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_931" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_932" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_933" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_934" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_935" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_936" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_937" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_938" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossOfAcquiree_939" xlink:to="lab_ifrs-full_ProfitLossOfAcquiree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossOfAcquiree_940" xlink:to="lab_ifrs-full_ProfitLossOfAcquiree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossOfAcquiree_941" xlink:to="lab_ifrs-full_ProfitLossOfAcquiree_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_942" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_943" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_944" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_945" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_946" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_947" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_948" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_949" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_950" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_951" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_952" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_953" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentProperty_954" xlink:to="lab_ifrs-full_PurchaseOfInvestmentProperty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentProperty_955" xlink:to="lab_ifrs-full_PurchaseOfInvestmentProperty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_956" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_957" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_958" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis_959" xlink:to="lab_ifrs-full_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember_960" xlink:to="lab_ifrs-full_RangesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_961" xlink:to="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_962" xlink:to="lab_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_963" xlink:to="lab_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_964" xlink:to="lab_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RelatedPartiesMember_965" xlink:to="lab_ifrs-full_RelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_966" xlink:to="lab_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_967" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_968" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_969" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_970" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_971" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_972" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_973" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_974" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPayments_975" xlink:to="lab_ifrs-full_ReserveOfSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPayments_976" xlink:to="lab_ifrs-full_ReserveOfSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_977" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_978" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_979" xlink:to="lab_ifrs-full_RetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_980" xlink:to="lab_ifrs-full_RetainedEarnings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_981" xlink:to="lab_ifrs-full_RetainedEarnings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_982" xlink:to="lab_ifrs-full_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_983" xlink:to="lab_ifrs-full_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_984" xlink:to="lab_ifrs-full_Revenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_985" xlink:to="lab_ifrs-full_Revenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueOfAcquiree_986" xlink:to="lab_ifrs-full_RevenueOfAcquiree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueOfAcquiree_987" xlink:to="lab_ifrs-full_RevenueOfAcquiree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_988" xlink:to="lab_ifrs-full_RightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_989" xlink:to="lab_ifrs-full_RightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_990" xlink:to="lab_ifrs-full_RightofuseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_991" xlink:to="lab_ifrs-full_RightofuseAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsMember_992" xlink:to="lab_ifrs-full_RightofuseAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_993" xlink:to="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_994" xlink:to="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_995" xlink:to="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_996" xlink:to="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_997" xlink:to="lab_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_998" xlink:to="lab_ifrs-full_SalesAndMarketingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_999" xlink:to="lab_ifrs-full_SalesAndMarketingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_1000" xlink:to="lab_ifrs-full_SegmentConsolidationItemsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsMember_1001" xlink:to="lab_ifrs-full_SegmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingExpense_1002" xlink:to="lab_ifrs-full_SellingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1003" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_1004" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_1005" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_1006" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_1007" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_1008" xlink:to="lab_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_1009" xlink:to="lab_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowings_1010" xlink:to="lab_ifrs-full_ShorttermBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowings_1011" xlink:to="lab_ifrs-full_ShorttermBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowings_1012" xlink:to="lab_ifrs-full_ShorttermBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowingsMember_1013" xlink:to="lab_ifrs-full_ShorttermBorrowingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermBorrowingsMember_1014" xlink:to="lab_ifrs-full_ShorttermBorrowingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_1015" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsAccruals_1016" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsAccruals_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1017" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_1018" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_1019" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_1020" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1021" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_1022" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1023" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1024" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_1025" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates_1026" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates_1027" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfTaxLosses_1028" xlink:to="lab_ifrs-full_TaxEffectOfTaxLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfTaxLosses_1029" xlink:to="lab_ifrs-full_TaxEffectOfTaxLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1030" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1031" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_1032" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1033" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_1034" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_1035" xlink:to="lab_ifrs-full_TopOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_1036" xlink:to="lab_ifrs-full_TopOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_1037" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_1038" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_1039" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1040" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1041" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_1042" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_1043" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_1044" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_1045" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_1046" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesAbstract_1047" xlink:to="lab_ifrs-full_TradeAndOtherPayablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1048" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1049" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1050" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_1051" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasuryShares_1052" xlink:to="lab_ifrs-full_TreasuryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasuryShares_1053" xlink:to="lab_ifrs-full_TreasuryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasurySharesMember_1054" xlink:to="lab_ifrs-full_TreasurySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1055" xlink:to="lab_ifrs-full_TypesOfRisksAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksMember_1056" xlink:to="lab_ifrs-full_TypesOfRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1057" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnallocatedAmountsMember_1058" xlink:to="lab_ifrs-full_UnallocatedAmountsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesMember_1059" xlink:to="lab_ifrs-full_UnusedTaxLossesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesMember_1060" xlink:to="lab_ifrs-full_UnusedTaxLossesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1061" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1062" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_1063" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_1064" xlink:to="lab_ifrs-full_WagesAndSalaries_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_1065" xlink:to="lab_ifrs-full_WagesAndSalaries_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WarrantLiability_1066" xlink:to="lab_ifrs-full_WarrantLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_1067" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_1068" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_1069" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_1070" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_1071" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_1072" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1073" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1074" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1075" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1076" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1077" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1078" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1079" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1080" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1081" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1082" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1083" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1084" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1085" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1086" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1087" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageMember_1088" xlink:to="lab_ifrs-full_WeightedAverageMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageMember_1089" xlink:to="lab_ifrs-full_WeightedAverageMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1090" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1091" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePrice2019_1092" xlink:to="lab_ifrs-full_WeightedAverageSharePrice2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePrice2019_1093" xlink:to="lab_ifrs-full_WeightedAverageSharePrice2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1094" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1095" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_1096" xlink:to="lab_ifrs-full_WeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_1097" xlink:to="lab_ifrs-full_WeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_1098" xlink:to="lab_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_1099" xlink:to="lab_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_1100" xlink:to="lab_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionCostsForProfessionalFees_1101" xlink:to="lab_imc_AcquisitionCostsForProfessionalFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionCostsForProfessionalFees_1102" xlink:to="lab_imc_AcquisitionCostsForProfessionalFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionCostsForProfessionalFees_1103" xlink:to="lab_imc_AcquisitionCostsForProfessionalFees_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionCostsOfCommonShares_1104" xlink:to="lab_imc_AcquisitionCostsOfCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionCostsOfCommonShares_1105" xlink:to="lab_imc_AcquisitionCostsOfCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionCostsOfCommonShares_1106" xlink:to="lab_imc_AcquisitionCostsOfCommonShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionOfSubsidiaryAbstract_1107" xlink:to="lab_imc_AcquisitionOfSubsidiaryAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionOfSubsidiaryAbstract_1108" xlink:to="lab_imc_AcquisitionOfSubsidiaryAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionOfTrichomeFinancialCorpMember_1109" xlink:to="lab_imc_AcquisitionOfTrichomeFinancialCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionOfTrichomeFinancialCorpMember_1110" xlink:to="lab_imc_AcquisitionOfTrichomeFinancialCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionOfTrichomeFinancialCorpMember_1111" xlink:to="lab_imc_AcquisitionOfTrichomeFinancialCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionTransactionCosts_1112" xlink:to="lab_imc_AcquisitionTransactionCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionTransactionCosts_1113" xlink:to="lab_imc_AcquisitionTransactionCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AcquisitionTransactionCosts_1114" xlink:to="lab_imc_AcquisitionTransactionCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdditionsToDisposalsRightOfUseAssets_1115" xlink:to="lab_imc_AdditionsToDisposalsRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdditionsToDisposalsRightOfUseAssets_1116" xlink:to="lab_imc_AdditionsToDisposalsRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdditionsToDisposalsRightOfUseAssets_1117" xlink:to="lab_imc_AdditionsToDisposalsRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjupharmGmbhMember_1118" xlink:to="lab_imc_AdjupharmGmbhMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjupharmGmbhMember_1119" xlink:to="lab_imc_AdjupharmGmbhMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjupharmGmbhMember_1120" xlink:to="lab_imc_AdjupharmGmbhMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjupharmsCeoMember_1121" xlink:to="lab_imc_AdjupharmsCeoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjupharmsCeoMember_1122" xlink:to="lab_imc_AdjupharmsCeoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjupharmsCeoMember_1123" xlink:to="lab_imc_AdjupharmsCeoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustedExercisePrice_1124" xlink:to="lab_imc_AdjustedExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustedExercisePrice_1125" xlink:to="lab_imc_AdjustedExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustedExercisePrice_1126" xlink:to="lab_imc_AdjustedExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_1127" xlink:to="lab_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_1128" xlink:to="lab_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_1129" xlink:to="lab_imc_AdjustedWeightedAverageSharesProfitLossAttributableToOwnersOfParent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1130" xlink:to="lab_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1131" xlink:to="lab_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1132" xlink:to="lab_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_1133" xlink:to="lab_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_1134" xlink:to="lab_imc_AdjustmentsForRevaluationOfOtherReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_1135" xlink:to="lab_imc_AdjustmentsForRevaluationOfOtherReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_1136" xlink:to="lab_imc_AdjustmentsForRevaluationOfOtherReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1137" xlink:to="lab_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1138" xlink:to="lab_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1139" xlink:to="lab_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_1140" xlink:to="lab_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AggregateGrossProceedsOfSubscriptionReceipts_1141" xlink:to="lab_imc_AggregateGrossProceedsOfSubscriptionReceipts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AggregateGrossProceedsOfSubscriptionReceipts_1142" xlink:to="lab_imc_AggregateGrossProceedsOfSubscriptionReceipts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AggregateGrossProceedsOfSubscriptionReceipts_1143" xlink:to="lab_imc_AggregateGrossProceedsOfSubscriptionReceipts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AggregatePurchasePriceOfBusinessAcquisition_1144" xlink:to="lab_imc_AggregatePurchasePriceOfBusinessAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AggregatePurchasePriceOfBusinessAcquisition_1145" xlink:to="lab_imc_AggregatePurchasePriceOfBusinessAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AggregatePurchasePriceOfBusinessAcquisition_1146" xlink:to="lab_imc_AggregatePurchasePriceOfBusinessAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AgreementAxis_1147" xlink:to="lab_imc_AgreementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AgreementAxis_1148" xlink:to="lab_imc_AgreementAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AgreementDomain_1149" xlink:to="lab_imc_AgreementDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AgreementDomain_1150" xlink:to="lab_imc_AgreementDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AgreementWithFarmerMember_1151" xlink:to="lab_imc_AgreementWithFarmerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AgreementWithFarmerMember_1152" xlink:to="lab_imc_AgreementWithFarmerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AllocatedPercentageOfShareCapital_1153" xlink:to="lab_imc_AllocatedPercentageOfShareCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AllocatedPercentageOfShareCapital_1154" xlink:to="lab_imc_AllocatedPercentageOfShareCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AllocatedPercentageOfShareCapital_1155" xlink:to="lab_imc_AllocatedPercentageOfShareCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountDepositedInEscrow_1156" xlink:to="lab_imc_AmountDepositedInEscrow_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountDepositedInEscrow_1157" xlink:to="lab_imc_AmountDepositedInEscrow_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountDepositedInEscrow_1158" xlink:to="lab_imc_AmountDepositedInEscrow_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfClassActionGroupIncurredDamages_1159" xlink:to="lab_imc_AmountOfClassActionGroupIncurredDamages_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfClassActionGroupIncurredDamages_1160" xlink:to="lab_imc_AmountOfClassActionGroupIncurredDamages_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfClassActionGroupIncurredDamages_1161" xlink:to="lab_imc_AmountOfClassActionGroupIncurredDamages_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfExpensesPaidByApplicant_1162" xlink:to="lab_imc_AmountOfExpensesPaidByApplicant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfExpensesPaidByApplicant_1163" xlink:to="lab_imc_AmountOfExpensesPaidByApplicant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfExpensesPaidByApplicant_1164" xlink:to="lab_imc_AmountOfExpensesPaidByApplicant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfNonCancellablePurchasePrice_1165" xlink:to="lab_imc_AmountOfNonCancellablePurchasePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfNonCancellablePurchasePrice_1166" xlink:to="lab_imc_AmountOfNonCancellablePurchasePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfNonCancellablePurchasePrice_1167" xlink:to="lab_imc_AmountOfNonCancellablePurchasePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfPersonalSuit_1168" xlink:to="lab_imc_AmountOfPersonalSuit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfPersonalSuit_1169" xlink:to="lab_imc_AmountOfPersonalSuit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfPersonalSuit_1170" xlink:to="lab_imc_AmountOfPersonalSuit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_1171" xlink:to="lab_imc_AmountOfPurchaseOfTreasuryCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_1172" xlink:to="lab_imc_AmountOfPurchaseOfTreasuryCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_1173" xlink:to="lab_imc_AmountOfPurchaseOfTreasuryCommonShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_1174" xlink:to="lab_imc_AmountOfPurchaseOfTreasuryCommonShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_1175" xlink:to="lab_imc_AmountOfSettlementOfWithholdingTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_1176" xlink:to="lab_imc_AmountOfSettlementOfWithholdingTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_1177" xlink:to="lab_imc_AmountOfSettlementOfWithholdingTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfSharesGranted_1178" xlink:to="lab_imc_AmountOfSharesGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfSharesGranted_1179" xlink:to="lab_imc_AmountOfSharesGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfSharesGranted_1180" xlink:to="lab_imc_AmountOfSharesGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfTranslationTransaction_1181" xlink:to="lab_imc_AmountOfTranslationTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfTranslationTransaction_1182" xlink:to="lab_imc_AmountOfTranslationTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfTranslationTransaction_1183" xlink:to="lab_imc_AmountOfTranslationTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfVotingEquityInterestsAcquired_1184" xlink:to="lab_imc_AmountOfVotingEquityInterestsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfVotingEquityInterestsAcquired_1185" xlink:to="lab_imc_AmountOfVotingEquityInterestsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfVotingEquityInterestsAcquired_1186" xlink:to="lab_imc_AmountOfVotingEquityInterestsAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_1187" xlink:to="lab_imc_AmountOfWarrantTransferredInEquityDuringPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_1188" xlink:to="lab_imc_AmountOfWarrantTransferredInEquityDuringPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_1189" xlink:to="lab_imc_AmountOfWarrantTransferredInEquityDuringPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountToBeDeliveredOverTermOfSalesAgreements_1190" xlink:to="lab_imc_AmountToBeDeliveredOverTermOfSalesAgreements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountToBeDeliveredOverTermOfSalesAgreements_1191" xlink:to="lab_imc_AmountToBeDeliveredOverTermOfSalesAgreements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountToBeDeliveredOverTermOfSalesAgreements_1192" xlink:to="lab_imc_AmountToBeDeliveredOverTermOfSalesAgreements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_1193" xlink:to="lab_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_1194" xlink:to="lab_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_1195" xlink:to="lab_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ApproximatelyCashAndCashEquivalents_1196" xlink:to="lab_imc_ApproximatelyCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ApproximatelyCashAndCashEquivalents_1197" xlink:to="lab_imc_ApproximatelyCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ApproximatelyCashAndCashEquivalents_1198" xlink:to="lab_imc_ApproximatelyCashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AreaOfCultivationAndProcessing_1199" xlink:to="lab_imc_AreaOfCultivationAndProcessing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AreaOfCultivationAndProcessing_1200" xlink:to="lab_imc_AreaOfCultivationAndProcessing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AreaOfCultivationAndProcessing_1201" xlink:to="lab_imc_AreaOfCultivationAndProcessing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ArrangementAgreementMember_1202" xlink:to="lab_imc_ArrangementAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ArrangementAgreementMember_1203" xlink:to="lab_imc_ArrangementAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ArrangementAgreementMember_1204" xlink:to="lab_imc_ArrangementAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AssetsLocationMember_1205" xlink:to="lab_imc_AssetsLocationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AssetsLocationMember_1206" xlink:to="lab_imc_AssetsLocationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AssetsLocationMember_1207" xlink:to="lab_imc_AssetsLocationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AttritionRate_1208" xlink:to="lab_imc_AttritionRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AttritionRate_1209" xlink:to="lab_imc_AttritionRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AttritionRate_1210" xlink:to="lab_imc_AttritionRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AutomaticExtensionPeriodOfAgreement_1211" xlink:to="lab_imc_AutomaticExtensionPeriodOfAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AutomaticExtensionPeriodOfAgreement_1212" xlink:to="lab_imc_AutomaticExtensionPeriodOfAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AutomaticExtensionPeriodOfAgreement_1213" xlink:to="lab_imc_AutomaticExtensionPeriodOfAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_1214" xlink:to="lab_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_1215" xlink:to="lab_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_1216" xlink:to="lab_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageSellingPricePerGramOfDriedCannabis_1217" xlink:to="lab_imc_AverageSellingPricePerGramOfDriedCannabis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageSellingPricePerGramOfDriedCannabis_1218" xlink:to="lab_imc_AverageSellingPricePerGramOfDriedCannabis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageSellingPricePerGramOfDriedCannabis_1219" xlink:to="lab_imc_AverageSellingPricePerGramOfDriedCannabis_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageStageOfGrowth_1220" xlink:to="lab_imc_AverageStageOfGrowth_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageStageOfGrowth_1221" xlink:to="lab_imc_AverageStageOfGrowth_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageStageOfGrowth_1222" xlink:to="lab_imc_AverageStageOfGrowth_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageYieldPerPlant_1223" xlink:to="lab_imc_AverageYieldPerPlant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageYieldPerPlant_1224" xlink:to="lab_imc_AverageYieldPerPlant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_AverageYieldPerPlant_1225" xlink:to="lab_imc_AverageYieldPerPlant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_1226" xlink:to="lab_imc_BankCreditRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_1227" xlink:to="lab_imc_BankCreditRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_1228" xlink:to="lab_imc_BankCreditRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_1229" xlink:to="lab_imc_BankCreditRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BankLoanAndLeaseLiabilities_1230" xlink:to="lab_imc_BankLoanAndLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BankLoanAndLeaseLiabilities_1231" xlink:to="lab_imc_BankLoanAndLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BankLoanAndLeaseLiabilities_1232" xlink:to="lab_imc_BankLoanAndLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BaseShelfProspectusMember_1233" xlink:to="lab_imc_BaseShelfProspectusMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BaseShelfProspectusMember_1234" xlink:to="lab_imc_BaseShelfProspectusMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BaseShelfProspectusMember_1235" xlink:to="lab_imc_BaseShelfProspectusMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BasicDilutedEarningsLossPerShare_1236" xlink:to="lab_imc_BasicDilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BasicDilutedEarningsLossPerShare_1237" xlink:to="lab_imc_BasicDilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BasicDilutedEarningsLossPerShare_1238" xlink:to="lab_imc_BasicDilutedEarningsLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_1239" xlink:to="lab_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_1240" xlink:to="lab_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_1241" xlink:to="lab_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BorrowingRecognisedAsOfAcquisitionDate_1242" xlink:to="lab_imc_BorrowingRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BorrowingRecognisedAsOfAcquisitionDate_1243" xlink:to="lab_imc_BorrowingRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BorrowingRecognisedAsOfAcquisitionDate_1244" xlink:to="lab_imc_BorrowingRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BulkCannabisMember_1245" xlink:to="lab_imc_BulkCannabisMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BulkCannabisMember_1246" xlink:to="lab_imc_BulkCannabisMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_BulkCannabisMember_1247" xlink:to="lab_imc_BulkCannabisMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CannabisPlantsMember_1248" xlink:to="lab_imc_CannabisPlantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CannabisPlantsMember_1249" xlink:to="lab_imc_CannabisPlantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CannabisPlantsMember_1250" xlink:to="lab_imc_CannabisPlantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CannacanadaIncMember_1251" xlink:to="lab_imc_CannacanadaIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CannacanadaIncMember_1252" xlink:to="lab_imc_CannacanadaIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CannacanadaIncMember_1253" xlink:to="lab_imc_CannacanadaIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CapitalExpenditures_1254" xlink:to="lab_imc_CapitalExpenditures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CapitalExpenditures_1255" xlink:to="lab_imc_CapitalExpenditures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CapitalExpenditures_1256" xlink:to="lab_imc_CapitalExpenditures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CapitalizedCostsOfInventories_1257" xlink:to="lab_imc_CapitalizedCostsOfInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CapitalizedCostsOfInventories_1258" xlink:to="lab_imc_CapitalizedCostsOfInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CapitalizedCostsOfInventories_1259" xlink:to="lab_imc_CapitalizedCostsOfInventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CarryforwardLossesForTaxPurposesDescription_1260" xlink:to="lab_imc_CarryforwardLossesForTaxPurposesDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CarryforwardLossesForTaxPurposesDescription_1261" xlink:to="lab_imc_CarryforwardLossesForTaxPurposesDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CarryforwardLossesForTaxPurposesDescription_1262" xlink:to="lab_imc_CarryforwardLossesForTaxPurposesDescription_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CarryforwardOperatingTaxLosses_1263" xlink:to="lab_imc_CarryforwardOperatingTaxLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CarryforwardOperatingTaxLosses_1264" xlink:to="lab_imc_CarryforwardOperatingTaxLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CarryforwardOperatingTaxLosses_1265" xlink:to="lab_imc_CarryforwardOperatingTaxLosses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CashAndCashEquivalentMember_1266" xlink:to="lab_imc_CashAndCashEquivalentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CashAndCashEquivalentMember_1267" xlink:to="lab_imc_CashAndCashEquivalentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CashConsiderationOfBusinessCombination_1268" xlink:to="lab_imc_CashConsiderationOfBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CashConsiderationOfBusinessCombination_1269" xlink:to="lab_imc_CashConsiderationOfBusinessCombination_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CashConsiderationOfBusinessCombination_1270" xlink:to="lab_imc_CashConsiderationOfBusinessCombination_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ChangeInRestrictedBankDeposits_1271" xlink:to="lab_imc_ChangeInRestrictedBankDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ChangeInRestrictedBankDeposits_1272" xlink:to="lab_imc_ChangeInRestrictedBankDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ChangeInRestrictedBankDeposits_1273" xlink:to="lab_imc_ChangeInRestrictedBankDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ChangeInTaxBenefitsNotRecognized_1274" xlink:to="lab_imc_ChangeInTaxBenefitsNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ChangeInTaxBenefitsNotRecognized_1275" xlink:to="lab_imc_ChangeInTaxBenefitsNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ChangeInTaxBenefitsNotRecognized_1276" xlink:to="lab_imc_ChangeInTaxBenefitsNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_1277" xlink:to="lab_imc_ChangesInNonCashWorkingCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_1278" xlink:to="lab_imc_ChangesInNonCashWorkingCapitalAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ClassesOfInventoriesAxis_1279" xlink:to="lab_imc_ClassesOfInventoriesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ClassesOfInventoriesAxis_1280" xlink:to="lab_imc_ClassesOfInventoriesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ClassesOfInventoriesDomain_1281" xlink:to="lab_imc_ClassesOfInventoriesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ClassesOfInventoriesDomain_1282" xlink:to="lab_imc_ClassesOfInventoriesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Commitment_1283" xlink:to="lab_imc_Commitment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Commitment_1284" xlink:to="lab_imc_Commitment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Commitment_1285" xlink:to="lab_imc_Commitment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationOptionPricePerShare_1286" xlink:to="lab_imc_CompensationOptionPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationOptionPricePerShare_1287" xlink:to="lab_imc_CompensationOptionPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationOptionPricePerShare_1288" xlink:to="lab_imc_CompensationOptionPricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationOptions2019Member_1289" xlink:to="lab_imc_CompensationOptions2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationOptions2019Member_1290" xlink:to="lab_imc_CompensationOptions2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationOptions2019Member_1291" xlink:to="lab_imc_CompensationOptions2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationUnitPerShare_1292" xlink:to="lab_imc_CompensationUnitPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationUnitPerShare_1293" xlink:to="lab_imc_CompensationUnitPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationUnitPerShare_1294" xlink:to="lab_imc_CompensationUnitPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationUnitsMember_1295" xlink:to="lab_imc_CompensationUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationUnitsMember_1296" xlink:to="lab_imc_CompensationUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CompensationUnitsMember_1297" xlink:to="lab_imc_CompensationUnitsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_1298" xlink:to="lab_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_1299" xlink:to="lab_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_1300" xlink:to="lab_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ConversionPricePerWarrant_1301" xlink:to="lab_imc_ConversionPricePerWarrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ConversionPricePerWarrant_1302" xlink:to="lab_imc_ConversionPricePerWarrant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ConversionPricePerWarrant_1303" xlink:to="lab_imc_ConversionPricePerWarrant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CostOfGoodsSoldInventory_1304" xlink:to="lab_imc_CostOfGoodsSoldInventory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CostOfGoodsSoldInventory_1305" xlink:to="lab_imc_CostOfGoodsSoldInventory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CostOfGoodsSoldInventory_1306" xlink:to="lab_imc_CostOfGoodsSoldInventory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CultivationsAndProcessingLicenseMember_1307" xlink:to="lab_imc_CultivationsAndProcessingLicenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CultivationsAndProcessingLicenseMember_1308" xlink:to="lab_imc_CultivationsAndProcessingLicenseMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CultivationsAndProcessingLicenseMember_1309" xlink:to="lab_imc_CultivationsAndProcessingLicenseMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerOneMember_1310" xlink:to="lab_imc_CustomerOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerOneMember_1311" xlink:to="lab_imc_CustomerOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerOneMember_1312" xlink:to="lab_imc_CustomerOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerRelationshipsMember_1313" xlink:to="lab_imc_CustomerRelationshipsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerRelationshipsMember_1314" xlink:to="lab_imc_CustomerRelationshipsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerRelationshipsMember_1315" xlink:to="lab_imc_CustomerRelationshipsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerThreeMember_1316" xlink:to="lab_imc_CustomerThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerThreeMember_1317" xlink:to="lab_imc_CustomerThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerThreeMember_1318" xlink:to="lab_imc_CustomerThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerTwoMember_1319" xlink:to="lab_imc_CustomerTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerTwoMember_1320" xlink:to="lab_imc_CustomerTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_CustomerTwoMember_1321" xlink:to="lab_imc_CustomerTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeemedIssuance_1322" xlink:to="lab_imc_DeemedIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeemedIssuance_1323" xlink:to="lab_imc_DeemedIssuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeemedIssuance_1324" xlink:to="lab_imc_DeemedIssuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeemedPricePerShare_1325" xlink:to="lab_imc_DeemedPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeemedPricePerShare_1326" xlink:to="lab_imc_DeemedPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeemedPricePerShare_1327" xlink:to="lab_imc_DeemedPricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxAssetsAbstract_1328" xlink:to="lab_imc_DeferredTaxAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxAssetsAbstract_1329" xlink:to="lab_imc_DeferredTaxAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1330" xlink:to="lab_imc_DeferredTaxAssetsAndLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1331" xlink:to="lab_imc_DeferredTaxAssetsAndLiabilitiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1332" xlink:to="lab_imc_DeferredTaxAssetsAndLiabilitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxAssetsMember_1333" xlink:to="lab_imc_DeferredTaxAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxAssetsMember_1334" xlink:to="lab_imc_DeferredTaxAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxAssetsMember_1335" xlink:to="lab_imc_DeferredTaxAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxLiabilitiesMember_1336" xlink:to="lab_imc_DeferredTaxLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxLiabilitiesMember_1337" xlink:to="lab_imc_DeferredTaxLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DeferredTaxLiabilitiesMember_1338" xlink:to="lab_imc_DeferredTaxLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DerivativeAssetsAsOfAcquisitionDate_1339" xlink:to="lab_imc_DerivativeAssetsAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DerivativeAssetsAsOfAcquisitionDate_1340" xlink:to="lab_imc_DerivativeAssetsAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DerivativeAssetsAsOfAcquisitionDate_1341" xlink:to="lab_imc_DerivativeAssetsAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1342" xlink:to="lab_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1343" xlink:to="lab_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1344" xlink:to="lab_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_1345" xlink:to="lab_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_1346" xlink:to="lab_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_1347" xlink:to="lab_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_1348" xlink:to="lab_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_1349" xlink:to="lab_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_1350" xlink:to="lab_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_1351" xlink:to="lab_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_1352" xlink:to="lab_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_1353" xlink:to="lab_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_1354" xlink:to="lab_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_1355" xlink:to="lab_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_1356" xlink:to="lab_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_1357" xlink:to="lab_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_1358" xlink:to="lab_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_1359" xlink:to="lab_imc_DescriptionOfExchangeOfSubscriptionReceiptAfterCompletionOfReverseTakeover_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfExpectedDividendYieldOptionsGranted_1360" xlink:to="lab_imc_DescriptionOfExpectedDividendYieldOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfExpectedDividendYieldOptionsGranted_1361" xlink:to="lab_imc_DescriptionOfExpectedDividendYieldOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfExpectedDividendYieldOptionsGranted_1362" xlink:to="lab_imc_DescriptionOfExpectedDividendYieldOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_1363" xlink:to="lab_imc_DescriptionOfOtherConvertibleSecritiesConversion_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_1364" xlink:to="lab_imc_DescriptionOfOtherConvertibleSecritiesConversion_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_1365" xlink:to="lab_imc_DescriptionOfOtherConvertibleSecritiesConversion_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_1366" xlink:to="lab_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_1367" xlink:to="lab_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_1368" xlink:to="lab_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_1369" xlink:to="lab_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_1370" xlink:to="lab_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_1371" xlink:to="lab_imc_DescriptionOfSharesAndWarrantsExchangedForPostConsolidation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_1372" xlink:to="lab_imc_DisclosureForSignificantAccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1373" xlink:to="lab_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1374" xlink:to="lab_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1375" xlink:to="lab_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_1376" xlink:to="lab_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_1377" xlink:to="lab_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_1378" xlink:to="lab_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1379" xlink:to="lab_imc_DisclosureOfCompositionOfShareCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1380" xlink:to="lab_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1381" xlink:to="lab_imc_DisclosureOfCompositionOfShareCapitalExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_1382" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_1383" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1384" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1385" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_1386" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_1387" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_1388" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_1389" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_1390" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_1391" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1392" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1393" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1394" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_1395" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_1396" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_1397" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_1398" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_1399" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_1400" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1401" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1402" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1403" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutExpensesRecognizedInConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_1404" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_1405" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_1406" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedOnAcquisitionDateExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_1407" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_1408" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_1409" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1410" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1411" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1412" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1413" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1414" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1415" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_1416" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_1417" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_1418" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_1419" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_1420" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_1421" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1422" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1423" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1424" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_1425" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_1426" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_1427" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_1428" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_1429" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_1430" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_1431" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1432" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1433" xlink:to="lab_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1434" xlink:to="lab_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1435" xlink:to="lab_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1436" xlink:to="lab_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_1437" xlink:to="lab_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_1438" xlink:to="lab_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_1439" xlink:to="lab_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_1440" xlink:to="lab_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_1441" xlink:to="lab_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_1442" xlink:to="lab_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_1443" xlink:to="lab_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_1444" xlink:to="lab_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1445" xlink:to="lab_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1446" xlink:to="lab_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_1447" xlink:to="lab_imc_DisclosureOfInformationAboutBalancesWithRelatedPartiesInStatementsOfProfitOrLossAndOtherComprehensiveIncomeExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_1448" xlink:to="lab_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_1449" xlink:to="lab_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_1450" xlink:to="lab_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_1451" xlink:to="lab_imc_DisclosureOfOtherAccountsReceivableAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1452" xlink:to="lab_imc_DisclosureOfOtherAccountsReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1453" xlink:to="lab_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1454" xlink:to="lab_imc_DisclosureOfOtherAccountsReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1455" xlink:to="lab_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1456" xlink:to="lab_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1457" xlink:to="lab_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_1458" xlink:to="lab_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_1459" xlink:to="lab_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_1460" xlink:to="lab_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfReverseTakeoverExplanatory_1461" xlink:to="lab_imc_DisclosureOfReverseTakeoverExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfReverseTakeoverExplanatory_1462" xlink:to="lab_imc_DisclosureOfReverseTakeoverExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfReverseTakeoverExplanatory_1463" xlink:to="lab_imc_DisclosureOfReverseTakeoverExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfReverseTakeoverLineItems_1464" xlink:to="lab_imc_DisclosureOfReverseTakeoverLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfReverseTakeoverTable_1465" xlink:to="lab_imc_DisclosureOfReverseTakeoverTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfReverseTakeoverTable_1466" xlink:to="lab_imc_DisclosureOfReverseTakeoverTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRightOfUseAssetsExplanatory_1467" xlink:to="lab_imc_DisclosureOfRightOfUseAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRightOfUseAssetsExplanatory_1468" xlink:to="lab_imc_DisclosureOfRightOfUseAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRightOfUseAssetsExplanatory_1469" xlink:to="lab_imc_DisclosureOfRightOfUseAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_1470" xlink:to="lab_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_1471" xlink:to="lab_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_1472" xlink:to="lab_imc_DisclosureOfRightOfUseAssetsExplanatoryExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1473" xlink:to="lab_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1474" xlink:to="lab_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1475" xlink:to="lab_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1476" xlink:to="lab_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1477" xlink:to="lab_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1478" xlink:to="lab_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfStatementOfProfitAndLossExplanatory_1479" xlink:to="lab_imc_DisclosureOfStatementOfProfitAndLossExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfStatementOfProfitAndLossExplanatory_1480" xlink:to="lab_imc_DisclosureOfStatementOfProfitAndLossExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfStatementOfProfitAndLossExplanatory_1481" xlink:to="lab_imc_DisclosureOfStatementOfProfitAndLossExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_1482" xlink:to="lab_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_1483" xlink:to="lab_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_1484" xlink:to="lab_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_1485" xlink:to="lab_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfTradeReceivablesExplanatory_1486" xlink:to="lab_imc_DisclosureOfTradeReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfTradeReceivablesExplanatory_1487" xlink:to="lab_imc_DisclosureOfTradeReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisclosureOfTradeReceivablesExplanatory_1488" xlink:to="lab_imc_DisclosureOfTradeReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisposalOfTerminationOfLeases_1489" xlink:to="lab_imc_DisposalOfTerminationOfLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisposalOfTerminationOfLeases_1490" xlink:to="lab_imc_DisposalOfTerminationOfLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisposalOfTerminationOfLeases_1491" xlink:to="lab_imc_DisposalOfTerminationOfLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisposalsOfRightOfUseAssets_1492" xlink:to="lab_imc_DisposalsOfRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisposalsOfRightOfUseAssets_1493" xlink:to="lab_imc_DisposalsOfRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DisposalsOfRightOfUseAssets_1494" xlink:to="lab_imc_DisposalsOfRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DocumentAndEntityAbstract_1495" xlink:to="lab_imc_DocumentAndEntityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_DocumentAndEntityInformationAbstract_1496" xlink:to="lab_imc_DocumentAndEntityInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_1497" xlink:to="lab_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EmployeesAndPayrollAccruals_1498" xlink:to="lab_imc_EmployeesAndPayrollAccruals_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EmployeesAndPayrollAccruals_1499" xlink:to="lab_imc_EmployeesAndPayrollAccruals_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EmployeesAndPayrollAccruals_1500" xlink:to="lab_imc_EmployeesAndPayrollAccruals_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EmployeesDirectorsAndAdvisorsMember_1501" xlink:to="lab_imc_EmployeesDirectorsAndAdvisorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EmployeesDirectorsAndAdvisorsMember_1502" xlink:to="lab_imc_EmployeesDirectorsAndAdvisorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EmployeesDirectorsAndAdvisorsMember_1503" xlink:to="lab_imc_EmployeesDirectorsAndAdvisorsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EquityIssuancePricePerShare_1504" xlink:to="lab_imc_EquityIssuancePricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EquityIssuancePricePerShare_1505" xlink:to="lab_imc_EquityIssuancePricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EquityIssuancePricePerShare_1506" xlink:to="lab_imc_EquityIssuancePricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EquityTransactionAxis_1507" xlink:to="lab_imc_EquityTransactionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EquityTransactionAxis_1508" xlink:to="lab_imc_EquityTransactionAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EquityTransactionDomain_1509" xlink:to="lab_imc_EquityTransactionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EquityTransactionDomain_1510" xlink:to="lab_imc_EquityTransactionDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EstimatedTotalAmountOfClassActionSuit_1511" xlink:to="lab_imc_EstimatedTotalAmountOfClassActionSuit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EstimatedTotalAmountOfClassActionSuit_1512" xlink:to="lab_imc_EstimatedTotalAmountOfClassActionSuit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_EstimatedTotalAmountOfClassActionSuit_1513" xlink:to="lab_imc_EstimatedTotalAmountOfClassActionSuit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExercisePriceOfWarrant_1514" xlink:to="lab_imc_ExercisePriceOfWarrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExercisePriceOfWarrant_1515" xlink:to="lab_imc_ExercisePriceOfWarrant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExercisePriceOfWarrant_1516" xlink:to="lab_imc_ExercisePriceOfWarrant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedDividendYieldOfWarrants_1517" xlink:to="lab_imc_ExpectedDividendYieldOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedDividendYieldOfWarrants_1518" xlink:to="lab_imc_ExpectedDividendYieldOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedDividendYieldOfWarrants_1519" xlink:to="lab_imc_ExpectedDividendYieldOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedLifeOfWarrants_1520" xlink:to="lab_imc_ExpectedLifeOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedLifeOfWarrants_1521" xlink:to="lab_imc_ExpectedLifeOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedLifeOfWarrants_1522" xlink:to="lab_imc_ExpectedLifeOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedVolatilityOfWarrants_1523" xlink:to="lab_imc_ExpectedVolatilityOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedVolatilityOfWarrants_1524" xlink:to="lab_imc_ExpectedVolatilityOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExpectedVolatilityOfWarrants_1525" xlink:to="lab_imc_ExpectedVolatilityOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExternalCustomersRevenues_1526" xlink:to="lab_imc_ExternalCustomersRevenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExternalCustomersRevenues_1527" xlink:to="lab_imc_ExternalCustomersRevenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ExternalCustomersRevenues_1528" xlink:to="lab_imc_ExternalCustomersRevenues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_1529" xlink:to="lab_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_1530" xlink:to="lab_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_1531" xlink:to="lab_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnSaleOfInventory_1532" xlink:to="lab_imc_FairValueAdjustmentOnSaleOfInventory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnSaleOfInventory_1533" xlink:to="lab_imc_FairValueAdjustmentOnSaleOfInventory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnSaleOfInventory_1534" xlink:to="lab_imc_FairValueAdjustmentOnSaleOfInventory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnSaleOfInventory_1535" xlink:to="lab_imc_FairValueAdjustmentOnSaleOfInventory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnSaleOfInventory_1536" xlink:to="lab_imc_FairValueAdjustmentOnSaleOfInventory_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1537" xlink:to="lab_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1538" xlink:to="lab_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1539" xlink:to="lab_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_1540" xlink:to="lab_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentsAbstract_1541" xlink:to="lab_imc_FairValueAdjustmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueAdjustmentsAbstract_1542" xlink:to="lab_imc_FairValueAdjustmentsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfCompensationUnits_1543" xlink:to="lab_imc_FairValueOfCompensationUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfCompensationUnits_1544" xlink:to="lab_imc_FairValueOfCompensationUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfCompensationUnits_1545" xlink:to="lab_imc_FairValueOfCompensationUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfInvestment_1546" xlink:to="lab_imc_FairValueOfInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfInvestment_1547" xlink:to="lab_imc_FairValueOfInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfInvestment_1548" xlink:to="lab_imc_FairValueOfInvestment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfUnitsIssued_1549" xlink:to="lab_imc_FairValueOfUnitsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfUnitsIssued_1550" xlink:to="lab_imc_FairValueOfUnitsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfUnitsIssued_1551" xlink:to="lab_imc_FairValueOfUnitsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfWarrants_1552" xlink:to="lab_imc_FairValueOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfWarrants_1553" xlink:to="lab_imc_FairValueOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfWarrants_1554" xlink:to="lab_imc_FairValueOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValueOfWarrants_1555" xlink:to="lab_imc_FairValueOfWarrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValuePerWarrant_1556" xlink:to="lab_imc_FairValuePerWarrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValuePerWarrant_1557" xlink:to="lab_imc_FairValuePerWarrant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FairValuePerWarrant_1558" xlink:to="lab_imc_FairValuePerWarrant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialAdvisorsMember_1559" xlink:to="lab_imc_FinancialAdvisorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialAdvisorsMember_1560" xlink:to="lab_imc_FinancialAdvisorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialAdvisorsMember_1561" xlink:to="lab_imc_FinancialAdvisorsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1562" xlink:to="lab_imc_FinancialInstrumentsAtAmortizedCostMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1563" xlink:to="lab_imc_FinancialInstrumentsAtAmortizedCostMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1564" xlink:to="lab_imc_FinancialInstrumentsAtAmortizedCostMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_1565" xlink:to="lab_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_1566" xlink:to="lab_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_1567" xlink:to="lab_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinishedGoodsMember_1568" xlink:to="lab_imc_FinishedGoodsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinishedGoodsMember_1569" xlink:to="lab_imc_FinishedGoodsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FinishedGoodsMember_1570" xlink:to="lab_imc_FinishedGoodsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_1571" xlink:to="lab_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_1572" xlink:to="lab_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_1573" xlink:to="lab_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FirstInstallmentMember_1574" xlink:to="lab_imc_FirstInstallmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FirstInstallmentMember_1575" xlink:to="lab_imc_FirstInstallmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FirstInstallmentMember_1576" xlink:to="lab_imc_FirstInstallmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FixedGrowthRate_1577" xlink:to="lab_imc_FixedGrowthRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FixedGrowthRate_1578" xlink:to="lab_imc_FixedGrowthRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FixedGrowthRate_1579" xlink:to="lab_imc_FixedGrowthRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FocusMedicalHerbsLtdMember_1580" xlink:to="lab_imc_FocusMedicalHerbsLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FocusMedicalHerbsLtdMember_1581" xlink:to="lab_imc_FocusMedicalHerbsLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FocusMedicalHerbsLtdMember_1582" xlink:to="lab_imc_FocusMedicalHerbsLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_FocusMedicalHerbsLtdMember_1583" xlink:to="lab_imc_FocusMedicalHerbsLtdMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ForeignCountriesTwoMember_1584" xlink:to="lab_imc_ForeignCountriesTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ForeignCountriesTwoMember_1585" xlink:to="lab_imc_ForeignCountriesTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ForeignCountriesTwoMember_1586" xlink:to="lab_imc_ForeignCountriesTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GainLossOnRevaluationOfFinancialInstruments_1587" xlink:to="lab_imc_GainLossOnRevaluationOfFinancialInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GainLossOnRevaluationOfFinancialInstruments_1588" xlink:to="lab_imc_GainLossOnRevaluationOfFinancialInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GainLossOnRevaluationOfFinancialInstruments_1589" xlink:to="lab_imc_GainLossOnRevaluationOfFinancialInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_1590" xlink:to="lab_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_1591" xlink:to="lab_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_1592" xlink:to="lab_imc_GalenIndustriesSingleMemberSocieteAnonymeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_1593" xlink:to="lab_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_1594" xlink:to="lab_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_1595" xlink:to="lab_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GreenhouseProductionEquipmentMember_1596" xlink:to="lab_imc_GreenhouseProductionEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GreenhouseProductionEquipmentMember_1597" xlink:to="lab_imc_GreenhouseProductionEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GreenhouseProductionEquipmentMember_1598" xlink:to="lab_imc_GreenhouseProductionEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GreenhouseStructureMember_1599" xlink:to="lab_imc_GreenhouseStructureMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GreenhouseStructureMember_1600" xlink:to="lab_imc_GreenhouseStructureMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GreenhouseStructureMember_1601" xlink:to="lab_imc_GreenhouseStructureMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GrossProceedsFromIssuanceOfUnits_1602" xlink:to="lab_imc_GrossProceedsFromIssuanceOfUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GrossProceedsFromIssuanceOfUnits_1603" xlink:to="lab_imc_GrossProceedsFromIssuanceOfUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GrossProceedsFromIssuanceOfUnits_1604" xlink:to="lab_imc_GrossProceedsFromIssuanceOfUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GrossProfitBeforeFairValueAdjustments_1605" xlink:to="lab_imc_GrossProfitBeforeFairValueAdjustments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GrossProfitBeforeFairValueAdjustments_1606" xlink:to="lab_imc_GrossProfitBeforeFairValueAdjustments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_GrossProfitBeforeFairValueAdjustments_1607" xlink:to="lab_imc_GrossProfitBeforeFairValueAdjustments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_HighlandGrowIncMember_1608" xlink:to="lab_imc_HighlandGrowIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_HighlandGrowIncMember_1609" xlink:to="lab_imc_HighlandGrowIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_HighlandGrowIncMember_1610" xlink:to="lab_imc_HighlandGrowIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_HighWayShinuaLtdMember_1611" xlink:to="lab_imc_HighWayShinuaLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_HighWayShinuaLtdMember_1612" xlink:to="lab_imc_HighWayShinuaLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_HighWayShinuaLtdMember_1613" xlink:to="lab_imc_HighWayShinuaLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1614" xlink:to="lab_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1615" xlink:to="lab_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_1616" xlink:to="lab_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1617" xlink:to="lab_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1618" xlink:to="lab_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1619" xlink:to="lab_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_1620" xlink:to="lab_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImcHoldingsLtdMember_1621" xlink:to="lab_imc_ImcHoldingsLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImcHoldingsLtdMember_1622" xlink:to="lab_imc_ImcHoldingsLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImcHoldingsLtdMember_1623" xlink:to="lab_imc_ImcHoldingsLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IMCOrdinaryShareholderMember_1624" xlink:to="lab_imc_IMCOrdinaryShareholderMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IMCOrdinaryShareholderMember_1625" xlink:to="lab_imc_IMCOrdinaryShareholderMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IMCOrdinaryShareholderMember_1626" xlink:to="lab_imc_IMCOrdinaryShareholderMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_1627" xlink:to="lab_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_1628" xlink:to="lab_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_1629" xlink:to="lab_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_1630" xlink:to="lab_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_1631" xlink:to="lab_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_1632" xlink:to="lab_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncomeTaxFromPreviousYears_1633" xlink:to="lab_imc_IncomeTaxFromPreviousYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncomeTaxFromPreviousYears_1634" xlink:to="lab_imc_IncomeTaxFromPreviousYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncomeTaxFromPreviousYears_1635" xlink:to="lab_imc_IncomeTaxFromPreviousYears_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncomeTaxLiabilityOfKeyPersonnel_1636" xlink:to="lab_imc_IncomeTaxLiabilityOfKeyPersonnel_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncomeTaxLiabilityOfKeyPersonnel_1637" xlink:to="lab_imc_IncomeTaxLiabilityOfKeyPersonnel_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncomeTaxLiabilityOfKeyPersonnel_1638" xlink:to="lab_imc_IncomeTaxLiabilityOfKeyPersonnel_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_1639" xlink:to="lab_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_1640" xlink:to="lab_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_1641" xlink:to="lab_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_1642" xlink:to="lab_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_1643" xlink:to="lab_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_1644" xlink:to="lab_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_1645" xlink:to="lab_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_1646" xlink:to="lab_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_1647" xlink:to="lab_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughForfeitedOptions_1648" xlink:to="lab_imc_IncreaseDecreaseThroughForfeitedOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughForfeitedOptions_1649" xlink:to="lab_imc_IncreaseDecreaseThroughForfeitedOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughForfeitedOptions_1650" xlink:to="lab_imc_IncreaseDecreaseThroughForfeitedOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_1651" xlink:to="lab_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_1652" xlink:to="lab_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_1653" xlink:to="lab_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_1654" xlink:to="lab_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_1655" xlink:to="lab_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_1656" xlink:to="lab_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_1657" xlink:to="lab_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_1658" xlink:to="lab_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_1659" xlink:to="lab_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_1660" xlink:to="lab_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_1661" xlink:to="lab_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_1662" xlink:to="lab_imc_IncreaseDecreaseThroughShareBasedPaymentTransactionsOfSubsidiary_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1663" xlink:to="lab_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1664" xlink:to="lab_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1665" xlink:to="lab_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_1666" xlink:to="lab_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_1667" xlink:to="lab_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_1668" xlink:to="lab_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_1669" xlink:to="lab_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_1670" xlink:to="lab_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_1671" xlink:to="lab_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_1672" xlink:to="lab_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialCapitalExpenditures_1673" xlink:to="lab_imc_InitialCapitalExpenditures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialCapitalExpenditures_1674" xlink:to="lab_imc_InitialCapitalExpenditures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialCapitalExpenditures_1675" xlink:to="lab_imc_InitialCapitalExpenditures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialConsolidationsRightOfUseAssets_1676" xlink:to="lab_imc_InitialConsolidationsRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialConsolidationsRightOfUseAssets_1677" xlink:to="lab_imc_InitialConsolidationsRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialConsolidationsRightOfUseAssets_1678" xlink:to="lab_imc_InitialConsolidationsRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialTermOfAgreement_1679" xlink:to="lab_imc_InitialTermOfAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialTermOfAgreement_1680" xlink:to="lab_imc_InitialTermOfAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InitialTermOfAgreement_1681" xlink:to="lab_imc_InitialTermOfAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IntangibleAssetsMember_1682" xlink:to="lab_imc_IntangibleAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IntangibleAssetsMember_1683" xlink:to="lab_imc_IntangibleAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IntangibleAssetsMember_1684" xlink:to="lab_imc_IntangibleAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterestIncomeOnPlanAssets_1685" xlink:to="lab_imc_InterestIncomeOnPlanAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterestIncomeOnPlanAssets_1686" xlink:to="lab_imc_InterestIncomeOnPlanAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterestIncomeOnPlanAssets_1687" xlink:to="lab_imc_InterestIncomeOnPlanAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterestIncomeOnPlanAssets_1688" xlink:to="lab_imc_InterestIncomeOnPlanAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterestPaidInRespectOfLoans_1689" xlink:to="lab_imc_InterestPaidInRespectOfLoans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterestPaidInRespectOfLoans_1690" xlink:to="lab_imc_InterestPaidInRespectOfLoans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterestPaidInRespectOfLoans_1691" xlink:to="lab_imc_InterestPaidInRespectOfLoans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterSegmentRevenues_1692" xlink:to="lab_imc_InterSegmentRevenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterSegmentRevenues_1693" xlink:to="lab_imc_InterSegmentRevenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InterSegmentRevenues_1694" xlink:to="lab_imc_InterSegmentRevenues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InventoriesLineItems_1695" xlink:to="lab_imc_InventoriesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InventoriesLineItems_1696" xlink:to="lab_imc_InventoriesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InventoriesTable_1697" xlink:to="lab_imc_InventoriesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InventoriesTable_1698" xlink:to="lab_imc_InventoriesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1699" xlink:to="lab_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1700" xlink:to="lab_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1701" xlink:to="lab_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_1702" xlink:to="lab_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate_1703" xlink:to="lab_imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate_1704" xlink:to="lab_imc_InvestmentsAndFinancialInstrumentsAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentsAsOfAcquisitionDate_1705" xlink:to="lab_imc_InvestmentsAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentsAsOfAcquisitionDate_1706" xlink:to="lab_imc_InvestmentsAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentsAsOfAcquisitionDate_1707" xlink:to="lab_imc_InvestmentsAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_1708" xlink:to="lab_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_1709" xlink:to="lab_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_1710" xlink:to="lab_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_1711" xlink:to="lab_imc_IPointMPointCFarmsIsraelLtdPointMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_1712" xlink:to="lab_imc_IPointMPointCFarmsIsraelLtdPointMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_1713" xlink:to="lab_imc_IPointMPointCFarmsIsraelLtdPointMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_1714" xlink:to="lab_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_1715" xlink:to="lab_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_1716" xlink:to="lab_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCPointHoldingsLtdMember_1717" xlink:to="lab_imc_IPointMPointCPointHoldingsLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCPointHoldingsLtdMember_1718" xlink:to="lab_imc_IPointMPointCPointHoldingsLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCPointHoldingsLtdMember_1719" xlink:to="lab_imc_IPointMPointCPointHoldingsLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCVenturesLtdPointMember_1720" xlink:to="lab_imc_IPointMPointCVenturesLtdPointMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCVenturesLtdPointMember_1721" xlink:to="lab_imc_IPointMPointCVenturesLtdPointMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IPointMPointCVenturesLtdPointMember_1722" xlink:to="lab_imc_IPointMPointCVenturesLtdPointMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IsraelAndGermanyAndCanadaMember_1723" xlink:to="lab_imc_IsraelAndGermanyAndCanadaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IsraelAndGermanyAndCanadaMember_1724" xlink:to="lab_imc_IsraelAndGermanyAndCanadaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IsraelAndGermanyAndCanadaMember_1725" xlink:to="lab_imc_IsraelAndGermanyAndCanadaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IsraelMember_1726" xlink:to="lab_imc_IsraelMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IsraelMember_1727" xlink:to="lab_imc_IsraelMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfCommonShares_1728" xlink:to="lab_imc_IssuanceOfCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfCommonShares_1729" xlink:to="lab_imc_IssuanceOfCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfCommonShares_1730" xlink:to="lab_imc_IssuanceOfCommonShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfCommonSharesAmount_1731" xlink:to="lab_imc_IssuanceOfCommonSharesAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfCommonSharesAmount_1732" xlink:to="lab_imc_IssuanceOfCommonSharesAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfCommonSharesAmount_1733" xlink:to="lab_imc_IssuanceOfCommonSharesAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfEquityOnReverseAcquisition_1734" xlink:to="lab_imc_IssuanceOfEquityOnReverseAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfEquityOnReverseAcquisition_1735" xlink:to="lab_imc_IssuanceOfEquityOnReverseAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfEquityOnReverseAcquisition_1736" xlink:to="lab_imc_IssuanceOfEquityOnReverseAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_1737" xlink:to="lab_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_1738" xlink:to="lab_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_1739" xlink:to="lab_imc_IssuanceOfSharesInConnectionWithReverseAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfSharesWithPrivatePlacement_1740" xlink:to="lab_imc_IssuanceOfSharesWithPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfSharesWithPrivatePlacement_1741" xlink:to="lab_imc_IssuanceOfSharesWithPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfSharesWithPrivatePlacement_1742" xlink:to="lab_imc_IssuanceOfSharesWithPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuanceOfSharesWithPrivatePlacement_1743" xlink:to="lab_imc_IssuanceOfSharesWithPrivatePlacement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssueOfEquity1_1744" xlink:to="lab_imc_IssueOfEquity1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssueOfEquity1_1745" xlink:to="lab_imc_IssueOfEquity1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssueOfEquity1_1746" xlink:to="lab_imc_IssueOfEquity1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssueOfEquity2_1747" xlink:to="lab_imc_IssueOfEquity2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssueOfEquity2_1748" xlink:to="lab_imc_IssueOfEquity2_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssueOfEquity2_1749" xlink:to="lab_imc_IssueOfEquity2_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuePricePerSubscriptionReceipt_1750" xlink:to="lab_imc_IssuePricePerSubscriptionReceipt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuePricePerSubscriptionReceipt_1751" xlink:to="lab_imc_IssuePricePerSubscriptionReceipt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_IssuePricePerSubscriptionReceipt_1752" xlink:to="lab_imc_IssuePricePerSubscriptionReceipt_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1753" xlink:to="lab_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1754" xlink:to="lab_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1755" xlink:to="lab_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LeaseLiabilityAsOfAcquisitionDate_1756" xlink:to="lab_imc_LeaseLiabilityAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LeaseLiabilityAsOfAcquisitionDate_1757" xlink:to="lab_imc_LeaseLiabilityAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LeaseLiabilityAsOfAcquisitionDate_1758" xlink:to="lab_imc_LeaseLiabilityAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LeaseLiabilityAsOfAcquisitionDate_1759" xlink:to="lab_imc_LeaseLiabilityAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LicensesWithIndefiniteLifeMember_1760" xlink:to="lab_imc_LicensesWithIndefiniteLifeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LicensesWithIndefiniteLifeMember_1761" xlink:to="lab_imc_LicensesWithIndefiniteLifeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LicensesWithIndefiniteLifeMember_1762" xlink:to="lab_imc_LicensesWithIndefiniteLifeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LicensesWithIndefiniteLifeMember_1763" xlink:to="lab_imc_LicensesWithIndefiniteLifeMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListedWarrantsMember_1764" xlink:to="lab_imc_ListedWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListedWarrantsMember_1765" xlink:to="lab_imc_ListedWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingBeforeCost_1766" xlink:to="lab_imc_ListingBeforeCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingBeforeCost_1767" xlink:to="lab_imc_ListingBeforeCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingBeforeCost_1768" xlink:to="lab_imc_ListingBeforeCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingCostOfReverseAcquisition_1769" xlink:to="lab_imc_ListingCostOfReverseAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingCostOfReverseAcquisition_1770" xlink:to="lab_imc_ListingCostOfReverseAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingCostOfReverseAcquisition_1771" xlink:to="lab_imc_ListingCostOfReverseAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingExpenseInReverseTakeover_1772" xlink:to="lab_imc_ListingExpenseInReverseTakeover_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingExpenseInReverseTakeover_1773" xlink:to="lab_imc_ListingExpenseInReverseTakeover_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ListingExpenseInReverseTakeover_1774" xlink:to="lab_imc_ListingExpenseInReverseTakeover_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_1775" xlink:to="lab_imc_LoanReceivableRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_1776" xlink:to="lab_imc_LoanReceivableRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_1777" xlink:to="lab_imc_LoanReceivableRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LoansPayableAsOfAcquisitionDate_1778" xlink:to="lab_imc_LoansPayableAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LoansPayableAsOfAcquisitionDate_1779" xlink:to="lab_imc_LoansPayableAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LoansPayableAsOfAcquisitionDate_1780" xlink:to="lab_imc_LoansPayableAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_1781" xlink:to="lab_imc_LongTermBorrowingsAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_1782" xlink:to="lab_imc_LongTermBorrowingsAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_1783" xlink:to="lab_imc_LongTermBorrowingsAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_1784" xlink:to="lab_imc_LongTermBorrowingsAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_1785" xlink:to="lab_imc_MajorComponentsOfIncomeTaxExpenseLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_1786" xlink:to="lab_imc_MajorComponentsOfIncomeTaxExpenseLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1787" xlink:to="lab_imc_MajorComponentsOfIncomeTaxExpenseTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1788" xlink:to="lab_imc_MajorComponentsOfIncomeTaxExpenseTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MarketPriceOfCommonShares_1789" xlink:to="lab_imc_MarketPriceOfCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MarketPriceOfCommonShares_1790" xlink:to="lab_imc_MarketPriceOfCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MarketPriceOfCommonShares_1791" xlink:to="lab_imc_MarketPriceOfCommonShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MedipharmLabsCorpMember_1792" xlink:to="lab_imc_MedipharmLabsCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MedipharmLabsCorpMember_1793" xlink:to="lab_imc_MedipharmLabsCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MedipharmLabsCorpMember_1794" xlink:to="lab_imc_MedipharmLabsCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MizrahiMember_1795" xlink:to="lab_imc_MizrahiMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MizrahiMember_1796" xlink:to="lab_imc_MizrahiMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymInternationalBrandsIncMember_1797" xlink:to="lab_imc_MymInternationalBrandsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymInternationalBrandsIncMember_1798" xlink:to="lab_imc_MymInternationalBrandsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymInternationalBrandsIncMember_1799" xlink:to="lab_imc_MymInternationalBrandsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymNutraceuticalsIncMember_1800" xlink:to="lab_imc_MymNutraceuticalsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymNutraceuticalsIncMember_1801" xlink:to="lab_imc_MymNutraceuticalsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymNutraceuticalsIncMember_1802" xlink:to="lab_imc_MymNutraceuticalsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymNutraceuticalsIncMember_1803" xlink:to="lab_imc_MymNutraceuticalsIncMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymNutraceuticalsMember_1804" xlink:to="lab_imc_MymNutraceuticalsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymNutraceuticalsMember_1805" xlink:to="lab_imc_MymNutraceuticalsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_MymNutraceuticalsMember_1806" xlink:to="lab_imc_MymNutraceuticalsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NavasotaFincoMember_1807" xlink:to="lab_imc_NavasotaFincoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NavasotaFincoMember_1808" xlink:to="lab_imc_NavasotaFincoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NavasotaMember_1809" xlink:to="lab_imc_NavasotaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NavasotaMember_1810" xlink:to="lab_imc_NavasotaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NavasotaMember_1811" xlink:to="lab_imc_NavasotaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NavasotaShareholdersMember_1812" xlink:to="lab_imc_NavasotaShareholdersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NavasotaShareholdersMember_1813" xlink:to="lab_imc_NavasotaShareholdersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NavasotaShareholdersMember_1814" xlink:to="lab_imc_NavasotaShareholdersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetCashTransferred_1815" xlink:to="lab_imc_NetCashTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetCashTransferred_1816" xlink:to="lab_imc_NetCashTransferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetCashTransferred_1817" xlink:to="lab_imc_NetCashTransferred_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetCashTransferred_1818" xlink:to="lab_imc_NetCashTransferred_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_1819" xlink:to="lab_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_1820" xlink:to="lab_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_1821" xlink:to="lab_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetLiabilitiesOnDateOfReverseAcquisition_1822" xlink:to="lab_imc_NetLiabilitiesOnDateOfReverseAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetLiabilitiesOnDateOfReverseAcquisition_1823" xlink:to="lab_imc_NetLiabilitiesOnDateOfReverseAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NetLiabilitiesOnDateOfReverseAcquisition_1824" xlink:to="lab_imc_NetLiabilitiesOnDateOfReverseAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1825" xlink:to="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1826" xlink:to="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1827" xlink:to="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1828" xlink:to="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_1829" xlink:to="lab_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1830" xlink:to="lab_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1831" xlink:to="lab_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1832" xlink:to="lab_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_1833" xlink:to="lab_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesCalledByWarrants_1834" xlink:to="lab_imc_NumberOfCommonSharesCalledByWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesCalledByWarrants_1835" xlink:to="lab_imc_NumberOfCommonSharesCalledByWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesCalledByWarrants_1836" xlink:to="lab_imc_NumberOfCommonSharesCalledByWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_1837" xlink:to="lab_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_1838" xlink:to="lab_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_1839" xlink:to="lab_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_1840" xlink:to="lab_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_1841" xlink:to="lab_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_1842" xlink:to="lab_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_1843" xlink:to="lab_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_1844" xlink:to="lab_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_1845" xlink:to="lab_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesReceived_1846" xlink:to="lab_imc_NumberOfCommonSharesReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesReceived_1847" xlink:to="lab_imc_NumberOfCommonSharesReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesReceived_1848" xlink:to="lab_imc_NumberOfCommonSharesReceived_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_1849" xlink:to="lab_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_1850" xlink:to="lab_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_1851" xlink:to="lab_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_1852" xlink:to="lab_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_1853" xlink:to="lab_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_1854" xlink:to="lab_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationUnitsIssued_1855" xlink:to="lab_imc_NumberOfCompensationUnitsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationUnitsIssued_1856" xlink:to="lab_imc_NumberOfCompensationUnitsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationUnitsIssued_1857" xlink:to="lab_imc_NumberOfCompensationUnitsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_1858" xlink:to="lab_imc_NumberOfCompensationWarrantsGrantedToAgents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_1859" xlink:to="lab_imc_NumberOfCompensationWarrantsGrantedToAgents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_1860" xlink:to="lab_imc_NumberOfCompensationWarrantsGrantedToAgents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationWarrantsToAcquired_1861" xlink:to="lab_imc_NumberOfCompensationWarrantsToAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationWarrantsToAcquired_1862" xlink:to="lab_imc_NumberOfCompensationWarrantsToAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfCompensationWarrantsToAcquired_1863" xlink:to="lab_imc_NumberOfCompensationWarrantsToAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOptionsExercisedUnderCashlessMechanism_1864" xlink:to="lab_imc_NumberOfOptionsExercisedUnderCashlessMechanism_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOptionsExercisedUnderCashlessMechanism_1865" xlink:to="lab_imc_NumberOfOptionsExercisedUnderCashlessMechanism_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOptionsExercisedUnderCashlessMechanism_1866" xlink:to="lab_imc_NumberOfOptionsExercisedUnderCashlessMechanism_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOptionsGranted_1867" xlink:to="lab_imc_NumberOfOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOptionsGranted_1868" xlink:to="lab_imc_NumberOfOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOptionsGranted_1869" xlink:to="lab_imc_NumberOfOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOrdinarySharesIssuedUponConversion_1870" xlink:to="lab_imc_NumberOfOrdinarySharesIssuedUponConversion_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOrdinarySharesIssuedUponConversion_1871" xlink:to="lab_imc_NumberOfOrdinarySharesIssuedUponConversion_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfOrdinarySharesIssuedUponConversion_1872" xlink:to="lab_imc_NumberOfOrdinarySharesIssuedUponConversion_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_1873" xlink:to="lab_imc_NumberOfPreferredSharesCommittedToBeAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_1874" xlink:to="lab_imc_NumberOfPreferredSharesCommittedToBeAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_1875" xlink:to="lab_imc_NumberOfPreferredSharesCommittedToBeAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfShareOptionsShareVestedRsu_1876" xlink:to="lab_imc_NumberOfShareOptionsShareVestedRsu_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfShareOptionsShareVestedRsu_1877" xlink:to="lab_imc_NumberOfShareOptionsShareVestedRsu_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfShareOptionsShareVestedRsu_1878" xlink:to="lab_imc_NumberOfShareOptionsShareVestedRsu_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesAvailableForFutureGrants_1879" xlink:to="lab_imc_NumberOfSharesAvailableForFutureGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesAvailableForFutureGrants_1880" xlink:to="lab_imc_NumberOfSharesAvailableForFutureGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesAvailableForFutureGrants_1881" xlink:to="lab_imc_NumberOfSharesAvailableForFutureGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1882" xlink:to="lab_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1883" xlink:to="lab_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1884" xlink:to="lab_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_1885" xlink:to="lab_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesIssuedInReverseTakeover_1886" xlink:to="lab_imc_NumberOfSharesIssuedInReverseTakeover_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesIssuedInReverseTakeover_1887" xlink:to="lab_imc_NumberOfSharesIssuedInReverseTakeover_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesIssuedInReverseTakeover_1888" xlink:to="lab_imc_NumberOfSharesIssuedInReverseTakeover_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesIssuedInReverseTakeover_1889" xlink:to="lab_imc_NumberOfSharesIssuedInReverseTakeover_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesRaisedInUSD_1890" xlink:to="lab_imc_NumberOfSharesRaisedInUSD_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesRaisedInUSD_1891" xlink:to="lab_imc_NumberOfSharesRaisedInUSD_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSharesRaisedInUSD_1892" xlink:to="lab_imc_NumberOfSharesRaisedInUSD_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_1893" xlink:to="lab_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_1894" xlink:to="lab_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_1895" xlink:to="lab_imc_NumberOfSubscriptionReceiptsIssuedInPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfUnitsIssued_1896" xlink:to="lab_imc_NumberOfUnitsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfUnitsIssued_1897" xlink:to="lab_imc_NumberOfUnitsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfUnitsIssued_1898" xlink:to="lab_imc_NumberOfUnitsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfUnitsIssuedPricePerShare_1899" xlink:to="lab_imc_NumberOfUnitsIssuedPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfUnitsIssuedPricePerShare_1900" xlink:to="lab_imc_NumberOfUnitsIssuedPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfUnitsIssuedPricePerShare_1901" xlink:to="lab_imc_NumberOfUnitsIssuedPricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantExercised_1902" xlink:to="lab_imc_NumberOfWarrantExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantExercised_1903" xlink:to="lab_imc_NumberOfWarrantExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantExercised_1904" xlink:to="lab_imc_NumberOfWarrantExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_1905" xlink:to="lab_imc_NumberOfWarrantsAndCompensationOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_1906" xlink:to="lab_imc_NumberOfWarrantsAndCompensationOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_1907" xlink:to="lab_imc_NumberOfWarrantsAndCompensationOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_1908" xlink:to="lab_imc_NumberOfWarrantsConvertedToOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_1909" xlink:to="lab_imc_NumberOfWarrantsConvertedToOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_1910" xlink:to="lab_imc_NumberOfWarrantsConvertedToOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedInReverseTakeover_1911" xlink:to="lab_imc_NumberOfWarrantsIssuedInReverseTakeover_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedInReverseTakeover_1912" xlink:to="lab_imc_NumberOfWarrantsIssuedInReverseTakeover_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedInReverseTakeover_1913" xlink:to="lab_imc_NumberOfWarrantsIssuedInReverseTakeover_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedUponConversion_1914" xlink:to="lab_imc_NumberOfWarrantsIssuedUponConversion_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedUponConversion_1915" xlink:to="lab_imc_NumberOfWarrantsIssuedUponConversion_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedUponConversion_1916" xlink:to="lab_imc_NumberOfWarrantsIssuedUponConversion_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_1917" xlink:to="lab_imc_NumberOfWarrantsIssuedUponConversionOfUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_1918" xlink:to="lab_imc_NumberOfWarrantsIssuedUponConversionOfUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_1919" xlink:to="lab_imc_NumberOfWarrantsIssuedUponConversionOfUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OranimPharmacyMember_1920" xlink:to="lab_imc_OranimPharmacyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OranimPharmacyMember_1921" xlink:to="lab_imc_OranimPharmacyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OranimPharmacyMember_1922" xlink:to="lab_imc_OranimPharmacyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OranimPharmMember_1923" xlink:to="lab_imc_OranimPharmMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OranimPharmMember_1924" xlink:to="lab_imc_OranimPharmMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OranimPlusPharmLtdMember_1925" xlink:to="lab_imc_OranimPlusPharmLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OranimPlusPharmLtdMember_1926" xlink:to="lab_imc_OranimPlusPharmLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OranimPlusPharmLtdMember_1927" xlink:to="lab_imc_OranimPlusPharmLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharedListedInStockExchangeMarket_1928" xlink:to="lab_imc_OrdinarySharedListedInStockExchangeMarket_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharedListedInStockExchangeMarket_1929" xlink:to="lab_imc_OrdinarySharedListedInStockExchangeMarket_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharedListedInStockExchangeMarket_1930" xlink:to="lab_imc_OrdinarySharedListedInStockExchangeMarket_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_1931" xlink:to="lab_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_1932" xlink:to="lab_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_1933" xlink:to="lab_imc_OrdinarySharesIssuedForEachShareAndEachConvertibleInstrumentHeld_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1934" xlink:to="lab_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1935" xlink:to="lab_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1936" xlink:to="lab_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_1937" xlink:to="lab_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedOptionsExercises_1938" xlink:to="lab_imc_OrdinarySharesIssuedOptionsExercises_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedOptionsExercises_1939" xlink:to="lab_imc_OrdinarySharesIssuedOptionsExercises_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedOptionsExercises_1940" xlink:to="lab_imc_OrdinarySharesIssuedOptionsExercises_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedOptionsExercises_1941" xlink:to="lab_imc_OrdinarySharesIssuedOptionsExercises_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_1942" xlink:to="lab_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_1943" xlink:to="lab_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_1944" xlink:to="lab_imc_OrdinarySharesIssuedToShareholdersForEachCommonShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesReservedForIssuance_1945" xlink:to="lab_imc_OrdinarySharesReservedForIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesReservedForIssuance_1946" xlink:to="lab_imc_OrdinarySharesReservedForIssuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OrdinarySharesReservedForIssuance_1947" xlink:to="lab_imc_OrdinarySharesReservedForIssuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCannabisMember_1948" xlink:to="lab_imc_OtherCannabisMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCannabisMember_1949" xlink:to="lab_imc_OtherCannabisMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCannabisMember_1950" xlink:to="lab_imc_OtherCannabisMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCannabisProductsMember_1951" xlink:to="lab_imc_OtherCannabisProductsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCannabisProductsMember_1952" xlink:to="lab_imc_OtherCannabisProductsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCannabisProductsMember_1953" xlink:to="lab_imc_OtherCannabisProductsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1954" xlink:to="lab_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1955" xlink:to="lab_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_1956" xlink:to="lab_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_1957" xlink:to="lab_imc_OtherCurrentPayablesToGovernmentAuthorities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_1958" xlink:to="lab_imc_OtherCurrentPayablesToGovernmentAuthorities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_1959" xlink:to="lab_imc_OtherCurrentPayablesToGovernmentAuthorities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherDeferredTaxAssestsMember_1960" xlink:to="lab_imc_OtherDeferredTaxAssestsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherDeferredTaxAssestsMember_1961" xlink:to="lab_imc_OtherDeferredTaxAssestsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherDeferredTaxAssestsMember_1962" xlink:to="lab_imc_OtherDeferredTaxAssestsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherMiscellaneousCurrentPayables_1963" xlink:to="lab_imc_OtherMiscellaneousCurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherMiscellaneousCurrentPayables_1964" xlink:to="lab_imc_OtherMiscellaneousCurrentPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherMiscellaneousCurrentPayables_1965" xlink:to="lab_imc_OtherMiscellaneousCurrentPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherOperatingSegmentsMember_1966" xlink:to="lab_imc_OtherOperatingSegmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherOperatingSegmentsMember_1967" xlink:to="lab_imc_OtherOperatingSegmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherOperatingSegmentsMember_1968" xlink:to="lab_imc_OtherOperatingSegmentsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1969" xlink:to="lab_imc_OtherPayablesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1970" xlink:to="lab_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1971" xlink:to="lab_imc_OtherPayablesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OtherPayablesRecognisedAsOfAcquisitionDate_1972" xlink:to="lab_imc_OtherPayablesRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OvernightMarketedOfferingMember_1973" xlink:to="lab_imc_OvernightMarketedOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_OvernightMarketedOfferingMember_1974" xlink:to="lab_imc_OvernightMarketedOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PackagedDriedCannabisMember_1975" xlink:to="lab_imc_PackagedDriedCannabisMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PackagedDriedCannabisMember_1976" xlink:to="lab_imc_PackagedDriedCannabisMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PackagedDriedCannabisMember_1977" xlink:to="lab_imc_PackagedDriedCannabisMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PanaxiaLogisticsLtdMember_1978" xlink:to="lab_imc_PanaxiaLogisticsLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PanaxiaLogisticsLtdMember_1979" xlink:to="lab_imc_PanaxiaLogisticsLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PanaxiaLogisticsLtdMember_1980" xlink:to="lab_imc_PanaxiaLogisticsLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PanaxiaLogisticsLtdMember_1981" xlink:to="lab_imc_PanaxiaLogisticsLtdMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PaymentsToShareholdersRelatedPartyTransactions_1982" xlink:to="lab_imc_PaymentsToShareholdersRelatedPartyTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PaymentsToShareholdersRelatedPartyTransactions_1983" xlink:to="lab_imc_PaymentsToShareholdersRelatedPartyTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PaymentsToShareholdersRelatedPartyTransactions_1984" xlink:to="lab_imc_PaymentsToShareholdersRelatedPartyTransactions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAcquisition_1985" xlink:to="lab_imc_PercentageOfAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAcquisition_1986" xlink:to="lab_imc_PercentageOfAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAcquisition_1987" xlink:to="lab_imc_PercentageOfAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_1988" xlink:to="lab_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_1989" xlink:to="lab_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_1990" xlink:to="lab_imc_PercentageOfAcquisitionOfOutstandingOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAwardsVest_1991" xlink:to="lab_imc_PercentageOfAwardsVest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAwardsVest_1992" xlink:to="lab_imc_PercentageOfAwardsVest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfAwardsVest_1993" xlink:to="lab_imc_PercentageOfAwardsVest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_1994" xlink:to="lab_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_1995" xlink:to="lab_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_1996" xlink:to="lab_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOptionsExercised_1997" xlink:to="lab_imc_PercentageOfOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOptionsExercised_1998" xlink:to="lab_imc_PercentageOfOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOptionsExercised_1999" xlink:to="lab_imc_PercentageOfOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOrdinarySharesHeld_2000" xlink:to="lab_imc_PercentageOfOrdinarySharesHeld_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOrdinarySharesHeld_2001" xlink:to="lab_imc_PercentageOfOrdinarySharesHeld_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_2002" xlink:to="lab_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_2003" xlink:to="lab_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_2004" xlink:to="lab_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOutstandingSharesAcquired_2005" xlink:to="lab_imc_PercentageOfOutstandingSharesAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOutstandingSharesAcquired_2006" xlink:to="lab_imc_PercentageOfOutstandingSharesAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOutstandingSharesAcquired_2007" xlink:to="lab_imc_PercentageOfOutstandingSharesAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOwnershipInterest_2008" xlink:to="lab_imc_PercentageOfOwnershipInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOwnershipInterest_2009" xlink:to="lab_imc_PercentageOfOwnershipInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfOwnershipInterest_2010" xlink:to="lab_imc_PercentageOfOwnershipInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesGranted_2011" xlink:to="lab_imc_PercentageOfRestrictedSharesGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesGranted_2012" xlink:to="lab_imc_PercentageOfRestrictedSharesGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesGranted_2013" xlink:to="lab_imc_PercentageOfRestrictedSharesGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_2014" xlink:to="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_2015" xlink:to="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_2016" xlink:to="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoOne_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_2017" xlink:to="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_2018" xlink:to="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_2019" xlink:to="lab_imc_PercentageOfRestrictedSharesVestOnMarchOneTwoZeroTwoZero_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRightsHold_2020" xlink:to="lab_imc_PercentageOfRightsHold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRightsHold_2021" xlink:to="lab_imc_PercentageOfRightsHold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfRightsHold_2022" xlink:to="lab_imc_PercentageOfRightsHold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfSharesGranted_2023" xlink:to="lab_imc_PercentageOfSharesGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfSharesGranted_2024" xlink:to="lab_imc_PercentageOfSharesGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfSharesGranted_2025" xlink:to="lab_imc_PercentageOfSharesGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_2026" xlink:to="lab_imc_PercentageOfWarrantsAndCompensationOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_2027" xlink:to="lab_imc_PercentageOfWarrantsAndCompensationOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_2028" xlink:to="lab_imc_PercentageOfWarrantsAndCompensationOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWarrantsExercised_2029" xlink:to="lab_imc_PercentageOfWarrantsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWarrantsExercised_2030" xlink:to="lab_imc_PercentageOfWarrantsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWarrantsExercised_2031" xlink:to="lab_imc_PercentageOfWarrantsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWithholdingTaxLiabilities_2032" xlink:to="lab_imc_PercentageOfWithholdingTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWithholdingTaxLiabilities_2033" xlink:to="lab_imc_PercentageOfWithholdingTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWithholdingTaxLiabilities_2034" xlink:to="lab_imc_PercentageOfWithholdingTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_2035" xlink:to="lab_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_2036" xlink:to="lab_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_2037" xlink:to="lab_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageRightToPurchaseOfTotalProduction_2038" xlink:to="lab_imc_PercentageRightToPurchaseOfTotalProduction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageRightToPurchaseOfTotalProduction_2039" xlink:to="lab_imc_PercentageRightToPurchaseOfTotalProduction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentageRightToPurchaseOfTotalProduction_2040" xlink:to="lab_imc_PercentageRightToPurchaseOfTotalProduction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentagesOfWarrantQuantityHeld_2041" xlink:to="lab_imc_PercentagesOfWarrantQuantityHeld_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentagesOfWarrantQuantityHeld_2042" xlink:to="lab_imc_PercentagesOfWarrantQuantityHeld_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PercentagesOfWarrantQuantityHeld_2043" xlink:to="lab_imc_PercentagesOfWarrantQuantityHeld_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PeriodicPaymentInstallmentAxis_2044" xlink:to="lab_imc_PeriodicPaymentInstallmentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PeriodicPaymentInstallmentAxis_2045" xlink:to="lab_imc_PeriodicPaymentInstallmentAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PeriodicPaymentInstallmentDomain_2046" xlink:to="lab_imc_PeriodicPaymentInstallmentDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PeriodicPaymentInstallmentDomain_2047" xlink:to="lab_imc_PeriodicPaymentInstallmentDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PharmYarokPharmacyMember_2048" xlink:to="lab_imc_PharmYarokPharmacyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PharmYarokPharmacyMember_2049" xlink:to="lab_imc_PharmYarokPharmacyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PharmYarokPharmacyMember_2050" xlink:to="lab_imc_PharmYarokPharmacyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PlanAssetsAmountsDeposited_2051" xlink:to="lab_imc_PlanAssetsAmountsDeposited_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PlanAssetsAmountsDeposited_2052" xlink:to="lab_imc_PlanAssetsAmountsDeposited_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PlanAssetsAmountsDeposited_2053" xlink:to="lab_imc_PlanAssetsAmountsDeposited_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PlanAssetsForeignCurrencyTranslationEffect_2054" xlink:to="lab_imc_PlanAssetsForeignCurrencyTranslationEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PlanAssetsForeignCurrencyTranslationEffect_2055" xlink:to="lab_imc_PlanAssetsForeignCurrencyTranslationEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PlanAssetsForeignCurrencyTranslationEffect_2056" xlink:to="lab_imc_PlanAssetsForeignCurrencyTranslationEffect_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PreliminaryShelfProspectusMember_2057" xlink:to="lab_imc_PreliminaryShelfProspectusMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PreliminaryShelfProspectusMember_2058" xlink:to="lab_imc_PreliminaryShelfProspectusMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PreliminaryShelfProspectusMember_2059" xlink:to="lab_imc_PreliminaryShelfProspectusMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PreTaxDiscountRateOfCashFlows_2060" xlink:to="lab_imc_PreTaxDiscountRateOfCashFlows_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PreTaxDiscountRateOfCashFlows_2061" xlink:to="lab_imc_PreTaxDiscountRateOfCashFlows_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PreTaxDiscountRateOfCashFlows_2062" xlink:to="lab_imc_PreTaxDiscountRateOfCashFlows_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PrivatePlacementsMember_2063" xlink:to="lab_imc_PrivatePlacementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PrivatePlacementsMember_2064" xlink:to="lab_imc_PrivatePlacementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PrivatePlacementsMember_2065" xlink:to="lab_imc_PrivatePlacementsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_2066" xlink:to="lab_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_2067" xlink:to="lab_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_2068" xlink:to="lab_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_2069" xlink:to="lab_imc_ProceedsFromInvestmentInRestrictedDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_2070" xlink:to="lab_imc_ProceedsFromInvestmentInRestrictedDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_2071" xlink:to="lab_imc_ProceedsFromInvestmentInRestrictedDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_2072" xlink:to="lab_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_2073" xlink:to="lab_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_2074" xlink:to="lab_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromSaleOfInvestment_2075" xlink:to="lab_imc_ProceedsFromSaleOfInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromSaleOfInvestment_2076" xlink:to="lab_imc_ProceedsFromSaleOfInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromSaleOfInvestment_2077" xlink:to="lab_imc_ProceedsFromSaleOfInvestment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_2078" xlink:to="lab_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_2079" xlink:to="lab_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_2080" xlink:to="lab_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProductionCostsCapitalizedBiologicalAssets_2081" xlink:to="lab_imc_ProductionCostsCapitalizedBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProductionCostsCapitalizedBiologicalAssets_2082" xlink:to="lab_imc_ProductionCostsCapitalizedBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProductionCostsCapitalizedBiologicalAssets_2083" xlink:to="lab_imc_ProductionCostsCapitalizedBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_2084" xlink:to="lab_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_2085" xlink:to="lab_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_2086" xlink:to="lab_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProFormaAdjustmentsMember_2087" xlink:to="lab_imc_ProFormaAdjustmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ProFormaAdjustmentsMember_2088" xlink:to="lab_imc_ProFormaAdjustmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PropertyPlantAndEquipmentAndIntangibleAssetsAbstract_2089" xlink:to="lab_imc_PropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_2090" xlink:to="lab_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_2091" xlink:to="lab_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_2092" xlink:to="lab_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PropertyPlantAndEquipmentUsingShares_2093" xlink:to="lab_imc_PropertyPlantAndEquipmentUsingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PropertyPlantAndEquipmentUsingShares_2094" xlink:to="lab_imc_PropertyPlantAndEquipmentUsingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PropertyPlantAndEquipmentUsingShares_2095" xlink:to="lab_imc_PropertyPlantAndEquipmentUsingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseConsiderationPayable_2096" xlink:to="lab_imc_PurchaseConsiderationPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseConsiderationPayable_2097" xlink:to="lab_imc_PurchaseConsiderationPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseConsiderationPayable_2098" xlink:to="lab_imc_PurchaseConsiderationPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseOfInterestsInSubsidiary_2099" xlink:to="lab_imc_PurchaseOfInterestsInSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseOfInterestsInSubsidiary_2100" xlink:to="lab_imc_PurchaseOfInterestsInSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseOfInterestsInSubsidiary_2101" xlink:to="lab_imc_PurchaseOfInterestsInSubsidiary_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseOfTreasuryCommonShares_2102" xlink:to="lab_imc_PurchaseOfTreasuryCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseOfTreasuryCommonShares_2103" xlink:to="lab_imc_PurchaseOfTreasuryCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchaseOfTreasuryCommonShares_2104" xlink:to="lab_imc_PurchaseOfTreasuryCommonShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_2105" xlink:to="lab_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_2106" xlink:to="lab_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_2107" xlink:to="lab_imc_PurchasePriceOfBusinessAcquisitionInCommonShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RayarokPharmLtdMember_2108" xlink:to="lab_imc_RayarokPharmLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RayarokPharmLtdMember_2109" xlink:to="lab_imc_RayarokPharmLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RayarokPharmLtdMember_2110" xlink:to="lab_imc_RayarokPharmLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2111" xlink:to="lab_imc_RealizedFairValueAdjustmentOnInventorySold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2112" xlink:to="lab_imc_RealizedFairValueAdjustmentOnInventorySold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2113" xlink:to="lab_imc_RealizedFairValueAdjustmentOnInventorySold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2114" xlink:to="lab_imc_RealizedFairValueAdjustmentOnInventorySold_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2115" xlink:to="lab_imc_RealizedFairValueAdjustmentOnInventorySold_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RealizedFairValueAdjustmentOnInventorySold_2116" xlink:to="lab_imc_RealizedFairValueAdjustmentOnInventorySold_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReceivablesFromGovernmentAuthorities_2117" xlink:to="lab_imc_ReceivablesFromGovernmentAuthorities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReceivablesFromGovernmentAuthorities_2118" xlink:to="lab_imc_ReceivablesFromGovernmentAuthorities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReceivablesFromGovernmentAuthorities_2119" xlink:to="lab_imc_ReceivablesFromGovernmentAuthorities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_2120" xlink:to="lab_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_2121" xlink:to="lab_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_2122" xlink:to="lab_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RemainingAmountOfCashPaid_2123" xlink:to="lab_imc_RemainingAmountOfCashPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RemainingAmountOfCashPaid_2124" xlink:to="lab_imc_RemainingAmountOfCashPaid_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RemainingAmountOfCashPaid_2125" xlink:to="lab_imc_RemainingAmountOfCashPaid_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RemainingInstallmentMember_2126" xlink:to="lab_imc_RemainingInstallmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RemainingInstallmentMember_2127" xlink:to="lab_imc_RemainingInstallmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RemainingInstallmentMember_2128" xlink:to="lab_imc_RemainingInstallmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RepaymentOfAforementionedBankLoan_2129" xlink:to="lab_imc_RepaymentOfAforementionedBankLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RepaymentOfAforementionedBankLoan_2130" xlink:to="lab_imc_RepaymentOfAforementionedBankLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RepaymentOfAforementionedBankLoan_2131" xlink:to="lab_imc_RepaymentOfAforementionedBankLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RestrictedShareUnitsMember_2132" xlink:to="lab_imc_RestrictedShareUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RestrictedShareUnitsMember_2133" xlink:to="lab_imc_RestrictedShareUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_2134" xlink:to="lab_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_2135" xlink:to="lab_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_2136" xlink:to="lab_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RevaluationOfExercisedWarrants_2137" xlink:to="lab_imc_RevaluationOfExercisedWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RevaluationOfExercisedWarrants_2138" xlink:to="lab_imc_RevaluationOfExercisedWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RevaluationOfExercisedWarrants_2139" xlink:to="lab_imc_RevaluationOfExercisedWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReverseAcquisitionAcquirerAxis_2140" xlink:to="lab_imc_ReverseAcquisitionAcquirerAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReverseAcquisitionAcquirerAxis_2141" xlink:to="lab_imc_ReverseAcquisitionAcquirerAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReverseAcquisitionAcquirerDomain_2142" xlink:to="lab_imc_ReverseAcquisitionAcquirerDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReverseAcquisitionAcquirerDomain_2143" xlink:to="lab_imc_ReverseAcquisitionAcquirerDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ReverseTakeoverAbstract_2144" xlink:to="lab_imc_ReverseTakeoverAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RevolvingCreditFacilityMember_2145" xlink:to="lab_imc_RevolvingCreditFacilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RevolvingCreditFacilityMember_2146" xlink:to="lab_imc_RevolvingCreditFacilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RevolyTradingAndMarketingLtdMember_2147" xlink:to="lab_imc_RevolyTradingAndMarketingLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RevolyTradingAndMarketingLtdMember_2148" xlink:to="lab_imc_RevolyTradingAndMarketingLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RevolyTradingAndMarketingLtdMember_2149" xlink:to="lab_imc_RevolyTradingAndMarketingLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_2150" xlink:to="lab_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_2151" xlink:to="lab_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_2152" xlink:to="lab_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_2153" xlink:to="lab_imc_RightOfUseAssetsAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_2154" xlink:to="lab_imc_RightOfUseAssetsAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_2155" xlink:to="lab_imc_RightOfUseAssetsAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RiskFreeInterestRateOfWarrants_2156" xlink:to="lab_imc_RiskFreeInterestRateOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RiskFreeInterestRateOfWarrants_2157" xlink:to="lab_imc_RiskFreeInterestRateOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RiskFreeInterestRateOfWarrants_2158" xlink:to="lab_imc_RiskFreeInterestRateOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RosenHighWayLtdMember_2159" xlink:to="lab_imc_RosenHighWayLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RosenHighWayLtdMember_2160" xlink:to="lab_imc_RosenHighWayLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_RosenHighWayLtdMember_2161" xlink:to="lab_imc_RosenHighWayLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareBasedCompensation_2162" xlink:to="lab_imc_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareBasedCompensation_2163" xlink:to="lab_imc_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareBasedCompensation_2164" xlink:to="lab_imc_ShareBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareBasedCompensation_2165" xlink:to="lab_imc_ShareBasedCompensation_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareBasedCompensations_2166" xlink:to="lab_imc_ShareBasedCompensations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareBasedCompensations_2167" xlink:to="lab_imc_ShareBasedCompensations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareBasedCompensations_2168" xlink:to="lab_imc_ShareBasedCompensations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareholdersMember_2169" xlink:to="lab_imc_ShareholdersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareholdersMember_2170" xlink:to="lab_imc_ShareholdersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareIncentivePlanMember_2171" xlink:to="lab_imc_ShareIncentivePlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareIncentivePlanMember_2172" xlink:to="lab_imc_ShareIncentivePlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareIncentivePlanMember_2173" xlink:to="lab_imc_ShareIncentivePlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SharePurchaseAgreementMember_2174" xlink:to="lab_imc_SharePurchaseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SharePurchaseAgreementMember_2175" xlink:to="lab_imc_SharePurchaseAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareSplitRatio_2176" xlink:to="lab_imc_ShareSplitRatio_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareSplitRatio_2177" xlink:to="lab_imc_ShareSplitRatio_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ShareSplitRatio_2178" xlink:to="lab_imc_ShareSplitRatio_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract_2179" xlink:to="lab_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsAbstract_2180" xlink:to="lab_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SimpleAgreementForFutureEquityMember_2181" xlink:to="lab_imc_SimpleAgreementForFutureEquityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SimpleAgreementForFutureEquityMember_2182" xlink:to="lab_imc_SimpleAgreementForFutureEquityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_StatementOfBalanceSheetLocationAxis_2183" xlink:to="lab_imc_StatementOfBalanceSheetLocationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_StatementOfBalanceSheetLocationDomain_2184" xlink:to="lab_imc_StatementOfBalanceSheetLocationDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SublimecultureIncMember_2185" xlink:to="lab_imc_SublimecultureIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SublimecultureIncMember_2186" xlink:to="lab_imc_SublimecultureIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SublimecultureIncMember_2187" xlink:to="lab_imc_SublimecultureIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SubscriptionReceiptsHoldersMember_2188" xlink:to="lab_imc_SubscriptionReceiptsHoldersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SubscriptionReceiptsHoldersMember_2189" xlink:to="lab_imc_SubscriptionReceiptsHoldersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SubscriptionReceiptsHoldersMember_2190" xlink:to="lab_imc_SubscriptionReceiptsHoldersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SubsequentEventMember_2191" xlink:to="lab_imc_SubsequentEventMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SubsequentEventMember_2192" xlink:to="lab_imc_SubsequentEventMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract_2193" xlink:to="lab_imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract_2194" xlink:to="lab_imc_SubsidiariesAssetsAndLiabilitiesAtDateOfAcquisitionAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_2195" xlink:to="lab_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_2196" xlink:to="lab_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_2197" xlink:to="lab_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SupplyAgreementMember_2198" xlink:to="lab_imc_SupplyAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SupplyAgreementMember_2199" xlink:to="lab_imc_SupplyAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_SupplyAgreementMember_2200" xlink:to="lab_imc_SupplyAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2201" xlink:to="lab_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2202" xlink:to="lab_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2203" xlink:to="lab_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_2204" xlink:to="lab_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_2205" xlink:to="lab_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_2206" xlink:to="lab_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2207" xlink:to="lab_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2208" xlink:to="lab_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2209" xlink:to="lab_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_2210" xlink:to="lab_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_2211" xlink:to="lab_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_2212" xlink:to="lab_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_2213" xlink:to="lab_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TermOfNonInterestBearingTradeReceivables_2214" xlink:to="lab_imc_TermOfNonInterestBearingTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TermOfNonInterestBearingTradeReceivables_2215" xlink:to="lab_imc_TermOfNonInterestBearingTradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TermOfNonInterestBearingTradeReceivables_2216" xlink:to="lab_imc_TermOfNonInterestBearingTradeReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TermOfWarrantsFromDateOfIssuance_2217" xlink:to="lab_imc_TermOfWarrantsFromDateOfIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TermOfWarrantsFromDateOfIssuance_2218" xlink:to="lab_imc_TermOfWarrantsFromDateOfIssuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TermOfWarrantsFromDateOfIssuance_2219" xlink:to="lab_imc_TermOfWarrantsFromDateOfIssuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TermOfWarrantsFromDateOfIssuance_2220" xlink:to="lab_imc_TermOfWarrantsFromDateOfIssuance_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ThresholdLimitOfOfferingPriceOfSecurities_2221" xlink:to="lab_imc_ThresholdLimitOfOfferingPriceOfSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ThresholdLimitOfOfferingPriceOfSecurities_2222" xlink:to="lab_imc_ThresholdLimitOfOfferingPriceOfSecurities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ThresholdLimitOfOfferingPriceOfSecurities_2223" xlink:to="lab_imc_ThresholdLimitOfOfferingPriceOfSecurities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TotalAcquisitionSubsidiary_2224" xlink:to="lab_imc_TotalAcquisitionSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TotalAcquisitionSubsidiary_2225" xlink:to="lab_imc_TotalAcquisitionSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TotalAcquisitionSubsidiary_2226" xlink:to="lab_imc_TotalAcquisitionSubsidiary_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TotalAllocatedAmountTranslationTransaction_2227" xlink:to="lab_imc_TotalAllocatedAmountTranslationTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TotalAllocatedAmountTranslationTransaction_2228" xlink:to="lab_imc_TotalAllocatedAmountTranslationTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TotalAllocatedAmountTranslationTransaction_2229" xlink:to="lab_imc_TotalAllocatedAmountTranslationTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2230" xlink:to="lab_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2231" xlink:to="lab_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2232" xlink:to="lab_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TradeReceivablesLineItems_2233" xlink:to="lab_imc_TradeReceivablesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TradeReceivablesLineItems_2234" xlink:to="lab_imc_TradeReceivablesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TradeReceivablesTable_2235" xlink:to="lab_imc_TradeReceivablesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TradeReceivablesTable_2236" xlink:to="lab_imc_TradeReceivablesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TranslationDifferencesOfDefferedTaxes_2237" xlink:to="lab_imc_TranslationDifferencesOfDefferedTaxes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TranslationDifferencesOfDefferedTaxes_2238" xlink:to="lab_imc_TranslationDifferencesOfDefferedTaxes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TranslationDifferencesOfDefferedTaxes_2239" xlink:to="lab_imc_TranslationDifferencesOfDefferedTaxes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeAssetFundingCorpMember_2240" xlink:to="lab_imc_TrichomeAssetFundingCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeAssetFundingCorpMember_2241" xlink:to="lab_imc_TrichomeAssetFundingCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeAssetFundingCorpMember_2242" xlink:to="lab_imc_TrichomeAssetFundingCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCannabisGpIncMember_2243" xlink:to="lab_imc_TrichomeFinancialCannabisGpIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCannabisGpIncMember_2244" xlink:to="lab_imc_TrichomeFinancialCannabisGpIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCannabisGpIncMember_2245" xlink:to="lab_imc_TrichomeFinancialCannabisGpIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCannabisManagerIncMember_2246" xlink:to="lab_imc_TrichomeFinancialCannabisManagerIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCannabisManagerIncMember_2247" xlink:to="lab_imc_TrichomeFinancialCannabisManagerIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCannabisManagerIncMember_2248" xlink:to="lab_imc_TrichomeFinancialCannabisManagerIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCorpMember_2249" xlink:to="lab_imc_TrichomeFinancialCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCorpMember_2250" xlink:to="lab_imc_TrichomeFinancialCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCorpMember_2251" xlink:to="lab_imc_TrichomeFinancialCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeFinancialCorpMember_2252" xlink:to="lab_imc_TrichomeFinancialCorpMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeJwcAcquisitionCorpMember_2253" xlink:to="lab_imc_TrichomeJwcAcquisitionCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeJwcAcquisitionCorpMember_2254" xlink:to="lab_imc_TrichomeJwcAcquisitionCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeJwcAcquisitionCorpMember_2255" xlink:to="lab_imc_TrichomeJwcAcquisitionCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeRetailCorpMember_2256" xlink:to="lab_imc_TrichomeRetailCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeRetailCorpMember_2257" xlink:to="lab_imc_TrichomeRetailCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeRetailCorpMember_2258" xlink:to="lab_imc_TrichomeRetailCorpMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeSecurityholdersMember_2259" xlink:to="lab_imc_TrichomeSecurityholdersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeSecurityholdersMember_2260" xlink:to="lab_imc_TrichomeSecurityholdersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TrichomeSecurityholdersMember_2261" xlink:to="lab_imc_TrichomeSecurityholdersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TypeOfCannabisAxis_2262" xlink:to="lab_imc_TypeOfCannabisAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TypeOfCannabisAxis_2263" xlink:to="lab_imc_TypeOfCannabisAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TypeOfCannabisDomain_2264" xlink:to="lab_imc_TypeOfCannabisDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_TypeOfCannabisDomain_2265" xlink:to="lab_imc_TypeOfCannabisDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_UnobservableInputAxis_2266" xlink:to="lab_imc_UnobservableInputAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_UnobservableInputAxis_2267" xlink:to="lab_imc_UnobservableInputAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_UnobservableInputDomain_2268" xlink:to="lab_imc_UnobservableInputDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_UnobservableInputDomain_2269" xlink:to="lab_imc_UnobservableInputDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_2270" xlink:to="lab_imc_UtilizationOfLossesNotPreviouslyRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_2271" xlink:to="lab_imc_UtilizationOfLossesNotPreviouslyRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_2272" xlink:to="lab_imc_UtilizationOfLossesNotPreviouslyRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_2273" xlink:to="lab_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_2274" xlink:to="lab_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_2275" xlink:to="lab_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_2276" xlink:to="lab_imc_ValueOfWarrantsConvertedToOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_2277" xlink:to="lab_imc_ValueOfWarrantsConvertedToOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_2278" xlink:to="lab_imc_ValueOfWarrantsConvertedToOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_2279" xlink:to="lab_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_2280" xlink:to="lab_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_2281" xlink:to="lab_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestingAxis_2282" xlink:to="lab_imc_VestingAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestingAxis_2283" xlink:to="lab_imc_VestingAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestingDomain_2284" xlink:to="lab_imc_VestingDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestingDomain_2285" xlink:to="lab_imc_VestingDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestingPercentageOfShareBasedArrangement_2286" xlink:to="lab_imc_VestingPercentageOfShareBasedArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestingPercentageOfShareBasedArrangement_2287" xlink:to="lab_imc_VestingPercentageOfShareBasedArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VestingPercentageOfShareBasedArrangement_2288" xlink:to="lab_imc_VestingPercentageOfShareBasedArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VironnaPharmacyMember_2289" xlink:to="lab_imc_VironnaPharmacyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VironnaPharmacyMember_2290" xlink:to="lab_imc_VironnaPharmacyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_VironnaPharmacyMember_2291" xlink:to="lab_imc_VironnaPharmacyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrant2021Member_2292" xlink:to="lab_imc_Warrant2021Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrant2021Member_2293" xlink:to="lab_imc_Warrant2021Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrant2021Member_2294" xlink:to="lab_imc_Warrant2021Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantPricePerShare_2295" xlink:to="lab_imc_WarrantPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantPricePerShare_2296" xlink:to="lab_imc_WarrantPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantPricePerShare_2297" xlink:to="lab_imc_WarrantPricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrants2018Member_2298" xlink:to="lab_imc_Warrants2018Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrants2018Member_2299" xlink:to="lab_imc_Warrants2018Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrants2018Member_2300" xlink:to="lab_imc_Warrants2018Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrants2019Member_2301" xlink:to="lab_imc_Warrants2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrants2019Member_2302" xlink:to="lab_imc_Warrants2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_Warrants2019Member_2303" xlink:to="lab_imc_Warrants2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsAndCompensationOptions2019Member_2304" xlink:to="lab_imc_WarrantsAndCompensationOptions2019Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsAndCompensationOptions2019Member_2305" xlink:to="lab_imc_WarrantsAndCompensationOptions2019Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsAndCompensationOptions2019Member_2306" xlink:to="lab_imc_WarrantsAndCompensationOptions2019Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsAndCompensationOptionsMember_2307" xlink:to="lab_imc_WarrantsAndCompensationOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsAndCompensationOptionsMember_2308" xlink:to="lab_imc_WarrantsAndCompensationOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsMeasuredAtFairValue_2309" xlink:to="lab_imc_WarrantsMeasuredAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsMeasuredAtFairValue_2310" xlink:to="lab_imc_WarrantsMeasuredAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsMeasuredAtFairValue_2311" xlink:to="lab_imc_WarrantsMeasuredAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsMeasuredAtFairValue_2312" xlink:to="lab_imc_WarrantsMeasuredAtFairValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsMember_2313" xlink:to="lab_imc_WarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsMember_2314" xlink:to="lab_imc_WarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WarrantsMember_2315" xlink:to="lab_imc_WarrantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_2316" xlink:to="lab_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_2317" xlink:to="lab_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_2318" xlink:to="lab_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_2319" xlink:to="lab_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_2320" xlink:to="lab_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_2321" xlink:to="lab_imc_WeightedTaxRateComposedOfFederalAndMunicipalTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WholesalesAndPharmaciesMember_2322" xlink:to="lab_imc_WholesalesAndPharmaciesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WholesalesAndPharmaciesMember_2323" xlink:to="lab_imc_WholesalesAndPharmaciesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WholesalesAndPharmaciesMember_2324" xlink:to="lab_imc_WholesalesAndPharmaciesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_2325" xlink:to="lab_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_2326" xlink:to="lab_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_2327" xlink:to="lab_imc_WhollyOwnedSubsidiaryOfNavasotaFincoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WithholdingTaxLiabilities_2328" xlink:to="lab_imc_WithholdingTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WithholdingTaxLiabilities_2329" xlink:to="lab_imc_WithholdingTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkingCapital_2330" xlink:to="lab_imc_WorkingCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkingCapital_2331" xlink:to="lab_imc_WorkingCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkingCapital_2332" xlink:to="lab_imc_WorkingCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkingCapitalOfBusinessAcquisition_2333" xlink:to="lab_imc_WorkingCapitalOfBusinessAcquisition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkingCapitalOfBusinessAcquisition_2334" xlink:to="lab_imc_WorkingCapitalOfBusinessAcquisition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkingCapitalOfBusinessAcquisition_2335" xlink:to="lab_imc_WorkingCapitalOfBusinessAcquisition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkInProgressMember_2336" xlink:to="lab_imc_WorkInProgressMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkInProgressMember_2337" xlink:to="lab_imc_WorkInProgressMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WorkInProgressMember_2338" xlink:to="lab_imc_WorkInProgressMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WriteDownsOfInventoriesRecognizedCostOfSales_2339" xlink:to="lab_imc_WriteDownsOfInventoriesRecognizedCostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WriteDownsOfInventoriesRecognizedCostOfSales_2340" xlink:to="lab_imc_WriteDownsOfInventoriesRecognizedCostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_WriteDownsOfInventoriesRecognizedCostOfSales_2341" xlink:to="lab_imc_WriteDownsOfInventoriesRecognizedCostOfSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_XintezaApiLtdMember_2342" xlink:to="lab_imc_XintezaApiLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imc_XintezaApiLtdMember_2343" xlink:to="lab_imc_XintezaApiLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis_2344" xlink:to="lab_srt_CurrencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProFormaMember_2345" xlink:to="lab_srt_ProFormaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain_2346" xlink:to="lab_srt_ScenarioUnspecifiedDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_2347" xlink:to="lab_srt_SegmentGeographicalDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_2348" xlink:to="lab_srt_StatementGeographicalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis_2349" xlink:to="lab_srt_StatementScenarioAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_2350" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2351" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>imc-20211231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETTables" roleURI="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails" roleURI="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET" roleURI="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONS" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDetails" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDetailTextuals" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSTables" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDetails1" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetails" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOME" roleURI="http://www.imcannabis.com/role/TAXESONINCOME"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetails2" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetails1" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetailTextuals" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMEDetails3" roleURI="http://www.imcannabis.com/role/TAXESONINCOMEDetails3"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TRADERECEIVABLESDetailTextuals" roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TRADERECEIVABLESTables" roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TRADERECEIVABLES" roleURI="http://www.imcannabis.com/role/TRADERECEIVABLES"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TRADERECEIVABLESDetails1" roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TRADERECEIVABLESDetails" roleURI="http://www.imcannabis.com/role/TRADERECEIVABLESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails" roleURI="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SELECTEDSTATEMENTSOFPROFITORLOSSDATATables" roleURI="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATATables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SELECTEDSTATEMENTSOFPROFITORLOSSDATA" roleURI="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATA"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OTHERPAYABLES" roleURI="http://www.imcannabis.com/role/OTHERPAYABLES"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OTHERPAYABLESDetails" roleURI="http://www.imcannabis.com/role/OTHERPAYABLESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OTHERPAYABLESTables" roleURI="http://www.imcannabis.com/role/OTHERPAYABLESTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables" roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY" roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails" roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1" roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2" roleURI="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OTHERACCOUNTSRECEIVABLE" roleURI="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLE"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OTHERACCOUNTSRECEIVABLEDetails" roleURI="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OTHERACCOUNTSRECEIVABLETables" roleURI="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLETables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYTables" roleURI="http://www.imcannabis.com/role/EQUITYTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYDetails" roleURI="http://www.imcannabis.com/role/EQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYDetails1" roleURI="http://www.imcannabis.com/role/EQUITYDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITY" roleURI="http://www.imcannabis.com/role/EQUITY"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYDetails2" roleURI="http://www.imcannabis.com/role/EQUITYDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYDetails3" roleURI="http://www.imcannabis.com/role/EQUITYDetails3"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYDetailTextuals" roleURI="http://www.imcannabis.com/role/EQUITYDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BIOLOGICALASSETSTables" roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BIOLOGICALASSETS" roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BIOLOGICALASSETSDetails" roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BIOLOGICALASSETSDetails1" roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BIOLOGICALASSETSDetailTextuals" roleURI="http://www.imcannabis.com/role/BIOLOGICALASSETSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES" roleURI="http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals" roleURI="http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RELATEDPARTYBALANCESANDTRANSACTIONS" roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RELATEDPARTYBALANCESANDTRANSACTIONSTables" roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RELATEDPARTYBALANCESANDTRANSACTIONSDetails" roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RELATEDPARTYBALANCESANDTRANSACTIONSDetails1" roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RELATEDPARTYBALANCESANDTRANSACTIONSDetails2" roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTS" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetails" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSTables" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetails1" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetails2" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetails3" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#FINANCIALINSTRUMENTSDetailTextuals" roleURI="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INVENTORIESDetails" roleURI="http://www.imcannabis.com/role/INVENTORIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INVENTORIES" roleURI="http://www.imcannabis.com/role/INVENTORIES"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INVENTORIESDetailTextuals" roleURI="http://www.imcannabis.com/role/INVENTORIESDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INVENTORIESTables" roleURI="http://www.imcannabis.com/role/INVENTORIESTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#NETEARNINGSLOSSPERSHARETables" roleURI="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARETables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#NETEARNINGSLOSSPERSHAREDetails" roleURI="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#NETEARNINGSLOSSPERSHARE" roleURI="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARE"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIES" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIES"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIESTables" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails1" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails2" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIESDetails" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUBSEQUENTEVENTS" roleURI="http://www.imcannabis.com/role/SUBSEQUENTEVENTS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SUBSEQUENTEVENTSDetailTextuals" roleURI="http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#DISCLOSUREOFNEWSTANDARDSINTHEPERIODPRIORTOTHEIRADOPTION" roleURI="http://www.imcannabis.com/role/DISCLOSUREOFNEWSTANDARDSINTHEPERIODPRIORTOTHEIRADOPTION"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#SIGNIFICANTACCOUNTINGESTIMATESANDASSUMPTIONSUSEDINTHEPREPARATIONOFTHEFINANCIALSTATEMENTS" roleURI="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGESTIMATESANDASSUMPTIONSUSEDINTHEPREPARATIONOFTHEFINANCIALSTATEMENTS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4" roleURI="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#GENERALDetailTextuals" roleURI="http://www.imcannabis.com/role/GENERALDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#GENERAL" roleURI="http://www.imcannabis.com/role/GENERAL"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RIGHTOFUSEASSETS" roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RIGHTOFUSEASSETSTables" roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETSTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RIGHTOFUSEASSETSDetails" roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#TAXESONINCOMETables" roleURI="http://www.imcannabis.com/role/TAXESONINCOMETables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#DocumentAndEntityInformation" roleURI="http://www.imcannabis.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RIGHTOFUSEASSETSDetailTextuals" roleURI="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals" roleURI="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INTANGIBLEASSETSNET" roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNET"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INTANGIBLEASSETSNETDetailTextuals" roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INTANGIBLEASSETSNETDetails" roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#INTANGIBLEASSETSNETTables" roleURI="http://www.imcannabis.com/role/INTANGIBLEASSETSNETTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OPERATINGSEGMENTSDetails" roleURI="http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OPERATINGSEGMENTSTables" roleURI="http://www.imcannabis.com/role/OPERATINGSEGMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#OPERATINGSEGMENTS" roleURI="http://www.imcannabis.com/role/OPERATINGSEGMENTS"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation" roleURI="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails" roleURI="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails"/>
  <roleRef xlink:type="simple" xlink:href="imc-20211231.xsd#EQUITYNumberOfRestrictedShareUnitsRSUDetails" roleURI="http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETTables">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseProductionEquipmentMember" xlink:label="loc_imc_GreenhouseProductionEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseStructureMember" xlink:label="loc_imc_GreenhouseStructureMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment" xlink:label="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_imc_GreenhouseProductionEquipmentMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_imc_GreenhouseStructureMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" xlink:to="loc_ifrs-full_CarryingAmountMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory" xlink:label="loc_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract_0" xlink:to="loc_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BiologicalAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoanReceivableRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DerivativeAssetsAsOfAcquisitionDate" xlink:label="loc_imc_DerivativeAssetsAsOfAcquisitionDate_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAsOfAcquisitionDate_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_24"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_25"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_27"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_33"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmacyMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_AssetsAbstract_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_imc_LoanReceivableRecognisedAsOfAcquisitionDate_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_imc_DerivativeAssetsAsOfAcquisitionDate_17" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_18" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_imc_InvestmentsAsOfAcquisitionDate_19" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_20" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_9" xlink:to="loc_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate_21" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_LiabilitiesAbstract_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_imc_LeaseLiabilityAsOfAcquisitionDate_25" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_27" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate_28" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_30" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_33" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmMember" xlink:label="loc_imc_OranimPharmMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPlusPharmLtdMember" xlink:label="loc_imc_OranimPlusPharmLtdMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmsCeoMember" xlink:label="loc_imc_AdjupharmsCeoMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsequentEventMember" xlink:label="loc_imc_SubsequentEventMember_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesReceivedOfConvertibleInstrument" xlink:label="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_24"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfSettlementOfWithholdingTaxLiabilities" xlink:label="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_25"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities" xlink:label="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_26"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilities" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilities_27"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel" xlink:label="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_28"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest" xlink:label="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_29"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses" xlink:label="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_31"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfShareOptionsShareVestedRsu" xlink:label="loc_imc_NumberOfShareOptionsShareVestedRsu_32"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree" xlink:label="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_33"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAcquisition" xlink:label="loc_imc_PercentageOfAcquisition_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_38"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_39"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfNonCancellablePurchasePrice" xlink:label="loc_imc_AmountOfNonCancellablePurchasePrice_40"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapitalOfBusinessAcquisition" xlink:label="loc_imc_WorkingCapitalOfBusinessAcquisition_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_42"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit" xlink:label="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_43"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountDepositedInEscrow" xlink:label="loc_imc_AmountDepositedInEscrow_44"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfSharesGranted" xlink:label="loc_imc_PercentageOfSharesGranted_45"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRestrictedSharesGranted" xlink:label="loc_imc_PercentageOfRestrictedSharesGranted_46"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingPercentageOfShareBasedArrangement" xlink:label="loc_imc_VestingPercentageOfShareBasedArrangement_47"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_51"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPlusPharmLtdMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_11" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_11" xlink:to="loc_imc_AdjupharmsCeoMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_RangeAxis_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_14" xlink:to="loc_ifrs-full_RangesMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_14" xlink:to="loc_ifrs-full_BottomOfRangeMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_14" xlink:to="loc_ifrs-full_TopOfRangeMember_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_18" xlink:to="loc_ifrs-full_NonadjustingEventsMember_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_18" xlink:to="loc_imc_SubsequentEventMember_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_NumberOfCommonSharesReceivedOfConvertibleInstrument_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_AmountOfSettlementOfWithholdingTaxLiabilities_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_PercentageOfWithholdingTaxLiabilities_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel_28" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest_29" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses_30" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_31" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_NumberOfShareOptionsShareVestedRsu_32" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_33" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_PercentageOfAcquisition_34" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_35" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_36" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_37" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_CashTransferred_38" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_CashConsiderationOfBusinessCombination_39" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_AmountOfNonCancellablePurchasePrice_40" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_WorkingCapitalOfBusinessAcquisition_41" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_42" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit_43" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_AmountDepositedInEscrow_44" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_PercentageOfSharesGranted_45" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_PercentageOfRestrictedSharesGranted_46" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_imc_VestingPercentageOfShareBasedArrangement_47" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_48" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_49" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_Revenue_50" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_21" xlink:to="loc_ifrs-full_ProfitLoss_51" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmacyMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_9" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetCashTransferred" xlink:label="loc_imc_NetCashTransferred_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_ifrs-full_CashTransferred_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_4" xlink:to="loc_imc_NetCashTransferred_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOME">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DeferredTaxAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAndLiabilitiesAxis" xlink:label="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsAndLiabilitiesDomain" xlink:label="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxAssetsMember" xlink:label="loc_imc_DeferredTaxAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeferredTaxLiabilitiesMember" xlink:label="loc_imc_DeferredTaxLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherDeferredTaxAssestsMember" xlink:label="loc_imc_OtherDeferredTaxAssestsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBiologicalAssetsMember" xlink:label="loc_ifrs-full_CurrentBiologicalAssetsMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IntangibleAssetsMember" xlink:label="loc_imc_IntangibleAssetsMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TranslationDifferencesOfDefferedTaxes" xlink:label="loc_imc_TranslationDifferencesOfDefferedTaxes_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesAxis_1" xlink:to="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1" xlink:to="loc_imc_DeferredTaxAssetsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DeferredTaxAssetsAndLiabilitiesDomain_1" xlink:to="loc_imc_DeferredTaxLiabilitiesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_5" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_5" xlink:to="loc_imc_OtherDeferredTaxAssestsMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_9" xlink:to="loc_ifrs-full_FinancialAssetsMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_9" xlink:to="loc_ifrs-full_CurrentBiologicalAssetsMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_9" xlink:to="loc_imc_IntangibleAssetsMember_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_9" xlink:to="loc_ifrs-full_OtherAssetsMember_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_14" xlink:to="loc_ifrs-full_DeferredTaxAssets_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_14" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_14" xlink:to="loc_imc_TranslationDifferencesOfDefferedTaxes_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_14" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_14" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MajorComponentsOfIncomeTaxExpenseTable" xlink:label="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL" xlink:label="loc_country_IL_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_DE" xlink:label="loc_country_DE_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA" xlink:label="loc_country_CA_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MajorComponentsOfIncomeTaxExpenseLineItems" xlink:label="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardOperatingTaxLosses" xlink:label="loc_imc_CarryforwardOperatingTaxLosses_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CarryforwardLossesForTaxPurposesDescription" xlink:label="loc_imc_CarryforwardLossesForTaxPurposesDescription_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1" xlink:to="loc_srt_StatementGeographicalAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4" xlink:to="loc_srt_SegmentGeographicalDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4" xlink:to="loc_country_IL_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4" xlink:to="loc_country_DE_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4" xlink:to="loc_country_CA_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseTable_1" xlink:to="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_9" xlink:to="loc_ifrs-full_ApplicableTaxRate_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_9" xlink:to="loc_imc_CarryforwardOperatingTaxLosses_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_9" xlink:to="loc_ifrs-full_DeferredTaxAssets_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_MajorComponentsOfIncomeTaxExpenseLineItems_9" xlink:to="loc_imc_CarryforwardLossesForTaxPurposesDescription_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMEDetails3">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="loc_ifrs-full_AccountingProfit_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:label="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonDeductibleIncomeExpenseNetForTaxPurposes" xlink:label="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfDifferentTaxRateOfSubsidiaries" xlink:label="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears" xlink:label="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears" xlink:label="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss" xlink:label="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UtilizationOfLossesNotPreviouslyRecognized" xlink:label="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInTaxBenefitsNotRecognized" xlink:label="loc_imc_ChangeInTaxBenefitsNotRecognized_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_AccountingProfit_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_ApplicableTaxRate_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_imc_NonDeductibleIncomeExpenseNetForTaxPurposes_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_imc_UtilizationOfLossesNotPreviouslyRecognized_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_imc_ChangeInTaxBenefitsNotRecognized_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract_4" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TRADERECEIVABLESDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfNonInterestBearingTradeReceivables" xlink:label="loc_imc_TermOfNonInterestBearingTradeReceivables_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_imc_TermOfNonInterestBearingTradeReceivables_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TRADERECEIVABLESTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfTradeReceivablesExplanatory" xlink:label="loc_imc_DisclosureOfTradeReceivablesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_imc_DisclosureOfTradeReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TRADERECEIVABLES">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TRADERECEIVABLESDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeReceivablesTable" xlink:label="loc_imc_TradeReceivablesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorCustomersMember" xlink:label="loc_ifrs-full_MajorCustomersMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerOneMember" xlink:label="loc_imc_CustomerOneMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerTwoMember" xlink:label="loc_imc_CustomerTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerThreeMember" xlink:label="loc_imc_CustomerThreeMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ForeignCountriesTwoMember" xlink:label="loc_imc_ForeignCountriesTwoMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TradeReceivablesLineItems" xlink:label="loc_imc_TradeReceivablesLineItems_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_imc_TradeReceivablesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TradeReceivablesTable_1" xlink:to="loc_ifrs-full_MajorCustomersAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersAxis_1" xlink:to="loc_ifrs-full_MajorCustomersMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_1" xlink:to="loc_imc_CustomerOneMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_1" xlink:to="loc_imc_CustomerTwoMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersMember_1" xlink:to="loc_imc_CustomerThreeMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TradeReceivablesTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_6" xlink:to="loc_ifrs-full_GeographicalAreasMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_6" xlink:to="loc_ifrs-full_CountryOfDomicileMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_6" xlink:to="loc_imc_ForeignCountriesTwoMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TradeReceivablesTable_1" xlink:to="loc_imc_TradeReceivablesLineItems_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TradeReceivablesLineItems_10" xlink:to="loc_ifrs-full_PercentageOfEntitysRevenue_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TRADERECEIVABLESDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WholesalesAndPharmaciesMember" xlink:label="loc_imc_WholesalesAndPharmaciesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_imc_WholesalesAndPharmaciesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" xlink:to="loc_ifrs-full_CurrentTradeReceivables_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_WagesAndSalaries_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATATables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory" xlink:label="loc_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeographicAllocationOfAssetsExplanatory" xlink:label="loc_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_imc_DisclosureOfGeographicAllocationOfAssetsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATA">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAdvancesToSuppliers" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LoansAndReceivables" xlink:label="loc_ifrs-full_LoansAndReceivables_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentBiologicalAssets" xlink:label="loc_ifrs-full_CurrentBiologicalAssets_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-full_LiabilitiesAbstract_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-full_ShorttermBorrowings_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_30"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMeasuredAtFairValue" xlink:label="loc_imc_WarrantsMeasuredAtFairValue_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_42"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_46"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_48"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_AssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CashAndCashEquivalents_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentRestrictedCashAndCashEquivalents_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentTradeReceivables_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentAdvancesToSuppliers_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentInvestments_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_LoansAndReceivables_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentBiologicalAssets_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_Inventories_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentAssets_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_RightofuseAssets_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_DeferredTaxAssets_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_Goodwill_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_12" xlink:to="loc_ifrs-full_NoncurrentAssets_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_Assets_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_LiabilitiesAbstract_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_ShorttermBorrowings_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_OtherCurrentPayables_25" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_27" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_CurrentLiabilities_28" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_30" xlink:to="loc_imc_WarrantsMeasuredAtFairValue_30" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_30" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_31" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_30" xlink:to="loc_ifrs-full_LongtermBorrowings_32" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_30" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_33" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_30" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_34" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_30" xlink:to="loc_ifrs-full_NoncurrentLiabilities_35" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesAbstract_23" xlink:to="loc_ifrs-full_Liabilities_37" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_EquityAbstract_39" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_39" xlink:to="loc_ifrs-full_IssuedCapital_39" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_39" xlink:to="loc_ifrs-full_TreasuryShares_40" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_39" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_41" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_39" xlink:to="loc_ifrs-full_ReserveOfSharebasedPayments_42" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_39" xlink:to="loc_ifrs-full_RetainedEarnings_43" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_39" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_44" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_39" xlink:to="loc_ifrs-full_NoncontrollingInterests_45" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_39" xlink:to="loc_ifrs-full_Equity_46" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_23" xlink:to="loc_ifrs-full_EquityAndLiabilities_48" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProfitBeforeFairValueAdjustments" xlink:label="loc_imc_GrossProfitBeforeFairValueAdjustments_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentsAbstract" xlink:label="loc_imc_FairValueAdjustmentsAbstract_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RealizedFairValueAdjustmentOnInventorySold" xlink:label="loc_imc_RealizedFairValueAdjustmentOnInventorySold_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="loc_ifrs-full_ProfitLossAttributableToAbstract_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_39"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_Revenue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_CostOfSales_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_imc_GrossProfitBeforeFairValueAdjustments_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_imc_FairValueAdjustmentsAbstract_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_FairValueAdjustmentsAbstract_4" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_FairValueAdjustmentsAbstract_4" xlink:to="loc_imc_RealizedFairValueAdjustmentOnInventorySold_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_FairValueAdjustmentsAbstract_4" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_GrossProfit_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OperatingExpense_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceIncome_15" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceCosts_16" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceIncomeCost_17" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_18" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_19" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLoss_20" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_21" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_21" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_21" xlink:to="loc_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_21" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_25" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_25" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_25" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_28" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_29" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToAbstract_30" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_30" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_30" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_30" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_31" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_30" xlink:to="loc_ifrs-full_ProfitLoss_32" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_34" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_34" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_34" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_34" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_35" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_34" xlink:to="loc_ifrs-full_ComprehensiveIncome_36" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareAbstract_38" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_38" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_38" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_38" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_39" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity1" xlink:label="loc_imc_IssueOfEquity1_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssueOfEquity2" xlink:label="loc_imc_IssueOfEquity2_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPurchaseOfTreasuryCommonShares" xlink:label="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughForfeitedOptions" xlink:label="loc_imc_IncreaseDecreaseThroughForfeitedOptions_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_23"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_TreasurySharesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_Equity_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_IssueOfEquity_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_imc_IssueOfEquity1_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_imc_IssueOfEquity2_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_imc_AmountOfPurchaseOfTreasuryCommonShares_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_17" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_18" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_imc_IncreaseDecreaseThroughForfeitedOptions_19" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_ProfitLoss_20" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_21" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_ComprehensiveIncome_22" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_10" xlink:to="loc_ifrs-full_Equity_23" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OTHERPAYABLES">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OTHERPAYABLESDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesAndPayrollAccruals" xlink:label="loc_imc_EmployeesAndPayrollAccruals_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCurrentPayablesToGovernmentAuthorities" xlink:label="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-full_CurrentDepositsFromCustomers_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherMiscellaneousCurrentPayables" xlink:label="loc_imc_OtherMiscellaneousCurrentPayables_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_imc_EmployeesAndPayrollAccruals_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_imc_OtherCurrentPayablesToGovernmentAuthorities_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_CurrentDepositsFromCustomers_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_imc_OtherMiscellaneousCurrentPayables_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_OtherCurrentPayables_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OTHERPAYABLESTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract" xlink:label="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0" xlink:to="loc_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0" xlink:to="loc_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract" xlink:label="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0" xlink:to="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract" xlink:label="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_imc_FocusMedicalHerbsLtdMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_CurrentAssets_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_NoncurrentAssets_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_CurrentLiabilities_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_NoncurrentLiabilities_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_Equity_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract" xlink:label="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_imc_FocusMedicalHerbsLtdMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_Revenue_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_ProfitLoss_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_ComprehensiveIncome_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract" xlink:label="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems" xlink:label="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_imc_FocusMedicalHerbsLtdMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable_1" xlink:to="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems_4" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLE">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOtherAccountsReceivableAbstract" xlink:label="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOtherAccountsReceivablesExplanatory" xlink:label="loc_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xlink:to="loc_imc_DisclosureOfOtherAccountsReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOtherAccountsReceivableAbstract" xlink:label="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReceivablesFromGovernmentAuthorities" xlink:label="loc_imc_ReceivablesFromGovernmentAuthorities_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xlink:to="loc_imc_ReceivablesFromGovernmentAuthorities_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xlink:to="loc_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xlink:to="loc_ifrs-full_OtherCurrentReceivables_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLETables">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfOtherAccountsReceivableAbstract" xlink:label="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfOtherAccountsReceivableAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnSaleOfInventory" xlink:label="loc_imc_FairValueAdjustmentOnSaleOfInventory_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue" xlink:label="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListingCostOfReverseAcquisition" xlink:label="loc_imc_ListingCostOfReverseAcquisition_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation" xlink:label="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable" xlink:label="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjustmentsForRevaluationOfOtherReceivable" xlink:label="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangesInNonCashWorkingCapitalAbstract" xlink:label="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_30"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_31"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfInvestmentProperty" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_35"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromInvestmentInRestrictedDeposits" xlink:label="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_36"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ChangeInRestrictedBankDeposits" xlink:label="loc_imc_ChangeInRestrictedBankDeposits_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_40"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue" xlink:label="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_41"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions" xlink:label="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_42"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_45"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_46"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestPaidInRespectOfLoans" xlink:label="loc_imc_InterestPaidInRespectOfLoans_47"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_48"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_51"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_52"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_53"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_54"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SupplementalDisclosureOfNonCashActivitiesAbstract" xlink:label="loc_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_55"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability" xlink:label="loc_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_55"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares" xlink:label="loc_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_56"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_imc_FairValueAdjustmentOnSaleOfInventory_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_imc_ListingCostOfReverseAcquisition_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_12" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation_13" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable_14" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_imc_AdjustmentsForRevaluationOfOtherReceivable_15" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_16" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_23" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ChangesInNonCashWorkingCapitalAbstract_17" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_24" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_28" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_30" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities_31" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_32" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_33" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/negativeTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_34" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_35" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_imc_ProceedsFromInvestmentInRestrictedDeposits_36" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_imc_ChangeInRestrictedBankDeposits_37" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_30" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_38" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_40" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue_41" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_42" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_43" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_44" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_45" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_46" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_imc_InterestPaidInRespectOfLoans_47" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_48" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_40" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_49" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_51" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_52" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_53" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_54" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_55" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_55" xlink:to="loc_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability_55" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SupplementalDisclosureOfNonCashActivitiesAbstract_55" xlink:to="loc_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares_56" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfCompositionOfShareCapitalExplanatory" xlink:label="loc_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory" xlink:label="loc_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRestrictedShareUnitsTableTextBlock" xlink:label="loc_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_DisclosureOfCompositionOfShareCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_DisclosureOfRestrictedShareUnitsTableTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised" xlink:label="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesIssuedOptionsExercises" xlink:label="loc_imc_OrdinarySharesIssuedOptionsExercises_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PurchaseOfTreasuryCommonShares" xlink:label="loc_imc_PurchaseOfTreasuryCommonShares_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInBusinessCombinationTransaction" xlink:label="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_OrdinarySharesIssuedOptionsExercises_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_PurchaseOfTreasuryCommonShares_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_NumberOfSharesIssuedInBusinessCombinationTransaction_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITY">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_5" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYDetails3">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfOptionsExercisedUnderCashlessMechanism" xlink:label="loc_imc_NumberOfOptionsExercisedUnderCashlessMechanism_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism" xlink:label="loc_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_NumberOfOptionsExercisedUnderCashlessMechanism_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareIncentivePlanMember" xlink:label="loc_imc_ShareIncentivePlanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeesDirectorsAndAdvisorsMember" xlink:label="loc_imc_EmployeesDirectorsAndAdvisorsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingAxis" xlink:label="loc_imc_VestingAxis_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestingDomain" xlink:label="loc_imc_VestingDomain_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstAnniversaryOfApplicableVestingCommencementDateMember" xlink:label="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember" xlink:label="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2018Member" xlink:label="loc_imc_Warrants2018Member_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2019Member" xlink:label="loc_imc_Warrants2019Member_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptions2019Member" xlink:label="loc_imc_CompensationOptions2019Member_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptions2019Member" xlink:label="loc_imc_WarrantsAndCompensationOptions2019Member_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionAxis" xlink:label="loc_imc_EquityTransactionAxis_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PrivatePlacementsMember" xlink:label="loc_imc_PrivatePlacementsMember_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OvernightMarketedOfferingMember" xlink:label="loc_imc_OvernightMarketedOfferingMember_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_28"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListedWarrantsMember" xlink:label="loc_imc_ListedWarrantsMember_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" xlink:label="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_34"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_35"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_37"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesCalledByWarrants" xlink:label="loc_imc_NumberOfCommonSharesCalledByWarrants_38"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfWarrantsFromDateOfIssuance" xlink:label="loc_imc_TermOfWarrantsFromDateOfIssuance_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_40"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WarrantLiability" xlink:label="loc_ifrs-full_WarrantLiability_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_42"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensation" xlink:label="loc_imc_ShareBasedCompensation_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_44"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssued" xlink:label="loc_imc_NumberOfUnitsIssued_45"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfSharesWithPrivatePlacement" xlink:label="loc_imc_IssuanceOfSharesWithPrivatePlacement_46"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssuedPricePerShare" xlink:label="loc_imc_NumberOfUnitsIssuedPricePerShare_47"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProceedsFromIssuanceOfUnits" xlink:label="loc_imc_GrossProceedsFromIssuanceOfUnits_48"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesIssuedInReverseTakeover" xlink:label="loc_imc_NumberOfSharesIssuedInReverseTakeover_49"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions" xlink:label="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_50"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OrdinarySharesReservedForIssuance" xlink:label="loc_imc_OrdinarySharesReservedForIssuance_51"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_52"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsExercised" xlink:label="loc_imc_PercentageOfWarrantsExercised_53"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_54"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_55"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_56"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOptionsExercised" xlink:label="loc_imc_PercentageOfOptionsExercised_57"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_58"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_59"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_60"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantExercised" xlink:label="loc_imc_NumberOfWarrantExercised_61"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevaluationOfExercisedWarrants" xlink:label="loc_imc_RevaluationOfExercisedWarrants_62"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:label="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_63"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfAwardsVest" xlink:label="loc_imc_PercentageOfAwardsVest_64"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfSharesAvailableForFutureGrants" xlink:label="loc_imc_NumberOfSharesAvailableForFutureGrants_65"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_66"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_67"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsIssued" xlink:label="loc_imc_NumberOfCompensationUnitsIssued_68"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitPerShare" xlink:label="loc_imc_CompensationUnitPerShare_69"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfOtherConvertibleSecritiesConversion" xlink:label="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_70"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsToAcquired" xlink:label="loc_imc_NumberOfCompensationWarrantsToAcquired_71"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantPricePerShare" xlink:label="loc_imc_WarrantPricePerShare_72"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationOptionPricePerShare" xlink:label="loc_imc_CompensationOptionPricePerShare_73"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_imc_ShareIncentivePlanMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_imc_EmployeesDirectorsAndAdvisorsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_7" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_imc_VestingAxis_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_VestingAxis_10" xlink:to="loc_imc_VestingDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_VestingDomain_10" xlink:to="loc_imc_FirstAnniversaryOfApplicableVestingCommencementDateMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_VestingDomain_10" xlink:to="loc_imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_14" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_14" xlink:to="loc_imc_Warrants2018Member_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_14" xlink:to="loc_imc_Warrants2019Member_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_14" xlink:to="loc_imc_CompensationOptions2019Member_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_14" xlink:to="loc_imc_WarrantsAndCompensationOptions2019Member_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_14" xlink:to="loc_imc_Warrant2021Member_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_imc_EquityTransactionAxis_21" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionAxis_21" xlink:to="loc_imc_EquityTransactionDomain_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionDomain_21" xlink:to="loc_imc_PrivatePlacementsMember_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionDomain_21" xlink:to="loc_imc_OvernightMarketedOfferingMember_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_25" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_25" xlink:to="loc_ifrs-full_NonadjustingEventsMember_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_25" xlink:to="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_28" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_28" xlink:to="loc_ifrs-full_EquityMember_28" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_28" xlink:to="loc_imc_ListedWarrantsMember_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_28" xlink:to="loc_ifrs-full_IssuedCapitalMember_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_32" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_NumberOfSharesIssued_33" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_ParValuePerShare_34" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_35" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_36" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_37" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_NumberOfCommonSharesCalledByWarrants_38" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_TermOfWarrantsFromDateOfIssuance_39" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_40" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_WarrantLiability_41" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_42" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_ShareBasedCompensation_43" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_44" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_NumberOfUnitsIssued_45" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_IssuanceOfSharesWithPrivatePlacement_46" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_NumberOfUnitsIssuedPricePerShare_47" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_GrossProceedsFromIssuanceOfUnits_48" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_NumberOfSharesIssuedInReverseTakeover_49" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions_50" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_OrdinarySharesReservedForIssuance_51" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_52" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_PercentageOfWarrantsExercised_53" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_54" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_55" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_56" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_PercentageOfOptionsExercised_57" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_58" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_59" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_60" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_NumberOfWarrantExercised_61" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_RevaluationOfExercisedWarrants_62" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_63" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_PercentageOfAwardsVest_64" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_NumberOfSharesAvailableForFutureGrants_65" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_66" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_67" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_NumberOfCompensationUnitsIssued_68" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_CompensationUnitPerShare_69" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_DescriptionOfOtherConvertibleSecritiesConversion_70" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_NumberOfCompensationWarrantsToAcquired_71" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_WarrantPricePerShare_72" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_32" xlink:to="loc_imc_CompensationOptionPricePerShare_73" order="410" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BIOLOGICALASSETSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BIOLOGICALASSETS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BIOLOGICALASSETSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProductionCostsCapitalizedBiologicalAssets" xlink:label="loc_imc_ProductionCostsCapitalizedBiologicalAssets_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets" xlink:label="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DecreaseDueToHarvestBiologicalAssets" xlink:label="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssets" xlink:label="loc_ifrs-full_BiologicalAssets_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_BiologicalAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_imc_ProductionCostsCapitalizedBiologicalAssets_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DecreaseDueToHarvestBiologicalAssets_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_BiologicalAssets_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssetsByTypeAxis" xlink:label="loc_ifrs-full_BiologicalAssetsByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BiologicalAssetsTypeMember" xlink:label="loc_ifrs-full_BiologicalAssetsTypeMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannabisPlantsMember" xlink:label="loc_imc_CannabisPlantsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputAxis" xlink:label="loc_imc_UnobservableInputAxis_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_UnobservableInputDomain" xlink:label="loc_imc_UnobservableInputDomain_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember" xlink:label="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageSellingPricePerGramOfDriedCannabis" xlink:label="loc_imc_AverageSellingPricePerGramOfDriedCannabis_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AveragePostHarvestCostsPerGramOfDriedCannabis" xlink:label="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AttritionRate" xlink:label="loc_imc_AttritionRate_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageYieldPerPlant" xlink:label="loc_imc_AverageYieldPerPlant_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AverageStageOfGrowth" xlink:label="loc_imc_AverageStageOfGrowth_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" xlink:to="loc_ifrs-full_BiologicalAssetsByTypeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BiologicalAssetsByTypeAxis_1" xlink:to="loc_ifrs-full_BiologicalAssetsTypeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BiologicalAssetsTypeMember_1" xlink:to="loc_imc_CannabisPlantsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" xlink:to="loc_imc_UnobservableInputAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_UnobservableInputAxis_4" xlink:to="loc_imc_UnobservableInputDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_UnobservableInputDomain_4" xlink:to="loc_imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_7" xlink:to="loc_imc_AverageSellingPricePerGramOfDriedCannabis_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_7" xlink:to="loc_imc_AveragePostHarvestCostsPerGramOfDriedCannabis_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_7" xlink:to="loc_imc_AttritionRate_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_7" xlink:to="loc_imc_AverageYieldPerPlant_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_7" xlink:to="loc_imc_AverageStageOfGrowth_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BIOLOGICALASSETSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets" xlink:label="loc_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract_0" xlink:to="loc_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfPersonalSuit" xlink:label="loc_imc_AmountOfPersonalSuit_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfClassActionGroupIncurredDamages" xlink:label="loc_imc_AmountOfClassActionGroupIncurredDamages_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfExpensesPaidByApplicant" xlink:label="loc_imc_AmountOfExpensesPaidByApplicant_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_imc_AmountOfPersonalSuit_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_imc_AmountOfClassActionGroupIncurredDamages_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xlink:to="loc_imc_AmountOfExpensesPaidByApplicant_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfBalancesWithRelatedPartiesExplanatory" xlink:label="loc_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_ifrs-full_RelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses" xlink:label="loc_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtAmortizedCostMember" xlink:label="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember" xlink:label="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMeasuredAtFairValue" xlink:label="loc_imc_WarrantsMeasuredAtFairValue_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_imc_FinancialInstrumentsAtAmortizedCostMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_5" xlink:to="loc_ifrs-full_CurrentInvestments_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_5" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAbstract_5" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_5" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_9" xlink:to="loc_imc_WarrantsMeasuredAtFairValue_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedVolatilityOfWarrants" xlink:label="loc_imc_ExpectedVolatilityOfWarrants_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedLifeOfWarrants" xlink:label="loc_imc_ExpectedLifeOfWarrants_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RiskFreeInterestRateOfWarrants" xlink:label="loc_imc_RiskFreeInterestRateOfWarrants_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExpectedDividendYieldOfWarrants" xlink:label="loc_imc_ExpectedDividendYieldOfWarrants_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValuePerWarrant" xlink:label="loc_imc_FairValuePerWarrant_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfWarrants" xlink:label="loc_imc_FairValueOfWarrants_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_1" xlink:to="loc_imc_Warrant2021Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" xlink:to="loc_imc_ExpectedVolatilityOfWarrants_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" xlink:to="loc_imc_ExpectedLifeOfWarrants_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" xlink:to="loc_imc_RiskFreeInterestRateOfWarrants_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" xlink:to="loc_imc_ExpectedDividendYieldOfWarrants_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" xlink:to="loc_imc_FairValuePerWarrant_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_4" xlink:to="loc_imc_FairValueOfWarrants_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanTenYearsMember" xlink:label="loc_ifrs-full_LaterThanTenYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankLoanAndLeaseLiabilities" xlink:label="loc_imc_BankLoanAndLeaseLiabilities_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_1" xlink:to="loc_ifrs-full_LaterThanTenYearsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7" xlink:to="loc_ifrs-full_LeaseLiabilities_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_7" xlink:to="loc_imc_BankLoanAndLeaseLiabilities_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowingsMember" xlink:label="loc_ifrs-full_ShorttermBorrowingsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsMember" xlink:label="loc_imc_WarrantsMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16" xlink:label="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_ShorttermBorrowingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember_1" xlink:to="loc_imc_WarrantsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_14" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities_15" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities_16" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities_17" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_18" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_19" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_6" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_20" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-full_CurrencyRiskMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_XintezaApiLtdMember" xlink:label="loc_imc_XintezaApiLtdMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentAxis" xlink:label="loc_imc_PeriodicPaymentInstallmentAxis_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PeriodicPaymentInstallmentDomain" xlink:label="loc_imc_PeriodicPaymentInstallmentDomain_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FirstInstallmentMember" xlink:label="loc_imc_FirstInstallmentMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingInstallmentMember" xlink:label="loc_imc_RemainingInstallmentMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParentMember" xlink:label="loc_ifrs-full_ParentMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NavasotaShareholdersMember" xlink:label="loc_imc_NavasotaShareholdersMember_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionAxis" xlink:label="loc_imc_EquityTransactionAxis_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PrivatePlacementsMember" xlink:label="loc_imc_PrivatePlacementsMember_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SharePurchaseAgreementMember" xlink:label="loc_imc_SharePurchaseAgreementMember_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OvernightMarketedOfferingMember" xlink:label="loc_imc_OvernightMarketedOfferingMember_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WarrantsAndCompensationOptionsMember" xlink:label="loc_imc_WarrantsAndCompensationOptionsMember_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2018Member" xlink:label="loc_imc_Warrants2018Member_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CompensationUnitsMember" xlink:label="loc_imc_CompensationUnitsMember_22"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrants2019Member" xlink:label="loc_imc_Warrants2019Member_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PreferenceSharesMember" xlink:label="loc_ifrs-full_PreferenceSharesMember_24"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Warrant2021Member" xlink:label="loc_imc_Warrant2021Member_25"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashAndCashEquivalentMember" xlink:label="loc_imc_CashAndCashEquivalentMember_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_29"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ListedWarrantsMember" xlink:label="loc_imc_ListedWarrantsMember_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="loc_currency_EUR_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_ILS" xlink:label="loc_currency_ILS_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="loc_currency_USD_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_GBP" xlink:label="loc_currency_GBP_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssued" xlink:label="loc_imc_NumberOfUnitsIssued_39"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfUnitsIssuedPricePerShare" xlink:label="loc_imc_NumberOfUnitsIssuedPricePerShare_40"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GrossProceedsFromIssuanceOfUnits" xlink:label="loc_imc_GrossProceedsFromIssuanceOfUnits_41"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_42"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TermOfWarrantsFromDateOfIssuance" xlink:label="loc_imc_TermOfWarrantsFromDateOfIssuance_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_45"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfWarrants" xlink:label="loc_imc_FairValueOfWarrants_46"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfWarrantTransferredInEquityDuringPeriod" xlink:label="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_47"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_48"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationWarrantsGrantedToAgents" xlink:label="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_49"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_50"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_51"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares" xlink:label="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_52"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProceedsFromWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_53"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_54"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfWarrantsAndCompensationOptionsExercised" xlink:label="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_55"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_56"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_57"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_58"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GainLossOnRevaluationOfFinancialInstruments" xlink:label="loc_imc_GainLossOnRevaluationOfFinancialInstruments_59"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_60"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_61"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfCompensationUnits" xlink:label="loc_imc_FairValueOfCompensationUnits_62"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_63"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_64"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfWarrantsConvertedToOrdinaryShares" xlink:label="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_65"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCompensationUnitsConvertedToOrdinaryShares" xlink:label="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_66"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversion" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversion_67"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ConversionPricePerWarrant" xlink:label="loc_imc_ConversionPricePerWarrant_68"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfWarrantsIssuedUponConversionOfUnits" xlink:label="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_69"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants" xlink:label="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_70"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfPreferredSharesCommittedToBeAcquired" xlink:label="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_71"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_72"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired" xlink:label="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_73"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_74"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfNonCancellablePurchasePrice" xlink:label="loc_imc_AmountOfNonCancellablePurchasePrice_75"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AmountOfTranslationTransaction" xlink:label="loc_imc_AmountOfTranslationTransaction_76"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TotalAllocatedAmountTranslationTransaction" xlink:label="loc_imc_TotalAllocatedAmountTranslationTransaction_77"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsInUnlistedSharesMeasuredAtFairValue" xlink:label="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_78"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_79"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:label="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_80"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ApproximatelyCashAndCashEquivalents" xlink:label="loc_imc_ApproximatelyCashAndCashEquivalents_81"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities_82"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_83"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_84"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_85"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesCalledByWarrants" xlink:label="loc_imc_NumberOfCommonSharesCalledByWarrants_86"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_87"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_88"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WarrantLiability" xlink:label="loc_ifrs-full_WarrantLiability_89"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareBasedCompensation" xlink:label="loc_imc_ShareBasedCompensation_90"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueOfInvestment" xlink:label="loc_imc_FairValueOfInvestment_91"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1" xlink:to="loc_ifrs-full_TypesOfRisksMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksMember_1" xlink:to="loc_ifrs-full_CurrencyRiskMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_dei_LegalEntityAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4" xlink:to="loc_dei_EntityDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4" xlink:to="loc_imc_XintezaApiLtdMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_imc_PeriodicPaymentInstallmentAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_PeriodicPaymentInstallmentAxis_7" xlink:to="loc_imc_PeriodicPaymentInstallmentDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_PeriodicPaymentInstallmentDomain_7" xlink:to="loc_imc_FirstInstallmentMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_PeriodicPaymentInstallmentDomain_7" xlink:to="loc_imc_RemainingInstallmentMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_11" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_11" xlink:to="loc_ifrs-full_ParentMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_11" xlink:to="loc_imc_NavasotaShareholdersMember_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_imc_EquityTransactionAxis_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionAxis_15" xlink:to="loc_imc_EquityTransactionDomain_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionDomain_15" xlink:to="loc_imc_PrivatePlacementsMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionDomain_15" xlink:to="loc_imc_SharePurchaseAgreementMember_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionDomain_15" xlink:to="loc_imc_OvernightMarketedOfferingMember_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_20" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20" xlink:to="loc_imc_WarrantsAndCompensationOptionsMember_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20" xlink:to="loc_imc_Warrants2018Member_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20" xlink:to="loc_imc_CompensationUnitsMember_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20" xlink:to="loc_imc_Warrants2019Member_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20" xlink:to="loc_ifrs-full_PreferenceSharesMember_24" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20" xlink:to="loc_imc_Warrant2021Member_25" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_20" xlink:to="loc_imc_CashAndCashEquivalentMember_26" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_29" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_29" xlink:to="loc_ifrs-full_EquityMember_29" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_29" xlink:to="loc_imc_ListedWarrantsMember_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_29" xlink:to="loc_ifrs-full_IssuedCapitalMember_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_srt_CurrencyAxis_33" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_33" xlink:to="loc_currency_AllCurrenciesDomain_33" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_33" xlink:to="loc_currency_EUR_33" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_33" xlink:to="loc_currency_ILS_34" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_33" xlink:to="loc_currency_USD_35" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_33" xlink:to="loc_currency_GBP_36" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfUnitsIssued_39" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfUnitsIssuedPricePerShare_40" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_GrossProceedsFromIssuanceOfUnits_41" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019_42" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_TermOfWarrantsFromDateOfIssuance_43" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_44" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_45" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_FairValueOfWarrants_46" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_AmountOfWarrantTransferredInEquityDuringPeriod_47" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_48" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfCompensationWarrantsGrantedToAgents_49" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_50" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_FinanceCosts_51" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares_52" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_ProceedsFromWarrantsAndCompensationOptionsExercised_53" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfWarrantsAndCompensationOptionsExercised_54" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_PercentageOfWarrantsAndCompensationOptionsExercised_55" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_56" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_57" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_58" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_GainLossOnRevaluationOfFinancialInstruments_59" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_60" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_61" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_FairValueOfCompensationUnits_62" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_63" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfWarrantsConvertedToOrdinaryShares_64" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_ValueOfWarrantsConvertedToOrdinaryShares_65" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfCompensationUnitsConvertedToOrdinaryShares_66" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfWarrantsIssuedUponConversion_67" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_ConversionPricePerWarrant_68" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfWarrantsIssuedUponConversionOfUnits_69" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants_70" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfPreferredSharesCommittedToBeAcquired_71" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_72" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired_73" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_74" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_AmountOfNonCancellablePurchasePrice_75" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_AmountOfTranslationTransaction_76" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_TotalAllocatedAmountTranslationTransaction_77" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue_78" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_CurrentPortionOfLongtermBorrowings_79" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_80" order="410" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_ApproximatelyCashAndCashEquivalents_81" order="420" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_FinancialLiabilities_82" order="430" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_NumberOfSharesIssued_83" order="440" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_ParValuePerShare_84" order="450" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_85" order="460" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_NumberOfCommonSharesCalledByWarrants_86" order="470" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_87" order="480" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_88" order="490" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_ifrs-full_WarrantLiability_89" order="500" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_ShareBasedCompensation_90" order="510" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_39" xlink:to="loc_imc_FairValueOfInvestment_91" order="520" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INVENTORIESDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InventoriesTable" xlink:label="loc_imc_InventoriesTable_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesAxis" xlink:label="loc_imc_ClassesOfInventoriesAxis_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ClassesOfInventoriesDomain" xlink:label="loc_imc_ClassesOfInventoriesDomain_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkInProgressMember" xlink:label="loc_imc_WorkInProgressMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FinishedGoodsMember" xlink:label="loc_imc_FinishedGoodsMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisAxis" xlink:label="loc_imc_TypeOfCannabisAxis_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TypeOfCannabisDomain" xlink:label="loc_imc_TypeOfCannabisDomain_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BulkCannabisMember" xlink:label="loc_imc_BulkCannabisMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PackagedDriedCannabisMember" xlink:label="loc_imc_PackagedDriedCannabisMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisProductsMember" xlink:label="loc_imc_OtherCannabisProductsMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherCannabisMember" xlink:label="loc_imc_OtherCannabisMember_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InventoriesLineItems" xlink:label="loc_imc_InventoriesLineItems_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CapitalizedCostsOfInventories" xlink:label="loc_imc_CapitalizedCostsOfInventories_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoriesAtFairValueLessCostsToSell" xlink:label="loc_ifrs-full_InventoriesAtFairValueLessCostsToSell_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_imc_InventoriesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_InventoriesTable_1" xlink:to="loc_imc_ClassesOfInventoriesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ClassesOfInventoriesAxis_1" xlink:to="loc_imc_ClassesOfInventoriesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ClassesOfInventoriesDomain_1" xlink:to="loc_imc_WorkInProgressMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_ClassesOfInventoriesDomain_1" xlink:to="loc_imc_FinishedGoodsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_InventoriesTable_1" xlink:to="loc_imc_TypeOfCannabisAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TypeOfCannabisAxis_5" xlink:to="loc_imc_TypeOfCannabisDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TypeOfCannabisDomain_5" xlink:to="loc_imc_BulkCannabisMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TypeOfCannabisDomain_5" xlink:to="loc_imc_PackagedDriedCannabisMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TypeOfCannabisDomain_5" xlink:to="loc_imc_OtherCannabisProductsMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_TypeOfCannabisDomain_5" xlink:to="loc_imc_OtherCannabisMember_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_InventoriesTable_1" xlink:to="loc_imc_InventoriesLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_InventoriesLineItems_11" xlink:to="loc_imc_CapitalizedCostsOfInventories_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_InventoriesLineItems_11" xlink:to="loc_ifrs-full_InventoriesAtFairValueLessCostsToSell_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_InventoriesLineItems_11" xlink:to="loc_ifrs-full_Inventories_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INVENTORIES">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INVENTORIESDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold" xlink:label="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryWritedown2011" xlink:label="loc_ifrs-full_InventoryWritedown2011_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_CostOfMerchandiseSold_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_InventoryWritedown2011_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INVENTORIESTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARETables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_EarningsPerShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings" xlink:label="loc_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_WeightedAverageShares_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARE">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIES">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" xlink:label="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" xlink:label="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureForSignificantAccountingPoliciesAbstract" xlink:label="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCPointHoldingsLtdMember" xlink:label="loc_imc_IPointMPointCPointHoldingsLtdMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FocusMedicalHerbsLtdMember" xlink:label="loc_imc_FocusMedicalHerbsLtdMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCFarmsIsraelLtdPointMember" xlink:label="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCVenturesLtdPointMember" xlink:label="loc_imc_IPointMPointCVenturesLtdPointMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember" xlink:label="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RayarokPharmLtdMember" xlink:label="loc_imc_RayarokPharmLtdMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RosenHighWayLtdMember" xlink:label="loc_imc_RosenHighWayLtdMember_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighWayShinuaLtdMember" xlink:label="loc_imc_HighWayShinuaLtdMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolyTradingAndMarketingLtdMember" xlink:label="loc_imc_RevolyTradingAndMarketingLtdMember_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPlusPharmLtdMember" xlink:label="loc_imc_OranimPlusPharmLtdMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmMember" xlink:label="loc_imc_OranimPharmMember_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisGpIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisGpIncMember_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCannabisManagerIncMember" xlink:label="loc_imc_TrichomeFinancialCannabisManagerIncMember_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeAssetFundingCorpMember" xlink:label="loc_imc_TrichomeAssetFundingCorpMember_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeJwcAcquisitionCorpMember" xlink:label="loc_imc_TrichomeJwcAcquisitionCorpMember_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeRetailCorpMember" xlink:label="loc_imc_TrichomeRetailCorpMember_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SublimecultureIncMember" xlink:label="loc_imc_SublimecultureIncMember_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CannacanadaIncMember" xlink:label="loc_imc_CannacanadaIncMember_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymInternationalBrandsIncMember" xlink:label="loc_imc_MymInternationalBrandsIncMember_22"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_HighlandGrowIncMember" xlink:label="loc_imc_HighlandGrowIncMember_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_26"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_IPointMPointCPointHoldingsLtdMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_FocusMedicalHerbsLtdMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_IPointMPointCFarmsIsraelLtdPointMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_IPointMPointCVenturesLtdPointMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_RayarokPharmLtdMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_RosenHighWayLtdMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_HighWayShinuaLtdMember_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_RevolyTradingAndMarketingLtdMember_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_OranimPlusPharmLtdMember_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_OranimPharmMember_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeFinancialCannabisGpIncMember_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeFinancialCannabisManagerIncMember_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeAssetFundingCorpMember_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeJwcAcquisitionCorpMember_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeRetailCorpMember_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_SublimecultureIncMember_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_CannacanadaIncMember_21" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_MymInternationalBrandsIncMember_22" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_HighlandGrowIncMember_23" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_26" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureForSignificantAccountingPoliciesAbstract" xlink:label="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseProductionEquipmentMember" xlink:label="loc_imc_GreenhouseProductionEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GreenhouseStructureMember" xlink:label="loc_imc_GreenhouseStructureMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageMember" xlink:label="loc_ifrs-full_WeightedAverageMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRatePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationRatePropertyPlantAndEquipment_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_imc_GreenhouseProductionEquipmentMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_imc_GreenhouseStructureMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_RangeAxis_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_9" xlink:to="loc_ifrs-full_RangesMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_9" xlink:to="loc_ifrs-full_BottomOfRangeMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_9" xlink:to="loc_ifrs-full_TopOfRangeMember_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_9" xlink:to="loc_ifrs-full_WeightedAverageMember_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_14" xlink:to="loc_ifrs-full_DepreciationRatePropertyPlantAndEquipment_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureForSignificantAccountingPoliciesAbstract" xlink:label="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureForSignificantAccountingPoliciesAbstract" xlink:label="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock" xlink:label="loc_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_24"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory" xlink:label="loc_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_25"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_21" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock_22" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_23" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_24" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory_25" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureForSignificantAccountingPoliciesAbstract" xlink:label="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="loc_ifrs-full_RightofuseAssetsMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_RangeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_1" xlink:to="loc_ifrs-full_RangesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_BottomOfRangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_1" xlink:to="loc_ifrs-full_TopOfRangeMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_5" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_BuildingsMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_5" xlink:to="loc_ifrs-full_MotorVehiclesMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_9" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_9" xlink:to="loc_ifrs-full_RightofuseAssetsMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureForSignificantAccountingPoliciesAbstract" xlink:label="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureForSignificantAccountingPoliciesAbstract" xlink:label="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-full_CustomerrelatedIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureForSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_LicencesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_CustomerrelatedIntangibleAssetsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_BrandNamesMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_RangeAxis_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_7" xlink:to="loc_ifrs-full_RangesMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_7" xlink:to="loc_ifrs-full_BottomOfRangeMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_7" xlink:to="loc_ifrs-full_TopOfRangeMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" xlink:label="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:label="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestIncomeOnPlanAssets" xlink:label="loc_imc_InterestIncomeOnPlanAssets_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_imc_InterestIncomeOnPlanAssets_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUBSEQUENTEVENTS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsequentEventMember" xlink:label="loc_imc_SubsequentEventMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementAxis" xlink:label="loc_imc_AgreementAxis_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementDomain" xlink:label="loc_imc_AgreementDomain_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SimpleAgreementForFutureEquityMember" xlink:label="loc_imc_SimpleAgreementForFutureEquityMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MizrahiMember" xlink:label="loc_imc_MizrahiMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_XintezaApiLtdMember" xlink:label="loc_imc_XintezaApiLtdMember_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_15"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolvingCreditFacilityMember" xlink:label="loc_imc_RevolvingCreditFacilityMember_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_18"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_19"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RemainingAmountOfCashPaid" xlink:label="loc_imc_RemainingAmountOfCashPaid_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_22"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_24"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DeemedPricePerShare" xlink:label="loc_imc_DeemedPricePerShare_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_26"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Commitment" xlink:label="loc_imc_Commitment_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_imc_SubsequentEventMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_imc_AgreementAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_AgreementAxis_4" xlink:to="loc_imc_AgreementDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_AgreementDomain_4" xlink:to="loc_imc_SimpleAgreementForFutureEquityMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_7" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7" xlink:to="loc_imc_PharmYarokPharmacyMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7" xlink:to="loc_imc_VironnaPharmacyMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7" xlink:to="loc_imc_MizrahiMember_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7" xlink:to="loc_imc_XintezaApiLtdMember_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7" xlink:to="loc_imc_OranimPharmacyMember_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_7" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_15" xlink:to="loc_ifrs-full_BorrowingsByNameMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_15" xlink:to="loc_imc_RevolvingCreditFacilityMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_imc_RemainingAmountOfCashPaid_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_ifrs-full_CashTransferred_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_imc_CashConsiderationOfBusinessCombination_23" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_ifrs-full_NumberOfSharesIssued_24" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_imc_DeemedPricePerShare_25" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_26" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_imc_Commitment_27" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_18" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_28" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/DISCLOSUREOFNEWSTANDARDSINTHEPERIODPRIORTOTHEIRADOPTION">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" xlink:label="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" xlink:label="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" xlink:label="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterestIncomeOnPlanAssets" xlink:label="loc_imc_InterestIncomeOnPlanAssets_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ReturnNetOfInterestIncomeReMeasurementGainLoss" xlink:label="loc_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BenefitsPaidOrPayable" xlink:label="loc_ifrs-full_BenefitsPaidOrPayable_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PlanAssetsAmountsDeposited" xlink:label="loc_imc_PlanAssetsAmountsDeposited_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PlanAssetsForeignCurrencyTranslationEffect" xlink:label="loc_imc_PlanAssetsForeignCurrencyTranslationEffect_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_imc_InterestIncomeOnPlanAssets_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_BenefitsPaidOrPayable_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_imc_PlanAssetsAmountsDeposited_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_imc_PlanAssetsForeignCurrencyTranslationEffect_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGESTIMATESANDASSUMPTIONSUSEDINTHEPREPARATIONOFTHEFINANCIALSTATEMENTS">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract" xlink:label="loc_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory" xlink:label="loc_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract_0" xlink:to="loc_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EmployeeBenefitAssetsAndLiabilitiesAbstract" xlink:label="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/GENERALDetailTextuals">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract" xlink:label="loc_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionAxis" xlink:label="loc_imc_EquityTransactionAxis_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_EquityTransactionDomain" xlink:label="loc_imc_EquityTransactionDomain_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OvernightMarketedOfferingMember" xlink:label="loc_imc_OvernightMarketedOfferingMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreliminaryShelfProspectusMember" xlink:label="loc_imc_PreliminaryShelfProspectusMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_7"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_8"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MizrahiMember" xlink:label="loc_imc_MizrahiMember_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmMember" xlink:label="loc_imc_OranimPharmMember_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RevolvingCreditFacilityMember" xlink:label="loc_imc_RevolvingCreditFacilityMember_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_SubsequentEventMember" xlink:label="loc_imc_SubsequentEventMember_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares" xlink:label="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_21"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_23"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_26"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_Commitment" xlink:label="loc_imc_Commitment_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_28"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_29"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_30"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AcquisitionCostsOfCommonShares" xlink:label="loc_imc_AcquisitionCostsOfCommonShares_31"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IssuanceOfCommonShares" xlink:label="loc_imc_IssuanceOfCommonShares_32"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_33"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_34"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree" xlink:label="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_35"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CashConsiderationOfBusinessCombination" xlink:label="loc_imc_CashConsiderationOfBusinessCombination_36"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_37"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_38"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_39"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_40"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfOutstandingSharesAcquired" xlink:label="loc_imc_PercentageOfOutstandingSharesAcquired_41"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PercentageOfRightsHold" xlink:label="loc_imc_PercentageOfRightsHold_42"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapitalOfBusinessAcquisition" xlink:label="loc_imc_WorkingCapitalOfBusinessAcquisition_43"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_44"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_45"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_imc_EquityTransactionAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionAxis_1" xlink:to="loc_imc_EquityTransactionDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionDomain_1" xlink:to="loc_imc_OvernightMarketedOfferingMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_EquityTransactionDomain_1" xlink:to="loc_imc_PreliminaryShelfProspectusMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_imc_TrichomeFinancialCorpMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_imc_MymNutraceuticalsIncMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_imc_PharmYarokPharmacyMember_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_imc_VironnaPharmacyMember_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_imc_MizrahiMember_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_5" xlink:to="loc_imc_OranimPharmMember_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_14" xlink:to="loc_ifrs-full_BorrowingsByNameMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_14" xlink:to="loc_imc_RevolvingCreditFacilityMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_17" xlink:to="loc_ifrs-full_NonadjustingEventsMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_17" xlink:to="loc_imc_SubsequentEventMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_ParValuePerShare_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_NumberOfSharesIssued_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_24" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_25" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_CashAndCashEquivalents_26" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_Commitment_27" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_BorrowingsInterestRate_28" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_29" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_Borrowings_30" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_AcquisitionCostsOfCommonShares_31" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_IssuanceOfCommonShares_32" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_33" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_34" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree_35" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_CashConsiderationOfBusinessCombination_36" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_37" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_CashTransferred_38" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_39" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_40" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_PercentageOfOutstandingSharesAcquired_41" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_PercentageOfRightsHold_42" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_imc_WorkingCapitalOfBusinessAcquisition_43" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_44" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_20" xlink:to="loc_ifrs-full_ProfitLoss_45" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/GENERAL">
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract" xlink:label="loc_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RIGHTOFUSEASSETS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfRightOfUseAssetsExplanatory" xlink:label="loc_imc_DisclosureOfRightOfUseAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_imc_DisclosureOfRightOfUseAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RIGHTOFUSEASSETSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandAndBuildingsMember" xlink:label="loc_ifrs-full_LandAndBuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InitialConsolidationsRightOfUseAssets" xlink:label="loc_imc_InitialConsolidationsRightOfUseAssets_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets" xlink:label="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalsOfRightOfUseAssets" xlink:label="loc_imc_DisposalsOfRightOfUseAssets_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisposalOfTerminationOfLeases" xlink:label="loc_imc_DisposalOfTerminationOfLeases_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_LandAndBuildingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_5" xlink:to="loc_ifrs-full_CarryingAmountMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_5" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_5" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" xlink:to="loc_ifrs-full_RightofuseAssets_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" xlink:to="loc_ifrs-full_AdditionsToRightofuseAssets_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" xlink:to="loc_imc_InitialConsolidationsRightOfUseAssets_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" xlink:to="loc_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" xlink:to="loc_imc_DisposalsOfRightOfUseAssets_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" xlink:to="loc_imc_DisposalOfTerminationOfLeases_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_9" xlink:to="loc_ifrs-full_RightofuseAssets_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/TAXESONINCOMETables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_dei_AuditedAnnualFinancialStatements_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_dei_AnnualInformationForm_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_45"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentInformationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1" xlink:to="loc_dei_DocumentInformationLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityRegistrantName_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentType_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AmendmentFlag_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AmendmentDescription_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityFilerCategory_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityVoluntaryFilers_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCurrentReportingStatus_15" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_16" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityInteractiveDataCurrent_17" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_18" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityEmergingGrowthCompany_19" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityExTransitionPeriod_20" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityFileNumber_21" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentRegistrationStatement_22" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentTransitionReport_23" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentAnnualReport_24" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentShellCompanyReport_25" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_26" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_ContactPersonnelName_27" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_CityAreaCode_28" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_LocalPhoneNumber_29" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityAddressPostalZipCode_30" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityAddressCountry_31" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine1_32" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine2_33" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityAddressCityOrTown_34" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine3_35" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityAddressStateOrProvince_36" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AuditedAnnualFinancialStatements_37" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AnnualInformationForm_38" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_Security12bTitle_39" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_TradingSymbol_40" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_SecurityExchangeName_41" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_42" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AuditorName_43" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AuditorLocation_44" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AuditorFirmId_45" order="410" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MotorVehiclesMember" xlink:label="loc_ifrs-full_MotorVehiclesMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementAxis" xlink:label="loc_imc_AgreementAxis_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementDomain" xlink:label="loc_imc_AgreementDomain_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AgreementWithFarmerMember" xlink:label="loc_imc_AgreementWithFarmerMember_9"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AreaOfCultivationAndProcessing" xlink:label="loc_imc_AreaOfCultivationAndProcessing_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AllocatedPercentageOfShareCapital" xlink:label="loc_imc_AllocatedPercentageOfShareCapital_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_MotorVehiclesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_RangeAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_5" xlink:to="loc_ifrs-full_RangesMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_5" xlink:to="loc_ifrs-full_BottomOfRangeMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_5" xlink:to="loc_ifrs-full_TopOfRangeMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_imc_AgreementAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_AgreementAxis_9" xlink:to="loc_imc_AgreementDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_AgreementDomain_9" xlink:to="loc_imc_AgreementWithFarmerMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_12" xlink:to="loc_imc_AreaOfCultivationAndProcessing_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_12" xlink:to="loc_imc_AllocatedPercentageOfShareCapital_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_12" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RelatedPartyTransactionsAbstract" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ShareholdersMember" xlink:label="loc_imc_ShareholdersMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-full_ProfessionalFeesExpense_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_1" xlink:to="loc_imc_ShareholdersMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_4" xlink:to="loc_ifrs-full_ProfessionalFeesExpense_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INTANGIBLEASSETSNET">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AdjupharmGmbhMember" xlink:label="loc_imc_AdjupharmGmbhMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PreTaxDiscountRateOfCashFlows" xlink:label="loc_imc_PreTaxDiscountRateOfCashFlows_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FixedGrowthRate" xlink:label="loc_imc_FixedGrowthRate_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_AdjupharmGmbhMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_5" xlink:to="loc_imc_PreTaxDiscountRateOfCashFlows_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_5" xlink:to="loc_imc_FixedGrowthRate_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_5" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CultivationsAndProcessingLicenseMember" xlink:label="loc_imc_CultivationsAndProcessingLicenseMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_CustomerRelationshipsMember" xlink:label="loc_imc_CustomerRelationshipsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_3"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_11"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_14"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_17"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_imc_CultivationsAndProcessingLicenseMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_imc_CustomerRelationshipsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_BrandNamesMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" xlink:to="loc_ifrs-full_CarryingAmountMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_7" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_7" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_11" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/INTANGIBLEASSETSNETTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasTable" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="loc_ifrs-full_GeographicalAreasMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="loc_ifrs-full_CountryOfDomicileMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ForeignCountriesTwoMember" xlink:label="loc_imc_ForeignCountriesTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignCountriesMember" xlink:label="loc_ifrs-full_ForeignCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OtherOperatingSegmentsMember" xlink:label="loc_imc_OtherOperatingSegmentsMember_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-full_OperatingSegmentsMember_7"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="loc_ifrs-full_UnallocatedAmountsMember_8"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ExternalCustomersRevenues" xlink:label="loc_imc_ExternalCustomersRevenues_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InterSegmentRevenues" xlink:label="loc_imc_InterSegmentRevenues_12"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_ifrs-full_CountryOfDomicileMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_imc_ForeignCountriesTwoMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_ifrs-full_ForeignCountriesMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasMember_1" xlink:to="loc_imc_OtherOperatingSegmentsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_7" xlink:to="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_7" xlink:to="loc_ifrs-full_OperatingSegmentsMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSegmentConsolidationItemsMember_7" xlink:to="loc_ifrs-full_UnallocatedAmountsMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_1" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_11" xlink:to="loc_imc_ExternalCustomersRevenues_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_11" xlink:to="loc_imc_InterSegmentRevenues_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_11" xlink:to="loc_ifrs-full_Revenue_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_11" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_11" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OPERATINGSEGMENTSTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/OPERATINGSEGMENTS">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_6"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems" xlink:label="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_WorkingCapital" xlink:label="loc_imc_WorkingCapital_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_10"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LoansPayableAsOfAcquisitionDate" xlink:label="loc_imc_LoansPayableAsOfAcquisitionDate_11"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_12"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentsAsOfAcquisitionDate_13"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate" xlink:label="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_14"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_15"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_16"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate" xlink:label="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_17"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_18"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LeaseLiabilityAsOfAcquisitionDate" xlink:label="loc_imc_LeaseLiabilityAsOfAcquisitionDate_19"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_20"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_21"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_BankCreditRecognisedAsOfAcquisitionDate" xlink:label="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_22"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_23"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_LongTermBorrowingsAsOfAcquisitionDate" xlink:label="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_24"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_25"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_26"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_27"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_28"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_29"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmacyMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable_1" xlink:to="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_WorkingCapital_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_LoansPayableAsOfAcquisitionDate_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_InvestmentsAsOfAcquisitionDate_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate_17" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_RightOfUseAssetsAsOfAcquisitionDate_18" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_LeaseLiabilityAsOfAcquisitionDate_19" order="100" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_20" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_21" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_BankCreditRecognisedAsOfAcquisitionDate_22" order="130" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_23" order="140" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_LongTermBorrowingsAsOfAcquisitionDate_24" order="150" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_25" order="160" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_26" order="170" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_27" order="180" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_28" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems_9" xlink:to="loc_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed_29" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_TrichomeFinancialCorpMember" xlink:label="loc_imc_TrichomeFinancialCorpMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_MymNutraceuticalsIncMember" xlink:label="loc_imc_MymNutraceuticalsIncMember_2"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_VironnaPharmacyMember" xlink:label="loc_imc_VironnaPharmacyMember_3"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PharmYarokPharmacyMember" xlink:label="loc_imc_PharmYarokPharmacyMember_4"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_OranimPharmacyMember" xlink:label="loc_imc_OranimPharmacyMember_5"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_PanaxiaLogisticsLtdMember" xlink:label="loc_imc_PanaxiaLogisticsLtdMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_ProFormaAdjustmentsMember" xlink:label="loc_imc_ProFormaAdjustmentsMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember" xlink:label="loc_srt_ProFormaMember_10"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="loc_ifrs-full_RevenueOfAcquiree_13"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-full_ProfitLossOfAcquiree_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_TrichomeFinancialCorpMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_MymNutraceuticalsIncMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_VironnaPharmacyMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PharmYarokPharmacyMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_OranimPharmacyMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_1" xlink:to="loc_imc_PanaxiaLogisticsLtdMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_srt_StatementScenarioAxis_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9" xlink:to="loc_imc_ProFormaAdjustmentsMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9" xlink:to="loc_srt_ProFormaMember_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_13" xlink:to="loc_ifrs-full_RevenueOfAcquiree_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_13" xlink:to="loc_ifrs-full_ProfitLossOfAcquiree_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="imc-20211231.xsd#imc_RestrictedShareUnitsMember" xlink:label="loc_imc_RestrictedShareUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_6"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_imc_RestrictedShareUnitsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_4" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image00003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !_ ,L# 2(  A$! Q$!_\0
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M+F*4W6FS-M24KAD;^ZW;Z'OCM7%52::NAWN?2'PT\;'Q7H[07C#^T[,!9?\
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M?)7AW29-=\0V&F1(6-Q,JMCLG5C^ !/X5];=!@5%5-6N[BDK!11161(4444
M%<=KGPS\/^(=8GU2^%U]IGV[_+EVK\JA1QCT KL:YZRU2X;QEKEG/./L=I;6
M\D:D !"V_<<]>PZ^E5%M:H:.>_X4SX4]+[_O_P#_ %J/^%,^%/2^_P"__P#]
M:J&E^/[Z5M;GN9V\F6QGO=.62W,?E>66P@)4!R5V-D$]2*@3QEXAC@LK2>Y
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+ %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image00013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "C :<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHHH **
M** "BBN+\;_$*P\*7BV<]M<7%TT8D"I@+@Y Y/T]*B=2--<TG8VH8>IB)^SI
M*[.THKPI_C5J4MRWV?3+2.(=%=F8G\>*LQ?&>]'^NTFV89YVR,./UKF>/HIV
M;/47#^.:NHK[T>V45Y##\:(BP\[1W SSLGSQ^57HOC)I#,!)I]Z@SR05./UJ
MEC:#^T92R/'1WI_BO\SU"BO/8?BWX;?&\7L?/\40./R-78?BAX5D(!OW0G^_
M XQ^.*M8FD_M(QEE>,CO2E]S.UHKFX/'/AF904UBU&?[Q*_S%78/$VAS@&+5
M[!L]/](4?UK158/9HYY86O#XH-?)FO156+4;*8 Q7ELX/0K*IS^M6$='&496
M'L<U5T]C%Q:W0ZBBBF(**** "BBB@ HHHH **** "BBB@ HKS_XE?%'2_ =U
M!:7MI=W5W-%YJ)$%"[<D<L3ZCTKR2\_:-U>6Z/V'1;&* =!+(SL?Q&/Y5M##
MU)JZ1C.O"#LV?3=%?-4'[1FI@_O]!LF&?X)F7C\<UJ0?M'0EAY_AV0+GG9=
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MZ^B:^=?VA#CQG;_]>B?^A/7)C%>G\SV<B=L2WY/]#S?33N9R235ZJ&EC#29
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M)-O%Z;!_*JLLACFVYX(XJY4U)-,F-1P::/L$^/?"HZZ]8?\ ?T4G_"?>%/\
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MS<<<TA['J'P3TPMJ,^K&ZMCF-H?LX?,HY4[B.PXKV*O$?@*%;7=28<E;<?\
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M4W'B5];-_9KY,<D'V/?^^.0/FV_W?>O&Y,?9FQZ_G7J7[,:AOB'.W7;8R?\
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M$-,VR=2\'_?!K;A\-WLJ1^7#*3+RB[@">,].O2H;GP_?0PB1X)UC&-S$C@D
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MCW*H>1Y&VJ@/<]S]!7.V7[F\,7\$H#K7H/@6!;F;5()<[)+94;:<'!)'6NO
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M1R^I*KA:=26\DF>Z?L_M_P 2?55])T/_ ([_ /6KU6O*?@ /^)5JQ_Z;(/\
MQTUZM7MX+^!$_/L\_P!_J?+\D%%%%=1Y)\W_ +20!\:V6>VED]?^FC5X/=*%
MNFVG.[YOI7NO[2R[O'&G].-,)Y./XV_.O";G N>,=.WUKUL/\,3R\1O(9111
M74<8E%%% Q,#T%+@#H***0"4444 ;EI&7TE=A^8J<#UYIEJ2_DSI]^,[6%%O
M,$TZ()]\*Q^G)IMJ?)NT[),N1]:U6Q-KG86&BC4XC>37'D6Z.$.U-[NQ&0%'
M3\2:Z8^'_L=DUPNC[EC&7DNF\QU'J4XP/PJCX9^30)"W1;V,G'^Z:Z.XO]/C
MOM5O+>YGGEO5:)8A"5"!NI8]\#L*^4S3'5HUI4E/E2MMIT^\^^R#*L//#0Q$
MJ7/)WW3:T=K=EIK=W*<MC>V6DPWV;1(IV4;(XE#)N'!88[XJ34M&FC6?,^EW
MTENH:>$1#>B\<\CW%6[_ %K3+F'4+5(9XTDCC6&4DG<8_N_+CY>]1ZEKD%Z=
M4C3]TL@7R98X,/*!C*/[?X5Y+K6NU4=_5^?_  #Z".&E.RE0BEU]U;/E\GM=
M^>EV<[J'AVUDNYTN+"6TEMP#+):'>J9&02IX[]B*XKQA:MIMQ';F9)D=!*DB
M @,ISV/(/!XKU?7-7@U%;Z-#+#&-CPLD97SL* 1)].QKR7XC2YOK/'>T4?\
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M-"?!&_R=^N6XSZ0,?ZU[G162P5%=#N?$6/\ YU]R_P CQ>/X*2QQJHUM./\
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0@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image00014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "  *L# 2(  A$! Q$!_\0
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M#2DK/^K*R^XWCCJL7=?U=W?WEV\F@\M8;4/L4Y+N>326NFWEY$9+>!F0=R0
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40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image00016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" 1B R\# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *DM_]<M1U);_ .N6AC6Y'1110(**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I+?_
M %RU'4EO_KEH8UN1T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J2W_URU'4EO\ ZY:&
M-;D=%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *DM_\ 7+4=26_^N6AC6Y'1110(****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6Q7IG@7X8^'O!\@N;2)[S4@,"\NL,R_[@'"_AS[UY#_PT!XB_P"@5I'Y2?\
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M44 %%%% !1110 4444 %26_^N6HZDM_]<M#&MR.BBB@04444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOKFOE[XT^&->U'XE:M=:?HNHW-LXBVRPV[,K8C4'! K:@_>-J+]X\HHKH/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M):B,'[7>?:%*-M4_<7U8@#J1S7%:/\,_%6N6'B"^UC5?[%NM<F<W5@]LDQ=
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M^.(6(_L)Y/>.>-A_Z%7UY16JKR-%6D?(MM\(?'$[ ?V(8O>6XC4?^A5U>A_
M#6)V1M;U6SLH_P")+<&9_P ^%_G7T?10ZTF#K2.*\&_#+PUX49)[.S^U7Z_\
MO=V1(X/JHZ+^ KMLYZTE%9-MZLS;;U84444A!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5);_ZY:CJ2W_URT,:W(Z***!!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5);_ .N6HZDM
M_P#7+0QK<CHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !4EO_KEJ.I+?_7+0QK<CHHHH
M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !4EO\ ZY:CJ2W_ -<M#&MR.BBB@04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %26_^N6HZDM_]<M#&MR.BBB@04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %26
M_P#KEJ.I+?\ URT,:W(Z***!!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5);_ZY:CJ2W_UR
MT,:W(Z***!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5);_ .N6HZDM_P#7+0QK<CHHHH$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M /IO4UE3B]XLRIQ=KQ93\=> ]<\!W5M+?/&T,CD6]Y:N0-PYQV96QS_6O?\
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M44 %%%% !4EO_KEJ.I+?_7+0QK<CHHHH$%%%% !1110 4444 %%%% !1110
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M0>GK6=IOQ!\.:AX8O/$$5Y)'I-I(8I)IHF3+<<*.K9R,8I<K%RLZNAB%!+$
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M]5MK^234M0DMF#01WMQYD:$<@XP,X/X5Z+UJYM/8J;3V*'B'_D7]5_Z\YO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5);_ZY:CJ2W_URT,:W(Z**
M*!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5);_ .N6HZDM_P#7+0QK<CHHHH$%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !4EO_KEJ.I+?_7+0QK<CHHHH$%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %26_^N6HZDM_
M]<M#&MR.BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%+@XSCCU
MH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **4@@X/!I* "BBE
M ).!R: $HHHH **** "BBB@ HHHH **** "BBB@ HHHZT %%*1CKQ24 %%%%
M !1110 4444 %%* 3T&:2@ HHI0,G YH 2BBB@ HHHH **** "BBB@ HHHH
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MK&^M-K(S"BBB@ HHHH **** "I+?_7+4=26_^N6AC6Y'1110(**** "BBB@
MHHHH *P_$OAJVU^\T2YN9YHGTF\%[$(\8=@,8;/;Z5N44T[ G87/.:\]U#X8
M0-J&H3Z'X@UC0[?46+WEI9NOER,>I&?ND^U>@T4U)K8:DUL<E<>!;)?"-KX=
MT>_U#1[* Y\RSD DER#N#DCG=G)JCX2^'7_",W5DUIXFUV:RM,[+"61?(((/
M!4#IDY^M=W11S/8?,]@I0<'BDHJ23SR/X9&SFNTT;Q7KVEZ9<SM</8VKH%5F
M.6VL1D UTMOX9MH/&+^(Q<7#7;V*V!C8@IL5MV[/7=6]15.393DV<_<>%+*X
M\8GQ%/))),;!M/:V8 Q-&QR2>^>U<Q;_  N;3EEM_#_B[Q!I&ER,6%E!(K+'
MGJ%8C(KT>BA28*3([6+[/;0P[WD\M%3?(<LV!C)/<GO4E%%(DP?$?AFVU[4]
M"OKF>:*31[HW4*QXQ(V,8;/;CM4WBWPYIWBO19=+U>-GMW(=61MKQN.C*>Q%
M;%%%V.[.)T+P/J&F:C9SW/C/Q!?VUJVY+29U"-@8 <@9857N_ANO]O:AJ6C>
M(]9T9-1?S;NWLW4)(_<@D94G^M=]13YF/G9Q6B?#ZUT/0M8TW2M8U6W_ +2N
M!<&Z60&>)AC[K8YSCDGGDUG:'\+1HLR-8^+?$4<0N/M,D E4)*Y(+;@!SNQS
M7HU%/G8<[%)R:K:E90:EI]S8WB>9;7,30RKG&588-6**DD\SB^$R?V2^D7'B
MSQ#-HP0I%9>:JI&#TS@98#T/%=#;^"+*#4_"]ZMU<F3P_:M:0*=N)5*A<OQU
MX[5U=%-R;*<VS#UCPW;:KXBT+69IYDGTAI6AC3&U]Z[3N[_E7,_\*HTB.\O&
MM-3UJSTV\=I)],M[HI ['KTYQ[9]J]"HH4FMA*36QB^#?#UOX5\.6NC6<TT\
M%ONVR2XW'<Q8YQQWK:HHI-WU$8/C7PS;>+=%&F7L\T$0GCN-\.-V4.0.>U2^
M,O#UOXK\-WFC7LTT%O<[0TD.-PVL&XSQVK9HHNQW9B^)_#UOXA\*7>@W4TT5
MM<PK TL>-X QR,\9XKG?%7PVA\1O9BX\0:Q;VUI'$L5M"Z^6KQC"R8(^][UW
ME%-2:V!2:V.<\-^%VTBUOK>_UG4]<BO!M==2<.%7!!48'0YYKF[;X7/IT<EK
MH7C#Q#I>E,Q864,BLL>>H5B,BO1Z*.9CYF<QXN\%:=XGTZQ@O)KN&[L"&M;^
M&3;/$P &[=WS@$^],\,>%+[1]2^V:AXKUG6<1&)(;HJ(USCYL <MQUKJJ*.9
MVL+F=K!6+KGAVWU?6="U*>::.72)WGA1,;9"R[2&SV^E;5%*XD[&)XN\.6WB
MC3;>RO)YH8X;N*[#18R6C.0#GL:P]=^'L-[X@NM:T76]4T"_O%"W9L6&V?'<
MJ>A]Q7;T4U)K8:DUL<._PST;_A!YO#$,UW%;SS+<SW6X---(&!W,2,<XK<\8
M>&[;Q3X9N-$O)YH;>8(&DBQO&T@CKQVK<HHYF',SF_%_A&T\3Z/9V5Q<W-K-
M92)-:W=N0)(9%& P[=*J6'@R>.RU6#5O$VLZL=0M6M&-RR!8E(Y9% P&]ZZ^
MBCF>P<SV,73?#MO8>#H_#D4TS6L=FUD)6QO*E2N?3/-8;_#RV'A_1=+M-;UN
MQ_LF(Q0W%I<>6S@G/S@#!KMJ*.9AS,Y3POX'LM"U:75I[_4M6U>2+R/MFH3;
MV2/KM4   5U=%%)MO<3;>Y@>./"]MXPT$Z5>W$]M%YR3B2#&X,AR.O%8NG^
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M-JNHZ;=Z<KB"6R958;L9.2.#QVI_A?PC<:%J9NY?$^NZJIC,?D7TH:,$X^;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5);_ZY:CJ2W_URT,:W(Z***!!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5);_P"N6HZDM_\ 7+0QK<CHHHH$%%%% !1110 4444 %%%% !1110 4444
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MD=%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBC#,6(4<#)/)JS4&84444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *DM_P#7
M+4=26_\ KEH8UN1T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J2W_URU'4EO_KEH8UN
M1T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ J2W_ -<M1U);_P"N6AC6Y'1110(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^5_PH^PV?_/G:_\ ?E?\*.>'\H<\/Y3YO_X:"\0_] W1ORD_^+H_X:"\0_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *DM_]<M1U);_ .N6AC6Y
M'1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "I+?_ %RU'4EO_KEH8UN1T444""BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ J2W_URU'4EO\ ZY:&-;D=%%% @HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *DM_\ 7+4=26_^N6AC6Y'1110(**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I+?_7+4=26
M_P#KEH8UN1T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ J2W_P!<M1U);_ZY:&-;D=%%
M% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *DM_]<M1U);_ .N6AC6Y'1110(**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "I+?_ %RU'4EO_KEH8UN1T444""BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH **** "I+?_ %RU'4EO_KEH8UN1T444""BBB@ HHHH **** "BBB@ HHHH
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M2XABCNPQ3")@-CG(XZ?6BP6-M2LBGC*GC!'6J?\ 9D7F/(KRJ[G+,'^8X!
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MOD>_M3&36#_9Y'@=&1'<M'DY !_A]CP:T*P;.[C<I%+$TH8!?-8X=VSG[O\
M".]7Y)6LX]Z'S(""0&R"@')Y]/K2$T7Z*AM[A)E&#M;NAZC_ #ZU-2$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !4EO_KEJ.I+?_7+0QK<CHHHH$%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK<_8H=E\/+=G)^1#M_ ^G_UJ8VC3HHHJ20HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J2W_UR
MU'4EO_KEH8UN1T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD9@BEG(50,DDX H 6BJ
M+Z@!,H$?[MEWAR<97(&1[<]ZM&XA"[O-CQTR&S3"Q)G')X Y)JG#;1SVL'G1
MYVG>N>,9.13YI_-B=+='D9AM#!<*,]R36;#JI&H+;Q)+*N5C"E-I  Y;GWZ^
MPH&D7;JQ:5V:.7:7;)R,XXZC_P"O59U<1@3RQBX+["DSX#)DXZ<X/!K0G@,S
M9,KJ K* IP#GN?<5E7_GP[1;K-,8QB1M^!(=O0\>GX<4($1RV%DUO#'%;JD]
MR>&*E@-IYQD\#T]JN9#V]RVD-"6P?N<9DQ[\?TI-.L&6[%Y-Q(T6W;YC/@G!
M.,] .F!6C)*L3Q*RO^\.T%5) /OZ4!<S]$ANHHQ]JC92PRS22;W+>GH!]*GN
MM4M+68Q32$28SM"DYJ[48@B#[A&H;U H 9#-'<$D(> #DX_"G;TC #."2^WC
M^\>@XI1##'(TRQJ)"/F8#DBLBVLD@CNC-(S),<-'Y>UL[N#D9- &G<6<-QL\
MX%@C;E&XC_\ 6/K4GF-YVS9\O0MGI4=N\Y:59D5=N-C ]1CZYJM/-+.&2(21
M2H<#+<,/[W&>/K0(T:K7-K'-=03.,M&&4=>]2VZ>7"B[0N!RH;=C\>]0ZA.+
M6$S/MV#ALYY] /?- ()98[;RXUA8_-A<+P#@GK22W,<#J;F5%R3L ST]6%+8
M"1(B)YC+,?F<XP 3V'L*CU!-/G4K>-!D?+EF (SSB@8UIIY1$;4%[8J7:0?>
M<8Z+TP<^M6;)4%K&8Q@,-W)!)SZD=34B%& V,&P <AL_C5.."\5SB:.)1(Q
M50=RDY ]O>@"Q)''<K)M6,G[F\C/U_*H+33_ +-=M.+B63<NUE<Y'' P.V,5
M+:Q+:EXQ(-C-N1,Y*YZ_KFK- $-U((8VD>0(J@]?Y^_TJM)=QF:-($,LGEF5
M=O;ICCWSP:NL%?*L V.Q&>M95Q]I>=H$C$:*",#(#QXX!;'R\YX%"!&G"&$
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M0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %26_^N6HZDM_]<M#&MR.BBB@04444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5BW$4=VUS]K$LB[\1Q[B%X]>PZ=ZVJ8T,3ON>)&;U*@TQIF)Y4T7F^1-"F1
M^ZS/N$0[CW'M^M.\Z\CB9TELVD49 $7+?CQ6TJ(OW44'V %/R:+A<R;:ZU"X
M5]J6JL$!5223GOGGC_Z]7KB4P6QG:%I)%7E4&3]![4MS;1W(3S,Y1MRLIP0?
MK2%)8>8F,J]2CGG\#_C0 L<K/$K-&T98[2C'!!K#MA']KF4S/<Q"0Q&,9.9#
M_>'7'4GG%:S+'?H\<B%H0596#8.1SVY!!J:3;"'DBB4R/UP,;CVR?ZT 9"K+
M-?Q_:<"2)Q&'MF(&"O*D9^OY UJQ3CS3$X*NIV]"0>,C!_G6#=ZG%),4MHC@
M.65L%<OQN(./7KU[],5LVEPL[ND<4L31G:6=.N.HR:;&T7:***DD#R*YZ&_%
MXRV:\!I"1(QV,N,XVC));CJ>#CO70G '/2JD]C'-AF^24 @,O\)(QD?A30T.
MM6N/F%P(W(; 9 0<=L@_KBLG6-5-O?CR6:2&#"SK%QM)/=OZ"MTD(F788'4F
MLR\L)7OH[F!T5R A#)G'<]/7%"!%B2[*+!*,O"^[)53D>F!63>WQMY)C<2O,
M&!5-HS'C@X(XR<$\^U6FU&UE;[/=-(C;5(D(*>9V.!U']0:CN%B6</%*L"*I
MC8+&#L"Y)QG@9!^M-#19N+^4QE[*(O&R^8)"O" ?>!''/\ZCETJTO5BNKIS.
M^T9;&%<=LBI([&*5(9+=XG@;YRS@N7&!@=<8J02RB-A;S)+(&$85EQM;'M^=
M(7H20VYCA;R$%NY 4  '&/7L:BEN9A=/#+:S.J8>.1.C8'/_ .JK%M),S;91
MN*EE9T7"D@\=_3^M+=/+$0Z<Q]&54+,/<8_PH K?:;2)G=,22A3(7ZGH.-WT
M(XJRUP$B:5\&+&0P.?\ /-8A@^U->R6S ,IV%E0X.%X)'][/4>PJS9ZL'CC"
M(A=2L<L:Y&TGN.,8ZY_"G8=BXBRQI)*J"2=\E%9LA>.F?[N?2E=[B(PK*\;]
MY,#!)/3:,]O?K39;-UFGN5N9%9@ -J!MH&20,^N:;%9036L;02R*_P!X3*P9
ML]QSTZGITI"'6,I=I(I76;R@ S-@,I_VAVR/TJ>XA@N3LGC#[>1NZ'O6<UN-
M.CFO)&<ONQM9\J1G R>_'K3=<>8P1S6-Q)'N&2=WRA>WRX).?:@ _LZRGLQ)
M9O+!&KEPP)VL<\G!ZC'2IO.F6R7[0TD3J<H58,\N/;&,'TZU-%%&T,UO+(\@
MVAR\@X(/(([8S586OE#[1YQNXR5*1F,=3@;AW_R:8RY8WHNHFF(6.'^$EN??
M/;J*-0)DM=L+Q@L1@ORIY^Z>>]96HO;7,US!=P1PS*K>0[L?F[[AQM!IBQ;;
M=A(T$:6^PQ>6 2C8QCK]>/?M18+%R_2=#$B3K%*=T\A!(&!CK[=L&DO@6TYK
MA!' Q&2@4G>!]T<<XSGH,U'_ &:9(HPUWNR,*X!.XGGGFH/L$DD,<0BG20-\
MV]A\V?XMP]""<#G% %O2K7SM. DFN0I!7R]X 3GH-O('MGI5RS3;=S;A*'"J
MIRV8\8XVU$7-A=1P+$9(YR0K9YWXR<D^M,O;BX5H4MMR,V55<\AN,%OIS[4"
M+%M;0F^GNEC <G8&[G'4_P"?2KM,AC$4*1CG:,9]:?2$%%%%( HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "I+?_7+4=26_^N6AC6Y'1110(**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHH **** "BBB@ HHHH **** "I+?_7+4=26_^N6AC6Y'1110(**** "BBB@
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M -<M1U);_P"N6AC6Y'1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4E
MO_KEJ.I+?_7+0QK<CHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4EO_ *Y:CJ2W_P!<
MM#&MR.BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %26_^N6HZDM_]<M#&MR.BBB@0444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %26_\ KEJ.I+?_ %RT,:W(Z***!!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
1 !1110 5);_ZY:**&-;G_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image00017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" #: @D# 2(  A$! Q$!_\0
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M4 0_9+?_ )X1?]\"C[);_P#/"+_O@5-10!#]DM_^>$7_ 'P*/LEO_P \(O\
MO@5-10!#]DM_^>$7_? H^R6__/"+_O@5-10!#]DM_P#GA%_WP*/LEO\ \\(O
M^^!4U% $/V2W_P">$7_? H^R6_\ SPB_[X%344 0_9+?_GA%_P!\"N4W'U/Y
MUV-<;0!UEE_QYP?]<U_E4U0V7_'G!_US7^534 %%%% !1110 5X'( ?A3= C
M(/B$@@_[XKWRL ^#]".E-IIL?]":X^UF/SI.9<YW9W9_#.* /+;R]N=%&N^
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M: .LLO\ CS@_ZYK_ "J:H;+_ (\X/^N:_P JFH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "FR-LC9\,VT$X49)^E.I) 61
ME5BA(P&&,CWYH XCPQXRO=:\/W^KQV%G/"H$EO#:WBLZ#'*3DXV./O' /RG
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ML@='Q@;<JP..>O6NHK#\-^'H]"NM3D@FWQ7;Q,D>S'E*D2Q@9SS]S/;K6Y0
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MGCC"#:I8Y(<GHI[5\B5VGP<)'Q*T4C^_)_Z*>JE0@HMH;BK'VPIR,BBH[?\
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M^+_Z ]?-E?2?[4G_ "+^G_\ 7XO_ * ]?-E=V'^ UAL%=G\'?^2D:+_OR?\
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M=H[MC&Z^6P)!&",MR"!MSDC K5TK4+;5=.M[^PD\VUN$$D3[2NY3T." 1^-
M%JBBB@ IK2*O4@4K<*:^2_VDYFF^($.[^"Q11_W\D_QJZ<.=V&E=GUCYT?\
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M7I'G1_WA^='G1_WA^= 'DEMX(UQ=4M#Y"1V%U>3R:DA=3E([EY[<\'G);'?
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M7_T:]8XGX29['K%%%%<1F%>6_M%3,OPUU*,=',(/_?U#7J5>3_M&?\D\OO\
M>B_]&I5T_B0UN?)=%%%>D;&UX*<Q>,M!D7JM_;L/PD6ONNQ<R6R,>I%?"/@_
M_D;=$_Z_H/\ T8M?=>F_\><7^Z*X\3NC.9:HHHKF($?[IKY&_:,_Y* G_7FG
M_H;U]<O]TU\C?M&?\E 3_KS3_P!#>ML/\94-SRVBBBN\U/<OV6_^0MK7^[#_
M .U*^FATKYE_9;_Y"VM?[L/_ +4KZ:'2O/K_ !LREN%%%%9$F5XD_P"05/\
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MH ZRR_X\X/\ KFO\JFJ&R_X\X/\ KFO\J+W8;.?S9C!'L.Z4-M*#')SVQZT
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M$L1A< C/'% '8T5S?@>\-S:WT;S7L[Q7)!DNH)8B<JI.!( 0,Y^4= 1[5TE
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MK0<0M-$)&B .0J%LE5!/ & .V*UJY/[7<?\ />7_ +[-'VNX_P">\O\ WV:
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MR PC^Z&P<;@,D8&>!69]KN/^>\O_ 'V:/M=Q_P ]Y?\ OLT =6JA%"H JJ,
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M]2 !S7/?:[C_ )[R_P#?9H^UW'_/>7_OLT =917)_:[C_GO+_P!]FC[7<?\
M/>7_ +[- &U#H.CP74MS#I6GQW$H822I;('?=][)QDY[^M-;P]HKV26;:1IS
M6:.9%@-LAC5C_$%Q@'WK'^UW'_/>7_OLT?:[C_GO+_WV: -AO#VBNUNSZ1IS
M-;@+"3;(3$ <@+QP 3GBKU[:6U];/;WMO#<V[XW13('5L'(R#P>:YG[7<?\
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4T =97&U-]KN/^>\O_?9J/% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image00018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" '* G # 2(  A$! Q$!_\0
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MB@ HHHH **898P<%US]:?0 4444 %%%% !1110 4444 %%%% !1110 4444
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ME3(&3S4-OJ-K<3&**8-)V&,9^E"G'N:*A27V5]QH/K6ON<M>,/I(1_*HWO\
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M@!NQ^M)]HF\[SA+)YI.=X8[L_6E]8\B_[+=_B_ [KQX3]DML#)RW]*3PZ?\
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M+X4T'0-,U<ZGYUDPO"U@%V-<'D[F/ISQZ5H2:SX8O[R3[=J%JNFW_DZJBO(
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M^E>],H88(!%<!XG\)E-0_M*T4R8SN ZJ">?J/Y?K7EYS@9^Q4J=W:]_N.?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME&;X]>+WSY45LH[%;7'_ *$QJQHGQ]\465WG5+&WU*T8\JP6"11[,O'Y@T7
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M\51:?K%WJLVLZPS2PRIM"Q@= >,'[I[=NU<M7$JE/EEVN:QIN4;H\@DENI%
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M\R+TQFX/TJ.1MLC+N5MI(W*<@X[CVJ)I*9YA^C6G_P#'A;?]<E_D*GJ#3_\
MCPMO^N2_R%3U8@J"09O83L0@(XWD_,/N\#V/?Z"IZ@D3-["_E!@J./,SRN2O
M&/?'Z4 3T444 %?'G[20S\3]?X!QI\)&?]PU]@LP%?'?[2<T4?Q2UQ9'"-)I
MT(3/0G9T^M '*^&K6'4+S2[.YN8K6WF:-)9Y6VK&G&YB3[9KZ,T/X@>%]=U6
M\T/3A=0H(3!"\NWRBL7"[ #GW^E?/7P]TVWUOQ1X?TN]<K;74T<<I!P2N,D
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M6REM9H/019'ZY]*GCUH1QQ VREUY9@0@;KZ+Q3.%)=6(;2;:"7A7/(!E&3^
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MQZTQC$4^5FW;<@8)R?0UIRLR]HCU67QUX.LO^$CNM&T75SJ.NV\L4WVF=#%
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M3BS]KU+6;@^TD:#_ - -;5K^SYX @QYEA>7!'>6[<9_[Y(KUJBG8#@;7X/>
M+;;Y?AFS;'_/4O)_Z$QK<L_ _A2RQ]E\-:-$1T*V4>?SQ7144 <WXK\'Z;X@
M\+:EH@BBLH[R$Q&6WB4,G<$#'J.E?&OQ(\#^+?#_ (C6#6;.2\_<K#;W=K"6
MCGC3@'@<-C&0>?YG[NHI-)NX[GP#IOA7QE-$8['PYJSHV>?[/<]?<K6]#\-?
MB9?,N-#OUR=P+M'%@^O)&*^X**GV<;W:'S,^,X?@3\1[MLW$-O"3CF:^4_\
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M$R7#%(+=I7/38"Q'Y5I6GACQ%>D?8]!U6?/>.TD;^0K]#8;:" 8@ACC'3Y$
M_E4M38M:'P/:_"SQW=C,7A?4Q_UTC\O_ -"Q6U9_ ?XA72AFT>. '_GM=Q C
M\ Q-?;U%%@/CJT_9M\:S,//N='MU/7=<.Q'Y(:V[7]EW5G/^F>)+&(=_*MWD
M_F5KZJHHL@/G"S_9;T]<?;/$UU)ZB*T5/YL:W+']F?PA"O\ I5_K-PWKYL:#
M]$KW.BG8#R>T_9^^'T!!DTRZN"/^>MY)S_WR17H'A7PSH_A336T_P_8I96C2
M&4QHS-ER "26).< ?E6Q10 4444 %%%% !1110 4444 %%%% !1110 4444
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MGIR.?UH OT5GMJUNHYW_ *?XT6.JP7MTT$(DW*NXD@8[>_O0!H4444 %%%%
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MFD"NJ#D<@?\ UZP-C:HI%.Y0?49I: "BBB@ HHHH **** "L/QS_ ,B=K/\
MUZR?RK<K$\<?\B?K/_7K)_Z#5TOC7J15^"7H?/>@>*K""UM+.]>1;:&Q,)9$
M+,9'&QASP%"$].M;_P#PF>DO<0XU"6)$$:[C$Y)P) W/49W+C'0^V:Y30[2<
MZ+"\-MIUV=N\[B!)&IZ!LC'4Y_ ?C=?3KT74ZI86+;U^5\#:@WGG&WG&<=B<
M#Z5](Z5*3=_S1\K&M7BE;\G_ )G&7<BR7$SH[.K2,P9P Q!)Y..]5D/[Q?\
M>%=!)K%H8@G]GHK;UW,0I) *[OX1S\O_ (\:9<7JZNRVVGZ.OVEB,&!-S8!S
MT ].*[:DY<NL3SZ4(N5U+7T9]7Z NS0M.7TMHQ_XZ*O51TV6*+3+1'D566%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '-_$K_DGWB/_L'S_P#H!K\^[<L\$:@P !2OS\'FOO[XF3JO@#Q&"?\
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M<P]6/[^/_>K<K U8_P"D1_[PK?H&%%%% !1110 4444 %%%% !1110 4444
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M*** $Q2XHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image00019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00019.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ", G # 2(  A$! Q$!_\0
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MI$3(N7;[HY')J$,S<>6?PI K?;+? *G>.OU%-7N3*S5D?2?Q"4&QMB&_>98
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M9;$5?@9]755U/4;/2[1[K4KJ"UMT^]),X11^)JU7-^/_  ?IWC70)--U)=K
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M]P))=F[:FT;3CU)KU.BG[:6C["]E'7S/ [^TNC;QP^(/@W!>/$@C\ZRFC8L
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M.3R#VQ5^WN-IP:^7:L?ITKO8>;>;^]^M*MK,?^6A_.DU*6Z6Q9[,Q"0<DR=
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M:3=8]Y(P?RW5E6?B!A XN;)X)("J21AP=K%6./S7'XBLFXOXW&\Z=JD8D)=
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M:]<;3;>)+>&81O%]AN'$P3<2-P*O[D US.O1);V]Q#;HXM)+-I%9GW"8@??
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MG_A?X8^+]1\.Z=>V"Z5]EN85FC\V9@^&YY&.O-?3$FC:9(29-.LG)Z[H%/\
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M -?,?_H0I0W*J? V?1WQ'_Y!5M_UW_\ 96KR^8_NHO\ <'\J]1^(W_((M_\
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M:EU58:ILTJ***YS<**** "O/?C\<?"G6?^V7_HU:]"KSC]H5MOPHU;W> ?\
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MC<J>*)&+]:O"UM5;#WT&/5(V:JTBPK=8W,\ 89;9L)'?BA2N*5)QU=OO1L>
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M?TAS_2OOO[-!_P \8_\ O@4"WA'2&/\ [Y%'UKR%]5\SX2AAN9V'DV]U,?\
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M(7/ZXKT2BM8Y?16^ISSS?$2^&R_KSN<OJNE'2_AWK%A"[W#+8W(4A>6)1C@
M?6OBS[%<2Z?&%MKK<HP0(&/]*^^Z*[Z=J:Y4<4<1)-REJV?GJ;252=\<R^NZ
M)A_2I40@ %5_&(YK]!&4,,, ?J*C-O">L,?_ 'R*OVGD7]9\CX&C4 \D?A%_
M]:KL*2RX6&*>3T"6Q/\ *ONS[/!_SQC_ .^14BJJC"@ >PQ3]IY#^M>1\36>
M@Z_=X%IHNLS#MLLV']*VK/X<^,KPC;X=OUSWGD2,?J:^P**7M&)XJ71'S-I7
MP/\ $UTP-ZVG:>O??*9F_)>/UKT;X>?"0>$?$46L2:PUW)'$\0B6W$:_-WSD
-UZG14N;9G*O.6C/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image00020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00020.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ", H4# 2(  A$! Q$!_\0
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M_P"^$_\ BJ^9U-SW@P/791N.[YD.?3;1]0H]@]A ^F/^&@?#?_0-U;_OA/\
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M^%..YCBVU0G?L>_T445N?,!1110 4444 %%%% !1110 4444 %%%% !1110
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M%YH =1DJ0V.,@J>1UKK_ ("H)OB[9L.1%;3-_P".X_K7'7MY+?7C7$S9PH5
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M1]=T445P&AX_^T-'N3PP_P#T]2)GZH/\*\T\.IC2=A[$BO5?VA(_^)%H<_\
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M+QVY!%3S:C"\$8>(OGETDCVN0>C;^[#UQR.HI&JE)*QRVJMFXA3_ &A7T?\
M !-OP^0_W[N9OU _I7S5J$B-J:>7N*;_ )=W7'O7U#\#X_+^&NF'^^TK_G(U
M5#<Y<R=J"]5^IWE%%%:G@!1110 5EW7AW1+N9IKK1].GE;DO);(S'\2*U**
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M6,!B_P RR;MP/'^T>E:)]R6<EK6LVUW;3I+I&J[)V;D3 XRZN0/D[8'YUGV
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1110!'<0)<1E)5W*>U8MQX5TR8DM ,UO44 <I)X&TE_^6>*A;P!I1[-78T4
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MXRD@RIZBGT4 85QX6TR<DM ,U2D\#Z4__+/%=510!QS> -*/\)IG_"O-*/\
M#^E=I10!Q8^'FDC^']*F3P%I*_P&NNHH YJ+P9I4?_++-:=CHME9,&@B"D=Z
*TJ* "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image00021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00021.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "U G # 2(  A$! Q$!_\0
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MZB@ HHS1F@ HHHH **** "BBJEWJ=C9R>7=7EO#)C.UY #B@"W16;_;VD_\
M02M/^_R_XT?V]I/_ $$K/_O\O^- &E16;_;VD_\ 02L_^_R_XT?V]I/_ $$K
M/_O\O^- &E168?$&D#KJ=D/^VR_XT?\ "0:.?^8I9?\ ?Y?\: -.BLT:[I)Z
M:E9_]_E_QIW]MZ5_T$;/_O\ +_C0!H45GC6M+/34;3_O\O\ C2_VQIO_ $$+
M3_O\O^- %^BJ']L:9_T$+3_O\O\ C3QJE@1D7ML1_P!=5_QH N44BL&4,I!4
MC((.0:6@ HIDTL<*%YG2-!U9C@5!_:5C_P _EM_W]7_&@"U153^TK'_G]MO^
M_J_XT?VE8_\ /[;?]_5_QH MT54_M*Q_Y_;;_OZO^-+_ &E8_P#/Y;?]_5_Q
MH M454_M.P_Y_;7_ +^K_C2C4;(]+RV_[^K_ (T 6J*K?;[/_GZM_P#OX/\
M&E^W6G_/U!_W\% %BBH/MMK_ ,_,/_?P4?;+;_GYA_[[% $]%0B[MSTGB/\
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MM(B,JSH,]]U 'K?A7_D7;#_KD*U:SO#L@ET.R8*B@QCA!@?E6C3).(^*I/\
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M=1Q0!ZKX0?S/#.G/_>B!K7K$\$_\BEI7_7!:VZ9)P_Q8N&M]&LV7'-QM.?\
M=-<>ELYLTFC:)"P^4&$'=^E=1\9SCP]9G_IZ _\ '6K-TI5;2[5&Y!B7/Y4A
MHQ%FOHVP1"?^V8JTMY<!>1'G_<%6)H_+D9&[?K43 8H&5+C4+P'Y-@_X#427
MVH-_$@^J"K3J/2H\4 )]JORO,J?]\"J[WUVAP60_5*M=*CDC#]10!#]OU <J
MZ8_W!3UU74.[I_WP*D1=JXI0@)Z4  U&^8?>3_O@4BW%^[<R(!_N"I50"I5
M"$T 5YGE"D*P:;'RJ$')KK/A?<//+J(DP&0(N ./XJY[ -BQMAMG9"-QZYQ6
MM\(>9M6SZ1_^S4"9Z31113$%%%% !1110 4444 %%%% !1110 4444 %%%%
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MN+F25B?-24<*.Q!P.>M1[2IW.J&$PDW94_P9U/\ PG^O_P#0.MO^_3_XTO\
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MP5*,\/3;['46[ZC_ &--;112-:SH$8[(]Q&&/][_ &CG\*YA_).WR3*<GG>
M/RYJ-5WMA06;T R:5?OC'7/TK,[X0Y;E^.TC5\B252HW ADSG_OJAH$G^=I)
MG[98H/\ V:K9$PD5&08SC(FBSR<=>E13P7YFPBJO0@-)$3[?SJ-2>;S*L42Q
M:C:;"Q!D0_-C/WAZ$U]"2-+';I;VQ2/SE#LS-@R'TS[>E?/B33MJ%O'.P)2=
M> !P<CN*^A);<W6APN.7B)(^F:[L+LSP,]OS0OYF=JK&S@:TCX<C]Z_<^WTK
MGK.;9<$>QKJ+T)JEOE"%O%7E?[X_QKC"&CNB&!4C.0:ZSY\^D/")SX8TL_\
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M^)-86[U'P_%J,RP+$)W9Q@ D[?E=?7TJSK6BIJU]I%WJ.@I=3Z7B2U;YE,+
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M_I4L5P!<0K_M 52L;@G59E'<&D,DU/P>_BWX8W]M:J#J5E>-<6H_O,$ 9/\
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M,B[=RGUJSG/7O#PQH&FC_IVC_P#016A6?H0QH>GC_IWC_P#015^F2</\8/\
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MO7.W,VKWVN*WV"WC,480XOR(\.5((P,X&W#8'/2MCXV-)'XL\/RPM&LB6<[
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,4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image00022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00022.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "@ 74# 2(  A$! Q$!_\0
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M34J_$OP>W37K7\0P_I7R@[N.L2?]\TS.?X$_*B[%_;57LOQ_S/K8?$3PB?\
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MU\I_C7R-A?\ GF?SH(C'6+_QZE]57F)\,4NDW^!]>)XIT!_NZWII_P"WE/\
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MA^M6<@]1BL:. F27)B \QNL>3_.I_L[GH8?^_?\ ]>ORJ45?<_1G$T&C4_\
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MP[_X\[KZI_*O%/C1_P E(U'_ *X1_P#H%?J_#?\ N5/T?YG-E3_X4JGI_D<
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M)!/!QTJGGFIY%XJ"I<5'1#22V%-36/-S /\ IO'_ #J U8T__CZ@_P"NT?\
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M7RQ\. #X[T'/_/['7U1XM&?#]W]!_,5S8[_=*O\ A?Y'U/#FZ_Q(\MC^_/\
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M^$_K7DC%#$ZR%<%F!#'J*]XUS2;?6;'[+=&14W!P4.""*YX_#[22.9;H_P#
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ME\QFVD@\&M^BN/$8V=>/*U9'K8'**>#G[2,FW:Q\E?%C+_$OQ" ,GS%X_P"
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M+M:UTLKUQY8->H_\(/:]KF0?\ 6E'@FU'_+S)_WPM"X?S".D5^*"69X:6[_
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MNM34^HF7_P")JN_P.T3_ )9ZGJ2_5E/]*[O:0NY+KY'TBX@P5[W?W'@MO-+
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6;V1PUN)JLM*<$O77_(****Y3Y@__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image00023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00023.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "[ 8D# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHKPO\
M:X\1ZIH7@C3(=(O);3[=>>5-)"Y1RBH6VAAR 3C/TH ]THK\U?\ A)==/76M
M4_\  N3_ !I/^$BUH]=8U+_P+D_QH'8_2NBOS2_M_6/^@MJ/_@5)_C1_;^K_
M /05U'_P*D_QH"Q^EM%?FE_;^L?]!;4?_ J3_&GKKNMD9_M;457^\;N0#^=
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MMJ?\BEX<_P"P@W_HLU]%U\Z_MH[3X3\.;F*_Z>V#C/\ RS- 'R2**D\E_P"
M;QZIS2[%7_6/S_=3D_GTH*(JD\HCF0A!Z'K^5+YN/]6 @]1R3^-)##-<SQP6
MT;S7$K!(XT&YG8] !W- '9>!_ =_XST/6[KP^/,OM*59'@E7_7(0>$/0.,'Y
M3U[&N*9BQRQ)/0YZBOK;X<ZBOA Z-H&FV4,6GVEK+)X@E%S$9K><A,32C=G:
M"6&.WX5XG\:/#]G:WFGZSX:M"?#MQ;K!]J2194:X4MNW,I(W$8)^OM0*YYI3
MHVV2*WH>:;10,<Z['9?0XK=\ _\ (]>'?^PC;_\ HQ:Q)>51_48/U'^16WX
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M4444STPKYT_;0*CPGX<W M_Q,'P,X_Y9FOHLU\Y?MH?\BCX=_P"P@_\ Z*-
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MVAZWJ1U'3;1[MH;FU58V"$ @,#G/-:-G!XR\-0Z!"MUID<4FH_:;.6659/\
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M/2"O(OVCO&.L^#=!TBZT"X2":>Z:*0O&'RNPGO[BO7:^??VQG">%/#Y/_/\
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M@>G]H-Q_VR:@#Y(R/[P_.DX_O?K1Y:?W%_*CRT_N+^5 N5=@PO\ >_6DPO\
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MG[U?3#_LY^$C]V\U=?\ MLI_]EJK)^S;X<)^35M67\4/]*=SSGE[/G(749.
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M,_447&JU.3LF?7%%9OAO6K+Q'H5EJ^E2^;97D0EC;&#@]CZ$'(/N*TJ9J%?
MOQNE:?XN^*V=BQ6\*#)Z * !^E??5?G]\8&W?%?Q<?\ J(R"@:.0I>/I24O^
M>*!@01]/6D^@)]A2DE5)08./K7O]U\/[6[\2#1H_ 4UEHC+&7\0B\D58H_+#
M-+ACLX.>* *'@46>D^#WTMI+*ZMM2CW72LI_?,<$'.WJF,+VW9S7C6J6D-AJ
M-Q:PW0NXX7*+,@P''X]_6O;/">EZ5JWAM[O1VN;#2%G^R:A9QQM++-*/NBQ<
M\AIA@,ISLY/O52+X>Z%JL'B72=+MXD\36R1W+,MV39Z6ID ,)<G]X43<SN>,
M\"@1XIN Z(/QYH+,>I/TZ5[SIW@+PA>0Z//HFFWFM0R:=J,@#3-&U_/;E%5E
M"\J&); '8C--T'X?Z3JM[X<_MGP;>^'6NM6:REM)KJ5OM$7V=G# M@C#+CB@
M=SP:BO9I_A]X<?PGXL\1:3,UUID21?81)(5ELIO."RPRJ.O!^5NXK7U#X=6%
MSXHO-&C\"WFDZ/$SY\0O>2%(XU3=YN&^4@GMGO0%SP/KTYHQZTK8R0'#*"0"
M!@$>M)^- !6GX5G^R^*M%N.3Y=["W!P?OCO695G22!K6F9.!]KBR?^!B@#])
M=PKXB^/#;OC3XCSSCRA_Y#6OK]M3&>M?''QKE\WXQ>(G]3%_Z+6ML-_%B95/
MA9R%%%&*]DY0_'\Z"<=>*7\J]&\#731>"IX].N/#,6J_VCN<:RL1)A\O^'>#
M_%Z5,I<JN-*YA_#M[2'5)97GE2^\LK"(\9VD88CD'=C(]LYJ_P#$^\M=1NK>
M\GDF_M5U 92@7='V+<GD>O?O77Z>-.NO$&FZ-:V>EZM>7MN9]6N=+"QI8S!B
M5FAEP FQ<;A]T_6J>OZAX7L;+[7)+::V8IV>,R!3/JMSWEF(_P!7;IT6,8W?
M2L.:\[V+M[MCR+<,<!?J>:"^>"WX9KV_/@2R\<7#L=(O3J\;LH&T6NG1^3Q@
M=/,9Q_P$>YJ#3'MOL_A8V(\$-I?V2W&H"]$'V@OG][G=\V<5?MO(7)YGBW%&
MX>HKU[4%\#R>%;+3+@65N]QJ-[&FI6^#+:!9/W+.!R\1!P?;D=*TM4;0X]6\
M1KX<7PDUQML3;B]$)@P$83>66XSD G%'MO(7)YGB'7IS179_$.'38H-)>&;2
MY-;E61]0722/LR#(\L#'RAL9SBN,_.M8OF5R6K!2$9I:*8'TY^R#<Y^'^JQ$
M8$6I-SGKE%-7?VM)O^+70H.DFHP@_AN-<Q^RM=BV\%ZRH)R=2)/_ 'PM6/VH
MKTS^ ].CS][4HS_XZ:\!G8]CP3%%%%2>*%%%=G\-[*WO1KIDT_3]2O8;5'M8
M+V01HSF0!N=R\[<]Z!QCS.Q@^%K>"XUNW%TZ*D9\P(ZDB5AR%^A[^U=?\2;J
M+5[&WO+FXC-];@0J_ED/.O3#<=L<=@*T9].TK3VTN35] L&U34+DVQTS2;C?
M)'#@;9DPS;90_09P1U%7O%&EZ)9PWG]NWR7ILY ES=1JJ29'W+2!%./,/620
MY Y H-U"T6CQW!]#28QU('XU[);Z!X0_X2S1;F]M;;[+J\5NEMI45P2D19,R
MS2OG( / &>3ST%06?A^W.F^''T[PMH^I07$6Z^N9[HJZ-YS*>/,'1 #TH(]B
MSR+CU)^@H_#]:]7OO#WA Z%]C9TL=0N=5O+:TU 2[EB$;?NEE7/^K8'&[MP:
MO:GX:TFUU+7HM$T/2M1GM_L(AMY[K"J&B)F93O&?F [T![%GC5%=;\0-)L]+
M_LMHXK6UU*YB>6\L;6<316WS80 Y."5Y(R:Y*@SE%Q=F)39%#1L#SD$4ZD;H
M>.U D?4W[+-R&^$%DIR/+NKA.3G^//X=:]<\]?6O"/V:;CR?A3;!3UO+@G_O
MJO4OMK>M4>V=77Y\_%@_\73\6G/_ #$I?YU^@U?']MI6F7_Q?\>:=K=O"UX;
M]IX!,N2R9.=OX%3]*QQ%94*;J-72-L/2=:HJ:=KGB&?>C=[_ *U[?!X=1_$:
MV4OA6S33S*Z_:A&2-@SAL]!T''?/'2NE_P"$$T _\P^S_P"_=>=/.:,+76_F
MCTH934G>S_!GS7GW_6I'N)WC*/<3LF,%6E8C\LU]'_\ "!^'_P#H'V?_ '[I
M#X"\/GKIUG_W[J/[<H=F7_8M7^9'!:+X4^(&H^%]"U)X+7_A'[8.-/BN[E+9
M!OR-^ 023U#'D_2I8_ ?B2!?FT7PRH<HKD:B!YF%Y##?SNSN(]:]GL$OKF6T
ML7U:X6UW+&J;@511P, \<#I6Y<>'FW2K%K<K2#<41BA)QM53G&.IY]A6]+-(
M58N48O\  PJ9;*G)1E)?B?/W_"">*K)DC73?#\$D(0*JZEAACDX&_P#C_B]:
M='X0\8R[733]$D>U16,C:L6*;2<N<R<$\J3QP*]ZO=)CL_.DEUF\F*^7Y;Q^
M6=Y;/?VP?PJRN@J[3F+6;W F$+,1'\QP,D\<CG^=:+'Q;MRZ^J_KH9O M*_-
M^#_KJ?.2_#SQ7?VCV5CIFAI)<>4C26^J+ND92>2-^"6SSD=N*Y'Q;/J>FZCJ
MFC:QIYLKM719(3<2L(=H'W06((8<YYZ\5]0:O:2Z=J'EV.J2.JJKA]J @GG@
M@?3D5S6O>&K/Q#?"\UP1W]V$$?G3C+;1T&?QKFGG-&$G&2=UZ'1#**LXJ2DM
M?4^7:*^C_P#A7OA__H'VG_?)H/P\\/?] ^T_(TO[<H=F5_8U;NOQ/G#-26DB
MQ:A92."RI.C$ X)P0>M>[7MI9:#-J=A#I<RH84:R^S%51W.-Q(/+\C&!SVKD
M?BMH.EZ/IVC"RLX+;5KN96:*(?,!CD8_WB!7;'&1DX*WQ;$XG*_84G451-K=
M+I_7G;4^GEE+HK=-P!KY8^+G/Q6UWJ<B/_T!:^HK<,+>$.,,$4$>AP*\!\</
M'H'QNFN]74I8:A H27' !4#/X$<UVJJZ7[Q*[73N>1&"J24).R?4\SP?0_E2
M[6_NM^5>S:UI^HRN)-!>W>W:,8R5Y;)Y!YXZ?K6Y#IT'DQ^:,R;1O*CC..<5
MRSXGA"*ERK7IS:KUT/3AP_*<G'F>G6VC]-3Y]VM_<;_ODTFTG^!O^^:^AO[/
MM?[I_*C^S[7^Z?RK'_6R'_/O\?\ @&O^K<OY_P /^">0^!/"NI>)KB^2RGEL
M[2"'=<RJK'()P$" @N3Z>@)KM[7P)J<$:PPZ_=HB((PHTDG"JV0.OKS73'3[
M0]5-;VCZ?X9&G#^T4!N/-R>&+%/3C@?KUJ5Q+[:5DDO5_P# %/('3C=MOT7_
M  3B$^'>J7+JK>)G7SD8DG3-H 9@6!YX)*@U"? .JR22.OB"Z9W#[\Z7C(8
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M:V@D=GMK6/U*] #R,G_&NBGF4:D>:*\K7U"IPS"E2;G5M):_"[6]=K_,[/\
M9NDW_#-%V@".]G48[\@Y/YUZE7F_[.VDW>G?#6U-[&T;WD\EU&C#!"-@*?QQ
MGZ&O4OL[5ZIYQU4S[17C'QD^%UKXRO(]9TNZ.F>(80 +E<A90.@;'(([,/H:
M]CGZ5E7"@]11OH!\NR^ _BS"=D>M0NHX!\]>?S6JEWX1^+MK;2SMJ:NL:%RL
M<J,Q ]!CD^U?431I_=%1-&OH*Y_J>'_Y]K[D;_6J_P#._O9\8-K7Q 4X^WZC
MGT-HW_Q%1GQ#\0%_Y?M0_P# ,_\ Q%?:)'N?SIN/K^=+ZGA_^?<?N0?6J_\
M._O9\6GQ)\0!Q]MO_P#P#/\ \12?\)/X_'_+]>_^ 9_^(K[4_$_G1CZ_G1]2
MP_\ S[C]R'];K_SO[V?%?_"5>/E_Y?KO_P  _P#["D_X2WQZ/^7ZY_\  /\
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M\L[K\=07_&E_X4Y\1S_#/_X,5_QK[+\M?[HI-B^@I\D>P79\;?\ "F?B,?\
MGK^.I#_&E_X4O\1CW?\ \&0_QK[(V+Z"C8OH*.2/8+L^.!\%/B(>K'\=2%.'
MP1^(1/,BCZZE7V+L7T%+L7T%'+'L%V?'R_ SQ\>MS$/KJ)_PJ:/X#^.&^_>V
MX_[?W/\ 2OKS8OH*<J+Z"CE78+L^9-"_9ZU"6 MKOB.Y@E/W8[1FD ^K,1^@
MKMO"_P !_#>EW4=UJ)O-:N8SE3>OF-3_ +@X/XYKVE$7T%3HJ^@II);"N9EK
4IX7'& !@ #I5W[(OI5M12TP/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image00024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00024.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $K F4# 2(  A$! Q$!_\0
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M%&* $WKZT;U]:7%&* $WKZT;U]:7%&* $WKZT;U]:7%&* $WKZT;U]:7%&*
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MINT_WC2X/J: %HI-I_O&DVG^\: '44F#_>-&#_>- "T4F#_>-&#ZF@!:***
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHII6GR74D;R*A V)U)- %J48C;:,MCCZUP^EWNO1WUJ^I+=?9,OYFZ$#/IG
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M4;Q[_E3J* &[Q[_E1O'O^5.HH ;O'O\ E1O'O^5.HH ;O'O^5&\>_P"5.HH
M;O'O^5&\>_Y4ZB@!N\>_Y4;Q[_E3J* &[Q[_ )4;Q[_E3J* &[Q[_E1O'O\
ME3J* &[Q[_E1O'O^5.HH ;O'O^5&\>_Y4ZB@!N\>_P"5&\>_Y4ZB@!N\>_Y4
MX'(HHH *0L!UI:* &[Q[_E1O'O\ E3J* &[Q[_E1O'O^5.HH ;O'O^5&\>_Y
M4ZB@!N\>_P"5&\>_Y4ZB@!N\>_Y4;Q[_ )4ZB@!N\>_Y4;Q[_E3J* &[Q[_E
M1O'O^5.HH ;O'O\ E1O'O^5.H)H Q)/$MC%J(L9O.CN6E$2J\>-Q(SD'N,?S
MJOK&LZ2\KZ9JD4OS.J!7C(#DY(*G/M5V\T*RNSND5A)YIF#AN=W'Z<#CV%)=
M:#8W<12Z1I2SAV8L=SG&.3Z8'2@"AI=GH6KV<TMG;M]GD)BD4[E#8&,8STQ6
M'XEALUU*'P]I&G1_:KY09K@KO%M&/XN<X; X]^:FTO5KB&[O],\,:*]S!;R%
M?M<UQB(OCD9ZG'3 ]*GGTS5-*TD2VCR3ZO=7 DNYHEW%N.%&>B#@5HER:LS;
MY]$;UKHMG9Z,^FV2>1"\90LHR22,%CZGZUDVGA06<@:"Z^]";>7]WMWH>O?M
MGCT]:K?:]9_LF]B<WRW^\-%MA!(]0,#&W/ )[4VUG\2_;[3SH[@VYGQ."@&#
MW (_@ YSW-9MWU9HE961HMX8BDLV@GG\[*%06B&T$D$MM!'/ '7M6]8Q?9;2
M& R/)Y:!-[=6P.IJR** &[Q[_E1O'O\ E3J* &[Q[_E2+]_\*?31]\_2@!U%
M%% #9.GXTZFR=/QJIJ2SF$"V=DD+  A01^.>U %VFIW^M85G<:@UP@D5S!OP
M[-%M8'T ],]ZVU)YP.] $E%-^;T%'S>@H =13?F]!1\WH* '44WYO04?-Z"@
M!U%-^;T%'S>@H =13?F]!1\WH* '44WYO04?-Z"@!U%-^;T%'S>@H =13?F]
M!1\WH* '44WYO049;T% #J*;EO0?G1EO0?G0 ZBF_-Z"C+>@H =13?F]!^=+
MEO04 +12<^@I>: "BCFCF@ HHYI.: %HIN6]!^=&6]!^= #J*;\WH*/F]!0
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MLLV,UM%(Z!&= Q7.<$CIFDY.6XU%(X^U\*W#RRB]\AHY9(9&;>204Z[< 8'
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M\#O2IW^M.S34[_6@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+2*U*;OWET Q;W(%+=0^,[YX#'/INF1A\R*F9F(^I&*/9]V@Y^R+=CH5]8F
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M] &W17-3>*$C2U86I*S0"5BTJJ(R<[0<^X.3VK+OO&5S*IBL;%X;A=A;SE+
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M=/O'BFDWLA.21T,/B&UENHH%6<-(K'+1X"8SPWH3M./I5(>,M/*JP2Y(8/\
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M+Q[!:7<NQZ]K,\2E/"UR%=<GS;B->O;%5[N]\6S11_V?I>FV85P'\ZYWX7Z
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M&\W);CC;QQG.,^W2M#POHVHZ?J337KHT+6ZQ@!]VPCHH&.W.3WST%=5P*,T
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M;1Z"EHH 3:/04;1Z"EHH 3:/04;1Z"EHH 3:/04;1Z"EHH 3:/04;1Z"EHH
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M.D2>9ILK&..,[VRJ# X]JJ^&WS)*@CC4)&N&5 I8$GKB@#8^UQ><(1+%YI.
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ME@9-P("AE9\\G>/Y&C4Y'CU@2' ";#D*'(7//'W@<]ZMZ787$%^9IDMD0QE
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M3I^-.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
A110 4444 %%%% !1110 4T??_"G4T?ZS\* '4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image00025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00025.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &R X\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNVO_ ($M_P#$TG_#1.I?]"]:?^!+?_$UXCDT;C0%CV[_ (:)U/\ Z%ZT_P#
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MB'QLUB[37;'3$DQ;);^=LQU<L1D_@*TI4W4ERDR=E<[X_$_PJ#C[=(?<0/\
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M]5'S_??D_ET'ZU$>3D\D]310 5)* 1&X  9>>.XX-1U*OS6KCNC!A]#P?Z4
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M:F4#T)7GD==F0L?]Q!@?_7_&HJ**!!115_1](O-=U.+3["/?-)U)X5%[LQ[
M4 DV[(];^$NBV>G:+'K5QM^V:C*T,!/4(,\#Z[23[ 5?\+^+H=9^(.M6MQ-A
MH_W-@A/!1"=^/]HG!^@]JQKAM+\$+H-C>ZU>.=/GEN(GBM T<N[Y73(/8EAZ
MC=6?H'@G3/$=S<ZUHNN:E$8+@R+(UH$P^=V%)/)']:#OBY1Y8QZ'I-_H$-YX
MLL=;OID\JQC\NVB/_/5CRQ_0 5X1X[L4T_QKJ4,8 1G$H [;@"?US7H.J_$#
M0KO4M.-WJ.I0KIT_F36XL=OFR+Q\W/&#GBJ'C#P5<:_;S>*],GGFEN0LOV&:
M()((PN!M&<DX&<'J*!5K5(OD/*Z***#A"BBB@ HHHH FN?F=9?\ GHH8_7H?
MU%0U-]^S]XG_ $;_ .N/UJ&@;"OH_P"&W_(@Z7_N-_Z$:^<*^C_AM_R(.E_[
MC?\ H1H.K!_$SJZ***9Z 4444 %%%% "&O*_CVR+X A,B%Q]OC^7=CG:U>J&
MO*/C]_R3R/\ Z_XOY-0!\V/<R.FP82/_ )YH,+^/K^-14E+04%*"0002".A'
M:DHH L?:O,XN(Q+_ +></^??\<T>0DG^HE#'^X_RM_@?\\57HH 5D9&*NI5A
MU!&#25,ES(JA'Q)&.BR#('T[C\*79;R_<<Q-_=DY7\&_Q'XT %E>W&G7T%[9
MRM#<V\@DBD7JK Y!KV"'XGZW)):>)[>]EGTR)ECUC2<#_1R>/,C.,[#U'HW!
MKQN2&2+&]2 >AZ@_0]#5S2-6N=%U!;NVVMP4EB<929#]Y&'<$4"/7-/\9^(M
M-^(\&EZEKTU_HM^I^QS.%PR2#,;@@=0>#[USO_">>+X-'\0+<ZW<M=65S##'
M(57*?.X;MWP*1M+35- @.CN\D4;M<Z0S'+P2CYI+1_?C<GKBG:EI7]L7U]]D
M4B/7)=-GCQV\PN'_ "8-^5 BWJ_BWQ3%H_AO3+34)WUO4$\^60!=[!SA%Z8
MQ_*GZCXAUV?4%TFQUQXX-+BW:MJS*"-W\6..<'Y54<D_2IX[2>]UO4-8L2D=
MU=*]MIDLO$=C91?))=,>PX(7U).*X'Q#K-I)#'HNB;UT:V?=O?A[N7O,_P!>
MP["@!GBCQ-<>([U"SR_9+<;($D.6([NV.-Q[^G2L&BB@H**** "BBB@"PG[R
MQD3O$PD'T/!_]EJO4]F1]I5&.%E!C/X\?SP?PJ$@J2#P0<$4  KV;]G;_D9M
M9_Z\U_\ 0Z\9%>S?LZ_\C-K7_7FG_H= F?1-%%% AIKP3XT122^,[;8I(%DN
M3T ^9NIKWH]*\"^-9/\ PF%J,G;]B4X[?>:NG"_Q#.I\)YYMAC^^QE;^ZG _
M/_"G"\F0%8F$2'JB#@_7U_&J]%>G8Y[DV^&3[Z>6W]Z/I^7^%(T#A2R8D0=6
M3G'U'45%2JQ5@RDJPZ$'!H 2BIO.5_\ 71AC_?7Y6_P-'D!_]2XD_P!D\-^7
M?\*+@0T4$$$@@@CJ#10!U'@GPE)XJU&;.[['9H);A8V'F2#LB9[G&,G@5WUU
MH'BRZ\):LBZ5]DFFF@M[*QAF0+;6Z'?D'.,EL9/4D5Y3HNL7.AZG'>VVUB 4
MDB?[DL9^\C#N"*[.RFL;-9HTFED\)Z\/*;>Q9["<<J&/8J>_=?I7/54N:YI&
MUCJT\$37M]:^*]5T[-]# 6NM-5E_TFZ3 1@<[0K<$Y[BF8\9/:V5S?Z:;MY[
MNY&HV33)L>W<(%49;' !QZ8]ZX[0H[FUM/%'A*\)\V2 RQ<\&2/D$>Q&#6'+
MYUUX5T6UC+%Y+VX5>3R6\L"H4&W9O_AK>H[GH0\)7/@^SU&Y\/Q-?:G>,8;2
M5BJFS@(Y)R>7[9'I2O'K]MIFB!M.%[$UC]BU6PEE7$BJ?E;).-V"<$5SFMV3
M:YXPM]#CF,5AI-L(YY<X6)% +L??H/K56^F@U60ZU>J\/A^S_P!'L+4':UR5
M_A'MW9NPXZU*4G9M_P!=!W2,OQ9X='A_44$,A>TN%+PAR-Z#NK#U'KWKGZM:
MCJ$^IWKW5P1O; 55&%11T51V %5:[()J*4MS)VOH%%%%,04444 3)\]K(O="
M''TZ'^E0U-;$"=58X5\HWT/%1$%2588(.#0 E?1OP?\ ^2=VG_7:;_T,U\Y5
M]'?"#_DG=I_UVF_]#-<N+_A_,TI?$=W1117FG0<%\7_^1&_[>HOZU\_35]!?
M%U6?P1A1D_:H_P"M> RK$GWV+G^ZG3\_\*Z:&YG,I;6=@JJ68] !DU/&#;9\
MR;;GK$N&)^HZ?G3'N'P50"-#U5.,_4]34->C'8YNI<^TPGB*/[*W]]?FS_4?
MA5>2&11O/S*3]]3D?G_C4=.21XVW(Q4^H-588VBIO,BD_P!8FUO[\8_F.GY8
MI# VW<A$BCJ4[?4=10!%1110!L:#HBZH\UU>3FTTJT >[NL9P.R*.[MT _&O
M1+K6;:;3= \->6-+L-4M'D@\MB&MG+_N'9AR2=OS>N\US/@CQ;=:;;7&A"\C
MM(KM]]O<R1*ZPS]!N!!^1N 3VZ^M=!J?C+Q-)X<:6.:.VUC2)/(U* VT;;D)
M^25<C@9X...0:YJG,Y69I&UA_A&*Z\'7MG/KDD[ZQJ-V+.TM)9F811[MKS$9
M[]!_]>LK4M(N?&6H1:KH,TD)N+DV^HP"9@MI*"<R=?N, 3]>*VK_ ,;ZO<:Q
MX5NH+E!9ZC'&)XS"A.\-AP&(R/PK+TWQMK8T/7]3N[I&6$B"V A10)&)Y.!S
M@>M1[]^9;_TAZ;&S;^*M+_X1S6M(M;-;_1-*$*LLI)>ZC+$2R9/1LX8?2O-O
M$&AIIDD=W83F[TFZ^:VN,<_[C^CCO78#7_$46C6=MYHGUO56#V\0A1?)A_O,
M ,<]>> .:YWQ/XBN+RWCT@7BW4<+;I[A4"K-)_L@#[@Z ]^M524E+04K6.7H
MHHKJ,PHHHH =&YCE20?PD&G3((YG0= >/IV_2HZFF^:*&3_9V'ZC_P"L10!#
M2]Z2E[UG,:W/7O@5_P ?^M?]<HOYM7M5>*_ G_C^UK_KE%_-J]JKR9_$SJCL
M%>??&)2W@V%5!)-Y'@ >S5Z#7GOQC)'@R(@D'[6G0^S5)-7X'Z'AWD"/_7R!
M/]A?F;_ZWXT>>$_U$83_ &S\S?GV_"H**1Y%^Q-]I=N)?WP_Z:<G\#UH\N*3
M_5OL;^Y(?Y'I^>*AHH"XYXWC;#J5/OWIM2),\8V@@I_<89'Y4[]Q)ZPM[\K_
M (C]: L0T5(\+QC+#*GHP.0?QJ.@1+;0/=74-O'M\R5UC7<V!DG R>PKV+2/
M!NI:-JFG:9:0)]A659M3O?-4/<LOS",+G(C!QQWZFO&.M=A8:C/KD5M/;RF/
MQ-I@#P2Y_P"/R)?X3ZNH_P"^AQ0;46D]=SJ[7P;KFM6FJZ9K<,=NDURU[9W/
MG(YAE+?,I .<,I_,5>FTK6K>:?2],M?LVCV>G306C"= TT[ ?O&P<@DYQGI^
M-<3J%_':Z_IOC#3E,=O<3![B$?\ +&8?ZQ/H1DCZTFH)]D\6>(S$3Y<UE-*F
M#_"X!_J:#:\5T.N_X15=5O;/7]:M$2_@0F\LXW0K>2*/D;(.!GN#Z56A3Q3<
MVFO7%YBWU">6&YLF2=2(W0D!!@\#;QSUKD09;'P%#;1!C<:Q='"CJR+@ ?B<
M?G5RXTV2*W7PO9S)'Y2_:=8O&/R1G^Z3Z+Z=SQ3'S+M_P['^+-%:YTXZ]);P
MV5\"!>P(ZE)&/\:8/!/<5P]:>K:C#<".RL$:+3;<_NE;[TC=Y'_VC^@XK,I'
M-4:<KH****#,**** )K7YI6B_P">JE/QZC]0*AI0Q5@RG# Y%2W0 N&*_=?#
MK]#S0/H0U]'_  V_Y$'2_P#<;_T(U\X5]'_#;_D0=+_W&_\ 0C0=6#^)G5T4
M44ST HHHH **** &FO*/C[_R3V/_ *_XOY-7JYZ5Y1\??^2>1_\ 7_%_)Z8'
MS/2TE+2*"BG1QR2OLCC=V_NHI)_(5+]AO/\ GSN?^_+?X4 045))!-#CSH98
M\]-Z%<_G3GM;F-"\EM.B#JS1L /QQ0!#114D4$TY(AADE(&2(T+8'X4 $<TD
M60C$*>JGD'ZCI3]T$OWE,+?WDY7\NH_#\JC:*1)/*>-UDSC85(;\NM#Q218\
MR-TSTW*1G\Z .D\)Z_-X9U R2H;K2IRHNHXFYX.5=?[KJ>0>/2OH"P\+:=J6
MGPZEI][');2H98)H^  V\DC^[@R2''\)..U?+<7F^8/)#F3ML!S^E='9>,=>
ML/#UYX<266.RNVW2(B;9!Z@>@;OZ_G0(W/B!XPMK@R^'] 91IJ%5N;A./M)3
MA47TB0< =SDGK7GM6_[.N'&8(I91_=$9##\/\,U \$T:[GAE11U+(0* (Z*<
ML;O]Q';'7:I-(5*DA@01U!&"*!B45(EO/*NZ."5U]40D?I1%;SSY\F"63;UV
M(6Q^5 $=%6/L%[_SY7/_ 'Y;_"HFAE241/%(LAQA&0ACGIQ0 SZ58O/FG\T#
MB91)^)Z_J#1/87MKG[39W,&,9\V)EQGIU'L?RH/[RP4]X7Q_P%N1^H/YT 0"
MO9OV=?\ D9=9_P"O-/\ T.O&17LW[.O_ ",NM?\ 7FG_ *'0A,^B:***!#&Z
M5X#\:O\ D<;7_KR7_P!":O?7Z5X%\:O^1QM?^O)?_0FKIPO\0SJ_">;T445Z
M9SA1110 4444 2B=B L@$BC^]U'T/6EV12?ZM]I_NR'^O^.*AHHL YXWC.'4
MJ??O6EHFK+ITTD-U$9]-N1LNH,_>7LP]&'4&L])G0;0<KW5AD?E2_N9/6)OS
M7_$?K2:NK,:\CT=K1K*?3-827[5_9^UA<K_R]V!.TL?]J/.UAZ8--L]*CTO4
M[7SUS;:1=ZA=-[J@C*?F63'UK+\$>)(](G73=7P^D3/E9OO"W<C!/^XP)##T
M.:]?OM!TO2]+?4;J\2.UB17>9CN&U=NW_>.40^Y KCFW!V9JE=7/-DTM;/1;
MK^UYF@AED%SKEPOWY)#\R6<?JW.6],^U<-KFLRZU>B5HU@MHE\NVM8_N01CH
MH_J>YJ[XJ\3/X@O$2%&@TVW+"VMR<GD\NY[NQY)KGZZ:<&M7N9R?1!1116A(
M4444 %%%% !4US\T@E_YZ*'_ ![_ *@U#4WW[3WC?]#_ /7'ZT 0U]'?!_\
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ML?\ U_Q?R>O5VKRCX^?\D]C_ .O^+^3TP/FBEI*6D4>@?!<D?$FVQ_SZS_\
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M;9&?K6I'5]9NK\J5$SY53V4< ?D*H445TI)*R,R9_GMHV[H2A_F/Z_E7T/\
M!_\ Y)W:?]=IO_0S7SY;1@Q2>;G8RY1<\N5YX]L9YKZ%^$3E_A]:L0!^^EP
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M@\\;^.:\1%>W_L]_/KFK2^MG&A^JOC^6*!,^@*#THHH$1OTKP+XU?\CC:_\
M7DO_ *$U>_-TKP'XU_\ (XVO_7DO_H35TX7^(9U/A/-Z***],YST:U\;Z#=:
M1HL&J#7+6YTF(1H-.G"1S8Q@GD$'C^=8^C^,XM+^(,GB,VL\L$A=3')-OE"L
M ,[SU;C^E<C16:I1U\RN9G?ZKXQT2/PKJ>C:0-8N6U*17DEU.4,(L'/RX/M3
M]'^(T>B^%M(TB*U>=8)9!?PRJ/+GA?.5'OR.U>>T4>RC:S#F9VWB3QI9:CXZ
MTS7].LY!!8I"!!/@$[&)QP3Q@UIZGXW\/32:GJ%H?$9OK^,J;>2[V01DC'\)
MY7VKS:BCV4=/(.9G=>"_&.E:!X;O]*U""XD:YG656CA210 !U#'':LS5]>TZ
MZ\66&J6<4JVMNT3.K0)&QVON. IQTKF**?LX\SEW#F=K'L%K\8;'^WKR>_L+
MB>S#;K!PJ^=!N4!U/.,$C/7_ .MYMH&M/HWB&UOA+<+;)<K+-'"Y!D4-G!&<
M'\:R**4:48W2Z@Y-FUXKUU_$.OWUXDMS]DFF,D,4SD^6"/3) _"N_'Q6T8:[
M8W3:+*\5O;+']H+D2JX!'"[MI7Z\\UY-11*E%I)] 4FCJO#/B+3M*\6W/B#5
M89[R96DEMD1%4-*Q/S-S\N,]L]?:KWBGQIIOBG0;9)+&ZM=6LYBT$OF^:"C'
M)!<X;KR..,"N'HING%RYNH<SM8ZZX\9RR^ K715NK\:A%>--)<>:<,AS\N[.
M3U'%6/ WB[3?#FEZO9:C!<2?;C'M,42.!MSG(8X/6N)HH=.+30<SO<ZCQ#X@
ML+W7=.O],2>-+7!;]S' V0V>-N1^)KKKKXC>'9EN[A[._N;J>'8 \4<3!L=3
M*A!/Y5Y312=*+2\@YF2!U8?O$!/]Y>#_ (5*ENNT2D[U/W4Z,WX>GN*8B*B"
M649!^XG][W/M4;NTC[F.3_*K]!#_ #F%PLK=5(XQC ';%?1GPE3R_ -L@Z">
M;'TWG%?.7FDC#@./?K^=?1OPD</\/;,C.!)*.>O#FN;%_ :4MSN****\TW.!
M^,'_ "(Q_P"ON+^M?/TM?0/Q?_Y$;_M[B_K7S]+730W,ZA5-%*:2O2CL<RW+
M6G:E>Z1?QWVGW#V]S']V1.H]1[CVK0UOQ9KGB*&.'5+]IX8VW+&$5%W>N% R
M:Q:*.57O8=SI[?XA>*;73DL8M481)'Y:,8U,BKZ!R,UD6NMZA9:7=Z=;W!2V
MNW228 #<64Y4ANH(/I6?10H170=V;&K>*=9URYL[G4+UI9[, 02A0K+R#G(Z
MG('-7M1^('B35=.EL;J^0PS*%F,<"(TH]&8#)KF:*7)'L%V=%IWC;6]+TJ'3
M+>2U:TA9FC2:U23:2<GEA[U1M/$&HV,^HS6\D:-J,3Q7($0PRL<D ?P_A671
M3Y(]@NS8U+Q1J^L:19:7?W7GVME_J=RC<.,<MU/'K5<ZU?'0%T,RK]@6?[0(
M]@SOQC.>OX5GT4<J70+FM8^)M8TS2GTVQO7M[9YA.WE?*V\8_B'..!QTJ1O%
M6K/XC7Q TL1U-<8E\E<9 QG;C&<=ZQ:*.6/85V;MUXQ\07^G75A>ZE+=6URP
M9TG ?!!R-I/*_A5";6+Z?1K;2))0;*VD:6*/8,JS=3GJ>M4:*%%+9!=F[I?C
M#6]'TW^SK*YB6U$AE$<D"2?,>I^8&H+7Q+J]CK$^JVMWY-Y.")62-0K@]05Q
MC''I6311RQ[#NS4U?Q'JVO+"FI7C31P9\J,(J(F>N%4 54C;;&'G >/^!&_B
M_'J!3$1502RCY?X5_O\ _P!:HY':1RS')_E[4)+9!<D<K.Y;?M8]FZ?0&EF1
MA!$S @C*'W[C^9_*H*L0.VR6,'JNX C(R/\ ZV:B>@+<]7^!7_']K/\ URB_
MFU>U5XM\#"#?:R0NW]U%G!XZM7M->3/XF=2V"O/?C)_R)D7_ %^1_P FKT*O
M//C)_P B9%_U^)_)JDBK\#]#PBBBBD>0=!X1\2KX9U*>>6U-S;W,#6\T:OL;
M:>ZGL:EUO7=&GT2/2M%TV\MHA+YCR75VTA/L%SC\:YJB@I3?+RG?6?C?19;'
M11JVG:@UWI"A8&M+C8CXQC<,^PJEI?C6.V\?7GB6ZM9 MPDBB*$C*[@ .3CT
MKCJ*"O:RT.]O?B(FJ>"KS2;^S=M4N%5&NT"@2*K J7[YQQ5?2?%>CGPM9Z)K
M-OJ2K9S-+%+I\P0ODDX;GW-<510'M97NSK%\56@\?VNOBWNA:6[#$<DQEE*A
M2.68]>>F>*O>*O%^CZWIMU%:6]S'<32!P9+:%0/FR?F7YJX6B@/:RLUW.\T?
MXA+HOAO2M+BMGF$$LGVV*0#RYXGS\H]^165XT\2VWB#Q#%J.FQSVT<5ND2AC
MM92I/3!]ZYBB@3JR<>5G4ZYXL.J>&-$TR*2\2>RC=+EVD.)<X]\G\:M:%XUM
M=%\'/I#Z8MY.UWY^)O\ 5;>/0YSQ7&44 JDKW.I\5>)+'Q-XBLKMHKB+388D
MB-OM7<B@Y8*<\Y]3717OQ*TG4H+[3;G1)DTR>W$$?ES9= OW"$/RK@^A["O-
M**!JK)-ON=+X8\4#0K35X)_M,HO+-K>'8_$;'/.">.O:H/"7B!?#_B>WU>[2
M:Y$2NK -EFRN!R:P:*"5.2MY'8^*?%FFZYIAMK2UNHI#,)"TJPA<<_W%![^M
M:6D?$2PLM+L+>[T^]GDLT"A?.1XWQ_OJ64>P->>44%>VG?F+^IZB-1U2ZNUM
MHX8II"ZP#D1@]@:@2*)U\QF*(#C!/WCZ _YQ3(XQM\V3(C!P .K'T'^--DD:
M5LG  &%4=%'H*";]6.F+E@77:,84#H!Z"OHCX:,S^ M.+')^?)]?G-?.BNR?
M=/!ZCL:^BOAD<^ =..,??Z?[YH.O"?$SKJ***9W!1110 4444 (:\H_: _Y)
M[#_U_P ?_H+UZN:\I_: _P"2>P?]A"/_ -!:@#YE%+2"K6GV%QJFHVUA:)ON
M+F58HU]6)Q046M$\/:OXCNS;:/I\UW*HRWECA!ZLQX'XFNG_ .%.^.?^@.G_
M (%1_P#Q5?1OA?PU8^$]!M]*L4 6, RRX^::3NY^OZ#BMB@5SY:_X4[XY_Z
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M  HFP[:[=?\ ?E:3_A1%E_T'KG_OPO\ C1]:I=P]G(\2HKVO_A1%IVUZX_\
M =?\:3_A1%K_ -!^?_P'7_&CZS2[A[.1XK17M7_"B+;_ *#\_P#X#+_C1_PH
MBU[Z_/\ ^ Z_XT?6:7</9R/%:*]L_P"%$6?_ $'KG_P'7_&E_P"%$6/?7KK_
M +\+_C1]:I=P]G(\2HKV[_A1.G]]=N_^_*TO_"B=._Z#EW_WZ2CZU2[A[.1X
MA4T<:JGFRCY/X5[N?\/>O;$^!6EA@7UF\90>1Y:C-2/\#])D?=)K%^3T "H
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M "U+'&NSS9<B,'  ZN?0?U-$2)L\V4XC!P #RY]!_C39)&F;)'0855'"CT%
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M_P"!2?XT6#F1LUYOKOA#6;YO'YM[=&_MF&V2RS*HWE%PV?[OXUU__"7>&_\
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M\2\=?!TA\]&W!@9<C!/4 $#\*V;:/1+36/!Y\)/ -6E9!?QV;Y5H=G[PR@'
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M^"[:OR6Q3P]X<O\ 77D@T?Q'K$M]K#[BHVN/W".PZ)@#-',PL>B^)OAWX?\
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M0N"\>XN8[J\N6 ,B*5"H.B\^Y)/X5USQ$%!\KU,8TWS:G:HBQHJ(H55&  .
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M>MM3GO;D176EI9[7@0DY?>/0 '\:W7\5ZR/AGK6L"Z7[=;7TL,4GEK\JK,%
MQT/%;ECX T_38]%-I<W$5SI18)<+M#3(Q)9'XP0<U#<?#;2;C49IS=Z@ME/<
M?:IM.6?%O))G.2N,]><9K5SIM[$*,DC#G\>:EIGC#6[._8?V2H2&WN-@ MYV
MBW*&/HQSU[XJI?ZQXK;P3H'B"#Q"86O!;P30_94;+NY!?)^HX]J[B;P9IERV
MN_:?,FCUG9Y\;$80JNT%>.#W^M-?P982>&-/T%I[C[-8R121OD;V,;;AGC'Z
M4E."MH/ED8GB@:]H>@VUP_BZ5;B,&+;%81M)>RLWR*JGH<8''UKI?"MOK-MX
M?MEU^[%SJ3 O*P4 )GHO'!QTS5/Q'X+MO$FI6=_-J.HVLUHI6'[),$VD]6Z'
MGMFM71=)&BZ>+-;V\O &+>;=R^8YSVSZ5$I)QMU]"DG<T:Y+XC>&QXE\(W,,
M2!KRW'GVWKN7JOXC(_*NMHJ8R<6FAM75CXVI>XKVC7/@I+J&N7EY8ZI!;6L\
MAD2%H22F>2.#TSFJ8^!-Y_%K\'X6Q_\ BJ]"6(IM;F"A*Y)\"F/VC6E[;(C^
MK5[17#^ O 4G@J>]>345N_M2J,+%LV[2?<YZUV^:\^3O)LW6PM>>_&3_ )$R
M+_K\3^35Z#FO/?C'_P B9%_U^)_)JDBK\#]#PBK6G6%QJNI6]A:)ON+APB#M
MD]S[#K56O5_@UX>\VYNM?G3Y8LP6^1_$?O-^6!^)I'ETH<\E$] \,>#=*\,6
M"100)+=$#S;EU!=S_0>PK?,$)ZPQGZJ*RO%8U!O#%^NEW*6UZ8\12NX0 Y'\
M1X!(X!]:X_PYKT6@V^LKJ3ZQ#=6=J+E[/49Q, .1NC<==S8%,]/FC!J-M#T(
MV=J>MM"?^V8I/L%F>MI!_P!^Q7FG@'7[C5Y]0T2_UJ2XFO;<7<4T,AWP,W#Q
MJ3T*\$4[3[;4$G\62'Q!K$@T<NENDESD-F$G+<<D$YXQTH$JJ:32/2/[.L?^
M?*W_ ._2_P"%)_9EA_SXVW_?E?\ "O.+'Q+>Z!_9.IZI>SSZ?J.C!_WKY"W$
M:;N/=A^9J>]UK4]$^&]FU]J31ZQJ\H"SS/C[.)#DG/8(M(/:QML=_P#V7IW>
MPM?^_*_X4W^R=-/_ ##[0_\ ;%?\*P_ &O-KGAM?/N5N+NSD:VGE5LB0J>'S
MW##!J+X?.SZ;K!=F;&M7@&3G \PTS2+4E='0_P!CZ7_T#;/_ +\+_A33H>DD
MY.EV1/O;I_A7*W>NW-G\7&LYKUTTJ+0&NY(B?D#"7!?ZXKEOAY\1;S5?%=W#
MJ.HPW,&JPR7EA;1R!FM=C,/)8#H2@#<T#LCU/^Q-)'32[+_P'3_"E_L;2_\
MH&V?_?A?\*\]\)1>)/&FEVWBM_%MS8^?<%H["WB1H(XE<KY; C)8@=<]ZY[2
MO&6LZSX@E\+3:I>6,,^MW*-J;#DHA!2VB;H&([GH.G6@+(]D_LC3!TTZT_[\
M+_A2_P!E:=_SX6O_ 'Y7_"N6^(=Y?Z%I.EZU8W4\<&G7L1O8PQQ+;L=K;O7&
M0:X"7XC:Q9WOB+49+EFT[58)ET ;N/,B<1#;_O;MWOB@+(]I_LO3_P#GPM?^
M_*_X4HTVQ'2RMA](E_PKQ#7=5FT/Q-_9?B#Q;XALX;31;>0R63LQ><YW,_!Z
MGUQ]:;/JOBJ\N?"UKJLWB)KB?299YX-'E6.9R)<([CI]TC/UH"R/=!9VHZ6T
M(QTQ&*<((1TAC'_ 17E,?]HZIXBT?PA)J^N:79'36OY3<7 %[<.7(\LR#^Z.
M<"H?%MUJW@ZZ\*PZ3J&I>()Q<W86*2<,\Q\OY4<C[P4\\\\&@=CU'5=#TW6K
M)[34+.*:)ACE>5]P>H/TKYS\7^&IO"NORV#L9(&'F6\I'WT/K[CH:]K^&K17
MGA6/5_[3GU&\OV,MW+*2/+E[QA.B!>F/QJE\6/#W]K>&/M\*9N=.)E&!RT9^
M^/Y'\*#GQ%)2C=;H\#KZ-^&?_(@:9]'_ /0VKYRKZ+^&C8\ :;GT?_T,TCGP
M?Q,Z^BF;Q1O%,] ?13=XHWB@!U%%% !7F7QUQ_P@$>?^?V/^35Z;7F/QV_Y$
M*'_K^C_]!:G'<SJ_ SYPP/2EP/2DI:Z#S0P/2CCTHKJ?"O@+4_%UM-/8W-E"
ML4GE[;B4JSG&>  <TF[#C%R=D<M@>E''I7H$WPBUV&]M;/[?I;SW,AC5$G8E
M<*6)8;>!@?J*Q]*\"ZEK&M:KIEM<6@?2PQN)G<B/Y3@X.,]CV[4<R*]G/L<O
MCVH_"NYT/X5:_K>FPWYEL[&"<9@^U2%6E!Z$  ]>V:Y_5/"VKZ1XB70KFU)O
MW95B1#N$F[[I4]P:+H'3DE=HQL#THP/2NG\6^!=5\&K:-J4ELXNMP0P.6P5Q
MD'('K2^%? FJ>+K6[N;&>T@AM659'N9"HR1GC /^31=6N')*_+;4Y?BC\*ZW
M5OASX@T;5-/L;B.!QJ$HAMYX9-T;,>Q.,CUZ=*JW'@O5(?&0\+1M!<:@6528
MF)1<KN))(Z <GBBZ!PDNASGX4?A72Z]X(U7P]X@L=%NF@DNKW;Y)A8E3N;:,
MY [T:_X&UGP]K]GHTR1W-W>*# +8E@^21CD#G(HN@Y)=CFL#THP/2NUU'X7^
M(=/U>PTI?LUU>7JLZ)!(2$5<99R0 !SUI^N_"O7M#TB;4O.LKV&W&;A;60LT
M6.N00,X[TN9![.?8X?\ "C ]*Z34_!&L:5X5LO$4ZQ-8W84@1L2\88?+N&.,
MUK)\*=>?5K;3?/L1<3VAO.9&Q&@(&&^7@Y/Z&CF0>SGV.%_"C ]*Z[Q%\.->
M\-Z:-2G^RW5EN"M-:2[PA)P,C /7C-:<7P>\1R6BNUQIT=X\7G+8O/B4K^6/
M;KCWHYD/V4[VL>??A1QZ4LBM%*\<BE71BK*>H(X(INX4[HSLQV!Z5ZY\"Y!'
M?ZT> 3%%_,UY#N%>I_!,YU?5O^O=/_0JF>QK0_B(]T^TFE^TU1S1FL3T2]]I
M]ZY3Q/\ #JU\;:C'J$VH36KQ1"';&@8,,DYY^M;N37&^*/'&K>&=7%I8I;/'
M)$LA\Y"2#DCC!'I51FX.Z)FTEJ:7ACX2Z=X;UZ'5?[0GNY( ?+22-0 Q&-W'
M<#->A$ @@C(/6O$?^%N>(_\ GAI__?IO_BJ7_A;?B/\ YX:?_P!^F_\ BJ)U
M)3=Y,S52"V/9/[,L/LBVGV&V^S(VY8?*78#G.0N,9SS4K6MN]RER\$37$:E4
ME* LH/4 ]0#7BO\ PMOQ'_SPT_\ []-_\51_PMOQ'_SPT_\ []-_\54W'[6)
M[!/H6D7-PUQ/I5E+,QRTDENC,3]2,U8%C:++)*+6$22H$D<1C+J.@)[CVKQ?
M_A;?B/\ YX:?_P!^F_\ BJ/^%M^(_P#GAI__ 'Z;_P"*HYF'M8'L*Z-I:Q^6
MNFV83RS%M$"XV$Y*]/NYYQTI]GI>GZ>6-E8VUL6^\8853/UP*\;_ .%M^(_^
M>&G_ /?IO_BJ/^%N>(_^>&G_ /?IO_BJ.9A[6!Z_-HUG/KUKK+J_VRUAD@C(
M;Y=KE2V1_P !%/U'1],U>-(]2T^UO$0Y5;B%9 I]LCBO'?\ A;?B/_GAI_\
MWZ;_ .*H_P"%M^(_^>&G_P#?IO\ XJE</;1/8KC2--N[!;"YT^UFLU "P20J
MR#'3"D8%2VUA9V=F+.VM((;4 @0QQA4P>HP.*\8_X6WXC_YX:?\ ]^F_^*H_
MX6WXC_YX:?\ ]^F_^*HN'MHGL%AH>DZ7YO\ 9^F6=IYW^L\B!4W_ %P.:<=(
MTUK*.R;3[0VD3!HX#"NQ"#D$+C .:\=_X6WXC_YX:?\ ]^F_^*H_X6WXC_YX
M:?\ ]^F_^*HN'MHGK7_",:!Y_G_V'IOG;M_F?9(]V[.<YQUSWJQ?:/IFJ,C:
MAIUI=L@(0W$"R;<^F1Q7CO\ PMSQ'_SPT_\ []-_\51_PMSQ'_SPT_\ []-_
M\51</;1/9?[-L-MNOV*VVVQW0#REQ$?5>/E/TI[V=K+=174EM$]Q""(Y60%T
M!Z@'J,UXO_PMSQ'_ ,\-/_[]-_\ %4?\+<\1_P#/#3_^_3?_ !5%P]M$]E&F
M6 MY[<65L(+ABTT8B7;(3U+#&"3WS3Y;*UFLS9RVT,EJ5"&%HP4VCH-O3%>+
M_P#"W/$?_/#3_P#OTW_Q5'_"W/$?_/#3_P#OTW_Q5%P]M$]CT_2=.TB$PZ;8
M6UG&3DI;Q*@)]\"H/$.AVWB/0KK2KO(CG7&\#E&'(8>X->1_\+;\1_\ /#3_
M /OTW_Q5'_"W/$?_ #PT_P#[]-_\534K.Z#VL34_X438?]!VZ_[\K7;>'-%B
M\)Z+%H\5P\Z1,S>8X )W'/0?6O-?^%N>(_\ GAI__?IO_BJ[?PUK=UKVB1:C
M>"-9I&8$1@A>#@=<UI*M.:M)A!P;]TZG[2/6C[2/6LS>:7>?6LS4I>,?$EUH
M&@_;K)8GF$RIB4$C!SGH17!+\7]?'6RT\_\  7'_ +-6_P#$,E_"Q'_3=/ZU
MY-LI,YZLY*6AWP^,6M=]-L#^+_XTX?&/5N^E61^CO7G^RC909^TEW/1!\9-2
M[Z/:GZ2M_A3Q\9;WOHL'X3G_  KSC92;* ]I/N>ECXS7'?0X_P +D_\ Q-+_
M ,+FE[Z&O_@3_P#8UQ<?A74Y/#SZZ(XA8+G+-( W!QP/K532=&O-;U!+&QC#
MW#@L S;1@#)YH'[29Z!_PN>3_H!C_P "?_L:7_A<[?\ 0"_\F?\ [&N2'@77
M&2^98(6%BQ6XQ,I*D*&/UX-5-$\+ZKXB\XZ;;B40XWLSA0,]!D]Z!\]0[G_A
M<_KH1_\  G_[&G?\+G7_ * 3?^!(_P#B:Y&R\ ^(-1@::TM8I8UD:/<)UP2I
MP<<\C/>JVL^$-8T"V2XU*V2*.1]BD2JQ)QGH#[4!SU+7.X_X7.G_ $ G_P#
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M%M^(_P#GC8?]^F_^*HN'MHGL-_I5KJFBSZ5>AI[:>$PR[F^9E(QG/K[UD2>
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M4;* *VRO8?!8QX3L1[-_Z$:\GV5ZSX.&/"ME]'_]"--&]#=F[1113.D****
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M'_\ 6JE2D]OS1QV-W91LK$_X2?\ Z=1_WW_]:C_A)S_SZ#_OO_ZU7]5J]OR
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ME?Y-75UR_CP9T2W_ .OE?Y-0QS^%GG&RC95C9[4FP^E0<!!LI-E6=A]*/+-
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M/I_XMW'_ -?\7\FKU%C@5Y+\>IMW@)$]+Z(_HU 'S<:*:6I-U #J*9NI=PH
M=13=PHW"@!U%-W"DW4 /HIFZC=0 ^BF;J-U #Z*9NHW4 /HIFZC=0 ^BF;J-
MU #Z*9NHW4 /HIFZC=0 XUZU\!S_ ,3C61_T[Q_^A&O(MU>L? I]NM:O[V\?
M_H1H ]Y45,B4V%<BK:)0 (E>*?%OCQB@_P"G2/\ FU>X\*,UX5\7)@?&*_\
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MO>OAR-W@73C_ -=/_0VI'I4MCJ%6IT2A$JU''0;")'5E4H1*E H ?2$TM(:
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M6_?Z*B_TJU'\$?#P^]>:FW_;5!_[+4NM$I09X5:P23RA%&237T;\/M(N-/\
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M,4$7E[O;<237J]EI\%C:Q6MM"L4$2A$11@*!VH.F"LA8XZLHE.6/':GA:"Q
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M_P"- %RBJG]J:?\ \_UK_P!_E_QI?[2L?^?VV_[^K_C0!:HJM_:-B>EY;_\
M?U?\:/[1LO\ G\M_^_J_XT 6:*K?VA9?\_EO_P!_5_QH_M*QQ_Q^V_\ W]7_
M !H LT56_M&Q/_+Y;_\ ?U?\:3^TK'_G]MO^_J_XT 6J*J_VG8?\_P!;?]_5
M_P :!J5@>E[;'_MJO^- %JBJW]HV/_/Y;_\ ?U?\:3^T[ #/VZV_[^K_ (T
M6J*I_P!K::.NH6G_ '^7_&D.L:6.NI68_P"VZ_XT 7:*H_VUI1_YB5G_ -_U
M_P :3^V]*_Z"=G_W_7_&@"_15#^W-(_Z"EE_X$+_ (TW^W]''75K'_P(3_&@
M#1HJE'K&F2_ZO4;1\_W9E/\ 6K@(89!!!Z$4 +1110 4444 %%%-DD2)"\CJ
MBCJS' % #J*Y^Y\<^%;24Q3^(-.5QU7[0IQ^M,'C_P (GIXBTW_P(6@#HZ*Y
MX>._"9Z>(M-_\"%_QJ1?&OA=ON^(--/_ &\I_C0!NT5CIXK\/2L%37-.9CT
MN4Y_6IO^$AT7_H+V/_@0G^- &E16=_PD&C$X&K6.?^OA/\:D&L:8WW=1LS])
MU_QH NT55&IV#=+ZV/TE7_&GB]M6Z7,)^D@H GHJ,3PGI*A^C"GAE/1@?QH
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M&[<G7M1_"8#^E,/Q$\;,N#KVIX_Z[BL"E568X52Q]AF@+&V?B!XT(P==U/\
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M(?%=RT^IZC*\9Z1J2D:^P4?UJ+Q9KDOB?Q=?ZC*Q(GF(0$_=C7A1^0_6JN
M .@KHH45-W>Q$Y6V(!:(!R2?P%.^S1^_Z5+2\=_TKL]C3[&7/+N5S:1'KFC[
M)%[_ *58P<9'/TI*/8T^PN:7<K_8XLY^:E^R1]F<?C4]%'L:?8.>7<@%J@'W
MG_.E%L@_B<_\"J:BCV-/L'-+N0FU0]&<?C3?L:]Y'JQ11[&GV#GEW*XL@S !
MY"3P .]'V1<G]Y)P<$>AK3TS2[W6M2@TW3XC+=W#;(P#C'JQ/8#KGVKUCQWX
M*L[_ $#2KS272ZUD3QZ?--&,"[<#:Q/N"#\WUK.4*46DT4G)J]SQ3[&O_/5Z
M3[&/^>KU:961V1P59258'L1UI*T]A3["YY=RM]C'_/5Z/L8_Y[/5FBE["GV%
MSR[E;['_ --GH^QG_GN]6E5F/RJ6^@IWE./O%4_WFH]A3[#YY%/[&?\ GN])
M]B/_ #W?\JNXB'5V?_=&!^M&]1]V,?\  CFCV%/L'/+N4A9L>!.Y^@I_]GR]
M3.R_[W%6C(Y&-Q ]!Q3*/84^P<\BN;,C_E[8GV6FFS<C!N&(]"*M44?5Z?8.
M>13^P?\ 37_QVC^S_P#IJ/\ OBKE%'U>GV#GD4O[/_Z:C_OBE_L__IJ/^^!5
MRBE]7I]@YY%/[!_TU'_? I?L/_30?]\"K=%'U>GV#GD5/L3#E9!D?[.*W/#_
M (X\3>%;E6L=2F\I3S;3,9(F'I@]/J*SJ9)&)$*]^Q]*SJ8:+5X;E1J/J?4G
M@+Q_8>.-.=XU^SZA !]IM2<[<]&4]U/K77U\=^"_$,WA;Q=I^IH["-)!'.H/
MWHF.&!_G]17V&K!E#*<J1D&N$V%HHHH Y+QYX]L/!&EK+,OGWTX(MK8'&XC^
M)O11ZU\UZ]XM\1>,+MI-0O9)(\_+"AV1(/9?ZG)JQ\1==E\3>/=0F+$QQRFV
M@7LL:$C]3D_C5".-8D"+T'ZT7,JM7D6FY233"!\T@'T%._L[_IL?^^15ZBD<
MOMZG<H'3 >LW_CE(=+_Z;#_OBM"B@/;U.YFG2B?^6P_[XI/[);_GLO\ WQ6G
M10'MZG<R_P"R7_Y[+_WQ1_9,G_/9/^^:U** ]O/N98TR8=)U'_ 33A87:_=N
MP/IFM*B@/K$R@+;41]V_8?1FIZC6%^[J<@^DK_XUWW@/P9_PF*:E"Z/ L,8,
M-Z.BR_W".C CD]Q7*7EG/I][/:7*;9H9&C?TRIP<4%.M42N45N-?3[NKSCZ3
MO_C4JZIXHC/R:[=#Z7+_ .-.HH)^L3*<CZY-,TLFIS-(YRS&XDR3^=(&UQ>F
MIW'_ (%2?XU=HH#ZQ,I^9KPZ:I<_^!<G^-.^T^(?^@M=<?\ 3W)_C5JB@?UB
M97^V^)/^@Q=_^!DG^-'V[Q*/^8Q>?^!DG^-6** ^L3(/[0\3?]!B\_\  R3_
M !IPU/Q2!QK5[_X&O_C4M% ?6)D8U?Q8.FMW_P#X&O\ XT[^VO%O_0<U#_P-
M?_&G447#ZS,:-<\7#_F.:A_X&O\ XT#7?%XZ:YJ/_@:W^-/P?0T8]2*+C^L3
M$_X2#QA_T'-2_P# UO\ &C_A(?&'_0;U+_P,;_&EXI* ^LS\A?\ A(_&'_0:
MU+_P,;_&ID\8>-;<[DUW4AC_ *>"W\Z@HH#ZS([+PS\<O$.F7$<.M*FIVF<,
M2H291Z@C@GV(_&OH#0=?TWQ+I,6IZ7<":VD[]"I[JP[$>E?(EW;+-&6  D'0
M^OM77_!OQ9-H'C*'39)#]@U-A#(K'A9/X&^N?E_$4(Z:=135SZ?HHHIF@444
M4 <1\79F@^&.L%3C>J1GZ%U!KY1'K[FOJ7XT-CX9WP]981_X^*^6EY7\30-"
MT444#%#$=/RI?E;_ &3^E-HH 4J5ZCCL>U)2JQ7H?J*=\C=?D/MR* &44YD9
M1DC(]1R*;0 44489LA,[NV!F@#M?AI9Q)X@.N7UFLVGZ:-Q>5PD2S$@)N+<9
M&2<>PKU;3/$"3Z);_P#"8+!SJ9N;.5KQ/*NHRYP_7D(#T]A7$:?J&C/H-NT>
ME3&QAV>=;?:^-FTK.K+MY.&,GJP.<_+@:$FIZ?\ :+J.72)[IK3>;6$W(9%F
M681P",%<+P>.V!SF@1Y;KVD7>AZU<V-Y:R6SAV>-'[QDDJ0>A&/2LY59SA5+
M'V&:]"\9ZKI?]D"P^RR3W0\L6MQ-<^:1M&))1P/E8C _O8W8'?S]II&&"YQZ
M#@?I0,=Y#C[Y2/\ WVY_+K1M@7K([G_97 _,U%10!+YJ+_JX4'N_S'_"FM-(
MPP7./0<"F44 %%%% !1110 4444 %%%*JLWW1GWH 2BG85>K9/HO^-&\_P (
M"_2@ VX^]Q29 Z#/N:2B@!<DTE%% &WX,&?&VB_Z1%;A;R-S+*^U5 8'K[]!
M]:^R:^(K%@NIV;9Z7$?_ *&*^W,T$BU6U(E=+NV'40N>/]TU8W54U1O^)3>\
M_P#+!_\ T$T ?%MO_P ?(SW%7JH6W-RI]5J_7?A/@?J8U-PHHHKJ,@I=V?O#
M/N.M)10 [;G[IS[=Z;13MY(PPW#WZ_G0,;13MH;[K<^C<4A!4X8$'T- A**<
M$<]%/UZ4%!C#NH]AS0,[3PA;S:#YFLL]PM^Z>5;6<*XDD!&\Y8CY257A>I!]
MQ74Z5K-UX=TL6NF+J%W-=77GRV)D3S+%B^64,1@J<X<_PYKFM'\2ZCJ5J;1-
M3NEU! LD9+X$C1_<8?@-KKW&&[&M0ZKK+7=S+;:A<Q"5)O)W-GRVF*]?78/,
MX]0*Y9IMZFJM;0Y;Q/HB)=2:IIERU]9W)\^0B/#0EF/YID$!O;FN=\HC[[HO
MU.3^E=9XD\2WFR72HKVX:,QBWE1G!"1CG8<=78_,Y['Y1TKD*WA>VIG*UR3]
MRO>1_H-HH\T#[D2+[D;C^M1T50AS22,,,[$>F<"FT44P"BBB@04444 %%%%
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MQPH)^@H.42BG^2X^\ O^\0*-B#[TH_X"": L,HI_[L=G;ZG%)O':-!]1G^=
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MV6MSS#X?^%K3Q;XEDTJ_EN+=5@:3,>%8,K $'(]ZT;3P/I\WQ7G\)2W-R+-
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MUV\N=-DU"#3]5M\[[&[B8.5_O*0<,/I4&D>!/$.J:G;PII-Y:CS%+33QE40
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MM26,:YQDCKCW[5RVT]20![UZ[\)/#VK6.J7NJZE:RVEB+8QXN009"2"3@\X
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M#_PC6J?\\8_^_@I?^$:U3_GC'_W]%>@Z8@U'3+>[ 3]ZN3L)*Y!P<9YQ5O\
ML_VKEGG5>$G%I77E_P $Z(Y50DE)-V?]=CS/_A&=4_YY1?\ ?T4?\(SJG_/*
M+_OZ*],_L_VH_L_VJ?[<K>7W?\$K^R*/G_7R/,_^$9U3_GE%_P!_11_PC.J?
M\\HO^_HKTS^S_:C^S_:E_;E;R^[_ ((?V11\_P"OD>9_\(SJO_/*+_OZ*/\
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M *[^9[+Q.$KI.;LSJ_"&C7NBV$YU.Y,US<2;RGF%Q&/3)ZGU-=%N3T%>9_\
M"U[;_H%3?]_EH_X6Q:=]+F_[_+6%3"8VI)SE#?T_S-Z>*PD(J*G^?^1Z9N3^
MZ*-R?W17F?\ PMBS_P"@7/\ ]_5I?^%LV7_0,N/^_JU'U'&?R?BO\R_KN%_G
M_/\ R/2]R>@HW)_=%>:?\+9L>^FW'_?U:7_A;.G_ /0.N?\ OXM'U'&?R?BO
M\P^N87^?\STK<GH*,I_=%>:_\+9T[_H'7/\ W\6E_P"%LZ;_ - ^Y_[[6E]2
MQ?\ )^7^8?7,+_/^9Z3N3^Z*LV&QK^#$L<)#@J[C(!'3->6_\+8TW_GPNO\
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M^5_QI?\ A:.A]XKS_OA?\:/JN+_D8?6L-_.COOW?I1B/TK@O^%H:'_SSO/\
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M+V2ZE$\;R@"589"JR8]17E=MKNK6"[;:YDC7T#D#\JL'Q?K_ /S^R?\ ??\
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M\C_ ]T\P^AH$I!! Z'N*\*_X2K7/^?\ D_[^&D_X2G6_^?\ D_[^&C^QY_\
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MQ_X![YO;T/Y4N]O0_E7@7]N:M_S^2?\ ?;?XT?VYJO\ S^2?]]M_C2_L9_\
M/S\/^"/^V(_\^_Q_X![[O;T/Y4F]O0UX'_;6J?\ /W)_WVW^-']L:G_S]R?]
M]-_C1_8S_P"?GX?\$/[87_/O\?\ @'OF]O0T;V]#7@?]K:G_ ,_4G_?34O\
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M'^'^9['YOO1YOO7C?_":Z[_S]#\Z0^-==SQ=#\Z/[*K_ ,R_'_(/[9I?R/\
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MEM&'KYF/Z5[\T9J(Q>U '@#?!S7>S6A_[:?_ %JC/P<U\_\ /G_W\_\ K5]
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M_ODTG]GIWG3_ +YKZ./PO\)$Y_LK'TF?_&C_ (5=X2_Z!(_[_/\ XT ?./\
M9Z=ID_[YI/L"_P#/5/\ OFOH[_A5OA+_ *!1_P"_[_XT?\*L\)?] L_]_P!_
M\:8'SC]@7_GK'^5(+!?^>D?Y5]&_\*K\)?\ 0-?_ +_O_C2?\*J\)?\ 0.D_
M\"'_ ,: /G/^SQ_SUC_*C^SQ_P ](_RKZ,_X53X2_P"@=)_X$2?XTG_"J/"7
M_0.D_P# A_\ &@#YU_L]?^>D7Y4G]GC/^LC_ "KZ+_X51X2_Z!TO_@0_^-'_
M  JCPE_T#I?_  (?_&@#YU_LY?\ GI$/PI?[.7_GI'^5?10^%7A(?\PZ0_\
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M ,@A!_VUC_QKZ,\GVH\GVHL!\Z_\*W\7G_F%1_\ ?Z/_ !H_X5MXN_Z!4?\
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M** 'CI3NU%% #:::** &TE%% "&FFBB@!M)110 8'I1@>E%% !@>E&!Z444
M&!Z4444 &!Z48'I110 8'I1@>E%% !@>E&!Z444 %%%% "X'I1@>E%% !111
M0 4H ]*** %IP ]*** '@4\"BB@"05(M%% #Q3Z** "DHHH ::0T44 -I***
M "DHHH ;2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
? +1110 "EHHH 6G444 .I:** '"EHHH 6BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image00026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00026.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %# 5T# 2(  A$! Q$!_\0
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MO\J+ :5%9*W>MP.1<Z9!<1]GL[CYC_P!PH'_ 'T:<_B"QMP/MQFL><$W411
M?]_[G_CU%F!J44U'21%>-E=&&593D$4ZD 4444 %%%% !1110 4444 %%%%
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M'3DYQ;2-(]VQ%7<=S8&,GU^M.HI %%%% !1110 4444 %%%% !1110 4444
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M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA$4*JC"J!P .U $,MP4;"[#CKSS5)F+')_G5E+4LQ+Y%2BUCQ@@F@"A14\\
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MI_=7:-:RC_:4%XS^ $@_X$*U:S=>^71Y;@=;5EN??$;!R/Q (_&M($$9'(-
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M HI3C/&:2@ IR$ Y/..U-HH =&=LBGT-3ZO9-J&E7%LA42LN8BW19 <H3]&
M/X56K40Y13ZB@!)8DGA>*091U*L/4'K6=X=>5O#]DD[;IX8_(E;U>,E&/YJ:
MFT>YFN])MY;C/GX*2$KC+*2I./<C-1Z/\GV^W_YXWDG_ (_B3_VI0(TJ***0
M&9XCU!M)\-:GJ"?ZRWMI)$_W@IQ^N*R_A]IJZ9X'TQ0#YMQ$+F5F^\SR?,2?
M?! _"K?C*V>\\%ZS!$"9&LY"H'<A2<?I2^$+Q=0\&:/<JPR]G&&*]F"@-^H-
M5]D?0QM2^(GA;S/[,EOOFGF>SG!1E,!P02P('&>,^_UKY\EUC5H]66\;4KAK
MZ >4EP)B64 %<!O3&?SKM/B/X!UO3K^\UYYAJ%I*^^694"/'GCYE'&.G(_'%
M><UTTXQ2NBXI'T5HWQ!\,:59QZ//J'SV$$,1E"M)Y\A&&V[02Q!ZGU-=/XIT
MJ/7/"NHV#J,S0-LW#.UP,J?P(%>#> ? >L^(;VWU2!UL[*WF#K=.H;+*<_*I
M^]@COQ]>E?0>I7*:=H=W<W$FY;>W9W=L#.%))X]:QFE&6A#T9F>!=3?5_ ^D
M7DC%Y&@V.QZLR$H3^:UO2L5B9AU KEOAG:/9_#O1XY!AGC:7\'=F'Z$5U;KO
M0J>XQ42^)B>YE44YT*,1UP<9IM(84444 *"5((ZBE#L,X[]\<TVK$-J7PS\+
MV]Z '0VVX;GZ=A5L   #H*4<#%%(04444 %%%% !1110 5G7)S.U:-4I[@%P
M$ .T]2* "UA#?O#G@\5;8$E>!C/-9[3._5L#T'%-5\.I). <TP+H0*^U&RO\
M2GG%0+;CS61L\<C%6HYHY"=IYI#-'YA7=AAWI 53<2*-@.,<>])]JDVX.#]1
M5UEC89.WGO5*X(\W"] ,4P(E)4AEX(JW<C="KX4GC)JG2Y.,9./2@8E%%% !
M1110 4444 %:4!S GTK-K1M_^/=* &6MY'=^>(PP,,K1,&'<8_3D53TYMNL:
MQ%W,T<OYQ*O_ +)5Z"WA@><Q##2R>9)SGYL ?AP!699G'BW5D[?9;5OQ)E']
M!0(V:***0"$!@00"",$'O7GOARY_X0CQ)/X5OR8].NY6GTF=ON?,?FBSZ@]/
M_KBO0ZS==T'3_$>ER:?J4'F0MR".&1NS*>QJD^C ?J^CV.NZ>UAJ,1FM796>
M,.5W8.1D@@XS@_A7)R>"-&7QA:PQ^';7^S!I\HD;R 4\PNFWGKNP&Y]"?6F1
MP>.?"@\FU6'Q+IJ#$:RR>5<H.P+'AL#OR3[5*GQ!OW^1?!>NM)DK\D0:/(R"
M-XXX((II-;#.HT;0M.\/VLEKID!@MWD,GE>8S!6/7&2<#CH.*Y#QE?OXGU.+
MP3I$I+2L'U2>,\6\(()7/]X\<?@>M(;KQQXK>:V@@@\.6:/Y<TC2":XY .%Q
MPIPP]#SUKJ?#OAK3O#-@;:PC8LYW33R'=),W]YCWHVU>X&I!#';6\<$*!(HD
M"(HZ  8 J2BBH$5IHRQ=>F?F'N15*M4J"0>XZ50NE"S' QD9I@-@B\V3:3@=
M35W[-%Q\O2H;(C+CO4\DP1U3!+'L*0#)X4\IBJ#<!V%2I]Q<]<4,&/W6Q^%-
M5B"0ZX/J.AH DHI%97&5(/TI: "BBB@ HHHH ***#TXH @GN/*^4<L1^54*5
MV+.6;J:2F,**** "@DDY)R:** "I'CVHKCE6_0U'4]N=X:(C((R/8T 0586-
M9XQLPKKU'K4#*58@C!%"LRG*D@^U #FB=.H_+G%-P<=#4]LTAEP#P>6S5T@$
M8/0T 95%6)[<IN9<;1TJO0 44^*(ROM'XGTJ2:V,:!@<^OM0!!6C;_ZA/I6=
M6G$,0H/84 5[.VD@NM0D<KMN+@2)@]A$B\_BIJC:?\CCJOM96H_\?GJYIMZ]
MZ+IF50L5R\*;>X7CGWSFJUBN[Q'J\OHD$6?HK-_[/1W UJ***0@HHHH *RM#
M<>5?0?Q07TX/_ F,@_1Q6K6381BW\0:M&.DXANOQ*F,_I$*:V OQR6_VR>",
M*)PJRR@+C.[*J2>_W"/PJ>H%M46_DNPS>9)$L3#/&%+$?C\QJ>D 4444 %->
M-9!AAFG44 5?L9!)60CTJ%2T,FYT8XK0I&4,I4]Z &Q2>:F[&*=M'/'6HH]T
M:B/9G'0CH:AEN26 0D+WXYH M!$ P% ^@I>]45NI%/9A[U-#<AVP^ 3T]Z +
M-%%% !1110 4C'"DXS@4M% &23DYHJ>XA\M\K]T_I4%,84444 %%%% !2JQ5
M@PZBDHH L7!64+(@Y/!%)';.YR1M7WJ..1HFRN.G>K$$LLLO)^4=1B@"Q'$L
M0PHI]%%(0UUWHR^HQ6;M/F;#QS@UJ56EA/GB0#Y0,G\* )HXUB7:/Q/K3F&Y
M2/48H1@Z!AT-+0!0F@,94#)R/UJ\!@ >E-<9=.,X/]*5]VQMF V#MSTS0!';
M+;B'?:B+RI"9 8L;6+');CKDG.:IZ7\UWJT@Z/><?\!BC4_J#5G3[7[#IMK:
M;MWD0I%GUV@#^E5/#SB;1TN5^[<RRSJ?57D9E_\ '2*8&I1112 **** "LVX
M_<^(;*7HL\,D)/JP*NH_(25I5D^(0\>G)?1??L9EN3_N+Q)^/EEQ30$]_92W
M%YIUS"RJUK.6<,?O(R,I'YE3_P !J_4-VDTEE.EM)Y<[1L(Y,9VMC@_G3;"X
MDN]/M[B6!X)98U=XG&&1B.5/T- %BBBBD 4444 %%% X% ",P522< 5EN=SL
MP[G-7+P_N@,]3TJE3 ****!DT=Q(K@EB1W!K0ZC-90.#FIDN70@$Y7T- B_1
M4"72.P!!7/K4]( HHHH 1E#*0PR#4(M(AG.3^-3T4 1I#&@P%'U-5Y[=41G!
M/7I5RHIXS)$5'7K]: ,ZBCI13&%%*/7L#3I'#N2% 'H* &JI8@ 9)K0@B\I,
M?Q'DTVVA$:;C]X_I4](04444 %%%% "  # & *6BN*\2Z_J=]K:^%?#+JE^5
MWWMZPRMG&?\ V<]OJ/7(:5P-G6?%FA^'7;^U-5AA8C(A^])_WRN3C\*YZ[^)
M^FR6\;V$&HF,RQEKAK%RGE[@6Q[E<@?6I].T3PQX.U*QM98Y+K5[]B%O+B-I
M9)&QDG=@@?0>N3ZUOR:CJ2^)HK!=-+:>T)=KS><*W9<8Z\'\QR.E5HAF;#XU
MT77]*NTT348Y[XP/Y5N05D+8.,*<$\XZ5T=G:QV5E!:0C$4$:QH/91@?RKE=
M7TGPMXMU:\TB>V*ZI:QK(US%$8Y(\YP0^.>F><CGO530M9U3P[K\?A?Q),;A
M9\_V;J3?\MP/X'_VO\\Y%%KK0#NZ***@04444 %-=%DC:-U#(P(8'H0:=10!
MEZ!+(VF"VGS]HLW-M(2>6V<*W_ EVM_P*IXKXMJ]Q821["D:2Q/GB1#D'\01
MS[,OK5=G6Q\1)N.V/4(]H]/-0$_FR9_[]U<OKR'3[22\N,B*(9=@/N+D98^P
MZGV%,"S1112 **** "BBB@".6,2H0>O:LT@@X/:M:JES Q;>@SGJ!0!4HHQ1
M3&%%%% !6E I2%0W6J5N TZ@C(K1I""BBB@ HHHH **** ,ZX7;.W'7FHJ?,
MY>5C[\4RF,4'&1ZTF,8]Z*7.0!CIQ0!IHP9%([BG5%&?*MU,G&!3893+*Y'W
M .*0B>BBB@ HHHH J:G?1Z7I-Y?R_P"KMH7F8>H4$_TKCO!6G:A;>!Y]7MQ%
M+KNK;KQGE&0Q;E%)R,#'Y9/6MSQRKOX$UP)G/V.0_@!D_I52QBU&_P#!WAUM
M#NX[11!;O('7.8P@RHX// 'IUJE\(^AMZ=!<3:?:2ZO!;G4$0;RB A&X/RDY
M[@<^W:M"@<#KGWHJ1%6ZA:.&XN+*"$WI0E"R#YVP, G(ZX Z]AZ5R7B/1=3U
MKX=2)J@C_MJT3[1$]N,8ECY!4Y_B /I][H,5V]8=I;ZI9IK$VJW\<]N[-);J
M%QY48&,'CT /U)IIV G\,ZM_;GAG3M3.-UQ K.!T#]&'Y@UJUQOPK1X_AOI(
M?(SYK $= 97(_P ?QKLJ)*S:!A1112 **** *6JV;WNGND.T7,9$MNS=%D7E
M?PSP?8D4ZRNH=5TR.?RB(YD(>*4<J>C(P]0<@CVJW62F[3=<:,D?9-0)9!C[
MDX'S#Z,HW?56]:8%Z"2WCD-C"<-!&AV<\*<A>3U^Z?RJQ4#VL37D5V<K+$C(
M"#@%3@D'\0#4L<B2Q+)&ZO&X#*RG(8'H0:0#J*** "BBB@ HHHH H78 FX[C
M-059O/\ 6K_NU6IC"BBK-FH+L2,XZ4 +:1MO+D$8'&:N444A!1110 4444 %
M%%% &?<1^7*<=#R*AJY>(2%8#IP:ITQA5RS5=I;'S XJH 20 ,DUI1QK&N%&
M* (KQ@(@,=32VJ;80>[<U))&LH ;L:<   !T%(0O>BBB@ HHHH BN;>.[M9K
M:9=T4R&-QZ@C!KS_ ,'M<+I>J>!;N[>VU*PW);S#[SP,<K(OKC/3W KT6N&\
M7V%IK'B33[33;I[7Q/;Q-<07,8XCC':3U4DX ]SVR#4>PT=!!>6>@1:9H][J
M)DNY5\J)I3\TI Z_I^M;&Y0P7<-Q!(&>2!U_F*\\7QI'I]U!%XYT5["]MSB&
M_2$RP,?5&&2I.!P,^_I5UM;\%3:]'X@/B*U$\<7E"/[0 I'J4ZYZ<_[(IN+"
MQT;ZG9:A=WNC6U\$OXH@7"'YH]V<'\,9_$>M<AXJEN-$\(6GA*SNY+[5]2'V
M.!I#\WEG@LW/ "\9_'UITWCJPO+Z<>#M'DU?5I1L>Y2$QQ+T ,CG&1P,?3J*
MUO"_A.?3[Z;7-<N1?:[<C#2#[D"?W(QV'O\ _7R6Y=6&QOZ5I\6DZ19Z=#_J
M[:%8E/K@8S^-7***@04444 %%%% !5;4+)=0LWMV=HV)#)(GWHW!RK#W! -6
M:* *&E7S7ENR3!5O+=O*N8QT5P,Y'^R00P]B*DLK.'3(6ACD(A:0M&CMQ'G^
M%?;.2!VS@< "JNIQRVDZZK:Q&1XUVW,2=98N3QZLIY'KEAWJW/#;:KI^W?O@
MF4.DD;<CNK*?4'!!I@6J*BAW1110S3B68)\S$!2^, M@>Y_6I:0!1110 444
M4 5+T<H?J*J5<O5^5&]#BJ@!)P!DTQ@$9A\H)^E:,,?EQ@=^]1V\!0ARQY'3
M%6*0@HHHH **** "BBB@ HHHH :Z[D9<9R*H"WE/\!_&M&B@""WM_+^9N6_E
M4]%% !1110 4444 %%%% $%Y>06%I)=7#[8HQR<9)/0 #N2< #N32K;6YNOM
MGV=!<F/RS*5&_;G.W/IGM4,9L]6@AN HEB24O$S XW*2NX>HZD'Z$=JAU6ZF
M#1Z?9DB\N0<./^6*#&Z0_3. .Y([9PP,VXL'U[Q+!<-/(--TQF!AX,=Q,5(.
M1Z)D<\\Y'&#5X^%_#S3><VA:89<YWFSCW9^N*T+2TAL;6.VMTVQ1C"@DD^Y)
M/))/))ZFIJ+@,BBCAC$<4:1H.BHN /PI]%%( HHHH **** "BBB@ HHHH *Q
M2/[!NRZJ!I=P^7P<"VD/\7^XQZ^A.>A.-JFR1I-$\4J*\;J596&0P/4&F@*U
M_8)?)&?,>&>%]\4T?WD/?Z@C@@]15@31F9H1(IE50S)GD YP<>G!_*L>.5]!
ME2VN7SI;$);SNQ)A8G C<GMT"L?H><$Z5Q8PW%S!<MN2> G9(C8.#C*GU4X'
M!] >H!H LT5 M[;M>O9B0"X1 YC(()4]QZCMD=ZGI %%%% #)AF)N*SX\&1<
ML%YZFM,C(P:H20%)0>JDT 7QTXHI%(905/% SCD8H 6BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *J;[358+FW_ -;"&,,N,A6/<9[^AQ[CUI+:
M]@U+[0D(D:%"8S,!A7/(8*>IQW(XST.0<#O9:+IB_*L%K"H1$C4GV"J!R23@
M #DDTP"^O8=+L@_EECQ'#!&/FD;'"*/P^@ R< 4S3+&6V66XNY%EO;@[I74<
M*!]U%_V5SQZDD]2:BL+2:>Y&IWZE;@@K# 2"+=#VXZN0!D_@..NI0 4444@"
MBBB@ HHHH **** "BBB@ HHHH **** &2Q1S1/%*BO&X*LC#(8'J"*R/-FT%
MMMP[S:62 DQY:V]G/4I_M=1WXYK:H(!&",@T[@0R6\$\L,SQH\D1+1/CE<C!
MP?<5 VH"+45M)X9(Q+_J9NJ2'&2N?X6Z\'KV)Y IFTN=$5GTV,W%EG<UCGYD
M]?*). /]@\>A'0Z5I>6]]!YMO)O7.U@1AE/<,#R"/0\T 3T53E%^EXCPM#+;
M,0'B?Y63U96&<_[I'X]JM[EWE-PW 9*YYQ2 6CKUHHH :J*I)50,TZBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHJ,R[XY3 8Y)$R-N_ W8Z$C..W:@"
M3H,U2L+R6^5YC;-#:MCR3(2'<=R5Q\HZ8R<^H%26<=VB,UY<)+(YSMC3:B#T
M'<_4G\!TJ"^U5;:46MM$;N^;!%NC ;0?XG/\*^YZ]@3Q3 ENKNUTFR5G 2-<
M1Q11KRQ[(BCJ?056M+*:YN1J&I+B93FWMPV5MQC&?0N><MVS@=R7V>FM'<F^
MO9?M%ZR[0V,)$O\ =C'8>I/)[G@ :- !1112 **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K/NM)CEN3>6TC6EZ0%,T8!W@= ZGAA^H[$5H44 9
M,>KO:LL.L1"UD9MB3J<P2G.!AOX2>/E;'/ +=:M7FEVE[-'/(A6YB&(YXV*R
M*/0,.WL>#Z5:DC26-HY$5T8896&01Z$5E_V7<6,F_2;@1Q8YLYLM%_P$]8_P
MRO\ LTP+EY<SVVQHK.2YC)/F")E#KZ$ D9_//L:L1N)(UD 8!@" RE2,^H/(
M-9@UR.WE6'5(7L';[LDC PL?:0<#V#;2?2K]Q;PWMN8I5WQM@\,1]"".0?<4
M 3457@MC:6K10R22$9*&>0N1Z L>2/KDTVTEO7+K>6L<)&,-%-YBM^8!'Y4@
M+5%4H]7L);QK,7*+<ABHBDRC,1UVAL;A[C(J[0 4444 %%%% !113)98X(FE
MED6.-!EG<X"CU)H ?156SU&SU#S/LDZSJF,NG*\^C=#^%)'-?/=E6LXX[8$C
MS&FR[>A"@8P?=L^U%@+=5[NZ-K&I2WGN'8X6.%<DGW)P /<D5'<Z;#>7"R7$
MD[(J@"$2E8\YZD#&[\<CCI4]S=6]G"9KF>.&(=7D8*/UI@1>7)>V 2Y5[=Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
;"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image00027.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00027.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0;!90# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD9QW,W"2D?[F*9Y<Y_Y9M6G13'<S?)N#_!^HI1;3GJ /J:T**!W,XV,S'/F
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M6UX<?[*__%5&_P 0K0*&CL+A@>[$ ?UKSO\ TLKM$! )R<N.?2G;+K>"(XP
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M* "BBB@ HHHH **** "BBB@ HHHH *\A_: _Y%K2?^OP_P#H!KUZO(?V@/\
MD6M)_P"OP_\ H!H&CP5XD\A& 96VY;/XG^6*W?#YS8O[/BL1V+VXPJC  R.I
MX/\ AT]JV?#W_'E)_P!=#_(5$;]32270UZOV^BZA=VAN8;9FB[<C+?0=ZSZ[
M32]6NDT6%(]+N))(XPJ,  C < YK.M.4$G$JE",G[QQ=-)J[::7?:B2]O S*
M3RYX7/U-+=:-J%F5$MLV&( *?,"?3BKYXWM<GDE:]BC25L)X;OFCW,T,9(^Z
MS'/Z"LZYL;BUF6*6,[F^[MY#?2E&I"3LF.5*<5=HKT5L0Z"Y0-/,$8_PJN<5
M5OM,DM$\Q7$D8ZD#!'U%)58-V3*E0J1CS-:%"DHI*T,@HHI* "DHI* %S3:*
M* "BDH)H #1U( [TF:;F@#1GTF2&W,YGA,9!*X;EL GI]!1)ID:RB*.]A=R0
M ,]<\>I[@_IZUFTE &E>6-I;#:MX7E5L,A0+CD>_H?YU%#;V4B9>Z*L%R0>.
M<=/SJC24 78?L&T^>9=W.-O3[HQ^N:%DT\#+PLVUR ,D%E)ZYSC('MW_ !JE
M24 2:G):N(1;0F-5+9))RW3!ZG'TJG(BA5(!''/UXI]Q]R/ZM_2F.<H" ,8Q
MQ^'_ ->@XZOQF_HI!TU<?WF_G5^LW0S_ ,2T?[[?SK1I"1=32[V2T^U+"3%C
M.<C)'KBJ6:ZJ'5+D:0I2PEWK%@/@!, ?>_KBN?M=-O+Q=T,)*?WB<#]:QA4;
MNYZ'35HI-*G=W*E%6I],O;=U5X&RQP"O()_"IQHEULRS1*?0L?\ "K=2"W9G
M&A5D[*+,VDJ:6VFAF$3H=Q^[CO\ 2K::7\N9)<,>RC-$JD(J[8Z>'JU&U%;&
M=259N;1[<;@P=/4#&*JU2DI*Z,YPE!\LE9A1124R0I***!!124E PHI**!!0
M:0FC- #XD,LT<8(&]@N3VR:FDLFB7?)+'L(!RISGIV^AS52DHU&7_P"SD\U(
MUNX6+-MP#R#_ )_.H9X((BRI,792 05 ['/?UJM24K/N!<6"T:-V^U'<L>X
MC&6QT_S_ $J./[)SYF_[_P##_=_QJO246"YUMI*4TB.0)G9%G:.^!5J.02'H
M00<$'ZU1@4MHD8 !.P'DX'!S4]JK*CY.<L>?4Y.:M;V/K<.OW$?1?D=:OW1]
M*6D7[H^E1S[O*^4$X() ZD=Z&[*Y#):2HXCD'KCW&*DJ*<W./,U8$[H**0D
M9)P*:LJ.<*ZD^@-6VEHQCJ*:[K&NYV"J.YJM_:5INV^;CW(.*'.,=V!:HI 0
MP!!!!Y!'>EJAA1124@"BBB@ I**2@!:2BB@ HHI*!CE1I#A!DT[R)<@;#D]
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M;O[V>:MTE%A\S,V;2SN'DOQW#TVULI([L>:ORJ"01R"?\FM2DHL/G=@.",,
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MM8XFD>XC"*,D[@:+:Z@NXO,@D#IG&1V->=D< \9'?VJQ:ZA=6+/]FD*9&"
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CW[07_(!T?\
MZ^G_ /0:]AKQ[]H+_D Z/_U]/_Z#0-'@)?</GY('![UNZ%_QYR?]=/Z"ETU(
MI/">JA]/CE92)$NB<-"P9!@>Q#-Q[4W0O^/23_KI_04BC5S29IN:,T@%S24E
M&: %S24F:3- '4Z7;P+9QRPKAR 2V.2>_P"%7=H4')'/')_.J&E"5=.B$R@
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MZO1/^05%]6_]"->ODG^\/T?YHPQ/P&A1117U1PA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>._M!?\@'1_P#KZ?\ ]!KV*O'?V@O^0#H__7T__H- T>-V4UO#
MX4U**6:\CEN)4$8CQY4A3!VOWS\Q(QZ4NB?\>DG_ %T/\A3].EN?^$1U:*WO
M+=8]Z-<6LN-TBDKAD]P1V[$U'HO_ !ZR?[_]!4E&IFDS3<T9H =FFYIN:3-
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MED"-"U)_*F8#RTW+]U<L#\W_ 'SQ]:F>QQS^-D^C_P#'@/\ ?;^=7ZS](/\
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M'#L%VM'Z$CGCW%8K>)-=GE!_M>_9SP L[#/X UZZ\T[_  ^FEU@$3MI[F<,
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M2NUJB*D5*+3.JL%3['<R.A=8WC;:'QGD\>X(STYJ22-8=>D18Y(P,G;)C(R
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M!VMNRDNMW2./,C0C^[@KQ6O9WD=[;GRVPPY96/(_'TI\R+/$T<B9!!ZC./\
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MJ<_A7.7&J7UTA2:YD93U7. ?P%5-Q'0XJU0E)MS>I#JQ6D5H='XM(^TVO/\
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MX!NIKS!GDL)3)M&!G:V<>U9GA'3;/P_X9.LW2 320F9WQDI'C(4?4?GGV%;
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ME4Y['5+ REA50;U1TWAK4[>W,]K/(L9:0NC,< ]B/THUG3])@L;B> H)R05
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MH'CJS2$9H RY4Q7C_P <AC1=*_Z^7_\ 0:]NEAW#BO%OCPA32-*!_P"?E_\
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M,.BZ='GKLM4'\A6A'#%$,1QH@]%4"GT4 %%%% !1110 4444 %%%% '*>-_
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M6:+#]DSY:+ 5)';W$W^K@D<C^ZA-?6,&A:1;9^SZ58Q9Z^7;HN?R%7PH484
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M[,.+PMHT0PNF6G_ H@?YU971;*(?NK6!/]V,"M.BJ22V,G*3W9S.LVHALI&
MXP/YUY_JT\T4J]ESA3CJ",,*]@N;6*[MVAF7*-UP<5P^LZ"]G]]/.MB?E?'0
M^_H?>O"S6A/VBQ"5XI6?EOJ=6%J1C[K*EMW^@JQFJ\'4U-FOEWN=95N607 W
MP"3 !SN_V@.GXU"MT7@D\NU0%4!6,KD\@>V,<^O;\K]&:I326Q2DK&=]KO6A
M8K;[7*DH/+/)QG!YXY-693=/;2!#LF*OMVD$9_AZBK&:*3FNB#F\BE)%>EN)
M@4Y&,[2>N#D?@>G:IV25I5._Y,$-AB./IZ^]2YQUI5!?[H+>PYIIRELA.12-
M@Q=#]JF 4YP6)SR,#KZ#]:L6\7D1!"Y<]V/?C']*M)9W<F-MK.0>_E-C^53#
M2-1/W;20_D/YFMEA\3-64&_DR7575E/-%:<7A_49/O1+%_ON/Z9J4>&;_P#O
MVX_X&?\ XFM(Y9BY;09'MJ:ZF/170+X5?'SWB@^T>?ZU*/"L7\=W)_P%0/YY
MK:.38Q[JWS1+Q%,YFC-=;'X:L4.2TS_[S#^@J0>'=,!R8'/UE;_&MXY#B'O)
M?C_D2\5#HCC<T$XZ\5W::58(H46<) _O(&/YFI4LK6(@QVT*$="L8%;QX?E]
MJI^'_!)>+71'GZ@O]T9SZ5*MI=/]RUG;W6)B/Y5Z%16T>'Z?VILEXI]$<*NC
MZ@ZY6TD_'C^=21Z!J;GFVV>[2+_0FNVHK>.189;MOY_\ AXJ9R0\+WO>6W_[
MZ;_"I4\*3'[]VB_[L9;^HKJ**VCD^#7V;_-DO$5.YSR^%(L?-=/_ ,!0#_&I
MH_"]DARTMP_LS+C]!6W16\<OPL=J:_,EU9OJ9?\ PCNF=X&/_;1O\:GCT?3H
MAA;.(_[Z[OYU=HK:.'HQ^&"7R1+G)[L@6RM$.4M85/M&!4X  P!@445JDEL2
M%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%-21),['5L'!VG.*=0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444U9$<D(ZL1UP<X
MH =1110 4444 %%%% !1110 4444 %%%% !7'_$>ZNK?PXBV[,D<LP29E/\
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M7!'N2J_RJ.TDU)I2+RVM(H]O!AN&<Y^A1>.O>KE% BEYFI_;-OV:T^R[OO\
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MNY-264"SMK26/;R9KAD.?H$;CIWJY10%BO=->+$IM(8)),_,)I2@ ]B%/\J
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MBB@96M'O65OML-O$V?E$,S2 _7*KBH[634VF(N[:TCBQPT5PSMGZ%!_.KM%
MBFTFI?;-JVUH;7</WAN&#X[_ "[,9_&ENWU%7465O:RICYC-.T9!]@$:K=%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4X&JNQ]K67_XF@#M**X9OBWX4SB*>ZF/I';M_7%9\OQJ\/)GRK#590,_,L2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLD<NT-N&+;CEFY_(U;HHY(K8+LH&VNBNW?$%P0 ,\?2I/*NR1NN5.  "8P2
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M_':R! AT25\_W[D+_P"RFJ<OQUG)_=:#"H/W=UWN_P#917C/V"Z(^]"/Q/\
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M//J*DNE5+N941T4.0JN,,HST/O4->@8"TE%)F@ HI*3- "YI*2B@ I#1FDH
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M.,'@CWI-:ICZ'8#[H^E.4KN^<$K@\?A3%^Z/I1FF(OM<:>,".Q;A@=S2\D8
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M4S<6LC7$/E1."V <$9XK6K&UR?A(,<'YLT''C[+#RN8V:3-(312/EPI**3-
M&-#P[<@<CJ<=ZDT[_D+P?4_^@FJX;;*K'H&S5G3^-6@Z_>/7_=-6WH3;WCJ<
MUT?@_5K+2+RYDO93&CQA5(0MDY]A7-5+!.;>0.J(Q!R-XSS6-2"G!Q9I&7*[
MGH>N>,=&O=!O;.WFE>66,JO[H@9_&N2\+:JNAZ[%?RV\TR*C#;$N6.1CO5 Z
MI<ED(\M2@ 7:F, 8Q]<8'6E;6]1)!^TL,# "J !^G_ZNE8PPZA!P6S*E-R=S
MHO$VK)XKUS3!]BNK2'<MNQE7!^9NW;H:[S4;[2_ /AI;:WP90I\B)VRTKG^)
MO;/4_@.U>.3:G>SLIDN9"58,I!Q@CH>.XR:@DEGNI6EE>6:0_>=R68_4FE+"
M\RC&^BZ$\]M3V<:CH/C'2%60Q2*<,UO(^V2-OS![]1P:Y_5]2TGP]8&UL_*#
MC.R"-MW/JQZ_GS7GHT^=D+%0".@)Y-$%A(\@$BE$[FB.62YDKNW8GZ[3BF[H
MKN[22,[G+,22?4FA8I'!*QLP'H,ULI96Z-D(#QC#<U/TKUHX-_:9YT\>OLHQ
MC83>0) ,D_P=Z2*PFD<JP* #J16S16OU2%S'Z]4LS)ETR5<F,AN>![5!-9S0
MIN8#&<<&MRDIRPD'L*..J+?4YSDG&.>F*L"PN2@;9^!/-;(1%^ZBCZ"EJ(X-
M?:9I/'R?PHQ[;3WFR9"44'&".:6YTYHH]\9:3U&.E:])6GU6'+8S^NU>;FZ=
MCFJ2K5]:FW<N"H1F^4 ]*IYKSIQ<79GJPFIQYHBYI,TF:3-26+2&DHS0 44F
M:0GF@ )K;\&'_BM]#_Z_H?\ T,5A$UN>#/\ D=]#_P"OZ'_T,4 ?5=%%%4(*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OGC]H'_
M )&W2^,_Z#T_[:-7T/7SO^T%C_A+=,ST^P\_]_&H \D8+C*G'^R:Z32C_P 2
MJV_W/ZU1\3PV<&MLE@=UN88G#&-HRY9 S,5;E222<#( Q@D<U<TO_D%6_P#N
M?UI#+N:;N'J*,U[KHUUIOA_X:Z?K,]@C^79Q-(8HEWN6P.IQGD]S2 \+/3/;
MUI,U[CH?Q(TOQ'JT6C#3KB,7 8)YH5D.%)(('; /K7#>-_"]O%X^M=+TB-8O
M[02-_*4?+$S,RG [+A=V/K3 Y"PTV^U:X^SZ?:37,O=8D)Q[GL![FNGT[X<^
M)/M]LU[I+):B0-+F:-CM!Y& Q-=UKNM:=\,]#M=+TJU22\F!8!^,XX,DA'))
M/ '\@*P/"WQ)U_4->CM[Y8)[>0-D1Q;-A )!R,^F.?6@J";DDC<MK*'3H%M;
M>$0QQ]$ Q@^^><U-6[K7V2ZM$NHI8_- !QN&XJ>Q'J/\:P*EGJTI<T;VL;%M
MH,MQ!'-YZ*LBA@-I)YJ23PY(J9CN%9O1EQG\:LW#LGAF)D8JPBCY!QZ53T&2
MZDO6)>1H=IW%B2,]OQIZ'-SU7%SOL4K&T2:]:WNG,(526Y ((QQS4-Y'%#=R
M1POOC4X5L@YX]16UY<$_B:97C211'R&&1NXI+.&$>(;N/RH]BIPNT8'W>U%C
M3VUGS/M<P ">@S]*6/!F0'D%A_.NCGUJ"RO&MTM_E#?O&4@<_3O5?7+6.*ZM
MKA%"F1\-@=3QS18<:S;2DK7V&^(((8!;^3%''DMG:H&>E98L;HV_GB!O*QNW
MD@#'XUTVH6/VZZM]_P#JHRQ?WZ8%8^NWKO/]C4%(H\9&,;CV_"AHSH56U&$=
M^ID9I**2I.T6L;Q/I+ZQHKP0C-PCK)%R!D]""3VP36Q29IBE%27*SPV16CD9
M'&&5BI&>A%,)K2\1QQ0>)-0CA"K&)CA5' SR1^>:RL\TSQ9*SL.S29I,TF:!
M"YI,\4F:3- "YKZ8^%'_ "372?\ MM_Z.>OF3-?37PG_ .2::3_VV_\ 1STT
M!VE%%%,04444 %%%% !56!;07]VT)'VEMGG\GT^7]*M55@LE@O[NZ#DM<;,J
M1P-HQ0(M4444#"BBB@ HHHH *R?%/_(HZU_UX3_^BVK6K)\4_P#(HZU_UX3_
M /HMJ /C+!QN'..OM5S2G+ZPKG&65R<  ?D.E5EC;R3,I/RL%X]P?\*LZ6&7
M6%#KM8*X*XQ@_3M2&='FC--S29I 21QO-,D4:EI)&"(H[DG %=%I?@O4;Z60
M78-G'&VTLZ[BQP?NC/(Z<].>,UV_PS\'VCZ.FMWL;FXG9A"-V (\@9QZD@\^
MF*W+N VUU)"?X3P?4=J3NCGKU)06AAZ%H%KH,,BPLTDLA^>5P,D=A["M:M:.
MWA/AR28QKYN&PY'(^:HM2,9MX-ED]OSRS(%W<>U2UU.:<&US29G4E7+?3+NY
M0.D>$/1G.,U#=6D]F?WT9 /1@<@TK,SY))7L0TE:D>A7#A"9(@K#)(R<"H[[
M2);.+S0XDC'WL#!%.S*=*:5VC/S6A!HMW-&'.R,'H')S^0%5+,I]NM_,QL\Q
M<YZ=:W-6@U"616M7<1A>5C?:<_IFFEI<JG33BY/4QY=/GANH[>4!3*P56'(/
M--OK-K&<1,X<E0V0,?YZ5<ENY[NXM;.\@"XD7=P0Q[?YQ5R/3K1=5>'R08Q
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M6(./^VC4 >=^+/\ D/R'[0T^8H_G,_FC[HX5L A1T"D J.",BK&EG_B5V_\
MN_UJ;Q-;6EY'>>(+::]N8[J\5([AH J9\L,ZR<Y$F2,=0<,<FH-,/_$LM_\
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MHH *R?%/_(HZU_UX3_\ HMJUJR?%/_(H:U_UX3_^BVH ^1-.1Y-.O(T8[FV
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M%L_)5I=QP#ALC./?'UK$C\4Z>?%VG_V>ABL1&;5LH$7YFR"!V ..OO5F\/\
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M-4?$KGQ#X,T[Q+I8S>63)>Q!!D\<2)^'.?\ =K>\6?VA)X2ODT^%OMDT0C5
M<E=Q"M^0)IB,+PE<17<^O>,KM@L$[LEN[#E;>+O^.!^*USGA[PM>>*I;SQ'K
M%Q]CL[N0S(H^\5]<GA5 P ?:M+Q_<0^&/ EAX<MI,-.%A+ 8S&N"[?B<?F:Z
MCQ-;:#'X=CLM7G-II89(U".R X'RK\O;C./:JC)Q=T3.$9JTMCG_ /A!-"U.
MT=M%U@RR+_%YJ2IGWVCBN6TCPM>:EX@ETJ;]R;<G[0_7:!Z>N>WYUTVAZQX
MT>Z)T5YS.05;RHYWR/?(QV%;OA[4K'4O$FL3VR2*S)!N$B%&. PZ'\/TKIC7
MGRM[G'/#4G.*V_R,R>#P+HD_]GW4<;SCAV</(5/^T1P/H*T/$EO:V?P]NH;+
M'V58E,6&W#:7!X/<<UYAJMA?0Z[<6LT$K73S,0H4DR9)P1ZYKT;4;6;3/A>;
M>X'[Z*!-XST.\''X=/PJIPY7%WOJ13J<RFN5*R97LK#2?!&@PZEJ,(FOY,8^
M4%@Y&=JYZ8'4^WT%:/AWQ=8^)+TPM9F"[A4O'O(;*]#@]CSTJOXRTR?Q/H-E
M=:7B8J?-5 P&]6';W'''UK,\"^%=0T_4VU+4(?("QE(XV8;B3U) Z#&?SJ'R
MRIN4G[QHG.%50@O=.FTO_D<?$'^[:_\ H#52\/7?V#PA>WFW?Y$MU)MSC.&8
MXJWIG_(X^(?]VT_] :LG3_\ DGNK_P#;Y_-JFU]/3\C2]G=?WOS*O@[QCJ>M
M:X]G>^2T;Q,Z[$VE",<>X^M:N@:5;6WB_7[B- &#QJF!]T.N]L?4X_*N)^''
M_(V+_P!>\G]*Z/[?J5A\0=6:SL);VU=81<)%C<OR#:PSW^]QWK2I"TI1CIH8
MT:C<(RGKK^AQM]XOURXU"6X&H7$'SG;%$Y5$'ICH?QKN?%\\UU\.HKBX39/*
M('D7&,,<$U!<:YX'2\DNYK,&]5R70VK;]X/.1]W.>]6?'UUO\$J\J&&2>2(B
M)CR#]X@^X --M.4;1L)1:A.\[Z'DV:;FDS1FNX\P7-0W47GV[QY )'!J3-)F
MDTFK,<9.+31S!R#@C!'44F:?<G_2I<@CYSQ4.:\5JSL?11=TF.S29XIN:0FD
M,=FMSP4?^*ZT+_K_ (?_ $,5@9K=\$G_ (KK0?\ K_A_]#% 'UG1115""BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYX_: P?&&
ME!N%^Q#/_?QJ^ALU\\?M 8;Q?I0/0V(S_P!_&H X[7;2&TTO4Q'83VQ:]C^Y
MN\I/O?(1G Z;ES[X/6J.FG_B6V_^[_6M[QM9):IJ;I;RK_I$$)::[+F-5C&Q
M #]]2!E6SP 1DY%<_IQ_XET'^[_6DQES-=S<>$]3M_ ,7B%O$$Y@^SQR1V:[
MP%5BH"YWXXSZ=JX/->ZQ:7<ZW\'=.TVTV^=<6ELJECPHW(23[  G\*2 \T\%
M^$9_&&INLTDL=A ,SSCDY/15SQN/Z#\*@\8Z=H>C:N=-T>>ZN&@RMS--(I7?
M_=7:HZ=SZ\=J]&\5ZC%\.O!UKHVCQNMQ<AD6Y*XP>-\A/]\YX]/H!7*_"*TM
M;[Q#?K>6T-RJVA91-&' .]>>>_-,#S_/%>I>#]9;4]*\N9AY]N=F%3:-F/E]
MO4?A7$^,8XX?&^K11(L<:73!410 !Z "O3OBU>S:?I6B7-O(8WCO"01_N'@^
MH]J5C6C5=.5R]%;7$ZDPP2.!W5214EDK)J=NCJ582KE6&".172223)9VSZ9'
M%- 0&P#]Y",@CZUD3W;76M69>V,$B2*&#'D\C':BQVQK2J)Z:%W6;"XO;B'R
M$!54.23@#FL2\T^YL0#,@VMP&4Y%;6NW]Q:M#' ^S<"S,!S]*5Y6O/#+RS89
M_+))QW!Z_I0S.E.<(1;V>AS-%)14G>+24F:3- #J3-)FDS0 N:3-)FD)H =F
MDS3<\UR%_P"/[.SU.2V2UDGAC)5Y48<L/[H/4>^:9,ZD8:R90\?:*5>+4[2V
M CPPN6C7H<Y#,/?)Y_/M7"9KV33?$6E:OM2VNE,K@_N7X?WX[_A6'K'@&TO)
M'GT^;[)(W)B*YC)]L<K^OTH.*MA^=\]/4\WS29JUJ.F7VE7#0WEN\3 \,1E6
M^AZ&J6:9PM-.S'9I,TW-)F@!V:^H/A)_R3'2/^VW_HYZ^6\U]1_"/_DF&C_]
MMO\ T<]- =M1113$%%%% !1110 52MKUY]3OK4JH6W\O:1U.X9YJ[56"ZAEO
MKJW1")8-GF,0,-N&10(M4444#"BBB@ HHHH *R?%/_(HZU_UX3_^BVK6S61X
MH/\ Q2.M?]>$_P#Z+:@#Y(T1AMF7S&!W*VQ5^]SZ]NO\JC7CQ-<8X'F2]_>I
M]!4-#<DJI V\LQ '/\SZGZ=2*JQE_P#A(IC(%#[Y=VPY&<\X/I2&;&:UK#Q'
MKEE8'2]/OIHK>9B#!$BY<MP><;B3P.M8^:]1^$FB6WE7OB2]"[;<F*%F'$>%
MW._UP0!^-(#'TWX4^([Z%99Q;6*L,A;B0[_Q"@X^AYKI]/T?6/"6GO%JY6>Q
MCP([FW;>D2YZ,,!@,G.XY [D5Q&O?$/7M9OI)8+^XL;3=^Z@MY"FU>V2.6/K
MG\,5N^$?BB]A;7%IXD>>^AVYAD"!Y/0HV2-PQZ\]?P+)D3@IJS.N1TD57C97
M4]&4@@_C3JQOAX$U634O(B\KP_:SL;<R +)\QW;#@XPH/)Z\C\-6S^(7A&\U
ME-)BA<+(_EQW+PJ(G;H.<[N>Q(J>4X_JTKO4?FE57?.Q6;'7 S6O/I"#5H84
MR() 6(SRH'4?R_.IKS5Q83?9K6"/;'P<\#Z#%*W<CV5KN;L8!ZX/KR*U]>@A
MMW@$,:1@AL[1C/2IM0$6H:4E^B;9%(SZ]<$>_-7[RQ6[O8)),&.+<2O]X\8_
M#BJY=#547RN*\CF9K&Y2S-Q(FR(KD,Q'?VZU?UM[E_(^T0)%RVT*^XGI5?7;
MJ6:YEC<%$B!"J>_O^-;MVBR:I8!AG;YC#Z@#'^/X4DN@HP34HQ?8R8- N98P
MTDBQ$]%(R:JWNG3V)7?AU8X5E[GTK6U&*PFN3]KO74J,",,,+^&*BN[ZS;2_
ML\$TDLB[?++(Q.01CG%-I!*E!)]+>8D>AVZ[(I[HBX<9"*1^@[UCW5NUI<O
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MNOSBX^V1PW$B 2812@;;QCVK ^'VF66L>,;:RU" 3V[QR%HRQ )"DCD$'K2
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M]HHKEU4?0 \?A6>TC/(TC,S.QW,Q.23ZD^M(J,G%W1])^)Y$6:!F=54(<DG
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MSBTQ_P"/M0!B>((HY/!^DRK%M-M'!&C_ -\2H[/^3H:QK(_Z%#_NUMZ\[IX
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MCVEQ'E[N</(=V/W9.U5SVR0Q_%:L?9OMLEL=3L+738!+(2X"P&55 /EX.._
M8^O?%#KI.W]?UH"@VC$M8?M5Y#;^8D?FR*F]^BY.,FO3+3PWX=\,(MQJ5S%+
M..0]P0!_P%/_ -9KSC6K(:?JDL DA=<!QY39"AAG'4],]^V#WJ@TC.=S,6)[
MDYK.K2E72Y9VCY=2H35-NZNSTB\^)T27.VST]I80?OR2;2WT&#C\ZZW1M;LM
M<M/M%I)G&!)&?O(3V(_K[5X1NJQ9:C=:=<K<6<[PRKT9?\\US5LLI2A:GHS6
M&*FG[VJ/?\T9KPYO%>NM,93JUT&/8/A?RZ?I6[I'Q&OX)DCU,+<P$_-(J 2
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MV;YO(CW%B>2#TIJ"_JXG-W_X8B/E 'YR3DX_I0&A/ 5SZ8-2;I T>52,,<C
M[=:0;]_S7$8&1WZ<4^4.<AE9-V44JIZ UN>!#_Q7_A__ +"$/_H8KGYF)9<R
M!\*.1V]JWO 1_P"+@^'_ /L(0_\ H8K)[FL=C["HHHIC"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** (I4RAQ7):YYD08C-=E65J>GK<Q-Q
MUH \HO=8>)R"37E_CV\-[JMLY.=L&/\ QXUZUXC\/2*69%->-^*X&AU2&.3(
MRG)]!DT .UT1)X>T;R[EC/) IN8 WRC:#Y3$>NUF&?:LFU;%K']*V_%6F16&
MG:;)'*9#(K1%LC!6,D(?KAN>W%8%N?\ 1X_I28RR6K;B364N+'$$:26BX@,F
MS'+G&=QP3O) _"L#(/!/'>NF:+4F5I1J^Y0[<+& Q;]V?E7C).Y<=.0/7-(N
M"$A_M^34@(9HHKNY4$HBJI8#<P<@+C.0WS=0:S([:[OE!DG_ -5$63>2<<NV
MW@'!)5SS5I8%EM)Q<:Q+&8W=1&[8)"JI&5R>YQ@$\CWR(KFVTY%<F]=IE<JJ
M&99 PW)SN'J&<X_7(.0MK^KDEU8*]QLN]6=[@1L2LB%F7:I;!);C.WC&>H]:
MAFTZRB@F<:G&\L:9\O: 6)!X')!(^7/U(Z@92.;23++]L1G;SF)=78LP\Q,'
M.<<J9,_0=^L$T^F^?"8X<QJBYPI'/?<"WS'Z%?Z4$NQ2W4FZKT.H6$+2J=.2
M:-I<H9#AECR3CO\ -C SSWIM_J=O=0>5#816YWABZXS@# &,<=23R>WI0396
MW*6ZDW5'NI-U!)(6I-U1[J3=0!*)&"[0Q"YS@'C/K32<]:9FDW4 /S1NJ/-&
M: ';J,U'FI(8)[@XAADE.<812?Y4 )FDS6I%X6\0SC,.@ZG(/5;20_TK3M?A
MOXQN_P#5Z!=K_P!=0(__ $(BBP'-1RM$X=>HS^HQ5JZU:\O XGD5P_4%%XZ]
M...IZ>IKL(O@UXUD(W6%O$#W>Z0_^@DUIVWP'\32_P"OO=-A_P"VCM_):+#N
MSSE]4OG.6NY3R#][N.E0F[N&SNN)3DEC\YY)[U[!#^SY?-_K_$$"?]<[4M_-
MA6M;?L^Z<O\ Q]:W>2?]<HE3^>:=@NSP0G-)7T?#\!/"Z$&2XU27V:= /T05
MKVWP;\%V_P![2#-[RW$A_DPHL(^6,U]1_!)B?AG9 D\3S >WSFMBW^&O@^W^
MYX=T\_\ 72+?_P"A9KI;.QM=/MDMK.WBMX$^['"@11] .*+"+-%%%, HHHH
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M0<;@WR]N>,54O#JSG[1<7D?F1J4"J0,*VT-C:-N#YHR<\Y/6I'@U!7B2;4'
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M[^#7]Q?7$RPW[RM-!^ZQ-G<N.-ISSQCO7V[7 >/_ (7:;XR0WEOLL]84?+<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4 %%%% !1110 4444 %%%% !1110 4444 %<5XS^&.A^,Y4NK@26E\N ;FW
M#.OHP/!^O6NUHH \JMO@'X8B(,]]J<Y Y'F(H/Y+G]:TX?@KX(B #Z?<3$=W
MNI!G_ODBO0J* .3M/AEX+L@HB\/6C;>AF!E_/<3FM6'PIX<MV5H- TN-EZ%+
M.,$?I6O10!%#;06Z[8(8XE'9$"C]*EHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HI%=6^ZP..N#2T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JB^M:5
M'(T<FIV2.I*LK3J"".H(S5ZOD;XC32Q^/M8"2NH^TR<!B/XC32N)NQ]5C6M*
M/34[+_P(7_&E_MC3#TU&T_[_ *_XU\;I9ZI)*T2-(SK&)2!)_">G?WJM;O>W
M4Z002RM(YP '-5RKN*[['VG_ &KIQZ7]K_W^7_&E_M*P/2]MO^_J_P"-?&<=
MOJDDTT0D<&$XD9I<*I]R3BF3)J<%PD#O-YCXV!7W;\],$=:5H[7"[['V@-0L
MCTN[<_\ ;0?XT[[=:?\ /U!_W\%?&\VF:U!$))&<*?27./UK/:YO%9E,TP9>
MHW'BA*,MF#;6Z/MC[9:_\_,/_?P4OVNVQG[1%_WV*^)?M=V#@SS CJ,FC[9=
M]YY?S-5R"YC[:6[MF("W$1).  XYJ:OD#P1/<2>.-#2261@-0M^&)_YZ+7U_
M4-6*3N%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#*3@,"?8TM<GX=B1=69@BAO+;D*!W%=90 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7R)\21_Q7^L?]?+_P#H1KZ[KY&^)/\ R/\ J_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M* *.M$C0M0(."+:3!'^Z:^:-^HW6JM;6LMU)-)*51$D;).?K7TOK7.A:@/\
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M+9Z ?XUTE<\HN+LSKC)25T%%%%(84444 %%%% !1110 4444 %%%% !1110
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M(&,2 =/H2.M'+2ML.\S,N9A<7<TP7:))&<+G.,G.*BJ^UK:_9C,DLQ$<RQ2
MJ.00QRO/^SW]:FDTN&.2ZB+3[X?-VMM&U@GXY]/SK3GBM".5LRN]**T8K"U-
MHMQ+-,H\KS"%0'^/9CK]/UJ9]%6.X:+SR</LSMZGS=G\N:'4CL'(S6^'0SX[
MT7_K]A_]"KZYKY)^':[?'^D(#G%]&,_1C7UM4SW*B%%%%04%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4M7YT2_\
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MHT.FZG/J.GF[:VU 6J@3.AVEE7L??/-3^&[])=,U+7=9GE)FO+>/=$HSE"&
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M_P EKM:XWX9#'A'/K<2'^5=E7S5?^)(^LH?PHA11161J%%%% !1110 4444
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M=*C&W+S^6QRN4K\WL]]=T:/_  CT'VQ8ETUO)56,4K3M_I("*=P106;DY^3
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(A\WY_TJA&E8??;Z5?JA8_ZT_P"[_A5^@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH I:O\ \@6__P"O>3_T$U\NW@+:A.H!),A
M '7FOJ+5_P#D"W__ %[R?^@FOF57\O6Y&$@C;?($D+8V,00ISVP2#GMUK2!$
MRF(G.!Y;<YQQUQUI.!CI7:1:K&MM:1+K""Y0R#[3Y[+\Q:7+8_ASN7D<MGG.
M!C+L;J!]0O6CE2VLY(9U>.2?"S,4D\L[3Z,5QUVGFM+F=C ROJ*,CU%:UEJT
MEKILB/(\I1]L,+2'"J\4RMCT&64D=^*VVO[-;R!UFM2KW"D_O5^Z9FE<GLH
MPN#@DFBX6./QP2!P.I]*4JV2"#DG!X[UM/+:Q3A%GC>.(6B.Z]&*@;R/4 YY
M[_C6G!J+11A;K5DGNO.#&<77\>V+'?D@!AYG;:1GYJ+A8XXY]_>O2/A,<R:L
M2<G$7_LU8.GZC CZC%<WV6GN(BTGGD+)M/SL3U)Y9@V1R >IKJ/ABL22:@(A
M$%,%N3Y;ELGY\EN3AO4<8XX%3-Z%16IZ+V/TH/?\:7L?I0>_XU@;##U_&HC]
MW\*F/7\:B/W?PH 9W_'^E6(^GY?TJ$C^=6(QQ^5,1K6?_'LOU-3U!:?\>X^M
M3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '&_$
M[_D46_Z[#_T%J\E\/C4&D9;&>WCWRQHPN$5EW8<JWS @8VMSVS7K/Q._Y%%O
M^NH_]!:O&+.^>TBEC5$82$$[O977_P!G/Y"O8P2;HM(\7'M*NF^QTK)KMJD4
M5YJ5K;92*4/.@+!FE9T1FV$CYT9CD[1SGTJMIUKK.K:<3#<Q?9V=H'#@#;@B
M8DX'0MCGU('>J,>O2!(4N;:&Z6-%P)BQW,KNX9N>>9&!!X(J*SUB>S@ABC4;
M8YS,1DC?D+P<=LH#]:[%3G9V2N>=*M3YE=NWJS0CO/$5T%@V2$7I9@S6RY8,
MP=L-MR%W$-@<<CUI;V\UTS3,7$FQ9?->"V"J 7(<G"@9)CSN]NO! B'B:8K;
MK):Q.D<*Q.NY@'"A IZ\']VOUY]L0SZXUS;RPS6L;AR64[F&UMTASP>?]:W'
ML/<&E"5_A1+JPM;G?XC[RYUAKA;VZ)@GM2KQ_NA$068G<  !G=DD^M37LFJR
M);A9[:662)@+2UA56194W$E54 [EP21G&.2*@U'7O[15U:RAB0QA%6([0IWL
MV0/3YB,?3G/--E\0S2626WD( (]C$NQSB$Q @'A?E/..I ]*.65E[J#VD+OW
MW^/]=B-[35=9U6)9K=Q<W&T[VAV @G&]L#ISRU>H>"$*>$K $$95C^;$UYVO
MBEEEMW%A %@P0BG:"P96!X]U^O/6O2O"+E_"VG%NT(7\!P/Y5Y^/<_9I-65_
M\SU,N4/:-Q=W;_(W*":*:?\ /Y5Y![0UJC/4_C3V_K3#U/X_RH 4=1]*M(:J
M#K^%64IH3-RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3>"YG9'OQ)]ORJ,D_P"17AK_ !%\5&-H!]K#-(&$AMT#@ <J!C&#D'IFJ_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;BXLXK5H+H1A(Y-X(**<Y_&M<)AZM&/+.5^W>QS5JL)N\$=[111788A1110
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M1110!QGQ._Y%!O\ KJ/_ $%J\?T?33?SY?(@0_,1_%["O8?B8K/X3*J"6,P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY&^)G_)0-7_Z^'_\
M0VKZYKY&^)G_ "4#5_\ KX?_ -#:KAN3+8Y"BIWM+B,X:)A\N[IVP3G\@?RI
M#:7 N/(\B0S8SL"DGUZ5I=&=F0UH6EY LENURKA[=@4>, E@#G:P_D?P],5%
MMYW1V6&1E0X8A3A3[T&WG5MK0R @XP5/O_@?R-$K/0:NB*G+(Z*RJ[*K<, <
M THAE)QY; C/48Z#)_(5(UG<JJ,87PXRIQU%-M"LR"O<? 6E"[\+:5+]JB3
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M[*XUFQ@MM+OT2:=%\V5<*"V,'.3ZBO3J\$\/-<W'B;1]NGF$+<Q%W*GF/<A
MR>O(W?R[U[W7%B*%.BU"FK([\+6G6BY3=PHHHKG.H**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<Y"P]^!@GD\U'<:/A8O,G,C1N6W%>H...<^F:T_"]L+:TN4#;LR[B<8&2!G
M[4KL+(WJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %?(_Q._Y*!JW_ %W?_P!#:OK?-?)'
MQ/\ ^2@ZK_UV?_T-JN&Y,MCFO,AD4F5@Q6, ;BW7!Z8[YQ4DAM"CLC1B1BV
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV-!C'1U[?C2_\*^\2X/^A)SU^9?\:+H->QD3:A!<70N5VP!K>2(6ZJ=D1*D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHBN9RU84444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $Q1B
MEHH ;MHVTZB@!NT4;13J* &[11M%.HH ;M%&VG44 )BC%+10 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)
MBEHH 3%&VEHH 3;1MI:* $VT;:6B@!-M&*6B@!,4M%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #34;+FI:0B@"
MH\=0-!6@5II2@#.-O[4W[-[5I>71Y8H S?LU'V:M+RQ1Y= &;]FH^S5I>71Y
M= &;]G]J>L'M5_RZ/+H JB!2,,H(]Q2-I5A-_K;*VD_WXE/]*NA*<!0!F_\
M".:(>NC:>?K:I_A3E\.Z(O(T;3Q]+5/\*T@*6@"I%IFGP?ZFQMH_]R%1_(5:
M"J.B@?A2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )
MBC%+10 F*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7"BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image00028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00028.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0R!WT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGWI?[5OS@&8_G0!Z_P"=%_ST7\Z/.B_YZ+^=>0C5K[G]\?SIPU>_'_+8_G2
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M.*4>,5]Z .QHKD!XRC(Z&E_X3",] : .NHKE!XNB.>#2CQ=$1T- '545RO\
MPET..AH'B^#N#0!U5%<M_P )A!CH:/\ A+[<CH: .IHKF%\70%@NTU8_X2:W
M*YVF@#?HK!'B:WS@J:N6.LP7TFQ.#[T :5%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\Q_^^C49N)O^>C^_S&E8C%1G([]: '>?-_SU?_OHTOGS8_UC^_S&HJ7G/7%
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M8:O=07<>]R49@&K//UH!Z'OF@+'I*D,H([BEJ*V.;:,_[-2TQ!1110 4444
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M1110 4444 %%%% !1110 4444 %%%% '"^+_ /D,)_UR'\S7,MUZ8KIO%_\
MR&$Y_P"60_F:YE^O7-(?03VQB@_3I1WQFD/US0 'Z4GX4'/3-'OF@ I/?%'M
MFD[YS0(.^,4AY/3\:4]>M)^/2@8=^G3K2]\XI._7K1T/7I0 O?I1WZ49XZ\T
MG?KTH 4_2FGZ4IZ=>M(?K0 QAUXIA^F:>W/>F'ZXH /PH[=,T8XZXS0?K0 H
M^E.'7IFD%*/7- #A]/PI^>,XI@^O6GCKUZ4 ._"BBDSSUH$!^E-'KBEZ=^M)
MCMGI0,>..U/'7I4:_7K3\>] $@YXQ2^O%-'UZTX=3S0 GT%)U[4IR.^<TG-
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M'K0 AZ]*.^"*0]>M'OF@0\8]*</7%-%.'KF@9)QUQD4IZ]*;CCKCVIW;KC-
MQ#UZ4G4=,TK=>M(/7- (!0/\BC]*.O\ C0!(IY Q5U/N#BJ2CD<]*NI]W&:
M'=ONU+;?\?4/'\8J+MUJ:U_X^X>?XQ0(]"C_ -4OTI]-C_U:_2G4Q!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!POC#_ )"\?_7(?S-<R_#=,5T_C+C5
MHS_TR'\S7+O][@YI#Z#13B>^*8".HI:!!12>])D=* #\*,^W%)GD\\T?CS0
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MK]*=3)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGC/I3.-U.'XT 2#VZ=J7MQ3..G-/'K0-"T4GUI,CJ>] "]N*.<>_I2'&>>U
MQUH D7Z59A/(!JJ,8[U/$>E %LU-9HTE["BC+%P:K_RK;\,1H^HLS=57(H Z
M] 0B@]A3J**9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9>OWD=KI-P
M&8;F0J!GGFO,'X%=5XT#MJ4(!.WRN1^)KE95V\#H*0R'O3LU'D9Z5(,9XZ4
M+_6CM1WI._2@ I#TI<>U(5.: &YXQ24_9[<TWRSG&#0 E+[T\0G'0YI1"?0T
M -'I3NE.\AO0YIPMSTP<T#L1Y]*3Z5/]G;T/%'V8^AH K&FFK7V4_P!TTGV0
M]U/O0*Q4.:6K/V-NX-'V-L?=- 6*W/XTM6?L;=P:3[&WH:!D%.7.:E%HP/0T
M[[*?[IH"Q$.**F^S-Z'BC[,V>AH$0'KS^%'89J7[,WH:7[.WH>:!$63^=/YR
M*?Y!]*7R&]*"K#3GCWZ4\>]'E-@\&G",CM]: $I*=L]1TI/H/K0 G/\ A0,X
MI>:.>XH 4>WZU+'4..YZBI%..M KEU3QQ6CH<H@U:$MC!XR:S$QM%2#(8, <
M@Y&* N>E45%;$FWC+==HJ6F(**** "BBB@ KS;Q$\DFL7*L3M5L 9KTFN UU
M(WU6Z'?(S^5 ',2 \TP$YJ>X0(Q !Q4*IG'!I#%[T[GIWIZQ$] :E%LS#I]:
M *M!ST[U>%D2>.E2"Q]: ,O!S05:M<6"_A3A8H,&@#%V-UIPC?%;8L8\]*<+
M.)0.* ,/RWI?*?I6\MG#TQ3Q9P^E [&"(G'.*##)CD5T2VD'3%/%I .@H"QS
M7D/C)'%)]G<]JZ;[+!Z"E^S08^Z,T <N;=_2D^S28Z5U0M;<]%%+]EM\<**!
M'*?9G].E+]ED]*ZO[+;\?**7[);_ -T4 <E]G?TI?L[XZ5U9M+?^Z*3[);_W
M10,Y?R'QG'UI?L\F.E=/]EM^FT4TVL&.!0%CF/*?TH\EZZ;[);9^[3#:VY_A
MH"QSOE/[4")ZZ%K.W!X6@V4..!0%C "-DFG^6Y/:MO[%'TQ3?L<>.!0!C[3C
M)I=AK7^PKVQ3/L0QQ0!E%3WI,'OUK3-D*8;(XH S^<TX9!QQS5K[*5' J,P8
M' - "Q_>%6CD?4U5C0@C@U<A&]L8- %O29Y;?4H2G\3 $5WU<79PQ)=P''.\
M5VE"$PHHHIB"BBB@ HHHH XGQ=JKM,^GK]U<,:Y"3.:ZGQ-;JVL2OCYB!_*N
M8G 5VR*0R$'CM3A[5&!S4@''M0(7MQVH[\4[9D=#2^6>1M/% R.DYS_*I_LY
M/8T?9F(Q@T 5O>DP<5>%F2>5/-*+%B.G2@$4>: 2.U:(L"3R.*>-//I0,S 3
MGI3N<UK#3<CI3ETS/;I0!D<^E)@YZ?2ML:9VQ2KI?7B@+&"0>M(5(KH/[*'I
MUZTG]D+Z4"L<\5/I2X/I]*Z'^R!QQ2_V,/2@=CG=IHP:Z+^QAZ4?V,/2@1SP
M!STZ4[#>E;_]D =!UZT?V3Z#I0,P><=*7DG..*W?[*'I2'2N,D<T 8.#BE /
M;I6S_9?M0=+QVH%8R%S^%/&1VK2_L]O2D-B0<$4#L9XSU]*>,U<-D1U%)]D/
M<&@"I]*/I5K[,>ZFD-OCJIS0!6&<45,83_=-(8\=C0 P'M4L9^84S;QT-.0<
MB@"X>F*OZ/=M::E&_P#"_P AJBB[L>]7;6V/VB$GH&!H [U3E0?6EIL?^K7Z
M4ZF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% '(>*G0:A$K8R8^*Y.ZA
M8DE2#]*Z/QB!_:T!/3R_ZFN<EN%C& M(93$;ENF:G6V<\'J:;'?JO'EXSU-6
M4O$/;D4 (EF_=A4@LCC&X5*DR-WQ3MZYX.: (ULACDC%/^QITR*7=QQ02>N.
M: '"TB'8<4X6T/?%1%VSTXII=P?NF@"UY$'H*<(8>X%4][_W31YDG]TT!8O^
M5 .<"I L'& .:S?,?^Z:/-D_N&@#4V0^U*%@'85E^;)UVFFF64_PF@#7Q;XX
M HQ!Z"L?S9?[II#--C[A- &T!;Y[4N+;T%8?G2X^Z:/.EZ[30,W,6WH*"+?M
MBL/SIO[II?-EP3M- &T1;]@*,0>@K&\Z7/W31YTI_A- KFSM@]!3=L'H*R?.
ME_NFCSI/[IH U3'!Z#BFF.#T%9HFDS]VG"5^>* L:!A@/IQ3?(A]![52\QO2
MG+(V>E %O[/#Z"FFWB]!S4(D8GI2[V]* )/LL9Z8J,VBYSD<TNX\<4NX^E $
M9LQZBF-9]@1S4Y8X_G29P>:!%5K-AT(XI!;R"K6\>M D3/6@=A(HI,@>AK0C
M2.),OCK55+M8^#S3;F9'B.T\Y&*!GH%MG[.F?2I:AM,_98\_W14U,D**** "
MBBB@ KSC6C_Q/;OYL?-W^E>CUY_X@M%DU6Y8<G(_E0!BRS1A</@_2DBG@/ P
M/K56:!@Y 4D^E-6U;IL-(#466//#+4PD&.&6LM;23KL-3QVLP_A- R[O([C-
M&]L]:A6"?CY34H@GZ;#0 GF,._2CSCUJ06\N.8S3Q;.?^61H K^<W3-'VAL=
M:L_9&_YXG-*+,Y_U!H K?:3C&:7[41SFK(M!_P ^Y!H^RJ/^7<_G0!6^U'IF
MC[8?6K0MT'_+N:3R(P?^/<T!J53=OZT&\?UJV((\_P#'N:4019_X]S0%RC]M
M?UH^W/ZU=^SP_P#/L?SI#!#_ ,^Q_.@"G]N?^]1]N?\ O=:M&*$#_CU/YTGE
MP_\ /K^M %<7K_WJ/MK?WJG*0?\ /M^M*(H3_P NQ_.@"O\ ;&Y^:E^VGKFK
M'DP_\^Q_.G?9HNUN: N5OM;=CBE%V?6K7V6,C_CW-/\ L4?'[F@"G]J;UI1<
M'KNJY]B3M":/L2]H30!5%PW3-.\YCR35@66!_JC2?9".D1H A$IQR:7S6SG-
M2&V?_GD:0V[]HS0 WS#TS2%SCK2^1)_SS(IAAF[*10 I9O44A)/4BHS;W';-
M,-M<=.: + 9>A(JQ'-"HQD UGBSG/4FA;8^9@B@"_%,W]KVBAP5+CI]:[^O/
M[2U$=]:L>OF#'YUZ!3!A1110(**** "BBB@#@?$4SKXAF0=-H_E6/.B.A)P#
M[UL>)HV&MS2KUVC^5<S<22,2K'-(9-';9'WU.:M);I^-9*.Z\J:L)<3 G/(]
M* -01H!TIPV@]!Q5!+F3N,^U2B<GC;0%BV' ["@2C/:JXDSU6G_*>HH"Q*)A
MGJ*47'N*B\I3WI?LZD?>H E^T>XI1=>XXJ/[(I_CI?L2_P!^@+DOVK'0CFE^
MV>_2HOL2G_EH*7["O3S10!+]M'K1]OYZU%]@7_GJ.:/[/3_GJ* )?[0Z<T?V
MA[U%_9J'_EJ*/[,7_GJ* )?[1_VJ/[1Z?-TJ+^RTSGS11_9<8_Y;#WH F_M(
M_P!ZC^T>GS5!_9L?_/<4G]G)_P ]A0&I8_M'WZTG]H>]0C3D_P">HI/[.7C]
MZ* +'V__ &A1]N_VA4/]G+_STH&G<?ZP4 3?;!GJ*/M@]:B_L[//F4O]G\_?
MH"Y)]J]Q2_:?<5&+'C[]!M"/XLF@+DHN/I1YV?2H_L_/WJ#" ?O9H D\W//%
M)N&<<<5&4 %(>.>M 7)-PQT%-.P\8%1%\?PYJ,W&T_<H F*1$]*3R4)P!BJS
M71'2,T"Y=C]PB@#2@MUR&S]*G^T&*X@0=W S^-92W,P8*N0*LQ&66> L.!(O
M\Z /0X^8U/M3J;'_ *M?I3J8@HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH Y'Q7$DM]"K'!V5R-S:LK_*-U=-XO)_M>W&[ \O_&LQ7B\Q07'-(9C?V?-G
M&PG-2IIL_/R'BMLW*QGIQ3QJ"?2@#(CTR?\ N&IUTZX]#]*TQ?@C@T\7U S.
M6PGQT-/%A<>A^E:(O":<+I\]#0!GK83]"#^5/_L^;T/TJ]]HD]Z/M$N>AH I
MBPE'.T_2E^Q2_P!PU;^TR^AIK74N>] %;['(.J&C[,^,^6:F-W+CH:;]MD[@
MT 1?9W_YYFCR'SGRS4GVQ_0FE%XQ/>@"/R3_ ,\CS2>2PZ1&IOMA^M.^V#'-
M %<Q$#'E&FE<'_4GBK1O%QR:C:[C(^^*!%<C_IB12>G[HU+]IC).)!2^:G]\
M&@9#@_\ /(TX(2/]214_G#L<TGVB@!GE?],C3A;Y_P"6)XH^U,*=]N?WH <+
M3(_U9I?L/^Q2"_D]#3_[0?CY30 S[#_L4?83_=I_]H/S\IH-_)D?*?>@!GV%
MNR]?TIOV&7T-2?;Y.?E/M0;^3T- $)L)NV:0V,WJ>/:IO[0D]#3&U%_0T 0M
M83X^\:C.G7!_C(_"K']HOZ&D-\Y[&@+%,Z=/C[YI/[+DZF3&*MFZ=O7FHC+(
M3@L: (&LRC ;LYJP+-5A9CQBG(R;OF<$TDY;9P^1D4 =[:G-M&?]D5-45M_Q
M[1X_NBI:9(4444 %%%% !7GNK/(=?NE#X 8?RKT*O,/$4C+K]T%.#N'\J )T
M2+>69@QQ4J20*>8^1WK&M2YF!))XZ5;D5F3(I#-19[<'[HJ47$(Z*/K7,2><
MI/)IHFF ^\:!G5BYCZ[13Q<KV%<FMS,.Y-3)>2C'7Z4 =1]I']VE^T\?=K 2
M\?T-3B\?'0T ;/VHY^[2?:SZ5E?:SCI2_:SZ4 :7VTY^[FHS>GIMS66UZ<GC
M%0/>MZ8S0!LF^X^[FD^V _PU@&^?K@BFF^<CH0: .C^UC'2G"Y4]JYK[8_O0
M;J3U(H Z7[0OM0;A#P<5S!N)3_$12&>4_P 1H Z1IT[.!4>]#QYH-<_YCD\D
MTX2M0!OAEP3D4OF #&:P?/?^\:3[3)CJ>#0!T'GA>U NL=JYPWD@[FF_;Y/>
M@#J/MP')6I!?*/X:Y;[>^>A-/&H/_=)H Z?^T%'\-+_:(_NUS0OR#]VGB_8_
MPT =!_:7&=E*=1YQM_&N?%\?[M+]N;'W: -TZCSG92?VB/[M89O6S]VH6O6_
MN$4 =#_:*YSMIAU >F:YPWKG^$T@NI">AH Z+[>.RU&UXQ/"UCK+(W8BIPTA
M7/(H O\ GR.?OXIZ8Y.\%L]:QV:1 22>*BMII-A.XYS0!O0NYU2U!;(WC^==
M[7G&FNSZG;;O[XKT>A"84444Q!1110 4444 </XAN -<EC*YPH_E63]BCGE!
M(V@U;\33>3XBF.W/RBLV.]9Y>!BD,N+I5MW<<=15A-+MO^>@]S5*24@;@.>]
M0&_9.Q/M0!LKIMJ!PZ\5(-/M!W%80U/!^[4BZF.XH&;@LK3VIPLK3/;FL=-1
M7TJ9;U?8T :8M;,=AQ2_9K/^Z/SJBMTA]*<+A#Z4 7/(L_04&"T[8'XU2,T?
MJ#4;7" ]J +WE6@/&/SI/*M/;\ZS6N4!SD5";M,]10!K^5:XZ@XH$-OZCG]*
MQS>(.F*47X% &QY,'&".*7[/#ZBL;^T !TH.I$#I0!L?9XL=<U&]O%]<UDG5
M&]"/ZTTZDQ['VH TS!'GA:/(C]*RQ?OTYJ4:AZB@#0$$=/\ *A&.16=_: ]*
M8=17TH UUCAR,L*D"0?WA6%_:"^@I?MZ>HH Z );@_>%.V6W7<!FN?%\G]ZG
M"\3^\#0!O>7;8QN%+LM>>1S6&+N,_P 0H^U1_P!X4 ;7EVH'44ABM/4<UC?:
MH_[PH-TF/O"@#7,-H?XAQ3?)M/45C&[0=P:B-ZN3S0!O&&T[$"HFAM.O%8GV
MU3WIXN0>E &HT5J/2F'[./NIDU1$X[BD^U!6X6@"ZL:O)NQ@"IEE42PJ!C,B
M\_C69'J!\TC;P#TJU%.)KJ#"X_>#^= ,]"C_ -6OTIU-C_U:_2G4R0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*-GM0!5"#U_^O2CZU,4/I1M]J &8![T\8]:4*>PIP'M0,,<8I>^:7!IP0Y%
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M/I05]Z?@FEVG H A9%[TWR0>]6-A]*58SZ4 R!+<>M6HX%"CGI2I'W_*IT7
MQ0(18EQUHE@ B8CTZU)T-$C9@(]:!F-&^V1^>]:-@^;V  _\M!_.LP!O-DXX
MW5=T]B+^W&.?-'\Z$(]4C_U:_2G4U.47Z4ZF(**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU8[@/<4 SUNU_P"/6/\ W14U0VO_ !ZQ_P"Z*FIB"BBB@ HHHH *\F\4$?\
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M B)ESFD4<\BI2#V[TWO0,<.E+ZT <<'K10 4>O% I: $I<>U !Z9ZT[GCD4
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M>:?V)!Z5 K8FSGO2 V)B#TZ50G&4?Z5863?'R>:A;EOK0,Y<<&48/WJFL/\
MD*VO_75?YTEPACN95_VLTNG_ /(5M?\ KJO\Z!'KR?<'TI:1?NCZ4M,04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHXH /PI<4E+F@ [4OX=:3\>M+QZT ./&.**3WSQ1Q3 =3E^E1YY^M2)TZ]*
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M'_+7]*/^$\TK.?,_2O*BHI-HH^JP%]=F>K?\)WI6/]9^E+_PGFE<'S/TKRC
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MKG^]4BC]ZGJ6H$>P0_ZB/_='\J?3(?\ 41_[HI],04444 %%%% !7D?C#/\
MPE5WQ_=_D*]<KR3Q>,^*KL_[O_H(H JZ0#_:,5=ASG&*Y#1Q_P 3",5UQQQ[
MTBD2*.<U*HX]Z@4CIVJ=.10 YA^[(QS67<#Y^G-:O&"/2LZZ YH$5^<YI<_G
M3./PI11T @OKM+*REN),!4'6O&;Z^N+Z]FG>5OG8D#/05Z3XYD*>&9=A.2ZB
MO+ ,'/K7-7E9V/=RJE%Q<V.WRC^,_G1OE_OG\Z3 Z=^](..O>L+L]?DAV'>9
M*.KL/QHWR]-[?G3<<^V*3I@CJ>E%V')#L.\R3!/F-CZT>9+WD-(?E QUHP,[
MO6E=AR0["[Y>[G\Z7?+_ 'S3<#=2#&>M%PY(]AV^3^^:/,D_OM2<9]J.S'TI
MW#V<>POF2'_EHWYT;Y>TA_.D*C''2D^4#J:+A[.'8=YDF?OG\Z7?+_?/YTP#
M(YI21C/>B[#DAV';Y<??/YT;Y<_?;\Z9A<\DXI<CKZTKL.2'8=YDG/[QL4%Y
M>SG\Z;@$#VI<CBG=BY(]CJ_!FN2V^H"PF<M'.V%+'I7I'..0,UXOI;;-7LV'
M43+_ #KV;W]JZJ,KH^?S2DH54UU'<YZ4=^1@TW(Z4O'4&MCS"5<XZ4;2\J@#
MOS2+@"K%HFYB?>@"V$*(!C%02GG!JPY[55D/S4#*M\YBT^X8?W2*YR!<0#/6
MMO5SC39,'@UBPC]R,=J!&CH6?[?L^!]ZO5:\KT(?\3ZS] U>J4Q!1110 444
M4 %%%% 'EOCO_D9,]O*%9&FY^U1\=ZU_'@_XJ,>\0K)TS_C\B]<T,9V8SM7C
MM3@>>*9V&:<N.](:)UIV#CZTQ,=ZD(&* ,RX7:Q.!UJ(YXQ5B[3//O54D4"N
M._"@D ?-P!3>,8JCK5P;;2;B9>JKBDW97+IQYI*/<XO7?$MS/?O%;/B.-B,C
MO64=:U#C]\WYU1SN/)Y)R:3C)R:\V523D?<TL#2A!1L7_P"VK_KYS?G1_;-_
M_P ]F_.J'THXZGL.*7/(U^J4NQ?_ +:O_P#GLWYT?VU?_P#/5OSJAQGBEX%/
MGD+ZI2[%[^V;\_\ +9OSH_MF_P#^>K?G5#C/'XTO':ESR#ZI2[%[^V+_ (_?
M-^=']LW_ /SU;\ZH>GZT4^=C^J4>Q?\ [9O^/WS?G1_;-_\ \]F]N:H\$4<4
MO:2#ZI1[%[^V;[M,WYT'6;_/^N;\ZH8 Z?6EXQ1SR#ZI1[%[^V;_ *><WYT?
MVU?_ //9N?>J&.E+QWZBCGD+ZI2[%[^V;_(Q,WYT?VU?\GS6_.J''KUZTO'K
M1SL?U2EV+W]LZA_SV;CWKHO#/B&2286=R02Y^4GK7'=\FI[*7[/>0S \HX/Z
MU<*K4D<^*P%.=&22U/7.?04#/H*:&#(K9^\ :.,=:]%/0^&:L[#AGTJ1>>E1
M#%2+C//:@$(X)8 "M""/;%G'-4XTWS UI$!4Q0,KR?2H68*K,>P)J63%4[UM
MMC.P[*: .=#F5Y9/5C5O3!_Q-;7_ *ZK_.J-MS%GU-:&FX_M6T_ZZK_.@1ZP
M.E+2#H*6F(**** "BBB@ HHHH **** "BBB@ IK_ '#3J;)]PT 55;N0,4\9
M[U&O;'6GKCM0!)SS1_DT@HQV]: #FE_R:3CKZ48[>M "C-'6CGBD+(K %U!/
M0$\F@!>:/\FCI28[>M !S2_Y-)QU]*,=O6@!?\BCO_.D]_2CCIZT +_D4AS1
M[^E!Q0 C9]*C/0T\^M1DC% #2<] .M7ATJAD<?6M =* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "H+C[R5/5>XQO4'T- $8Z\=:E7-1
M#&.?3BI%]Z '#-'/%(,4<=?6@!?\BDYHQV]*..OK0 O^11SQ36*HI+L% [DX
MI(Y8)@3%*KX.#M;.*8#Z3FEQSQ2<=?6D O\ D4G-&.WI1QU]: %_R*.<=*3'
M;TI>.OK0 ?RI.W(ZT8[&@\T ,.?04P]#CIZTYNM1L=WXT 3VO\56*K6O\0JS
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0_\ 'O'G^Z*=[5ZD=C\\J/WV2*:M6B&29<=!5->?K6MIT8\LN1SVIF=R\W3
MJK)G!YJ=S[56D/6@97D[UGZL<:<>>6.*T'Y%8FL3 LL/H-Q%"$RI:C]UQVJ]
MIN?[5M3_ --%_G5*V_U'3O5[3?\ D*VO''F+0!ZF.E+2#I2TQ!1110 4444
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MU97_ %R<?Q"@1ZQ%_J4_W13Z9%_J4_W13Z8@HHHH **** "O*O%__(SW7/\
M=_D*]5KRGQ?_ ,C1=<?W?Y"@"#1O^0@O/05TK^N>M<QHI_T]>/6NH;UQ2*0P
M<#K4BGWJ+M]VGK]/PH L*>V:<W(//:HE/M3^QXH S+@8E-0]#]:GNP=^<57%
M '.^.O\ D6'&<_O!7F]GS>P9/5Q7H_CD_P#%,OQC]XM>;VKA+R%V&%5P2:Y*
M_P 1]!E?\!GN1M(9M+#NH8E'7'_ @?Z5P5OK;0^(]<U=8L2QVXC(]<$*3^-;
MY\66,:$+.A ' SZD5BVMSI3^,]3MY)8ULY;91YAZ,PP?Z5%S.,''F<D;UMI,
M&JV^E0,HCCFLI'QZ$NK"M1K% FF3$#<]V488]%85SNJ^+;,66;-D22U540+W
M!QG^53KXNLHW:1ID9895D1?4D$'^=%T+DJ;HUKE?*TZS!PRK>2G;CI]ZHM*N
M$N[VY4PXA6%"#VD4C@?AQ4%UXBTHV=G*+F,F25BR9^[G)IEKXBTFVD!6:)4A
M3S ,]<_P_AFFF2H2Y=NYDV>!<ZA(!\R72D#T^5J5M>U&Y34'-R%$8M2%QU#+
MR/ZT^2^TNUL]0NH[F-Y)2LP0'O@C'ZUCV$MC>O?K+=)"H6V=<G[VU,$46-.5
MO=$GQ+L4L-0LPA!$V^;CWQQ7#^^:Z;QEJR:Q<6[(X;R6=1CTXQ7,Y''%0ST<
M,FJ23#KQGM1^/L*/08HSM93MR :FYN=)X*$7]M213X*RPE0#W.179:O*OV6X
M@MU\QI<*UN.NWG)KE="U&*_U(6L-D(Y'4A9 /N>_X5T1#PSR6CJ8V0X-X>_M
MFF>?7?[Q'&:[I<%C;6\L2^4\A(>(]5'%8G3D=Z[+Q-<):Z:+=XA<-,WRW/7&
M.WZUQ@ZT(ZZ$G*.HOMGK1Z?-2?AUI?3CI0;%K3O^0E:C_IJO/XU[$3P#GM7C
MFG'_ (F=KQ_RU7^=>P$\=.U=.'V9X.;?%$,\XS5JV3S)U&<\U34]\5KZ5'U<
MCO70>.C4("KMSG%5II%3DGM4TCA8RQ&*YZ^O3O)'ITH O-=@GK4<L@$3R$_=
M4DUDPS-*_3'-3:I-Y&FLO\4G H$8:R--YCL<EC6A ?W(K-BR(3Q6C!_J>E &
MGH(_XG]KSGDUZ;7F6@?\A^UX[FO3:8@HHHH **** "BBB@#S3QT?^*@09_Y9
M"L?2\_;H3GH:U_'G_(>3C_ED.:R-+/\ I\(QWH&=6WW<4T=.N*<V=N,4WMTS
M2&2I]:F0^]5U/M4JGIQ0!+USS67<<-UYS6EU& *S[OA\XZT 5AUZUE>(S_Q(
M;CZ#^=:GX5E^(O\ D W(QV'\ZF?PLVPW\:/JCS/T&>":]0L_!&FSVMO+Y0Y5
M2_OE2?YUY=_=^7/S"O<-.NEBLTB)Y:W0C\!7!32ZGUN9U*D8Q4#BY_#FDKJ>
ME0Q[3YFX3H#Z#K3)O#%B[VTL"@PSWJHN/[ISQ6E/IPA\1:;=!^;HOM7VVFMB
MVTY+/2M.M3(#+#<"1AWX-5;6[.&=>I&*Y7NOU9CZCX'LK;2YKA(_GBA)/U[5
M%;^$].^TW<$D&=J(5;^[G/-=CJ%['*L\ P5N;<L/P_\ UU7FVQWTCQ#S(Y(D
M5F'08S3:1C'%5G%IG.#PCI"W#1F,.RY8+GJ/3\/ZU4BT:'3-;V6K!2+1GS[@
MBNBM+9K>\O9"?,8RL\1_WNJC\A562U>76EFC4M&;5T##UR*5E<UA6J6:;*"Z
M!H<J2.+,,\<<CL >I7'^-<]XCT.#3M%L[V%,?:%1@?8YS75Z82?M7EKN9H;G
M8!W^[63XQG#^"M'A/$D)"L/PI-+E-,-4J>U4?,X+\>M'?K2?A2]^E8GT(>G-
M7]%M(K_5H+>4X1FP?>L_M71:=HMM'=VLRZ@H8.'QG]*:W,:\W&#.RU70H&@T
M^TD DCA@8[O^>?'6N U+0Y;",312^?#GYG X6NZN9Y+NXAN9IC;LJ8-L?^6H
M]*H:PBWVGRQ./L"A=P0\;R.:N21XV%KSIM1. '0<T?CTH(Y/Z4>^*S/?0=NM
M*G^L7V(I.W2E7[Z_44UN14^!GJL)_<1XZ%13LGIFHX?]1'_NBG9YZ5ZBV/SR
MI\;)XEW.HSU-=!#'Y< &<8K&T^(O.K$9 -;;' ]J9F1NWJ<9JM(Z@XW5!=W8
M4FLO[49).O>@9J,0W0\$]:YB_D\W49B#PG%;4DIBLY9>RKQ7,1.69F(R6))H
M$S1M<^3U[U>TW_D+6O\ UT7^=4+7_4D_I5_3.=5M>/\ EHM 'J=%%%,04444
M %%%% !1110 4444 %%%% !39/N&G4V3[AH H ^_6I1TQGO40Z]*E'3I0,>#
MCOU%._&FCZ=J=^% A?QH]>:/PZTGX4 ,F_X]YO\ <;^5?&TH_?2_[Y_G7V3-
M_P >\O'\!_E7QM+G[1)Q_&?YUU8;J1(Z[Q+XF-QX5T30K28>3%;J]Q@]6QC'
MX<UR 7 '-(  ?N]>M;NA^%=3UZ"6>VMI&B3@,HX)]*ZDE#4C<S;&[FL+^"]M
MG*30L&4CUJSJVKWNNZG)?7TQ>1N%)[+Z53F@FM)W@GB*2QL0RGJ*%#R.L<:E
MG<[54>M4DK\PKO87'OFNX^&/BB30/$<5B[_Z'>2!7ST#= ?Y5B77@[6K+3/M
MLEC*$V[GR/NCUK%B<HZR+PRL&7V(-#2J1L)7BSV#XQ^*Y4E30+27"/'NN,=P
M>U>0* ,5>UK4WUO5Y]0E!5I O!]@!3]+T'4M:$CV5K))'&<$J.]%.*IPU%.\
MGH5;:XEM;N&\@?;/"X=&'8BOI3PCX@3Q+X<M]0!'FG*2K_=85\V7%K/9W#V]
MU"T4JG#(W45ZS\%;G%KJEJ3C#JX7Z\'^59XN"E#F0Z<K.QZI_&.?QK2'05F_
MQCBM(=!7FG2Q:***!!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK_@,ZR3X<W\5]IUL6)-ZNXG^[@9J.W\ WUUJFIZ>CDR6!!/^T",BNY&H7?\
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M6@"AK4HBLUM@?F8Y/TK#@QSS5O59_M%](P' X JI#WP*!%^V_P!5C-:&F?\
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M3U%!7D*<=,T'IUYHSQ\PHYSQ3 LZ?C^T[7G_ ):K_.O6NN,5Y)IV?[3M<?\
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M)_\ K5&*E&,.5#I)N5SILY8$>M:8Z5F'.]?K6F.E>8= 4444 %%%% !1110
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M8^&B>'N.>.30;'PWMX>?(]ZRY=,N(;8W$C?("5 ]P<&H)+2:&RAN6SLF) _
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MOC-"ZQ(DLDF<EP OMC-33:VS6:A#^\8%6/MVI:F3<TRM_8USB-<?.QQ[4O\
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MW+CUK3'2LS!W 'J36F.E04PHHHH$%%%% !1110 4444 %%%% !1110 4444
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M/XN*!ENUD\R!3_=&,5.<8!Q6383>7-Y9/!K6Y]: (YL>0W':L-OOG'K6Y/\
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M#E9<L_N-]:LU4L61D;9(KX/:K=!(4444 %%%% !1110 4444 %%%% !1110
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M?_4MWJ:'A ,T".A\+<^([48[G^5>L5Y-X3.?$EL<^O\ *O6: "BBB@ HHHH
M**** /*_B2!_;\'KY 'ZUR$)(E48^M=?\2O^0];_ /7$?S-<C"?G [F@#O='
M(.F)Q]*OC'3%9VB<Z>O-:0^M(HIZBNZUZ=#Q6,25(8=JW[L9MWYK"V\CTH V
MX9!)"K]3BGOA5/':L_39#DQYX%7+AL0$Y[4 8;GYV.,\UFZ[_P @>;CM_6M
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M\ZS[?HP''-7K8@747/\ RT7^=,9[;%_JD_W13Z9%_JD_W13Z!!1110 4444
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MF1 ,DX*D>O'2ER,YXS7H%YI]FUC-*JC?>11CIT&W(_E7(W6DK:Z/;WF?WDC
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MT4JAME/PR'T445D>N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_(&O_P#KO_05Z97F?P;.=&OS_P!-_P"@KTRJ1X.-_CR"BBBF<H4444 %%%%
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MB%?I7&:/C^R[/K_JUKL[;_4K]*\>?Q,^BA\*)6^Z?>L&]CYSZ5O^M9=W$,\
M^]248C$XP?2HDE,4@9>U3S)M8GG%5'(_.@DZ&&9;VW(XSC%9-Y985L#H*KVM
MZUK,,_=)YK</E7EN9(SU'(H*.4C@=0WIFI[92+N ?]-5_G6@;8!6SVJHJJNH
M6XY_UJ_SH$T>TQ_ZI/\ =%.IL?\ JD_W13J8@HHHH **** "O'?'^?\ A+)?
M]Q?Y5[%7COCX9\62_P"XH_2@#$MARI_"N\T<$:8F<5PMJ!D#GK7>Z=B/34)Z
M;<TAD5_<;$\L?>:LGG-3W#^=,SG.,\5!QVS0-B<EJU[)-D(]:S[>#<V3TK61
M0D8% APSG/%8-X"MY(/>M[Y?>L34@!>DCN!0,YCQ=D:$W3[XKA(93;SI)UVF
MN[\6X_L)NOWQ7 ?S-<=?61]#E7\%FV=:@V2!4.?^6?'YT3:VDL!0)ANH('>L
M0* V"I!'J*3IG@AL]#7/9'H\B-]]<@EMUC=2&Z$BIK?6+46[.5&8EP>.M<T5
M&.]&WY>C;6[]C3Y4'(CH#KUM)&L;QX XR!S5*^U)+R%8@/NL#^ K+&.H!!)[
MTN>.!CTHMJ"@D=;=>++22QFM8D8"-%\@D=\8.:CU9(6\&V,N_-P\B!E!Z *1
M7+E1CIP*D:>1XDB+$JG(!-7<B-%*W*,&3SZ5;TNZ2SOXYI@=BMSBJ9QQUI<%
M^ I)]!2Z&TE=6.HC\4VT<:*(S\@"].JU-_PEMIA@8L$P%#@=6_PKCR,8WJ1G
MIQUHXST)]*FQE[*)V*^*M-95+0G<!@_+WJ'_ (2J#R5C$0)7 4D=A7)_)N%*
M,9X'%.R'[*)8NIC<7<T_]]BU0\C@=^::-HQUP:4GC(!HT--$A??THYZ>M(2,
MXYH[>_:F,LV!/]H6W_75?YUZS:#-PF?6O);'']H6W_71?YUZU9X\]<9[5TT-
MF>#F_P <3IE/&?:D<91E]:5<8&.F*7C''X5T'CF)>0DY)QP*RI 0"*Z.YMP<
MD9K&N[< $C- C+;.=V>E:>G:ES]GFQDG@UFR)LX[55?AMRDC% '2WUL-A(P1
MZBLN2WVIT[59TW4//3[-+][^$U)=*%C./PH&/\(_\C/!GL#C\J]5KRGPD0/$
M\ YY!_E7JU,D**** "BBB@ HHHH \L^)?_(;M_3R?ZFN3ML\=,5U?Q+_ .0Y
M;^IA'\S7*6^ W.<T =OH.1I^?<U=FD\F%F/7M5;0E TY>O/-0ZA-OD,8Z+Z4
MBKE)W9V9_P"(FF'-+[4*GF-WQ0!?TY".>]:!)]J@MXQ'&.O(J8XQWH Q;]2+
MML5B:UG^RI_H*W]47;*I/<5@:W_R"9O;'\ZF?PLVPW\:'JCANX^HKJ(M-M[M
MU$KH-R@C![ 5R_%2"YD7D.V0-O6O*9][4@Y+0WY;"Q97*-RV-N3Z5;>SL;JV
M6=F4$+G /I7)B=^FYOSI5GD5=H=L =,TK,ATF=2EA97C(>X &!4,VFZ>JEA)
MR'\OK6':ZC/9R[HSD[2 #5<S.V=SMUSP>].P>RE<V[F*V^RLO&]1QBMW2[*6
MVL+:%[E2\T;O&=_0''%<1YSY)R22,&GK>SC81*_[L%1S51=B:M"4TK'6:0@F
MTKQ!*$1D_>$DCGVQ^M<9T&16KI^MO8:5>6:C+7/!)]#UK*XQ]*;8\/3E&4K]
M;$UG_P ?D ;&-X'-=G'86)DN)I&3>"V ",8-<.."&&>#FI/M4QW$2-SUYJ2Z
MU.4]4=O#I>EV,T>UU8L2AR0?2JYT33I@NV4 *^T\]JY#[3-O!,CYZ]:474R
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MFZ_RI)=9OIM/6Q>0^0AZ9ZUHVG@S5+[1FU./:(57=@]<8S6"BF1TC169G;
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M?34?^J3_ '17S+I/.KV7_7=/YBOIJ/\ U2?[HK*KN>SE/PR'4445D>N%%%%
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M1\[#NN#T-*#)\P$C 'KS][ZTE(?QH!**%S-GF=V7T+4NZ<_>GD/.3\W?M3<
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M"G ZGTKIMUBMO&8V4,X^?Z=ZCD-E )0K*5E3H*.87LD<ZJ2R<*I.!^E&R5<
MH?F&1QVKI)38VMHKPNOF-%M;'J:D:2P^R(7*F0+A?84<PU21RO.?I1[4^?;]
MIEV?=W'%,[&KZ&'VCUO1\_V79\_\LUKL[8GR1D]17%Z/_P @NRX_Y9KFNUML
M>2..U>//XF?0P^%$_..HJ">(N.U3<>E+P>U248-W;$CMQ6/-"R$UUD\ 8=*S
M)K5<G(^E F<T^X=>*EL+R2TD^]\C$;A[5:NH4!QCK6<P^1ACO0!TMPH\MBO
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MI?@?RJKJ9_XEU]D<C7N#1U&G:/HC*\<QK%XHN"H \P;C]2:YOOQZUT_CP?\
M%329_N _SKE^.N*UCL>1B/XLA?QH.:3CIBCWQ3,1>_6EI,"D]\4 +WZTO..:
M3CIBE'TH!%W2?^0Q9?\ 7=/_ $(5]-1_ZI/]T5\R:0,:U8_]?"?^A"OIN/\
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M'/[P506=WCSV-7="Y\0V7'\8H ]?HHHIB"BBB@ HHHH **** "BBB@ HHHH
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M;N%7FM2'C!/1@*Q/#'B&.S\4WFJ70 %PKGD]"32MN7[2$5#4V,%M-\.;>@U
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MXK3T+_D/V?'\= 'K%%%%,04444 %%%% !1110 4444 %%%% !4=Q_P >TO\
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M+4#Z&&^,=>IJ:Q<>:4S5>4G<?6G6;$7*@]:!&L>M8=Y_Q]R?6MSOGUK"N_\
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MI6+?G%T])C+?AL!O$%NO."K?RKR#Q-;&S\5:I!C&+ER/H2<5[!X9S_PD5O\
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M=YSG J-<[1S02=)X/'_$Z4CL#7HU>=>#O^0RN3VKT6F(**** "BBB@ HHHH
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M/^6J_P ZHVO^J].:OV'_ "$;7G_EJO\ .@D]9'04M(/NCZ4M, HHHH ****
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M444Q!1110 4444 %%%% !1110 4444 %(_W&^E+2-]P_2@&?,NM?\AW4>/\
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M5"4C+<_C0!&,Y''>NU\._P#(,''\1KB@1GKUKL_#ASIQ'HU,#8HHHH ****
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MI_2D,U]+SYG3C%:YZUD:61OQ[5J,<&@8UJN2_P#'JO':L]VX/-7YB/LB\]J
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MB$#'(-;'AX?\3^US_>/\JSY(O)F=>P-:GAX#^W;7_>/\J!,])HHHIB"BBB@
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M[8KLO#7_ "#F_P!^N+7@\]*[+PN<V$G^_P#TH W**** "BBB@ HHHH ****
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MH,Y^^*8'?4444 %%%% !1110 4444 %%%% !7 ?%U"WA!#_=N%)_(UW]<?\
M$VS-[X&O54'<A5ACZT,VP[M5B_,^?#FD/M^M+VSZTUNG-0?7H.<<8I,X_&@X
MQWI..:9:%YZ>E3V=N;JX5%Z+R:K_ $_&MS1+<1PO,>K<#Z4FRHJ[-0 *H4
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M,;A[5R.:CJST(TY3=D97AOPY?>)-1%O;HP3(W.5X(KZ:\/Z!9^']-CM+2((
M!N..2:;X?\.6'A[3H[6TA5=H&3CDFMBO/K57-GJT**IH****Q-PI#]T_2EI#
M]T_2@#Q^\S_:5W_UV--MI6AN(WSWYI;O_D)7G_79JBQSGTI#.QYV@YZT9/Y5
M!9N);6-O]GFICVX^M PW$=Z:Q)[]*&^E1%N>: !W/:FH3R*8Q[4J=?6@"IJ/
M^JCJ/3AG4;;':5?YTW4) 9%3TI^FC_B8V_'_ "U7^= CU =**!THIB"BBB@
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M65*XENF/IQ6OX<_Y#EL/<_R- CT2BBBF(**** "BBB@ HHHH **** "BBB@
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M9P3R^#=T?,2:'JS'"V3FK^G?#C6-8N@)2UNK<@D=*^C8]/MHCE(@/PJP%4=
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M.17"Z5K\>AZBLKVXFSU)/W*]6T;Q'I^M@BUE#2* 77TJ971ZF7PHSBU-ZL\
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MOH?94*:A%)$L[@#'M5--N,4I\P\L* OI6!T(DXP2.U)WX/6D^;TIW/IUI
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M^O7^=4(<F-B/6K^CC.N6/_7=/YBA$GL]%%%, HHHH **** "O*OB5C^WH/\
MKB/YFO5:\J^)7_(>@_ZXC^9H Y",X/%=-I'^J/6N:C^\ >]=-I'$1I#1>X]Z
ML69&YNM5V)S5BR'R,>^:!DEP T9!S6#<P8D+#-= ^?:J[VZR-S0!SV".H-!Z
M8%:UQ;PQ@GO68WS. OK0(ZSP_C^TK'KDJ<_E7=UP^B KK%FO'"G^5=C>W M+
M22<C.T9IH3)Z*Y:S\9VTD>)D<2# QCJ:M'Q78_98[C#;7R0._!Q5^SEV%=&_
M17.OXNLPT! ;;(I8^PIB^,+/SI RMM'W:/9R[!='2T5SEQXKMK4HTBL5D&5
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M^=:^G_ZZX./)8#M0!T.C8\P_2M4XW'K65HP(;VQ6J3\V*0T2V?\ Q\?A5F<
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MN'RGFND%K!@<+[THMK?J ,5'*=W]F/N<X20A)5N!QQ55[BXDCV!7"^P-=?\
M9XCP%%/6)%.%C&3VQ51BNH?V6W]HXM(IV( 1_P 15E(KK&,'GVKK@&(XC'7
M^6FM%.P&(3SVQ561?]F1C]HYJ.QN).&/ ]JOVNF>4VY^:UULKMT1TMWVNVQ6
MQP6]/K6O8^$=5O+]+1XS"[$??&*'%%+#T:>LF>I_!H*OA6X1>BW)_D*]&KB_
MAGH\NC>'IX965F:Y?./8X_I7:5:V/ Q+BZLN7:X4444S$**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** .(^)/_ ""(O][^HKS*,<C
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M!D*>5"B9SM4"GT45 !6=KMC'J6CW%I,P5)%P2>U:-4]4!.GRXC,AQ]T=Z:W
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MD<8J[KW^NB_W:J)_J5YH$=1X"XU&;Z#^M>BUYYX$'_$QGYSP/ZUZ'3$%%%%
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MR1ZU;/2D(]3WI?QIGG-MZLBEX9>,\U-Q^512]5^M2_6@5Q5'S?6IZ@7KQ4]
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MD_OVH ]H_M.S_P">Z?G1_:=G_P ]T_.O&?.N,?Z]J=YT_P#SW:@#V3^T[/\
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MG/O2_P!NZIC_ (^Y/SH ]DHKQP:[JG7[7)S[T?VYJA)'VN3CGK0!['17C?\
M;NJ?\_<GYTIU[4SG%W)^= ['L=%>.?V]J9;F[D&?>C^W=4'_ "]R?G0(]CKG
M?&&HQVNC3V^X>;,NT+WP>*\__M[5,_\ 'W)^=5KBZN+V3S+B9G8#C/:D U?E
M 7TJ0=.E1^V>:D'UH&.0\CZUU\!S"I]JY 8]<5UED<VB9/:@$3GIZU!("2>/
MPJ?MZ5$_UH&56^E96M_\>:C'&^M9_K67K7_'B.?X^M C(@_X]NG>MOPA_P C
M1!Q_"W\JQ;?_ (]NO>MOPA_R-$'/\+?R- CU&BBBF 4444 %%%% !1110 44
M44 %%%% !1110!0<9E?CO3AR.F!36/[YN>_2N<\2^*9O#]W:0QVWG1S*SR-G
M[BC'^-%B9SC%79THR>WTJ3\*Y(^-<27J+;@_995BZ]<Y_P *T[S7?LFJ/8B/
M<8[0W)/T[46)]K$V22#@"E'/45Q=_P".Y(--CNK:T$KN5^7/8]:;%X]N)WU%
MDL ;>T4[7S]YO2FHLAXBG?<[7D'I2BLS1M7_ +6TS[6R>4Z_*Z?W6 Y%<O\
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MV"9Y'I5RBX[B33V)NQXQ[5Y9\8?]=I'&/O\ ]*]3]><^]>6?&''F:1SG[_\
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MUN^!TIQ.!S44I"H>>M &1J#DMCWJAU[5-=.&D;G@&H?:@0<XSWI#_*E]Z::
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METRB-8KJ(7(4<!_FYJQX<G@@UU'F7)>U,29'\1Z5Z4_A;1VBN$:SB(N'#O\
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MI<C/>@0'.?:F-G%.XS33C'>@8P]:9@DXIYQ[TSOQG- A/K1C)Q1WXH'7CK3
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M-9FL '37Z]10#,2U_P!6WKFM_P (C_BI83_LG^58%I_J6QZUT'A$#_A)(/\
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M5OW<4^P@]>W^-=5;X.MZ0.<_V.?Y&D[#I<W/9^7YF?XCX^'>G+C_ )>Y,?\
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MG)-)DY^M(?UH_G02.YSUXHY/XTE)0,#^E-.3QVIU-./QH 8?:FD=_6G'%--
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MWNP[Y'6G&33NB90MHS#\+>%;+PM:-%:J/,D.7?UKI!4*_2IZ&W)W8DK#)O\
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MH8.O2I3RW2D,;CG^M8VH<RGFMIOE4DC\*Y^\?=.V!0!6/UJ(_6G,W'2HR:!
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M>IH./6F?2CG'O0 X8V\FO,?B9C^U+3G_ )9C^M>F<YKS+XE_\A2UQS^[_J:
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M;>JL ,$568$-T% SGM74?V@&]4Q6EX+Q_P )+'_N&JVL)\JN ,YP:L>#,_\
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MZ080#VKYUTG4UN]:M9)0%N)+B*,*.F-X-?18Z5$]SU,#+F38M%%%0=X4444
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MI3,C).<>U"].M,0\GG&*3/.<9I">Y.*0^G2@!>V.OO2<[L=:,C.<X]J;^-
M3\W3I7">/N;VUX_A_J:[ECQR>M<'X]/^EVG/'E]?SH RM,QYD?'>MBXG$88
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M4\]<T .HHHH **** "BBB@ HHHH ***:QY SB@!U%)NYQ[9I$Y&: '45'(S
M\= ,FFB4E\XXSB@":BHG?#XSZ4J/DK]* )**** "BBB@ HHHH *R]9T^&_6'
MS4#&-MRYK4KA/B5XKF\*6=I<PP>;O8@KGZ47L 2^&BK?N9]@RQX/J./RIR:%
M-'I)C$A:<*%#=^I/]:Y'3_C5ITX07ENL /WCZ5T]G\2_"5SRNJ#=TQBK]JQ.
M)J:7I<ECJ)501&OSLW]\D?TKF?BT/^)99'T<_P!*ZR#Q5HEUM$5^#Z5QWQ3O
M;:XTFT,4H<;SS^5'-S,Y\4G[&1R_A<;M%O1_=NH"?Q858TFXDFT=Y+AR6$[@
M$^E<WINL-865[;*,_:0N&S]TKR#5)+N94,:SG83G&>]:61X4:CBE8[[3+.2!
MHFDMRVRZ8,A'K&<?S%2V*QO)=/+A%8M;L#_#NXQ^&:X,ZOJ(8G[?(&+A\Y[@
M8S4!U"Y(<&Z;YWWL,]6]:7+H:>WMLCO[N*VATRULQ<JL8\V/&>ORL :HK)9&
MQM[47";G^5SG[H";2?TS7$R7I8J);DD)TSVHL]8LK"_CNI,3!"=T9_B!ZT6'
M&I.3V.BO[B"WT2ZL%G$@#JD:YZ]#NK'6^PL:!.1&(\_1LUD:AKME/>RSQ@)O
M;*H/X1Z53;6\_<3CUI713H5IO1'K_A.Z$OC^VC+X58E*CU.P9KV>OFCX7W<E
M[\0M.>1R3\_!_P!TU]+U$MSUL+3E"%I!1114G2%%%% !1110 4444 %%%% !
M1137Z#ZT +N&[%(&R:39WH0=?K3 %<$GVI5;<,TPA0& XP*>N #BD NX>M(K
M9)'I475E./2I4[GWI@.HHHI %%%% !1110 A. 2>U8,'BK1;BX:!=0B\Y6VL
MF>16Y+_J7_W37Q_XEDFL?$]\\$AA=9<DK2;8TKGUW#*DR!XG#J>XJ8QJRD,,
MANM?'=MXR\06XQ'JTZJ/X0:V+;XHZ_9D;YY9OJU%[#Y3ZKDXA<#^Z:^7]4RF
MMW#8Y67(J]!\<=5A4"2Q+Y]6KB[CQ++=74DYAP7.[&>E*1Z.6UH492Y^IWOB
M+6EEUV.YMFW*C"4%?4J%(_\ ':C3Q=/OE=HV9GD1P?3:>?SK@O[?(/$( %(?
M$+9(\G]:5ST_K.&45%L[%M=N3]F";@ML[,H]B<XH_P"$@U R[Q,X;+'/N1C^
ME<6WB"0D$1X]LTW^W9<#]WC'O18'C<-8ZG[=? <7#@C(Z^IR?UK3O+]9/#5K
M$DF)E8[D'7.2<UP#:Q,_J#ZU"U]<,V5D;/K18QGCZ+:L=.S+SYC<D\DTW^U&
MMX&MX9OE+;MH/<=ZYDS2$$R3')J2')(/7T--(PJYJ[6BCZK^&<C3> M.D<DL
MV\DG_>-==7,?#VU>S\"Z7$XPQBW?F<_UKIZH\B4N:384444$A1110 4444 %
M%%% !1110 4444 %%%% !1110 PDXY[TPYIW&WJ:8: $.14?UXI_?)J-L=/6
M@!K=<8IAZY]*>V/6HB0!@'K0!S/C<G^PGR/XA_,5YW#*5<?45Z%XY.-"8CD;
MAG\Q7F*/R#GO0!>O]19;@(#_  UFRW#,Y;-170::=G!.!BH/+;IDT 2M*3]#
M41?CVIRVS/R":?\ V9(WKS0(KDC&:;E<9JU_9,OO3O[)?'>BX6*>5HW 'VJY
M_9I [\5$=//3FG<+$&\>E+Y@SGM4AL#GJ:/L!P!DT7 B\T>GXTOG#/08J7[
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M%N+=35AQ\PQTI=I(S0!V_@%BPO >GRUV8]ZY#P# PM+J4C"LX4'Z5V0'Y@T
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M.E:<+KM' JH+696'[I\?2I/+FS_JGS]* +N]/:HW8>U5_+F/_+-_RH\N7/\
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M%0B,YSCK7HQ\#Q#(W'CCK3/^$)A'5CB@#A(]RX ]:MK*5QBNN/@N('AC2?\
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M2%7[/$#(IZ[>:[>R@>)!N'-6$C08(%24@"BBB@ HHHH **** "BBB@ HHHH
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M&3THVC'2@" IWI#&,5/M YI,#(..: (3&,4FSC'IUJ;:">AI-H(Z<T 0F/\
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M 0A:<H-2;0>:7;SG% #-OI2A3G I^/;ZTH /:@! ,TH!!XIP7!]Z4#';B@!
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ME% #0"*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<]:?@XZ?3VIV >U $6TXQ2\Y'ZU)VZ4;1CI0 S!SSSFEVYYS3PN. * ,<8H
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M'M2\_C2@>W%+CY>E  !WSS3@".] Z9QTI1Z^M "T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ,<YH 9COFD('K3\48'I0!&>O]:3]*EP,XQ3<'GB@!GZ4F*D(.!QTHP>>.M
M$>.>31WQFG;3UQ1MZ''6@!E%/V\].E(.O2@!O>D[8I_X4G>@!N,GZ48///6G
M>G%!^E #-O')HV^]//;BC'M0 S YYHV^]/Q[48]J &;1SS1CD\]:=M]NM+CV
MH 9MI<'GGK3NXXI<4 1[3ZTI!SG-.QT.*,=?YT -[CGI2GI2CITI?PS0 VBG
M[><8I,<=,T )CWH'3K3MN#C%&PCC% #<'UI>_I3L'&,9]Z4@[LXH 3 SC-
MQG-.(Y'%+@>E " 8'7I2]0>>M&!C%+0 #I1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4AYI:* $Q\V:3:?6G44 ,VXYS1M^;K3Z.
M] #-HZYHV@GK3\4F,=!0 P@>M-]:EQ\W3BDQQTYH C]*/6I<?-TXI,<=.: (
M\<=<8HJ7'/3BD(XZ<T 1X_\ UTF*DP<#CI1@\\=: (\>]&*DP<#CI1@\\=:
M(\>]&*DP<#CI1@\\=: (\>]+3\' XZ4<^E #,=/:EQW_ ,BG\^E&#@\4 1XH
M[U( <\BC'!XH ;@9/-)VJ3'/2C ]* &8'K2[>>M.P/2EH 9M')STI=O7GK3L
M"B@!,<T#O2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4'I1
M10 F.GM1CK2T4 )C@<]*0#OFG44 ,V]1F@#D'-/HH 9MZC- '(.:?10!'@9Q
MF@ 9ZT_ H Y/% #0H/>D ![T_'H*,<GCZ4 ,P/6D 'K3\<#BEQSTH 9@>M(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 A&:,?-FEHH **** "BBB@ HHHH 0C(Q1CG-+10 F.,48YS2T4
M )CC%&.<TM% "8XQ1CG-+10 F.,4M%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 )CG-+110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image00029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00029.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $" J # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*** "BBB@ HHHH **** "BBB@ HHHH \R^+PS'I'3K-U_P"V=>3,?E0XP">
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M$'WJ?)PN:KZU5[F7]E83^3\7_F=M_P +(DSC^RTS_P!?'_V-!^(\H_YA2?\
M@1_]C7!H><TXG-'UJKW*_LK"7^#\7_F=S_PLF7MI2?\ @1_]C2?\+*E_Z!2?
M^!!_^)KA@,"H\\FE]:K=_P AK*L'_)^+_P SO#\2Y1_S"DQ_U\'_ .)I/^%F
MRX_Y!2?^!!_^)KS^5\':*>1LBR>II?6ZW?\ (K^R,'_)^+_S.]'Q-E(S_9*?
M^!'_ -C2?\+/<?>TE1_V\?\ V-<#(=H51WJ*?Y2H]J'BZW?\AK*,&_L?B_\
M,]'/Q*<+G^REQ_U\?_8UV^G7?V_3+2\V;/M$*2[<YV[E!QG\:\(E;%J#ZBO;
M?#G_ "*^D_\ 7E#_ .@"NS"5IU)-29XN;X*AAZ<94HVN_,TZ***[CP0HHHH
M*^7O$(QXE\2/ETVWMT0588?]\HVL#GCG/3DX]*^H:^8->#GQ/XC5&B&^\NP=
MS8)'FKP>F.<<Y]:Z</NSGK]##NXT:R\T1A6*,V"Q)3][CD_0XYS_ "JC5^\%
MJ+69(LAE+8!4*1^\XSCJ<=B!BJ':NV!QU.@44459F%)2U=TE]/34H_[4A>2S
M;*R;&(9,C 88ZD'G'>D]@2NRM%;S3K(T,3R")-\A5<[5]3Z"KXT"^.AG5]L7
MV<8.WS 7*%BN_;UV[EVY/<BNWU&_TG2K*.PN9K9I%TIX(IK-5?S X*X;'3)"
M2 GU;KU/.0^,YK*.RCLK&WV0V?V69;E?,\X$DL#TPI)SCV')K)3E+9&KA&.[
M&VWA2.1;5)+NZ>YGA29H[.R:X%NC\J9"&!&0<X )_3,"^&'DT.348KM&D221
M?LYC(9D0J&8?3>"0<<9/:F1^*]1C6#Y+1WMD$=O+);JSQ(/N@$]AVSG%5X?$
M&HPO;N)MSP3R3JSC<69\!]W]X$#D'U-.TPO3-"]\&7EI>:K +NS/]FM$KM)+
MY8<R#(VEN/KDBL:;3+R&6:,P^9Y*AY&@82JJD9!+*2,8]ZWHO&]T;J[FNK?+
M7<J23/:S/;R-M0H!N&>.^"#SG\)].\4VD+7VXZA'+J-XC33I<;'CB /(90,L
M&;.",$#I23FMT%J;V9QU%=O/IVG:YJ^IWT\<J1O*(;7[)(A%Q* -QW$ %F!W
MA<*6)('(KDM0M$LKZ6WCN$N$7!65. P(!&1V/.".Q!':KC-/0F4''4+.S^U;
MOGV[?:K?]C\?Z[]*32#CS?PK4'(.:T2(,H:4N.93^5>G>'?B7)H&@6>E+I23
MBV38)#<;=W)/3:<=:\\G;85/;-*K9:E*G&:]Y!&I*#]UGJA^,LH_Y@D?_@4?
M_B*3_A<LQZ:''_X%'_XBO+9!@4D/(K/ZM2[&GUBKW/4F^,\R]="C_P# L_\
MQ%(/C/,W(T*/'_7V?_B*\JG.#2J<+BCZM2["^L5>YZH?C3,/^8#'_P"!9_\
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MR?Q^G8U*][&)1&1_$$&&&2?IUZT^\N( PW,/N[^G:EW6[M$%^]DE< CG'/\
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MRYDZ5!+)MGB;/!K3T_4Y9-!.ELL9B#9#<YQG.,9VYR?O8W8XSCBLB]0QE/\
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M';(0I?UXIDQ,L^T?2K/";$%>=M&Q]7T-[P>P3Q;IA/\ SV _/BO=Z\%\*_\
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M\0?QH>GZA1117<> %%%% !7R[KJ*?%GB9MYWK=W.%V@@KNDR<YXP<=N_;O\
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M!PI^M>W_  )3_B6:S)_>FC7\E/\ C6&(_A,TI+]Z>N4445YAVA1110 4444
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M/I7N_P #<?\ "/:F>_VL?^@"L<1_"+I-^UL>IT445YAVA1110 4444 %%%%
M!1110 4444 %%%% !1110!YE\7O]7I'UF_\ :=>4S<RXX/\ D5ZM\7^(M(XS
MS-_[3KRF49E//?\ PKRZW\9_UT1];E_^Y07]?$RS:G=&3CJ:GJO9_P"IZ$<]
M#5BN.?Q,]JF[P04E*>E*FFWD@1P9]C*[JS*JJX09;!(YQCM2C&X3GR=/R_4;
M14TNDW$,BK*'R[^6,2@C=QQD'CK_ #]#4G]@R+<26SN!(DJ1X:1VW,QXQC/U
MJ_9^OW&;K]5;[_\ @&?Y !7YVP"QQQSDYI@CAC1M\F01@EF'^>P_*M-M &[,
MBVWF!'8@@$C8VTC/KZ?AZTW5]'73;&=D92N2F H4\H"#C/U'X=^VJ4GU9S2G
M371=;:M[?*QFA[8;/WJ%@<J2^3GG_$TK2P!RS9R, G:3]/Y_K70Z#8VEZMT;
MD#=; 3D$D!HUSN7(Z?P\U5\5VEK8W'V>U50 =S%7W#F0E>_]W;3C#F2D]GIO
MY^A,ZZA*5-)72OMIHO4R 80-R0MD\?ZL@_J/:EWLK8%N^#SD;?\ &IJO6L]E
M%;)YT+/.LX?( (VY7@@]>C<>]9*2;_S.J4)16GX)?K<S0\I!Q$ 1T#-_AFDS
M-Q\D8]?G/^%;3:A9(LQ2V'SN656C4!5R?ER#GT_E6/+<P^829(TW$D#<!3LO
MLJ_WD*3^VVO6W^1IJ=L47K@4RZ19WP ,J,4Y%RJ-U&!4$I,5TWH>:P=SK@M2
MLT,L+;@IXK;LI(;J'YE D'6H8'5ER1D&F.\=JQ>(?,:I/J*?O:=2Y)*L"D9K
M*-QN<G-137;/G)K/EN#&<[PHVDG/U'^-4HN;LA65.+DS6\[WI#-6.;QL'YUX
M;!8=!R!_6ECNF=)&Y&TX&5(_G3]C*UQ*K!NQK>?3C<X0\UA)?.T6YBH;'W?7
MY0?ZY^E*MV[;.00?O_[!(&!^>:IX>2)CB*<K6_K^O^":"ON)Q3))"M0I)@Y%
M66Q)'G%2U9G0RMYH--@/^D*?>DD7'(I(<^:#Z5I96 ZSP?,$\::63T,VW\P1
M_6O>J^>O"K?\5=I//_+U'_Z%7T+7;@=(-'R7$*_?0?E^H4445VGSX4444 %?
M*_BH >+-48QJV=6N03TS\_3/^>M?5%?*_B<'_A,=4.01_:]QA0N2?WGZ_P">
MM=.&W9S8C9&)<9>,*&.$16((//RJ/2H>U6)=QB)+*/W('.06P%XYQ[=,_E5?
MM7; Y*@444^,KSF,NW\(SQ^/K^E69K4925IK>0H^XZ'9$*,$,T^..O\ RTII
MN)(_/1+.S3!R<*'V_0L34<Z-%1GV?W,JVES]ED=]F[?$\>,XQN4KG]:T+;7G
MLY[>:"VC#P(@3<Q(5E8,K =CN!/H=QIHO[Z18P$L1LVX*V<*D9Z9(7)_&G17
MVKP22S0:A/;LZMN,$AC#!>HPN*SE4AU:-8X>JUHF01WMV3(T<.[S-H4[2=FU
M2J[3[ XYS4TVG:]>/%'-87TCHA";H6S@DMZ<\DTZ>^OKC1+J*YO;B=%N82!)
M*S#E9#T/X4R#3X'@20Y.\!NO88W?UJ*M>-)*4NIKA\'4Q$G"&ZW_ *UZDF-;
M+/=-(T3(2I=Y%C(._P SC)'\9SQ41@U&.6*<WT*NP 61;Z,E0!CG:Q(XX^E5
MI2#I<&!@>?+Q_P !2JE;I'(V: LHY)9%GUBTC95QN?S7#8Z %4-1/:VD<(;^
MT$D<G!2*)B0/7+!12.]J$(C7YL]<9_G3)IHFW".,*I4 949!%9QG)]&;SHPB
MG[R?H3^78+*/L]S<R-CI);J@S]0YIT;JCL2,@"J\5O,K!VAD"X^\5.*DV?(X
M[XXKIAL<DMR!X=WS**2WD:WF!=,KW!I\;D'%7"(GBPX_&G9;HKG:]V1=$<#1
MB6/ !YJE>70V[%-5WN?+3RHSA!5.27-)NP0IN3\B<2>]+YGO5R-+>9E*V2;=
MJXV-(0S&/=CKZ^^3E<=\I#!:[X5=4>,2 22ER > 0IYXSDKQS\N>QJ/:&WL$
M4_,]Z!+[U/I$%M=O(MR<?<"G=CDNH_7)'XTZ&"-XV9K;,@CC*1[RN_.[+<GT
M&[/08STR*/:![!%2:8E0":BW';D4_45@B: 02;\Q#S>ORR#[PY';VXJO')V/
M2CFN6J?*K"/+@U&[Y7BII5!YJI(&'04F:1LRW:G;&WUKW3X$2AM(UB/^);A&
M/T*G_"O![<D1?-P2:]O^ AS;Z]_OP?R>LL1_"8X+W[GLE%%%>:=(4444 %%%
M% !1110 4444 %%%% !1110 4444 >9?%[_5Z1_VV_\ :=>52\2YZ?Y%>K?%
MW_5Z1GUF_P#:=>42G,F1GGMCZ5Y=;^-+^NB/KLOM]2A_7VF3V6/)XZ9JS5:R
MXA[]>]6:XY_$SV:/\- >E21ZM+$BQH[[-A4#RRPP2">V.2/QJ.JT5P9-A*A=
MRAO7.>U."=FR*TE=1=M>ZN77U>YD7.QF*R^:/W2@ACU()YQ[=*:;^\=Y"S3Y
MDQN)<?-CIGGM53S)CYF5QCA<*>>!2LTV3M4\9]!]/\:T:?\ 3,5RK57^27_#
MCO.NRJJ43:IX!E/'KCBFRI-*DBET4.",X)//XT.LK/\ *2 &!Y/4=Q0$<%=Q
M!QUYZTKI6DK?UZE<KE>,KM?=^5A=LO&9%]\+C/ZTR2'*$27#[<@\[1CGZ4I@
MSNRV,K@8'Z_6ATC=CF3&3C:"/J::=GH_P%*+<6FOQ?\ F#)&YW-(_''$A4?I
M2;(=@4@LHRWSDG^=. C"D;LC&:;OB5L#[PX Y[Y']#^5";V5P:C>[4=1D?V<
M[F2!1U!.P#./\]Z1KM4BW! ,= 3CMFGAXE=8_+P6/3 X/6IP !P,4Y22=Y*_
MS)A"3C:$DFM[+J:!<!44'G S4,Q$DC'\*D:9%*' )XJK-&\5PY4Y4G./2N9Z
MG?#<L(S1Q'# <]QFL^>2>60K&ZL<$X$9/ Y/?TI+F\.P(@R>_-5(IY8G,BKA
MB"O4'@C!_0UM3B[:D2BKM]?G^A,\%XB992,KNYA;IZ]>E0^7<JNYB N<9,1Q
MG\ZDEU6^F?+G)V>66.W)7TSBHWN[AXO*8?N]V[;P.<8S^5;_ -=#./-]K\Y$
M;/*K(-Z'<V/N'C@GU]JO#2M3,0E"+Y9Q\VT=UW_WO[O-9S>8S1G9]ULGGV(_
MK6FFMWJ6:VH2/8L;Q@D<X;KSZXX^E4K=?T(J>T_Y=]^O-M;_ #*,/VB>62.,
MAF1L86,DGY0Q/7W_ $IS6]WS[9S^Z/&.O?MD5%;RSVUP\T:@,7W*<@X^4#O]
M*L_VC>"99LCS <@X7&< =,8["D[?U8:Y_P ^LN[M^%B%(+HMA<$^@B/^-6(8
M[DY P<8SB(]^G>HUU&\1PZ'##&",9&!CT]*([^Z12J@ ''93TSCM[TGK_2':
M7;\9$YC=20Y!]@N/ZT*%W[>A(I%G>=BT@^8G)Z?TIN<7"^]8M.YT1V-OPT%3
MQ7I&#S]LB'_CXKZ&KY[\-H/^$HTD_P#3Y#_Z&*^A*[L"[Q9\IQ#_ !8>@444
M5W'SP4444 %?*_BEV3Q;JV,+C5K@AR.X?U_^O_2OJBOECQ.';QAJP !5-5N&
MXZ_ZP#_"NG#;LYL1LC&G)$8=8\$Q!22N 1M4?G[^^:K=JM2@QQ$L%WF+&UNH
M&U>>G^<55KM@<E0*GM8+J5V>V@EE,0W,8T+;1TR<=*@JS9VHNFE!E$8CCW[B
M..H ^@R>M5*UM2(MJ2:+OV'4&8PRK;1LRD_OKB./@G.<LP[U ;6=09)+NU3S
M&*M^_5B,^RY.*O66@P3Z^VF7%XT*I((S*8SASY@7CKUSP?7&<#)$+Z=9*9O]
M)'RR*L9+X#Y1B>H'0A03T^;Z&L5&"V1O*K5>K?XD$EI$NX?VQ9ML7Y=JR_-C
MH!^[_G2QIIA"-/J5X';_ %GE6H?;^)D7/Z4DL%DC1M'*K*K() SYX.2>@!(P
M0.!G@^U/E?2Q9Q*$W3;)0S1AN&SE#SC([>N"<C@ U9=".:3W?XC5N-/BL[BV
MQ=3AY4='^6+A0P&1\W][U[4QI],$BF.RNM@7!62Z#<^O"#\J1KFW::-\,H"D
ML5B4?/G/"],'@>WH>E3'54:<NMHJJ6&$0XPN "!U[*/7%.Q-_,=%,\EBD*:)
M%,BR$B3$Q.2!QPP'0"DMGO!YMW9Z;;K"WRG= )47D#CS-W.2._<41ZG(J2"W
MM /,^4D#J,X'(P<@$#@@'N"320W6I6=M/91Q-&&;#@IAE*G<1_X[R/:C4>A*
MW]KW4<=TL$$8@*[9+>WBB8%NGW%!)Y'YCUI9)M8_LYY'U>;R7&\PM/(-XP#G
M!X.,@?CQFH//U(VLRNZB!,,Z,JD$H0HXQU&0/I[4V]34;&WC@ENF\ED#K&DA
MV@,"0,=.AS_P+ZTK!?U'RVLT,V;NX:2545NNX889')/UZ"JWF??(Z8P*BAE8
MN [L5 Q@FGDB5)$7 XSFMH:(S=FQF.]6S<62P*LT%PS@<LLZJ/RV'^=9X8Q#
MY^@[TGF6,J#S;FY1^ZI;JP'XEQ_*B4DD:QI.4O(GWV<IRMI=D9QQ<+_\14,L
MED& ^S7/.<'[2O;_ (!0'TZ%?EOKT'VM5_\ CE0J=/=LM>WF!G ^R)CG_MI7
M,W*__#GHQC1Y>M_E_7<D+V*G#6MT".QN%_\ B*G>.P$=LR6]TQEB:0C[0O&&
M8?W/1:K$::QR;V])/<VJ_P#QRIVFTXK:[+N\5K=-H/V5#D[V;/\ K/\ :Q^%
M-M\NF_S)2ASZ_#?YV_S)[>TLY-0MK:6VND$TR1%A<H<9(_V/0U57[$T>\6EU
MM]3<KC_T#W%6(+VPBOK6YEO+R003"7;]D09PP)Y\SOBJ:?V>%*"]O-IZC[(O
M/_D2IC[3EUW^9K-8?VCY+\O3:X/]B!YM;KC//VE<<?\  *>GV0*6-I=;1U/V
ME?3/]RFDZ?L*?;KW:3DC[*N/_1E1DZ>.#?7NT]1]E7_XY1[_ /5Q6H^?X%X&
MQ*9:UN<8S_Q\K_\ $528+N. 0N> 3DU,CZ=@ WMX1C'_ !Z)_P#'*AR#G:21
MV)%:P;ZF%113]S85 K+GIBO:/@&1CQ H/ -N?_1M>*P<AAZ&O:_@* /^$@Q_
MT[?^U:BO_"9%/2=CV6BBBO-.H**** "BBB@ HHHH **** "BBB@ HHHH ***
M* /,OB]Q%I)QG_7<?]^Z\H*GCGZ#/TKUCXO'$6DGWE_G'7DV/F7/3'T]*\VM
M_%E_71'U> :^J4_G_P"E,M6>/)XJQ5>S_P!0,58KAG\3/<I? @I*6DJ#01B0
M./45"&F97.,,!\H[$X%3T52E;H9R@Y/>Q"/,.WJ#W+8.?R[T2([(0&&[MVJ6
MH8XF4 .0V .3STJT^I$H6]W5W\QOE[55!(H8YQD=30XC(7<['<2@*\]?I]*<
MD 24R!CD]O\ /TIPC4<\DYSDU3FK[F:IRM;EM^.F@F8V;CDYVFE6)%;<%P:!
M$@)('4Y//>GU#ETB;1AUDE<3:I.2!GZ4M%%3<M)"DCSD/H<U!=WHB7EU7U9C
MBIP"9>/0_P JRKI!,Q5\\'(P2"/RJZ<4Y>]L7)M1?+N,E4RI@.5).<@U&T3G
M'[YAC'XX/]:E&   , < "CK70G8SE%2U962VE!YN6(SGO^76E*[ICF[QNXV
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MHQ(/6BR"QH?VJSS%RC(Q;<?+DVC.0<]#SQU]E].7V%M<7\YAMHM[XSMW 8Y
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH 0TE%% "4444 -HHHH 2DHHH
M2BBB@!**** "EHHH <*>*** '4M%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !2444 )2444 )2444 )1110 E)110 E%%% !2T44 *
M*<*** '"G444 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image00030.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00030.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %# N\# 2(  A$! Q$!_\0
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MT%%<_P#\)AIG]VX_[X'^-'_"8:9Z3_\ ? _QI>PJ_P K']<P_P#.OO1T%%8
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MI_SWC_)O\*3RD_Y[Q_DW^%1X-&*5GW"S[DGE)_SWC_)O\*7R8_\ GYB_)O\
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MB3;;R?[A_E3CFH+GFWD_W#_*@%N;^@M:?VM#]I5FRP\K;V?(QFO0*\QT9O\
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M_P :7S;?_GK_ .1C_C4WS#^,?G3@S_WA^=(+E4RVO>;_ ,CG_&F^;:?\]_\
MR.?\:N[G]1^=&]_4?G0%REYMG_S\_P#D<_XTX26YZ7/_ )&/^-6]S?[/YTTC
M/54/Y4!<@!C/2=C])#_C3@F>DTG_ 'U3]B'K'%^0H\F+O%#_ -\B@+B!"/\
MEM*?Q%13QEH9/WLGW3V7_"I_+@ YBB_!144D4+HP\F,<?W10%R]H@)U>Q_Z[
M)_.O4*\PT-@-5L"<\RI^IKT^O+S#XUZ'T>2+]U+U/+/C*,C1?^V__M.O,%\U
M8%\N3;\[9^<+G@>]>H_&,931OK-_[)7EDHQ;H?\ ;;^0KS9;F&,E;$S^7Z$@
M>ZW9$W_D8?XU*)[S'^OS]9A_C5&.8KQ4GF,W\8'XTK''*?K]_P#P"UYMV?\
MEK_Y&'^-)ONC_P M/_(X_P :K_-_SU'_ 'U1\W_/4?G18GVB\_O_ . 3YN#_
M ,M/_(X_QI/](_YZG_O^/\:B^;_GJ/\ OJDR_P#ST'_?5%@]HO/[_P#@$O\
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M_P#%4OVK3_\ G]3_ ,"F_P#BJO>8QZ-BERW]_P#6ES+S^\GE,_[1IW_/XO\
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MR[S_ )]7_P"_ _PI-EW_ ,^K?]^1_A5?+?WOUI,M_?\ UI<C\ON_X(<K+/\
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M_>>KOE#TI?+% _:(H[3_ 'GI<'^\]7O+%+Y8]*!>T*7(_O&E_.KFP>E&P>E
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M<$!PHR=OK5>TN#:7<<XCCEV'.R10RM[$5TLOB2SM8;9+.)IXUC8>5-D>43G
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M:\[\4_\ (PW'T3_T$5T8#^+\CY;.?]V^:_4PHO\ 63_[_P#[*M/-,B_UD_\
MUT_]E6GFO81\LQ***2F(7-2(:BIP-)@6UY%07EC%?1+'*6 5MP*X]".X]SSU
M]*>C5,#4,:=C/N]'AO+KSW=U8ILP.F,$'^8_[Y%2)8,DBOYY)$@D.5SD[-AY
M)]*NTE(KF9EOH4#2R2++(C2,78C'4G</R-36^FK;7 F69R<MD'H00!C\-HJ]
M3:8<S,M-"@B1E260;E9#SV88/^-3KIR 7 >1W\Y55O; _P ]:NTTT!S,CBC6
MW@2),[4&!FD)I6IE4B1X-!IHI30 E)2TAI@6_#PSJ>G?[Z5ZC7E_A[_D*Z?_
M +ZUZA7D8_\ B+T/I\E_@2]?T1Y?\9?^/71_]^7^2UY4/^/=_P#?7^1KU;XR
MC_0M)/\ TTD_DM>4C_CV?_?7^35Y\CFQW^\OT_0A--IS=:::#@0E+FFT9H&2
MHW-6XSD51!JQ"](SFB]%(T4BR)]X>HS5J'4;B":25"I:0@MD<<'BJ2G(IV:3
M2>YG"M4I_"[%W^TI<*&CC;:JJ-V[HH(]?0TD.IW%O#Y,>T1[]^TC(SD$?RJG
MFDS1RHI8FLG=2+QU:X(880;@0Q4$9SD]C[GIZTV/5;F**.,$;8_N]0>C#J#G
M^(_D*HTAHY8E+$UKWYF6YM1FFB,;!<$!<\DX&/?_ &1^55KF[EN7#RMN8#&<
M =\_S)J,U$U"20G4G/XF-9J0&FF@4QVT'FFFG4TT"0E.?[D?^[_4TP]*>_\
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M .JU:Q8^C2;:I0Z;>W$LD45M(9(QEU(P5_.HTM+F1&=+>5E0X8JA(!]Z6O\
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MYU;_ '(OYM7JM>5?!_\ X^-6_P!R+^;5ZK7'6^-GQ>;_ .^3^7Y(*\\\5_\
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M_-:[7PS_ ,@MO^NI_D*]_A__ 'I_X7^://S+^%\_T-FOF?4_^0O>_P#7=_\
MT(U],5\T:J,:Q?#TN)/_ $(U]SA]V:Y!_$GZ(AN_]>WT'\A4%3W7^N_X"O\
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M"$/GH. 2,9_2FL=1EU6=$>1+>,IMX4 Y'/53GGT(H#WMKEJ*QL[<Y@M8(O\
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MRBG[:,4#N-I*6B@!AIXZQ?3^IIC5-" 9[8'H2/\ T*@TCLSZDJMJ/_(,N_\
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M S@MYACYXCY4#Z?GG"GS0E*^Q3E:25MSHF_X^X_^N;?S6NZ\/_\ (%@^K?\
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M_P!?TMNZ"EI*6J,">VF$$P<C(VD8QGMQ6D-2M!_RP)Y!^X.,;??V/YUEK(H
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MRHE8FK:T6[>HIFNR[-Y^&8Y)\P#MCUIC;V/[RY!/3EB?Y?04[R&[A1[%@*#
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MJ3N[)J+_ +PW&[]^P\O>PV%?E/('T[=NO0?99?\ G^N/R3_XFG?9'[WEP?\
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MX\VM_#6I/_J[ Q^[83^=6X_"FJNV&2.,>K2#^F:[ZBH>.JOL;1R;#K=M_/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0W!WT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M #P/_?0H EHJ+S)?^>!_[Z%'F2_\\#_WT* ):*B\R7_G@?\ OH4>9+_SP/\
MWT* ):*B\R7_ )X'_OH4>9+_ ,\#_P!]"@"6BHO,E_YX'_OH4>9+_P \#_WT
M* ):*B\R7_G@?^^A1YDO_/ _]]"@"6BHO,E_YX'_ +Z%'F2_\\#_ -]"@"6B
MHO,E_P">!_[Z%'F2_P#/ _\ ?0H EHJ+S)?^>!_[Z%'F2_\ / _]]"@"6BHO
M-D[P/^!'^-'G@?>CD7_@.?Y4 2T5&L\3' D7/H3@_E4E !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !12,ZHI9V"J.I)P*@^VP'[A:3CJB%@?Q'%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J7
MO2+_ 'Q5NJM[TB_WQ0!:'2BCM10 4444 %%%% !1110 4444 <)\0_B%/X'-
MGY.F1WGV@,3OG,>W'_ 3577_ !_KWA;28-3U31M(DMYB-JV^J/Y@S_LM"/QP
M:F^(_@&^\:M9FSOX+7[/NSYJ,<Y],57UKX2:;<):WN@FVT?6+95Q-%;JT,I'
M]Z/IG/?\\UHN2R'H=3:^*K>Z\+VVO)8:@T,Z!A!#;-+*,_[*YK,D^(<$*EY/
M#'BA8U&6D.EL ![\YHUSPWXF\0>'(;-_$8TN_C;+RZ<C+'*/?D.OX-CZ]L"S
M^&FKI:-;W$_AYFVD?:)+*YGE8^I+3C!_SBDN7J&AV>A^+]&\1Z9+?:5<27,<
M0_>1K$PD4^FTC)/TKSSQ1\3=7?Q#::5H\=UIL$G^LEGTQWN2<9^6)\9_(^M=
M-\/? ^H>"M/U"&:^MKF:X(:,JC!5(!ZYZ]:QM0^'WBS4_%-MXAN-4T,7MO\
M<1+681GC'(WY_(BFN12\@TN:/A^[\17FK1Q-K^L/$OS2+J/ALP*X] ^% /YU
MMW_C2*QNY+8:!XBNFC."]OICLC?1C@&I]+A\7"Y(UB\T5[8J0/L5M*D@/8Y=
MV'Z5QDWPT\1-K$UY-XAM=6CD<E(]42X98P3T"),%./ICVI:-Z@=%:_$S0I=7
M@TJ]AU+2[ZX*K##J%F\1<L<#'4<GC-7_ !!XVT3PW=0V=[/+)?3@&*SMHFEE
M?)P,*/4],]:XJX^$^I3^*-)U8:AI44=E+$[0VMG)"K!'W'@R/S[Y_"MGQ?\
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MVE95& 996D;\68DG\352WZ2?]=6_F::)GL2T4451D%%%% !4=SDVTP R2C
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M_P#?0_QH\V7_ )]V_P"^A_C7D]_\0?&=KXDB\/VEOX?U+4FX=+19BL)_VBQ
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M+_S[M_WT/\:/-D_Y]V_[Z'^-2T4 1>;+_P \&_[Z'^-'FR?\^[_]]#_&I:*
M(O-E_P"?=O\ OH?XT>;)_P ^[_\ ?0_QJ6B@"+S9?^?=O^^A_C1YLG_/N_\
MWT/\:EHH B\V7_G@W_?0_P :/-D_Y]W_ .^A_C4M% $7FR_\^[?]]#_&CS9/
M^?=_^^A_C4M% $7FR_\ /NW_ 'T/\:/-D_Y]V_[Z'^-2T4 1>;+_ ,^[?]]#
M_&CS9?\ GW;_ +Z'^-2T4 1>9-_SP_-Q1FX/\,:_B6_PJ6B@"'RI6^_.?H@Q
M3D@C0[@OS>IY-244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%%  >E9FA)*EC()M-BT]OM$I$,1&&&\X?CNP^
M8_6M,]*Q_#;6[:;*;;4)K^/[5,#+,&RK>8V4Y[*<@>PH V**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** *S6,6]GB+0LW4QG /X'C]*;Y%RI_UD4B^ZE3^?/\ *K=<G?\
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MZ!<?C6QJGB31]&TV'4;Z_BCM9V589%R_FEONA N2V?:C4.1%C]]_S[2?FO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@GMGO6CY]U_SS@_[^'_XFCS[O_GG!_W\;_XFEJ',BY15/S[K_GG!_P!_#_\
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M-;L3_L."/UQ19CYD6J*@6\@9@A?8Q. LBE2?IGK^%3TAA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #7_U;?+NX/'K
M61X54)X=M0-(.DC;_P >9;=Y?MG K7?_ %;?-MX//I6-X3DCD\.6C1:M)JJ%
M.+R12&D]R#S3 VZ***0!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !VJAI']H_9'_M-H&G\Z3:8>GE[CL_';C/
MO5\]*Q/"WV#^RYO[.AN(8?M<^Y;C[Q?S&W$<G@MDCVQ0!MT444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&T@3391;Z=-8)]JG)BF+$L?,;+_-SAC\P[8- &Q1110 4444 %%%% !1110
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M_.W-Z*S!,CIR0*=G>P.+O8Z3VKC/B3X/N/%^AVUM8QV8O8+A766Y.-J?Q*&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 (V=IVXSCC-4-$.H-I,!U22T>\
M*_O&M,^7GVS5Z3'EMD$C!R!WK%\("Q'AFS&FV-Q96NS]W!<YWJ/?)- &Y111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 (^=C8(4XZGM67X<>XDT.V>ZU2WU28
MK\UW;A=DGN-O%:;_ .K;Y=W!X]:R/"P5?#UH$TEM)79_QYL<F/VZ"@#9HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^X\1^-V\4ZE:R7.JV6FQ/BWFM_#[78;V^5?UJHIL7*F>J^7<_P#/.+_OZ?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>8G]]?SK+O9K+3K.2[NE1(4QN80ENIQT4$FLZT\2^'+[48M/M[N WDH+1P/
MR,X')(#*,]#1RCYO(Z7S$_OK^='F)_?7\ZI^3#_SQC_[X%'D0\?NH_;Y!2L+
MG+GF)_?7\Z/,3^^OYU3\B'_GC'_WP*/(A_YXQ\?[ HL'.7/,3^^OYT>8G]]?
MSJF((?\ GC'_ -\"E^S1_P#/"/\ [X%%@YRWYB?WU_.CS$_OK^=5/LT7_/"/
M_O@4GDPY_P!3'_WP*+!SESS$_OK^='F)_?7\ZI^1#_SQC_[X%'D0Y_U,?_?
MHL'.7/,3^^OYT>8G]]?SJGY$/_/&/_O@4>3#S^YC_P"^!18.<N>8G]]?SH\Q
M/[Z_G65?W.G:78RWM\8(+6%=TDCH,*/P%.LY++4+.&[M!#+;SH'CD5!AE/(/
M2BP<_D:?F)_?7\Z/,3^^OYUSD7B'PY-K1T:/4+!M27.;88WY')'3K6MY,/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;Z&I(ZC]/DDEL(6E;=)M 9L8R?6K-5-,_P"/"+Z5;J#8**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT- (73/^/"+Z5;JGIG_(/B^E7*@W"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH :_P#JV^7=P>/6L?PHBQ^'+15TA])4)Q9N
MY8Q^V3S6P_\ JV^;;P>?2LCPJ4;P[:&/5I-579Q>2 @R>_/- &S1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU_Y]H?\ OV*GHH @^QVO_/M#_P!^Q1]CM?\ GVA_[]BIZ* (/L=K_P ^T/\
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M^L^)UTZW_L&:S?=Y<]MJXDE8 $Y$>P$GCD#ISR<5U>H:E9:39O>:C=16MLA
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MX TG-)3L3SL7[1/_ ,\HO^_I_P#B:7SY_P#GE%_W\/\ \33:*+(7,QWGS_\
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MB3TZM_A244[$<[&[[S_GM!_WX/\ \71OO/\ GO!_WX/_ ,73J*+!S,;OO/\
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MTZBDHL',QN^\_P">T'_?@_\ Q=&^\_Y[0?\ ?@__ !=.HHL',QN^\_Y[0?\
M?@__ !=&^\_Y[0?]^#_\73J*+!S,;OO/^>T'_?@__%T;[S_GM!_WX/\ \73J
M*+!S,;OO/^>T'_?@_P#Q=&^\_P">T'_?@_\ Q=.HHL',QN^\_P">T'_?@_\
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M  XN;QH ,#L1&^?R%&@K(P?"?B=M:U*_LY=7M+N>WP3!%I<]H\0)XW&5CGZ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** &O\ ZMOFV\'GTK'\*%6\.6A75VU8
M;/\ C\92#+[X))_6ME\[&P QQT/>LSPZEQ'HENESI=OI<H7YK2W*[(_8;>*
M-2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5]+W.7/]CZ\BQ$GOY<C!?_'*%;J))/<[72]>TO6O.&G7:W!A($JA64H3TR&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 V3'EMDD#!R16)X0:P?PS9MIEW=7=
MH4_=S79S(P]^!_*MQL[3MQNQQFJ.C?VG_94/]KI;)?;?W@ML[,^V: +]%%%
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M<8^[%_WT?\*7RKC/W8O^^C_A5JBBX^5%3RKC'W8O^^C_ (4>5<9^[%_WT?\
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M[]'_ .*HN@Y6)12_9Y_^>L7_ 'Z/_P 51Y$__/:+_OT?_BJ+H.5B44OD3_\
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M7(?$K_D5%_Z_K7_T<E=?7(?$K_D5%_Z_K7_T<E '56__ ![1?[@_E4M16_\
MQ[1?[@_E4M !1110 4444 %<'XL\9^(_#%C<:A+X=L3912!%D.I$N^2 #L$?
M'7UKO*X#Q9X5\6^*].N-,N-3T.*QDD#(8[.42@ Y&29".W/%5&U]1HZ+P?K[
M^)_"UGK$ENMN]P&)B5]P7#$=<#TKG]4^(LP\8+X7T#25U#4!Q+)/<>3%'ZY^
M5B<#!.!],U-X1\.>*O#-A9:4=1T:;3+<G.+243$$DGYO,VYY]*AU3X=3_P#"
M7CQ3X?U=;#4#S+'<6_G12GH?XE(R.#C\,4URWU @U?XBZGX2U:SM?%.B6T-K
M=9V7=C>&51C&<JR*>,C\^]:'C;XB6WA!K.WBL)=0OKO)CA1P@ &.6."1U';U
MK-U7X<ZIXNU2SN_%FM6LMO:YV6>GVC1*<XSEF=CS@9^G:M'QM\.[?Q<]G<PZ
MA)IU]:?ZN98Q(I''5<@]N.1WI^Y=7#0I:[XV\5>%M,AU35_#-@]F[!76SU!W
MDBR,_,#$!^1K6NO&CW'A.UUWP_I5QJJSLH:)#AX0?O%E&22O0A<UD:WX+\6^
M*=.CTS6/$NGQ62,&9K*P=9)L<?-F7 _ =:Z2WT";0?#$6D>&W@@>-0BSW0+X
M]7*C&YCU[#)_"D^6P:&;9^.MD5TVKV$UML<):[(I ]Z2,XCB=5?/;H1P3G%;
MFB7FK7]N]SJ>G1Z>KM^Y@\WS) OJ^!@'V&<>M<W=> +L6.^PU^YCUB617N]1
ME7,MPH.3&&7!B3IPF,8[UN^&M)U+2;>X74=3:\\R3=%&2[B!<?=#NQ9N><GU
MJ781N4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH :_^K;Y=W!X]:Q_":Q+X<M!#I,NE($XL
MY22T?L<\UL/_ *MOFV\'GTK(\+.LGAVT9=6;504_X_&0J9??!Z4 ;-%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<%
MI/\ R6+7/^O*/_V6N]K@M)_Y+%KG_7E'_2JCU&CO:***D04444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?:#_ +]K_A4U% 7(?LEK_P ^T'_?L?X4?9+7C_1H/^_:_P"%344!<A^R6O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD_\ )8M<_P"O*/\ I7>UP6D_\EBUS_KRC_\ 9:J/4:.]HHHJ1!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7(
M?$K_ )%1?^OZU_\ 1R5U]<=\3-W_  B(V;=WVVUQNZ9\Y* .LM_^/:+_ '!_
M*I:QH&U_R(]L6FXVC&99/_B:DW>(/^>6F?\ ?V3_ .)I@:M%96[Q!_SRTS_O
M[)_\31N\0?\ /+3/^_LG_P 318!D'_(;U'Z1_P C5VLS3C='5-0^UK LO[O(
MA8D=#Z@5ITS*>X4444R0HHHH 4=17C&BP'4/&WC$7&B76MK!=KY<:78B\G.[
M@;G7.<=O2O9JIVFD:=I]U=W5G90P3W;;[B1%P92.A;UZFFG8J,K'E_ADS:QX
MVB&AO-X>@L68WVE7=_,\TXZ ^2V5"@]P>XK8T[Q)KGBGQOJVB0WZZ);Z<[*$
MC@22YG ;&_,@("GKPO<5VUUHNEW]Y!=W6GV\UU;G,,[)\\?T;J*CU+P[HFLN
M'U/2+&]<='GMU=A]"1D4W(KF3.,\6:]KG@B_TG&N#5(KVY6![2]MXED /\:M
M&%_4&MSQ/_PF)N[-]!1#IVW-TD!B%WG_ &#,#'CIUYK3T_PMX?TBX%QIVB:?
M:W Z316ZB3_OK&?UI^J>'-$UN1)-5TBRO)$&$DG@5G49Z GD4KBYD<<_B*;2
M;ZW_ +<UGQ/I4+2J#_:6G6C0R<_=,L*$*#TSD8IOC;QSJFF^)]-T#1TC3[;$
MD@N\([ON8@+&'94SQG))ZBNLM?!_AJRN$N;?0-.2>,@I*;=69"#_  DY(_"M
M&^TZPU*#R=0LK:\B_P">=Q"LB_DP-%U<.:-SA+R;QU%;[]+A\12W:\B/4;?3
M# Y]#Y<BLH]P36?XO\6>+-,?PK#O72+R_P#,6\@6..9=PV8QG/ R>AKK[;P7
MX+G7?;Z#H\T:M_!"CH&^G(S6I>Z!I&I/:M>Z9;3M:?\ 'OOC'[K/7;Z=!^5.
MZ'S(R]0TC78K&:>W\7WR3QH756LK9H^!G&WRP?\ QZJWPX\3WWBOPJE_J*0K
M<ARC&%2H;!P#CUKK6571D905888'H1533-(T[1K7[+IEE#:09R8X5P,U-]"6
MU8N=JXKXM221?#;4WCD>-MT/S(Q!'[Q>XKMNX'6JNHZ;9:K9R6.HVL5S;2$;
MX91E6P<C(^H%"=F).SN<;X0U+Q$/">G"'0H;J(1_+-)J85FY/4%#_.L;P7=7
MMQ\6O$@O-T4FU<VXG,B1G;T!X!_(5Z=:6EO86L=M:0)!;Q#"1H,!1[57@T73
M+;4I]2@L(([ZX_UMPJ?._'<]Z?,NQ7,C@?B<FI^'_#/]J)K5Q=R+<(B17MG:
M21J&/./W.?UKTF'>UK$[ Y9 3V[5AR>!O"TK,TN@V,C,<G='G)JQ8^%M"TNY
M^TZ?I=O:S[2@DB7! /7%#:L#:M8XVV\4:Q>>+=4TG4;R^MG@.;>'1+>*<;,]
M7=E<[NG!"_2M'P[9^-;S5[N35=5U&VTA&_T7S(K5)Y>>CJL; #'?*GVJ&/X;
M-;7=U.+W3=4:=MV_7]+^VRH/0.)%..?2I[+X<6T'B"TUAYK*TDM5(6'1; 6*
M29_YZ'<Q8>W%-M=!W1QW@.TN[GXA>*4M=2DL"+B8L\4*.S#S.V\$#\JZ'QAK
M'B+P3<Z5<1:X^IVUW=""2VOK6(8!ZD-$JFNXLM"TG3;RXO+'3K>WN;DEII8T
MPTA)R23WYIVI:/INL)"FI6,%VL+^9$)5SL;U'O1S78<ZN6H7\V&.3&-Z!L=<
M9I_M2*H5551A5& /2EJ3,\S\2Z@^@?%[2M3O)GBTR>S,&YI-L8;)R3DXX!'-
M/'Q9A:SO);O1KFPB:W:;3IIGRMZ!UQP #R. 3UKN=5T'2-<2)-6TZVO5B),8
MGCW;<]<52U.S\*ZI''9ZI'I%PMN<)%.\?[L^@&>.U4FNIHFNQPWAC58?#GPT
MTTZEXAET^ZOI3+ ZP_:9I%/94(/'3G&!Z\U?U._\26>FR7EOJ?B8-&F_?=:7
M9^3^*@*X'ZUW%SHFD7^GQV-UIEE<V: >7#)"KHN.FT$<?A5"/P/X40 +X;TL
MD#C=;*Q4>V1Q^%%T',CG](U?Q+XR^'$&J:7>Q6&L[FP4C1HYMA(P0X.,XSQW
M[XJ&R^*-I#X8N9M6B\C7K(^1+IVX>9--G:"@XR"<$XSCGK7=:?IECI-FMGI]
MK%:VRDD11+A03R>/K7.0>!HY?&<OB;5KF"\N!Q:PQVWE) ,8!/S$NV.Y_ #B
MDFNHDXECP6/$DNE->^);IFN;IC)':>5&HMD/1<J 6..Y]?6NEHHI,AN["BCU
MHH *1_N-]#2TC_<;Z&@$+IG_ "#XOI5NJFF?\>$7TJW4&X4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-G:=N,XXS5#1#J/
M]E0?VM';)>[?WBVN?+S[9J])CRVW D8.<5A^#5T]/"]FNF6]W;V@3]W'=C$B
MCWY- &]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0$JW5?8U:J#<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?3]*,'T-/^Q6G_/K#_W[%'V*T_Y]8?\ OV*+AR#,'T_2C!]#3_L5I_SZP_\
M?L4?8K3_ )]8?^_8I7#D&8/'%&#Z4_[%:?\ /K#_ -^Q1]BM/^?6'_OV*+AR
M#,'T-&#Z&G_8K3_GUA_[]BC[%:?\^L/_ '[%%PY!F#Z&C!]*?]BM/^?6'_OV
M*/L5I_SZP_\ ?L4[AR#",<D8J)IX1P9$SZ Y/Y596SM4;<EM"K>H0"I554&%
M4*/0"E<?(4=\K_ZJ!V[9<; /SY_(4Z.Q+2"6Z<2,IRJ 81?P[GW/Z5=HHN4H
MI!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 U_]6WS;>#SZ5D^%R#X>M2NKG5AL_X_",&3WZFM=\[&P QQT/>LOPZD
M\>B6Z7.E0:7,%^:TM]NR/V&WB@#5HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K@M)_P"2Q:Y_UY1_TKO:X+2?^2Q:
MY_UY1_TJH]1H[VBBBI$%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M153[1=?\\(/^_P ?_B*/M%U_SP@_[_-_\119AS(MT54^T77_ #P@_P"_Q_\
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M+Z5<J38**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#CG_Q5)_PE%M_SZW'_ ([_ /%4<K"QNT5A_P#"46W_ #ZW'_CO_P 52?\
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M_KRC_I7>UP6D_P#)8M<_Z\H__9:J/4:.]HHHJ1!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+>/_ /D7[?\
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M6-]"^CB,#['!<_9)=V.29/+<M^!7Z=ZYCQ9X#\4>(--6"&.-2&R5NM=FNO\
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M)%PH\2:9@G <W"A"?][[OZUL2R2S6)FT][>5G4-"[N3$V>^5ZCZ478<S//\
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MXWT-+2/]QOH: 0:9_P @^+Z5<JIIG_'A%]*MU!N%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%4=8O'L-+FN(UW.H 7G
MH2<9_6@"+4=;MM/)B&9KC_GDAZ?4]JYZYUC4+HG=/Y,9'^KA^7_Q[[V?H1]*
MH -DL[;G8Y=CU8TM:J*15A H#%L?,>K=S]3WI:**L84444@"BGK&[\HC-]!F
ME\B;_GD__?)H CHIS*R':RL&]",&E,4BKN:-P/4J:8#**<JL[812QZX S0R,
MA 92I/J,9H ;1112 ***<L;M]U&/T%,!M%/,4B_>C88]0:90 4444 %%%%(
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M%% !1110 4444 %%%% !1110 4444 %<KX__ .1?M_\ L(VG_HY*ZJN5\?\
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M#4#'+)%:O/'<*@0_+@8('!ZCG Z5F>&/$7BCQ!JGV+^VHX@8R[2/9QM@ CH
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M_P">47_?T_\ Q-&RY_YY1?\ ?T__ !-6Z*+ARHJ;+G_GE%_W]/\ \31LN?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@46#G+U%4?(A_P">,?\ WP*/)AS_ *F/_O@46#G+U%4?(A_YXQ_]\"CR8?\
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M** "BBB@ HHHH **** "BBB@ HHHH P=3\.K+(UQ8E8Y6.7B8X1_<?W3_/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ K@M)_Y+%KG_7E'_2N]K@M)_Y+%KG_ %Y1_P#LM5'J-'>T445(@HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KD/B5_R*B?]?UK_ .CDKKZY#XE?\BHG_7]:_P#HY* .JM_^/:+_ '!_
M*I:BM_\ CVB_W!_*I: "BBB@#'@_Y#>H_2/^1J[5*#_D-ZC](_Y&KM4C*>X4
M444R0JE>Z/INHW-K<WME#//:/OMY)%R8F]15VB@!LD:2QM%(@:-P0RGH16;#
MX:T2WTA]*ATNVCT^1BS6ZKA&)ZG%:E+Z_C0,YP^ O"9.X^'K#=V)CYJ>X\*Z
M<?#]WHVG^;I4%R/FDL6V.ISG@\_C7+?#;4K_ %#Q#XNCO+ZZN8[>]"PI-*SB
M,9;A03P/I7H<BN8V"'8Q! 8C.#ZX[TW>]F-MIG"6WPY-M:QP&/PG="-=HFNO
M#0DE8>K,)QD^^!FM'PYX$L= 2_!G:=;\$3VR((;4 \82$$A>.^2:Y;6W\16_
MQ3\-Z:?$+,]Q#*P=(-D8PK?>B#X<\=2:[ZST_78;N.2\UR*YMUSOB73UC+<<
M?,&..>>E#OW*=[;EVPT^STNRBLK"WCMK6(82*,85<G/\ZK2Z;HT>M1:I-;VB
M:FR^5'</@2,/[HSUZUREGXOUGQ-XOU+1-%^Q:?;Z>H,ES=0M<22$_P!U0RA?
MQ)K#\=VFJ6_BWP3_ &EJ4-ZIU-?+V6GDE#N7.<,0?R'XT*.MF"@[ZGK-%+_%
MBC!&,CK4F9EGPWHAU@:N=)LSJ(Z7)B!<'USZ^]+)X>T>;64UB33;9M23&VZ*
M?O!QCK]*TO2L_7+^;2]#O+Z"W:XF@C+K$!U/^ ZT]1W;(=4\->']5D^TZII&
MGSR C]_-"N_T'S=?PS4'_"%>%MT;#P]IH>)PZ,MNH8,.AR!D_CFN2\!:9%XP
ML(O%GB*7^U+Z65C##*,P6NUB $C^Z.G4C/N>M>A7EE'J%LUO*]PB'!)MYWA<
M?\"0AA^=/;0;TTN%[;SSV$T%I.MM,Z%8YFB\P1G'7;D9^F:P?!W@NT\(6<ZQ
MRBZOKER]Q=F((7/H%&=JCTR>2:XK2A<W7Q<U;09M5U=M-MU7RH1J=P-N8P?O
M;]QY/<UZBL$ECIK0V0::6-#Y*W5P[%V[!G.YL9[\T/0;36A:H-><QZ[XV1W_
M +:M;K2WW806.B&^BQZEHY6;_P =%=)X3UI=9@N/^)[9ZK)"P#"&R>TDASGA
MT=B><<<#H:+"<6C8O]-L-5M_L^HV-M>09W"*YA61<^N&!&>:R%\!^$5DWCPU
MI?'\)ME*_P#?/3]*Y;QCXH\3^%_$>DV5O?V-S%J+OA9[+:(P",#*MD]?TKKX
M+#Q*MU'+=:_9O"&R\,6E[ 1Z!C*Q'UHM97'9I;EVXT;3+O2VTN:PMVL& 4VW
ME@1X!R!M''4"K4,$5M;QPPQK'%$H1$4<*!P *YCQ!K[6VJ#3[+Q!:6UR%W/:
M)I,M_<8]2L3Y4?5:Y;5_'NN^'[JP)N!J$%S<+"Z7F@W&GLH/=7<@,?;&:$K@
MHMGHT.C:;;:C<ZA!90QWETH6>=5^:0#H":S'\">%)&)?P_8N6.3N3.2>_6L7
MQKX^G\.W.EZ?8VB27FH;"))@76,,<<(N"Y]@1FJT^O\ BN*W>6UEN[JX121!
M+X8GCCD/]T,'RN?4YII,:C(ZRS\/>'M!=KRTL+.Q8KM:7[O'IDG%2:+;Z#I]
MN;3138Q1,Y<Q6TBG+'J< U7\/WUQXCT%9=:T.2QG+;9;2ZCR#[@,.1SW]Z\\
MU"TM;7X]V$=O;0PJ+6,A8XPHZGL!22ON"5]SU*[TC3KV^M;Z[LX9KJT):WF=
M?FCSUQZ56O\ PSX>UJ475]H^GW<IQB=H5+G_ (&.?UK691@A@"#P0>XKS#QW
M:1^ K:W\1>&G.FRR7*Q3V41Q;W(()_U?0-QP1CO0M63'70ZNY\/>#=$,>ISZ
M3I=D8#\DPA5"&/ICEF/XDT:M9>#[^.#4-;L]-W3?ZJ:^A$4K<=!N ?IV]*6^
MTO\ X2_0-)O)&DT^\3R[R$%0_E.5^ZRD#<,,1V/TJYJFCW>KZ?#;R:S=64BX
M,LFG@1^;[<Y91[!OQH'ZLQ7TKX>_85U!-.T>:V@DYN;6W$@C;U=HP2,=RW [
MXKK+>6":WCEMI$DA9<H\; @CV([5BP^&Y+#0[C3=/O(H3.3OG>S3(!X)VIM#
M-_M-GGDYZ5?T72(-!T>WTVU=VB@! :3&2222>/<TF)VL:%%'K102%(_W&^AI
M:1_N-]#0"%TS_CPB^E6ZJ:9_QX1?2K=0;A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO]AM/^?:+_O@4?8;3_GVB_[X%6** *_V&T_Y]HO^^!1]AM/^?:+_ +X%6**
M(!9VHZ6\7_? J545!A%"CT Q3J* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X+2?^2Q:Y_UY
M1_TKO:X+2?\ DL6N?]>4?_LM5'J-'>T445(@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD/B5_R*B_\ 7]:_
M^CDKKZY#XE?\BHG_ %_6O_HY* .JM_\ CVB_W!_*I:BM_P#CVB_W!_*I: "B
MBB@ IKR)$A>1U11U9C@"JUW=/&Z00*#,X)RPX4#J3^G%0I;IO$LA,TP_C?M]
M!T'X4TB7)(L?;H3_ *L/+Z%$.T_1C\OZTW[0=Q*VQ4_WG91G\LT4>].Q/.QW
MGS_\\8O^_A_^)H\^?_GE%_W\/_Q--HHL+G8HGF _U,0_[:'_ .)I?/G_ .>4
M7_?P_P#Q--HHL'.P621,[;>%<]<.>?\ QVG>?/\ \\HO^_A_^)IM%%@YV+Y\
MV<^3%G_KH?\ XFCSY_\ GC%_W\/_ ,32446#G8>;+_SPA_[[/_Q-*)IAT@B'
M_;0__$TE%%@YV*)I5&%@B ]I#_\ $T>=-G/D19]?,/\ \32>E%%@YV.\^?\
MYY1?]_#_ /$T>?/_ ,\HO^_A_P#B:;118.=CO/G_ .>47_?P_P#Q-'VB?_GE
M%_W\/_Q--HHL'.QWVB?_ )Y1?]_#_P#$T>?/_P \HO\ OX?_ (FFT46#G8[S
MY_\ GE%_W\/_ ,31Y\__ #RB_P"_A_\ B:;118.=CO/G_P">47_?P_\ Q-'G
MS_\ /*+_ +^'_P")IM%%D'.QWVB?_GE%_P!_#_\ $T>?/_SRB_[^'_XFFT46
M#G8[[1/_ ,\HO^_A_P#B://G_P">47_?P_\ Q--HHL'.QWGS_P#/*+_OX?\
MXFCSY_\ GE%_W\/_ ,33:/2BP<['>?/_ ,\HO^_A_P#B://G_P">47_?P_\
MQ--HHL'.QWVB?_GE%_W\/_Q-'GS_ //*+_OX?_B:;118.=CO/G_YY1?]_#_\
M31Y\_P#SRB_[^'_XFFT46#G8X7$W>%/PD.?Y4?;,#+6\P&><;6Q^1)IOK118
M.=DD=W!*^Q9 )/[C@JWY'FIZI21I*A21%=#_  L,BHBTUEEXRTL Y:-FR5'J
MI/\ (_AZ4K%J29I44R*5)X4EB8-&ZAE8="#3Z104444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BJ[W]G')Y;W<"OG&UI #FK%
M!14,UY:VQ GN88B>@D<+G\ZD21)4#QNKJ>C*<@T .HJ.:XAMUW331Q+ZNP _
M6DAN(+A=T$T<J^J,&'Z4 2T5#/>6UKM^T7$,.\X7S'"[C[9J4L I8D!0,DDT
M +13(I8YHUDBD62-AE60Y!'L:?0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1_2C[+,I^2Y+#TE0''Y8_7-'E7 S\L3$=#O(S^AQ^9IW(Y6']:*;LN^\,/\
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MG_/2D\NZ_P">4/\ W^/_ ,31Y=U_SRA_[^G_ .)HN'*Q?ZT4GEW7_/*'_O\
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M1110 4444 %%%% !1110 4444 %<3I/_ "577O\ KUB_D*[:N)TC_DJNO?\
M7K%_(52ZC1VU%%%2(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *XG2?^2JZ]_UZQ?R%=M7$Z3_
M ,E5U[_KUB_D*I=1H[:BBBI$%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@M;>&WA7I'#&$4?@*IRNC1R5CSWX4>)+_5K/4H-<U1IM0AFQY-PRK)&O/\.
M14.N>)]0C^+.BZ79:J?[/E8":WB965N#UZG]:[/7+#P^R"\U?0X+]@0H8:6;
MN3\E1FQ[XQ6!9^(O $NI!+'2P^H69(VV_A^<S0$<=%BRM&^M@36]C$%O)=?'
MG5H8=1FL&.EJ?.@$9<C*?*-ZL/TSQ4GBO5M5\)ZOI,6D^)[O4I[NY6*73KL1
M3$IW8;4##'^>*[B]TSP[J5N-1U32].D1E#&74+1591VW>8,J?8XQ2VJ>&]#
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M6K^+['0;U;;6[&\L[.4[([]T62W<_P!UBI)4_P"\!TJ=/#'A6]5+M- T2<3
M.LPLXF#@\Y!QSGUH3T'>W0J^";KQ)<Z5+_PDB6S3QR;8IX)$/FKZD(2H(/&!
M735#:VMM8VZV]G;PV\"?=BAC"(.>P'%35)#U84444""J.L?\@>Z_W/ZU>JCK
M'_('NO\ <I#6YL+]Q?I2TB_<7Z4M2;!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %<3I'_)5=>_Z]8OY"NVKAM)D/\ PMS7(\#!M(CG\JJ/4:.YHHHJ
M1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^A*@$=P2*ZNN)\03LGQ(\,Q!5P_FY/?[C4XH$=G%%'!"D,2+'&BA511@*!T
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M+2?^2Q:Y_P!>4?\ [+7>UP6D_P#)8M<_Z\H_Z54>HT=[1114B"BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!:3_R6
M+7/^O*/^E=[7!:3_ ,EBUS_KRC_]EJH]1H[VBBBI$%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRSTFT6VLH1'&"2><LS'DLQ/))/))ZT; 6Z***0!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTC4+/RXM!T9<CYDM]#U!I4_[:*BE3[D"O4]/U*\O)G2ZT.^T\* 1)/+"ZM[
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M[/#_ ,\8_P#OD52L?^0E??\  /\ T&M&H-EL1_9X?^>,?_?(H^SP_P#/&/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD;:GICK)';3G:DX4[@N?X3GN?TZUT&@Z\^KQ-'<Z;?Z=>Q >=!=6[(,^JO\
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MC/8P  ">VC$C@D\!0589/3D8_G7%375^]A_:$6H^,TC==\=S)>Z4D>,<$J7
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M]5U(["!#=3HZY]@J#FAJPW&QM45Y?X0UO4O&EQJ U;Q)<Z3<P3%5TJT,4+Q
M$CYBZ%V_2I3X@U71_B+IWAZTUUM<L[I'\^*<1/+:X&0=\:@C_@6?ZT<K#D/2
M_P"M'^?\_P"17E5KXTU#PSKGB+2-9N9=1O%F5].B+C+AR-B+TX&X$^P-)X@\
M>ZT-!N](FA71?%9FBC@CBDW"179?F0L,=#@]>0:?*[AR,]6_K15/2H+FWTFU
MAO)WGN5C'FR2'EF[YJY4D!U-+@]>/SJO=VMK>VKV][##/;R##QS*&1A[@\5Y
M!<Z'HB_&Z+3AI=@-/-DC_9O(3RB<]=N,9]Z:5RHQN>S'THK&O+>TT7PU>II$
M,%E'%&SHMJBJJMZ@#C-<A\/4U;Q3X-M]0U#Q1K(D>212L+PJ.&('S>66_P#'
ML>U%M+@HZ7/2/:BO-+?7M;T3XJ6GA:75IM3TZZ0D&\CC\V/$9;AT5<\CN.AJ
M+2?%&I^)/%VJZ3J>O2>'UMG*064"Q132 'AB\JL3D<_*!P:.5CY&>H45AZ?I
MPL=03/B?4;LL#BTN9X7#\=>$#^_!K8FGAMH))[B6.&&,%I))&"JH'4DG@"D2
MU8DJGJH/]F3,I*L@W(PZJ?4>])IVL:7K",^F:C9WR(0&:VG60+]=IXIVI_\
M(+N/]R@%N:J_='TI:1?NCZ4M0;!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4<BF^9&,_O$^7K\PXKQNQT'59/B%#J'@[1;[P_I.]?M+7,9MXI5'WOW3>HX
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M]O4UY7\,M4/AWPTNF:CI&N0W!G8A1I,Y4 GKD+@4[XA?;KCQ!:H_@FWU&SC
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+'5=!DE#G^Z93'&5'N6II7+C%'6IHW@Z]LO[4_L;1'MBAE-S+91J-HZL2RC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]BF'*Q:*;B;_ )]F_P"^UH_??\^[?]]BD'*QX) Q^E)3<3?\^S?]]K2_OO\
MGW;_ +[% <K%HIN)O^?=O^^UH_??\^[?]]K0'*QU%-Q-_P ^[?\ ?:T?OO\
MGW;_ +[6@.5CJ*;B;_GW;_OM:,3?\^S?]]K3#E8ZBFXF_P"?=O\ OM:,3?\
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MBNWTWP)X7TF\%Y9Z-;K= Y6:3,KJ?4%R2/PK5U31]-UNS-IJEC!=P$YV3(&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLOVB%RRH>I # @X[$?A6S/XST:U@:XG&JQPJ,M*^C7@0#UW>5C'O18=I&_\
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M6BD*[$Q)_P ]Y?\ QW_"C$G_ #WE_P#'?\*YGQKXSA\%Z=!>2V,EX)7V!8Y
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MN!5VI- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!!K1K.L?\ D)7WU3_T&M&H9LM@HHHH&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*^^J?^@UHUG6!SJ%\PY7* 'MP.:T:AFJV"BBB@84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
I110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %9!@0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:&W\5P/K'_\ 7IP\?:%_STF'_;.ER2[%K%T']M?>=/17-?\ "=Z%_P ]Y/\
MOV:D7QOH)_Y?"/JAHY9=A_6J'\Z^]'0T5A+XRT!O^8@@^J-_A4@\5Z$>FI1?
MD?\ "CEEV']9H_SK[T;-%8P\6:$3QJ47Y'_"G?\ "4:)C/\ :,/Z_P"%+E?8
M?MZ7\R^\UZ*R1XGT4_\ ,1A_,T?\)-HO_01@_.BS'[6G_,OO-:BLL>(]&)P-
M1M_^^J7_ (2'1_\ H(V__?=%F/VD.Z-.BLY==TENFHVW_?P5,NJZ<WW;^U/_
M &V7_&BS#VD.Y;HJM_:-CC/VVWQZ^:O^-(-3L#TOK8_]M5_QI68^>/<M457%
M]9DX%U ?I(*>+F C(GC(_P!\4%71+13%FB<X65&/H&%/H **J:CJ,&F6WGW!
M;:6V@*,G-8;^-;,?ZNVF;ZD"LY580=I,VIX>K45X1NCIZ*Y0>.(,_-92 >S@
M_P!*LIXSTQE!99U)[; ?ZU*Q%)_:+>#Q"^PSHJ*P/^$PTKUF_P"^/_KT[_A+
MM*_OR_\ ?%5[:G_,B?JU;^1_<;M%8B^+-)/_ "V<?5*D'B?23_R]8^JFCVM/
M^9?>+ZO6_D?W,UZ*S!XATD_\OJ?D?\*#XATD'!O4_(_X4_:P[H7L*J^R_N-.
MBLT:_I1_Y?8_R- \0:4>E['^1_PI\\>Y/LI_RLTJ*SO[?TK_ )_8_P!:/[>T
MO_G]B_6CGCW#V<^S-&BJ']MZ9_S^Q?G2C6=-)XO8?^^J.:/</9S[%ZBJJZE8
MO]V\@/\ VT%/%Y:GI<PG_MH*?,NXN278GHJM_:%E_P _EO\ ]_5_QIWVZT_Y
M^H/^_@HNA<K)Z*B%U;GI/$?HXH^T09QYT?\ WT*8B6B@$$9'-,FE2"&2:0X1
M%+,?0"@!]%>>3?&3PXF?*@OI?0^6 #^M4S\:]*#8_LRZ*^NX4^5E^SGV/3Z*
M\[M_C+X<D'[Z&^B/_7,$?SJXOQ9\*D9^T7 ]C#1RL/9R['<45Q0^*WA0_P#+
MY*/K$:>OQ2\)$\ZBP^L3?X468N278[*BN27XF>$6_P"8N@^L;_X5*OQ%\),.
M-:A_%'_PHLPY)=CJ**YO_A/_  KC_D-6_P"3?X4\>.O##=-9MOS/^%%F'++L
M=#16 /&WAH_\QFU_[ZIW_"9^&_\ H,VG_?=%F+E?8W:*PQXR\.'IK-G_ -_*
M>/%OAXC(UFR_[_"E8+,V:*Q_^$K\/G_F,V7_ '^6I5\2:&_W=8L#_P!O"?XT
M6"S-.BJ UO26Z:I9'Z7"?XTXZSI8/.I68_[;K_C0%F7:*IC5M-;IJ%J?I,O^
M-2K?6C_=NH&^D@- B>BHOM,'_/:/_OL5(K*XRK!AZ@YH 6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM^=-\R0?QM^9H D\J<?\LY1_P$T?OU[S#\331-(#_K'_ .^C4RR2-_RT;\Z
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MB@9J8PTGE&@"/(I0R^U.\HTQH3Z4 /RM-.TU'Y34\(10 THM)Y8J6D.* !
M.*<9 =JG^\*CS4$I^92/[PJH[DSV/2/AM96[:G-=FZ"W$:E5@[L#WKT^O'?A
MP^?%<6>IA?\ E7L5>IA'>D?+9M%K$N[W2."U-H)M1E:VB,:@D,/5LG)JE:(1
M;C(Z,P_\>-2W3[+ZX [2O_Z$:@LY\P?\#?\ ]"-?*U6Y2DWW_P SC1<"CTH*
MU'O-.$GJ*Q*$*>U1M'[58!S12 I%".U)S5PJ#3#%S3 K?-4J;JD$>*>%% #,
M\<BHF ]*L;*:8@: *XXZ4[-2^32>4: &[E]J=N2FM"?2H_*;TH E)4U&44T!
M&%2#B@"+RUIR* :><4PT 2&7:"#Z5)ID$5RMK')*(E9!ESVXJG*<J?I2:>VZ
MV@5CQL7^0K6E)1:;5]42STZO/OB'-9FY@MQ;G[:%#F;_ &/F^7\^:]!KS'XB
M'9XA@([VJ_\ H35]U1^(\?-9-89V.;"'R$/N1_*E"CTI@G_T=<_WS_(4GF9Z
M5V(^3E>Y*5'I32E()/:GA@:9&I$T?M4+1D=JN4A&:+#4BCR*7YJM-'GM3?+I
M6*YB)=U3 ^HIP44NT4[$MD+X]*C^E63&#3/)I6&FB(&G;E[BG^52&$T!= &2
M@E<5$86]*!$U [(<54TWRUJ0+CK3N* N0A #4P;:*C.*:3\M ;EPE9$BR<#;
M_4UZ[H%K#9Z+;06]P+B-0<2#H<G->+ABJQC/\)_F:];\%D'PI9D?[?\ Z$:Y
MZ_PH]K)FE6E&W0L>));:+2&^TPF4,VU .S8.#7!11G8WX5VGC#_D"J?29?ZU
MQ45QA6!]*\'&O][;R/T'+HOV%UW)54=Q3]H]*B$V[I2B0^E<)W-,>4IC1^U/
M#@T^@5VBFT1]*B((K0(IC1@]J"U4[E+FG+NS5CR:<$ IE.:&*3CD4-@]JFVB
MD,8-(SYE<J$#M0#5@P"D\DB@OF1%N'<4X,G?%.,)-1- WI0&C)=R4Q@K5'Y+
MYZ&I%0CK0.R0PQ+2>6M3\>E-;% *3%3Y1P:F20.C+]*JYI@8KN(]130G&YVW
MA.WB2.:=9@9'^5HQ_" >M;]TT:6<[S+NB6-BZ^HQR*Y7P80US='OL7^==/J(
MSI=V/6%__037M85ITD?-XV+5>29\QW\UE=ZW-<:9;&ULI) 883_ N!Q4+IMF
M<$=&(_6JD$Q3R_PJS-.#<2_[Y_G7H'0K(<%'I04J/S#UQ3A)FF4(8_:HFB]J
ML@TN!0%B@5([4G-72@/:F>5185BM\W:IDW"GB/%2!10%B,D8Y%0L!Z5:*"F&
M#/2@+%<9I^:D\DYI/*- 6&!D]J=N3M36A;L*C\I_0T 2-M-,**:4(PIXXH B
M\M:D0 4IQZ4R@"W;2@7,8/K77_#/3[2[\5PS37BP2V^)(H^,RGT%<+&?])C/
MO70>!)<>,]'SWN5%2]B)ZQ:/I6BBBL#S@HHHH **** "BBB@ HHHH **9+-%
M!&9)I%1!U9C@5BVWC#1;S6AI-I>+/=8)(CY Q[TTF]A-I&[1169XBO#8>'-1
MNE;:T=NY4^^TXH2N[#>A-=ZOIUBI:ZO88@.NYQ6-%X_\.7&L1:9#J"23RG"E
M?ND^F:^<]-MKC7M8@LS,QDNI,98YP3S4FL:1?>&-;>SN 8[B!]R./XAV85U+
M#QV;U.9UY;I'U=17$?#KQJGB725M[N9/[3AXD7IO'9J[>N:47%V9T1DI*Z.3
M\<^-;;PEIO!#W\RD01_U/M7A$]WXA\<:LJ2-+>W#'Y4485!].@KH/B_<23>-
M/+<_+%" OZUU_P $[&!=%O+X &>2783W KJBE3I\W4YI-U)\O0PM+^"NHSA7
MU&]B@!ZI&,D5KR? ^T\L^7JLN_MN08KK?'/C-_!UK;SK8?:EF;;]_;M/Y5Y[
M-\;]1<?NM)AC^LN[^E2I5IZHIJE'1E+4O@SKMNC-:3V]UZ+G!_E7KW@V"XM?
M"EC;W<+0S1)M9&[&O')OC'XFESY/V6(?]<<UZ5\,?$=[XDT">?4)A+<1SE"0
M,<8%*JJG+[P4W#F]TJ_&  ^##D=)17B>@:'<^(M0>QL\>>(C(H/\6.U>U?&)
MBO@X =Y17GGPA_Y'M?\ KW;^=72;5)LFHKU$C.\%>(9O!WBK-V&CA+>5=1D<
MC_\ 57TE;7,-Y;1W-NXDAD4,C#H17DGQ;\%H(V\0Z?"=^?\ 2E7H1_>J/X2^
M-6#+X=OY%\O'^BN?_0?\*FHE4CSQ*@W"7(SCOB7_ ,C]J7U%>O?"A=O@6UXQ
MEF/ZUY#\3/\ D?M2^H_E7L?PN_Y$6R_'^=.K_"0J?\1FUXKF^S^%=2E)QMA/
M^%?+=I;->WD-M'CS)G"+]37TC\2+D6_@74LG_6(%'YBOG/2KPZ;J=K>K%YK6
M[APF>N*>&7NMBK_$D=S)\)/%-BXELYXFD'1HY"I%1R6GQ*T8??U"0+W$A?\
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MIQ="87EOCF&3_OL?X4?;+7M'(/\ @8_PIOVDGI%%_P!^E_PH\]^T47_?I?\
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M]H?_ )YQ_P#?L?X4:CNOZ2%\^+W_ .^__K4[[1#[_P#?7_UJ9]HE_P"><?\
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MF"Y&.(XS_P!LU_PH^T/VAB_[]+_A0/47[9;?W)/^^A_A1]LM_P"Z_P#WW_\
M6H\^3_GC%_WZ7_"CSI?^>,7_ 'Z7_"@-1OVN#T?_ +[_ /K4?:X/]K_OO_ZU
M.\]^\,7_ 'Z7_"D-P_\ SRB_[]+_ (4!J)]KM^^[_OO_ .M2B\M>^?\ OO\
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M-5HR[X;O;[4/#]G=ZE"L-U*@9T7WZ5JT 8&!VHKF>YT(****0!1110 4444
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M_P :7I_D'B__ ) 3?]=%_K7"1\JW^Z:[KQB2-#X[RKG]:X2+H_\ NFO QO\
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M-2&F.2%8A=Q R .](T0VE7JW^[63I-_/=R.LKI( BOE%V["<Y0^XQ6LO5O\
M=JY0<)<K!24E='4>"<_:+STVK_.NLO?^/"X_ZY-_*N3\$_\ 'Q>?[J_SKK+W
M_CQN/^N3?RKU\)_"1\UC_P#>9?UT/E!/];C_ &OZTMS_ ,?,O^^W\Z:O$W_
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MZ#'^-/S/Y<?3.?FW>F?\*FS3":4JU^B*AAN7[3^\"0!@#%1EJ&--K(ZA]--
MI#0 W !R ,GOBF2?=J0U')]TTUN3+X6=K\,QGQ0Q](&KV&O(/AE_R,TG_7 _
MSKU^O4PG\(^6S?\ WI^B/-[O_D(77_79_P#T(U2MO]7(/21OYU>O.-1NO^NS
M_P#H1JC;?=E_ZZ-7RU7XY^OZG&N@311S(8Y45T/56&0:2...&,1Q(J(.BJ,
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M'%-)).222>I-!I* ''_4K_O'^E>O^#ACPK8_[I/ZFO(/^7=?]X_R%>P^$/\
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M7J,<T#&FFFGL,4RF,2HV^Z:DJ)NC4X[HF?PL[KX8_P#(RR_]<#_.O7J\A^&
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M6WLD>_\ 4UI[%KXFE\_\KF#DGL;M%89TC5'^_KMP/^N:A:!HVI(<IKMT?]\
MT_90_G7X_P"1-WV-RBL7[/X@@'R7]M<#^[)%M/YBD.JZE:_\?NE,5'62V?</
MR/-+V+?PM/Y_YV#F[FG-4:55AUBQOCMAG'F#K&XVL/P-65K.47%VDK&T6G'0
M'J.I&J.I-$%*G1O]VDI4_B_W::!['8>"!^[NS_M#^5=3/_Q[R_[A_E7+>"/]
M3=_[P_E74S_\>\G^X?Y5[6%_@Q/E\?\ [S+^NA\FW/\ Q^7'_75_YFB\_P!>
M?]U?_012W0Q>W(])7_F:2[_UY_W5_P#017>;%4FFFG&F&@!AHH-)0 \5**B%
M2+0!82IE-6-.T74=1YMK5RG>1OE7\S6Y%X7MK?\ Y"&JQJW>.W&\_GTJ95(P
M^)E1O)VBKOR, &GCI741VOAZW/RV=S<M_>EDVC\A5M;_ $^-<0Z'9 >K+DUA
M+'45U.F.%Q#VA^1QF?I1FNU_M.V[Z/8$?]<Z8\VCS_Z[1(5]3 Q0U*Q]%E/!
MXA?9_%''5&_2NL?1]!N?]3<W-HYZ"0;U'X]:S[SPKJ$49EM6CO81SN@;G'NO
M6NB%>G/X6<\XRA\::]3G0>:<W2D*LDA5U*L#R&&"*#6A!$>M)2FDQ0(:/]:/
MK79?#49^(EC]93_XZ:XU?]8/K7:?#3_DHMG_ -M?_032>Q$_A9]#4445@< 4
M444 %%%% !7SM\3-;FUSQB]GN_T>T;RHP/7N:^B#]T_2OEFY)E\6WK/R?/8U
MI"7)&4^R"-/VM6%+^9I&A&@CC5%& !3J*.U?,MMN[/T=)15ELC/U6Y\J 1J<
M,_\ *LF"TEN3^[7CN31=R/+<NS]0<8]*W[)%2SC"]"N:]]S> PT>57DSXZ--
M9QCY.;:A'IU,2;3[B%=S+E1U(J33+HPSB-C^[?\ 0UO8SP>AKF+A0ES(J] W
M%/"XAXV$J55$9A@EE56GB,.WOL_ZV9T]9&H,UIJ4%U'PRD-GZ5>L)'ELT9QS
MT^M0ZM")+7?W0UYV#?L,7RR]#V\TBL7ESJ07121[CI=\FI:5:WD?W9HPWTXJ
MW7'?#2^^U>%A"3EK>0J?H>G\J[&O4G'EDT?'Q=XIA7FOQ9M,Q6%X!]TE"?SK
MTJN9\?:<NH>$[DD9> B1/KW_ $JJ4K33%45X,\PL9?-LXV/4#!J'57VV1']X
MXJ/1GW6S+Z'-,UI_W<:>IS7F0HVQ_)Y_\$^MJXERR?VKW<;?H>D?"RU,7AV:
MX88,TQ ]P.E=U6-X3M19^%M/A"X(B!/N:V:]*H[S;/DX*T4@[UXG\09C>>-)
M80<^6JH/R!KVT=:\$U*;[;XSO)CSB8C\N*JG+DC*?9%1I^UJPI=VD;'PSG-M
MXLDMR?\ 6QE,?E7L5>%^&I_L/CJUDSC=)C\Z]U/!HJOFY9=TA<GLYRI]FT)7
M!?%6S670[:[ _>12;<^U=[7-^/;;[3X.O0!EDVL/S&:5)VFF345XL\LTYMUC
M'[<4W4Y/+LFYY;@5%HSYM67T-0ZT_P#JH_7FO-C1OC^3SO\ J?65,5RY.JBW
MY4OT/2_A;:>5X<EN",--,1^ Z?SKN:Q?"5@=.\+V,#C$GEAG'N:VJ]&H[S;/
ME(*T4@KF/'NJ?V7X6GVG]Y/^[7VKIZ\O^+%Z6N+&P4]!O84Z,>::%4=HLX_1
MH]L#N>I.*TZAM8A#:QH/3)^M,OI7AM6:,9;^5>)7;Q&)=NK/N\)!8+ QYOLJ
M[_-F7J=UYTWEK]Q/U-1Q:;<3+N"A0>F:99HLMY&'Y!//O72=.!VKU<3B7@HQ
MHTD?.X# K-:D\3B'I?9',3VLMN<2+@=C6OI=UYL/DL?G3I[BIM117LI-W\/(
MK"MI7BN$>,9;/3UIQE]?PKYE:2(E'^Q\?'D=X27SM_P.AT],EC$T31MT88IP
M)*@D8)[4M?/IN+NC[.45.-GLS0^%NJS:1XVCLFD(M[H,CKGC('R_K7T+7S!I
M#&/QWIA0X)NXQ^;"OI^OIIRYXQGW1^<RI^RJ3IK[+:"BBBLP"BBB@ HHHH *
M*** "O,OC7_R+5C_ -?7_LIKTVO,OC9_R+5C_P!?7_LIJZ7QHBI\#/%+?[L_
M_7(_S%5GZU:M_NS_ /7(_P Q55^M>@<!&:::4TVD,;2BB@4 =5IF@V$5A;ZA
MJ<KR"<%HK>+C.#CDUL)J4JI]GTVW2UBZ!85^8_4]:IYSX:T4_P#3.0?^/5O^
M'7,6C7TR!?-CW,K$<C"UX6)JU*E9T^:R1]7@L/0HX2.)Y.:3[^MBG%HFIW"^
M88&Y[NW)JI+#+;RM%,A1UZJ:L)KFHB82FZ8D?PGH?:MCQ/&)DL9T7]Y*"N/7
MIC^=<3A"4'*%]#U56K4ZT:=5*TKVMTL/TO0;6XL8+BYD</*>%!P#Z?I6->V_
MV._F@.2$? ]Q6[J\[:>VEPQ!ML.&.!VZ?XU5\4P[;N*Y4?+*G/U'_P!:M*U.
M*@[+56.?"5ZDJR<W>,[V\K/_ "-.XT_0K.*(W*LAD4$?,?2J&IZ/:K8?;]/F
M+PC[P)SQ6KJ.FQZG;VFZY$+*@QD=>*S]1D@T?1WTN-VDFD.6)&  >M:5(*SO
M%)=SEPU:;<.2;<KZKI8S+O2S;:7!?"8,LO&W'(JM$-0M(1=P"5(C_$/NGZUT
M\5E'J'AVPBEF\I1SGUY/%9&NZ@\:C3((G@@C&#N&"_\ ]:LITE!<^VB^\[*.
M*G5E[&UW=WOM;]3)U&&SU32[N[:U6&\MT#^9%P'Y Y'XUQIKLHN=)U8?].I/
M_CPKC37MY=4E.C>3N?,9S1IT<4XTU96&TUNE.IIZ5W'E#XO]1)]5_K7OOPA.
M? L8]+B7_P!"KP&/_4R?5?ZU[W\'CGP3CTN9/YUSU_@-Z'QG6^(3CP[J!_Z8
M-_*OGO\ Y9_A7T)XB_Y%W4/^N#?RKY['^K_"O#QOQ1/K<E^"?R$'^J7Z"HS4
MG_+-?H*B-<+W/<C\*$-,-./6DH*$[TCR%"BI&TDDC;41>K'TI>]+$<:III_Z
M>D_G6V'@IU%&6QRXVK*EAY3AND;=AX2O[O#ZA.+:(_\ +*+EC]3VKJ;+2=(T
M904BAB;_ )Z2L"Q_$T:M>OIVD75Y$F]XDRJ^^<?UK)L;#1KO2TU#5KB.\DD3
M?))-)POL!GBO9A%*.FB\CXNK6G4E>;N_,Z4:G:_VC'8B0F>2,R* ."H[YJN^
MLLNL7.G+!\T-MYX<GAO:N<NO,E\0Z.=%FC@\VR81/*I(VY]*EM8;NV\73I?W
M2W$TEBQWJN !@\5IR)+Y&+F_Q+5EK7BC4[!+RTT^S\IQQ^\.?R-6+G5-=?6U
MTZQ6V#BU29Q*.A/!Y^M<EI<NB1Z9&;W5[R*56.88F.!@\<"MZZ@?5O%T9M+V
M6U:33TD21!R1DD UJXI/;\#)2;6Y=3Q3=0Z5J$MU9H+RPE2.1%;Y6W' (JW;
M>)O])CM]1T^XLI9?]66&5<^@QWKFG,*^#]8M]C"_BN$6Y9FW&0[QAA[=:O/!
M<P:]I,>KWLMS Q#VK*H 608P&_,5+A'73^K%*<M-?ZN=%+%INO6*RM'%<P/]
MUB.?3ZYKD-:\.'1[62^L[@M;1D;H9>2 2!P?QJ_-ILK>)9-*CG>+3W_T]D3(
M.[."H/IGFM'Q2/\ BEKX#LJX_P"^UK*4(NT7JF;TJLZ;YX.S1Q9--IW:DKYP
M_0!M1-T-2U$_W351W1,_A9WWPN./$%T/6W_J*]:KR+X8'_BI)AZP'^=>NUZN
M$_A(^5S;_>G\CSG43G5+HG_GJW\ZSX/];=?]=?\ V1:OZA_R%+K_ *ZM_.J$
M/^LNO^NO_LBU\O6_BU/5_F<:Z"FFFE-,-<PQ#3:<:2F ,ZQQL['"JI8GV%8L
M6J:IK _XE%J(;8]+NXZ'W5>]:MU_QY7 _P"F3_\ H)JOX4.?#&GCTBQ^M>SE
M6&I55*=17M;TZF51NZ2%MO#%LT@FU*:74)^N9C\@^BUT,,4<*!(D6-0, *,"
MN$G\7ZA;^(I(E@5]/280GY><^N?6ND@UUI+Y;8P ;KI[?<&Z;1G-?1NG))+H
M81G#H;H-9EQ=ZA'K-O:));K%.KNI*DD!=N0?KFD?6HXO[4WPO_Q+P&;!'S@K
MGC\L5F7/C33[:^$$UG-YR!<-@'&Y0>OXBB,)7V'*4;;DA\27AM(7$#*[1W!,
MC)\C%%8C;_WSS6EH>I3:@)#-(C852 H (SGTK.A\4Z:^M?V2UBT969H%=E4K
MNR0<?7^M&D>*K2\U?^SH[ VV\L$<  ,5[<?0U<HNS]TB,E?XCJ<U6N[6WO(C
M'<PQS(1R'7-8\'B598]8=X0JZ>S ?-]_&0/S(K%T_P 0:U*K)?)Y3--"R$IC
M,;DC'TXJ%3EN4ZD=C2DT*YTYFFT6Z,:CDVLQW1M]/2K^F7IU#3H;IH_+9QRH
M.<$5%HLTUU'>S2R,ZM<R+'G^%0<8%1>&_P#D!PCT9Q_X\:\7.:4%34[>]??Y
M,TI/6RV-,TVG&D-?.'01M]ZGZ8<30GTF/_H1IC=:-/.#&?20_P#H1K6E\2]4
M)GI]>;_$H_\ $QL1_P!,F_G7I%>;?$K_ )"5C_UQ/\Z^YI?&CR<S_P!UE\OS
M1QJ_\>TG^\O]:@/6IU_X]I/]Y?ZU >M=9\J]D)332FDH 2E%)2BD!N26^F:*
ML9OM]W=.@D6%.% /3)JG/K^H7@^SVP%O">!#;+CCW[FG^*O^0E:GULXC^AKH
M= CF7PEYVGPQ?;B2%<@9//K]*^=K5:U>M*FY62['Z]@,#@<NP5+$0IIRG;5^
M?Z'/0>%]9N5\S[*5SWD;!-+I&A-?ZO+I]R[6\D2%FXR<@@8_6NHTBVUR.]-S
MJ%ZLORD"W6526/\ (53TI[D^.KA[N$PRR1M\G7CC'UX%8_5J:<6T]7;4[7F-
M>2JI2C[L;IQ[_/?UL<OJ-LMEJ5Q;(Q98I"@)ZG!K0\,V-MJ6K_9[I"T9B8X!
MQR,56\0<>(+[_KJ:N>#W"^(X03]Y6 _*N:$5]847M<]"O.;P#FGKRWO\BAJT
M$=KJ]W;PC$<<K*H/8"M*XT.WC\,6VIK))YLC*K*>G)JIXC4IXBOLC&92P^AK
M<O25^'MGNX)D0C\S5PA%RJ)K9,QJUJBIX=Q?Q.-_.Z*MUX+O416MIHI@R@A"
M=K?_ %ZRUFUG09=K+-"O=)%RC?TKK]?MK2Y@L&N-3^PNL8V'H#P.]<_K,MY!
MH_D-JT%_:R. -O+(1SUK:M1C3;<+JWG_ $SEP>+J8B,85K24G9IQ:^YVL_P&
M3O:ZAI+7\=L+>=)0DBH?D;(Z@=JR35^P_P"1:O?:XC_D:HFO>P%253#QE)W9
M^8<3X:EALSJ4Z,;1TT]4-I#TI:0]*[#P1_\ RP7_ 'C_ "%>R^%CGPOIW_7%
M17C7_+!?]X_R%>Q^$CGPM8?]<_ZUA6V1[63_ ,67H,\7'&@2>[K7 1??_ UW
M_B[_ ) ,G^^M<##_ *P?C7A8W^*O0_0,K_@2]?T1"U-IS4VN ]="&FTM%,H2
MJ%[JRVMP+6""2YNV7<(T'0>I-7ZR8^/%\H];('_Q^M*2BVV^B,ZC:22ZA]@U
M&_&_4KP6\/>" X'XM5F$Z/I-G+<PK%LB^^R?.V:PFGM;K6]0BU>\800N!#&7
MVJ>O&._:JRVD;PZU/8Q.EAY2JFX$9(8'C\C^==RI.6DG9:;*RUM^)R.:6J7?
MU.Z6[#Z<;N-<@PF10W?C(KFY_$>HRZ583VXBBENIGB(VY P<#K6OITBOX7A?
M=\OV7D_\!YKDG#CPUI3(</\ ;'*$^Y&*G#4H<S36SM^#%4D[:=O\C:N+SQ!H
MLT$U[/%/!)($91VI\KZU?Z]?VUEJ'DQPD,JMTP<56D2]EUBTM_$%Q^Z+;H?+
M V.WH3VJ1Y=2B\5ZC_9D,<CE5WB0XP*V26Z4;VWZ;HC[R1=>U.TL=0AN?+:\
MLRI#8X921_C746\K2VD,K<,\:L<>I&:X^]TZ]@T;5+_42GVFXV_*AR  174V
M4T8TVUS(@_<IU8?W17-B8PY>:"6_3T7ZEPO>S,74;S0KV\EM+T+'/$VW>PVG
M/LPIGF7NCQB9;A;ZPW*IWM\Z9( P>_453 NFU[6%M[*WNT+IO69@,?+QC]:F
MN+=;;PO<!;8VQ:57:+=N"G>O3VXJW&,>6-[IVTT>_P"*&FVF_7^O,Z0TRGGI
M3:\\ZD)2Q_Q?2DH3JWTH0/8['P0?W=V/]H&NJF_U,G^Z:Y+P0?FO!_NUULW^
MHD_W3_*O:PO\&)\OC_\ >)?UT/DV\YO[K_KL_P#Z$:2\_P!<?]U?_012WG_'
M_=?]=G_]"-%Y_KS_ +J_^@BN\V13---*::: &FDI324 :.CZ7)J]X8(Y$C"H
M7=WZ*HZFNGMX-'TK!MX#>W _Y:S?=!]A63X//_$RNQZV4O\ 2M/2UCDU&W25
M0R,X!![UP8NM.,E"+M<[<'0IU%.=351Z%PW>HZDP0&1U[)&,*/RJ5]%U"*$R
MO:N% R?45JZM>W=A<):V"".,KG]W'S6CI$MZNG7$NILP7JIDX.,5R>QC*;C)
MMON;O&3ITE4IQBHO9=68>DZ,-2MY9C/L$9P0!DGC-2:#ID&J-,LSNNP C;5[
MPLP:UOL=-V1^1J+PF<7=TO\ L?UI0IP;AIO<=?$54JZ3^&UO*Y6UK21IDT9C
M+-#(.">Q]*<^DQ#P^NI"5]YZI@8^]BM&TE76+*[TV9OWT3,8F/IGC\OY&F2*
MZ>"FC<$,C[6!['S*/90;<DM+/Y,2Q-5*%.3]Y22?FF9C:/)_8XU(2KY>,E,<
MCYL50@^TC=+;>8"G)://%=580QW/A%(9I1$C9RY[?/4%U<+X?L?*LH&?S.3<
M-RI-)T$DI;*WXE0QLVY4K<TN9I=%;U_IF$9K;5G2WU2V#NQ"K<(-LBD^OK7)
M:A;BSU"XM@Q812%,GO@UT<4C2ZA'(YRS2J2?QK$UX8U_4!_TW?\ G7;@:DII
MJ3O8PQU&%*:Y%:Z,RDI32&O0.$8/]:/K7:?#4X^(EB?4RC_QTUQ?_+0?6NP^
M'1Q\0K#_ 'W'Z&D]B)_"SZ+HHHK X HHHH **** #M7S)XOL7T7QS>QLI53+
MO4G^)3WKZ;KS+XN^%I=4TV'5K*$R7%KD2A1R4]?PYK6DU=QEL]"9.46IQW3N
M>;YR,CO16?IEX)H_)<X=>![UH5\[7HRHS<)=#]"PN)AB:2JPV9CZM:A2)T'7
MAJ99ZF8$$<J[D'0CJ*V)8UFB:-NA%91T5\\2C'TKT\-B:%2A[+$O;8^?QV!Q
M=#%_6<"OBWV_7N23ZPNPB%3N/<]JS[:%KNZ"D]3EC5O^Q9/^>H_*K]E9BTC(
M)W.>IK5XC"X:D_J[O)F$<%F&.Q$7C5:"]+>FG<LHH1 B] ,"F3IYEO(GJ*DH
MKPU)J7-U/K)0C*#ATM8T?A;J+V^MW&GEOW4Z9Q_M#I_.O7*\(T*X_LOQK:3
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MG-_YBN.[5V-KS8ZJ/^G&3^E<=7L97_!^9\[Q!_O?R0TTUNE/-,/2O2/$!/\
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MZFLZ#_677_77_P!D6OF*_P#%J>K_ #.-;(5NM1DT]^IJ/-<XQ:2EHH BN/\
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MVI+VG.K6T14OJRHMN]I-OS3Z^EK&,?*&HCR&)B\T;"1@XS6+X@'_ !46H?\
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M>*S+B[2;3;2V ;?#NW$].3216EYJ$F8HY)F)Y8]/Q)I;C^R](S_:%R+B<?\
M+M;G//\ M-V_G4PIU*TOW:W-YUJ&$@O;25T[V7_#O\1;-&-AJC[3L%E*"V.
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MY959R=VS>,8[#":S=>&=!O?^N1IU]K%I8OY3N9+AN%@B&YR?IVJI]COM7YU
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M[B);6X:0(L8;@*3Z=!4&H:XD.HJ;2&%Q$ HE/)(]!Z=Q6---<7DP,CR32'@
MY)_"K']E-!$)]1FCLH.QD/S-]%ZFDISF_P!VC7V%*C%?6)=]/7MU97FGDO;X
MS% ))'!VH.]97B48\17H_P!NKUUXD@LT:'1H2C$8:ZE&7/\ NCHM<X[O([.[
M%W8Y+,<DFO1PE"5.\I;LX,5B(UG%05E$0TTTZFFNPYAG\0^M==\-U)^(-@/1
MW/Z&N1_B'UKLOAD,_$2S_P"VO_H)I/8SG\+/HBBBBL#@"BBB@ HHHH ****
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M "BBB@ KSGXT_P#(EV__ %_1_P#H+UZ-7G/QI_Y$FW_Z_H__ $%ZNG\:(J?
MSPR#[L__ %R/\Q566K5O]V?_ *Y'^8JG+7><! :*0TE QV:6FTM #Q4J>OZU
M"*Z+2;^WATTVPN!;3/,'E>2+>CH!@+^I..])NPTKCM,\1:MI^%AO)-@_@<[U
M_(UO1>+4EQ]NTBTF/=H\QL?QJ"'2-&O09HI3"LAEFX?F*(' .W!STZ<'!J./
MPS/)%O2X3B.-R&5N"XR!QGM_.LW&C4^-&D:E>D[TY->C--=;\/2?ZRRO(?\
MKG('_G3O[1\,GGS-4^GEI_C6+_8-Z54H87+E@BK)R^TX. <>E4K>TGN[AH8(
M]TBJ6() P!USFLW@,,];'2LUQL=.=G1OJ_AR,?)#J$Q]'*K_ "JM+XIM(O\
MCRT:!2.C7#F0_P!*QKK3[BTA$TJKY9;:&5PPSC/:K2:"SOY<MY#'*J"22/!)
M1#W_ /K4UA,-#51)GF.,J:.;(+_Q+JU\ICDNF2(\>7$-BX_#K6?:6%U?.5MH
MB^#@DD 9],GC/M73/H-AI2I/>DR;#&)8W(&TE\< =1MR:K7FMQ69EBL9%E)
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MS%4I:[SA*YI*#24ABTM-I10!(O6IEJ$5(M,1;@D:-LHQ4XQD''%;=KKE_ &
MF$BL02)%W9(&!^@Q7/H>:M1M[U22>Y+;6QT$6NS1B _9[<R6^?)D*\H22>/Q
M-5;+49K"[>YBP9'1ER>V[J:I*:<:?*B>9EY=9G^SM#/%#<[I/,W3+NYQBJ]Q
MJ][/"8GE&T@*2% ) Z GTJLU0G.:7*BE)A++)*VZ21G/JQS4=.HQ0 VBG8I,
M8H$)3&Z5)4;4#%3_ %,GU7^M?0GPF_Y)_9_]=9?_ $,U\]I_J9/JO]:^AOA0
M-OP_L_>24_\ CYKGK_";T/B.KU+_ )!5Y_UP?_T$U\WK_J?^ U](:E_R"[S_
M *X/_P"@FOF]?]3_ ,!KP\;\43ZW)/@J?+]1/^62_P"Z*K-5@_ZI?]T56;K7
M$]SW(_"AM+FFT4AC\TX5'3Q0!,M3(:KK4RFD,MJJ.,,H(/M3Q;Q8& 1@Y&#C
M%0QM5E6JE4G'9F4J-.3O**%6-43:H.#U]ZC^S1>6$ ( .00>:GZTTT*I-.]Q
M.C3:LXKL5VMXCC*!B.YY-!'-/:FTG*4MV7&G"/PJPVDIV*,4BQ**7%)2 ::A
MD^Z:G/2H)/NFJCN3/X6>A_"G_D+W_P#UP'_H5>JUY5\*1_Q-K\_], /_ !ZO
M5:]7"?PD?*9M_O3^7Y'GVN_\A^\_WQ_Z"*QX?]9=?]=O_9%K8UW_ )#]Y_O+
M_P"@BL>'_677_7;_ -D6OEZ_\6IZO\SD6R(Y.M1&I9.M0FN<8M+FF9I<TP)!
M4JU"*D6D!80U90(PPRAOJ*J*:GC:@!?[(T]RY^S*K.&5BO&=PY_G4MMIUO:R
M^;&':3;L#.Y8A?09Z"I4:I1S5NM4:LY,7+'>Q6^P6WVB:<QYDF #$GT&./2J
MRZ/8QP^28C)&  %D8L !TQZ5I&HFH5:HMI/_ (;8.6/8@2&*%%2*-45?N@#I
M3C3J3%0VV[L8VEI<48I )24ZDI 0OUJQH7_(0M/^N_\ [/5=^M6-!&=0M/\
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MW\9Q_P 4/'_U^Q_^@M7HE>>?&89\#I[7D?\ )JNG\:(J? SPB#[D_P#UR/\
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MSE_D:X0?ZQ?K7>?"G_D?U_ZY2_R-3+8SJ?"SWVBBBL3@"BBB@ HHHH ****
M"BBB@ KQE[FXE^.HC2>01AP'0,<$#VKV:O"$U.'3OBMKVJ3X*69E(SW(/%;4
M5OZ&55['3?$7XCW?A_58-.T=H_.0;K@NH8<]!]:[*3Q+!IGA*'6]3.U3&K.$
M'<^E>$ZKI=W?Z"_BW4"?.O[L+$O^SGK^M='X]U*ZU-M&\):?\V8T,@7NQ]?8
M<&M'2B[)?,S51ZL]4L/&&C7^AC6%N?*LRVPO(,8/I6C9ZOIVH+NM+R&4?[+5
MY'\2XX_#O@S2/#< Y;YWQW/?]:NZ5\(H9=&L[RTU6[L;N:%9&*G(!(STS4>S
MA:[=C3GE>UCUP$$9!S17EWC2^U3P/X(T^TMM4DEU!IPIG/WG'>O0=#-RVB6;
M7DGF7#1 R-ZFLW"RN6I7=C0HKAO&7CR;PQKNGZ=%9K<?:@"26QC)Q7;1.9(4
M<C!902/2DXM)-]1J2;L/HHK(@\4:-<:Q)I,5_$U]&Q5H<_-D=:23872->BD)
M !). *J6FJV%_*\5I=Q3/']Y4;)%(9<HJ*>XAMH_,GE6-/[S' IT,T<\0DA=
M71NC*<@T /HJO<7]I:N%N+B*)B,@.V,TVWU*RNG*0744C#LK FG9A<M457O+
MZUT^W,]Y.D$0.-[G S6/)XX\+Q?ZS7+)<>LE"BWL)M+<Z"BJNGZC::K9I=V,
MZ3V[YVR(<@XK(U+QKHVDZ[#H]W)*MW,0% 3*\].:%%MV0-I:G0T5S/C?Q9_P
MB&BI?"V%R[RK&L>_;U[T^#Q.FH^")=>LPH86[2!6Y"L!G!I\CM<7,KV.CI"P
M'4@?6O+]!\8Z[XB\#:WJ#O'%=6Q/E-$N, #)KG?">F^)O'UI+=3^)I[>*-MI
M"Y+']:OV6]WL1[3:RW/:+W5+'3K5KF[N8XH5."Y/%<E?_%CPK99"7C7+C^&%
M<G]:J:GX&6R^'FI:9)>S7C?ZY7DZAA7*_"RS\.7&D7DVL06OVBWE WS8Z'/^
M%5&$.5RW%*<KI;'7:YX]F;P$OB/0XNL@1EF7E,^HKD+"X^(_BNQ_M.UO52 @
ME-GR;L=@!7H5[#HGB;PIJ6F:-/;2($*X@QA'QQ7(?!;49474M%F<YMWWJA[#
M./Z54;*#:6J%*[DDV:OPY\;WFL7%QHNL@#4+;.&Q@L <'(]:]&KP[7I/^$2^
M,D-\JE8+EE+ ="&^7^9KW $,H8'((R*SJQ2::ZETV[-/H+11161H%%%% !11
M10 4444 %%%% !1110 5Y_\ &/\ Y$7_ +>H_P"35Z!7 ?&+_D13_P!?4?\
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M%.IDM$Q?-1DTF:* L*#S4J-4%.#8H!HMYXJ*2F;Z:6S3N2D----.IM(H<?\
M4K_O'^0KVW0O^0!I_P#U[I_Z"*\2/^I7_>/\A7MNAG.@:>1WMT_]!%85]D>Y
MDS_>2]$,\1$#P_>$_P!S^HKS2+_6+^/\J]*\1\^'KS']S^HKS:'_ %J_C_*O
M#QW\2)]]E7\&7K^A W2HC4S]*A-<![41M%%%!8HIPIM.%(3'BG4P4X4$,<*>
M#3!3A02R=7Q3_,JO3LT$.(]CFFYI*2@$B9&JPK<52!Q4@DH)E$GD(Q55NM/9
M\TPT!%6&FA.I^E%*GWC]*:W+>QVG@C_CPNO^NH_E745S'@H_\2ZX'I+_ $KI
MZ]O#?PHGRV-_WB7J?*?B#CQ)JG_7W+_Z$:I7O^O;_=7_ -!%7O$/_(S:K_U]
MR?\ H1JC>_Z]O]U?_017<C9;(SGJ*I'ZU'0 4"BB@"05(M1K4@H D%.%,%/%
M R134JM4(J0=*8R<24I;-0CI2@T#N/S3U-19I0: +2MQ2L:@#TN^F.XUZBIY
M---(0Q?]8/J*[SX4_P#(_K[Q2_RKA!]\?6NY^%;8^($0_O1R_P C2EL9U/A9
M[_1116!P!1110 4444 %%%% !1110 C'"D^@KYK?39_$GQ(OK" L%N+M_-([
M)GFOI6LVWT#2K35)-3M[**.\D!#RJ.2*UIU.2YG4ASV/._BO:P:1X1TBSMUV
MQ03 (OL,5G_"W1[C6O$,_BB]7,48\N GNV,'\,5W?CSP@_C#2HK:.Z\B2%BZ
MDC()]/TK3\+Z&GAWP_:Z:F"8E^<CN?6J]HE3MU)Y&ZE^AY+\4%GUKX@V.DVI
M!E" )[-UK>T:R^).EZM96MU+%-IH<+(X;)"XKF=>N-5TGXI3:])H]U<PP2?N
M]L9((VXSFO1?#?Q(TWQ#J$>G+;SV]XRY\N135RYE!65U8B-G)W=F<=\6I3>^
M,="TX'(4\K]2/\*]B@C$5O'&/X5 KQ/Q/=6]S\:K<W$RQV\!C5F8\*0.:]DM
M]5TZZ*K;WUM*QZ*DJDG\,UG47NQ1I!^])GD'CUC??%G1[;KL>)2/0;J]J "J
M .@&*\024:S\=%*?,L3G ';:,U[A15T45Y!3U;8=!7S)J&JR:7\2KS4H7*M'
MJ#L2/3=7TQ*<0N?137S7'HC^(=6\2-"-TUN))HQZD-5X>VMR:]]+'M/C;Q5!
MHO@][M''GW4>RW [DCK]!7 _ ]&;6=8F8DDPIR?7<:YR"YU'QW+IFER(1;Z9
M;GS'] .K'\JZ[X(1_O-7D XR$'X$U3@H4VNI*DY5$RU\:M2_T"QTF)B99I-Y
M53R1T'ZUH_![5!<>&I-.D?$UG(5*$\@$URMS-9^(?C/F^GB6RLVQF1PJG R.
M3[U/X#NH]-^*FKV,4J/#<L[*RL"#DY&#2<?W?+\P4OWG-\AWQ7LEOO'6A6LS
M.L5RIC+*<'J*J^+? C^ [.WU_1+^X,L,@#AVSU[UJ_%(F/QUX5EQD*S?S%=/
M\4QN\ W9]U/\Z(R:4$-Q3<F87C35#X@^#<>HG'F2-$S8]=W-4O _P[\.Z]X8
MMM0O8I'FDSNP_%1VZ&7X!*,?= (_ UA>$?!>O>)/#\=Q::RUM9DD"(,1@_A3
M6D6D[:B>LDVKZ'N.C:/9Z%IL=A8(4MX\[5)SUKR[XS6$EM>Z5KL"',3;'8#W
MR,_@*])\,Z1+H7A^UTZ:X-Q)"#F0DY.23W^M5/'.EC5_"&H6Q7<WE[E'N*QA
M+EG<UG&\+'G/Q)U0>(-%\,):MD7^6 ]"-O7\Z;X0O7LO!GBOP_=MMGM(9'56
MX)!7M^5<CX=O)-3U7PYID@):UN6 'H"1Q^E=-\4[:70O%1U&V0B/4+5H7/8D
M@AOTQ71RI6IF%V_?-OX46GVCX?ZI'C/GB1?S3%<5X.UCQ)I,]]IOA^T^T/YA
M#C;G9@XKTGX-Q[?!"M_>E-<3X?U>T\'?$W5Q?R&*V9FR<9Y)W4D[RFMQM646
M>C^$/^$INM/OU\40Q@R#$(4]L<C%>2>%/"-IKOC*^T?4)I8?)+L!&<9P>E>K
M:;\4-$U;68=.LUGD:5MHDVG:/K7&>(M#\1:+\2+C4O#EBT[3#S-S#Y,MU%3!
MR3:>ERII-)K6QZ9X:\(Z7X5AECT]7'G8\PNV<UY3I][#X,^+][]K?R;.8MN;
ML 1Q^M=+H6G_ !%N]<L[O5KM(;..0-+!D89>XKHO$?P\T;Q/JL=_?>:'1-I$
M9 W?6I346^9WN4TY)<JM8\W\:ZM;^.?&&EVF@1M<- Z[Y , X;)_"O<8$,5O
M'&3DJH4_@*RM$\+:-X>4_P!FV4<3L,-)U9JV:SG--)+9%PBU=OJ%%%%9EA11
M10 4444 %%%% !1110 4444 %>??&3_D1A_U]Q_R:O0:\Y^-1QX(A][Z,?\
MCKU=/XT14^%GA=O]R?\ ZY'^8JE-TJY!]V?_ *Y'^8JE+7><)6-%!ZT4AA2@
M44X ]A0 HIXI K=E;\J>(I#TC<_\!- AP-/6D$,W_/*3_ODU(L$Y'^HE_P"^
M#3N HIX'- MYP,^1+]=AJ18)3_#C_>('\Z=Q6&@4M2_9IL=$Q_UT7_&@V[@
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M'JDW_H)KBP/G ]Z[3X8?\E&M/]V;_P! :E+8FI\+/H.BBBL#SPHHHH ****
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MYI7O<KE5K%*UTC3K)5%M8VT6WH4B /YU=HHJ;C"BBB@ HHHH **** "BBB@
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M>G/UQ6+Y<1/-R?Q0FD*P XS(WN !2Y7W#F78Z)?^$:AF<-M>,G"X+$CU//\
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MKC)ZTUS=W4\;SY8K@ DC@4-;3_:&D5<?.2#N'K3*.D?PC#!:+//<2C9YIF
M^55W[2/KM_6N9@^\W^XW\JUKG7=5O$N$GNX,3JJ2  #(&<?S-9T,(!8F:$94
MC[U)7ZBBI6]XVHO#L!M5F>\(W1%\# VG<!S[<YI7T;385F+7+';"63,B\OC[
MO'IQ^?M6'L7H;D^G0D4&.$#/FL_L%Q_.BS#E?<W$M]#CMD,DB&4D'EVZ8YS[
M_P!:;>W&A?9)DM8/WS)A&V]&S_45B#[.!]V4GTR*421?\^X_[[-%A\I'6EIF
MJI80R(]OYIWB2,[L;7 QD^H]JS<T!2Q^4$_053*:3W$W%I=S')+9)]\UV?PQ
M('Q&M/I-_P"@&N0%O*2#MP!W/%=7\,V'_"P[$YR#YN/^^32>Q$_A9]#T445@
M< 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR#:2B;E_ C@UYN,BVXV1]#DU2$5-2:6QB^8GDJ-PZ"JC,I/45UA\%^(F3/\
M9,_/JM57\"^(\$G1YSCT6N3V<GKRL]A8BFM.>/\ 7S.=R/4?G2@CU'YULMX.
M\0+UT.\^OD&HF\,:Q']_1[M?K :7(^S*]O#^9?>9GRGK@_6G )Z+5XZ%J*_>
MTRX'_;$T?V/?#KI\_P#WZ-'*_,?M(OJOO*>U?1:>-OM5O^Q[_P#Z!T__ 'Y-
M._LF_'_,.G'_ &R-+E?F'M(]T50RC^(4X2I_?%6ETK43]W3[C\(C4R:)K#\)
MIEV?I$:.3R8>U7\R_KYE$2I_>%.\Y>V3]!6K%X3\12_=TB['NT9%7(O /B:?
MIIY7_?D5?YFFJ4GM%D2Q--;U%_7S.>\X?W7_ "I1,3_ ?SKKH_ACXA?&\6\?
MUDSC\JOP_"?43_K]1ME_W%8_TJE0J/[)E+'X=;U/N.#\UNR@?4TN]SW45Z;#
M\);<#,^JRL?1(@/ZUH6_PNT2/!EFNY2/]L ?RK186IV1A+-<,OM-_+_ACR3D
M]7_(4Y8?-.%#N?0<U[;;>!/#MKR-/61O61B:V;;3+&S %O9P18Z%(P#^=:+!
MSZLYYYQ2^S!OU?\ PYX=8^$]9O\ !M]-EVG^)QM'YFMJ/X::\WW_ +-&/>3/
M\J]AHK58.'5MG)+.*[^!)'%^#_!=UX=U"6[N;J*0O%L"1@\<^]=I1171"$8+
MEB>=6K3K3YY[GE^I'_BHM7_Z^1_Z M4(KB&*:Z620*3+D ^FU:Z#5="U'^V[
MZ=+5Y(YY Z,G/&T#\.E0C1=3*?\ 'G+]"M?+UZ53V\_=;NW^8ULCGY;F MQ*
MI_&FB2/^^OYUL2>'=2D?_D'R'GNE0-X;OP>=+D/TBS6+H36\7]P7,_S$_OK^
M=.W1G@LI!]2*LG0KA/O::P^L/_UJ:-+8?\N7_D+_ .M2]E)?9?W#N5PEM_=A
M_(4\);]EA_(5*+$#K9C_ +]?_6J0:><9%ED?]<O_ *U+DEV8$2B$?\\Q^52"
M:%>LB#\:>+!A_P N7_D+_P"M2BW8'BV(Q_TSI>S;Z,!GVVV'6=:>+VW[3+4J
MV]QD;8)/P4U833=1E^Y:3GWVFG[&3^P_Z^07\RG]M@QPY;_=!-*+Q3_RRG_[
M]FM!=%U5VV_9)!]>!5@>%]5(R8T'MO%:+"57M3?]?(5_,Q_M;$X6WD/^]\O\
MZ=]IF[6_YN*WHO"-\_,DT4?MDDU9B\''/[Z\_P"^%K6.7XA[0_'_ ((<R[G,
MB2Y(Z0#\33@)R.9U!]HZZR/PA;*V9+F5U]  *N1^&M-C?<8W?V9N*VCE6(?9
M"YT<1]G#+AIY3GK\V*FATHS.!%:LYZC@G^==]%IME!GR[:,9ZY7/\ZL@!1@
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MWN?^^33NB7&79E,1,?X3^53+;2'I&?RJ;[+J'>"Y_P"^32_V??O_ ,NMP?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
4* "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>image4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $=!2,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BH+V[CL+*:[F.(XD+M^
M%>:3_$/6'F9H4MXHR?E0IN('UK"MB(4OB.O#8*KB+N&R/4J*\H_X6!KG]ZW_
M ._7_P!>C_A8&N?WK?\ []?_ %ZQ^OTO,ZO['Q'E]YZO17E'_"P-<_O6_P#W
MZ_\ KT?\+ UW^];_ /?K_P"O1]?I>8?V/B/+[SU>BO*/^%@:[_>M_P#OU_\
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M?\+L\8?\]+'_ ,!__KT?\+L\8?\ /2Q_\!O_ *]/V,@YD?2=%?-G_"[/&/\
MSTL?_ ;_ .O1_P +L\8_\]+'_P !O_KT>QD',CZ3HKYK_P"%V>,?^>EC_P"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP_0UX6J%_E4X/J*\O,%[T3Z')7[DUZ#1-<@Y"I_WS_\ 6I3<W)P"(\GL$_\
MK5(-/E;_ );O@]P:D_LB7K]J8Y]Z\ZS/:;B5O-N!R0@'KM_^M2>;<>B?]\__
M %JN?V-,#\URV/8T\:*[=+LCZFGRR%SQ*'GRDX78<=?D/^%.$USGH@_X#_\
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M[NLX#*3W&S_ZU:/_  C[G[MT]+_PCK][MOPHN@Y9&69KH]0G_?'_ -:D,T_
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MC_ZU(9[C@#RRWIY?_P!:M?\ X1B8\K=.1[FC_A&)#TNWS0*S,E;F]7E1&/\
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M&X8SCC(S7TCJR>9HU\G]ZWD'_CIKYO1&D^56*DCJ*SF>KE[]V0T37*G(6/\
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MGO04HDDUS(3@,:I7#?O%SUQ4ZC<<U#<+B53_ +- UN>W_#%-G@FW/]^61O\
MQ[']*["N8^'J;/ ^F^ZLWYL:Z>M5L?/UW>K+U84444S(**** "BBB@ HHHH
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M_P!V.1O_ !TUSL[A4;Z&NL^$$>_QEO\ ^>=JY_4#^M 1^)'O-%%%([0HHHH
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ML9_@SU%)HTIUN9VL9T8^6JMP3YP^E6UX2J5PVZ88[+0:+<^@O!">7X*TI?\
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MHY"76[:'33'3]2TN:V?5;:V8:A+,"^3N4]#Q573[^RT32M1 -O>RR3K&L3'
M>-?XN.V:PQ=;2#Y2\+C%,6Z*LI:*-]H PP]L4^32PG6UNMSJI]2L)-8OKQ;J
M%1=Z:01NZ2$ ;?KQ42:[;7GANRBGF1+R"ZA$FXX+(IX;\JY:.Y\I=OE(V&W
MM_*G"[PP/DQG#$X(XYS_ (_H*.1#6(?W_J=->WFF:=?:EJ=M?)=W=WO6&.,'
M$8;J2?6N4A&#4LDWF1[?*1?FR"HY[\?K38Q32LB)SYV1SG)(]%-=M\'H]WB2
M\D_N6N/S8?X5PLQ^=_\ =->B?!E,ZCJDGI"B_J:F?P,UH*]:)Z_1117(>T%%
M%% '%?%F/S/AKJO^P(V_\?6O _#9Q;3_ /71:^A_B3'YOPYUQ?2VW?D0?Z5\
MZ^'FQ:W'LRFNFC\)G/<Z*Z&Z,5?T&.2[T#5]+L)EAU*=D=,OL,J#J@-4G^:!
M3[5E72XY'!J[71)M>+;66QU#PM!<+LEAM8D<9S@A^>:T?$>MQZ1<ZDT<R?;H
M-<2Y6 GYF01@9^AZ5Y],SL<L[$CH2>E7M4\0R:K+;W%S96YO(D"/<#.9@!@;
MEZ9]Z.38+G2F;PY';>(=2L=7C5M2LG1+&52KH[')&>A&>E5=1U^(^*O#[V^J
M$64,%LLY24A%*_>#"N3-^,C_ $:' 8MMQQSGC]?T%1&['FP2>1&#$,$ ??\
MK1R!<[J\DT?6]*U.R?7K*S+ZQ)=1M+E@Z$8!&/6L[1]2TOPQI&NXDM-3FEF2
MWBA=B!-$.2V!VR?TKEA?!&4^1'\H(QVZY_\ K5&E\8W1F@BDV  !AQP"/Z_H
M*?)I87,=_-KFDW'B>;5?MMO$+W1'21-_W)BN-GUZ54A\46>H> +6RNKB--1M
MKJW1@YP9(D<$-GO@?RKAX;P0(5\B-_G#@MVP>GTIXU#YPWV:$X<M@KQSGM^/
MZ"CD0[G>:GJ6@Z3KFK>(;358M0O[L.EK!"IVQ;A@LS5Y] /FJ66Z\Z(Q^1$F
M7W!E&".O'TY_2DA&*$K(=[C+@Y)'^R?Y5WOP&BW^.+B3_GG9-^K**\_G/S-[
M*:]._9]C!\1:M)_=M%7\W_\ K5,_A974^@:***Y"PHHHH Y?XB)O\":G_LJK
M?DPKQC03B&;_ 'EKV_QPGF>"=77_ *=R?RYKP[1&Q!/]5-,YZOQ&[<#,=6M)
M1[C2=1L+258[Z8JR9;:9%'50:K-\T(-9]PO&101>QI>(8)+6]T&*9=LD<$:N
M,YP0W/-7-9U1-.GNV21/M46JK.(B>2NP#\JX^0L3RS$CIDU:O]8?4)(9I[:$
MW,:[7E&?W@ P-PZ9]Z0<VYMF318[;6;RTU% ;VW95M9%(=&)R1[U#=ZO'_PD
MFDO%?_Z+''")2LA" C[V:YXW8R/W$> Q.,<=_P#']*C^T_O(G\I/W8Q@#[WU
MH%SG4W#:=JFFW5L^K6ULQU&2=2^3N4\#I533K^QT/2M3PUO?2R3K$D3$@21C
MG=QVS6 +K:0?*3@8QVIBW15E+11OM  ##VQ_6@.?6YUL^IZ?+K5[?"ZA47>E
ME2N[I*0!M^O%11Z_;7OAFQAGG1+R"ZA$FXX+(IX;\!7*17/E)M\I&^?<"W\J
M<+S# ^1$<,3@CCG/^/Z"F'.SJ;Z]TK3;[4]3MK]+R\O Z0QQJ=L0;J6/K7(1
M#FI9)_-CV>5&OS;LJ.>_'TYIL8Q0)N[(+@Y8CT4UWWP7CSXBOY,?=M,?FP_P
MKSV8Y=_937I?P33-[JTGI%&OZF@=/XT>QT444CL"BBB@ KYM\1)Y7Q%U%/2^
M;]3FOI*OG7QDGE?$O4/>Y5OS KLP?Q/T-J.[+\7*,/<U'9O#;ZO:S7 S#',K
M/QVS3K<Y:1?<U!.O6NO?0T.AO-/OHK3Q+>W,@G@N8 89E<,&7=GCTP*H^'KB
M&TT/2;B>58X8M3<N['A?W9KEYRPRH9@OIGBI+35WL[&YL9+>.YM)R&,<A(VL
M.C CH:GV3Y;?UV%RZ&HESIFLZ>EA?7RV=Q9SN;>=E+(\;-DJ<=*N:MK%H1XC
M>UOTWW!M_(:-\%]H&[%<D+P(J#R(SL&,XY/U_P ]Z8;H&,H8(^4VYQS]?KT_
M*J]EK_7>Y7(==I&LVJP^'6N]03S()IVG,CY* @[<UD_V9I=KK%C*=;M+F%[K
M=+LR!&H.<G/Y5B_:<1*GE+PA7=WY-->\).1$@& ",=<'--4FFVF'+;8ZW5_$
M5CK>DZY;-';VT@E66!PYS<$'&?KM%6(?$]C:>,(V:YCDT^>TACE<'*HZC@_@
M?YUPQN1OA80QCRQC _B^OO3OMW*_Z/%A2QX'/)]:7L(VMT_K_(/9JQU<ATG5
M-(FM;G6;>U"ZG-.?XF9#TV@>M8'B#4X=4U-6M49+2")8( W7:O<_6JB7N!&/
MLT!V<'Y?O?6H ,MG'4U4*?*[C4;,=(=L-4'7,RCU J[<G$55HE\S48$_O,@_
M45JBD?65C'Y6GVT?]R)5_("K%(!@ #M2UX)PA1110 5X+XF79X]OQ_T]9_/!
MKWJO#/&B^7\0+SWD1O\ QT5$]CNP'QM>1;BY5A[U#$8XK^"689C21688[9J2
M$_/(/>HIEZTCM\C:N;.Z UR]ED$UO/;GR9 ^01G(&.V!6?HDT=OH]G-*X2./
M4@78]%&RL*;<"0&('IFGVNI/:6\]JT*3V\^"T;Y&".A!'0T7U)]B^2V_]6-#
M[18:G:O8W=V+:2"X=[><C<K*QR0:MW^IVN[6FM[Q-TL,*PLC8+$=<5S0N=H4
M>2GR]^YIGV@;"ODQ\KMSC]?KTI7-/8*_]=[_ *'1Z;JD"VVC&YO%\R&ZD>7>
M^2JD'!-9TUA81:A;R_VM;3QR7.9 H(V+G.3FLH3XC5?+7@$9[\TC7)XQ&@X
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M0=#OXP1YCDIN&#@KGFO0/!G@/2O"&FQI# DE\5'G7++EF/?![#VKA_C_ /\
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M2(O@!_R,&K?]>H_]"%8OQI.H#QUY=[(CQ+"#;%5QA#U!]\UM? #_ )&#5O\
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M)&Z*HR:!-%!A6WX?U V-CJ3R*7A14?8H7.XM@$9![9IIT:WDE:RAO?,U$#A
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M$O2- PP!6G/I>I3^9%;V<UM9RN'VR'"+CH68^E-TZ^CM-:M;#37_ '(8F>X
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MCC)#ON&%(Z@GM3C<P!XT,J;I03&N[E@/3UZUYSJ^E/)XIOO"X1A8ZTZ7SD=
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MD"@_E3Y(HY5VR1JZYSAAD9I]% #7C25"DB*ZGJ&&10\<<J[9$5UZX89%.HH
M*@N;*TO HNK6&<+]WS8PV/SJ>B@!%540(BA5 P !@"H!868N?M(M(!<?\]?+
M&[\^M6** &R1QS1M'*BNC#!5AD'\*CM[2VM$*6UO%"I.2L:!0?RJ:B@!K1HY
M4NBL5.5)&<'VH=$D0HZ*RGJ&&13J* &M'&SJ[(I=?NL1R/I045F5BH++T)'(
MIU% !4%S8VEYM^U6L$^W[OFQAL?3-3T4 ,\N/RO*V+Y>-NS'&/3%!AB.S,:'
MRSE/E'R_3TI]% $<\$-S$8IX8Y8SU610P/X&B"WAMHA%;PQQ1CHD:A0/P%24
M4 -,:%PY12X& V.0*%C1-VQ%7<<G QDTZB@!H1%9F"J&;J0.30D:1 B-%0$Y
M(48R?6G44 %%%% !1110 4444 %97B5/,\-:BH_YX,:U:HZRN_1+Y?6!_P"1
MJ*BO!HTHNU2+\T>/6Z[M.D/HXJU8/SBJMHQ_L^;T!!J6P61Y/W<;OCKM7.*\
M&.ZL?8SVE<W1TJS]E0V)DVDOM+[MV,8..G>JT*O)\JHS,.H J9H[L1&,)-L)
MR5P<5U1\T>?/=).P3Z>B26896Q(0LG/4XSQ_GM6/=01-'=NB8\HH%VL2.3SU
MJY.M\&+!)]V[=G:>OK5&5M3$CN!=;G&&.T\BIFXO[/\ 5C2DIK5S7W^=_P#@
M$8LX !(\;R 6RRE%;!8EL51AMHI-6:WD5A&"_P KG!& 3SBI-FHQN'2.Y5E7
M:I"G@>E9\WVBWEW.)(Y#GE@03GK6$I)6?+L=<(R?,E/=::EJWM;>=D8+A6NQ
M%A7)&W'8_P!:O"PMDNV5H]H6 R&-I.%.<#YA[5BVZW3*/(68JK;OD!(#>OUJ
MW"NHQN&1+E64;00IX'I54Y1MK$SK0G=VG^)!(1EB!@9X&>E95RV6Q6Q/;W6U
MG>";N22AK&DBFDS(L3F,=6"G'YUE)/L=-.4;;DMD@ D8_P!VO6/AF/\ B273
M_P!ZXQ^2BO)[9L1N/:O7OALFWPNS?WKAS^@%=&!7[Y>APYL_]F?JCL****]L
M^4"BBB@ KQKXIQX\86C_ -^V3]&:O9:\B^+:[=>TR3U@(_)O_KUK2^(Y,:OW
M1Q]X/+U%B.YS77V-K;OHJ2^6_G&!I?,W<</C&*X[4F(O#GT!K=L9;^*Q6&;[
M0EL?NJX(4]ZWEL>=3:4G='21:1'/>7405RB1J$P>CL,C/MUJ*ST>VN;:VEE<
MJ3O\Q=W)[+C\:K*M_(H=4N&!(<,%/)'0U7EAU$%66&ZW)DJ0C<9ZXJ+/N=%X
M[\I7N=/M_P"QC-LD\X0>?YF[Y?O[=N*;?^'K*&[M A=HI[Q83\_(&WYE^N>_
MO52YAU4VYMA#>>1G/E[&VY^E9\L>M%PWE7Q82>8#L;A^F[ZU5GW,7*/6/8K:
MU;00&UEMXGB2>(N8V;=M(8KU]#BM*[T#3AJEC#'$^R2=HI )2<X0,,DCY3SV
MR,5D7MOJ]U*9KFWO97QR[QL3BJ,VIW\\L;R7D[O%Q&2Y)7MQ56;6C,N:*;O'
ML;ZZ38PW=YYD./)MHY3"\YPCL1E=P!S[?6FPZ4K>''U QOY@?>.?E\L$ CZY
M/Z5GVRZ[;R>9%'?H^P)N",#M'0?2I4M]5VX,%YC84QL;[I.2/IFIU[FJ:?V>
MY<O+"QEO&ABC^SJ+'S]SRD@,5!&>.@S7,ZS:QVNK36\/^K3;CG/50?ZU<O\
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M'N*]/>TB?JHJ!M,@;^ 4 ?/\WP\3R4B2ZG"H,#* GK5:/X?R0.&6\<X]8O\
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M.<>J5[@VC0'^ 5&="MS_  "@CV<>QY-#:2PJ 58X]J9<VLLRD*"/J*]8/AZ
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' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>image6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image6.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #@ 2L# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>M93H2CJM3>&(A+1Z&-FDS0P*L58$$'!![4F:Q-R])/%&R_9[VZP"&SY8!R
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M7R-\BL?E(/0>_P#^KZ<X6).2:Y:U>WNQ.RAA[KFF:MQKUS<V\D,D4!1Q@X#
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3 "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>imc_img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 imc_img01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" HK!S$# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445%<7<%G'YE
MQ/';Q]-TC[: ):FL_P#CYA/^T*X#Q+XX&H-_8_AT_;+Z?Y&GB'R1@]3GUQ3-
M.\*^)_"<EM)IFI?VA'D>;9S],]RI/7\_2FXZ&L8ZJY[)17%_\)1XD_Z%MOS_
M /KT5ARG;8N4445L>:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %!Z48[TOW06/ ')+=* ,7Q5XGM_"NF&ZF :5CMBBSR[?X5Y<=2
MT_4Y/M_B"YFU6_D.(M-M<A(P>@)'_P"NM6YLV^)OC291(RZ19C9O'L>@]R<_
MA7HFF^&],T4 65E%"P_BVY<^^X\UII%&EU%'"Z+H?BB2-I-,@M/#MLW*1;0T
MC>F2036YX"U[6M0\37>GZHT;-8J%?R@ &8GJ?PKL%^]RP'>N#\!W'VC6O%FJ
M#_5-*0K>N-W^ _.D]2XRNSN/^$\LO]O]**\E^V_[5%9<ITV9Z[1115'GA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT4G-%<IU',T445N>>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#_%UP;Q]$US]QJT'RH[<"9?\?YTY1+Y3L:*-N.O\Z*@@**&98U+NZHHY+,<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ9T)6/DK<R\X^2(_U%4+KQUX?\23166IZ9/%;2'"W%TN I]CVS6C9_$#PHS
M+-':G_II;[,?I5G5M6\+>(]/:UN]0LY8&&5.\ H?4'UIAIV,+4/A2JJ9=&U
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:+%%&".HQ12)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%VNIZKG^%A5R1HXX9&F*B(*=Y?[N,<YKSZZ\.O8RMKO@VZ24$YFLHVRDF.H
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MS1_^/Z]AMF/17;G\J=IFL6&M1F2PNXKE1U\MLXHL%B[4UG_Q]1?[PJ&IK/\
MX^HO]X5+''='14445F=YR]%%%:GGA1110 4444 %%%% !1110 4444 %%%%
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M?S:]_P )7801K&NBN27DC7YL@'AO3\*Z-N6)[4[!82ER:2BD DB[HV&\J2I
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.Q2.*(94MZ9KD=47Q)JFGRWVM7W]@Z6N"8K==TG)QCCGI5*_<I-OJ3KH6O\
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ME23+##9&1VS2W5V.]U=GHPSM!]1FBE8[CGGIT_K25DS%A1110 4444 %%%%
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M&3BK-7.R&+E'1JY^"6X*VULJW]TCG\JU-%\+:YXDF6#2-&U#4IF.%2VM'?\
M4#^M?N!)X&\,22"1O#>C,ZY 8Z="6&>O\-:EA96NEQB.QM;>S3.=MO"L8_\
M'0*U>-[(U>,MLC\QO@[_ ,$Z_'GC::"[\7NO@O1C@M')B2\D4\X5.B]>K5^A
M?PG^#?A/X)^&ET7PIIB64)P9[A_FGN7'\4C]\_D.U=ISDDG)HKBJ5YU-SDJ5
MIU-&%%%%8'.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSI]"K9'X5D\$_LLSE@_Y6?M[17YK_#;_ (*7>-O#[1VWC#1K+Q19C"M=6_\
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M-]CJ\.>_<IUKZ,W'@'UKQYPE!VD>3.#@^5A1114$!111^M !7FOQL_:&\%_
M31Q=^)]0!O9%S:Z1;$-<S_[J]AG^(UY1^UG^VGIOP16X\,^%_)U?QPZ8D;.Z
M#3LCAG]7[A?SK\Q_%'BG6?&VO76M:_J4^K:K=,6FNKA]S'/8=@!Z#BN^AA74
MUEHCNHX=SUEL>V_'?]M;Q]\:)KBRMKM_"OAEB0FF:=(5>5>WFR#ECCL,"OGU
M?EZ=>21ZTM%>M&G&FK11ZL8QBK104445904444 %%%% !1110 5<T;6M0\-Z
MG%J6DWUQINH0D&.YM93'(ISGJ*IT4-)Z,&C[B_9__P""CE_I36^B_%*)M2LF
M(C3Q!:(!-$.F94'WQ[CG%???AOQ'I7C+1+76=$U"WU73+E=T5W:N&1AZ9[?0
M\U^$5>K? ']I/Q;^SWKRSZ/.UYHLSYO-%N'/D7 ]5_N.!T(KSJV%C+6&C.&K
MA5+6.C/V7^E%<'\%_C7X8^.W@^'7_#=UNVX2ZL9"/.M)".4<>GH>AKO*\J2<
M79GDN+B[,****D04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %4M<UBVT#39KV[8K#& <#JQ/115WGM^M
M<#XVF3Q)XJT?P_ QECC?SKO;T !X!_#/YU25QQ6I4FLO$?Q$FM+R1(-,L(9/
M-MUD'[P\\&O2OX0<C![@]^] 55^5%V(!@(.P Z5B^*O$ECX=TQGO"Q:8&-(8
M^'?/''I1?FT0[\VB.8U#4]4\9>)I;#0[U[&RL5(DNE^Z[Y__ %U8_L/QQ;#]
MUK]M<@?PR)BF?"S2=4TRWN3<6PMM.N&WQ1R_Z[VS[?6MB/QI%-XP_L&.TEWK
MD-<,0%.%SP.]5Y%[;(L>&9-?9;B/74@#+@PO ?O>N:VZ4FDJ'J9MW"BBBD(*
M*** "BBB@ HHHH ***.>U !17/2>-+2S\1'1[V%[.4_-'.[#RW4C@Y]?\*VX
M=0M+B01Q7<,DAZ*D@.:JQ5F34HZT%<=_PI*DDAM=/M;,RFVMXH&F.^1HTP7/
MO5?5]=T[0HC)?W<=L,<!C\Q_"EUR.X?1[P6LK07(B8I(N."!7!>"/#VDZCHA
M\1:TSWLZES(UTQ9$V^WK5)=64EW-RS^*F@W$K(TTUL@&5DFCPK_2N?O_ ! G
MBK7K+5F@DM-!TDEVGEXWMV 'KGM1\0/$6GWWAJRN-)MX3"TQA$S0#Y !G"US
M6HZMK6O>%8C*BQZ58LJNZ@*)6)XZ=ZT26YM&*W1W&J?%""[\,W=QIBR1W9E%
MO&DHY!;HPK:\$^%8_#.FAF_>:A<#?<7!///.W\*YCQ5X9M=)\!VESID'%O+'
M=R'.2V0,\^U>@:9?1ZIIEK=1D^7-&KC\N14/38B7PZ%/5O#>CZI,M[J5I'*\
M*Y,TA(V@<BO+=>D3Q'K6LWNFM]GTUHA%+<2?*DKCH![G%;/Q0\17-]=2Z'IZ
M2LL0#71B&<^Q]A6AX1LXO&'@N71[JS&FI"ZI^Z."S#D-@]ZM7BKCC=*YS/P]
M\4:AH5K>)#IESJ=FS [8>?*;O].*[)OBEI1TJYG/F6][""HLYAARYZ >M<-:
M7;>&;7Q+]AG:.+<MG"C-ARY/WZZ7P7]BUG4I+37K"(Z_:H&660?-*F,@D="1
M3:6XY);D_@WP#97VE+J.N68NK^[<S$2$_*IZ5U=OX6T6U'[K2[9?JF?YUID?
M@>]%9.1DY,;'$D*!(D6-!_"BA1^5.HHJ20HHHH **** "BBB@ HHHH *Y'XC
M:/=ZA9V5_8Q">ZL)A+Y8&&9<\@>PKKJ <'-4F-.QY1X6\86EOXYU&YNHVLX]
M1P!Y_'EN.Q]JC\876JW&M!/$:7,>A[LHMB-R.O8Y[_C7JEQI]I>?Z^T@FSQ\
M\8J588UA6((IB VA",CCZU7,B^;R."L_B)H6CV26FAZ=<W#=%@6$I\WJ35SP
M7HFJ'7;WQ!JL:6DUTH46J]0.V:["&W@A8F."-#W9% )I[,6;)I<Q+DK:'*:;
MX#6P\97&N&Y$XDW,L97!5FZG/M5?Q3X!E\2>)+74A>""&,*&3!W#:>WUKLZ*
M5V',[D5_9Q:E:S6L^XPRJ4?:=I(^M<1X!74--U2]TU=*%CI49:023*=[<X'S
M=Z[SC&<X'?)P!237$5O"9II42!>2\C #\Z$'0AN;^UM9(HY[B.*20XCC<\D^
MU3_SZUXEHL<WC7X@+-)*6VR-/G.=J*> /TKVYNIXP2>:)*R"4;6$HHHJ23GO
M%FNZGIL/DZ3I<UY=,.)@F43_ !-<GX#T/Q#_ ,)4^JZG'-&A1ED><\OGHH':
MO30Q'\1%+DECWJDRKVZ"=AFBBCKQ4DE35M3BT>S:YG_U8=4_$D#^M7/XOTKB
M/BX+IO"Z>2K.@G4R,HS@ '!_/^5:MCK4VH> TU"T4S77V4[0O)+@8_G5VTN7
MRW.B]OTKE/$_C*ZT_5(](TBQ^W:HZ;^?NHOO1\.]8U/6=#EEU7<9HY=@9DVL
M1@=1]<TGBKPE=7^HIK&CW1M-6C3&W.%E4=C[TEH]1+>S.6O->U/34ET]_#L=
MEK=VWEQ7=NN0V?O'/K69H?B&X\'6.KV8F\YUN8T1P>-P.7/Y?SKKK7XF&Q:.
M#Q%I5Q97"'#31QY0'ID>E<CXD\"3K'<:CI]PMUHS1M=I(/4D94^_^%:HU7F>
MS*P>-7!^\ 1^-+67X5U!=4\-Z=<J=VZ%0?J!@UJ5BUJ8M:F1XLTR[UC19;>Q
MN&M+AF#+)N(Z'D&F^$-&N]!T1+6]G%S<;V9I 21R?4]:V:*+A?H%%%%(0444
M4 %%%% !4-[>1:=9S74[^7#"N]F]A4U8_C"*"X\+ZDEW.+:$Q',OIZ?K3 Y+
MXA>++'5/!\26ETP:\D4B(@J[1@\[AV&:C^&^EPZEK=QK4-I]EL($\BU3'4X
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M@ HHHH **** "BBB@ HHHH **** $4 9XI:** "BBB@ HHHH **** "BBB@
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MKU>*U;0\5JVC"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ!;*?E^A;[Q^M>8TF-HQVI:[8Q4(J*.N*44D@HHHJAA1110 4444 %%%'J:
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M'C(V_A/4M(C3R1-+F%E&,(6.X?R_.NI^%-B_]J7U];PR6^F&!8EW_P ;#O\
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MQ[T5GS2.TYBBBBM#SPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX>L;J6^'DO<E2L&<D8[G\Z[8\\CI42;(D^EPZ\]3ZU+9_P#'U%_O"H:FL_\
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ML%%%%2(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCCSK.7'*./3T/>O%Q-%PES+9GD8BERRYELSO:**,'TKA.$***.: "E52> *
M#D8'/TKY$_;<_:XM/ASHE]X%\(7JS^+[Z+R;JZ@<'^S8F'()'_+1AP!V&:TI
MP=1V1I3@ZCLCY9_;N^-$7Q9^,\]AILXGT+PXK6%NZ'*RRYS+(/\ @7'X5\XT
M;MW))8DY.[DD]>OK2U]#"/(E$]Z$>5)!1115EA1110 4+"UPRQ(,O*0B^Y/
MHKT7]G?P6WQ"^./@K0@N^*?48Y9>,@1QGS&/T^7'XU$I<L2).T3]B/AWH?\
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M>:6ZN)9YY9)YY7+R2R,6=V/4L3U)-,I:[:=-4U[J.R%.-->Z%%%%:F@4444
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M8[;4-37PK.U]8QIF[L)0?*=.X4G_ /6*TC8N*3W/5;*^@U*UAN8)5EBF3>C
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M &L)TCA5<R)N&Y2.JX^O'XUQTFIZUXMMY-1EU)/#>@Y*QN>&D'K[UOW?PO\
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M10 4444 <!\<_@WIWQX\ R^$]4U&YTRUDGCN#<6B@ON0Y YXKYP_X==^"O\
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MT Q_6DT'P>_BNX@F6P71M!B8,GR_O9R#U)]ZT-MCTK4-4L/#]GYMY+%9VXX
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MS/=Z*YSXD>.]/^&/@/7/%6J'_0M*MFN'0'!D(Z(/]HG 'UKYI^%'_!13P_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5D^+K%]2\,ZE;Q_ZUH3M]\<XK6I5XY_#V
MH \LDM?[:^'^EZI8?+J.C_*548("GD?R/YUW_AWQ!;>)-+@NX77S)%!DCW#*
ML.HQZ5RFI>'=6\):I<:EX?C6ZL;C+7&G-WSUP.]8EG9^&O$%TYL[JY\-ZMNS
MY,C$*&[8_P BM7JC:W,>G:S8C4=(O;5ER9(63;^'%<Y\+M0\[P>D<C?\>K/&
MQ/8#G^M<Q>^(/$FE74WAO[1%J-U.JQPW"$!DSZGZ9KJET%/"7@'4+>([I_LT
MDLLF?O/MY/\ GTHM9"M9%+X4[I++5[E01#+>,8QZ^O\ .K7Q*TDWNA#486"7
MFGMYL<G0X[C^OX5AZ5XRMO!OA#0H1;FXDN%:9E7@JFX@GZ_X5U]]:V'C[P^!
M%=2"TF*OOA(W?[K4M;B=U(M^'=6&N:'9W^W!FC^8>C#@_K_.M"O/?!MO=:/X
MTO=%_M&:ZL;2WR%DZ9.,<=NM>AX/I4R6I,E9B4445))!?7T.EVLUU<N$AA0N
MS?2O%K>.YUZZBAYC?6[OS7(Z^2#Q^'_Q->L>+M$D\1>';NPA=8YI K+GH2#D
M"N1\"Z5J-QXHDNM4M/LS6%LMO$JC"^F1V/<UI'17-(VLV=EK7AJSU;P^VD_Z
MJWVJ$V#[F.C?7-<S'\/]<CA55\4W$>P;8U4$( .G>NZ^]T&37&>*_'TVG:LF
MEZ4D$]U]Z9YV"JO^S]:2NQ*Y"B>.M$8PQ_9M;B_AD;AE_E2Z=H^H66HW'BCQ
M+/'YEO"=EO!SY8]?3UJ"U^*EQ<P^2FA7$^H(=KI"<Q@^N:BU2/QCXNL9K-M.
MM],LI<;A(WS8JM>Q2NBROQ9M]OFC1K_[+_SW5>"/7I5V&W\*>/+E+Q%CFNE(
M!4MLDX[$=ZZ;3;%=-TNTLEPRPQ*F!T)QS7*>+/"?AOS$N;BY&B7DG*30OLW?
MA4Z7LA:7T.@N/%&E:?JB:9+>107+*"L;?='H,]NU8?B+P7J4NN?VUH-Z+.\D
M7;*C#Y9/?Z_X56TWX::3=:7,UQ<OJ4UV=ZWRD@KCIBFQ_"T[</K^HL%X4*0.
M/QH^8UIU-7PCX1ET&:[O]1N/MNJW1_>38P%'H*Z.6:*",O.Z11]S(P /YUY[
M<1^(OA_<1-!/-KNG2_)Y39+(W;ITKD?%<>KPW]M>^(('G2=2ZVZN52/_ &<C
MH?YT[-A:_4Z32]:M? _BS58IF":=??/#-!\Z(?H*I^'[34M6NKE_#J/90S,?
MM&KW'WY><_+Z<]AZ=:AT;PSH'C2U=--DETK4HADV\[[T;U([_E6_9^*=8\&Q
M1Z?K6E//;1#9%<6:@J5]P.,_E5[%^A93X5PR*6O]6OKF=OO-OVC\!47@[P/J
MOA_Q/)=W-Q'<6@B:%)-Y+D=N*W-!\?:/KTQ@1VM+D?\ +&Y&UC]*Z(@]QQ65
MVC/5;B4445)F%%%% !1110 =AWHHYHH **** "BBB@ I>5YX!I** %SW&,U3
MUK3(=<TVYLKA=T4R[3['L15NB@""QLTL].AM#ADCC$>5X[8_6N4\(^%[OP?X
M@U"$-Y^FWBETD'5&!SAO?FNRHIW*3"BBBD2%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444?Q8(&[Z
M\_E0 4?2BB@#FO&W@U?%>GQQ0/';7$3%U;9\K9Z@X_3\:U] TU]'T6RL9'\V
M2"((S+T+=_PJ]2<<=?QIWTL-R;5CFO'WB2;P[HI^R12/=3 HC*A81#NQKE?"
M?B[P_P"%-%+)/+>ZG.=TP5/F=_0?2O4&4-D%0P_NMR*JKI-E'-YRV4 E!X=8
MQFFFBTTD>=V<VLZGXVMM<M]"N+:!E$4BR$<ITSS[5Z?QS@\=O6C<2>2324F[
MD-W"BBBD(**** "J>LZD-'TF[O2GF>1&7VYQFKE4]8L1JFEWMHW2:)D_$CC]
M:8'$1^(O%?B^WBCTVP7287&XWC'((]JBT6WUU?B'93:U;?O%@:$7,2_(X )!
M)]>:VOA9?/=>%1!(?FLY6AQ]#D?SKK_O=>1U^E7S6TL:.5M+'!_%;1K&XTR+
M4;JY>&:W'EQ1J,^;GM^E,^&_B)[79X?U"#[#<JH> ,-OF(><'WYI?$"_\)-\
M0M,TO(:VL%\^8=1GKC_T'\ZO?$C1GN;&+5K-,7^G,)0R]2@ZC],T[Z6&GIRC
M8?AK:1^*&U0S;K??YZVI&0)/\,UI^%]/UFSDOI-7NUNFFDS"JG(5>?R[5<\.
M:_!XDTB&]@898 21CJCXY!K3Y!QT_I4MO8AM[,3I]**Y_P 27VN6>JZ6FEP1
M2VDT@2?<O*>O/;C^5=!@#@=:FQ-NH4444@,CQ1X=B\4:6;*:9H!O#AU&<$56
ML? ]O9^'9-%M965IFR\TG)9LCM^%=!4UG_Q]1?[U.^A<7JD<1_PJO4O^?B'\
MJ*]9HJ/:,[]3EZ***H\T**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** / OV\O^35?&'^_:_P#H]*\>_P""6_\ R)?CO_L(0?\ HMJ]
MB_;R_P"35?&'^_:_^CTKQ[_@EO\ \B7X[_["$'_HMJ[H_P "7J=L?X'S/MX5
M\ _\%.OBBTEUX9^'MC+GRQ_:=]&IZN?EA4_^/''TK[XNKVWTZUGN[EECM[>-
MI96<X"J!DFOQF\=^-M>^,OQVUKQ;I.F7&O7;ZB;JUM([9I_W$;8B!10?E  S
M]:6%AS2YNP8:%Y<SZ&C\3?ACKW[,/C+P%JY>5;NXL;76XY#QY<V09(L_[/ _
M&OUU\%>*[3Q]X1T7Q%8,'L]4M(KI,=MP&1^!R/PK\H?CQ\2_C!\9M%LG\<>$
M[BWL]'9YH[R'1WMA"K##;GV_=QZ^E?6G_!-#XI#Q#\-=4\&W<^^\\/W'VBW5
MCDM;2<\>RL#_ -]5M6@Y04GNC>O#GBI+='R]^U-I]]\6OVQ/$FBZ6?.NI+E+
M"W![F.($C\]U>H_\$R?B$VB^./%'@6\/EC4HOMEM&QP?/AX=0.QVDY_W:Y7]
MFMCXW_;^N]5(\X1ZIJ5X>XVIO45S_P 8+>[_ &6?VRI]<L8F%G!J UBU0<"6
M";)=!_P(L*T?OQ]EY&K2E'V?D=C^W%KU[\;/VG](^'VBOY_]EJFGQJ.@N)!O
MD)^@VUC?\$[-2;P_^TQ/I,K<76GW5J<\9:,Y'_H-=3^P#X9G^*W[1'BKXCZM
M&THL?.G5FY N+AB .?[J$X^E<%\&O^+=?M[6]HI\M%\175C\W39,S #\F%'V
M73[(6G(Z?5(_5I>N!7Y9?MW>-=4^)_[2I\)6\S/9:1)#IEE;Y^3SI-I=\=SE
M@,^U?J:O#>G-?E)^VUX;U+X7_M3WOB!(66#4)H-8L9&^[(5VAESZ@K_X]7+A
M[<YQX>W,?>7PG_9)^'/PK\+V>G'PY8:WJHB7[9J>HPB62:3'S$;ONC/  [5V
M/@GX+^#?AOXDU?6_#&BPZ+=:M$D-W#:Y6%]IW A/X3]*P/A3^TWX ^+'A>TU
M6U\2Z;IMZT2M>:=?W202V\F/F4AR,C.>1U%=3X3^+G@[QSX@U31O#^OVNKWF
MDPK-?&S;?' I. "XX)/M6$O:-OF9$_:-M,^4?^"FWQ5_LCP;H/@*UFQ/JDO]
MHWJ*>1#&?D4_[S<X]J^0?B?\&]:^!^@_#;Q2\DB3Z_9+J<?&/(F1]P3/J5VG
M\:N_M#^.]1^/?[0WB#5M'LKC5XX[C[+IUK;Q-,Q@@X!"@$D9#$_6N@^,GQ0^
M,_Q?\'6>C^+/!UQ'H^DN+B"6'17@, 1-OWMO"[>M>E3@Z<8Q[[GH4UR1BOO/
MT^^"WQ"M_BM\-/"_BJ!E;^TK6-YE4_=E'RR#_OH'\Z_(WXC>$=5\=?M >.-(
MT:U-[J#:E?3QVZ'YG"$LP'J< U]>_P#!+_XHB]T?Q#X!NILR6<@U2P1C_P L
MVP) /8-@UY%\"?\ E(7+Z_VUJ'\FK.G'V4Y^2,J:]G*?D>I?\$\?VGFNV@^%
M?BB\(FB8G0[JX;!;!RULQ/<<[?Q%>8>"Q_QL??M_Q45Q_P"@5N_MW?LWW'PR
M\51?%+P?%):Z1=7*37JVWRBPN]V1(N.BN?P!^M>6?LP^)[[QI^V%X2UW4WWZ
ME?Z@TUPX& [^7@M]3@?G51C%IU(;-&D8Q:<H]4=W_P %*HFN/VA-)A3&Z328
M(USZF0@?SK&_97^.&K?LJ_%J^\(^,(Y;3P_?3I#J-O)S]CF.-EPGM@C/J#6]
M_P %(/\ DY#0?3^SK7_T;7NW[;/[,"_%3P!8^-/#MIYGB[2+",W$$8&Z^M50
M$K[NHR0>XXH4H\D83V9*:Y8PGLSPG_@I?/'=?&_PU+!(DT4FC6[I)&<JP,N0
MP/H<U^C<.KVOAWP1;:K?.L5E8Z7'=2LW94A4G^5?B+K_ (RU;Q;!X?M]7N7N
MQI$4=C:O)RZ0B0$(2>3CG&:_1_\ ;T^*'_"$?LWZ1X>M9_*U/Q-#;6HP<$6Z
MQJTI_'@?C6-2FTX0)K4VU")\:^#_  5K?[8'QJ\;:BLDBRRV]YK!?KM5?^/>
M(Y_O8 _&O7O^"9WQ,D\/_$+7_ =_+Y4>KPFYMXF/W;N$X=<'N5R/<BO(/@#\
M1/BU\%['4+[P%X6N;JWUD(7O7TA[A9$3.-C8^[GWKCHO%GBCX<?&'3O&NIZ5
M<Z!K2:BNJM;R6K6P92^7"H0/E(ST]:ZI1YDX=+:&\H\T7'RT/N?_ (*@8_X5
M%X2/4?VT?;_EF:\D^!?QX^"G@W]F"7PQXTT^#5O%#?:]UG_9V^5]Y_=XE(X^
MN>*]-_X*1:]:>*/@+X#UFP=9+'4-22ZA9>FUX=P_G7*_LH_L]_!3XA? C3M<
M\;_8XM<FFN5N)I=7^S.D:MA3LWCM[5SQM[)<W<RI^[37-W.;_P""9'A2\OOB
MIXE\20M'!IMCI[6KP^:"[/(V5&,Y(4#.[&*XC]MS_D\34?\ KZT[_P!"2J'[
M,4Q\*_MDZ+I_@[4)K_2/[5GLDF4_\?-GSDN.XQ@\^F:O_MN ?\-AZD <C[3I
M_/\ P)*VM^]OY%V]]^:/7_\ @J9I>I2-\/M1"2'1TAFMS(/N).0"-WN1GFH/
MV>_VC/V?(/AEHW@_QGX4L](O88A'=W5YIPG@N7_YZM(,MSWR.*^M?CA\0OAU
MX7L]%\/_ !+%L-'\1%H(GU"'S+8.B _.>=N>S5\C_M'?LI?!+0?AGK/B_P '
M^+K?3;RUB,]KI\>I1W<-RQ(Q&JY+ G/&.E84Y*45"2:,:<E)*+31]@? GP#X
M&\"^$KE_AW<1W'AC5[IK^/R)O-A1F&"L9ZA?8]*]%KX._P""6>JZG)9>/=,9
MY'T>(P3QHQ)2.8Y! [#CL*^\:Y*L>6;5[G#5CRS:O<\^_:&_Y(/X]_[ \_\
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M&^MFPE)+#1]8;?%_NI*/F'_ LUZE/%)Z3T/3IXJ,M):'Y]45Z)\1OV>/B/\
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M=?T-'FA^<3SQO"L'@_QQX<2">2<W$C[Y)3R<<8_6O0O$5J]YH&HV\8S));R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%@MP(?MUJ)>FWS5SGTZ]:M-Z?CQWKR[Q]\/9'O%U72('F@E^:6"'A@QZ,/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J:M8#5-
M*N[,G'GQ-&/KCBK=% 'B-[?>9X?L--NT'VO2K[R9%8?>C8Y_GQ7H%_\ "_0+
M[YX(9;(GYE\A_P"AXKE?BYH+6=]#JT (2XQ'-@8 <=#^/]*]/M[I5TN*X_@\
MA7XZ\+FM7W1M)[-'GD.JOX(9_#NBNNJZE--O\QQM2)B.A]<8]>];6B^!;F;4
M4U;Q'=G4+Y>8X?X(_3_(KEK3PS??$BXDU@?9=-M6<@>6OSMSWQU/3DUZ/H&A
M#0;,Q->W-]TPUR^=OL/042>@I.R\S5)/)/6DH[_THK(R"FS2QV\3RR.L<2+N
M9R< #U)IU9_B'1QKVBW5@TAA\Y<>8.QZCCTH R;7XC:)>ZFEA!,[RNVQ'$?R
M,WL?ZUTWH1R".M><V/P=C$&+O4Y9)5!""$;%4]C4M]XPM? &FQ:/;F35-2@7
M:S29V*Q^O;T ]:MI=#1Q71GH/X45G^'_ +:=)MY+^3S+R1?,DP.%S_"/ID5H
M5+,VK!1112 **** "G;CW)P?>FT4 'THHHH **;-(MO#)-(=D4:EF<] /6HK
M&[6_LX;E 5210R[NN.WY_P!: )Z*** "BBB@ HHK.U_7K?P[IZWEV&\DR+'\
MIYYH T:*K:?JMEJ]N9K*XCN(QC)C/W<]B*L_A0 #YN1S17*:E\1+33_$@T=+
M6:ZGW*A>/'WCVQ75\]@!_.G8+-"G=M8(0)"/EW=,]LUSWA2^UV_FOGUE8X4A
M<Q11QIMW8_B]Q704NZA,:=A***&.WD\#U-(04R:9+>&25SA(T+DYXX%<GXB\
M9W^G^(1I.G:6M_,\0E1C)C<#WKFO&6N>*UT65=0M[;3;2<["%8&1Q_='-6HM
MEJ+8[PUXXUG6/%UB))E:SO'=!:H!\B@\,:U/B==S:M-9>';$>;=3MYSC.-H4
M?+SVI?A9X7BTVQ;5)S&UW*-BJI!\E?3V)IVNZ5KFE^,)-=TFSCU-9HA%L9A^
M[..O456G,::<QPFA^%S>:NJZQYUC91!FN)IODVMV"D]<UVE]KOA34/#_ /PC
M=M,S)M\NV^0G:PY!S]?YUF:IX)UKQ+;M<W>HPW6K;ABQ64!8E],=,UK7OP[N
M=7TW1+=C!920AGNGA0 Y]L=3[TV#MU9I_#;6?MWADI<,HN+.0V\DC$ X[<_G
M751S1SQAXG61#T9#D?G7)WWPZLSX9ETG3Y7MC+(LKSR?,9&'3<*V_#.DR:'H
M%C82LKR0(59E)P3GK6;,I6W3-.BBBI)"BBB@ HHHH **** "BE&/Q]!7+Q^+
MI;_Q@ND:?"EQ:PJ3=SD_<;T!IE)7.G]Z\Q\::9;:3XH,]MK$NE37R@O%:JQD
M=B?; P:].X'M6'?>"]-U#5FU.5&-_C]VY8E48# ./K3BTAQ=C)\!ZW>R7VH:
M'JDOVB]LOF6;J67T/N/4U2^*'B2POM)ET6V?[9J,DBE4A!8*0?7UK(T/P+XB
MDDO+26;^SK624^?=*<R3\]O:N^\/>$=,\,P[;. &<CYIY1EV/]/PJG8IV1,^
MJ6_A_P /P7-_)Y20PH'(ZYP/UKEU^(6K:J[R:3X>FN;0' FE.-U8GQ'U#Q!=
M*UI?V"VVE[PWFPKYO _B+?TXKN?"OB+3=4LX+.QO1=2P0+O^4J2!QG%%NK#;
M5G.75KXM\9@6UW$FB::W^M"M\[CN.IKL;&QL/#&CK!#MMK.W4YD8XSQR3[U?
MSSSBL/QMI9UGPMJ%NN3)Y?F+MXY7G'Y5-[Z(A/F>AY[X)\%S^((;V^M-4GTW
M=.\:M&N?-3/MBJOAW4K7P3XFU2/[))J-RC&. C&<YY/L:T] NM9\7:3I^E:?
M&VD:9!&!<W:*1O/<#W^E:=U\*]&M;:<F]N6O?*=T+R@$E1R<8R:TO8VN8T6K
M:IX'\'3R& V=WJ-XQC,O5%(R3CU^M=S\/]0N]6\*VMS?;GG+,F^08+KGK5;X
M>71UCP=9O=JMS)"SQ[I5W'@]>:R_%'B6YU75GT71KN*TM+>(R7=XN,1J.H!'
MITXJ=R/BT.YNKJWTVU>6XECMX%ZR,0JBJ]OKNG7B!XK^"12=HVR UXQKES<V
M^ABR6]&JZ,THDANAG*/_ '6!Y'T-:^B>#=1U!;V_33X[(-9[+94?<LCG'S+R
M<9QGGO1RVW'R+JSUWGVS]**Y3P3J6LK;I8:W82Q21C$5U@$/CLQ['WKJZAZ&
M3"J>L:O:Z%I\EW>2>7"G/'WF]A5RN;O?!X\07ZW6M3&:*,_N;*(D(H]6/4DT
MAHY+X>W5[XE\<WNM.K+!Y;!CGY0#]U1^ KU%]VUMG+X.W/KCBH[6U@L8!!;1
M+#$IR(T7 %29JKI[ W=W1S'@^P\0Z?<7JZS*EQ!*=\3+)N*'/3IZ5T]%%2V)
MNX4444""BBB@ HHHH ***5<'K0 WS(V9E#J77JN>1^%+CDURFA^&&_X2K5M;
MN@P=YBELA)QM'!?'OTKJ^_%-H;"N>\>ZM>Z+X;GN+$$W!95#@9V ]\5T-(RA
MUVNH=?1@"*0BCH%U<WFBV<]['Y5U)&&=1V/_ -?K5^CTHH;!L53C';'K@T?>
M_P#K]:2CG% #)[A+6WDGD.$C4R$^P&37F/ANWL+K3-6\2ZWY1EN9'%N;@@@8
M&!M'?G _"NQ\=&ZE\.S6MC"\]U=E8D5.P/4GT&!6!X;^%B0K!)K<S73QKB.U
M5CY:>N?4UI$TCHBO\,-!BOE&OW$KRW"LT<:%=JKVR/PS7H]<S'XZTN/7HM"M
M87DD4[ ;<#8OJ/PKIR"*EO4F0E%%'-22%%%% !1110 4444 %%%% !6'X@\&
M6_B:[L91,]I=V[C9<)UVYR0:W*FL_P#CZB_WA3O9%P?O&;_PKV3_ *#-U^7_
M ->BNUQ[T5C<] Y:BBBM3S HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBCN!0!R7Q2DC7P;<AUW%Y
M45,]FS_^NL+1O' LO -TMP<W]G_HJ1GJ<Y"_C_A6A\7+B&/P_;PF9!/YZN(L
M_,0,\XKF_!/@J_UJ\M]2OU,>G"3SPLGWI3VX]*V7PFR7NZG>^ -)DT7PM:0S
M K-)F5E(Z9YQ^6*Z':2QQU_E2]<=/Z"N=US^W5US3'M)%.E>:HN$C'[S'?=Z
MCZ5GNS+=F'X[\8:CINJ1V>D;2]M$9[G*@C;U"D_YZUV&A:G_ &SHEG?X"F>/
M<0!T/?\ K7.>(/AQ;Z]X@?4'O)(8I%"R0QK]['09KJ--T^#2K.*TM4\N",;5
M&?\ /O3=K%/EL6,>U+COTK'\2:X_A_3S<Q6,U_)TVPC(7W/M7G<?QBU9K@+]
M@MW5C\L:AMWY@]?PJ5%O82BWL>M@_P# N>*\L^+#6<>OZ;Y<,DFHX#2&,?ZQ
M<\#'<YXKN/#.NWVN0^;=:1)IR8R&D<'<?IC-7WT>QFU*/4);99+N--BLP^Z.
M>GOS36CU!>Z]2/1;Z]U*U$][9"P+G*PE]S].IXXK0HY[DD^]%)^0F[A1112$
M%%%% !1110 N-PKF?&7BR;0?LUG86YN]6N^(DQP!W-:EY#K+9^QSV<8[>;$Q
M_D:XOQ!H/BL7T6N-/932Z>A9/+!7*]^*I(J*UU,?Q5H.OV%I;S7E]>7US>,P
MGM[;<R(G7;P*[GPCXOMO$$DMBMI-83VD:_N9N#MQC./RK1\+ZZ/$>@VFH*OE
MF4$.H[-WKE_$D8T?XC:'?1<"\!@E _B'3/Y?RJ_(O?2QW=%&>?2BLC(****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX8T/0-59K#5GN['6U8B1Y9-HD]<9XK:^&&EVMOX@UZ6U7=!;MY$+'G SSS^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]<^)VCZ6I2V?^T;G/"P_=!_WJ=F5:^AUP;&#UQS7/Z%X*M/#^M76HV]Q,[7
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MLCO.7HHHK4\T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGK7J6GNEO;V]G+=1R7<42HZAP6R!Z4I(F4;(N44##%@I#%>" >114$!1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #]*K:EJEII-H]S
M>3K;PK_$QY)]*J>)/$5KX7L7NKDY_ACC4\NV.E<GHWA>]\87*:SXD8^3P8+
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M*SQYR%;'.*EVB/Y!P%XP  !["CJ>>2.]0VB6[] HHHI$A1110 4444 %%%%
M!1110 4444 %%%% !5;4M,M=8M7M;R!9X6ZHPSS5FC..: ,#0]8\/_;)](TH
M1+-&&\V%(B!\O!Y[U)HW@[3- U.ZO;.(H\PQMS\J=SM^O%7[/1;'3[B6>VM8
MX9I/OR*.6SS_ (U<IMCOYGEWCKPWK/B7QLMLFYK0QAHI#GRHU[D_CVZUNR?"
MG2I-/MK;S[B(Q'>[HW^L;N2,>G KM/\ .>]&>]-RZ#<G:PR&-+>".%,A8U"C
MZ ?K3Z.:*G<DAO%F:SN!;$)<%&$;-T#8X/YUC^"]/U33=%$>KW!GN6<L%Z[
M>V>];U'UIA>P=Q]:X/Q];W>G^)M%UBQLWOIHPT;1*"<]2/IG)&:[RE#;>A^G
M&<47'%V/'_&FG^(M3L?[8U2&"S6W($:QC]X,GN>>_J:[GX?>)O\ A)M"#3'_
M $RW.R7C[WHWX_TKH;JUAOK=[>YB6:&3AD<9!J+3M+L])A\BSMDMXNNV,=_7
M/>J<KJQ3ES="TS-M8@;FP<"O)]#\)ZSXH\;"ZUB"6&&.82.TO3 /"K7K'\JE
MM>;B,_[0J;Z#IZ,WO)7T_2BI:*RN=QR]%%%:'FA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYDC7RW[\KQS6]A6!##*D8(KR^W\*^(;/6-0T/3[AK+29)//:X'93T5?>FGS
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MY?A52V-8[GHU%%%8'7<Y>BBBM3S@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,KQ!XEL_#%O!/?;Q'*_E_*,D<9SBK.EZQ9
M:U;^?97*W,??:>5]B.U<+\4+Q?[9T:WD021P*US)&1PV.Q_[Y/YUI?"O2?LN
MB3:@^U7OY#*$48"*"0 /UJW'W2W'W;G:@9.*\R\6:F]KX\N+R-!,^F66Y5;E
M0Q[_ /CV:]-7[U<#X;M8]<\:>*Y)E#Q.@M]I].G]*(Z!#N5+'QMK^C0V>H:N
ML-[I%YM/G6XP8B>QQ_45Z+#+'<PQS0NLL3C<KKR&!%<'X!M4NM/USPY?J+BW
MM)R@W>A)Z?B,TS39+KX>^(K;3)YFN-%OF/D22=8G/;V]Z;2Z%.SV/0J*"NWC
MCUHK,R"BBB@ _+\>E<5>_%*TMM0N+6WT^ZO%@.'E0=.<'CVKM5X]JX/5/#?B
M&T\67]_H/V>"*Z159I"",]^/K5*Q4;-G4>'_ !+8^)K4SV<NXK]^-_OI]16I
M7,>#?!O_  C;W5U<3K<ZA=?ZQT&%ZY]JZ>A^0G:^@4445(@KE_B-K$^C^&)F
MMP1),PB,O9 W4UU%0WEC!J%G):W*++#(-K*?Z52".YQVG_#+1;S0K$;V,XC#
MF[MWP6SSGOD9_E7/^&M$M4^(D2:9)/>6UCN,]Q-R ^#P#5VPED^'WBNWTF34
MQ_8UPCN!-P(L],'UXK1^$_S6.K[0'C-XVR7NXYYS^OXU>NYMK8[FBC^5%9&(
M4444 %%%% !1110 4444 &.U!&VH[JZCL;6>YD.(XD+M] *Y/P'XZF\637D5
MQ!';F!?,$B_=*D]_>FD-1;.PKA_&OAW5;K7K;5M&BV3V\>Z1UDV^=@_=QWX]
M:ZVQU:QU1I%M+N&Y:/[ZQL&*_7%6QU]Z:T!.S,Z;747P_-JP0C9"9#&5Y5@.
M5(]C7&^!_"MIXBMVUG6V74;VY)?R7;*QKGC(]\'\J['Q-(EKX;U.0Q^8BV[G
M8!P>.:\Q^$-\UKKLL$C8CN+<GD\?+SG\JJ.S:-(WLVCKO'_A32X_"%Y+!9PV
MLMLOF(\2 =^AK$^$NIR6\E[IUQ*/LJ0BY3=QMSU_#'\JLZUK%W\0+B31=%C*
MZ<K@7-XW (!Z#V_G6MJWPTTS4FMWCGN+.2.)86,+8WJ!@9_6G>RU'>R]XP-8
M^(&MW<%UJ.E0)!HUK*(S<,NYI#G'0]?Z5=\<+)9W&C^++51*D"()H6 (V-W'
MYFKWC:RL_#?P[N+*$;( !%&#U9B>OUJ/Q [:;\*A%/\ ZQK6.,@CN>E&FZ&K
M+8Y?6YM/U[Q9?OJ]]/9VC0+)8LN=N, CCOWKKOAAJ5U?>')%E9IS;RF.%I#@
ME0..<?YS7*Z/X&U?Q=HUM/>7:VD$$86SCDC&2/4^U=7X%UZY::ZT'4X([>_L
M "/)4*KIZX''I]<TWL$M59&!XLT'QCXFN2DD42V0;Y((9P$^IR06/O5KPG\*
MS8W27FJRI)(G*6\).T'W/>O167!YY/I0HW>X]JCFZ(CG=K6*NJ:7::S:/:WD
M"W%NQ!VL>A]?8UP_BKX:#R+67P['':W$+%F^<AV/8[CZ>E;%GX=UBU\976IF
M\C_LZ4X-L'8G!'7'3M74TKV)NXE31X[N'2;2._E\Z[6,"5_[S5<'7BDIDRR2
M1.L3B.4CY&(R >U*]R;W,C4O!^G:MK5MJ=RLGVF#;MVO@''J,5MG[WJ.U<5I
M/Q"D_MW^QM9L_LEX6V"6,YC8]N#T!]:[4CWXQQ0[E.XE&:*P?%7C*U\+F*)X
MY+N\FY2WA^\1ZF@G<WJ*R/"WB:W\5:>]Q"C0O&VR2)^2I[5KT/0+6"CCOTHH
MI <]H_@BQT;5-0NXV:1;O[UNP'EKDY(QW_\ KUNPVT-OQ##'"/2-0H]NE244
MQZA1112$'M2BDHH XWXG:'J.K65I-IHEEEA8B2*%]K,A]/6O/AX4UK6)DMH+
M&_B3(R;N0[$]>M>YT;B2.]6I-=#2,G$X/QMH,>E_#9[5_*FGME3]\(PI)SV[
MU5^'TAF\7ZH^/^72+/Y"NH\=6,NH>$[^"VC:>5E&U%&6)!KG_ACH^HV5SJ5Y
M?6[VPF1(T23AN#UQ57T*O[NIWU<E\0+[Q!9VUO'HL+.LN1)+"-TB'T [#WKK
M:7]14(R1QG@G3_%5K)OU:[5K1AD0S'>^?4$=/QKL\_C28HI-W"]SE?B)X=EU
MW14:T5FOK9P\6WACG@C/ZUS^D_"N^BN+8WVH1M:K*MQ)&BY=G'8FO2J*?,/F
M:T(-2T^'6+">TG3=%,I4JW;/0CW%>/1OJ-[!!X-:)VF@O-WF2 \1@]?H*]HI
MIBC\[S3&K2XQYA4;OSII]P3(;K2[6]M5MKJWANHD4*%D7(X&,U);P16L*0PQ
MB&)!A47H!4E%3N2[A1112 5>2/2L'1/[;_MS51?20MIP8&V2,@L!V^G'7-:>
ML7YTW2[JYQDQ1ED"C)+=!C\<5PW@/P7J<5\-;U2YEAFD.X0;OF;/]_V]JKH4
MM%<]#HH_3\:*DD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBCIUH *
M*.E% !1110 4444 %5M0U*WTFW^TW3^7!O"ECT&3CG\ZL^M8_C#29=;\-WME
M"4$LBC;YA 7J"<GTX-- MS8^\H93NC/.Y>A]**\^\(^%=<M[JUF;Q LFG0J%
M*V\A?('1,=A7H1^\:&K%25BAKNGR:MH]Y9Q2^3)-&563TKAM+^&>K/9I9W^L
MFWLE/_'K9CJ3W)XKT@#/%<%KGQ<LM,GF@M;.6[GC)1S(VQ1CKBFF.+[&U8_#
MOP]9Q^7_ &='.>[S$L?K706]O':VZ0Q)LB0;%4=% Z?SJGHFJKK6DV]_'$R>
M:N_RR>1[5F>&=:U?4KR]BU33C8I&0T#;2-XY]3UIZL3NR;5[/1=.NAKNI(B3
MQ[5%PXR0>QQ65IO@#3I-;A\0)>RW:R,9U5@,.2,@_K71:UH5GXAL?LE\C26^
M\,55B,D>XK+UB'7;6XTZTT**&&QC 66:3#%1P  #[?SHN/4Z+'3.!QT%36G_
M !]19_O5 ,*HYSV],^]3VG_'U'_O"H8H[G14445D=QR]%%%:GGA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWE]%!,>?+)Y'U]*JP[6-.BFPRQSQ))"ZO&PRKJ<A@:=4B!20.*,T44 %%%%
M!1110 4444 %%%% !1110 4444 (5W* <'ZTO7)/WN]%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444""L7Q-_;LEJ(=#6%)&^]-*VTK[ 5M44%
M(J:2UZVGP?V@B17F,2"-MPX[@^_6JOB;Q):^%]--U<_,S';'$O5S6J*XSXD^
M'[CQ#'I-M:KEFG.YNR#')IQ\P6^I/'X^%Q)H30Z?,;?4PP9N?W9!(Q_,_2NM
M/UR??M5/2]+@T?3;:RA^>.!<*S@9)[GVJW_^NAVZ!*W0****0@^HKB/BCXBN
M-+TY+&V5U:Z_UMPJDA$[@'UZUU'B#5/[#T6\U!4\TVZ;PA/7D=:\7U[5!K6H
M)<:;+<1?:/\ 66;O]UO]GL5-:06MS2"U.C^'DD%GXN%MI$MQ<Z;);8F>12 )
M!WY]_P"=>J5@>!=.OM+\.P0ZA&L=UDGY<$[2>,FM^IGN3)W=A1P<]#61)X3T
M::=YI=,MI)'.YBRYR:UJ*28KL;'$D,:1Q(J1H,*BC  ]J?@TE0WEY;Z?"9;J
M:."(<[I&P*-1:DDDB0QM)(RHBC+.S8 'K7(77Q8T2WF,:">X56VO*B?*OOFM
M^\N=*U;09Y9Y8YM-D4[Y-PP1Z?6O,_#_ (-M_%%Q='2YKBRT?<J/YPSYZCT_
M'^=7%::FB6FIZY#-'<0QRQ-OC9 RMZJ>:CNM6M=%C2[O)?*@5PI8C/)/ IUM
M:QV5K#!&-L,:!$!ZX  YIMVMBR*-3\DVP<$_:,8SVJ'84?B+7_"PM!_Y_?\
MQQO\**S?/\&?W+/_ +Y%%18[B]1115'G!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4GV-)2>HF[A1112$%%%% !1110 4444 %%'TQBCOCO0 4444 %%%% !1110
MJ\$&O//$'A74M)\1GQ!I\2ZLI.Y[6XY9<_W?;T]*]"^M+GI33L-,\:\6:]HV
MK6<C'1;C3=<!&QL;!G//2O5?#MK)8Z#8PS.TDPA7>6.3G&?ZU<GMX;Q0)XHY
M0.1O4-3^O/'KTJFU8;DK6"CVHHJ"0HHHH Q_%7]K?V+-_8NQ;S.26/.W_9]Z
M3PC)J<N@6[ZQG[;\P.Y=K!<\9%:SW$,<B1O*JR2?=0L 6^@I_3UH'L@HHHH$
M%%%.7/8T -HHY_"CI0 =>*,YY_"L[6O$.G^'XXFOI_+\TX1 ,LU:*L&&0V01
MG<!U]#0 PPQR2(S(I9?NDC./I4G+<<D>A-<YXV\6'PK90-'"+BZG?"0GICJQ
MJWX<\5:?XHM_,M9<2#_60-]]3]/3WIV=BN5V-C./F(R1Q7'6_P /C;^,_P"V
M_M[RIO,IC;ARW89[J/2KVFZQJMYXHN[.ZLA9V<$.Z(_>,N6QG=].U=%33!:!
MWHHHJ20KE_&WA&Z\5267DWXLXH.67!R<_2NHHIK0+F!K'@72M<@1+E)/,1 J
MR+(>P R1TS6=HOPMT?2I_.E$E\RG*+,?E7\!78#GI5>]U"VTVU>YNITAA49+
MN>*I-E*3+ 4*J@* H&!@?RHK@X_BM&VH!VT^6/1F;RA>$<[_ %(Z8KO RLJL
MA#(W*L.XQD&I:8FFMPHHHI""BBB@ HHHH **** "BBB@ HHHH **** "CKSW
MHHH *YGXA:MJ&B^'OM&G$QMY@6251DHO]X5TU(T:R*R.H=&X96 *G\*I!L>(
M7WB/4O$T,$5X@U.WTYQ-/]G&/-C..H]J[*+PWX9\;::9="9=/OH?FC,9(>,]
M@P/45VECH]AI>_[):16V\8?RT'S?6O,O&]]'X-\9-=::%MY9;0[U0<;CP#CU
M[U=U(V3YMCK? ?B*ZU*&[TW4N=2L'\N1N[KV-=57*?#KP_#I>C17S9EO[U \
MTSG+8[#Z5U=1+0R>X4445(@HHHH **** "BBB@ '-16UU#>PB6"59H\D;D.1
MD=J=-$)X9(B2H=2NY3@C(QFN9\'^'XO \-S;75_&[W4VZ+>^-PQV![YIVN-(
MZFBE8$'!&,<&DI""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH */
MTHHH 7/S9)XZ\UYK\0-4O+75K?1-"3[/-./-E^S *[,QX&1^)KTD=16 G@^"
M/Q>VNF:1I#'M\KC ?ID?A51E8J+L3SWL?A'PNDUWNE%K$@;:=Q=NF,GWKF-#
M^).H:]JR16VB.UGG;*48ED)]3TKL-;T2W\0:>]E=%Q$S*Q\LX/'2DT/0[+PW
M8BTL(S'%G<Q)R6/J30K6#W4C0_3_ #THHHJ23A=>T_4M+\3+?V-[<7]W<(RQ
M61X6('HQQQM'H>]:OA/PI=:-ON-1U*>]O'/*>8?*3/)P.Y]ZZ0*JL2%P3U8=
M?I2U3>A3>@>E%%%20'UK-U+Q'8:1>06E]/\ 9GG4F-F'R^G7IFM*LW7/#=AX
MCMTAOH=^P[D93AD/L:I%(YZXN/\ A6]G?7=Y?S:BMS+FVMI.JGZYZ?X5PD_B
MO5M4U2WOHK^0W_F 065NI*HI[-7>^,=)T*WAM+W7;BXE@A7R(80>I'4X'4G'
M6K?@F\T;4+6>32-/%I'"_EEF0!FXSGU_,U>B5S32USI5,GEIYJ[9< L/1L<T
MM'/?OW[D^]%9;F3"IK/_ (^HO]X5#4UG_P ?47^\*3''='14445F=YR]%%%:
MGGA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2H/$7Q,M;(R6VDQC5+P+D^6,QH/4D=?PIV@Z'IGB_P ,17=Q9VXO[F-U>:-
MIW9(!X_"E9;LFW=&_?:3I_BK3K4W,(N(3MFCR?;I]*YOQCX#EUS5+&XTZ06J
M,A@N64[=L?; [\'&*=\.-6E6"XT&].V_L&*JK=63.<C_ #WK2\:>-(?"<-I\
M@FGE<#R_2,'YC]>:G6^@M4[(@TOX9Z#IK1N;=KN:,Y#S-W^@KJL!<  8 QQQ
M_D5%9W<6H6D5S;OO@E0,I]1[^]2U+;ZD._4****0@HHHH *Y+Q7XZ;0-6@LK
M2S.H3;/,GC7[R+U'3OU_2NN'45YYK/A/6= U*^UC0I_MC7(8313 %P".B^O_
M -:KC8N-NIV/AW7K;Q)I<5[:[@C95E8<J1U!K1KG?A[I#Z/X3M8I59)9"9'1
M^JDGO[XQ715/4EJS"BBBD(.._(K(\4>)K7PI8"XG#2RNVR*!3\SFMA?O5Y%X
MC.O:QXN-Q;Z9<XC/E69DC.U!TWG/'J:N*U*B=!I>CZQXAUZTU_7&CL+:T^>"
MWSAOQS_6M]O'6A?;HK)=026>1]F(\D9Z<M6%#\+5O(]VKZQ>7=P_+JCG:?;G
MM7(^+)M'L[^'3].L1%;:?,&N+G(\R1_[H)JM):&EE(]H_BP1STQ6'JGC?1M%
MU+[#>W313@?,=F0OL<4F@^.-*\39%M<>7<_Q6\PVMG';-<S<:?;R?%::U>&.
M]BNK;?<1R+GR_EZC\AT]:E1U(4=;,I:]XITZZ^(-C<W,S-IMC'O1XP65W/.1
MC\*[_1?$FF>((W>PNUN H^91PP]R#VKS_4M'B\'^,K"UTF,745[CS-.E7<JJ
M3]X'M_\ 6J;Q9]C\*ZY!K6B7-JD\?R75C&X&]>Y"_2JDDT:22=K'I='UZ53T
MC5;;6M-@O;5MT,HXR.1ZK]:N5E:Q@U8Y#QEX8U?5M8T_4--FM@UDN42?.-V<
MD]/I4WA'PK>:?J%YJVL3)<ZG<#:/+Z*GM[UU63T[U5U2ZFM=.N9K>)IYUC8Q
MQJ.6;' JN;2Q7-I8\^\=?\(KJ6L&:[U.6.[B7RYH;=2WF =CZ4[P;H<.O>;K
M^KQYLX,K:6[#"11KW([_ .-;'@7PLECH;7FI6BOJ%P[32&9 63VY[_XTRW^)
MVAW*M:W$%S:[OW9ADA)4^HXJ^;H7?H<KJFL0^)9GU35YI(M"AD\JSL(.#,P]
MO3U/OBNO\$^*M*OIGTJRTZ;2Y(U\P0NN1CUSZU!H'PULM/U@ZBTS7-HK>;9V
M\@.(\\_,#UQ6# VO^%=6UAXM,6XN;J4L+^?B)5)S]!GC\J-):%:25B_J>DVG
MBKXG2V=[&9;2WM,LJL1\W6H=6LH?AMXGTZ[TT$6-Y^ZEL]VYCSU%;W@?P[<V
M]U=:W?WL5[=WR#/DX9 ,]C^'Z5S/C+7["R\>:;J%O+]M-H-MT@&]4&>H]Z/(
M76QZEUP><=E/:BH+&_@U2SAN[:3S()1E&]O0^]3UFS%A1112 **** "BBB@
MHHHH **** "BBB@ HHHH */THHH XKXD>$[GQ!_9T^GPK+=1N4</C&T]S]#4
M?AGX5V&ELMQJ16_NAR%'$:GZ=Z[KD=J2KYM+%<SM8HR:'I\NH1WK6<7VN/E)
M@,,O&.U7N_/Z44N#4;D[B44=P.YZ44 %%%% !1110 4444 %,FACNK>2&9%D
MAD4JR,."#U%/HZ4 >7:A!JWPYO);?2S<7FF7D;>3& 6\F0\?F*OV?PGMKSP_
M M[--#J4O[V:12&!8\X(/85Z'NQTYI.O7D]SZU7,7S,IS1+I^C21I")X[> J
M(6/WP%Z>U>2:-XCN]'U"WU6RTY-/TN\G%O)"LA:-FZ'@]#[U[%>0-=6=S C^
M4TL;(']"1C->6Z/\)]460-=W4<213I(L0;<),');V-5'8J%K.YZOV_7I12MR
M:2LV8]0HHH__ %4#&RS1P1M)*ZQ1KU=S@"JFDZQ9ZU%+)8R^?#&VPR*, MZC
MUJ/Q!H,'B72GL;B1XH6=6+1GG(HT'0K;PWIJ65J6,(.X-(<EB>N?2F/H:-%%
M%(04444 %'4BC^=<YJ[>(9/$5JUA#&-,A/[W?(!YN>I_ 8Q]*8'1]L]J*.Y]
M.V>HHI %%&1N SR>@H[9[4 *O#"N.\.^!KO1_$5QJLNI^89&?,* D,IYP2?3
MCI785R>O_$.'1=8FL(M/N+U[<*TSQ#A >>E4BD=9UQQS16)H?C+2/$6%M;I5
ME/'D2_+)^&:J^.%\0M:VW]@[>6/G;<;\=L9I68K=#I:*9 6:"-W!5V4%E/4'
M R*?2$!SM.W[V#BO$-*T.-;JXUO796M[".9F56_UER^X\*/PZU[A@^E><1Z9
M;7WQ2NK?5MTZ*GF6<;GY,<';C_/2M(FL/,Z/0/B!HWB&5+>*1K>Y8?+;S+M)
MP/7H?_KUK:EH=AJ\UO)=VR3O;MNC9OX3_45R$"PWWQ:E*B)%LK8#  7+$=,?
MC^E=[W]J3TV(>CT.0^('B/5_#-O;7-A'"UHS;7W)DQMZ9ST->;Z;K4+:/JZ&
MRFN=9OF(%RJ;MJG&?H>OYU[=J&GPZM8RV=RH:&92I!Y'U^M8W@?PR?"NDO;N
MPDGDE9F<8^[G"C/TQ34DD.,DD7/"^GC3?#NG6Y0*Z0KNXY)QW_.M7]*/?J:.
M>QQ6>[(ZE*QUBSU&ZO+:WF$DUJ^R5.F#ZCU]*NURNJ1Z3\/=/FU6VL-\SR"-
MB';<^XY))/'O73Q2>=#')M*AU#;6.2.*!V'U-9_\?47^\*A]/>IK7Y;B(G@;
M@,F@([HZ*BBBLCO.7HHHK4\\**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBF7%Q%:023SR"
M**,%G=N@ H DVG@>M)Z?E7$7GQ*6\F^RZ!IT^JS$XW;2J9_K5SP7XOEU>VU$
M:L8[6\LI"9@PVA4[?E@U7*RN5V.KHQGBN#;XG2S7D[6.BW&H:9&VS[1'G);Z
M8Z5%J7Q(N-3L9K+3=(O1J$P\M2Z<)GC(HY1J+-'7OB!I1\/ZL]K=AKN(-$(S
MPVX_+E1W'6M'P'I)T?PK91N")I%\U\CG+<X_+%96C_##38+'3GO(M]_"1)(Z
MMPS'G:?4"NT[ #@>GI[4VU:R"35K(****@@*1D62-D=5D1LJ5894CW%+0 /E
M!'/IZT <+JG@F\T&\?5/"\QBDSNDL6)*/W./\*VO"/C&#Q.IADB^R:E =LEH
MW!SW(]J/&7BAO#=K#'!$USJ-TWEP18XSZGZ9%<Q'X#U[4KQ]9N]1BL=39?D6
M!, <=&(]JOIJ:+5:CO$EWJ7CG6;C0=,9(+&T<?:+DG&2.W_UO:NT\/:';^']
M)AL[8JT:#YF'5V/4G]:\GU[PGJO@W3//GOM]O--B5+9RK.3W)_SUK=^'^B^(
M['6%F:.:TTIE/F1W$F[<,?+@>N:I[:%;K0],HHHK(Q"BBB@ HHHH **** ,C
MQ1X?_P"$ETA['[2]MN(8.H_0TI\,:?<:':Z9>0+=PP1JJEACD#D\=/\ Z]:U
M%-.PT[&99^&]-TFQN(+&TCMUDC92RK\QR.F:X+P'XZTOPYH#:?J$\D<\4[@!
M4+9!^E>H57_LRR/)L;8D]_*7_"J4NY2EW.+OK&T\<R+K/AR]^S:K:D(692 X
M]#G\>?PIO_"&W#1ZEJ_B:\BN9_LS1IMXCC&,9^O^--U/1=;\/^+I[SPY:))!
M>1YE1L"-6'7_ .M]36-XG\1W7B>S&EWFW1M0B<>9;S';%.!_M'@>O/X56O0O
M7H)X?^(A\/>%;*TBMOMMRC/E68@! 3@_Y]*],T/6(O$&DP7\. )5R55L[#W4
M_K^E>0>&+/4KC4KJVTI+>:[9?+FNV :*%#P54].GYUVGA;X;W7AV\2Z_MIXV
MSEX8(_D?U!__ %4-+<<DCN)'6%=TC+&N<;F.!2\'D'(]17.>,/!I\61PH]_-
M;11$$QQJ"K>Y]Z;HO]N6OB"6PN+>!=&AB @DCR,X& ">Y]:BUS$Z6EVD=JQO
M%GB)?"^AS7NS?,"$BC/\3'^E<[\+;V_UH:GJ5]<//(T@B3=]T#!) ';M22';
M2YW5&<>W>J^H7#6.GW$T<;3/&C,D:C)8@=!6#X(UC6=:@NY-8M!:[&'E#RRF
M<]>IYHLQ)'3<?EQ12[2.HI*0@HHHH "<<TOIQ@=J.:SM6\0:;H*J;^[CMRW*
MAOO$>PH Y_Q3\0#X3\20VD]N)K*6$.3'P\9R<X]15:;P7I3ZI)XG9C<6)A^U
MBU"_>?&<_3V]:YGQ]XSTSQ!)"MM9+=P0\&YDRC<G[J__ %Z[=O%]AI/@^TOY
M(I(XVB$<-K(,228 &,=Q[UK\*-ME<YG1X],^)]Q=EM._LF[MP&2[M6_(,.!F
MNB\'>#+KP[J6H7FH70OIY0L<<I^]M'UZ'I6#HW@_5?$2O?SW']@VLYW):V2;
M"1V)QC/XUH^&M3U#PWXC/AS5IS=12+NM+I^I_P!FD[B=WL:?BOP3_P )%?07
MUOJ$NGWD:>69$&<KZ=?\YJO;?"W0EL5AN('N)^K7)<JQ/YX%=>:2INR%)H@T
M_3[?3+..UM8A#%&,*J\#WJ?Z452UK5H=!TN>_N#F.%<[1QN]!^-+<6Y6\1>)
M['PS;QRW;G]X=L<:#+-[_2E\/^)].\2PO)83ERG^L1AM=/J#7,^%=%NO$FJM
MXEUJ/ 88M+9N0B]C@_Y.:Z#1_"EMHNM:CJ4+L6O !Y1& G.3C';BGI8>G4V\
M]\TQ[:!FWF&-F'1C&,BGT4B;V#UY_'TKD/'6@ZIXHGL=.MD5=.+>9/,SXQCH
M,5U] Q^/Y4)V'%V=SR?0[/Q+=PW'ARVE-EI]K.Z2WC @[<_=!^G\ZZN[\!6%
MAX0OM/LHLSO"6\YOF=V7D#/I[5O:YH\>O:7+8R2R0([!M\)VL,>_>N/ATK5/
M _B"PCM9[G5M*O&\IXWRQ3_#'K5WN7>^ITG@O[5_PB]A]L@2VE"#$:#  [$C
MUK;I2O;IC_./I25GNS._4**** "BBB@ HHHH **** "BBB@ HHHH **/\<44
M %,FF2VMY)Y3MCB4NS$XP ,FGFN#^(VKRW5Y9^'895M/M1!N+ASA53TS5)7'
M%79R(UC6M4O[6Z@U.=)M0NV2& $[5C!ZX]*]J^;Y0QW-CEO7M7E.HV=N=8MI
MO#&H(TFFPA6,J@01 #D[SP2U=!X+^(-QXCN#:7&G.95ZW-N-T?'<^E5)::&D
MHZ';5R_B+Q]9Z/-]DLD.IZFQVK;P\A3Z,174GZ<XKS/7KZR\%_$J.^V&.":W
M+2+$N26/&0/4TH+N3%$G@.]U?Q!XPO+O4I6(LT,9ASA8V/8"O2.U>5:'<:V_
MBZ?5M(TB>&RNF'GPS$*K?[6>E>K=<8&#QP/Y4I;CEN-HHHJ3,/R_&JUKJ=I?
M3SQ6\\<\D&!)L.=N>U62 RD$!E(P0>AK(T7PM9>'[R[GL@T2704M!G*H1U*T
MQZ,UZ***0BOJ$%Q=:?<0VLBPW$B%$=LX4GOQ7.>%;Z'P^T'AR]U'[7J:[G#9
M) YSLR>]1?$OQ%<:/HZP6$ICO)G 9D'S(AZGVKG_ (4:'<-J5WJ\\;-"4V12
M3K\SL3R1GIZ9]ZM+0T2]T].9EBC+NZH@ZLQP!1&ZR*&1UD7LRG(KF/B-H5_X
M@T%;>P 9UE#O&QQO4#H/6I?ASITVE^$[>&XB:"?>Y:-QAASQ^E)K0FVATE%%
M%22%%%% !116=:^(=-N]4FTZ&[C>\B^]&K#\1GO0 S7?$EEX;6V-Z^SSW"+S
MR!W;Z5IK@@$'*MR#CJ.U>9_$2UM_^$K@N=5$CZ1- 8A)%\WDR>N!WSVK7^%>
MJW-]I-S:S2&XBLY/+AN<8#KV'X5;C9%N.ESMJ***@@***CN+F&SA,L\J0Q#J
M\AP!0!)[4>U(K*\:NIW(PW*P[CUH;)4A<;L<9Z9I@+[^O6C'J..AKR'P?X@U
M_2O$DNEO!+>^9,3+;N>4R3\X/8=Z]<N$9XI$1S$[(5#]2I(Z^]/J4T<?K7@F
M_O\ Q5:ZI'JLGV8."T>[:8U'9.W-=FW+$^]<_P"$_"\_AF.=)M3FO_,)VJ_"
M(,]ASR:WZ3=Q/L&<<CK7">)K/4/"OB1O$6GPF]M)D\N\@49(' S7=T>QZ&B]
M@B['D^M:IH>NZYX>N=*1(KE[D?:(U3:PP1C(_/FO6F^\3^ ^E4(]#TZ&\^TQ
MV-O'<_\ /98P&SZU>SGW]ZIM-#DTQ/:D;)1@#AB" 3V..*6BH).9\&^&=2T#
M[4;_ %-K[S&)CCW$J.<YYZ4SQOX7;5OLU_87*VVK6Q_<2$[?,_V3^-=37 ^(
M-(&N>.[1X]7@$EJT;?8&)W +R>!QDBJCJ7%W9SMR^CWU])_PD%M>Z%K!8[KJ
M,DHS?WO_ -7%:_A/QA/INO1Z-/?)K-I+_J;N+YG7Z^WUKH_%OBK1=-O(-.U*
MV^VS38Q&L8;;DX'Z^E:VF^'],TEO,L[""V=AR1& W_UJIM6*;5M30XR?K11G
M^>:*S,@H'48HJ.XF6WA>5PQ5!DA5W'\!W- '._$#0;[Q#HL%K8+&TJS"1O,?
M   _6LO'CVW0,!I\H4 >6,9P!]:UO#NK:UJVKW<MYIS66EE1Y'G#$F[U_$?E
M72#[V>_M57T+YK=#A[?XC/9O]EUW3Y-'N7^5)]I,>>Q/M3K#P3J^K7UI-JGB
M)[JW619$2V! 89R/2I/B/KUI'I\FDK$M]J5R-B0!=QC)_B]C]*W/#-JWAGPU
M9QW;L9+6',HYX[X!]NE4]C2.ZT-?_A,[3_GSO?\ OT:*Y_\ X6K-_P! ]?S-
M%8\K.DWZ***H\\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***/:@ HI6!5<G@>IIJ$2+E&5QTRIS0 M%%% !12X.<4;&
MQG'% "5Q7Q*U1YK>#P_9!GOM08 [?X4!_P _E7:X]#FN#CNDU;XL1S67[Z"S
MMVBGE"\*V#W_ !JHZLJ*.RTG38-&L(+.WC6-(T"G: ,D#DD^N:Y#Q#\.WUOQ
M2;I9_L^G7"@W:IP68=@*[HG\J;P*7,[W$I-:D5C8VVE6<=K:1""", !%Z?CZ
M_6IOY^H%%%*X:A1110(**** %^]GG'O7DMAX;O=8\5ZM87VJW4&IV_[Z&=6.
MUAGTSTP17K(P3@]*\[LM4M-%^(VNS:K.MLTD0\F24X!7(X_0?K5Q+ALPN-!U
M+1;@Z]X@U*._CTV,_9E7();^'/'<D5I:!\4K'4)(X-0A?3+EQ\OF#$;#M@U+
MXDU33/%WAW4K#3[R*ZN?*,RQH>?D(--\.6>G>./!=B+ZW64Q)Y#,.'1EXX/Y
M4]+:E=-3*\?>)+3Q%:C0=*#7]Y)*OS0C*I@^M=_9Q-;V=O"_+1Q*IYSR!R:J
M:+X?T_P];^38VZ0\8+@99OJU:%2_(ER5K(****D@**** "BBB@ HHHH ****
M "BC_P#510 <?0=ZH:MH&G:]M6^LXKK;T+=1^/6K]8/C#Q5_PC%G;^7#]IO;
ME_+AASQN[G_/K3C>XU?H:>DZ+9:+:F"PM5MXR<E5[_4U;Y['FN%@^)4VENT/
MB+2Y["7J)(4+)[<4FF_%K3Y;AX+^-K<AL+<19:-@.F1U!IN+*Y6]S<\5^,['
MPFL'VB)Y9)N$CB'.!W)HTOQUHVJ:7]N^U1VD2MM87&%8'T_SZ5G>(-8\(>)(
MX+:^OHYOFQ$T).Y2>V0.GUK!\2^ SHVH6%QIVF?VEIL66FM=Q9G;NQ[^GY55
ME8KE74B^(WB*T\1265EI\RW=O;*US/+&<J,#U_SVI(=:G\*_#O2X[+Y=2U"9
MI!M&3M#>GY4\^(O#;:;=:?=:1<Z#]I38\BQ$]#P,^@J30=.TS1H3X@N=;CUF
M.PBVVT,?!3T&#5;JQ6EK&LOQ:TQ=,@E\F:>_=<-:QC[K#KSV%<GJ'Q-UK7/.
M@MF%GYN0J1=50<L2W7-6C8ZOJVFW=_!IMKH>ES*T\LZ\S2)[$_TQ7/6L,6C^
M%KJ[D;-SJ(,%NIY*Q9^9_P >E4DBE%;G1_#OQ1-%X@@L!>3WEG>)@K.<M%(!
MG\C_ %KTR_UBQTJ(R7=W# O^VW/Y=:\+LI;_ ,+26.JHD*2W43K K=EQM#8_
M']*]'\/_  RL/L\-[JQ;4+Z4"1R\A,>3R,"IDD3)):AJ/Q7L8VD33+&YU%U&
M2P4JGYU8\#WVJZS?76HRWBSZ3(@\E,#*L?X?J.0?48K"\;^)+S20^EZ=I[Z1
M8$['NE@P6!Z[<#I71?#O^Q8-*DAT>Z:Z<$-<&08;<1UQV_"I=K7)=N4ZOU]:
M\[O%M];^(FH2744<]EI=H<I(?E+8Z?F?TKM]:UJU\/Z?+=W<H15!VK_?.. /
M6N'\)6-M'X7U35=:,41U1V<&<XXYQC\?Y"E'N3'N<KH6M:/>:T]]KH.R,,8;
M:*(+$N.F0.YX_K77^%]%G\7ZE_PD6KQXME^6RLFX55'0X]/YUR7@/POINM:@
M@OM1A)C/RV@^]+CH"?3VKT+QYXCDT&QM+#3&C34+IA#&@',:$=0.WM5RW-),
ML>(_'UCH-TMH$EU"^/#06X!*_7/0^U<AXT\4:7XBT6SU.SF-MJEE.NVWD&'S
MGE?H*;J5G;^#?#IN-/U!+G7OM*B>Y5@Y4D\C'H>E;'A2ST;QQ"NHW=DB:M;2
M;9Q&< L.C8I:($DM3N+6=[FS@FD3RY98U=E]&(!(J2E/MGVK%\6>(D\*Z0;T
MP_:'9A&D>[&2:S6K,=WH;/J>PZYKA/BKJEI-X?%O'>0R2BX1C&C@G&>>*C'A
M_P 2>,-LNL7G]EV#<K9VQ^8CW_\ KUKV?PS\.V:8:R^TL1R\SDD_RJMBE[KU
M.BT]@;&U\OA#"A4>@P*FIL<26\:11C;'&H55Z@ <4ZHZD[L****!!1110 4#
MY<8Z"BB@ ]\T444 %%%% !1110 4444 %%%% !1110 =C6#K7C;3]!U6#3KA
M)C<3;=I505^;OFMZL/Q&VA6%Q::EK"0^:K"*&60$X.<]/\XIKS&O,W67;QUQ
MQ24V*1)HUDB<21.-RLIR"#W!IU(09Q[5S_C3PG'XJTWRUVI>P_-!)[C^$^QK
MH*HZMK%KHMN6N+J&WD928EE;&X@=*I%1T/)-0\%WV@M8K?QM<VMQ,@=;8_ND
M)/(;WKV*RTVUTFW6WM(4@@'18QC_ #^-<_X+\:)XR6ZCEM5MI80K,A;<K _Q
M?I3=+\;1:SXSETNU.ZSAA;,G_/20>GL*;NRG>1U/\0P/UJG/HUC=7R7LUM'+
M=(NQ)'7)51VJZ125*9G>POW5QG !Z5QGCG2?$#2"_P!)U*4I",FS  Z=QQS7
M949QSUH3U&G;<\E3XS:@NQ6T^W<@ 'ELL>AX]:]'\.ZE>:II:75]:+8N_*P[
M]Q"^IIUKX;TJQN'N(;&%)Y&+LY0,=QZD9Z4SQ79W>H>';ZWL21=2)M3G'X>U
M5H]BKJ6R--'61=R,KKZJ<BE.17F6AV.N?#OP_<W<T"RM)<1H+,-ORISG'/!K
MT>QN#>6<,S0/;&1=WDR?>3V-2U83C8=/<0VD+S7$BPPH,L[G  KS_7_BU"K_
M &;1D$\I.T7,PVQ@DXR ?YUUGB[19?$6@S:?"ZQ-*R99NBJ#D_6J,/PYT2+1
M'TWR#)YOW[AL>9N]0>WTIJP*UM3C=2TC4M"\1:!J6JWPO)[RYQ)C[B+T !^E
M=Q:ZEJ\WBR6%M.>'157RXY67:0P.=P'H>E81^%LK/ 6UZZECMW#QQR1[@"".
MF37>YW*.WZ4Y-6+E):"Y.3V^E)_.BBH,@HHHH ***/UH CN%=K>81<2>6VWZ
MX.*\J\)^#[;Q-H=PT<SV6N6MT^^XY[]!],>G>O1_$US+9>&]3G@;;-';L4([
M'IFLGX::?!9^$K6>+/FW8\Z5B>2U7'17+B[(O:#X5MM"TI[(R/?+(_F2M=#?
MO;N<=A6K;6L-E'Y=O#'!'UV1J%'UXJ6BI;N3J%%%%(0=*S/$7AVU\2Z>+*[9
MUAWB3Y#@DCM]*T_TK+UCQ1I7A]E2_O4@=AN$9Y;'KB@#2AA6U@CAC!$<:A%Y
MSP!BG5F:#XBL?$MO)-8.TB1-L8,,$=\XK3Z4V-D:VT2W+W*QH+B0 /+@;FQT
MYJ3Z]:,YY'2BD(/3THHHH **** "BBB@ HHHH /TK&TWPG8Z9K5UJR&22\N-
MVYI&R%R<G'%;-%.XTRE<:)I]W>1W<]G#+=1_=E8<C%73R:**!7"BBBD 4H.#
MD<4E% !U/J.V:S]:U1=-T^[:-U^U1P-,D>1NP!]['^>E:(KS+Q8="U?5+]K6
M>XF\0;?LR6_(1FZ9!QV&:J**BKC?#5YIOACPZOB2_/VW5[XLR9/SGYB, 'H*
MZ;3_ !YHNO:?)%)=+93-&8WM[CY2&([>M9_A'X:II+07>JR?:[N(8CASF.+_
M !-=/)X3T;4]02>ZTZWEE+ E@I!/N<=ZJ32-$U=*YYE]F;_GM17M?_"%Z)_T
M#(?U_P :*R]H=EV4J***9YH4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML_\ CZB_WA294?B1T5%%%9G?8Y>BBBM3S@HHHH **** "BBB@ HHHH ****
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M-:HTEP1CS9CDCZ5T+8Z Y IOTZ5-^Q/-V%_7T-)112)"BBB@ HHHH *FM/\
MCYB/;=4-9FJV6JR317&DWWDSJP)MY5!B<>GJ#[T%1^)'=T5PW]K>,?\ GQA_
M[X/^-%9\IZ!HT445H>:%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?#L'B!8[3:P$;Q$-(@[#(_2J*_9=+\/Z'JP >^^VR-+GDL 1D'_/>M74M/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGN]=U52NH7YW(C<%$^GOQ^5=@R[3BOGK4M2OYKZ226\N+F]SNDDBE;">P [
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLIQ=7D[R$-!LY1^<$8%6HZ%J%UJ>N^,%MY]!N8)[[^S3+A4FW;2#G]:S]0\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *53CTQ[TE% &%X?\&V/AW4KZ]M]QFNG)&[HBDY*C\:W:**>X]P[9[45
MS\.L:Q_PE4ME)IA;2OX;M!@].IKH,?EZ4@%&>U9?B;6O^$?T*[OPH=HD^5&Z
M%CTK3K(\5:(_B/0I[!)5A\QE)D<<  YJD.)P=YHNM:QX?N=7U'Q 5E6'STL[
M=@ !VSBN\\'ZE+JWAC3KN<GSI(?G]R#C/Z5R#?#_ ,,JT%C_ &M,=2D^4&*;
M<S'N-HZ#ZUV=KI<NA^'5L+!A+/;PLD+2< GMG'UJI6*E8T^A([T5B>$#K/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KD/BAILEQX?CO(=WVBPE$RX/.._\
M2NOQGC]*X[QEXJD\\:!I427>IW0*2*?F6)3US^'Y4X[E1.ET?5(];T>SO8R"
MDT8;CUQR/SJY6%X+\.S>&=$2RFN/M$F_?Q]U,]A_GO6[2>XGN%%%% @H^G%%
M% CBOB7X?DO(;76;5/.N+ AFA89#H#G.*YGQA%IGB@:)J5BNR]U.40/@_*N.
M#QV/^%>N8!#*1N1OE*GH5]ZX)?A=]G\01WMOJ'E64<WVA;?;DJV<X';'O6L6
M;1D=MI]A%I=G;V<"[885"*N.N.YKD_$'CJ62\;2/#\!OM3)VM,G,<7O[FNKU
M+S6T^Z\EB)C$^T^AP<5R7PECMU\+M+'$HNC,XN"W4G/3/IBH6S;)6S;*DGAF
MX\(^#]6OUD\_7)HMTUQU(!/(4^P-9>J>'HH_AG87%A$UR ZW4_J_K^ ]*[#X
MB7%[;>$[LV$1G+?NY#MR1&>K ?I7/Z7XZTO0?#.F6&GQ2ZK=-'M^SHN"#WW?
MG5I]2UW+TVJ:-I?@FZUK2;:"%IHO+W(OS+(W&#Z8_I6KX TE]%\+VD3??D!F
M8'U;G^5<1X;\+Z=XJNKJ'SKO2ECEWSZ2W(^H]N*]5C41QH@'"@#\N/Y4I"D.
MHHHK,R"BD=A%&TCLJHHW,S'  ]:Y7PQXXD\4:]>6=O;H+.W!99BQ+LN<*<?A
M5)7&E<ZNB@?,<56CU2SFF,*7<+R@X,:R L#Z8J1%FBBB@ H'RT44 "L>1T'I
M1110 5R'Q4-J/"KK.&>7S0(%4\E^1R!Z#-=?4<EO#,T;21+(T9^0NN=ON*:T
M&G9GDO@[0O$S6;QV$":3'/S+?3+\[KZ ?3TKT+PGX5C\*V<L*W$EU+,^^21^
M,GVK<R?J:*;E<J4N;8.M''<9%4]:U6/0])N;^8%XH%W%%X))XQ_*L#P;X\/B
MB\EM);+[).D?G)M?.Y#Z^_(I6N2E<T+?QEIEUK4FDK(\=^CE/+>/JPZD&N1^
M+6CZG?7VGW-G;S7$$*GF$$E&SUQ]*W];T'1]'U)O%%PTT,L+!Y/*&Y7SQTK*
MD\7ZSXPNXK7PY#)IUN 6DOKA.,>U6O(TBM;H9X=D?7OB$]U< L;"R1/F_OD#
M/!^IKK5\*Z.E^;Q=-MQ<YSOV]_7'3-8?@GPWJNB:OJD^J-%.;H*WVB-OO,"<
M\=J[&E)]B9/L'Y>E'3GC\J**@@,_EZ4444 %%%% !110* .#\<*EIXR\-7)"
MVX,A5I^@Z]#^?ZU9USQS=^&]62TU?3(AITQP+F-\Y4]]I_6MCQCX=7Q-H4ML
MH N5(>!F[,*Q=%^'">:MWK]RVK7>  CL3&G'3WK1-6U-4U;4BNO&7AS19/\
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M"6''E3V_R.GY=?QK89OR[4E9F-R*UCEAA1)I?/<#!EQ@M]1ZU+112 *FL_\
MCZB_WA4-36?_ !]1?[PI,<=T=%11169WG+T445J>>%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$VH"PM;B'1;@&0K<)MV,.@'^>E5>Q>R9Z7^GKS2445B8!1110 4444 %%%%
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M'T>P:U@D#,)NGF,/4=<8KNAS]?I3:L-JQR6@_#_3O"^H/J#W3W"PIB%KD@+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 *
MI(((ZUY[XJM)_ ^LGQ)I[J+6XD6.[MF[D^GY$UZ#^E>7?&I[D2Z='\WV38Q&
M/N^9G_"JCN7#>QUNG?$+2M5LKV>U>3S+6$S-#*-I/T]1FL'PEX9;QBT/B'79
M&N1*Q:WM,_(JYXR*YK6KJ.QN+6^L'M)OM.G"TEC#@%6*@,3[UW7@W5-+T'PQ
M96EQK%I(\2_,PDS@DYP*T:MJ:6Y=3A6T,ZE9^)+\7%PE[IL_[A$8A57.>GM7
MJOA?5/[9T"PNQ*)6>,*[+V8=0?>O-=)\9Z=X9\1:TCXU"PO9-WFP_3H0>V.*
MV_AC9W/]H:E=6\4UGHDAQ#;3=V/.1]!W]Z4EH*2T)_&7A74/&GB"UA0_9M,M
M8_FG?G+'KM'KC%=19VEAX2T-8?-$%E:K@R2GN>I-:9R><=1TS7EWBS7H/$^L
M?9);GRO#^GMFXEZ^<X/W1ZGL/:I5Y:(E+F1TGB'Q?X<N?#<LMQ(FIVLC&(1)
MRS-C].O6H_A=I^H6.A3?;%>."27?:PRGYE0]?PKSS6=)D\0/-J&B:/<6.EK'
MO=G;"MC^(9Z'%>D?#?4K_5O#\,UVT9A4&*/:IWG;W)[U36A4E[IU=%%%9&(4
M444 %%%% !SVZUS?Q"CU*3PW(FE"0R[U\Q8?O%.]6/$/C+3?#<B17+2/=. 8
MX8T)+9Z<]*UK&>6ZM8Y98#:R.N?*8Y*]^?>FM!KN<-\,M+U:)KJYOI;N*T7Y
M(+>X;ENY8CVKNKNZBL;66XG<1PQ@L[>@%8\FM:C'XN33GLF;3I8]R70!X8#D
M?G53Q]XHE\,Z:#'I_P!M2?,;-(?D48Z''KFGNR]6QUC\2/#]])(@O?)*=YU*
MJWN#72HPD4,IR&&0:^=M-T>\\1:@8=.LRY=LX0?NX^_4]J]YT.SO[*T5-0O5
MNY\!<1IL10!P /ZU4E8)1L:0/!!Y'N :3GZ>PX%%%09:A1112&%%%% @HHHH
M&%%%% !111[T <GXX\<VGAF![58_/OY8SA <!%/&21ZUPM]H:^%FTG4 \-VN
MI*OFVUTN0,@$\^G/6NO\0?#(Z]XBEU![\Q6TQ7S8@N3P.Q[#BNAU#PGI&K6]
MO#>62W"6Z"./<2"J^WO6ET:*2(M%\-^'[>0W6FVEJ9#R9(B'QTZ58\5:PWA_
MP_>7X"F2-?ESR-Q.!7,:A\-WT^5;OPW>R:9/T=&D.TKW-<?>0Z&LTL-YJ.KZ
MW<JV)'M@1&SXZ"A13'RJ6MQ^J>'VL]/T6\EGEN=>U*X6126R%4X/]1^->S@%
M549YQR:\T\*PW/B#Q;;37=I)9VVF6BB"*8_-S]TGWZG\*]+Y/)/-*78F78*/
MKQ1SV_6N(\>?$-O#-S%9V,4<UR!NE\WHJGHOUI)7)2N=P,C'45Y1XQ\)V'_"
M;:=9V:[6OCON+=>%49Y8>G>NSNO'%CI.@6U]?.L=U-&'%F#ER2.F.PK(\$V,
MEU<S^*M8DCBFN@1;K(X"QQ],\^PIQ3B6DXZF=XJT&S\%WWAZ[MK<KIEM,3.W
M4Y)'S'\OTKTFWN8KZW2XA<20R#<CKT(-9\E]I&N6MQ;M=VUW;[?WJ[P<#WKE
M8/"OB/PM(Z^'[Z&ZTYCN6VNC]W/IG^E-^\M0W6IWNTTE>:^(KKQGH^DRZE>:
MI;VJ*57R8%R22>U=YX?:Y?0[-[R4S73Q*\C,.<GG'ZU+C9$N-M2]4-Y=0V%K
M+<W,JPP1#+NW05-TKB?BI,TFFZ98(QS=72J5'4@?_K_2E$25RIK/Q.L]2TG5
M8=.EFM;E(=T4TBXWC.#MS^-8[ZE<> _#^D/I5H&N-0C\R:\D0NS'/W!71>//
M 2:II=K_ &;;JES:XC$:  ,F.GX=?SKK[6QCM].M[3 811*BL1DY  R/0UI=
M(T;44><ZCJEQXR\0>'[5;3[-J%JPGNF4Y\L<<>P[X]:ZKQ1X''B"^BU"VOY=
M/OXDV)(HRNT'/U[UQVBZTOP_U36K6]L;B]O&FW1W$:%C(#T!/XU1\6>(O$,S
M6HU*8Z9:W9R+2!L.$S]YOPQ1:^Q5KV9+K6DZ;8VK:):*VO>(+F7S7N%/^J;O
MR*R-8U;6=/N[?2H=6ENI;8!0T#Y^8X.WWQQ7H5]X1BT'PA>#0(6>^F3(N"<R
MR(>N#]*X22%9])L;/2= O8M4MY%EDN64Y9AU'TS5(::ZGHGP_P#$&JZ[82G4
MK7RUA.Q+C:5,A]U/?WKJJBLYI+BS@DEB:&1D4M&W\)QR/YU+6+W.=[Z!1112
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHJ-R;W"BCKQ7.>(/B!I'A^0PR2M=72\&" 9(/H3VH$='14=K<+>6L,\8^65
MX#=1FI/>@#F?'QU9=) TNQAOB"3+YB!V4?[*^])X?OM,\/Z3:+J#6.DZA<H'
MEA4;#_LY'45>\5Z9J>K:;Y.EWXT^?.2Q'7VSVK@/&'A-Y]0L"^HVLVKW$2P2
MP73X+,!]Y3C@?6M5JC5;6.K^)'BJ^\.:3:SZ?M8W#L/./S #'&.W-;^FW!71
M;*XNYTW-"C-(QP,D5P6J?#G6[CPSI=@+J.:6V9F>)WPHSTP?:J%U\*_$$MI!
M"VI0W"1Y*PM(VU/8?6G96'RP?4])7Q)I+R%1J=J6'&/-%:$<BS*KQL)$/(9#
MD&O%M8^&.J:7I<M](+5A" 7B@!W%>^:[?P1X\TC4K2VL"%TVXB0*D)/R-_NG
MUJ7'0EQ70T['QO8ZAXBFT6&.=IXR5\S&4..3]*Z"J,.AV-KJDVHPVRQ7<R[9
M'3HW?I5[)-9D,**/PS2@$CGGZ'I0(2BBCW[4 *VU<Y8+SCDXYK*\4ZU+X?\
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MQWXDO&U0:#9SQZ:CQ>9<7<C;=JGJ%-5/A9;W#:GJ%Q;RSR:+MV*\Y_UC@_>
M[=ZOETN5RZ'H]%%%02%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5-9_P#'U%_O"H:FL_\ CZB_WA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(ECFFR((L\9/5B:VO#'B >)M-^WI UO$TK(B,<D@=ZT+JSM[Y0MS!'<*.TB
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M&N3<QQ,?*?&&"DY /T_PK4HIWTL.[M8H66@Z=IMT]S:6<=O<2+MD=!][G/\
M/FK_ .6?I111>XMQ0<#!.0>M4)]!TRZDWRZ=:ROG.YXQFKV#Z4>U%QZHIZ=H
MNGZ.TC6-I%;-(<L47!/XU<[444;BUZA1112 **** "DDCCD&'5)<=/,4''YT
MM%%["NT'T) [>M<)XST74/'&L1Z?!_HVG6?S37## +GJ%]2!_,UW='/';'Y
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MT445J>>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVU\3F&9II;.]A&([F'[P^OM51]UZE1=C2D\/Z;/<&:33K<R]2S1#-75 5<*
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MQ4-6):L)1112$%%%% !1110 4H&>@S[4*I;IUKRSQ=XFN+SQ.]E/J-QH.GP
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MV^^F4%RN?X>^#5Q+CYE36O'EQK3?V?I%HVG6#G!2U3]ZX]\5<T7PO+K&IZ9
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MCB>XF6)9'$:;^,L3@"FPMKH344NW'0TE(04444 %%%% !1110 4444 %%%%
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MSHJ***S.\Y>BBBM3SPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUQD]J@TVW&JQ3W6L/=:?I2C$(C;RXO9 ._3K7<^+/"KKH,.GZ!I4!,I4RR'
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M;E64Y!_&FM![%;1='MM"TV&PM5(AC[MR23U/U-<!XPNM/O/B+9VNM2A-,MX
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M0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPVECCS;NZF58E'+<=Q[=JZ[3X6MM/MH9#NDCB52WN!5/N6]KDU%%%20%%%%
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MZ.BBBLCO.7HHHK4\\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>BV.BP&*QM8[93UV#D_4]ZN4.W03?8/Y?6BBBI$%%%% !1110 4444 %%%%
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MI3(TC<GV'X"G>%;S5;W21)K-N+:[W'Y5P,KVXK9I"\A***.E( HHHH ****
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MK%%&,LSG %<+X7\#2WFH?V]K@5;N1O-CM4&U4]"<?RJ;XJLUQ!HUH69+>ZO
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MO]X5#4UG_P ?47^\*3''='14445F=YR]%%%:GGA1110 4444 %%%% !1110
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M!^DB]*GH **** "BBB@ HHHH **** "E]<FL[6M8CT..WFF \F2987;^[N.
M:T#[<C&: "BBB@ HHHH **** "BBB@ _SS61>>$='U"ZDN+FPBFGD.7D=<EO
M3O6O13O8:=C)L_"6C:?.LUOIMO',O(<)DY]:URQ/7)I**6KW%=]0_6BN3\4>
M,+S0=>L-.MM/^U+<@#S&)7YB>,$>@J[=>*);/QA;:,UC(89H\_:>HW>WL*?*
MQV-^C%*JG'3M6?K&N6&@PF:^N4A4<A#RS?0=Z0MQ-?FTV+2YEU9HX[)QM<R]
M#Z8]ZX67P7+9:9%J_A74;J4!A)';,PVLN>W'\ZHZYXL;Q)-;7.IZ3<'PNLF
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M*** "C\,T44 8NM>$['7-2L;^<,+FU8%67HP!R 1]:VR/T]._O244!<****
M"BBB@ HHHH *FL_^/J+_ 'A4-36?_'U%_O"DQQW1T5%%%9G><O1116IYX444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <1\4/]9X=_Z_1_2NX;
M[Q^M<-\5,+'H3]&6^7'Z5W.?Y53V+?02BBBI("BBB@ HHHH Y[XAJ[>"M5V
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MCZ#J2IJ,$*,Z_,A!SEAG'')Q6G0M+0[FBN8\ V.M66GSKK<\DDF_;&DK!BH
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M !1110 4444 %36?_'U%_O"H:FL_^/J+_>I#CN=%11169WG+T445J>>%%%%
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MT(/DW"[@K@9QZ&JT/AK38=674DM56[5=BLN0% &!@>M3S75F2Y:69J;F'?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMOW-5]0U"+2K&:\G;;#"N]L=<>U5S=BG+2R.4FTF_'CPWCZU%#9'&ZW23:V
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MTHIEO/'=0I+#(LL3C*NAR"/44^D(**** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1M/$0]3]147@'XAHL8TS5'RD*GR;M4)!4#[K?TJK71>K1Z// EU!)!*OFQR
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M][J-P/-3S.D0/3'O5SXK.\?@NZ"=&D16/H.IK7T;5M-72[&*+4+9@L2HO[T
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M%)CCNCHJ***S.\Y>BBBM3SPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1Q)G<1&NT$^M25G)\QE)WV"BBBD(**** "BBB@ HHHH **** "BBB@ HHHH
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MH:XP> @/?]3^5=K96,6FV<-K FR&% BK]*KX2](HR?#/A&Q\+QM]G!FN9/\
M67,O+-_A6WQSC/YT44MR HHHI %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5-9_P#'U%_O"H:FL_\ CZB_WA28X[HZ*BBBLSO.7HHHK4\\****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY:$=))#\HR>XSFK^G^&_$GB"QBOKKQ#)9?:!O\B%3PIZ#@US=K8S:A:IX8M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2VNCKF=8XV=V5$499F. !ZUR5Y\4M"M9C$CW%W@X,EO'N7\S5OXB6\]QX.U
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M "BN=\3>-8/#E[:VGV>2\GG8%HX^JJ3@'_ZU=%Z=?3D<],T#L%%%% @HHHH
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M5804=44@L<_>W?\ UJWK'PIJWBHVJZG -(T*#F/3X_OOZ9]<]R>:]%50&WX
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MPI,<=T=%11169WG+T445J>>%%%% !1110 4444 %%%% !1110 4444 %%%%
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M,^J.'C^+&GJN+K3[VUG[Q[,_K2K\6=-4YFL-0@C/_+1X\BNU:-)""\:NP[L
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M;ZU:&&20I!<1@D-\V!D?E1:X^6YWM%%%(04444 %%%% !1110 4444 %%%%
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M# ,K<$'TI(HHX8PL<:1J.R+@?I3J/TH"X45''<Q232PK*K2Q8\Q >5STS4E
M!1110 <$$$9%8FD^#=)T74YKZUMRMQ)G!=MP3/7;]:VZ*=QW#WHHHI""BBCG
MM0(/QQ5/6-8M/#]C)>7LHBBCX]R>P'O57Q)XFLO"UEY]TX9V_P!5;J?FD/H*
MY;2/#=]XPOH]9\0C9;#FUL.B@9ZD?Y-4D6D2^#+>\\0>(KCQ1=QF"%X_)M8S
MUV],_I7=4BJ$5550JJ, +P /0>U+2;$W<****0@HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !4UG_Q]1?[PJ&IK/_CZB_WA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XKXM1M_P (W;R8
MS%%=(TF/3/>NQMI$FM8)8\&)D4KCIC'%1:IIL.LZ=<65RI:&9=K>H/8CZ5Q7
MAK5[OP?J<?AW6"&M9,_8KS/!7/W3[?R-7O$O>)WU%*RE>M)WQ4$!]:&P^-P!
M(Z-CD?2BBG>P7L$BK-&4D19%;ED9<J?KFDC1(8PD<:1*.B1C"CZ 4M%(8444
M4""BBB@ HHHH **** "BBCKT&: "G?=?D9QS7$^.O'%A:Z3=6=A>)/J4Q^SB
M.)LE2>"<_P">M1>!=1U.QURY\/:K.;EH8%FAD;DXP.,_0U5M+E<NES8N/ &B
M7GGM=6OGS32M*\Q8ALGN*QI/AY?:/(9O#NLS6K=3;SMN4^V>GZ5W7THR>U+F
M#FT/,]6\3W&L^'=8T768!::O;Q^:-O E (.17:^#[AKGPKI<A^\8%!/Z?TK,
M\;>!1XLGM)HI1;31MMED/5HSV^M=)8V<6G64%I""(84"*#UP*IM6&VK$U%%%
M00<%X[<:7XNT#5KI#)81Y5MPR$8G@G]/RKO=RR*&5O,1^0P^;.?2J.N:/#KV
MDW5A*%*S+A21]UL<'\#7/?#759+S19M/N2?M&GR&%L]<=OZBKW1IT-FUUW2_
M$%]>Z8CK/+;'$D9Z-ZD>M5KCP#X>NLE],B4D\E"0?YU+H_@[3=!U*XO;.)DE
MF7:=S$A><G%;7UI7[$[&+HWA.S\/NW]G236\3G<\&X%&_,9K9Y)/IC.3VI>G
M7BN9\9>*I]#:TL;"%;G5+MBL2/R$'3)]?_K5.XM9#O%7C3_A'KVWLHM.EU&X
MN(]Z1H1TSC'OTK(\#:=?-XGU75[K3&TN*XC"1Q;=JXSV_*K.B^#=7.O6VLZW
MJ0N;FW4A(47H"",9[=:[/<3DDY)J]EH4]%82BBL?Q-XIM/"UFLTP:260XAAC
M^\YJ-]B-S952W\.17 ?$+Q[#8K=Z+!"US/+%L:56&U=PQC'K7-ZWXFU34+C_
M (F>H3::KG]WI]@N9?\ @73!^IK$OK.>S6"^MM)NH(8&\U[B\R2[9XS6L8VW
M-HQMN>G>"_ 4?A_3[J&ZD2Z6^C7S(RN HQG'ZU!/\(=$EF+QR74"DY"K)D*:
MR](\;:WI2F6_MSKMG-ADEL\%HR>JG'3']*Z7P]X\L]>U!K%[6>PN\92.Y !D
M^GO2?-<3YEJ97C*:\T/3=+T:QOIPUY+Y7VJ=LNJ]-H(QZU#J?A/PUX+TMKS4
M8'U*Y8[5$C'=*Y[  UT?C+PN?$^FK%%*(+V!Q+!+V#?YQ7/V?A;7]<UFQN/$
M3V\EI8\I&ASO;L2/7H2?:EY@K-%/P7X)N7UB#7;F"#3(ERT%I&,'!&!U/3G\
MZ]*;K[U@>(_"J^(+NRN/MDEG):L#B/HXSG!_SWK?Y8]#FE>Y$F)11VSGBBI)
M#H?0USIG\1#Q8(O)B;0NN[@, 1_,&JWC+Q]#X1F@@%O]IGD&]D!VA5]<^M=-
M8WB:A8P7,7,4T8D7GH".E,K8E[^U%%%(D**** "E)R324?0YH **/QHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ,CUP/7TJMJ5XVGZ;/=Q0O<M&A=(X^2Y[8Q4>M::-9TB
MZL6E: 3)M\Q>-OO7*Z;KNF?#_38M*O[Q[S458ETAW.<GH/;Z525RHKJ7?!?B
MZ^\3+(+G2GM$CZS9^0GTYYS755FZ7JMSJN'_ +-FLK8G[]PP5V^BCI6E_"#2
M8I;Z!1112$%8TW@W19]4&HO8K]J#;RRL0"W8XZ5LT4[CN!)/4Y_Q]:***0@H
MHI5&YAT_&@"EJ>L6.C1QR7UREK'(VU6DZ$^E4]2\4V5CH%QJ\#K>VT0_Y9-]
MXYQ@'UKSCQYXP7Q%#+ICZ?);O:S%C)N!.5XSCT(K"D\42ZAI=IHXB:VTF(AI
M(X%WR2'J2Q]ZU4350TNST&#XE7$MYI\<VB36D%W(J)-,WKW'K7>%>3C[H/:O
M-/%6I6VN>%])UC2SFWTN8!X),!@!T_'BNU\-^)[;Q59M=6T4T2C (F3:,]\'
MN*F2L*4>QJT9Z\G'KG%'TK!\8>)_^$8L8VCA\^]N'\N"'W]34;F9H:[JJ:%I
M%SJ$D32I NXQJ<$]NM8NE_$"UE\.+K&HI]@221HXHADO)CT]:RO^$9\8:Y;E
M]0UF&T209^S(@8#V/!K'_L>74O$2^&O$-\TPC7S+2: !0&[KC%:)(U25BLBZ
M=8^)(M4OK?.CZO&_ERS\M;L>,U;\(>/+;PSH5W82[KR6WG(M5AY\Y6/:O03X
M;TW^R+?3Y;5+BUMAF-),GD#K7C'AKPOJ7B34[B;3XXX5AE8F>3(C4[C@#_ZU
M7HT4FF>G:#XZGOM832]5TR32KJ9=\.YCA_SZ50D^$UI)?32KJ-TEG,^^6W7J
MQSG!.:KW'@_['))K7BO5?M20H$58<J5SZ$<T_P *Z5%=7G]H^'-=G<1MMEM+
MW+ CT/\ CBI?D)^1SFI:-_PBMUJFC7*Q0:?J:%K:XSD)MY /]:[OX<ZU/K7A
M>!IX6C>WQ")/X9,<9'X5A:]I^H>/Y[_3GM?L_P!@F;[-?,,1MQ]QL]?J*[C1
M=/&EZ19V@"CR(PA '&>YINW*$OA+E&?SHHK$Q"BBB@ HHHH **/KQ10 4>W>
M@5S?BKQQ:^'6%K OV[5'XCM8SG&?7'\J=@6ITO _B7\Z I;H,_2O/[3P#J7B
M)C?^(-2F@N9!\D%NV/*7T/H:F;X>ZKI_S:7XCND*\JMQ\P_'K5617*NYW//3
M'-5-4UBST.T:ZO9UAB7UZGV KB9/&GB'PSFTUG2OM\[?+!<6_P!V0]LXX_*I
MM)\%WNOW::MXHD\^3K%8]%C]-W^'>E8:B5%CU#XG7T$LL+6/AR!]RH_WIR/\
M:]%CC6&-8T4)&@VJH[ =*55$<81 JHHX"C 'L!12;N2Y=@HHHI""BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "IK/_ (^HO]X5#4UG_P ?47^\*3''='14445F=YR]%%%:GGA1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !SVK+\
M2>'+3Q1IIM;K<I!W1R+]Y&]?I[5J44[V&G8\_ETWQ?X2@\^SOTUJSA'S02K\
MP4>E=9X:\16WBC2TO+<;,';)&>L;=P:U!\OL?6N"TW'A'XC7-J3Y-AJJ>9'V
M0/5:,OXD=[12M]:2H,PHHHH **** "BBB@ HHHH **** "E'7CC^M)10!Y=]
MAB^'7B<R7]K'>:/>/F.[= S0-[UJ^)+B.Q\?>'=6B=7AO%\@LIX8=!_2NTU#
M3[;5+22UNH5F@<?,C?S'H:YK1?AGINCZC'=F>XO/)YABF;Y8S[5HI)FBDF=<
MW4BDHHK,S"BBB@ HHHH *X730-$^*=_;?=AU&$2KGCD<\?CFNZ_6N#\?*K>,
M/"Z@B)S+_K\X) (X^G^-5'L7'<[W\*I:MK%GH=FUW>SK#&HXSU8^@'>KS=<<
MYZ5YS\1?#>J>)_$6GVUI&6MEBRTC#]W&<G)/OBE'5DK>S._L;R._M8+J$YAF
M0.O'.#7!^$[B+Q-X^U/4Y''^BCR;:(GYL="0/P_6NXTFQ32]-M;)#E8(ECSW
M.!U%><>)9-+UKQ4L&B.]IK<98"YC.V*5QSL/O[U2M?0J/4]1X/TI*YWP7XGE
M\1V<J7:>3J5J1'<1XP">?F _.NBJ62]-PKS_ .(6G:NWB&PU&QLC=Q6\+*A4
M<1.<_,0?3->@5A>)/"S>)%\M]4NK2#_GC  %/^]ZTXZ,<=&4? ?AJSTNS:ZD
MDAOM6D^:XF#!RA)S@>G]:ZBYACOK>2"=%N(9!AD<9!'TK@;7P.W@'S=7L+NX
MN_*3YK1(_P#6@]CC^==;X9U:[UK2H[J]LOL$K$XCSG(]?:F[E2N<IJW@O4O#
MU\]]X4'E+-&8I;<OR,]US7*0^$_%=](HDLY/M$,@9+J:3#1_0GJ*]K_G4<UQ
M'"5\V98RYVKN('/I0I I#-/CN8[.".[D6:[5,221C 8^N*F;ODUP'CQO$S:Y
M:0Z2LZ6A13NA'R;L\ECV%=\NX1IOY;:,X]:E]R9*VIF>*+RYL-!O)[3F[QLB
M/^TQP/\ /M7.^#9O$EK)=3>()&-C#&2H8!B[9[;?\\TWXD:3K?B"2RL=,B9K
M15WRR;@JEL\ _3^M:W@/0;_PWH[6][/YDC/O54;<(QC[N:K2Q6G*<YHFI7OB
MCQ=?:A-<36>CVBYVR#8"N>,_B,GZ5W&EZWI^N+(;"YCN?+^\$/(_"N.\0:ZO
MCSPOJMKI,,PGMW4RQD??4$]#WZ=*Y[PO?VY\7:4=$M)(Y)(O*OK1E("XX)/K
MZ_A56NA\MT>E:UX1TKQ!<03W]KYTL/"MN(R/]KU%:<42P1)'&BI&@PJKQ@>@
MKRE?%D'A'Q=?-]MN-7AE;]XS,42)N_R]\"O5895N(8I8SNCD4,I/?/\ D5#(
M:=A]%%%22%'\0'?I4=S$9K>:,$@LA7(//2N$\!>.I+Z.[L=58*UC&9#<MU*J
M<8;WYJK7V*L=[-(L,4DC'"("S,>@ ZUQ-G\2UNYUG-E,NGNXAAVH6D<YP6..
M !69/?>)O'EK?3Z:RV.DA2D<+X!G'<=.O%=+\/=<AU3P^ELD:VMQ9CR9;?D$
M'/7\>_OFG:R*Y;+4Z?;W'0]Z2N6TGP[K$?BB?5=2U!9(&4B.UA9MBYZ#![ 5
MU-2R&%%%%(04444 %%%% !1110 4444 %%%% !1110 444?C0 4444 %%%%
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MVL8PWO\ _JK2R>J-;*6J)[CQ-XA\7[K71M-DTVUD^]>7'!V^HJAX9\,0:?\
M$1+-6,JZ?;^:\C=9)".3^OZ"K4_Q U^_O([&STN"PN)/N+>/S^1Q6QX3\+ZK
MI^O7NK:O=6\UU<)M(B'0\?A1L+5%#P7(B^//$J3MY%U))\D3<;U!ZC]#^-=Y
M7'>//#TLC0:WID@AU:T^;KAI$';'>MKPOXDA\4:3'>1#9)G9+'W1AU'X]:A]
MR):JYKT9QCFCCG) '?)P,5P/C?XE1:=#)9Z3()[P_P"LN%&4A'3CWJ5&Y*CS
M'?[2N3C';^N*3=N)R?I7FGPNDUK4-0ENY;F:;3=FUFN&SO?V_P ^E>ETVK#:
MMH'X9KF_B'I?]J>$[S8,RP 3H1ZKUQ^!(KI*YOQ5X;O]<O=/:UOOLL"%A<IN
M(#J>V._>DMQ1W.0\)>+-0\.V^GG4YGN]%O1B.Y8EC"P.,$^F17J6X2*K*0RL
M,@J>".QKR'R]4T_1+_PP^B3WGF3,UO-M^5!G@_U_&O3O#FGSZ5H%A:71#7$4
M>UR.1GTS[#BKD7/N:6??O^E)DT>OM2,P5220 !G-9F9GZ/X?L=!:Z-E!Y(N'
MWN,Y&?8=JNQVT,,S31PQQRO]Z14 8_6LJ+QEH<UTUNNIV_G XP6P"?8]ZV5^
M90PY7J&[4]1ZF/JGA'2=8DWW-FKNSB0LG!8CH#[5HRS0Z?8O*0$MX(RW ^ZH
M'2J5]K<6Z:SL)8+K51&6CM]WIW8]A7"WGB;6M'\.W\7B/9)<72M%;0  2'(P
M7./X<=*=FR[-FIX3\>7?BWQ,\4<"P::D+-MZD]-K,?SXKN^X%>%Z1,?#NEF_
MT_Q%"E\,/)8A3\P)X'N17H_PZTW4K;39+[4KJ25[P^<ML_(CSW^I':FXCE&Q
MKZSXLTGPZNZ\NT63J(4.YS^ KA/"^BZ1XNM-4MH;J>SNKBX:22,@;_*SE5^F
M>3[UIZI\);+5-4GO(M0D@60EFC"AL/\ 7/2N-FT76IKY+"&PN!K%JYB:]A;:
MKICC)_'KZ5<;(<8QL;VB^,F\&0:MI5Q,+S[*=MCLYW9_A/T/-=/\/-!ETO2Y
M+V\7;J%^WG29Z@9R!^I_.N9\!^%=(M]65;N]34=6CRWD1@LD)!YW'US77KJV
ML?\ "9"QDLE&DR1$I<+R<CG)/;TQ4R\A2.B_6DHHK,R#DY QGMGI7,:'XBUK
M4]5N+6XT=+>&"0H]P7/..FT=ZZ>J^H:G;:59R7-Y,L,,8R68]3Z =S0-6+'3
MKZXHK.\/^(+7Q+8_:[0MY>2I5Q@@BM&@04444 %%%% !1110 4444 %%%*,]
MNM &)XB\41>'+K3898'E%Y-Y6]!]WW_.ML]?6N-U#7K[7M>ETK2;.+RK1QYF
MH7";EB8?W1ZBNLL[<V]NL;323OU:23DL>_TJN@WHB6BBCU]NM2(***221(EW
M.ZHN<;F.!0 M%'7'N,BEVX..,^F>: $H]:K3:E:VZW1>9,VR;YD4Y91C.<5R
M\/Q8T*XNXH!]HQ(0HF>/Y>>E.S'9G8YHK(\4>)K;PGI:WMPC3!I/+6.,CYB:
MOZ?>+J%C!=*C1+,@<1R## &D(I^)O$4/A?29+V93)M(5(U."Q/05PZ_$#Q&N
MJ65L]E:!KL@Q6ZMEPI/5N>*] UC1[37K%[.\0R0MSD'# CN#69H'@?2?#=PU
MQ:0NUPPV^9*VXJ/:KC:VI:LD7]<UZT\.V)N[]_+3.T*@+'=Z"K.FWT&J6-O=
MV[;X)DW*Q[U0\3>&[7Q5IZVETTD:*XD5D(R#W_,5?L;&#3;."VMT\N*%0B#T
M'O2%I8XKQ=X3U_QA?JIDM[/383B--^XGU8@=ZU/#/P_M/#]P+R>5K_4  !/)
MT48_A':NHZ4?YQ1S!S:6.,\2?#M->\36VI^=MB9A]IB/4A>A'N:Z'Q)J&G:/
MI3W6I(K6D9 5=H)W=@H-:-1W%E;7P1+F".=%;<%D&0#V.*+A?5%?1M437-.B
MO8HI((I,E4E&&Q5VN8T/7-8OO$U]IT^GI#I]ODI/M*\#H!V-=1MI,3T$HHHI
M""BBB@ HH^O%';- !TK%\:6)U+PKJ4 &YC$6'X<UM[<CV]:"O!# %6X.>E U
MN>/:/K/B'QGH;:%:0VWD+&L4LS'#!,\&J6J>'9)?'5IHB?O!&L4;.!@%5Y)K
MT+0_"#>&O&$]S9<Z;>0L"G_/)P<_E1X?THS^,M>UF1<;7^S0\>@^8UJI(UYD
M=+=-/;VA%G&LLRKMC61MJ^@R?2O/[KX>Z\MQ)K0UA9=84ET4)E>/X037HP]>
ME+G# CIZ5"E;4S4K'E]]X^N_$FAIHMM:2KKER?(N HX10>3]?Y5Z#H.CIH>B
MVFG*=Z0)@MC@D\FK$-C;6UQ+/#!'%/*?WDB( S>^:E8B-6;DA03A>3@<_G1S
M7V&Y=CROP[:V.H>*/$&HM%%9_95D$%F3C#8.6P:ZCX4Q[/!L+$\R2R,?SJFV
ME^&/B-J$\\4-TES'Q-/&#$&]CD=:ZW2-(MM"T^*RLT*01Y(#')R>IJI/0J3T
M+@^E<[>1Z]'XO62R$;Z4\2B99FP-P[K[UT5+SZUF0)GYCTP?PHHHH)#K7.>)
MO'%KX?NH[1()+^_<9^SP]0/>NB9Q%&[GD*"Q7Z#-<+\-;;^U+K5?$%Q\]S<3
MF.,X^XHJDNI2743PUI=[XE\3S^(-7LGMH8U"VEM-U7WQ7>?>ZFE//4Y/KGFD
MI-B;N+N.>I_.@_SZXZ4E% @HHHI %%%% !1110 4444 %%%% !1110 4444
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MP5.&\M@<?E0P9-6)XH\*6GBRUBAN6DB,;;D>,]/7COFMIV6-&=W$:*"S.QP
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M!1114$!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5-9_\?47^\*AJ:S_ ./J+_>%)CCNCHJ***S.\Y>BBBM3SPHHHH ****
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MJW[RT;[MRGJOKQVJTE8N*4D>V^GO2_=SDXKAD\6>++F,F'PN4!'WI&(I'O\
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MX45_8A<5:H^O_P!:BLFS!A1112 **** "BBB@ HHHH **** #VHHHH ****
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M3\\X&2:#[4H]^E ,RH/#ME;^(+G657_2YT$>3T7U(]S_ $K5/Y5SWB"XU_\
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M1?GE'HIYX^E>EZ/I<6AZ7;V,#,T<*[0S=3S5W)/;%)2E*XG*X4445)(4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444JKE@* (KFZBL;>
M2>>188HQN9G/ %<(/$7B'QM-)_8$:Z=IBML^V3#YFQW%5+'2Y_B/K6IG4;Z3
M^RK&<QI:Q<*W/3CZ5Z-;VT5G;QV\$:Q0QJ%1%'  _K[U7PEZ1.*7X927QSJV
MNWEX#]Z.,[5/Z_TKH])\*Z3H<(2TL84(ZR.H=C^)K6HI7%S!_P#JQ0,C'-%%
M)L5Q<GUI***!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5-
M9_\ 'U%_O"H:FL_^/J+_ 'A28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *FL_P#CZB_WA4-36?\ Q]1?[PI,<=T=%111
M69WG+T445J>>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!$4$LS'  '>L32_'&AZQ>-:6M^K3@XVL-N?IGK63\3M2D_LVVT>U.+O4Y1&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ5S&H3/\4KJW.E7<]IY 'GVTP/EKSU!'!->B0Z+96]W]L6UB^VE0K7 7YWX
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M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J:S_X^HO]X5#4UG_Q]1?[PI,<=T=%11169WG+T445
MJ>>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4UG_P ?47^\
M*AJ:S_X^HO\ >%)CCNCHJ***S.\Y>BBBM3SPHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!YLQ0'RUQ@L3V/O6BC;<U4;&'J.EV-O+!X=\/P"?59MOVN_!W%%_B /;GO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !4UG_P ?47^\*AJ:S_X^HO\ >%)CCNCHJ***S.\Y>BBBM3SPHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !C P,<8'I24F[B;N%%%%(04444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %36?_ !]1?[PJ&IK/_CZB_P!X4F..Z.BHHHK,[SEZ***U//"BBB@
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J:S_P"/J+_>%0U-9_\
M'U%_O"DQQW1T5%%%9G><O1116IYX4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%% [8ZT <5\4O$"Z9HITZ,,US?#:I'\*YY)^O2N/\ "=IJ;W$L
M7A^X.FW)C"W=K<GIC^->.GZBI->G/BCXH16X^:&&=8@!TVKR?UK<\= 6OC72
MI-&)&NL<RHGW2OJ_X?I6UNANE;0P=>\*WGA76+'4[NY746DN8U9I5YD8_>_
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M>4 \2-_^OBO055$1510JJ %51@8':JV+^$7UX^E)114D!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %36?_ !]1?[PJ&IK/_CZB_P!X
M4F..Z.BHHHK,[SEZ***U//"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#'U%_O"H:FL_\ CZB_WA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ J:S_ ./J+_>%0U-9_P#'U%_O"DQQW1T5%%%9G><O1116IYX4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU)114$!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4UG_P ?47^\
M*AJ:S_X^HO\ >%)CCNCHJ***S.\Y>BBBM3SPHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 56(/'%8FL>#='UYM]W9J)NGFQ?(_P"8K:HHV!:'$_\ "I--Z?;[\1_\
M\_-X%;FA^#])\/\ S6EJIE_Y[2DNWZUM44^9E<S%W$"DHHI;B]0HHHH$%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %36?_'U%_O"H:FL_^/J+_>%)CCNCHJ***S.\Y>BBBM3SPHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IK/_
M (^HO]X5#4UG_P ?47^\*3''='14445F=YR]%%%:GGA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %36?_'U%_O"H:FL
M_P#CZB_WA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ J:S_X^HO\ >%0U-9_\?47^\*3'
M'='14445F=YR]%%%:GGA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %36?\ Q]1?[PJ&IK/_ (^HO]X4F..Z.BHHHK,[
MSEZ***U//"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *FL_^/J+_>%0U-9_\?47^\*3''='14445F=YR]%%%:GGA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%'IVH **/4]N]+M.<4 )13O+.<=Z:Q52H9T4L<#
M<P&3Z4[,?*^P44[RS[?G1Y;8SCCUHLPLQM%'0D4=B:0@HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *FL_^/J+
M_>%0U-9_\?47^\*3''='14445F=YR]%%%:GGA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHHKPCPPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ J:S_X^HO]X5#4UG_Q]1?[PI,<
M=T=%11169WG+T445J>>%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7ZDLI5N1BOGZ]/V<VNAX=:G[.5A****P.<**** "O./V@/C9I?P%^'-]XDU
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY'^UIX4U?QM^SYXLT30K"34]6NHD6"TAQO<[QG&?I6M%VFFS6D_?3/QN]/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK:4V95/X;/U4SW]S24II*^</GPHHHH *4?+TX/M244 *6)]QG/-&??GUI**
M#]:*** /(?VP/^37_B1_V"V_F*_&\5^R'[8'_)K_ ,2/^P6W\Q7XWBO7P/P,
M]7!_PV+1117HGH"'I7T]_P $Y_\ DY.U_P"P9=?^@U\PGI7T]_P3G_Y.3M?^
MP9=?^@UAB/X9C4^!GZH4445\\> %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %36?_
M !]1?[PJ&IK/_CZB_P!X4F..Z.BHHHK,[SEZ***U//"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "IK/\ X^HO]X5#4UG_ ,?47^\*3''='14445F=YR]%
M%%:GGA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5%=7=O8VLUU<SQV]K"AEE
MGE8*B(!DL2> *AUG5[#P]H]YJFJ7D-AIUI&9;BYN&"I&@'))-?E]^UQ^V=?_
M !LO+CPSX6DET[P1"^'DR5EU+'\4GI'Z)WZFMZ5)U6=%&DZC\B[^V=^V%)\8
MKV7P?X1G>#P7;28FN1E7U*13]X^D8[#OU]J^4.E& %P/I2U[D*:IQY4>S""I
MK0***3I6IH+6]X \#ZI\3/&6D^&-%A,VHZG.(4QG"#^)SZ!1DGZ5@>W?I@=<
M^E?IY^P7^S*WPM\+'QKXBM/+\5:S$/L\$J_-96I&0,=G?@GN!@5SUJBI0\S&
MK4]G%GT7\,?A[IOPI\ Z+X5TI MKIL"Q%\?-))C+N?<MDUT]'/XXXQ17@2DV
MVV>"VVVV%%%%(05^>/\ P5(OVD\8> [(GY8K*>;MU9P/_9?TK]#J_-G_ (*?
MW!;XP>$X<8VZ%OS[F>0?T_6NO"K]Z=>&_B'QQ1117NGM!1^E%% 'Z@?\$UK+
M[-^S[=W.TJ+K6)WR1QP%3^E?5M?-O_!/&,1_LP:1@DE]0O'.?>4U])5\]6?[
MQG@UM9L****P, HHHH =&<2*?>OQ1_:&L_[-^/'C^W*[=FL7'!'3+D_UK]K5
M^\/K7XV?M:P+#^TK\10.2=5=SGW_ /UFO1P;]]GH8/=GDE%%%>N>J%+&Q2:-
M@.0ZD'/H:2F2?*I/IS2>PGL?N[X7O6U+POHUVWWKBRAE)^J _P!:TZY?X4S?
M:/A;X-FQCS-&LVY]X5KJ*^:ENSYV7Q-!1114DA1110 4444 %%%% !2X[GI[
MT?0UXE^TU^U%H'[.OA\JWEZGXKNXR;'1U;DC^_+C[J#/XXXJHQ<G9%TX^T=D
M:?[1W[1F@?L[^$7OM09;W7[Q673-)4_-/(!]YQ_"@XR?RS7Y&?$#Q]KGQ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %36
M?_'U%_O"H:FL_P#CZB_WA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHH_2@ K(\7>+M'\">'+[7M?OX=-TFSC,DUQ,V!CT'J3V Y-4/B1\1
MM ^%/A&]\1^);U+'3K5<\L \K=D0=V-?E#^TM^U!X@_:)\1EIV?3O"MK(QT_
M1P< #H))?[TAZ^@[5TT:#JN_0Z*-!U'<VOVJOVN-9_: U9]+TUIM+\$6TG^C
MV&=KW+#I+-]>R]!7SY]W';V_K1VQU'O_ #HX]*]R,(P5D>U&"@M HHHJRPI&
M^4\G&*-VT9/3OWQ7UG^QM^QM/\6KJW\8>,;9[?P5!)NM[.3*OJ3CT[B+W[]*
MSJ5%2C=D5)JG&[.@_81_9*/B[4+7XB^,;(_V%:/OTK3YU_X^Y0>)6!_Y9J>G
MJ?:OT<+?_6]JBM;6&QM8+6VB2"V@01Q11J J(. H Z "I*\&K5=65V>%5J2J
M2N%%%%8F04444 %?FG_P4\_Y+3X6_P"P /\ THDK]+*_-3_@IX/^+T>%S_U
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M%2-0. H'04]55%"JJJB@!4 X&!@8_"EKPJE651W9XE2K*H_(****Q,0HHHH
M****  =:_.+_ (*A6VWXF>#;@\J^DO&./24G^HK]':^!/^"INGA;KX=Z@H.2
MMW 3V/W"!_.NO"Z53JPK_>'P;1117NGMA1110!^J/_!.6\%S^S3:P@DM;ZI=
MHV?=\C^=?3E?('_!,;5!<_!GQ%9$_/:ZTV5] T2-G\\_E7U]7S]96J2/ K?Q
M&+1117.8A1110 Z/[Z_6OQ>_:@O!J'[1GQ%G7<0VL3*-Q]#C^E?M#&0)%).
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5-9_P#'U%_O"H:FL_\
MCZB_WA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *=&I9@!U)P.,TWZ5Q/QN
M\<#X:_"/Q;XF#A)K"PE,!SC]ZPVI^K9_"FE=V'%<SL?FW^W;\<V^+'Q<GT;3
M[@OX;\-LUI;JK?++/G$LGOS\H/H*^;./I0TTES(\\S%YI6,CLW5F)R<_B:*^
MCIQ4(I'T,(J$4D%%%%:%A6KX5\*:OXX\16.@Z#82ZGJUZXCAMHAR2>Y] .YJ
M[\/?A]KWQ2\76/AOPW8M?ZK>-A$ ^5%[NQ[*!U-?K#^S1^RYX?\ V=?#P,6S
M5?%5S&!?:PR\^\4?]U![<GO7-6KJDK+<YZU94].I@?LJ_LAZ1\ =-CUC51%J
MOCFXB FO, I9Y',</]6[U]$_3CC%' &!G\:*\.4W)W9XLIRF[MA1114$!111
M0 4444 %%%% !1110 =.:P?'WAM/&'@/Q'H3+O74=.GM@/5F0A1^>*WJ<K;6
M!]#T[52T947RM,_!2XLY--O)[.88FMY&B?(P05)!'YU'7M/[8WP^/PX_:(\5
MV4:%+*^E&I6O& 4E&XX]@Q/Y5XM7T=-\T4SZ"#YHIA1115EG5?"CQM+\.?B;
MX7\31$C^S;^*9^>-F</^:DBOW @NH;ZVANH&WP31K+$ZG@JP!!'X5^"C="*_
M5[]@WXR+\3_@I:Z3=W ;7/#.VPG0G+O !^YD/X9&?5:\W&PNE)'GXJ&BDCZ0
MHH/%%>2>2%'THI&9(HGDDD6*)%+O(QP%4 DDGVH&M3XH_P""GGQ 33?!7A?P
M9#+B?4KDW]R@//DQC:F?8L3_ -\U^=/\Z]?_ &KOB^/C5\:M:UJVDW:1;-]B
MT[T\B,D!O^!'+?C7D-?08>')32/?HQY*:"BBBN@V$ZU]S?\ !+KPB+GQ%XU\
M4R(=MM:Q6$3XXR[;W _[Y6OAAF"Y)X'<U^MO["?P]/@']G;1)9X?+O\ 7';5
M9MPYVOQ&/^^ OYUQXJ7+3L<F)ERT['T$>:***\,\4***![T >6_M,?&.+X'?
M"#6?$89?[4=?LFFHW1KE\A>/11D_A7XTWU]<ZI>7%Y>3/<7=Q(TLTTARSN3D
MDGUS7VE_P4\\?/J'C;PMX.AEQ;Z;:-?3HIZRR$JN1ZA5_6OBBO<PM/ECS,]K
M#0487"BBBNPZPI#^?XT9'KC]*^IOV0OV-;WXTW%OXI\4QR6'@:&3<D>-KZDP
M/W%](\]6[XP*SJ5%3C=DSFJ:NSG_ -E;]D;6/V@-435=2\[2?!%L^V>^VX>Z
M8'_5PYZ^[=J_5#PEX1T;P#X=LM!\/Z?#IFDV:;(;>$8 ]23W)ZDGDU=T?1[#
MP]I=MINEVD.GZ=:QB*"UMT"I&H[ 5;KQ*M:51W/%JUG484445S',%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!Y#^V!_P FP?$C_L%-_,5^-X[U
M^Q_[8'_)K_Q(_P"P6W\Q7XX#O7KX'X&>K@_@8M%%%>B>@(>E?3W_  3G_P"3
MD[7_ +!EU_Z#7S":^G?^"=!_XR4MA_U#+K_T&L,1_#9C5^!GZHT445\\> %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %36?\ Q]1?[PJ&IK/_ (^HO]X4F..Z.BHH
MHK,[SEZ***U//"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHW'U/YT?4X!]3@?K9_PWK\$O^AIN/_!?-_\ $TG_  WM\$O^AIG_ /!?-_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,_\ 76X_]&5Y^,^ XL7\!]!T445XYXX4444 %?G;_P %3/\ D>/ '_8,N/\
MT8M?HE7YV_\ !4HY\<> ?^P;<?\ HQ:ZL-_%1U87^*?$=+24M>\>V%%%% !1
M110 4444 %%%% !1110 4444 +'_ *V+_KHG_H0K]V/"G_(IZ'_UX6__ *+6
MOPGC_P!;%_UT3_T(5^['A/\ Y%/0_P#KPM__ $6M>=C-HGGXS9&I1117D'E!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !4UG_ ,?47^\*AJ:S_P"/J+_>%)CCNCHJ***S.\Y>BBBM3SPH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KY)_X*;,%_9_T@E@!_;T &3C^!Z^MJP?&G@'PW\1])33/%.C6
MNNZ>DRW"VUVI9!( 0&X(Y )_.M*<N229I3ER23/PM\U/[Z_]]"CS4_OK_P!]
M"OV=_P"&5?@[_P!$XT/_ +\M_P#%4?\ #*OP=_Z)QH?_ 'Y;_P"*KT?KD?Y3
MTOK<>Q^,7FI_?7_OH4>:G]]?^^A7[._\,J_!W_HG&A_]^6_^*H_X95^#O_1.
M-#_[\M_\51]<A_*'UN/8_&+S4_OK_P!]"CS4_OK_ -]"OV=_X95^#O\ T3C0
M_P#ORW_Q5'_#*OP=_P"B<:'_ -^6_P#BJ/KD/Y0^MQ['XQ>:G]]?^^A1YJ?W
MU_[Z%?L[_P ,J_!W_HG&A_\ ?EO_ (JC_AE7X._]$XT/_ORW_P 51]<A_*'U
MN/8_&+S4_OK_ -]"CS4_OK_WT*_9W_AE7X._]$XT/_ORW_Q5'_#*OP=_Z)QH
M?_?EO_BJ/KD/Y0^MQ['XQ>:G]]?^^A1YJ?WU_P"^A7[._P##*OP=_P"B<:'_
M -^6_P#BJ/\ AE7X._\ 1.-#_P"_+?\ Q5'UR/\ *'UN/8_&+S4_OK_WT*/-
M3^^OYBOV=_X95^#O_1.-#_[\M_\ %4?\,J_!W_HG.A_]^6_^*H^N1_E#ZW'L
M?GA_P3]D7_AI_P /@,I/V6Z[_P"Q7ZQ=.*X3PE\!?ASX#UJ+6/#O@S2M'U2)
M2J7=K&RR*",$ [N]=V:X:]55972.&M4525[!1116!SA1110 4444 ''0].F#
MR/Q]:^2/VC/V -"^)5Q=>(/ \L'A?Q%(3)-8[<6=TWK@?ZLGU''M7UO0?\\5
MI"I*#NF7"I*#T/Q#^)/P=\:?"+4WLO%?A^[TM@2%N&0M!)[I(/E-<;N!&0<C
MU%?O-JFF66N6,ECJ5G!J%E(,/;W4:R1D>FTC']:\%\<_L(?![QM))-'H$OAZ
M[<DF?1[@Q=?]@Y6O1AC%]M'HPQ4?M(_)/U[]^.:7GTK]!M>_X);Z5(Q;1?'M
MW O:/4+)6 _X$IY_*N9D_P""6.N[FV?$33=O;=8RYK=8JD]S=8BGW/A_\:3(
M/3FONW3_ /@EE>AQ]N^(EN8^XMK%\_\ CQKT;PO_ ,$S_AQI,B2ZUK&M>(&7
M&8RZVT;?4+D_K3>*I+8'B::/S0M+>;4+I+:UADN[F0X2&W0N['T %?4OP)_X
M)_\ C7XDR6^I>+5D\&^'VPY2=?\ 39E_V(_X01W:OT.^'_P0\ _"R,#PMX4T
M[2I!_P O"Q;YB?7S&RWY$5W!8MG))]:Y)XMVM Y9XMOW8G)_#/X5^%_@_P"&
M8M"\*Z9'IUDGWV^]+.W]Z1^K&NKHHKSG)MW9Y\FY.["BBBD(**** "G)RZCW
MIM'/;K0!^,/[5$B#]I+XC@LH/]LS=2/:O+?-3^^OYBOVKU[]G+X7>)M8O-5U
M;P)H^H:E>2F:XNIHF+RN>K,=W6J/_#*OP=_Z)QH?_?EO_BJ]2&+44E8]6.*C
M&*5C\8O-3^^O_?0H\U/[Z_\ ?0K]GO\ AE;X._\ 1.-#_P"_+?\ Q5)_PRK\
M'?\ HG&A_P#?EO\ XJG]<C_*/ZW'L?C%YJ?WU_[Z%'FI_?7_ +Z%?L[_ ,,J
M_!W_ *)QH?\ WY;_ .*H_P"&5?@[_P!$XT/_ +\M_P#%4?7(_P H?6X]C\8O
M-3^^O_?0H\U/[Z_]]"OV=_X95^#O_1.-#_[\M_\ %4?\,J_!W_HG&A_]^6_^
M*H^N1_E#ZW'L?C%YJ?WU_P"^A1YJ?WU_[Z%?L[_PRK\'?^B<:'_WY;_XJC_A
ME7X._P#1.-#_ ._+?_%4?7(_RA];CV/QB\U/[Z_]]"CS4_OK_P!]"OV=_P"&
M5?@[_P!$XT/_ +\M_P#%4?\ #*OP=_Z)QH?_ 'Y;_P"*H^N1_E#ZW'L?C%YJ
M?WU_[Z%'FI_?7_OH5^SO_#*OP=_Z)QH?_?EO_BJ/^&5?@[_T3C0_^_+?_%4?
M7(_RA];CV/QB,B?WU_,5^MO[!+!OV7_#)!R/-N>1_P!=*[#_ (95^#O_ $3C
M0O\ ORW_ ,57?>%_">B^!]$@T?P_IEOI&E0$F*SME(C0DY)&2:YZ^(56-K'/
M6KQJ1M8U:***XCA"BBB@ K\Z_P#@J6RIXX\!!F /]FW'_HQ:_12N1\<?"'P3
M\3+BTN/%?AC3_$$]HAC@DO4+&-3@D#!'I6U*I[.?,;T9JG.Y^'HE3^^O_?0H
M\U/[Z_\ ?0K]G?\ AE7X._\ 1.-#_P"_+?\ Q5'_  RK\'?^B<:'_P!^6_\
MBJ[_ *Y'^4[_ *W'L?C%YJ?WU_[Z%'FI_?7_ +Z%?L[_ ,,J_!W_ *)QH?\
MWY;_ .*H_P"&5?@[_P!$XT/_ +\M_P#%4?7(?RA];CV/QB\U/[Z_]]"CS4_O
MK_WT*_9W_AE7X._]$XT/_ORW_P 51_PRK\'?^B<:'_WY;_XJCZY#^4/K<>Q^
M,7FI_?7_ +Z%'FI_?7_OH5^SO_#*OP=_Z)QH?_?EO_BJ/^&5?@[_ -$XT/\
M[\M_\51]<A_*'UN/8_&+S4_OK_WT*/-3^^O_ 'T*_9W_ (95^#O_ $3C0_\
MORW_ ,51_P ,J_!W_HG&A_\ ?EO_ (JCZY#^4/K<>Q^,7FI_?7_OH4>:G]]?
M^^A7[._\,J_!W_HG&A_]^6_^*H_X95^#O_1.-#_[\M_\51]<C_*'UN/8_&+S
M4_OK_P!]"CS4_OK^8K]G?^&5?@[_ -$XT/\ [\M_\51_PRK\'?\ HG&A?]^6
M_P#BJ/KD?Y0^MQ['XR1S)YL7SK_K$[_[0K]VO"?/A+0S_P!.%O\ ^BUK@?\
MAE?X/ @CX<Z'D'(_<MU_[ZKT^"&.UMXX(4$<,:A$1>B@# 'X5S5ZZK6T.:O6
MC5M9#Z***XSB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "IK/_CZB_P!X5#4UG_Q]1?[PI,<=T=%11169
MWG+T445J>>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4N:2B@!2W&.M)110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %36?_ !]1?[PJ&IK/_CZB_P!X4F..Z.BHHHK,[SEZ
M***U//"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *FL_P#CZB_WA4-36?\ Q]1?[PI,<=T=%11169WG+T445J>>%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!4UG_P ?47^\*AJ:S_X^HO\ >%)CCNCHJ***S.\Y>BBBM3SPHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXJ^-V\I,G6;S/R@_\M37ZY_LHX'[-GPZP-H_LF/'ZU^2'Q:X^*GC;_L,W?\
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MY@!(1GH:_)/]OK_DZCQ7_P!<K3_T0E<N$UJ'+A;\[/'?"_PK\5^-K&2]\/\
MA?4-9LXY/*>>SMBZ*^,[<CO@C\ZV/^&>?B1_T(&N?^ 35]]?\$Q977X&>(-K
M%1_;\O ./^6,5?7OVB3^^W_?1KHJ8J4)M6-YXIQG:Q^)/_#//Q([> -=S_UX
MM7O/[#?P>\:>$?VDO#VIZSX1U32K"*VNP]U=6IC12T#@ GL23^M?I[YTG=V/
MXF@S.PP78KZ$USRQ4I)JQA+%.2:L,QUK\N/^"D\:R?M%197)_L>W]_XFK]2/
M6ORZ_P""DHS^T5&/^H/;_P WI83^*&$_B:GA'@/X%^.OBAIMQJ'A+PE?^(+*
MWE\B6>SC#*DF,[3SUQC\ZW[S]DOXO:?;F6Y^&VMQQ#_IW#?H#7VI_P $O/\
MDD7BX]_[<'_HD5]E+(PZ'!]16]3%3A-Q2.BIB7"=DC\)[C3?$'P\UA8Y[;4_
M#&IQ'*9$EK(N.X(QGFOM3]C_ /;FUBY\0:?X'^(UZ=1MKQU@T_7) !+%(>%2
M8_Q*3QN[5];?M$_![1?C9\+]8TO5K2-[Z"WDN-/O=O[VWF525*MUP<8([@U^
M+I>2U;S0VR>%@^Y#T93G/YC]*N$H8F#36I490Q$7='[WE2&V\;O2O#_VK?VE
M[']G7P3#/!''?>*=4W)IEC)]T8ZS2#^ZN>GKBO2OA7K<_BGX9^$=6NCFXO\
M2K6XE/\ M-&I/ZFOR?\ VQ/B1/\ $S]H#Q1=M*S66FSG2[-<Y58XL@X'NVXU
MR4://4:>R.2A3YJC71'G'CSXA>)OBIX@DU7Q-JEUKFI3O\HF)*KD\)&@X ]
M*ZG2?V9OBOK6BC5;#X?ZY/8;=RRBWVY&,Y"G!Q7UC_P3H_9XTJ\T67XG:_8I
M>7;SM!HT<RADB5>'E /!;/ ],&OO1I'=MQ8EO<_YQ734Q/LWR01TU,2J3M%'
MX/O#J_@W72&BOM UJT;./GM[B(Y_ CO7Z#_L2_MEWOC[4[?X?>.[K[1KK(1I
M>KR8#704?ZJ7_;P.#WQ7K'[8W[/&F_&KX9ZEJ-O9QCQ?H\#W5C>HH$DJJ"6A
M<_Q!AGKT.*_)K2-8NO#^IV6K6$TEM>64R74,T9PR.C!A^.16B<,5#5:EIPQ$
M;M:G[R[2OUKY)_X*:*&^ &D9 (_MZ'J/^F;5]+^ ?%*^./ OAWQ"H4?VII\-
MV0O0,R L!_P+-?-/_!3/_D@.CXZ_V]#_ .@/7G45^]BCSZ,;5$C\W/!W@76_
MB%KD6B^&M'FUG5IE9X[.U0-(RJ,L0/85Z$/V/OC+W^&>M?C O^-=I_P3Z_Y.
MAT$_].EU_P"BC7ZPY/4GO7?6KRI2LD=]:O*G))(_#CQ9\(_&/P^42^(/".J:
M'&#@SW-JRH#_ +P&!7>?!+]J[Q]\$=4@>PU>XU?00P\_1=0E,L3Q]PA/*'TQ
MQ7["ZE9VVL:?-8ZA;17UE.I26WN%#HZD8(*G(K\>OVN?A18_!OXZ:YH6DH8M
M'E5+ZSA;)\J.0$E,^@(;'M12JQQ#Y9H*=:-9VFC]9/A;\2-&^+7@G2?%6@R^
M9I]\F[8W+Q..&C;_ &E.17Y>?M+?!#QYKWQ\\=:AIW@K6+ZRN=2:2*XAM"R.
MN%Y!%?2O_!+O6KJZ^'?C;2Y&S:6.IPRPJ3G:98VWX^NP5]KB5U  =N/<UR<_
MU>;44<G-]7F^4_$K_AGGXD?]"!KO_@"U<WXI\ ZYX'N;>W\1:'>:)<7"EXHK
MV$QLZC@D ]1FOW:\^3^^WYFOSE_X*E,S?$?P%N8D_P!DW'?_ *:K791Q,JD^
M5HZJ.(=25FCY \*_#_7O',]Q#X=T*\UN:W4/,EC"9#&I. 3CIS71_P##/'Q(
M_P"A U[_ , 6KZF_X)9;E\9_$(AB#_9MOW_Z;"OT0\Z3_GHWYFE5Q4J<W%+8
M=;$.G+EL?DW^RS\$_'?A[]H7P)J6H^#=7T^PM[\--=7%J52,8/)/85^L3'YB
M/>G&9V'+M^=,Z\^]>?6JNJ[M'GU:KJ.X4445@8!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %36?_'U%_O"H:FL
M_P#CZB_WA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-.USZR;[Q/;-?DI^WU_R=1XK_P"N5I_Z(2OUK7%?DK^WT/\ C*CQ7Z^5:?\
MHA*YL'_$.;"?Q#ZO_P""8L,C? OQ!M1G']OR\J,C_4Q5]??9IO\ GD__ 'R:
M_"[P]\3/%?@VTDL]"\4:KH=I(_FO;V-RT2%S@;L#O@#\JU?^%]?$;_HH/B+_
M ,#WK6IA74FW<VJ8=U)-W/V\^S3?\\9/^^34?_ZZ_&#P3\<OB#=>-/#\$WC[
MQ!+#+J$"/&]\Y#*7 (([BOV@/7!Y&?Z5QU:+I/<XJM%TNHE?EW_P4D_Y.*B_
M[ ]O_-Z_42OR[_X*2?\ )Q4?_8'M_P";UM@_XAKA/XA[Y_P2]_Y)!XN/_4<_
M]HBOLC!K\HOV8?VR'_9M\(ZOH2^$U\0#4+[[:9FN_)V'8%VXQ[?K7KE[_P %
M3KYH2+3X<6T4G3=/J)9?T%.I0G.;:6AI5H2J3;1]M_%#QE8_#_X<^(M?U*=;
M>ULK&5B['&7*D*H]221@>]?AN[/=,Y*G?,_W3URQZ?K7L'QX_:H\<?M &.WU
MZ>*PT2%]\6DZ?E(0XZ.Y/+GZ]*Z_]C']FG4_C)X^L=>U*SDM_!>D3+<SW,B8
M6[D4Y6%#_%R.2. !733@J$&Y'13A["#NS].?A'HLOAOX7^$-*G3$UGI%O ^3
MT*PC(_.OQ1\=2-)XX\3L6);^U+OYCU_USU^[$9_>'  !!X'TK\)?' _XK3Q/
M_P!A2\_]'O66$UE)F6%?,Y,_6_\ 8SMX[;]F+P$J# :R=_Q,KDU[/7CW['G_
M ";'\/\ _KP/_HQJ]AKAJ_&SAJ?&QL\*7-K/ XRDD;*?H0:_"3Q7;K:^)-=@
M3_5QWUTB]N!*P'\J_=Y>_P#NG^1K\)?&7_(V>(_^PE=_^CGKNP75';@^I^P7
M[*3,W[./P^+')_LQ/YG]*\B_X*9?\D!T?_L/0_\ H#UZ[^RC_P FX_#[_L&+
M_P"A&O(O^"FAV_ #2..FO0_^BWKFA_'7J<]/^,?*7_!/LA?VH-!_Z]+K_P!%
MFOUB(/ZU^'_PG^*.M_!GQK:^*O#IMCJEM')'']JC\R,JZ[3\OT->\-_P4A^+
MY!Q_8.?;3_\ [*NVO1E4G='97HRJ2T/U(VY!/\(&23P /4GL*_(+]M;XB:?\
M2OVB/$6H:5<"[TVS6/3H;A3E9/*&&(/<;B>?:HOB+^V9\6OB9I<^G:IXF^PZ
M;,");?281:K(/0D$G'XUS7P2^ /B[X\>(X-.\/Z?*+#</M>K2H1;VZ9Y8MT+
M>@'6BC1]@^>HRJ-+V"YI,^W/^"8?AF;3OA3XHUV5&2'5=46.'/\ $(4()^F7
M_2OLJN;^&_P^TKX5^!=(\*Z+%Y=AIL(B#8YD?^*0^[')/UKI*\VK+GDV>74E
MSR;"OSG_ ."I'_)1_ 7_ &";C_T:E?HQ7YS_ /!4C_DH_@+_ +!-Q_Z-2M\+
M_%-<-_$1<_X)9_\ (Y_$+_L&V_\ Z-K]#*_//_@EG_R.?Q"_[!MO_P"C:_0R
MEB/XLBL7_%"BBBN0Y HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>&#&4BL+Z1(.>?))W1X^JD5^FO[!_C\>._V<]#AEF\V^T.232YO[P"',8/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "IK/\ X^HO]X5#4UG_ ,?47^\*3''='144
M45F=YR]%%%:GGA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU7\ _P#DA_@+/_0&M1_Y#%=V,YK"\!^%E\#^"="\.K<F]72K*.S%P5V^8$4
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MO?I>_:4MQ*6VJ1MP?][]*XJ4N6:DSAHR49J3/SV_X)]X_P"&H- /;[)=<_\
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MR^(#J-F+0P-:"$1X8-N!!YZ8KZ-..>,"L:CBY^[L95>5R?*)7YS_ /!4C/\
MPL;P)[:1<=_^FJ5^C%?/'[4'['\/[2WB'0=5E\5R>'CI5I):B)+03>;N8-N)
M)XQBJHR4)W9="2ISNSYX_P""6;?\5G\0O^P;;_\ HT5^AU?/O[+_ .R+#^S1
MK'B'4(O%,GB(ZM;QVYC>U$/E['#;N#SFOH*E6DIS<D%>:J3N@HHHK YPHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ J:S_ ./J+_>%0U-9_P#'U%_O"DQQW1T5%%%9G><O1116IYX4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 'I1110 4444 '&<@8HXHHH 6DHHH *%R.]%% "<_6EHHH *7
M)_"DHH **** #OUH_E110 4444 +NZTGMVHHH&%%%% @HP*** "BBB@ _'FC
MZT44 %''^3110 N?\YHS_G-)10 N?\YI*** "BBB@ HHHH **** "CT]***
M#ZT444 '-%%% !1110 N?\YHS_G-)10 N?\ .:3)^M%% !1SZT44 %%%% !1
M110 4444  S1W_QYHHH .G%%%% !1_*BB@ HHHH */IQ110 4444 %%%% !^
M-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5-9_\?47^\*AJ:S_X^HO]X4F..Z.BHHHK,[SE
MZ***U//"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *FL_\ CZB_WA4-36?_ !]1?[PI,<=T=%11169WG+T445J>>%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5-9_\?47^\*AJ:S_ ./J+_>%)CCNCHJ***S.\Y>BBBM3SPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IK/_CZB_P!X
M5#4UG_Q]1?[PI,<=T=%11169WG+T445J>>%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% @HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %36?_'U%_O"H:FL_P#CZB_W
MA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH **** "BBB@ HHHH ****
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M3_XJCZEYA]3?<_=?;[?J*-OM^HK\*/\ A-/$G_0Q:M_X&R?_ !5'_":>)/\
MH8M6_P# V3_XJCZEYA]3?<_=?;[?J*-OM^HK\*/^$T\2?]#%JW_@;)_\51_P
MFGB3_H8M6_\  V3_ .*H^I>8?4WW/W7V^WZBC;[?J*_"C_A-/$G_ $,6K?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#Q5?LUYC?WF_[Z-'F-_>;_ +Z-'UR78/KD^R/QE_X92^,/_1.M:_[]K_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !4UG_P ?47^\*AJ:S_X^HO\ >%)CCNCHJ***S.\Y>BBB
MM3SPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "IK/\ X^HO]X5#4UG_ ,?47^\*3''='14445F=YR]%%%:GGA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %36?
M_'U%_O"H:FL_^/J+_>%)CCNCHJ***S.\Y>BBBM3SPHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IK/_ (^HO]X5#4UG
M_P ?47^\*3''='14445F=YR]%%%:GGA1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %36?_'U%_O"H:FL_P#CZB_WA28X
M[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ J:S_X^HO\ >%0U-9_\?47^\*3''='14445F=YR
M]%%%:GGA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %36?\ Q]1?[PJ&IK/_ (^HO]X4F..Z.BHHHK,[SEZ***U//"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*FL_^/J+_>%0U-9_\?47^\*3''='14445F=YR]%%%:GGA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %36?_ !]1?[PJ
M&IK/_CZB_P!X4F..Z.BHHHK,[SEZ***U//"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *FL_P#CZB_WA4-36?\ Q]1?
M[PI,<=T=%11169WG+T445J>>%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5-9_\?47^\*AJ:S_X^HO]X4F..Z.BHHHK
M,[SEZ***U//"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *FL_\ CZB_WA4-36?_ !]1?[PI,<=T=%11169WG+T445J>
M>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5-9_\?47^\*AJ:S_ ./J+_>%)CCNCHJ***S.\Y>BBBM3SPHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IK/_CZB
M_P!X5#4UG_Q]1?[PI,<=T=%11169WG+T445J>>%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5-9_P#'U%_O"H:FL_\
MCZB_WA28X[HZ*BBBLSO.7HHHK4\\**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ J:S_X^HO]X5#4UG_Q]1?[PI,<=T=%
'11169WG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>imc_img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 imc_img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
M= !F P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _5.BBB@ HHHH **** "BFEP&Q@TF\9Z4K@/II;'8FJ=WK5I8
MA_.F5-O4$\_E7,:K\08$&+)/,8]"XP*^6S7B?*<EBY8S$1371-.7W(Z:6&JU
MG:$3L1,I!/(QUS5*;7[&"YB@:=?-D<1JJD'DG KS#4O%.HZF,/-Y2_W8S@5#
MH3;M>TXGD_:8\D]?O"OQ_%^+=*KBZ6%RRA=3E&+E/3>44[)>O5GLPR>:@YU9
M;)[>A[-1117]%'SH444UF"]:G6X#J:S;34;7*J"2, =SP*P]3\::98;@9O-=
M>-D8)KS<=FF"RVFZN,K1@O-I?A>[-(4YU7:"N;_F<]*BN+Z&U0O*XC0=68UY
M]J7Q"GNAMLT\E3QEN37/RRW^JRL7$T_X$BOR/-?%/ 4).CE=*5>?2R:C^5W]
MQZ]+*JDM:K43O=4\?6-IN$&;ENQ3I7*:AXUU*\W+&PMT;^%>OYU4@\+ZI.!M
MM6"GNWRBM6S^'M_-_K9(H1ZCYJ_-<;FW'G$K<:%&=*#Z13CH_-V;/3IT<!A=
M9239S)F>9RTTI=^[,>3^--W[G.<MCUKO;7X;1 (9[MV(ZA1@5K6_@;2X3DP^
M8?\ :->5AO"SB/'/VF)<8-[\TKO]?S-99MAJ>D%<\K7G&>#TP.:U_#VGW+ZU
M8LMO)M2XC9B5P  PR:]/@T*RMD"1V\:J.?NU;2!4(P ,>@K[S*_"!X;$4\1B
ML7?EDI6C'JFI;M^1PU<Y<DXPANK:LEHHHK^DSYHBGF\H#"LY/9:R;Z[U.="M
MM;1PGIOGDX_+'/YUJSD#;D9I%"H6& ?QKBQ&&E732J.-^UOSZ%*2CT.5F\):
MCJ.UKO5FQW2)< ?3FIK3X>:;&&,K33N3G<SD'Z<5TGF[6 ZY]Q2QSAUSC@],
M\5\S'A#)G4]K7H^UEWFW/_TIG5];K)<L967EH9MOX4TVV<,EK'D'@D9-:*6B
M1@A0!]%'%*UP%(' ]22/0_X4&XP!D8SZ_2OI*&7X/"QY:%&,5Y12_0YI3G/X
MI-_,7R<=\_6@0XZD?7%"SAAG'ZBI%.X9KN225D9V0@7 ]:=113L,**** "BB
MB@#QG]J?QGK7@7P)I>HZ%?-87CZI'"TBJK;HS%*Q7D'J4%?+,?[1/Q'^51XJ
MN022"3%'R>?]CZ5]&?MJ?\DPTG_L,1_^D\]?*7PPOK'3?B'X=N]3>./3H;^-
M[EYEW)Y8;G([_E0!T)_:,^(IQN\576"!@B&(C_T"O8/B!\3_ !KJ_P ,]"\;
M^%-7EM+5(S;:M:0K&?)G!P'RRY()R/\ OD]Z]&_X6I\'F!*WVAX[9L?;_<KL
M-*C\+>//!MW'I*6MSX?U%)(Y&M8MB.,;6P,#GT/J* /DKX?_ +3'BNS\8Z5+
MX@UN;4M'\[%Q&R(H\LAE+_*H/&Y6 [XKZK^+/Q A\ > +_61*))6C,=HH;&^
M1S\F#SZY^E?"7Q!\#7OPX\87VA7Y\Z:!U=9 .)4(RK#/;!'_  )3Z5;\7?%3
M5?&7A7P_H5\P:UT>)D5@?FG[*S9XRHPH]J -RT_:#^)=]=PVUKXDNI996$<<
M2Q1;F8\ #*^OK7V_\-;+7+#P5I<7B2^;4-;,>^ZF8*,.3G:-H (7.,]\5\H_
MLG_"]_$GB4^*;Q0;#3G*1(W(>?'#>A Y_&OM*$YC!(Q[4 /HHHH **** "BB
MB@#Y_P#VU/\ DF&D_P#88C_])YZ^0/#'A^[\5>(-.TBP:%+R]G\F)IR0FXCC
M.%/>OK[]M4_\6QTD#!8ZQ'A2P7/[F88R?K7R#X4\1S^$?$.G:U9I;S7=C.)X
MUN5RF]6Z'#9[=B* /7S^QQXX+C_2]$R. 1<R$C'4X\OTKZ=^!G@74/A_\/+3
M1-6:&2]@GF=WMR2A#2%AC('K7S5_PV=XT[Z;X>8^IAF_^/5M^"OVN?&.O^+-
M$TJ?3=#^S7M]#;RM%!/O1'D525/FD9P3C- ';?M?^ +'4/!(\3KMAU+3&C0S
M,"3+$SE0F?\ ?D!^F:^/[#3C?:I;6H/DL\\<3%ER(LL!SZ\\5]T?M3N'^"/B
M ,FY-UME2<!AY\?_ .JOASPT0?$6D91F(NX?O.WRG<#SE0"<\T ?HS\.O MG
MX \'Z=HEHQD2VCP\F OF.3EF('O74*NT8IL1RO/7/>GT %%%% !1110 4444
M <WXZ\$:'X]TZVL-?L4O[..<3I%([*/, (!^4@]&:N03]G'X<MEQX8A+,. +
MF8 ]>X>H_P!H?6-6TG0_#,>CZC=Z7/?:Y!9//8JK3;720856X9B<8%8_P_\
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M#D?-GJ :Y/2_@&_A_398='O[2RNSJDNH12/IT;P)$Z%!;M'N^9%1FVX88)H
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+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111322424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IM CANNABIS CORP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001792030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">40-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">68,217,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">544331111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">4690500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kibbutz<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Central District<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Glil Yam<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditedAnnualFinancialStatements', window );">Audited Annual Financial Statements</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AnnualInformationForm', window );">Annual Information Form</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMCC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KOST FORER GABBAY & KASIERER<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel-Aviv, Israel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">CT Corporation System<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">572-3133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1015 15th Street N.W.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">DC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AnnualInformationForm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag with value true on a form if it is an annual report containing an annual information form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AnnualInformationForm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditedAnnualFinancialStatements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag with value true on a form if it is an annual report containing audited financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditedAnnualFinancialStatements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111340856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,903<span></span>
</td>
<td class="nump">$ 8,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRestrictedCashAndCashEquivalents', window );">Restricted deposit</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">16,711<span></span>
</td>
<td class="nump">5,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAdvancesToSuppliers', window );">Advances to suppliers</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="nump">3,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Other accounts receivable</a></td>
<td class="nump">14,481<span></span>
</td>
<td class="nump">689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentInvestments', window );">Investments and financial instruments</a></td>
<td class="nump">3,129<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LoansAndReceivables', window );">Loans receivable</a></td>
<td class="nump">2,708<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Biological assets</a></td>
<td class="nump">1,687<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">29,391<span></span>
</td>
<td class="nump">8,370<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">84,311<span></span>
</td>
<td class="nump">27,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">30,268<span></span>
</td>
<td class="nump">5,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Investments</a></td>
<td class="nump">2,429<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets, net</a></td>
<td class="nump">18,162<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets, net</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">30,885<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">121,303<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">203,077<span></span>
</td>
<td class="nump">10,973<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">287,388<span></span>
</td>
<td class="nump">38,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">13,989<span></span>
</td>
<td class="nump">2,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Bank Loans</a></td>
<td class="nump">9,502<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Other accounts payable and accrued expenses</a></td>
<td class="nump">20,143<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets', window );">Accrued purchase consideration liabilities</a></td>
<td class="nump">6,039<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current maturities of lease liabilities</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">51,227<span></span>
</td>
<td class="nump">6,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>NON-CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WarrantsMeasuredAtFairValue', window );">Warrants measured at fair value</a></td>
<td class="nump">6,022<span></span>
</td>
<td class="nump">16,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">17,820<span></span>
</td>
<td class="nump">823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term loans</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan', window );">Employee benefit liabilities, net</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">6,591<span></span>
</td>
<td class="nump">1,503<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">31,216<span></span>
</td>
<td class="nump">19,237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">82,443<span></span>
</td>
<td class="nump">25,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital and premium</a></td>
<td class="nump">237,677<span></span>
</td>
<td class="nump">37,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury Stock</a></td>
<td class="num">(660)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Translation reserve</a></td>
<td class="nump">2,614<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Reserve from share-based payment transactions</a></td>
<td class="nump">12,348<span></span>
</td>
<td class="nump">5,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(50,743)<span></span>
</td>
<td class="num">(33,001)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Total equity attributable to shareholders of the Company</a></td>
<td class="nump">201,236<span></span>
</td>
<td class="nump">11,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="nump">3,709<span></span>
</td>
<td class="nump">1,513<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">204,945<span></span>
</td>
<td class="nump">12,610<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total equity and liabilities</a></td>
<td class="nump">$ 287,388<span></span>
</td>
<td class="nump">$ 38,116<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAdvancesToSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current advances made to suppliers before goods or services are received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAdvancesToSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables for the purchase of non-current assets. [Refer: Payables for purchase of non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity resulting from share-based payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_WarrantsMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of warrants measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_WarrantsMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111526792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">$ 54,300<span></span>
</td>
<td class="nump">$ 15,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of revenues</a></td>
<td class="nump">42,418<span></span>
</td>
<td class="nump">7,081<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_GrossProfitBeforeFairValueAdjustments', window );">Gross profit before fair value adjustments</a></td>
<td class="nump">11,882<span></span>
</td>
<td class="nump">8,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueAdjustmentsAbstract', window );"><strong>Fair value adjustments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Unrealized change in fair value of biological assets</a></td>
<td class="nump">7,210<span></span>
</td>
<td class="nump">11,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RealizedFairValueAdjustmentOnInventorySold', window );">Realized fair value adjustments on inventory sold in the year</a></td>
<td class="num">(8,796)<span></span>
</td>
<td class="num">(10,122)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets', window );">Total fair value adjustments</a></td>
<td class="num">(1,586)<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit after fair value adjustments</a></td>
<td class="nump">10,296<span></span>
</td>
<td class="nump">10,468<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">32,219<span></span>
</td>
<td class="nump">11,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="nump">8,995<span></span>
</td>
<td class="nump">3,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation</a></td>
<td class="nump">7,471<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Total operating expenses</a></td>
<td class="nump">48,685<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Profit (loss) from operating activities</a></td>
<td class="num">(38,389)<span></span>
</td>
<td class="num">(8,245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">22,024<span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance expenses</a></td>
<td class="num">(1,648)<span></span>
</td>
<td class="num">(20,504)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Finance income (expense), net</a></td>
<td class="nump">20,376<span></span>
</td>
<td class="num">(20,227)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before income taxes</a></td>
<td class="num">(18,013)<span></span>
</td>
<td class="num">(28,472)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(18,518)<span></span>
</td>
<td class="num">(28,734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Other comprehensive income that will not be reclassified to profit or loss in subsequent periods:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Remeasurement gain (loss) on defined benefit plans</a></td>
<td class="nump">21<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation to presentation currency</a></td>
<td class="nump">858<span></span>
</td>
<td class="nump">1,144<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods</a></td>
<td class="nump">879<span></span>
</td>
<td class="nump">1,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Other comprehensive income that will be reclassified to profit or loss in subsequent periods:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Adjustments arising from translating financial statements of foreign operation</a></td>
<td class="nump">530<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Total other comprehensive income that will be reclassified to profit or loss in subsequent periods</a></td>
<td class="nump">530<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Total other comprehensive income</a></td>
<td class="nump">1,409<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="num">(17,109)<span></span>
</td>
<td class="num">(27,744)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>Net loss attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Equity holders of the Company</a></td>
<td class="num">(17,763)<span></span>
</td>
<td class="num">(28,698)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="num">(755)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(18,518)<span></span>
</td>
<td class="num">(28,734)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract', window );"><strong>Total comprehensive income (loss) attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Equity holders of the Company</a></td>
<td class="num">(16,357)<span></span>
</td>
<td class="num">(27,808)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="num">(752)<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss</a></td>
<td class="num">$ (17,109)<span></span>
</td>
<td class="num">$ (27,744)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Net loss per share attributable to equity holders of the Company:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (0.74)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) excluding exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FairValueAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FairValueAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_GrossProfitBeforeFairValueAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to gross profit before fair value adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_GrossProfitBeforeFairValueAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_RealizedFairValueAdjustmentOnInventorySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Realized fair value adjustments on inventory sold in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_RealizedFairValueAdjustmentOnInventorySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111552168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Share Capital and premium [Member]</div></th>
<th class="th"><div>Treasury shares [Member]</div></th>
<th class="th"><div>Reserve from share-based payment transactions [Member]</div></th>
<th class="th"><div>Translation reserve [Member]</div></th>
<th class="th"><div>Retained earnings (deficit) [Member]</div></th>
<th class="th"><div>Equity attributable to owners of parent [Member]</div></th>
<th class="th"><div>Non-controlling interests [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 25,947<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,677<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
<td class="num">$ (4,273)<span></span>
</td>
<td class="nump">$ 24,660<span></span>
</td>
<td class="nump">$ 1,449<span></span>
</td>
<td class="nump">$ 26,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercise of warrants and compensation options</a></td>
<td class="nump">10,251<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,251<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">834<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(222)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughForfeitedOptions', window );">Forfeited Options</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(28,698)<span></span>
</td>
<td class="num">(28,698)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(28,734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">920<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="nump">890<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">920<span></span>
</td>
<td class="num">(28,728)<span></span>
</td>
<td class="num">(27,808)<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="num">(27,744)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">37,040<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,829<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
<td class="num">(33,001)<span></span>
</td>
<td class="nump">11,097<span></span>
</td>
<td class="nump">1,513<span></span>
</td>
<td class="nump">12,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of common shares, net of issuance costs</a></td>
<td class="nump">195,259<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">195,259<span></span>
</td>
<td class="nump">2,948<span></span>
</td>
<td class="nump">198,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AmountOfPurchaseOfTreasuryCommonShares', window );">Purchase of treasury common shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(660)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercise of warrants and compensation options</a></td>
<td class="nump">4,293<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,293<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(920)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,471<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,471<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughForfeitedOptions', window );">Forfeited Options</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(17,763)<span></span>
</td>
<td class="num">(17,763)<span></span>
</td>
<td class="num">(755)<span></span>
</td>
<td class="num">(18,518)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
<td class="num">(17,742)<span></span>
</td>
<td class="num">(16,357)<span></span>
</td>
<td class="num">(752)<span></span>
</td>
<td class="num">(17,109)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 237,677<span></span>
</td>
<td class="nump">$ 660<span></span>
</td>
<td class="nump">$ 12,348<span></span>
</td>
<td class="nump">$ 2,614<span></span>
</td>
<td class="num">$ (50,743)<span></span>
</td>
<td class="nump">$ 201,236<span></span>
</td>
<td class="nump">$ 3,709<span></span>
</td>
<td class="nump">$ 204,945<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AmountOfPurchaseOfTreasuryCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase of treasury common shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AmountOfPurchaseOfTreasuryCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IncreaseDecreaseThroughForfeitedOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from forfeited options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IncreaseDecreaseThroughForfeitedOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111677992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash provided from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (18,518)<span></span>
</td>
<td class="num">$ (28,734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments for non-cash items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets', window );">Unrealized gain on changes in fair value of biological assets</a></td>
<td class="num">(7,210)<span></span>
</td>
<td class="num">(11,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueAdjustmentOnSaleOfInventory', window );">Fair value adjustment on sale of inventory</a></td>
<td class="nump">8,796<span></span>
</td>
<td class="nump">10,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue', window );">Fair value adjustment on Warrants, Investments, and Accounts Receivable</a></td>
<td class="num">(21,638)<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">3,021<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization of intangible assets</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation of right-of-use assets</a></td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment of goodwill</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceIncomeCost', window );">Finance income, net</a></td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDeferredTaxExpense', window );">Deferred tax benefit</a></td>
<td class="nump">278<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based payments expenses</a></td>
<td class="nump">7,471<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation', window );">Share based acquisition costs related to business combination</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">Total adjustments for non-cash items</a></td>
<td class="num">(4,230)<span></span>
</td>
<td class="nump">22,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ChangesInNonCashWorkingCapitalAbstract', window );"><strong>Changes in non-cash working capital:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Increase in trade receivables, net</a></td>
<td class="num">(6,602)<span></span>
</td>
<td class="num">(3,534)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Increase in other accounts receivable and advances to suppliers</a></td>
<td class="nump">845<span></span>
</td>
<td class="num">(1,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets', window );">Decrease in biological assets, net of fair value adjustments</a></td>
<td class="nump">6,412<span></span>
</td>
<td class="nump">11,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Increase in inventories, net of fair value adjustments</a></td>
<td class="num">(19,707)<span></span>
</td>
<td class="num">(12,729)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Increase in trade payables</a></td>
<td class="nump">5,573<span></span>
</td>
<td class="nump">2,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Changes in employee benefit liabilities, net</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Increase in other accounts payable and accrued expenses</a></td>
<td class="nump">2,661<span></span>
</td>
<td class="nump">1,929<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInWorkingCapital', window );">Changes in non-cash working capital</a></td>
<td class="num">(10,790)<span></span>
</td>
<td class="num">(1,398)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities', window );">Taxes paid</a></td>
<td class="num">(834)<span></span>
</td>
<td class="num">(601)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(34,372)<span></span>
</td>
<td class="num">(7,919)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(4,578)<span></span>
</td>
<td class="num">(2,617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities', window );">Proceeds from loans receivable</a></td>
<td class="nump">7,796<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Purchase of intangible assets</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Acquisition of subsidiaries</a></td>
<td class="nump">12,536<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities', window );">Investments in associates</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(1,347)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentProperty', window );">Proceeds from sale of investment</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ProceedsFromInvestmentInRestrictedDeposits', window );">Proceeds from (investment in) restricted deposits</a></td>
<td class="nump">17<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(9,012)<span></span>
</td>
<td class="num">(4,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash provided by financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of share capital, net of issuance costs</a></td>
<td class="nump">28,131<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue', window );">Proceeds from issuance of warrants measured at fair value</a></td>
<td class="nump">11,222<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions', window );">Proceeds from exercise of warrants and compensation options</a></td>
<td class="nump">3,682<span></span>
</td>
<td class="nump">6,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of options</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of lease liability</a></td>
<td class="num">(633)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Repayment of lease liability interest</a></td>
<td class="num">(1,347)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from bank loan</a></td>
<td class="nump">7,804<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InterestPaidInRespectOfLoans', window );">Interest paid in respect of loans</a></td>
<td class="num">(261)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">48,731<span></span>
</td>
<td class="nump">6,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of foreign exchange on cash and cash equivalents</a></td>
<td class="num">(329)<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">5,018<span></span>
</td>
<td class="num">(5,041)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">8,885<span></span>
</td>
<td class="nump">13,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">13,903<span></span>
</td>
<td class="nump">8,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_SupplementalDisclosureOfNonCashActivitiesAbstract', window );"><strong>Supplemental disclosure of non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability', window );">Right-of-use asset recognized with corresponding lease liability</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares', window );">Conversion of warrant and compensation options into common shares</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="nump">$ 3,873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDeferredTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDeferredTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value less costs to sell of biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the repayment of advances and loans made to other parties (other than advances and loans of a financial institution), classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for income taxes paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire equity or debt instruments of other entities (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investment property. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents adjustments for share based acquisiotion costs related to business comintation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ChangesInNonCashWorkingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ChangesInNonCashWorkingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about conversion of warrant and compensation options into common shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FairValueAdjustmentOnSaleOfInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment on sale of inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FairValueAdjustmentOnSaleOfInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to fair value adjustment on warrants measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InterestPaidInRespectOfLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid in respect of loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InterestPaidInRespectOfLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to proceeds from exercise of warrants and compensation options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ProceedsFromInvestmentInRestrictedDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents cash inflow from investments in restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ProceedsFromInvestmentInRestrictedDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to proceeds from issuance of warrants measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to right-of-use asset recognized with corresponding lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_SupplementalDisclosureOfNonCashActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_SupplementalDisclosureOfNonCashActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084407016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Additional information)<br> &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems', window );"><strong>Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Acquisition of subsidiary</a></td>
<td class="nump">$ 12,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems', window );"><strong>Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WorkingCapital', window );">Working capital (excluding cash and cash equivalents)</a></td>
<td class="nump">9,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="nump">3,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">15,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">15,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="num">(15,037)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">6,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">67,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liability</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Common shares issued upon the acquisition</a></td>
<td class="num">(99,028)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems', window );"><strong>Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate', window );">Accrued purchase consideration liability</a></td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">2,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">3,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liability</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Common shares issued upon the acquisition</a></td>
<td class="num">(6,960)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="nump">6,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems', window );"><strong>Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WorkingCapital', window );">Working capital (excluding cash and cash equivalents)</a></td>
<td class="nump">4,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LoansPayableAsOfAcquisitionDate', window );">Loans payable</a></td>
<td class="num">(915)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate', window );">Property, plant and equipment and right of use assets</a></td>
<td class="nump">6,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="nump">4,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">6,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="num">(873)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">17,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">39,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="num">(915)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liability</a></td>
<td class="num">(4,061)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Common shares issued upon the acquisition</a></td>
<td class="num">(62,620)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="num">(131)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems', window );"><strong>Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WorkingCapital', window );">Working capital (excluding cash and cash equivalents)</a></td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate', window );">Accrued purchase consideration liability</a></td>
<td class="num">(1,855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate', window );">Property, plant and equipment and right of use assets</a></td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">2,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="num">(1,026)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liability</a></td>
<td class="num">(532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Common shares issued upon the acquisition</a></td>
<td class="num">(3,319)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="nump">1,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems', window );"><strong>Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WorkingCapital', window );">Working capital (excluding cash and cash equivalents)</a></td>
<td class="num">(646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate', window );">Accrued purchase consideration liability</a></td>
<td class="num">(1,332)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">1,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">4,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="num">(1,042)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liability</a></td>
<td class="num">(224)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Common shares issued upon the acquisition</a></td>
<td class="num">(4,606)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="nump">3,169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember', window );">Oranim pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems', window );"><strong>Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WorkingCapital', window );">Working capital (excluding cash and cash equivalents)</a></td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate', window );">Accrued purchase consideration liability</a></td>
<td class="num">(2,726)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate', window );">Property, plant and equipment and right of use assets</a></td>
<td class="nump">389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="nump">1,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">1,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="num">(1,312)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">2,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">2,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="num">(1,849)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liability</a></td>
<td class="num">(688)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Common shares issued upon the acquisition</a></td>
<td class="num">(4,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="nump">$ 1,619<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-controlling interest in the acquiree recognised at the acquisition date for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents accrued purchase consideration liability as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount Investment and financial instruments as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InvestmentsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents investments as of acquisition date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InvestmentsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_LeaseLiabilityAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents lease liability as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_LeaseLiabilityAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_LoansPayableAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loans payable recognised as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_LoansPayableAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_LongTermBorrowingsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents long term borrowings as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_LongTermBorrowingsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognized as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents property, plant and equipment and right of use assets as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_RightOfUseAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents right of use assets as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_RightOfUseAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108891976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract', window );"><strong>Disclosure Of General Information About Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">GENERAL [Text Block]</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1:-</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GENERAL</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate information:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM Cannabis Corp. (the "Company" or "IMCC") is listed for trading on the Canadian Securities Exchange (&#8220;CSE&#8221;) and, commencing from March 1, 2021, on NASDAQ under the ticker symbol &#8220;IMCC&#8221;. IMCC&#8217;s main office is located in Kibutz Glil-Yam, Israel.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IMCC operates in the field of medical cannabis, through Focus Medical Herbs Ltd. ("Focus"), which is licensed under the regulations of medical cannabis by the Israeli Ministry of Health ("MOH") through its Israel Medical Cannabis Agency ("IMCA") to breed, grow and supply medical cannabis product in Israel and all of its operations are performed pursuant to the Israeli Dangerous Drugs Ordinance (New Version), 1973 (the "Dangerous Drugs Ordinance"), and the related regulations issued by IMCA. During 2021 IMCC entered to the retail market using pharmacies selling medical cannabis and other pharma products.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In Europe, IMCC operates through Adjupharm, a German-based subsidiary acquired by IMC Holdings on March 15, 2019. Adjupharm is an EU-GMP certified medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In Canada, IMCC operates through Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;) d/b/a JWC and MYM, both Canadian federally licensed producer of cannabis products in the adult-use recreational cannabis market in Canada.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company and its subsidiaries do not engage in any U.S. cannabis-related activities as defined in Canadian Securities Administrators Staff Notice 51-352.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company, its subsidiaries and Focus (collectively: the "Group"), operate in geographical reporting segments (note 23). The majority of the Group&#8217;s revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">COVID-19:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Since March 31, 2020, the outbreak of the novel strain of coronavirus ("COVID-19") and the ongoing pandemic, has resulted in governments worldwide enacting various emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods, closing of non-essential businesses and social distancing, have caused material disruption to businesses globally resulting in an economic slowdown.</span></span></div>
                </div>
              </div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group has taken proactive measures to protect the health and safety of its employees in order to continue delivering high quality medical cannabis products to its patients and to maintain its financial health, including postponed planned investments in certain jurisdictions until global economic risks subside.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To date, the Group&#8217;s cannabis operations, results and financial position have not been materially impacted by COVID-19 related issues. Apart for temporary delays in Canada, the Group has not experienced material disruptions in its labor inputs and cultivation and processing activities, there have been no indicators of material issues to the Group&#8217;s supply chain, and on the consumer side, product demand has remained stable and medical cannabis has been declared an essential service across Israel, Germany and Canada, as such, the Group's overall distribution remains relatively unimpacted.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">While the precise impact of the COVID-19 outbreak on the Group remains unknown, the rapid spread of COVID-19 and declaration of the outbreak as a global pandemic have resulted in travel advisories and restrictions, certain restrictions on business operations, social distancing precautions and restrictions on group gatherings which are having direct impacts on businesses in Canada, Israel, Germany and elsewhere in the world. Such additional precautionary measures could also impact the Group&#8217;s business. The spread of COVID-19 may also have a material adverse effect on global economic activity and could result in volatility and disruption to global supply chains and the financial and capital markets. These disruptions could cause interruptions in supplies and other services from third parties upon which the Group relies; decrease demand for products; and cause staff shortages, reduced customer traffic, and increased government regulation, all of which may materially and negatively impact the business, financial condition and results of operations of the Group.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity and capital resources:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 10, 2021, the Company completed an overnight marketed offering (the &#8220;Offering&#8221;) of 6,086,956 Common Shares (each an &#8220;Offered Share&#8221;) at a price of US$5.75 per Offered Share for aggregate gross proceeds of approximately US$35 million (approximately $42,502) (see Note 15d).</span></span></div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021, the Company's cash position (cash and cash equivalents) totaled $13,903 and the Company's working capital (current assets less current liabilities) amounted to $33,084. In the year ended December 31, 2021, the Company had an operating loss of ($38,389) and negative cash flows from operating activities of ($34,372). The Company&#8217;s current operating budget includes various assumptions concerning the level and timing of cash receipts from sales and cash outlays for operating expenses and capital expenditures, including a cost saving plan. The Company is planning to finance its operations from its existing and future working capital resources and to continue to evaluate additional sources of capital and financing. However, there is no assurance that additional capital and or financing will be available to the Company, and even if available, whether it will be on terms acceptable to the Company or in amounts required. Accordingly, the Company&#8217;s board of directors approved a cost saving plan, to be implemented if needed, in whole or in part, at its discretion, to allow the Company to continue its operations and meet its cash obligations. The cost saving plan consist of cost reduction due to efficiencies and synergies, which include mainly the following steps: reduction in payroll and headcount, reduction in compensation paid to key management personnel, operational efficiencies and reduced capital expenditures. The Company and the board of directors believe that its existing financial resources and its operating plans, including the effects of the costs saving plan, will be adequate to satisfy its expected liquidity requirements for a period of at least twelve months from the end of the reporting period.</span></span></div>
                  <div style="line-height:1.25">
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <div>
                            <div style="line-height:1.25">&#160;</div>
                          </div>
                        </div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year, TJAC and certain MYM subsidiaries entered into a revolving credit facility (the &#8220;Facility&#8221;) with a private Canadian creditor. The Facility is guaranteed by Trichome Financial Corp. Advances from the Facility is used for working capital needs.</span></span></div>
                      </div>
                    </div>
                  </div>
                  <div style="line-height:1.25">
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Facility has a total commitment of up to $10,000 and has a one-year term, renewable upon mutual agreement by the parties on May 14, 2022 for up to two additional periods of 180 days. The borrowing base available for draw at any time throughout the Facility is a function of the trade receivable and inventory balances at the time of drawdown. The Facility bears interest at the higher of 9.75% and the Toronto Dominion Bank Prime Rate plus 7.30% per annum. The balance as at December 31, 2021 was $8,582.</span></span></div>
                  </div>
                </div>
              </div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In January 2022, Focus entered into a Revolving Credit Facility with Bank Mizrahi (the &#8220;Mizrahi Facility&#8221;). The Mizrahi Facility is guaranteed by Focus assets. Advances from the Mizrahi Facility will be used for working capital needs.</span></span></div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Mizrahi Facility has a total commitment of up to NIS 15,000 thousand (approximately $6,000) and has a one-year term for on-going needs and 6 months term for imports and purchases needs. The Mizrahi Facility is renewable upon mutual agreement by the parties. The borrowing base available for draw at any time throughout the Mizrahi Facility and is subject to several covenants to be measured on a quarterly basis. The Mizrahi Facility bears interest of Israeli Prime interest plus 1.5% (approximately 3.3%) per annum.</span></span></div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="vertical-align:top;width:22pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Strategic developments:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:14.15pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 2, 2019, IMC undertook a restructuring process (the "IMC Restructuring") to divest its holdings in Focus, I.M.C Pharma Ltd and I.M.C.C. Ltd. (the "Licensed Entities") and sold its interest to the two Principal Shareholders of the Company. In the process, IMC restructured its connection to the Government Issued License, from Direct Ownership to a Business Agreement relationship, according to which IMC will still gain most of the economic values generated from the License, without directly owning it. Furthermore, IMC has the option to buy back the ownership of the license from the two Principal Shareholders. The restructuring process was subject to the prior approval of the Ministry of Health (the "MOH") and became effective on June 24, 2019.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;text-indent:0pt;margin-left:92.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following the IMC Restructuring of the Licensed Entities, the Company does not currently hold, directly or indirectly, any licenses to engage in the cultivation, production, processing, distribution or sale of medical cannabis in Israel.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;text-indent:0pt;margin-left:92.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent to the IMC Restructuring, according to accounting criteria in IFRS 10, the Company is still viewed as effectively exercising control over Focus, and therefore, the accounts of Focus continue to be consolidated with those of the Company.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:14.15pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 8, 2021, the Company announced that Focus signed a multi-year supply agreement with GTEC Holdings Ltd. (&#8220;GTEC&#8221;), a Canadian licensed producer of handcrafted and high-quality cannabis (the &#8220;GTEC Agreement&#8221;). According to the GTEC Agreement, Focus will import GTEC&#8217;s high-THC medical cannabis inflorescence into Israel to be sold under the IMC brand. With the arrival of these commercial shipments, the Company will launch a new category of imported premium indoor medical cannabis products under its well-established brand.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:92.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The first import of the Canadian-grown high-THC strains from GTEC&#8217;s subsidiary, Grey Bruce Farms Incorporated (&#8220;GBF&#8221;), arrived during September 2021. According to the GTEC Agreement, Focus will purchase a minimum quantity of 500kg of high-THC medical cannabis inflorescence from GBF and will be the exclusive recipient of GTEC cannabis products in the Israeli market for a period of 12 months from the date that the first shipment of GTEC products arrives in Israel (the &#8220;Exclusive Term&#8221;). The Exclusive Term can be extended under the terms of the GTEC Agreement by an additional 6 months.</span></span></div>
                </div>
              </div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">3.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 12, 2021, the Company filed a preliminary short form base shelf prospectus (the &#8220;Preliminary Shelf Prospectus&#8221;) with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada (the &#8220;Securities Commissions&#8221;), and on March 15, 2021, the Company filed a corresponding shelf registration statement on Form F-10 with the SEC, under the Multijurisdictional Disclosure System (&#8220;MJDS&#8221;) established between Canada and the United States.</div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:96pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 31, 2021, in connection with the Preliminary Shelf Prospectus, the Company filed a final short form base shelf prospectus (the &#8220;Final Shelf Prospectus&#8221;) with the Securities Commissions and a corresponding shelf registration statement on Form F-10 (the &#8220;Registration Statement&#8221;) with the SEC. The Final Shelf Prospectus and the Registration Statement enable the Company to offer up to US$250 million (or its equivalent in other currencies) of Common Shares, warrants, subscription receipts, debt securities, units (collectively, the &#8220;Qualified Securities&#8221;), or any combination of such Qualified Securities from time to time, during the 25-month period that the Final Shelf Prospectus is effective. The specific terms of any offering under the Final Shelf Prospectus and the intended use of the net proceeds will be established in a prospectus supplement, which will be filed with the Securities Commissions and the SEC in connection with any such offering.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">4.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 12, 2021, Adjupharm entered into a supply agreement with Northern Green Canada Inc. (&#8220;NGC&#8221;) (the &#8220;NGC Supply Agreement&#8221;). Under the terms of the NGC Supply Agreement, NGC will provide Adjupharm with three new strains of medical cannabis products, to be distributed under the IMC brand to German pharmacies pursuant to Adjupharm&#8217;s distribution agreements with its German distribution partners. Shipments from NGC commenced in October 2021.</div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">5.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 18, 2021, the Company acquired all of Trichome Financial Corp.&#8217;s ("Trichome" or "TFC") issued and outstanding shares (the &#8220;Trichome Shares&#8221;). Pursuant to the terms of the Trichome Transaction, former holders of Trichome Shares and former holders of Trichome convertible instruments (the &#8220;Trichome Securityholders&#8221;) received 0.24525 of a Common Share for each Trichome Share held and each in-the-money convertible instrument of Trichome. As a result of the Trichome Transaction, a total of 10,104,901 Common Shares were issued to the Trichome Securityholders. In addition, 100,916 Common Shares were issued to financial advisors for advisory fees in connection with the Trichome Transaction.</div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">6.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 29, 2021, Adjupharm entered into a supply agreement with MediPharm Labs Corp. (&#8220;MediPharm Labs&#8221;) for certain medical cannabis extract products to be delivered by MediPharm Labs over an initial two-year term with an automatic two-year extension period. Shipments from MediPharm Labs commenced in October 2021.</div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top">7.</td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>On March 30, 2021, Zur Rose Pharma GmbH (&#8220;Zur Rose&#8221;) and the Company entered into a termination settlement agreement in connection with the sales agreements announced in July 2020 according to Zur Rose's request, and under which Adjupharm received a termination fee. According to the termination agreement, no inventory will be transferred from Zur Rose to Adjupharm or vice versa.</div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div/>
              <div style="text-align:justify;margin-left:74.7pt;line-height:1.25">&#160;</div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During March 2021, Adjupharm entered into two supply agreements with supply partners in China, under which Adjupharm bought COVID-19 rapid antigen test kits. Concurrently, Adjupharm entered into several resale agreements with reseller partners in Germany, under which Adjupharm sold the COVID-19 antigen test kits to pharmacies and retailers in Germany.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="text-align:justify;margin-left:74.7pt;line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>
                            <div>
                              <div>
                                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 30, 2021, the Company announced that its wholly-owned Israeli subsidiary, IMC Holdings, signed a definitive agreement (the &#8220;Panaxia Agreement&#8221;) with Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd. (collectively &#8220;Panaxia&#8221;) (the &#8220;Panaxia Transaction&#8221;). Pursuant to the Panaxia Agreement, IMC Holdings will acquire Panaxia&#8217;s trading house license and in-house pharmacy activities, certain distribution assets and an option to purchase a pharmacy with licenses to sell medical cannabis to patients, for an aggregate purchase price of NIS 18.7 million (approximately $7,000), comprised of NIS 7.6 million (approximately $2,800) in cash and NIS 11.1 million (approximately $4,200) in Common Shares (the &#8220;Panaxia Consideration Shares&#8221;). As of December 31, 2021, all of the cash consideration was paid and all of the common shares consideration were issued.</span></span></div>
                              </div>
                              <div style="text-align:justify">&#160;</div>
                              <div>
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia Transaction will be finalized in two stages, with an option of a third stage. Upon the initial closing, on May 30, 2021, all online-related activities and intellectual property will be transferred to IMC Holdings. The second stage requires that Panaxia will transfer its IMC-GDP license, which allows the holder to store and distribute medical cannabis in Israel, to IMC Holdings or its subsidiary (the &#8220;Panaxia IMC-GDP License&#8221;). The second stage was subject to MOH approval, which granted its approval subsequent to December 31, 2021, on February 15, 2022. Panaxia Transaction includes an option to acquire Panaxia&#8217;s pharmacy (the &#8220;Panaxia Option&#8221;), including licenses to dispense and sell products to cannabis patients (the &#8220;Panaxia Pharmacy Licenses&#8221;) for additional payment in the amount equal to the medical cannabis inventory of the pharmacy at the time of exercise. The option was exercised on February 1, 2022.</span></span></div>
                                </div>
                              </div>
                            </div>
                          </div>
                          <div>
                            <div style="line-height:1.25">&#160;</div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Panaxia Agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of all of the abovementioned acquired assets and activities and the rights to obtain all economic benefits from those assets and activities. Accordingly, the Company has concluded that it exercises control over the acquired assets and activities as of the date of the definitive agreement, which is the date from which the assets are included in these consolidated financial statements.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 9, 2021, the Company acquired all the issued and outstanding shares of MYM Nutraceuticals Inc. and closed the MYM transaction (the &#8220;MYM Transaction&#8220;). The Company acquired MYM's licensed producer subsidiary Highland Grow Inc., pursuant to a plan of arrangement to be completed under the Business Corporations Act in British Columbia. MYM operates two licensed, craft cultivation facilities in Canada; SublimeCulture Inc. in Laval, Quebec, and Highland Grow Inc., in Antigonish, Nova Scotia. MYM&#8217;s flagship brand, Highland, is an ultra-premium brand sold in most provinces throughout Canada. Under the terms of the MYM Transaction, the shareholders of MYM will receive 0.022 Common Shares of IMCC for each common share of MYM. As a result of the MYM transaction, a total of 10,073,437 Common shares were issued to the MYM former shareholders (including 49,802 Common Shares issued to a financial advisor of MYM).</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div>
                            <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 28, 2021, IMC Holdings entered into a definitive agreement to acquire all of the issued and outstanding share of R.A. Yarok Pharm Ltd., Rosen High Way Ltd. and High Way Shinua Ltd. (collectively "Pharm Yarok Group"). The aggregate consideration for the Pharm Yarok Group acquisition is NIS 11,900 thousand (approximately $4,600), of which NIS 3,500 thousand (approximately $1,300) shall be in the form of issuance of Common Shares of the Company at closing to the former shareholders. The closing of the Pharm Yarok Group acquisition is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022. As of December 31, 2021, the Company has not transferred the Common Share consideration. Pharm Yarok Group is a leading medical cannabis pharmacy and trading company located in central Israel, Rosen High Way, a trade and distribution center providing medical cannabis storage, distribution services and logistics solutions for cannabis companies and pharmacies in Israel and High Way Shinua, an applicant for a medical cannabis transportation license from the IMCA, the receipt of which would permit High Way Shinua to transport large quantities of medical cannabis to and from Pharm Yarok&#8217;s pharmacy and Rosen High Way&#8217;s distribution center and to and from third parties in the medical cannabis sector, including medical cannabis growing facilities, pharmacies, manufacturers and distribution centers across Israel.</span></span></div>
                          </div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of the Pharm Yarok Group and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over the Pharm Yarok Group as of the date of the definitive agreement, which is the date from which the accounts of the Pharm Yarok Group are included in these consolidated financial statements.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 16, 2021, IMC Holdings signed a definitive agreement to acquire 51% of the outstanding ordinary shares of Revoly Trading and Marketing Ltd. ("Vironna") for a total consideration of NIS 8,500 thousand (approximately $3,300), of which NIS 5,000 thousand (approximately $1,950) in cash and NIS 3,500 thousand (approximately $1,350) is in Common Shares of the Company to be issued at closing of Vironna transaction. The closing is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022. As of December 31, 2021, the Company paid a consideration amounted to NIS 3,750 (approximately 1,400) to the former shareholders of Virrona. Vironna is a leading pharmacy licensed to dispense and sell medical cannabis to licensed medical cannabis patients, located in central Israel.</span></span></div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021 the Company paid a consideration amounted to NIS 3,750 (approximately $1,400) to the former shareholders of Vironna.</span></span></div>
                          </div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of Vironna and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over Vironna as of the date of the definitive agreement, which is the date from which the accounts of Vironna are included in these consolidated financial statements.</span></span></div>
                          </div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:78pt">&#160;</td>
                        <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 1, 2021, IMC Holdings signed a definitive agreement to acquire 51% of the rights in Oranim Pharm, one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area, by acquiring 51.3% of the outstanding shares of Oranim Plus, which holds 99.5% of the rights in Oranim Pharm (the &#8220;Oranim Transaction&#8221;).</span></span></div>
                          <div>&#160;</div>
                          <div>
                            <div style="line-height:1.25">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Oranim Transaction closed on March 28, 2022, upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS 11,940 (approximately $4,900), consisting of NIS 5,202 (approximately $2,104) paid in cash upon signing, NIS 5,202 (approximately $2,104) which will be paid in cash on the first quarter of 2023 and NIS 1,536 (approximately $630) paid in 251,001 Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#8217;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.</span></span></div>
                              <div style="line-height:1.25">&#160;</div>
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of Oranim and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over Oranim as of the date of the definitive agreement, which is the date from which the accounts of Oranim are included in these consolidated financial statements.</span></span></div>
                            </div>
                          </div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Approval of consolidated financial statements:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements of the Group were authorized for issue by the board of directors on March 31, 2022.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Definitions:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In these financial statements:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:95pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;float:left">

                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company, or IMCC</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM Cannabis Corp.</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IM Cannabis Corp., its Subsidiaries and Focus</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Companies that are controlled by the Company (as defined in IFRS 10) and whose accounts are consolidated with those of the Company</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25;clear:both">&#160;</div>
                  <div style="margin-left:95pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;float:left">

                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAD or $</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canadian Dollar</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NIS</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New Israeli Shekel</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">USD or US$</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States Dollar</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">&#160;</td>
                          <td style="width:3.65%;vertical-align:top">&#160;</td>
                          <td style="width:73.71%;vertical-align:top">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:22.64%;vertical-align:top">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EURO or &#8364;</span></span></div>
                          </td>
                          <td style="width:3.65%;vertical-align:top">
                            <div style="text-align:center;line-height:1.25">-</div>
                          </td>
                          <td style="width:73.71%;vertical-align:top">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25;clear:both">&#160;</div>
                </div>
              </div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of general information about financial statements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109376360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureForSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure For Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">SIGNIFICANT ACCOUNTING POLICIES [Text Block]</a></td>
<td class="text">
          <div>
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>NOTE 2:-</span></span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>SIGNIFICANT ACCOUNTING POLICIES</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
            <div>
              <div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following accounting policies have been applied consistently in the financial statements for all periods presented, unless otherwise stated.</span></span></span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Basis of presentation:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB").</span></span></span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Group's financial statements have been prepared on a cost basis, except for:</span></span></span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Financial instruments which are presented at fair value through profit or loss.</span></span></span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Biological assets which are presented at fair value less cost to sell up to the point of harvest.</span></span></span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Group has elected to present the profit or loss items using the function of expense method.</span></span></span></span></span></span>
                    </div>
                  </div>

                <p style="margin:0pt">&#160;</p>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Consolidated financial statements:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The consolidated financial statements comprise the financial statements of companies that are controlled by the Company (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Potential voting rights are considered when assessing whether an entity has control. The consolidation of the financial statements commences on the date on which control is obtained and ends when such control ceases.</span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, and 2020, major subsidiaries over which the Company has control, directly or indirectly, include<span style="font-weight:bold">:</span></span></span></span></span>
                    </div>

                      <div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="1" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left">

                              <tr>
                                <td rowspan="2" style="width:67.71%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subsidiaries</span></span></span></span></div>
                                </td>
                                <td colspan="3" style="width:32.29%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Percentage ownership</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:14.18%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2020</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C. Holdings Ltd (&#8221;IMC&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Focus Medical Herbs Ltd. ("Focus") *)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C Farms Israel Ltd. ("IMC Farms")</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C Ventures Ltd. ("IMC Ventures")</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C - International Medical Cannabis Portugal Unipessoal Lda</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Adjupharm GmbH (&#8220;Adjupharm&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90.02%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">92.5%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>R.A. Yarok Pharm Ltd. (&#8220;Pharm Yarok&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Rosen High Way Ltd. (&#8220;Rosen High Way&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>High Way Shinua Ltd. (&#8220;HW Shinua&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revoly Trading and Marketing Ltd. (&#8220;Vironna&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oranim Plus Pharm LTD.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51.3%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oranim Pharm</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Corp. (&#8220;Trichome&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Cannabis GP Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Cannabis Manager Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Asset Funding Corp.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Retail Corp.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MYM Nutraceuticals Inc. (&#8220;MYM&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SublimeCulture Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CannaCanada Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MYM International Brands Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Highland Grow Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-width:2px;border-style:solid;border-color:rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25;clear:both">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>*) See also Note 1b(1)</span></span></span></span></div>
                      </div>

                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The financial statements of the Company and of the subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all companies in the Group. Significant intragroup balances and transactions and gains or losses resulting from intragroup transactions are eliminated in full in the consolidated financial statements.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-controlling interests in subsidiaries represent the equity in subsidiaries not attributable, directly or indirectly, to a parent. Non-controlling interests are presented in equity separately from the equity attributable to the equity holders of the Company. Profit or loss and components of other comprehensive income are attributed to the Company and to non-controlling interests. Losses are attributed to non-controlling interests even if they result in a negative balance of non-controlling interests in the consolidated statement of financial position.</span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The disposal of a subsidiary that does not result in a loss of control is recognized as a change in equity. Upon the disposal of a subsidiary resulting in loss of control, the Company:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the subsidiary's assets (including goodwill) and liabilities.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the carrying amount of non-controlling interests.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the adjustments arising from translating financial statements carried to equity.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes the fair value of the consideration received.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes the fair value of any remaining investment.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Reclassifies the components previously recognized in other comprehensive income (loss) on the same basis as would be required if the subsidiary had directly disposed of the related assets or liabilities.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes any resulting difference (surplus or deficit) as gain or loss.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Business combinations and goodwill:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Business combinations are accounted for by applying the acquisition method. The cost of the acquisition is measured at the fair value of the consideration transferred on the acquisition date with the addition of non-controlling interests in the acquiree. In each business combination, the Company chooses whether to measure the non-controlling interests in the acquiree based on their fair value on the acquisition date or at their proportionate share in the fair value of the acquiree's net identifiable assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Direct acquisition costs are carried to the statement of profit or loss as incurred.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In a business combination achieved in stages, equity interests in the acquiree that had been held by the acquirer prior to obtaining control are measured at the acquisition date fair value while recognizing a gain or loss resulting from the revaluation of the prior investment on the date of achieving control.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Contingent consideration is recognized at fair value on the acquisition date and classified as a financial asset or liability in accordance with IFRS 9. Subsequent changes in the fair value of the contingent consideration are recognized in profit or loss. If the contingent consideration is classified as an equity instrument, it is measured at fair value on the acquisition date without subsequent remeasurement.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill is initially measured at cost which represents the excess of the acquisition consideration and the amount of non-controlling interests over the net identifiable assets acquired and liabilities assumed. If the resulting amount is negative, the acquirer recognizes the resulting gain on the acquisition date.</span></span></span></span></div>
                  </div>

                <div/>
                <div>
                  <p style="margin:0pt">&#160;</p>

                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Functional currency, presentation currency and foreign currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Functional currency and presentation currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The functional currency of the Company is the Canadian dollar ("CAD"). The Group determines the functional currency of each Group entity.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Assets, including fair value adjustments upon acquisition, and liabilities of an investee which is a foreign operation, and of each Group entity for which the functional currency is not the presentation currency are translated at the closing rate at each reporting date. Profit or loss items are translated at average exchange rates for all periods presented. The resulting translation differences are recognized in other comprehensive income (loss).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Upon the full or partial disposal of a foreign operation resulting in loss of control in the foreign operation, the cumulative gain (loss) from the foreign operation which had been recognized in other comprehensive income is transferred to profit or loss. Upon the partial disposal of a foreign operation which results in the retention of control in the subsidiary, the relative portion of the amount recognized in other comprehensive income is reattributed to non-controlling interests.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Transactions, assets and liabilities in foreign currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Transactions denominated in foreign currency are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at each reporting date into the functional currency at the exchange rate at that date. Exchange rate differences, other than those capitalized to qualifying assets or accounted for as hedging transactions in equity, are recognized in profit or loss.</span></span></span></span></div>
                    <div/>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-monetary assets and liabilities denominated in foreign currency and measured at cost are translated at the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currency and measured at fair value are translated into the functional currency using the exchange rate prevailing at the date when the fair value was determined.</span></span></span></span>
                    </div>

                </div>
                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash equivalents:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash equivalents are considered as highly liquid investments, including unrestricted short-term bank deposits with an original maturity of three months or less from the date of investment or with a maturity of more than three months, but which are redeemable on demand without penalty and which form part of the Group's cash management.</span></span></span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>f.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term deposits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term bank deposits are deposits with an original maturity of more than three months from the date of investment and which do not meet the definition of cash equivalents. The deposits are presented according to their terms of deposit.</span></span></span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt">&#160;</td>
                            <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>g.</span></span></span></span></td>
                            <td style="width:auto;vertical-align:top;text-align:justify">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement:</span></span></span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></span></span></span></div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></span></span></span></div>
                      <div/>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>All assets and liabilities measured at fair value or for which fair value is disclosed are categorized into levels within the fair value hierarchy based on the lowest level input that is significant to the entire fair value measurement:</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="margin-left:95pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left">

                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 1</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">&#160;</td>
                              <td style="width:3.58%;vertical-align:top">&#160;</td>
                              <td style="width:82.14%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 2</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>inputs other than quoted prices included within Level 1 that are observable directly or indirectly.</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">&#160;</td>
                              <td style="width:3.58%;vertical-align:top">&#160;</td>
                              <td style="width:82.14%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 3</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>

                <div style="line-height:1.25;clear:both">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>h.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Biological assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s biological assets consist of cannabis plants.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2, Inventories. These costs include the direct cost of planting and growing materials as well as other indirect costs such as utilities and supplies used in the cultivation process.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Indirect labor for individuals involved in the cultivation and quality control process is also included, as well as depreciation on growing equipment and overhead costs such as rent to the extent it is associated with the growing space. All direct and indirect costs of biological assets are capitalized as they are incurred, and they are all subsequently recorded within the line item cost of revenues on the Group&#8217;s statements of profit or loss and other comprehensive income in the period that the related product is sold.</span></span></span></span></div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventories after harvest. The fair value is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred (e.g., post-harvest costs). The net unrealized gains or losses arising from changes in fair value less cost to sell during the period are included in the gross profit for the related period and are recorded in a separate line on the face of the Group&#8217;s statements of profit or loss and other comprehensive income.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Determination of the fair values of the biological assets requires the Group to make assumptions about how market participants assign fair values to these assets. These assumptions primarily relate to the level of effort required to bring the cannabis up to the point of harvest, costs to convert the harvested cannabis to finished goods, sales price, risk of loss, expected future yields from the cannabis plants and estimating values during the growth cycle.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group accretes fair value on a straight-line basis according to stage of growth (e.g., a cannabis plant that is 50% through its growing cycle would be ascribed approximately 50% of its harvest date expected fair value, subject to wastage adjustments).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The fair value of biological assets is categorized within Level 3 of the fair value hierarchy. For the inputs and assumptions used in determining the fair value of biological assets, see Note 8.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s estimates are, by their nature, subject to change and differences from the anticipated yield will be reflected in the gain or loss on biological assets in future periods.</span></span></span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>i.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories are measured at the lower of cost and net realizable value. The cost of inventories comprises costs of purchase and costs incurred in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and estimated costs necessary to make the sale. The Group reviews inventory for obsolete, redundant and slow-moving goods and any such inventory are written-down to net realizable value.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories of purchased finished goods and packing materials are initially valued at cost and subsequently at the lower of cost and net realizable value.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The direct and indirect costs of inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labor and depreciation expense on equipment involved in packaging, labeling and inspection.</span></span></span></span></div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of revenues on the Group&#8217;s statements of profit or loss and other comprehensive income at the time cannabis is sold, except for realized fair value amounts included in inventory sold which are recorded as a separate line item on the face of the statements of profit or loss and other comprehensive income.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has otherwise been damaged.</span></span></span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>j.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property, plant and equipment:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation, accumulated impairment losses and excluding day-to-day servicing expenses. Cost includes spare parts and auxiliary equipment that are used in connection with plant and equipment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is depreciated separately using the component method.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values which are determined through the exercise of judgement and calculated on a straight-line basis over the useful lives of the assets at annual rates as follows:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>

                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr>
                                <td style="width:49.99%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Mainly %</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Buildings</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Greenhouse production equipment</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7 - 33</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Greenhouse structure</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.5</span></span></td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.5</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Motor vehicles</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>15-33</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Computer, software and equipment</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20 - 50</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leasehold improvements</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>See below</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>See below</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>

                    </div>
                    <div style="line-height:1.25;clear:both">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leasehold improvements are depreciated on a straight-line basis over the shorter of the lease term and the useful life of the improvement.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate. Depreciation of an asset ceases at the earlier of the date that the asset is classified as held for sale and the date that the asset is derecognized.</span></span></span></span></div>
                  </div>

                <div/>
                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>k.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Impairment of non-financial assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group evaluates the need to record an impairment of non-financial assets whenever events or changes in circumstances indicate that the carrying amount is not recoverable. If the carrying amount of non-financial assets exceeds their recoverable amount, the assets are reduced to their recoverable amount. The recoverable amount is the higher of fair value less costs of sale and value in use. In measuring value in use, the expected future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the asset. The recoverable amount of an asset that does not generate independent cash flows is determined for the cash-generating unit to which the asset belongs. Impairment losses are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>An impairment loss of an asset, other than goodwill, is reversed only if there have been changes in the estimates used to determine the asset's recoverable amount since the last impairment loss was recognized. Reversal of an impairment loss, as above, shall not be increased above the lower of the carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized for the asset in prior years and its recoverable amount. The reversal of impairment loss of an asset presented at cost is recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following criteria are applied in assessing impairment of these specific assets:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill in respect of subsidiaries:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company reviews goodwill for impairment once a year, on December 31, or more frequently if events or changes in circumstances indicate that there is an impairment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit (or group of cash-generating units) to which the goodwill has been allocated. The Company identified the operations and Israel, Canada and Europe as three separate cash-generating units.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>An impairment loss is recognized if the recoverable amount of the cash-generating unit (or group of cash-generating units) to which goodwill has been allocated is less than the carrying amount of the cash-generating unit (or group of cash-generating units). Any impairment loss is allocated first to goodwill. Impairment losses recognized for goodwill cannot be reversed in subsequent periods. During the year ended December 31, 2021, the Company recorded goodwill impairment in the amount of $275 with respect to the cash generating unit in Germany.</span></span></span></span></div>
                  </div>

                <div/>
                <div>
                  <p style="margin:0pt">&#160;</p>

                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>l.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue recognition:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from contracts with customers is recognized when the control over the goods or services is transferred to the customer. The transaction price is the amount of the consideration that is expected to be received based on the contract terms, excluding amounts collected on behalf of third parties (such as taxes).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In determining the amount of revenue from contracts with customers, the Group evaluates whether it is a principal or an agent in the arrangement. The Group is a principal when the Group controls the promised goods or services before transferring&#160;</span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>them to the customer. In these circumstances, the Group recognizes revenue for the gross amount of the consideration. When the Group is an agent, it recognizes revenue for the net amount of the consideration, after deducting the amount due to the principal.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from the sale of goods:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from the sale of cannabis products is generally recognized at a point in time when control over the goods have been transferred to the customer. Payment is typically due prior to or upon delivery and revenue is recognized upon the satisfaction of the performance obligation. The Group satisfies its performance obligation and transfers control upon delivery and acceptance by the customer.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Variable consideration:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group determines the transaction price separately for each contract with a customer. When exercising this judgment, the Group evaluates the effect of each variable amount in the contract, taking into consideration discounts, penalties, variations, claims, and non-cash consideration. In determining the effect of the variable consideration, the Group normally uses the "most likely amount" method described in the Standard. Pursuant to this method, the amount of the consideration is determined as the single most likely amount in the range of possible consideration amounts in the contract. According to the Standard, variable consideration is included in the transaction price only to the extent that it is highly probable that a significant reversal in the amount of revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span></span></span></span></div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Bill-and-hold arrangements:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Due to strict regulations of storage and handling large quantities of cannabis products, the Group's customer may request the Group to retain physical possession of a sold product until it is delivered to the customer at a future point in time. Revenue from bill-and-hold sales is recognized before the product is physically delivered to the customer when all of the following criteria are met:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a) The reason for the bill-and-hold arrangement is substantive (for example, the customer has requested the arrangement);</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b)</span></span><span> </span><span><span>The product is identified separately as belonging to the customer;</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c)</span></span><span> </span><span><span>The product currently is ready for physical delivery to the customer;</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d)</span></span><span> </span><span><span>The Group does not have the ability to use the product by selling it or delivering it to another customer.</span></span></span></span></div>

                </div>
                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>m.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leases:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For leases in which the Group is the lessee, the Group recognizes on the commencement date of the lease a right-of-use asset and a lease liability, excluding leases whose term is up to 12 months and leases for which the underlying asset is of low value. For these excluded leases, the Group has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Group has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the lease liability includes all unpaid lease payments discounted at the interest rate implicit in the lease, if that rate can be readily determined, or otherwise using the Group's incremental borrowing rate. After the commencement date, the Group measures the lease liability using the effective interest rate method.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the right-of-use asset is recognized in an amount equal to the lease liability plus lease payments already made on or before the commencement date and initial direct costs incurred. The right-of-use asset is measured applying the cost model and amortized over the shorter of its useful life and the lease term. The periods of amortization are: Land and buildings &#8211; 5-12 years; Motor vehicles &#8211; 3 years.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div/>
                    </div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Variable lease payments that depend on an index:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the Group uses the index rate prevailing on the commencement date to calculate the future lease payments.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For leases in which the Group is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the right-of-use asset, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease extension and termination options:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In the event of any change in the expected exercise of the lease extension option or in the expected non-exercise of the lease termination option, the Group remeasures the lease liability based on the revised lease term using a revised discount rate as of the date of the change in expectations. The total change is recognized in the carrying amount of the right-of-use asset until it is reduced to zero, and any further reductions are recognized in profit or loss.</span></span></span></span></div>
                  </div>

                <p style="margin:0pt">&#160;</p>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>n.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research and development expenditures:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research expenditures are recognized in profit or loss when incurred.</span></span></span></span></div>
                  </div>

                <div style="line-height:1.25">
                  <div/>
                </div>
                <div>
                  <p style="margin:0pt">&#160;</p>

                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>o.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial instruments:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group apply the provisions of IFRS 9, "Financial Instruments".</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial assets are measured upon initial recognition at fair value plus transaction costs that are directly attributable to the acquisition of the financial assets, except for financial assets measured at fair value through profit or loss in respect of which transaction costs are recorded in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group classifies and measures debt instruments in the financial statements based on the following criteria:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s business model for managing financial assets; and</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The contractual cash flow terms of the financial asset.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Debt instruments are measured at amortized cost when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s business model is to hold the financial assets in order to collect their contractual cash flows, and the contractual terms of the financial assets give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. After initial recognition, the instruments in this category are measured according to their terms at amortized cost using the effective interest rate method, less any provision for impairment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Debt instruments are measured at fair value through profit or loss when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial asset which is a debt instrument does not meet the criteria for measurement at amortized cost or at fair value through other comprehensive income. After initial recognition, the financial asset is measured at fair value and gains or losses from fair value adjustments are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Equity instruments:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Investments in equity instruments do not meet the above criteria and accordingly are measured at fair value through profit or loss. Dividends from investments in equity instruments are recognized in profit or loss when the right to receive the dividends is established.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div/>
                    </div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Impairment of financial assets:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group evaluates at the end of each reporting period the loss allowance for financial debt instruments measured at amortized cost. The Group has short-term financial assets, principally trade receivables, in respect of which the Group applies a simplified approach and measures the loss allowance in an amount equal to the lifetime expected credit losses. The impairment loss, if any, is recognized in profit or loss with a corresponding allowance that is offset from the carrying amount of the assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognition of financial assets:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial asset is derecognized only when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The contractual rights to the cash flows from the financial asset has expired; or</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has transferred substantially all the risks and rewards deriving from the contractual rights to receive cash flows from the financial asset or has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset; or</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has retained its contractual rights to receive cash flows from the financial asset but has assumed a contractual obligation to pay the cash flows in full without material delay to a third party.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities measured at amortized cost:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities measured at fair value through profit or loss:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>At initial recognition, the Group measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs incurred at initial recognition are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>After initial recognition, changes in fair value are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div/>
                    </div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognition of financial liabilities:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial liability is derecognized only when it is extinguished, that is when the obligation specified in the contract is discharged or cancelled or expires. A financial liability is extinguished when the debtor discharges the liability by paying in cash, other financial assets, goods or services; or is legally released from the liability.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issue of a unit of securities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The issue of a unit of securities involves the allocation of the proceeds received (before issue expenses) to the securities issued in the unit based on the following order: financial derivatives and other financial instruments measured at fair value in each period. Then fair value is determined for financial liabilities that are measured at amortized cost. The proceeds allocated to equity instruments are determined to be the residual amount. Issue costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></span></span></span></div>

                </div>
                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>p.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Employee benefit liabilities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has several employee benefit plans:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term employee benefits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term employee benefits are benefits that are expected to be settled wholly before twelve months after the end of the annual reporting period in which the employees render the related services. These benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Post-employment benefits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has defined contribution plans pursuant to section 14 to the Israeli Severance Pay Law under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods. Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense when contributed concurrently with performance of the employee's services.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div/>
                    </div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group also operates a defined benefit plan in respect of severance pay pursuant to the Israeli Severance Pay Law. According to the Severance Pay Law, employees are entitled to severance pay upon dismissal or retirement. The liability for termination of employment is measured using the projected unit credit method. The actuarial assumptions include expected salary increases and rates of employee turnover based on the estimated timing of payment. The amounts are presented based on discounted expected future cash flows using a discount rate determined by reference to market yields at the reporting date on high quality corporate bonds that are linked to the Consumer Price Index with a term that is consistent with the estimated term of the severance pay obligation.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In respect of its severance pay obligation to certain of its employees, the Group makes current deposits in pension funds and insurance companies (the "plan assets"). Plan assets comprise assets held by a long-term employee benefit fund or qualifying insurance policies. Plan assets are not available to the Group&#8217;s own creditors and cannot be returned directly to the Group.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The liability for employee benefits shown in the statement of financial position reflects the present value of the defined benefit obligation less the fair value of the plan assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remeasurements of the net liability are recognized in other comprehensive income in the period in which they occur.</span></span></span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>q.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based payment transactions:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group's employees and service providers are entitled to remuneration in the form of equity-settled share-based payments.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Equity-settled transactions:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The cost of equity-settled transactions with employees is measured at the fair value of the equity instruments granted at grant date. The fair value is determined using an acceptable option pricing model.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As for other service providers, the cost of the transactions is measured at the fair value of the goods or services received as consideration for equity instruments granted.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The cost of equity-settled transactions is recognized in profit or loss together with a corresponding increase in equity during the period which the performance and/or service conditions are to be satisfied ending on the date on which the relevant employees become entitled to the award (the "vesting period"). The cumulative expense recognized for equity-settled transactions at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group's best estimate of the number of equity instruments that will ultimately vest.</span></span></span></span></div>
                  </div>

                <div/>
                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>r.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Provisions:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A provision in accordance with IAS 37 is recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. When the Group expects part or all of the expense to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense is recognized in the statement of profit or loss net of any reimbursement.</span></span></span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>s.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Taxes on income:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current or deferred taxes are recognized in profit or loss, except to the extent that they relate to items which are recognized in other comprehensive income or equity.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current taxes:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The current tax liability is measured using the tax rates and tax laws that have been enacted or substantively enacted by the reporting date as well as adjustments required in connection with the tax liability in respect of previous years.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are computed in respect of temporary differences between the carrying amounts in the financial statements and the amounts attributed for tax purposes.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are measured at the tax rate that is expected to apply when the asset is realized, or the liability is settled, based on tax laws that have been enacted or substantively enacted by the reporting date.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred tax assets are reviewed at each reporting date and reduced to the extent that it is not probable that they will be utilized. Deductible carryforward losses and temporary differences for which deferred tax assets had not been recognized are reviewed at each reporting date and a respective deferred tax asset is recognized to the extent that their utilization is probable.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are offset if there is a legally enforceable right to offset a current tax asset against a current tax liability and the deferred taxes relate to the same taxpayer and the same taxation authority.</span></span></span></span></div>
                  </div>

                <div/>
                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>t.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Earnings per share:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Earnings per share are calculated by dividing the net income attributable to equity holders of the Group by the weighted number of Common Shares outstanding during the period.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Potential Common Shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share from continuing operations. Potential Common Shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share. The Company's share of earnings of investees is included based on its share of earnings per share of the investees multiplied by the number of shares held by the Company.</span></span></span></span></div>
                  </div>

                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>u.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Expenditures relating to internally generated intangible assets, excluding capitalized development costs, are recognized in profit or loss when incurred.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company acquired brand with indefinite life. The Company believes that it will use the asset perpetually, with no intention of discontinuing the brand in the future. Intangible assets with indefinite useful lives are not systematically amortized and are tested for impairment annually or whenever there is an indication that the intangible asset may be impaired. The useful life of these assets is reviewed annually to determine whether their indefinite life assessment continues to be supportable. If the events and circumstances do not continue to support the assessment, the change in the useful life assessment from indefinite to finite is accounted for prospectively as a change in accounting estimate and on that date the asset is tested for impairment. Commencing from that date, the asset is amortized systematically over its useful life.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible assets with a finite useful life are amortized over their useful life and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for an intangible asset are reviewed at least at each year end.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortization is calculated on a straight-line basis over the useful life of the assets as follows:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>

                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

                            <tr>
                              <td style="width:76.8%;vertical-align:top">&#160;</td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Years</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">&#160;</td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cultivations and processing license</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6-19</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationships</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5-19</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Brand</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9 - indefinite</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other intangibles</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3-9</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>

                  </div>

                <p style="margin:0pt">&#160;</p>

                  <div>
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>v.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Government grants:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A government grant is recorded as a reduction of expenses or the cost of a related asset when there is reasonable assurance that the entity will comply with the relevant conditions and the grant will be received. When a government grant is for the purchase of an asset, the cost of the asset is reduced by the value of the grant on acquisition if all conditions for the grant are met and it is reasonably certain to be received, resulting in a reduction of depreciation expense over the useful life of the asset in the statement of profit and loss.</span></span></span></span></div>
                        </div>
                      </div>
                    </div>
                  </div>

                <div>
                  <div>
                    <div style="line-height:1.25">
                      <div style="line-height:1.25">&#160;</div>

                        <div>
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>w.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Treasury shares:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="margin-left:85.05pt;text-align:justify;line-height:1.25">&#160;</div>
                          <div style="margin-left:85.05pt;text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Company shares held by the Company and/or subsidiaries are recognized at cost of purchase and presented as a deduction from equity. Any gain or loss arising from a purchase, sale, issue or cancellation of treasury shares is recognized directly in equity.</span></span></span></div>
                        </div>

                      <div style="line-height:1.25">&#160;</div>
                    </div>
                  </div>
                </div>

                  <div>
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>x.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating segments:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                          <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker ("CODM"), who is responsible for allocating resources and assessing performance of the operating segments. The Company's Chief Executive Officer is the CODM. The Company has determined that it operates in three operating segments (see Note 23).</span></span></span></span></div>
                        </div>
                      </div>
                    </div>
                  </div>

              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureForSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureForSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131107736408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract', window );"><strong>Significant Accounting Estimates And Assumptions Used In Preparation Of Financial Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory', window );">SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS [Text Block]</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 3:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements:</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">
                  <p style="margin:0pt">&#160;</p>
                </div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">a.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Judgments:</span></span></div>
                      </td>
                    </tr>

                </table>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Determining the fair value of share-based payment transactions:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The fair value of share-based payment transactions is determined upon initial recognition by an acceptable option pricing model. The inputs to the model include share price, exercise price and assumptions regarding expected volatility, expected life of share option and expected dividend yield.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Discount rate for a lease liability:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">When the Group is unable to readily determine the discount rate implicit in a lease in order to measure the lease liability, the Group uses an incremental borrowing rate. That rate represents the rate of interest that the Group would have to pay to borrow over a similar term and with similar security, the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment. When there are no financing transactions that can serve as a basis, the Group determines the incremental borrowing rate based on its credit risk, the lease term and other economic variables deriving from the lease contract's conditions and restrictions. In certain situations, the Group is assisted by an external valuation expert in determining the incremental borrowing rate.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">b.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Estimates and assumptions:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The key assumptions made in the financial statements concerning uncertainties at the reporting date and the critical estimates computed by the Group that may result in a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Assessment of going concern:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The use of the going concern basis of preparation of the financial statements. At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Group will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.</span></span></div>
                <div/>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In arriving at this determination, the Group has undertaken a thorough review of the Group&#8217;s cash flow forecast and potential liquidity risks. Cash flow projections have been prepared which show that the Group&#8217;s operations will be cash generative during the period of at least 12 months from the date of approval of the consolidated financial statements.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Biological assets and inventory:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In calculating the value of the biological assets and inventory, management is required to make several estimates, including estimating the stage of growth of the cannabis up to the point of harvest, harvesting costs, selling costs, average or expected selling prices and list prices, expected yields for the cannabis plants, and oil conversion factors. The valuation of work-in-process and finished goods also requires the estimate of conversion costs incurred, which become part of the carrying amount for the inventory. The Group must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has otherwise been damaged. See Note 9 for further information.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Legal claims:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In estimating the likelihood of legal claims filed against the Group entities, the Group management rely on the opinion of its legal counsel. These estimates are based on the legal counsel's best professional judgment, taking into account the stage of proceedings and legal precedents in respect of the different issues. Since the outcome of the claims may be determined in courts, the results could differ from these estimates.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Deferred tax assets:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Deferred tax assets are recognized for unused carryforward tax losses and deductible temporary differences to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgment is required to determine the amount of deferred tax assets that can be recognized, based upon the timing and level of future taxable profits, its source and the tax planning strategy.</span></span></div>
                <div/>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Impairment of goodwill:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Group reviews goodwill for impairment at least once a year. This requires management to make an estimate of the projected future cash flows from the continuing use of the cash-generating unit (or a group of cash-generating units) to which the goodwill is allocated and also to choose a suitable discount rate for those cash flows.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:85.05pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Determining the fair value of an unquoted financial assets and liabilities:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The fair value of unquoted financial assets in Level 3 of the fair value hierarchy is determined using valuation techniques, generally using future cash flows discounted at current rates applicable for items with similar terms and risk characteristics. Changes in estimated future cash flows and estimated discount rates, after consideration of risks such as liquidity risk, credit risk and volatility, are liable to affect the fair value of these assets.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of significant accounting estimates and assumptions used in the preparation of the financial statements explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131107736280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract', window );"><strong>Disclosure of expected impact of initial application of new standards or interpretations [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations', window );">DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION [Text Block]</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 4:-</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION</span></span></div>
                </td>
              </tr>

          </table>
          <div style="text-align:justify;line-height:1.25;font-style:italic">
            <p style="margin:0pt">&#160;</p>
            <p style="margin-left:56.7pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">a. Amendment to IAS 1, "Presentation of Financial Statements":</span></span></p>
          </div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In January 2020, the IASB issued an amendment to IAS 1, "Presentation of Financial Statements" ("the Amendment") regarding the criteria for determining the classification of liabilities as current or non-current.</span></span>
            <p style="margin:0pt">&#160;</p>
          </div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendment includes the following clarifications:</span></span></div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">What is meant by a right to defer settlement;</span></span></div>
                </td>
              </tr>

          </table>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">That a right to defer must exist at the end of the reporting period;</span></span></div>
                </td>
              </tr>

          </table>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">That classification is unaffected by the likelihood that an entity will exercise its deferral right;</span></span></div>
                </td>
              </tr>

          </table>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">That only if an embedded derivative in a convertible liability is itself an equity instrument would the terms of a liability not impact its classification.</span></span></div>
                </td>
              </tr>

          </table>
          <div/>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendment is effective for annual periods beginning on or after January 1, 2023 and must be applied retrospectively.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Group is evaluating the possible impact of the Amendment on its current loan agreements.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">b. Amendments to IFRS 3, "Business Combinations":</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In May 2020, the IASB issued Amendments to IFRS 3 Business Combinations &#8211; Reference to the Conceptual Framework which are intended to replace a reference to the Framework for the Preparation and Presentation of Financial Statements with a reference to the Conceptual Framework for Financial Reporting, that was issued in March 2018, without significantly changing its requirements.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The IASB added an exception to the recognition principle of IFRS 3 to avoid the issue of potential &#8216;day 2&#8217; gains or losses arising for liabilities and contingent liabilities that would be within the scope of IAS 37 Provisions, Contingent Liabilities and Contingent Assets or IFRIC 21 Levies, if incurred separately</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">According to the exception, liabilities and contingent liabilities within the scope of IAS 37 or IFRIC 21 will be recognized on the acquisition date according to the criteria in IAS 37 or IFRIC 21 and not according to the Conceptual Framework.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendments also clarify that contingent assets do not qualify for recognition at the acquisition date.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendments are effective for annual reporting periods beginning on or after January 1, 2022 and apply prospectively.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">c. Amendment to IAS 8, "Accounting Policies, Changes to Accounting Estimates and Errors":</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In February 2021, the IASB issued an amendment to IAS 8, "Accounting Policies, Changes to Accounting Estimates and Errors" ("the Amendment"), in which it introduces a new definition of "accounting estimates".</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Accounting estimates are defined as "monetary amounts in financial statements that are subject to measurement uncertainty". The Amendment clarifies the distinction between changes in accounting estimates and changes in accounting policies and the correction of errors.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendment is to be applied prospectively for annual reporting periods beginning on or after January 1, 2023 and is applicable to changes in accounting policies and changes in accounting estimates that occur on or after the start of that period. Early application is permitted.</span></span></div>
          <div/>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Group is evaluating the effects of the Amendment on its financial statements.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">d. Amendment to IAS 12, "Income Taxes":</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">In May 2021, the IASB issued an amendment to IAS 12, "Income Taxes" ("IAS 12"), which narrows the scope of the initial recognition exception under IAS 12.15 and IAS 12.24 ("the Amendment").</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">According to the recognition guidelines of deferred tax assets and liabilities, IAS 12 excludes recognition of deferred tax assets and liabilities in respect of certain temporary differences arising from the initial recognition of certain transactions. This exception is referred to as the "initial recognition exception". The Amendment narrows the scope of the initial recognition exception and clarifies that it does not apply to the recognition of deferred tax assets and liabilities arising from transactions that are not a business combination and that give rise to equal taxable and deductible temporary differences, even if they meet the other criteria of the initial recognition exception.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.5pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Amendment applies for annual reporting periods beginning on or after January 1, 2023, with earlier application permitted. In relation to leases and decommissioning obligations, the Amendment is to be applied commencing from the earliest reporting period presented in the financial statements in which the Amendment is initially applied. The cumulative effect of the initial application of the Amendment should be recognized as an adjustment to the opening balance of retained earnings (or another component of equity, as appropriate) at that date.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:56.5pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Group estimates that the initial application of the Amendment is not expected to have a material impact on its financial statements.</span></span></div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 30<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_30_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108729560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Disclosure of detailed information about business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">BUSINESS COMBINATIONS [Text Block]</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div style="text-align:justify;line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman, Times, serif;font-size:10pt">NOTE 5:-</span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">BUSINESS COMBINATIONS</span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trichome Financial Corp.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 18, 2021, the Company acquired Trichome Financial Corp. (&#8220;Trichome&#8221; or "TFC"), a Canadian adult-use recreational cannabis producer (the "Trichome Transaction").</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Trichome Transaction was completed pursuant to the terms and subject to the conditions of arrangement agreement dated December 30, 2020 (the "Arrangement Agreement"), whereby the Company agreed to acquire all of the issued and outstanding Trichome Shares under a statutory plan of arrangement under the <span style="font-style:italic">Business Corporations Act </span>(Ontario) ("OBCA").</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the terms of the Arrangement Agreement, former holders of Trichome Shares received 0.24525 IMC Common Shares for each Trichome Share previously held (the &#8220;Exchange Ratio&#8221;) and former holders of Trichome in-the-money convertible instruments received a net payment of IMC Shares based on the Exchange Ratio (the &#8220;Consideration&#8221;).</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon completion of the Trichome Transaction, the total Consideration paid to former holders of Trichome Shares and in-the-money convertible instruments equaled to the issuance of 10,104,901 Common Shares, valued at approximately $99,028 at the market price per share of $9.8 on the date of the acquisition. The results of operations of Trichome were consolidated in the Company's consolidated financial statements commencing on the date of acquisition.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a valuation study prepared by management with the assistance of an external valuation specialist.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon acquisition, other payables of Trichome include approximately $8,131 to settle withholding tax liabilities to Canada Revenue Agency (&#8220;CRA&#8221;), with a corresponding indemnification asset comprised of 927,463 IMCC&#8217;s Common Shares withheld to cover the tax liabilities (the "Purchaser Balance Shares"). In addition, in connection with the Trichome Transaction, certain directors and officers of Trichome and TJAC, one of which is currently serving as chairman of the board of directors of the Company, agreed to indemnify and hold harmless the Company, Trichome, and TJAC against 75% of the withholding tax liabilities to CRA. Each indemnifying director or officer agreed to indemnify for: (a) 75% of such liability that is on account of such director or officer&#8217;s personal Canadian income tax liability, plus (b) jointly and severally indemnify 75% of any liability for penalties and interest in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a)).</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, subsequent to the reporting period, on January 6, 2022, the Company and certain former Trichome directors, one of which is currently serving as chairman of the Company's board of directors, signed an amendment to the tax indemnification agreement, and agreed to indemnify and hold harmless the Company and pay the Company the following amounts in cash as soon as practicable and in no event no later than February 28, 2022: (a). any portion of remittance to the CRA on account of any non-residence Canadian estimated at approximately $1,886, plus (b) 75% of any liabilities for penalties up to December 31, 2021 and 100% of any penalties from January 1, 2022 onward (estimated at approximately $604), and indemnify 75% of any liabilities for interest through December 31, 2021 and 100% of any interest from January 1, 2022 (estimated at approximately $342), in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a) above), plus (c) To the extent not captured above in sections (a) and (b), 100% of the withholding taxes tax liabilities, <span style="text-decoration:underline">subtracting</span> all cash proceeds received by Trichome or IMC from the sale of the Purchaser Balance Shares.</span></span></div>
                <div/>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;margin-left:50.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of the date of the issuance of these consolidated financial statements, the former Trichome director and current chairman of the Company's board of director, transferred the Company cash in the amount of $3,250. Further, on March 30, 2022, the Company and the former Trichome director and current chairman of the Company's board of director, entered into several security agreements under which the former Trichome director and current chairman of the Company's board of director pledged 833,508 Common Shares and 275,125 vested RSU&#8217;s in favor of the Company to secure the indemnification asset for the remaining tax withholding liability. Such pledge of securities was registered in Ontario and British Columbia.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                    </div>
                    <div style="text-align:justify;margin-left:49.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 18, 2021, 700,000 options were granted to Trichome&#8217;s employees under the 2018 Plan (see Note 18).</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:50.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition costs of Trichome include the issuance of 50,525 Common Shares, valued at $495 to financial advisors for advisory fees in connection with the Trichome Transactions.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:50.85pt;line-height:1.25">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trichome's revenue and net loss included in the Company&#8217;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $9,223 and $(17,983), respectively.</span></span></p>
                      <div style="margin-left:50.85pt;line-height:1.25">&#160;</div>
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the Trichome Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                      <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                    </div>
                  </div>
                </div>

                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="text-align:justify;margin-left:63pt;line-height:1.25">
                            <div>
                              <div>
                                <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                    <tr>
                                      <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">55,563</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(25,372</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                      </td>
                                    </tr>

                                </table>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>

              </div>
              <p style="margin:0pt">&#160;</p>
              <p style="margin-left:56.7pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and TFC been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></p>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MYM Nutraceuticals Inc.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 9, 2021, the Company, through its wholly owned subsidiary, Trichome, completed the acquisition of MYM Nutraceuticals (&#8220;MYM&#8221;). MYM is a Canadian cultivator, processor, and distributor of premium cannabis via its two wholly owned subsidiaries; SublimeCulture Inc. (&#8220;Sublime&#8221;) located near Montreal, Quebec, and Highland Grow Inc. (&#8220;Highland&#8221;), located in Antigonish, Nova Scotia. MYM&#8217;s flagship brand, Highland, is an ultra-premium brand sold in most provinces throughout Canada.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company acquired all the issued and outstanding shares of MYM. The Company acquired MYM's licensed producer subsidiary Highland Grow Inc., pursuant to a plan of arrangement under the Business Corporations Act in British Columbia. Under the terms of the MYM Transaction, the shareholders of MYM received 0.022 Common Shares of IMCC for each common share of MYM. As a result of the MYM transaction, a total of 10,073,437 Common Shares were issued to the MYM former shareholders and financial advisors, resulting in former MYM shareholders holding approximately 15% of the total number of issued and outstanding Common Shares immediately after closing. Total consideration of the issued shares, warrants and stock options valued at approximately $62,620.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management with the assistance of an external valuation specialist.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition costs of MYM include the issuance of 49,802 Common Shares, valued at $312 to financial advisors for advisory fees in connection with the MYM Transactions.</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MYM's revenue and net profit included in the Company&#8217;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $11,024 and $130, respectively.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group including Trichome and MYM.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the MYM Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                <div style="text-align:justify;margin-left:0pt;line-height:1.25">&#160;</div>

                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25">
                            <div style="margin-left:63pt">
                              <div>
                                <div>
                                  <div style="line-height:1.25">&#160;</div>
                                  <div style="line-height:1.25">
                                    <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                        <tr>
                                          <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,639</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(20,132</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                          </td>
                                        </tr>

                                    </table>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>

                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and MYM been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia's Assets and Operations</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 30, 2021, the Company acquired all Panaxia's online-related activities and intellectual property. The aggregate purchase price of NIS 18.7 million (approximately $7,000). In order to complete the acquisition, the Company will issue Common Shares in the aggregate amount of NIS 11.1 million (approximately $4,200).</span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;text-indent:0pt;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2021, the Company issued the four installments of the Panaxia Consideration Shares, in the aggregate amount of 934,755, at a various of share price ranging between US$5.01 to US$3.1. The total consideration represents an aggregate amount of US$3,397 thousand (approximately $4,290). The fifth and final installment of Panaxia Consideration Shares will be issued following the Panaxia GDP License Closing.</span></span></div>
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <div/>
                </div>
              </div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Group recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by an external valuation specialist.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As part of the acquisition, the Company purchased an option to purchase the Panaxia pharmacy, including cannabis-related licenses (see Note 1 (9)). As the exercise price of the option relates only to the medical cannabis inventory at the date of exercise, the Company has allocated $2,837 of the non-cancellable purchase price to effectively reflect the Company&#8217;s advance payment for the estimated fair value of the licenses and other assets of the Panaxia pharmacy that will be acquired upon exercise of the option.</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group and Panaxia's acquired assets.</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia's results of operation for the acquisition date through December 31, 2021, were immaterial to the consolidated financial statements.</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              </div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharm Yarok pharmacy</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 28, 2021, IMC Holdings entered into a definitive agreement to acquire all of the issued and outstanding share of R.A. Yarok Pharm Ltd., Rosen High Way Ltd. and High Way Shinua Ltd. (collectively "Pharm Yarok Group"). The aggregate consideration for the Pharm Yarok Group acquisition was NIS 11,900 thousand (approximately $4,600), of which approximately NIS 3,500 thousand (approximately $1,300) shall be invested by the shareholders of Pharm Yarok Group in the Company at closing in consideration for Common Shares. The closing of the Pharm Yarok Group acquisition is conditional upon receipt of all requisite approvals, including from the MOH<span style="font-weight:bold">, </span>which granted its approval subsequent to December 31, 2021, on February 15, 2022.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharm Yarok Group's revenue and net profit included in the Company&#8217;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $4,897 and $1, respectively.</span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                <div/>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the Pharm Yarok Group Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                <div style="text-align:justify;margin-left:0pt;line-height:1.25;font-family:'Times New Roman', Times, serif">&#160;</div>

                  <div>
                    <div style="margin-left:0t">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58,345</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(18,986</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>

                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Pharm Yarok Group been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></div>
              </div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vironna pharmacy</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 16, 2021, IMC Holdings has signed a definitive agreement to acquire 51% of the outstanding ordinary shares of Revoly Trading and Marketing Ltd. ("Vironna") for a total consideration of NIS 8,500 thousand (approximately $3,300), of which NIS 5,000 thousand (approximately $1,950) in cash and NIS 3,500 thousand (approximately $1,350) is in common shares of the Company to be issued at closing of Vironna transaction. The closing is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group and the pharmacies. The Group has elected to measure the non-controlling interest in this business combination based on the fair value of the identifiable net assets acquired (excluding goodwill).</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the Vironna Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                <div style="text-align:justify;margin-left:0pt;line-height:1.25">&#160;</div>

                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma profit or loss for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,816</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(18,180</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>

                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Vironna been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></div>
              </div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oranim pharmacy</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 1, 2021, IMC Holdings signed a definitive agreement to acquire 51% of the rights in Oranim Pharm, one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area, by acquiring 51.3% of the outstanding shares of Oranim Plus, which holds 99.5% of the rights in Oranim Pharm (the &#8220;Oranim Transaction&#8221;).</span></span></div>
                <div style="line-height:1.25">&#160;</div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Oranim Transaction closed on March 28, 2022, upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS 11,940 (approximately $4,900), consisting of NIS 5,202 (approximately $2,104) paid in cash upon signing, NIS 5,202 (approximately $2,104) which will be paid in cash on the first quarter of 2023 and NIS 1,536 (approximately $630) paid in 251,001 Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#8217;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.</span></span></div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oranim's revenue and net profit included in the Company&#8217;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $1,410 and $46, respectively.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Had the Oranim Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:</span></span></div>
                <div style="text-align:justify;margin-left:0pt;line-height:1.25">&#160;</div>

                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma profit or loss for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">67,589</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(17,870</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                                <div style="line-height:1.25">&#160;</div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>

                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Oranim been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.</span></span></div>
              </div>
              <div style="line-height:1.25">
                <div/>
                <div style="line-height:1.25">&#160;</div>
              </div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of the identifiable assets acquired and liabilities assumed on the acquisition date:</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>

                <div>
                  <div style="line-height:1.25;margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value</span></span></div>
                          </td>
                          <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TFC</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MYM</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vironna</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharm Yarok</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oranim</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">362</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">131</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">57</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">105</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">485</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">3,240</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,548</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">259</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">456</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,329</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indemnification asset</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">8,131</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biological assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">785</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">63</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,883</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4,180</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">639</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">346</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,043</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">19</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loan receivable</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8,470</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,122</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,837</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">15,193</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">6,105</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">210</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,145</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">389</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">88</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">114</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right of use assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">15,037</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">630</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,312</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">319</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6,458</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">17,200</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">2,316</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">974</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">2,991</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">776</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">61,992</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">32,979</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">3,481</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">3,026</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">7,549</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">3,720</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(15,196</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(4,442</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(854</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,448</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,777</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank loans</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(915</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(15,037</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(873</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,312</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long term loans</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(1,042</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax, net</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(4,061</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(532</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(224</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(688</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(30,233</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(10,291</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1,386</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(2,714</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(3,777</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable assets, net</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">31,759</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">22,688</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,095</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">312</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">3,772</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">3,720</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill arising on acquisition</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">67,269</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">39,932</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,250</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">4,294</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,907</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">3,240</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Controlling interest</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1,026</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1,849</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total purchase price</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">99,028</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">62,620</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">3,319</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">4,606</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">4,830</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">6,960</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108106008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TRADE RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">TRADE RECEIVABLES [Text Block]</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt">NOTE 6:-</span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt">TRADE RECEIVABLES</span></div>
                </td>
              </tr>

          </table>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>

                <div>
                  <div style="margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wholesalers and pharmacies</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">16,711</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">5,501</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivables are non-interest bearing and are generally on terms of 30 to 90 days. As of December 31, 2021 and 2020, there were no material past-due receivables.</span></span></div>
              <div>
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Major customers data as a percentage of total revenues:</span></span></div>
                  <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
                </div>
              </div>

                <div>
                  <div>
                    <div>
                      <div style="line-height:1.25;margin-left:63pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Reporting segment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Customer A</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Canada</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">17</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Customer B</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:9%;text-align:center" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Israel</span></span></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">35</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>

            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108456856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCOUNTS RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfOtherAccountsReceivableAbstract', window );"><strong>Disclosure of other accounts receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfOtherAccountsReceivablesExplanatory', window );">OTHER ACCOUNTS RECEIVABLE [Text Block]</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 7:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OTHER ACCOUNTS RECEIVABLE</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:63pt">

                    <div>
                      <div>
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,716</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">472</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government authorities</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,338</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">75</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties (see Note 21)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">11</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">36</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indemnification assets (see Note 5)</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,112</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other receivables (including related parties - see Note 5)</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,304</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">106</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">14,481</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">689</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>

                </div>
              </div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfOtherAccountsReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfOtherAccountsReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfOtherAccountsReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other accounts receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfOtherAccountsReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108920632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory', window );">BIOLOGICAL ASSETS [Text Block]</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                  <tr>
                    <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt">NOTE 8:-</span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt">BIOLOGICAL ASSETS</span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group&#8217;s biological assets consist of cannabis plants. The changes in the carrying value of biological assets are as follows:</span></span></div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
              <div style="margin-left:63pt">

                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of January 1, 2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">52</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production costs capitalized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,717</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value less cost to sell due to biological transformation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">11,782</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transferred to inventory upon harvest</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(14,478</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange translation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">5</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of December 31, 2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">78</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions related to acquisitions of Trichome and MYM</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">848</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production costs capitalized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">10,454</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value less cost to sell due to biological transformation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">7,210</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transferred to inventory upon harvest</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(16,977</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange translation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">74</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of December 31, 2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,687</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>

              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021, the weighted average fair value less cost to sell was $2.48 per gram.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of biological assets is categorized within Level 3 of the fair value hierarchy.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The inputs and assumptions used in determining the fair value of biological assets include:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling price per gram - calculated as the weighted average historical selling price for all strains of cannabis sold by the Group, which is expected to approximate future selling prices.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post-harvest costs - calculated as the cost per gram of harvested cannabis to complete the sale of cannabis plants post-harvest, consisting of the cost of direct and indirect materials, depreciation and labor as well as labelling and packaging costs.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Attrition rate - represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average yield per plant - represents the expected number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Stage of growth - represents the weighted average number of weeks out of the average weeks growing cycle that biological assets have reached as of the measurement date.<span style="font-weight:bold"> </span>The growing cycle is approximately 12 weeks.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table quantifies each significant unobservable input, and also provides the impact a 10% increase/decrease in each input would have on the fair value of biological assets:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:63pt">

                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10% change as at</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average selling price per gram of dried cannabis (in CAD)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3.64</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">6.01</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">296</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">8.86</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average post-harvest costs per gram of dried cannabis (in CAD)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1.16</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">0.83</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">140</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">0.23</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Attrition rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">27</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">5</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">100</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">0.43</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average yield per plant (in grams)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">47</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">54</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">228</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">7.64</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average stage of growth</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">47</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">212</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">7.64</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>

              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These estimates are subject to volatility in market prices and a number of uncontrollable factors, which could significantly affect the fair value of biological assets in future periods.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group&#8217;s estimates are, by their nature, subject to change including differences in the anticipated yield. These changes will be reflected in the gain or loss on biological assets in future periods.</span></span></div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 43<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108920632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">INVENTORIES [Text Block]</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt">NOTE 9:-</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt">INVENTORIES</span></div>
                  </td>
                </tr>

            </table>
            <div>
              <div>
                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <div style="margin-left:63pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized costs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair valuation adjustment, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying value</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work in progress:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bulk cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">14,113</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">3,336</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">17,449</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other cannabis products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,074</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,074</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Packaged dried cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">8,974</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">270</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">9,244</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other cannabis products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">744</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">744</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">880</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">880</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">25,785</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">3,606</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">29,391</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div/>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:63pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized costs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair valuation adjustment, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying value</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work in progress:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bulk cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,130</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">4,728</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">6,858</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Packaged dried cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">363</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">603</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">966</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">546</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">546</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,039</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,331</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,370</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>

                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the years ended December 31, 2021 and 2020, inventory expensed to cost of revenue of cannabis products was $43,720 and $17,203, respectively, which included $8,796 and $10,122 of non-cash expense, respectively, related to the changes in fair value of inventory sold.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, during the years ended December 31, 2021 and 2020, write-downs of inventories recognized in cost of revenue amounted to $nil and $291, respectively.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues in 2021 and 2020, also include production overhead not allocated to costs of inventories produced and recognized as an expense as incurred.</span></span></div>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39__IAS02_g36-39_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109338696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract', window );"><strong>Disclosure Of Detailed Information About Property Plant And Equipment And Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory', window );">PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET [Text Block]</a></td>
<td class="text">
          <div>
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 10:-</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:63pt">

                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings and improvements</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greenhouse production equipment</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greenhouse structure</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer, software and equipment</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,675</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,534</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">884</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">174</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">19</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4,286</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">705</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,123</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">648</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">95</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">44</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,615</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">97</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">104</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">63</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">10</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">276</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,477</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,761</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,595</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">279</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">65</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">7,177</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,932</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,846</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">508</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">261</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">31</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">4,578</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions related to acquisitions</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">18,828</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,584</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">455</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">263</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">23,130</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(81</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">79</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">79</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">44</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">11</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">132</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance December as of 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">23,156</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">8,270</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">2,182</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,039</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">370</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">35,017</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">46</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">534</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">280</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">26</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">894</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">132</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">350</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">147</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">52</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">9</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">690</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">35</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">17</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">3</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">61</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">184</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">919</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">444</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">81</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">17</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,645</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,554</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">993</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">206</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">241</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">27</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,021</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">4</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">40</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">26</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">11</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">2</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">83</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,742</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,952</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">676</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">333</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">46</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">4,749</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">21,414</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">6,318</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,506</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">706</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">324</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">30,268</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,293</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,842</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,151</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">198</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">48</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">5,532</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>

                  </div>
                </div>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment and intangible assets, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084396152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">INTANGIBLE ASSETS, NET [text block]</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 11:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span>INTANGIBLE ASSETS, NET</span></span></div>
                      </td>
                    </tr>

                </table>
                <div>
                  <div>
                    <div style="line-height:1.25">&#160;</div>

                      <div>
                        <div style="line-height:1.25;margin-left:63pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                              <tr>
                                <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cultivations and processing license *)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer relationships</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Brand</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost:</span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">831</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">58</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">63</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">62</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,014</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchases</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">93</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">93</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustment derived from purchase price allocation</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">110</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">110</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">26</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">32</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,060</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">58</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">63</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">68</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,249</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:middle;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial consolidations</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8,950</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">10,337</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">11,300</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">128</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">30,715</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(49</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">279</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">236</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">9,961</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">10,674</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">11,363</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">202</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">32,200</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated amortization and impairment:</span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">125</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">125</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization recognized in the year</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">31</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">31</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">156</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">157</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization recognized in the year</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">618</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">469</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">8</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">63</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,158</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">774</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">469</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">8</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">64</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,315</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:4px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost at December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">9,187</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">10,205</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">11,355</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">138</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">30,885</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost at December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">904</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">58</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">63</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">67</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,092</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:45pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*) The licenses consist of GMP and GDP licenses. </span></span></div>
                      </div>

                    <div/>
                    <div>
                      <div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">
                          <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of goodwill and intangible assets:</span></span>
                        </div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Adjupahrm's</span> recoverable <span>amounts</span> of the intangible assets and the goodwill <span>were</span> determined based on the value in use which is calculated at the expected estimated future cash flows, as determined according to the budget for the next three years and approved by the Company&#8217;s management. The pre-tax discount rate of the cash flows is 13.06%. The projected cash flows for the period exceeding three years was estimated using a fixed growth rate of 3%, representing the long-term average growth rate as customary in Adjupharm&#8217;s business.<span> For the year ended December 31, 2021, the Company recorded a goodwill impairment in the amount of $275 with respect to Adjupharm.</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Trichome's</span> recoverable <span>amounts</span> of the intangible assets and the goodwill <span>were</span> determined based on the value in use which is calculated at the expected estimated future cash flows, as determined according to the budget for the next three years and approved by the Company&#8217;s management. The pre-tax discount rate of the cash flows is 11.78%. The projected cash flows for the period exceeding <span>three</span> years was estimated using a fixed growth rate of 4%, representing the long-term average growth rate as customary in Trichome's business.<span> Based on the analysis performed the Company did not record goodwill impairment.</span></span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisitions during the year:</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2021, the Group entered into several business combination transactions. As part of these acquisitions, the Group identified cultivations and processing licenses, customer relationship, brand and others. The intangible assets identified have finite life and are being amortized on a straight-line basis over the useful life of the assets. During the year ended on December 31, 2021 and 2020, the Group recorded amortization expenses in the amount of $1,158 and $31, respectively. The amortization expenses are included in the <span>cost of revenues</span> and in the selling and marketing expenses.</span></span></div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109700152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RIGHT-OF-USE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfRightOfUseAssetsExplanatory', window );">RIGHT-OF-USE ASSETS [Text Block]</a></td>
<td class="text">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt">NOTE 12:-</span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt">RIGHT-OF-USE ASSETS</span></div>
              </td>
            </tr>

        </table>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>

              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Land and buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">955</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">195</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,150</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">107</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">107</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">50</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">12</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">62</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(73</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(73</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,005</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">241</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,246</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,408</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">270</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,678</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial consolidations</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">16,956</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">23</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">16,979</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">145</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">12</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">157</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">19,514</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">546</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">20,060</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated depreciation:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">80</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">47</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">127</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">107</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">102</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">209</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">7</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">10</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(35</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(35</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">194</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">117</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">311</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,438</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">112</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,550</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">27</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">10</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">37</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,659</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">239</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,898</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost at December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">17,855</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">307</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">18,162</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost at December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">811</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">124</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">935</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>

            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group has entered into leases of land, buildings and motor vehicles which are used for the Group's operations.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases of buildings have lease terms of between 5 and 12 years, whereas leases of motor vehicles usually have lease terms of 3 years.</span></span></div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfRightOfUseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entire disclosure related to right of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfRightOfUseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109658648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT ASSETS AND LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract', window );"><strong>Employee Benefit Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory', window );">EMPLOYEE BENEFIT ASSETS AND LIABILITIES [Text Block]</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 13:-</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span>EMPLOYEE BENEFIT ASSETS AND LIABILITIES</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employee benefits consist of short-term benefits and post-employment benefits.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:-28.35pt;margin-left:80pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160; Post-employment benefits:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">According to the labor laws and Severance Pay Law in Israel, the Group is required to pay compensation to an employee upon dismissal or retirement or to make current contributions in defined contribution plans pursuant to Section 14 to the Severance Pay Law, as specified below. The Group&#8217;s liability is accounted for as a post-employment benefit only for employees not under Section 14. The computation of the Group&#8217;s employee benefit liability is made in accordance with a valid employment contract or a collective employees agreement based on the employee's salary and employment term which establish the entitlement to receive the compensation.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The post-employment employee benefits are normally financed by contributions classified as defined benefit plans, as detailed below:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Defined benefit plans:</p>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group accounts for the payment of compensation, that is not covered by contributions in defined contribution plans, as above, as a defined benefit plan for which an employee benefit liability is recognized and for which the Group deposits amounts in a long-term employee benefit fund and in qualifying insurance policies.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expenses recognized in the consolidated statements of profit or loss and other comprehensive income:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current service cost</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">146</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">166</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">14</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">10</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total employee benefit expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">160</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">176</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income on plan assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">7</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">4</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The defined benefit liability (asset), net:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Defined benefit obligation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">668</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">588</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value of plan assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(277</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(217</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net defined benefit liability</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">391</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">371</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div/>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in the present value of defined benefit liabilities:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">588</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">390</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current service cost</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">146</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">166</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">14</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">10</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits paid</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(50</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(23</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Re-measurement loss on defined benefit plans</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(33</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">32</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation effect</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">3</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">13</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">668</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">588</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in the fair value of plan assets:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Plan assets comprise assets held by a long-term employee benefit funds and qualifying insurance policies.</span></span></div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">217</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">128</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">7</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Return, net of interest income - remeasurement gain (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(12</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits paid</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(50</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(23</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts deposited</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">116</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">101</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation effect</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(1</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">5</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">277</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">217</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The principal assumptions underlying the defined benefit plan:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div>
              <div style="margin-left:90pt">

                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:85%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.5</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.58</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salary growth</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.64</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.37</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>

              </div>
            </div>
            <div style="line-height:1.25;clear:both">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Based on reasonably possible changes of the principal assumptions underlying the defined benefit plan as mentioned above, occurring at the end of the reporting period, the changes would have an immaterial effect on the consolidated financial statements.</span></span></div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS19_g2-7_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EmployeeBenefitAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109658648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER PAYABLES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">OTHER PAYABLES [Text Block]</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 14:-</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span>OTHER PAYABLES</span></span></div>
                </td>
              </tr>

          </table>
          <div>
            <div>
              <div>
                <div style="line-height:1.25">&#160;</div>

                  <div style="margin-left:63pt">
                    <div>
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">6,146</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">407</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and payroll accruals</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8,267</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,545</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government authorities</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4,002</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">642</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">875</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances from customers</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">137</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">741</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other payables</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">716</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">162</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">20,143</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">3,497</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>

              </div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109242584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">FINANCIAL INSTRUMENTS [Text Block]</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>NOTE 15:-</span></span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">FINANCIAL INSTRUMENTS</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div>
          <div>
            <div style="text-align:justify;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The carrying values of the financial instruments which are measured at fair value through profit and loss as of December 31, 2021, and 2020, summarized in the following table:</span></span></span></span></div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
            <div style="line-height:1.25;margin-left:56.7pt">

                <div>
                  <div>
                    <div>
                      <div style="line-height:1.25">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets:</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,429</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,341</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c,e</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative assets</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">14</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:64%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities:</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6,022</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">16,540</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b,d</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>

            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:74.7pt;vertical-align:top;align:right">
                        <div style="margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></div>
                      </td>
                      <td style="width:auto;vertical-align:top">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management believes that the carrying amount of cash and cash equivalents, restricted bank deposit, trade receivables, other accounts receivable, loans receivables, trade payables, bank loans, other account payables and accrued expenses and purchase consideration payable, and approximate their fair value due to the short-term maturities of these instruments.</span></span></p>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:74.7pt;vertical-align:top;align:right">
                        <div style="margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></div>
                      </td>
                      <td style="width:auto;vertical-align:top">
                        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021 and 2020, there were nil and 9,729,264 2019 Warrants outstanding from private placements in 2019 (2019 Warrants). The Company re-measured the warrants, according to their trading price in the market, in the amount of $<span style="-sec-ix-hidden:Fxbrl_20220307151218509">nil</span> and $16,540, respectively (level 1 in fair value hierarchy). As a result, for the year ended December 31, 2021 and 2020, the Company recognized a revaluation gain (loss) of $15,929 and $(16,283), respectively, in the consolidated statement of profit or loss and other comprehensive income, which unrealized gain is included in finance income (expense). During 2021, amount&#160;of $611 of the 2019 Warrants transferred to equity and the rest expired.</span></span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div/>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On December 26, 2019, IMC entered into a share purchase agreement (the &#8220;SPA&#8221;) with Xinteza API Ltd. ("Xinteza"), a company with a unique biosynthesis technology.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The investment in the investee is accounted for as financial asset measured at fair value through profit or loss. The fair value of the investment as of December 31, 2021 and 2020, was $2,429 and $2,341, respectively.</span></span></span></span></div>
            <div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021 and 2020, the fair value of the Xinteza was categorized within Level 3 of the fair value hierarchy. The fair value was based on financing rounds for the purchase of preferred shares during 2020 (see Note 24).</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:74.7pt;vertical-align:top;align:right">
                      <div style="margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></div>
                    </td>
                    <td style="width:auto;vertical-align:top">
                      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On May 10, 2021, the Company completed an overnight marketed offering (the &#8220;Offering&#8221;)&#160;of&#160;6,086,956 Common Shares (each an &#8220;Offered Share&#8221;) at a price of US$5.75 per Offered Share for aggregate gross proceeds of approximately US$35 million ($42,502). The Company also issued 3,043,478 Common Share purchase warrants (each an &#8220;2021 Warrant&#8221;) to the purchasers of Offered Shares, for no additional consideration, that entitle the holders to purchase 3,043,478 Common Shares of the Company at an exercise price of US$7.2 per Common Share for a term of 5 years from the closing date.</span></span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As the exercise price of the 2021 Warrants is denominated in US dollars, which is not the functional currency of the Company, the 2021 Warrants are accounted for as a derivative liability, which is measured at fair value. Gross proceeds in the amount of $30,670 were recorded as Share capital and premium, and $11,832 were recorded as a Warrant liability, based on a valuation using the Black &amp; Scholes option pricing model. The transaction costs incurred as a result of the Common Shares issuance amounted to approximately $3,800, of which approximately $1,296 (attributed to the issuance of the Warrants classified as liabilities) were recorded as an expense in the Company's consolidated statements of profit or loss and approximately $2,539 (attributed to the issuance of share capital) as a deduction from Share capital and premium.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, there were 3,043,478 of 2021 Warrants outstanding and the Company re-measured the 2021 Warrants, according to Black &amp; Scholes model, in the amount of $6,022. As a result, for the year ended December 31, 2021, the Company recognized a revaluation gain of $5,810 in the consolidated statement of profit or loss and other comprehensive income, which unrealized gain is included in finance income (expense).</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div/>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The 2021 warrants fair value was measured using the Black &amp; Scholes model with the following key assumptions:</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:81pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td style="width:15.97%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31,</span></span></span></span></div>
                        </td>
                        <td style="width:1.11%;vertical-align:top">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                        </td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Sensitivity</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected volatility</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83 %</span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td rowspan="2" style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Increase (decrease) in key assumptions would</span></span></span></span></div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>result in increase (decrease) in fair value.</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life (in years)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.342</span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk-free interest rate</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.85%</span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td rowspan="2" style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Increase (decrease) in key assumptions would</span></span></span></span></div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>result in decrease (increase) in fair value.</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected dividend yield</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0%</span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value:</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Per Warrant (Canadian Dollar)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.979</span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Warrants (Canadian Dollar in thousands)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$6,022</span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Financial risk management:</span></span></span></p>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has exposure to the following risks from its use of financial instruments:</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share price risk:</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group's investments in unlisted shares are sensitive to market price risk arising from uncertainties about future value of these investments. The Group manages the price risk through diversification and by placing limits on individual and total investment in shares.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company's Board of directors reviews and approves all decisions related to investments in shares.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>At the reporting date, the Group's exposure to investments in unlisted shares measured at fair value was $2,429.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div/>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Credit risk:</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The maximum credit exposure as of December 31, 2021, is the carrying amount of cash and cash equivalents, accounts receivable and other current assets. The Group does not have significant credit risk with respect to customers. All cash and cash equivalents are placed with major Israeli financial institutions.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loan receivable credit risk is managed by each loan separately according to the Group&#8217;s policy, procedures and control relating to the borrower&#8217;s credit risk management. At the end of each period, the individual loan values are assessed based on a credit risk analysis. As of December 31, 2021, the Group had 2 loans outstanding (2020: nil loans) with a total balance of approximately $2.71 million.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The expected credit loss analysis is generally based on Management&#8217;s understanding of the borrower&#8217;s experience/integrity, financial health, business plans, capacity, products, customers, contracts, competitive advantages/disadvantages, and other pertinent factors when assessing credit risk. This would also include the assessment of the borrower&#8217;s forecasts as well as taking into consideration any security and/or collateral the Company has on the outstanding balance.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As security on the loan receivable to Biome Grow Inc., the borrower holds approximately 744,000 IM Cannabis Corp. common shares, on December 31, 2021. These shares cannot be sold without the proceeds from any sale being provided to the Company as repayment for the loan until the balance is fully discharged.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, the Company assessed the overall risk of the loan receivable balance and concluded that no expected credit loss under IFRS 9 was required.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Liquidity risk:</span></span></span></span></div>
            <div style="line-height:1.25">
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, the Group's financial liabilities with liquidity risk consist of trade payables and other accounts payable which have contractual maturity dates within one year, bank loans and lease liabilities. The Group manages its liquidity risk by reviewing its capital requirements on an ongoing basis. Based on the Group's working capital position at December 31, 2021, management considers liquidity risk to be low. The table below summarizes the maturity profile of the Group&#8217;s bank loans and lease liabilities based on contractual undiscounted payments (including interest payments):</span></span></span></span></div>
            </div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2021:</span></span></span></span></div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="line-height:1.25;font-weight:400;font-family:'Times New Roman',Times,serif;margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less than one year</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1 to 5 years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6 to 10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&gt;10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,130</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,781</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,760</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,620</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Bank Loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,502</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,632</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,781</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,760</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,620</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2020:</span></span></span></span></div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less than one year</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1 to 5 years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6 to 10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&gt;10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>232</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>547</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>515</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>
            <div/>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The maturity profile of the Group's other financial liabilities with liquidity risk (trade payables, other account payable and accrued expenses) as of December 31, 2021 and 2020, are less than one year.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Currency rate risk<span style="font-weight:bold">:</span></span></span></span></span></div>
            <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25;font-style:italic">&#160;</div>
            <div style="line-height:1.25">
              <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, a portion of the Group's financial assets and liabilities held in Euro, NIS, USD and GBP consist of cash and cash equivalents in the amount of EUR 742 thousand (approximately $1,069), NIS 16,718 thousand (approximately $6,845), USD 1,136 thousand (approximately $1,447) and GBP 2 thousand (approximately $9) respectively. The Group's objective in managing its foreign currency risk is to minimize its net exposure to foreign currency cash flows by transacting, to the greatest extent possible, with third parties in NIS. The Group does not currently use foreign exchange contracts to hedge its exposure of its foreign currency cash flows as management has determined that this risk is not significant at this point of time.</span></span></span></span></div>
              <div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25">&#160;</div>
            </div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:56.7pt">&#160;</td>
                    <td style="width:27.75pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Changes in liabilities arising from financing activities:</span></span></span></p>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
            <div style="margin-left:90pt">

                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total liabilities arising from financing activities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1, 2020</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,050</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">197</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,247</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new leases</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">107</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">107</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash flows</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(250</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(250</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Conversion of warrant</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,873</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,873</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other changes</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">144</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effect of changes in fair value</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,155</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,155</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31, 2020</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">990</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,540</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,530</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issuance of new warrants</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,832</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,832</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,504</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,504</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new leases</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,678</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,678</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions related to acquisitions</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,957</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,222</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,179</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayments</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(700</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,980</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,680</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effective interest</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,347</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,347</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other changes</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">117</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(611</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(361</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effect of changes in fair value</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,739</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,739</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31, 2021</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,894</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,374</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,022</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,290</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>

            </div>
          </div>
        </div>
        <div>
          <div>
            <div>
              <div>
                <div>
                  <div style="margin-left:90pt">&#160;</div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109242424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract', window );"><strong>Disclosure of contingent liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory', window );">CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES [Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 16:-</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Legal proceedings:</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:27.75pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">a.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">On August 19, 2019, a motion was filed for approval of a class action (the &#8220;Motion&#8221;) against 17 companies (the &#8220;Companies&#8221;) operating in the field of medical cannabis in Israel, including Focus. The applicant&#8217;s argument is that the Companies did not accurately mark the concentration of active ingredients in their products. The personal suit sum for every class member stands at NIS 15,585 ($5,900) and the total amount of the class action suit is estimated at NIS 686,000 ($259,000). On June 2, 2020, the Companies submitted their response to the Motion. The Companies argue in their response that the threshold conditions for approval of a class action were not met, since there is no reasonable possibility that the causes of action in the Motion will be decided in favor of the class group. On July 3, 2020, the applicant submitted his response to the Companies&#8217; response. On July 5, 2020 the applicant was absent from the hearing. As a result, on July 23, 2020, the Companies filed an application for a ruling of expenses, which received a response from the applicant on August 12, 2020, asking to decline this request. On September 21, 2020, the court ruled that the applicant would pay the Companies&#8217; expenses amount of NIS 750. On July 14, 2021 a hearing was held. The court recommended the parties to negotiate independently to avoid litigation, and if negotiations fail, then to begin mediation proceedings. The parties agreed to follow the court&#8217;s recommendations, though the negotiations between the parties have not yet begun. On November 3, 2021 the court ruled the parties will file an update regarding the mediation procedure, in 30 days. The parties conducted unsuccessful negotiations and are now waiting for a court decision regarding the continuation of the proceedings.</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">At this preliminary stage, based on the opinion of its legal counsel, Focus&#8217; management cannot assess the chances of approval of the Motion nor the chances of the claims under the Motion being accepted if the Motion is approved. Therefore, no provision has been recorded in respect thereof.</span></span></div>
                    <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">b.</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">On October 6, 2019, Focus received a decision regarding a petition that was filed against the MOH, concerning the new regulatory framework of the cannabis market and demanding that the court resolve as follows:</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:103.05pt">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">that the MOH immediately suspend the implementation of the new regulation that harms, disproportionally, the medical cannabis patients;</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">that the implementation of the new regulation, as is, would cause violation of constitutional rights of the medical cannabis patients; and</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right">&#160;</td>
                          <td style="width:10.35pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">&#8226;</span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">that the MOH amend the flaws of the new regulation, prior to becoming effective, and to establish new regulations regarding labeling and use of pesticides.</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">According to the decision, Focus was attached to the proceedings and filed its response on November 12, 2019.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">On March 8, 2020, the court decided to extend the validity of the interim injunction, so that the medical cannabis use licenses, which were extended under the decision, would continue to be valid until May 15, 2020, or 10 days after the date the MOH comes to a conclusion regarding the price control of medical cannabis products, whichever comes first, subject to another court decision.</span></span></div>
                    <div/>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The court also decided that if a further extension of the period of the interim injunction is granted beyond May 15, 2020, to the extent required, it would be subject to medical surveillance by the attending physician, that his details of which were included in the patient&#8217;s existing use license.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 29, 2020, the respondents represented by the State Attorney&#8217;s Office filed an update notice stating that the Appeals Committee unanimously decided against imposing price controls on medical cannabis products and that the Prices Committee would hold a follow-up hearing in four months. The respondents also requested to update the Court again in two months.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 25, 2020, the petitioner submitted their response to the respondents&#8217; update notice.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 25, 2021, the respondents represented by the State Attorney&#8217;s Office filed an updating notice stating that the Prices Committee had come to a decision against imposing price controls on medical cannabis products. However, the Prices Committee announced that it will issue a request for information to the corporations engaged in the medical cannabis market and assess the market every six months. Following the aforementioned, the respondents represented by the State Attorney&#8217;s Office believe that the appeal should be rejected and the interim injunction should be canceled. On April 13, 2021, three of the respondents filed a response to the court, requesting to reject the appeal and to cancel the interim injunction.</span></span></div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;</span></span></div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 25, 2021, the petitioner filed a response to the update notice to the court, objecting to the position of the respondents represented by the State Attorney&#8217;s Office, requesting the court to resolve as requested in the petition and grant the requested remedies to the petitioner. On July 6, 2021, the petitioner filed an urgent request to the court, to issue orders to the respondents represented by the State Attorney&#8217;s Office, to request information from corporations engaged in the medical cannabis market in order to continue the examination of the market, according to the Prices Committee&#8217;s announcement mentioned above, and requested the court to reschedule the hearing set to occur on September 19, 2021, to an earlier date. The petitioner&#8217;s request was rejected by the court on July 7, 2021, and on September 19, 2021, a hearing was held. On November 16, 2021 the Supreme court of Israel ruled that motion will be deleted and interim injunction will be expired after 10 days. Following a request submitted by the petitioner on November 15, 2021, the Supreme court of Israel determined that the interim injunction will extend until March 1, 2022. Further requests submitted for an extension of the interim injunction were denied.</span></span></div>
                        <div style="line-height:1.25">&#160;</div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                            <tr>
                              <td style="width:56.7pt">&#160;</td>
                              <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 11, 2021, the Company was informed that a claim (the &#8220;Construction Proceedings&#8221;) was filed by the municipal committee presiding over planning and construction in southern Israel (the &#8220;Construction Committee&#8221;) against Focus, Focus&#8217; directors and officers, and certain landowners, including Oren Shuster and Rafael Gabay, claiming for inadequate permitting for construction relating to the Focus Facility (&#8220;Construction Allegations&#8221;). A hearing was set to June 13, 2022.</span></span></div>
                              </td>
                            </tr>

                        </table>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At this preliminary stage, based on the opinion of its legal counsel, Focus&#8217; management cannot assess the chances of the claim advancing or the potential outcome of the Construction Proceedings.</span></span></div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 86<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_86&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109242584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">TAXES ON INCOME [Text Block]</a></td>
<td class="text">
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 17:-</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TAXES ON INCOME</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax rates applicable to the Group:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company and its Canadian subsidiaries are subject to tax rates applicable in Canada. The combined federal and provincial rate for 2021 and 2020 is 26.5%.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Israeli subsidiaries are subject to Israeli corporate income tax rate of 23% in 2021 and 2020.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:85.05pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The German subsidiary is subject to weighted tax rate of approximately 29.1% (composed of Federal and Municipal tax).</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Carryforward losses for tax purposes:</p>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward operating tax losses of the Israeli subsidiaries total approximately $3,153, as of December 31, 2021. These losses can be carried forward to future years and offset against taxable income in the future without any time limitation. No deferred tax assets were recorded with regards to IMC Holdings ltd. since the Company does not anticipate to utilize the net operating losses in the foreseeable future.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward operating tax losses of the German subsidiary as of December 31, 2021, amounted to approximately $8,964. Accumulated tax losses can be carried forward without time restrictions and can be deducted from future profits and capital gains unless they exceed &#8364;1,000 thousand (approximately $1,441). Any excess of such amount will be limited to 60% of the profits or capital gains. Unused carried forward losses will be subject to such limitation in the future. No deferred tax assets were recorded with regards to the German subsidiary since the Company does not anticipate to utilize the net operating losses in the foreseeable future.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward operating tax losses of Canadian subsidiaries as of December 31, 2021, amounted to approximately $54,218. These losses can be carried forward to future years and offset against taxable income in the future without any time limitation. Deferred tax assets of approximately $1,542, relating to these losses were recognized in the financial statements.</span></span></div>
        <div/>
        <p style="margin:0pt">&#160;</p>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Income tax expense (benefit):</p>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">
          <p style="margin:0pt">&#160;</p>
        </div>

          <div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">248</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">278</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax from previous years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">505</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">262</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Deferred taxes:</p>
              </td>
            </tr>

        </table>
        <div>
          <div style="text-align:justify;margin-left:56.7pt;line-height:1.25">&#160;</div>

            <div style="margin-left:90pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statements of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">financial position</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statements of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">profit or loss</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward tax losses and other</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,542</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">769</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">892</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(440</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other deferred tax assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">14</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,556</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">769</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">891</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(440</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory and biological assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">863</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,239</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(431</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">385</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">7,261</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">264</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(189</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(11</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">7</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">7</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">8,131</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,503</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(613</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">374</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Translation differences</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">54</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">63</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax expenses, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">278</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(66</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(6,575</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(734</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The deferred taxes are reflected in the statements of financial position as follows:</span></span></div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">769</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,591</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,503</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The deferred taxes are computed based on the tax rates that are expected to apply upon realization.</span></span></div>
        <div/>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:56.7pt">&#160;</td>
              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of tax expense and the accounting profit multiplied by the Company's domestic tax rate for 2021 and 2020:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="margin-left:90pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income tax</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(18,013</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(28,472</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate in Canada 26.5%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(4,773</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(7,545</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in income tax due to:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses (non-taxable income), net for tax purposes</span></span></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,447</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,306</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of different tax rate of subsidiaries</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">310</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">161</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments in respect of current income tax of previous years</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(21</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">303</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognition (derecognition) of tax benefit in respect of losses of previous years</span></span></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">846</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(830</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrecognized tax benefit in respect of loss for the year</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4,093</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,771</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Utilization of losses not previously recognized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,466</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in tax benefits not recognized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">5,252</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other adjustments</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(289</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">96</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">505</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">262</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>

      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108777208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIssuedCapitalExplanatory', window );">EQUITY [Text Block]</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 18:-</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span>EQUITY</span></span></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition of share capital:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>

            <div>
              <div style="line-height:1.25;margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Authorized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued and outstanding</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Authorized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued and outstanding</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="14" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares without par value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unlimited</span></span></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">68,217,894</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unlimited</span></span></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">39,765,799</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares confer upon their holders the right to participate in the general meeting where each Ordinary share has one voting right in all matters, receive dividends if and when declared and to participate in the distribution of surplus assets in case of liquidation of the Company.</span></span></div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
          <div/>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 12, 2021, the Company's shareholders general meeting resolved to consolidated all of its issued and outstanding Ordinary shares on a four (4) to one (1) basis (the &#8220;Share Consolidation&#8221;). Following the Share Consolidation, the number of Listed Warrants outstanding was not altered; however, the exercise terms were adjusted such that four Listed Warrants are exercisable for one Ordinary Share following the payment of an adjusted exercise price of $5.20. The earnings per share, in these consolidated financial statements, give effect to the Share Consolidation for all periods presented.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital issuance during the reporting period:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 10, 2021, the Company completed an overnight marketed offering (the &#8220;Offering&#8221;) of 6,086,956 Common Shares (each an &#8220;Offered Share&#8221;) at a price of US$5.75 per Offered Share for aggregate gross proceeds of approximately US$35 million ($42,502). The Company also issued 3,043,478 Common Share purchase warrants (each an &#8220;2021 Warrant&#8221;) to the purchasers of Offered Shares, for no additional consideration, that entitle the holders to purchase 3,043,478 Common Shares of the Company at an exercise price of US$7.2 per Common Share for a term of 5 years from the closing date.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As the exercise price of the 2021 Warrants is denominated in US dollars, which is not the functional currency of the Company, the 2021 Warrants are accounted for as a derivative liability, which is measured at fair value. Gross proceeds in the amount of $30,670 were recorded as Share capital and premium, and $11,832 were recorded as a Warrant liability, based on a valuation using the Black &amp; Scholes option pricing model. The transaction costs incurred as a result of the Common Shares issuance amounted to approximately $3,800, of which approximately $1,296 (attributed to the issuance of the Warrants classified as liabilities) were recorded as an expense in the Company's consolidated statements of profit or loss and approximately $2,539 (attributed to the issuance of share capital) as a deduction from Share capital and premium.</span></span></div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to the terms of the Offering, the placement agents held an over-allotment option to purchase up to an additional 913,044 Offered Shares and 456,522 2021 Warrants on the same terms and conditions for a period of 30 days following the closing date. The over- allotment option was not exercised by the placement agents and expired as of June 30, 2021. The Company recorded expenses in the amount of approximately $800 under share-based compensation expenses with respect to the Offering.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Offering was conducted pursuant to the Company's effective shelf registration statement on Form F-10 filed with the U.S. Securities and Exchange Commission and a corresponding Canadian shelf prospectus filed with the Securities Regulatory Authority in each of the provinces and territories of Canada and a final prospectus supplement which was filed with the SEC on May 5, 2021.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div/>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in issued and outstanding share capital:</span></span></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>

            <div>
              <div style="margin-left:90pt">
                <div>
                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">36,435,837</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of Warrants and Compensation options exercised</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,169,769</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of options exercises</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">160,193</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">39,765,799</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of Warrants and Compensation options exercised</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">633,784</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of options exercises</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">517,346</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of treasury common shares</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(101,649</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued related secondary transaction and business combinations</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">27,402,614</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">68,217,894</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>

          <div>&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share option plan:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="text-align:justify;margin-right:28.35pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Awards granted under the company&#8217;s current plan which was approved by the board of directors on December 19, 2018 (&#8220;2018 Plan&#8221;) are subject to vesting schedules and unless determined otherwise by the administrator of the 2018 Plan, generally vest following a period of three years from the applicable vesting commencement date, such that 33.3% of the awards vest on the first anniversary of the applicable vesting commencement date and 66.7% of the awards vest in eight equal installments upon the lapse of each three-month period thereafter. Subject to the discretion of the 2018 Plan administrator, if an award has not been exercised within seven years after the date of the grant, the award expires. As of December 31, 2021, 1,607,550 Ordinary shares are available for future grants under the 2018 Plan.</span></span></div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div/>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value for options granted during the years ended December 31, 2021 and 2020, to the Group's employees, directors and advisors was estimated using the Black &amp; Scholes option pricing model with the following assumptions:</span></span></div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
          <div style="margin-left:90pt">

              <div>
                <div>
                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price (in CAD)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$4.5 - $10.12</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.6 - $8.56</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected life of share options (Years)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3-4</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.77 - 9</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Volatility (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80.61-83.68</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74.8 - 80.39</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Annual risk-free rate (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.52-0.77</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.25 &#8211; 0.37</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share price (in CAD)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">$10.02</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.48 &#8211; $8.56</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>

          </div>
          <div style="line-height:1.25">&#160;</div>
          <div>
            <div>
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The weighted average fair value of each option on the grant date amounted to $4.16.</span></span></div>
              <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                <p style="margin:0pt">&#160;</p>
              </div>
            </div>
          </div>
        </div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table lists the number of share options and the weighted average exercise prices of share options in the 2018 Plan:</span></span></div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="line-height:1.25;margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in CAD</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,154,870</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2.2</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,964,265</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">6.2</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercised during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(517,346</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2.43</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options forfeited during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(158,544</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">4.08</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">5,443,245</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">3.91</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,888,480</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
              <p style="margin:0pt">&#160;</p>
            </div>
            <div/>
            <div style="margin-left:90pt">&#160;</div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in CAD</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,940,000</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1.6</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">905,000</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4.24</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercised during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(160,193</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1.8</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options forfeited during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(529,937</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1.8</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">3,154,870</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2.2</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,328,770</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1.8</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The weighted average remaining contractual life for the share options outstanding as of December 31, 2021, and 2020 was 5.37 and 7.32 years respectively.</span></span></div>
        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The share-based payment expenses for the year ended December 31, 2021 and 2020, amounted to $7,471 and $3,382, respectively.</span></span>
            <p style="margin:0pt">&#160;</p>
          </div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table lists the number of restricted share units (&#8220;RSUs&#8221;) as of December 31, 2021:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:90pt">

              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of RSU</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">550,000</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the end of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">550,000</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">229,006</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>

          </div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other convertible securities:</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021, there are 134,872, 2019 Compensation Units Options to acquire Compensation Units at a price of $1.05 per unit. Each Compensation Unit consists of one IMCC Ordinary Share and one half IMCC Warrant, with each whole IMCC Warrant exercisable for one IMC Ordinary Share at an exercise price of $1.3. These Units are exercisable at any time until August 2022.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2021, there are 182,609 compensation warrants. Each Compensation Warrant is exercisable for one Common Share at an exercise price of US$6.61 (approximately $8.42). These Warrants are exercisable at any time following the date that is six months after the date of the Compensation warrants agency agreement until the date that is the three and one half year anniversary of the agency agreement.</span></span></div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108891672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELECTED STATEMENTS OF PROFIT OR LOSS DATA<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">SELECTED STATEMENTS OF PROFIT OR LOSS DATA [Text Block]</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt">NOTE 19:-</span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div style="font-weight:bold"><span style="font-size:10pt">SELECTED STATEMENTS OF PROFIT OR LOSS DATA</span></div>
                </td>
              </tr>

          </table>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>

                <div>
                  <div style="margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">19,718</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">6,897</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">6,004</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">930</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109523448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">NET EARNINGS (LOSS) PER SHARE [Text Block]</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 20:-</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NET EARNINGS (LOSS) PER SHARE</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Details of the number of shares and income (loss) used in the computation of earnings per share:</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:63pt">

                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted number of shares (in thousands)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to equity holders of the Company</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted number of shares (in thousands)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to equity holders of the Company</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the computation of basic net earnings</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">57,963</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(17,763</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">38,565</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(28,698</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of potential dilutive Ordinary shares&#160;- Warrants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,810</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(21,739</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the computation of diluted net earnings</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">59,773</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(39,502</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">38,565</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(28,698</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>

                    </table>

                </div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">For 2021, and 2020, potentially dilutive securities (share options) were excluded from the calculation of diluted earnings per share as they are antidilutive.</p>
                      </td>
                    </tr>
                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">&#160;</td>
                      <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:56.7pt">&#160;</td>
                      <td style="width:28.35pt;vertical-align:top;align:right">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">**)</p>
                      </td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Including the effect of Share Consolidation (See Note 18a).</p>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131110631208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">RELATED PARTY BALANCES AND TRANSACTIONS [Text Block]</a></td>
<td class="text">
            <div>
              <div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                      <tr>
                        <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span>NOTE 21:-</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span>RELATED PARTY BALANCES AND TRANSACTIONS</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
              <div>
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balances and transactions:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes balances with related parties in the statements of financial position:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>

                    <div>
                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts receivables</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">11</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">36</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts payables</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">875</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">-</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>

                  <div/>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes the transactions with related parties in the consolidated statements of profit or loss and other comprehensive income:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>

                    <div>
                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,116</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">617</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>

                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions with related parties mainly includes compensation for management services and bonus in the ordinary course of business and short-term lease payments.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:56.7pt">&#160;</td>
                        <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation of key management personnel of the Group:</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="text-align:justify;margin-left:84.75pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's key management personnel are the directors, senior executives and a managing company which provides the Company with key management personnel services.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div>

                      <div>
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payroll and related expenses</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2,377</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2,005</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">5,700</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,791</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees *)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,029</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,391</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25">&#160;</div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:85.05pt">&#160;</td>
                              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Includes payments to shareholders for the years ended 2021 and 2020 of $455 and $534, respectively.</span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>

                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25">
                            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                                <tr>
                                  <td style="width:56.7pt">&#160;</td>
                                  <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif">c.</td>
                                  <td style="width:auto;vertical-align:top;text-align:justify">
                                    <div>See Note 5 for indemnification agreement with a former director of TFC, currently serving as the Company's chairman of the board of directors.</div>
                                  </td>
                                </tr>

                            </table>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109341288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract', window );"><strong>Summarized Financial Information For Partly Owned Subsidiary [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory', window );">SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY [Text Block]</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span><span style="font-size:10pt">NOTE 22:-</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span><span style="font-size:10pt">SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Summarized financial information for Focus as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Statement of financial position at reporting date (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Current assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">22,913</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">16,531</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Non-current assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">4,473</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">4,226</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Current liabilities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(19,616</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(11,341</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Non-current liabilities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1,883</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(2,274</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total equity</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">5,887</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">7,142</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Operating results (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Revenues</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">14,747</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">13,823</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net income (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,524</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">968</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Other comprehensive income</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">37</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(22</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total comprehensive income (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(1,487</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">946</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Cash flows (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From operating activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,346</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,882</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From investing activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(783</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,656</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From financing activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">560</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(184</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Effect of foreign exchange on cash and cash equivalents</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">169</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">39</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net increase in cash and cash equivalents</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,292</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">81</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109317544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING SEGMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">OPERATING SEGMENTS</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 23:-</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OPERATING SEGMENTS</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt">&#160;</td>
                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Reporting operating segments:</p>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>

            <div>
              <div style="margin-left:90pt">&#160;</div>
              <div>
                <div>
                  <div style="line-height:1.25;margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2021:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">25,431</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">20,247</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">8,622</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">54,300</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10,654</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,353</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,142</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,149</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated corporate expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(7,240</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(7,240</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(38,389</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation, amortization and impairment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,424</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,879</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">701</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,004</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                    <div>&#160;</div>
                  </div>
                  <div style="line-height:1.25;margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2020:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,826</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,064</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">15,890</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,090</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,744</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,834</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated corporate expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(2,411</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(2,411</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,245</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation, amortization and impairment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">617</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">73</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">690</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
              <div>
                <div>
                  <div style="line-height:1.25;margin-left:90pt">&#160;</div>
                </div>
              </div>
            </div>

        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109341448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">SUBSEQUENT EVENTS [Text Block]</a></td>
<td class="text">
              <div>
                <div>
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 24:-</span></span></td>
                          <td style="width:auto;vertical-align:top">
                            <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SUBSEQUENT EVENTS</span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revolving Credit</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In January 2022, Focus entered into a Revolving Credit Facility with Bank Mizrahi (the &#8220;Mizrahi Facility&#8221;). The Mizrahi Facility is guaranteed by Focus assets. Advances from the Mizrahi Facility will be used for working capital needs.</span></span></div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Mizrahi Facility has a total commitment of up to NIS 15,000 thousand (approximately $6,000) and has a one-year term for on-going needs and 6 months term for imports and purchases needs. The Mizrahi Facility is renewable upon mutual agreement by the parties. The borrowing base available for draw at any time throughout the Mizrahi Facility and is subject to several covenants to be measured on a quarterly basis. The Mizrahi Facility bears interest of Israeli Prime interest plus 1.5% (approximately 3.3%) per annum.</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Xinteza</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 24, 2022, IMC Holdings entered into a Simple Agreement for Future Equity (SAFE) with Xinteza, under which IMC Holdings invested US$100,000 (approximately $125), in exchange for additional future shares of Xinteza.</span></span></div>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing of Pharm Yarok Transaction</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 14, 2022, the Pharm Yarok Transaction closed upon receipt of all requisite approvals, including the IMCA approval, for an aggregate consideration of NIS 11,900 (approximately $4,600), of which NIS 8,400 (approximately $3,300) was paid in cash upon signing the definitive agreement, and NIS 3,500 (approximately $1,300) paid upon closing. The acquisition of the outstanding ordinary shares of HW Shinua is pending receipt of the requisite approval from the IMCA. In connection with closing of the Pharm Yarok Transaction, the Company completed a non-brokered private placement with former shareholders of Pharm Yarok and Rosen High Way on March 14, 2022. A total of 523,700 Common Shares were issued at a deemed price of $2.616 for aggregate proceeds of $1,370. The calculation of the deemed price was based on the average closing price of Common Shares on the CSE over the 8 trading day period immediately preceding March 14, 2022.</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing of Vironna Transaction</span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25">
                      <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 14, 2022, the Vironna Transaction closed upon receipt of all requisite approvals, including the approval of the IMCA in consideration of NIS 8,500 (approximately $3,330), comprised of NIS 5,000 (approximately $1,960) in cash and NIS 3,500 (approximately $1,700) in Common Shares issued on closing. In satisfaction of the cash consideration component, NIS 3,750 (approximately $1,470) was paid at signing of the definitive agreement and the remaining NIS 1,250 (approximately $490) will be paid post-closing of the Vironna Transaction. In satisfaction of the share consideration component, the Company issued 485,362 Common Shares at a deemed issue price of US$2.209 per share (approximately $2.8092), calculated based on the average closing price of the Common Shares of on the NASDAQ for the 14 trading day period immediately preceding closing. The shares issued are subject to a staggered three-month lockup commencing on the date of issuance.</span></span>
                        <p style="margin:0pt">&#160;</p>
                      </div>
                    </div>
                    <div/>
                    <div style="line-height:1.25">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25">
                          <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold">&#160;</div>
                          <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing of Panaxia Transaction</span></span></div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 14, 2022, IMC Holdings acquired the Panaxia GDP License following receipt of the requisite IMCA approval and assigned it to IMC Pharma in accordance with the terms of the Panaxia Transaction (the &#8220;<span style="font-weight:bold">Panaxia GDP License Closing</span>&#8221;). The aggregate consideration for the Panaxia Transaction was NIS 18,700 (approximately $7,200), of which NIS 7,600 (approximately $2,900) was paid in two cash instalments and NIS 11,100 (approximately $4,300) payable in Common Shares (&#8220;<span style="font-weight:bold">Panaxia Consideration Shares</span>&#8221;). To satisfy the share consideration component of the Panaxia Transaction, the Company issued four instalments of an aggregate of 93,755 Panaxia Consideration Shares between August 9, 2021 and March 14, 2022, with the deemed price of each instalment of Panaxia Consideration Shares determined based on the average closing price of the Common Shares on Nasdaq during the 10 trading day period immediately prior to issuance. The fifth and final instalment of Panaxia Consideration Shares will be issued following the Panaxia GDP License Closing. The Panaxia Transaction includes a further option to acquire, for no additional consideration, a pharmacy from Panaxia, including requisite licenses to dispense and sell medical cannabis to patients, that the Company has exercised (&#8220;<span style="font-weight:bold">Panaxia Pharmacy Closing</span>&#8221;). The Panaxia Pharmacy Closing is expected to occur during the third quarter of 2022.</span></span></div>
                          <div style="text-align:justify;margin-left:33.9pt;line-height:1.25">&#160;</div>
                        </div>
                      </div>
                      <div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing of Oranim Transaction</span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="line-height:1.25">
                        <div style="text-align:justify;margin-left:33.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 28, 2022, the Oranim Transaction closed upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS 11,940 (approximately $4,900), consisting of NIS 5,202 (approximately $2,104) paid in cash upon signing, NIS 5,202 (approximately $2,104) which will be paid in cash on the first quarter of 2023 and NIS 1,536 (approximately $630) paid in 251,001 Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#8217;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.</span></span></div>
                      </div>
                    </div>
                  </div>
                </div>
                <div>
                  <div>
                    <div style="text-align:justify;margin-left:33.9pt;line-height:1.25">&#160;</div>
                  </div>
                </div>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111591784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureForSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure For Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory', window );">Basis of presentation [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Basis of presentation:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB").</span></span></span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Group's financial statements have been prepared on a cost basis, except for:</span></span></span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Financial instruments which are presented at fair value through profit or loss.</span></span></span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Biological assets which are presented at fair value less cost to sell up to the point of harvest.</span></span></span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Group has elected to present the profit or loss items using the function of expense method.</span></span></span></span></span></span>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory', window );">Consolidated financial statements [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Consolidated financial statements:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The consolidated financial statements comprise the financial statements of companies that are controlled by the Company (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Potential voting rights are considered when assessing whether an entity has control. The consolidation of the financial statements commences on the date on which control is obtained and ends when such control ceases.</span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2021, and 2020, major subsidiaries over which the Company has control, directly or indirectly, include<span style="font-weight:bold">:</span></span></span></span></span>
                    </div>

                      <div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="1" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left">

                              <tr>
                                <td rowspan="2" style="width:67.71%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subsidiaries</span></span></span></span></div>
                                </td>
                                <td colspan="3" style="width:32.29%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Percentage ownership</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:14.18%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2020</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C. Holdings Ltd (&#8221;IMC&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Focus Medical Herbs Ltd. ("Focus") *)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C Farms Israel Ltd. ("IMC Farms")</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C Ventures Ltd. ("IMC Ventures")</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C - International Medical Cannabis Portugal Unipessoal Lda</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Adjupharm GmbH (&#8220;Adjupharm&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90.02%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">92.5%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>R.A. Yarok Pharm Ltd. (&#8220;Pharm Yarok&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Rosen High Way Ltd. (&#8220;Rosen High Way&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>High Way Shinua Ltd. (&#8220;HW Shinua&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revoly Trading and Marketing Ltd. (&#8220;Vironna&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oranim Plus Pharm LTD.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51.3%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oranim Pharm</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Corp. (&#8220;Trichome&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Cannabis GP Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Cannabis Manager Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Asset Funding Corp.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Retail Corp.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MYM Nutraceuticals Inc. (&#8220;MYM&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SublimeCulture Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CannaCanada Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MYM International Brands Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Highland Grow Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-width:2px;border-style:solid;border-color:rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25;clear:both">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>*) See also Note 1b(1)</span></span></span></span></div>
                      </div>

                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The financial statements of the Company and of the subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all companies in the Group. Significant intragroup balances and transactions and gains or losses resulting from intragroup transactions are eliminated in full in the consolidated financial statements.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-controlling interests in subsidiaries represent the equity in subsidiaries not attributable, directly or indirectly, to a parent. Non-controlling interests are presented in equity separately from the equity attributable to the equity holders of the Company. Profit or loss and components of other comprehensive income are attributed to the Company and to non-controlling interests. Losses are attributed to non-controlling interests even if they result in a negative balance of non-controlling interests in the consolidated statement of financial position.</span></span></span></span>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The disposal of a subsidiary that does not result in a loss of control is recognized as a change in equity. Upon the disposal of a subsidiary resulting in loss of control, the Company:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the subsidiary's assets (including goodwill) and liabilities.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the carrying amount of non-controlling interests.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognizes the adjustments arising from translating financial statements carried to equity.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes the fair value of the consideration received.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes the fair value of any remaining investment.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Reclassifies the components previously recognized in other comprehensive income (loss) on the same basis as would be required if the subsidiary had directly disposed of the related assets or liabilities.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recognizes any resulting difference (surplus or deficit) as gain or loss.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory', window );">Business combinations and goodwill [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Business combinations and goodwill:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Business combinations are accounted for by applying the acquisition method. The cost of the acquisition is measured at the fair value of the consideration transferred on the acquisition date with the addition of non-controlling interests in the acquiree. In each business combination, the Company chooses whether to measure the non-controlling interests in the acquiree based on their fair value on the acquisition date or at their proportionate share in the fair value of the acquiree's net identifiable assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Direct acquisition costs are carried to the statement of profit or loss as incurred.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In a business combination achieved in stages, equity interests in the acquiree that had been held by the acquirer prior to obtaining control are measured at the acquisition date fair value while recognizing a gain or loss resulting from the revaluation of the prior investment on the date of achieving control.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Contingent consideration is recognized at fair value on the acquisition date and classified as a financial asset or liability in accordance with IFRS 9. Subsequent changes in the fair value of the contingent consideration are recognized in profit or loss. If the contingent consideration is classified as an equity instrument, it is measured at fair value on the acquisition date without subsequent remeasurement.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill is initially measured at cost which represents the excess of the acquisition consideration and the amount of non-controlling interests over the net identifiable assets acquired and liabilities assumed. If the resulting amount is negative, the acquirer recognizes the resulting gain on the acquisition date.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory', window );">Functional currency, presentation currency and foreign currency [Policy Text Block]</a></td>
<td class="text">
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Functional currency, presentation currency and foreign currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Functional currency and presentation currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The functional currency of the Company is the Canadian dollar ("CAD"). The Group determines the functional currency of each Group entity.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Assets, including fair value adjustments upon acquisition, and liabilities of an investee which is a foreign operation, and of each Group entity for which the functional currency is not the presentation currency are translated at the closing rate at each reporting date. Profit or loss items are translated at average exchange rates for all periods presented. The resulting translation differences are recognized in other comprehensive income (loss).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Upon the full or partial disposal of a foreign operation resulting in loss of control in the foreign operation, the cumulative gain (loss) from the foreign operation which had been recognized in other comprehensive income is transferred to profit or loss. Upon the partial disposal of a foreign operation which results in the retention of control in the subsidiary, the relative portion of the amount recognized in other comprehensive income is reattributed to non-controlling interests.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Transactions, assets and liabilities in foreign currency:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Transactions denominated in foreign currency are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at each reporting date into the functional currency at the exchange rate at that date. Exchange rate differences, other than those capitalized to qualifying assets or accounted for as hedging transactions in equity, are recognized in profit or loss.</span></span></span></span></div>
                    <div/>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-monetary assets and liabilities denominated in foreign currency and measured at cost are translated at the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currency and measured at fair value are translated into the functional currency using the exchange rate prevailing at the date when the fair value was determined.</span></span></span></span>
                    </div>
                  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash equivalents [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash equivalents:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash equivalents are considered as highly liquid investments, including unrestricted short-term bank deposits with an original maturity of three months or less from the date of investment or with a maturity of more than three months, but which are redeemable on demand without penalty and which form part of the Group's cash management.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory', window );">Short-term deposits [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>f.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term deposits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term bank deposits are deposits with an original maturity of more than three months from the date of investment and which do not meet the definition of cash equivalents. The deposits are presented according to their terms of deposit.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory', window );">Fair value measurement [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:56.7pt">&#160;</td>
                            <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>g.</span></span></span></span></td>
                            <td style="width:auto;vertical-align:top;text-align:justify">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement:</span></span></span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></span></span></span></div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></span></span></span></div>
                      <div/>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>All assets and liabilities measured at fair value or for which fair value is disclosed are categorized into levels within the fair value hierarchy based on the lowest level input that is significant to the entire fair value measurement:</span></span></span></span></div>
                      <div style="line-height:1.25">&#160;</div>
                      <div style="margin-left:95pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left">

                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 1</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">&#160;</td>
                              <td style="width:3.58%;vertical-align:top">&#160;</td>
                              <td style="width:82.14%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 2</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>inputs other than quoted prices included within Level 1 that are observable directly or indirectly.</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">&#160;</td>
                              <td style="width:3.58%;vertical-align:top">&#160;</td>
                              <td style="width:82.14%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:14.29%;vertical-align:top">
                                <div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Level 3</span></span></span></span></div>
                              </td>
                              <td style="width:3.58%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                              </td>
                              <td style="width:82.14%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory', window );">Biological assets [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>h.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Biological assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s biological assets consist of cannabis plants.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2, Inventories. These costs include the direct cost of planting and growing materials as well as other indirect costs such as utilities and supplies used in the cultivation process.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Indirect labor for individuals involved in the cultivation and quality control process is also included, as well as depreciation on growing equipment and overhead costs such as rent to the extent it is associated with the growing space. All direct and indirect costs of biological assets are capitalized as they are incurred, and they are all subsequently recorded within the line item cost of revenues on the Group&#8217;s statements of profit or loss and other comprehensive income in the period that the related product is sold.</span></span></span></span></div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventories after harvest. The fair value is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred (e.g., post-harvest costs). The net unrealized gains or losses arising from changes in fair value less cost to sell during the period are included in the gross profit for the related period and are recorded in a separate line on the face of the Group&#8217;s statements of profit or loss and other comprehensive income.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Determination of the fair values of the biological assets requires the Group to make assumptions about how market participants assign fair values to these assets. These assumptions primarily relate to the level of effort required to bring the cannabis up to the point of harvest, costs to convert the harvested cannabis to finished goods, sales price, risk of loss, expected future yields from the cannabis plants and estimating values during the growth cycle.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group accretes fair value on a straight-line basis according to stage of growth (e.g., a cannabis plant that is 50% through its growing cycle would be ascribed approximately 50% of its harvest date expected fair value, subject to wastage adjustments).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The fair value of biological assets is categorized within Level 3 of the fair value hierarchy. For the inputs and assumptions used in determining the fair value of biological assets, see Note 8.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s estimates are, by their nature, subject to change and differences from the anticipated yield will be reflected in the gain or loss on biological assets in future periods.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>i.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories are measured at the lower of cost and net realizable value. The cost of inventories comprises costs of purchase and costs incurred in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and estimated costs necessary to make the sale. The Group reviews inventory for obsolete, redundant and slow-moving goods and any such inventory are written-down to net realizable value.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inventories of purchased finished goods and packing materials are initially valued at cost and subsequently at the lower of cost and net realizable value.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The direct and indirect costs of inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labor and depreciation expense on equipment involved in packaging, labeling and inspection.</span></span></span></span></div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of revenues on the Group&#8217;s statements of profit or loss and other comprehensive income at the time cannabis is sold, except for realized fair value amounts included in inventory sold which are recorded as a separate line item on the face of the statements of profit or loss and other comprehensive income.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has otherwise been damaged.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>j.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property, plant and equipment:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation, accumulated impairment losses and excluding day-to-day servicing expenses. Cost includes spare parts and auxiliary equipment that are used in connection with plant and equipment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is depreciated separately using the component method.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values which are determined through the exercise of judgement and calculated on a straight-line basis over the useful lives of the assets at annual rates as follows:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>

                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr>
                                <td style="width:49.99%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Mainly %</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Buildings</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Greenhouse production equipment</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7 - 33</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Greenhouse structure</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.5</span></span></td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.5</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Motor vehicles</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>15-33</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Computer, software and equipment</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20 - 50</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leasehold improvements</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>See below</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>See below</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>

                    </div>
                    <div style="line-height:1.25;clear:both">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leasehold improvements are depreciated on a straight-line basis over the shorter of the lease term and the useful life of the improvement.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate. Depreciation of an asset ceases at the earlier of the date that the asset is classified as held for sale and the date that the asset is derecognized.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory', window );">Impairment of non-financial assets [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>k.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Impairment of non-financial assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group evaluates the need to record an impairment of non-financial assets whenever events or changes in circumstances indicate that the carrying amount is not recoverable. If the carrying amount of non-financial assets exceeds their recoverable amount, the assets are reduced to their recoverable amount. The recoverable amount is the higher of fair value less costs of sale and value in use. In measuring value in use, the expected future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the asset. The recoverable amount of an asset that does not generate independent cash flows is determined for the cash-generating unit to which the asset belongs. Impairment losses are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>An impairment loss of an asset, other than goodwill, is reversed only if there have been changes in the estimates used to determine the asset's recoverable amount since the last impairment loss was recognized. Reversal of an impairment loss, as above, shall not be increased above the lower of the carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized for the asset in prior years and its recoverable amount. The reversal of impairment loss of an asset presented at cost is recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The following criteria are applied in assessing impairment of these specific assets:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill in respect of subsidiaries:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company reviews goodwill for impairment once a year, on December 31, or more frequently if events or changes in circumstances indicate that there is an impairment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit (or group of cash-generating units) to which the goodwill has been allocated. The Company identified the operations and Israel, Canada and Europe as three separate cash-generating units.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>An impairment loss is recognized if the recoverable amount of the cash-generating unit (or group of cash-generating units) to which goodwill has been allocated is less than the carrying amount of the cash-generating unit (or group of cash-generating units). Any impairment loss is allocated first to goodwill. Impairment losses recognized for goodwill cannot be reversed in subsequent periods. During the year ended December 31, 2021, the Company recorded goodwill impairment in the amount of $275 with respect to the cash generating unit in Germany.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue recognition [Policy Text Block]</a></td>
<td class="text">
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>l.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue recognition:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from contracts with customers is recognized when the control over the goods or services is transferred to the customer. The transaction price is the amount of the consideration that is expected to be received based on the contract terms, excluding amounts collected on behalf of third parties (such as taxes).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In determining the amount of revenue from contracts with customers, the Group evaluates whether it is a principal or an agent in the arrangement. The Group is a principal when the Group controls the promised goods or services before transferring&#160;</span></span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>them to the customer. In these circumstances, the Group recognizes revenue for the gross amount of the consideration. When the Group is an agent, it recognizes revenue for the net amount of the consideration, after deducting the amount due to the principal.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from the sale of goods:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revenue from the sale of cannabis products is generally recognized at a point in time when control over the goods have been transferred to the customer. Payment is typically due prior to or upon delivery and revenue is recognized upon the satisfaction of the performance obligation. The Group satisfies its performance obligation and transfers control upon delivery and acceptance by the customer.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Variable consideration:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group determines the transaction price separately for each contract with a customer. When exercising this judgment, the Group evaluates the effect of each variable amount in the contract, taking into consideration discounts, penalties, variations, claims, and non-cash consideration. In determining the effect of the variable consideration, the Group normally uses the "most likely amount" method described in the Standard. Pursuant to this method, the amount of the consideration is determined as the single most likely amount in the range of possible consideration amounts in the contract. According to the Standard, variable consideration is included in the transaction price only to the extent that it is highly probable that a significant reversal in the amount of revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span></span></span></span></div>
                    <div/>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Bill-and-hold arrangements:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Due to strict regulations of storage and handling large quantities of cannabis products, the Group's customer may request the Group to retain physical possession of a sold product until it is delivered to the customer at a future point in time. Revenue from bill-and-hold sales is recognized before the product is physically delivered to the customer when all of the following criteria are met:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a) The reason for the bill-and-hold arrangement is substantive (for example, the customer has requested the arrangement);</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b)</span></span><span> </span><span><span>The product is identified separately as belonging to the customer;</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c)</span></span><span> </span><span><span>The product currently is ready for physical delivery to the customer;</span></span></span></span></div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>d)</span></span><span> </span><span><span>The Group does not have the ability to use the product by selling it or delivering it to another customer.</span></span></span></span></div>
                  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>m.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leases:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For leases in which the Group is the lessee, the Group recognizes on the commencement date of the lease a right-of-use asset and a lease liability, excluding leases whose term is up to 12 months and leases for which the underlying asset is of low value. For these excluded leases, the Group has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Group has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the lease liability includes all unpaid lease payments discounted at the interest rate implicit in the lease, if that rate can be readily determined, or otherwise using the Group's incremental borrowing rate. After the commencement date, the Group measures the lease liability using the effective interest rate method.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the right-of-use asset is recognized in an amount equal to the lease liability plus lease payments already made on or before the commencement date and initial direct costs incurred. The right-of-use asset is measured applying the cost model and amortized over the shorter of its useful life and the lease term. The periods of amortization are: Land and buildings &#8211; 5-12 years; Motor vehicles &#8211; 3 years.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div/>
                    </div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Variable lease payments that depend on an index:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On the commencement date, the Group uses the index rate prevailing on the commencement date to calculate the future lease payments.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For leases in which the Group is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the right-of-use asset, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease extension and termination options:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In the event of any change in the expected exercise of the lease extension option or in the expected non-exercise of the lease termination option, the Group remeasures the lease liability based on the revised lease term using a revised discount rate as of the date of the change in expectations. The total change is recognized in the carrying amount of the right-of-use asset until it is reduced to zero, and any further reductions are recognized in profit or loss.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development expenditures [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>n.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research and development expenditures:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research expenditures are recognized in profit or loss when incurred.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory', window );">Financial instruments [Policy Text Block]</a></td>
<td class="text">
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>o.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial instruments:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group apply the provisions of IFRS 9, "Financial Instruments".</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial assets are measured upon initial recognition at fair value plus transaction costs that are directly attributable to the acquisition of the financial assets, except for financial assets measured at fair value through profit or loss in respect of which transaction costs are recorded in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group classifies and measures debt instruments in the financial statements based on the following criteria:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s business model for managing financial assets; and</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The contractual cash flow terms of the financial asset.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Debt instruments are measured at amortized cost when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group&#8217;s business model is to hold the financial assets in order to collect their contractual cash flows, and the contractual terms of the financial assets give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. After initial recognition, the instruments in this category are measured according to their terms at amortized cost using the effective interest rate method, less any provision for impairment.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Debt instruments are measured at fair value through profit or loss when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial asset which is a debt instrument does not meet the criteria for measurement at amortized cost or at fair value through other comprehensive income. After initial recognition, the financial asset is measured at fair value and gains or losses from fair value adjustments are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Equity instruments:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Investments in equity instruments do not meet the above criteria and accordingly are measured at fair value through profit or loss. Dividends from investments in equity instruments are recognized in profit or loss when the right to receive the dividends is established.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div/>
                    </div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Impairment of financial assets:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group evaluates at the end of each reporting period the loss allowance for financial debt instruments measured at amortized cost. The Group has short-term financial assets, principally trade receivables, in respect of which the Group applies a simplified approach and measures the loss allowance in an amount equal to the lifetime expected credit losses. The impairment loss, if any, is recognized in profit or loss with a corresponding allowance that is offset from the carrying amount of the assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognition of financial assets:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial asset is derecognized only when:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The contractual rights to the cash flows from the financial asset has expired; or</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has transferred substantially all the risks and rewards deriving from the contractual rights to receive cash flows from the financial asset or has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset; or</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:113.4pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has retained its contractual rights to receive cash flows from the financial asset but has assumed a contractual obligation to pay the cash flows in full without material delay to a third party.</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities measured at amortized cost:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financial liabilities measured at fair value through profit or loss:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>At initial recognition, the Group measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs incurred at initial recognition are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>After initial recognition, changes in fair value are recognized in profit or loss.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div/>
                    </div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derecognition of financial liabilities:</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A financial liability is derecognized only when it is extinguished, that is when the obligation specified in the contract is discharged or cancelled or expires. A financial liability is extinguished when the debtor discharges the liability by paying in cash, other financial assets, goods or services; or is legally released from the liability.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issue of a unit of securities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The issue of a unit of securities involves the allocation of the proceeds received (before issue expenses) to the securities issued in the unit based on the following order: financial derivatives and other financial instruments measured at fair value in each period. Then fair value is determined for financial liabilities that are measured at amortized cost. The proceeds allocated to equity instruments are determined to be the residual amount. Issue costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></span></span></span></div>
                  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Employee benefit liabilities [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>p.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Employee benefit liabilities:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has several employee benefit plans:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term employee benefits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short-term employee benefits are benefits that are expected to be settled wholly before twelve months after the end of the annual reporting period in which the employees render the related services. These benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:85.05pt">&#160;</td>
                          <td style="width:28.15pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Post-employment benefits:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group has defined contribution plans pursuant to section 14 to the Israeli Severance Pay Law under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods. Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense when contributed concurrently with performance of the employee's services.</span></span></span></span></div>
                    <div style="line-height:1.25">
                      <div/>
                    </div>
                    <div style="text-align:justify;margin-left:113.2pt;line-height:1.25">
                      <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group also operates a defined benefit plan in respect of severance pay pursuant to the Israeli Severance Pay Law. According to the Severance Pay Law, employees are entitled to severance pay upon dismissal or retirement. The liability for termination of employment is measured using the projected unit credit method. The actuarial assumptions include expected salary increases and rates of employee turnover based on the estimated timing of payment. The amounts are presented based on discounted expected future cash flows using a discount rate determined by reference to market yields at the reporting date on high quality corporate bonds that are linked to the Consumer Price Index with a term that is consistent with the estimated term of the severance pay obligation.</span></span></span></span>
                    </div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In respect of its severance pay obligation to certain of its employees, the Group makes current deposits in pension funds and insurance companies (the "plan assets"). Plan assets comprise assets held by a long-term employee benefit fund or qualifying insurance policies. Plan assets are not available to the Group&#8217;s own creditors and cannot be returned directly to the Group.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The liability for employee benefits shown in the statement of financial position reflects the present value of the defined benefit obligation less the fair value of the plan assets.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:113.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remeasurements of the net liability are recognized in other comprehensive income in the period in which they occur.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payment transactions [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>q.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based payment transactions:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Group's employees and service providers are entitled to remuneration in the form of equity-settled share-based payments.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Equity-settled transactions:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The cost of equity-settled transactions with employees is measured at the fair value of the equity instruments granted at grant date. The fair value is determined using an acceptable option pricing model.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As for other service providers, the cost of the transactions is measured at the fair value of the goods or services received as consideration for equity instruments granted.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The cost of equity-settled transactions is recognized in profit or loss together with a corresponding increase in equity during the period which the performance and/or service conditions are to be satisfied ending on the date on which the relevant employees become entitled to the award (the "vesting period"). The cumulative expense recognized for equity-settled transactions at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group's best estimate of the number of equity instruments that will ultimately vest.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>r.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Provisions:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A provision in accordance with IAS 37 is recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. When the Group expects part or all of the expense to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense is recognized in the statement of profit or loss net of any reimbursement.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Taxes on income [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>s.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Taxes on income:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current or deferred taxes are recognized in profit or loss, except to the extent that they relate to items which are recognized in other comprehensive income or equity.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current taxes:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The current tax liability is measured using the tax rates and tax laws that have been enacted or substantively enacted by the reporting date as well as adjustments required in connection with the tax liability in respect of previous years.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are computed in respect of temporary differences between the carrying amounts in the financial statements and the amounts attributed for tax purposes.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are measured at the tax rate that is expected to apply when the asset is realized, or the liability is settled, based on tax laws that have been enacted or substantively enacted by the reporting date.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred tax assets are reviewed at each reporting date and reduced to the extent that it is not probable that they will be utilized. Deductible carryforward losses and temporary differences for which deferred tax assets had not been recognized are reviewed at each reporting date and a respective deferred tax asset is recognized to the extent that their utilization is probable.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deferred taxes are offset if there is a legally enforceable right to offset a current tax asset against a current tax liability and the deferred taxes relate to the same taxpayer and the same taxation authority.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Earnings per share [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>t.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Earnings per share:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Earnings per share are calculated by dividing the net income attributable to equity holders of the Group by the weighted number of Common Shares outstanding during the period.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Potential Common Shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share from continuing operations. Potential Common Shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share. The Company's share of earnings of investees is included based on its share of earnings per share of the investees multiplied by the number of shares held by the Company.</span></span></span></span></div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt">&#160;</td>
                          <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>u.</span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible assets:</span></span></span></span></div>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Expenditures relating to internally generated intangible assets, excluding capitalized development costs, are recognized in profit or loss when incurred.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company acquired brand with indefinite life. The Company believes that it will use the asset perpetually, with no intention of discontinuing the brand in the future. Intangible assets with indefinite useful lives are not systematically amortized and are tested for impairment annually or whenever there is an indication that the intangible asset may be impaired. The useful life of these assets is reviewed annually to determine whether their indefinite life assessment continues to be supportable. If the events and circumstances do not continue to support the assessment, the change in the useful life assessment from indefinite to finite is accounted for prospectively as a change in accounting estimate and on that date the asset is tested for impairment. Commencing from that date, the asset is amortized systematically over its useful life.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible assets with a finite useful life are amortized over their useful life and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for an intangible asset are reviewed at least at each year end.</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortization is calculated on a straight-line basis over the useful life of the assets as follows:</span></span></span></span></div>
                    <div style="line-height:1.25">&#160;</div>

                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

                            <tr>
                              <td style="width:76.8%;vertical-align:top">&#160;</td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Years</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">&#160;</td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cultivations and processing license</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6-19</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationships</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5-19</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Brand</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9 - indefinite</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other intangibles</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3-9</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>

                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock', window );">Government grants [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>v.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Government grants:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A government grant is recorded as a reduction of expenses or the cost of a related asset when there is reasonable assurance that the entity will comply with the relevant conditions and the grant will be received. When a government grant is for the purchase of an asset, the cost of the asset is reduced by the value of the grant on acquisition if all conditions for the grant are met and it is reasonably certain to be received, resulting in a reduction of depreciation expense over the useful life of the asset in the statement of profit and loss.</span></span></span></span></div>
                        </div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory', window );">Treasury shares [Policy Text Block]</a></td>
<td class="text">
                        <div>
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>w.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Treasury shares:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="margin-left:85.05pt;text-align:justify;line-height:1.25">&#160;</div>
                          <div style="margin-left:85.05pt;text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Company shares held by the Company and/or subsidiaries are recognized at cost of purchase and presented as a deduction from equity. Any gain or loss arising from a purchase, sale, issue or cancellation of treasury shares is recognized directly in equity.</span></span></span></div>
                        </div>
                      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory', window );">Operating segments [Policy Text Block]</a></td>
<td class="text">
                  <div>
                    <div>
                      <div>
                        <div style="line-height:1.25">
                          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                              <tr>
                                <td style="width:56.7pt">&#160;</td>
                                <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>x.</span></span></span></span></td>
                                <td style="width:auto;vertical-align:top;text-align:justify">
                                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating segments:</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                          <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25">&#160;</div>
                          <div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker ("CODM"), who is responsible for allocating resources and assessing performance of the operating segments. The Company's Chief Executive Officer is the CODM. The Company has determined that it operates in three operating segments (see Note 23).</span></span></span></span></div>
                        </div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for business combinations and goodwill. [Refer: Business combinations [member]; Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the derecognition of financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for fair value measurement. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the currency of the primary economic environment in which the entity operates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 46<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for short term deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureForSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureForSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108921976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureForSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure For Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">Disclosure of detailed information about subsidiaries [Table Text Block]</a></td>
<td class="text">
                      <div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="1" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left">

                              <tr>
                                <td rowspan="2" style="width:67.71%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Subsidiaries</span></span></span></span></div>
                                </td>
                                <td colspan="3" style="width:32.29%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Percentage ownership</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:14.18%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2020</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C. Holdings Ltd (&#8221;IMC&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Focus Medical Herbs Ltd. ("Focus") *)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C Farms Israel Ltd. ("IMC Farms")</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C Ventures Ltd. ("IMC Ventures")</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>I.M.C - International Medical Cannabis Portugal Unipessoal Lda</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Adjupharm GmbH (&#8220;Adjupharm&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90.02%</span></span></td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">92.5%</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>R.A. Yarok Pharm Ltd. (&#8220;Pharm Yarok&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Rosen High Way Ltd. (&#8220;Rosen High Way&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>High Way Shinua Ltd. (&#8220;HW Shinua&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Revoly Trading and Marketing Ltd. (&#8220;Vironna&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oranim Plus Pharm LTD.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51.3%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oranim Pharm</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>51%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Corp. (&#8220;Trichome&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Cannabis GP Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Financial Cannabis Manager Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Asset Funding Corp.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trichome Retail Corp.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MYM Nutraceuticals Inc. (&#8220;MYM&#8221;)</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>SublimeCulture Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CannaCanada Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MYM International Brands Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Highland Grow Inc.</span></span></span></span></div>
                                </td>
                                <td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100%</span></span></span></span></div>
                                </td>
                                <td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:15.01%;vertical-align:bottom;border-width:2px;border-style:solid;border-color:rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;text-indent:15.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25;clear:both">&#160;</div>
                        <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>*) See also Note 1b(1)</span></span></span></span></div>
                      </div>
                    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory', window );">Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment [Table Text Block]</a></td>
<td class="text">
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr>
                                <td style="width:49.99%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Mainly %</span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">&#160;</td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Buildings</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Greenhouse production equipment</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7 - 33</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Greenhouse structure</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.5</span></span></td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.5</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Motor vehicles</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>15-33</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Computer, software and equipment</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20 - 50</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                                <td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></td>
                              </tr>
                              <tr>
                                <td style="width:49.99%;vertical-align:top">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Leasehold improvements</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>See below</span></span></span></span></div>
                                </td>
                                <td style="width:4.17%;vertical-align:top">&#160;</td>
                                <td style="width:20.83%;vertical-align:top">
                                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>See below</span></span></span></span></div>
                                </td>
                              </tr>

                          </table>
                        </div>
                      <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory', window );">Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets [Table Text Block]</a></td>
<td class="text">
                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt">

                            <tr>
                              <td style="width:76.8%;vertical-align:top">&#160;</td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;border-bottom:#000000 2px solid">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Years</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">&#160;</td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cultivations and processing license</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6-19</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationships</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5-19</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Brand</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                              <td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9 - indefinite</span></span></span></span></div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width:76.8%;vertical-align:top">
                                <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other intangibles</span></span></span></span></div>
                              </td>
                              <td style="width:3.57%;vertical-align:top">&#160;</td>
                              <td style="width:19.64%;vertical-align:top">
                                <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3-9</span></span></span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureForSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureForSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about amortization calculated on straight-line basis over useful life of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about depreciation rate calculated on straight line basis over useful lives of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084898424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory', window );">Disclosure of detailed information about cash outflow/inflow on the acquisition [Table Text Block]</a></td>
<td class="text">
                <div>
                  <div style="line-height:1.25;margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value</span></span></div>
                          </td>
                          <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TFC</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MYM</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vironna</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pharm Yarok</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oranim</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Panaxia</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">362</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">131</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">57</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">105</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">485</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">3,240</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,548</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">259</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">456</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,329</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indemnification asset</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">8,131</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biological assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">785</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">63</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,883</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4,180</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">639</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">346</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,043</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">19</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loan receivable</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8,470</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,122</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,837</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">15,193</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">6,105</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">210</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,145</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">389</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">88</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">114</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right of use assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">15,037</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">630</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,312</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">319</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6,458</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">17,200</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">2,316</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">974</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">2,991</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">776</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">61,992</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">32,979</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">3,481</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">3,026</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">7,549</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">3,720</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(15,196</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(4,442</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(854</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,448</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,777</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank loans</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(915</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liability</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(15,037</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(873</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,312</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long term loans</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(1,042</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax, net</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(4,061</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(532</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(224</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(688</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable liabilities</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(30,233</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(10,291</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1,386</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(2,714</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(3,777</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total identifiable assets, net</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">31,759</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">22,688</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,095</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">312</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">3,772</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">3,720</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill arising on acquisition</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">67,269</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">39,932</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,250</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">4,294</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,907</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">3,240</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Controlling interest</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1,026</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1,849</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total purchase price</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">99,028</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">62,620</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">3,319</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">4,606</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">4,830</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">6,960</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Disclosure of detailed information about business combinations [Table Text Block]</a></td>
<td class="text">
                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="text-align:justify;margin-left:63pt;line-height:1.25">
                            <div>
                              <div>
                                <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                    <tr>
                                      <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">55,563</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                    </tr>
                                    <tr>
                                      <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                      </td>
                                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(25,372</td>
                                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                      </td>
                                    </tr>

                                </table>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Disclosure of detailed information about business combinations [Table Text Block]</a></td>
<td class="text">
                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25">
                            <div style="margin-left:63pt">
                              <div>
                                <div>
                                  <div style="line-height:1.25">&#160;</div>
                                  <div style="line-height:1.25">
                                    <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                        <tr>
                                          <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,639</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                        </tr>
                                        <tr>
                                          <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                          </td>
                                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(20,132</td>
                                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                          </td>
                                        </tr>

                                    </table>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Disclosure of detailed information about business combinations [Table Text Block]</a></td>
<td class="text">
                  <div>
                    <div style="margin-left:0t">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma results for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58,345</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(18,986</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Disclosure of detailed information about business combinations [Table Text Block]</a></td>
<td class="text">
                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma profit or loss for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,816</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(18,180</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember', window );">Oranim pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Disclosure of detailed information about business combinations [Table Text Block]</a></td>
<td class="text">
                  <div>
                    <div style="margin-left:0pt">
                      <div>
                        <div>
                          <div style="line-height:1.25;margin-left:63pt">
                            <div>
                              <div>
                                <div style="line-height:1.25">&#160;</div>
                                <div style="line-height:1.25">
                                  <table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto">

                                      <tr>
                                        <td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proforma profit or loss for the year ended</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net revenues</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">67,589</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                      </tr>
                                      <tr>
                                        <td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                        </td>
                                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom">(17,870</td>
                                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                        </td>
                                      </tr>

                                  </table>
                                </div>
                                <div style="line-height:1.25">&#160;</div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Section Disclosures application of paragraphs 59 and 61<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;doctype=Appendix&amp;subtype=B&amp;dita_xref=IFRS03_gB64-B67_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about Cash outflow/inflow on the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108907016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TRADE RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfTradeReceivablesExplanatory', window );">Disclosure of trade receivables [Table Text Block]</a></td>
<td class="text">
                <div>
                  <div style="margin-left:63pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wholesalers and pharmacies</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">16,711</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">5,501</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory', window );">Disclosure of major customers [Table Text Block]</a></td>
<td class="text">
                <div>
                  <div>
                    <div>
                      <div style="line-height:1.25;margin-left:63pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Reporting segment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Customer A</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25">
                                  <div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Canada</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">17</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Customer B</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:9%;text-align:center" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Israel</span></span></td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">35</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">%</span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of major customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfTradeReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Table information related to trade receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfTradeReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111535368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCOUNTS RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfOtherAccountsReceivableAbstract', window );"><strong>Disclosure of other accounts receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory', window );">Disclosure of detailed information about other accounts receivable [Table Text Block]</a></td>
<td class="text">
                    <div>
                      <div>
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,716</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">472</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government authorities</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,338</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">75</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties (see Note 21)</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">11</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">36</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indemnification assets (see Note 5)</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,112</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other receivables (including related parties - see Note 5)</span></span></div>
                                </div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,304</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">106</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">14,481</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">689</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about other accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfOtherAccountsReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfOtherAccountsReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109383368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory', window );">Disclosure of reconciliation of changes in biological assets [Table Text Block]</a></td>
<td class="text">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of January 1, 2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">52</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production costs capitalized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,717</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value less cost to sell due to biological transformation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">11,782</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transferred to inventory upon harvest</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(14,478</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange translation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">5</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of December 31, 2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">78</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions related to acquisitions of Trichome and MYM</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">848</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Production costs capitalized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">10,454</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value less cost to sell due to biological transformation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">7,210</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transferred to inventory upon harvest</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(16,977</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign exchange translation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">74</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:88%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at of December 31, 2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,687</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory', window );">Disclosure of detailed information about Impact on fair value of 10% increase/decrease in each input [Table Text Block]</a></td>
<td class="text">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10% change as at</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average selling price per gram of dried cannabis (in CAD)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3.64</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">6.01</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">296</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">8.86</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average post-harvest costs per gram of dried cannabis (in CAD)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1.16</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">0.83</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">140</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">0.23</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Attrition rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">27</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">5</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">100</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">0.43</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average yield per plant (in grams)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">47</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">54</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">228</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">7.64</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average stage of growth</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">47</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">212</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">7.64</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about Impact on fair value of 10% increase/decrease in each input.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111305704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory', window );">Disclosure of detailed information about inventories [Table Text Block]</a></td>
<td class="text">
                  <div>
                    <div style="margin-left:63pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized costs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair valuation adjustment, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying value</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work in progress:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bulk cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">14,113</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">3,336</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">17,449</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other cannabis products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,074</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,074</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Packaged dried cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">8,974</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">270</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">9,244</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other cannabis products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">744</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">744</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other products</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">880</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">880</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">25,785</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">3,606</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">29,391</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                      <p style="margin:0pt">&#160;</p>
                    </div>
                    <div/>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:63pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalized costs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair valuation adjustment, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying value</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work in progress:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bulk cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,130</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">4,728</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">6,858</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished goods:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Packaged dried cannabis</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">363</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">603</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">966</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">546</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">546</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,039</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,331</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,370</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131110243032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract', window );"><strong>Disclosure Of Detailed Information About Property Plant And Equipment And Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Disclosure of detailed information about property, plant and equipment [Table Text Block]</a></td>
<td class="text">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings and improvements</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greenhouse production equipment</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greenhouse structure</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer, software and equipment</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,675</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,534</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">884</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">174</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">19</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4,286</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">705</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,123</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">648</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">95</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">44</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2,615</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">97</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">104</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">63</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">10</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">276</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,477</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,761</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,595</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">279</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">65</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">7,177</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,932</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,846</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">508</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">261</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">31</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">4,578</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions related to acquisitions</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">18,828</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,584</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">455</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">263</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">23,130</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(81</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">79</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">79</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">44</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">11</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">132</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance December as of 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">23,156</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">8,270</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">2,182</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,039</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">370</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">35,017</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation:</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">46</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">534</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">280</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">26</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">894</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">132</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">350</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">147</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">52</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">9</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">690</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">35</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">17</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">3</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">61</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance, December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">184</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">919</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">444</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">81</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">17</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,645</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation during the year</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,554</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">993</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">206</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">241</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">27</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,021</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">4</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">40</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">26</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">11</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">2</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">83</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,742</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,952</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">676</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">333</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">46</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">4,749</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">21,414</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">6,318</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,506</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">706</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">324</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">30,268</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom">
                              <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,293</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,842</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,151</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">198</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">48</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">5,532</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111247272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Disclosure of detailed information about intangible assets [Table Text Block]</a></td>
<td class="text">
                      <div>
                        <div style="line-height:1.25;margin-left:63pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                              <tr>
                                <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cultivations and processing license *)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer relationships</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Brand</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost:</span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">831</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">58</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">63</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">62</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,014</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchases</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">93</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">93</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustment derived from purchase price allocation</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">110</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">110</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">26</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">32</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,060</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">58</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">63</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">68</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,249</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:middle;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial consolidations</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8,950</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">10,337</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">11,300</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">128</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">30,715</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(49</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">279</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">236</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">9,961</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">10,674</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">11,363</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">202</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">32,200</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated amortization and impairment:</span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">125</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">125</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization recognized in the year</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">31</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">31</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transaction</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">156</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">157</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortization recognized in the year</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">618</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">469</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">8</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">63</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,158</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">774</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">469</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">8</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">64</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">1,315</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:4px" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost at December 31, 2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">9,187</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">10,205</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">11,355</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">138</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">30,885</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortized cost at December 31, 2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">904</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">58</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">63</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">67</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,092</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:45pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*) The licenses consist of GMP and GDP licenses. </span></span></div>
                      </div>
                    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111188840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RIGHT-OF-USE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract', window );"><strong>Disclosure of quantitative information about right-of-use assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Disclosure of detailed information about right-of-use assets [Table Text Block]</a></td>
<td class="text">
              <div style="margin-left:63pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Land and buildings</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Motor vehicles</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">955</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">195</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,150</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">107</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">107</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">50</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">12</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">62</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(73</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(73</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,005</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">241</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,246</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">New leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,408</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">270</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,678</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial consolidations</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">16,956</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">23</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">16,979</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">145</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">12</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">157</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">19,514</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">546</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">20,060</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated depreciation:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">80</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">47</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">127</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">107</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">102</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">209</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">7</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">10</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Termination of leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(35</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(35</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">194</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">117</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">311</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year:</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,438</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">112</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,550</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency translation adjustments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">27</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">10</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">37</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;padding-bottom:4px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,659</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">239</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">1,898</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost at December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">17,855</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">307</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">18,162</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciated cost at December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">811</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">124</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">935</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111428888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT ASSETS AND LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract', window );"><strong>Employee Benefit Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory', window );">Disclosure of detailed information about defined benefit plans [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current service cost</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">146</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">166</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">14</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">10</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total employee benefit expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">160</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">176</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income on plan assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">7</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">4</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory', window );">Disclosure of detailed information about defined benefit liability (asset) [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Defined benefit obligation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">668</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">588</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value of plan assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(277</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(217</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net defined benefit liability</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">391</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">371</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory', window );">Disclosure of detailed information about changes in present value of defined benefit liabilities [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">588</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">390</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current service cost</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">146</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">166</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">14</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">10</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits paid</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(50</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(23</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Re-measurement loss on defined benefit plans</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(33</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">32</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation effect</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">3</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">13</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">668</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">588</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory', window );">Disclosure of detailed information about changes in the fair value of plan assets [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">217</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">128</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">7</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Return, net of interest income - remeasurement gain (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(12</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits paid</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(50</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(23</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts deposited</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">116</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">101</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation effect</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(1</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">5</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">277</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">217</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory', window );">Disclosure of detailed information about principal assumptions underlying the defined benefit plan [Table Text Block]</a></td>
<td class="text">
                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:85%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.5</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.58</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salary growth</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.64</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.37</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 138<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_138&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value of defined benefit plan assets. [Refer: Plan assets [member]; Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 142<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_142&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information of present value of defined benefit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EmployeeBenefitAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111305704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER PAYABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory', window );">Disclosure of detailed information of other current payables [Table Text Block]</a></td>
<td class="text">
                  <div style="margin-left:63pt">
                    <div>
                      <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">6,146</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">407</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and payroll accruals</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">8,267</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1,545</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government authorities</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4,002</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">642</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">875</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances from customers</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">137</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">741</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                              <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other payables</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">716</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">162</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">20,143</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">3,497</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information of other current payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108160328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory', window );">Disclosure of carrying values of financial instruments [Table Text Block]</a></td>
<td class="text">
                <div>
                  <div>
                    <div>
                      <div style="line-height:1.25">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial assets:</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investments</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,429</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,341</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c,e</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative assets</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">14</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:middle;width:64%" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial liabilities:</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">6,022</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">16,540</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b,d</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory', window );">Disclosure of information about key assumptions to measure fair value of warrants [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="margin-left:81pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td style="width:15.97%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31,</span></span></span></span></div>
                        </td>
                        <td style="width:1.11%;vertical-align:top">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2021</span></span></span></span></div>
                        </td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Sensitivity</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected volatility</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83 %</span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td rowspan="2" style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Increase (decrease) in key assumptions would</span></span></span></span></div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>result in increase (decrease) in fair value.</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected life (in years)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.342</span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk-free interest rate</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.85%</span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td rowspan="2" style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Increase (decrease) in key assumptions would</span></span></span></span></div>
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>result in decrease (increase) in fair value.</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Expected dividend yield</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0%</span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair value:</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center">&#160;</td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">&#160;</td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center">&#160;</td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Per Warrant (Canadian Dollar)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.979</span></span></td>
                        <td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:46.96%;vertical-align:top">
                          <div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Warrants (Canadian Dollar in thousands)</span></span></span></span></div>
                        </td>
                        <td style="width:1.73%;vertical-align:top">&#160;</td>
                        <td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$6,022</span></span></td>
                        <td style="width:3.48%;vertical-align:top">&#160;</td>
                        <td style="width:30.75%;vertical-align:top">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities', window );">Disclosure of maturity analysis for lease liabilities [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2021:</span></span></span></span></div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="line-height:1.25;font-weight:400;font-family:'Times New Roman',Times,serif;margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less than one year</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1 to 5 years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6 to 10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&gt;10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,130</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,781</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,760</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,620</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Bank Loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,502</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,632</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,781</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,760</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,620</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2020:</span></span></span></span></div>
                <div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold">&#160;</div>
                <div style="margin-left:90pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less than one year</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1 to 5 years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6 to 10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&gt;10</span></span></span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>years</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>232</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>547</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>515</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory', window );">Disclosure of changes in liabilities arising from financing activities [Table Text Block]</a></td>
<td class="text">
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease liabilities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Warrants</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total liabilities arising from financing activities</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of January 1, 2020</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,050</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">197</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,247</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new leases</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">107</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">107</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash flows</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(250</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(250</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Conversion of warrant</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,873</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,873</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other changes</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">144</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effect of changes in fair value</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,155</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,155</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31, 2020</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">990</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,540</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,530</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issuance of new warrants</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,832</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,832</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new loans</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,504</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,504</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions for new leases</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,678</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,678</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions related to acquisitions</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,957</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,222</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,179</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayments</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(700</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,980</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,680</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effective interest</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,347</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,347</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other changes</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">117</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(611</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(361</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Effect of changes in fair value</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,739</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,739</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance as of December 31, 2021</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,894</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,374</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,022</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,290</span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35K<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35K&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key assumptions to measure fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109412728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory', window );">Disclosure of detailed information about Income tax expense (benefit) [Table Text Block]</a></td>
<td class="text">
          <div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">248</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred, net</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">278</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax from previous years</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">505</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">262</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Disclosure of detailed information about deferred taxes [Table Text Block]</a></td>
<td class="text">
            <div style="margin-left:90pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statements of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">financial position</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statements of</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">profit or loss</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carryforward tax losses and other</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,542</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">769</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">892</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(440</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other deferred tax assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">14</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,556</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">769</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">891</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(440</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory and biological assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">863</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,239</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(431</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">385</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">7,261</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">264</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(189</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(11</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">7</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">7</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">8,131</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,503</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(613</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">374</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Translation differences</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">54</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">63</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax expenses, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">278</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(66</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(6,575</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">(734</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory', window );">Disclosure of detailed information about deferred tax assets and liabilities [Table Text Block]</a></td>
<td class="text">
          <div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">769</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,591</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,503</span></span></td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory', window );">Disclosure of detailed information about reconciliation of tax expense and accounting profit [Table text Block]</a></td>
<td class="text">
          <div>
            <div style="margin-left:90pt">
              <div>
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income tax</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(18,013</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(28,472</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate in Canada 26.5%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(4,773</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(7,545</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in income tax due to:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses (non-taxable income), net for tax purposes</span></span></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,447</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,306</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of different tax rate of subsidiaries</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">310</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">161</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments in respect of current income tax of previous years</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(21</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">303</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognition (derecognition) of tax benefit in respect of losses of previous years</span></span></div>
                          </div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">846</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(830</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrecognized tax benefit in respect of loss for the year</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4,093</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,771</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Utilization of losses not previously recognized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,466</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in tax benefits not recognized</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">5,252</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other adjustments</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(289</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">96</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">505</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">262</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about deferred tax assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Income Tax Expense Benefits Explanatory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Reconciliation of tax expense and the accounting profit Explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108806776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfCompositionOfShareCapitalExplanatory', window );">Disclosure of composition of share capital [Table Text Block]</a></td>
<td class="text">
            <div>
              <div style="line-height:1.25;margin-left:90pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2020</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Authorized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued and outstanding</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Authorized</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued and outstanding</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="14" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares without par value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unlimited</span></span></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">68,217,894</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unlimited</span></span></td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">39,765,799</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory', window );">Disclosure of changes in issued and outstanding share capital [Table Text Block]</a></td>
<td class="text">
            <div>
              <div style="margin-left:90pt">
                <div>
                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of January 1, 2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">36,435,837</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of Warrants and Compensation options exercised</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,169,769</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of options exercises</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">160,193</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">39,765,799</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of Warrants and Compensation options exercised</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">633,784</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued as a result of options exercises</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">517,346</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of treasury common shares</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(101,649</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Common Shares issued related secondary transaction and business combinations</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">27,402,614</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">68,217,894</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory', window );">Disclosure of detailed information about options, valuation assumptions [Table Text Block]</a></td>
<td class="text">
              <div>
                <div>
                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price (in CAD)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$4.5 - $10.12</span></span></div>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.6 - $8.56</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected life of share options (Years)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3-4</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.77 - 9</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Volatility (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80.61-83.68</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74.8 - 80.39</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Annual risk-free rate (%)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.52-0.77</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.25 &#8211; 0.37</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share price (in CAD)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">$10.02</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$1.48 &#8211; $8.56</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfRestrictedShareUnitsTableTextBlock', window );">Disclosure of restricted share units [Table Text Block]</a></td>
<td class="text">
              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of RSU</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">550,000</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding at the end of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">550,000</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">229,006</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Disclosure of number and weighted average exercise prices of share options [Table Text Block]</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25;margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in CAD</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">3,154,870</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2.2</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,964,265</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">6.2</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercised during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(517,346</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">2.43</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options forfeited during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(158,544</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">4.08</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">5,443,245</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">3.91</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,888,480</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
              <p style="margin:0pt">&#160;</p>
            </div>
            <div/>
            <div style="margin-left:90pt">&#160;</div>
            <div style="margin-left:90pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2020</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average exercise price</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in CAD</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,940,000</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1.6</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">905,000</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">4.24</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercised during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(160,193</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">1.8</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options forfeited during the year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(529,937</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1.8</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">3,154,870</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2.2</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                      <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,328,770</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1.8</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of changes in issued and outstanding share capital explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfCompositionOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Composition Of Share Capital Explanatory [Table Text Block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfCompositionOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about options, valuation assumptions [Table Text Block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfRestrictedShareUnitsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of restricted share units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfRestrictedShareUnitsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131110271800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELECTED STATEMENTS OF PROFIT OR LOSS DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory', window );">Disclosure of statement of profit and loss [Table Text Block]</a></td>
<td class="text">
                <div>
                  <div style="margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">19,718</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">6,897</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:76%" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">6,004</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">930</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expenses by nature. [Refer: Expenses, by nature]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesByNatureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131110319496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Disclosure of earnings per share [Table text block]</a></td>
<td class="text">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="14" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted number of shares (in thousands)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to equity holders of the Company</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted number of shares (in thousands)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to equity holders of the Company</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the computation of basic net earnings</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">57,963</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(17,763</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">38,565</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(28,698</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect of potential dilutive Ordinary shares&#160;- Warrants</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,810</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(21,739</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the computation of diluted net earnings</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">59,773</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(39,502</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">38,565</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(28,698</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>

                    </table>
                  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108571192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory', window );">Disclosure of balances with related parties [Table Text Block]</a></td>
<td class="text">
                    <div>
                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts receivables</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">11</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">36</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts payables</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">875</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">-</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Disclosure of transactions between related parties [Table Text Block]</a></td>
<td class="text">
                    <div>
                      <div style="margin-left:90pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,116</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">617</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">Disclosure of information about key management personnel [Table Text Block]</a></td>
<td class="text">
                      <div>
                        <div style="margin-left:90pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2020</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payroll and related expenses</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2,377</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">2,005</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">5,700</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,791</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional fees *)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,029</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">1,391</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="line-height:1.25">&#160;</div>
                        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                            <tr>
                              <td style="width:85.05pt">&#160;</td>
                              <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                              <td style="width:auto;vertical-align:top;text-align:justify">
                                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Includes payments to shareholders for the years ended 2021 and 2020 of $455 and $534, respectively.</span></span></div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfBalancesWithRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information about balances with related parties in statements of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfBalancesWithRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108456728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract', window );"><strong>Summarized Financial Information For Partly Owned Subsidiary [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory', window );">Disclosure of statement of financial position for partly owned subsidiary [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Statement of financial position at reporting date (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Current assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">22,913</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">16,531</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Non-current assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">4,473</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">4,226</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Current liabilities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(19,616</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(11,341</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Non-current liabilities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(1,883</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">(2,274</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total equity</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">5,887</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">7,142</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory', window );">Disclosure of operating results for partly owned subsidiary [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Operating results (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Revenues</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">14,747</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">13,823</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net income (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,524</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">968</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Other comprehensive income</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">37</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(22</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total comprehensive income (loss)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(1,487</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">946</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory', window );">Disclosure of statement cash flows for partly owned subsidiary [Table Text Block]</a></td>
<td class="text">
              <div>
                <div style="margin-left:63pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Year ended</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2021</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2020</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Cash flows (as presented in Focus' financial statements):</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From operating activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">2,346</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">1,882</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From investing activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(783</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">(1,656</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">From financing activities</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">560</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">(184</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Effect of foreign exchange on cash and cash equivalents</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">169</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">39</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net increase in cash and cash equivalents</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">2,292</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">81</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section Presentation of a statement of cash flows<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS07_g10-17_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashFlowStatementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of operating results for partly owned subsidiary explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of statement of financial position for partly owned subsidiary explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131110434776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING SEGMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory', window );">Disclosure of operating segments [Table Text Block]</a></td>
<td class="text">
            <div>
              <div style="margin-left:90pt">&#160;</div>
              <div>
                <div>
                  <div style="line-height:1.25;margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2021:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">25,431</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">20,247</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">8,622</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">-</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">54,300</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10,654</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,353</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,142</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,149</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated corporate expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(7,240</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(7,240</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(38,389</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation, amortization and impairment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,424</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,879</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">701</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,004</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                    <div>&#160;</div>
                  </div>
                  <div style="line-height:1.25;margin-left:90pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2020:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,826</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,064</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">15,890</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,090</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,744</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,834</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated corporate expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(2,411</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">(2,411</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating loss</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,245</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation, amortization and impairment</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">617</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">73</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">690</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
              <div>
                <div>
                  <div style="line-height:1.25;margin-left:90pt">&#160;</div>
                </div>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of geographical information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131067947400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL (Narrative) (Details)<br> $ / shares in Units, &#8362; in Thousands, $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="10">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 09, 2021 </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 10, 2021 </div>
<div>CAD ($) </div>
<div>Shares</div>
</th>
<th class="th">
<div>May 10, 2021 </div>
<div>USD ($) </div>
<div>Shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Feb. 12, 2021</div></th>
<th class="th">
<div>Mar. 30, 2022 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 18, 2021 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 29, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 30, 2022 </div>
<div>ILS (&#8362;) </div>
<div>Shares</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 01, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Aug. 16, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 16, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>May 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>May 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares', window );">Description of share consolidation of issued and outstanding ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company's shareholders general meeting resolved to consolidated all of its issued and outstanding Ordinary shares on a four (4) to one (1) basis (the &#8220;Share Consolidation&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,765,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,919)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of common shares issued in business combination | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,104,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree', window );">Number of common shares issued for each share of acquiree | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.24525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,525<span></span>
</td>
<td class="nump">50,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_Commitment', window );">Total Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Borrowings, interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prime Rate plus 7.30% per annum<span></span>
</td>
<td class="text">Prime Rate plus 7.30% per annum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of common shares issued in business combination | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,073,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree', window );">Number of common shares issued for each share of acquiree | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of issued and outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of common shares issued in business combination | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">18,700<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">&#8362; 18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">&#8362; 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200<span></span>
</td>
<td class="nump">18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok pharmacy [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,950<span></span>
</td>
<td class="nump">&#8362; 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">&#8362; 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of issued and outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna pharmacy [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="nump">485,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="nump">1,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">&#8362; 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MizrahiMember', window );">Mizrahi [Member] | Revolving Credit Facility [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_Commitment', window );">Total Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Borrowings, interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prime interest plus 1.5% (approximately 3.3%) per annum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmMember', window );">Oranim Pharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of issued and outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PercentageOfOutstandingSharesAcquired', window );">Percentage of outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PercentageOfRightsHold', window );">Percentage of rights hold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmMember', window );">Oranim Pharm [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IssuanceOfCommonShares', window );">Issuance of common shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of common shares issued in business combination | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 630<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="nump">&#8362; 1,536<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="nump">&#8362; 11,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember', window );">Overnight Marketed Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,086,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,502<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of warrants issued for common shares | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456,522<span></span>
</td>
<td class="nump">456,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WorkingCapitalOfBusinessAcquisition', window );">Working capital of business acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EquityTransactionAxis=imc_PreliminaryShelfProspectusMember', window );">Preliminary Shelf Prospectus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs recognised as an expense for transactions that are recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_CashConsiderationOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents cash consideration of business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_CashConsiderationOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_Commitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_Commitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about description of share consolidation of issued and outstanding ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IssuanceOfCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents issuance of common shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IssuanceOfCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issued for each share of acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PercentageOfOutstandingSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of outstanding shares acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PercentageOfOutstandingSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PercentageOfRightsHold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of rights hold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PercentageOfRightsHold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_WorkingCapitalOfBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents working capital of business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_WorkingCapitalOfBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=imc_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=imc_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_MizrahiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_MizrahiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_OranimPharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EquityTransactionAxis=imc_PreliminaryShelfProspectusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EquityTransactionAxis=imc_PreliminaryShelfProspectusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111158104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill', window );">Goodwill impairment with respect to the cash generating unit in Europe</a></td>
<td class="nump">$ 275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member] | Right-of-use assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Land and buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Land and buildings [Member] | Right-of-use assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Land and buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Land and buildings [Member] | Right-of-use assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss on goodwill recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Goodwill; Impairment loss; Impairment loss recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131085140056">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCPointHoldingsLtdMember', window );">I.M.C. Holdings Ltd ("IMC") [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_FocusMedicalHerbsLtdMember', window );">Focus Medical Herbs Ltd. ("Focus") [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">74.00%<span></span>
</td>
<td class="nump">74.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCFarmsIsraelLtdPointMember', window );">I.M.C Farms Israel Ltd. ("IMC Farms") [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCVenturesLtdPointMember', window );">I.M.C Ventures Ltd. ("IMC Ventures") [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember', window );">I.M.C - International Medical Cannabis Portugal Unipessoal Lda [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember', window );">Adjupharm GmbH ("Adjupharm") [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">90.02%<span></span>
</td>
<td class="nump">92.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RayarokPharmLtdMember', window );">R.A. Yarok Pharm Ltd. (&#8220;Pharm Yarok&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RosenHighWayLtdMember', window );">Rosen High Way Ltd. (&#8220;Rosen High Way&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_HighWayShinuaLtdMember', window );">High Way Shinua Ltd. (&#8220;HW Shinua&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RevolyTradingAndMarketingLtdMember', window );">Revoly Trading and Marketing Ltd. (&#8220;Vironna&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_OranimPlusPharmLtdMember', window );">Oranim Plus Pharm LTD. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">51.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_OranimPharmMember', window );">Oranim Pharm [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCannabisGpIncMember', window );">Trichome Financial Cannabis GP Inc. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCannabisManagerIncMember', window );">Trichome Financial Cannabis Manager Inc. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeAssetFundingCorpMember', window );">Trichome Asset Funding Corp. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeJwcAcquisitionCorpMember', window );">Trichome JWC Acquisition Corp. (&#8220;TJAC&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeRetailCorpMember', window );">Trichome Retail Corp. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_SublimecultureIncMember', window );">SublimeCulture Inc. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_CannacanadaIncMember', window );">CannaCanada Inc. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_MymInternationalBrandsIncMember', window );">MYM International Brands Inc. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_HighlandGrowIncMember', window );">Highland Grow Inc. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Percentage ownership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See also Note 1b(1)</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCPointHoldingsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCPointHoldingsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_FocusMedicalHerbsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_FocusMedicalHerbsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCFarmsIsraelLtdPointMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCFarmsIsraelLtdPointMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCVenturesLtdPointMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCVenturesLtdPointMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RayarokPharmLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RayarokPharmLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RosenHighWayLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RosenHighWayLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_HighWayShinuaLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_HighWayShinuaLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RevolyTradingAndMarketingLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_RevolyTradingAndMarketingLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_OranimPlusPharmLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_OranimPlusPharmLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_OranimPharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_OranimPharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCannabisGpIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCannabisGpIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCannabisManagerIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCannabisManagerIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeAssetFundingCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeAssetFundingCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeJwcAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeJwcAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeRetailCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeRetailCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_MymNutraceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_MymNutraceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_SublimecultureIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_SublimecultureIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_CannacanadaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_CannacanadaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_MymInternationalBrandsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_MymInternationalBrandsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_HighlandGrowIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_HighlandGrowIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108628216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member] | Mainly [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember', window );">Greenhouse production equipment [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember', window );">Greenhouse production equipment [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember', window );">Greenhouse production equipment [Member] | Mainly [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember', window );">Greenhouse structure [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember', window );">Greenhouse structure [Member] | Mainly [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member] | Mainly [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer, software and equipment [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer, software and equipment [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer, software and equipment [Member] | Mainly [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment', window );">Depreciation rate, property, plant and equipment</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRatePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRatePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111144344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Cultivations and processing license [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill', window );">Amortization rate</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Cultivations and processing license [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill', window );">Amortization rate</a></td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer relationships [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill', window );">Amortization rate</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer relationships [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill', window );">Amortization rate</a></td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill', window );">Amortization rate</a></td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangibles [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill', window );">Amortization rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangibles [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill', window );">Amortization rate</a></td>
<td class="nump">9.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amortisation rate used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131072960888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS (Narrative) (Details)<br> $ / shares in Units, $ / shares in Units, &#8362; in Thousands, $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 01, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 09, 2021 </div>
<div>Shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Sep. 01, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Sep. 01, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 18, 2021 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 29, 2022 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 06, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>ILS (&#8362;) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($) </div>
<div>Shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 30, 2022 </div>
<div>CAD ($) </div>
<div>Shares</div>
</th>
<th class="th">
<div>Mar. 30, 2022 </div>
<div>ILS (&#8362;) </div>
<div>Shares</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Shares</div>
</th>
<th class="th">
<div>Dec. 01, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Aug. 16, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 16, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>May 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>May 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,964,265<span></span>
</td>
<td class="nump">2,964,265<span></span>
</td>
<td class="nump">905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of common shares issued in business combination | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,104,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Market price of common shares | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AmountOfSettlementOfWithholdingTaxLiabilities', window );">Amount of settlement of withholding tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities', window );">Number of common shares comprised to cover tax liabilities | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">927,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PercentageOfWithholdingTaxLiabilities', window );">Percentage of withholding tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel', window );">Percentage of income tax liability of key personnel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest', window );">Percentage of withholding tax liabilities of penalties and interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses', window );">Impairment loss of indemnification asset and penalty and interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree', window );">Number of common shares issued for each share of acquiree | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.24525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,525<span></span>
</td>
<td class="nump">50,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets', window );">Description of contingent consideration of acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(a). any portion of remittance to the CRA on account of any non-residence Canadian estimated at approximately $1,886, plus (b) 75% of any liabilities for penalties up to December 31, 2021 and 100% of any penalties from January 1, 2022 onward (estimated at approximately $604), and indemnify 75% of any liabilities for interest through December 31, 2021 and 100% of any interest from January 1, 2022 (estimated at approximately $342), in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a) above), plus (c) To the extent not captured above in sections (a) and (b), 100% of the withholding taxes tax liabilities, subtracting all cash proceeds received by Trichome or IMC from the sale of the Purchaser Balance Shares<span></span>
</td>
<td class="text">(a). any portion of remittance to the CRA on account of any non-residence Canadian estimated at approximately $1,886, plus (b) 75% of any liabilities for penalties up to December 31, 2021 and 100% of any penalties from January 1, 2022 onward (estimated at approximately $604), and indemnify 75% of any liabilities for interest through December 31, 2021 and 100% of any interest from January 1, 2022 (estimated at approximately $342), in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a) above), plus (c) To the extent not captured above in sections (a) and (b), 100% of the withholding taxes tax liabilities, subtracting all cash proceeds received by Trichome or IMC from the sale of the Purchaser Balance Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AmountOfSettlementOfWithholdingTaxLiabilities', window );">Amount of settlement of withholding tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses', window );">Impairment loss of indemnification asset and penalty and interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of common shares issued in business combination | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,073,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Market price of common shares | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree', window );">Number of common shares issued for each share of acquiree | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of issued and outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">833,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfShareOptionsShareVestedRsu', window );">Number of RSU vested | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of common shares issued in business combination | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">18,700<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">&#8362; 18,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">&#8362; 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AmountOfNonCancellablePurchasePrice', window );">Amount of non cancellable purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="nump">18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Market price of common shares | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Market price of common shares | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok pharmacy [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of issued and outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">&#8362; 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,950<span></span>
</td>
<td class="nump">&#8362; 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">&#8362; 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna pharmacy [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">$ 3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="nump">1,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition costs</a></td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">&#8362; 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmMember', window );">Oranim Pharm [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of issued and outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 11,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmMember', window );">Oranim Pharm [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of common shares issued in business combination | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,001<span></span>
</td>
<td class="nump">251,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="nump">$ 630<span></span>
</td>
<td class="nump">&#8362; 1,536<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="nump">&#8362; 11,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPlusPharmLtdMember', window );">Oranim Plus Pharm Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PercentageOfAcquisition', window );">Percentage of acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of issued and outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs recognised as an expense for transactions that are recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the contingent consideration arrangements and the arrangements for indemnification assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_g_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AmountOfNonCancellablePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents amount of non cancellable purchase price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AmountOfNonCancellablePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AmountOfSettlementOfWithholdingTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents amount of settlement of withholding tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AmountOfSettlementOfWithholdingTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_CashConsiderationOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents cash consideration of business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_CashConsiderationOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents impairment loss of indemnification asset and penalty and interest expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents number of common shares comprised to cover tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issued for each share of acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfShareOptionsShareVestedRsu">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options granted in share vested RSU.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfShareOptionsShareVestedRsu</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PercentageOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about percentage of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PercentageOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of income tax liability of Key Personnel.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PercentageOfWithholdingTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents percentage of withholding tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PercentageOfWithholdingTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents percentage of withholding tax liabilities of penalties and interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_OranimPharmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPlusPharmLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_OranimPlusPharmLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131072898184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS - Disclosure of detailed information about proforma acquisition (Details) - Pro Forma [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Net revenues</a></td>
<td class="nump">$ 55,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Net loss</a></td>
<td class="num">(25,372)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Net revenues</a></td>
<td class="nump">61,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Net loss</a></td>
<td class="num">(20,132)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Net revenues</a></td>
<td class="nump">56,816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Net loss</a></td>
<td class="num">(18,180)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Net revenues</a></td>
<td class="nump">58,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Net loss</a></td>
<td class="num">(18,986)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember', window );">Oranim pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Net revenues</a></td>
<td class="nump">67,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Net loss</a></td>
<td class="num">$ (17,870)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ProFormaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ProFormaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131081028232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS - Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)<br> &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 16, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 16, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>May 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>May 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification asset</a></td>
<td class="nump">$ 2,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="nump">362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification asset</a></td>
<td class="nump">8,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate', window );">Biological assets</a></td>
<td class="nump">785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="nump">3,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LoanReceivableRecognisedAsOfAcquisitionDate', window );">Loan receivable</a></td>
<td class="nump">8,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">15,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DerivativeAssetsAsOfAcquisitionDate', window );">Derivative assets</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">15,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">6,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable assets</a></td>
<td class="nump">61,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="num">(15,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="num">(15,037)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total identifiable liabilities</a></td>
<td class="num">(30,233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total identifiable assets, net</a></td>
<td class="nump">31,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill arising on acquisition</a></td>
<td class="nump">67,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">99,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember', window );">MYM Nutraceuticals Inc. (&#8220;MYM&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="nump">2,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate', window );">Biological assets</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="nump">4,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LoanReceivableRecognisedAsOfAcquisitionDate', window );">Loan receivable</a></td>
<td class="nump">2,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">6,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DerivativeAssetsAsOfAcquisitionDate', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">17,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable assets</a></td>
<td class="nump">32,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="num">(4,442)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="num">(915)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="num">(873)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax</a></td>
<td class="num">(4,061)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total identifiable liabilities</a></td>
<td class="num">(10,291)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total identifiable assets, net</a></td>
<td class="nump">22,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill arising on acquisition</a></td>
<td class="nump">39,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">62,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate', window );">Biological assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="nump">639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LoanReceivableRecognisedAsOfAcquisitionDate', window );">Loan receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DerivativeAssetsAsOfAcquisitionDate', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">2,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable assets</a></td>
<td class="nump">3,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="num">(854)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax</a></td>
<td class="num">(532)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total identifiable liabilities</a></td>
<td class="num">(1,386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total identifiable assets, net</a></td>
<td class="nump">2,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill arising on acquisition</a></td>
<td class="nump">2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="num">(1,026)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">3,319<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">&#8362; 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="nump">456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate', window );">Biological assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LoanReceivableRecognisedAsOfAcquisitionDate', window );">Loan receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">1,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DerivativeAssetsAsOfAcquisitionDate', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable assets</a></td>
<td class="nump">3,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="num">(1,448)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="num">(1,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax</a></td>
<td class="num">(224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total identifiable liabilities</a></td>
<td class="num">(2,714)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total identifiable assets, net</a></td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill arising on acquisition</a></td>
<td class="nump">4,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">4,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember', window );">Oranim pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="nump">485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="nump">1,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate', window );">Biological assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="nump">1,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LoanReceivableRecognisedAsOfAcquisitionDate', window );">Loan receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DerivativeAssetsAsOfAcquisitionDate', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">1,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">2,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable assets</a></td>
<td class="nump">7,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="num">(1,777)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="num">(1,312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax</a></td>
<td class="num">(688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total identifiable liabilities</a></td>
<td class="num">(3,777)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total identifiable assets, net</a></td>
<td class="nump">3,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill arising on acquisition</a></td>
<td class="nump">2,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="num">(1,849)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">4,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate', window );">Biological assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LoanReceivableRecognisedAsOfAcquisitionDate', window );">Loan receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">2,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DerivativeAssetsAsOfAcquisitionDate', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RightOfUseAssetsAsOfAcquisitionDate', window );">Right of use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsAsOfAcquisitionDate', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable assets</a></td>
<td class="nump">3,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LeaseLiabilityAsOfAcquisitionDate', window );">Lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_LongTermBorrowingsAsOfAcquisitionDate', window );">Long term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total identifiable liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total identifiable assets, net</a></td>
<td class="nump">3,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill arising on acquisition</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">$ 6,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">&#8362; 18,700<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">&#8362; 18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-controlling interest in the acquiree recognised at the acquisition date for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_BiologicalAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents biological assets recognised as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_BiologicalAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DerivativeAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents derivative assets as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DerivativeAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable assets acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for liabilities assumed in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount Investment and financial instruments as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InvestmentsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents investments as of acquisition date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InvestmentsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_LeaseLiabilityAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents lease liability as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_LeaseLiabilityAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_LoanReceivableRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for loan receivable acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_LoanReceivableRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_LongTermBorrowingsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents long term borrowings as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_LongTermBorrowingsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_RightOfUseAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents right of use assets as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_RightOfUseAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other receivables acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_TrichomeFinancialCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_MymNutraceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131110265944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TRADE RECEIVABLES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TermOfNonInterestBearingTradeReceivables', window );">Term of non interest bearing trade receivables</a></td>
<td class="text">30 to 90 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TermOfNonInterestBearingTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents term of non interest bearing trade receivables .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TermOfNonInterestBearingTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109372776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TRADE RECEIVABLES - Disclosure of trade receivables (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">$ 16,711<span></span>
</td>
<td class="nump">$ 5,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_WholesalesAndPharmaciesMember', window );">Wholesalers and pharmacies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">$ 16,711<span></span>
</td>
<td class="nump">$ 5,501<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_WholesalesAndPharmaciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_WholesalesAndPharmaciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111341768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TRADE RECEIVABLES - Disclosure of major customers (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=imc_CustomerOneMember', window );">Customer A [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TradeReceivablesLineItems', window );"><strong>Trade Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of total revenues</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=imc_CustomerThreeMember', window );">Customer C [Member] | Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TradeReceivablesLineItems', window );"><strong>Trade Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of total revenues</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TradeReceivablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TradeReceivablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=imc_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=imc_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=imc_ForeignCountriesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=imc_ForeignCountriesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=imc_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=imc_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108595160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER ACCOUNTS RECEIVABLE - Disclosure of detailed information about other accounts receivable (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfOtherAccountsReceivableAbstract', window );"><strong>Disclosure of other accounts receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">$ 2,716<span></span>
</td>
<td class="nump">$ 472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ReceivablesFromGovernmentAuthorities', window );">Government authorities</a></td>
<td class="nump">2,338<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties', window );">Related parties</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification asset</a></td>
<td class="nump">2,112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables</a></td>
<td class="nump">7,304<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Total other accounts receivable</a></td>
<td class="nump">$ 14,481<span></span>
</td>
<td class="nump">$ 689<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables due from related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfOtherAccountsReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfOtherAccountsReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ReceivablesFromGovernmentAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount receivables from government authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ReceivablesFromGovernmentAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131110363240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD_per_gram</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets', window );">Weighted average fair value less cost to sell</a></td>
<td class="nump">2.48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the weighted average fair value less cost to sell of biological assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131080940616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract', window );"><strong>Disclosure of detailed information about biological assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Beginning Balance</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets', window );">Additions related to acquisitions of Trichome and MYM</a></td>
<td class="nump">848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ProductionCostsCapitalizedBiologicalAssets', window );">Production costs capitalized</a></td>
<td class="nump">10,454<span></span>
</td>
<td class="nump">2,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets', window );">Changes in fair value less cost to sell due to biological transformation</a></td>
<td class="nump">7,210<span></span>
</td>
<td class="nump">11,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseDueToHarvestBiologicalAssets', window );">Transferred to inventory upon harvest</a></td>
<td class="num">(16,977)<span></span>
</td>
<td class="num">(14,478)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets', window );">Foreign exchange translation</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Ending Balance</a></td>
<td class="nump">$ 1,687<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in biological assets resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of living animals or plants recognised as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 43<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseDueToHarvestBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseDueToHarvestBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) arising from changes in fair value less costs to sell of biological assets due to physical changes. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Section Example 1 XYZ Dairy Ltd<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS41_IE_ex1__IAS41_IE_ex1_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in biological assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ProductionCostsCapitalizedBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of production costs capitalized on biological assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ProductionCostsCapitalizedBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108686984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BIOLOGICAL ASSETS - Disclosure of detailed information about Impact on fair value if 10% increase decrease in each input (Details) - Cannabis Plants [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD_per_gram </div>
<div>Gram</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD_per_gram </div>
<div>Gram</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems', window );"><strong>Disclosure of detailed information about biological assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AverageSellingPricePerGramOfDriedCannabis', window );">Average selling price per gram of dried cannabis (in CAD)</a></td>
<td class="nump">3.64<span></span>
</td>
<td class="nump">6.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AveragePostHarvestCostsPerGramOfDriedCannabis', window );">Average post-harvest costs per gram of dried cannabis (in CAD)</a></td>
<td class="nump">1.16<span></span>
</td>
<td class="nump">0.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AttritionRate', window );">Attrition rate</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AverageYieldPerPlant', window );">Average yield per plant (in grams) | Gram</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AverageStageOfGrowth', window );">Average stage of growth</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsByTypeAxis=imc_CannabisPlantsMember', window );">10% change [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems', window );"><strong>Disclosure of detailed information about biological assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AverageSellingPricePerGramOfDriedCannabis', window );">Average selling price per gram of dried cannabis (in CAD)</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">8.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AveragePostHarvestCostsPerGramOfDriedCannabis', window );">Average post-harvest costs per gram of dried cannabis (in CAD)</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">0.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AttritionRate', window );">Attrition rate</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">0.43%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AverageYieldPerPlant', window );">Average yield per plant (in grams) | Gram</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">7.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AverageStageOfGrowth', window );">Average stage of growth</a></td>
<td class="nump">212.00%<span></span>
</td>
<td class="nump">7.64%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AttritionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AttritionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AveragePostHarvestCostsPerGramOfDriedCannabis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the average post-harvest costs per gram of dried cannabis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AveragePostHarvestCostsPerGramOfDriedCannabis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AverageSellingPricePerGramOfDriedCannabis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the average selling price per gram of dried cannabis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AverageSellingPricePerGramOfDriedCannabis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AverageStageOfGrowth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage for average stage of growth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AverageStageOfGrowth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AverageYieldPerPlant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expected number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AverageYieldPerPlant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsByTypeAxis=imc_CannabisPlantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsByTypeAxis=imc_CannabisPlantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_UnobservableInputAxis=imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_UnobservableInputAxis=imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084897144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfMerchandiseSold', window );">Inventory expensed to cost of goods sold</a></td>
<td class="nump">$ 43,720<span></span>
</td>
<td class="nump">$ 17,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold', window );">Non-cash expense related to the changes in fair value of inventory sold</a></td>
<td class="nump">8,796<span></span>
</td>
<td class="nump">10,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Write downs of inventories recognized cost of sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 291<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfMerchandiseSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of merchandise that was sold during the period and recognised as an expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfMerchandiseSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of non cash expense related to the changes in fair value of inventory sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131080933928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Disclosure of detailed information about inventories (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CapitalizedCostsOfInventories', window );">Capitalized costs</a></td>
<td class="nump">$ 25,785<span></span>
</td>
<td class="nump">$ 3,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoriesAtFairValueLessCostsToSell', window );">Fair valuation adjustment, net</a></td>
<td class="nump">3,606<span></span>
</td>
<td class="nump">5,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Carrying value</a></td>
<td class="nump">29,391<span></span>
</td>
<td class="nump">8,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ClassesOfInventoriesAxis=imc_WorkInProgressMember', window );">Work in progress [Member] | Bulk cannabis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CapitalizedCostsOfInventories', window );">Capitalized costs</a></td>
<td class="nump">14,113<span></span>
</td>
<td class="nump">2,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoriesAtFairValueLessCostsToSell', window );">Fair valuation adjustment, net</a></td>
<td class="nump">3,336<span></span>
</td>
<td class="nump">4,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Carrying value</a></td>
<td class="nump">17,449<span></span>
</td>
<td class="nump">6,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ClassesOfInventoriesAxis=imc_WorkInProgressMember', window );">Work in progress [Member] | Other cannabis products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CapitalizedCostsOfInventories', window );">Capitalized costs</a></td>
<td class="nump">1,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoriesAtFairValueLessCostsToSell', window );">Fair valuation adjustment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Carrying value</a></td>
<td class="nump">1,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ClassesOfInventoriesAxis=imc_FinishedGoodsMember', window );">Finished goods [Member] | Packaged dried cannabis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CapitalizedCostsOfInventories', window );">Capitalized costs</a></td>
<td class="nump">8,974<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoriesAtFairValueLessCostsToSell', window );">Fair valuation adjustment, net</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Carrying value</a></td>
<td class="nump">9,244<span></span>
</td>
<td class="nump">966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ClassesOfInventoriesAxis=imc_FinishedGoodsMember', window );">Finished goods [Member] | Other cannabis products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CapitalizedCostsOfInventories', window );">Capitalized costs</a></td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoriesAtFairValueLessCostsToSell', window );">Fair valuation adjustment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Carrying value</a></td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ClassesOfInventoriesAxis=imc_FinishedGoodsMember', window );">Finished goods [Member] | Other products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InventoriesLineItems', window );"><strong>Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CapitalizedCostsOfInventories', window );">Capitalized costs</a></td>
<td class="nump">880<span></span>
</td>
<td class="nump">546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoriesAtFairValueLessCostsToSell', window );">Fair valuation adjustment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Carrying value</a></td>
<td class="nump">$ 880<span></span>
</td>
<td class="nump">$ 546<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoriesAtFairValueLessCostsToSell">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories carried at fair value less costs to sell. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoriesAtFairValueLessCostsToSell</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_CapitalizedCostsOfInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of capitalized costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_CapitalizedCostsOfInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InventoriesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InventoriesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ClassesOfInventoriesAxis=imc_WorkInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ClassesOfInventoriesAxis=imc_WorkInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TypeOfCannabisAxis=imc_BulkCannabisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TypeOfCannabisAxis=imc_BulkCannabisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TypeOfCannabisAxis=imc_OtherCannabisProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TypeOfCannabisAxis=imc_OtherCannabisProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ClassesOfInventoriesAxis=imc_FinishedGoodsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ClassesOfInventoriesAxis=imc_FinishedGoodsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TypeOfCannabisAxis=imc_PackagedDriedCannabisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TypeOfCannabisAxis=imc_PackagedDriedCannabisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TypeOfCannabisAxis=imc_OtherCannabisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TypeOfCannabisAxis=imc_OtherCannabisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131083884120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET - Disclosure of detailed information about property, plant and equipment (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">$ 5,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation during the year</a></td>
<td class="nump">3,021<span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">30,268<span></span>
</td>
<td class="nump">5,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">7,177<span></span>
</td>
<td class="nump">4,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions during the year</a></td>
<td class="nump">4,578<span></span>
</td>
<td class="nump">2,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions related to acquisitions</a></td>
<td class="nump">23,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">35,017<span></span>
</td>
<td class="nump">7,177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(1,645)<span></span>
</td>
<td class="num">(894)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation during the year</a></td>
<td class="nump">3,021<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(4,749)<span></span>
</td>
<td class="num">(1,645)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings and improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">2,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">21,414<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings and improvements [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">2,477<span></span>
</td>
<td class="nump">1,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions during the year</a></td>
<td class="nump">1,932<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions related to acquisitions</a></td>
<td class="nump">18,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="num">(81)<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">23,156<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings and improvements [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(184)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation during the year</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(1,742)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember', window );">Greenhouse production equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">1,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">6,318<span></span>
</td>
<td class="nump">1,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember', window );">Greenhouse production equipment [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">2,761<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions during the year</a></td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">1,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions related to acquisitions</a></td>
<td class="nump">3,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">8,270<span></span>
</td>
<td class="nump">2,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember', window );">Greenhouse production equipment [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(919)<span></span>
</td>
<td class="num">(534)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation during the year</a></td>
<td class="nump">993<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(1,952)<span></span>
</td>
<td class="num">(919)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember', window );">Greenhouse structure [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">1,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">1,506<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember', window );">Greenhouse structure [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">1,595<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions during the year</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">2,182<span></span>
</td>
<td class="nump">1,595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember', window );">Greenhouse structure [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(444)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation during the year</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(676)<span></span>
</td>
<td class="num">(444)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer, software and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">706<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer, software and equipment [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions during the year</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions related to acquisitions</a></td>
<td class="nump">455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer, software and equipment [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation during the year</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">(333)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">324<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions during the year</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions related to acquisitions</a></td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Balance</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation during the year</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Balance</a></td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseProductionEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imc_GreenhouseStructureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084905784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="nump">$ 1,158<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember', window );">Adjupharm GmbH ("Adjupharm") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PreTaxDiscountRateOfCashFlows', window );">Pre-tax discount rate of cash flows</a></td>
<td class="nump">13.06%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FixedGrowthRate', window );">Fixed growth rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCorpMember', window );">Trichome Financial Corp. (&#8220;Trichome&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PreTaxDiscountRateOfCashFlows', window );">Pre-tax discount rate of cash flows</a></td>
<td class="nump">11.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FixedGrowthRate', window );">Fixed growth rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FixedGrowthRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the fixed growth rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FixedGrowthRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PreTaxDiscountRateOfCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the pre tax discount rate of cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PreTaxDiscountRateOfCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_TrichomeFinancialCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131083991944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">$ 1,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization recognized in the year</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">30,885<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">1,249<span></span>
</td>
<td class="nump">1,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Initially consolidated company</a></td>
<td class="nump">30,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill', window );">Fair value adjustment derived from final purchase price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">32,200<span></span>
</td>
<td class="nump">1,249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization and impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="num">(157)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization recognized in the year</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="num">(1,315)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CultivationsAndProcessingLicenseMember', window );">Cultivations and processing license [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">9,187<span></span>
</td>
<td class="nump">904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CultivationsAndProcessingLicenseMember', window );">Cultivations and processing license [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">1,060<span></span>
</td>
<td class="nump">831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Initially consolidated company</a></td>
<td class="nump">8,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill', window );">Fair value adjustment derived from final purchase price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="num">(49)<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">9,961<span></span>
</td>
<td class="nump">1,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CultivationsAndProcessingLicenseMember', window );">Cultivations and processing license [Member] | Accumulated amortization and impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="num">(156)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization recognized in the year</a></td>
<td class="nump">618<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="num">(774)<span></span>
</td>
<td class="num">(156)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CustomerRelationshipsMember', window );">Customer relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">10,205<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CustomerRelationshipsMember', window );">Customer relationships [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Initially consolidated company</a></td>
<td class="nump">10,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill', window );">Fair value adjustment derived from final purchase price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">10,674<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CustomerRelationshipsMember', window );">Customer relationships [Member] | Accumulated amortization and impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization recognized in the year</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="num">(469)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">11,355<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Initially consolidated company</a></td>
<td class="nump">11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill', window );">Fair value adjustment derived from final purchase price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">11,363<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand [Member] | Accumulated amortization and impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization recognized in the year</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Initially consolidated company</a></td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill', window );">Fair value adjustment derived from final purchase price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other [Member] | Accumulated amortization and impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Beginning Balance</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization recognized in the year</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Ending Balance</a></td>
<td class="num">$ (64)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fair value adjustment derived from final purchase price allocation, intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CultivationsAndProcessingLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CultivationsAndProcessingLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=imc_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108572472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RIGHT-OF-USE ASSETS (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Land and buildings [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Land and buildings [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084533960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RIGHT-OF-USE ASSETS - Disclosure of detailed information about right-of-use assets (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="nump">$ 935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Additions during the year: Depreciation and amortization</a></td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="nump">18,162<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions during the year: New leases</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InitialConsolidationsRightOfUseAssets', window );">Additions during the year: Initial consolidations</a></td>
<td class="nump">16,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets', window );">Additions during the year: Adjustments arising from translating financial statements from functional currency to presentation currency</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalsOfRightOfUseAssets', window );">Disposals during the year:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="nump">20,060<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="num">(311)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Additions during the year: Depreciation and amortization</a></td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets', window );">Additions during the year: Adjustments arising from translating financial statements from functional currency to presentation currency</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalsOfRightOfUseAssets', window );">Disposals during the year:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalOfTerminationOfLeases', window );">Disposals during the year: Termination of leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="num">(1,898)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember', window );">Land and buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="nump">811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="nump">17,855<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember', window );">Land and buildings [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions during the year: New leases</a></td>
<td class="nump">1,408<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InitialConsolidationsRightOfUseAssets', window );">Additions during the year: Initial consolidations</a></td>
<td class="nump">16,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets', window );">Additions during the year: Adjustments arising from translating financial statements from functional currency to presentation currency</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalsOfRightOfUseAssets', window );">Disposals during the year:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="nump">19,514<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember', window );">Land and buildings [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="num">(194)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Additions during the year: Depreciation and amortization</a></td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets', window );">Additions during the year: Adjustments arising from translating financial statements from functional currency to presentation currency</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalsOfRightOfUseAssets', window );">Disposals during the year:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalOfTerminationOfLeases', window );">Disposals during the year: Termination of leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="num">(1,659)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions during the year: New leases</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InitialConsolidationsRightOfUseAssets', window );">Additions during the year: Initial consolidations</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets', window );">Additions during the year: Adjustments arising from translating financial statements from functional currency to presentation currency</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalsOfRightOfUseAssets', window );">Disposals during the year:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="nump">546<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember', window );">Motor vehicles [Member] | Accumulated depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Beginning Balance</a></td>
<td class="num">(117)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Additions during the year: Depreciation and amortization</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets', window );">Additions during the year: Adjustments arising from translating financial statements from functional currency to presentation currency</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalsOfRightOfUseAssets', window );">Disposals during the year:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisposalOfTerminationOfLeases', window );">Disposals during the year: Termination of leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Ending Balance</a></td>
<td class="num">$ (239)<span></span>
</td>
<td class="num">$ (117)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisposalOfTerminationOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to disposal of termination of leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisposalOfTerminationOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisposalsOfRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to disposal of right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisposalsOfRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to adjustments arising from translating financial statements from functional currency to presentation currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InitialConsolidationsRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of initial consolidations of right of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InitialConsolidationsRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_MotorVehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109444104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about expenses recognized in consolidated statements of profit or loss and other comprehensive income (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract', window );"><strong>Employee Benefit Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostDefinedBenefitPlans', window );">Current service cost</a></td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseDefinedBenefitPlans', window );">Interest expenses</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Total employee benefit expenses</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InterestIncomeOnPlanAssets', window );">Interest income on plan assets</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense of employee service in the current period arising from defined benefit plans. [Refer: Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase in net defined benefit liability (asset) resulting from current service cost]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense arising from defined benefit plans. [Refer: Interest expense; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 5<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_5&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EmployeeBenefitAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InterestIncomeOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of interest income on plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InterestIncomeOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109402328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about defined benefit liability (asset) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract', window );"><strong>Employee Benefit Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Defined benefit obligation</a></td>
<td class="nump">$ 668<span></span>
</td>
<td class="nump">$ 588<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="num">(277)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
<td class="num">$ (128)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan', window );">Net defined benefit liability</a></td>
<td class="nump">$ 391<span></span>
</td>
<td class="nump">$ 371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit in a defined benefit plan. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EmployeeBenefitAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111423592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in present value of defined benefit liabilities (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract', window );"><strong>Employee Benefit Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Balance at January 1,</a></td>
<td class="nump">$ 588<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest expenses</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset', window );">Benefits paid</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Re-measurement loss on defined benefit plans</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset', window );">Foreign currency translation effect</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Balance at December 31,</a></td>
<td class="nump">$ 668<span></span>
</td>
<td class="nump">$ 588<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan in respect of settlements. [Refer: Decrease (increase) in net defined benefit liability (asset) resulting from gains (losses) arising from settlements; Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EmployeeBenefitAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084715944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in the fair value of plan assets (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract', window );"><strong>Employee Benefit Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Balance at January 1,</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InterestIncomeOnPlanAssets', window );">Interest income</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss', window );">Return, net of interest income - remeasurement gain (loss)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BenefitsPaidOrPayable', window );">Benefits paid</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PlanAssetsAmountsDeposited', window );">Amounts deposited</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PlanAssetsForeignCurrencyTranslationEffect', window );">Foreign currency translation effect</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Balance at December 31,</a></td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BenefitsPaidOrPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of benefits paid or payable for retirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BenefitsPaidOrPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EmployeeBenefitAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InterestIncomeOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of interest income on plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InterestIncomeOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PlanAssetsAmountsDeposited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of plan assets amount deposited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PlanAssetsAmountsDeposited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PlanAssetsForeignCurrencyTranslationEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of foreign currency translation effect.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PlanAssetsForeignCurrencyTranslationEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ReturnNetOfInterestIncomeReMeasurementGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information Return net of interest income re measurement gain loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ReturnNetOfInterestIncomeReMeasurementGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108518056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about principal assumptions underlying the defined benefit plan (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract', window );"><strong>Employee Benefit Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">2.58%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases', window );">Salary growth</a></td>
<td class="nump">4.64%<span></span>
</td>
<td class="nump">3.37%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EmployeeBenefitAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EmployeeBenefitAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084435816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER PAYABLES - Disclosure of detailed information of other current payables (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses</a></td>
<td class="nump">$ 6,146<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EmployeesAndPayrollAccruals', window );">Employees and payroll accruals</a></td>
<td class="nump">8,267<span></span>
</td>
<td class="nump">1,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_OtherCurrentPayablesToGovernmentAuthorities', window );">Government authorities</a></td>
<td class="nump">4,002<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties', window );">Related parties</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDepositsFromCustomers', window );">Advances from customers</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_OtherMiscellaneousCurrentPayables', window );">Other payables</a></td>
<td class="nump">716<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Total other payables</a></td>
<td class="nump">$ 20,143<span></span>
</td>
<td class="nump">$ 3,497<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDepositsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current deposits from customers. [Refer: Deposits from customers]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDepositsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EmployeesAndPayrollAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of employees and payroll accruals including salaries and other salaries related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EmployeesAndPayrollAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_OtherCurrentPayablesToGovernmentAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other current payables to government authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_OtherCurrentPayablesToGovernmentAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_OtherMiscellaneousCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous current payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_OtherMiscellaneousCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131079709704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Narrative) (Details)<br> $ / shares in Units, $ / shares in Units, &#8364; in Thousands, &#8362; in Thousands, &#163; in Thousands, $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="4"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 10, 2021 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 10, 2021 </div>
<div>USD ($) </div>
<div>Shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>GBP (&#163;) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>ILS (&#8362;) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 10, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 12, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of warrants exercisable | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Net proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,131<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,648<span></span>
</td>
<td class="nump">$ 20,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercise price of compensation option | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.43<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,964,265<span></span>
</td>
<td class="nump">905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.2<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities', window );">Aggregate consideration to acquire preferred shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 1,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,429<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue', window );">Investments in unlisted shares measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Outstanding balance of 2 loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,710<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">39,765,799<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Issuance of new warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueOfInvestment', window );">Fair value of the investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,429<span></span>
</td>
<td class="nump">$ 2,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrants2019Member', window );">2019 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 16,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AmountOfWarrantTransferredInEquityDuringPeriod', window );">Amount of warrant transferred in equity during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (611)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of warrants outstanding | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,729,264<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_GainLossOnRevaluationOfFinancialInstruments', window );">(Gain) loss on revaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,929<span></span>
</td>
<td class="num">$ (16,283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member', window );">2021 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TermOfWarrantsFromDateOfIssuance', window );">Term of warrants from date of issuance</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance expenses including FV of compensation units</a></td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of warrants outstanding | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,043,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,043,478<span></span>
</td>
<td class="nump">3,043,478<span></span>
</td>
<td class="nump">3,043,478<span></span>
</td>
<td class="nump">3,043,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_GainLossOnRevaluationOfFinancialInstruments', window );">(Gain) loss on revaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of warrants issued for common shares | Shares</a></td>
<td class="nump">3,043,478<span></span>
</td>
<td class="nump">3,043,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCommonSharesCalledByWarrants', window );">Number of common shares called by warrants | shares</a></td>
<td class="nump">3,043,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Exercise price of warrants issued per common share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Issuance of new warrants</a></td>
<td class="nump">$ 30,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant liability</a></td>
<td class="nump">11,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member', window );">2021 Warrant [Member] | Listed Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance expenses including FV of compensation units</a></td>
<td class="nump">1,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member', window );">2021 Warrant [Member] | Share Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance expenses including FV of compensation units</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember', window );">Overnight Marketed Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Net proceeds from private placement</a></td>
<td class="nump">$ 42,502<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted in share-based payment arrangement | Shares</a></td>
<td class="nump">913,044<span></span>
</td>
<td class="nump">913,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="nump">6,086,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of warrants issued for common shares | Shares</a></td>
<td class="nump">456,522<span></span>
</td>
<td class="nump">456,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [Member] | Cash And Cash Equivalent [Member] | EUR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Risk exposure associated with instruments sharing characteristic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [Member] | Cash And Cash Equivalent [Member] | NIS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Risk exposure associated with instruments sharing characteristic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 16,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [Member] | Cash And Cash Equivalent [Member] | USD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Risk exposure associated with instruments sharing characteristic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [Member] | Cash And Cash Equivalent [Member] | GBP [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Risk exposure associated with instruments sharing characteristic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPortionOfLongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPortionOfLongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire equity or debt instruments of other entities (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingOtherEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph B8<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B8_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AmountOfWarrantTransferredInEquityDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of warrant transferred in equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AmountOfWarrantTransferredInEquityDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FairValueOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FairValueOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FairValueOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FairValueOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_GainLossOnRevaluationOfFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>gain loss on revaluation of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_GainLossOnRevaluationOfFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_InvestmentsInUnlistedSharesMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments in unlisted shares measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_InvestmentsInUnlistedSharesMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfCommonSharesCalledByWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares called by warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfCommonSharesCalledByWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to share based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TermOfWarrantsFromDateOfIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of warrants from date of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TermOfWarrantsFromDateOfIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrants2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrants2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=imc_ListedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=imc_ListedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_CashAndCashEquivalentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_CashAndCashEquivalentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131081018904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Disclosure of carrying values of financial instruments (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAbstract', window );"><strong>Financial assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentInvestments', window );">Investments and Financial Instruments</a></td>
<td class="nump">$ 3,129<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Investments</a></td>
<td class="nump">2,429<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WarrantsMeasuredAtFairValue', window );">Warrants</a></td>
<td class="nump">$ 6,022<span></span>
</td>
<td class="nump">$ 16,540<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_WarrantsMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of warrants measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_WarrantsMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108482552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Disclosure of information about key assumptions to measure fair value of warrants (Details) - 2021 Warrant [Member]<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>Year </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ExpectedVolatilityOfWarrants', window );">Expected volatility</a></td>
<td class="nump">83.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ExpectedLifeOfWarrants', window );">Expected life (in years) | Year</a></td>
<td class="nump">4.342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RiskFreeInterestRateOfWarrants', window );">Risk-free interest rate</a></td>
<td class="nump">0.85%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ExpectedDividendYieldOfWarrants', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValuePerWarrant', window );">Fair value: Per Warrant (Canadian Dollar) | $ / shares</a></td>
<td class="nump">$ 1.979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_FairValueOfWarrants', window );">Total Warrants (Canadian Dollar in thousands) | $</a></td>
<td class="nump">$ 6,022<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ExpectedDividendYieldOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividend yield of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ExpectedDividendYieldOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ExpectedLifeOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected life of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ExpectedLifeOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ExpectedVolatilityOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected volatility of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ExpectedVolatilityOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FairValueOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FairValueOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_FairValuePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value per warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_FairValuePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_RiskFreeInterestRateOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk free interest rate of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_RiskFreeInterestRateOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131085093800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Disclosure of maturity analysis for lease liabilities (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 3,130<span></span>
</td>
<td class="nump">$ 232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Bank Loans</a></td>
<td class="nump">9,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BankLoanAndLeaseLiabilities', window );">Total</a></td>
<td class="nump">12,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">1 to 5 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">11,781<span></span>
</td>
<td class="nump">547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BankLoanAndLeaseLiabilities', window );">Total</a></td>
<td class="nump">11,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember', window );">6 to 10 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">12,760<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BankLoanAndLeaseLiabilities', window );">Total</a></td>
<td class="nump">12,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTenYearsMember', window );">&gt;10 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">2,620<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Bank Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_BankLoanAndLeaseLiabilities', window );">Total</a></td>
<td class="nump">$ 2,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankBorrowingsUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph B11D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B11D&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph IG31A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG31A&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankBorrowingsUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_BankLoanAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total amount of bank loan and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_BankLoanAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTenYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTenYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111477800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Disclosure of changes in liabilities arising from financing activities (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning balance</a></td>
<td class="nump">$ 17,530<span></span>
</td>
<td class="nump">$ 1,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Issuance of new warrants</a></td>
<td class="nump">11,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities', window );">Additions for new loans</a></td>
<td class="nump">8,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Additions for new leases</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities', window );">Additions related to acquisitions</a></td>
<td class="nump">19,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities', window );">Conversion of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,873)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="num">(2,680)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities', window );">Effective interest</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other changes</a></td>
<td class="num">(361)<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Effect of changes in fair value</a></td>
<td class="num">(21,739)<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending balance</a></td>
<td class="nump">35,290<span></span>
</td>
<td class="nump">17,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember', window );">Short-term loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Issuance of new warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities', window );">Additions for new loans</a></td>
<td class="nump">8,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Additions for new leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities', window );">Additions related to acquisitions</a></td>
<td class="nump">1,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities', window );">Conversion of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="num">(700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities', window );">Effective interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other changes</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Effect of changes in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending balance</a></td>
<td class="nump">9,894<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning balance</a></td>
<td class="nump">990<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Issuance of new warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities', window );">Additions for new loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Additions for new leases</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities', window );">Additions related to acquisitions</a></td>
<td class="nump">17,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities', window );">Conversion of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="num">(1,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities', window );">Effective interest</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other changes</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Effect of changes in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending balance</a></td>
<td class="nump">19,374<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=imc_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning balance</a></td>
<td class="nump">16,540<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Issuance of new warrants</a></td>
<td class="nump">11,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities', window );">Additions for new loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Additions for new leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities', window );">Additions related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities', window );">Conversion of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,873)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities', window );">Repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities', window );">Effective interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other changes</a></td>
<td class="num">(611)<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Effect of changes in fair value</a></td>
<td class="num">(21,739)<span></span>
</td>
<td class="nump">20,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending balance</a></td>
<td class="nump">$ 6,022<span></span>
</td>
<td class="nump">$ 16,540<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes in fair values. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A__IAS07_IE_A_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingOtherEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from related to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease through effective interest, liabilities arising from financing activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes in repayments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the cash outflow for payments for warrant conversions liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_ShorttermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=imc_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=imc_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111226856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 21, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract', window );"><strong>Disclosure of contingent liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AmountOfPersonalSuit', window );">Amount of personal suit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="nump">&#8362; 15,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Estimated total amount of class action suit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259,000<span></span>
</td>
<td class="nump">&#8362; 686,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_AmountOfExpensesPaidByApplicant', window );">Amount of expenses paid by applicant</a></td>
<td class="nump">&#8362; 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 86<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_86_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimatedFinancialEffectOfContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AmountOfExpensesPaidByApplicant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of Companies&#8217; expenses paid by applicant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AmountOfExpensesPaidByApplicant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AmountOfPersonalSuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of personal suit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AmountOfPersonalSuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131083883592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_MajorComponentsOfIncomeTaxExpenseLineItems', window );"><strong>Major Components Of Income Tax Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_MajorComponentsOfIncomeTaxExpenseLineItems', window );"><strong>Major Components Of Income Tax Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CarryforwardOperatingTaxLosses', window );">Carryforward operating tax losses</a></td>
<td class="nump">$ 3,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_MajorComponentsOfIncomeTaxExpenseLineItems', window );"><strong>Major Components Of Income Tax Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CarryforwardOperatingTaxLosses', window );">Carryforward operating tax losses</a></td>
<td class="nump">$ 54,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember', window );">Adjupharm GmbH ("Adjupharm") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_MajorComponentsOfIncomeTaxExpenseLineItems', window );"><strong>Major Components Of Income Tax Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">29.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember', window );">Adjupharm GmbH ("Adjupharm") [Member] | German [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_MajorComponentsOfIncomeTaxExpenseLineItems', window );"><strong>Major Components Of Income Tax Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CarryforwardOperatingTaxLosses', window );">Carryforward operating tax losses</a></td>
<td class="nump">$ 8,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CarryforwardLossesForTaxPurposesDescription', window );">Description of carryforward losses for tax purposes</a></td>
<td class="text">Accumulated tax losses can be carried forward without time restrictions and can be deducted from future profits and capital gains unless they exceed &#8364;1,000 thousand (approximately $1,441). Any excess of such amount will be limited to 60% of the profits or capital gains<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_CarryforwardLossesForTaxPurposesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carryforward losses for tax purposes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_CarryforwardLossesForTaxPurposesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_CarryforwardOperatingTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents Carryforward operating tax losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_CarryforwardOperatingTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_MajorComponentsOfIncomeTaxExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Major components Of Income Tax Expense [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_MajorComponentsOfIncomeTaxExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imc_AdjupharmGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111200248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME - Disclosure of detailed information about income tax expense (benefit) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred, net</a></td>
<td class="nump">278<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod', window );">Income tax from previous years</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 262<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments of tax expense (income) recognised in the period for current tax of prior periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 80<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_80_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084931496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME - Disclosure of detailed information about deferred taxes (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets, net</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">6,591<span></span>
</td>
<td class="nump">1,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TranslationDifferencesOfDefferedTaxes', window );">Translation differences</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax expenses, net</a></td>
<td class="nump">278<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liabilities, net</a></td>
<td class="num">(6,575)<span></span>
</td>
<td class="num">(734)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxAssetsMember', window );">Deferred tax assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets, net</a></td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax expenses, net</a></td>
<td class="nump">891<span></span>
</td>
<td class="num">(440)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxAssetsMember', window );">Deferred tax assets [Member] | Carryforward tax losses and other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets, net</a></td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax expenses, net</a></td>
<td class="nump">892<span></span>
</td>
<td class="num">(440)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxAssetsMember', window );">Deferred tax assets [Member] | Other deferred tax assests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets, net</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax expenses, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxLiabilitiesMember', window );">Deferred tax liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">8,131<span></span>
</td>
<td class="nump">1,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax expenses, net</a></td>
<td class="num">(613)<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxLiabilitiesMember', window );">Deferred tax liabilities [Member] | Inventory and biological assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax expenses, net</a></td>
<td class="num">(431)<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxLiabilitiesMember', window );">Deferred tax liabilities [Member] | Intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">7,261<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax expenses, net</a></td>
<td class="num">(189)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxLiabilitiesMember', window );">Deferred tax liabilities [Member] | Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred tax expenses, net</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TranslationDifferencesOfDefferedTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents translation differences of deffered taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TranslationDifferencesOfDefferedTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=imc_OtherDeferredTaxAssestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=imc_OtherDeferredTaxAssestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DeferredTaxAssetsAndLiabilitiesAxis=imc_DeferredTaxLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_CurrentBiologicalAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_CurrentBiologicalAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=imc_IntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=imc_IntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108846648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TAXES ON INCOME - Disclosure of detailed information about statements of financial position deferred taxes (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Non-current assets</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">$ 6,591<span></span>
</td>
<td class="nump">$ 1,503<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131085122440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME - Disclosure of detailed information about reconciliation of tax expense and accounting profit (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Loss before income tax</a></td>
<td class="num">$ (18,013)<span></span>
</td>
<td class="num">$ (28,472)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory tax rate in Canada</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Statutory tax rate in Canada</a></td>
<td class="num">$ (4,773)<span></span>
</td>
<td class="num">$ (7,545)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract', window );"><strong>Increase (decrease) in income tax due to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NonDeductibleIncomeExpenseNetForTaxPurposes', window );">Non-deductible expenses (non-taxable income), net for tax purposes</a></td>
<td class="num">(3,447)<span></span>
</td>
<td class="nump">6,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries', window );">Effect of different tax rate of subsidiaries</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears', window );">Adjustments in respect of current income tax of previous years</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears', window );">Recognition (derecognition) of tax benefit in respect of losses of previous years</a></td>
<td class="nump">846<span></span>
</td>
<td class="num">(830)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss', window );">Unrecognized tax benefit in respect of loss for the year</a></td>
<td class="nump">4,093<span></span>
</td>
<td class="nump">1,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_UtilizationOfLossesNotPreviouslyRecognized', window );">Utilization of losses not previously recognized</a></td>
<td class="num">(1,466)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ChangeInTaxBenefitsNotRecognized', window );">Change in tax benefits not recognized</a></td>
<td class="nump">5,252<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Other adjustments</a></td>
<td class="num">(289)<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 262<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ChangeInTaxBenefitsNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in tax benefits not recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ChangeInTaxBenefitsNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NonDeductibleIncomeExpenseNetForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non deductible (income) expense, net for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NonDeductibleIncomeExpenseNetForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of tax effect of adjustments in respect of current Income tax of previous years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TaxEffectOfDifferentTaxRateOfSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to different tax rates of subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TaxEffectOfDifferentTaxRateOfSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recognition of tax benefit in respect of losses of previous years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax benefit in respect of loss for the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_UtilizationOfLossesNotPreviouslyRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of utilization of losses not previously recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_UtilizationOfLossesNotPreviouslyRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131079409240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Narrative) (Details)<br> $ / shares in Units, $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 10, 2021 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 10, 2021 </div>
<div>USD ($) </div>
<div>Shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 12, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($) </div>
<div>Shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 10, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares', window );">Description of share consolidation of issued and outstanding ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company's shareholders general meeting resolved to consolidated all of its issued and outstanding Ordinary shares on a four (4) to one (1) basis (the &#8220;Share Consolidation&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">39,765,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Gross proceeds from warrants recorded as Share capital and premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,832,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019', window );">Exercise price of warrants exercisable | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.20<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions', window );">Proceeds from exercise of warrants and compensation options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,682,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average value of each option grant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of share options exercised | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercise price of compensation option | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted | Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,964,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,382,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCompensationUnitsIssued', window );">Number of compensation unit issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CompensationUnitPerShare', window );">Compensation unit per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCompensationWarrantsToAcquired', window );">Number of compensation warrants to acquired | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,609<span></span>
</td>
<td class="nump">182,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_WarrantPricePerShare', window );">Warrant price per share | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.42<span></span>
</td>
<td class="nump">$ 6.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember', window );">Overnight Marketed Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="nump">6,086,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares</a></td>
<td class="nump">$ 42,502,000<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of warrants issued for common shares | Shares</a></td>
<td class="nump">456,522<span></span>
</td>
<td class="nump">456,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ShareBasedCompensation', window );">Expenses for share based compensation</a></td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted | Shares</a></td>
<td class="nump">913,044<span></span>
</td>
<td class="nump">913,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member', window );">2021 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of warrants issued for common shares | Shares</a></td>
<td class="nump">3,043,478<span></span>
</td>
<td class="nump">3,043,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Exercise price of warrants issued per common share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfCommonSharesCalledByWarrants', window );">Number of common shares called by warrants | shares</a></td>
<td class="nump">3,043,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_TermOfWarrantsFromDateOfIssuance', window );">Term of warrants</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Gross proceeds from warrants recorded as Share capital and premium</a></td>
<td class="nump">$ 30,670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant liability</a></td>
<td class="nump">11,832,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Transaction costs incurred for common share issuance</a></td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member', window );">2021 Warrant [Member] | Listed Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Transaction costs incurred for common share issuance</a></td>
<td class="nump">1,296,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member', window );">2021 Warrant [Member] | Share Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Transaction costs incurred for common share issuance</a></td>
<td class="nump">$ 2,539,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imc_ShareIncentivePlanMember', window );">2018 Share Incentive Plan" (the "2018 Plan") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,382,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfSharesAvailableForFutureGrants', window );">Number of shares available for future grants | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,607,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value of each option grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life for the share options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 3 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imc_ShareIncentivePlanMember', window );">2018 Share Incentive Plan" (the "2018 Plan") [Member] | Vest on the first anniversary of the applicable vesting commencement date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PercentageOfAwardsVest', window );">Awards vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imc_ShareIncentivePlanMember', window );">2018 Share Incentive Plan" (the "2018 Plan") [Member] | Vest in eight equal installments upon the lapse of each three-month period thereafter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PercentageOfAwardsVest', window );">Awards vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingOtherEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_CompensationUnitPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the compensation unit per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_CompensationUnitPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about description of share consolidation of issued and outstanding ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfCommonSharesCalledByWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares called by warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfCommonSharesCalledByWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfCompensationUnitsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of compensation unit issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfCompensationUnitsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfCompensationWarrantsToAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of compensation warrants to acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfCompensationWarrantsToAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfSharesAvailableForFutureGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares available for future grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfSharesAvailableForFutureGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PercentageOfAwardsVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of awards vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PercentageOfAwardsVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to proceeds from exercise of warrants and compensation options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount related to share based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_TermOfWarrantsFromDateOfIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of warrants from date of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_TermOfWarrantsFromDateOfIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_WarrantPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents warrant price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_WarrantPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_EquityTransactionAxis=imc_OvernightMarketedOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imc_Warrant2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=imc_ListedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=imc_ListedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imc_ShareIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imc_ShareIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_VestingAxis=imc_FirstAnniversaryOfApplicableVestingCommencementDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_VestingAxis=imc_FirstAnniversaryOfApplicableVestingCommencementDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_VestingAxis=imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_VestingAxis=imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111575640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EQUITY - Disclosure of composition of share capital (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">39,765,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding</a></td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">39,765,799<span></span>
</td>
<td class="nump">36,435,837<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131085089608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Disclosure of changes in issued and outstanding share capital (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Beginning Balance</a></td>
<td class="nump">39,765,799<span></span>
</td>
<td class="nump">36,435,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised', window );">Common Shares issued as a result of Warrants and Compensation options exercised</a></td>
<td class="nump">633,784<span></span>
</td>
<td class="nump">3,169,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_OrdinarySharesIssuedOptionsExercises', window );">Common Shares issued as a result of options exercises</a></td>
<td class="nump">517,346<span></span>
</td>
<td class="nump">160,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_PurchaseOfTreasuryCommonShares', window );">Purchase of treasury common shares</a></td>
<td class="num">(101,649)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_NumberOfSharesIssuedInBusinessCombinationTransaction', window );">Common Shares issued related secondary transaction and business combinations</a></td>
<td class="nump">27,402,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ending Balance</a></td>
<td class="nump">68,217,894<span></span>
</td>
<td class="nump">39,765,799<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_NumberOfSharesIssuedInBusinessCombinationTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in business combination transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_NumberOfSharesIssuedInBusinessCombinationTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about Ordinary shares issued as a result of Warrants and Compensation options exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_OrdinarySharesIssuedOptionsExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about ordinary shares issued as a result of options exercises.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_OrdinarySharesIssuedOptionsExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_PurchaseOfTreasuryCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of purchase of treasury common shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_PurchaseOfTreasuryCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131072891944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Disclosure of detailed information about options, valuation assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Year </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price</a></td>
<td class="nump">$ 10.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of share options | Year</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="nump">80.61%<span></span>
</td>
<td class="nump">74.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Annual risk-free rate</a></td>
<td class="nump">0.52%<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 10.12<span></span>
</td>
<td class="nump">$ 8.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of share options | Year</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="nump">83.68%<span></span>
</td>
<td class="nump">80.39%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Annual risk-free rate</a></td>
<td class="nump">0.77%<span></span>
</td>
<td class="nump">0.37%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.56<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111130952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Disclosure of number of restricted share units ("RSU") (Details) - Restricted Share Units [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>Shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">RSU outstanding at the beginning</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">RSU granted during the year</a></td>
<td class="nump">550,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">RSU exercisable at the end of year</a></td>
<td class="nump">229,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">RSU outstanding at the end of the year</a></td>
<td class="nump">550,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=imc_RestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=imc_RestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108509784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY - Disclosure of number and weighted average exercise prices of share options (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Options outstanding at the beginning of the year - Number of options | Shares</a></td>
<td class="nump">3,154,870<span></span>
</td>
<td class="nump">2,940,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Options granted during the year - Number of options | Shares</a></td>
<td class="nump">2,964,265<span></span>
</td>
<td class="nump">905,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Options exercised during the year - Number of options | Shares</a></td>
<td class="num">(517,346)<span></span>
</td>
<td class="num">(160,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Options forfeited during the year - Number of options | Shares</a></td>
<td class="num">(158,544)<span></span>
</td>
<td class="num">(529,937)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Options outstanding at the end of year - Number of options | Shares</a></td>
<td class="nump">5,443,245<span></span>
</td>
<td class="nump">3,154,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Options exercisable at the end of year - Number of options | Shares</a></td>
<td class="nump">1,888,480<span></span>
</td>
<td class="nump">1,328,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Options outstanding at the beginning of the year - Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Options granted during the year - Weighted average exercise price | $ / shares</a></td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">4.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Options exercised during the year - Weighted average exercise price | $ / shares</a></td>
<td class="nump">2.43<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Options forfeited during the year - Weighted average exercise price | $ / shares</a></td>
<td class="nump">4.08<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Options outstanding at the end of year - Weighted average exercise price | $ / shares</a></td>
<td class="nump">3.91<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Options exercisable at the end of year - Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108851560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELECTED STATEMENTS OF PROFIT OR LOSS DATA - Disclosure of statement of profit and loss (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Salaries and related expenses</a></td>
<td class="nump">$ 19,718<span></span>
</td>
<td class="nump">$ 6,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">$ 6,004<span></span>
</td>
<td class="nump">$ 930<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131067886696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS (LOSS) PER SHARE - Disclosure of earnings per share (Details) - CAD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">For the computation of basic net earnings, Weighted number of shares</a></td>
<td class="nump">57,963<span></span>
</td>
<td class="nump">38,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">For the computation of basic net earnings, Net loss attributable to equity holders of the Company</a></td>
<td class="num">$ (17,763)<span></span>
</td>
<td class="num">$ (28,698)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares', window );">Effect of potential dilutive Ordinary shares - Warrants, Weighted number of shares</a></td>
<td class="nump">1,810<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects', window );">Effect of potential dilutive Ordinary shares - Warrants, Net loss attributable to equity holders of the Company</a></td>
<td class="num">$ (21,739)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">For the computation of diluted net earnings, Weighted number of shares</a></td>
<td class="nump">59,773<span></span>
</td>
<td class="nump">38,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings', window );">For the computation of diluted net earnings, Net loss attributable to equity holders of the Company</a></td>
<td class="num">$ (39,502)<span></span>
</td>
<td class="num">$ (28,698)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss) from continuing operations]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131079659416">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS (Narrative) (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,029<span></span>
</td>
<td class="nump">$ 1,391<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imc_ShareholdersMember', window );">Shareholders [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 455<span></span>
</td>
<td class="nump">$ 534<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes payments to shareholders for the years ended 2021 and 2020 of $455 and $534, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imc_ShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imc_ShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131084672312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of financial position (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountsReceivableRelatedPartyTransactions', window );">Other accounts receivables</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Other accounts payables</a></td>
<td class="nump">$ 875<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsReceivableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsReceivableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131109420472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of profit or loss and other comprehensive income (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">$ 32,219<span></span>
</td>
<td class="nump">$ 11,549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember', window );">Related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">$ 1,116<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131108906728">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about key management personnel (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RelatedPartyTransactionsAbstract', window );"><strong>Related party transactions [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses', window );">Payroll and related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,377<span></span>
</td>
<td class="nump">$ 2,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,029<span></span>
</td>
<td class="nump">$ 1,391<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes payments to shareholders for the years ended 2021 and 2020 of $455 and $534, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key management personnel compensation payroll and related expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131111268200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement of financial position for partly owned subsidiary (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems', window );"><strong>Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">$ 84,311<span></span>
</td>
<td class="nump">$ 27,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">203,077<span></span>
</td>
<td class="nump">10,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(51,227)<span></span>
</td>
<td class="num">(6,269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="num">(31,216)<span></span>
</td>
<td class="num">(19,237)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">204,945<span></span>
</td>
<td class="nump">12,610<span></span>
</td>
<td class="nump">$ 26,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember', window );">Focus Medical Herbs Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems', window );"><strong>Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">22,913<span></span>
</td>
<td class="nump">16,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">4,473<span></span>
</td>
<td class="nump">4,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(19,616)<span></span>
</td>
<td class="num">(11,341)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="num">(1,883)<span></span>
</td>
<td class="num">(2,274)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">$ 5,887<span></span>
</td>
<td class="nump">$ 7,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131085406536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of operating results for partly owned subsidiary (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems', window );"><strong>Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">$ 54,300<span></span>
</td>
<td class="nump">$ 15,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Segment income (loss)</a></td>
<td class="num">(18,518)<span></span>
</td>
<td class="num">(28,734)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="nump">1,409<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="num">(17,109)<span></span>
</td>
<td class="num">(27,744)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember', window );">Focus Medical Herbs Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems', window );"><strong>Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">14,747<span></span>
</td>
<td class="nump">13,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Segment income (loss)</a></td>
<td class="num">(1,524)<span></span>
</td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="nump">37<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="num">$ (1,487)<span></span>
</td>
<td class="nump">$ 946<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131085406040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems', window );"><strong>Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">From operating activities</a></td>
<td class="num">$ (34,372)<span></span>
</td>
<td class="num">$ (7,919)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">From investing activities</a></td>
<td class="num">(9,012)<span></span>
</td>
<td class="num">(4,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">From financing activities</a></td>
<td class="nump">48,731<span></span>
</td>
<td class="nump">6,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of foreign exchange on cash and cash equivalents</a></td>
<td class="num">(329)<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">5,018<span></span>
</td>
<td class="num">(5,041)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember', window );">Focus Medical Herbs Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems', window );"><strong>Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">From operating activities</a></td>
<td class="nump">2,346<span></span>
</td>
<td class="nump">1,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">From investing activities</a></td>
<td class="num">(783)<span></span>
</td>
<td class="num">(1,656)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">From financing activities</a></td>
<td class="nump">560<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of foreign exchange on cash and cash equivalents</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">$ 2,292<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imc_FocusMedicalHerbsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131080782312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING SEGMENTS (Details) - CAD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">$ 54,300<span></span>
</td>
<td class="nump">$ 15,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Segment loss</a></td>
<td class="num">(38,389)<span></span>
</td>
<td class="num">(8,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation, amortization and impairment</a></td>
<td class="nump">6,004<span></span>
</td>
<td class="nump">930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">54,300<span></span>
</td>
<td class="nump">15,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Segment loss</a></td>
<td class="num">(31,149)<span></span>
</td>
<td class="num">(5,834)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation, amortization and impairment</a></td>
<td class="nump">6,004<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_UnallocatedAmountsMember', window );">Unallocated amounts [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Segment loss</a></td>
<td class="num">(7,240)<span></span>
</td>
<td class="num">(2,411)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember', window );">Israel [Member] | Operating segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">25,431<span></span>
</td>
<td class="nump">13,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Segment loss</a></td>
<td class="num">(10,654)<span></span>
</td>
<td class="num">(2,090)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation, amortization and impairment</a></td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=imc_ForeignCountriesTwoMember', window );">Canada [Member] | Operating segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">20,247<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Segment loss</a></td>
<td class="num">(15,353)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation, amortization and impairment</a></td>
<td class="nump">3,879<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember', window );">Germany [Member] | Operating segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">8,622<span></span>
</td>
<td class="nump">2,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Segment loss</a></td>
<td class="num">(5,142)<span></span>
</td>
<td class="num">(3,744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation, amortization and impairment</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=imc_OtherOperatingSegmentsMember', window );">Other [Member] | Operating segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Segment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation, amortization and impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=imc_OtherOperatingSegmentsMember', window );">Other [Member] | Unallocated amounts [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Segment loss</a></td>
<td class="num">$ (7,240)<span></span>
</td>
<td class="num">$ (2,411)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_UnallocatedAmountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_UnallocatedAmountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=imc_ForeignCountriesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=imc_ForeignCountriesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=imc_OtherOperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=imc_OtherOperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131083093544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS  (Narrative) (Details)<br> $ / shares in Units, $ / shares in Units, &#8362; in Thousands, $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 15, 2022 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 24, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Feb. 24, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 16, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Aug. 16, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>May 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>May 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,765,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,217,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember', window );">Pharm Yarok Pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember', window );">Vironna Pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">&#8362; 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">&#8362; 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember', window );">Oranim pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember', window );">Panaxia Logistics Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">&#8362; 18,700<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">&#8362; 18,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="nump">7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Value of common shares issued in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember', window );">Subsequent Event [Member] | Pharm Yarok Pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">&#8362; 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeemedPricePerShare', window );">Deemed price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuing shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember', window );">Subsequent Event [Member] | Vironna Pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">&#8362; 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="nump">3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RemainingAmountOfCashPaid', window );">Remaining amount of cash paid</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="nump">1,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">&#8362; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="nump">485,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_DeemedPricePerShare', window );">Deemed price per share | (per share)</a></td>
<td class="nump">$ 2.8092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember', window );">Subsequent Event [Member] | Mizrahi [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_Commitment', window );">Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Borrowings, interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prime interest plus 1.5% (approximately 3.3%) per annum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember', window );">Subsequent Event [Member] | Oranim pharmacy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="nump">&#8362; 11,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_RemainingAmountOfCashPaid', window );">Remaining amount of cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630<span></span>
</td>
<td class="nump">1,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="nump">&#8362; 5,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember', window );">Subsequent Event [Member] | Panaxia Logistics Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="nump">18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imc_CashConsiderationOfBusinessCombination', window );">Cash consideration of business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">&#8362; 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember', window );">Subsequent Event [Member] | Simple Agreement For Future Equity [Member] | Xinteza Api Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs recognised as an expense for transactions that are recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_CashConsiderationOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents cash consideration of business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_CashConsiderationOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_Commitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount of commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_Commitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_DeemedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents share issued at deemed price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_DeemedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_RemainingAmountOfCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents remaining amount of cash paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_RemainingAmountOfCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PharmYarokPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_VironnaPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_OranimPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_PanaxiaLogisticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imc_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_MizrahiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_MizrahiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=imc_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=imc_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imc_AgreementAxis=imc_SimpleAgreementForFutureEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imc_AgreementAxis=imc_SimpleAgreementForFutureEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imc_XintezaApiLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imc_XintezaApiLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>zk2227544_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full"
  xmlns:imc="http://www.imcannabis.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="imc-20211231.xsd" xlink:type="simple"/>
    <context id="C_20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:OvernightMarketedOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-10</instant>
        </period>
    </context>
    <context id="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:OvernightMarketedOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-18</endDate>
        </period>
    </context>
    <context id="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-18</instant>
        </period>
    </context>
    <context id="C_20210301to20210331_imcEquityTransactionAxis_imcPreliminaryShelfProspectusMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:PreliminaryShelfProspectusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-30</instant>
        </period>
    </context>
    <context id="C_20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-09</instant>
        </period>
    </context>
    <context id="C_20210701to20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-09</endDate>
        </period>
    </context>
    <context id="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-16</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imc:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imc:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imc:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MizrahiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imc:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MizrahiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-01</instant>
        </period>
    </context>
    <context id="C_20211101to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-12-01</endDate>
        </period>
    </context>
    <context id="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-28</endDate>
        </period>
    </context>
    <context id="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-28</instant>
        </period>
    </context>
    <context id="C_20230331_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-30</instant>
        </period>
    </context>
    <context id="C_20220301to20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-30</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:OvernightMarketedOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:EquityTransactionAxis">imc:OvernightMarketedOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCPointHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCPointHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcFocusMedicalHerbsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcFocusMedicalHerbsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCFarmsIsraelLtdPointMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCFarmsIsraelLtdPointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCFarmsIsraelLtdPointMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCFarmsIsraelLtdPointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCVenturesLtdPointMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCVenturesLtdPointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCVenturesLtdPointMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCVenturesLtdPointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:AdjupharmGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:AdjupharmGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRayarokPharmLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:RayarokPharmLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRosenHighWayLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:RosenHighWayLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcHighWayShinuaLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:HighWayShinuaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRevolyTradingAndMarketingLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:RevolyTradingAndMarketingLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcOranimPlusPharmLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:OranimPlusPharmLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCannabisGpIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeFinancialCannabisGpIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCannabisManagerIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeFinancialCannabisManagerIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeAssetFundingCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeAssetFundingCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeJwcAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeJwcAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeRetailCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:TrichomeRetailCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcMymNutraceuticalsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcSublimecultureIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:SublimecultureIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcCannacanadaIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:CannacanadaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcMymInternationalBrandsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:MymInternationalBrandsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcHighlandGrowIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:HighlandGrowIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcOranimPharmMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:OranimPharmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20220106_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-18</endDate>
        </period>
    </context>
    <context id="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="C_20210701to20210731_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPlusPharmLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPlusPharmLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-01</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220228_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_srtStatementScenarioAxis_srtProFormaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_srtStatementScenarioAxis_srtProFormaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_srtStatementScenarioAxis_srtProFormaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_srtStatementScenarioAxis_srtProFormaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_srtStatementScenarioAxis_srtProFormaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220329_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:MymNutraceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-29</endDate>
        </period>
    </context>
    <context id="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="C_20220228_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:TrichomeFinancialCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="C_20211130to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPlusPharmLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPlusPharmLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-30</startDate>
            <endDate>2021-12-01</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:WholesalesAndPharmaciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:WholesalesAndPharmaciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:ForeignCountriesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">imc:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:ForeignCountriesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">imc:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullMajorCustomersAxis_imcCustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">imc:CustomerThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullMajorCustomersAxis_imcCustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">imc:CustomerThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByTypeAxis">imc:CannabisPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByTypeAxis">imc:CannabisPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:UnobservableInputAxis">imc:ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByTypeAxis">imc:CannabisPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:UnobservableInputAxis">imc:ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsByTypeAxis">imc:CannabisPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:WorkInProgressMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:BulkCannabisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:PackagedDriedCannabisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:OtherCannabisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:WorkInProgressMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:BulkCannabisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:PackagedDriedCannabisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:OtherCannabisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:WorkInProgressMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:OtherCannabisProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:ClassesOfInventoriesAxis">imc:FinishedGoodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="imc:TypeOfCannabisAxis">imc:OtherCannabisProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseStructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imc:GreenhouseProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">imc:CultivationsAndProcessingLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MotorVehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrants2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrants2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrants2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrants2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyEUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-10</instant>
        </period>
    </context>
    <context id="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_imcListedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imc:ListedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:Warrant2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyUSD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyGBP">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imc:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">imc:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:ShorttermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTenYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="C_20200901to20200921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-21</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imc:IntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imc:IntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imc:IntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imc:IntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_countryCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_srtStatementGeographicalAxis_countryCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_srtStatementGeographicalAxis_countryCA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember_srtStatementGeographicalAxis_countryDE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imc:AdjupharmGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:CurrentBiologicalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:CurrentBiologicalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:CurrentBiologicalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:CurrentBiologicalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imc:OtherDeferredTaxAssestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imc:OtherDeferredTaxAssestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imc:OtherDeferredTaxAssestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imc:OtherDeferredTaxAssestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:DeferredTaxAssetsAndLiabilitiesAxis">imc:DeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <instant>2021-02-12</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember_imcVestingAxis_imcFirstAnniversaryOfApplicableVestingCommencementDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:VestingAxis">imc:FirstAnniversaryOfApplicableVestingCommencementDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember_imcVestingAxis_imcVestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:VestingAxis">imc:VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imc:ShareIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-12</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imc:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imc:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imc:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:ShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:ShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imc:FocusMedicalHerbsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:OtherOperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:ForeignCountriesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:OtherOperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:ForeignCountriesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:OtherOperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">imc:OtherOperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:UnallocatedAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-14</endDate>
        </period>
    </context>
    <context id="C_20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PharmYarokPharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-14</instant>
        </period>
    </context>
    <context id="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-15</instant>
        </period>
    </context>
    <context id="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:VironnaPharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-15</endDate>
        </period>
    </context>
    <context id="C_20220224_ifrsfullBusinessCombinationsAxis_imcXintezaApiLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember_imcAgreementAxis_imcSimpleAgreementForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="imc:AgreementAxis">imc:SimpleAgreementForFutureEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:XintezaApiLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-24</instant>
        </period>
    </context>
    <context id="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-14</endDate>
        </period>
    </context>
    <context id="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-28</endDate>
        </period>
    </context>
    <context id="C_20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:PanaxiaLogisticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-14</instant>
        </period>
    </context>
    <context id="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792030</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imc:OranimPharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imc:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-28</instant>
        </period>
    </context>
    <unit id="CAD">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="CAD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="CAD_per_gram">
        <measure>imc:CAD_per_gram</measure>
    </unit>
    <unit id="Euro">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="GBP">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="Gram">
        <measure>imc:Gram</measure>
    </unit>
    <unit id="NIS">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="Percentage">
        <measure>pure</measure>
    </unit>
    <unit id="Share">
        <measure>shares</measure>
    </unit>
    <unit id="Shares">
        <measure>imc:Shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Year">
        <measure>imc:Year</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="C_20210101to20211231"
      id="Fdei_AmendmentFlag20210428202814091">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20210101to20211231"
      id="Fdei_DocumentFiscalPeriodFocus20210429051843186">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="C_20210101to20211231"
      id="Fdei_EntityCentralIndexKey20210429052436020">0001792030</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127171057126">40-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127171446547">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127171502435">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127174220165">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127174238742">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127174257693">2021</dei:DocumentFiscalYearFocus>
    <dei:EntityFileNumber
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127183253874">001-40065</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220330004226495">IM CANNABIS CORP.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127184823952">Kibbutz</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127184832100">Glil Yam</dei:EntityAddressCityOrTown>
    <dei:EntityAddressAddressLine2
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127171721059">Central District</dei:EntityAddressAddressLine2>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20210101to20211231"
      id="Fxbrl_202201271717500750">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressCountry
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127171750075">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127171814154">4690500</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127183540865">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127183547075">544331111</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220127171927497">CT Corporation System</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220127173042173">1015 15th Street N.W.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220127173057817">Suite 1000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressStateOrProvince
      contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220127173143201">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCityOrTown
      contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220127183641142">DC</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220127173211571">20005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220127171957498">202</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20210101to20211231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220127172010394">572-3133</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127173232257">Common Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127173247903">IMCC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127173300401">NASDAQ</dei:SecurityExchangeName>
    <dei:AnnualInformationForm
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127172617316">true</dei:AnnualInformationForm>
    <dei:AuditedAnnualFinancialStatements
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127172603175">true</dei:AuditedAnnualFinancialStatements>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220330182452069"
      unitRef="Share">68217894</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127172155423">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127173332170">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127173417479">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329232541677">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127173751487">false</dei:IcfrAuditorAttestationFlag>
    <imc:FairValueOfWarrants
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"
      id="Fxbrl_20220307151218509"
      unitRef="CAD"
      xsi:nil="true"/>
    <dei:AuditorFirmId
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220307182718716">1281</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220331114820452">KOST FORER GABBAY &amp; KASIERER</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220331114812741">Tel-Aviv, Israel</dei:AuditorLocation>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426233757561"
      unitRef="CAD">13903000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426233800468"
      unitRef="CAD">8885000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentRestrictedCashAndCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460496"
      unitRef="CAD">1000</ifrs-full:CurrentRestrictedCashAndCashEquivalents>
    <ifrs-full:CurrentRestrictedCashAndCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460498"
      unitRef="CAD">18000</ifrs-full:CurrentRestrictedCashAndCashEquivalents>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460500"
      unitRef="CAD">16711000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460502"
      unitRef="CAD">5501000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentAdvancesToSuppliers
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426234249914"
      unitRef="CAD">2300000</ifrs-full:CurrentAdvancesToSuppliers>
    <ifrs-full:CurrentAdvancesToSuppliers
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460506"
      unitRef="CAD">3602000</ifrs-full:CurrentAdvancesToSuppliers>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460508"
      unitRef="CAD">14481000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460510"
      unitRef="CAD">689000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:CurrentInvestments
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220304221017303_1619460508"
      unitRef="CAD">3129000</ifrs-full:CurrentInvestments>
    <ifrs-full:CurrentInvestments
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220329160641034"
      unitRef="CAD">0</ifrs-full:CurrentInvestments>
    <ifrs-full:LoansAndReceivables
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220304221019540_1619460508"
      unitRef="CAD">2708000</ifrs-full:LoansAndReceivables>
    <ifrs-full:LoansAndReceivables
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220304221019540_1619460510"
      unitRef="CAD">0</ifrs-full:LoansAndReceivables>
    <ifrs-full:CurrentBiologicalAssets
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460512"
      unitRef="CAD">1687000</ifrs-full:CurrentBiologicalAssets>
    <ifrs-full:CurrentBiologicalAssets
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460514"
      unitRef="CAD">78000</ifrs-full:CurrentBiologicalAssets>
    <ifrs-full:Inventories
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460516"
      unitRef="CAD">29391000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460518"
      unitRef="CAD">8370000</ifrs-full:Inventories>
    <ifrs-full:CurrentAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426234123886"
      unitRef="CAD">84311000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426234133919"
      unitRef="CAD">27143000</ifrs-full:CurrentAssets>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460520"
      unitRef="CAD">30268000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460521"
      unitRef="CAD">5532000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460523"
      unitRef="CAD">2429000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460525"
      unitRef="CAD">2341000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220304221411676_1619460523"
      unitRef="CAD">14000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220304221411676_1619460525"
      unitRef="CAD">0</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460527"
      unitRef="CAD">18162000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460529"
      unitRef="CAD">935000</ifrs-full:RightofuseAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220329160437531"
      unitRef="CAD">16000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460533"
      unitRef="CAD">769000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460535"
      unitRef="CAD">30885000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460537"
      unitRef="CAD">1092000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:Goodwill
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460539"
      unitRef="CAD">121303000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460541"
      unitRef="CAD">304000</ifrs-full:Goodwill>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426234204773"
      unitRef="CAD">203077000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426234215841"
      unitRef="CAD">10973000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="C_20211231"
      decimals="-3"
      id="F1619460543"
      unitRef="CAD">287388000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="C_20201231"
      decimals="-3"
      id="F1619460544"
      unitRef="CAD">38116000</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313044_xbrl_20210426233921125"
      unitRef="CAD">13989000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313044_xbrl_20210426233933872"
      unitRef="CAD">2605000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:ShorttermBorrowings
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313048_xbrl_20220304221731619_xbrl_20210426233921125"
      unitRef="CAD">9502000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313048_xbrl_20220304221731619_xbrl_20210426233933872"
      unitRef="CAD">0</ifrs-full:ShorttermBorrowings>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313051_xbrl_20210427033851578_xbrl_20210426233921125"
      unitRef="CAD">20143000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313051_xbrl_20210427033851578_xbrl_20210426233933872"
      unitRef="CAD">3497000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:NoncurrentPayablesForPurchaseOfNoncurrentAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313056_xbrl_20220329160505098_xbrl_20210427033851578_xbrl_20210426233921125"
      unitRef="CAD">6039000</ifrs-full:NoncurrentPayablesForPurchaseOfNoncurrentAssets>
    <ifrs-full:NoncurrentPayablesForPurchaseOfNoncurrentAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313056_xbrl_20220329160505098_xbrl_20210427033851578_xbrl_20210426233933872"
      unitRef="CAD">0</ifrs-full:NoncurrentPayablesForPurchaseOfNoncurrentAssets>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313060_xbrl_20210427033854332_xbrl_20210426233921125"
      unitRef="CAD">1554000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313060_xbrl_20210427033854332_xbrl_20210426233933872"
      unitRef="CAD">167000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313064_xbrl_20210427033931366_xbrl_20210426233921125"
      unitRef="CAD">51227000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313064_xbrl_20210427033931366_xbrl_20210426233933872"
      unitRef="CAD">6269000</ifrs-full:CurrentLiabilities>
    <imc:WarrantsMeasuredAtFairValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313067_xbrl_20210427033920380_xbrl_20210426233921125"
      unitRef="CAD">6022000</imc:WarrantsMeasuredAtFairValue>
    <imc:WarrantsMeasuredAtFairValue
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313067_xbrl_20210427033920380_xbrl_20210426233933872"
      unitRef="CAD">16540000</imc:WarrantsMeasuredAtFairValue>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313072_xbrl_20210427033922448_xbrl_20210426233921125"
      unitRef="CAD">17820000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313072_xbrl_20210427033922448_xbrl_20210426233933872"
      unitRef="CAD">823000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313077_xbrl_20220304221737546_xbrl_20210426233921125"
      unitRef="CAD">392000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313077_xbrl_20220329160537332"
      unitRef="CAD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313082_xbrl_20210427033924518_xbrl_20210426233921125"
      unitRef="CAD">391000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313082_xbrl_20210427033924518_xbrl_20210426233933872"
      unitRef="CAD">371000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313088_xbrl_20210427033927355_xbrl_20210426233921125"
      unitRef="CAD">6591000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313088_xbrl_20210427033927355_xbrl_20210426233933872"
      unitRef="CAD">1503000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313091_xbrl_20210427033933320_xbrl_20210426233921125"
      unitRef="CAD">31216000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313091_xbrl_20210427033933320_xbrl_20210426233933872"
      unitRef="CAD">19237000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313094_xbrl_20210427033935883_xbrl_20210426233921125"
      unitRef="CAD">82443000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313094_xbrl_20210427033935883_xbrl_20210426233933872"
      unitRef="CAD">25506000</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313097_xbrl_20210427033938627_xbrl_20210426233921125"
      unitRef="CAD">237677000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313097_xbrl_20210427033938627_xbrl_20210426233933872"
      unitRef="CAD">37040000</ifrs-full:IssuedCapital>
    <ifrs-full:TreasuryShares
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331133126667_xbrl_20220331115313100_xbrl_20210427033941066_xbrl_20210426233921125"
      unitRef="CAD">660000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331133126667_xbrl_20220331115313100_xbrl_20210427033941066_xbrl_20210426233933872"
      unitRef="CAD">0</ifrs-full:TreasuryShares>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313100_xbrl_20210427033941066_xbrl_20210426233921125"
      unitRef="CAD">2614000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313100_xbrl_20210427033941066_xbrl_20210426233933872"
      unitRef="CAD">1229000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313104_xbrl_20210427033942879_xbrl_20210426233921125"
      unitRef="CAD">12348000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313104_xbrl_20210427033942879_xbrl_20210426233933872"
      unitRef="CAD">5829000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:RetainedEarnings
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313110_xbrl_20220329160657991"
      unitRef="CAD">-50743000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313110_xbrl_20210427033946850_xbrl_20210426233933872"
      unitRef="CAD">-33001000</ifrs-full:RetainedEarnings>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313114_xbrl_20210427033951810_xbrl_20210426233921125"
      unitRef="CAD">201236000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313114_xbrl_20210427033951810_xbrl_20210426233933872"
      unitRef="CAD">11097000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313117_xbrl_20210427033953741_xbrl_20210426233921125"
      unitRef="CAD">3709000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313117_xbrl_20210427033953741_xbrl_20210426233933872"
      unitRef="CAD">1513000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313120_xbrl_20210427033956310_xbrl_20210426233921125"
      unitRef="CAD">204945000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313120_xbrl_20210427033956310_xbrl_20210426233933872"
      unitRef="CAD">12610000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331115313126_xbrl_20210427033958391_xbrl_20210426233921125"
      unitRef="CAD">287388000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331115313126_xbrl_20210427033958391_xbrl_20210426233933872"
      unitRef="CAD">38116000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440911_0"
      unitRef="CAD">54300000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440912_1"
      unitRef="CAD">15890000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440913_2"
      unitRef="CAD">42418000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440914_4"
      unitRef="CAD">7081000</ifrs-full:CostOfSales>
    <imc:GrossProfitBeforeFairValueAdjustments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440913_3"
      unitRef="CAD">11882000</imc:GrossProfitBeforeFairValueAdjustments>
    <imc:GrossProfitBeforeFairValueAdjustments
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440914_5"
      unitRef="CAD">8809000</imc:GrossProfitBeforeFairValueAdjustments>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440915_6"
      unitRef="CAD">-7210000</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440915_7"
      unitRef="CAD">-11781000</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <imc:RealizedFairValueAdjustmentOnInventorySold
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440916_8"
      unitRef="CAD">-8796000</imc:RealizedFairValueAdjustmentOnInventorySold>
    <imc:RealizedFairValueAdjustmentOnInventorySold
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440916_9"
      unitRef="CAD">-10122000</imc:RealizedFairValueAdjustmentOnInventorySold>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440938_59"
      unitRef="CAD">-1586000</ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440935_58"
      unitRef="CAD">1659000</ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets>
    <ifrs-full:GrossProfit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440917_10"
      unitRef="CAD">10296000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440917_11"
      unitRef="CAD">10468000</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440918_12"
      unitRef="CAD">32219000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440918_13"
      unitRef="CAD">11549000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440918_14"
      unitRef="CAD">8995000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440919_15"
      unitRef="CAD">3782000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440919_16"
      unitRef="CAD">7471000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440920_17"
      unitRef="CAD">3382000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:OperatingExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440920_18"
      unitRef="CAD">48685000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440923_19"
      unitRef="CAD">18713000</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440923_20"
      unitRef="CAD">-38389000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440924_21"
      unitRef="CAD">-8245000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440924_22"
      unitRef="CAD">22024000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440925_23"
      unitRef="CAD">277000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440925_24"
      unitRef="CAD">1648000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440925_25"
      unitRef="CAD">20504000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncomeCost
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440939_63"
      unitRef="CAD">20376000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440939_62"
      unitRef="CAD">-20227000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440926_26"
      unitRef="CAD">-18013000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440926_27"
      unitRef="CAD">-28472000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440938_61"
      unitRef="CAD">505000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440938_60"
      unitRef="CAD">262000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440933_50"
      unitRef="CAD">-18518000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440926_28"
      unitRef="CAD">-28734000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440927_29"
      unitRef="CAD">21000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440927_30"
      unitRef="CAD">-30000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <imc:OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440928_31"
      unitRef="CAD">858000</imc:OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation>
    <imc:OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440928_32"
      unitRef="CAD">1144000</imc:OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220330105653040"
      unitRef="CAD">879000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440930_36"
      unitRef="CAD">1114000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440928_33"
      unitRef="CAD">530000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220330104957708"
      unitRef="CAD">-124000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220330105030452"
      unitRef="CAD">530000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329161258158_20220330051440929_34"
      unitRef="CAD">-124000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440934_54"
      unitRef="CAD">1409000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440930_37"
      unitRef="CAD">990000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440934_53"
      unitRef="CAD">-17109000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20220330051440931_38"
      unitRef="CAD">-27744000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440931_41"
      unitRef="CAD">-17763000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210429031558975_20220330051440931_38"
      unitRef="CAD">-28698000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440932_43"
      unitRef="CAD">-755000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210429031601577_20220330051440931_38"
      unitRef="CAD">-36000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440932_45"
      unitRef="CAD">-18518000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210429031603982_20220330051440931_38"
      unitRef="CAD">-28734000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440933_47"
      unitRef="CAD">-16357000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210429031606217_20220330051440931_38"
      unitRef="CAD">-27808000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440935_57"
      unitRef="CAD">-752000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220305001358684_xbrl_20210429031608567_20220330051440931_38"
      unitRef="CAD">64000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20220330051440935_55"
      unitRef="CAD">-17109000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210429031555262_20220330051440931_38"
      unitRef="CAD">-27744000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20210101to20211231"
      decimals="2"
      id="F20220330051440933_49"
      unitRef="CAD_per_Share">-0.31</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20200101to20201231"
      decimals="2"
      id="Fxbrl_20210429031610940_20220330051440931_38"
      unitRef="CAD_per_Share">-0.74</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20220304225246562_20220330051440933_49"
      unitRef="CAD_per_Share">-0.66</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20200101to20201231"
      decimals="2"
      id="Fxbrl_20220304225246562_xbrl_20210429031610940_20220330051440931_38"
      unitRef="CAD_per_Share">-0.74</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:Equity
      contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427043804777"
      unitRef="CAD">25947000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331152938637"
      unitRef="CAD">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427043835299"
      unitRef="CAD">2677000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427043847996"
      unitRef="CAD">309000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427044150767"
      unitRef="CAD">-4273000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427044209998"
      unitRef="CAD">24660000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427044222698"
      unitRef="CAD">1449000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20191231"
      decimals="-3"
      id="Fxbrl_20220331152619284_xbrl_20220330110625887_xbrl_20210427044250512_xbrl_20210427044236232"
      unitRef="CAD">26109000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20220307164315736"
      unitRef="CAD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331152957756"
      unitRef="CAD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20220307164334470"
      unitRef="CAD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20220307164346894"
      unitRef="CAD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767"
      unitRef="CAD">-28698000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">-28698000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698"
      unitRef="CAD">-36000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220331152619296_xbrl_20220330110625897_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232"
      unitRef="CAD">-28734000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20220307164433814"
      unitRef="CAD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153012074"
      unitRef="CAD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20220307164735655"
      unitRef="CAD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043847996"
      unitRef="CAD">920000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767"
      unitRef="CAD">-30000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">890000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698"
      unitRef="CAD">100000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220331152619307_xbrl_20220330110625905_xbrl_20210518144954610"
      unitRef="CAD">990000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20220307165502005"
      unitRef="CAD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153017953"
      unitRef="CAD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20220307165521053"
      unitRef="CAD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043847996"
      unitRef="CAD">920000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767"
      unitRef="CAD">-28728000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">-27808000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698"
      unitRef="CAD">64000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220331152619318_xbrl_20220330110625913_xbrl_20210518145022467"
      unitRef="CAD">-27744000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043804777"
      unitRef="CAD">10251000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153024528"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20220307163751023"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20220307163815415"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20220307163818710"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">10251000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20220307163821464"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220331152619328_xbrl_20220330110625921_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232"
      unitRef="CAD">10251000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20210427050437231_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043804777"
      unitRef="CAD">834000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153030687"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20210427050437231_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043835299"
      unitRef="CAD">-222000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20220307163940519"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20220307164007256"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20210427050437231_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">612000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20220307164019521"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220331152619342_xbrl_20220330110625929_xbrl_20210427050437231_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232"
      unitRef="CAD">612000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20220307164035856"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153036705"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20210427050439933_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043835299"
      unitRef="CAD">3382000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20220307164102449"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20220307164107463"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20210427050439933_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">3382000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20220307164111616"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220331152619354_xbrl_20220330110625936_xbrl_20210427050439933_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232"
      unitRef="CAD">3382000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20210427050443077_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043804777"
      unitRef="CAD">8000</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153044624"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20210427050443077_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043835299"
      unitRef="CAD">-8000</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164153527"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164156983"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164202520"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20200101to20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164205648"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220331152619365_xbrl_20220330110625944_xbrl_20220307164209239"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043804777"
      unitRef="CAD">37040000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153050313"
      unitRef="CAD">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043835299"
      unitRef="CAD">5829000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043847996"
      unitRef="CAD">1229000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044150767"
      unitRef="CAD">-33001000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044209998"
      unitRef="CAD">11097000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044222698"
      unitRef="CAD">1513000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044236232"
      unitRef="CAD">12610000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307170312581"
      unitRef="CAD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153058296"
      unitRef="CAD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307170315877"
      unitRef="CAD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307170321197"
      unitRef="CAD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307155902102_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767"
      unitRef="CAD">-17763000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307155902102_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">-17763000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307155902102_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698"
      unitRef="CAD">-755000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152619388_xbrl_20220330110625967_xbrl_20220307155902102_xbrl_20210427050445685_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044236232"
      unitRef="CAD">-18518000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307170444933"
      unitRef="CAD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153107256"
      unitRef="CAD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307170447637"
      unitRef="CAD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307155930775_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767"
      unitRef="CAD">1385000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307155930775_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">21000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307155930775_xbrl_20210427050447636_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698"
      unitRef="CAD">1406000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307170450660"
      unitRef="CAD">3000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152619398_xbrl_20220330110625975_xbrl_20220307155930775_xbrl_20210518144954610"
      unitRef="CAD">1409000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307170532133"
      unitRef="CAD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153117672"
      unitRef="CAD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307170536180"
      unitRef="CAD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427043847996"
      unitRef="CAD">1385000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044150767"
      unitRef="CAD">-17742000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044209998"
      unitRef="CAD">-16357000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210427050449725_xbrl_20210427050355491_xbrl_20210427044612131_xbrl_20210427044222698"
      unitRef="CAD">-752000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152619408_xbrl_20220330110625984_xbrl_20220307155950009_xbrl_20210518145022467"
      unitRef="CAD">-17109000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307163134704"
      unitRef="CAD">195259000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153126080"
      unitRef="CAD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307165902694"
      unitRef="CAD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307165905614"
      unitRef="CAD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307165908173"
      unitRef="CAD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307163140520"
      unitRef="CAD">195259000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307163150688"
      unitRef="CAD">2948000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152619419_xbrl_20220330110625992_xbrl_20220329163503844_xbrl_20220307163146144"
      unitRef="CAD">198207000</ifrs-full:IssueOfEquity>
    <imc:AmountOfPurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163134704"
      unitRef="CAD">0</imc:AmountOfPurchaseOfTreasuryCommonShares>
    <imc:AmountOfPurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153132886"
      unitRef="CAD">660000</imc:AmountOfPurchaseOfTreasuryCommonShares>
    <imc:AmountOfPurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165902694"
      unitRef="CAD">0</imc:AmountOfPurchaseOfTreasuryCommonShares>
    <imc:AmountOfPurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165905614"
      unitRef="CAD">0</imc:AmountOfPurchaseOfTreasuryCommonShares>
    <imc:AmountOfPurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165908173"
      unitRef="CAD">0</imc:AmountOfPurchaseOfTreasuryCommonShares>
    <imc:AmountOfPurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163140520"
      unitRef="CAD">660000</imc:AmountOfPurchaseOfTreasuryCommonShares>
    <imc:AmountOfPurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163150688"
      unitRef="CAD">0</imc:AmountOfPurchaseOfTreasuryCommonShares>
    <imc:AmountOfPurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152740981_xbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163146144"
      unitRef="CAD">660000</imc:AmountOfPurchaseOfTreasuryCommonShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163134704"
      unitRef="CAD">4293000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153139767"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165902694"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165905614"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307165908173"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163140520"
      unitRef="CAD">4293000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163150688"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152619430_xbrl_20220330110626000_xbrl_20220307163146144"
      unitRef="CAD">4293000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307163240807"
      unitRef="CAD">1053000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153148112"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307163301903"
      unitRef="CAD">-920000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307165946701"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307165951582"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307163252383"
      unitRef="CAD">133000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307165954221"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152619440_xbrl_20220330110626008_xbrl_20220307163257391"
      unitRef="CAD">133000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307170100045"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153159871"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307163358129"
      unitRef="CAD">7471000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307170106621"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307170109341"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307163406296"
      unitRef="CAD">7471000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307170112750"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152619450_xbrl_20220330110626016_xbrl_20220307163411209"
      unitRef="CAD">7471000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307163448120"
      unitRef="CAD">32000</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153206792"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307163454584"
      unitRef="CAD">-32000</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170207069"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170209869"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170213973"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170217605"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <imc:IncreaseDecreaseThroughForfeitedOptions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220331152619461_xbrl_20220330110626024_xbrl_20220307170219764"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughForfeitedOptions>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043804777"
      unitRef="CAD">237677000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220331153221850"
      unitRef="CAD">660000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043835299"
      unitRef="CAD">12348000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427043847996"
      unitRef="CAD">2614000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044150767"
      unitRef="CAD">-50743000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullEquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044209998"
      unitRef="CAD">201236000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="-3"
      id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044222698"
      unitRef="CAD">3709000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220331152823792_xbrl_20220331152619471_xbrl_20220330110649701_xbrl_20220330110626033_xbrl_20220307160007303_xbrl_20220307153847871_xbrl_20210427044551075_xbrl_20210427044236232"
      unitRef="CAD">204945000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325714_xbrl_20210427212508026_42"
      unitRef="CAD">-18518000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325714_xbrl_20210427212508026_45"
      unitRef="CAD">-28734000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325717_xbrl_20210427212508026_82"
      unitRef="CAD">7210000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325717_xbrl_20210427212508026_85"
      unitRef="CAD">11781000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets>
    <imc:FairValueAdjustmentOnSaleOfInventory
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325719_xbrl_20210427212508026_92"
      unitRef="CAD">8796000</imc:FairValueAdjustmentOnSaleOfInventory>
    <imc:FairValueAdjustmentOnSaleOfInventory
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325719_xbrl_20210427212508026_95"
      unitRef="CAD">10122000</imc:FairValueAdjustmentOnSaleOfInventory>
    <imc:FairValueAdjustmentOnWarrantsMeasuredAtFairValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325721_xbrl_20210427212508026_102"
      unitRef="CAD">-21638000</imc:FairValueAdjustmentOnWarrantsMeasuredAtFairValue>
    <imc:FairValueAdjustmentOnWarrantsMeasuredAtFairValue
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325721_xbrl_20210427212508026_105"
      unitRef="CAD">20155000</imc:FairValueAdjustmentOnWarrantsMeasuredAtFairValue>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325722_xbrl_20210427212508026_112"
      unitRef="CAD">3021000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325722_xbrl_20210427220705525"
      unitRef="CAD">690000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325725_xbrl_20210427212508026_122"
      unitRef="CAD">1158000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325725_xbrl_20210427212508026_125"
      unitRef="CAD">31000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325727_xbrl_20210427212508026_132"
      unitRef="CAD">1550000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325727_xbrl_20210427212508026_135"
      unitRef="CAD">209000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329173028847_xbrl_20220307153325727_xbrl_20210427212508026_132"
      unitRef="CAD">275000</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329173028847_xbrl_20220307153325727_xbrl_20210427212508026_135"
      unitRef="CAD">0</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325732_xbrl_20210427212508026_152"
      unitRef="CAD">-1262000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325732_xbrl_20210427212508026_155"
      unitRef="CAD">-72000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForDeferredTaxExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325737_xbrl_20210427212508026_172"
      unitRef="CAD">278000</ifrs-full:AdjustmentsForDeferredTaxExpense>
    <ifrs-full:AdjustmentsForDeferredTaxExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325737_xbrl_20210427212508026_175"
      unitRef="CAD">-66000</ifrs-full:AdjustmentsForDeferredTaxExpense>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325740_xbrl_20210427212508026_182"
      unitRef="CAD">7471000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325740_xbrl_20210427212508026_185"
      unitRef="CAD">3382000</ifrs-full:AdjustmentsForSharebasedPayments>
    <imc:AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307171622635_xbrl_20220307153325740_xbrl_20210427212508026_182"
      unitRef="CAD">807000</imc:AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation>
    <imc:AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307171622635_xbrl_20220307153325740_xbrl_20210427212508026_185"
      unitRef="CAD">0</imc:AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220330111711599"
      unitRef="CAD">-4230000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307171810554"
      unitRef="CAD">22814000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325743_xbrl_20210427212508026_232"
      unitRef="CAD">-6602000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325743_xbrl_20210427212508026_235"
      unitRef="CAD">-3534000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325745_xbrl_20210427212508026_242"
      unitRef="CAD">845000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325745_xbrl_20210427212508026_245"
      unitRef="CAD">-1029000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325747_xbrl_20210427212508026_252"
      unitRef="CAD">6412000</ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325747_xbrl_20210427212508026_255"
      unitRef="CAD">11771000</ifrs-full:AdjustmentsForDecreaseIncreaseInBiologicalAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325749_xbrl_20210427212508026_262"
      unitRef="CAD">-19707000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325749_xbrl_20210427212508026_265"
      unitRef="CAD">-12729000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325751_xbrl_20210427212508026_272"
      unitRef="CAD">5573000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325751_xbrl_20210427212508026_275"
      unitRef="CAD">2135000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329173032872_xbrl_20220307153325727_xbrl_20210427212508026_132"
      unitRef="CAD">28000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329173032872_xbrl_20220307153325727_xbrl_20210427212508026_135"
      unitRef="CAD">59000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325753_xbrl_20210427212508026_282"
      unitRef="CAD">2661000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325753_xbrl_20210427212508026_285"
      unitRef="CAD">1929000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:IncreaseDecreaseInWorkingCapital
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220330111727799"
      unitRef="CAD">10790000</ifrs-full:IncreaseDecreaseInWorkingCapital>
    <ifrs-full:IncreaseDecreaseInWorkingCapital
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307171854245"
      unitRef="CAD">1398000</ifrs-full:IncreaseDecreaseInWorkingCapital>
    <ifrs-full:IncomeTaxesPaidClassifiedAsOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325756_xbrl_20210427212508026_322"
      unitRef="CAD">834000</ifrs-full:IncomeTaxesPaidClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidClassifiedAsOperatingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325756_xbrl_20210427212508026_325"
      unitRef="CAD">601000</ifrs-full:IncomeTaxesPaidClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325758_xbrl_20210427212508026_342"
      unitRef="CAD">-34372000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325758_xbrl_20210427212508026_345"
      unitRef="CAD">-7919000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325760_xbrl_20210427212508026_382"
      unitRef="CAD">4578000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325760_xbrl_20210427212508026_385"
      unitRef="CAD">2617000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329173036345_xbrl_20220307153325727_xbrl_20210427212508026_132"
      unitRef="CAD">7796000</ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities>
    <ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329173036345_xbrl_20220307153325727_xbrl_20210427212508026_135"
      unitRef="CAD">0</ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307171952934"
      unitRef="CAD">17000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325762_xbrl_20210427212508026_392"
      unitRef="CAD">93000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329173043305_xbrl_20220307153325727_xbrl_20210427212508026_132"
      unitRef="CAD">12536000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329173043305_xbrl_20220307153325727_xbrl_20210427212508026_135"
      unitRef="CAD">0</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325764_xbrl_20210427212508026_412"
      unitRef="CAD">13000</ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
    <ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325764_xbrl_20210427212508026_415"
      unitRef="CAD">1347000</ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfInvestmentProperty
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329173040761_xbrl_20220307153325727_xbrl_20210427212508026_132"
      unitRef="CAD">319000</ifrs-full:ProceedsFromSalesOfInvestmentProperty>
    <ifrs-full:ProceedsFromSalesOfInvestmentProperty
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329173040761_xbrl_20220307153325727_xbrl_20210427212508026_135"
      unitRef="CAD">0</ifrs-full:ProceedsFromSalesOfInvestmentProperty>
    <imc:ProceedsFromInvestmentInRestrictedDeposits
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172134302"
      unitRef="CAD">17000</imc:ProceedsFromInvestmentInRestrictedDeposits>
    <imc:ProceedsFromInvestmentInRestrictedDeposits
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325767_xbrl_20210427212508026_422"
      unitRef="CAD">-18000</imc:ProceedsFromInvestmentInRestrictedDeposits>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307153325768_xbrl_20210427212508026_442"
      unitRef="CAD">-9012000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307153325768_xbrl_20210427212508026_445"
      unitRef="CAD">-4075000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172743523"
      unitRef="CAD">28131000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729012_xbrl_20210427215700978_45"
      unitRef="CAD">0</ifrs-full:ProceedsFromIssuingShares>
    <imc:ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172754354"
      unitRef="CAD">11222000</imc:ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue>
    <imc:ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729012_xbrl_20210427215700978_55"
      unitRef="CAD">0</imc:ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue>
    <imc:ProceedsFromExerciseOfWarrantsAndCompensationOptions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172807316"
      unitRef="CAD">3682000</imc:ProceedsFromExerciseOfWarrantsAndCompensationOptions>
    <imc:ProceedsFromExerciseOfWarrantsAndCompensationOptions
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729014_xbrl_20210427215700978_62"
      unitRef="CAD">6378000</imc:ProceedsFromExerciseOfWarrantsAndCompensationOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172825275"
      unitRef="CAD">133000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729015_xbrl_20210427215700978_72"
      unitRef="CAD">612000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172729016_xbrl_20210427215700978_82"
      unitRef="CAD">633000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729016_xbrl_20210427215700978_85"
      unitRef="CAD">182000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172729018_xbrl_20210427215700978_92"
      unitRef="CAD">1347000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729018_xbrl_20210427215700978_95"
      unitRef="CAD">68000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329173046962_xbrl_20220307153325727_xbrl_20210427212508026_132"
      unitRef="CAD">7804000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329173046962_xbrl_20220307153325727_xbrl_20210427212508026_135"
      unitRef="CAD">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <imc:InterestPaidInRespectOfLoans
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329173048705_xbrl_20220307153325727_xbrl_20210427212508026_132"
      unitRef="CAD">261000</imc:InterestPaidInRespectOfLoans>
    <imc:InterestPaidInRespectOfLoans
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329173048705_xbrl_20220307153325727_xbrl_20210427212508026_135"
      unitRef="CAD">0</imc:InterestPaidInRespectOfLoans>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172729020_xbrl_20210427215700978_122"
      unitRef="CAD">48731000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729020_xbrl_20210427215700978_125"
      unitRef="CAD">6740000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172729023_xbrl_20210427215700978_142"
      unitRef="CAD">-329000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729023_xbrl_20210427215700978_145"
      unitRef="CAD">213000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172729026_xbrl_20210427215700978_162"
      unitRef="CAD">5018000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172729026_xbrl_20210427215700978_165"
      unitRef="CAD">-5041000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220307172729028_xbrl_20210427215700978_172"
      unitRef="CAD">8885000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20191231"
      decimals="-3"
      id="Fxbrl_20220307172729028_xbrl_20210427215700978_175"
      unitRef="CAD">13926000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220307172729029_xbrl_20210427215700978_192"
      unitRef="CAD">13903000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220307172729029_xbrl_20210427215700978_195"
      unitRef="CAD">8885000</ifrs-full:CashAndCashEquivalents>
    <imc:RightOfUseAssetRecognizedWithCorrespondingLeaseLiability
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307172905854"
      unitRef="CAD">1678000</imc:RightOfUseAssetRecognizedWithCorrespondingLeaseLiability>
    <imc:RightOfUseAssetRecognizedWithCorrespondingLeaseLiability
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307172910627"
      unitRef="CAD">107000</imc:RightOfUseAssetRecognizedWithCorrespondingLeaseLiability>
    <imc:ConversionOfWarrantAndCompensationOptionsIntoCommonShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220330111757801_xbrl_20220307172905854"
      unitRef="CAD">611000</imc:ConversionOfWarrantAndCompensationOptionsIntoCommonShares>
    <imc:ConversionOfWarrantAndCompensationOptionsIntoCommonShares
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220330111757801_xbrl_20220307172910627"
      unitRef="CAD">3873000</imc:ConversionOfWarrantAndCompensationOptionsIntoCommonShares>
    <imc:WorkingCapital
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192044218"
      unitRef="CAD">9427000</imc:WorkingCapital>
    <imc:InvestmentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192100237"
      unitRef="CAD">319000</imc:InvestmentsAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192110027"
      unitRef="CAD">15193000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <imc:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192141446"
      unitRef="CAD">15037000</imc:RightOfUseAssetsAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192154487"
      unitRef="CAD">15037000</imc:LeaseLiabilityAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192211517"
      unitRef="CAD">6458000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192430436"
      unitRef="CAD">67269000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192639580"
      unitRef="CAD">99028000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307192702047"
      unitRef="CAD">-362000</imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307192806702"
      unitRef="CAD">19000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330113651881"
      unitRef="CAD">126000</imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate>
    <imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307193013323"
      unitRef="CAD">2837000</imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307193039391"
      unitRef="CAD">88000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220329174843710"
      unitRef="CAD">776000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220329174840742"
      unitRef="CAD">3240000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307193122971"
      unitRef="CAD">6834000</imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed>
    <imc:WorkingCapital
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307193456660"
      unitRef="CAD">4471000</imc:WorkingCapital>
    <imc:LoansPayableAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220329204248256"
      unitRef="CAD">915000</imc:LoansPayableAsOfAcquisitionDate>
    <imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307193740554"
      unitRef="CAD">6735000</imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307193816797"
      unitRef="CAD">873000</imc:LeaseLiabilityAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307193849545"
      unitRef="CAD">4061000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307193933291"
      unitRef="CAD">17200000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307193944864"
      unitRef="CAD">39932000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307193955745"
      unitRef="CAD">62620000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307194049791"
      unitRef="CAD">-131000</imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed>
    <imc:WorkingCapital
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194121487"
      unitRef="CAD">-646000</imc:WorkingCapital>
    <imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194236629"
      unitRef="CAD">1332000</imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194257463"
      unitRef="CAD">1145000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <imc:LongTermBorrowingsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194320592"
      unitRef="CAD">1042000</imc:LongTermBorrowingsAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194401824"
      unitRef="CAD">224000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194344048"
      unitRef="CAD">974000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194415736"
      unitRef="CAD">4294000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194436762"
      unitRef="CAD">3169000</imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed>
    <imc:WorkingCapital
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194451648"
      unitRef="CAD">44000</imc:WorkingCapital>
    <imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194515521"
      unitRef="CAD">1855000</imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate>
    <imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194530593"
      unitRef="CAD">210000</imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194555258"
      unitRef="CAD">532000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194543835"
      unitRef="CAD">2316000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194624324"
      unitRef="CAD">2250000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194638374"
      unitRef="CAD">1026000</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
    <imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194655155"
      unitRef="CAD">1407000</imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed>
    <imc:WorkingCapital
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220329175339862"
      unitRef="CAD">595000</imc:WorkingCapital>
    <imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194732438"
      unitRef="CAD">2726000</imc:AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate>
    <imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307194836563"
      unitRef="CAD">389000</imc:PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate>
    <imc:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307195057774"
      unitRef="CAD">1312000</imc:RightOfUseAssetsAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307195108937"
      unitRef="CAD">1312000</imc:LeaseLiabilityAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307195122194"
      unitRef="CAD">2991000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307195315301"
      unitRef="CAD">688000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307195328601"
      unitRef="CAD">2907000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307195339713"
      unitRef="CAD">1849000</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
    <imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307195352650"
      unitRef="CAD">1619000</imc:NetIdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220307183747880">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 1:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GENERAL&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate information:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IM Cannabis Corp. (the "Company" or "IMCC") is listed for trading on the Canadian Securities Exchange (&#x201c;CSE&#x201d;) and, commencing from March 1, 2021, on NASDAQ under the ticker symbol &#x201c;IMCC&#x201d;. IMCC&#x2019;s main office is located in Kibutz Glil-Yam, Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IMCC operates in the field of medical cannabis, through Focus Medical Herbs Ltd. ("Focus"), which is licensed under the regulations of medical cannabis by the Israeli Ministry of Health ("MOH") through its Israel Medical Cannabis Agency ("IMCA") to breed, grow and supply medical cannabis product in Israel and all of its operations are performed pursuant to the Israeli Dangerous Drugs Ordinance (New Version), 1973 (the "Dangerous Drugs Ordinance"), and the related regulations issued by IMCA. During 2021 IMCC entered to the retail market using pharmacies selling medical cannabis and other pharma products.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In Europe, IMCC operates through Adjupharm, a German-based subsidiary acquired by IMC Holdings on March 15, 2019. Adjupharm is an EU-GMP certified medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In Canada, IMCC operates through Trichome JWC Acquisition Corp. (&#x201c;TJAC&#x201d;) d/b/a JWC and MYM, both Canadian federally licensed producer of cannabis products in the adult-use recreational cannabis market in Canada.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company and its subsidiaries do not engage in any U.S. cannabis-related activities as defined in Canadian Securities Administrators Staff Notice 51-352.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company, its subsidiaries and Focus (collectively: the "Group"), operate in geographical reporting segments (note 23). The majority of the Group&#x2019;s revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;COVID-19:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Since March 31, 2020, the outbreak of the novel strain of coronavirus ("COVID-19") and the ongoing pandemic, has resulted in governments worldwide enacting various emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods, closing of non-essential businesses and social distancing, have caused material disruption to businesses globally resulting in an economic slowdown.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Group has taken proactive measures to protect the health and safety of its employees in order to continue delivering high quality medical cannabis products to its patients and to maintain its financial health, including postponed planned investments in certain jurisdictions until global economic risks subside.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;To date, the Group&#x2019;s cannabis operations, results and financial position have not been materially impacted by COVID-19 related issues. Apart for temporary delays in Canada, the Group has not experienced material disruptions in its labor inputs and cultivation and processing activities, there have been no indicators of material issues to the Group&#x2019;s supply chain, and on the consumer side, product demand has remained stable and medical cannabis has been declared an essential service across Israel, Germany and Canada, as such, the Group's overall distribution remains relatively unimpacted.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;While the precise impact of the COVID-19 outbreak on the Group remains unknown, the rapid spread of COVID-19 and declaration of the outbreak as a global pandemic have resulted in travel advisories and restrictions, certain restrictions on business operations, social distancing precautions and restrictions on group gatherings which are having direct impacts on businesses in Canada, Israel, Germany and elsewhere in the world. Such additional precautionary measures could also impact the Group&#x2019;s business. The spread of COVID-19 may also have a material adverse effect on global economic activity and could result in volatility and disruption to global supply chains and the financial and capital markets. These disruptions could cause interruptions in supplies and other services from third parties upon which the Group relies; decrease demand for products; and cause staff shortages, reduced customer traffic, and increased government regulation, all of which may materially and negatively impact the business, financial condition and results of operations of the Group.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liquidity and capital resources:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 10, 2021, the Company completed an overnight marketed offering (the &#x201c;Offering&#x201d;) of 6,086,956 Common Shares (each an &#x201c;Offered Share&#x201d;) at a price of US$5.75 per Offered Share for aggregate gross proceeds of approximately US$35 million (approximately $42,502) (see Note 15d).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2021, the Company's cash position (cash and cash equivalents) totaled $13,903 and the Company's working capital (current assets less current liabilities) amounted to $33,084. In the year ended December 31, 2021, the Company had an operating loss of ($38,389) and negative cash flows from operating activities of ($34,372). The Company&#x2019;s current operating budget includes various assumptions concerning the level and timing of cash receipts from sales and cash outlays for operating expenses and capital expenditures, including a cost saving plan. The Company is planning to finance its operations from its existing and future working capital resources and to continue to evaluate additional sources of capital and financing. However, there is no assurance that additional capital and or financing will be available to the Company, and even if available, whether it will be on terms acceptable to the Company or in amounts required. Accordingly, the Company&#x2019;s board of directors approved a cost saving plan, to be implemented if needed, in whole or in part, at its discretion, to allow the Company to continue its operations and meet its cash obligations. The cost saving plan consist of cost reduction due to efficiencies and synergies, which include mainly the following steps: reduction in payroll and headcount, reduction in compensation paid to key management personnel, operational efficiencies and reduced capital expenditures. The Company and the board of directors believe that its existing financial resources and its operating plans, including the effects of the costs saving plan, will be adequate to satisfy its expected liquidity requirements for a period of at least twelve months from the end of the reporting period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year, TJAC and certain MYM subsidiaries entered into a revolving credit facility (the &#x201c;Facility&#x201d;) with a private Canadian creditor. The Facility is guaranteed by Trichome Financial Corp. Advances from the Facility is used for working capital needs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Facility has a total commitment of up to $10,000 and has a one-year term, renewable upon mutual agreement by the parties on May 14, 2022 for up to two additional periods of 180 days. The borrowing base available for draw at any time throughout the Facility is a function of the trade receivable and inventory balances at the time of drawdown. The Facility bears interest at the higher of 9.75% and the Toronto Dominion Bank Prime Rate plus 7.30% per annum. The balance as at December 31, 2021 was $8,582.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In January 2022, Focus entered into a Revolving Credit Facility with Bank Mizrahi (the &#x201c;Mizrahi Facility&#x201d;). The Mizrahi Facility is guaranteed by Focus assets. Advances from the Mizrahi Facility will be used for working capital needs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Mizrahi Facility has a total commitment of up to NIS 15,000 thousand (approximately $6,000) and has a one-year term for on-going needs and 6 months term for imports and purchases needs. The Mizrahi Facility is renewable upon mutual agreement by the parties. The borrowing base available for draw at any time throughout the Mizrahi Facility and is subject to several covenants to be measured on a quarterly basis. The Mizrahi Facility bears interest of Israeli Prime interest plus 1.5% (approximately 3.3%) per annum.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Strategic developments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:14.15pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 2, 2019, IMC undertook a restructuring process (the "IMC Restructuring") to divest its holdings in Focus, I.M.C Pharma Ltd and I.M.C.C. Ltd. (the "Licensed Entities") and sold its interest to the two Principal Shareholders of the Company. In the process, IMC restructured its connection to the Government Issued License, from Direct Ownership to a Business Agreement relationship, according to which IMC will still gain most of the economic values generated from the License, without directly owning it. Furthermore, IMC has the option to buy back the ownership of the license from the two Principal Shareholders. The restructuring process was subject to the prior approval of the Ministry of Health (the "MOH") and became effective on June 24, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;text-indent:0pt;margin-left:92.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Following the IMC Restructuring of the Licensed Entities, the Company does not currently hold, directly or indirectly, any licenses to engage in the cultivation, production, processing, distribution or sale of medical cannabis in Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;text-indent:0pt;margin-left:92.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent to the IMC Restructuring, according to accounting criteria in IFRS 10, the Company is still viewed as effectively exercising control over Focus, and therefore, the accounts of Focus continue to be consolidated with those of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:14.15pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 8, 2021, the Company announced that Focus signed a multi-year supply agreement with GTEC Holdings Ltd. (&#x201c;GTEC&#x201d;), a Canadian licensed producer of handcrafted and high-quality cannabis (the &#x201c;GTEC Agreement&#x201d;). According to the GTEC Agreement, Focus will import GTEC&#x2019;s high-THC medical cannabis inflorescence into Israel to be sold under the IMC brand. With the arrival of these commercial shipments, the Company will launch a new category of imported premium indoor medical cannabis products under its well-established brand.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:92.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The first import of the Canadian-grown high-THC strains from GTEC&#x2019;s subsidiary, Grey Bruce Farms Incorporated (&#x201c;GBF&#x201d;), arrived during September 2021. According to the GTEC Agreement, Focus will purchase a minimum quantity of 500kg of high-THC medical cannabis inflorescence from GBF and will be the exclusive recipient of GTEC cannabis products in the Israeli market for a period of 12 months from the date that the first shipment of GTEC products arrives in Israel (the &#x201c;Exclusive Term&#x201d;). The Exclusive Term can be extended under the terms of the GTEC Agreement by an additional 6 months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;3.&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;On March 12, 2021, the Company filed a preliminary short form base shelf prospectus (the &#x201c;Preliminary Shelf Prospectus&#x201d;) with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada (the &#x201c;Securities Commissions&#x201d;), and on March 15, 2021, the Company filed a corresponding shelf registration statement on Form F-10 with the SEC, under the Multijurisdictional Disclosure System (&#x201c;MJDS&#x201d;) established between Canada and the United States.&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:96pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 31, 2021, in connection with the Preliminary Shelf Prospectus, the Company filed a final short form base shelf prospectus (the &#x201c;Final Shelf Prospectus&#x201d;) with the Securities Commissions and a corresponding shelf registration statement on Form F-10 (the &#x201c;Registration Statement&#x201d;) with the SEC. The Final Shelf Prospectus and the Registration Statement enable the Company to offer up to US$250 million (or its equivalent in other currencies) of Common Shares, warrants, subscription receipts, debt securities, units (collectively, the &#x201c;Qualified Securities&#x201d;), or any combination of such Qualified Securities from time to time, during the 25-month period that the Final Shelf Prospectus is effective. The specific terms of any offering under the Final Shelf Prospectus and the intended use of the net proceeds will be established in a prospectus supplement, which will be filed with the Securities Commissions and the SEC in connection with any such offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;4.&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;On March 12, 2021, Adjupharm entered into a supply agreement with Northern Green Canada Inc. (&#x201c;NGC&#x201d;) (the &#x201c;NGC Supply Agreement&#x201d;). Under the terms of the NGC Supply Agreement, NGC will provide Adjupharm with three new strains of medical cannabis products, to be distributed under the IMC brand to German pharmacies pursuant to Adjupharm&#x2019;s distribution agreements with its German distribution partners. Shipments from NGC commenced in October 2021.&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;5.&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;On March 18, 2021, the Company acquired all of Trichome Financial Corp.&#x2019;s ("Trichome" or "TFC") issued and outstanding shares (the &#x201c;Trichome Shares&#x201d;). Pursuant to the terms of the Trichome Transaction, former holders of Trichome Shares and former holders of Trichome convertible instruments (the &#x201c;Trichome Securityholders&#x201d;) received 0.24525 of a Common Share for each Trichome Share held and each in-the-money convertible instrument of Trichome. As a result of the Trichome Transaction, a total of 10,104,901 Common Shares were issued to the Trichome Securityholders. In addition, 100,916 Common Shares were issued to financial advisors for advisory fees in connection with the Trichome Transaction.&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;6.&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;On March 29, 2021, Adjupharm entered into a supply agreement with MediPharm Labs Corp. (&#x201c;MediPharm Labs&#x201d;) for certain medical cannabis extract products to be delivered by MediPharm Labs over an initial two-year term with an automatic two-year extension period. Shipments from MediPharm Labs commenced in October 2021.&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;7.&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;On March 30, 2021, Zur Rose Pharma GmbH (&#x201c;Zur Rose&#x201d;) and the Company entered into a termination settlement agreement in connection with the sales agreements announced in July 2020 according to Zur Rose's request, and under which Adjupharm received a termination fee. According to the termination agreement, no inventory will be transferred from Zur Rose to Adjupharm or vice versa.&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="text-align:justify;margin-left:74.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During March 2021, Adjupharm entered into two supply agreements with supply partners in China, under which Adjupharm bought COVID-19 rapid antigen test kits. Concurrently, Adjupharm entered into several resale agreements with reseller partners in Germany, under which Adjupharm sold the COVID-19 antigen test kits to pharmacies and retailers in Germany.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="text-align:justify;margin-left:74.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 30, 2021, the Company announced that its wholly-owned Israeli subsidiary, IMC Holdings, signed a definitive agreement (the &#x201c;Panaxia Agreement&#x201d;) with Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd. (collectively &#x201c;Panaxia&#x201d;) (the &#x201c;Panaxia Transaction&#x201d;). Pursuant to the Panaxia Agreement, IMC Holdings will acquire Panaxia&#x2019;s trading house license and in-house pharmacy activities, certain distribution assets and an option to purchase a pharmacy with licenses to sell medical cannabis to patients, for an aggregate purchase price of NIS 18.7 million (approximately $7,000), comprised of NIS 7.6 million (approximately $2,800) in cash and NIS 11.1 million (approximately $4,200) in Common Shares (the &#x201c;Panaxia Consideration Shares&#x201d;). As of December 31, 2021, all of the cash consideration was paid and all of the common shares consideration were issued.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/div&gt;
                              &lt;div style="text-align:justify"&gt;&#160;&lt;/div&gt;
                              &lt;div&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Panaxia Transaction will be finalized in two stages, with an option of a third stage. Upon the initial closing, on May 30, 2021, all online-related activities and intellectual property will be transferred to IMC Holdings. The second stage requires that Panaxia will transfer its IMC-GDP license, which allows the holder to store and distribute medical cannabis in Israel, to IMC Holdings or its subsidiary (the &#x201c;Panaxia IMC-GDP License&#x201d;). The second stage was subject to MOH approval, which granted its approval subsequent to December 31, 2021, on February 15, 2022. Panaxia Transaction includes an option to acquire Panaxia&#x2019;s pharmacy (the &#x201c;Panaxia Option&#x201d;), including licenses to dispense and sell products to cannabis patients (the &#x201c;Panaxia Pharmacy Licenses&#x201d;) for additional payment in the amount equal to the medical cannabis inventory of the pharmacy at the time of exercise. The option was exercised on February 1, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                          &lt;div&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Panaxia Agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of all of the abovementioned acquired assets and activities and the rights to obtain all economic benefits from those assets and activities. Accordingly, the Company has concluded that it exercises control over the acquired assets and activities as of the date of the definitive agreement, which is the date from which the assets are included in these consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 9, 2021, the Company acquired all the issued and outstanding shares of MYM Nutraceuticals Inc. and closed the MYM transaction (the &#x201c;MYM Transaction&#x201c;). The Company acquired MYM's licensed producer subsidiary Highland Grow Inc., pursuant to a plan of arrangement to be completed under the Business Corporations Act in British Columbia. MYM operates two licensed, craft cultivation facilities in Canada; SublimeCulture Inc. in Laval, Quebec, and Highland Grow Inc., in Antigonish, Nova Scotia. MYM&#x2019;s flagship brand, Highland, is an ultra-premium brand sold in most provinces throughout Canada. Under the terms of the MYM Transaction, the shareholders of MYM will receive 0.022 Common Shares of IMCC for each common share of MYM. As a result of the MYM transaction, a total of 10,073,437 Common shares were issued to the MYM former shareholders (including 49,802 Common Shares issued to a financial advisor of MYM).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman', Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 28, 2021, IMC Holdings entered into a definitive agreement to acquire all of the issued and outstanding share of R.A. Yarok Pharm Ltd., Rosen High Way Ltd. and High Way Shinua Ltd. (collectively "Pharm Yarok Group"). The aggregate consideration for the Pharm Yarok Group acquisition is NIS 11,900 thousand (approximately $4,600), of which NIS 3,500 thousand (approximately $1,300) shall be in the form of issuance of Common Shares of the Company at closing to the former shareholders. The closing of the Pharm Yarok Group acquisition is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022. As of December 31, 2021, the Company has not transferred the Common Share consideration. Pharm Yarok Group is a leading medical cannabis pharmacy and trading company located in central Israel, Rosen High Way, a trade and distribution center providing medical cannabis storage, distribution services and logistics solutions for cannabis companies and pharmacies in Israel and High Way Shinua, an applicant for a medical cannabis transportation license from the IMCA, the receipt of which would permit High Way Shinua to transport large quantities of medical cannabis to and from Pharm Yarok&#x2019;s pharmacy and Rosen High Way&#x2019;s distribution center and to and from third parties in the medical cannabis sector, including medical cannabis growing facilities, pharmacies, manufacturers and distribution centers across Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                          &lt;div&gt;&#160;&lt;/div&gt;
                          &lt;div&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of the Pharm Yarok Group and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over the Pharm Yarok Group as of the date of the definitive agreement, which is the date from which the accounts of the Pharm Yarok Group are included in these consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 16, 2021, IMC Holdings signed a definitive agreement to acquire 51% of the outstanding ordinary shares of Revoly Trading and Marketing Ltd. ("Vironna") for a total consideration of NIS 8,500 thousand (approximately $3,300), of which NIS 5,000 thousand (approximately $1,950) in cash and NIS 3,500 thousand (approximately $1,350) is in Common Shares of the Company to be issued at closing of Vironna transaction. The closing is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022. As of December 31, 2021, the Company paid a consideration amounted to NIS 3,750 (approximately 1,400) to the former shareholders of Virrona. Vironna is a leading pharmacy licensed to dispense and sell medical cannabis to licensed medical cannabis patients, located in central Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div&gt;&#160;&lt;/div&gt;
                          &lt;div&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2021 the Company paid a consideration amounted to NIS 3,750 (approximately $1,400) to the former shareholders of Vironna.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                          &lt;div&gt;&#160;&lt;/div&gt;
                          &lt;div&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of Vironna and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over Vironna as of the date of the definitive agreement, which is the date from which the accounts of Vironna are included in these consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 1, 2021, IMC Holdings signed a definitive agreement to acquire 51% of the rights in Oranim Pharm, one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area, by acquiring 51.3% of the outstanding shares of Oranim Plus, which holds 99.5% of the rights in Oranim Pharm (the &#x201c;Oranim Transaction&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div&gt;&#160;&lt;/div&gt;
                          &lt;div&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Oranim Transaction closed on March 28, 2022, upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS 11,940 (approximately $4,900), consisting of NIS 5,202 (approximately $2,104) paid in cash upon signing, NIS 5,202 (approximately $2,104) which will be paid in cash on the first quarter of 2023 and NIS 1,536 (approximately $630) paid in 251,001 Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#x2019;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The definitive agreement provides the Company with the power to unilaterally make all decisions regarding the financial and operating policies of Oranim and the rights to obtain all related economic benefits. Accordingly, the Company has concluded that it exercises control over Oranim as of the date of the definitive agreement, which is the date from which the accounts of Oranim are included in these consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Approval of consolidated financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These consolidated financial statements of the Group were authorized for issue by the board of directors on March 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Definitions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In these financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:95pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;float:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company, or IMCC&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IM Cannabis Corp.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Group&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IM Cannabis Corp., its Subsidiaries and Focus&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Companies that are controlled by the Company (as defined in IFRS 10) and whose accounts are consolidated with those of the Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:95pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;float:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CAD or $&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canadian Dollar&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NIS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New Israeli Shekel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;USD or US$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States Dollar&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:22.64%;vertical-align:top"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EURO or &#x20ac;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:3.65%;vertical-align:top"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;-&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:73.71%;vertical-align:top"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="INF"
      id="Fxbrl_20220307170913338"
      unitRef="Share">6086956</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="2"
      id="Fxbrl_20220307170948470"
      unitRef="USD_per_Share">5.75</ifrs-full:ParValuePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-6"
      id="Fxbrl_20220307171019742"
      unitRef="USD">35000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-3"
      id="Fxbrl_20220307171043027"
      unitRef="CAD">42502000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-3"
      id="Fxbrl_20220331182715214"
      unitRef="CAD">13903000</ifrs-full:CashAndCashEquivalents>
    <imc:WorkingCapitalOfBusinessAcquisition
      contextRef="C_20210101to20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-3"
      id="Fxbrl_20220331182724959"
      unitRef="CAD">33084000</imc:WorkingCapitalOfBusinessAcquisition>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-3"
      id="Fxbrl_20220331182734077"
      unitRef="CAD">38389000</ifrs-full:ProfitLoss>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20210101to20211231_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-3"
      id="Fxbrl_20220331182741710"
      unitRef="CAD">34372000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <imc:Commitment
      contextRef="C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220329205334515"
      unitRef="CAD">10000000</imc:Commitment>
    <ifrs-full:BorrowingsInterestRate
      contextRef="C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="4"
      id="Fxbrl_20220329205347563"
      unitRef="Percentage">0.0975</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20210101to20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      id="Fxbrl_20220329205408971">Prime Rate plus 7.30% per annum</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:Borrowings
      contextRef="C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220329205433115"
      unitRef="CAD">8582000</ifrs-full:Borrowings>
    <imc:Commitment
      contextRef="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329205922485"
      unitRef="NIS">15000000</imc:Commitment>
    <imc:Commitment
      contextRef="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329205932629"
      unitRef="CAD">6000000</imc:Commitment>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20220101to20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      id="Fxbrl_20220329210005703">Prime interest plus 1.5% (approximately 3.3%) per annum</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20210301to20210331_imcEquityTransactionAxis_imcPreliminaryShelfProspectusMember"
      decimals="-3"
      id="Fxbrl_20220307194534506"
      unitRef="CAD">250000</ifrs-full:ProceedsFromIssuingShares>
    <imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree
      contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="5"
      id="Fxbrl_20220307194135003"
      unitRef="Share">0.24525</imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="INF"
      id="Fxbrl_20220307194151562"
      unitRef="Shares">10104901</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="INF"
      id="Fxbrl_20220307195240886"
      unitRef="Shares">100916</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-5"
      id="Fxbrl_20220307200014261"
      unitRef="NIS">18700000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307200046653"
      unitRef="CAD">7000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-5"
      id="Fxbrl_20220307200107493"
      unitRef="NIS">7600000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307200134508"
      unitRef="CAD">2800000</ifrs-full:CashTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-5"
      id="Fxbrl_20220307200206030"
      unitRef="NIS">11100000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210530_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307200228576"
      unitRef="CAD">4200000</ifrs-full:EquityInterestsOfAcquirer>
    <imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree
      contextRef="C_20210701to20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="3"
      id="Fxbrl_20220307200834899"
      unitRef="Share">0.022</imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="INF"
      id="Fxbrl_20220307200817040"
      unitRef="Shares">10073437</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307201725524"
      unitRef="NIS">11900000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307201758765"
      unitRef="CAD">4600000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307201821101"
      unitRef="NIS">3500000</imc:CashConsiderationOfBusinessCombination>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20210701to20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307202056453"
      unitRef="CAD">1300000</imc:CashConsiderationOfBusinessCombination>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="2"
      id="Fxbrl_20220307202117552"
      unitRef="Percentage">0.51</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307202222452"
      unitRef="NIS">8500000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307202242557"
      unitRef="CAD">3300000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307202311207"
      unitRef="NIS">5000000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307202330181"
      unitRef="CAD">1950000</ifrs-full:CashTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307202357538"
      unitRef="NIS">3500000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307202352263"
      unitRef="CAD">1350000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220331212128675"
      unitRef="NIS">3750000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220331212312579"
      unitRef="CAD">1400000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330115934890"
      unitRef="NIS">3750000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330120001545"
      unitRef="CAD">1400000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="2"
      id="Fxbrl_20220329210049470"
      unitRef="Percentage">0.51</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <imc:PercentageOfOutstandingSharesAcquired
      contextRef="C_20211101to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="3"
      id="Fxbrl_20220329212025165"
      unitRef="Percentage">0.513</imc:PercentageOfOutstandingSharesAcquired>
    <imc:PercentageOfRightsHold
      contextRef="C_20211101to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="3"
      id="Fxbrl_20220329212039013"
      unitRef="Percentage">0.995</imc:PercentageOfRightsHold>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330051544769"
      unitRef="NIS">11940000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330051718080"
      unitRef="CAD">4900000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashTransferred
      contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330052411078"
      unitRef="NIS">5202000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330052442122"
      unitRef="CAD">2104000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20230331_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330052520089"
      unitRef="NIS">5202000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20230331_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330052537340"
      unitRef="CAD">2104000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330052615545"
      unitRef="NIS">1536000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330052633479"
      unitRef="CAD">630000</ifrs-full:CashTransferred>
    <imc:IssuanceOfCommonShares
      contextRef="C_20220301to20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20220330052707919"
      unitRef="Share">251001</imc:IssuanceOfCommonShares>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180805473">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;NOTE 2:-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following accounting policies have been applied consistently in the financial statements for all periods presented, unless otherwise stated.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Basis of presentation:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB").&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Group's financial statements have been prepared on a cost basis, except for:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Financial instruments which are presented at fair value through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Biological assets which are presented at fair value less cost to sell up to the point of harvest.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Group has elected to present the profit or loss items using the function of expense method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Consolidated financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The consolidated financial statements comprise the financial statements of companies that are controlled by the Company (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Potential voting rights are considered when assessing whether an entity has control. The consolidation of the financial statements commences on the date on which control is obtained and ends when such control ceases.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2021, and 2020, major subsidiaries over which the Company has control, directly or indirectly, include&lt;span style="font-weight:bold"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;

                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="margin-left:90pt"&gt;
                          &lt;table border="0" cellpadding="1" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left"&gt;

                              &lt;tr&gt;
                                &lt;td rowspan="2" style="width:67.71%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="3" style="width:32.29%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Percentage ownership&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:14.18%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C. Holdings Ltd (&#x201d;IMC&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Focus Medical Herbs Ltd. ("Focus") *)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C Farms Israel Ltd. ("IMC Farms")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C Ventures Ltd. ("IMC Ventures")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C - International Medical Cannabis Portugal Unipessoal Lda&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Adjupharm GmbH (&#x201c;Adjupharm&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90.02%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92.5%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;R.A. Yarok Pharm Ltd. (&#x201c;Pharm Yarok&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Rosen High Way Ltd. (&#x201c;Rosen High Way&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;High Way Shinua Ltd. (&#x201c;HW Shinua&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revoly Trading and Marketing Ltd. (&#x201c;Vironna&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Oranim Plus Pharm LTD.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51.3%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Oranim Pharm&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Corp. (&#x201c;Trichome&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Cannabis GP Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Cannabis Manager Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Asset Funding Corp.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome JWC Acquisition Corp. (&#x201c;TJAC&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Retail Corp.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;MYM Nutraceuticals Inc. (&#x201c;MYM&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;SublimeCulture Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;CannaCanada Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;MYM International Brands Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Highland Grow Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-width:2px;border-style:solid;border-color:rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;*) See also Note 1b(1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;

                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The financial statements of the Company and of the subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all companies in the Group. Significant intragroup balances and transactions and gains or losses resulting from intragroup transactions are eliminated in full in the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-controlling interests in subsidiaries represent the equity in subsidiaries not attributable, directly or indirectly, to a parent. Non-controlling interests are presented in equity separately from the equity attributable to the equity holders of the Company. Profit or loss and components of other comprehensive income are attributed to the Company and to non-controlling interests. Losses are attributed to non-controlling interests even if they result in a negative balance of non-controlling interests in the consolidated statement of financial position.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The disposal of a subsidiary that does not result in a loss of control is recognized as a change in equity. Upon the disposal of a subsidiary resulting in loss of control, the Company:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognizes the subsidiary's assets (including goodwill) and liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognizes the carrying amount of non-controlling interests.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognizes the adjustments arising from translating financial statements carried to equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Recognizes the fair value of the consideration received.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Recognizes the fair value of any remaining investment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Reclassifies the components previously recognized in other comprehensive income (loss) on the same basis as would be required if the subsidiary had directly disposed of the related assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Recognizes any resulting difference (surplus or deficit) as gain or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Business combinations and goodwill:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Business combinations are accounted for by applying the acquisition method. The cost of the acquisition is measured at the fair value of the consideration transferred on the acquisition date with the addition of non-controlling interests in the acquiree. In each business combination, the Company chooses whether to measure the non-controlling interests in the acquiree based on their fair value on the acquisition date or at their proportionate share in the fair value of the acquiree's net identifiable assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Direct acquisition costs are carried to the statement of profit or loss as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In a business combination achieved in stages, equity interests in the acquiree that had been held by the acquirer prior to obtaining control are measured at the acquisition date fair value while recognizing a gain or loss resulting from the revaluation of the prior investment on the date of achieving control.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Contingent consideration is recognized at fair value on the acquisition date and classified as a financial asset or liability in accordance with IFRS 9. Subsequent changes in the fair value of the contingent consideration are recognized in profit or loss. If the contingent consideration is classified as an equity instrument, it is measured at fair value on the acquisition date without subsequent remeasurement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Goodwill is initially measured at cost which represents the excess of the acquisition consideration and the amount of non-controlling interests over the net identifiable assets acquired and liabilities assumed. If the resulting amount is negative, the acquirer recognizes the resulting gain on the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div/&gt;
                &lt;div&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Functional currency, presentation currency and foreign currency:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.15pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Functional currency and presentation currency:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The functional currency of the Company is the Canadian dollar ("CAD"). The Group determines the functional currency of each Group entity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Assets, including fair value adjustments upon acquisition, and liabilities of an investee which is a foreign operation, and of each Group entity for which the functional currency is not the presentation currency are translated at the closing rate at each reporting date. Profit or loss items are translated at average exchange rates for all periods presented. The resulting translation differences are recognized in other comprehensive income (loss).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Upon the full or partial disposal of a foreign operation resulting in loss of control in the foreign operation, the cumulative gain (loss) from the foreign operation which had been recognized in other comprehensive income is transferred to profit or loss. Upon the partial disposal of a foreign operation which results in the retention of control in the subsidiary, the relative portion of the amount recognized in other comprehensive income is reattributed to non-controlling interests.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.15pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Transactions, assets and liabilities in foreign currency:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Transactions denominated in foreign currency are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at each reporting date into the functional currency at the exchange rate at that date. Exchange rate differences, other than those capitalized to qualifying assets or accounted for as hedging transactions in equity, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-monetary assets and liabilities denominated in foreign currency and measured at cost are translated at the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currency and measured at fair value are translated into the functional currency using the exchange rate prevailing at the date when the fair value was determined.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;

                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash equivalents:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash equivalents are considered as highly liquid investments, including unrestricted short-term bank deposits with an original maturity of three months or less from the date of investment or with a maturity of more than three months, but which are redeemable on demand without penalty and which form part of the Group's cash management.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Short-term deposits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Short-term bank deposits are deposits with an original maturity of more than three months from the date of investment and which do not meet the definition of cash equivalents. The deposits are presented according to their terms of deposit.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value measurement:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div/&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;All assets and liabilities measured at fair value or for which fair value is disclosed are categorized into levels within the fair value hierarchy based on the lowest level input that is significant to the entire fair value measurement:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="margin-left:95pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Level 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;inputs other than quoted prices included within Level 1 that are observable directly or indirectly.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Level 3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Biological assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group&#x2019;s biological assets consist of cannabis plants.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2, Inventories. These costs include the direct cost of planting and growing materials as well as other indirect costs such as utilities and supplies used in the cultivation process.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Indirect labor for individuals involved in the cultivation and quality control process is also included, as well as depreciation on growing equipment and overhead costs such as rent to the extent it is associated with the growing space. All direct and indirect costs of biological assets are capitalized as they are incurred, and they are all subsequently recorded within the line item cost of revenues on the Group&#x2019;s statements of profit or loss and other comprehensive income in the period that the related product is sold.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventories after harvest. The fair value is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred (e.g., post-harvest costs). The net unrealized gains or losses arising from changes in fair value less cost to sell during the period are included in the gross profit for the related period and are recorded in a separate line on the face of the Group&#x2019;s statements of profit or loss and other comprehensive income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Determination of the fair values of the biological assets requires the Group to make assumptions about how market participants assign fair values to these assets. These assumptions primarily relate to the level of effort required to bring the cannabis up to the point of harvest, costs to convert the harvested cannabis to finished goods, sales price, risk of loss, expected future yields from the cannabis plants and estimating values during the growth cycle.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group accretes fair value on a straight-line basis according to stage of growth (e.g., a cannabis plant that is 50% through its growing cycle would be ascribed approximately 50% of its harvest date expected fair value, subject to wastage adjustments).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The fair value of biological assets is categorized within Level 3 of the fair value hierarchy. For the inputs and assumptions used in determining the fair value of biological assets, see Note 8.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group&#x2019;s estimates are, by their nature, subject to change and differences from the anticipated yield will be reflected in the gain or loss on biological assets in future periods.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Inventories:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Inventories are measured at the lower of cost and net realizable value. The cost of inventories comprises costs of purchase and costs incurred in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and estimated costs necessary to make the sale. The Group reviews inventory for obsolete, redundant and slow-moving goods and any such inventory are written-down to net realizable value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Inventories of purchased finished goods and packing materials are initially valued at cost and subsequently at the lower of cost and net realizable value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The direct and indirect costs of inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labor and depreciation expense on equipment involved in packaging, labeling and inspection.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of revenues on the Group&#x2019;s statements of profit or loss and other comprehensive income at the time cannabis is sold, except for realized fair value amounts included in inventory sold which are recorded as a separate line item on the face of the statements of profit or loss and other comprehensive income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has otherwise been damaged.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;j.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Property, plant and equipment:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation, accumulated impairment losses and excluding day-to-day servicing expenses. Cost includes spare parts and auxiliary equipment that are used in connection with plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is depreciated separately using the component method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values which are determined through the exercise of judgement and calculated on a straight-line basis over the useful lives of the assets at annual rates as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;

                        &lt;div style="margin-left:90pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Mainly %&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Greenhouse production equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7 - 33&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Greenhouse structure&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Computer, software and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20 - 50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;

                    &lt;/div&gt;
                    &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Leasehold improvements are depreciated on a straight-line basis over the shorter of the lease term and the useful life of the improvement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate. Depreciation of an asset ceases at the earlier of the date that the asset is classified as held for sale and the date that the asset is derecognized.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;k.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Impairment of non-financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group evaluates the need to record an impairment of non-financial assets whenever events or changes in circumstances indicate that the carrying amount is not recoverable. If the carrying amount of non-financial assets exceeds their recoverable amount, the assets are reduced to their recoverable amount. The recoverable amount is the higher of fair value less costs of sale and value in use. In measuring value in use, the expected future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the asset. The recoverable amount of an asset that does not generate independent cash flows is determined for the cash-generating unit to which the asset belongs. Impairment losses are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;An impairment loss of an asset, other than goodwill, is reversed only if there have been changes in the estimates used to determine the asset's recoverable amount since the last impairment loss was recognized. Reversal of an impairment loss, as above, shall not be increased above the lower of the carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized for the asset in prior years and its recoverable amount. The reversal of impairment loss of an asset presented at cost is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following criteria are applied in assessing impairment of these specific assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Goodwill in respect of subsidiaries:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company reviews goodwill for impairment once a year, on December 31, or more frequently if events or changes in circumstances indicate that there is an impairment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit (or group of cash-generating units) to which the goodwill has been allocated. The Company identified the operations and Israel, Canada and Europe as three separate cash-generating units.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;An impairment loss is recognized if the recoverable amount of the cash-generating unit (or group of cash-generating units) to which goodwill has been allocated is less than the carrying amount of the cash-generating unit (or group of cash-generating units). Any impairment loss is allocated first to goodwill. Impairment losses recognized for goodwill cannot be reversed in subsequent periods. During the year ended December 31, 2021, the Company recorded goodwill impairment in the amount of $275 with respect to the cash generating unit in Germany.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div/&gt;
                &lt;div&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;l.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue recognition:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue from contracts with customers is recognized when the control over the goods or services is transferred to the customer. The transaction price is the amount of the consideration that is expected to be received based on the contract terms, excluding amounts collected on behalf of third parties (such as taxes).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In determining the amount of revenue from contracts with customers, the Group evaluates whether it is a principal or an agent in the arrangement. The Group is a principal when the Group controls the promised goods or services before transferring&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;them to the customer. In these circumstances, the Group recognizes revenue for the gross amount of the consideration. When the Group is an agent, it recognizes revenue for the net amount of the consideration, after deducting the amount due to the principal.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue from the sale of goods:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue from the sale of cannabis products is generally recognized at a point in time when control over the goods have been transferred to the customer. Payment is typically due prior to or upon delivery and revenue is recognized upon the satisfaction of the performance obligation. The Group satisfies its performance obligation and transfers control upon delivery and acceptance by the customer.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Variable consideration:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group determines the transaction price separately for each contract with a customer. When exercising this judgment, the Group evaluates the effect of each variable amount in the contract, taking into consideration discounts, penalties, variations, claims, and non-cash consideration. In determining the effect of the variable consideration, the Group normally uses the "most likely amount" method described in the Standard. Pursuant to this method, the amount of the consideration is determined as the single most likely amount in the range of possible consideration amounts in the contract. According to the Standard, variable consideration is included in the transaction price only to the extent that it is highly probable that a significant reversal in the amount of revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Bill-and-hold arrangements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Due to strict regulations of storage and handling large quantities of cannabis products, the Group's customer may request the Group to retain physical possession of a sold product until it is delivered to the customer at a future point in time. Revenue from bill-and-hold sales is recognized before the product is physically delivered to the customer when all of the following criteria are met:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;a) The reason for the bill-and-hold arrangement is substantive (for example, the customer has requested the arrangement);&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;span&gt; &lt;/span&gt;&lt;span&gt;&lt;span&gt;The product is identified separately as belonging to the customer;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;c)&lt;/span&gt;&lt;/span&gt;&lt;span&gt; &lt;/span&gt;&lt;span&gt;&lt;span&gt;The product currently is ready for physical delivery to the customer;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;d)&lt;/span&gt;&lt;/span&gt;&lt;span&gt; &lt;/span&gt;&lt;span&gt;&lt;span&gt;The Group does not have the ability to use the product by selling it or delivering it to another customer.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;m.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Leases:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For leases in which the Group is the lessee, the Group recognizes on the commencement date of the lease a right-of-use asset and a lease liability, excluding leases whose term is up to 12 months and leases for which the underlying asset is of low value. For these excluded leases, the Group has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Group has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On the commencement date, the lease liability includes all unpaid lease payments discounted at the interest rate implicit in the lease, if that rate can be readily determined, or otherwise using the Group's incremental borrowing rate. After the commencement date, the Group measures the lease liability using the effective interest rate method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On the commencement date, the right-of-use asset is recognized in an amount equal to the lease liability plus lease payments already made on or before the commencement date and initial direct costs incurred. The right-of-use asset is measured applying the cost model and amortized over the shorter of its useful life and the lease term. The periods of amortization are: Land and buildings &#x2013; 5-12 years; Motor vehicles &#x2013; 3 years.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div/&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Variable lease payments that depend on an index:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On the commencement date, the Group uses the index rate prevailing on the commencement date to calculate the future lease payments.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For leases in which the Group is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the right-of-use asset, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease extension and termination options:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In the event of any change in the expected exercise of the lease extension option or in the expected non-exercise of the lease termination option, the Group remeasures the lease liability based on the revised lease term using a revised discount rate as of the date of the change in expectations. The total change is recognized in the carrying amount of the right-of-use asset until it is reduced to zero, and any further reductions are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;n.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Research and development expenditures:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Research expenditures are recognized in profit or loss when incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;
                  &lt;div/&gt;
                &lt;/div&gt;
                &lt;div&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;o.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial instruments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group apply the provisions of IFRS 9, "Financial Instruments".&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial assets are measured upon initial recognition at fair value plus transaction costs that are directly attributable to the acquisition of the financial assets, except for financial assets measured at fair value through profit or loss in respect of which transaction costs are recorded in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group classifies and measures debt instruments in the financial statements based on the following criteria:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group&#x2019;s business model for managing financial assets; and&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The contractual cash flow terms of the financial asset.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Debt instruments are measured at amortized cost when:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group&#x2019;s business model is to hold the financial assets in order to collect their contractual cash flows, and the contractual terms of the financial assets give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. After initial recognition, the instruments in this category are measured according to their terms at amortized cost using the effective interest rate method, less any provision for impairment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Debt instruments are measured at fair value through profit or loss when:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A financial asset which is a debt instrument does not meet the criteria for measurement at amortized cost or at fair value through other comprehensive income. After initial recognition, the financial asset is measured at fair value and gains or losses from fair value adjustments are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Equity instruments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Investments in equity instruments do not meet the above criteria and accordingly are measured at fair value through profit or loss. Dividends from investments in equity instruments are recognized in profit or loss when the right to receive the dividends is established.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div/&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Impairment of financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group evaluates at the end of each reporting period the loss allowance for financial debt instruments measured at amortized cost. The Group has short-term financial assets, principally trade receivables, in respect of which the Group applies a simplified approach and measures the loss allowance in an amount equal to the lifetime expected credit losses. The impairment loss, if any, is recognized in profit or loss with a corresponding allowance that is offset from the carrying amount of the assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognition of financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A financial asset is derecognized only when:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The contractual rights to the cash flows from the financial asset has expired; or&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has transferred substantially all the risks and rewards deriving from the contractual rights to receive cash flows from the financial asset or has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset; or&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has retained its contractual rights to receive cash flows from the financial asset but has assumed a contractual obligation to pay the cash flows in full without material delay to a third party.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial liabilities measured at amortized cost:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial liabilities measured at fair value through profit or loss:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;At initial recognition, the Group measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs incurred at initial recognition are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;After initial recognition, changes in fair value are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div/&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognition of financial liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A financial liability is derecognized only when it is extinguished, that is when the obligation specified in the contract is discharged or cancelled or expires. A financial liability is extinguished when the debtor discharges the liability by paying in cash, other financial assets, goods or services; or is legally released from the liability.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issue of a unit of securities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The issue of a unit of securities involves the allocation of the proceeds received (before issue expenses) to the securities issued in the unit based on the following order: financial derivatives and other financial instruments measured at fair value in each period. Then fair value is determined for financial liabilities that are measured at amortized cost. The proceeds allocated to equity instruments are determined to be the residual amount. Issue costs are allocated to each component pro rata to the amounts determined for each component in the unit.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;p.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Employee benefit liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has several employee benefit plans:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.15pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Short-term employee benefits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Short-term employee benefits are benefits that are expected to be settled wholly before twelve months after the end of the annual reporting period in which the employees render the related services. These benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.15pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Post-employment benefits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has defined contribution plans pursuant to section 14 to the Israeli Severance Pay Law under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods. Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense when contributed concurrently with performance of the employee's services.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div/&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group also operates a defined benefit plan in respect of severance pay pursuant to the Israeli Severance Pay Law. According to the Severance Pay Law, employees are entitled to severance pay upon dismissal or retirement. The liability for termination of employment is measured using the projected unit credit method. The actuarial assumptions include expected salary increases and rates of employee turnover based on the estimated timing of payment. The amounts are presented based on discounted expected future cash flows using a discount rate determined by reference to market yields at the reporting date on high quality corporate bonds that are linked to the Consumer Price Index with a term that is consistent with the estimated term of the severance pay obligation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In respect of its severance pay obligation to certain of its employees, the Group makes current deposits in pension funds and insurance companies (the "plan assets"). Plan assets comprise assets held by a long-term employee benefit fund or qualifying insurance policies. Plan assets are not available to the Group&#x2019;s own creditors and cannot be returned directly to the Group.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The liability for employee benefits shown in the statement of financial position reflects the present value of the defined benefit obligation less the fair value of the plan assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Remeasurements of the net liability are recognized in other comprehensive income in the period in which they occur.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;q.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share-based payment transactions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group's employees and service providers are entitled to remuneration in the form of equity-settled share-based payments.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Equity-settled transactions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The cost of equity-settled transactions with employees is measured at the fair value of the equity instruments granted at grant date. The fair value is determined using an acceptable option pricing model.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As for other service providers, the cost of the transactions is measured at the fair value of the goods or services received as consideration for equity instruments granted.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The cost of equity-settled transactions is recognized in profit or loss together with a corresponding increase in equity during the period which the performance and/or service conditions are to be satisfied ending on the date on which the relevant employees become entitled to the award (the "vesting period"). The cumulative expense recognized for equity-settled transactions at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group's best estimate of the number of equity instruments that will ultimately vest.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;r.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Provisions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A provision in accordance with IAS 37 is recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. When the Group expects part or all of the expense to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense is recognized in the statement of profit or loss net of any reimbursement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;s.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Taxes on income:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current or deferred taxes are recognized in profit or loss, except to the extent that they relate to items which are recognized in other comprehensive income or equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current taxes:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The current tax liability is measured using the tax rates and tax laws that have been enacted or substantively enacted by the reporting date as well as adjustments required in connection with the tax liability in respect of previous years.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes are computed in respect of temporary differences between the carrying amounts in the financial statements and the amounts attributed for tax purposes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes are measured at the tax rate that is expected to apply when the asset is realized, or the liability is settled, based on tax laws that have been enacted or substantively enacted by the reporting date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred tax assets are reviewed at each reporting date and reduced to the extent that it is not probable that they will be utilized. Deductible carryforward losses and temporary differences for which deferred tax assets had not been recognized are reviewed at each reporting date and a respective deferred tax asset is recognized to the extent that their utilization is probable.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes are offset if there is a legally enforceable right to offset a current tax asset against a current tax liability and the deferred taxes relate to the same taxpayer and the same taxation authority.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;t.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Earnings per share:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Earnings per share are calculated by dividing the net income attributable to equity holders of the Group by the weighted number of Common Shares outstanding during the period.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Potential Common Shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share from continuing operations. Potential Common Shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share. The Company's share of earnings of investees is included based on its share of earnings per share of the investees multiplied by the number of shares held by the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;u.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Intangible assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Expenditures relating to internally generated intangible assets, excluding capitalized development costs, are recognized in profit or loss when incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company acquired brand with indefinite life. The Company believes that it will use the asset perpetually, with no intention of discontinuing the brand in the future. Intangible assets with indefinite useful lives are not systematically amortized and are tested for impairment annually or whenever there is an indication that the intangible asset may be impaired. The useful life of these assets is reviewed annually to determine whether their indefinite life assessment continues to be supportable. If the events and circumstances do not continue to support the assessment, the change in the useful life assessment from indefinite to finite is accounted for prospectively as a change in accounting estimate and on that date the asset is tested for impairment. Commencing from that date, the asset is amortized systematically over its useful life.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Intangible assets with a finite useful life are amortized over their useful life and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for an intangible asset are reviewed at least at each year end.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization is calculated on a straight-line basis over the useful life of the assets as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                      &lt;div style="margin-left:90pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cultivations and processing license&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6-19&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationships&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5-19&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Brand&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9 - indefinite&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other intangibles&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3-9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;

                  &lt;/div&gt;

                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;v.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Government grants:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A government grant is recorded as a reduction of expenses or the cost of a related asset when there is reasonable assurance that the entity will comply with the relevant conditions and the grant will be received. When a government grant is for the purchase of an asset, the cost of the asset is reduced by the value of the grant on acquisition if all conditions for the grant are met and it is reasonably certain to be received, resulting in a reduction of depreciation expense over the useful life of the asset in the statement of profit and loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                        &lt;div&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;w.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Treasury shares:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                          &lt;div style="margin-left:85.05pt;text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="margin-left:85.05pt;text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Company shares held by the Company and/or subsidiaries are recognized at cost of purchase and presented as a deduction from equity. Any gain or loss arising from a purchase, sale, issue or cancellation of treasury shares is recognized directly in equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;

                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;x.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Operating segments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                          &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker ("CODM"), who is responsible for allocating resources and assessing performance of the operating segments. The Company's Chief Executive Officer is the CODM. The Company has determined that it operates in three operating segments (see Note 23).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <imc:DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329175807659">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Basis of presentation:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB").&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Group's financial statements have been prepared on a cost basis, except for:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Financial instruments which are presented at fair value through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Biological assets which are presented at fair value less cost to sell up to the point of harvest.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Group has elected to present the profit or loss items using the function of expense method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </imc:DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory>
    <imc:DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329175822403">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Consolidated financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The consolidated financial statements comprise the financial statements of companies that are controlled by the Company (subsidiaries). Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Potential voting rights are considered when assessing whether an entity has control. The consolidation of the financial statements commences on the date on which control is obtained and ends when such control ceases.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2021, and 2020, major subsidiaries over which the Company has control, directly or indirectly, include&lt;span style="font-weight:bold"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;

                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="margin-left:90pt"&gt;
                          &lt;table border="0" cellpadding="1" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left"&gt;

                              &lt;tr&gt;
                                &lt;td rowspan="2" style="width:67.71%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="3" style="width:32.29%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Percentage ownership&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:14.18%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C. Holdings Ltd (&#x201d;IMC&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Focus Medical Herbs Ltd. ("Focus") *)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C Farms Israel Ltd. ("IMC Farms")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C Ventures Ltd. ("IMC Ventures")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C - International Medical Cannabis Portugal Unipessoal Lda&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Adjupharm GmbH (&#x201c;Adjupharm&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90.02%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92.5%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;R.A. Yarok Pharm Ltd. (&#x201c;Pharm Yarok&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Rosen High Way Ltd. (&#x201c;Rosen High Way&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;High Way Shinua Ltd. (&#x201c;HW Shinua&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revoly Trading and Marketing Ltd. (&#x201c;Vironna&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Oranim Plus Pharm LTD.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51.3%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Oranim Pharm&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Corp. (&#x201c;Trichome&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Cannabis GP Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Cannabis Manager Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Asset Funding Corp.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome JWC Acquisition Corp. (&#x201c;TJAC&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Retail Corp.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;MYM Nutraceuticals Inc. (&#x201c;MYM&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;SublimeCulture Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;CannaCanada Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;MYM International Brands Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Highland Grow Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-width:2px;border-style:solid;border-color:rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;*) See also Note 1b(1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;

                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The financial statements of the Company and of the subsidiaries are prepared as of the same dates and periods. The consolidated financial statements are prepared using uniform accounting policies by all companies in the Group. Significant intragroup balances and transactions and gains or losses resulting from intragroup transactions are eliminated in full in the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-controlling interests in subsidiaries represent the equity in subsidiaries not attributable, directly or indirectly, to a parent. Non-controlling interests are presented in equity separately from the equity attributable to the equity holders of the Company. Profit or loss and components of other comprehensive income are attributed to the Company and to non-controlling interests. Losses are attributed to non-controlling interests even if they result in a negative balance of non-controlling interests in the consolidated statement of financial position.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The disposal of a subsidiary that does not result in a loss of control is recognized as a change in equity. Upon the disposal of a subsidiary resulting in loss of control, the Company:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognizes the subsidiary's assets (including goodwill) and liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognizes the carrying amount of non-controlling interests.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognizes the adjustments arising from translating financial statements carried to equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Recognizes the fair value of the consideration received.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Recognizes the fair value of any remaining investment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Reclassifies the components previously recognized in other comprehensive income (loss) on the same basis as would be required if the subsidiary had directly disposed of the related assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Recognizes any resulting difference (surplus or deficit) as gain or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                </imc:DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329175848956">
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="margin-left:90pt"&gt;
                          &lt;table border="0" cellpadding="1" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left"&gt;

                              &lt;tr&gt;
                                &lt;td rowspan="2" style="width:67.71%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="3" style="width:32.29%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Percentage ownership&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:14.18%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C. Holdings Ltd (&#x201d;IMC&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:justify;text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Focus Medical Herbs Ltd. ("Focus") *)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C Farms Israel Ltd. ("IMC Farms")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C Ventures Ltd. ("IMC Ventures")&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;I.M.C - International Medical Cannabis Portugal Unipessoal Lda&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Adjupharm GmbH (&#x201c;Adjupharm&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90.02%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);text-align:center"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92.5%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;R.A. Yarok Pharm Ltd. (&#x201c;Pharm Yarok&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Rosen High Way Ltd. (&#x201c;Rosen High Way&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;High Way Shinua Ltd. (&#x201c;HW Shinua&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revoly Trading and Marketing Ltd. (&#x201c;Vironna&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Oranim Plus Pharm LTD.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51.3%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Oranim Pharm&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;51%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Corp. (&#x201c;Trichome&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Cannabis GP Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Financial Cannabis Manager Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Asset Funding Corp.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome JWC Acquisition Corp. (&#x201c;TJAC&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trichome Retail Corp.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;MYM Nutraceuticals Inc. (&#x201c;MYM&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;SublimeCulture Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;CannaCanada Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;MYM International Brands Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:67.71%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Highland Grow Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:14.18%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:5.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:3.09%;vertical-align:bottom;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:15.01%;vertical-align:bottom;border-width:2px;border-style:solid;border-color:rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;text-indent:15.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;*) See also Note 1b(1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    </ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember"
      decimals="2"
      id="Fxbrl_20210428001615262"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember"
      decimals="2"
      id="Fxbrl_20210428001631987"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="2"
      id="Fxbrl_20210428001641289"
      unitRef="Percentage">0.74</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="2"
      id="Fxbrl_20210428001652437"
      unitRef="Percentage">0.74</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCFarmsIsraelLtdPointMember"
      decimals="2"
      id="Fxbrl_20210428001659914"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCFarmsIsraelLtdPointMember"
      decimals="2"
      id="Fxbrl_20210428001713337"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCVenturesLtdPointMember"
      decimals="2"
      id="Fxbrl_20210428001722758"
      unitRef="Percentage">0.75</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCVenturesLtdPointMember"
      decimals="2"
      id="Fxbrl_20210428001736856"
      unitRef="Percentage">0.75</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember"
      decimals="2"
      id="Fxbrl_20210428001743430"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember"
      decimals="2"
      id="Fxbrl_20210428001754308"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember"
      decimals="4"
      id="Fxbrl_20210428001801659"
      unitRef="Percentage">0.9002</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200101to20201231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember"
      decimals="3"
      id="Fxbrl_20210428001814769"
      unitRef="Percentage">0.925</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRayarokPharmLtdMember"
      decimals="2"
      id="Fxbrl_20220305032351336"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRosenHighWayLtdMember"
      decimals="2"
      id="Fxbrl_20220305032435671"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcHighWayShinuaLtdMember"
      decimals="2"
      id="Fxbrl_20220305032441119"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcRevolyTradingAndMarketingLtdMember"
      decimals="2"
      id="Fxbrl_20220305032443758"
      unitRef="Percentage">0.51</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcOranimPlusPharmLtdMember"
      decimals="3"
      id="Fxbrl_20220305032446574"
      unitRef="Percentage">0.513</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcOranimPharmMember"
      decimals="2"
      id="Fxbrl_20220329174636210"
      unitRef="Percentage">0.51</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCorpMember"
      decimals="2"
      id="Fxbrl_20220305032451591"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCannabisGpIncMember"
      decimals="2"
      id="Fxbrl_20220305032454600"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCannabisManagerIncMember"
      decimals="2"
      id="Fxbrl_20220305032457516"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeAssetFundingCorpMember"
      decimals="2"
      id="Fxbrl_20220305032500270"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeJwcAcquisitionCorpMember"
      decimals="2"
      id="Fxbrl_20220305032503012"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeRetailCorpMember"
      decimals="2"
      id="Fxbrl_20220305032505302"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcMymNutraceuticalsIncMember"
      decimals="2"
      id="Fxbrl_20220305032509141"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcSublimecultureIncMember"
      decimals="2"
      id="Fxbrl_20220305032511796"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcCannacanadaIncMember"
      decimals="2"
      id="Fxbrl_20220305032514444"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcMymInternationalBrandsIncMember"
      decimals="2"
      id="Fxbrl_20220305032516853"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcHighlandGrowIncMember"
      decimals="2"
      id="Fxbrl_20220305032520965"
      unitRef="Percentage">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329175911648">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Business combinations and goodwill:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Business combinations are accounted for by applying the acquisition method. The cost of the acquisition is measured at the fair value of the consideration transferred on the acquisition date with the addition of non-controlling interests in the acquiree. In each business combination, the Company chooses whether to measure the non-controlling interests in the acquiree based on their fair value on the acquisition date or at their proportionate share in the fair value of the acquiree's net identifiable assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Direct acquisition costs are carried to the statement of profit or loss as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In a business combination achieved in stages, equity interests in the acquiree that had been held by the acquirer prior to obtaining control are measured at the acquisition date fair value while recognizing a gain or loss resulting from the revaluation of the prior investment on the date of achieving control.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Contingent consideration is recognized at fair value on the acquisition date and classified as a financial asset or liability in accordance with IFRS 9. Subsequent changes in the fair value of the contingent consideration are recognized in profit or loss. If the contingent consideration is classified as an equity instrument, it is measured at fair value on the acquisition date without subsequent remeasurement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Goodwill is initially measured at cost which represents the excess of the acquisition consideration and the amount of non-controlling interests over the net identifiable assets acquired and liabilities assumed. If the resulting amount is negative, the acquirer recognizes the resulting gain on the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329175927408">
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Functional currency, presentation currency and foreign currency:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.15pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Functional currency and presentation currency:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The functional currency of the Company is the Canadian dollar ("CAD"). The Group determines the functional currency of each Group entity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Assets, including fair value adjustments upon acquisition, and liabilities of an investee which is a foreign operation, and of each Group entity for which the functional currency is not the presentation currency are translated at the closing rate at each reporting date. Profit or loss items are translated at average exchange rates for all periods presented. The resulting translation differences are recognized in other comprehensive income (loss).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Upon the full or partial disposal of a foreign operation resulting in loss of control in the foreign operation, the cumulative gain (loss) from the foreign operation which had been recognized in other comprehensive income is transferred to profit or loss. Upon the partial disposal of a foreign operation which results in the retention of control in the subsidiary, the relative portion of the amount recognized in other comprehensive income is reattributed to non-controlling interests.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.15pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Transactions, assets and liabilities in foreign currency:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Transactions denominated in foreign currency are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at each reporting date into the functional currency at the exchange rate at that date. Exchange rate differences, other than those capitalized to qualifying assets or accounted for as hedging transactions in equity, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-monetary assets and liabilities denominated in foreign currency and measured at cost are translated at the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currency and measured at fair value are translated into the functional currency using the exchange rate prevailing at the date when the fair value was determined.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                  </ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329175940657">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash equivalents:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash equivalents are considered as highly liquid investments, including unrestricted short-term bank deposits with an original maturity of three months or less from the date of investment or with a maturity of more than three months, but which are redeemable on demand without penalty and which form part of the Group's cash management.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <imc:DescriptionOfAccountingPolicyForShortTermDepositsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329175952040">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Short-term deposits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Short-term bank deposits are deposits with an original maturity of more than three months from the date of investment and which do not meet the definition of cash equivalents. The deposits are presented according to their terms of deposit.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </imc:DescriptionOfAccountingPolicyForShortTermDepositsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180045498">
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value measurement:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value measurement is based on the assumption that the transaction will take place in the asset's or the liability's principal market, or in the absence of a principal market, in the most advantageous market.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div/&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;All assets and liabilities measured at fair value or for which fair value is disclosed are categorized into levels within the fair value hierarchy based on the lowest level input that is significant to the entire fair value measurement:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="margin-left:95pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;float:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Level 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;inputs other than quoted prices included within Level 1 that are observable directly or indirectly.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:14.29%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Level 3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.58%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:82.14%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180104000">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Biological assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group&#x2019;s biological assets consist of cannabis plants.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group capitalizes the direct and indirect costs incurred related to the biological transformation of the biological assets between the point of initial recognition and the point of harvest. The direct and indirect costs of biological assets are determined using an approach similar to the capitalization criteria outlined in IAS 2, Inventories. These costs include the direct cost of planting and growing materials as well as other indirect costs such as utilities and supplies used in the cultivation process.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Indirect labor for individuals involved in the cultivation and quality control process is also included, as well as depreciation on growing equipment and overhead costs such as rent to the extent it is associated with the growing space. All direct and indirect costs of biological assets are capitalized as they are incurred, and they are all subsequently recorded within the line item cost of revenues on the Group&#x2019;s statements of profit or loss and other comprehensive income in the period that the related product is sold.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group then measures the biological assets at fair value less cost to sell up to the point of harvest, which becomes the basis for the cost of inventories after harvest. The fair value is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price per gram and also for any additional costs to be incurred (e.g., post-harvest costs). The net unrealized gains or losses arising from changes in fair value less cost to sell during the period are included in the gross profit for the related period and are recorded in a separate line on the face of the Group&#x2019;s statements of profit or loss and other comprehensive income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Determination of the fair values of the biological assets requires the Group to make assumptions about how market participants assign fair values to these assets. These assumptions primarily relate to the level of effort required to bring the cannabis up to the point of harvest, costs to convert the harvested cannabis to finished goods, sales price, risk of loss, expected future yields from the cannabis plants and estimating values during the growth cycle.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group accretes fair value on a straight-line basis according to stage of growth (e.g., a cannabis plant that is 50% through its growing cycle would be ascribed approximately 50% of its harvest date expected fair value, subject to wastage adjustments).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The fair value of biological assets is categorized within Level 3 of the fair value hierarchy. For the inputs and assumptions used in determining the fair value of biological assets, see Note 8.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group&#x2019;s estimates are, by their nature, subject to change and differences from the anticipated yield will be reflected in the gain or loss on biological assets in future periods.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180123766">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Inventories:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Inventories are measured at the lower of cost and net realizable value. The cost of inventories comprises costs of purchase and costs incurred in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and estimated costs necessary to make the sale. The Group reviews inventory for obsolete, redundant and slow-moving goods and any such inventory are written-down to net realizable value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Inventories of purchased finished goods and packing materials are initially valued at cost and subsequently at the lower of cost and net realizable value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The direct and indirect costs of inventory initially include the fair value of the biological asset at the time of harvest. They also include subsequent costs such as materials, labor and depreciation expense on equipment involved in packaging, labeling and inspection.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;All direct and indirect costs related to inventory are capitalized as they are incurred, and they are subsequently recorded within cost of revenues on the Group&#x2019;s statements of profit or loss and other comprehensive income at the time cannabis is sold, except for realized fair value amounts included in inventory sold which are recorded as a separate line item on the face of the statements of profit or loss and other comprehensive income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has otherwise been damaged.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180143529">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;j.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Property, plant and equipment:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Property, plant and equipment are measured at cost, including directly attributable costs, less accumulated depreciation, accumulated impairment losses and excluding day-to-day servicing expenses. Cost includes spare parts and auxiliary equipment that are used in connection with plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is depreciated separately using the component method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation of property, plant and equipment is dependent upon estimates of useful lives and residual values which are determined through the exercise of judgement and calculated on a straight-line basis over the useful lives of the assets at annual rates as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;

                        &lt;div style="margin-left:90pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Mainly %&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Greenhouse production equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7 - 33&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Greenhouse structure&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Computer, software and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20 - 50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;

                    &lt;/div&gt;
                    &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Leasehold improvements are depreciated on a straight-line basis over the shorter of the lease term and the useful life of the improvement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The useful life, depreciation method and residual value of an asset are reviewed at least each year-end and any changes are accounted for prospectively as a change in accounting estimate. Depreciation of an asset ceases at the earlier of the date that the asset is classified as held for sale and the date that the asset is derecognized.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <imc:DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180155278">
                        &lt;div style="margin-left:90pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Mainly %&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Greenhouse production equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7 - 33&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Greenhouse structure&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Computer, software and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;20 - 50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:49.99%;vertical-align:top"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="width:4.17%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:20.83%;vertical-align:top"&gt;
                                  &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;See below&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                      </imc:DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="2"
      id="Fxbrl_20210428114838689"
      unitRef="Percentage">0.03</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"
      decimals="2"
      id="Fxbrl_20210428114857761"
      unitRef="Percentage">0.03</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220329173228210"
      unitRef="Percentage">0.07</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20210428115020727"
      unitRef="Percentage">0.33</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"
      decimals="2"
      id="Fxbrl_20210428115024767"
      unitRef="Percentage">0.20</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="3"
      id="Fxbrl_20210428115125656"
      unitRef="Percentage">0.125</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"
      decimals="3"
      id="Fxbrl_20210428115209711"
      unitRef="Percentage">0.125</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220305025214234"
      unitRef="Percentage">0.15</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220305025221411"
      unitRef="Percentage">0.33</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"
      decimals="2"
      id="Fxbrl_20210428115232296"
      unitRef="Percentage">0.33</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20210428115240783"
      unitRef="Percentage">0.20</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20210428115300225"
      unitRef="Percentage">0.50</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember_ifrsfullRangeAxis_ifrsfullWeightedAverageMember"
      decimals="2"
      id="Fxbrl_20210428115304297"
      unitRef="Percentage">0.33</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180214735">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;k.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Impairment of non-financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group evaluates the need to record an impairment of non-financial assets whenever events or changes in circumstances indicate that the carrying amount is not recoverable. If the carrying amount of non-financial assets exceeds their recoverable amount, the assets are reduced to their recoverable amount. The recoverable amount is the higher of fair value less costs of sale and value in use. In measuring value in use, the expected future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the asset. The recoverable amount of an asset that does not generate independent cash flows is determined for the cash-generating unit to which the asset belongs. Impairment losses are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;An impairment loss of an asset, other than goodwill, is reversed only if there have been changes in the estimates used to determine the asset's recoverable amount since the last impairment loss was recognized. Reversal of an impairment loss, as above, shall not be increased above the lower of the carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized for the asset in prior years and its recoverable amount. The reversal of impairment loss of an asset presented at cost is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following criteria are applied in assessing impairment of these specific assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Goodwill in respect of subsidiaries:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company reviews goodwill for impairment once a year, on December 31, or more frequently if events or changes in circumstances indicate that there is an impairment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit (or group of cash-generating units) to which the goodwill has been allocated. The Company identified the operations and Israel, Canada and Europe as three separate cash-generating units.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;An impairment loss is recognized if the recoverable amount of the cash-generating unit (or group of cash-generating units) to which goodwill has been allocated is less than the carrying amount of the cash-generating unit (or group of cash-generating units). Any impairment loss is allocated first to goodwill. Impairment losses recognized for goodwill cannot be reversed in subsequent periods. During the year ended December 31, 2021, the Company recorded goodwill impairment in the amount of $275 with respect to the cash generating unit in Germany.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory>
    <ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329175750854"
      unitRef="CAD">275000</ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180239966">
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;l.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue recognition:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue from contracts with customers is recognized when the control over the goods or services is transferred to the customer. The transaction price is the amount of the consideration that is expected to be received based on the contract terms, excluding amounts collected on behalf of third parties (such as taxes).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In determining the amount of revenue from contracts with customers, the Group evaluates whether it is a principal or an agent in the arrangement. The Group is a principal when the Group controls the promised goods or services before transferring&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;them to the customer. In these circumstances, the Group recognizes revenue for the gross amount of the consideration. When the Group is an agent, it recognizes revenue for the net amount of the consideration, after deducting the amount due to the principal.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue from the sale of goods:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue from the sale of cannabis products is generally recognized at a point in time when control over the goods have been transferred to the customer. Payment is typically due prior to or upon delivery and revenue is recognized upon the satisfaction of the performance obligation. The Group satisfies its performance obligation and transfers control upon delivery and acceptance by the customer.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Variable consideration:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group determines the transaction price separately for each contract with a customer. When exercising this judgment, the Group evaluates the effect of each variable amount in the contract, taking into consideration discounts, penalties, variations, claims, and non-cash consideration. In determining the effect of the variable consideration, the Group normally uses the "most likely amount" method described in the Standard. Pursuant to this method, the amount of the consideration is determined as the single most likely amount in the range of possible consideration amounts in the contract. According to the Standard, variable consideration is included in the transaction price only to the extent that it is highly probable that a significant reversal in the amount of revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Bill-and-hold arrangements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Due to strict regulations of storage and handling large quantities of cannabis products, the Group's customer may request the Group to retain physical possession of a sold product until it is delivered to the customer at a future point in time. Revenue from bill-and-hold sales is recognized before the product is physically delivered to the customer when all of the following criteria are met:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;a) The reason for the bill-and-hold arrangement is substantive (for example, the customer has requested the arrangement);&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;span&gt; &lt;/span&gt;&lt;span&gt;&lt;span&gt;The product is identified separately as belonging to the customer;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;c)&lt;/span&gt;&lt;/span&gt;&lt;span&gt; &lt;/span&gt;&lt;span&gt;&lt;span&gt;The product currently is ready for physical delivery to the customer;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;d)&lt;/span&gt;&lt;/span&gt;&lt;span&gt; &lt;/span&gt;&lt;span&gt;&lt;span&gt;The Group does not have the ability to use the product by selling it or delivering it to another customer.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  </ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180258174">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;m.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Leases:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group accounts for a contract as a lease when the contract terms convey the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For leases in which the Group is the lessee, the Group recognizes on the commencement date of the lease a right-of-use asset and a lease liability, excluding leases whose term is up to 12 months and leases for which the underlying asset is of low value. For these excluded leases, the Group has elected to recognize the lease payments as an expense in profit or loss on a straight-line basis over the lease term. In measuring the lease liability, the Group has elected to apply the practical expedient in the Standard and does not separate the lease components from the non-lease components (such as management and maintenance services, etc.) included in a single contract.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On the commencement date, the lease liability includes all unpaid lease payments discounted at the interest rate implicit in the lease, if that rate can be readily determined, or otherwise using the Group's incremental borrowing rate. After the commencement date, the Group measures the lease liability using the effective interest rate method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On the commencement date, the right-of-use asset is recognized in an amount equal to the lease liability plus lease payments already made on or before the commencement date and initial direct costs incurred. The right-of-use asset is measured applying the cost model and amortized over the shorter of its useful life and the lease term. The periods of amortization are: Land and buildings &#x2013; 5-12 years; Motor vehicles &#x2013; 3 years.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div/&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Variable lease payments that depend on an index:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On the commencement date, the Group uses the index rate prevailing on the commencement date to calculate the future lease payments.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For leases in which the Group is the lessee, the aggregate changes in future lease payments resulting from a change in the index are discounted (without a change in the discount rate applicable to the lease liability) and recorded as an adjustment of the lease liability and the right-of-use asset, only when there is a change in the cash flows resulting from the change in the index (that is, when the adjustment to the lease payments takes effect).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease extension and termination options:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A non-cancelable lease term includes both the periods covered by an option to extend the lease when it is reasonably certain that the extension option will be exercised and the periods covered by a lease termination option when it is reasonably certain that the termination option will not be exercised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In the event of any change in the expected exercise of the lease extension option or in the expected non-exercise of the lease termination option, the Group remeasures the lease liability based on the revised lease term using a revised discount rate as of the date of the change in expectations. The total change is recognized in the carrying amount of the right-of-use asset until it is reduced to zero, and any further reductions are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      id="Fxbrl_20210428003310749">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      id="Fxbrl_20220329174340454">P12Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfAssetsAxis_ifrsfullRightofuseAssetsMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      id="Fxbrl_20210428003342464">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180321864">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;n.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Research and development expenditures:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Research expenditures are recognized in profit or loss when incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180346271">
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;o.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial instruments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group apply the provisions of IFRS 9, "Financial Instruments".&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial assets are measured upon initial recognition at fair value plus transaction costs that are directly attributable to the acquisition of the financial assets, except for financial assets measured at fair value through profit or loss in respect of which transaction costs are recorded in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group classifies and measures debt instruments in the financial statements based on the following criteria:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group&#x2019;s business model for managing financial assets; and&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The contractual cash flow terms of the financial asset.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Debt instruments are measured at amortized cost when:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group&#x2019;s business model is to hold the financial assets in order to collect their contractual cash flows, and the contractual terms of the financial assets give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. After initial recognition, the instruments in this category are measured according to their terms at amortized cost using the effective interest rate method, less any provision for impairment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Debt instruments are measured at fair value through profit or loss when:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A financial asset which is a debt instrument does not meet the criteria for measurement at amortized cost or at fair value through other comprehensive income. After initial recognition, the financial asset is measured at fair value and gains or losses from fair value adjustments are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Equity instruments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Investments in equity instruments do not meet the above criteria and accordingly are measured at fair value through profit or loss. Dividends from investments in equity instruments are recognized in profit or loss when the right to receive the dividends is established.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div/&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Impairment of financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group evaluates at the end of each reporting period the loss allowance for financial debt instruments measured at amortized cost. The Group has short-term financial assets, principally trade receivables, in respect of which the Group applies a simplified approach and measures the loss allowance in an amount equal to the lifetime expected credit losses. The impairment loss, if any, is recognized in profit or loss with a corresponding allowance that is offset from the carrying amount of the assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognition of financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A financial asset is derecognized only when:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The contractual rights to the cash flows from the financial asset has expired; or&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has transferred substantially all the risks and rewards deriving from the contractual rights to receive cash flows from the financial asset or has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset; or&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:113.4pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has retained its contractual rights to receive cash flows from the financial asset but has assumed a contractual obligation to pay the cash flows in full without material delay to a third party.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial liabilities measured at amortized cost:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, except for financial liabilities at fair value through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Financial liabilities measured at fair value through profit or loss:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;At initial recognition, the Group measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs incurred at initial recognition are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;After initial recognition, changes in fair value are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div/&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25;font-style:italic"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derecognition of financial liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A financial liability is derecognized only when it is extinguished, that is when the obligation specified in the contract is discharged or cancelled or expires. A financial liability is extinguished when the debtor discharges the liability by paying in cash, other financial assets, goods or services; or is legally released from the liability.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issue of a unit of securities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The issue of a unit of securities involves the allocation of the proceeds received (before issue expenses) to the securities issued in the unit based on the following order: financial derivatives and other financial instruments measured at fair value in each period. Then fair value is determined for financial liabilities that are measured at amortized cost. The proceeds allocated to equity instruments are determined to be the residual amount. Issue costs are allocated to each component pro rata to the amounts determined for each component in the unit.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  </ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180423129">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;p.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Employee benefit liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has several employee benefit plans:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.15pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Short-term employee benefits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Short-term employee benefits are benefits that are expected to be settled wholly before twelve months after the end of the annual reporting period in which the employees render the related services. These benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.15pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Post-employment benefits:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has defined contribution plans pursuant to section 14 to the Israeli Severance Pay Law under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods. Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense when contributed concurrently with performance of the employee's services.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div/&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.2pt;line-height:1.25"&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group also operates a defined benefit plan in respect of severance pay pursuant to the Israeli Severance Pay Law. According to the Severance Pay Law, employees are entitled to severance pay upon dismissal or retirement. The liability for termination of employment is measured using the projected unit credit method. The actuarial assumptions include expected salary increases and rates of employee turnover based on the estimated timing of payment. The amounts are presented based on discounted expected future cash flows using a discount rate determined by reference to market yields at the reporting date on high quality corporate bonds that are linked to the Consumer Price Index with a term that is consistent with the estimated term of the severance pay obligation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In respect of its severance pay obligation to certain of its employees, the Group makes current deposits in pension funds and insurance companies (the "plan assets"). Plan assets comprise assets held by a long-term employee benefit fund or qualifying insurance policies. Plan assets are not available to the Group&#x2019;s own creditors and cannot be returned directly to the Group.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The liability for employee benefits shown in the statement of financial position reflects the present value of the defined benefit obligation less the fair value of the plan assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Remeasurements of the net liability are recognized in other comprehensive income in the period in which they occur.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180444112">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;q.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share-based payment transactions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group's employees and service providers are entitled to remuneration in the form of equity-settled share-based payments.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Equity-settled transactions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The cost of equity-settled transactions with employees is measured at the fair value of the equity instruments granted at grant date. The fair value is determined using an acceptable option pricing model.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As for other service providers, the cost of the transactions is measured at the fair value of the goods or services received as consideration for equity instruments granted.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The cost of equity-settled transactions is recognized in profit or loss together with a corresponding increase in equity during the period which the performance and/or service conditions are to be satisfied ending on the date on which the relevant employees become entitled to the award (the "vesting period"). The cumulative expense recognized for equity-settled transactions at the end of each reporting period until the vesting date reflects the extent to which the vesting period has expired and the Group's best estimate of the number of equity instruments that will ultimately vest.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180502044">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;r.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Provisions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A provision in accordance with IAS 37 is recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. When the Group expects part or all of the expense to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense is recognized in the statement of profit or loss net of any reimbursement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180515843">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;s.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Taxes on income:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current or deferred taxes are recognized in profit or loss, except to the extent that they relate to items which are recognized in other comprehensive income or equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Current taxes:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The current tax liability is measured using the tax rates and tax laws that have been enacted or substantively enacted by the reporting date as well as adjustments required in connection with the tax liability in respect of previous years.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes are computed in respect of temporary differences between the carrying amounts in the financial statements and the amounts attributed for tax purposes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes are measured at the tax rate that is expected to apply when the asset is realized, or the liability is settled, based on tax laws that have been enacted or substantively enacted by the reporting date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred tax assets are reviewed at each reporting date and reduced to the extent that it is not probable that they will be utilized. Deductible carryforward losses and temporary differences for which deferred tax assets had not been recognized are reviewed at each reporting date and a respective deferred tax asset is recognized to the extent that their utilization is probable.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Deferred taxes are offset if there is a legally enforceable right to offset a current tax asset against a current tax liability and the deferred taxes relate to the same taxpayer and the same taxation authority.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180531964">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;t.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Earnings per share:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Earnings per share are calculated by dividing the net income attributable to equity holders of the Group by the weighted number of Common Shares outstanding during the period.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Potential Common Shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share from continuing operations. Potential Common Shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share. The Company's share of earnings of investees is included based on its share of earnings per share of the investees multiplied by the number of shares held by the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180552397">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;u.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Intangible assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Expenditures relating to internally generated intangible assets, excluding capitalized development costs, are recognized in profit or loss when incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company acquired brand with indefinite life. The Company believes that it will use the asset perpetually, with no intention of discontinuing the brand in the future. Intangible assets with indefinite useful lives are not systematically amortized and are tested for impairment annually or whenever there is an indication that the intangible asset may be impaired. The useful life of these assets is reviewed annually to determine whether their indefinite life assessment continues to be supportable. If the events and circumstances do not continue to support the assessment, the change in the useful life assessment from indefinite to finite is accounted for prospectively as a change in accounting estimate and on that date the asset is tested for impairment. Commencing from that date, the asset is amortized systematically over its useful life.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Intangible assets with a finite useful life are amortized over their useful life and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for an intangible asset are reviewed at least at each year end.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization is calculated on a straight-line basis over the useful life of the assets as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                      &lt;div style="margin-left:90pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cultivations and processing license&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6-19&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationships&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5-19&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Brand&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9 - indefinite&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other intangibles&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3-9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;

                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <imc:DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180600739">
                      &lt;div style="margin-left:90pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cultivations and processing license&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6-19&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationships&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5-19&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Brand&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;9 - indefinite&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="width:76.8%;vertical-align:top"&gt;
                                &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other intangibles&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td style="width:3.57%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:19.64%;vertical-align:top"&gt;
                                &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3-9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    </imc:DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory>
    <ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20210428001001956"
      unitRef="Percentage">0.06</ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220330223227617"
      unitRef="Percentage">0.19</ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220305030257948"
      unitRef="Percentage">0.05</ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCustomerrelatedIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220305030251804"
      unitRef="Percentage">0.19</ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="2"
      id="Fxbrl_20220305030301699"
      unitRef="Percentage">0.09</ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20210428001115825"
      unitRef="Percentage">0.03</ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20210428001141104"
      unitRef="Percentage">0.09</ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill>
    <imc:DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220331163201761">
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;v.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Government grants:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;A government grant is recorded as a reduction of expenses or the cost of a related asset when there is reasonable assurance that the entity will comply with the relevant conditions and the grant will be received. When a government grant is for the purchase of an asset, the cost of the asset is reduced by the value of the grant on acquisition if all conditions for the grant are met and it is reasonably certain to be received, resulting in a reduction of depreciation expense over the useful life of the asset in the statement of profit and loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </imc:DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220331163659981">
                        &lt;div&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;w.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Treasury shares:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                          &lt;div style="margin-left:85.05pt;text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="margin-left:85.05pt;text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Company shares held by the Company and/or subsidiaries are recognized at cost of purchase and presented as a deduction from equity. Any gain or loss arising from a purchase, sale, issue or cancellation of treasury shares is recognized directly in equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      </ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220331163640497">
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                              &lt;tr&gt;
                                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;x.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Operating segments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                          &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker ("CODM"), who is responsible for allocating resources and assessing performance of the operating segments. The Company's Chief Executive Officer is the CODM. The Company has determined that it operates in three operating segments (see Note 23).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory>
    <imc:DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329181026512">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;NOTE 3:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Judgments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Determining the fair value of share-based payment transactions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The fair value of share-based payment transactions is determined upon initial recognition by an acceptable option pricing model. The inputs to the model include share price, exercise price and assumptions regarding expected volatility, expected life of share option and expected dividend yield.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Discount rate for a lease liability:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;When the Group is unable to readily determine the discount rate implicit in a lease in order to measure the lease liability, the Group uses an incremental borrowing rate. That rate represents the rate of interest that the Group would have to pay to borrow over a similar term and with similar security, the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment. When there are no financing transactions that can serve as a basis, the Group determines the incremental borrowing rate based on its credit risk, the lease term and other economic variables deriving from the lease contract's conditions and restrictions. In certain situations, the Group is assisted by an external valuation expert in determining the incremental borrowing rate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Estimates and assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The key assumptions made in the financial statements concerning uncertainties at the reporting date and the critical estimates computed by the Group that may result in a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Assessment of going concern:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The use of the going concern basis of preparation of the financial statements. At each reporting period, management assesses the basis of preparation of the financial statements. These financial statements have been prepared on a going concern basis in accordance with IFRS. The going concern basis of presentation assumes that the Group will continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In arriving at this determination, the Group has undertaken a thorough review of the Group&#x2019;s cash flow forecast and potential liquidity risks. Cash flow projections have been prepared which show that the Group&#x2019;s operations will be cash generative during the period of at least 12 months from the date of approval of the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Biological assets and inventory:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In calculating the value of the biological assets and inventory, management is required to make several estimates, including estimating the stage of growth of the cannabis up to the point of harvest, harvesting costs, selling costs, average or expected selling prices and list prices, expected yields for the cannabis plants, and oil conversion factors. The valuation of work-in-process and finished goods also requires the estimate of conversion costs incurred, which become part of the carrying amount for the inventory. The Group must also determine if the cost of any inventory exceeds its net realizable value, such as cases where prices have decreased, or inventory has spoiled or has otherwise been damaged. See Note 9 for further information.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Legal claims:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In estimating the likelihood of legal claims filed against the Group entities, the Group management rely on the opinion of its legal counsel. These estimates are based on the legal counsel's best professional judgment, taking into account the stage of proceedings and legal precedents in respect of the different issues. Since the outcome of the claims may be determined in courts, the results could differ from these estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Deferred tax assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Deferred tax assets are recognized for unused carryforward tax losses and deductible temporary differences to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgment is required to determine the amount of deferred tax assets that can be recognized, based upon the timing and level of future taxable profits, its source and the tax planning strategy.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Impairment of goodwill:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Group reviews goodwill for impairment at least once a year. This requires management to make an estimate of the projected future cash flows from the continuing use of the cash-generating unit (or a group of cash-generating units) to which the goodwill is allocated and also to choose a suitable discount rate for those cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Determining the fair value of an unquoted financial assets and liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The fair value of unquoted financial assets in Level 3 of the fair value hierarchy is determined using valuation techniques, generally using future cash flows discounted at current rates applicable for items with similar terms and risk characteristics. Changes in estimated future cash flows and estimated discount rates, after consideration of risks such as liquidity risk, credit risk and volatility, are liable to affect the fair value of these assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </imc:DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329181612814">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;NOTE 4:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-style:italic"&gt;
            &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
            &lt;p style="margin-left:56.7pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;a. Amendment to IAS 1, "Presentation of Financial Statements":&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In January 2020, the IASB issued an amendment to IAS 1, "Presentation of Financial Statements" ("the Amendment") regarding the criteria for determining the classification of liabilities as current or non-current.&lt;/span&gt;&lt;/span&gt;
            &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
          &lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Amendment includes the following clarifications:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;What is meant by a right to defer settlement;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;That a right to defer must exist at the end of the reporting period;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;That classification is unaffected by the likelihood that an entity will exercise its deferral right;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;That only if an embedded derivative in a convertible liability is itself an equity instrument would the terms of a liability not impact its classification.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div/&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Amendment is effective for annual periods beginning on or after January 1, 2023 and must be applied retrospectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Group is evaluating the possible impact of the Amendment on its current loan agreements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;b. Amendments to IFRS 3, "Business Combinations":&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In May 2020, the IASB issued Amendments to IFRS 3 Business Combinations &#x2013; Reference to the Conceptual Framework which are intended to replace a reference to the Framework for the Preparation and Presentation of Financial Statements with a reference to the Conceptual Framework for Financial Reporting, that was issued in March 2018, without significantly changing its requirements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The IASB added an exception to the recognition principle of IFRS 3 to avoid the issue of potential &#x2018;day 2&#x2019; gains or losses arising for liabilities and contingent liabilities that would be within the scope of IAS 37 Provisions, Contingent Liabilities and Contingent Assets or IFRIC 21 Levies, if incurred separately&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;According to the exception, liabilities and contingent liabilities within the scope of IAS 37 or IFRIC 21 will be recognized on the acquisition date according to the criteria in IAS 37 or IFRIC 21 and not according to the Conceptual Framework.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Amendments also clarify that contingent assets do not qualify for recognition at the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Amendments are effective for annual reporting periods beginning on or after January 1, 2022 and apply prospectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;c. Amendment to IAS 8, "Accounting Policies, Changes to Accounting Estimates and Errors":&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In February 2021, the IASB issued an amendment to IAS 8, "Accounting Policies, Changes to Accounting Estimates and Errors" ("the Amendment"), in which it introduces a new definition of "accounting estimates".&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Accounting estimates are defined as "monetary amounts in financial statements that are subject to measurement uncertainty". The Amendment clarifies the distinction between changes in accounting estimates and changes in accounting policies and the correction of errors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Amendment is to be applied prospectively for annual reporting periods beginning on or after January 1, 2023 and is applicable to changes in accounting policies and changes in accounting estimates that occur on or after the start of that period. Early application is permitted.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div/&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Group is evaluating the effects of the Amendment on its financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;d. Amendment to IAS 12, "Income Taxes":&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;In May 2021, the IASB issued an amendment to IAS 12, "Income Taxes" ("IAS 12"), which narrows the scope of the initial recognition exception under IAS 12.15 and IAS 12.24 ("the Amendment").&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;According to the recognition guidelines of deferred tax assets and liabilities, IAS 12 excludes recognition of deferred tax assets and liabilities in respect of certain temporary differences arising from the initial recognition of certain transactions. This exception is referred to as the "initial recognition exception". The Amendment narrows the scope of the initial recognition exception and clarifies that it does not apply to the recognition of deferred tax assets and liabilities arising from transactions that are not a business combination and that give rise to equal taxable and deductible temporary differences, even if they meet the other criteria of the initial recognition exception.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.5pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Amendment applies for annual reporting periods beginning on or after January 1, 2023, with earlier application permitted. In relation to leases and decommissioning obligations, the Amendment is to be applied commencing from the earliest reporting period presented in the financial statements in which the Amendment is initially applied. The cumulative effect of the initial application of the Amendment should be recognized as an adjustment to the opening balance of retained earnings (or another component of equity, as appropriate) at that date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:56.5pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The Group estimates that the initial application of the Amendment is not expected to have a material impact on its financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <ifrs-full:DisclosureOfBusinessCombinationsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329194521699">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="text-align:justify;line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;NOTE 5:-&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;BUSINESS COMBINATIONS&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trichome Financial Corp.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 18, 2021, the Company acquired Trichome Financial Corp. (&#x201c;Trichome&#x201d; or "TFC"), a Canadian adult-use recreational cannabis producer (the "Trichome Transaction").&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Trichome Transaction was completed pursuant to the terms and subject to the conditions of arrangement agreement dated December 30, 2020 (the "Arrangement Agreement"), whereby the Company agreed to acquire all of the issued and outstanding Trichome Shares under a statutory plan of arrangement under the &lt;span style="font-style:italic"&gt;Business Corporations Act &lt;/span&gt;(Ontario) ("OBCA").&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with the terms of the Arrangement Agreement, former holders of Trichome Shares received 0.24525 IMC Common Shares for each Trichome Share previously held (the &#x201c;Exchange Ratio&#x201d;) and former holders of Trichome in-the-money convertible instruments received a net payment of IMC Shares based on the Exchange Ratio (the &#x201c;Consideration&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Upon completion of the Trichome Transaction, the total Consideration paid to former holders of Trichome Shares and in-the-money convertible instruments equaled to the issuance of 10,104,901 Common Shares, valued at approximately $99,028 at the market price per share of $9.8 on the date of the acquisition. The results of operations of Trichome were consolidated in the Company's consolidated financial statements commencing on the date of acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Group recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a valuation study prepared by management with the assistance of an external valuation specialist.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Upon acquisition, other payables of Trichome include approximately $8,131 to settle withholding tax liabilities to Canada Revenue Agency (&#x201c;CRA&#x201d;), with a corresponding indemnification asset comprised of 927,463 IMCC&#x2019;s Common Shares withheld to cover the tax liabilities (the "Purchaser Balance Shares"). In addition, in connection with the Trichome Transaction, certain directors and officers of Trichome and TJAC, one of which is currently serving as chairman of the board of directors of the Company, agreed to indemnify and hold harmless the Company, Trichome, and TJAC against 75% of the withholding tax liabilities to CRA. Each indemnifying director or officer agreed to indemnify for: (a) 75% of such liability that is on account of such director or officer&#x2019;s personal Canadian income tax liability, plus (b) jointly and severally indemnify 75% of any liability for penalties and interest in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a)).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition, subsequent to the reporting period, on January 6, 2022, the Company and certain former Trichome directors, one of which is currently serving as chairman of the Company's board of directors, signed an amendment to the tax indemnification agreement, and agreed to indemnify and hold harmless the Company and pay the Company the following amounts in cash as soon as practicable and in no event no later than February 28, 2022: (a). any portion of remittance to the CRA on account of any non-residence Canadian estimated at approximately $1,886, plus (b) 75% of any liabilities for penalties up to December 31, 2021 and 100% of any penalties from January 1, 2022 onward (estimated at approximately $604), and indemnify 75% of any liabilities for interest through December 31, 2021 and 100% of any interest from January 1, 2022 (estimated at approximately $342), in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a) above), plus (c) To the extent not captured above in sections (a) and (b), 100% of the withholding taxes tax liabilities, &lt;span style="text-decoration:underline"&gt;subtracting&lt;/span&gt; all cash proceeds received by Trichome or IMC from the sale of the Purchaser Balance Shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:justify;margin-left:50.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of the date of the issuance of these consolidated financial statements, the former Trichome director and current chairman of the Company's board of director, transferred the Company cash in the amount of $3,250. Further, on March 30, 2022, the Company and the former Trichome director and current chairman of the Company's board of director, entered into several security agreements under which the former Trichome director and current chairman of the Company's board of director pledged 833,508 Common Shares and 275,125 vested RSU&#x2019;s in favor of the Company to secure the indemnification asset for the remaining tax withholding liability. Such pledge of securities was registered in Ontario and British Columbia.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:49.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 18, 2021, 700,000 options were granted to Trichome&#x2019;s employees under the 2018 Plan (see Note 18).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:50.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition costs of Trichome include the issuance of 50,525 Common Shares, valued at $495 to financial advisors for advisory fees in connection with the Trichome Transactions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:50.85pt;line-height:1.25"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trichome's revenue and net loss included in the Company&#x2019;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $9,223 and $(17,983), respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;div style="margin-left:50.85pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Had the Trichome Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="margin-left:0pt"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="text-align:justify;margin-left:63pt;line-height:1.25"&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma results for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                    &lt;/tr&gt;
                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                    &lt;/tr&gt;
                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                        &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;55,563&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                    &lt;/tr&gt;
                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                    &lt;/tr&gt;
                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                        &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(25,372&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                    &lt;/tr&gt;

                                &lt;/table&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
              &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;p style="margin-left:56.7pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and TFC been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;MYM Nutraceuticals Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 9, 2021, the Company, through its wholly owned subsidiary, Trichome, completed the acquisition of MYM Nutraceuticals (&#x201c;MYM&#x201d;). MYM is a Canadian cultivator, processor, and distributor of premium cannabis via its two wholly owned subsidiaries; SublimeCulture Inc. (&#x201c;Sublime&#x201d;) located near Montreal, Quebec, and Highland Grow Inc. (&#x201c;Highland&#x201d;), located in Antigonish, Nova Scotia. MYM&#x2019;s flagship brand, Highland, is an ultra-premium brand sold in most provinces throughout Canada.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company acquired all the issued and outstanding shares of MYM. The Company acquired MYM's licensed producer subsidiary Highland Grow Inc., pursuant to a plan of arrangement under the Business Corporations Act in British Columbia. Under the terms of the MYM Transaction, the shareholders of MYM received 0.022 Common Shares of IMCC for each common share of MYM. As a result of the MYM transaction, a total of 10,073,437 Common Shares were issued to the MYM former shareholders and financial advisors, resulting in former MYM shareholders holding approximately 15% of the total number of issued and outstanding Common Shares immediately after closing. Total consideration of the issued shares, warrants and stock options valued at approximately $62,620.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management with the assistance of an external valuation specialist.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition costs of MYM include the issuance of 49,802 Common Shares, valued at $312 to financial advisors for advisory fees in connection with the MYM Transactions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;MYM's revenue and net profit included in the Company&#x2019;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $11,024 and $130, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group including Trichome and MYM.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Had the MYM Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:0pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="margin-left:0pt"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="margin-left:63pt"&gt;
                              &lt;div&gt;
                                &lt;div&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma results for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;/tr&gt;
                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;/tr&gt;
                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,639&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;/tr&gt;
                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;/tr&gt;
                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(20,132&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                        &lt;/tr&gt;

                                    &lt;/table&gt;
                                  &lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and MYM been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Panaxia's Assets and Operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 30, 2021, the Company acquired all Panaxia's online-related activities and intellectual property. The aggregate purchase price of NIS 18.7 million (approximately $7,000). In order to complete the acquisition, the Company will issue Common Shares in the aggregate amount of NIS 11.1 million (approximately $4,200).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;text-indent:0pt;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During 2021, the Company issued the four installments of the Panaxia Consideration Shares, in the aggregate amount of 934,755, at a various of share price ranging between US$5.01 to US$3.1. The total consideration represents an aggregate amount of US$3,397 thousand (approximately $4,290). The fifth and final installment of Panaxia Consideration Shares will be issued following the Panaxia GDP License Closing.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;div/&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Group recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by an external valuation specialist.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As part of the acquisition, the Company purchased an option to purchase the Panaxia pharmacy, including cannabis-related licenses (see Note 1 (9)). As the exercise price of the option relates only to the medical cannabis inventory at the date of exercise, the Company has allocated $2,837 of the non-cancellable purchase price to effectively reflect the Company&#x2019;s advance payment for the estimated fair value of the licenses and other assets of the Panaxia pharmacy that will be acquired upon exercise of the option.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group and Panaxia's acquired assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Panaxia's results of operation for the acquisition date through December 31, 2021, were immaterial to the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pharm Yarok pharmacy&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 28, 2021, IMC Holdings entered into a definitive agreement to acquire all of the issued and outstanding share of R.A. Yarok Pharm Ltd., Rosen High Way Ltd. and High Way Shinua Ltd. (collectively "Pharm Yarok Group"). The aggregate consideration for the Pharm Yarok Group acquisition was NIS 11,900 thousand (approximately $4,600), of which approximately NIS 3,500 thousand (approximately $1,300) shall be invested by the shareholders of Pharm Yarok Group in the Company at closing in consideration for Common Shares. The closing of the Pharm Yarok Group acquisition is conditional upon receipt of all requisite approvals, including from the MOH&lt;span style="font-weight:bold"&gt;, &lt;/span&gt;which granted its approval subsequent to December 31, 2021, on February 15, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pharm Yarok Group's revenue and net profit included in the Company&#x2019;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $4,897 and $1, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-family:'Times New Roman', Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Had the Pharm Yarok Group Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:0pt;line-height:1.25;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="margin-left:0t"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma results for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58,345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(18,986&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                      &lt;/tr&gt;

                                  &lt;/table&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-family:'Times New Roman', Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Pharm Yarok Group been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vironna pharmacy&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 16, 2021, IMC Holdings has signed a definitive agreement to acquire 51% of the outstanding ordinary shares of Revoly Trading and Marketing Ltd. ("Vironna") for a total consideration of NIS 8,500 thousand (approximately $3,300), of which NIS 5,000 thousand (approximately $1,950) in cash and NIS 3,500 thousand (approximately $1,350) is in common shares of the Company to be issued at closing of Vironna transaction. The closing is conditional upon receipt of all requisite approvals, including from the MOH, which granted its approval subsequent to December 31, 2021, on February 15, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The goodwill arising on acquisition is attributed to the expected benefits from the synergies of the combination of the activities of the Group and the pharmacies. The Group has elected to measure the non-controlling interest in this business combination based on the fair value of the identifiable net assets acquired (excluding goodwill).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Had the Vironna Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:0pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="margin-left:0pt"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma profit or loss for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,816&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(18,180&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                      &lt;/tr&gt;

                                  &lt;/table&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Vironna been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Oranim pharmacy&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 1, 2021, IMC Holdings signed a definitive agreement to acquire 51% of the rights in Oranim Pharm, one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area, by acquiring 51.3% of the outstanding shares of Oranim Plus, which holds 99.5% of the rights in Oranim Pharm (the &#x201c;Oranim Transaction&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Oranim Transaction closed on March 28, 2022, upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS 11,940 (approximately $4,900), consisting of NIS 5,202 (approximately $2,104) paid in cash upon signing, NIS 5,202 (approximately $2,104) which will be paid in cash on the first quarter of 2023 and NIS 1,536 (approximately $630) paid in 251,001 Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#x2019;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The acquisition is accounted for under IFRS 3 as a business combination. Accordingly, the Company recognized the fair value of the assets acquired and liabilities assumed in the business combination based on a preliminary valuation study prepared by management, with the assistance of an external valuation specialist.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Oranim's revenue and net profit included in the Company&#x2019;s consolidated financial statements of profit or loss and other comprehensive income (loss) since date of acquisition through December 31, 2021, were $1,410 and $46, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Had the Oranim Transaction occurred on January 1, 2021, the Company's proforma results for the year ended December 31, 2021, would have been as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:0pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="margin-left:0pt"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma profit or loss for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;67,589&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(17,870&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                      &lt;/tr&gt;

                                  &lt;/table&gt;
                                &lt;/div&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These proforma results are based on estimates and assumptions, which the Company believes are reasonable. They are not necessarily the results that would have been realized had the Company and Oranim been a combined company during the period presented and are not necessarily indicative of the Company's consolidated results of operations in future periods. The proforma results include adjustments related to purchase accounting, primarily amortization of intangible assets, depreciation related to the excess of fair value over cost attributable to purchased property, plant and equipment and elimination of inter-company transactions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the identifiable assets acquired and liabilities assumed on the acquisition date:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;TFC&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;MYM&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vironna&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pharm Yarok&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Oranim&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Panaxia&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;362&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;131&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;57&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;105&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;485&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;3,240&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,548&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;259&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;456&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,329&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Indemnification asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;8,131&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;785&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;63&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,883&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4,180&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;639&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;346&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,043&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;19&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loan receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8,470&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,122&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,837&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;15,193&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;6,105&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;210&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,145&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;389&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;88&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;114&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right of use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;15,037&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;630&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,312&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;319&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6,458&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;17,200&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;2,316&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;974&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;2,991&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;776&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total identifiable assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;61,992&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;32,979&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;3,481&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;3,026&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;7,549&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;3,720&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(15,196&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(4,442&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(854&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,448&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,777&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bank loans&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(915&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(15,037&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(873&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,312&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long term loans&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(1,042&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(4,061&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(532&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(224&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(688&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total identifiable liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(30,233&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(10,291&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1,386&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(2,714&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(3,777&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total identifiable assets, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;31,759&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;22,688&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,095&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;312&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;3,772&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;3,720&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;67,269&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;39,932&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,250&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;4,294&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,907&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;3,240&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Controlling interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1,026&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1,849&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total purchase price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;99,028&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;62,620&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;3,319&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;4,606&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;4,830&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;6,960&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
    <imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree
      contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="INF"
      id="Fxbrl_20220307110902344"
      unitRef="Share">0.24525</imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="INF"
      id="Fxbrl_20220307111239473"
      unitRef="Shares">10104901</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307111656470"
      unitRef="CAD">99028000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="1"
      id="Fxbrl_20220307112139590"
      unitRef="CAD_per_Share">9.8</ifrs-full:WeightedAverageSharePrice2019>
    <imc:AmountOfSettlementOfWithholdingTaxLiabilities
      contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220307113337443"
      unitRef="CAD">8131000</imc:AmountOfSettlementOfWithholdingTaxLiabilities>
    <imc:NumberOfCommonSharesComprisedToCoverTaxLiabilities
      contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="INF"
      id="Fxbrl_20220307113737321"
      unitRef="Share">927463</imc:NumberOfCommonSharesComprisedToCoverTaxLiabilities>
    <imc:PercentageOfWithholdingTaxLiabilities
      contextRef="C_20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="2"
      id="Fxbrl_20220307114138552"
      unitRef="Percentage">0.75</imc:PercentageOfWithholdingTaxLiabilities>
    <imc:PercentageOfIncomeTaxLiabilityOfKeyPersonnel
      contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="2"
      id="Fxbrl_20220307115015063"
      unitRef="Percentage">0.75</imc:PercentageOfIncomeTaxLiabilityOfKeyPersonnel>
    <imc:PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="2"
      id="Fxbrl_20220307115543699"
      unitRef="Percentage">0.75</imc:PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest>
    <ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      id="Fxbrl_20220330191719220">(a). any portion of remittance to the CRA on account of any non-residence Canadian estimated at approximately $1,886, plus (b) 75% of any liabilities for penalties up to December 31, 2021 and 100% of any penalties from January 1, 2022 onward (estimated at approximately $604), and indemnify 75% of any liabilities for interest through December 31, 2021 and 100% of any interest from January 1, 2022 (estimated at approximately $342), in connection with the withholding tax liabilities to CRA (other than penalties and interest included in (a) above), plus (c) To the extent not captured above in sections (a) and (b), 100% of the withholding taxes tax liabilities, subtracting all cash proceeds received by Trichome or IMC from the sale of the Purchaser Balance Shares</ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets>
    <imc:AmountOfSettlementOfWithholdingTaxLiabilities
      contextRef="C_20220228_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330124011350"
      unitRef="CAD">1886000</imc:AmountOfSettlementOfWithholdingTaxLiabilities>
    <imc:PercentageOfWithholdingTaxLiabilities
      contextRef="C_20220228_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="2"
      id="Fxbrl_20220330193642073"
      unitRef="Percentage">0.75</imc:PercentageOfWithholdingTaxLiabilities>
    <imc:ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses
      contextRef="C_20210101to20220106_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220307115900761"
      unitRef="CAD">604000</imc:ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses>
    <imc:ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330124114735"
      unitRef="CAD">342000</imc:ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220101to20220329_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330192028586"
      unitRef="CAD">3250000</imc:CashConsiderationOfBusinessCombination>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20220101to20220329_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20220330192102646"
      unitRef="Shares">833508</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <imc:NumberOfShareOptionsShareVestedRsu
      contextRef="C_20220101to20220329_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20220330192110530"
      unitRef="Share">275125</imc:NumberOfShareOptionsShareVestedRsu>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="INF"
      id="Fxbrl_20220307120624587"
      unitRef="Shares">700000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="INF"
      id="Fxbrl_20220330192011641"
      unitRef="Share">50525</imc:NumberOfCommonSharesIssuedForEachShareOfAcquiree>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330192148479"
      unitRef="CAD">495000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220331214307369"
      unitRef="CAD">9223000</ifrs-full:Revenue>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220331214325044"
      unitRef="CAD">-17983000</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      id="Fxbrl_20220330123723483">
                  &lt;div&gt;
                    &lt;div style="margin-left:0pt"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="text-align:justify;margin-left:63pt;line-height:1.25"&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma results for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                    &lt;/tr&gt;
                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                    &lt;/tr&gt;
                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                        &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;55,563&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                    &lt;/tr&gt;
                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                    &lt;/tr&gt;
                                    &lt;tr&gt;
                                      &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                        &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(25,372&lt;/td&gt;
                                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                    &lt;/tr&gt;

                                &lt;/table&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:RevenueOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190134706"
      unitRef="CAD">55563000</ifrs-full:RevenueOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190144416"
      unitRef="CAD">25372000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="C_20210701to20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="3"
      id="Fxbrl_20220307120720781"
      unitRef="CAD_per_Share">0.022</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="0"
      id="Fxbrl_20220307120937114"
      unitRef="Shares">10073437</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20210709_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="2"
      id="Fxbrl_20220307121350539"
      unitRef="Percentage">0.15</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20210701to20210731_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220329192615920"
      unitRef="CAD">62620000</imc:CashConsiderationOfBusinessCombination>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="0"
      id="Fxbrl_20220307122913529"
      unitRef="Shares">49802</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220307122555337"
      unitRef="CAD">312000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220331215450232"
      unitRef="CAD">11024000</ifrs-full:Revenue>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220331215520463"
      unitRef="CAD">130000</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      id="Fxbrl_20220330123735576">
                  &lt;div&gt;
                    &lt;div style="margin-left:0pt"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;div style="margin-left:63pt"&gt;
                              &lt;div&gt;
                                &lt;div&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma results for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;/tr&gt;
                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;/tr&gt;
                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,639&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;/tr&gt;
                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;/tr&gt;
                                        &lt;tr&gt;
                                          &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(20,132&lt;/td&gt;
                                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;/td&gt;
                                        &lt;/tr&gt;

                                    &lt;/table&gt;
                                  &lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:RevenueOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190211970_xbrl_20220330190134706"
      unitRef="CAD">61639000</ifrs-full:RevenueOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190211971_xbrl_20220330190144416"
      unitRef="CAD">20132000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-5"
      id="Fxbrl_20220307125230132"
      unitRef="NIS">18700000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307125345805"
      unitRef="CAD">7000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-5"
      id="Fxbrl_20220330122217153"
      unitRef="NIS">11100000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210430_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307125608129"
      unitRef="CAD">4200000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="0"
      id="Fxbrl_20220307131926196"
      unitRef="Shares">934755</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220307132023182"
      unitRef="USD_per_Share">5.01</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="1"
      id="Fxbrl_20220330192212149"
      unitRef="USD_per_Share">3.1</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307132039714"
      unitRef="USD">3397000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307132056716"
      unitRef="CAD">4290000</ifrs-full:EquityInterestsOfAcquirer>
    <imc:AmountOfNonCancellablePurchasePrice
      contextRef="C_20210801to20210901_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307132441448"
      unitRef="CAD">2837000</imc:AmountOfNonCancellablePurchasePrice>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307133023192"
      unitRef="NIS">11900000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307133051776"
      unitRef="CAD">4600000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307133203826"
      unitRef="NIS">3500000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210728_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307133222265"
      unitRef="CAD">1300000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220331220521372"
      unitRef="CAD">4897000</ifrs-full:Revenue>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220331220540248"
      unitRef="CAD">1000</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      id="Fxbrl_20220330123743649">
                  &lt;div&gt;
                    &lt;div style="margin-left:0t"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma results for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58,345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(18,986&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                      &lt;/tr&gt;

                                  &lt;/table&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:RevenueOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190224662_xbrl_20220330190134706"
      unitRef="CAD">58345000</ifrs-full:RevenueOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190224663_xbrl_20220330190144416"
      unitRef="CAD">18986000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="2"
      id="Fxbrl_20220307133736844"
      unitRef="Percentage">0.51</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307133928334"
      unitRef="NIS">8500000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307133953098"
      unitRef="CAD">3300000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307134020187"
      unitRef="NIS">5000000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307134036725"
      unitRef="CAD">1950000</ifrs-full:CashTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307134113504"
      unitRef="NIS">3500000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20210816_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220307134154458"
      unitRef="CAD">1350000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      id="Fxbrl_20220330123749662">
                  &lt;div&gt;
                    &lt;div style="margin-left:0pt"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma profit or loss for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,816&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(18,180&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                      &lt;/tr&gt;

                                  &lt;/table&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:RevenueOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190228697_xbrl_20220330190134706"
      unitRef="CAD">56816000</ifrs-full:RevenueOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190228698_xbrl_20220330190144416"
      unitRef="CAD">18180000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="2"
      id="Fxbrl_20220329195853626"
      unitRef="Percentage">0.51</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPlusPharmLtdMember"
      decimals="3"
      id="Fxbrl_20220329200250557"
      unitRef="Percentage">0.513</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <imc:PercentageOfAcquisition
      contextRef="C_20211130to20211201_ifrsfullBusinessCombinationsAxis_imcOranimPlusPharmLtdMember"
      decimals="3"
      id="Fxbrl_20220330194335276"
      unitRef="Percentage">0.995</imc:PercentageOfAcquisition>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="-3"
      id="Fxbrl_20220330194524953"
      unitRef="NIS">11940000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="-3"
      id="Fxbrl_20220330194533750"
      unitRef="CAD">4900000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="-3"
      id="Fxbrl_20220330194704101"
      unitRef="NIS">5202000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="-3"
      id="Fxbrl_20220330194720950"
      unitRef="CAD">2104000</ifrs-full:CashTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="-3"
      id="Fxbrl_20220330194734087"
      unitRef="NIS">5202000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20211201_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="-3"
      id="Fxbrl_20220330194743991"
      unitRef="CAD">2104000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:CashTransferred
      contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330195227206"
      unitRef="NIS">1536000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330195403469"
      unitRef="CAD">630000</ifrs-full:CashTransferred>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20220330_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="0"
      id="Fxbrl_20220330195039123"
      unitRef="Shares">251001</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="-3"
      id="Fxbrl_20220331221005776"
      unitRef="CAD">1410000</ifrs-full:Revenue>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmMember"
      decimals="-3"
      id="Fxbrl_20220331221022416"
      unitRef="CAD">46000</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      id="Fxbrl_20220330123755549">
                  &lt;div&gt;
                    &lt;div style="margin-left:0pt"&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                            &lt;div&gt;
                              &lt;div&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:75%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;padding-bottom:2px;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proforma profit or loss for the year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;67,589&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                      &lt;/tr&gt;
                                      &lt;tr&gt;
                                        &lt;td style="vertical-align:top;width:82%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="text-align:justify;text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(17,870&lt;/td&gt;
                                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                        &lt;/td&gt;
                                      &lt;/tr&gt;

                                  &lt;/table&gt;
                                &lt;/div&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:RevenueOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190234189_xbrl_20220330190134706"
      unitRef="CAD">67589000</ifrs-full:RevenueOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_srtStatementScenarioAxis_srtProFormaMember"
      decimals="-3"
      id="Fxbrl_20220330190234192_xbrl_20220330190144416"
      unitRef="CAD">17870000</ifrs-full:ProfitLossOfAcquiree>
    <imc:DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220330123331378">
                &lt;div&gt;
                  &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="22" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;TFC&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;MYM&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vironna&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pharm Yarok&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Oranim&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Panaxia&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;362&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;131&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;57&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;105&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;485&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;3,240&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,548&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;259&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;456&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,329&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Indemnification asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;8,131&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biological assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;785&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;63&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,883&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4,180&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;639&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;346&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,043&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;19&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loan receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8,470&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,122&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,837&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;15,193&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;6,105&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;210&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,145&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;389&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;88&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;114&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right of use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;15,037&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;630&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,312&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;319&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6,458&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;17,200&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;2,316&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;974&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;2,991&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;776&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total identifiable assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;61,992&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;32,979&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;3,481&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;3,026&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;7,549&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;3,720&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(15,196&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(4,442&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(854&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,448&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,777&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bank loans&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(915&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(15,037&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(873&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,312&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long term loans&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(1,042&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(4,061&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(532&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(224&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(688&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total identifiable liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(30,233&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(10,291&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1,386&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(2,714&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(3,777&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total identifiable assets, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;31,759&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;22,688&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,095&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;312&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;3,772&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;3,720&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;67,269&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;39,932&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,250&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;4,294&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,907&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;3,240&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Controlling interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1,026&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1,849&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:28%;padding-bottom:4px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total purchase price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;99,028&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;62,620&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;3,319&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;4,606&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;4,830&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;6,960&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </imc:DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320385_xbrl_20220307141209947"
      unitRef="CAD">362000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320385_xbrl_20220307141550820"
      unitRef="CAD">131000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320385_xbrl_20220307141553693"
      unitRef="CAD">57000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320385_xbrl_20220307141558414"
      unitRef="CAD">105000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320385_xbrl_20220307141604824"
      unitRef="CAD">485000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320385_xbrl_20220329194053618_xbrl_20220307141604824"
      unitRef="CAD">0</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">3240000</imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">2548000</imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">259000</imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">456000</imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320401_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">1329000</imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320401_xbrl_20220329194053619_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">8131000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">0</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320416_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320416_xbrl_20220329194053622_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <imc:BiologicalAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">785000</imc:BiologicalAssetsRecognisedAsOfAcquisitionDate>
    <imc:BiologicalAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">63000</imc:BiologicalAssetsRecognisedAsOfAcquisitionDate>
    <imc:BiologicalAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</imc:BiologicalAssetsRecognisedAsOfAcquisitionDate>
    <imc:BiologicalAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</imc:BiologicalAssetsRecognisedAsOfAcquisitionDate>
    <imc:BiologicalAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320432_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:BiologicalAssetsRecognisedAsOfAcquisitionDate>
    <imc:BiologicalAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320432_xbrl_20220329194053624_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:BiologicalAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">3883000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">4180000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">639000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">346000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320447_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">1043000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320447_xbrl_20220329194053627_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">19000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <imc:LoanReceivableRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">8470000</imc:LoanReceivableRecognisedAsOfAcquisitionDate>
    <imc:LoanReceivableRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">2122000</imc:LoanReceivableRecognisedAsOfAcquisitionDate>
    <imc:LoanReceivableRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</imc:LoanReceivableRecognisedAsOfAcquisitionDate>
    <imc:LoanReceivableRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</imc:LoanReceivableRecognisedAsOfAcquisitionDate>
    <imc:LoanReceivableRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320464_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:LoanReceivableRecognisedAsOfAcquisitionDate>
    <imc:LoanReceivableRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320464_xbrl_20220329194053630_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:LoanReceivableRecognisedAsOfAcquisitionDate>
    <imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">0</imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate>
    <imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">0</imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate>
    <imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate>
    <imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate>
    <imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320479_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate>
    <imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320479_xbrl_20220329194053633_xbrl_20220329193905714_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">2837000</imc:InvestmentAndFinancialInstrumentsAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">15193000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">6105000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">210000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">1145000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320496_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">389000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320496_xbrl_20220329194053636_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">88000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <imc:DerivativeAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">114000</imc:DerivativeAssetsAsOfAcquisitionDate>
    <imc:DerivativeAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">0</imc:DerivativeAssetsAsOfAcquisitionDate>
    <imc:DerivativeAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</imc:DerivativeAssetsAsOfAcquisitionDate>
    <imc:DerivativeAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</imc:DerivativeAssetsAsOfAcquisitionDate>
    <imc:DerivativeAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320512_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:DerivativeAssetsAsOfAcquisitionDate>
    <imc:DerivativeAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320512_xbrl_20220329194053639_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:DerivativeAssetsAsOfAcquisitionDate>
    <imc:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">15037000</imc:RightOfUseAssetsAsOfAcquisitionDate>
    <imc:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">630000</imc:RightOfUseAssetsAsOfAcquisitionDate>
    <imc:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</imc:RightOfUseAssetsAsOfAcquisitionDate>
    <imc:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</imc:RightOfUseAssetsAsOfAcquisitionDate>
    <imc:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320528_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">1312000</imc:RightOfUseAssetsAsOfAcquisitionDate>
    <imc:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320528_xbrl_20220329194053642_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:RightOfUseAssetsAsOfAcquisitionDate>
    <imc:InvestmentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">319000</imc:InvestmentsAsOfAcquisitionDate>
    <imc:InvestmentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">0</imc:InvestmentsAsOfAcquisitionDate>
    <imc:InvestmentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</imc:InvestmentsAsOfAcquisitionDate>
    <imc:InvestmentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</imc:InvestmentsAsOfAcquisitionDate>
    <imc:InvestmentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320544_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:InvestmentsAsOfAcquisitionDate>
    <imc:InvestmentsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320544_xbrl_20220329194053644_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:InvestmentsAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">6458000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">17200000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">2316000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">974000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320559_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">2991000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320559_xbrl_20220329194053647_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">776000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">61992000</imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">32979000</imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">3481000</imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">3026000</imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320575_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">7549000</imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320575_xbrl_20220329194053651_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">3720000</imc:IdentifiableAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">15196000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">4442000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">854000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">1448000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320595_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">1777000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320595_xbrl_20220329194053654_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">0</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">915000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320616_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320616_xbrl_20220329194053657_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">15037000</imc:LeaseLiabilityAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">873000</imc:LeaseLiabilityAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</imc:LeaseLiabilityAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</imc:LeaseLiabilityAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320634_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">1312000</imc:LeaseLiabilityAsOfAcquisitionDate>
    <imc:LeaseLiabilityAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320634_xbrl_20220329194053660_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:LeaseLiabilityAsOfAcquisitionDate>
    <imc:LongTermBorrowingsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">0</imc:LongTermBorrowingsAsOfAcquisitionDate>
    <imc:LongTermBorrowingsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">0</imc:LongTermBorrowingsAsOfAcquisitionDate>
    <imc:LongTermBorrowingsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">0</imc:LongTermBorrowingsAsOfAcquisitionDate>
    <imc:LongTermBorrowingsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">1042000</imc:LongTermBorrowingsAsOfAcquisitionDate>
    <imc:LongTermBorrowingsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320653_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:LongTermBorrowingsAsOfAcquisitionDate>
    <imc:LongTermBorrowingsAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320653_xbrl_20220329194053663_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:LongTermBorrowingsAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">0</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">4061000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">532000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">224000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320672_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">688000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320672_xbrl_20220329194053667_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">30233000</imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">10291000</imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">1386000</imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">2714000</imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320691_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">3777000</imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate>
    <imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320691_xbrl_20220329194053670_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</imc:IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">31759000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">22688000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">2095000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">312000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320712_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">3772000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320712_xbrl_20220329194053674_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">3720000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">67269000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">39932000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">2250000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">4294000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320730_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">2907000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320730_xbrl_20220329194053678_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">3240000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">0</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
    <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">0</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
    <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">1026000</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
    <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">0</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
    <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320746_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">1849000</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
    <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320746_xbrl_20220329194053681_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">0</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember"
      decimals="-3"
      id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141209947"
      unitRef="CAD">99028000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcMymNutraceuticalsIncMember"
      decimals="-3"
      id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141550820"
      unitRef="CAD">62620000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141553693"
      unitRef="CAD">3319000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141558414"
      unitRef="CAD">4606000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember"
      decimals="-3"
      id="Fxbrl_20220330122320762_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">4830000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20211231_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember"
      decimals="-3"
      id="Fxbrl_20220330122320762_xbrl_20220329194053685_xbrl_20220307143605674_xbrl_20220307143540873_xbrl_20220307143323930_xbrl_20220307143227449_xbrl_20220307143205527_xbrl_20220307143143317_xbrl_20220307143123232_xbrl_20220307143106776_xbrl_20220307143045671_xbrl_20220307143026064_xbrl_20220307143009427_xbrl_20220307142951728_xbrl_20220307142933024_xbrl_20220307142913905_xbrl_20220307142852525_xbrl_20220307142833804_xbrl_20220307142810582_xbrl_20220307142741495_xbrl_20220307141724448_xbrl_20220307141707010_xbrl_20220307141649915_xbrl_20220307141604824"
      unitRef="CAD">6960000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210426191039932">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;NOTE 6:-&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;TRADE RECEIVABLES&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="margin-left:63pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wholesalers and pharmacies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;16,711&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;5,501&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade receivables are non-interest bearing and are generally on terms of 30 to 90 days. As of December 31, 2021 and 2020, there were no material past-due receivables.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Major customers data as a percentage of total revenues:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;

                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Reporting segment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Customer A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;17&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Customer B&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:9%;text-align:center" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;35&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <imc:DisclosureOfTradeReceivablesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210426191155044">
                &lt;div&gt;
                  &lt;div style="margin-left:63pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wholesalers and pharmacies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;16,711&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;5,501&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </imc:DisclosureOfTradeReceivablesExplanatory>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember"
      decimals="-3"
      id="Fxbrl_20210426190339676"
      unitRef="CAD">16711000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember"
      decimals="-3"
      id="Fxbrl_20210426190345555"
      unitRef="CAD">5501000</ifrs-full:CurrentTradeReceivables>
    <imc:TermOfNonInterestBearingTradeReceivables
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210426191849044">30 to 90 days</imc:TermOfNonInterestBearingTradeReceivables>
    <ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220331172019313">
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Reporting segment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Customer A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;
                                  &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;17&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Customer B&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:9%;text-align:center" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;35&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember"
      decimals="2"
      id="Fxbrl_20220331165550704_xbrl_20210426191350509"
      unitRef="Percentage">0.17</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember"
      decimals="2"
      id="Fxbrl_20220331165550704_xbrl_20210426191400900"
      unitRef="Percentage">0</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullMajorCustomersAxis_imcCustomerThreeMember"
      decimals="2"
      id="Fxbrl_20220331165550709_xbrl_20220305042416894_xbrl_20210426191357662"
      unitRef="Percentage">0.08</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullMajorCustomersAxis_imcCustomerThreeMember"
      decimals="2"
      id="Fxbrl_20220331165550709_xbrl_20220305042416894_xbrl_20210426191404650"
      unitRef="Percentage">0.35</ifrs-full:PercentageOfEntitysRevenue>
    <imc:DisclosureOfOtherAccountsReceivablesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210426231213664">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 7:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;OTHER ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:63pt"&gt;

                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,716&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;472&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government authorities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,338&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;75&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related parties (see Note 21)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;11&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;36&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Indemnification assets (see Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other receivables (including related parties - see Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,304&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;14,481&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;689&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;

                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </imc:DisclosureOfOtherAccountsReceivablesExplanatory>
    <imc:DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329180126756">
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,716&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;472&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government authorities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,338&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;75&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related parties (see Note 21)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;11&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;36&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Indemnification assets (see Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other receivables (including related parties - see Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,304&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;14,481&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;689&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  </imc:DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426231559629"
      unitRef="CAD">2716000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426231605028"
      unitRef="CAD">472000</ifrs-full:CurrentPrepaidExpenses>
    <imc:ReceivablesFromGovernmentAuthorities
      contextRef="C_20211231"
      decimals="-3"
      id="F1619459180"
      unitRef="CAD">2338000</imc:ReceivablesFromGovernmentAuthorities>
    <imc:ReceivablesFromGovernmentAuthorities
      contextRef="C_20201231"
      decimals="-3"
      id="F1619459182"
      unitRef="CAD">75000</imc:ReceivablesFromGovernmentAuthorities>
    <ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties
      contextRef="C_20211231"
      decimals="-3"
      id="F1619459184"
      unitRef="CAD">11000</ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties
      contextRef="C_20201231"
      decimals="-3"
      id="F1619459186"
      unitRef="CAD">36000</ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220329180514111_1619459184"
      unitRef="CAD">2112000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220331221427744"
      unitRef="CAD">0</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20211231"
      decimals="-3"
      id="F1619459188"
      unitRef="CAD">7304000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20201231"
      decimals="-3"
      id="F1619459190"
      unitRef="CAD">106000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426231654374"
      unitRef="CAD">14481000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426231703888"
      unitRef="CAD">689000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220305053941977">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;NOTE 8:-&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;BIOLOGICAL ASSETS&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Group&#x2019;s biological assets consist of cannabis plants. The changes in the carrying value of biological assets are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:63pt"&gt;

                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;52&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production costs capitalized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,717&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in fair value less cost to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;11,782&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(14,478&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign exchange translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;5&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;78&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions related to acquisitions of Trichome and MYM&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;848&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production costs capitalized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;10,454&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in fair value less cost to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;7,210&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(16,977&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign exchange translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;74&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,687&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;

              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2021, the weighted average fair value less cost to sell was $2.48 per gram.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of biological assets is categorized within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The inputs and assumptions used in determining the fair value of biological assets include:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Selling price per gram - calculated as the weighted average historical selling price for all strains of cannabis sold by the Group, which is expected to approximate future selling prices.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Post-harvest costs - calculated as the cost per gram of harvested cannabis to complete the sale of cannabis plants post-harvest, consisting of the cost of direct and indirect materials, depreciation and labor as well as labelling and packaging costs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Attrition rate - represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average yield per plant - represents the expected number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Stage of growth - represents the weighted average number of weeks out of the average weeks growing cycle that biological assets have reached as of the measurement date.&lt;span style="font-weight:bold"&gt; &lt;/span&gt;The growing cycle is approximately 12 weeks.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table quantifies each significant unobservable input, and also provides the impact a 10% increase/decrease in each input would have on the fair value of biological assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:63pt"&gt;

                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10% change as at&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average selling price per gram of dried cannabis (in CAD)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3.64&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;6.01&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;296&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;8.86&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average post-harvest costs per gram of dried cannabis (in CAD)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1.16&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;0.83&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;140&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;0.23&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Attrition rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;27&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;5&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;100&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;0.43&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average yield per plant (in grams)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;47&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;54&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;228&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;7.64&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average stage of growth&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;47&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;212&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;7.64&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;

              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These estimates are subject to volatility in market prices and a number of uncontrollable factors, which could significantly affect the fair value of biological assets in future periods.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Group&#x2019;s estimates are, by their nature, subject to change including differences in the anticipated yield. These changes will be reflected in the gain or loss on biological assets in future periods.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory>
    <ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329181608492">
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;52&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production costs capitalized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,717&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in fair value less cost to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;11,782&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(14,478&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign exchange translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;5&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;78&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions related to acquisitions of Trichome and MYM&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;848&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Production costs capitalized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;10,454&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in fair value less cost to sell due to biological transformation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;7,210&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transferred to inventory upon harvest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(16,977&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign exchange translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;74&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:88%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,687&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                </ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory>
    <ifrs-full:BiologicalAssets
      contextRef="C_20191231"
      decimals="-3"
      id="Fxbrl_20210427143031968_02"
      unitRef="CAD">52000</ifrs-full:BiologicalAssets>
    <imc:ProductionCostsCapitalizedBiologicalAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427143031968_22"
      unitRef="CAD">2717000</imc:ProductionCostsCapitalizedBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427143031968_32"
      unitRef="CAD">11782000</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets>
    <ifrs-full:DecreaseDueToHarvestBiologicalAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427143031968_42"
      unitRef="CAD">14478000</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427143031968_52"
      unitRef="CAD">5000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets>
    <ifrs-full:BiologicalAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210427143031968_72"
      unitRef="CAD">78000</ifrs-full:BiologicalAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220305053519199"
      unitRef="CAD">848000</ifrs-full:AcquisitionsThroughBusinessCombinationsBiologicalAssets>
    <imc:ProductionCostsCapitalizedBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427143031968_92"
      unitRef="CAD">10454000</imc:ProductionCostsCapitalizedBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427143031968_102"
      unitRef="CAD">7210000</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets>
    <ifrs-full:DecreaseDueToHarvestBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427143031968_112"
      unitRef="CAD">16977000</ifrs-full:DecreaseDueToHarvestBiologicalAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427143031968_122"
      unitRef="CAD">74000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets>
    <ifrs-full:BiologicalAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210427143031968_142"
      unitRef="CAD">1687000</ifrs-full:BiologicalAssets>
    <imc:WeightedAverageFairValueLessCostToSellOfBiologicalAssets
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20210427144456174"
      unitRef="CAD_per_gram">2.48</imc:WeightedAverageFairValueLessCostToSellOfBiologicalAssets>
    <imc:DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329181632284">
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10% change as at&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average selling price per gram of dried cannabis (in CAD)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3.64&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;6.01&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;296&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;8.86&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average post-harvest costs per gram of dried cannabis (in CAD)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1.16&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;0.83&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;140&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;0.23&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Attrition rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;27&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;5&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;100&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;0.43&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average yield per plant (in grams)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;47&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;54&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;228&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;7.64&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average stage of growth&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;47&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;212&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;7.64&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                </imc:DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory>
    <imc:AverageSellingPricePerGramOfDriedCannabis
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="2"
      id="Fxbrl_20210427143313240_32"
      unitRef="CAD_per_gram">3.64</imc:AverageSellingPricePerGramOfDriedCannabis>
    <imc:AverageSellingPricePerGramOfDriedCannabis
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="2"
      id="Fxbrl_20210427143313240_35"
      unitRef="CAD_per_gram">6.01</imc:AverageSellingPricePerGramOfDriedCannabis>
    <imc:AverageSellingPricePerGramOfDriedCannabis
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="0"
      id="Fxbrl_20210427143313240_38"
      unitRef="CAD_per_gram">296</imc:AverageSellingPricePerGramOfDriedCannabis>
    <imc:AverageSellingPricePerGramOfDriedCannabis
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="2"
      id="Fxbrl_20210427143313240_311"
      unitRef="CAD_per_gram">8.86</imc:AverageSellingPricePerGramOfDriedCannabis>
    <imc:AveragePostHarvestCostsPerGramOfDriedCannabis
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="2"
      id="Fxbrl_20210427143313240_42"
      unitRef="CAD_per_gram">1.16</imc:AveragePostHarvestCostsPerGramOfDriedCannabis>
    <imc:AveragePostHarvestCostsPerGramOfDriedCannabis
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="2"
      id="Fxbrl_20210427143313240_45"
      unitRef="CAD_per_gram">0.83</imc:AveragePostHarvestCostsPerGramOfDriedCannabis>
    <imc:AveragePostHarvestCostsPerGramOfDriedCannabis
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="0"
      id="Fxbrl_20210427143313240_48"
      unitRef="CAD_per_gram">140</imc:AveragePostHarvestCostsPerGramOfDriedCannabis>
    <imc:AveragePostHarvestCostsPerGramOfDriedCannabis
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="2"
      id="Fxbrl_20210427143313240_411"
      unitRef="CAD_per_gram">0.23</imc:AveragePostHarvestCostsPerGramOfDriedCannabis>
    <imc:AttritionRate
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="2"
      id="Fxbrl_20210427143924034"
      unitRef="Percentage">0.27</imc:AttritionRate>
    <imc:AttritionRate
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="2"
      id="Fxbrl_20210427143932866"
      unitRef="Percentage">0.05</imc:AttritionRate>
    <imc:AttritionRate
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="2"
      id="Fxbrl_20210427143313240_58"
      unitRef="Percentage">1</imc:AttritionRate>
    <imc:AttritionRate
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="4"
      id="Fxbrl_20210427143313240_511"
      unitRef="Percentage">0.0043</imc:AttritionRate>
    <imc:AverageYieldPerPlant
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="0"
      id="Fxbrl_20210427143313240_62"
      unitRef="Gram">47</imc:AverageYieldPerPlant>
    <imc:AverageYieldPerPlant
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="0"
      id="Fxbrl_20210427143313240_65"
      unitRef="Gram">54</imc:AverageYieldPerPlant>
    <imc:AverageYieldPerPlant
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="0"
      id="Fxbrl_20210427143313240_68"
      unitRef="Gram">228</imc:AverageYieldPerPlant>
    <imc:AverageYieldPerPlant
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="2"
      id="Fxbrl_20210427143313240_611"
      unitRef="Gram">7.64</imc:AverageYieldPerPlant>
    <imc:AverageStageOfGrowth
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="2"
      id="Fxbrl_20210427144405650"
      unitRef="Percentage">0.47</imc:AverageStageOfGrowth>
    <imc:AverageStageOfGrowth
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember"
      decimals="2"
      id="Fxbrl_20210427144416600"
      unitRef="Percentage">0.04</imc:AverageStageOfGrowth>
    <imc:AverageStageOfGrowth
      contextRef="C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="2"
      id="Fxbrl_20210427143313240_78"
      unitRef="Percentage">2.12</imc:AverageStageOfGrowth>
    <imc:AverageStageOfGrowth
      contextRef="C_20200101to20201231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember_imcUnobservableInputAxis_imcImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember"
      decimals="4"
      id="Fxbrl_20210427143313240_711"
      unitRef="Percentage">0.0764</imc:AverageStageOfGrowth>
    <ifrs-full:DisclosureOfInventoriesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329182238572">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;NOTE 9:-&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;INVENTORIES&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="margin-left:63pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalized costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair valuation adjustment, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Work in progress:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bulk cannabis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;14,113&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;3,336&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;17,449&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other cannabis products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,074&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,074&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished goods:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Packaged dried cannabis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;8,974&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;270&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;9,244&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other cannabis products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;744&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;744&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;880&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;880&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;25,785&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,606&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;29,391&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:63pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalized costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair valuation adjustment, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Work in progress:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bulk cannabis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,130&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;4,728&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;6,858&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished goods:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Packaged dried cannabis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;363&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;603&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;966&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;546&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;546&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,039&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the years ended December 31, 2021 and 2020, inventory expensed to cost of revenue of cannabis products was $43,720 and $17,203, respectively, which included $8,796 and $10,122 of non-cash expense, respectively, related to the changes in fair value of inventory sold.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition, during the years ended December 31, 2021 and 2020, write-downs of inventories recognized in cost of revenue amounted to $nil and $291, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenues in 2021 and 2020, also include production overhead not allocated to costs of inventories produced and recognized as an expense as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </ifrs-full:DisclosureOfInventoriesExplanatory>
    <imc:DisclosureOfDetailedInformationAboutInventoriesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329182411079">
                  &lt;div&gt;
                    &lt;div style="margin-left:63pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalized costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair valuation adjustment, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Work in progress:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bulk cannabis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;14,113&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;3,336&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;17,449&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other cannabis products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,074&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,074&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished goods:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Packaged dried cannabis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;8,974&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;270&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;9,244&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other cannabis products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;744&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;744&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;880&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;880&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;25,785&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,606&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;29,391&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:63pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalized costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair valuation adjustment, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Work in progress:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bulk cannabis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,130&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;4,728&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;6,858&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished goods:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Packaged dried cannabis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;363&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;603&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;966&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;546&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;546&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,039&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </imc:DisclosureOfDetailedInformationAboutInventoriesExplanatory>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_32"
      unitRef="CAD">14113000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_35"
      unitRef="CAD">3336000</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_38"
      unitRef="CAD">17449000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember"
      decimals="-3"
      id="Fxbrl_20220305055723308_xbrl_20210427170247861_32"
      unitRef="CAD">1074000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember"
      decimals="-3"
      id="Fxbrl_20220305055723308_xbrl_20210427170247861_35"
      unitRef="CAD">0</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember"
      decimals="-3"
      id="Fxbrl_20220305055723308_xbrl_20210427170247861_38"
      unitRef="CAD">1074000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_62"
      unitRef="CAD">8974000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_65"
      unitRef="CAD">270000</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_68"
      unitRef="CAD">9244000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember"
      decimals="-3"
      id="Fxbrl_20220305055726052_xbrl_20210427170247861_32"
      unitRef="CAD">744000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember"
      decimals="-3"
      id="Fxbrl_20220305055726052_xbrl_20210427170247861_35"
      unitRef="CAD">0</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisProductsMember"
      decimals="-3"
      id="Fxbrl_20220305055726052_xbrl_20210427170247861_38"
      unitRef="CAD">744000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_72"
      unitRef="CAD">880000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_75"
      unitRef="CAD">0</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20211231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170247861_78"
      unitRef="CAD">880000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210427170247861_92"
      unitRef="CAD">25785000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210427170247861_95"
      unitRef="CAD">3606000</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210427170247861_98"
      unitRef="CAD">29391000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170825076_xbrl_20210427170247861_32"
      unitRef="CAD">2130000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170825076_xbrl_20210427170247861_35"
      unitRef="CAD">4728000</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcWorkInProgressMember_imcTypeOfCannabisAxis_imcBulkCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427170825076_xbrl_20210427170247861_38"
      unitRef="CAD">6858000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427171142473_xbrl_20210427170825076_xbrl_20210427170247861_32"
      unitRef="CAD">363000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427171142473_xbrl_20210427170825076_xbrl_20210427170247861_35"
      unitRef="CAD">603000</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcPackagedDriedCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427171142473_xbrl_20210427170825076_xbrl_20210427170247861_38"
      unitRef="CAD">966000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427171147303_xbrl_20210427170825076_xbrl_20210427170247861_32"
      unitRef="CAD">546000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427171147303_xbrl_20210427170825076_xbrl_20210427170247861_35"
      unitRef="CAD">0</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20201231_imcClassesOfInventoriesAxis_imcFinishedGoodsMember_imcTypeOfCannabisAxis_imcOtherCannabisMember"
      decimals="-3"
      id="Fxbrl_20210427171147303_xbrl_20210427170825076_xbrl_20210427170247861_38"
      unitRef="CAD">546000</ifrs-full:Inventories>
    <imc:CapitalizedCostsOfInventories
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210427170825095_xbrl_20210427170247861_92"
      unitRef="CAD">3039000</imc:CapitalizedCostsOfInventories>
    <ifrs-full:InventoriesAtFairValueLessCostsToSell
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210427170825095_xbrl_20210427170247861_95"
      unitRef="CAD">5331000</ifrs-full:InventoriesAtFairValueLessCostsToSell>
    <ifrs-full:Inventories
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210427170825095_xbrl_20210427170247861_98"
      unitRef="CAD">8370000</ifrs-full:Inventories>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220305060115471"
      unitRef="CAD">43720000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220305060123021"
      unitRef="CAD">17203000</ifrs-full:CostOfMerchandiseSold>
    <imc:NonCashExpenseRelatedToChangesInFairValueOfInventorySold
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220305060132060"
      unitRef="CAD">8796000</imc:NonCashExpenseRelatedToChangesInFairValueOfInventorySold>
    <imc:NonCashExpenseRelatedToChangesInFairValueOfInventorySold
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220305060137861"
      unitRef="CAD">10122000</imc:NonCashExpenseRelatedToChangesInFairValueOfInventorySold>
    <ifrs-full:InventoryWritedown2011
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220305060148238"
      unitRef="CAD">0</ifrs-full:InventoryWritedown2011>
    <ifrs-full:InventoryWritedown2011
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220305060156909"
      unitRef="CAD">291000</ifrs-full:InventoryWritedown2011>
    <imc:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220307122814376">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 10:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:63pt"&gt;

                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings and improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Greenhouse production equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Greenhouse structure&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer, software and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,675&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,534&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;884&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;174&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;19&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4,286&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;705&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,123&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;648&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;95&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;44&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,615&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;97&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;104&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;63&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;10&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;276&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,477&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,761&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,595&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;279&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;65&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;7,177&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,932&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,846&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;508&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;261&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;31&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;4,578&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions related to acquisitions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;18,828&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,584&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;455&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;263&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;23,130&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(81&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;79&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;79&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;44&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;11&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;132&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance December as of 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;23,156&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;8,270&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;2,182&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,039&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;370&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;35,017&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;46&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;534&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;280&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;26&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;894&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;132&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;350&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;147&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;52&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;9&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;690&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;35&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;17&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;3&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;61&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;184&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;919&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;444&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;81&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;17&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,645&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,554&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;993&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;206&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;241&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;27&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,021&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;4&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;40&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;26&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;11&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;2&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;83&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,742&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,952&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;676&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;333&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;46&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;4,749&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;21,414&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;6,318&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,506&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;706&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;324&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;30,268&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,293&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,842&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,151&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;198&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;48&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;5,532&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;

                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </imc:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329184043140">
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings and improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Greenhouse production equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Greenhouse structure&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer, software and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,675&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,534&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;884&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;174&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;19&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4,286&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;705&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,123&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;648&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;95&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;44&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2,615&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;97&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;104&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;63&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;10&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;276&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,477&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,761&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,595&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;279&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;65&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;7,177&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,932&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,846&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;508&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;261&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;31&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;4,578&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions related to acquisitions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;18,828&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,584&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;455&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;263&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;23,130&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(81&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;79&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;79&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;44&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;11&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;132&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance December as of 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;23,156&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;8,270&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;2,182&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,039&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;370&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;35,017&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;46&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;534&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;280&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;26&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;894&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;132&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;350&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;147&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;52&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;9&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;690&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;35&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;17&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;3&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;61&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;184&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;919&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;444&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;81&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;17&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,645&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,554&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;993&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;206&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;241&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;27&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,021&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;4&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;40&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;26&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;11&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;2&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;83&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,742&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,952&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;676&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;333&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;46&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;4,749&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;21,414&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;6,318&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,506&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;706&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;324&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;30,268&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:middle;width:28%;padding-bottom:4px" valign="bottom"&gt;
                              &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,293&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,842&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,151&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;198&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;48&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;5,532&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    </ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113510514_xbrl_20210427131155081_32"
      unitRef="CAD">1675000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113510514_xbrl_20210427131155081_35"
      unitRef="CAD">1534000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113510514_xbrl_20210427131155081_38"
      unitRef="CAD">884000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113510514_xbrl_20210427131155081_311"
      unitRef="CAD">174000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113510514_xbrl_20210427131155081_314"
      unitRef="CAD">19000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307113510514_xbrl_20210427131155081_317"
      unitRef="CAD">4286000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_32"
      unitRef="CAD">705000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_35"
      unitRef="CAD">1123000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_38"
      unitRef="CAD">648000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_311"
      unitRef="CAD">95000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_314"
      unitRef="CAD">44000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307113528872_xbrl_20210427131511257_xbrl_20210427131155081_317"
      unitRef="CAD">2615000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_32"
      unitRef="CAD">97000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_35"
      unitRef="CAD">104000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_38"
      unitRef="CAD">63000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_311"
      unitRef="CAD">10000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_314"
      unitRef="CAD">2000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307113600984_xbrl_20210427131658021_xbrl_20210427131511257_xbrl_20210427131155081_317"
      unitRef="CAD">276000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_32"
      unitRef="CAD">2477000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_35"
      unitRef="CAD">2761000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_38"
      unitRef="CAD">1595000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_311"
      unitRef="CAD">279000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_314"
      unitRef="CAD">65000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307113634554_xbrl_20210427131514920_xbrl_20210427131155081_317"
      unitRef="CAD">7177000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_32"
      unitRef="CAD">1932000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_35"
      unitRef="CAD">1846000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_38"
      unitRef="CAD">508000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_311"
      unitRef="CAD">261000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_314"
      unitRef="CAD">31000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_317"
      unitRef="CAD">4578000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_32"
      unitRef="CAD">18828000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_35"
      unitRef="CAD">3584000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_38"
      unitRef="CAD">0</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_311"
      unitRef="CAD">455000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_314"
      unitRef="CAD">263000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220329185025103_xbrl_20220307113712753_xbrl_20210427131518641_xbrl_20210427131155081_317"
      unitRef="CAD">23130000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_32"
      unitRef="CAD">-81000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_35"
      unitRef="CAD">79000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_38"
      unitRef="CAD">79000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_311"
      unitRef="CAD">44000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_314"
      unitRef="CAD">11000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307113724480_xbrl_20210427131909061_xbrl_20210427131518641_xbrl_20210427131155081_317"
      unitRef="CAD">132000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_32"
      unitRef="CAD">23156000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_35"
      unitRef="CAD">8270000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_38"
      unitRef="CAD">2182000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_311"
      unitRef="CAD">1039000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_314"
      unitRef="CAD">370000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307113742308_xbrl_20210427131522203_xbrl_20210427131155081_317"
      unitRef="CAD">35017000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">-46000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">-534000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">-280000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">-26000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">-8000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307113930228_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">-894000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">132000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">350000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">147000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">52000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">9000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307113942371_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">690000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">6000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">35000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">17000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">3000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307113955043_xbrl_20210427132722866_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">61000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">-184000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">-919000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">-444000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">-81000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">-17000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307114006817_xbrl_20210427132450050_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">-1645000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">1554000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">993000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">206000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">241000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">27000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307114016354_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">3021000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">4000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">40000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">26000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">11000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">2000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307114026387_xbrl_20210427132917234_xbrl_20210427132729402_xbrl_20210427132446443_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">83000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">-1742000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">-1952000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">-676000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">-333000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">-46000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307114036313_xbrl_20210427132453139_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">-4749000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">21414000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">6318000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">1506000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">706000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">324000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220307114045489_xbrl_20210427132253247_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">30268000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_32"
      unitRef="CAD">2293000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseProductionEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_35"
      unitRef="CAD">1842000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_imcGreenhouseStructureMember"
      decimals="-3"
      id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_38"
      unitRef="CAD">1151000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_311"
      unitRef="CAD">198000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_314"
      unitRef="CAD">48000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220307114053913_xbrl_20210427132255709_xbrl_20210427131529546_xbrl_20210427131155081_317"
      unitRef="CAD">5532000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220307140548178">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;NOTE 11:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                      &lt;div&gt;
                        &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cultivations and processing license *)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer relationships&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Brand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;831&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;58&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;63&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;62&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,014&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;93&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;93&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value adjustment derived from purchase price allocation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;110&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;110&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;26&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;32&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,060&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;58&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;63&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;68&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,249&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:middle;width:40%" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial consolidations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8,950&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;10,337&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;11,300&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;128&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;30,715&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(49&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;279&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;236&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;9,961&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;10,674&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;11,363&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;202&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;32,200&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Accumulated amortization and impairment:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;125&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;125&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization recognized in the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;31&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;31&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;156&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;157&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization recognized in the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;618&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;469&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;8&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;63&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,158&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;774&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;469&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;8&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;64&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,315&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:4px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost at December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;9,187&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;10,205&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;11,355&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;138&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;30,885&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost at December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;904&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;58&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;63&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;67&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,092&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*) The licenses consist of GMP and GDP licenses. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;

                    &lt;div/&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;
                          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of goodwill and intangible assets:&lt;/span&gt;&lt;/span&gt;
                        &lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Adjupahrm's&lt;/span&gt; recoverable &lt;span&gt;amounts&lt;/span&gt; of the intangible assets and the goodwill &lt;span&gt;were&lt;/span&gt; determined based on the value in use which is calculated at the expected estimated future cash flows, as determined according to the budget for the next three years and approved by the Company&#x2019;s management. The pre-tax discount rate of the cash flows is 13.06%. The projected cash flows for the period exceeding three years was estimated using a fixed growth rate of 3%, representing the long-term average growth rate as customary in Adjupharm&#x2019;s business.&lt;span&gt; For the year ended December 31, 2021, the Company recorded a goodwill impairment in the amount of $275 with respect to Adjupharm.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Trichome's&lt;/span&gt; recoverable &lt;span&gt;amounts&lt;/span&gt; of the intangible assets and the goodwill &lt;span&gt;were&lt;/span&gt; determined based on the value in use which is calculated at the expected estimated future cash flows, as determined according to the budget for the next three years and approved by the Company&#x2019;s management. The pre-tax discount rate of the cash flows is 11.78%. The projected cash flows for the period exceeding &lt;span&gt;three&lt;/span&gt; years was estimated using a fixed growth rate of 4%, representing the long-term average growth rate as customary in Trichome's business.&lt;span&gt; Based on the analysis performed the Company did not record goodwill impairment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisitions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2021, the Group entered into several business combination transactions. As part of these acquisitions, the Group identified cultivations and processing licenses, customer relationship, brand and others. The intangible assets identified have finite life and are being amortized on a straight-line basis over the useful life of the assets. During the year ended on December 31, 2021 and 2020, the Group recorded amortization expenses in the amount of $1,158 and $31, respectively. The amortization expenses are included in the &lt;span&gt;cost of revenues&lt;/span&gt; and in the selling and marketing expenses.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220330130355466">
                      &lt;div&gt;
                        &lt;div style="line-height:1.25;margin-left:63pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cultivations and processing license *)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer relationships&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Brand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;831&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;58&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;63&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;62&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,014&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;93&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;93&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value adjustment derived from purchase price allocation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;110&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;110&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;26&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;32&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,060&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;58&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;63&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;68&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,249&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:middle;width:40%" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial consolidations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8,950&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;10,337&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;11,300&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;128&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;30,715&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(49&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;279&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;236&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;9,961&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;10,674&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;11,363&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;202&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;32,200&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Accumulated amortization and impairment:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;125&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;125&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization recognized in the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;31&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;31&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;156&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;157&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization recognized in the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;618&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;469&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;8&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;63&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,158&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;774&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;469&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;8&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;64&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;1,315&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:4px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost at December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;9,187&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;10,205&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;11,355&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;138&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;30,885&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost at December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;904&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;58&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;63&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;67&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,092&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:45pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*) The licenses consist of GMP and GDP licenses. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    </ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439090_xbrl_20220307141937626_32"
      unitRef="CAD">831000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439090_xbrl_20220307141937626_35"
      unitRef="CAD">58000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439090_xbrl_20220307141937626_38"
      unitRef="CAD">63000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439090_xbrl_20220307141937626_311"
      unitRef="CAD">62000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220330125439090_xbrl_20220307141937626_314"
      unitRef="CAD">1014000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439096_xbrl_20220307141937626_52"
      unitRef="CAD">93000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439096_xbrl_20220307141937626_55"
      unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439096_xbrl_20220307141937626_58"
      unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439096_xbrl_20220307141937626_511"
      unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220330125439096_xbrl_20220307141937626_514"
      unitRef="CAD">93000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439103_xbrl_20220307141937626_72"
      unitRef="CAD">110000</imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
    <imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439103_xbrl_20220307141937626_75"
      unitRef="CAD">0</imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
    <imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439103_xbrl_20220307141937626_78"
      unitRef="CAD">0</imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
    <imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439103_xbrl_20220307141937626_711"
      unitRef="CAD">0</imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
    <imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220330125439103_xbrl_20220307141937626_714"
      unitRef="CAD">110000</imc:FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439110_xbrl_20220307141937626_82"
      unitRef="CAD">26000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439110_xbrl_20220307141937626_85"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439110_xbrl_20220307141937626_88"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439110_xbrl_20220307141937626_811"
      unitRef="CAD">6000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220330125439110_xbrl_20220307141937626_814"
      unitRef="CAD">32000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439135_xbrl_20220307141937626_172"
      unitRef="CAD">1060000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439135_xbrl_20220307141937626_175"
      unitRef="CAD">58000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439135_xbrl_20220307141937626_178"
      unitRef="CAD">63000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439135_xbrl_20220307141937626_1711"
      unitRef="CAD">68000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220330125439135_xbrl_20220307141937626_1714"
      unitRef="CAD">1249000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439123_xbrl_20220307141937626_132"
      unitRef="CAD">8950000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439123_xbrl_20220307141937626_135"
      unitRef="CAD">10337000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439123_xbrl_20220307141937626_138"
      unitRef="CAD">11300000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439123_xbrl_20220307141937626_1311"
      unitRef="CAD">128000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220330125439123_xbrl_20220307141937626_1314"
      unitRef="CAD">30715000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439130_xbrl_20220307141937626_152"
      unitRef="CAD">-49000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439130_xbrl_20220307141937626_155"
      unitRef="CAD">279000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439130_xbrl_20220307141937626_158"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439130_xbrl_20220307141937626_1511"
      unitRef="CAD">6000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220330125439130_xbrl_20220307141937626_1514"
      unitRef="CAD">236000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_172"
      unitRef="CAD">9961000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_175"
      unitRef="CAD">10674000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_178"
      unitRef="CAD">11363000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_1711"
      unitRef="CAD">202000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220330125646730_xbrl_20220330125439135_xbrl_20220307141937626_1714"
      unitRef="CAD">32200000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439146_xbrl_20220307141937626_212"
      unitRef="CAD">-125000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439146_xbrl_20220307141937626_215"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439146_xbrl_20220307141937626_218"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439146_xbrl_20220307141937626_2111"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220330125439146_xbrl_20220307141937626_2114"
      unitRef="CAD">-125000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439152_xbrl_20220307141937626_232"
      unitRef="CAD">31000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439152_xbrl_20220307141937626_235"
      unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439152_xbrl_20220307141937626_238"
      unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439152_xbrl_20220307141937626_2311"
      unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220330125439152_xbrl_20220307141937626_2314"
      unitRef="CAD">31000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_152"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_155"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_158"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_1511"
      unitRef="CAD">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220330125439159_xbrl_20220330001912626_xbrl_20220307141937626_1514"
      unitRef="CAD">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_212"
      unitRef="CAD">-156000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_215"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_218"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_2111"
      unitRef="CAD">-1000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220330130028539_xbrl_20220330125439146_xbrl_20220307141937626_2114"
      unitRef="CAD">-157000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439171_xbrl_20220307141937626_282"
      unitRef="CAD">618000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439171_xbrl_20220307141937626_285"
      unitRef="CAD">469000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439171_xbrl_20220307141937626_288"
      unitRef="CAD">8000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439171_xbrl_20220307141937626_2811"
      unitRef="CAD">63000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220330125439171_xbrl_20220307141937626_2814"
      unitRef="CAD">1158000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_212"
      unitRef="CAD">-774000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_215"
      unitRef="CAD">-469000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_218"
      unitRef="CAD">-8000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_2111"
      unitRef="CAD">-64000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220330130034185_xbrl_20220330125439146_xbrl_20220307141937626_2114"
      unitRef="CAD">-1315000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125439199_xbrl_20220307141937626_332"
      unitRef="CAD">9187000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125439199_xbrl_20220307141937626_335"
      unitRef="CAD">10205000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125439199_xbrl_20220307141937626_338"
      unitRef="CAD">11355000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125439199_xbrl_20220307141937626_3311"
      unitRef="CAD">138000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220330125439199_xbrl_20220307141937626_3314"
      unitRef="CAD">30885000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCultivationsAndProcessingLicenseMember"
      decimals="-3"
      id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_332"
      unitRef="CAD">904000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_imcCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_335"
      unitRef="CAD">58000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullBrandNamesMember"
      decimals="-3"
      id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_338"
      unitRef="CAD">63000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_3311"
      unitRef="CAD">67000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220330125518600_xbrl_20220330125439199_xbrl_20220307141937626_3314"
      unitRef="CAD">1092000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <imc:PreTaxDiscountRateOfCashFlows
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember"
      decimals="4"
      id="Fxbrl_20220330155201027"
      unitRef="Percentage">0.1306</imc:PreTaxDiscountRateOfCashFlows>
    <imc:FixedGrowthRate
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember"
      decimals="2"
      id="Fxbrl_20220330155206614"
      unitRef="Percentage">0.03</imc:FixedGrowthRate>
    <imc:PreTaxDiscountRateOfCashFlows
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCorpMember"
      decimals="4"
      id="Fxbrl_20220330155214030"
      unitRef="Percentage">0.1178</imc:PreTaxDiscountRateOfCashFlows>
    <imc:FixedGrowthRate
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcTrichomeFinancialCorpMember"
      decimals="2"
      id="Fxbrl_20220330155228366"
      unitRef="Percentage">0.04</imc:FixedGrowthRate>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329191726094"
      unitRef="CAD">1158000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329191733000"
      unitRef="CAD">31000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <imc:DisclosureOfRightOfUseAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220307141811709">
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;NOTE 12:-&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;RIGHT-OF-USE ASSETS&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Land and buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;955&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;195&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,150&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;107&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;107&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency translation adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;50&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;12&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;62&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Termination of leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(73&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(73&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,005&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;241&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,246&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,408&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;270&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,678&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial consolidations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;16,956&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;23&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;16,979&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency translation adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;145&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;12&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;157&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;19,514&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;546&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;20,060&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Accumulated depreciation:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;80&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;47&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;127&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency translation adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;107&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;102&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;209&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;7&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;10&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Termination of leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(35&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(35&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;194&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;117&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;311&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,438&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;112&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,550&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency translation adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;27&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;10&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;37&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,659&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;239&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,898&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciated cost at December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;17,855&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;307&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;18,162&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciated cost at December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;811&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;124&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;935&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Group has entered into leases of land, buildings and motor vehicles which are used for the Group's operations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases of buildings have lease terms of between 5 and 12 years, whereas leases of motor vehicles usually have lease terms of 3 years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </imc:DisclosureOfRightOfUseAssetsExplanatory>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329194217051">
              &lt;div style="margin-left:63pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Land and buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Motor vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;955&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;195&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,150&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;107&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;107&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency translation adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;50&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;12&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;62&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Termination of leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(73&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(73&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,005&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;241&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,246&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;New leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,408&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;270&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,678&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial consolidations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;16,956&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;23&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;16,979&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency translation adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;145&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;12&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;157&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;19,514&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;546&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;20,060&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Accumulated depreciation:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;80&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;47&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;127&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency translation adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;107&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;102&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;209&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;7&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;10&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Termination of leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(35&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(35&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;194&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;117&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;311&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,438&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;112&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,550&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:19.85pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency translation adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;27&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;10&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;37&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;padding-bottom:4px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,659&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;239&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;1,898&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciated cost at December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;17,855&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;307&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;18,162&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciated cost at December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;811&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;124&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;935&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428014246210"
      unitRef="CAD">955000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428022230797"
      unitRef="CAD">195000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20210428022421203"
      unitRef="CAD">1150000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428014424092"
      unitRef="CAD">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428022537849"
      unitRef="CAD">107000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20210428022621021"
      unitRef="CAD">107000</ifrs-full:AdditionsToRightofuseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428014325451"
      unitRef="CAD">50000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428022836982"
      unitRef="CAD">12000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20210428022847986"
      unitRef="CAD">62000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:DisposalsOfRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428014527242"
      unitRef="CAD">0</imc:DisposalsOfRightOfUseAssets>
    <imc:DisposalsOfRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428023002933"
      unitRef="CAD">73000</imc:DisposalsOfRightOfUseAssets>
    <imc:DisposalsOfRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20210428023006679"
      unitRef="CAD">73000</imc:DisposalsOfRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428014547381"
      unitRef="CAD">1005000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428023017413"
      unitRef="CAD">241000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20210428023025786"
      unitRef="CAD">1246000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307122947840_xbrl_20210428014006957"
      unitRef="CAD">1408000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307122947840_xbrl_20210428021124387"
      unitRef="CAD">270000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307122947840_xbrl_20210428021147875"
      unitRef="CAD">1678000</ifrs-full:AdditionsToRightofuseAssets>
    <imc:InitialConsolidationsRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307123710791_xbrl_20220307123031391_xbrl_20210428014124845"
      unitRef="CAD">16956000</imc:InitialConsolidationsRightOfUseAssets>
    <imc:InitialConsolidationsRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307123710791_xbrl_20220307123031391_xbrl_20210428021302764"
      unitRef="CAD">23000</imc:InitialConsolidationsRightOfUseAssets>
    <imc:InitialConsolidationsRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307123710791_xbrl_20220307123031391_xbrl_20210428021307406"
      unitRef="CAD">16979000</imc:InitialConsolidationsRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307123031391_xbrl_20210428014124845"
      unitRef="CAD">145000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307123031391_xbrl_20210428021302764"
      unitRef="CAD">12000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307123031391_xbrl_20210428021307406"
      unitRef="CAD">157000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307123129951_xbrl_20210428014547381"
      unitRef="CAD">19514000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307123129951_xbrl_20210428023017413"
      unitRef="CAD">546000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220307123129951_xbrl_20210428023025786"
      unitRef="CAD">20060000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307135007912_xbrl_20210428020341467"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307135007912_xbrl_20210428023603385"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307135007912_xbrl_20210428023612922"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428020734633"
      unitRef="CAD">80000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428023713580"
      unitRef="CAD">47000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20210428023717794"
      unitRef="CAD">127000</ifrs-full:DepreciationRightofuseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428020742540"
      unitRef="CAD">107000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428023727834"
      unitRef="CAD">102000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20210428023741739"
      unitRef="CAD">209000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:DisposalsOfRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307132720695_xbrl_20210428020742540"
      unitRef="CAD">-7000</imc:DisposalsOfRightOfUseAssets>
    <imc:DisposalsOfRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307132720695_xbrl_20210428023727834"
      unitRef="CAD">-3000</imc:DisposalsOfRightOfUseAssets>
    <imc:DisposalsOfRightOfUseAssets
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307132720695_xbrl_20210428023741739"
      unitRef="CAD">-10000</imc:DisposalsOfRightOfUseAssets>
    <imc:DisposalOfTerminationOfLeases
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428020806401"
      unitRef="CAD">0</imc:DisposalOfTerminationOfLeases>
    <imc:DisposalOfTerminationOfLeases
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428023804125"
      unitRef="CAD">35000</imc:DisposalOfTerminationOfLeases>
    <imc:DisposalOfTerminationOfLeases
      contextRef="C_20200101to20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20210428023808004"
      unitRef="CAD">35000</imc:DisposalOfTerminationOfLeases>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428020408668"
      unitRef="CAD">-194000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428023815203"
      unitRef="CAD">-117000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20210428023819149"
      unitRef="CAD">-311000</ifrs-full:RightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307131754692_xbrl_20210428020734633"
      unitRef="CAD">1438000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307131754692_xbrl_20210428023713580"
      unitRef="CAD">112000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307131754692_xbrl_20210428023717794"
      unitRef="CAD">1550000</ifrs-full:DepreciationRightofuseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220329195505515"
      unitRef="CAD">27000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307131805140_xbrl_20210428023727834"
      unitRef="CAD">10000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets
      contextRef="C_20210101to20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307131805140_xbrl_20210428023741739"
      unitRef="CAD">37000</imc:IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220307131824811_xbrl_20210428020408668"
      unitRef="CAD">-1659000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20220307131824811_xbrl_20210428023815203"
      unitRef="CAD">-239000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220307131824811_xbrl_20210428023819149"
      unitRef="CAD">-1898000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428020854390"
      unitRef="CAD">17855000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428023827416"
      unitRef="CAD">307000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210428023839804"
      unitRef="CAD">18162000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231_ifrsfullClassesOfAssetsAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20210428020927004"
      unitRef="CAD">811000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231_ifrsfullClassesOfAssetsAxis_ifrsfullMotorVehiclesMember"
      decimals="-3"
      id="Fxbrl_20210428023851484"
      unitRef="CAD">124000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210428023855676"
      unitRef="CAD">935000</ifrs-full:RightofuseAssets>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      id="Fxbrl_20220329201032463">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      id="Fxbrl_20220329201049706">P12Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullMotorVehiclesMember"
      id="Fxbrl_20220329201112618">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfEmployeeBenefitsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329201131360">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;NOTE 13:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;EMPLOYEE BENEFIT ASSETS AND LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employee benefits consist of short-term benefits and post-employment benefits.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:80pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160; Post-employment benefits:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;According to the labor laws and Severance Pay Law in Israel, the Group is required to pay compensation to an employee upon dismissal or retirement or to make current contributions in defined contribution plans pursuant to Section 14 to the Severance Pay Law, as specified below. The Group&#x2019;s liability is accounted for as a post-employment benefit only for employees not under Section 14. The computation of the Group&#x2019;s employee benefit liability is made in accordance with a valid employment contract or a collective employees agreement based on the employee's salary and employment term which establish the entitlement to receive the compensation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The post-employment employee benefits are normally financed by contributions classified as defined benefit plans, as detailed below:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Defined benefit plans:&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Group accounts for the payment of compensation, that is not covered by contributions in defined contribution plans, as above, as a defined benefit plan for which an employee benefit liability is recognized and for which the Group deposits amounts in a long-term employee benefit fund and in qualifying insurance policies.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expenses recognized in the consolidated statements of profit or loss and other comprehensive income:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current service cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;146&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;166&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;14&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;10&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total employee benefit expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;160&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;176&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest income on plan assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;7&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;4&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The defined benefit liability (asset), net:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Defined benefit obligation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;668&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;588&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value of plan assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(277&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(217&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net defined benefit liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;391&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;371&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in the present value of defined benefit liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;588&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;390&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current service cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;146&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;166&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;14&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;10&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefits paid&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(50&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(23&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Re-measurement loss on defined benefit plans&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(33&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;32&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation effect&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;3&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;13&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;668&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;588&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in the fair value of plan assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Plan assets comprise assets held by a long-term employee benefit funds and qualifying insurance policies.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;217&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;128&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;7&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Return, net of interest income - remeasurement gain (loss)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(12&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefits paid&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(50&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(23&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amounts deposited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;116&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;101&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation effect&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(1&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;5&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;277&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;217&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The principal assumptions underlying the defined benefit plan:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div&gt;
              &lt;div style="margin-left:90pt"&gt;

                  &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:85%"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discount rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salary growth&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;

              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25;clear:both"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Based on reasonably possible changes of the principal assumptions underlying the defined benefit plan as mentioned above, occurring at the end of the reporting period, the changes would have an immaterial effect on the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfEmployeeBenefitsExplanatory>
    <ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220307103530609">
              &lt;div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current service cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;146&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;166&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;14&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;10&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total employee benefit expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;160&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;176&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest income on plan assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;7&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;4&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220308141108822_32"
      unitRef="CAD">146000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220308141108822_35"
      unitRef="CAD">166000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220308141108822_42"
      unitRef="CAD">14000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220308141108822_45"
      unitRef="CAD">10000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220308141108822_62"
      unitRef="CAD">160000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220308141108822_65"
      unitRef="CAD">176000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <imc:InterestIncomeOnPlanAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220308141108822_82"
      unitRef="CAD">7000</imc:InterestIncomeOnPlanAssets>
    <imc:InterestIncomeOnPlanAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220308141108822_85"
      unitRef="CAD">4000</imc:InterestIncomeOnPlanAssets>
    <ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210428001049579">
              &lt;div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Defined benefit obligation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;668&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;588&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value of plan assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(277&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(217&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net defined benefit liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;391&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;371&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210428001118428_32"
      unitRef="CAD">668000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210428001118428_35"
      unitRef="CAD">588000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210428001118428_42"
      unitRef="CAD">277000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210428001118428_45"
      unitRef="CAD">217000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210428001118428_62"
      unitRef="CAD">391000</ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210428001118428_65"
      unitRef="CAD">371000</ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan>
    <imc:DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210428021526510">
              &lt;div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;588&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;390&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current service cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;146&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;166&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;14&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;10&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefits paid&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(50&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(23&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Re-measurement loss on defined benefit plans&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(33&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;32&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation effect&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;3&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;13&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;668&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;588&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </imc:DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210428002251218_22"
      unitRef="CAD">588000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="C_20191231"
      decimals="-3"
      id="Fxbrl_20210428002251218_25"
      unitRef="CAD">390000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428002251218_42"
      unitRef="CAD">146000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428002251218_45"
      unitRef="CAD">166000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428002251218_52"
      unitRef="CAD">14000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428002251218_55"
      unitRef="CAD">10000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428002251218_62"
      unitRef="CAD">50000</ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428002251218_65"
      unitRef="CAD">23000</ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307101447477"
      unitRef="CAD">-33000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428002251218_75"
      unitRef="CAD">32000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428002251218_82"
      unitRef="CAD">3000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428002251218_85"
      unitRef="CAD">13000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210428002251218_102"
      unitRef="CAD">668000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210428002251218_105"
      unitRef="CAD">588000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210428011816903">
              &lt;div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;217&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;128&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;7&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Return, net of interest income - remeasurement gain (loss)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(12&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefits paid&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(50&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(23&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amounts deposited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;116&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;101&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency translation effect&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(1&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;5&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;277&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;217&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210428011902333_22"
      unitRef="CAD">217000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="C_20191231"
      decimals="-3"
      id="Fxbrl_20210428011902333_25"
      unitRef="CAD">128000</ifrs-full:PlanAssetsAtFairValue>
    <imc:InterestIncomeOnPlanAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428011902333_42"
      unitRef="CAD">7000</imc:InterestIncomeOnPlanAssets>
    <imc:InterestIncomeOnPlanAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428011902333_45"
      unitRef="CAD">4000</imc:InterestIncomeOnPlanAssets>
    <imc:ReturnNetOfInterestIncomeReMeasurementGainLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307102836883"
      unitRef="CAD">-12000</imc:ReturnNetOfInterestIncomeReMeasurementGainLoss>
    <imc:ReturnNetOfInterestIncomeReMeasurementGainLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428011902333_55"
      unitRef="CAD">2000</imc:ReturnNetOfInterestIncomeReMeasurementGainLoss>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428011902333_62"
      unitRef="CAD">50000</ifrs-full:BenefitsPaidOrPayable>
    <ifrs-full:BenefitsPaidOrPayable
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428011902333_65"
      unitRef="CAD">23000</ifrs-full:BenefitsPaidOrPayable>
    <imc:PlanAssetsAmountsDeposited
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428011902333_72"
      unitRef="CAD">116000</imc:PlanAssetsAmountsDeposited>
    <imc:PlanAssetsAmountsDeposited
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428011902333_75"
      unitRef="CAD">101000</imc:PlanAssetsAmountsDeposited>
    <imc:PlanAssetsForeignCurrencyTranslationEffect
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307102903475"
      unitRef="CAD">-1000</imc:PlanAssetsForeignCurrencyTranslationEffect>
    <imc:PlanAssetsForeignCurrencyTranslationEffect
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428011902333_85"
      unitRef="CAD">5000</imc:PlanAssetsForeignCurrencyTranslationEffect>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210428011902333_102"
      unitRef="CAD">277000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210428011902333_105"
      unitRef="CAD">217000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329201156328">
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:85%"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discount rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salary growth&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                </ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="C_20211231"
      decimals="3"
      id="Fxbrl_20210428012929372"
      unitRef="Percentage">0.035</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="C_20201231"
      decimals="4"
      id="Fxbrl_20210428013107936"
      unitRef="Percentage">0.0258</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="C_20211231"
      decimals="4"
      id="Fxbrl_20210428012940683"
      unitRef="Percentage">0.0464</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="C_20201231"
      decimals="4"
      id="Fxbrl_20210428013001589"
      unitRef="Percentage">0.0337</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210426222203301">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;NOTE 14:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;OTHER PAYABLES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div style="margin-left:63pt"&gt;
                    &lt;div&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;6,146&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;407&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employees and payroll accruals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8,267&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,545&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government authorities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4,002&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;642&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related parties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;875&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advances from customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;137&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;741&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;716&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;162&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;20,143&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;3,497&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <imc:DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210426223553105">
                  &lt;div style="margin-left:63pt"&gt;
                    &lt;div&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;6,146&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;407&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employees and payroll accruals&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;8,267&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1,545&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government authorities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4,002&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;642&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related parties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;875&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advances from customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;137&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;741&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;716&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;162&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;20,143&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;3,497&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </imc:DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426222226328_32"
      unitRef="CAD">6146000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426222226328_35"
      unitRef="CAD">407000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <imc:EmployeesAndPayrollAccruals
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426222226328_42"
      unitRef="CAD">8267000</imc:EmployeesAndPayrollAccruals>
    <imc:EmployeesAndPayrollAccruals
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426222226328_45"
      unitRef="CAD">1545000</imc:EmployeesAndPayrollAccruals>
    <imc:OtherCurrentPayablesToGovernmentAuthorities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426222226328_52"
      unitRef="CAD">4002000</imc:OtherCurrentPayablesToGovernmentAuthorities>
    <imc:OtherCurrentPayablesToGovernmentAuthorities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426222226328_55"
      unitRef="CAD">642000</imc:OtherCurrentPayablesToGovernmentAuthorities>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220307110310848_xbrl_20210426222226328_52"
      unitRef="CAD">875000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220307110310848_xbrl_20210426222226328_55"
      unitRef="CAD">0</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:CurrentDepositsFromCustomers
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426222226328_62"
      unitRef="CAD">137000</ifrs-full:CurrentDepositsFromCustomers>
    <ifrs-full:CurrentDepositsFromCustomers
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426222226328_65"
      unitRef="CAD">741000</ifrs-full:CurrentDepositsFromCustomers>
    <imc:OtherMiscellaneousCurrentPayables
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426222226328_72"
      unitRef="CAD">716000</imc:OtherMiscellaneousCurrentPayables>
    <imc:OtherMiscellaneousCurrentPayables
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426222226328_75"
      unitRef="CAD">162000</imc:OtherMiscellaneousCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210426222226328_92"
      unitRef="CAD">20143000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210426222226328_95"
      unitRef="CAD">3497000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220127180958259">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0);border:0px"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;NOTE 15:-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The carrying values of the financial instruments which are measured at fair value through profit and loss as of December 31, 2021, and 2020, summarized in the following table:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:56.7pt"&gt;

                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,429&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,341&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c,e&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;14&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:64%" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6,022&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;16,540&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b,d&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:74.7pt;vertical-align:top;align:right"&gt;
                        &lt;div style="margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management believes that the carrying amount of cash and cash equivalents, restricted bank deposit, trade receivables, other accounts receivable, loans receivables, trade payables, bank loans, other account payables and accrued expenses and purchase consideration payable, and approximate their fair value due to the short-term maturities of these instruments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:74.7pt;vertical-align:top;align:right"&gt;
                        &lt;div style="margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2021 and 2020, there were nil and 9,729,264 2019 Warrants outstanding from private placements in 2019 (2019 Warrants). The Company re-measured the warrants, according to their trading price in the market, in the amount of $&lt;span style="-sec-ix-hidden:Fxbrl_20220307151218509"&gt;nil&lt;/span&gt; and $16,540, respectively (level 1 in fair value hierarchy). As a result, for the year ended December 31, 2021 and 2020, the Company recognized a revaluation gain (loss) of $15,929 and $(16,283), respectively, in the consolidated statement of profit or loss and other comprehensive income, which unrealized gain is included in finance income (expense). During 2021, amount&#160;of $611 of the 2019 Warrants transferred to equity and the rest expired.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On December 26, 2019, IMC entered into a share purchase agreement (the &#x201c;SPA&#x201d;) with Xinteza API Ltd. ("Xinteza"), a company with a unique biosynthesis technology.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The investment in the investee is accounted for as financial asset measured at fair value through profit or loss. The fair value of the investment as of December 31, 2021 and 2020, was $2,429 and $2,341, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:74.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2021 and 2020, the fair value of the Xinteza was categorized within Level 3 of the fair value hierarchy. The fair value was based on financing rounds for the purchase of preferred shares during 2020 (see Note 24).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:74.7pt;vertical-align:top;align:right"&gt;
                      &lt;div style="margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top"&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On May 10, 2021, the Company completed an overnight marketed offering (the &#x201c;Offering&#x201d;)&#160;of&#160;6,086,956 Common Shares (each an &#x201c;Offered Share&#x201d;) at a price of US$5.75 per Offered Share for aggregate gross proceeds of approximately US$35 million ($42,502). The Company also issued 3,043,478 Common Share purchase warrants (each an &#x201c;2021 Warrant&#x201d;) to the purchasers of Offered Shares, for no additional consideration, that entitle the holders to purchase 3,043,478 Common Shares of the Company at an exercise price of US$7.2 per Common Share for a term of 5 years from the closing date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:74.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As the exercise price of the 2021 Warrants is denominated in US dollars, which is not the functional currency of the Company, the 2021 Warrants are accounted for as a derivative liability, which is measured at fair value. Gross proceeds in the amount of $30,670 were recorded as Share capital and premium, and $11,832 were recorded as a Warrant liability, based on a valuation using the Black &amp;amp; Scholes option pricing model. The transaction costs incurred as a result of the Common Shares issuance amounted to approximately $3,800, of which approximately $1,296 (attributed to the issuance of the Warrants classified as liabilities) were recorded as an expense in the Company's consolidated statements of profit or loss and approximately $2,539 (attributed to the issuance of share capital) as a deduction from Share capital and premium.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:74.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2021, there were 3,043,478 of 2021 Warrants outstanding and the Company re-measured the 2021 Warrants, according to Black &amp;amp; Scholes model, in the amount of $6,022. As a result, for the year ended December 31, 2021, the Company recognized a revaluation gain of $5,810 in the consolidated statement of profit or loss and other comprehensive income, which unrealized gain is included in finance income (expense).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:74.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The 2021 warrants fair value was measured using the Black &amp;amp; Scholes model with the following key assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:81pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:15.97%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.11%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Sensitivity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83 %&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td rowspan="2" style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Increase (decrease) in key assumptions would&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;result in increase (decrease) in fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected life (in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.342&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.85%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td rowspan="2" style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Increase (decrease) in key assumptions would&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;result in decrease (increase) in fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Per Warrant (Canadian Dollar)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.979&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Warrants (Canadian Dollar in thousands)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$6,022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:27.75pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Financial risk management:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group has exposure to the following risks from its use of financial instruments:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share price risk:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Group's investments in unlisted shares are sensitive to market price risk arising from uncertainties about future value of these investments. The Group manages the price risk through diversification and by placing limits on individual and total investment in shares.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company's Board of directors reviews and approves all decisions related to investments in shares.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;At the reporting date, the Group's exposure to investments in unlisted shares measured at fair value was $2,429.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Credit risk:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The maximum credit exposure as of December 31, 2021, is the carrying amount of cash and cash equivalents, accounts receivable and other current assets. The Group does not have significant credit risk with respect to customers. All cash and cash equivalents are placed with major Israeli financial institutions.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Loan receivable credit risk is managed by each loan separately according to the Group&#x2019;s policy, procedures and control relating to the borrower&#x2019;s credit risk management. At the end of each period, the individual loan values are assessed based on a credit risk analysis. As of December 31, 2021, the Group had 2 loans outstanding (2020: nil loans) with a total balance of approximately $2.71 million.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The expected credit loss analysis is generally based on Management&#x2019;s understanding of the borrower&#x2019;s experience/integrity, financial health, business plans, capacity, products, customers, contracts, competitive advantages/disadvantages, and other pertinent factors when assessing credit risk. This would also include the assessment of the borrower&#x2019;s forecasts as well as taking into consideration any security and/or collateral the Company has on the outstanding balance.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As security on the loan receivable to Biome Grow Inc., the borrower holds approximately 744,000 IM Cannabis Corp. common shares, on December 31, 2021. These shares cannot be sold without the proceeds from any sale being provided to the Company as repayment for the loan until the balance is fully discharged.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2021, the Company assessed the overall risk of the loan receivable balance and concluded that no expected credit loss under IFRS 9 was required.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Liquidity risk:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2021, the Group's financial liabilities with liquidity risk consist of trade payables and other accounts payable which have contractual maturity dates within one year, bank loans and lease liabilities. The Group manages its liquidity risk by reviewing its capital requirements on an ongoing basis. Based on the Group's working capital position at December 31, 2021, management considers liquidity risk to be low. The table below summarizes the maturity profile of the Group&#x2019;s bank loans and lease liabilities based on contractual undiscounted payments (including interest payments):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31, 2021:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-weight:400;font-family:'Times New Roman',Times,serif;margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6 to 10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,130&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,781&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,760&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,620&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Bank Loans&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,632&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,781&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,760&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,620&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31, 2020:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6 to 10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;232&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;547&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;515&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The maturity profile of the Group's other financial liabilities with liquidity risk (trade payables, other account payable and accrued expenses) as of December 31, 2021 and 2020, are less than one year.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Currency rate risk&lt;span style="font-weight:bold"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2021, a portion of the Group's financial assets and liabilities held in Euro, NIS, USD and GBP consist of cash and cash equivalents in the amount of EUR 742 thousand (approximately $1,069), NIS 16,718 thousand (approximately $6,845), USD 1,136 thousand (approximately $1,447) and GBP 2 thousand (approximately $9) respectively. The Group's objective in managing its foreign currency risk is to minimize its net exposure to foreign currency cash flows by transacting, to the greatest extent possible, with third parties in NIS. The Group does not currently use foreign exchange contracts to hedge its exposure of its foreign currency cash flows as management has determined that this risk is not significant at this point of time.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;text-indent:0.2pt;margin-left:85.25pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:27.75pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Changes in liabilities arising from financing activities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;

                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Loans&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total liabilities arising from financing activities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,050&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;197&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,247&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions for new leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash flows&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(250&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(250&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Conversion of warrant&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,873&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,873&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other changes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;144&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Effect of changes in fair value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,155&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,155&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,540&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issuance of new warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,832&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,832&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions for new loans&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,504&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,504&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions for new leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions related to acquisitions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,957&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,222&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Repayments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,980&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,680&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Effective interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,347&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,347&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other changes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;117&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(611&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(361&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Effect of changes in fair value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,739&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,739&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,894&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,374&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,290&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="margin-left:90pt"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220330172624864">
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,429&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,341&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c,e&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;14&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:middle;width:64%" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;6,022&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;16,540&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b,d&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220329223311547"
      unitRef="CAD">2429000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220329223315071"
      unitRef="CAD">2341000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220329223237105"
      unitRef="CAD">14000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220329223240586"
      unitRef="CAD">0</ifrs-full:DerivativeFinancialAssets>
    <imc:WarrantsMeasuredAtFairValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220329223347812"
      unitRef="CAD">6022000</imc:WarrantsMeasuredAtFairValue>
    <imc:WarrantsMeasuredAtFairValue
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220329223351533"
      unitRef="CAD">16540000</imc:WarrantsMeasuredAtFairValue>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"
      decimals="0"
      id="Fxbrl_20220307151139626"
      unitRef="Shares">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"
      decimals="0"
      id="Fxbrl_20220307151154183"
      unitRef="Shares">9729264</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <imc:FairValueOfWarrants
      contextRef="C_20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"
      decimals="-3"
      id="Fxbrl_20220307151235866"
      unitRef="CAD">16540000</imc:FairValueOfWarrants>
    <imc:GainLossOnRevaluationOfFinancialInstruments
      contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"
      decimals="-3"
      id="Fxbrl_20220307151251929"
      unitRef="CAD">15929000</imc:GainLossOnRevaluationOfFinancialInstruments>
    <imc:GainLossOnRevaluationOfFinancialInstruments
      contextRef="C_20200101to20201231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"
      decimals="-3"
      id="Fxbrl_20220307151302587"
      unitRef="CAD">-16283000</imc:GainLossOnRevaluationOfFinancialInstruments>
    <imc:AmountOfWarrantTransferredInEquityDuringPeriod
      contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrants2019Member"
      decimals="-3"
      id="Fxbrl_20220330165537653"
      unitRef="CAD">-611000</imc:AmountOfWarrantTransferredInEquityDuringPeriod>
    <imc:FairValueOfInvestment
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220307152515478"
      unitRef="CAD">2429000</imc:FairValueOfInvestment>
    <imc:FairValueOfInvestment
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220307152523843"
      unitRef="CAD">2341000</imc:FairValueOfInvestment>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="INF"
      id="Fxbrl_20220307163118507"
      unitRef="Share">6086956</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="2"
      id="Fxbrl_20220307163417937"
      unitRef="USD_per_Share">5.75</ifrs-full:ParValuePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-6"
      id="Fxbrl_20220307163443857"
      unitRef="USD">35000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-3"
      id="Fxbrl_20220307163523146"
      unitRef="CAD">42502000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="INF"
      id="Fxbrl_20220307163702422"
      unitRef="Shares">3043478</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <imc:NumberOfCommonSharesCalledByWarrants
      contextRef="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="INF"
      id="Fxbrl_20220307163754895"
      unitRef="Share">3043478</imc:NumberOfCommonSharesCalledByWarrants>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="1"
      id="Fxbrl_20220307163844033"
      unitRef="USD_per_Share">7.2</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <imc:TermOfWarrantsFromDateOfIssuance
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      id="Fxbrl_20220307163948158">P5Y</imc:TermOfWarrantsFromDateOfIssuance>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220330205829057"
      unitRef="CAD">30670000</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:WarrantLiability
      contextRef="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220307164106252"
      unitRef="CAD">11832000</ifrs-full:WarrantLiability>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220307164212467"
      unitRef="CAD">3800000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_imcListedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220307164249420"
      unitRef="CAD">1296000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220307164323867"
      unitRef="CAD">2539000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="0"
      id="Fxbrl_20220307164958756"
      unitRef="Shares">3043478</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <imc:FairValueOfWarrants
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220307165020147"
      unitRef="CAD">6022000</imc:FairValueOfWarrants>
    <imc:GainLossOnRevaluationOfFinancialInstruments
      contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220307165113616"
      unitRef="CAD">5810000</imc:GainLossOnRevaluationOfFinancialInstruments>
    <imc:DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329223154529">
              &lt;div&gt;
                &lt;div style="margin-left:81pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:15.97%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.11%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Sensitivity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83 %&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td rowspan="2" style="width:30.75%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Increase (decrease) in key assumptions would&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;result in increase (decrease) in fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected life (in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.342&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.85%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td rowspan="2" style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Increase (decrease) in key assumptions would&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;result in decrease (increase) in fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Expected dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair value:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Per Warrant (Canadian Dollar)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.979&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:46.96%;vertical-align:top"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Warrants (Canadian Dollar in thousands)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.73%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:17.08%;vertical-align:bottom;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$6,022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:3.48%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:30.75%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </imc:DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory>
    <imc:ExpectedVolatilityOfWarrants
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="2"
      id="Fxbrl_20220329223021813"
      unitRef="Percentage">0.83</imc:ExpectedVolatilityOfWarrants>
    <imc:ExpectedLifeOfWarrants
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="INF"
      id="Fxbrl_20220329223013508"
      unitRef="Year">4.342</imc:ExpectedLifeOfWarrants>
    <imc:RiskFreeInterestRateOfWarrants
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="4"
      id="Fxbrl_20220329222952838"
      unitRef="Percentage">0.0085</imc:RiskFreeInterestRateOfWarrants>
    <imc:ExpectedDividendYieldOfWarrants
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="2"
      id="Fxbrl_20220329222933423"
      unitRef="Percentage">0</imc:ExpectedDividendYieldOfWarrants>
    <imc:FairValuePerWarrant
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="3"
      id="Fxbrl_20220329222915365"
      unitRef="CAD_per_Share">1.979</imc:FairValuePerWarrant>
    <imc:FairValueOfWarrants
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220329222904812"
      unitRef="CAD">6022000</imc:FairValueOfWarrants>
    <imc:InvestmentsInUnlistedSharesMeasuredAtFairValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210427224020199"
      unitRef="CAD">2429000</imc:InvestmentsInUnlistedSharesMeasuredAtFairValue>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="C_20201231"
      decimals="-6"
      id="Fxbrl_20220330172537567"
      unitRef="CAD">0</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="C_20211231"
      decimals="-4"
      id="Fxbrl_20220330172516049"
      unitRef="CAD">2710000</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220330172643568">
              &lt;div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31, 2021:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-weight:400;font-family:'Times New Roman',Times,serif;margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6 to 10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,130&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,781&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,760&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,620&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Bank Loans&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,502&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,632&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,781&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,760&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,620&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31, 2020:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:90pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1 to 5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6 to 10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&amp;gt;10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;232&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;547&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;515&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220329212619375_xbrl_20210427163720349"
      unitRef="CAD">3130000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220329212619375_xbrl_20210427163723287"
      unitRef="CAD">11781000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember"
      decimals="-3"
      id="Fxbrl_20220329212619375_xbrl_20210427163727563"
      unitRef="CAD">12760000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember"
      decimals="-3"
      id="Fxbrl_20220329212619375_xbrl_20210427163734208"
      unitRef="CAD">2620000</ifrs-full:LeaseLiabilities>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163720349"
      unitRef="CAD">9502000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163723287"
      unitRef="CAD">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember"
      decimals="-3"
      id="Fxbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163727563"
      unitRef="CAD">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember"
      decimals="-3"
      id="Fxbrl_20220330172035221"
      unitRef="CAD">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <imc:BankLoanAndLeaseLiabilities
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220330172101460_xbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163720349"
      unitRef="CAD">12632000</imc:BankLoanAndLeaseLiabilities>
    <imc:BankLoanAndLeaseLiabilities
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220330172101460_xbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163723287"
      unitRef="CAD">11781000</imc:BankLoanAndLeaseLiabilities>
    <imc:BankLoanAndLeaseLiabilities
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember"
      decimals="-3"
      id="Fxbrl_20220330172101460_xbrl_20220330172000574_xbrl_20220329212619375_xbrl_20210427163727563"
      unitRef="CAD">12760000</imc:BankLoanAndLeaseLiabilities>
    <imc:BankLoanAndLeaseLiabilities
      contextRef="C_20211231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember"
      decimals="-3"
      id="Fxbrl_20220330172101460_xbrl_20220330172035221"
      unitRef="CAD">2620000</imc:BankLoanAndLeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220329212624036_xbrl_20210427163720349"
      unitRef="CAD">232000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220329212624036_xbrl_20210427163723287"
      unitRef="CAD">547000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsAndNotLaterThanTenYearsMember"
      decimals="-3"
      id="Fxbrl_20220329212624036_xbrl_20210427163727563"
      unitRef="CAD">515000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20201231_ifrsfullMaturityAxis_ifrsfullLaterThanTenYearsMember"
      decimals="-3"
      id="Fxbrl_20220330172705239"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220307162554779"
      unitRef="Euro">742000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220330170051458"
      unitRef="CAD">1069000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyILS"
      decimals="-3"
      id="Fxbrl_20220330170247232"
      unitRef="NIS">16718000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyILS"
      decimals="-3"
      id="Fxbrl_20220307162836343"
      unitRef="CAD">6845000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyUSD"
      decimals="-3"
      id="Fxbrl_20220308025139279"
      unitRef="USD">1136000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyUSD"
      decimals="-3"
      id="Fxbrl_20220330171444278"
      unitRef="CAD">1447000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220329223709214"
      unitRef="GBP">2000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic
      contextRef="C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcCashAndCashEquivalentMember_ifrsfullTypesOfRisksAxis_ifrsfullCurrencyRiskMember_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220330171518133"
      unitRef="CAD">9000</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220330172731189">
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Loans&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total liabilities arising from financing activities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,050&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;197&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,247&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions for new leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash flows&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(250&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(250&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Conversion of warrant&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,873&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,873&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other changes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;144&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Effect of changes in fair value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,155&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,155&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,540&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,530&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Issuance of new warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,832&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,832&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions for new loans&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,504&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,504&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions for new leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,678&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions related to acquisitions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,957&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,222&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,179&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Repayments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,980&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,680&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Effective interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,347&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,347&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other changes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;117&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(611&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(361&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Effect of changes in fair value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,739&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,739&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,894&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,374&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,022&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,290&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              </ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102110_xbrl_20210427191805093_22"
      unitRef="CAD">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102110_xbrl_20210427191805093_25"
      unitRef="CAD">1050000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20191231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102110_xbrl_20210427191805093_28"
      unitRef="CAD">197000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20191231"
      decimals="-3"
      id="Fxbrl_20220329212102110_xbrl_20210427191805093_211"
      unitRef="CAD">1247000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102117_xbrl_20210427191805093_72"
      unitRef="CAD">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102117_xbrl_20210427191805093_75"
      unitRef="CAD">107000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102117_xbrl_20210427191805093_78"
      unitRef="CAD">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329212102117_xbrl_20210427191805093_711"
      unitRef="CAD">107000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102122_xbrl_20210427191805093_82"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102122_xbrl_20210427191805093_85"
      unitRef="CAD">-250000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102122_xbrl_20210427191805093_88"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329212102122_xbrl_20210428131426043"
      unitRef="CAD">-250000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102128_xbrl_20220307143134242_xbrl_20210427191805093_82"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102128_xbrl_20220307143134242_xbrl_20210427191805093_85"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102128_xbrl_20220307143134242_xbrl_20210427191805093_88"
      unitRef="CAD">-3873000</imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329212102128_xbrl_20220307143134242_xbrl_20210428131426043"
      unitRef="CAD">-3873000</imc:IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102134_xbrl_20210427191805093_92"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102134_xbrl_20210427191805093_95"
      unitRef="CAD">83000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102134_xbrl_20210427191805093_98"
      unitRef="CAD">61000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329212102134_xbrl_20210427191805093_911"
      unitRef="CAD">144000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102144_xbrl_20210427191805093_102"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102144_xbrl_20210427191805093_105"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102144_xbrl_20210427191805093_108"
      unitRef="CAD">20155000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220329212102144_xbrl_20210427191805093_1011"
      unitRef="CAD">20155000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212124535_xbrl_20210427191805093_202"
      unitRef="CAD">0</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212124535_xbrl_20210427191805093_205"
      unitRef="CAD">990000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20201231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212124535_xbrl_20210427191805093_208"
      unitRef="CAD">16540000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220329212124535_xbrl_20210427191805093_2011"
      unitRef="CAD">17530000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102165_xbrl_20220307144239893_xbrl_20210427191805093_142"
      unitRef="CAD">0</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102165_xbrl_20220307144239893_xbrl_20210427191805093_145"
      unitRef="CAD">0</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102165_xbrl_20220307144239893_xbrl_20210427191805093_148"
      unitRef="CAD">11832000</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329212102165_xbrl_20220307144239893_xbrl_20210427191805093_1411"
      unitRef="CAD">11832000</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_142"
      unitRef="CAD">8504000</imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_145"
      unitRef="CAD">0</imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_148"
      unitRef="CAD">0</imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_1411"
      unitRef="CAD">8504000</imc:IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102182_xbrl_20210427191805093_142"
      unitRef="CAD">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102182_xbrl_20210427191805093_145"
      unitRef="CAD">1678000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102182_xbrl_20210427191805093_148"
      unitRef="CAD">0</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329212102182_xbrl_20210427191805093_1411"
      unitRef="CAD">1678000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_142"
      unitRef="CAD">1957000</imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_145"
      unitRef="CAD">17222000</imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_148"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_1411"
      unitRef="CAD">19179000</imc:IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102188_xbrl_20220308020126882"
      unitRef="CAD">-700000</imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102188_xbrl_20220308020527303"
      unitRef="CAD">-1980000</imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102188_xbrl_20220308020559808"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329212102188_xbrl_20220308020714179"
      unitRef="CAD">-2680000</imc:IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220330174504470_xbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_142"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220330174504470_xbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_145"
      unitRef="CAD">1347000</imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220330174504470_xbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_148"
      unitRef="CAD">0</imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities>
    <imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220330174504470_xbrl_20220330174330928_xbrl_20220329212102175_xbrl_20220307144242152_xbrl_20210427191805093_1411"
      unitRef="CAD">1347000</imc:IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102194_xbrl_20210427191805093_172"
      unitRef="CAD">133000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102194_xbrl_20210427191805093_175"
      unitRef="CAD">117000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102194_xbrl_20210427191805093_178"
      unitRef="CAD">-611000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329212102194_xbrl_20210427191805093_1711"
      unitRef="CAD">-361000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220329212102199_xbrl_20210427191805093_182"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220329212102199_xbrl_20210427191805093_185"
      unitRef="CAD">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220329212102199_xbrl_20220308014213241"
      unitRef="CAD">-21739000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329212102199_xbrl_20220308014228650"
      unitRef="CAD">-21739000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullShorttermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220330171822805_xbrl_20220329212124535_xbrl_20210427191805093_202"
      unitRef="CAD">9894000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220330171822805_xbrl_20220329212124535_xbrl_20210427191805093_205"
      unitRef="CAD">19374000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20211231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_imcWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220330171822805_xbrl_20220329212124535_xbrl_20210427191805093_208"
      unitRef="CAD">6022000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220330171822805_xbrl_20220329212124535_xbrl_20210427191805093_2011"
      unitRef="CAD">35290000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:DisclosureOfContingentLiabilitiesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329201614038">
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;NOTE 16:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Legal proceedings:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:27.75pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;On August 19, 2019, a motion was filed for approval of a class action (the &#x201c;Motion&#x201d;) against 17 companies (the &#x201c;Companies&#x201d;) operating in the field of medical cannabis in Israel, including Focus. The applicant&#x2019;s argument is that the Companies did not accurately mark the concentration of active ingredients in their products. The personal suit sum for every class member stands at NIS 15,585 ($5,900) and the total amount of the class action suit is estimated at NIS 686,000 ($259,000). On June 2, 2020, the Companies submitted their response to the Motion. The Companies argue in their response that the threshold conditions for approval of a class action were not met, since there is no reasonable possibility that the causes of action in the Motion will be decided in favor of the class group. On July 3, 2020, the applicant submitted his response to the Companies&#x2019; response. On July 5, 2020 the applicant was absent from the hearing. As a result, on July 23, 2020, the Companies filed an application for a ruling of expenses, which received a response from the applicant on August 12, 2020, asking to decline this request. On September 21, 2020, the court ruled that the applicant would pay the Companies&#x2019; expenses amount of NIS 750. On July 14, 2021 a hearing was held. The court recommended the parties to negotiate independently to avoid litigation, and if negotiations fail, then to begin mediation proceedings. The parties agreed to follow the court&#x2019;s recommendations, though the negotiations between the parties have not yet begun. On November 3, 2021 the court ruled the parties will file an update regarding the mediation procedure, in 30 days. The parties conducted unsuccessful negotiations and are now waiting for a court decision regarding the continuation of the proceedings.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;At this preliminary stage, based on the opinion of its legal counsel, Focus&#x2019; management cannot assess the chances of approval of the Motion nor the chances of the claims under the Motion being accepted if the Motion is approved. Therefore, no provision has been recorded in respect thereof.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;On October 6, 2019, Focus received a decision regarding a petition that was filed against the MOH, concerning the new regulatory framework of the cannabis market and demanding that the court resolve as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:103.05pt"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;that the MOH immediately suspend the implementation of the new regulation that harms, disproportionally, the medical cannabis patients;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;that the implementation of the new regulation, as is, would cause violation of constitutional rights of the medical cannabis patients; and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:10.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;that the MOH amend the flaws of the new regulation, prior to becoming effective, and to establish new regulations regarding labeling and use of pesticides.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:113.4pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;According to the decision, Focus was attached to the proceedings and filed its response on November 12, 2019.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;On March 8, 2020, the court decided to extend the validity of the interim injunction, so that the medical cannabis use licenses, which were extended under the decision, would continue to be valid until May 15, 2020, or 10 days after the date the MOH comes to a conclusion regarding the price control of medical cannabis products, whichever comes first, subject to another court decision.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The court also decided that if a further extension of the period of the interim injunction is granted beyond May 15, 2020, to the extent required, it would be subject to medical surveillance by the attending physician, that his details of which were included in the patient&#x2019;s existing use license.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On October 29, 2020, the respondents represented by the State Attorney&#x2019;s Office filed an update notice stating that the Appeals Committee unanimously decided against imposing price controls on medical cannabis products and that the Prices Committee would hold a follow-up hearing in four months. The respondents also requested to update the Court again in two months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On November 25, 2020, the petitioner submitted their response to the respondents&#x2019; update notice.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 25, 2021, the respondents represented by the State Attorney&#x2019;s Office filed an updating notice stating that the Prices Committee had come to a decision against imposing price controls on medical cannabis products. However, the Prices Committee announced that it will issue a request for information to the corporations engaged in the medical cannabis market and assess the market every six months. Following the aforementioned, the respondents represented by the State Attorney&#x2019;s Office believe that the appeal should be rejected and the interim injunction should be canceled. On April 13, 2021, three of the respondents filed a response to the court, requesting to reject the appeal and to cancel the interim injunction.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 25, 2021, the petitioner filed a response to the update notice to the court, objecting to the position of the respondents represented by the State Attorney&#x2019;s Office, requesting the court to resolve as requested in the petition and grant the requested remedies to the petitioner. On July 6, 2021, the petitioner filed an urgent request to the court, to issue orders to the respondents represented by the State Attorney&#x2019;s Office, to request information from corporations engaged in the medical cannabis market in order to continue the examination of the market, according to the Prices Committee&#x2019;s announcement mentioned above, and requested the court to reschedule the hearing set to occur on September 19, 2021, to an earlier date. The petitioner&#x2019;s request was rejected by the court on July 7, 2021, and on September 19, 2021, a hearing was held. On November 16, 2021 the Supreme court of Israel ruled that motion will be deleted and interim injunction will be expired after 10 days. Following a request submitted by the petitioner on November 15, 2021, the Supreme court of Israel determined that the interim injunction will extend until March 1, 2022. Further requests submitted for an extension of the interim injunction were denied.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 11, 2021, the Company was informed that a claim (the &#x201c;Construction Proceedings&#x201d;) was filed by the municipal committee presiding over planning and construction in southern Israel (the &#x201c;Construction Committee&#x201d;) against Focus, Focus&#x2019; directors and officers, and certain landowners, including Oren Shuster and Rafael Gabay, claiming for inadequate permitting for construction relating to the Focus Facility (&#x201c;Construction Allegations&#x201d;). A hearing was set to June 13, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At this preliminary stage, based on the opinion of its legal counsel, Focus&#x2019; management cannot assess the chances of the claim advancing or the potential outcome of the Construction Proceedings.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </ifrs-full:DisclosureOfContingentLiabilitiesExplanatory>
    <imc:AmountOfPersonalSuit
      contextRef="C_20190819"
      decimals="0"
      id="Fxbrl_20220307111845176"
      unitRef="NIS">15585</imc:AmountOfPersonalSuit>
    <imc:AmountOfPersonalSuit
      contextRef="C_20190819"
      decimals="-3"
      id="Fxbrl_20220307111901359"
      unitRef="CAD">5900000</imc:AmountOfPersonalSuit>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="C_20190819"
      decimals="0"
      id="Fxbrl_20220307111912751"
      unitRef="NIS">686000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities
      contextRef="C_20190819"
      decimals="0"
      id="Fxbrl_20220307111939958"
      unitRef="CAD">259000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
    <imc:AmountOfExpensesPaidByApplicant
      contextRef="C_20200901to20200921"
      decimals="-3"
      id="Fxbrl_20220307120511602"
      unitRef="NIS">750000</imc:AmountOfExpensesPaidByApplicant>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220307102745883">
    &lt;div&gt;
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 17:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;TAXES ON INCOME&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax rates applicable to the Group:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company and its Canadian subsidiaries are subject to tax rates applicable in Canada. The combined federal and provincial rate for 2021 and 2020 is 26.5%.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Israeli subsidiaries are subject to Israeli corporate income tax rate of 23% in 2021 and 2020.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The German subsidiary is subject to weighted tax rate of approximately 29.1% (composed of Federal and Municipal tax).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Carryforward losses for tax purposes:&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carryforward operating tax losses of the Israeli subsidiaries total approximately $3,153, as of December 31, 2021. These losses can be carried forward to future years and offset against taxable income in the future without any time limitation. No deferred tax assets were recorded with regards to IMC Holdings ltd. since the Company does not anticipate to utilize the net operating losses in the foreseeable future.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carryforward operating tax losses of the German subsidiary as of December 31, 2021, amounted to approximately $8,964. Accumulated tax losses can be carried forward without time restrictions and can be deducted from future profits and capital gains unless they exceed &#x20ac;1,000 thousand (approximately $1,441). Any excess of such amount will be limited to 60% of the profits or capital gains. Unused carried forward losses will be subject to such limitation in the future. No deferred tax assets were recorded with regards to the German subsidiary since the Company does not anticipate to utilize the net operating losses in the foreseeable future.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carryforward operating tax losses of Canadian subsidiaries as of December 31, 2021, amounted to approximately $54,218. These losses can be carried forward to future years and offset against taxable income in the future without any time limitation. Deferred tax assets of approximately $1,542, relating to these losses were recognized in the financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div/&gt;
        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Income tax expense (benefit):&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;
          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:90pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;248&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;278&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax from previous years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;505&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Deferred taxes:&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div&gt;
          &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div style="margin-left:90pt"&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statements of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;financial position&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statements of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carryforward tax losses and other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,542&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;769&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;892&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(440&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;14&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;769&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(440&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory and biological assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;863&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,239&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(431&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;385&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;7,261&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;264&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(189&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(11&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;7&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;7&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;8,131&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,503&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(613&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;374&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Translation differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;54&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;63&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax expenses, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;278&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;(66&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;(6,575&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;(734&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The deferred taxes are reflected in the statements of financial position as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:90pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;769&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,591&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,503&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The deferred taxes are computed based on the tax rates that are expected to apply upon realization.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div/&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation of tax expense and the accounting profit multiplied by the Company's domestic tax rate for 2021 and 2020:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:90pt"&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss before income tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(18,013&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(28,472&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statutory tax rate in Canada 26.5%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(4,773&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(7,545&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Increase (decrease) in income tax due to:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible expenses (non-taxable income), net for tax purposes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,447&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of different tax rate of subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;310&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;161&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments in respect of current income tax of previous years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(21&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;303&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognition (derecognition) of tax benefit in respect of losses of previous years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(830&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unrecognized tax benefit in respect of loss for the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4,093&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,771&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Utilization of losses not previously recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,466&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in tax benefits not recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;5,252&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(289&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;96&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;505&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;262&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20200101to20201231_srtStatementGeographicalAxis_countryCA"
      decimals="3"
      id="Fxbrl_202104280257057420"
      unitRef="Percentage">0.265</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryCA"
      decimals="3"
      id="Fxbrl_20210428025705742"
      unitRef="Percentage">0.265</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20200101to20201231_srtStatementGeographicalAxis_countryIL"
      decimals="2"
      id="Fxbrl_202104280257290750"
      unitRef="Percentage">0.23</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryIL"
      decimals="2"
      id="Fxbrl_20210428025729075"
      unitRef="Percentage">0.23</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember"
      decimals="3"
      id="Fxbrl_20210428030550834"
      unitRef="Percentage">0.291</ifrs-full:ApplicableTaxRate>
    <imc:CarryforwardOperatingTaxLosses
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryIL"
      decimals="-3"
      id="Fxbrl_20220307095851065"
      unitRef="CAD">3153000</imc:CarryforwardOperatingTaxLosses>
    <imc:CarryforwardOperatingTaxLosses
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember_srtStatementGeographicalAxis_countryDE"
      decimals="-3"
      id="Fxbrl_20220307095908173"
      unitRef="CAD">8964000</imc:CarryforwardOperatingTaxLosses>
    <imc:CarryforwardLossesForTaxPurposesDescription
      contextRef="C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember_srtStatementGeographicalAxis_countryDE"
      id="Fxbrl_20220307095922900">Accumulated tax losses can be carried forward without time restrictions and can be deducted from future profits and capital gains unless they exceed &#x20ac;1,000 thousand (approximately $1,441). Any excess of such amount will be limited to 60% of the profits or capital gains</imc:CarryforwardLossesForTaxPurposesDescription>
    <imc:CarryforwardOperatingTaxLosses
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryCA"
      decimals="-3"
      id="Fxbrl_20220329211452593"
      unitRef="CAD">54218000</imc:CarryforwardOperatingTaxLosses>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20211231_srtStatementGeographicalAxis_countryCA"
      decimals="-3"
      id="Fxbrl_20220307095858151"
      unitRef="CAD">1542000</ifrs-full:DeferredTaxAssets>
    <imc:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210428060043799">
          &lt;div&gt;
            &lt;div style="margin-left:90pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;248&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;278&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax from previous years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;505&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;262&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </imc:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427094354029_32"
      unitRef="CAD">248000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427094354029_35"
      unitRef="CAD">25000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427094354029_42"
      unitRef="CAD">278000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427094354029_45"
      unitRef="CAD">-66000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307100344404_xbrl_20210427094354029_52"
      unitRef="CAD">-21000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307100344404_xbrl_20210427094354029_55"
      unitRef="CAD">303000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307100354540_xbrl_20210427094354029_72"
      unitRef="CAD">505000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307100354540_xbrl_20210427094354029_75"
      unitRef="CAD">262000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210428104409367">
            &lt;div style="margin-left:90pt"&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statements of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;financial position&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statements of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;profit or loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carryforward tax losses and other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,542&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;769&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;892&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(440&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;14&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;769&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;891&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(440&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory and biological assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;863&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,239&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(431&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;385&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;7,261&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;264&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(189&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(11&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;7&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;7&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;8,131&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,503&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(613&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;374&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Translation differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;54&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;63&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax expenses, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;278&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;(66&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:52%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;(6,575&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;(734&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220307103151334_xbrl_20210427112936081"
      unitRef="CAD">1542000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220307103151334_xbrl_20210427113018999"
      unitRef="CAD">769000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220307103151334_xbrl_20210427113140287"
      unitRef="CAD">892000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullUnusedTaxLossesMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220307103151334_xbrl_20210427113201752"
      unitRef="CAD">-440000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220329210821784_xbrl_20220307103151334_xbrl_20210427112936081"
      unitRef="CAD">14000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220329210821784_xbrl_20220307103151334_xbrl_20210427113018999"
      unitRef="CAD">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220329210821784_xbrl_20220307103151334_xbrl_20210427113140287"
      unitRef="CAD">-1000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_imcOtherDeferredTaxAssestsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220329210821784_xbrl_20220307103151334_xbrl_20210427113201752"
      unitRef="CAD">0</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220331171524784"
      unitRef="CAD">1556000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220329210826079_xbrl_20220307103151334_xbrl_20210427113018999"
      unitRef="CAD">769000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220331192929580"
      unitRef="CAD">891000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxAssetsMember"
      decimals="-3"
      id="Fxbrl_20220329210826079_xbrl_20220307103151334_xbrl_20210427113201752"
      unitRef="CAD">-440000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220307103207524_xbrl_20210427113257053"
      unitRef="CAD">863000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220307103207524_xbrl_20210427113323428"
      unitRef="CAD">1239000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220307103207524_xbrl_20210427113423549"
      unitRef="CAD">-431000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullCurrentBiologicalAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220307103207524_xbrl_20210427113603540"
      unitRef="CAD">385000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20210427113340299"
      unitRef="CAD">7261000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20210427113406244"
      unitRef="CAD">264000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20210427113633253"
      unitRef="CAD">-189000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_imcIntangibleAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20210427113654579"
      unitRef="CAD">-11000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220307112741861_xbrl_20210427113340299"
      unitRef="CAD">7000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220307112741861_xbrl_20210427113406244"
      unitRef="CAD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220307112741861_xbrl_20210427113633253"
      unitRef="CAD">7000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231_ifrsfullClassesOfFinancialAssetsAxis_ifrsfullOtherAssetsMember_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220307112741861_xbrl_20210427113654579"
      unitRef="CAD">0</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220331171931145_xbrl_20220307112741861_xbrl_20210427113340299"
      unitRef="CAD">8131000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220331171931145_xbrl_20220307112741861_xbrl_20210427113406244"
      unitRef="CAD">1503000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220331171931145_xbrl_20220307112741861_xbrl_20210427113633253"
      unitRef="CAD">-613000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231_imcDeferredTaxAssetsAndLiabilitiesAxis_imcDeferredTaxLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220331171931145_xbrl_20220307112741861_xbrl_20210427113654579"
      unitRef="CAD">374000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <imc:TranslationDifferencesOfDefferedTaxes
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427113820707"
      unitRef="CAD">54000</imc:TranslationDifferencesOfDefferedTaxes>
    <imc:TranslationDifferencesOfDefferedTaxes
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427113843779"
      unitRef="CAD">63000</imc:TranslationDifferencesOfDefferedTaxes>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307103227012_xbrl_20210427113935230"
      unitRef="CAD">278000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307103227012_xbrl_20210427114000622"
      unitRef="CAD">-66000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210427114021277"
      unitRef="CAD">6575000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210427114130511"
      unitRef="CAD">734000</ifrs-full:DeferredTaxLiabilityAsset>
    <imc:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210428104428889">
          &lt;div&gt;
            &lt;div style="margin-left:90pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;769&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,591&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,503&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </imc:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210427142712404"
      unitRef="CAD">16000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210427142717641"
      unitRef="CAD">769000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210427142728434_xbrl_20210427142712404"
      unitRef="CAD">6591000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20210427142728434_xbrl_20210427142717641"
      unitRef="CAD">1503000</ifrs-full:DeferredTaxLiabilities>
    <imc:DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210428172327161">
          &lt;div&gt;
            &lt;div style="margin-left:90pt"&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss before income tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(18,013&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(28,472&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statutory tax rate in Canada 26.5%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(4,773&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(7,545&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Increase (decrease) in income tax due to:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible expenses (non-taxable income), net for tax purposes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,447&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of different tax rate of subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;310&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;161&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments in respect of current income tax of previous years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(21&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;303&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognition (derecognition) of tax benefit in respect of losses of previous years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(830&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unrecognized tax benefit in respect of loss for the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4,093&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,771&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Utilization of losses not previously recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,466&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in tax benefits not recognized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;5,252&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(289&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;96&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;505&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;262&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </imc:DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory>
    <ifrs-full:AccountingProfit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307113918000_xbrl_20210428023705327_32"
      unitRef="CAD">-18013000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307113918000_xbrl_20210428023705327_35"
      unitRef="CAD">-28472000</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20200101to20201231"
      decimals="3"
      id="Fxbrl_202203292102487510"
      unitRef="Percentage">0.265</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20210101to20211231"
      decimals="3"
      id="Fxbrl_20220329210248751"
      unitRef="Percentage">0.265</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428023705327_52"
      unitRef="CAD">-4773000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428023705327_55"
      unitRef="CAD">-7545000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <imc:NonDeductibleIncomeExpenseNetForTaxPurposes
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307113927129_xbrl_20210428023705327_92"
      unitRef="CAD">-3447000</imc:NonDeductibleIncomeExpenseNetForTaxPurposes>
    <imc:NonDeductibleIncomeExpenseNetForTaxPurposes
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307113927129_xbrl_20210428023705327_95"
      unitRef="CAD">6306000</imc:NonDeductibleIncomeExpenseNetForTaxPurposes>
    <imc:TaxEffectOfDifferentTaxRateOfSubsidiaries
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428023705327_102"
      unitRef="CAD">310000</imc:TaxEffectOfDifferentTaxRateOfSubsidiaries>
    <imc:TaxEffectOfDifferentTaxRateOfSubsidiaries
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428023705327_105"
      unitRef="CAD">161000</imc:TaxEffectOfDifferentTaxRateOfSubsidiaries>
    <imc:TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307113934767_xbrl_20210428023705327_112"
      unitRef="CAD">-21000</imc:TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears>
    <imc:TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307113934767_xbrl_20210428023705327_115"
      unitRef="CAD">303000</imc:TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears>
    <imc:TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307113941983_xbrl_20210428023705327_122"
      unitRef="CAD">846000</imc:TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears>
    <imc:TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307113941983_xbrl_20210428023705327_125"
      unitRef="CAD">-830000</imc:TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears>
    <imc:TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210428023705327_132"
      unitRef="CAD">4093000</imc:TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss>
    <imc:TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210428023705327_135"
      unitRef="CAD">1771000</imc:TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss>
    <imc:UtilizationOfLossesNotPreviouslyRecognized
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307114620089_xbrl_20210428023705327_132"
      unitRef="CAD">-1466000</imc:UtilizationOfLossesNotPreviouslyRecognized>
    <imc:UtilizationOfLossesNotPreviouslyRecognized
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307114620089_xbrl_20210428023705327_135"
      unitRef="CAD">0</imc:UtilizationOfLossesNotPreviouslyRecognized>
    <imc:ChangeInTaxBenefitsNotRecognized
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220329211130030"
      unitRef="CAD">5252000</imc:ChangeInTaxBenefitsNotRecognized>
    <imc:ChangeInTaxBenefitsNotRecognized
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220330193418718"
      unitRef="CAD">0</imc:ChangeInTaxBenefitsNotRecognized>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307113950203_xbrl_20210428023705327_142"
      unitRef="CAD">-289000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307113950203_xbrl_20210428023705327_145"
      unitRef="CAD">96000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307113956196_xbrl_20210428023705327_162"
      unitRef="CAD">505000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307113956196_xbrl_20210428023705327_165"
      unitRef="CAD">262000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:DisclosureOfIssuedCapitalExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220307121844648">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;NOTE 18:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;EQUITY&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition of share capital:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="line-height:1.25;margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Authorized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued and outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Authorized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued and outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="14" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares without par value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unlimited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;68,217,894&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unlimited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;39,765,799&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares confer upon their holders the right to participate in the general meeting where each Ordinary share has one voting right in all matters, receive dividends if and when declared and to participate in the distribution of surplus assets in case of liquidation of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div/&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 12, 2021, the Company's shareholders general meeting resolved to consolidated all of its issued and outstanding Ordinary shares on a four (4) to one (1) basis (the &#x201c;Share Consolidation&#x201d;). Following the Share Consolidation, the number of Listed Warrants outstanding was not altered; however, the exercise terms were adjusted such that four Listed Warrants are exercisable for one Ordinary Share following the payment of an adjusted exercise price of $5.20. The earnings per share, in these consolidated financial statements, give effect to the Share Consolidation for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital issuance during the reporting period:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;text-indent:0pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 10, 2021, the Company completed an overnight marketed offering (the &#x201c;Offering&#x201d;) of 6,086,956 Common Shares (each an &#x201c;Offered Share&#x201d;) at a price of US$5.75 per Offered Share for aggregate gross proceeds of approximately US$35 million ($42,502). The Company also issued 3,043,478 Common Share purchase warrants (each an &#x201c;2021 Warrant&#x201d;) to the purchasers of Offered Shares, for no additional consideration, that entitle the holders to purchase 3,043,478 Common Shares of the Company at an exercise price of US$7.2 per Common Share for a term of 5 years from the closing date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As the exercise price of the 2021 Warrants is denominated in US dollars, which is not the functional currency of the Company, the 2021 Warrants are accounted for as a derivative liability, which is measured at fair value. Gross proceeds in the amount of $30,670 were recorded as Share capital and premium, and $11,832 were recorded as a Warrant liability, based on a valuation using the Black &amp;amp; Scholes option pricing model. The transaction costs incurred as a result of the Common Shares issuance amounted to approximately $3,800, of which approximately $1,296 (attributed to the issuance of the Warrants classified as liabilities) were recorded as an expense in the Company's consolidated statements of profit or loss and approximately $2,539 (attributed to the issuance of share capital) as a deduction from Share capital and premium.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to the terms of the Offering, the placement agents held an over-allotment option to purchase up to an additional 913,044 Offered Shares and 456,522 2021 Warrants on the same terms and conditions for a period of 30 days following the closing date. The over- allotment option was not exercised by the placement agents and expired as of June 30, 2021. The Company recorded expenses in the amount of approximately $800 under share-based compensation expenses with respect to the Offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Offering was conducted pursuant to the Company's effective shelf registration statement on Form F-10 filed with the U.S. Securities and Exchange Commission and a corresponding Canadian shelf prospectus filed with the Securities Regulatory Authority in each of the provinces and territories of Canada and a final prospectus supplement which was filed with the SEC on May 5, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div/&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in issued and outstanding share capital:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:90pt"&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;36,435,837&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued as a result of Warrants and Compensation options exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,169,769&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued as a result of options exercises&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;160,193&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;39,765,799&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued as a result of Warrants and Compensation options exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;633,784&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued as a result of options exercises&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;517,346&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchase of treasury common shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(101,649&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued related secondary transaction and business combinations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;27,402,614&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;68,217,894&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share option plan:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;div style="text-align:justify;margin-right:28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Awards granted under the company&#x2019;s current plan which was approved by the board of directors on December 19, 2018 (&#x201c;2018 Plan&#x201d;) are subject to vesting schedules and unless determined otherwise by the administrator of the 2018 Plan, generally vest following a period of three years from the applicable vesting commencement date, such that 33.3% of the awards vest on the first anniversary of the applicable vesting commencement date and 66.7% of the awards vest in eight equal installments upon the lapse of each three-month period thereafter. Subject to the discretion of the 2018 Plan administrator, if an award has not been exercised within seven years after the date of the grant, the award expires. As of December 31, 2021, 1,607,550 Ordinary shares are available for future grants under the 2018 Plan.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div/&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value for options granted during the years ended December 31, 2021 and 2020, to the Group's employees, directors and advisors was estimated using the Black &amp;amp; Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:90pt"&gt;

              &lt;div&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price (in CAD)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$4.5 - $10.12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.6 - $8.56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life of share options (Years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3-4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.77 - 9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Volatility (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80.61-83.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74.8 - 80.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Annual risk-free rate (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.52-0.77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.25 &#x2013; 0.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share price (in CAD)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;$10.02&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.48 &#x2013; $8.56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;

          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The weighted average fair value of each option on the grant date amounted to $4.16.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table lists the number of share options and the weighted average exercise prices of share options in the 2018 Plan:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25;margin-left:90pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;in CAD&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the beginning of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,154,870&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2.2&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options granted during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,964,265&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;6.2&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercised during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(517,346&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2.43&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options forfeited during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(158,544&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;4.08&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;5,443,245&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;3.91&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercisable at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,888,480&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
            &lt;/div&gt;
            &lt;div/&gt;
            &lt;div style="margin-left:90pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;in CAD&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the beginning of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,940,000&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1.6&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options granted during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;905,000&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4.24&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercised during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(160,193&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1.8&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options forfeited during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(529,937&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1.8&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,154,870&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2.2&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercisable at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,328,770&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1.8&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The weighted average remaining contractual life for the share options outstanding as of December 31, 2021, and 2020 was 5.37 and 7.32 years respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The share-based payment expenses for the year ended December 31, 2021 and 2020, amounted to $7,471 and $3,382, respectively.&lt;/span&gt;&lt;/span&gt;
            &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table lists the number of restricted share units (&#x201c;RSUs&#x201d;) as of December 31, 2021:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:90pt"&gt;

              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of RSU&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at the beginning of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;550,000&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at the end of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;550,000&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;229,006&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other convertible securities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2021, there are 134,872, 2019 Compensation Units Options to acquire Compensation Units at a price of $1.05 per unit. Each Compensation Unit consists of one IMCC Ordinary Share and one half IMCC Warrant, with each whole IMCC Warrant exercisable for one IMC Ordinary Share at an exercise price of $1.3. These Units are exercisable at any time until August 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2021, there are 182,609 compensation warrants. Each Compensation Warrant is exercisable for one Common Share at an exercise price of US$6.61 (approximately $8.42). These Warrants are exercisable at any time following the date that is six months after the date of the Compensation warrants agency agreement until the date that is the three and one half year anniversary of the agency agreement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfIssuedCapitalExplanatory>
    <imc:DisclosureOfCompositionOfShareCapitalExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210427121410409">
            &lt;div&gt;
              &lt;div style="line-height:1.25;margin-left:90pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Authorized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued and outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Authorized&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued and outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="14" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:2pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares without par value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unlimited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;68,217,894&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);text-align:center" valign="bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unlimited&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;39,765,799&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </imc:DisclosureOfCompositionOfShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_202104271329324710"
      unitRef="Share">68217894</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20210427132932471"
      unitRef="Share">68217894</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20201231"
      decimals="0"
      id="Fxbrl_202104271330424370"
      unitRef="Share">39765799</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20201231"
      decimals="0"
      id="Fxbrl_20210427133042437"
      unitRef="Share">39765799</ifrs-full:NumberOfSharesIssued>
    <imc:DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares
      contextRef="C_20210201to20210212"
      id="Fxbrl_20210507094522618">the Company's shareholders general meeting resolved to consolidated all of its issued and outstanding Ordinary shares on a four (4) to one (1) basis (the &#x201c;Share Consolidation&#x201d;)</imc:DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20210212"
      decimals="2"
      id="Fxbrl_20210428025124509"
      unitRef="CAD_per_Share">5.20</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="INF"
      id="Fxbrl_20220307134209235"
      unitRef="Share">6086956</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="C_20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="2"
      id="Fxbrl_20220307134216792"
      unitRef="USD_per_Share">5.75</ifrs-full:ParValuePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-6"
      id="Fxbrl_20220307134221776"
      unitRef="USD">35000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-3"
      id="Fxbrl_20220307134525529"
      unitRef="CAD">42502000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="0"
      id="Fxbrl_20220307135057180"
      unitRef="Shares">3043478</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <imc:NumberOfCommonSharesCalledByWarrants
      contextRef="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="INF"
      id="Fxbrl_20220307135100170"
      unitRef="Share">3043478</imc:NumberOfCommonSharesCalledByWarrants>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="1"
      id="Fxbrl_20220307135107559"
      unitRef="USD_per_Share">7.2</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <imc:TermOfWarrantsFromDateOfIssuance
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      id="Fxbrl_20220307135111415">P5Y</imc:TermOfWarrantsFromDateOfIssuance>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220330214546764"
      unitRef="CAD">30670000</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:WarrantLiability
      contextRef="C_20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220307140626252"
      unitRef="CAD">11832000</ifrs-full:WarrantLiability>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member"
      decimals="-3"
      id="Fxbrl_20220307142301551"
      unitRef="CAD">3800000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_imcListedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20220307142339609"
      unitRef="CAD">1296000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210501to20210510_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220307142409945"
      unitRef="CAD">2539000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="0"
      id="Fxbrl_20220307143348504"
      unitRef="Shares">913044</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="0"
      id="Fxbrl_20220308030459847"
      unitRef="Shares">456522</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <imc:ShareBasedCompensation
      contextRef="C_20210501to20210510_imcEquityTransactionAxis_imcOvernightMarketedOfferingMember"
      decimals="-3"
      id="Fxbrl_20220307143408530"
      unitRef="CAD">800000</imc:ShareBasedCompensation>
    <imc:DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210427121439324">
            &lt;div&gt;
              &lt;div style="margin-left:90pt"&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;36,435,837&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued as a result of Warrants and Compensation options exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,169,769&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued as a result of options exercises&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;160,193&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;39,765,799&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued as a result of Warrants and Compensation options exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;633,784&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued as a result of options exercises&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;517,346&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchase of treasury common shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(101,649&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common Shares issued related secondary transaction and business combinations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;27,402,614&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;68,217,894&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </imc:DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20191231"
      decimals="0"
      id="Fxbrl_20210427133123064"
      unitRef="Share">36435837</ifrs-full:NumberOfSharesOutstanding>
    <imc:OrdinarySharesIssuedForWarrantsCompensationOptionsExercised
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20220307144224467"
      unitRef="Share">3169769</imc:OrdinarySharesIssuedForWarrantsCompensationOptionsExercised>
    <imc:OrdinarySharesIssuedOptionsExercises
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20220307144242882"
      unitRef="Share">160193</imc:OrdinarySharesIssuedOptionsExercises>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20201231"
      decimals="0"
      id="Fxbrl_20220329204938286"
      unitRef="Share">39765799</ifrs-full:NumberOfSharesOutstanding>
    <imc:OrdinarySharesIssuedForWarrantsCompensationOptionsExercised
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20210427133401725"
      unitRef="Share">633784</imc:OrdinarySharesIssuedForWarrantsCompensationOptionsExercised>
    <imc:OrdinarySharesIssuedOptionsExercises
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20210427133438825"
      unitRef="Share">517346</imc:OrdinarySharesIssuedOptionsExercises>
    <imc:PurchaseOfTreasuryCommonShares
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20220331132832770_xbrl_20210427133438825"
      unitRef="Share">-101649</imc:PurchaseOfTreasuryCommonShares>
    <imc:NumberOfSharesIssuedInBusinessCombinationTransaction
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20220329204930433"
      unitRef="Share">27402614</imc:NumberOfSharesIssuedInBusinessCombinationTransaction>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20220331132628095_xbrl_20220329204938286"
      unitRef="Share">68217894</ifrs-full:NumberOfSharesOutstanding>
    <imc:PercentageOfAwardsVest
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember_imcVestingAxis_imcFirstAnniversaryOfApplicableVestingCommencementDateMember"
      decimals="3"
      id="Fxbrl_20210428045024529"
      unitRef="Percentage">0.333</imc:PercentageOfAwardsVest>
    <imc:PercentageOfAwardsVest
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember_imcVestingAxis_imcVestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember"
      decimals="3"
      id="Fxbrl_20210428045112168"
      unitRef="Percentage">0.667</imc:PercentageOfAwardsVest>
    <imc:NumberOfSharesAvailableForFutureGrants
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"
      decimals="INF"
      id="Fxbrl_20210428045403965"
      unitRef="Share">1607550</imc:NumberOfSharesAvailableForFutureGrants>
    <imc:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220330181507214">
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price (in CAD)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$4.5 - $10.12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.6 - $8.56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life of share options (Years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3-4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.77 - 9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Volatility (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80.61-83.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74.8 - 80.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Annual risk-free rate (%)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.52-0.77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.25 &#x2013; 0.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share price (in CAD)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;$10.02&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.48 &#x2013; $8.56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </imc:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="1"
      id="Fxbrl_20220331133104084"
      unitRef="Year">4.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20210427160732853"
      unitRef="CAD_per_Share">10.12</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="1"
      id="Fxbrl_20220330181149385"
      unitRef="CAD_per_Share">1.6</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220307161038207"
      unitRef="CAD_per_Share">8.56</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20210428121057426"
      unitRef="Percentage">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20200101to20201231"
      decimals="2"
      id="Fxbrl_20210428121113706"
      unitRef="Percentage">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="0"
      id="Fxbrl_20220331133137764"
      unitRef="Year">3</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="0"
      id="Fxbrl_20220331133141244"
      unitRef="Year">4</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220307161708165"
      unitRef="Year">2.77</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="0"
      id="Fxbrl_20220330200053762"
      unitRef="Year">9</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="4"
      id="Fxbrl_20210427160903917"
      unitRef="Percentage">0.8061</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="4"
      id="Fxbrl_20210427160936839"
      unitRef="Percentage">0.8368</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="3"
      id="Fxbrl_20220307162031008"
      unitRef="Percentage">0.748</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="4"
      id="Fxbrl_20220307161318878"
      unitRef="Percentage">0.8039</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="4"
      id="Fxbrl_20210427160915068"
      unitRef="Percentage">0.0052</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20210101to20211231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="4"
      id="Fxbrl_20210427160941503"
      unitRef="Percentage">0.0077</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="4"
      id="Fxbrl_20220307162108015"
      unitRef="Percentage">0.0025</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="4"
      id="Fxbrl_20210427161034953"
      unitRef="Percentage">0.0037</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20210427160921239"
      unitRef="CAD_per_Share">10.02</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220307161914661"
      unitRef="CAD_per_Share">1.48</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20200101to20201231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220307161919055"
      unitRef="CAD_per_Share">8.56</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"
      decimals="2"
      id="Fxbrl_20210428045752591"
      unitRef="CAD">4.16</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220330181524286">
          &lt;div&gt;
            &lt;div style="line-height:1.25;margin-left:90pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;in CAD&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the beginning of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,154,870&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2.2&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options granted during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,964,265&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;6.2&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercised during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(517,346&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;2.43&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options forfeited during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(158,544&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;4.08&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;5,443,245&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;3.91&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercisable at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,888,480&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
            &lt;/div&gt;
            &lt;div/&gt;
            &lt;div style="margin-left:90pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:90pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;in CAD&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the beginning of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,940,000&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1.6&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options granted during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;905,000&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;4.24&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercised during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(160,193&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;1.8&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options forfeited during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(529,937&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1.8&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;3,154,870&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2.2&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercisable at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,328,770&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1.8&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20201231"
      decimals="0"
      id="Fxbrl_20210427151729421"
      unitRef="Shares">3154870</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20201231"
      decimals="1"
      id="Fxbrl_20210427151739167"
      unitRef="CAD_per_Share">2.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20210427152243944_xbrl_20210427151729421"
      unitRef="Shares">2964265</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20210101to20211231"
      decimals="1"
      id="Fxbrl_20210427152243944_xbrl_20210427151739167"
      unitRef="CAD_per_Share">6.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20210427152252702_xbrl_20210427151729421"
      unitRef="Shares">517346</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20210427152252702_xbrl_20210427151739167"
      unitRef="CAD_per_Share">2.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20210427152314692_xbrl_20210427151729421"
      unitRef="Shares">158544</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20210427152314692_xbrl_20210427151739167"
      unitRef="CAD_per_Share">4.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20210427152318936_xbrl_20210427151729421"
      unitRef="Shares">5443245</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231"
      decimals="2"
      id="Fxbrl_20210427152318936_xbrl_20210427151739167"
      unitRef="CAD_per_Share">3.91</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20210427152329288_xbrl_20210427151729421"
      unitRef="Shares">1888480</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20210427152329288_xbrl_20210427151739167"
      unitRef="CAD_per_Share">2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20191231"
      decimals="0"
      id="Fxbrl_20210427152819985_xbrl_20210427151729421"
      unitRef="Shares">2940000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20191231"
      decimals="1"
      id="Fxbrl_20210427152819985_xbrl_20210427151739167"
      unitRef="CAD_per_Share">1.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20210427152847303_xbrl_20210427152252702_xbrl_20210427151729421"
      unitRef="Shares">905000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20200101to20201231"
      decimals="2"
      id="Fxbrl_20210427152847303_xbrl_20210427152252702_xbrl_20210427151739167"
      unitRef="CAD_per_Share">4.24</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20220307162905758"
      unitRef="Shares">160193</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20200101to20201231"
      decimals="1"
      id="Fxbrl_20210427152923934_xbrl_20210427152252702_xbrl_20210427151739167"
      unitRef="CAD_per_Share">1.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20210427152954396_xbrl_20210427152314692_xbrl_20210427151729421"
      unitRef="Shares">529937</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20200101to20201231"
      decimals="1"
      id="Fxbrl_20210427152954396_xbrl_20210427152314692_xbrl_20210427151739167"
      unitRef="CAD_per_Share">1.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20201231"
      decimals="0"
      id="Fxbrl_20210427152737742_xbrl_20210427151729421"
      unitRef="Shares">3154870</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20201231"
      decimals="1"
      id="Fxbrl_20210427152737742_xbrl_20210427151739167"
      unitRef="CAD_per_Share">2.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20201231"
      decimals="0"
      id="Fxbrl_20210427152755407_xbrl_20210427152329288_xbrl_20210427151729421"
      unitRef="Shares">1328770</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20201231"
      decimals="1"
      id="Fxbrl_20210427152755407_xbrl_20210427152329288_xbrl_20210427151739167"
      unitRef="CAD_per_Share">1.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"
      id="Fxbrl_20210428050338427">P5Y4M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"
      id="Fxbrl_20210428050423397">P7Y3M25D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20210101to20211231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20210428050534423"
      unitRef="CAD">7471000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200101to20201231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_imcShareIncentivePlanMember"
      decimals="-3"
      id="Fxbrl_20210428050553662"
      unitRef="CAD">3382000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <imc:DisclosureOfRestrictedShareUnitsTableTextBlock
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220331142049125">
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of RSU&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at the beginning of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;550,000&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding at the end of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;550,000&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable at the end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;229,006&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </imc:DisclosureOfRestrictedShareUnitsTableTextBlock>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20201231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember"
      decimals="0"
      id="Fxbrl_20220331142205906"
      unitRef="Shares">0</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210101to20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember"
      decimals="0"
      id="Fxbrl_20220331142240032_xbrl_20220331142226473"
      unitRef="Shares">550000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember"
      decimals="0"
      id="Fxbrl_20220331142238345_xbrl_20220331142226473"
      unitRef="Shares">550000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember"
      decimals="0"
      id="Fxbrl_20220331142226473"
      unitRef="Shares">229006</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <imc:NumberOfCompensationUnitsIssued
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20210428052830824"
      unitRef="Share">134872</imc:NumberOfCompensationUnitsIssued>
    <imc:CompensationUnitPerShare
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20210428052914309"
      unitRef="CAD_per_Share">1.05</imc:CompensationUnitPerShare>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20211231"
      decimals="1"
      id="Fxbrl_20210428221901063"
      unitRef="CAD_per_Share">1.3</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019>
    <imc:NumberOfCompensationWarrantsToAcquired
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220307164205426"
      unitRef="Share">182609</imc:NumberOfCompensationWarrantsToAcquired>
    <imc:WarrantPricePerShare
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20220307164229262"
      unitRef="USD_per_Share">6.61</imc:WarrantPricePerShare>
    <imc:WarrantPricePerShare
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20220307164249110"
      unitRef="CAD_per_Share">8.42</imc:WarrantPricePerShare>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210427100445784">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;NOTE 19:-&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;SELECTED STATEMENTS OF PROFIT OR LOSS DATA&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="margin-left:90pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;19,718&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;6,897&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;6,004&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;930&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <ifrs-full:DisclosureOfExpensesByNatureExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210427100708194">
                &lt;div&gt;
                  &lt;div style="margin-left:90pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;19,718&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;6,897&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation and amortization&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;6,004&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;930&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </ifrs-full:DisclosureOfExpensesByNatureExplanatory>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427100925380"
      unitRef="CAD">19718000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427100933315"
      unitRef="CAD">6897000</ifrs-full:WagesAndSalaries>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427100940703"
      unitRef="CAD">6004000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427100945493"
      unitRef="CAD">930000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210427205249017">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 20:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NET EARNINGS (LOSS) PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;text-indent:-28.35pt;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Details of the number of shares and income (loss) used in the computation of earnings per share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:63pt"&gt;

                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="14" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted number of shares (in thousands)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss attributable to equity holders of the Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted number of shares (in thousands)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss attributable to equity holders of the Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the computation of basic net earnings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;57,963&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(17,763&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;38,565&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(28,698&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of potential dilutive Ordinary shares&#160;- Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,810&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(21,739&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the computation of diluted net earnings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;59,773&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(39,502&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;38,565&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(28,698&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;

                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;For 2021, and 2020, potentially dilutive securities (share options) were excluded from the calculation of diluted earnings per share as they are antidilutive.&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;**)&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Including the effect of Share Consolidation (See Note 18a).&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:EarningsPerShareExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329202427967">
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="14" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted number of shares (in thousands)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss attributable to equity holders of the Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted number of shares (in thousands)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss attributable to equity holders of the Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the computation of basic net earnings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;57,963&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(17,763&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;38,565&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(28,698&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect of potential dilutive Ordinary shares&#160;- Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,810&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(21,739&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-11.35pt;margin-left:11.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the computation of diluted net earnings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;59,773&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(39,502&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;38,565&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(28,698&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  </ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427205400026"
      unitRef="Share">57963000</ifrs-full:WeightedAverageShares>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427205437082"
      unitRef="CAD">-17763000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427205536092"
      unitRef="Share">38565000</ifrs-full:WeightedAverageShares>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427205617852"
      unitRef="CAD">-28698000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307121716390_xbrl_20210427205407010"
      unitRef="Share">1810000</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307121716390_xbrl_20210427205455173"
      unitRef="CAD">-21739000</ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307121716390_xbrl_20210427205556085"
      unitRef="Share">0</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307121716390_xbrl_20210427205635597"
      unitRef="CAD">0</ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427205423040"
      unitRef="Share">59773000</ifrs-full:AdjustedWeightedAverageShares>
    <imc:ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20210427205511938"
      unitRef="CAD">-39502000</imc:ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427205605821"
      unitRef="Share">38565000</ifrs-full:AdjustedWeightedAverageShares>
    <imc:ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20210427205710012"
      unitRef="CAD">-28698000</imc:ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329202733485">
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;NOTE 21:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;RELATED PARTY BALANCES AND TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balances and transactions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes balances with related parties in the statements of financial position:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                    &lt;div&gt;
                      &lt;div style="margin-left:90pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other accounts receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;11&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;36&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other accounts payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;875&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;

                  &lt;div/&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes the transactions with related parties in the consolidated statements of profit or loss and other comprehensive income:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                    &lt;div&gt;
                      &lt;div style="margin-left:90pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,116&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;617&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;

                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions with related parties mainly includes compensation for management services and bonus in the ordinary course of business and short-term lease payments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Compensation of key management personnel of the Group:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:84.75pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's key management personnel are the directors, senior executives and a managing company which provides the Company with key management personnel services.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;

                      &lt;div&gt;
                        &lt;div style="margin-left:90pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payroll and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,377&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,005&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;5,700&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,791&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fees *)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,029&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,391&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Includes payments to shareholders for the years ended 2021 and 2020 of $455 and $534, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;

                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;
                            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                                &lt;tr&gt;
                                  &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;c.&lt;/td&gt;
                                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                    &lt;div&gt;See Note 5 for indemnification agreement with a former director of TFC, currently serving as the Company's chairman of the board of directors.&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;

                            &lt;/table&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <imc:DisclosureOfBalancesWithRelatedPartiesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210427131318809">
                    &lt;div&gt;
                      &lt;div style="margin-left:90pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other accounts receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;11&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;36&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other accounts payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;875&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;-&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  </imc:DisclosureOfBalancesWithRelatedPartiesExplanatory>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220307104833531"
      unitRef="CAD">11000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220307104845316"
      unitRef="CAD">36000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220307104839541"
      unitRef="CAD">875000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220307104859580"
      unitRef="CAD">0</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210427131331015">
                    &lt;div&gt;
                      &lt;div style="margin-left:90pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,116&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;617&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  </ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220307104908732"
      unitRef="CAD">1116000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember"
      decimals="-3"
      id="Fxbrl_20220307104917251"
      unitRef="CAD">617000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329202746014">
                      &lt;div&gt;
                        &lt;div style="margin-left:90pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payroll and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,377&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,005&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;5,700&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,791&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional fees *)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,029&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,391&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                            &lt;tr&gt;
                              &lt;td style="width:85.05pt"&gt;&#160;&lt;/td&gt;
                              &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Includes payments to shareholders for the years ended 2021 and 2020 of $455 and $534, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    </ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
    <imc:KeyManagementPersonnelCompensationPayrollAndRelatedExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307105144170_33"
      unitRef="CAD">2377000</imc:KeyManagementPersonnelCompensationPayrollAndRelatedExpenses>
    <imc:KeyManagementPersonnelCompensationPayrollAndRelatedExpenses
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307105144170_37"
      unitRef="CAD">2005000</imc:KeyManagementPersonnelCompensationPayrollAndRelatedExpenses>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307105144170_53"
      unitRef="CAD">5700000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307105144170_57"
      unitRef="CAD">2791000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220307105144170_73"
      unitRef="CAD">1029000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220307105144170_77"
      unitRef="CAD">1391000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember"
      decimals="-3"
      id="Fxbrl_20210428150056331"
      unitRef="CAD">455000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember"
      decimals="-3"
      id="Fxbrl_20210428150102383"
      unitRef="CAD">534000</ifrs-full:ProfessionalFeesExpense>
    <imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329203000331">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;NOTE 22:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:56.7pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Summarized financial information for Focus as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:63pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Statement of financial position at reporting date (as presented in Focus' financial statements):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;22,913&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;16,531&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;4,473&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;4,226&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(19,616&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(11,341&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1,883&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(2,274&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Total equity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;5,887&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;7,142&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:63pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Operating results (as presented in Focus' financial statements):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;14,747&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;13,823&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,524&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;968&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Other comprehensive income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;37&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(22&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Total comprehensive income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(1,487&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;946&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:63pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Cash flows (as presented in Focus' financial statements):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;From operating activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,346&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,882&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;From investing activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(783&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,656&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;From financing activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;560&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(184&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Effect of foreign exchange on cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;169&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;39&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net increase in cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,292&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;81&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory>
    <imc:DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20211101180453497">
              &lt;div&gt;
                &lt;div style="margin-left:63pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Statement of financial position at reporting date (as presented in Focus' financial statements):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;22,913&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;16,531&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;4,473&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;4,226&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(19,616&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(11,341&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(1,883&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;(2,274&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Total equity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;5,887&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;7,142&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </imc:DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory>
    <ifrs-full:CurrentAssets
      contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191133109"
      unitRef="CAD">22913000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191144582"
      unitRef="CAD">16531000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191158221"
      unitRef="CAD">4473000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191226933"
      unitRef="CAD">4226000</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191326124"
      unitRef="CAD">19616000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191406056"
      unitRef="CAD">11341000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191417856"
      unitRef="CAD">1883000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191429475"
      unitRef="CAD">2274000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191635902"
      unitRef="CAD">5887000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191646280"
      unitRef="CAD">7142000</ifrs-full:Equity>
    <imc:DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20210427192610728">
              &lt;div&gt;
                &lt;div style="margin-left:63pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Operating results (as presented in Focus' financial statements):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;14,747&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;13,823&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,524&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;968&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Other comprehensive income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;37&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(22&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Total comprehensive income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(1,487&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;946&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </imc:DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191726984"
      unitRef="CAD">14747000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191745209"
      unitRef="CAD">13823000</ifrs-full:Revenue>
    <ifrs-full:ProfitLoss
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307114024627"
      unitRef="CAD">-1524000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191809544"
      unitRef="CAD">968000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191832288"
      unitRef="CAD">37000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191842488"
      unitRef="CAD">-22000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20220307114037336"
      unitRef="CAD">-1487000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191908793"
      unitRef="CAD">946000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DisclosureOfCashFlowStatementExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20211101180440768">
              &lt;div&gt;
                &lt;div style="margin-left:63pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Cash flows (as presented in Focus' financial statements):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;From operating activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;2,346&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;1,882&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;From investing activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(783&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;(1,656&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;From financing activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;560&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;(184&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Effect of foreign exchange on cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;169&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;39&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="text-indent:-11.35pt;margin-left:14.15pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net increase in cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;2,292&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;81&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfCashFlowStatementExplanatory>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191937819"
      unitRef="CAD">2346000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427191954835"
      unitRef="CAD">1882000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427192003002"
      unitRef="CAD">-783000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427192021497"
      unitRef="CAD">-1656000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427192037922"
      unitRef="CAD">560000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427192055898"
      unitRef="CAD">-184000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427192111522"
      unitRef="CAD">169000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427192126179"
      unitRef="CAD">39000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427192135939"
      unitRef="CAD">2292000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20200101to20201231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember"
      decimals="-3"
      id="Fxbrl_20210427192146811"
      unitRef="CAD">81000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329215029228">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 23:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;OPERATING SEGMENTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:56.7pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:28.35pt;vertical-align:top;align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Reporting operating segments:&lt;/p&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:90pt"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25;margin-left:90pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Germany&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31, 2021:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;25,431&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;20,247&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;8,622&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;54,300&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,654&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,142&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated corporate expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(7,240&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(7,240&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total operating loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(38,389&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation, amortization and impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,424&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,879&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,004&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div&gt;&#160;&lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25;margin-left:90pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Germany&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31, 2020:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,826&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,064&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;15,890&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,090&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,744&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated corporate expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(2,411&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(2,411&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total operating loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,245&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation, amortization and impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;617&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;690&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25;margin-left:90pt"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      </ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329215112392">
            &lt;div&gt;
              &lt;div style="margin-left:90pt"&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25;margin-left:90pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Germany&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31, 2021:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;25,431&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;20,247&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;8,622&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;-&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;54,300&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,654&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,142&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated corporate expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(7,240&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(7,240&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total operating loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(38,389&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation, amortization and impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,424&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,879&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,004&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div&gt;&#160;&lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25;margin-left:90pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Germany&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31, 2020:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,826&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,064&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;15,890&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,090&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,744&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated corporate expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(2,411&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;(2,411&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="text-indent:-8.5pt;margin-left:8.5pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total operating loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,245&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation, amortization and impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;617&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;690&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25;margin-left:90pt"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214608778_xbrl_20220329214324071_33"
      unitRef="CAD">25431000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214608778_xbrl_20220329214324071_37"
      unitRef="CAD">20247000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214608778_xbrl_20220329214324071_311"
      unitRef="CAD">8622000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214608778_xbrl_20220329214324071_315"
      unitRef="CAD">0</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214608778_xbrl_20220329214324071_319"
      unitRef="CAD">54300000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214612834_xbrl_20220329214324071_33"
      unitRef="CAD">-10654000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214612834_xbrl_20220329214324071_37"
      unitRef="CAD">-15353000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214612834_xbrl_20220329214324071_311"
      unitRef="CAD">-5142000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220330174842986"
      unitRef="CAD">0</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214612834_xbrl_20220329214324071_319"
      unitRef="CAD">-31149000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember"
      decimals="-3"
      id="Fxbrl_20220330175419300_xbrl_20220330174842986"
      unitRef="CAD">-7240000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember"
      decimals="-3"
      id="Fxbrl_20220330175419300_xbrl_20220329214612834_xbrl_20220329214324071_319"
      unitRef="CAD">-7240000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220330175616814_xbrl_20220330175419300_xbrl_20220329214612834_xbrl_20220329214324071_319"
      unitRef="CAD">-38389000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214614963_xbrl_20220329214324071_33"
      unitRef="CAD">1424000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214614963_xbrl_20220329214324071_37"
      unitRef="CAD">3879000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214614963_xbrl_20220329214324071_311"
      unitRef="CAD">701000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214614963_xbrl_20220329214324071_315"
      unitRef="CAD">0</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214614963_xbrl_20220329214324071_319"
      unitRef="CAD">6004000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:Revenue
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_33"
      unitRef="CAD">13826000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_37"
      unitRef="CAD">0</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_311"
      unitRef="CAD">2064000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_315"
      unitRef="CAD">0</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833635_xbrl_20220329214608778_xbrl_20220329214324071_319"
      unitRef="CAD">15890000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220331234028017"
      unitRef="CAD">-2090000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220331234158016"
      unitRef="CAD">0</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214843707_xbrl_20220329214612834_xbrl_20220329214324071_311"
      unitRef="CAD">-3744000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214843707_xbrl_20220329214612834_xbrl_20220329214324071_315"
      unitRef="CAD">0</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214843707_xbrl_20220329214612834_xbrl_20220329214324071_319"
      unitRef="CAD">-5834000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember"
      decimals="-3"
      id="Fxbrl_20220330175700057_xbrl_20220330175419300_xbrl_20220330174842986"
      unitRef="CAD">-2411000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullUnallocatedAmountsMember"
      decimals="-3"
      id="Fxbrl_20220330175700057_xbrl_20220330175419300_xbrl_20220329214612834_xbrl_20220329214324071_319"
      unitRef="CAD">-2411000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220330175717885_xbrl_20220330175616814_xbrl_20220330175419300_xbrl_20220329214612834_xbrl_20220329214324071_319"
      unitRef="CAD">-8245000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullCountryOfDomicileMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_33"
      unitRef="CAD">617000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_37"
      unitRef="CAD">0</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_ifrsfullForeignCountriesMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_311"
      unitRef="CAD">73000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20200101to20201231_ifrsfullGeographicalAreasAxis_imcOtherOperatingSegmentsMember_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_315"
      unitRef="CAD">0</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20200101to20201231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember"
      decimals="-3"
      id="Fxbrl_20220329214833641_xbrl_20220329214614963_xbrl_20220329214324071_319"
      unitRef="CAD">690000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220329213127264">
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 24:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revolving Credit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In January 2022, Focus entered into a Revolving Credit Facility with Bank Mizrahi (the &#x201c;Mizrahi Facility&#x201d;). The Mizrahi Facility is guaranteed by Focus assets. Advances from the Mizrahi Facility will be used for working capital needs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Mizrahi Facility has a total commitment of up to NIS 15,000 thousand (approximately $6,000) and has a one-year term for on-going needs and 6 months term for imports and purchases needs. The Mizrahi Facility is renewable upon mutual agreement by the parties. The borrowing base available for draw at any time throughout the Mizrahi Facility and is subject to several covenants to be measured on a quarterly basis. The Mizrahi Facility bears interest of Israeli Prime interest plus 1.5% (approximately 3.3%) per annum.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Xinteza&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 24, 2022, IMC Holdings entered into a Simple Agreement for Future Equity (SAFE) with Xinteza, under which IMC Holdings invested US$100,000 (approximately $125), in exchange for additional future shares of Xinteza.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Closing of Pharm Yarok Transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 14, 2022, the Pharm Yarok Transaction closed upon receipt of all requisite approvals, including the IMCA approval, for an aggregate consideration of NIS 11,900 (approximately $4,600), of which NIS 8,400 (approximately $3,300) was paid in cash upon signing the definitive agreement, and NIS 3,500 (approximately $1,300) paid upon closing. The acquisition of the outstanding ordinary shares of HW Shinua is pending receipt of the requisite approval from the IMCA. In connection with closing of the Pharm Yarok Transaction, the Company completed a non-brokered private placement with former shareholders of Pharm Yarok and Rosen High Way on March 14, 2022. A total of 523,700 Common Shares were issued at a deemed price of $2.616 for aggregate proceeds of $1,370. The calculation of the deemed price was based on the average closing price of Common Shares on the CSE over the 8 trading day period immediately preceding March 14, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Closing of Vironna Transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 14, 2022, the Vironna Transaction closed upon receipt of all requisite approvals, including the approval of the IMCA in consideration of NIS 8,500 (approximately $3,330), comprised of NIS 5,000 (approximately $1,960) in cash and NIS 3,500 (approximately $1,700) in Common Shares issued on closing. In satisfaction of the cash consideration component, NIS 3,750 (approximately $1,470) was paid at signing of the definitive agreement and the remaining NIS 1,250 (approximately $490) will be paid post-closing of the Vironna Transaction. In satisfaction of the share consideration component, the Company issued 485,362 Common Shares at a deemed issue price of US$2.209 per share (approximately $2.8092), calculated based on the average closing price of the Common Shares of on the NASDAQ for the 14 trading day period immediately preceding closing. The shares issued are subject to a staggered three-month lockup commencing on the date of issuance.&lt;/span&gt;&lt;/span&gt;
                        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                    &lt;div/&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;
                          &lt;div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                          &lt;div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Closing of Panaxia Transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 14, 2022, IMC Holdings acquired the Panaxia GDP License following receipt of the requisite IMCA approval and assigned it to IMC Pharma in accordance with the terms of the Panaxia Transaction (the &#x201c;&lt;span style="font-weight:bold"&gt;Panaxia GDP License Closing&lt;/span&gt;&#x201d;). The aggregate consideration for the Panaxia Transaction was NIS 18,700 (approximately $7,200), of which NIS 7,600 (approximately $2,900) was paid in two cash instalments and NIS 11,100 (approximately $4,300) payable in Common Shares (&#x201c;&lt;span style="font-weight:bold"&gt;Panaxia Consideration Shares&lt;/span&gt;&#x201d;). To satisfy the share consideration component of the Panaxia Transaction, the Company issued four instalments of an aggregate of 93,755 Panaxia Consideration Shares between August 9, 2021 and March 14, 2022, with the deemed price of each instalment of Panaxia Consideration Shares determined based on the average closing price of the Common Shares on Nasdaq during the 10 trading day period immediately prior to issuance. The fifth and final instalment of Panaxia Consideration Shares will be issued following the Panaxia GDP License Closing. The Panaxia Transaction includes a further option to acquire, for no additional consideration, a pharmacy from Panaxia, including requisite licenses to dispense and sell medical cannabis to patients, that the Company has exercised (&#x201c;&lt;span style="font-weight:bold"&gt;Panaxia Pharmacy Closing&lt;/span&gt;&#x201d;). The Panaxia Pharmacy Closing is expected to occur during the third quarter of 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                      &lt;div style="text-align:justify;text-indent:5.65pt;margin-left:28.25pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Closing of Oranim Transaction&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 28, 2022, the Oranim Transaction closed upon receipt of all requisite approvals, including the approval of the MOH, for an aggregate consideration of NIS 11,940 (approximately $4,900), consisting of NIS 5,202 (approximately $2,104) paid in cash upon signing, NIS 5,202 (approximately $2,104) which will be paid in cash on the first quarter of 2023 and NIS 1,536 (approximately $630) paid in 251,001 Common Shares on March 30, 2022. The number of Oranim Consideration Shares issuable was calculated based on the average closing price of the IM Cannabis&#x2019;s common shares on the NASDAQ over the 14 trading day period immediately preceding closing of the Oranim Transaction.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div style="text-align:justify;margin-left:33.9pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <imc:Commitment
      contextRef="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329223134208"
      unitRef="NIS">15000000</imc:Commitment>
    <imc:Commitment
      contextRef="C_20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329223153627"
      unitRef="CAD">6000000</imc:Commitment>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20220101to20220131_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcMizrahiMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      id="Fxbrl_20220329223218739">Prime interest plus 1.5% (approximately 3.3%) per annum</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:CashTransferred
      contextRef="C_20220224_ifrsfullBusinessCombinationsAxis_imcXintezaApiLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember_imcAgreementAxis_imcSimpleAgreementForFutureEquityMember"
      decimals="-3"
      id="Fxbrl_20220329223259937"
      unitRef="USD">100000000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220224_ifrsfullBusinessCombinationsAxis_imcXintezaApiLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember_imcAgreementAxis_imcSimpleAgreementForFutureEquityMember"
      decimals="-3"
      id="Fxbrl_20220329223315604"
      unitRef="CAD">125000</ifrs-full:CashTransferred>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329221439771"
      unitRef="NIS">11900000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329221602829"
      unitRef="CAD">4600000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashTransferred
      contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329221622189"
      unitRef="NIS">8400000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329221639196"
      unitRef="CAD">3300000</ifrs-full:CashTransferred>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329221659019"
      unitRef="NIS">3500000</imc:CashConsiderationOfBusinessCombination>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329221729021"
      unitRef="CAD">1300000</imc:CashConsiderationOfBusinessCombination>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20220329222245289"
      unitRef="Share">523700</ifrs-full:NumberOfSharesIssued>
    <imc:DeemedPricePerShare
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="3"
      id="Fxbrl_20220329222303937"
      unitRef="CAD_per_Share">2.616</imc:DeemedPricePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222335449"
      unitRef="CAD">1370000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222443158"
      unitRef="NIS">8500000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222455333"
      unitRef="CAD">3330000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222524996"
      unitRef="NIS">5000000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222532217"
      unitRef="CAD">1960000</ifrs-full:CashTransferred>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222635077"
      unitRef="NIS">3500000</imc:CashConsiderationOfBusinessCombination>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222731001"
      unitRef="CAD">1700000</imc:CashConsiderationOfBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222850576"
      unitRef="NIS">3750000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329222905170"
      unitRef="CAD">1470000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <imc:RemainingAmountOfCashPaid
      contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329223724818"
      unitRef="NIS">1250000</imc:RemainingAmountOfCashPaid>
    <imc:RemainingAmountOfCashPaid
      contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220329223758083"
      unitRef="CAD">490000</imc:RemainingAmountOfCashPaid>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20220329222929291"
      unitRef="Share">485362</ifrs-full:NumberOfSharesIssued>
    <imc:DeemedPricePerShare
      contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="3"
      id="Fxbrl_20220329222959892"
      unitRef="USD_per_Share">2.209</imc:DeemedPricePerShare>
    <imc:DeemedPricePerShare
      contextRef="C_20220301to20220315_ifrsfullBusinessCombinationsAxis_imcVironnaPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="4"
      id="Fxbrl_20220329223024923"
      unitRef="CAD_per_Share">2.8092</imc:DeemedPricePerShare>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330134550268"
      unitRef="NIS">18700000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330134609277"
      unitRef="CAD">7200000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashTransferred
      contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164414250"
      unitRef="NIS">7600000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164432661"
      unitRef="CAD">2900000</ifrs-full:CashTransferred>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164507219"
      unitRef="NIS">11100000</imc:CashConsiderationOfBusinessCombination>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164533802"
      unitRef="CAD">4300000</imc:CashConsiderationOfBusinessCombination>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20220314_ifrsfullBusinessCombinationsAxis_imcPanaxiaLogisticsLtdMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20220330164604289"
      unitRef="Share">93755</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330134555740"
      unitRef="NIS">11940000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330134613556"
      unitRef="CAD">4900000</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashTransferred
      contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164420263"
      unitRef="NIS">5202000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164438402"
      unitRef="CAD">2104000</ifrs-full:CashTransferred>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164457290"
      unitRef="NIS">5202000</imc:CashConsiderationOfBusinessCombination>
    <imc:CashConsiderationOfBusinessCombination
      contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164539832"
      unitRef="CAD">2104000</imc:CashConsiderationOfBusinessCombination>
    <imc:RemainingAmountOfCashPaid
      contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164654292"
      unitRef="NIS">1536000</imc:RemainingAmountOfCashPaid>
    <imc:RemainingAmountOfCashPaid
      contextRef="C_20220301to20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="-3"
      id="Fxbrl_20220330164712477"
      unitRef="CAD">630000</imc:RemainingAmountOfCashPaid>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20220328_ifrsfullBusinessCombinationsAxis_imcOranimPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20220330164611928"
      unitRef="Share">251001</ifrs-full:NumberOfSharesIssued>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20210428001641289"
          xlink:label="Fxbrl_20210428001641289"
          xlink:type="locator"/>
        <link:footnote id="FN20220329225335286" xlink:label="FN20220329225335286" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See also Note 1b(1)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20210428001641289"
          xlink:to="FN20220329225335286"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20210428001652437"
          xlink:label="Fxbrl_20210428001652437"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20210428001652437"
          xlink:to="FN20220329225335286"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220307105144170_73"
          xlink:label="Fxbrl_20220307105144170_73"
          xlink:type="locator"/>
        <link:footnote id="FN20220308122848898" xlink:label="FN20220308122848898" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes payments to shareholders for the years ended 2021 and 2020 of $455 and $534, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220307105144170_73"
          xlink:to="FN20220308122848898"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220307105144170_77"
          xlink:label="Fxbrl_20220307105144170_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220307105144170_77"
          xlink:to="FN20220308122848898"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>146
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M_)5<\[<F.ES)<1SWY(PZGH-@'==8QZA8_5D6;^O&2.'-?>=P@E"<U!0GJ$P
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M3>/DN$7N4Q)#)<52C,TF (K;=9!'L>;1UF,G<<:R,(:C.@<TEA@MJFV.:W,
MQ:V[PMJ=7YN%E$:D_Y0$/)L$/-RF%[&&_"V>B$M_6/Y(YCS,)7S0)J06I>WD
MHG4YPGJ_AULWU#M1,1UX2Y<B:43"!::WXS%&8LW?PWU[&Q:HPL(5RY[YWF6+
M%J&[8'X9_((Q[:S6X%X]'4]FI.CP,/@"K3F8?]FE]DS06_3:2AW/.K^'^_46
M:F^,\.;7]_,%F=S/KF;D4S :!8_D>Y:N?R+7P7QZ!5<Q1IL,/-RYMXPFK>];
MUFN16/#D,'B)7P[(5$G&$XS+9@$/M^PMUR26*9E>-F+A"BX]Q<H+SQJ]ASOS
M*%=P!3+06&0:9I;DRRTW=0^V#NA9J_9._[?51L\ZKM>R)%.APWQ)B2SCR?Y.
MV2*T@##493)8D@)(;$'4.K#?XINM%6Z+ '6P"M>W=NOC;MFMPFT1&9R812L/
M*_Y]:[L^[I;?4."V*%+'<;"YIF_MUW]?\=VEFFR1=!UW0-R!7D&Y(LW^T]W1
M9VQAV]]9=7]?+=ZEMFR1G.=0:1'706<+OO5C_WW%>5M5V2)WB>5]W[JQ_[Z:
MO)X</TCQ$F=A\U?&-3\'36C]G0TKLP95;,LI$II)4[EW55^MM_Z"<L/+WE[N
M&]XRLX2E2,*?H*ES= *ADN567'FBQ;K8_EH*K45:'*XXB[@T-\#O3T+H[8EY
M0+TA.OP;4$L#!!0    ( !U!A%10Z,DWG@<  #H@   8    >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&ULC9I=<]HX%(;_BH;9B]V9IEB2O^@DF2$DW3*30C;0
MW=E+!43PU+:\LIPT_WXE0S!81R(W!9,C^=6Q]#Y'<B]?A?Q9;SE7Z%>1E_75
M8*M4]64XK%=;7K#ZLZAXJ?^R$;)@2E_*YV%=2<[6;:,B'Y(@B(<%R\K!]67[
MVX.\OA2-RK.2/TA4-T7!Y-L-S\7KU0 /WG]XS)ZWROPPO+ZLV#-?</6C>I#Z
M:GCH99T5O*PS42+)-U>#,?XR"1/3H(WX.^.O]=%W9(;R),1/<S%=7PT"HXCG
M?*5,%TQ_O/ )SW/3D];QW[[3P>&>IN'Q]_?>O[:#UX-Y8C6?B/R?;*VV5X-T
M@-9\PYI</8K7;WP_H,CTMQ)YW?Z+7G>QB;[CJJF5*/:-]761E;M/]FN?B*,&
M.'0T(/L&Y*,-Z+X!;0>Z4]8.ZY8I=GTIQ2N2)EKW9KZTN6E;Z]%DI7F,"R7U
M7S/=3EU/YK/%_'YZ.U[>W:+%4G]\OYLM%VC^%7V=SL:SR71\CQ[FB^ER.I^A
M"S09WZ+??_L#_8:R$BVWHJE9N:XOATIK,3T.5_O[WNSN2QSWO>6KSXCB3X@$
M! /-)Q]O'IPV'^H,'-) #FD@;7_4E88?CX]ZW&B\6-PM%U\\/=)#C[3M,73U
MR.HMTKE!*_.%_]=D+RSGI0)SM>LJ;KLR"^_E&M-10"^'+\<IL:/2-(T.02<R
MPX/,T"OSD==*9BO%UWKR5Z+.%*1OUT=TK*^G#8A(867105GD5;:4;,VU4ZRX
MSMQ3SL'$1?9MXP3WQ=E1411@6%Y\D!=[Y8W7+ZQ<\1HIH3VPJO*,2U!B;-V<
MT"#H*;2#:!P06&%R4)AX%<[5EDOMDRO1Z&EWE$E(96(G,@S3?B+MJ#@=P2K3
M@\K4JW):ON@I6)B5T2Z735;JO&8LUP:CIV93N-9,:J<,DU%/L!T4P')'![DC
MK]Q[P<ISN1S93SP)TIXR.\BA# >=E0=>;3>9R,5SMM*Y8W7-X;3M^SA=,FG2
M4P=$)8[UC(]0@\\^ZE()F<%K>=_Z)&\C.NK/02 LI8DK>1T ,/';C5 Z;ZM&
M2JW1ES]BWSZDEN4 823!(77([*B"J1=4L_GLXN.PPAT&L)\##U)7AE*]?4)5
MSDP"]%(TT*K,^ON$2@YR =NV3P,2]^<Z$!9%U&%ON ,$]A/BR#I <;;MD]!R
M""B*A@XXX(X.V(^'6RZU09@2U3>7;-O'85^?'>.:ZQT8L)\,;;%^(3873?TN
MS_V( 3*D."9]F7;8B#IJ$]RQ ?OA<,LW7"_(-5+LUUFAMM?CN*_2CDEB!\!P
MAP3L9\*T5*Q\SC0-SFJT79\&QS7<7J8=AH.18[V0C@_$SX<_A5B_9GD.*2,
M%@BF5@T*Q-$@="CKR$#\9-B9;RG*B_,&3 !,!#1(^@@#XG02$X<#DZ.=PD=
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M&D1)_/L7V1BD+Q3R L= F,;C4K2LK;@Y_4HV_ UJ.>BFPRY'5B0Y&0/TI8I
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M-T\>/C3)2J]C,RHWNJ!?%F6UCFOZ6"T?FDVEXY1O6N</I^/QHX?K."OVG_W
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MQ3<,L.!SLK5V-6VT-_M\BBGR%$F8$J*]IR667OM\&C65@HOPE"4(VVVMC1\
M<Z.'<L6I*\\Y,<E(#D")G+L)M2$I>9\0[/O.&^\GU!")#><EBLA$T_.XN%(?
M*CSC(]1GDQ,V.![-QM\Q5J1@VZPM1X0N3F3K;?BC;NB'>X^CH\?3T1[!I9_B
MHD'J!OY'MMS<4_B/7N'/1.']IEBGF;2+[(\J7F4=$W#?]4U!Z.S_NJWQ0HP
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M]'?<4T)\0-N$$6#&Y2Y>\.7'2ZXUA5R .V0EO<[T#1(MT[*>6*"_Z"K)N)6
MC(A2"BY%.7=@X4"E%ZR"W &7A[/52H ,,^&Y] G*/$M9WSE DX(;W;?RO2D[
M.&EP/AXJC1"OZ$E(.CA?D(>9;%EPOKB&/"2VV5II&VGXJ:\^O0CF,<1U66"
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ME&[) 4L/7G:9T8LGW<L73ZR#?PKXKVWNX5]P\$SW&JSGER^ 3F_--3B)>"[
M.-\=G1\EWR) WQU=G5]>71P]@9'Q\9<OMOK6O ./$+,)E5G!T+/%M\^..,KE
M_^B:+4Z)Y1I=LZ&/>!>J:?$!^'W5-)W_ Q>X;]K/!-[+_P=02P,$%     @
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M!S0A<^E=-3B)G5P]_A+H8ZF3"22*8HALX0=C(L)">?9OT+'ADK1C$# +5^I
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M&;LX289)\^%>S^:!/@Q.CTLY4P\J_%K>.;P-6BZ9SE7AM2V$4].3Y&QX>'Y
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MA)T*]5PBA50F=%XBB>B3+G30T@A9ED:GDO,+GPLDH0^RR*3+O+ .^X)R*);
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MS;9B$T/!.^SK543VPOHZF2W-I)9V"AU<4<(,TVP.NRKDI&+54)9AJE,\1U!
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MH8^: K)Y[$G1NB2T"X?5_]Z-+8O05I"NL,[$=0^5D"&*K%.?76A?)Q*T%W:
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MKZ0AANZ8TTI&90U(OY;2["XV0+OD)W\!4$L#!!0    ( !U!A%0^5@'5MP(
M *4%   9    >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;)542V_;, R^^U<0
MQ@XKD-;//!8D 9(L6PNL;9"FW:'H0;&96*AM>9+RV+\?):=I"C0!=I%(BOSX
M$,G>5LA7E2%JV!5YJ?INIG75]3R59%@P=24J+.EE*63!-+%RY:E*(DNM49%[
MH>^WO(+QTAWTK&PJ!SVQUCDO<2I!K8N"R;\CS,6V[P;NFV#&5YDV F_0J]@*
M'U _5E-)G'= 27F!I>*B!(G+OCL,NJ/8Z%N%)XY;=42#R60AQ*MA;M*^ZYN
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MR3A*R70\W@LRRL:H WY_H0/&]-(@2J?8CG!G41<O#U+<@+-&V000C>R *DW
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M+:7!2NJZ-E]0U@#75U*:;F #]#]#\_\ 4$L#!!0    ( !U!A%1)[]';800
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MUJA7W9O 0*[:QO87YV'V\.P8][?MU^W]F^4ZTZN2\K[")8D&)W'H@>[? ?W
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M]_O[93<P<NUNYX4T>->[;H./*ZKL!EQ?2FEV ZM@_UR;_ =02P,$%     @
M'4&$5!)7O<-S!@  R@\  !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
MI5=A;^,V#_[N7T%DV[L.:),X:9LN;UL@N>:V#KV[XM+MQ3#L@V(SL7"RY)/D
MYK)?/U**D[1->L/>#W%LBZ3(AP])ZW)I["=7('KX4BKMKEJ%]]6PTW%9@:5P
M;5.AII6YL:7P]&@7'5=9%'E0*E6GU^V>=THA=>OZ,KR[M]>7IO9*:KRWX.JR
M%'8U1F665ZVTU;SX*!>%YQ>=Z\M*+'"*_M?JWM)39V,EER5J)XT&B_.KUB@=
MCD]9/@C\)G'I=NZ!(YD9\XD?;O.K5I<=0H699PN"_A[Q#2K%ALB-SVN;K<V6
MK+A[WUA_&V*G6&;"X1NC_B=S7URU+EJ0XUS4RG\TRY]Q'<\9V\N,<N$*RRA[
MUF]!5CMORK4R>5!*'?_%ES4..PH7W0,*O;5"+_@=-PI>W@@OKB^M68)E:;+&
M-R'4H$W.2<U)F7I+JY+T_/7DW?W=A]\G$QA/WD_>WC[ :#J=/$QA]/X&[FY'
MX]N[VX?;R?2RXVDS5NED:\/C:+AWP'#:@W=&^\+!1.>8/S70(2\WKO8:5\>]
M5RW>8-:&?GH,O6XO?<5>?Q-Z/]CK'PJ]K)19(<(8-<ZEAY%SZ!V,= YW4LRD
MDEZB@S]&,^<MT>?/5S8]W6QZ&C8]_?_PAC\>\(N'L3+9IS_W@?_Z+N\_/$P@
M[0]/DG^X7[(!8Q;!<) 9JCSGP<S!%<;Z$X^VW"X+0JDRSI]@T*0Z]9O%-MP?
M6!G"*,N,S:5>@#?@"P0E9L;2=1EM3O$1K= 9PKU8P9U8@M1PZZQ =1SD?[*F
MKD Z:@F?:VDQ9T,5R6:FI%;E1*AV>B<T8!-57=&[7+I2.B<4T(86/2D'Y^B)
MQ$OQ":GBK.57%+RW<E:S+<<>4*$3QOF3!:B4H-6JMJX6I$1&INMFDYXVX;V(
MYQB$ U=A)N>2#,ZX+[;AH8GL/]]<]-+!?QVH-057'*L@U&KM29[Z,!L0A\ '
MH]4J2#7!.]#&0TU5:'?\BULR9K6/D%&B_0LO\!DOGKI5BAP9'1&2&J)<2E^0
M=X]"R1QVW O 41$QVH*>5.C+C[CCIEA8C!GA/IL#I['8"GQ/L E%DR/P9,=T
M(.:RD%D!Z+R8*>F*J*F]]"J:I'18S)!W].O &[)$*)[C^3QR\L\B04FC0#'"
M4G.\E,#5,[9D2C@7DTN):HC3X!<X<QQ7O)"JH< P$>WD9I_P<$N.A@<N))CC
M(.)'#L^?A,2E(CRGB'.?&>+@/E=?)79PDHKS$>/=WE""(Q'[W7K;RQ;"WRRT
M_(N!T?F.YK:L<Z0T!*S+&">3"Y31B]A^7FPP)UX':R3XN2;2S5?<6Z1V=:RZ
MRBB941MO)[-V,OG"".$35Z1>$T([$LT%%QFQR ?:. :VLB84%G4IXV*7,J1B
M ^(6"_Y$>>0ZH&<<)K^CH.+CH0<TLK"<D22-K83'%E^ZR9MUEW%H'V7&>SN?
M?$M%><[7\_/DEDK=$I<!&X>IH:3=Y,%XZEXO0-A*G7<A'>SH1Y]@G5)*(T\X
MVF1 O],D:R=,K>=YW2;M*"C\< P:_3 Y$,USTAHJP$5@(6UR?GY!U[.+B^2M
MD);;0HT!TZT[<-0;#)(?Z"^EO^0]?8D>](AL]7],^3I(D[R=O"F$7J!KDDC9
M< SL9IM#AH@0PYT0QM17F"Q4,K\(77./H1"CW[SC_I1QPEY-U[CI')6@9GAT
MU@U1]BG(CWA2HB".QN84>&7T_F8!1WU2@7XOH>]0^LK4ZRF5K8 ZJG8JMF^<
MSZFC0I_F_FX\3Y*VFP]\@=[\4(:&<+^3KL!ZZ;!Y+E"%UO+5.HVE\Y4J_7I2
MF"94)KV+%S0?$*<_HJ^M#HSE*.0SD1-@R+?(+^C< D>,/Z4F[1'.O5?2-EIW
MI76;HDRE*5&@F_ZCU!RE9.CLE>1P'<3XYK$R"6>=R8IJGK"NRRIV[3#*54#0
M[RE?3MPNN;]+;J0+8P,LM;6DWSY+>NVSBV0:I^F"/F%]D9RVST]IK3^ <3-]
MZ93GC*:!NN+IZ.1,$?'7G%E_+?QK#WFD< 9(GN=!'#,F8_Q8C<")$SQO=K*$
MN?6\5J&5)H]?@XT[2U,3"PM!?9AL2SIA4MXE-\N(O=G3Y>,(9Z%MOV_O^\;O
M[)RO2K2+<(KD0B!,XU%K\W9S4!W%\]E6/)YRWPF[(-J#PCFI=MN#LQ;8>'*,
M#]Y4X;0V,Y[.?N&VH,,V6A:@];DQOGG@#3;']^N_ 5!+ P04    "  =0814
MQD1PLZ@"  !D!0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6R-5-MN
MVS ,??=7$,8>T_H2Y[(@"9"TV058UR#--@Q%'Q2;B8W*DB<IE_[]*#GQ4J -
M]B*)$L\A>21JN)?J6>>(!@XE%WKDY\94@R#0:8XET]>R0D$G:ZE*9LA4FT!7
M"EGF0"4/XC#L!B4KA#\>NKVY&@_EUO!"X%R!WI8E4R]3Y'(_\B/_M+$H-KFQ
M&\%X6+$-/J#Y4<T564'#DA4E"EU( 0K7(W\2#::)]7<./PO<Z[,UV$I64CY;
MXVLV\D.;$'),C65@-.WP!CFW1)3&GR.GWX2TP//UB?V3JYUJ63&--Y+_*C*3
MC_R^#QFNV9:;A=Q_P6,]'<N72J[="/O:-TE\2+?:R/((I@S*0M0S.QQU. /T
MPW< \1$0N[SK0"[+6V;8>*CD'I3U)C:[<*4Z-"57"'LI#T;1:4$X,[Y??IDM
M8#[Y/9E^FST, T.<]B1(C_AIC8_?P4<QW$EA<@TSD6'VFB"@9)J,XE-&T_@B
MXRVFU]".6A"'<72!K]U4V'9\[7?XEHIE"$QD($V.BD15"H6!BKVP%4<-CVRE
MC:+G\70A6M)$2URTY+_TA,<E'@Q,N4R?G]X2]R*9;<B!KEB*(Y\Z3J/:H3_^
M?K^<090,KKS7L3P2#LL554CB>58\.X3>)$W5%C/  S6R1NU]@&XK2KHT)V'/
MFY45ER](.EB)2!0E.:=F(1#C&OJMN-N#J-5).MYGN4,E2BL>VYI<JL(4A$M:
M81A#-XF]!7)FT+(H=]+O=>#*FV0[)E(RUTJ6QS>-2D/4[D$OB;Q[=RW-=?2B
M+D3=F-*+0\JS38MV*_G8@[=N)SA[^42Z<?VM(95;8>HF:':;+V12=\X_]_K_
MN6-J4P@-'-<$#:]['1]4W=.U863E^F@E#57@ECE]@ZBL YVOI30GPP9H/M;Q
M7U!+ P04    "  =0814H1C09P,/   6*   &0   'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6RM6FEOXT82_<Y?T?!.$@N@99&Z/0=@>V:R7LR%\<QF@2 ?
M6F1+ZC7%5MBD/<JOWU?538HZ[$F"A0&9(KNKZWQU4"\>3'%GETJ5XMLJR^W+
MDV59KB_.SVVR5"MINV:M<CR9FV(E2WPM%N=V72B9\J95=A[W>J/SE=3YR:L7
M?.]3\>J%J<I,Y^I3(6RU6LEB<Z4R\_#R)#JI;WS6BV5)-\Y?O5C+A;I5Y=?U
MIP+?SALJJ5ZIW&J3BT+-7YY<1A=7 UK/"_ZMU8-M70N29&;,'7VY25^>](@A
ME:FD) H2_^[5M<HR(@0V?O<T3YHC:6/[NJ;^EF6'+#-IU;7)?M%IN7QY,CD1
MJ9K+*BL_FX=_*B_/D.@E)K/\*1[<VO'@1"25+<W*;P8'*YV[__*;UT-KPZ3W
MR(;8;XB9;W<0<_E:EO+5B\(\B()6@QI=L*B\&\SIG(QR6Q9XJK&O?/7VYL/E
MA^N;RW?BYL/ME\]?W[_Y\.7VQ7D)TK3@//%DKAR9^!$R42S>F[Q<6O$F3U6Z
M2^ </#6,Q35C5_&3%%^KI"OZ42CB7AP]0:_?"-IG>OW'Z&F;9,96A1)F#KN5
M4F<J%3IWCLT>,H/7BKG.99YHF>&9+8L*'EA:\:N<X0M\Z+<G>!DTO R8E\%?
M4;KX]8OZ5HJKS"1WOQVSP-,T/WS\\D9$PXNSX"CUX,M2B406Q4;G"W$OLTI9
M4D2)V\<E?ECJ9"DD]+52DO26"@GM2%VX[=A:F&JQ%.O"S'4I9)X**-@*R81A
M/[6:J:*Q8<@K<-4+/03H/]@ C@>3 1^(MU+.,G41M/<'M)\^>L$'4ZK@;<.P
MM%:5]B*XR>^5+1WC<3B(I_CL#Z(@"14H%?I>4O#[Y2(:B+,6D4S+F<YTJ14H
M_0(=22(S"GMQ+*)1.!ST@EF8!K(;O)<YD(J.$3.5:85#P3W44K:U*U>FP@HH
M(9%VR6+SA?J] B,9,1D"T*!JG910P4SF=_#(M;&Z# 6\+%5XG"@LABJPUH!\
M 0!+B*YM/0NA<9G;W=6.P%IN_'<FS^OV*#5KF$7<+"IPH[X!\*V_N:Z*9 G0
M$XD!#J>J<)'B-SJ3RC4\X)M&$)%/*/A'RTE2<A3#^K%+4Y1GI2I6 +"R*ECA
MW@=Q0LOWNL&L&UP>=Z.6%Y$L2CS01ZXS?C -Q_$TC$<#+(FFHC$F MN66$#F
MF1=F!:<EGX":,IDHYS?P1-YTNK.UTQ44.M=FM9;Y!IH^:\*!A'KPRT)6:L$'
M.'FA K($W<!AB:H]'8Y_IV!G_W7K+,](BB#I!A_SK=CQ*&2N0G'S_EJ 3U5P
MT. ,"8U2>#8VDHM".><\)<H__F,2Q[WGMY\N^2IZWD%N*9?B/]BM_I#B\M.-
M>%>F77%ZXF^==" &3.U$Y<525+G^'4:<:6,W.9E*P^=5LLQ-9A8;IQW=A%\M
MEKNC<&%K=P/?P%J"A_EN_/Y)@,%>PA=W8FN91[$6#X\@4,MU'K#DF0,*NOF,
MT8*#<JVX3L@@V9_RP".<U JF0Q(XV<(XJ".%0CWO !N9Z#?HN]V_U @P&'-S
M(".1HN(C%8@^KSXX%O23IY;52J0:3P!IE&AS59!2V4LL(K&@+<2X.+6P#$&I
MB >=;I"RS[V7&Q'U:K N6TY/'I$I,J#,A;E714ZUCO=DXFF.HXAXV^\^^IN-
M\X$I8.ID%$Z'(R*]@BBWCK=3)2G7Y#M[09@?-P3@'=+'$FA]O7TV[(Z'8@W3
M[*QW7K9 ,"PHPA<%)27X4*)4RA9M 5:V(3K](4JK+"-D.WTVB,-A+]X+>YE9
M U>V!)#]L#?HAX/Q9$>(K?)K2#B0BIW'XTHCE ?'>G?!'.[( VPAB7)$?)IJ
MPE\$S@X>ARX)P?5UF3$(BZ7)4B(&\@UCQQEORH!&5LKE2 .J2#1VM14^[L:L
M[QW!6=V"<1VKAF*C) YFE.6TB* EWTBA;HXINGE(G>ZV%60).5*5&Q2]LG2%
MPM=;D:). /G0ER=8DQN7?N=5GM3*J>#X>;+9DRP\<@@)<(!/$@<W-4-='6Q:
M9QX'K*[X>=?7#B&^WPM'XY[+64C:2!A$Q'I-)G*M2^DR&>)WI:N52['/HBB<
M]./#?;*6I,UF Q22^7(INV(C$#M72'EWXD>Y6C\7MPD<A5Q@[?(ZK$'+5B95
MF8L Y+#<2M=")<9RGF3]^O/A0&B 6IIN.18%#)"JU@"E3+,7?<_ZX:0'T,%^
M7W#N/H[">#H2I[)$L32K/ F&^YJV/[FQ:)(AJ>BY=@RV:KO.$?7E=;E3V\J[
MRD^6(\QD.F7G0_%0^C*!L;6=D/:+(&(;&-*??H]MVS9ZIW:\M'+*Y@!ZU"\>
MS4X[9=$VXK%TU_';%1'1;2/ ?I&SLW.OTCGF3>P^QRH<KJF9]=IQPB9Y$6P
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M@CH0LYK?<OI9BRX(4PHV(QB%+H]V*KZ9@=34@=>,J&_(P?EBFSY8AJ5*%TZ
MAGF8\ZCD+0&D;4,RU4FIHOD[BKZT?A\-'=6Z(J;:G5/]?(T\X=*@7JEN,.\&
MU\PB2]?VV9U>?OOVB7]1XU^;._ ZQ(UZ$.+G(G^)*F#1EQ4<AO^2>26+C?
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M .\7!B[%+[1!_SO]F_\"4$L#!!0    ( !U!A%3D>>UZ>@<  !83   9
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M#5,.^=CM'::CR72"C5A.XP3&:?S)]WCBQBN\']'+TZX.S.]PAUK(0A5XT4-
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M'C JRT].!Q== L\HY08$5.HY2^29-BL2%L #^&VJ3JE*;<N*T63W/B58OI-
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MB X4N#>8#H; _[D*TRAR9_/XOU1@@GDUBJ?.ARZM$9(J+N+<W1+)=B8Z#OS
MG<8+YV2<5Z4R6Q$412 Y<%@A29,EE5IE*$3S)34O+$PX<V,_=*=!_ TS!H,!
MVT$K;TM 5Z"Q\ZESCA83[<6:K =1;(;A#&E#GYK+8/;,M(U0S=L&@.<L=;-+
MB\L2]$B6%(DP02QQRNX%"Q8D6# 7QWTCBXL/H+EKS2&B:99_MKGK1AF>+NC@
M,6VR-E*;(B.SI(IJ $P$EN!>W5(?V$HB4SRP.:JL=FUAR\[MAF'D5F(QJ _#
MZE%O*J4.VU#HG.F$Y[Y..G(\VD2;#JBHN(,),HJ\Z(=. FD-SCS;8K;2E:%&
MN4!ZK0SAH%O['8S8'-.I-QOE0.F.!RSUI:$!KD"&R3+;?73G*"*36XMCSHRL
M\FE.QWB=(<BT2JY@:R3PG6O:DXRD4L/CB=[$^QYP[1F)E8Z/6:BL+I4J!J%)
MB1,B&PSI16MU9FM9D;8M$\:KNU.WK;S&$^?CD> B.4[]F3N9^/?.+KAQOY$Z
MZT?Y55/3">':YI1=4/2ZV2JZZ]?M 4";++I@&DS)5A=%AZ(C44HNI*SG=E9%
M\]]LJ>IB6"[O%,UMNWCB>I3>:$,7%(,$C9PSR7_>F>]JU2  D)YRJ\M3YS=(
M/B*XPP>*?(9XN3^ '<.!%^>O3YPGL3<1I^B[?2\(G2>!-Z6KN3>9.J_;@S-Q
MIZE]//[A!(].08EJ*SAE>C5H:SN['I,LYL2)3F,G]&8S[%DXOY1(HCRM$!EG
M[GO3X'0>>=.Y,XN].=;@5K1PSHN"(J#2YO/IBH*Z(CC1%M^;A*<^Z.%7..$)
M.PB>">R:M1GS4#%HY+-&\;Q?;A4C5-QRQ%$M03BC.1S"I NRUA5M #)@VF@>
MC#<P8##UF.:@>V609IK&I_V3L'UC<3\S)LW^O&SN[VP[T1[K#V+ 'BKO>I.6
M@//KXRP=:T?G?<MOV/=(.X OT5T6=.[5Q3O%#_4>D]B=8^@-O;#?_D"TB=!=
M3&,WG$[$=+!ZEVL.UQ]WE?T$Y..HWX'(7BD]QN$XF,S=21QC1^SY\\<4(JQ#
M%=XV<>,X<L-X(B)O$1Q*QNX=V86I?3YWXSF4?\P?_O_1'[!P[+L^!A/$]C?]
ML? GO#;VPOA[W-%UBB>@/O\>;TS"A;M S.YO^(8SQC'U35]$X=R=S4CQN1B-
M>8S64A>V8A?\)HFR#^<U*A4\P^Y%W9Z<#]6PKE!PVI\@0?&=F1>%;85IASXT
M$MF=S1S#:;$[@.X'Q4Z4NT<"?%"=]I(3FM"9??@D<J-YZ(XP_YZTA5TU8,B-
M,%ND*>B]0]<@?KRZ-KO><-PPPP$)ZYWWWXE@Y]3YZ0&THD\@M(Z1:I%P;^GE
MHZ!Q0L#3]Z>.\ISWU% 1, "66M-ZTX^M3Q_N8+@-XVXEB BS_,HG6.S/.]=L
MO0[(=."2?&ETI<96[9^"HY[Y]@R</.")2RI4]W;9XV)C3Z_HE<?;=Q<7A^\]
M>)PMZ&T:AG5>T YHKNTWN ;>4E>R]W3TE0H6W"/_P+$R-(BX,S.JT_#@/0WO
MQ'R@<\(9^@9QWJP;-,JP</A(\S@P/9 ^]1?[)R_=.?V8T3K=M!E5;^_\^Y'S
M\BGZ&G%\>"CDQ>WK!:,>?CDU5'K_&(Q;#IY1()W17T5NW]Z/-]T78RKS\5=R
MAW]HJCB[6+O>(\\'BSQ.[:&#0VAL]CD@ZXV]B#\;?.*0JVK-'W+0M P9[-<.
M_=W^6Y%S^XG$;KG]T.2=K) AC,C4"EO1#DZ.[-O?[J(NM_S!Q+*LZS+GGQLE
M,1G0 CQ?E67=71"#_@N:E_\&4$L#!!0    ( !U!A%2OB&SZ@0(  %4%   9
M    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;*5446_:,!!^YU><HCUV30BT
MI0@B0:%:I;8@DFV:JCZ8Y$BL.C&S3:'[]3L[D#&I19/V$MOG^[[[[G+GP5:J
M%UT@&MB5HM)#KS!FW?=]G198,GTNUUC1S4JJDADZJMS7:X4L<Z!2^&$07/HE
MXY47#9QMKJ*!W!C!*YPKT)NR9.IMC$)NAU[;.Q@6/"^,-?C18,URC-%\7<\5
MG?R&)>,E5IK+"A2NAMZHW1]WK;]S^,9QJX_V8#-92OEB#W?9T NL(!28&LO
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MH,'YU84'JA[B^F#DV@W.4AH:0[<MZ-U#91WH?B6E.1QL@.8EC7X#4$L#!!0
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MNR?@I)E\C^'-^W$E]*J4AE2PQ%1ZW,]"HIN9W#A6;?P<7"B+4]6;:WS&0+L
M/%\J9?>.*] ]C--_ 5!+ P04    "  =0814/C[,DKX'  !&%   &0   'AL
M+W=O<FMS:&5E=',O<VAE970S,"YX;6RM6%U3VT@6?<^OZ/)DMD*5L"7Y Y,
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MKFO+9=^A3G!8PJ"DSQ#B=3>UBEA!A>ED8HNG!=N @0E P9K"^55?E9\V()E
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MB!X[>DYR_>J&   A% YL$L#/((,G=VU#?K &]83,;O"D9(8A/'5.8(HUZ+8
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M71H*F@HM! A02PA"90_[5W4W;BY5 MD<@G.AR6@0HAKRK&'&EZ04H!.(4!0
MN?1XEYV:Q=UBCAE5W;FNGQZ46 N&Y=#9(;B;)@9&F4%!5'7R. NPHT4O$X02
M4F"=0' -",]:15/=OT,X>:\N8L\M97=I-AY3B$8*\I6)O!G_#KI89*\%4^)D
M?+=[>UAT2:*0]2LB!1BMOM!B IX*"M\&M(A1*\>B"AA-R)1B?7+$!_W+C0E(
M X.5Q%<0GDI=K&)BC&H- .]\+A,BC3LSIP-,D:5#-F#KP(697<BO,* ; YY
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MQ(; L[)R@7T^,1(_(\D_B8$?#/W$Z$HOZ2]\S<?5\WC152V2O0)>=-6,Y*^
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MRY(^@% [ WJ_4<H>-NZ"[I-J_B]02P,$%     @ '4&$5+HNP80E P    <
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MRD$U4'8:J8%=2WB60D,:Q2A,*(.$9Y#'P#G0,"'Q .\/O!U:K&>M95L\ R9
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M#(496;YYA$Z@"Y 7N$Q&I7<KF&&$0X4ADIS50V2+H,Q0(PK2=(PL@C3"55)
M&@7C.#O-Z1W"GD$R+AVQ),W?8!9#&91Y;*WEXY&SA@SQ )T*\.[VYE75-1WF
M$4-'&JD,^SQ4'^:?-2W&VH;WC30B_^P0UB3SYB^!%*WD5K#/KKH!RP.>*;$$
M!P5,_TF7!UB(WTY"EA]DL_$WD<CC D9Y"2YO<1!C%;X5SS&&<5#!> 9I?'07
ML2NL>"#FOVI8TF40%V-;VA$&/K,3U,[<)+7%C^DOBF\!LTU31J,OFV;<-TV9
M8(?""OT;&E:[ZF.(A-[<W"U=7F^NEL?S<_C:;1:^>%2PU;?NZ;18G3#]^W+<
M/;[.\_Y1^D>\?]KOB-HR+'M.-Z@:G8\S'U3_7/8+(UOW1*VEP7O%37?XA4&5
M%<#SC93FL+ &CM\LL[\!4$L#!!0    ( !U!A%2.[6BCL0,  /$(   9
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;)U6VV[C-A!]UU<,A#[L G)T]PVV
M@3C)=E,T;1![VX=B'VAI;+.A1"])Q4F_OD/*]J9M8AN%88FD.&?.S)D1-=I*
M]:C7B :>*U'KL;\V9C,,0UVLL6+Z0FZPIB=+J2IF:*I6H=XH9*4SJD281%$W
MK!BO_<G(K=VKR4@V1O :[Q7HIJJ8>IFBD-NQ'_O[A0>^6AN[$$Y&&[;"&9HO
MFWM%L_" 4O(*:\UE#0J78_\R'DXSN]]M^(WC5K\:@XUD(>6CG=R68S^RA%!@
M82P"H]L37J$0%HAH?-MA^@>7UO#U>(_^R<5.L2R8QBLI?N>E68_]O@\E+EDC
MS(/<?L9=/+G%*Z30[@K;W=[(AZ+11E8[8V)0\;J]L^=='LXQ2'8&B>/=.G(L
MKYEADY&26U!V-Z'9@0O561,Y7EM19D;14TYV9O)P^^/G>>?73YTOLQNXG,UN
MYC/X,&<+@?KC*#3DP>X+BQW:M$5+WD&+$[B3M5EKN*E++/\)$!*U []DSV^:
M'$6\QN("TCB )$KB(WCI(=[4X:7OX7%="*D;A2"7\*UAM>&&V<H 7K<U[HIE
M004,RDK:D<M.HQ&8UF@T_,$6VB@JIJ]'V&0'-IECDYW%ID3#N,#R7"9.)ICC
MLX&ID,7CU[<$.TK MOQ0;UB!8Y]Z6J-Z0G_R,ZM+L/]%PT7)ZY7V[J21"IYP
MS0NJ#&\N#1/>E=1FZ$V98'5A6=D8?F)U0\T-K6*1]P,,\IRN\<!=@SB/O,NR
MY#8V#66C"![,&N$%F1IZOU ;"Z0NT]"!..K9OW?5*(5U\0*4]UJ+75[*/ZD[
MZ/5 F<@CH,KK)A[E<R,U$V\@SU%1^[2VQ//@Y$,O]3ZVUW^%0J6'U0+5OOS(
M21!%.2193*,DZYX92!QD41^2GK7O]OK>;4U&3$!!AE+PDK40<3<8Y%U(4C?J
M#4Z''6>YC3O.>R>8$]]!D,<9Y!DYB(*H2R(415,UA$KU5B*)7W#GX82@E#'Z
M'8O\^A68JR)6267X7VZ!:J!OBR+KV6I(SM"V+8*$G ^.R L]H+Q%[ZN<YE9E
M>SVM\B"#."; ./[?<5K1TS[!D#Q!3C5_,L[$A@GI&5(&W7Q 93*@47_0_\Z#
MA"RH(X&9_UK9;/>"OFO%-'+)[P>Q[9@SK*U@_=AA))GMZ#2'MUY^X:MCJ$*U
M<H>M)MBF-NV)=%@]G.>7[3'V?7O[,7#'U(I3U@4NR32ZZ.5^^P[<3XS<N$-M
M(0T=D6ZXIF\25'8#/5]*:?83Z^#PE3/Y&U!+ P04    "  =0814!F':-C8$
M   4#   &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6RU5UUO*C<0?=]?
M,5JU$I'N!7;Y;$20("$J59)&@;:ZJNZ#V1W BM?>VMZ0_/N.#6RXM[!%5?K
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M:3)U[J0!./8(?$Z'6YN%K#6K,K#[4X/0+;",>UC&'X E(+)6&%#8O5AKH0G
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M^YBM=.I2**DW?,G635\P3#QT_1 ()UT,W!B'K?^P0^@/#]PX")/N^\SY- C
MU(0,8TIMB&+:B]D>AJ$/%2.8(E,W^D4PJ*U!DVEHP><&"0YL[<=*%KD^!.JU
MQ!]OM.(E5W-[X= DE75EFJZ\7^WO-$=-*_]$WER(OC(UAZX/@I,#JS=*H*%0
MS26CF1BYM(W]3!JX)MCA NYE7"$!_,\E]&WM!#?H;WJ'_P!02P,$%     @
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M:W-H965T<R]S:&5E=#0U+GAM;+U76V_;-A1^UZ\@O&ZP 5G6A;IU28#<MG5
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MX-G(=WUO "_H0PP,7O <'I-9P64C*.(+E!5$2BKUHUP16,M(S10IT%]D+I6
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M%PV53:#]0DIS"*Q ^T;&?P!02P,$%     @ '4&$5"N;K(?? @  1P8  !D
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MN@X#]0?+)=&I1QW7(_>(._?^NZ1S6?M3TN+3&]CC$FRA:L-D;KJ=:YH I-<
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MI 4J:&_5.^T'DPQ@-;%9VT![O_[&#F3I7<M=5_LEL9-GQL_,,V.[LY/J2:\
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M"\#_"RG-86(7J"Z#O;\!4$L#!!0    ( !U!A%07&NAK( ,  ! '   9
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MQ@?@\[76[NCX OU'</8G4$L#!!0    ( !U!A%3#SY"64PX  +M7   9
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M'+5?X-XOE+*O$P]0]_FC?P%02P,$%     @ '4&$5+(VL8IY!@  PR<  !D
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MA(KB!'W\D>MIKW:*#JIU>^?_ U!+ P04    "  =0814YG.5,S($  "*&@
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M]&YYN*$DH=(^8.ZOA-!O)S9!O?TT_A=02P,$%     @ '4&$5.8F5'A4 P
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MKXF^YQ!A-NCU'>?J.# )ZIO3Y!]02P,$%     @ '4&$5,80</W3#   :%0
M !D   !X;"]W;W)K<VAE971S+W-H965T-3@N>&ULK9QK;]LX%H;_BI =+#I
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MC^ ].S!M (_T 5B, &A4@W<>(\!T XC%%4 3=+(;G/+8 L(<(!8_ #H*!L3
MG0.&6D!@G T"_A@VW /@L0]XK3_AR:!A%P"/7R#,!6+Q#1"%'>\ PSL 'O/
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M]*0'OV8 PS@ S)V[A2H2%I[$&38#\/@,O/<^''&&L0 \SH(P.6)Q&$B)O-D
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M>@J#\!-$013N@<\^#@]>PWURI+<EZFV)'-_@$-\K"S*7+V:48_MNW 5<T:.
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MI#K@33-55S!P':#^;QF3KQU]RC>7^O0?4$L#!!0    ( "!!A%0L;6=A0@(
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MT@S [VLA]*%C)JCN;..?4$L#!!0    ( "!!A%1?>^2 P@(  , &   9
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MS0C+G=FDNG8G9A->J)3E]$X 6609$3^N:<KW4P<Z3Q?NV7JCR@ON;+(E:_I
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ME 'Z_HIS]712[F T.U:S_P!02P,$%     @ ($&$5-KYYQA4"0  3$   !D
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M'6FVE7L.P[6VT*OM.BLJA[@SLV>3^YQ!K\?31^2BT5I5M+^+1M;TAC0,.]?
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M[A,=Q$J[ZA@%S%9]GZ3V +:R62P#:WV ;:2$H_VF -C*#^Q/U7[*)K)K$04
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M?U/EV^;QHON\JO*T>;D1H:1X'2"_?\CSZON;NH'#$VHW_P=02P,$%     @
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ME@W8$1HE@.%>\",T @"[%6 CAESF6)L2&,+VG;&C? 1I] 2.GDW_EY=ZX '
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M=8B((H.>X'L0!JW5S, 6T[*U?9J9ML^5T%^IYJG!^'$V_?Y[/(;A^&G\,%E
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MAMY#J*P ?5]):5XWUD#SPAK^ E!+ P04    "  @0814^KXZ2W0#  !D"0
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M4_N$<'/P%TS]_GA@:L.%A@(S@@QN!Q0U58_T>F'DUDW%M30T8]UG3L\@5%:
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ME>Y@=ICK?PP(DZ#7,\[5/C!MK/EK)?\!4$L#!!0    ( "!!A%248;.G P,
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MQ?:=D>V!5@_U:Q=SI;7*ZH]K*9:RJ S,]RNE]/-!%6#WYL[T?U!+ P04
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MXC 0AE_%BGI1I&X3$@A5!4@<NMI>T%9M]R"M]L(D$^)M8K.V _3M=^R$E$-
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MG?;[(O%:>AN(FU1M%!YUM#;(>#?Z6,==MYMOZ3--%1>O^0=KSGC,ERRLU?D
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M/,DO5Y1$5&0 _7[!N7J[R0:HCMZG_P-02P,$%     @ ($&$5)##:_YG @
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M1M,12NB:%*E^$KO?:$4H-/9BD2K[BW:5K#M"<:&TR"IE0) Q7OZ3URH0!PI
MM%_!JQ2\MD)P1,&O%'Q+M$1F:5T3319S*79(&FFP9@8V-E8;V#!NTOBL)7QE
MH*<7GR[_O'E&#_?H]G[Y<'>#3M$U4W$J5"$I$FN(B"8LI0EBO*P9&_L5% 0D
M,18\9BDK%T%8DU=$7Z'"%$6$)Y"C6!1<,[Y!N11KIM')M;6GQN!H>7F-3CZ,
MT0>PC3YM1:% 1\T=#;0,.">N*%R5%+PC%+"'[@376X5N>$*3]P8<B$<=%&\?
ME"MOT.(UC<^0CS\BS_5P#Z#ESZN[ W#\.D>^M><?L7='O@J)8I'E@E.N53O4
M)XS#1SI&?Y&5TA)VQM\#7H/::V"]!D>\_BZ40BL*6:>H=&"<]J6GM!-9.^;8
M>%F<XJF+_;GS<ABT'C%O&DR\6NP=S+"&&0["?-9$%UK(-QL22;1!BY:$DX3T
M@1VVYD5GH?M+7\K_N]X[.E%-)_I?Z43=H :323OT/5*3, C[(S^IH4X&R_*6
MQ] X3/TEM!R-#=:F5E!2P+\X'PC+M/8U'0S+O>"GL+<+./17*=U7OD(G'#Z
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M9,^ X $#OS+P]PW" 8.@,@C&SA!6!N&> 1HRB"J#J*AN68ZBEI=4T;,3D3\
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MZ&\':&M YQNES//"7C#\D5G\ %!+ P04    "  @08148B4*W,,#  !M#@
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MX_9XH_[5Y\ZY+(3%*UW\DBGEP^!S "DN15705*^_89-/S^DENK#^']:-;11
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M&G.Y8<9O:S(CT:^WH%B:R1=35VF)9B(WKN0L2CED0 XFZ#TOU$:BMT4"R6D
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MFQCS(*ORHVIHL;4O^$IHK ?L9X85&Y7& ,?7 L]+W3 3-#7@^%]02P,$%
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M),DL(ZM%,ELFZ>KF;K8DGTC&=,ZE;A4061(FNAODCF*-UP/-Y%3DH%& J?"
M.350D(8JPW"1":(-KN %,-H2E$Q@.*.<-%(SQW.4@:&,ZV/,EB89.?IP3#Y8
MY*J2K::BT!/?H&9;N9_W^JXZ?>$!?1GD)R0:?21A$([>@*?OAP?/X3XZ/=@=
M#G:'CB\Z9/>>+8_$*"HT=?=9DU]TK7$A-[__D2<:\D0NS_A GCM3@<(>R65K
M_5:0 ]O2-8<W+>RXSAR7;?MM/$*OMOLVO0Z)SH:09R6.AQ+'_U-B0Q\/UC=^
ME?SB_/1%@:]C@A?U^7M=8E^HKU1M&!K/H41,<')^ZA'5=7TW,;)QC;.6!MO0
M#2M\*$'9 -POI31/$]N+P],;_P502P,$%     @ ($&$5%>^_<_> @  60<
M !H   !X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;,5576_:,!3]*U=1'UII
M:TCXVBI "A_;*K4, =LT37LPR85836QF&^C^_:Z=D%):T%ZFO22V<\_)N??8
MUYV=5 \Z133PF&="=[W4F/6-[^LXQ9SI:[E&05^64N7,T%2M?+U6R!('RC,_
MK-5:?LZX\'H=MS91O8[<F(P+G"C0FSQGZG<?,[GK>H&W7YCR56KL@M_KK-D*
M9VB^K">*9G[%DO <A>92@,)EUXN"FT';QKN KQQW^F ,-I.%E ]V<IMTO9H5
MA!G&QC(P>FUQ@%EFB4C&KY+3JWYI@8?C/?L'ESOELF :!S+[QA.3=KUW'B2X
M9)O,3.7N$Y;Y-"U?+#/MGK K8VL>Q!MM9%Z"24'.1?%FCV4=#@!!ZP0@+ 'A
M,:!Q E O 767:*',I35DAO4Z2NY V6ABLP-7&X>F;+BP+LZ,HJ^<<*8W'=U%
M\]$0)M%T_AWZT5TT'HQF$(V',)]&XUDTF-]^'L_@+0RYCC.I-PI!+H&+8@<Y
M*Q:T/:B8&1,Q:DK I&1PQ@PFL&;*<%KD K2A%=H 1EN"M9)+;D J(%(-3"0@
M38H*8IG3?DSM1MDBX6B.<#E$PWBFKTC((!K"Y<457%C2>2HWFL"ZXQLJATW*
MC\O4^T7JX8G4@Q#NI3"IAI%(,'E.X%,=JV*&^V+VP[.,0XROH1Z\@; 6!J\(
M&OP]O'9&3KWRMN[XZJ?XGCEF%!.:N<.C88%FARA>V/3#<@ GG_3/,PH:E8*&
M4] XH> C"E0L<^ZRA+8OUR3#'ES 1VI$&E^SK>!L.4[;A;:]>A@&[SO^]K"6
M+Z."H-EXBGHFN%D);IX5/#VNQSWF"U3G:M&JJ%O_R8UVI:#]#]QHOU+GH'5D
MQLN@5M ^LL(_Z%(YJI5KWIK.^T:8XHQ5J]7]$+FV>+3>IWNC:/-/-,6E<\_4
MBE-!,UP29>VZ36ZKHI$7$R/7KA<NI*'.ZH8IW7VH; !]7TII]A/[@^HV[?T!
M4$L#!!0    ( "!!A%0N=&ZM-@,  "T(   :    >&PO=V]R:W-H965T<R]S
M:&5E=#$P,2YX;6R=5FV/VC@0_BNC:#^T4KMY(T!7@!22/=U*[18!=]6IZ@>3
M#"1:Q\[99EG^?6TGFU(:4-4O))[,///,>%Z8'+AXD@6B@I>*,CEU"J7J.]>5
M68$5D;>\1J:_;+FHB-)'L7-E+9#DUJBB;N!Y0[<B)7-F$RM;B-F$[Q4M&2X$
MR'U5$7&<(^6'J>,[KX)EN2N4$;BS24UVN$+U3[T0^N1V*'E9(9,E9R!P.W5B
M_RX=&WVK\&^)!WGR#B:2#>=/YO"03QW/$$**F3((1#^>,4%*#9"F\7^+Z70N
MC>'I^ROZ7S9V'<N&2$PX_5+FJI@Z8P=RW)(]54M^^!O;>"*#EW$J[2\<6EW/
M@6PO%:]:8\V@*EGS)"]M'G['(&@-@C,#?WC!(&P-PG.#P06#06LPL)EI0K%Y
M2(DBLXG@!Q!&6Z.9%YM,:ZW#+YFY]I42^FNI[=1L>?\Q7M^GL(B7Z_]@'G^,
M'Y/[%<2/*:R7\>,J3M8/GQ]7\![24F:4R[U X%LH65-R]NXVNI[@"8^:&-.U
MHJM"08U"<L:0PIL4%2FI?*M!DCB%-S=OX48#P+K@>TE8+B>NTJ$80F[6TDX:
MVL$%VGX GSA3A81[EF/^,X"K<] E(GA-1!)<14PQNX70?P>!%_@]A-+?-_>N
MT F[>PDM7GCI7I 2A3G41*@C*$&8)+93)'PE&ZD%F?IVQ<^@\S.P?@87_"S(
M47!*05^#[N+&)[[HH2*Q]UH:M*%%,R/E>1:$H]'$?3Y-58^2YT6=TD]$HXYH
M=)7HJB "WYL6SR'CE6%HJZ^/9(,4G?B/1IYW1O)7I6#TP>\G.>Q(#J]G4_ M
M2C,2"84M]J9P?AWBJ_^M+Z3A+RGUO>##64@]2N&ED$;.F6#<Q3C^ X+SZT8/
M+*/['*6NYZ,9#Q(4!VFNM. TUZ,"]#@!52 <D>@3FJZVK6@KTS25F3HW@RBR
M@ILH'+S3!2MKM(N#'F_[FL$]&8P5BIU=,%+7SYZIID<Z:;?#YG9TG\D3O=O\
M'GD\NDM&/?+Y^"ZQN]#]X;99I)^(V)6ZBREN-07O=J0K4#3+J3DH7MMQO>%*
M#W_[6NA]CL(HZ.];SM7KP3CH_B',O@-02P,$%     @ ($&$5%XH@"6Q P
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MV#;EPQ@[6R(R WR^XER]3K(75+UR]S]02P,$%     @ ($&$5,N;DVGR P
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M+[GZ-E5Y<GIS>W%W^G#U]1+<7UQ>7WQ]N <?SZDD:28^@2]@=GH./G[X!#Z
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MDN75X9*2A/(R0'T_9TP^GY0-VLWSZ7]02P,$%     @ ($&$5*_P0D)("0
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MS!NH<O:KL.01J9 @"&%%]IO \>S7XA7'6&@:TFO:>/D8L6]+OAK!,%F3ZQ+
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M5&\'T-NIW@Z@MVM^; /T=JJW ^CM5&\'T-NIW@Z@MU.]'4!OIWH[@-Y.]78
MO9WJ[0!Z>]7; _3VJK<'Z.U5;P_0VS</2P!Z>]7; _3VJK<'Z.U5;P_0VZO>
M'J"W5[T]0&^O>GN WD'U#@"]@^H= 'H'U3L ] ZJ=P#H'9J'W0"]@^H= 'H'
MU3L ] ZJ=P#H'53O - [J-X!H'=4O2- [ZAZ1X#>4?6. +VCZAT!>D?5.P+T
MCLV?E0"]H^H= 7I'U3L"](ZJ=P3H'57O"- [J=X)H'=2O1- [Z1Z)X#>2?5.
M +V3ZIT >B?5.P'T3LUA$X#>2?5. +V3ZIT >B?5.P'TSJIW!NB=5>\,T#NK
MWAF@=U:],T#OK'IG@-Y9]<X O;/JG0%ZY^:P($#OK'IG@-Y9]<X O8OJ70!Z
M%]6[ /0NJG<!Z%U4[P+0NZC>!:!W4;T+0.^B>A> WD7U+@"]2W/8&Z!W4;T+
M0.^J>E> WE7UK@"]J^I= 7I7U;L"]*ZJ=P7H757O"M"[JMX5H'=5O2M [ZIZ
M5X#>M1G6 >AM33NN _#;FF9@QP $MZ89V3$ PZUIAG8,0'%KFK$= W#<FF9P
MQP DMZ89W3'?:?DX?>R&\5KTM6X"OE/NZ?+9X?K]G\NOB^W]_HEU?YLQ/OX%
M4$L#!!0    ( "!!A%2A0-8C;0(  /\[   3    6T-O;G1E;G1?5'EP97-=
M+GAM;,W;WVZ;,!3'\5>)N*T"V& #4].;=K=;+_8"#)P&A7^RW2Y]^SFDK;2I
MBU9ETKXW08GM\SOX2)^[7'][GHU;'89^=)MHY_W\*4E<LS-#[>)I-F-8V4YV
MJ'WX:A^2N6[V]8-)9)KJI)E&;T:_]L<:T<WUG=G6C[U??3Z$GUTWC9O(FMY%
MJ]O3QF/6)JKGN>^:VH?UY&EL?TM9OR3$X>2RQ^VZV5V%#5'R;L)QY<\!+^>^
M/AEKN]:L[FOKO]1#V)4<^L3YY]ZX^'R)=WJ<MMNN,>W4/ [A2.QF:^K6[8SQ
M0Q^?BEZ=3_;AALWI4UR<OY0Y%QAVWMMI=F%BUGP\[G4DQ]/K.10RUG?G7_$M
M,92^^/W,<=JM:?\R.USOC\GNEWFX9'E<?L>_SOBM_@?[D) ^,D@?.:0/!>E#
M0_HH('V4D#XJ2!\BI31"$5502!444P4%54%155!8%117!05609%54F25%%DE
M159)D5529)44625%5DF155)DE119,XJL&476C")K1I$UH\B:463-*+)F%%DS
MBJP91=:<(FM.D36GR)I39,TILN8467.*K#E%UIPB:TZ155%D5119%45619%5
M4615%%D5159%D5519%44635%5DV155-DU119-45639%54V35%%DU159-D;6@
MR%I09"THLA8460N*K 5%UH(B:T&1M:#(6E!D+2FREA192XJL)476DB)K29&U
MI,A:4F0M*;*6%%DKBJP51=:*(FM%D;6BR%I19*THLE8462N*K!5%5I%2:!4I
MQ5:14G 5*457D5)X%2G%5Y'^3V"_3]/^'\<OSWBHN_$U/UG^]WOS$U!+ 0(4
M Q0    ( !U!A%0'04UB@0   +$    0              "  0    !D;V-0
M<F]P<R]A<' N>&UL4$L! A0#%     @ '4&$5)[TP-SO    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ '4&$
M5)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    "  =0814$D86EUD&   <'0  &
M@($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ '4&$
M5%#HR3>>!P  .B   !@              ("!G0X  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( !U!A%1H-+4X5 <  -0>   8
M      " @7$6  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M"  =0814K30/PIH&   P(P  &               @('['0  >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ '4&$5&809P4;"0  P"<  !@
M             ("!RR0  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( !U!A%08G/44N D  #$\   8              " @1PN  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  =0814JKR]<5P?  !'
M8   &               @($*.   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ '4&$5'TLT4F5)P  0H4  !@              ("!G%<
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !U!A%0"5JV5
MK0H  %H;   8              " @6=_  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    "  =0814>4>QDG8(  "Z%P  &0
M@(%*B@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !U!
MA%0)8HX1CQ0  +1.   9              " @?>2  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ '4&$5.)Y$SS3 @  \ 4  !D
M         ("!O:<  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    "  =0814/E8!U;<"  "E!0  &0              @(''J@  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( !U!A%2^\;I6<08  ,8/
M   9              " @;6M  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ '4&$5',02C_I P  & D  !D              ("!7;0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  =08142>_1
MVV$$  "8"0  &0              @(%]N   >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( !U!A%00_TO?-P4   T,   9
M  " @16]  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
M'4&$5/[A.+,+!   N@D  !D              ("!@\(  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    "  =0814$E>]PW,&  #*#P  &0
M            @('%Q@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( !U!A%3&1'"SJ (  &0%   9              " @6_-  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ '4&$5*$8T&<##P
M%B@  !D              ("!3M   'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    "  =0814.+D:+X(+  "S'P  &0              @(&(
MWP  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( !U!A%3D
M>>UZ>@<  !83   9              " @4'K  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ '4&$5!A!5DD&#0  32,  !D
M     ("!\O(  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !U!A%1DEXU9'P,  "0'   9              "
M@1P/ 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ '4&$
M5#X^S)*^!P  1A0  !D              ("!<A(! 'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    "  =0814G^B#*THP  "TK@  &0
M        @(%G&@$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( !U!A%2!_Q5+, 4  %X,   9              " @>A* 0!X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ '4&$5*R5WO E!@  4Q0
M !D              ("!3U ! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    "  =0814943UUHL"  #-!0  &0              @(&K5@$
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !U!A%3>??3;
MP (  +H%   9              " @6U9 0!X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ '4&$5&BC!@/J P  7@D  !D
M ("!9%P! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  =
M0814NB[!A"4#    !P  &0              @(&%8 $ >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( !U!A%0FZ&M*:@0  '()   9
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M970T,BYX;6Q02P$"% ,4    "  =0814O"A(6DT%  #U#0  &0
M    @('D=P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M !U!A%3(S#::(@4  "D-   9              " @6A] 0!X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ '4&$5&LG%.Y2!0  ^ \  !D
M             ("!P8(! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    "  =0814MVJ#.(L"   O!0  &0              @(%*B $ >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( !U!A%0KFZR'WP(
M $<&   9              " @0R+ 0!X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ '4&$5%'BGO]: P  [@<  !D              ("!
M(HX! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  =0814
MW/E$P 8$   8"@  &0              @(&SD0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( !U!A%07&NAK( ,  ! '   9
M      " @?"5 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ '4&$5,//D)93#@  NU<  !D              ("!1YD! 'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    "  =0814Z5\L1(D#  #S#P
M&0              @('1IP$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+
M 0(4 Q0    ( !U!A%2R-K&*>08  ,,G   9              " @9&K 0!X
M;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ '4&$5.9SE3,R
M!   BAH  !D              ("!0;(! 'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6Q02P$"% ,4    "  =0814YB94>%0#  #S#@  &0
M@(&JM@$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( !U!
MA%0<YO?OG@X  'M<   9              " @36Z 0!X;"]W;W)K<VAE971S
M+W-H965T-38N>&UL4$L! A0#%     @ '4&$5"'#(BJ, P  10T  !D
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M=#8Q+GAM;%!+ 0(4 Q0    ( !U!A%31ZO[VT0(  . '   9
M  " @83A 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @
M($&$5"QM9V%" @  FP0  !D              ("!C.0! 'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6Q02P$"% ,4    "  @0814# *(HW0#  !["0  &0
M            @($%YP$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4
M Q0    ( "!!A%1?#5"@S@,  +\-   9              " @;#J 0!X;"]W
M;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ ($&$5%][Y(#" @
MP 8  !D              ("!M>X! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX
M;6Q02P$"% ,4    "  @0814TN>PS0<$  "]$@  &0              @(&N
M\0$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( "!!A%3:
M^><85 D  $Q    9              " @>SU 0!X;"]W;W)K<VAE971S+W-H
M965T-C@N>&UL4$L! A0#%     @ ($&$5."B]$T+ P  - D  !D
M     ("!=_\! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "!!A%35L"6 K@(  .4&   9              "
M@2P8 @!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ ($&$
M5/:0SMMN P  ;0D  !D              ("!$1L" 'AL+W=O<FMS:&5E=',O
M<VAE970W-2YX;6Q02P$"% ,4    "  @0814^KXZ2W0#  !D"0  &0
M        @(&V'@( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0
M   ( "!!A%0B ;D1: (  +0%   9              " @6$B @!X;"]W;W)K
M<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ ($&$5&0 BG?O @  :0@
M !D              ("! "4" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q0
M2P$"% ,4    "  @0814:QO3 .8(  "5+@  &0              @($F* (
M>&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( "!!A%1? * S
MA@(  ,$&   9              " @4,Q @!X;"]W;W)K<VAE971S+W-H965T
M.# N>&UL4$L! A0#%     @ ($&$5)1ALZ<# P  @ <  !D
M ("! #0" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    "  @
M0814%>UN_5L#  !)#0  &0              @($Z-P( >&PO=V]R:W-H965T
M<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( "!!A%0(U9\O9@8  ,4C   9
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M970X-RYX;6Q02P$"% ,4    "  @0814D,-K_F<"  !P!0  &0
M    @('34 ( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    (
M "!!A%3ZM)9D9 0  "$.   9              " @7%3 @!X;"]W;W)K<VAE
M971S+W-H965T.#DN>&UL4$L! A0#%     @ ($&$5)646/]U"   LR@  !D
M             ("!#%@" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"
M% ,4    "  @0814M(BEO$("  #=!0  &0              @(&X8 ( >&PO
M=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( "!!A%0^EM$5,P,
M -0(   9              " @3%C @!X;"]W;W)K<VAE971S+W-H965T.3(N
M>&UL4$L! A0#%     @ ($&$5&(E"MS# P  ;0X  !D              ("!
MFV8" 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    "  @0814
M5C[!.*4"  !V!@  &0              @(&5:@( >&PO=V]R:W-H965T<R]S
M:&5E=#DT+GAM;%!+ 0(4 Q0    ( "!!A%1)[DWTP0,  !X/   9
M      " @7%M @!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%
M  @ ($&$5-JBYI2A @  #@8  !D              ("!:7$" 'AL+W=O<FMS
M:&5E=',O<VAE970Y-BYX;6Q02P$"% ,4    "  @0814N0TC6$,#   /"@
M&0              @(%!= ( >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+
M 0(4 Q0    ( "!!A%1(W9NL" ,  $ (   9              " @;MW @!X
M;"]W;W)K<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ ($&$5(!3+UMR
M @  A@4  !D              ("!^GH" 'AL+W=O<FMS:&5E=',O<VAE970Y
M.2YX;6Q02P$"% ,4    "  @08145[[]S]X"  !9!P  &@
M@(&C?0( >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4    "  @
M0814+G1NK38#   M"   &@              @(&Y@ ( >&PO=V]R:W-H965T
M<R]S:&5E=#$P,2YX;6Q02P$"% ,4    "  @08147BB );$#  !?#   &@
M            @($GA ( >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q02P$"
M% ,4    "  @0814'^@N79L#   W"P  &@              @($0B ( >&PO
M=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    "  @0814RYN3:?(#
M  #Y#   &@              @('CBP( >&PO=V]R:W-H965T<R]S:&5E=#$P
M-"YX;6Q02P$"% ,4    "  @0814+&NM:)4$  !(%P  &@
M@($-D ( >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4    "  @
M0814K_!"0D@)  "N-@  &@              @(':E ( >&PO=V]R:W-H965T
M<R]S:&5E=#$P-BYX;6Q02P$"% ,4    "  @0814!YK<0XD#  #1&   #0
M            @ %:G@( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( "!!A%27
MBKL<P    !,"   +              "  0ZB @!?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( "!!A%3:A."H,0<  *9%   /              "  ?>B @!X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  @0814XPVLQ_\"  !%/@  &@
M        @ %5J@( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  @0814H4#6(VT"  #_.P  $P              @ &,K0( 6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     <@!R %P?   JL (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>427</ContextCount>
  <ElementCount>473</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>116</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Additional information)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Additional information)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0008 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/GENERAL</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0010 - Disclosure - SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGESTIMATESANDASSUMPTIONSUSEDINTHEPREPARATIONOFTHEFINANCIALSTATEMENTS</Role>
      <ShortName>SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0011 - Disclosure - DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/DISCLOSUREOFNEWSTANDARDSINTHEPERIODPRIORTOTHEIRADOPTION</Role>
      <ShortName>DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0012 - Disclosure - BUSINESS COMBINATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BUSINESSCOMBINATIONS</Role>
      <ShortName>BUSINESS COMBINATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0013 - Disclosure - TRADE RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TRADERECEIVABLES</Role>
      <ShortName>TRADE RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0014 - Disclosure - OTHER ACCOUNTS RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLE</Role>
      <ShortName>OTHER ACCOUNTS RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0015 - Disclosure - BIOLOGICAL ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BIOLOGICALASSETS</Role>
      <ShortName>BIOLOGICAL ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0016 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0017 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0018 - Disclosure - INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/INTANGIBLEASSETSNET</Role>
      <ShortName>INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0019 - Disclosure - RIGHT-OF-USE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RIGHTOFUSEASSETS</Role>
      <ShortName>RIGHT-OF-USE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0020 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIES</Role>
      <ShortName>EMPLOYEE BENEFIT ASSETS AND LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0021 - Disclosure - OTHER PAYABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OTHERPAYABLES</Role>
      <ShortName>OTHER PAYABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0022 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0023 - Disclosure - CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES</Role>
      <ShortName>CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0024 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TAXESONINCOME</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0025 - Disclosure - EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EQUITY</Role>
      <ShortName>EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0026 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATA</Role>
      <ShortName>SELECTED STATEMENTS OF PROFIT OR LOSS DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0027 - Disclosure - NET EARNINGS (LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARE</Role>
      <ShortName>NET EARNINGS (LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0028 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONS</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0029 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY</Role>
      <ShortName>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0030 - Disclosure - OPERATING SEGMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OPERATINGSEGMENTS</Role>
      <ShortName>OPERATING SEGMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0031 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0034 - Disclosure - BUSINESS COMBINATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables</Role>
      <ShortName>BUSINESS COMBINATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/BUSINESSCOMBINATIONS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0035 - Disclosure - TRADE RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TRADERECEIVABLESTables</Role>
      <ShortName>TRADE RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/TRADERECEIVABLES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0036 - Disclosure - OTHER ACCOUNTS RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLETables</Role>
      <ShortName>OTHER ACCOUNTS RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLE</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0037 - Disclosure - BIOLOGICAL ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BIOLOGICALASSETSTables</Role>
      <ShortName>BIOLOGICAL ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/BIOLOGICALASSETS</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0038 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/INVENTORIES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0039 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0040 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/INTANGIBLEASSETSNETTables</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/INTANGIBLEASSETSNET</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0041 - Disclosure - RIGHT-OF-USE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RIGHTOFUSEASSETSTables</Role>
      <ShortName>RIGHT-OF-USE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/RIGHTOFUSEASSETS</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0042 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables</Role>
      <ShortName>EMPLOYEE BENEFIT ASSETS AND LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIES</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0043 - Disclosure - OTHER PAYABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OTHERPAYABLESTables</Role>
      <ShortName>OTHER PAYABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/OTHERPAYABLES</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0044 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0045 - Disclosure - TAXES ON INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TAXESONINCOMETables</Role>
      <ShortName>TAXES ON INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/TAXESONINCOME</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0046 - Disclosure - EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EQUITYTables</Role>
      <ShortName>EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/EQUITY</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0047 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATATables</Role>
      <ShortName>SELECTED STATEMENTS OF PROFIT OR LOSS DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATA</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0048 - Disclosure - NET EARNINGS (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARETables</Role>
      <ShortName>NET EARNINGS (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARE</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0049 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONS</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0050 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables</Role>
      <ShortName>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0051 - Disclosure - OPERATING SEGMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OPERATINGSEGMENTSTables</Role>
      <ShortName>OPERATING SEGMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/OPERATINGSEGMENTS</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0052 - Disclosure - GENERAL (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/GENERALDetailTextuals</Role>
      <ShortName>GENERAL (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/GENERAL</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0053 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0054 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0055 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0056 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0057 - Disclosure - BUSINESS COMBINATIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals</Role>
      <ShortName>BUSINESS COMBINATIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0058 - Disclosure - BUSINESS COMBINATIONS - Disclosure of detailed information about proforma acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails</Role>
      <ShortName>BUSINESS COMBINATIONS - Disclosure of detailed information about proforma acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0059 - Disclosure - BUSINESS COMBINATIONS - Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails</Role>
      <ShortName>BUSINESS COMBINATIONS - Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0061 - Disclosure - TRADE RECEIVABLES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TRADERECEIVABLESDetailTextuals</Role>
      <ShortName>TRADE RECEIVABLES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/TRADERECEIVABLESTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0062 - Disclosure - TRADE RECEIVABLES - Disclosure of trade receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TRADERECEIVABLESDetails</Role>
      <ShortName>TRADE RECEIVABLES - Disclosure of trade receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0063 - Disclosure - TRADE RECEIVABLES - Disclosure of major customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TRADERECEIVABLESDetails1</Role>
      <ShortName>TRADE RECEIVABLES - Disclosure of major customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0064 - Disclosure - OTHER ACCOUNTS RECEIVABLE - Disclosure of detailed information about other accounts receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails</Role>
      <ShortName>OTHER ACCOUNTS RECEIVABLE - Disclosure of detailed information about other accounts receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0065 - Disclosure - BIOLOGICAL ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BIOLOGICALASSETSDetailTextuals</Role>
      <ShortName>BIOLOGICAL ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/BIOLOGICALASSETSTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0066 - Disclosure - BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BIOLOGICALASSETSDetails</Role>
      <ShortName>BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0067 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about Impact on fair value if 10% increase decrease in each input (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1</Role>
      <ShortName>BIOLOGICAL ASSETS - Disclosure of detailed information about Impact on fair value if 10% increase decrease in each input (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0068 - Disclosure - INVENTORIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/INVENTORIESDetailTextuals</Role>
      <ShortName>INVENTORIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/INVENTORIESTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0069 - Disclosure - INVENTORIES - Disclosure of detailed information about inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES - Disclosure of detailed information about inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0070 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET - Disclosure of detailed information about property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET - Disclosure of detailed information about property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0071 - Disclosure - INTANGIBLE ASSETS, NET (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/INTANGIBLEASSETSNETTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0072 - Disclosure - INTANGIBLE ASSETS, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/INTANGIBLEASSETSNETTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0073 - Disclosure - RIGHT-OF-USE ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals</Role>
      <ShortName>RIGHT-OF-USE ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/RIGHTOFUSEASSETSTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0074 - Disclosure - RIGHT-OF-USE ASSETS - Disclosure of detailed information about right-of-use assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails</Role>
      <ShortName>RIGHT-OF-USE ASSETS - Disclosure of detailed information about right-of-use assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0075 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about expenses recognized in consolidated statements of profit or loss and other comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails</Role>
      <ShortName>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about expenses recognized in consolidated statements of profit or loss and other comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0076 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about defined benefit liability (asset) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1</Role>
      <ShortName>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about defined benefit liability (asset) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0077 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in present value of defined benefit liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2</Role>
      <ShortName>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in present value of defined benefit liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0078 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in the fair value of plan assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3</Role>
      <ShortName>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in the fair value of plan assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0079 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about principal assumptions underlying the defined benefit plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4</Role>
      <ShortName>EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about principal assumptions underlying the defined benefit plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0080 - Disclosure - OTHER PAYABLES - Disclosure of detailed information of other current payables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OTHERPAYABLESDetails</Role>
      <ShortName>OTHER PAYABLES - Disclosure of detailed information of other current payables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0081 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0082 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of carrying values of financial instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Disclosure of carrying values of financial instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0083 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of information about key assumptions to measure fair value of warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Disclosure of information about key assumptions to measure fair value of warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0084 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of maturity analysis for lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Disclosure of maturity analysis for lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0085 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of changes in liabilities arising from financing activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Disclosure of changes in liabilities arising from financing activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0086 - Disclosure - CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals</Role>
      <ShortName>CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0087 - Disclosure - TAXES ON INCOME (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals</Role>
      <ShortName>TAXES ON INCOME (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/TAXESONINCOMETables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0088 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about income tax expense (benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TAXESONINCOMEDetails</Role>
      <ShortName>TAXES ON INCOME - Disclosure of detailed information about income tax expense (benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0089 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about deferred taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TAXESONINCOMEDetails1</Role>
      <ShortName>TAXES ON INCOME - Disclosure of detailed information about deferred taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0090 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about statements of financial position deferred taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TAXESONINCOMEDetails2</Role>
      <ShortName>TAXES ON INCOME - Disclosure of detailed information about statements of financial position deferred taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0091 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about reconciliation of tax expense and accounting profit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/TAXESONINCOMEDetails3</Role>
      <ShortName>TAXES ON INCOME - Disclosure of detailed information about reconciliation of tax expense and accounting profit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0092 - Disclosure - EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EQUITYDetailTextuals</Role>
      <ShortName>EQUITY (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/EQUITYTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0093 - Disclosure - EQUITY - Disclosure of composition of share capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EQUITYDetails</Role>
      <ShortName>EQUITY - Disclosure of composition of share capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0094 - Disclosure - EQUITY - Disclosure of changes in issued and outstanding share capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EQUITYDetails1</Role>
      <ShortName>EQUITY - Disclosure of changes in issued and outstanding share capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0095 - Disclosure - EQUITY - Disclosure of detailed information about options, valuation assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EQUITYDetails2</Role>
      <ShortName>EQUITY - Disclosure of detailed information about options, valuation assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0096 - Disclosure - EQUITY - Disclosure of number of restricted share units ("RSU") (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails</Role>
      <ShortName>EQUITY - Disclosure of number of restricted share units ("RSU") (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0097 - Disclosure - EQUITY - Disclosure of number and weighted average exercise prices of share options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/EQUITYDetails3</Role>
      <ShortName>EQUITY - Disclosure of number and weighted average exercise prices of share options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0098 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA - Disclosure of statement of profit and loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails</Role>
      <ShortName>SELECTED STATEMENTS OF PROFIT OR LOSS DATA - Disclosure of statement of profit and loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0099 - Disclosure - NET EARNINGS (LOSS) PER SHARE - Disclosure of earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails</Role>
      <ShortName>NET EARNINGS (LOSS) PER SHARE - Disclosure of earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARETables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0100 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0101 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of financial position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of financial position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0102 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of profit or loss and other comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of profit or loss and other comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0103 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about key management personnel (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails2</Role>
      <ShortName>RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about key management personnel (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0104 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement of financial position for partly owned subsidiary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails</Role>
      <ShortName>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement of financial position for partly owned subsidiary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0105 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of operating results for partly owned subsidiary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1</Role>
      <ShortName>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of operating results for partly owned subsidiary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0106 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2</Role>
      <ShortName>SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0107 - Disclosure - OPERATING SEGMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails</Role>
      <ShortName>OPERATING SEGMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/OPERATINGSEGMENTSTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="exhibit_99-2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0108 - Disclosure - SUBSEQUENT EVENTS  (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals</Role>
      <ShortName>SUBSEQUENT EVENTS  (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.imcannabis.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>106</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="40-F" original="exhibit_99-2.htm">exhibit_99-2.htm</File>
    <File doctype="40-F" original="zk2227544.htm">zk2227544.htm</File>
    <File>exhibit_99-1.htm</File>
    <File>exhibit_99-3.htm</File>
    <File>exhibit_99-4.htm</File>
    <File>exhibit_99-5.htm</File>
    <File>exhibit_99-6.htm</File>
    <File>exhibit_99-7.htm</File>
    <File>exhibit_99-8.htm</File>
    <File>imc-20211231.xsd</File>
    <File>imc-20211231_cal.xml</File>
    <File>imc-20211231_def.xml</File>
    <File>imc-20211231_lab.xml</File>
    <File>imc-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>imc_img01.jpg</File>
    <File>imc_img02.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1310">http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>152
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "exhibit_99-2.htm zk2227544.htm": {
   "axisCustom": 7,
   "axisStandard": 26,
   "contextCount": 427,
   "dts": {
    "calculationLink": {
     "local": [
      "imc-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "imc-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "exhibit_99-2.htm",
      "zk2227544.htm"
     ]
    },
    "labelLink": {
     "local": [
      "imc-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "imc-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "imc-20211231.xsd",
      "reference-2009-12-16.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 849,
   "entityCount": 1,
   "hidden": {
    "http://www.imcannabis.com/20211231": 1,
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 4
   },
   "keyCustom": 147,
   "keyStandard": 326,
   "memberCustom": 65,
   "memberStandard": 45,
   "nsprefix": "imc",
   "nsuri": "http://www.imcannabis.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227544.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001 - Document - Document and Entity Information",
     "role": "http://www.imcannabis.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227544.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0011 - Disclosure - DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION",
     "role": "http://www.imcannabis.com/role/DISCLOSUREOFNEWSTANDARDSINTHEPERIODPRIORTOTHEIRADOPTION",
     "shortName": "DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0102 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of profit or loss and other comprehensive income (Details)",
     "role": "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of profit or loss and other comprehensive income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullRelatedPartiesMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "imc:KeyManagementPersonnelCompensationPayrollAndRelatedExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0103 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about key management personnel (Details)",
     "role": "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails2",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about key management personnel (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "imc:KeyManagementPersonnelCompensationPayrollAndRelatedExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAssets",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0104 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement of financial position for partly owned subsidiary (Details)",
     "role": "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails",
     "shortName": "SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement of financial position for partly owned subsidiary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory",
       "div",
       "div",
       "div",
       "imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0105 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of operating results for partly owned subsidiary (Details)",
     "role": "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1",
     "shortName": "SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of operating results for partly owned subsidiary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory",
       "div",
       "div",
       "div",
       "imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0106 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details)",
     "role": "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2",
     "shortName": "SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "div",
       "div",
       "div",
       "imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcFocusMedicalHerbsLtdMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0107 - Disclosure - OPERATING SEGMENTS (Details)",
     "role": "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails",
     "shortName": "OPERATING SEGMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "div",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullSegmentConsolidationItemsAxis_ifrsfullOperatingSegmentsMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:NumberOfSharesOutstanding",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfCompositionOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unitRef": "Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0108 - Disclosure - SUBSEQUENT EVENTS  (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals",
     "shortName": "SUBSEQUENT EVENTS  (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20220301to20220314_ifrsfullBusinessCombinationsAxis_imcPharmYarokPharmacyMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_imcSubsequentEventMember",
      "decimals": "3",
      "lang": null,
      "name": "imc:DeemedPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD_per_Share",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0012 - Disclosure - BUSINESS COMBINATIONS",
     "role": "http://www.imcannabis.com/role/BUSINESSCOMBINATIONS",
     "shortName": "BUSINESS COMBINATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0013 - Disclosure - TRADE RECEIVABLES",
     "role": "http://www.imcannabis.com/role/TRADERECEIVABLES",
     "shortName": "TRADE RECEIVABLES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfOtherAccountsReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0014 - Disclosure - OTHER ACCOUNTS RECEIVABLE",
     "role": "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLE",
     "shortName": "OTHER ACCOUNTS RECEIVABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfOtherAccountsReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0015 - Disclosure - BIOLOGICAL ASSETS",
     "role": "http://www.imcannabis.com/role/BIOLOGICALASSETS",
     "shortName": "BIOLOGICAL ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0016 - Disclosure - INVENTORIES",
     "role": "http://www.imcannabis.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0017 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET",
     "role": "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0018 - Disclosure - INTANGIBLE ASSETS, NET",
     "role": "http://www.imcannabis.com/role/INTANGIBLEASSETSNET",
     "shortName": "INTANGIBLE ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfRightOfUseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0019 - Disclosure - RIGHT-OF-USE ASSETS",
     "role": "http://www.imcannabis.com/role/RIGHTOFUSEASSETS",
     "shortName": "RIGHT-OF-USE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfRightOfUseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0020 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES",
     "role": "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIES",
     "shortName": "EMPLOYEE BENEFIT ASSETS AND LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION",
     "role": "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
     "shortName": "CONSOLIDATED STATEMENTS OF FINANCIAL POSITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentRestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0021 - Disclosure - OTHER PAYABLES",
     "role": "http://www.imcannabis.com/role/OTHERPAYABLES",
     "shortName": "OTHER PAYABLES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0022 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.imcannabis.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0023 - Disclosure - CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES",
     "role": "http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES",
     "shortName": "CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0024 - Disclosure - TAXES ON INCOME",
     "role": "http://www.imcannabis.com/role/TAXESONINCOME",
     "shortName": "TAXES ON INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0025 - Disclosure - EQUITY",
     "role": "http://www.imcannabis.com/role/EQUITY",
     "shortName": "EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0026 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA",
     "role": "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATA",
     "shortName": "SELECTED STATEMENTS OF PROFIT OR LOSS DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0027 - Disclosure - NET EARNINGS (LOSS) PER SHARE",
     "role": "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARE",
     "shortName": "NET EARNINGS (LOSS) PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0028 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS",
     "role": "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONS",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0029 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY",
     "role": "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY",
     "shortName": "SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0030 - Disclosure - OPERATING SEGMENTS",
     "role": "http://www.imcannabis.com/role/OPERATINGSEGMENTS",
     "shortName": "OPERATING SEGMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0003 - Statement - CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME",
     "role": "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0031 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.imcannabis.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "imc:DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "imc:DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0034 - Disclosure - BUSINESS COMBINATIONS (Tables)",
     "role": "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
     "shortName": "BUSINESS COMBINATIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfTradeReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0035 - Disclosure - TRADE RECEIVABLES (Tables)",
     "role": "http://www.imcannabis.com/role/TRADERECEIVABLESTables",
     "shortName": "TRADE RECEIVABLES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfTradeReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfOtherAccountsReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0036 - Disclosure - OTHER ACCOUNTS RECEIVABLE (Tables)",
     "role": "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLETables",
     "shortName": "OTHER ACCOUNTS RECEIVABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfOtherAccountsReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0037 - Disclosure - BIOLOGICAL ASSETS (Tables)",
     "role": "http://www.imcannabis.com/role/BIOLOGICALASSETSTables",
     "shortName": "BIOLOGICAL ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0038 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.imcannabis.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0039 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET (Tables)",
     "role": "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0040 - Disclosure - INTANGIBLE ASSETS, NET (Tables)",
     "role": "http://www.imcannabis.com/role/INTANGIBLEASSETSNETTables",
     "shortName": "INTANGIBLE ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0004 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "role": "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20191231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "imc:DisclosureOfRightOfUseAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0041 - Disclosure - RIGHT-OF-USE ASSETS (Tables)",
     "role": "http://www.imcannabis.com/role/RIGHTOFUSEASSETSTables",
     "shortName": "RIGHT-OF-USE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "imc:DisclosureOfRightOfUseAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0042 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES (Tables)",
     "role": "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables",
     "shortName": "EMPLOYEE BENEFIT ASSETS AND LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0043 - Disclosure - OTHER PAYABLES (Tables)",
     "role": "http://www.imcannabis.com/role/OTHERPAYABLESTables",
     "shortName": "OTHER PAYABLES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0044 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0045 - Disclosure - TAXES ON INCOME (Tables)",
     "role": "http://www.imcannabis.com/role/TAXESONINCOMETables",
     "shortName": "TAXES ON INCOME (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfCompositionOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0046 - Disclosure - EQUITY (Tables)",
     "role": "http://www.imcannabis.com/role/EQUITYTables",
     "shortName": "EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfCompositionOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0047 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA (Tables)",
     "role": "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATATables",
     "shortName": "SELECTED STATEMENTS OF PROFIT OR LOSS DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0048 - Disclosure - NET EARNINGS (LOSS) PER SHARE (Tables)",
     "role": "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARETables",
     "shortName": "NET EARNINGS (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfBalancesWithRelatedPartiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0049 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "role": "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfBalancesWithRelatedPartiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0050 - Disclosure - SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY (Tables)",
     "role": "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables",
     "shortName": "SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "imc:DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0051 - Disclosure - OPERATING SEGMENTS (Tables)",
     "role": "http://www.imcannabis.com/role/OPERATINGSEGMENTSTables",
     "shortName": "OPERATING SEGMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210201to20210212",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0052 - Disclosure - GENERAL (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/GENERALDetailTextuals",
     "shortName": "GENERAL (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullBorrowingsByNameAxis_imcRevolvingCreditFacilityMember_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember",
      "decimals": "-3",
      "lang": null,
      "name": "imc:Commitment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0053 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "imc:DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0054 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about subsidiaries (Details)",
     "role": "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Disclosure of detailed information about subsidiaries (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "imc:DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcIPointMPointCPointHoldingsLtdMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "imc:DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0055 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment (Details)",
     "role": "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "imc:DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "imc:DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0056 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets (Details)",
     "role": "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES -Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "imc:DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullLicencesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AmortisationRateIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0057 - Disclosure - BUSINESS COMBINATIONS (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
     "shortName": "BUSINESS COMBINATIONS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210301to20210318_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember",
      "decimals": "1",
      "lang": null,
      "name": "ifrs-full:WeightedAverageSharePrice2019",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD_per_Share",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_srtStatementScenarioAxis_srtProFormaMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueOfAcquiree",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0058 - Disclosure - BUSINESS COMBINATIONS - Disclosure of detailed information about proforma acquisition (Details)",
     "role": "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
     "shortName": "BUSINESS COMBINATIONS - Disclosure of detailed information about proforma acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember_srtStatementScenarioAxis_srtProFormaMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueOfAcquiree",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfOtherAccountsReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0059 - Disclosure - BUSINESS COMBINATIONS - Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)",
     "role": "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
     "shortName": "BUSINESS COMBINATIONS - Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:TermOfNonInterestBearingTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0061 - Disclosure - TRADE RECEIVABLES (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/TRADERECEIVABLESDetailTextuals",
     "shortName": "TRADE RECEIVABLES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:TermOfNonInterestBearingTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Additional information)",
     "role": "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Additional information)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullBusinessCombinationsAxis_imcTrichomeFinancialCorpMember",
      "decimals": "-3",
      "lang": null,
      "name": "imc:WorkingCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentTradeReceivables",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0062 - Disclosure - TRADE RECEIVABLES - Disclosure of trade receivables (Details)",
     "role": "http://www.imcannabis.com/role/TRADERECEIVABLESDetails",
     "shortName": "TRADE RECEIVABLES - Disclosure of trade receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWholesalesAndPharmaciesMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0063 - Disclosure - TRADE RECEIVABLES - Disclosure of major customers (Details)",
     "role": "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1",
     "shortName": "TRADE RECEIVABLES - Disclosure of major customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullGeographicalAreasAxis_imcForeignCountriesTwoMember_ifrsfullMajorCustomersAxis_imcCustomerOneMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfOtherAccountsReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentPrepaidExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0064 - Disclosure - OTHER ACCOUNTS RECEIVABLE - Disclosure of detailed information about other accounts receivable (Details)",
     "role": "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails",
     "shortName": "OTHER ACCOUNTS RECEIVABLE - Disclosure of detailed information about other accounts receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfOtherAccountsReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentPrepaidExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "imc:WeightedAverageFairValueLessCostToSellOfBiologicalAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD_per_gram",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0065 - Disclosure - BIOLOGICAL ASSETS (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/BIOLOGICALASSETSDetailTextuals",
     "shortName": "BIOLOGICAL ASSETS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "imc:WeightedAverageFairValueLessCostToSellOfBiologicalAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD_per_gram",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:BiologicalAssets",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0066 - Disclosure - BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)",
     "role": "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails",
     "shortName": "BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20191231",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:BiologicalAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "imc:DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "imc:AverageSellingPricePerGramOfDriedCannabis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD_per_gram",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0067 - Disclosure - BIOLOGICAL ASSETS - Disclosure of detailed information about Impact on fair value if 10% increase decrease in each input (Details)",
     "role": "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1",
     "shortName": "BIOLOGICAL ASSETS - Disclosure of detailed information about Impact on fair value if 10% increase decrease in each input (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "imc:DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullBiologicalAssetsByTypeAxis_imcCannabisPlantsMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "imc:AverageSellingPricePerGramOfDriedCannabis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD_per_gram",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CostOfMerchandiseSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0068 - Disclosure - INVENTORIES (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/INVENTORIESDetailTextuals",
     "shortName": "INVENTORIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CostOfMerchandiseSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "imc:CapitalizedCostsOfInventories",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0069 - Disclosure - INVENTORIES - Disclosure of detailed information about inventories (Details)",
     "role": "http://www.imcannabis.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES - Disclosure of detailed information about inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "imc:CapitalizedCostsOfInventories",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0070 - Disclosure - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET - Disclosure of detailed information about property, plant and equipment (Details)",
     "role": "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET - Disclosure of detailed information about property, plant and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0071 - Disclosure - INTANGIBLE ASSETS, NET (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals",
     "shortName": "INTANGIBLE ASSETS, NET (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_imcAdjupharmGmbhMember",
      "decimals": "4",
      "lang": null,
      "name": "imc:PreTaxDiscountRateOfCashFlows",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0008 - Disclosure - GENERAL",
     "role": "http://www.imcannabis.com/role/GENERAL",
     "shortName": "GENERAL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0072 - Disclosure - INTANGIBLE ASSETS, NET (Details)",
     "role": "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
     "shortName": "INTANGIBLE ASSETS, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfRightOfUseAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0073 - Disclosure - RIGHT-OF-USE ASSETS (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
     "shortName": "RIGHT-OF-USE ASSETS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0074 - Disclosure - RIGHT-OF-USE ASSETS - Disclosure of detailed information about right-of-use assets (Details)",
     "role": "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails",
     "shortName": "RIGHT-OF-USE ASSETS - Disclosure of detailed information about right-of-use assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "div",
       "div",
       "imc:DisclosureOfRightOfUseAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20191231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentServiceCostDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0075 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about expenses recognized in consolidated statements of profit or loss and other comprehensive income (Details)",
     "role": "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails",
     "shortName": "EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about expenses recognized in consolidated statements of profit or loss and other comprehensive income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentServiceCostDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0076 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about defined benefit liability (asset) (Details)",
     "role": "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1",
     "shortName": "EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about defined benefit liability (asset) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:RecognisedLiabilitiesDefinedBenefitPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0077 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in present value of defined benefit liabilities (Details)",
     "role": "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2",
     "shortName": "EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in present value of defined benefit liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PlanAssetsAtFairValue",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0078 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in the fair value of plan assets (Details)",
     "role": "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3",
     "shortName": "EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about changes in the fair value of plan assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "imc:ReturnNetOfInterestIncomeReMeasurementGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0079 - Disclosure - EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about principal assumptions underlying the defined benefit plan (Details)",
     "role": "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4",
     "shortName": "EMPLOYEE BENEFIT ASSETS AND LIABILITIES - Disclosure of detailed information about principal assumptions underlying the defined benefit plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0080 - Disclosure - OTHER PAYABLES - Disclosure of detailed information of other current payables (Details)",
     "role": "http://www.imcannabis.com/role/OTHERPAYABLESDetails",
     "shortName": "OTHER PAYABLES - Disclosure of detailed information of other current payables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "1",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019",
      "reportCount": 1,
      "unitRef": "CAD_per_Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0081 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
     "shortName": "FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "imc:InvestmentsInUnlistedSharesMeasuredAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentInvestments",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0082 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of carrying values of financial instruments (Details)",
     "role": "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Disclosure of carrying values of financial instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "imc:ExpectedVolatilityOfWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0083 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of information about key assumptions to measure fair value of warrants (Details)",
     "role": "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1",
     "shortName": "FINANCIAL INSTRUMENTS - Disclosure of information about key assumptions to measure fair value of warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullClassesOfFinancialInstrumentsAxis_imcWarrant2021Member",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "imc:ExpectedVolatilityOfWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0084 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of maturity analysis for lease liabilities (Details)",
     "role": "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2",
     "shortName": "FINANCIAL INSTRUMENTS - Disclosure of maturity analysis for lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0085 - Disclosure - FINANCIAL INSTRUMENTS - Disclosure of changes in liabilities arising from financing activities (Details)",
     "role": "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3",
     "shortName": "FINANCIAL INSTRUMENTS - Disclosure of changes in liabilities arising from financing activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20191231",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20190819",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "imc:AmountOfPersonalSuit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0086 - Disclosure - CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals",
     "shortName": "CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20190819",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "imc:AmountOfPersonalSuit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:ApplicableTaxRate",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unitRef": "Percentage",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0087 - Disclosure - TAXES ON INCOME (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals",
     "shortName": "TAXES ON INCOME (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:ApplicableTaxRate",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_srtStatementGeographicalAxis_countryIL",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0088 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about income tax expense (benefit) (Details)",
     "role": "http://www.imcannabis.com/role/TAXESONINCOMEDetails",
     "shortName": "TAXES ON INCOME - Disclosure of detailed information about income tax expense (benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeferredTaxAssets",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0089 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about deferred taxes (Details)",
     "role": "http://www.imcannabis.com/role/TAXESONINCOMEDetails1",
     "shortName": "TAXES ON INCOME - Disclosure of detailed information about deferred taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "imc:TranslationDifferencesOfDefferedTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeferredTaxAssets",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0090 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about statements of financial position deferred taxes (Details)",
     "role": "http://www.imcannabis.com/role/TAXESONINCOMEDetails2",
     "shortName": "TAXES ON INCOME - Disclosure of detailed information about statements of financial position deferred taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AccountingProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0091 - Disclosure - TAXES ON INCOME - Disclosure of detailed information about reconciliation of tax expense and accounting profit (Details)",
     "role": "http://www.imcannabis.com/role/TAXESONINCOMEDetails3",
     "shortName": "TAXES ON INCOME - Disclosure of detailed information about reconciliation of tax expense and accounting profit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AccountingProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0010 - Disclosure - SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS",
     "role": "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGESTIMATESANDASSUMPTIONSUSEDINTHEPREPARATIONOFTHEFINANCIALSTATEMENTS",
     "shortName": "SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210201to20210212",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "imc:DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0092 - Disclosure - EQUITY (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/EQUITYDetailTextuals",
     "shortName": "EQUITY (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "INF",
      "lang": null,
      "name": "imc:NumberOfCompensationUnitsIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Share",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:NumberOfSharesOutstanding",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfCompositionOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unitRef": "Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0093 - Disclosure - EQUITY - Disclosure of composition of share capital (Details)",
     "role": "http://www.imcannabis.com/role/EQUITYDetails",
     "shortName": "EQUITY - Disclosure of composition of share capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfCompositionOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "reportCount": 1,
      "unitRef": "Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0094 - Disclosure - EQUITY - Disclosure of changes in issued and outstanding share capital (Details)",
     "role": "http://www.imcannabis.com/role/EQUITYDetails1",
     "shortName": "EQUITY - Disclosure of changes in issued and outstanding share capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "imc:DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "0",
      "lang": null,
      "name": "imc:OrdinarySharesIssuedForWarrantsCompensationOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Share",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0095 - Disclosure - EQUITY - Disclosure of detailed information about options, valuation assumptions (Details)",
     "role": "http://www.imcannabis.com/role/EQUITYDetails2",
     "shortName": "EQUITY - Disclosure of detailed information about options, valuation assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "imc:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percentage",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "imc:DisclosureOfRestrictedShareUnitsTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0096 - Disclosure - EQUITY - Disclosure of number of restricted share units (\"RSU\") (Details)",
     "role": "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails",
     "shortName": "EQUITY - Disclosure of number of restricted share units (\"RSU\") (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "imc:DisclosureOfRestrictedShareUnitsTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231_ifrsfullComponentsOfEquityAxis_imcRestrictedShareUnitsMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0097 - Disclosure - EQUITY - Disclosure of number and weighted average exercise prices of share options (Details)",
     "role": "http://www.imcannabis.com/role/EQUITYDetails3",
     "shortName": "EQUITY - Disclosure of number and weighted average exercise prices of share options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20191231",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0098 - Disclosure - SELECTED STATEMENTS OF PROFIT OR LOSS DATA - Disclosure of statement of profit and loss (Details)",
     "role": "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails",
     "shortName": "SELECTED STATEMENTS OF PROFIT OR LOSS DATA - Disclosure of statement of profit and loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WeightedAverageShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0099 - Disclosure - NET EARNINGS (LOSS) PER SHARE - Disclosure of earnings per share (Details)",
     "role": "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails",
     "shortName": "NET EARNINGS (LOSS) PER SHARE - Disclosure of earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WeightedAverageShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Share",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfessionalFeesExpense",
      "reportCount": 1,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0100 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Narrative) (Details)",
     "role": "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20210101to20211231_ifrsfullCategoriesOfRelatedPartiesAxis_imcShareholdersMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:ProfessionalFeesExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfBalancesWithRelatedPartiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0101 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of financial position (Details)",
     "role": "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails",
     "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS - Disclosure of information about balances with related parties in statements of financial position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "imc:DisclosureOfBalancesWithRelatedPartiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exhibit_99-2.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "CAD",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 116,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "German [Member]"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Israel [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "verboseLabel": "EUR [Member]"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "verboseLabel": "GBP [Member]"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_ILS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel, New Shekels",
        "verboseLabel": "NIS [Member]"
       }
      }
     },
     "localname": "ILS",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "verboseLabel": "USD [Member]"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.imcannabis.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ifrs-full_AccountingProfit": {
     "auth_ref": [
      "r62",
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accounting profit",
        "terseLabel": "Income (loss) before income tax",
        "verboseLabel": "Loss before income tax"
       }
      }
     },
     "localname": "AccountingProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": {
     "auth_ref": [
      "r72",
      "r80",
      "r134",
      "r146",
      "r155"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated depreciation, amortisation and impairment [member]",
        "terseLabel": "Accumulated depreciation [Member]",
        "verboseLabel": "Accumulated amortization and impairment [Member]"
       }
      }
     },
     "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration transferred, acquisition-date fair value",
        "negatedLabel": "Common shares issued upon the acquisition",
        "positiveLabel": "Total consideration",
        "terseLabel": "Total purchase price",
        "totalLabel": "Total purchase price",
        "verboseLabel": "Common shares issued upon the acquisition"
       }
      }
     },
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of acquisition-related costs recognised as an expense for transactions that are recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination",
        "terseLabel": "Acquisition costs",
        "verboseLabel": "Aggregate consideration"
       }
      }
     },
     "localname": "AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsBiologicalAssets": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in biological assets resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, biological assets",
        "terseLabel": "Additions related to acquisitions of Trichome and MYM"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsBiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, intangible assets other than goodwill",
        "terseLabel": "Initially consolidated company"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, property, plant and equipment",
        "terseLabel": "Additions related to acquisitions"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates",
        "verboseLabel": "Discount rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of salary increases",
        "verboseLabel": "Salary growth"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails4"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, intangible assets other than goodwill",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "terseLabel": "Additions during the year"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions to right-of-use assets",
        "verboseLabel": "Additions during the year: New leases"
       }
      }
     },
     "localname": "AdditionsToRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjusted weighted average number of ordinary shares outstanding",
        "verboseLabel": "For the computation of diluted net earnings, Weighted number of shares"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails": {
       "order": 20.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments of tax expense (income) recognised in the period for current tax of prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for current tax of prior periods",
        "verboseLabel": "Income tax from previous years"
       }
      }
     },
     "localname": "AdjustmentsForCurrentTaxOfPriorPeriod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInBiologicalAssets": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 50.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in biological assets",
        "verboseLabel": "Decrease in biological assets, net of fair value adjustments"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInBiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 30.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "terseLabel": "Increase in inventories, net of fair value adjustments"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 0.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade accounts receivable",
        "terseLabel": "Increase in other accounts receivable and advances to suppliers"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade and other receivables",
        "terseLabel": "Increase in trade receivables, net"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDeferredTaxExpense": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 110.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for deferred tax expense",
        "terseLabel": "Deferred tax expense (benefit), net",
        "verboseLabel": "Deferred tax benefit"
       }
      }
     },
     "localname": "AdjustmentsForDeferredTaxExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForFinanceIncomeCost": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 80.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for finance income (cost)",
        "negatedLabel": "Finance income, net",
        "terseLabel": "Finance income, net"
       }
      }
     },
     "localname": "AdjustmentsForFinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 130.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gains (losses) on changes in the fair value less costs to sell of biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gains (losses) on change in fair value less costs to sell, biological assets",
        "negatedLabel": "Unrealized gain on changes in fair value of biological assets",
        "verboseLabel": "Unrealized change in fair value of biological assets"
       }
      }
     },
     "localname": "AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill": {
     "auth_ref": [
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss on goodwill recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Goodwill; Impairment loss; Impairment loss recognised in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for impairment loss recognised in profit or loss, goodwill",
        "terseLabel": "Goodwill impairment with respect to the cash generating unit in Europe"
       }
      }
     },
     "localname": "AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r169"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 70.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss",
        "terseLabel": "Impairment of goodwill"
       }
      }
     },
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 60.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in employee benefit liabilities",
        "terseLabel": "Changes in employee benefit liabilities, net"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 40.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "terseLabel": "Increase in trade payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInWorkingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade and other payables",
        "terseLabel": "Increase in other accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLoss": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 30.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss)",
        "terseLabel": "Total adjustments for non-cash items",
        "totalLabel": "Total adjustments for non-cash items"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for non-cash items:"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r169"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 100.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Share-based payments expenses",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r27",
      "r93",
      "r218",
      "r226",
      "r227",
      "r260",
      "r278",
      "r280",
      "r303",
      "r304",
      "r306",
      "r312"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]"
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 120.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation, intangible assets other than goodwill",
        "positiveLabel": "Amortization expense",
        "terseLabel": "Amortization recognized in the year",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals",
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amortisation method used for intangible assets other than goodwill with finite useful lives. [Refer: Intangible assets other than goodwill; Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation method, intangible assets other than goodwill",
        "verboseLabel": "Amortization method"
       }
      }
     },
     "localname": "AmortisationMethodIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AmortisationRateIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amortisation rate used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation rate, intangible assets other than goodwill",
        "verboseLabel": "Amortization rate"
       }
      }
     },
     "localname": "AmortisationRateIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "auth_ref": [
      "r105",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts payable, related party transactions",
        "terseLabel": "Other accounts payables"
       }
      }
     },
     "localname": "AmountsPayableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsReceivableRelatedPartyTransactions": {
     "auth_ref": [
      "r105",
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts receivable, related party transactions",
        "terseLabel": "Other accounts receivables"
       }
      }
     },
     "localname": "AmountsReceivableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ApplicableTaxRate": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "terseLabel": "Statutory tax rate in Canada"
       }
      }
     },
     "localname": "ApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r24",
      "r210",
      "r211",
      "r213",
      "r288",
      "r291"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Segment assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BankBorrowingsUndiscountedCashFlows": {
     "auth_ref": [
      "r279",
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Bank borrowings, undiscounted cash flows",
        "verboseLabel": "Bank Loans"
       }
      }
     },
     "localname": "BankBorrowingsUndiscountedCashFlows",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BenefitsPaidOrPayable": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of benefits paid or payable for retirement benefit plans."
       }
      },
      "en-us": {
       "role": {
        "label": "Benefits paid or payable",
        "negatedTerseLabel": "Benefits paid",
        "verboseLabel": "Benefits paid"
       }
      }
     },
     "localname": "BenefitsPaidOrPayable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BiologicalAssets": {
     "auth_ref": [
      "r17",
      "r148",
      "r153"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of living animals or plants recognised as assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Biological assets",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "BiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BiologicalAssetsByTypeAxis": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Biological assets by type [axis]"
       }
      }
     },
     "localname": "BiologicalAssetsByTypeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BiologicalAssetsTypeMember": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all biological assets when disaggregated by type. It also represents the standard value for the 'Biological assets by type' axis if no other member is used. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Biological assets, type [member]"
       }
      }
     },
     "localname": "BiologicalAssetsTypeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Borrowings": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings"
       }
      }
     },
     "localname": "Borrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      }
     },
     "localname": "BorrowingsByNameAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [member]"
       }
      }
     },
     "localname": "BorrowingsByNameMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BorrowingsInterestRate": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings, interest rate"
       }
      }
     },
     "localname": "BorrowingsInterestRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_BorrowingsInterestRateBasis": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings, interest rate basis"
       }
      }
     },
     "localname": "BorrowingsInterestRateBasis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 10.0,
       "parentTag": "imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 60.0,
       "parentTag": "imc_TotalAcquisitionSubsidiary",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings recognised as of acquisition date",
        "negatedLabel": "Bank Loans",
        "terseLabel": "Bank loan"
       }
      }
     },
     "localname": "BorrowingsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r236",
      "r275",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "terseLabel": "Bottom of range [Member]"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails2",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BrandNamesMember": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Brand names [member]",
        "terseLabel": "Brand [Member]"
       }
      }
     },
     "localname": "BrandNamesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings [member]",
        "terseLabel": "Buildings and improvements [Member]",
        "verboseLabel": "Land and buildings [Member]"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Business combinations [axis]"
       }
      }
     },
     "localname": "BusinessCombinationsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "auth_ref": [
      "r72",
      "r77",
      "r134",
      "r139",
      "r145",
      "r146",
      "r147",
      "r153",
      "r155",
      "r253",
      "r265",
      "r266",
      "r318",
      "r321"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      }
     },
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountMember": {
     "auth_ref": [
      "r77",
      "r139",
      "r145",
      "r147",
      "r153",
      "r253",
      "r265",
      "r266",
      "r318",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      }
     },
     "localname": "CarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r20",
      "r183",
      "r206"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 0.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1": {
       "order": 0.0,
       "parentTag": "imc_NetCashTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents recognised as of acquisition date",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents acquired with the acquiree at the acquisition date"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r157",
      "r185"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash provided by financing activities",
        "verboseLabel": "From financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Cash provided by financing activities:"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r157",
      "r185"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash used in investing activities",
        "verboseLabel": "From investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r157",
      "r185"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 0.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "terseLabel": "Net cash used in operating activities",
        "totalLabel": "Net cash used in operating activities",
        "verboseLabel": "From operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "verboseLabel": "Cash provided from operating activities:"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities",
        "negatedLabel": "Acquisition of subsidiary",
        "negativeTerseLabel": "Acquisition of subsidiaries",
        "verboseLabel": "Acquisition of subsidiary"
       }
      }
     },
     "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the repayment of advances and loans made to other parties (other than advances and loans of a financial institution), classified as investing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash receipts from repayment of advances and loans made to other parties, classified as investing activities",
        "terseLabel": "Proceeds from loans receivable",
        "verboseLabel": "Repayment of loan receivable"
       }
      }
     },
     "localname": "CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashTransferred": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1": {
       "order": 10.0,
       "parentTag": "imc_NetCashTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash transferred",
        "negatedTerseLabel": "Cash paid",
        "terseLabel": "Cash paid"
       }
      }
     },
     "localname": "CashTransferred",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfFinancialAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of financial assets [abstract]",
        "terseLabel": "Financial assets:"
       }
      }
     },
     "localname": "CategoriesOfFinancialAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of financial liabilities [abstract]",
        "terseLabel": "Financial liabilities:"
       }
      }
     },
     "localname": "CategoriesOfFinancialLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals",
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r125",
      "r127",
      "r214",
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r125",
      "r214",
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets [member]"
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r273",
      "r274",
      "r302",
      "r314",
      "r315",
      "r316"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r270"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsMember": {
     "auth_ref": [
      "r265",
      "r267",
      "r268",
      "r270"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments, class [member]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of current inventories [abstract]"
       }
      }
     },
     "localname": "ClassesOfInventoriesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]",
        "verboseLabel": "Other comprehensive income that will be reclassified to profit or loss in subsequent periods:"
       }
      }
     },
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]",
        "terseLabel": "Other comprehensive income that will not be reclassified to profit or loss in subsequent periods:",
        "verboseLabel": "Other comprehensive income (loss) that will not be reclassified to profit or loss in subsequent periods:"
       }
      }
     },
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r4",
      "r42",
      "r191",
      "r193",
      "r198",
      "r203"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "terseLabel": "Total comprehensive income (loss)",
        "totalLabel": "Total comprehensive loss",
        "verboseLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income attributable to [abstract]",
        "verboseLabel": "Total comprehensive income (loss) attributable to:"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r4",
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to non-controlling interests",
        "verboseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "auth_ref": [
      "r4",
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent",
        "terseLabel": "Equity holders of the Company"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComputerEquipmentMember": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Computer, software and equipment [member]",
        "terseLabel": "Computer, software and equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CostOfMerchandiseSold": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of merchandise that was sold during the period and recognised as an expense."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of merchandise sold",
        "verboseLabel": "Inventory expensed to cost of goods sold"
       }
      }
     },
     "localname": "CostOfMerchandiseSold",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfSales": {
     "auth_ref": [
      "r2",
      "r54"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "imc_GrossProfitBeforeFairValueAdjustments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "negatedLabel": "Cost of revenues",
        "terseLabel": "Cost of revenues",
        "verboseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CountryOfDomicileMember": {
     "auth_ref": [
      "r296",
      "r297"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the country in which the entity is registered and where it has its legal address or registered office."
       }
      },
      "en-us": {
       "role": {
        "label": "Country of domicile [member]",
        "terseLabel": "Israel [Member]"
       }
      }
     },
     "localname": "CountryOfDomicileMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrencyRiskMember": {
     "auth_ref": [
      "r283",
      "r307",
      "r308",
      "r309",
      "r310"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Currency risk [Member]"
       }
      }
     },
     "localname": "CurrencyRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails": {
       "order": 0.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAdvancesToSuppliers": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 80.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current advances made to suppliers before goods or services are received."
       }
      },
      "en-us": {
       "role": {
        "label": "Current advances to suppliers",
        "verboseLabel": "Advances to suppliers"
       }
      }
     },
     "localname": "CurrentAdvancesToSuppliers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r28",
      "r198",
      "r199"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Total current assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentBiologicalAssets": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 40.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current biological assets. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current biological assets",
        "verboseLabel": "Biological assets"
       }
      }
     },
     "localname": "CurrentBiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentBiologicalAssetsMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for current biological assets. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current biological assets [member]",
        "verboseLabel": "Inventory and biological assets [Member]"
       }
      }
     },
     "localname": "CurrentBiologicalAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentDepositsFromCustomers": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails": {
       "order": 40.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current deposits from customers. [Refer: Deposits from customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current deposits from customers",
        "terseLabel": "Advances from customers"
       }
      }
     },
     "localname": "CurrentDepositsFromCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentInvestments": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 50.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current investments."
       }
      },
      "en-us": {
       "role": {
        "label": "Current investments",
        "terseLabel": "Investments and Financial Instruments",
        "verboseLabel": "Investments and financial instruments"
       }
      }
     },
     "localname": "CurrentInvestments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 20.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "verboseLabel": "Current maturities of lease liabilities"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r30",
      "r198",
      "r201"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "negatedLabel": "Current liabilities",
        "totalLabel": "Total current liabilities",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "verboseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentPortionOfLongtermBorrowings": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current portion of non-current borrowings",
        "verboseLabel": "Outstanding balance of 2 loans"
       }
      }
     },
     "localname": "CurrentPortionOfLongtermBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails": {
       "order": 20.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepaid expenses",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "CurrentPrepaidExpenses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentRestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 70.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current restricted cash and cash equivalents",
        "terseLabel": "Restricted bank deposit",
        "verboseLabel": "Restricted deposit"
       }
      }
     },
     "localname": "CurrentRestrictedCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentServiceCostDefinedBenefitPlans": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The expense of employee service in the current period arising from defined benefit plans. [Refer: Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase in net defined benefit liability (asset) resulting from current service cost]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current service cost, defined benefit plans",
        "verboseLabel": "Current service cost"
       }
      }
     },
     "localname": "CurrentServiceCostDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current service cost, net defined benefit liability (asset)",
        "verboseLabel": "Current service cost"
       }
      }
     },
     "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails": {
       "order": 0.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax expense (income)",
        "totalLabel": "Total current tax expense (income) and adjustments for current tax of prior periods",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTradeReceivables": {
     "auth_ref": [
      "r29",
      "r33"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 20.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Wholesalers and pharmacies",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "CurrentTradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CustomerrelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships."
       }
      },
      "en-us": {
       "role": {
        "label": "Customer-related intangible assets [member]",
        "terseLabel": "Customer relationships [Member]"
       }
      }
     },
     "localname": "CustomerrelatedIntangibleAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DecreaseDueToHarvestBiologicalAssets": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease due to harvest, biological assets",
        "negatedTerseLabel": "Transferred to inventory upon harvest",
        "terseLabel": "Transferred to inventory upon harvest"
       }
      }
     },
     "localname": "DecreaseDueToHarvestBiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r21",
      "r25",
      "r64"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 60.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "terseLabel": "Non-current assets",
        "verboseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income)",
        "verboseLabel": "Deferred, net"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income) recognised in profit or loss",
        "verboseLabel": "Deferred tax expenses, net"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "auth_ref": [
      "r21",
      "r25",
      "r64"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 40.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities",
        "positiveTerseLabel": "Non-current liabilities",
        "terseLabel": "Deferred tax liability",
        "verboseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 60.0,
       "parentTag": "imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 40.0,
       "parentTag": "imc_TotalAcquisitionSubsidiary",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities recognised as of acquisition date",
        "negatedLabel": "Deferred tax liability",
        "negatedTerseLabel": "Deferred tax",
        "terseLabel": "Deferred tax",
        "verboseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liability (asset)",
        "negatedLabel": "Deferred tax liabilities, net",
        "verboseLabel": "Deferred tax assets (liabilities), net"
       }
      }
     },
     "localname": "DeferredTaxLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r1",
      "r3",
      "r54",
      "r207",
      "r286",
      "r293"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation and amortisation expense",
        "positiveLabel": "Depreciation, amortization and impairment",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortisationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails",
      "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r75",
      "r79"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 90.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, property, plant and equipment",
        "negatedLabel": "Depreciation, property, plant and equipment",
        "terseLabel": "Depreciation during the year",
        "verboseLabel": "Depreciation of property, plant and equipment"
       }
      }
     },
     "localname": "DepreciationPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationRatePropertyPlantAndEquipment": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation rate, property, plant and equipment"
       }
      }
     },
     "localname": "DepreciationRatePropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "auth_ref": [
      "r222"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 60.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, right-of-use assets",
        "terseLabel": "Depreciation of right-of-use assets",
        "verboseLabel": "Additions during the year: Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativeFinancialAssets": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 20.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivative financial assets",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for biological assets. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for biological assets [text block]",
        "verboseLabel": "Biological assets [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for business combinations and goodwill. [Refer: Business combinations [member]; Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for business combinations and goodwill [text block]",
        "verboseLabel": "Business combinations and goodwill [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the derecognition of financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for derecognition of financial instruments [text block]",
        "verboseLabel": "Financial instruments [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for earnings per share [text block]",
        "terseLabel": "Earnings per share [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for employee benefits [text block]",
        "terseLabel": "Employee benefit liabilities [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for fair value measurement. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for fair value measurement [text block]",
        "verboseLabel": "Fair value measurement [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the currency of the primary economic environment in which the entity operates."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for functional currency [text block]",
        "verboseLabel": "Functional currency, presentation currency and foreign currency [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for impairment of non-financial assets [text block]",
        "verboseLabel": "Impairment of non-financial assets [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for income tax."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for income tax [text block]",
        "terseLabel": "Taxes on income [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]",
        "terseLabel": "Intangible assets [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for leases [text block]",
        "terseLabel": "Leases [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "verboseLabel": "Inventories [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "verboseLabel": "Provisions [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenue recognition [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for research and development expense [text block]",
        "verboseLabel": "Research and development expenditures [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for segment reporting."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for segment reporting [text block]",
        "terseLabel": "Operating segments [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for share-based payment transactions [text block]",
        "terseLabel": "Share-based payment transactions [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for treasury shares [text block]",
        "terseLabel": "Treasury shares [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]",
        "verboseLabel": "Cash equivalents [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the contingent consideration arrangements and the arrangements for indemnification assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of arrangement for contingent consideration arrangements and indemnification assets",
        "terseLabel": "Description of contingent consideration of acquisition"
       }
      }
     },
     "localname": "DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]",
        "verboseLabel": "DISCLOSURE OF NEW STANDARDS IN THE PERIOD PRIOR TO THEIR ADOPTION [Text Block]"
       }
      }
     },
     "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/DISCLOSUREOFNEWSTANDARDSINTHEPERIODPRIORTOTHEIRADOPTION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of expected impact of initial application of new standards or interpretations [abstract]"
       }
      }
     },
     "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected volatility, share options granted",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Option life, share options granted",
        "terseLabel": "Expected life of share options"
       }
      }
     },
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails2"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Risk free interest rate, share options granted",
        "terseLabel": "Annual risk-free rate"
       }
      }
     },
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Dilutive effect of convertible instruments on number of ordinary shares",
        "verboseLabel": "Effect of potential dilutive Ordinary shares - Warrants, Weighted number of shares"
       }
      }
     },
     "localname": "DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_DisclosureOfBusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [abstract]"
       }
      }
     },
     "localname": "DisclosureOfBusinessCombinationsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for business combinations."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of business combinations [text block]",
        "terseLabel": "BUSINESS COMBINATIONS [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfBusinessCombinationsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBusinessCombinationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [line items]"
       }
      }
     },
     "localname": "DisclosureOfBusinessCombinationsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfBusinessCombinationsTable": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of business combinations."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [table]"
       }
      }
     },
     "localname": "DisclosureOfBusinessCombinationsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCashFlowStatementExplanatory": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for a statement of cash flows."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of cash flow statement [text block]",
        "verboseLabel": "Disclosure of statement cash flows for partly owned subsidiary [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCashFlowStatementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [abstract]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [abstract]"
       }
      }
     },
     "localname": "DisclosureOfContingentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesExplanatory": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities [text block]",
        "verboseLabel": "CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfContingentLiabilitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of deferred taxes [text block]",
        "terseLabel": "Disclosure of detailed information about deferred taxes [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [text block]",
        "terseLabel": "Disclosure of detailed information about defined benefit plans [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about biological assets [abstract]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about biological assets. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about biological assets [text block]",
        "terseLabel": "BIOLOGICAL ASSETS [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about biological assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsTable": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of biological assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about biological assets [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBiologicalAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [text block]",
        "terseLabel": "Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date [Table Text Block]",
        "verboseLabel": "Disclosure of detailed information about business combinations [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r262",
      "r267",
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [text block]",
        "terseLabel": "Disclosure of carrying values of financial instruments [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [text block]",
        "terseLabel": "Disclosure of detailed information about intangible assets [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [text block]",
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of earnings per share [text block]",
        "verboseLabel": "NET EARNINGS (LOSS) PER SHARE [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for employee benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of employee benefits [text block]",
        "terseLabel": "EMPLOYEE BENEFIT ASSETS AND LIABILITIES [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfEmployeeBenefitsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of entity's operating segments [text block]",
        "terseLabel": "SELECTED STATEMENTS OF PROFIT OR LOSS DATA [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "SUBSEQUENT EVENTS [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of expenses by nature [text block]",
        "terseLabel": "Disclosure of statement of profit and loss [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value of defined benefit plan assets. [Refer: Plan assets [member]; Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value of plan assets [text block]",
        "terseLabel": "Disclosure of detailed information about changes in the fair value of plan assets [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfFairValueOfPlanAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsTable": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [abstract]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments [text block]",
        "terseLabel": "FINANCIAL INSTRUMENTS [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsTable": {
     "auth_ref": [
      "r262",
      "r267",
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "verboseLabel": "GENERAL [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/GENERAL"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [text block]",
        "terseLabel": "Disclosure of operating segments [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [line items]"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasTable": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to geographical areas."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [table]"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "terseLabel": "TAXES ON INCOME [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of information about key management personnel [text block]",
        "terseLabel": "Disclosure of information about key management personnel [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [abstract]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets [text block]",
        "verboseLabel": "INTANGIBLE ASSETS, NET [text block]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of inventories [text block]",
        "verboseLabel": "INVENTORIES [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfInventoriesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIssuedCapitalExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of issued capital [text block]",
        "terseLabel": "EQUITY [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfIssuedCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [text block]",
        "terseLabel": "Disclosure of detailed information about defined benefit liability (asset) [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [abstract]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]",
        "terseLabel": "Disclosure of number and weighted average exercise prices of share options [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [text block]",
        "terseLabel": "OPERATING SEGMENTS"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [abstract]",
        "verboseLabel": "Acquisition of a subsidiary:"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "verboseLabel": "Disclosure of detailed information about right-of-use assets [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to right-of-use assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [table]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in biological assets [text block]",
        "terseLabel": "Disclosure of reconciliation of changes in biological assets [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [text block]",
        "terseLabel": "Disclosure of changes in liabilities arising from financing activities [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [line items]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of liabilities arising from financing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [table]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "verboseLabel": "RELATED PARTY BALANCES AND TRANSACTIONS [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of major customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of major customers [text block]",
        "verboseLabel": "Disclosure of major customers [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfSegmentsMajorCustomersExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [text block]",
        "terseLabel": "Disclosure of detailed information about principal assumptions underlying the defined benefit plan [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r115",
      "r117",
      "r209"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [text block]",
        "terseLabel": "Disclosure of detailed information about subsidiaries [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [line items]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "auth_ref": [
      "r115",
      "r117",
      "r209"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "verboseLabel": "SIGNIFICANT ACCOUNTING POLICIES [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails2",
      "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails2",
      "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other payables [text block]",
        "terseLabel": "OTHER PAYABLES [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERPAYABLES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other receivables [text block]",
        "verboseLabel": "TRADE RECEIVABLES [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [text block]",
        "terseLabel": "Disclosure of transactions between related parties [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [line items]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals",
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals",
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in intangible assets other than goodwill resulting from disposals. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, intangible assets other than goodwill",
        "terseLabel": "Disposals"
       }
      }
     },
     "localname": "DisposalsIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [abstract]",
        "terseLabel": "Net loss per share attributable to equity holders of the Company:",
        "verboseLabel": "Net loss per share attributable to equity holders of the Company:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Earnings per share [text block]",
        "verboseLabel": "Disclosure of earnings per share [Table text block]"
       }
      }
     },
     "localname": "EarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r171",
      "r172"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 30.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "verboseLabel": "Effect of foreign exchange on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForBusinessCombinationsMember": {
     "auth_ref": [
      "r252",
      "r254"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for business combinations [member]"
       }
      }
     },
     "localname": "EntitysTotalForBusinessCombinationsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals",
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for segment consolidation items [member]"
       }
      }
     },
     "localname": "EntitysTotalForSegmentConsolidationItemsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSubsidiariesMember": {
     "auth_ref": [
      "r115",
      "r117",
      "r209"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for subsidiaries [member]"
       }
      }
     },
     "localname": "EntitysTotalForSubsidiariesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r24",
      "r34",
      "r190",
      "r192",
      "r210",
      "r211",
      "r213"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity",
        "verboseLabel": "Total equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [abstract]",
        "terseLabel": "EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY :",
        "verboseLabel": "EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities [abstract]",
        "verboseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "EquityAndLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent",
        "totalLabel": "Total equity attributable to shareholders of the Company"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent [member]",
        "verboseLabel": "Equity attributable to owners of parent [Member]"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityInterestsOfAcquirer": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity interests of acquirer",
        "verboseLabel": "Value of common shares issued in business combination"
       }
      }
     },
     "localname": "EquityInterestsOfAcquirer",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [Member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EstimatedFinancialEffectOfContingentLiabilities": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimated financial effect of contingent liabilities",
        "verboseLabel": "Estimated total amount of class action suit"
       }
      }
     },
     "localname": "EstimatedFinancialEffectOfContingentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Exercise price, share options granted",
        "terseLabel": "Exercise price"
       }
      }
     },
     "localname": "ExercisePriceShareOptionsGranted2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails2"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected dividend as percentage, share options granted",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 30.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedLabel": "Finance expenses",
        "verboseLabel": "Finance expenses"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income",
        "verboseLabel": "Finance income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncomeCost": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "totalLabel": "Finance income (expense), net"
       }
      }
     },
     "localname": "FinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss": {
     "auth_ref": [
      "r276"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at fair value through profit or loss",
        "totalLabel": "Total financial assets at fair value through profit or loss",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValueThroughProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsMember": {
     "auth_ref": [
      "r273",
      "r274",
      "r302",
      "r314",
      "r315",
      "r316"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, class [member]"
       }
      }
     },
     "localname": "FinancialAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilities": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities"
       }
      }
     },
     "localname": "FinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ForeignCountriesMember": {
     "auth_ref": [
      "r296",
      "r297"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for countries outside the entity's country of domicile. [Refer: Country of domicile [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Foreign countries [member]",
        "terseLabel": "Germany [Member]"
       }
      }
     },
     "localname": "ForeignCountriesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gain (loss) on remeasurement, net defined benefit liability (asset)",
        "verboseLabel": "Re-measurement loss on defined benefit plans"
       }
      }
     },
     "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets": {
     "auth_ref": [
      "r154",
      "r156"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) arising from changes in fair value less costs to sell of biological assets due to physical changes. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on fair value adjustment attributable to physical changes, biological assets",
        "terseLabel": "Changes in fair value less cost to sell due to biological transformation"
       }
      }
     },
     "localname": "GainsLossesOnFairValueAdjustmentAttributableToPhysicalChangesBiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets",
       "weight": -1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "commentaryGuidance": "A positive or negative XBRL value can be entered for this element. Refer to the standard element label to determine the correct sign. Use a negative value for terms in brackets.",
        "label": "Gains (losses) on fair value adjustment, biological assets",
        "negatedLabel": "Unrealized change in fair value of biological assets",
        "totalLabel": "Total gains (losses) on fair value adjustment, biological assets",
        "verboseLabel": "Unrealized change in fair value of biological assets"
       }
      }
     },
     "localname": "GainsLossesOnFairValueAdjustmentBiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) excluding exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "commentaryGuidance": "A positive or negative XBRL value can be entered for this element. Refer to the standard element label to determine the correct sign. Use a negative value for terms in brackets.",
        "label": "Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, assets",
        "negatedTotalLabel": "Total fair value adjustments",
        "totalLabel": "Total fair value adjustments"
       }
      }
     },
     "localname": "GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 20.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "General and administrative expense",
        "verboseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeographicalAreasAxis": {
     "auth_ref": [
      "r82",
      "r219",
      "r298",
      "r313"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      }
     },
     "localname": "GeographicalAreasAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeographicalAreasMember": {
     "auth_ref": [
      "r82",
      "r219",
      "r298",
      "r313"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [member]"
       }
      }
     },
     "localname": "GeographicalAreasMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Goodwill": {
     "auth_ref": [
      "r16",
      "r128",
      "r129",
      "r253"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 40.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r252",
      "r255"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "imc_TotalAcquisitionSubsidiary",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill recognised as of acquisition date",
        "terseLabel": "Goodwill arising on acquisition",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "auth_ref": [
      "r72",
      "r134",
      "r146",
      "r155",
      "r253",
      "r266",
      "r268",
      "r269",
      "r318",
      "r321"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]",
        "terseLabel": "Cost [Member]"
       }
      }
     },
     "localname": "GrossCarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossProfit": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit after fair value adjustments"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": {
     "auth_ref": [
      "r248",
      "r255"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Identifiable assets acquired (liabilities assumed)",
        "terseLabel": "Total identifiable assets, net",
        "totalLabel": "Total identifiable assets, net"
       }
      }
     },
     "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r248",
      "r255"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 70.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 30.0,
       "parentTag": "imc_TotalAcquisitionSubsidiary",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Identifiable intangible assets recognised as of acquisition date",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r49",
      "r59",
      "r62",
      "r63",
      "r113",
      "r208",
      "r287"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      },
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "positiveTerseLabel": "Income tax expense",
        "terseLabel": "Income tax expense (benefit)",
        "totalLabel": "Income tax expense (benefit)",
        "verboseLabel": "Income tax expense (recovery), net"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r174"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for income taxes paid, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes paid, classified as operating activities",
        "negatedLabel": "Taxes paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "auth_ref": [
      "r183"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents",
        "totalLabel": "Increase (decrease) in cash and cash equivalents",
        "verboseLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInWorkingCapital": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 0.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in working capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in working capital",
        "negatedTotalLabel": "Changes in non-cash working capital",
        "terseLabel": "Changes in non-cash working capital",
        "totalLabel": "Changes in non-cash working capital"
       }
      }
     },
     "localname": "IncreaseDecreaseInWorkingCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through acquisition of subsidiary, equity",
        "terseLabel": "Issuance of shares related to acquisitions in Israel"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughAcquisitionOfSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in fair values. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through changes in fair values, liabilities arising from financing activities",
        "terseLabel": "Effect of changes in fair value"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through changes in foreign exchange rates, net defined benefit liability (asset)",
        "verboseLabel": "Foreign currency translation effect"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of warrants."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of warrants, equity",
        "terseLabel": "Exercise of warrants and compensation options"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through financing cash flows, liabilities arising from financing activities",
        "negatedLabel": "Cash flows",
        "terseLabel": "Cash flows"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in biological assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Biological assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, biological assets",
        "terseLabel": "Foreign exchange translation"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, property, plant and equipment",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from obtaining or losing control of subsidiaries or other businesses. [Refer: Liabilities arising from financing activities; Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities",
        "terseLabel": "Additions due to acquisition of subsidiary"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through other changes, liabilities arising from financing activities",
        "terseLabel": "Other changes"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through share-based payment transactions, equity",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r180",
      "r186"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase through new leases, liabilities arising from financing activities",
        "terseLabel": "Additions for new leases"
       }
      }
     },
     "localname": "IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 20.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails": {
       "order": 40.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Indemnification assets recognised as of acquisition date",
        "verboseLabel": "Indemnification asset"
       }
      }
     },
     "localname": "IndemnificationAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r16",
      "r139"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 50.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r126",
      "r140",
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestExpenseDefinedBenefitPlans": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails": {
       "order": 0.0,
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense arising from defined benefit plans. [Refer: Interest expense; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "commentaryGuidance": "Interest expense on the defined benefit obligation represents an increase in net defined benefit liability and should be tagged with a positive value. Interest income on the plan assets represents a decrease in net defined benefit liability (equivalent to an increase in a net defined benefit asset) and should be tagged with a negative value. Interest on the effect of the asset ceiling represents an increase in net defined benefit liability and should be tagged with a positive value.",
        "label": "Interest expense, defined benefit plans",
        "verboseLabel": "Interest expenses"
       }
      }
     },
     "localname": "InterestExpenseDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense (income), net defined benefit liability (asset)",
        "verboseLabel": "Interest expenses"
       }
      }
     },
     "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r173"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 40.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest paid, classified as financing activities",
        "negatedLabel": "Repayment of lease liability interest"
       }
      }
     },
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Inventories": {
     "auth_ref": [
      "r18",
      "r29",
      "r99"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current inventories",
        "terseLabel": "Inventories",
        "verboseLabel": "Carrying value"
       }
      }
     },
     "localname": "Inventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoriesAtFairValueLessCostsToSell": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of inventories carried at fair value less costs to sell. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventories, at fair value less costs to sell",
        "verboseLabel": "Fair valuation adjustment, net"
       }
      }
     },
     "localname": "InventoriesAtFairValueLessCostsToSell",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoryRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r248",
      "r255"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 40.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventory recognised as of acquisition date",
        "terseLabel": "Inventory",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoryWritedown2011": {
     "auth_ref": [
      "r53",
      "r101"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventory write-down",
        "verboseLabel": "Write downs of inventories recognized cost of sales"
       }
      }
     },
     "localname": "InventoryWritedown2011",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssueOfEquity": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Issue of equity",
        "terseLabel": "Issuance of common shares, net of issuance costs"
       }
      }
     },
     "localname": "IssueOfEquity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 40.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "verboseLabel": "Share capital and premium"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share Capital [Member]",
        "verboseLabel": "Share Capital and premium [Member]"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, share-based payment",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel of entity or parent [member]",
        "terseLabel": "Key management personnel [Member]"
       }
      }
     },
     "localname": "KeyManagementPersonnelOfEntityOrParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LandAndBuildingsMember": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Land and buildings [member]",
        "verboseLabel": "Land and buildings [Member]"
       }
      }
     },
     "localname": "LandAndBuildingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember": {
     "auth_ref": [
      "r11",
      "r278",
      "r282"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years and not later than ten years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than five years and not later than ten years [member]",
        "terseLabel": "6 to 10 years [Member]"
       }
      }
     },
     "localname": "LaterThanFiveYearsAndNotLaterThanTenYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r277",
      "r282"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year and not later than five years [member]",
        "terseLabel": "1 to 5 years [Member]"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanTenYearsMember": {
     "auth_ref": [
      "r11",
      "r278",
      "r282"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than ten years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than ten years [member]",
        "terseLabel": ">10 years [Member]"
       }
      }
     },
     "localname": "LaterThanTenYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "auth_ref": [
      "r181",
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities [member]",
        "terseLabel": "Lease liabilities [Member]"
       }
      }
     },
     "localname": "LeaseLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      },
      "en-us": {
       "role": {
        "label": "Leasehold improvements [member]",
        "verboseLabel": "Leasehold improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r24",
      "r210",
      "r211",
      "r213",
      "r288",
      "r292"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities",
        "terseLabel": "Segment liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r182"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities",
        "periodEndLabel": "Liabilities arising from financing activities, ending balance",
        "periodStartLabel": "Liabilities arising from financing activities, beginning balance"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [member]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1": {
       "order": 10.0,
       "parentTag": "ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset)",
        "periodEndLabel": "Balance at December 31,",
        "periodStartLabel": "Balance at January 1,",
        "verboseLabel": "Defined benefit obligation"
       }
      }
     },
     "localname": "LiabilityAssetOfDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1",
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LicencesMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Licences [member]",
        "terseLabel": "Licences [Member]",
        "verboseLabel": "Cultivations and processing license [Member]"
       }
      }
     },
     "localname": "LicencesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LoansAndReceivables": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 60.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Loans and receivables",
        "terseLabel": "Loans receivable"
       }
      }
     },
     "localname": "LoansAndReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermBorrowings": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 20.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current portion of non-current borrowings",
        "terseLabel": "Long term loans",
        "verboseLabel": "Long-term loans"
       }
      }
     },
     "localname": "LongtermBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major components of tax expense (income) [abstract]"
       }
      }
     },
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersAxis": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Major customers [axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersMember": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Customers [member]"
       }
      }
     },
     "localname": "MajorCustomersMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MajorOrdinaryShareTransactionsMember": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for major ordinary share transactions. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Major ordinary share transactions [member]",
        "verboseLabel": "Event after reporting period [Member]"
       }
      }
     },
     "localname": "MajorOrdinaryShareTransactionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for derivative financial liabilities [text block]",
        "terseLabel": "Disclosure of maturity analysis for lease liabilities [Table Text Block]"
       }
      }
     },
     "localname": "MaturityAnalysisForDerivativeFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r27",
      "r93",
      "r218",
      "r226",
      "r227",
      "r260",
      "r272",
      "r278",
      "r303",
      "r304",
      "r306",
      "r312"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MotorVehiclesMember": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing self-propelled ground vehicles used in the entity's operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Motor vehicles [member]",
        "terseLabel": "Motor vehicles [Member]"
       }
      }
     },
     "localname": "MotorVehiclesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonadjustingEventsMember": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]"
       }
      }
     },
     "localname": "NonadjustingEventsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-controlling interest in the acquiree recognised at the acquisition date for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interest in acquiree recognised at acquisition date",
        "negatedLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterests": {
     "auth_ref": [
      "r22",
      "r194",
      "r196"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]",
        "verboseLabel": "Non-controlling interests [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r28",
      "r198",
      "r200"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "terseLabel": "Carrying amounts of non-current assets",
        "totalLabel": "Total non-current assets",
        "verboseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [abstract]",
        "terseLabel": "NON-CURRENT ASSETS:"
       }
      }
     },
     "localname": "NoncurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r30",
      "r198",
      "r202"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "negatedLabel": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities",
        "verboseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "verboseLabel": "NON-CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentPayablesForPurchaseOfNoncurrentAssets": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 30.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current payables for the purchase of non-current assets. [Refer: Payables for purchase of non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current payables for purchase of non-current assets",
        "terseLabel": "Accrued purchase consideration liabilities"
       }
      }
     },
     "localname": "NoncurrentPayablesForPurchaseOfNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 30.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current net defined benefit liability",
        "verboseLabel": "Employee benefit liabilities, net"
       }
      }
     },
     "localname": "NoncurrentRecognisedLiabilitiesDefinedBenefitPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "auth_ref": [
      "r26",
      "r226",
      "r227",
      "r278",
      "r282",
      "r312"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Not later than one year [member]",
        "terseLabel": "Less than one year [Member]"
       }
      }
     },
     "localname": "NotLaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of instruments or interests issued or issuable",
        "verboseLabel": "Number of common shares issued in business combination"
       }
      }
     },
     "localname": "NumberOfInstrumentsOrInterestsIssuedOrIssuable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "auth_ref": [
      "r237",
      "r240"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Number of warrants issued for common shares",
        "verboseLabel": "RSU granted during the year"
       }
      }
     },
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments exercisable in share-based payment arrangement",
        "verboseLabel": "RSU exercisable at the end of year"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement",
        "terseLabel": "Number of warrants exercised"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments outstanding in share-based payment arrangement",
        "periodEndLabel": "RSU outstanding at the end of the year",
        "periodStartLabel": "RSU outstanding at the beginning",
        "terseLabel": "Number of warrants outstanding"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "auth_ref": [
      "r228",
      "r232",
      "r236"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Options outstanding at the end of year - Number of options",
        "periodStartLabel": "Options outstanding at the beginning of the year - Number of options"
       }
      }
     },
     "localname": "NumberOfOutstandingShareOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercisable in share-based payment arrangement",
        "periodEndLabel": "Options exercisable at the end of year - Number of options",
        "verboseLabel": "RSU exercisable at the end of year"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercised in share-based payment arrangement",
        "negatedLabel": "Options exercised during the year - Number of options",
        "terseLabel": "Options exercised during the year - Number of options",
        "verboseLabel": "Number of share options exercised"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options forfeited in share-based payment arrangement",
        "negatedLabel": "Options forfeited during the year - Number of options",
        "terseLabel": "Options forfeited during the year - Number of options"
       }
      }
     },
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options granted in share-based payment arrangement",
        "positiveLabel": "RSU granted during the year",
        "terseLabel": "Options granted during the year - Number of options",
        "verboseLabel": "Number of share options granted"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails3",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares outstanding",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "NumberOfSharesOutstanding",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails",
      "http://www.imcannabis.com/role/EQUITYDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OperatingExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all operating expenses."
       }
      },
      "en-us": {
       "role": {
        "label": "Operating expense",
        "negatedTerseLabel": "Other expenses",
        "terseLabel": "Other expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OperatingSegmentsMember": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Operating segments [member]",
        "verboseLabel": "Operating segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherAssetsMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for assets that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other assets [member]",
        "terseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 30.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to acquire equity or debt instruments of other entities (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities",
        "negatedLabel": "Investments in associates",
        "negatedTerseLabel": "Other cash payments to acquire equity or debt instruments of other entities",
        "terseLabel": "Aggregate consideration to acquire preferred shares"
       }
      }
     },
     "localname": "OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "auth_ref": [
      "r6",
      "r41",
      "r52",
      "r205"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Total other comprehensive income",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r31",
      "r52"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, exchange differences on translation",
        "totalLabel": "Other comprehensive income, net of tax, exchange differences on translation",
        "verboseLabel": "Adjustments arising from translating financial statements of foreign operation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": {
     "auth_ref": [
      "r31",
      "r52",
      "r81"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans",
        "terseLabel": "Remeasurement gain (loss) on defined benefit plans",
        "verboseLabel": "Re-measurement loss on defined benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r55"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax",
        "totalLabel": "Total other comprehensive income that will be reclassified to profit or loss in subsequent periods"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r55"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax",
        "totalLabel": "Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentPayables": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other current payables",
        "terseLabel": "Other accounts payable and accrued expenses",
        "totalLabel": "Total other payables"
       }
      }
     },
     "localname": "OtherCurrentPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentReceivables": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "terseLabel": "Other receivables",
        "verboseLabel": "Other accounts receivable"
       }
      }
     },
     "localname": "OtherCurrentReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIntangibleAssetsMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other intangible assets [member]",
        "terseLabel": "Other [Member]",
        "verboseLabel": "Other intangibles [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 80.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ParentMember": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an entity that controls one or more entities."
       }
      },
      "en-us": {
       "role": {
        "label": "Parent [member]",
        "terseLabel": "IMC [Member]"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments for share issue costs",
        "terseLabel": "Fees and other issuance expenses"
       }
      }
     },
     "localname": "PaymentsForShareIssueCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan in respect of settlements. [Refer: Decrease (increase) in net defined benefit liability (asset) resulting from gains (losses) arising from settlements; Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments in respect of settlements, net defined benefit liability (asset)",
        "negatedTerseLabel": "Benefits paid",
        "verboseLabel": "Benefits paid"
       }
      }
     },
     "localname": "PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 80.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Repayment of lease liability"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of the entity's revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of entity's revenue",
        "verboseLabel": "Percentage of total revenues"
       }
      }
     },
     "localname": "PercentageOfEntitysRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of voting equity interests acquired",
        "terseLabel": "Percentage of issued and outstanding shares acquired"
       }
      }
     },
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PlanAssetsAtFairValue": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1": {
       "order": 0.0,
       "parentTag": "ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Plan assets, at fair value",
        "negatedLabel": "Fair value of plan assets",
        "periodEndLabel": "Balance at December 31,",
        "periodStartLabel": "Balance at January 1,",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "PlanAssetsAtFairValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1",
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": {
     "auth_ref": [
      "r81",
      "r94"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "commentaryGuidance": "Use this line item to tag employee benefits expenses including expenses from share-based payment transactions with employees (or when expenses from share-based payment transactions with employees are zero). Do NOT use this line item to tag employee benefits expenses excluding expenses from share-based payment transactions with employees.",
        "label": "Post-employment benefit expense in profit or loss, defined benefit plans",
        "negatedLabel": "Employee benefits expense",
        "totalLabel": "Total employee benefit expenses"
       }
      }
     },
     "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PreferenceSharesMember": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Preference shares [member]",
        "terseLabel": "Convertible preferred shares [Member]"
       }
      }
     },
     "localname": "PreferenceSharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r163"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 60.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from borrowings, classified as financing activities",
        "terseLabel": "Proceeds from bank loan"
       }
      }
     },
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 30.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options",
        "terseLabel": "Proceeds from exercise of options"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issue of ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssuingOtherEquityInstruments": {
     "auth_ref": [
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issuing other equity instruments",
        "terseLabel": "Issuance of new warrants",
        "verboseLabel": "Gross proceeds from warrants recorded as Share capital and premium"
       }
      }
     },
     "localname": "ProceedsFromIssuingOtherEquityInstruments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 50.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares",
        "terseLabel": "Net proceeds from private placement",
        "verboseLabel": "Proceeds from issuance of share capital, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuingShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromSalesOfInvestmentProperty": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 50.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of investment property. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from sales of investment property",
        "terseLabel": "Proceeds from sale of investment"
       }
      }
     },
     "localname": "ProceedsFromSalesOfInvestmentProperty",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      },
      "en-us": {
       "role": {
        "label": "Professional fees expense",
        "terseLabel": "Payments to shareholders",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFeesExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals",
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r40",
      "r167",
      "r191",
      "r193",
      "r198",
      "r288",
      "r290",
      "r305",
      "r317"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "positiveTerseLabel": "Net Loss",
        "terseLabel": "Segment income (loss)",
        "totalLabel": "Net Loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to [abstract]",
        "verboseLabel": "Net loss attributable to:"
       }
      }
     },
     "localname": "ProfitLossAttributableToAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r43",
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity",
        "verboseLabel": "For the computation of basic net earnings, Net loss attributable to equity holders of the Company"
       }
      }
     },
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to owners of parent",
        "netLabel": "For the computation of diluted net earnings, Net loss attributable to equity holders of the Company",
        "terseLabel": "Equity holders of the Company",
        "verboseLabel": "For the computation of basic net earnings, Net loss attributable to equity holders of the Company"
       }
      }
     },
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r1",
      "r2",
      "r258",
      "r288",
      "r290"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) before tax",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing operations attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss) from continuing operations]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from continuing operations attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share",
        "verboseLabel": "Effect of potential dilutive Ordinary shares - Warrants, Net loss attributable to equity holders of the Company"
       }
      }
     },
     "localname": "ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r51",
      "r119"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "positiveTerseLabel": "Net Loss",
        "terseLabel": "Segment loss",
        "totalLabel": "Profit (loss) from operating activities",
        "verboseLabel": "Net loss for the year"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossOfAcquiree": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) of acquiree since acquisition date",
        "negatedLabel": "Net loss",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLossOfAcquiree",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r15",
      "r77"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r78",
      "r126",
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r248",
      "r255"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 10.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 50.0,
       "parentTag": "imc_TotalAcquisitionSubsidiary",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment recognised as of acquisition date",
        "terseLabel": "Property, plant and equipment",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "auth_ref": [
      "r114",
      "r116",
      "r197"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "Percentage ownership"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r158"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 40.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of intangible assets, classified as investing activities",
        "negatedLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r158"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 70.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Purchase of property, plant and equipment",
        "terseLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r236",
      "r275",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails2",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r236",
      "r275",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails2",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deficit in a defined benefit plan. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability",
        "totalLabel": "Net defined benefit liability"
       }
      }
     },
     "localname": "RecognisedLiabilitiesDefinedBenefitPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of average effective tax rate and applicable tax rate [abstract]",
        "terseLabel": "Increase (decrease) in income tax due to:"
       }
      }
     },
     "localname": "ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RelatedPartiesMember": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Joint ventures [member]; Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Related parties [Member]"
       }
      }
     },
     "localname": "RelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions [abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of borrowings, classified as financing activities",
        "negatedLabel": "Repayment of bank loan"
       }
      }
     },
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "verboseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 30.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation",
        "verboseLabel": "Translation reserve"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "auth_ref": [
      "r10",
      "r103"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation [member]",
        "verboseLabel": "Translation reserve [Member]"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReserveOfSharebasedPayments": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity resulting from share-based payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments",
        "verboseLabel": "Reserve from share-based payment transactions"
       }
      }
     },
     "localname": "ReserveOfSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]",
        "verboseLabel": "Reserve from share-based payment transactions [Member]"
       }
      }
     },
     "localname": "ReserveOfSharebasedPaymentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetainedEarnings": {
     "auth_ref": [
      "r34",
      "r55"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 20.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings",
        "terseLabel": "Accumulated deficit",
        "verboseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarnings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r9",
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Retained earnings (deficit) [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r1",
      "r2",
      "r47",
      "r198",
      "r204",
      "r258",
      "r285",
      "r289",
      "r295",
      "r296",
      "r299"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "imc_GrossProfitBeforeFairValueAdjustments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME",
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueOfAcquiree": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue of acquiree since acquisition date",
        "terseLabel": "Net revenues"
       }
      }
     },
     "localname": "RevenueOfAcquiree",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 30.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "verboseLabel": "Right-of-use assets, net"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssetsMember": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets [member]"
       }
      }
     },
     "localname": "RightofuseAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Risk exposure associated with instruments sharing characteristic",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "totalLabel": "Total cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "RiskExposureAssociatedWithInstrumentsSharingCharacteristic",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      },
      "en-us": {
       "role": {
        "label": "Sales and marketing expense",
        "verboseLabel": "Selling and marketing expenses"
       }
      }
     },
     "localname": "SalesAndMarketingExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]"
       }
      }
     },
     "localname": "SegmentConsolidationItemsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Share issue related cost",
        "positiveTerseLabel": "Transaction costs incurred for common share issuance",
        "terseLabel": "Share capital issuance cost",
        "verboseLabel": "Issuance expenses including FV of compensation units"
       }
      }
     },
     "localname": "ShareIssueRelatedCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParentheticals",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares reserved for issue under options and contracts for the sale of shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares reserved for issue under options and contracts for sale of shares",
        "terseLabel": "Ordinary shares reserved for issuance"
       }
      }
     },
     "localname": "SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_ShorttermBorrowings": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 40.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current borrowings",
        "terseLabel": "Bank Loans",
        "totalLabel": "Total borrowings"
       }
      }
     },
     "localname": "ShorttermBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermBorrowingsMember": {
     "auth_ref": [
      "r181",
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for short-term borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term borrowings [member]",
        "terseLabel": "Short-term loans [Member]"
       }
      }
     },
     "localname": "ShorttermBorrowingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "auth_ref": [
      "r115",
      "r117",
      "r209"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 30.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income) at applicable tax rate",
        "terseLabel": "Adjustments in respect of current income tax of previous years",
        "verboseLabel": "Statutory tax rate in Canada"
       }
      }
     },
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [member]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r236",
      "r275",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "terseLabel": "Top of range [Member]"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails2",
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current payables [abstract]"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails": {
       "order": 30.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current payables to related parties",
        "terseLabel": "Related parties"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "auth_ref": [
      "r32",
      "r35"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade payables",
        "verboseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "auth_ref": [
      "r19",
      "r33"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 30.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current receivables",
        "totalLabel": "Total other accounts receivable",
        "verboseLabel": "Other accounts receivable"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails": {
       "order": 0.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current receivables due from related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current receivables due from related parties",
        "verboseLabel": "Related parties"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivablesDueFromRelatedParties",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 0.0,
       "parentTag": "imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other payables recognised as of acquisition date",
        "negatedLabel": "Trade and other payables",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [abstract]"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TreasuryShares": {
     "auth_ref": [
      "r34",
      "r118"
     ],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 10.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares",
        "negatedLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TreasurySharesMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares [Member]"
       }
      }
     },
     "localname": "TreasurySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfRisksAxis": {
     "auth_ref": [
      "r259",
      "r263",
      "r264",
      "r307",
      "r308",
      "r309",
      "r311"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      }
     },
     "localname": "TypesOfRisksAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksMember": {
     "auth_ref": [
      "r259",
      "r263",
      "r264",
      "r307",
      "r308",
      "r309",
      "r311"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Risks [member]"
       }
      }
     },
     "localname": "TypesOfRisksMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_UnallocatedAmountsMember": {
     "auth_ref": [
      "r294",
      "r300"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for items that have not been allocated to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Unallocated amounts [member]"
       }
      }
     },
     "localname": "UnallocatedAmountsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses [member]",
        "verboseLabel": "Carryforward tax losses and other [Member]"
       }
      }
     },
     "localname": "UnusedTaxLossesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Useful life measured as period of time, intangible assets other than goodwill",
        "verboseLabel": "Amortization of intangible assets on straight-line basis"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Useful life measured as period of time, property, plant and equipment"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailTextuals"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WagesAndSalaries": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wages and salaries",
        "terseLabel": "Salaries and related expenses"
       }
      }
     },
     "localname": "WagesAndSalaries",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WarrantLiability": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of warrant liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Warrant liability"
       }
      }
     },
     "localname": "WarrantLiability",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement",
        "terseLabel": "Exercise price of warrants exercisable"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement",
        "terseLabel": "Exercise price of warrants exercised"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement",
        "verboseLabel": "Exercise price of warrants issued per common share"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement",
        "periodEndLabel": "Options exercisable at the end of year - Weighted average exercise price"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement",
        "terseLabel": "Options exercised during the year - Weighted average exercise price",
        "verboseLabel": "Exercise price of compensation option"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails3",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement",
        "terseLabel": "Options forfeited during the year - Weighted average exercise price"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement",
        "terseLabel": "Options granted during the year - Weighted average exercise price",
        "verboseLabel": "Weighted average value of each option grant"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/EQUITYDetails3",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r228",
      "r232"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Options outstanding at the end of year - Weighted average exercise price",
        "periodStartLabel": "Options outstanding at the beginning of the year - Weighted average exercise price"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average fair value at measurement date, share options granted",
        "verboseLabel": "Weighted average fair value of each option grant"
       }
      }
     },
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageMember": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r275",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an average in which each quantity to be averaged is assigned a weight that determines the relative effect of each quantity on the average."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average [member]",
        "terseLabel": "Mainly [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life of outstanding share options",
        "verboseLabel": "Weighted average remaining contractual life for the share options outstanding"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageSharePrice2019": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price",
        "verboseLabel": "Market price of common shares"
       }
      }
     },
     "localname": "WeightedAverageSharePrice2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price, share options granted",
        "terseLabel": "Share price"
       }
      }
     },
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails2"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares outstanding",
        "verboseLabel": "For the computation of basic net earnings, Weighted number of shares"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents accrued purchase consideration liability as of acquisition date.",
        "label": "Accrued Purchase Consideration Liability As Of Acquisition Date",
        "negatedLabel": "Accrued purchase consideration liability"
       }
      }
     },
     "localname": "AccruedPurchaseConsiderationLiabilityAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AcquisitionCostsOfCommonShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents acquisition costs of common shares.",
        "label": "Acquisition Costs Of Common Shares",
        "verboseLabel": "Acquisition costs of common shares"
       }
      }
     },
     "localname": "AcquisitionCostsOfCommonShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_AdjupharmGmbhMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Adjupharm Gmbh.",
        "label": "Adjupharm Gmbh [Member]",
        "terseLabel": "Adjupharm GmbH (\"Adjupharm\") [Member]"
       }
      }
     },
     "localname": "AdjupharmGmbhMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1",
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_AdjupharmsCeoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Adjupharm's CEO.",
        "label": "Adjupharms Ceo [Member]",
        "terseLabel": "Adjupharm's CEO [Member]"
       }
      }
     },
     "localname": "AdjupharmsCeoMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_AdjustmentsForNonCashInterestIncomeOnLoansReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents adjustments for non cash interest income on loans receivable.",
        "label": "Adjustments For Non Cash Interest Income On Loans Receivable",
        "negatedLabel": "Non-cash interest income on loans receivable",
        "verboseLabel": "Non-cash interest income on loans receivable"
       }
      }
     },
     "localname": "AdjustmentsForNonCashInterestIncomeOnLoansReceivable",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AdjustmentsForRevaluationOfOtherReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 0.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents adjustments for revaluation of other receivable.",
        "label": "Adjustments For Revaluation Of Other Receivable",
        "verboseLabel": "Revaluation of other receivable"
       }
      }
     },
     "localname": "AdjustmentsForRevaluationOfOtherReceivable",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents adjustments for share based acquisiotion costs related to business comintation.",
        "label": "Adjustments For Share Based Acquisiotion Costs Related To Business Comintation",
        "terseLabel": "Share based acquisition costs related to business combination",
        "verboseLabel": "Share based acquisiotion costs related to business comintation"
       }
      }
     },
     "localname": "AdjustmentsForShareBasedAcquisiotionCostsRelatedToBusinessComintation",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AgreementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Agreement [Axis]"
       }
      }
     },
     "localname": "AgreementAxis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_AgreementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents domain information related to agreement.",
        "label": "Agreement [Domain]"
       }
      }
     },
     "localname": "AgreementDomain",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_AgreementWithFarmerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents member information related to farmer.",
        "label": "Agreement With Farmer [Member]"
       }
      }
     },
     "localname": "AgreementWithFarmerMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_AllocatedPercentageOfShareCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated percentage of share capital.",
        "label": "Allocated Percentage Of Share Capital",
        "verboseLabel": "Allocated percentage of share capital"
       }
      }
     },
     "localname": "AllocatedPercentageOfShareCapital",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_AmountDepositedInEscrow": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents amount deposited in escrow.",
        "label": "Amount Deposited In Escrow",
        "terseLabel": "Amount deposited in escrow"
       }
      }
     },
     "localname": "AmountDepositedInEscrow",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountOfClassActionGroupIncurredDamages": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of class action group incurred damages.",
        "label": "Amount Of Class Action Group Incurred Damages",
        "verboseLabel": "Amount of class action group incurred damages"
       }
      }
     },
     "localname": "AmountOfClassActionGroupIncurredDamages",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountOfExpensesPaidByApplicant": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of Companies\u2019 expenses paid by applicant.",
        "label": "Amount Of Expenses Paid By Applicant",
        "terseLabel": "Amount of expenses paid by applicant"
       }
      }
     },
     "localname": "AmountOfExpensesPaidByApplicant",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountOfNonCancellablePurchasePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents amount of non cancellable purchase price.",
        "label": "Amount Of Non Cancellable Purchase Price",
        "verboseLabel": "Amount of non cancellable purchase price"
       }
      }
     },
     "localname": "AmountOfNonCancellablePurchasePrice",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountOfPersonalSuit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of personal suit.",
        "label": "Amount Of Personal Suit",
        "terseLabel": "Amount of personal suit"
       }
      }
     },
     "localname": "AmountOfPersonalSuit",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONTINGENTLIABILITIESGUARANTEESCOMMITMENTSANDCHARGESDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountOfPurchaseOfTreasuryCommonShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase of treasury common shares.",
        "label": "Amount Of Purchase Of Treasury Common Shares",
        "negatedLabel": "Purchase of treasury common shares",
        "terseLabel": "Purchase of treasury common shares"
       }
      }
     },
     "localname": "AmountOfPurchaseOfTreasuryCommonShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountOfSettlementOfWithholdingTaxLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents amount of settlement of withholding tax liabilities.",
        "label": "Amount Of Settlement Of Withholding Tax Liabilities",
        "verboseLabel": "Amount of settlement of withholding tax liabilities"
       }
      }
     },
     "localname": "AmountOfSettlementOfWithholdingTaxLiabilities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountOfTranslationTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of translation transaction.",
        "label": "Amount Of Translation Transaction",
        "terseLabel": "Amount of translation transaction"
       }
      }
     },
     "localname": "AmountOfTranslationTransaction",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountOfWarrantTransferredInEquityDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of warrant transferred in equity during the period.",
        "label": "Amount Of Warrant Transferred In Equity During Period",
        "verboseLabel": "Amount of warrant transferred in equity during the period"
       }
      }
     },
     "localname": "AmountOfWarrantTransferredInEquityDuringPeriod",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AmountToReleaseSecurityProvidedForBankLoanAndBankCredit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount for release of security provided for bank loan and bank credit.",
        "label": "Amount To Release Security Provided For Bank Loan And Bank Credit",
        "terseLabel": "Amount to release security provided for bank loan and bank credit"
       }
      }
     },
     "localname": "AmountToReleaseSecurityProvidedForBankLoanAndBankCredit",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ApproximatelyCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of approximately cash and cash equivalents.",
        "label": "Approximately Cash And Cash Equivalents",
        "terseLabel": "Approximately cash and cash equivalents"
       }
      }
     },
     "localname": "ApproximatelyCashAndCashEquivalents",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_AreaOfCultivationAndProcessing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to the area of cultivation and processing.",
        "label": "Area Of Cultivation And Processing",
        "verboseLabel": "Area of cultivation and processing"
       }
      }
     },
     "localname": "AreaOfCultivationAndProcessing",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetailTextuals"
     ],
     "xbrltype": "areaItemType"
    },
    "imc_AttritionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the weighted average percentage of biological assets which are expected to fail to mature into cannabis plants that can be harvested.",
        "label": "Attrition Rate",
        "terseLabel": "Attrition rate"
       }
      }
     },
     "localname": "AttritionRate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_AveragePostHarvestCostsPerGramOfDriedCannabis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the average post-harvest costs per gram of dried cannabis.",
        "label": "Average Post Harvest Costs Per Gram Of Dried Cannabis",
        "terseLabel": "Average post-harvest costs per gram of dried cannabis (in CAD)"
       }
      }
     },
     "localname": "AveragePostHarvestCostsPerGramOfDriedCannabis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "decimalItemType"
    },
    "imc_AverageSellingPricePerGramOfDriedCannabis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the average selling price per gram of dried cannabis.",
        "label": "Average Selling Price Per Gram Of Dried Cannabis",
        "terseLabel": "Average selling price per gram of dried cannabis (in CAD)"
       }
      }
     },
     "localname": "AverageSellingPricePerGramOfDriedCannabis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "decimalItemType"
    },
    "imc_AverageStageOfGrowth": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage for average stage of growth.",
        "label": "Average Stage Of Growth",
        "terseLabel": "Average stage of growth"
       }
      }
     },
     "localname": "AverageStageOfGrowth",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_AverageYieldPerPlant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the expected number of grams of finished cannabis inventory which are expected to be obtained from each harvested cannabis plant.",
        "label": "Average Yield Per Plant",
        "terseLabel": "Average yield per plant (in grams)"
       }
      }
     },
     "localname": "AverageYieldPerPlant",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "decimalItemType"
    },
    "imc_BankCreditRecognisedAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 20.0,
       "parentTag": "imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      },
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "imc_TotalAcquisitionSubsidiary",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for bank credit assumed in a business combination.",
        "label": "Bank Credit Recognised As Of Acquisition Date",
        "negatedLabel": "Bank credit",
        "terseLabel": "Bank credit"
       }
      }
     },
     "localname": "BankCreditRecognisedAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_BankLoanAndLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total amount of bank loan and lease liabilities.",
        "label": "Bank Loan And Lease Liabilities",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "BankLoanAndLeaseLiabilities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_BiologicalAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 30.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents biological assets recognised as of acquisition date.",
        "label": "Biological Assets Recognised As Of Acquisition Date",
        "verboseLabel": "Biological assets"
       }
      }
     },
     "localname": "BiologicalAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_BulkCannabisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents member information related to Bulk cannabis.",
        "label": "Bulk Cannabis [Member]",
        "verboseLabel": "Bulk cannabis [Member]"
       }
      }
     },
     "localname": "BulkCannabisMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CannabisPlantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for cannabis plants.",
        "label": "Cannabis Plants [member]",
        "verboseLabel": "Cannabis Plants [Member]"
       }
      }
     },
     "localname": "CannabisPlantsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CannacanadaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for CannaCanada Inc.",
        "label": "Cannacanada Inc [Member]",
        "terseLabel": "CannaCanada Inc. [Member]"
       }
      }
     },
     "localname": "CannacanadaIncMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CapitalizedCostsOfInventories": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of capitalized costs of inventories.",
        "label": "Capitalized Costs Of Inventories",
        "verboseLabel": "Capitalized costs"
       }
      }
     },
     "localname": "CapitalizedCostsOfInventories",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_CarryforwardLossesForTaxPurposesDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carryforward losses for tax purposes",
        "label": "Carryforward Losses For Tax Purposes Description",
        "terseLabel": "Description of carryforward losses for tax purposes"
       }
      }
     },
     "localname": "CarryforwardLossesForTaxPurposesDescription",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_CarryforwardOperatingTaxLosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Carryforward operating tax losses.",
        "label": "Carryforward Operating Tax Losses",
        "terseLabel": "Carryforward operating tax losses"
       }
      }
     },
     "localname": "CarryforwardOperatingTaxLosses",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_CashAndCashEquivalentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent",
        "label": "Cash And Cash Equivalent [Member]"
       }
      }
     },
     "localname": "CashAndCashEquivalentMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CashConsiderationOfBusinessCombination": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents cash consideration of business combination.",
        "label": "Cash Consideration Of Business Combination",
        "verboseLabel": "Cash consideration of business combination"
       }
      }
     },
     "localname": "CashConsiderationOfBusinessCombination",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ChangeInRestrictedBankDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 0.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to change in restricted bank deposits.",
        "label": "Change In Restricted Bank Deposits",
        "negatedLabel": "Change in restricted bank deposits"
       }
      }
     },
     "localname": "ChangeInRestrictedBankDeposits",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ChangeInTaxBenefitsNotRecognized": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 60.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of change in tax benefits not recognized.",
        "label": "Change In Tax Benefits Not Recognized",
        "verboseLabel": "Change in tax benefits not recognized"
       }
      }
     },
     "localname": "ChangeInTaxBenefitsNotRecognized",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ChangesInNonCashWorkingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes In Non Cash Working Capital [Abstract]",
        "terseLabel": "Changes in non-cash working capital:"
       }
      }
     },
     "localname": "ChangesInNonCashWorkingCapitalAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_ClassesOfInventoriesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Classes Of Inventories [Axis]"
       }
      }
     },
     "localname": "ClassesOfInventoriesAxis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_ClassesOfInventoriesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the standard value for the Inventories.",
        "label": "Classes Of Inventories [Domain]"
       }
      }
     },
     "localname": "ClassesOfInventoriesDomain",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_Commitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of commitment.",
        "label": "Commitment",
        "terseLabel": "Total Commitment"
       }
      }
     },
     "localname": "Commitment",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_CompensationOptionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to compensation option price per share.",
        "label": "Compensation Option Price Per Share",
        "verboseLabel": "Compensation option price per share"
       }
      }
     },
     "localname": "CompensationOptionPricePerShare",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "imc_CompensationOptions2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation options 2019.",
        "label": "Compensation Options 2019 [Member]",
        "verboseLabel": "2019 Compensation Options [Member]"
       }
      }
     },
     "localname": "CompensationOptions2019Member",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CompensationUnitPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the compensation unit per share.",
        "label": "Compensation Unit Per Share",
        "verboseLabel": "Compensation unit per share"
       }
      }
     },
     "localname": "CompensationUnitPerShare",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "imc_CompensationUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation units.",
        "label": "Compensation Units [Member]",
        "terseLabel": "Compensation units [Member]"
       }
      }
     },
     "localname": "CompensationUnitsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ConversionOfWarrantAndCompensationOptionsIntoCommonShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about conversion of warrant and compensation options into common shares.",
        "label": "Conversion Of Warrant And Compensation Options Into Common Shares",
        "terseLabel": "Conversion of warrant and compensation options into common shares"
       }
      }
     },
     "localname": "ConversionOfWarrantAndCompensationOptionsIntoCommonShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ConversionPricePerWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion price per warrant.",
        "label": "Conversion Price Per Warrant",
        "terseLabel": "Conversion price per warrant"
       }
      }
     },
     "localname": "ConversionPricePerWarrant",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "imc_CultivationsAndProcessingLicenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for cultivations and processing license.",
        "label": "Cultivations And Processing License [Member]",
        "verboseLabel": "Cultivations and processing license [Member]"
       }
      }
     },
     "localname": "CultivationsAndProcessingLicenseMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents member information related to Customer one.",
        "label": "Customer One [Member]",
        "terseLabel": "Customer A [Member]"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CustomerRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets related to customer relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents member information related to Customer B.",
        "label": "Customer Three [Member]",
        "terseLabel": "Customer C [Member]"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents member information related to Customer B.",
        "label": "Customer Two [Member]",
        "terseLabel": "Customer B [Member]"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_DeemedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents share issued at deemed price per share.",
        "label": "Deemed Price Per Share",
        "verboseLabel": "Deemed price per share"
       }
      }
     },
     "localname": "DeemedPricePerShare",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "imc_DeferredTaxAssetsAndLiabilitiesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Deferred Tax Assets And Liabilities [Axis]"
       }
      }
     },
     "localname": "DeferredTaxAssetsAndLiabilitiesAxis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_DeferredTaxAssetsAndLiabilitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets And Liabilities [Domain]"
       }
      }
     },
     "localname": "DeferredTaxAssetsAndLiabilitiesDomain",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_DeferredTaxAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for deferred tax assets.",
        "label": "Deferred Tax Assets [Member]",
        "verboseLabel": "Deferred tax assets [Member]"
       }
      }
     },
     "localname": "DeferredTaxAssetsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_DeferredTaxLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for deferred tax liabilities.",
        "label": "Deferred Tax Liabilities [Member]",
        "verboseLabel": "Deferred tax liabilities [Member]"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_DerivativeAssetsAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 80.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents derivative assets as of acquisition date.",
        "label": "Derivative Assets As Of Acquisition Date",
        "verboseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssetsAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for basis of presentation.",
        "label": "Description Of Accounting Policy For Basis Of Presentation Explanatory",
        "terseLabel": "Basis of presentation [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBasisOfPresentationExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for changes in accounting policies new financial reporting accounting standards and amendments.",
        "label": "Description Of Accounting Policy For Changes In Accounting Policies New Financial Reporting Accounting Standards And Amendments Explanatory",
        "terseLabel": "Changes in accounting policies - initial application of new financial reporting and accounting standards and amendments to existing financial reporting and accounting standards [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForChangesInAccountingPoliciesNewFinancialReportingAccountingStandardsAndAmendmentsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for consolidated financial statements.",
        "label": "Description Of Accounting Policy For Consolidated Financial Statements Explanatory",
        "verboseLabel": "Consolidated financial statements [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForConsolidatedFinancialStatementsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grant.",
        "label": "Description Of Accounting Policy For Government Grant Explanatory [Policy Text Block]",
        "terseLabel": "Government grants [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrantExplanatoryPolicyTextBlock",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DescriptionOfAccountingPolicyForShortTermDepositsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for short term deposits.",
        "label": "Description Of Accounting Policy For Short Term Deposits Explanatory",
        "terseLabel": "Short-term deposits [Policy Text Block]"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForShortTermDepositsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DescriptionOfOtherConvertibleSecritiesConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the description of other convertible secrities conversion.",
        "label": "Description Of Other Convertible Secrities Conversion",
        "terseLabel": "Description of other convertible secrities conversion"
       }
      }
     },
     "localname": "DescriptionOfOtherConvertibleSecritiesConversion",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about description of share consolidation of issued and outstanding ordinary shares.",
        "label": "Description Of Share Consolidation Of Issued And Outstanding Ordinary Shares",
        "terseLabel": "Description of share consolidation of issued and outstanding ordinary shares"
       }
      }
     },
     "localname": "DescriptionOfShareConsolidationOfIssuedAndOutstandingOrdinaryShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureForSignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure For Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "DisclosureForSignificantAccountingPoliciesAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureOfBalancesWithRelatedPartiesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about balances with related parties in statements of financial position.",
        "label": "Disclosure Of Balances With Related Parties Explanatory",
        "terseLabel": "Disclosure of balances with related parties [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfBalancesWithRelatedPartiesExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of changes in issued and outstanding share capital explanatory.",
        "label": "Disclosure Of Changes In Issued And Outstanding Share Capital Explanatory",
        "terseLabel": "Disclosure of changes in issued and outstanding share capital [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfChangesInIssuedAndOutstandingShareCapitalExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfCompositionOfShareCapitalExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Composition Of Share Capital Explanatory [Table Text Block].",
        "label": "Disclosure Of Composition Of Share Capital Explanatory",
        "terseLabel": "Disclosure of composition of share capital [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCompositionOfShareCapitalExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.",
        "label": "Disclosure Of Detailed Information About Additional Cash Flow Information [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationLineItems",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to additional cash flow information.",
        "label": "Disclosure Of Detailed Information About Additional Cash Flow Information [Table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutAdditionalCashFlowInformationTable",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about amortization calculated on straight-line basis over useful life of intangible assets.",
        "label": "Disclosure Of Detailed Information About Amortization Calculated On Straight Line Basis Over Useful Life Of Intangible Assets Explanatory",
        "terseLabel": "Disclosure of detailed information about amortization calculated on straight-line basis over the useful life of intangible assets [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutAmortizationCalculatedOnStraightLineBasisOverUsefulLifeOfIntangibleAssetsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about Cash outflow/inflow on the acquisition.",
        "label": "Disclosure Of Detailed Information About Cash Outflow Inflow From Acquisition Explanatory",
        "terseLabel": "Disclosure of detailed information about cash outflow/inflow on the acquisition [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutCashOutflowInflowFromAcquisitionExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about deferred tax assets and liabilities.",
        "label": "Disclosure Of Detailed Information About Deferred Tax Assets And Liabilities Explanatory",
        "terseLabel": "Disclosure of detailed information about deferred tax assets and liabilities [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about depreciation rate calculated on straight line basis over useful lives of property, plant and equipment.",
        "label": "Disclosure Of Detailed Information About Depreciation Rate Calculated On Straight Line Basis Over Useful Lives Of Property, Plant And Equipment Explanatory",
        "terseLabel": "Disclosure of detailed information about depreciation rate calculated on straight-line basis over useful lives of property, plant and equipment [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutDepreciationRateCalculatedOnStraightLineBasisOverUsefulLivesOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about Impact on fair value of 10% increase/decrease in each input.",
        "label": "Disclosure Of Detailed Information About Impact On Fair Value Of Ten Percent Increase Decrease In Each Input Explanatory",
        "terseLabel": "Disclosure of detailed information about Impact on fair value of 10% increase/decrease in each input [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutImpactOnFairValueOfTenPercentIncreaseDecreaseInEachInputExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Income Tax Expense Benefits Explanatory",
        "label": "Disclosure Of Detailed Information About Income Tax Expense Benefits Explanatory",
        "terseLabel": "Disclosure of detailed information about Income tax expense (benefit) [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutInventoriesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about inventories.",
        "label": "Disclosure Of Detailed Information About Inventories Explanatory",
        "terseLabel": "Disclosure of detailed information about inventories [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutInventoriesExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of information about key assumptions to measure fair value of warrants.",
        "label": "Disclosure Of Detailed Information About Key Assumptions To Measure Fair Value Of Warrants Explanatory",
        "terseLabel": "Disclosure of information about key assumptions to measure fair value of warrants [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutKeyAssumptionsToMeasureFairValueOfWarrantsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about options, valuation assumptions [Table Text Block].",
        "label": "Disclosure Of Detailed Information About Options Valuation Assumptions Explanatory",
        "terseLabel": "Disclosure of detailed information about options, valuation assumptions [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about other accounts receivable.",
        "label": "Disclosure Of Detailed Information About Other Accounts Receivable Explanatory",
        "terseLabel": "Disclosure of detailed information about other accounts receivable [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutOtherAccountsReceivableExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information of present value of defined benefit liabilities.",
        "label": "Disclosure Of Detailed Information About Present Value Of Defined Benefit Liabilities Explanatory",
        "verboseLabel": "Disclosure of detailed information about changes in present value of defined benefit liabilities [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPresentValueOfDefinedBenefitLiabilitiesExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Detailed Information About Property Plant And Equipment And Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentAndIntangibleAssetsAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Reconciliation of tax expense and the accounting profit Explanatory.",
        "label": "Disclosure Of Detailed Information About Reconciliation Of Tax Expense And Accounting Profit Explanatory",
        "terseLabel": "Disclosure of detailed information about reconciliation of tax expense and accounting profit [Table text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutReconciliationOfTaxExpenseAndAccountingProfitExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to details of Summarized financial information for partly owned subsidiary.",
        "label": "Disclosure Of Detailed Information About Summarized Financial Information For Partly Owned Subsidiary [Table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutSummarizedFinancialInformationForPartlyOwnedSubsidiaryTable",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information of other current payables.",
        "label": "Disclosure Of Detailed Information Of Other Current Payables Explanatory",
        "terseLabel": "Disclosure of detailed information of other current payables [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationOfOtherCurrentPayablesExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERPAYABLESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfGeneralInformationAboutFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of general information about financial statements [Abstract]",
        "label": "Disclosure Of General Information About Financial Statements [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureOfGeographicAllocationOfAssetsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of geographic allocation of total assets explanatory",
        "label": "Disclosure Of Geographic Allocation Of Assets Explanatory",
        "terseLabel": "Disclosure of geographic allocation of assets [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfGeographicAllocationOfAssetsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfGeographicAllocationOfRevenuesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of geographic allocation of revenues.",
        "label": "Disclosure Of Geographic Allocation Of Revenues Explanatory",
        "terseLabel": "Disclosure of geographic allocation of revenues [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfGeographicAllocationOfRevenuesExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SELECTEDSTATEMENTSOFPROFITORLOSSDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of operating results for partly owned subsidiary explanatory.",
        "label": "Disclosure Of Operating Results For Partly Owned Subsidiary Explanatory",
        "verboseLabel": "Disclosure of operating results for partly owned subsidiary [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfOperatingResultsForPartlyOwnedSubsidiaryExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfOtherAccountsReceivableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other accounts receivable [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfOtherAccountsReceivableAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureOfOtherAccountsReceivablesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of other accounts receivables.",
        "label": "Disclosure Of Other Accounts Receivables Explanatory",
        "verboseLabel": "OTHER ACCOUNTS RECEIVABLE [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfOtherAccountsReceivablesExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment and intangible assets, net.",
        "label": "Disclosure Of Property, Plant And Equipment And Intangible Assets, Net Explanatory",
        "terseLabel": "PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS, NET [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentAndIntangibleAssetsNetExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfRestrictedShareUnitsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of restricted share units.",
        "label": "Disclosure Of Restricted Share Units [Table Text Block]",
        "terseLabel": "Disclosure of restricted share units [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfRestrictedShareUnitsTableTextBlock",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfRightOfUseAssetsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entire disclosure related to right of use assets.",
        "label": "Disclosure Of Right Of Use Assets Explanatory",
        "verboseLabel": "RIGHT-OF-USE ASSETS [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfRightOfUseAssetsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of significant accounting estimates and assumptions used in the preparation of the financial statements explanatory.",
        "label": "Disclosure Of Significant Accounting Estimates And Assumptions Used In Preparation Of Financial Statements Explanatory",
        "verboseLabel": "SIGNIFICANT ACCOUNTING ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfSignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementsExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGESTIMATESANDASSUMPTIONSUSEDINTHEPREPARATIONOFTHEFINANCIALSTATEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of statement of financial position for partly owned subsidiary explanatory.",
        "label": "Disclosure Of Statement Of Financial Position For Partly Owned Subsidiary Explanatory",
        "verboseLabel": "Disclosure of statement of financial position for partly owned subsidiary [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfStatementOfFinancialPositionForPartlyOwnedSubsidiaryExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Summarized Financial Information For Partly Owned Subsidiary Explanatory",
        "verboseLabel": "SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfSummarizedFinancialInformationForPartlyOwnedSubsidiaryLineItems",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_DisclosureOfTradeReceivablesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Table information related to trade receivable.",
        "label": "Disclosure Of Trade Receivables Explanatory",
        "terseLabel": "Disclosure of trade receivables [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfTradeReceivablesExplanatory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "imc_DisposalOfTerminationOfLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to disposal of termination of leases.",
        "label": "Disposal Of Termination Of Leases",
        "negatedLabel": "Disposals during the year: Termination of leases"
       }
      }
     },
     "localname": "DisposalOfTerminationOfLeases",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_DisposalsOfRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to disposal of right-of-use assets.",
        "label": "Disposals Of Right Of Use Assets",
        "negatedLabel": "Disposals during the year:"
       }
      }
     },
     "localname": "DisposalsOfRightOfUseAssets",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_EmployeeBenefitAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Benefit Assets And Liabilities [Abstract]"
       }
      }
     },
     "localname": "EmployeeBenefitAssetsAndLiabilitiesAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "stringItemType"
    },
    "imc_EmployeesAndPayrollAccruals": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of employees and payroll accruals including salaries and other salaries related costs.",
        "label": "Employees And Payroll Accruals",
        "terseLabel": "Employees and payroll accruals"
       }
      }
     },
     "localname": "EmployeesAndPayrollAccruals",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_EmployeesDirectorsAndAdvisorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about employees directors and advisors.",
        "label": "Employees Directors And Advisors [Member]",
        "terseLabel": "Employees directors and advisors [Member]"
       }
      }
     },
     "localname": "EmployeesDirectorsAndAdvisorsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_EquityTransactionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about equity transactions.",
        "label": "Equity Transaction [Axis]"
       }
      }
     },
     "localname": "EquityTransactionAxis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_EquityTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Transaction [Domain]",
        "label": "Equity Transaction [Domain]"
       }
      }
     },
     "localname": "EquityTransactionDomain",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ExpectedDividendYieldOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected dividend yield of warrants.",
        "label": "Expected Dividend Yield Of Warrants",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ExpectedDividendYieldOfWarrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_ExpectedLifeOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected life of warrants.",
        "label": "Expected Life Of Warrants",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "ExpectedLifeOfWarrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"
     ],
     "xbrltype": "decimalItemType"
    },
    "imc_ExpectedVolatilityOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected volatility of warrants.",
        "label": "Expected Volatility Of Warrants",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ExpectedVolatilityOfWarrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_ExternalCustomersRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about external customers revenues.",
        "label": "External Customers Revenues",
        "terseLabel": "External customers"
       }
      }
     },
     "localname": "ExternalCustomersRevenues",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fair value adjustment derived from final purchase price allocation, intangible assets other than goodwill.",
        "label": "Fair Value Adjustment Derived From Final Purchase Price Allocation, Intangible Assets Other Than Goodwill",
        "terseLabel": "Fair value adjustment derived from final purchase price allocation"
       }
      }
     },
     "localname": "FairValueAdjustmentDerivedFromFinalPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_FairValueAdjustmentOnSaleOfInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 50.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value adjustment on sale of inventory.",
        "label": "Fair Value Adjustment On Sale Of Inventory",
        "negatedLabel": "Realized fair value adjustments on inventory sold in the period",
        "terseLabel": "Realized fair value adjustments on inventory sold in the period",
        "verboseLabel": "Fair value adjustment on sale of inventory"
       }
      }
     },
     "localname": "FairValueAdjustmentOnSaleOfInventory",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_FairValueAdjustmentOnWarrantsMeasuredAtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 40.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to fair value adjustment on warrants measured at fair value.",
        "label": "Fair Value Adjustment On Warrants Measured At Fair Value",
        "terseLabel": "Fair value adjustment on Warrants, Investments, and Accounts Receivable",
        "verboseLabel": "Fair value adjustment on warrants measured at fair value"
       }
      }
     },
     "localname": "FairValueAdjustmentOnWarrantsMeasuredAtFairValue",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_FairValueAdjustmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Adjustments [Abstract]",
        "terseLabel": "Fair value adjustments:"
       }
      }
     },
     "localname": "FairValueAdjustmentsAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_FairValueOfCompensationUnits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of compensation units.",
        "label": "Fair Value Of Compensation Units",
        "terseLabel": "Fair value of compensation units"
       }
      }
     },
     "localname": "FairValueOfCompensationUnits",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_FairValueOfInvestment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of the investment.",
        "label": "Fair Value Of Investment",
        "terseLabel": "Fair value of the investments"
       }
      }
     },
     "localname": "FairValueOfInvestment",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_FairValueOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of warrants.",
        "label": "Fair Value Of Warrants",
        "terseLabel": "Total Warrants (Canadian Dollar in thousands)",
        "verboseLabel": "Fair value of warrants"
       }
      }
     },
     "localname": "FairValueOfWarrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_FairValuePerWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value per warrant.",
        "label": "Fair Value Per Warrant",
        "terseLabel": "Fair value: Per Warrant (Canadian Dollar)"
       }
      }
     },
     "localname": "FairValuePerWarrant",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "imc_FinancialInstrumentsAtAmortizedCostMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the financial instruments at amortised cost category.",
        "label": "Financial Instruments At Amortized Cost [Member]",
        "terseLabel": "Amortized cost [Member]"
       }
      }
     },
     "localname": "FinancialInstrumentsAtAmortizedCostMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_FinancialInstrumentsAtFairValueThroughProfitOrLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the financial instruments at fair value through profit or loss.",
        "label": "Financial Instruments At Fair Value Through Profit Or Loss [Member]",
        "terseLabel": "FVTPL [Member]"
       }
      }
     },
     "localname": "FinancialInstrumentsAtFairValueThroughProfitOrLossMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_FinishedGoodsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to Finished goods.",
        "label": "Finished Goods [Member]",
        "verboseLabel": "Finished goods [Member]"
       }
      }
     },
     "localname": "FinishedGoodsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_FirstAnniversaryOfApplicableVestingCommencementDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for first anniversary of applicable vesting commencement date.",
        "label": "First Anniversary Of Applicable Vesting Commencement Date [Member]",
        "verboseLabel": "Vest on the first anniversary of the applicable vesting commencement date [Member]"
       }
      }
     },
     "localname": "FirstAnniversaryOfApplicableVestingCommencementDateMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_FirstInstallmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First installment of payment.",
        "label": "First Installment [Member]",
        "terseLabel": "First installment [Member]"
       }
      }
     },
     "localname": "FirstInstallmentMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_FixedGrowthRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the fixed growth rate.",
        "label": "Fixed Growth Rate",
        "terseLabel": "Fixed growth rate"
       }
      }
     },
     "localname": "FixedGrowthRate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_FocusMedicalHerbsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Focus Medical Herbs Ltd [Member]",
        "label": "Focus Medical Herbs Ltd [Member]",
        "terseLabel": "Focus Medical Herbs Ltd. (\"Focus\") [Member]",
        "verboseLabel": "Focus Medical Herbs Ltd [Member]"
       }
      }
     },
     "localname": "FocusMedicalHerbsLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails1",
      "http://www.imcannabis.com/role/SUMMARIZEDFINANCIALINFORMATIONFORPARTLYOWNEDSUBSIDIARYDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ForeignCountriesTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for countries outside the entity's country of domicile. [Refer: Country of domicile [member]]",
        "label": "Foreign Countries Two [Member]",
        "terseLabel": "Canada [Member]"
       }
      }
     },
     "localname": "ForeignCountriesTwoMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails",
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_GainLossOnRevaluationOfFinancialInstruments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "gain loss on revaluation of financial instruments.",
        "label": "Gain Loss On Revaluation Of Financial Instruments",
        "terseLabel": "(Gain) loss on revaluation"
       }
      }
     },
     "localname": "GainLossOnRevaluationOfFinancialInstruments",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_GoodwillAndIntangibleAssetsAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents goodwill and intangible assets as of acquisition date.",
        "label": "Goodwill And Intangible Assets As Of Acquisition Date",
        "verboseLabel": "Goodwill and intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_GreenhouseProductionEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for greenhouse production equipment.",
        "label": "Greenhouse Production Equipment [Member]",
        "terseLabel": "Greenhouse production equipment [Member]"
       }
      }
     },
     "localname": "GreenhouseProductionEquipmentMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_GreenhouseStructureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for greenhouse structure.",
        "label": "Greenhouse Structure [Member]",
        "terseLabel": "Greenhouse structure [Member]"
       }
      }
     },
     "localname": "GreenhouseStructureMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_GrossProceedsFromIssuanceOfUnits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about gross proceeds from issuance of units under private placements.",
        "label": "Gross Proceeds From Issuance Of Units",
        "terseLabel": "Gross proceeds from issuance of units"
       }
      }
     },
     "localname": "GrossProceedsFromIssuanceOfUnits",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_GrossProfitBeforeFairValueAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 10.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to gross profit before fair value adjustment.",
        "label": "Gross Profit Before Fair Value Adjustments",
        "totalLabel": "Gross profit before fair value adjustments"
       }
      }
     },
     "localname": "GrossProfitBeforeFairValueAdjustments",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_HighWayShinuaLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for High Way Shinua Ltd. (\u201cHW Shinua\u201d).",
        "label": "High Way Shinua Ltd [Member]",
        "terseLabel": "High Way Shinua Ltd. (\u201cHW Shinua\u201d) [Member]"
       }
      }
     },
     "localname": "HighWayShinuaLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_HighlandGrowIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Highland Grow Inc.",
        "label": "Highland Grow Inc [Member]",
        "terseLabel": "Highland Grow Inc. [Member]"
       }
      }
     },
     "localname": "HighlandGrowIncMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_IPointMPointCFarmsIsraelLtdPointMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for I.M.C Farms Israel Ltd. (\"IMC Farms\").",
        "label": "I Point M Point C Farms Israel Ltd Point [Member]",
        "verboseLabel": "I.M.C Farms Israel Ltd. (\"IMC Farms\") [Member]"
       }
      }
     },
     "localname": "IPointMPointCFarmsIsraelLtdPointMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for i point m point c international medical cannabis portugal unipessoal lda.",
        "label": "I Point M Point C International Medical Cannabis Portugal Unipessoal Lda [Member]",
        "verboseLabel": "I.M.C - International Medical Cannabis Portugal Unipessoal Lda [Member]"
       }
      }
     },
     "localname": "IPointMPointCInternationalMedicalCannabisPortugalUnipessoalLdaMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_IPointMPointCPointHoldingsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for I.M.C. Holdings Ltd (\"IMC\").",
        "label": "I Point M Point C Point Holdings Ltd [Member]",
        "terseLabel": "I.M.C. Holdings Ltd (\"IMC\") [Member]"
       }
      }
     },
     "localname": "IPointMPointCPointHoldingsLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_IPointMPointCVenturesLtdPointMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for i point m point c ventures ltd point (\"imc ventures\").",
        "label": "I Point M Point C Ventures Ltd Point [Member]",
        "verboseLabel": "I.M.C Ventures Ltd. (\"IMC Ventures\") [Member]"
       }
      }
     },
     "localname": "IPointMPointCVenturesLtdPointMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 0.0,
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable assets acquired in a business combination.",
        "label": "Identifiable Assets Recognised As Of Acquisition Date",
        "totalLabel": "Total identifiable assets"
       }
      }
     },
     "localname": "IdentifiableAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for liabilities assumed in a business combination.",
        "label": "Identifiable Liabilities Recognised As Of Acquisition Date",
        "negatedTotalLabel": "Total identifiable liabilities",
        "totalLabel": "Total identifiable liabilities"
       }
      }
     },
     "localname": "IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact On Fair Value Ten Percent Increase Decrease In Each Input [Member]",
        "label": "Impact On Fair Value Ten Percent Increase Decrease In Each Input [Member]",
        "verboseLabel": "10% change [Member]"
       }
      }
     },
     "localname": "ImpactOnFairValueTenPercentIncreaseDecreaseInEachInputMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents impairment loss of indemnification asset and penalty and interest expenses.",
        "label": "Impairment Loss Of Indemnification Asset And Penalty And Interest Expenses",
        "verboseLabel": "Impairment loss of indemnification asset and penalty and interest expenses"
       }
      }
     },
     "localname": "ImpairmentLossOfIndemnificationAssetAndPenaltyAndInterestExpenses",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in financial liabilities on the basis of their measurement categories in accordance with IFRS 16.",
        "label": "Increase Decrease In Financial Liabilities On Basis Of Initial Application Of I F R S 16",
        "terseLabel": "Initial application of IFRS 16"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinancialLiabilitiesOnBasisOfInitialApplicationOfIFRS16",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from related to acquisitions.",
        "label": "Increase Decrease Through Acquisitions, Liabilities Arising From Financing Activities",
        "verboseLabel": "Additions related to acquisitions"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughAcquisitionsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease through effective interest, liabilities arising from financing activities",
        "label": "Increase Decrease Through Effective Interest, Liabilities Arising From Financing Activities",
        "verboseLabel": "Effective interest"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughEffectiveInterestLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseDecreaseThroughForfeitedOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from forfeited options.",
        "label": "Increase Decrease Through Forfeited Options",
        "terseLabel": "Forfeited Options"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughForfeitedOptions",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from changes through initial consolidations.",
        "label": "Increase (Decrease) Through Initial Consolidations, Property, Plant And Equipment",
        "verboseLabel": "Initial consolidations"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughInitialConsolidationsPropertyPlantAndEquipment",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/PROPERTYPLANTANDEQUIPMENTANDINTANGIBLEASSETSNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to adjustments arising from translating financial statements from functional currency to presentation currency.",
        "label": "Increase Decrease Through Net Exchange Differences Right Of Use Assets",
        "verboseLabel": "Additions during the year: Adjustments arising from translating financial statements from functional currency to presentation currency"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesRightOfUseAssets",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in repayments.",
        "label": "Increase Decrease Through Repayments Liabilities Arising From Financing Activities",
        "terseLabel": "Repayments"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughRepaymentsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the cash outflow for payments for warrant conversions liability.",
        "label": "Increase Decrease Through Warrant Conversions Liabilities Arising From Financing Activities",
        "negatedLabel": "Payments of other equity instruments",
        "terseLabel": "Conversion of warrant"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughWarrantConversionsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseThroughInitialConsolidationsArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from Initial consolidations.",
        "label": "Increase Through Initial Consolidations Arising From Financing Activities",
        "terseLabel": "Initial consolidations"
       }
      }
     },
     "localname": "IncreaseThroughInitialConsolidationsArisingFromFinancingActivities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from new loans.",
        "label": "Increase Through New Loans, Liabilities Arising From Financing Activities",
        "terseLabel": "Additions for new loans"
       }
      }
     },
     "localname": "IncreaseThroughNewLoansLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_InitialConsolidationsRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of initial consolidations of right of use assets.",
        "label": "Initial Consolidations Right Of Use Assets",
        "verboseLabel": "Additions during the year: Initial consolidations"
       }
      }
     },
     "localname": "InitialConsolidationsRightOfUseAssets",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RIGHTOFUSEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Intangible assets.",
        "label": "Intangible Assets [Member]",
        "verboseLabel": "Intangible assets [Member]"
       }
      }
     },
     "localname": "IntangibleAssetsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_InterSegmentRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about inter segment revenues.",
        "label": "Inter Segment Revenues",
        "terseLabel": "Inter-segment revenues"
       }
      }
     },
     "localname": "InterSegmentRevenues",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_InterestIncomeOnPlanAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of interest income on plan assets.",
        "label": "Interest Income On Plan Assets",
        "terseLabel": "Interest income",
        "verboseLabel": "Interest income on plan assets"
       }
      }
     },
     "localname": "InterestIncomeOnPlanAssets",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails",
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_InterestPaidInRespectOfLoans": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 70.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for interest paid in respect of loans.",
        "label": "Interest Paid In Respect Of Loans",
        "negatedLabel": "Interest paid in respect of loans"
       }
      }
     },
     "localname": "InterestPaidInRespectOfLoans",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_InventoriesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Inventories [Line Items]"
       }
      }
     },
     "localname": "InventoriesLineItems",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_InventoriesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to inventories.",
        "label": "Inventories [Table]"
       }
      }
     },
     "localname": "InventoriesTable",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_InvestmentAndFinancialInstrumentsAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 60.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount Investment and financial instruments as of acquisition date.",
        "label": "Investment And Financial Instruments As Of Acquisition Date",
        "terseLabel": "Investments and financial Instruments",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentAndFinancialInstrumentsAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_InvestmentsAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 100.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents investments as of acquisition date",
        "label": "Investments As Of Acquisition Date",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_InvestmentsInUnlistedSharesMeasuredAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in unlisted shares measured at fair value.",
        "label": "Investments In Unlisted Shares Measured At Fair Value",
        "terseLabel": "Investments in unlisted shares measured at fair value"
       }
      }
     },
     "localname": "InvestmentsInUnlistedSharesMeasuredAtFairValue",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IssuanceOfCommonShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents issuance of common shares.",
        "label": "Issuance Of Common Shares",
        "verboseLabel": "Issuance of common shares"
       }
      }
     },
     "localname": "IssuanceOfCommonShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_IssuanceOfSharesWithPrivatePlacement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about issuance of shares in connection with 2019 private placement.",
        "label": "Issuance Of Shares With Private Placement",
        "terseLabel": "Issuance of shares in connection with 2019 private placement",
        "verboseLabel": "Issuance of shares in private placement"
       }
      }
     },
     "localname": "IssuanceOfSharesWithPrivatePlacement",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_IssueOfEquity1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments.",
        "label": "Issue Of Equity 1",
        "terseLabel": "Issuance of shares related to MYM"
       }
      }
     },
     "localname": "IssueOfEquity1",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_IssueOfEquity2": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments.",
        "label": "Issue Of Equity 2",
        "verboseLabel": "Issuance of shares in Nasdaq"
       }
      }
     },
     "localname": "IssueOfEquity2",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_KeyManagementPersonnelCompensationPayrollAndRelatedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key management personnel compensation payroll and related expenses.",
        "label": "Key Management Personnel Compensation Payroll And Related Expenses",
        "verboseLabel": "Payroll and related expenses"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationPayrollAndRelatedExpenses",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_LeaseLiabilityAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 30.0,
       "parentTag": "imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents lease liability as of acquisition date.",
        "label": "Lease Liability As Of Acquisition Date",
        "negatedLabel": "Lease liability",
        "verboseLabel": "Lease liability"
       }
      }
     },
     "localname": "LeaseLiabilityAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ListedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listed Warrants.",
        "label": "Listed Warrants [Member]"
       }
      }
     },
     "localname": "ListedWarrantsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ListingCostOfReverseAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 30.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about listing cost of reverse acquisition.",
        "label": "Listing Cost Of Reverse Acquisition",
        "verboseLabel": "Listing cost of reverse acquisition"
       }
      }
     },
     "localname": "ListingCostOfReverseAcquisition",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_LoanReceivableRecognisedAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 50.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for loan receivable acquired in a business combination.",
        "label": "Loan Receivable Recognised As Of Acquisition Date",
        "verboseLabel": "Loan receivable"
       }
      }
     },
     "localname": "LoanReceivableRecognisedAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_LoansPayableAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loans payable recognised as of acquisition date.",
        "label": "Loans Payable As Of Acquisition Date",
        "negatedLabel": "Loans payable"
       }
      }
     },
     "localname": "LoansPayableAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_LongTermBorrowingsAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 40.0,
       "parentTag": "imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents long term borrowings as of acquisition date.",
        "label": "Long Term Borrowings As Of Acquisition Date",
        "negatedLabel": "Long term loans",
        "verboseLabel": "Long term loans"
       }
      }
     },
     "localname": "LongTermBorrowingsAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_MajorComponentsOfIncomeTaxExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major components Of Income Tax Expense [Line Items]",
        "label": "Major Components Of Income Tax Expense [Line Items]"
       }
      }
     },
     "localname": "MajorComponentsOfIncomeTaxExpenseLineItems",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_MajorComponentsOfIncomeTaxExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major Components Of Income Tax Expense [Table]",
        "label": "Major Components Of Income Tax Expense [Table]"
       }
      }
     },
     "localname": "MajorComponentsOfIncomeTaxExpenseTable",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_MizrahiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Mizrahi.",
        "label": "Mizrahi [Member]"
       }
      }
     },
     "localname": "MizrahiMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_MymInternationalBrandsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for MYM International Brands Inc.",
        "label": "Mym International Brands Inc [Member]",
        "terseLabel": "MYM International Brands Inc. [Member]"
       }
      }
     },
     "localname": "MymInternationalBrandsIncMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_MymNutraceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for MYM Nutraceuticals Inc. (\u201cMYM\u201d).",
        "label": "Mym Nutraceuticals Inc [Member]",
        "terseLabel": "MYM Nutraceuticals Inc. (\u201cMYM\u201d) [Member]",
        "verboseLabel": "MYM transaction [Member]"
       }
      }
     },
     "localname": "MymNutraceuticalsIncMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_NavasotaShareholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Navasota shareholders",
        "label": "Navasota Shareholders [Member]",
        "terseLabel": "Navasota shareholders [Member]"
       }
      }
     },
     "localname": "NavasotaShareholdersMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_NetCashTransferred": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value, at acquisition date, of net cash transferred as consideration in a business combination.",
        "label": "Net Cash Transferred",
        "negatedTotalLabel": "Net cash outflow",
        "totalLabel": "Net cash outflow"
       }
      }
     },
     "localname": "NetCashTransferred",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_NetIdentifiableAssetsAcquiredLiabilitiesAssumed": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognized as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination.",
        "label": "Net Identifiable Assets Acquired (Liabilities Assumed)",
        "verboseLabel": "Identifiable assets acquired (liabilities assumed)"
       }
      }
     },
     "localname": "NetIdentifiableAssetsAcquiredLiabilitiesAssumed",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_NonCashExpenseRelatedToChangesInFairValueOfInventorySold": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of non cash expense related to the changes in fair value of inventory sold.",
        "label": "Non Cash Expense Related To Changes In Fair Value Of Inventory Sold",
        "negatedLabel": "Realized fair value adjustments on inventory sold in the period",
        "terseLabel": "Realized fair value adjustments on inventory sold in the period",
        "verboseLabel": "Non-cash expense related to the changes in fair value of inventory sold"
       }
      }
     },
     "localname": "NonCashExpenseRelatedToChangesInFairValueOfInventorySold",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_NonDeductibleIncomeExpenseNetForTaxPurposes": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 0.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non deductible (income) expense, net for tax purposes.",
        "label": "Non Deductible (Income) Expense, Net For Tax Purposes",
        "terseLabel": "Non-deductible (income) expense, net for tax purposes",
        "verboseLabel": "Non-deductible expenses (non-taxable income), net for tax purposes"
       }
      }
     },
     "localname": "NonDeductibleIncomeExpenseNetForTaxPurposes",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_NumberOfCommonSharesCalledByWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares called by warrants.",
        "label": "Number Of Common Shares Called By Warrants",
        "terseLabel": "Number of common shares called by warrants"
       }
      }
     },
     "localname": "NumberOfCommonSharesCalledByWarrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfCommonSharesComprisedToCoverTaxLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents number of common shares comprised to cover tax liabilities.",
        "label": "Number Of Common Shares Comprised To Cover Tax Liabilities",
        "verboseLabel": "Number of common shares comprised to cover tax liabilities"
       }
      }
     },
     "localname": "NumberOfCommonSharesComprisedToCoverTaxLiabilities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfCommonSharesIssuedForEachShareOfAcquiree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issued for each share of acquiree.",
        "label": "Number Of Common Shares Issued For Each Share Of Acquiree",
        "verboseLabel": "Number of common shares issued for each share of acquiree"
       }
      }
     },
     "localname": "NumberOfCommonSharesIssuedForEachShareOfAcquiree",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issued for exercised of options under cashless mechanism.",
        "label": "Number Of Common Shares Issued For Exercised Of Options Under Cashless Mechanism",
        "terseLabel": "Number of common shares issued for exercised of options under cashless mechanism"
       }
      }
     },
     "localname": "NumberOfCommonSharesIssuedForExercisedOfOptionsUnderCashlessMechanism",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfCommonSharesReceivedOfConvertibleInstrument": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents number of common shares received of convertible instrument.",
        "label": "Number Of Common Shares Received Of Convertible Instrument",
        "verboseLabel": "Number of common shares received of convertible instrument"
       }
      }
     },
     "localname": "NumberOfCommonSharesReceivedOfConvertibleInstrument",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfCompensationUnitsConvertedToOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of compensation units converted to ordinary shares.",
        "label": "Number Of Compensation Units Converted To Ordinary Shares",
        "terseLabel": "Number of compensation units converted to ordinary shares"
       }
      }
     },
     "localname": "NumberOfCompensationUnitsConvertedToOrdinaryShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfCompensationUnitsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of compensation unit issued.",
        "label": "Number Of Compensation Units Issued",
        "terseLabel": "Number of compensation unit issued"
       }
      }
     },
     "localname": "NumberOfCompensationUnitsIssued",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfCompensationWarrantsGrantedToAgents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of compensation warrants granted to agents.",
        "label": "Number Of Compensation Warrants Granted To Agents",
        "terseLabel": "Number of compensation warrants granted to agents"
       }
      }
     },
     "localname": "NumberOfCompensationWarrantsGrantedToAgents",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfCompensationWarrantsToAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of compensation warrants to acquired.",
        "label": "Number Of Compensation Warrants To Acquired",
        "terseLabel": "Number of compensation warrants to acquired"
       }
      }
     },
     "localname": "NumberOfCompensationWarrantsToAcquired",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfOptionsExercisedUnderCashlessMechanism": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options exercised under cashless mechanism.",
        "label": "Number Of Options Exercised Under Cashless Mechanism",
        "terseLabel": "Number of options exercised under cashless mechanism"
       }
      }
     },
     "localname": "NumberOfOptionsExercisedUnderCashlessMechanism",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails3"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfPreferredSharesCommittedToBeAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of preferred shares committed to acquired.",
        "label": "Number Of Preferred Shares Committed To Be Acquired",
        "terseLabel": "Number of preferred shares committed to acquire"
       }
      }
     },
     "localname": "NumberOfPreferredSharesCommittedToBeAcquired",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfShareOptionsShareVestedRsu": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options granted in share vested RSU.",
        "label": "Number Of Share Options Share Vested Rsu",
        "terseLabel": "Number of RSU vested"
       }
      }
     },
     "localname": "NumberOfShareOptionsShareVestedRsu",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfSharesAvailableForFutureGrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares available for future grants.",
        "label": "Number Of Shares Available For Future Grants",
        "terseLabel": "Number of shares available for future grants"
       }
      }
     },
     "localname": "NumberOfSharesAvailableForFutureGrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfSharesIssuedInBusinessCombinationTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in business combination transaction.",
        "label": "Number Of Shares Issued In Business Combination Transaction",
        "terseLabel": "New shares from Issuance of business acquisition transaction",
        "verboseLabel": "Common Shares issued related secondary transaction and business combinations"
       }
      }
     },
     "localname": "NumberOfSharesIssuedInBusinessCombinationTransaction",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfSharesIssuedInReverseTakeover": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in reverse takeover.",
        "label": "Number Of Shares Issued In Reverse Takeover",
        "terseLabel": "Number of shares issued in Reverse Takeover",
        "verboseLabel": "Number of Finco shares issued in reverse takeover"
       }
      }
     },
     "localname": "NumberOfSharesIssuedInReverseTakeover",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfUnitsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about number of units issued.",
        "label": "Number Of Units Issued",
        "terseLabel": "Number of units issued"
       }
      }
     },
     "localname": "NumberOfUnitsIssued",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfUnitsIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the number of units issued per share.",
        "label": "Number Of Units Issued Price Per Share",
        "terseLabel": "Number of units issued, price per share"
       }
      }
     },
     "localname": "NumberOfUnitsIssuedPricePerShare",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "imc_NumberOfWarrantExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of warrant exercised.",
        "label": "Number Of Warrant Exercised",
        "verboseLabel": "Number of warrant exercised"
       }
      }
     },
     "localname": "NumberOfWarrantExercised",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfWarrantsAndCompensationOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Warrants and Compensation options exercised.",
        "label": "Number Of Warrants And Compensation Options Exercised",
        "terseLabel": "Number of warrants and compensation options exercised"
       }
      }
     },
     "localname": "NumberOfWarrantsAndCompensationOptionsExercised",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfWarrantsConvertedToOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants converted to Ordinary shares.",
        "label": "Number Of Warrants Converted To Ordinary Shares",
        "terseLabel": "Number of warrants converted to ordinary shares"
       }
      }
     },
     "localname": "NumberOfWarrantsConvertedToOrdinaryShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfWarrantsIssuedUponConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants  issued upon conversion.",
        "label": "Number Of Warrants Issued Upon Conversion.",
        "terseLabel": "Number of warrants issued upon conversion"
       }
      }
     },
     "localname": "NumberOfWarrantsIssuedUponConversion",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_NumberOfWarrantsIssuedUponConversionOfUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants issued upon conversion of units.",
        "label": "Number Of Warrants Issued Upon Conversion Of Units",
        "terseLabel": "Number of warrants issued upon conversion of units"
       }
      }
     },
     "localname": "NumberOfWarrantsIssuedUponConversionOfUnits",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_OranimPharmMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Oranim Pharm.",
        "label": "Oranim Pharm [Member]"
       }
      }
     },
     "localname": "OranimPharmMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_OranimPharmacyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents information about Oranim pharmacy entity.",
        "label": "Oranim Pharmacy [Member]",
        "verboseLabel": "Oranim pharmacy [Member]"
       }
      }
     },
     "localname": "OranimPharmacyMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_OranimPlusPharmLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Oranim Plus Pharm LTD.",
        "label": "Oranim Plus Pharm Ltd [Member]",
        "terseLabel": "Oranim Plus Pharm LTD. [Member]"
       }
      }
     },
     "localname": "OranimPlusPharmLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_OrdinarySharesIssuedForWarrantsCompensationOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about Ordinary shares issued as a result of Warrants and Compensation options exercised.",
        "label": "Ordinary Shares Issued For Warrants Compensation Options Exercised",
        "terseLabel": "Ordinary shares issued as a result of Warrants and Compensation options exercised",
        "verboseLabel": "Common Shares issued as a result of Warrants and Compensation options exercised"
       }
      }
     },
     "localname": "OrdinarySharesIssuedForWarrantsCompensationOptionsExercised",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_OrdinarySharesIssuedOptionsExercises": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about ordinary shares issued as a result of options exercises.",
        "label": "Ordinary Shares Issued Options Exercises",
        "terseLabel": "Ordinary shares issued as a result of options exercises",
        "verboseLabel": "Common Shares issued as a result of options exercises"
       }
      }
     },
     "localname": "OrdinarySharesIssuedOptionsExercises",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_OrdinarySharesReservedForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the ordinary shares reserved for issuance.",
        "label": "Ordinary Shares Reserved For Issuance",
        "verboseLabel": "Percentage of ordinary shares reserved for issuance"
       }
      }
     },
     "localname": "OrdinarySharesReservedForIssuance",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_OtherCannabisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to other cannabis.",
        "label": "Other Cannabis [Member]",
        "verboseLabel": "Other products [Member]"
       }
      }
     },
     "localname": "OtherCannabisMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_OtherCannabisProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for other cannabis products.",
        "label": "Other Cannabis Products [Member]",
        "terseLabel": "Other cannabis products [Member]"
       }
      }
     },
     "localname": "OtherCannabisProductsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated.",
        "label": "Other Comprehensive Income That Will Not Be Reclassified Net Of Tax Exchange Differences On Translation",
        "verboseLabel": "Exchange differences on translation to presentation currency"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedNetOfTaxExchangeDifferencesOnTranslation",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_OtherCurrentPayablesToGovernmentAuthorities": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails": {
       "order": 20.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other current payables to government authorities.",
        "label": "Other Current Payables To Government Authorities",
        "terseLabel": "Government authorities"
       }
      }
     },
     "localname": "OtherCurrentPayablesToGovernmentAuthorities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_OtherDeferredTaxAssestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Other deferred tax assests.",
        "label": "Other Deferred Tax Assests [Member]",
        "verboseLabel": "Other deferred tax assests [Member]"
       }
      }
     },
     "localname": "OtherDeferredTaxAssestsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_OtherMiscellaneousCurrentPayables": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails": {
       "order": 50.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous current payables.",
        "label": "Other Miscellaneous Current Payables",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "OtherMiscellaneousCurrentPayables",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERPAYABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_OtherOperatingSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about other operating segments.",
        "label": "Other Operating Segments [Member]",
        "terseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OtherOperatingSegmentsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OPERATINGSEGMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_OtherPayablesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 50.0,
       "parentTag": "imc_IdentifiableLiabilitiesRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for other payables assumed in a business combination.",
        "label": "Other Payables Recognised As Of Acquisition Date",
        "negatedLabel": "Other payables",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "OtherPayablesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "monetaryItemType"
    },
    "imc_OvernightMarketedOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information of overnight marketed offering.",
        "label": "Overnight Marketed Offering [Member]"
       }
      }
     },
     "localname": "OvernightMarketedOfferingMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_PackagedDriedCannabisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents member information releated to Packaged dried cannabis.",
        "label": "Packaged Dried Cannabis [Member]",
        "verboseLabel": "Packaged dried cannabis [Member]"
       }
      }
     },
     "localname": "PackagedDriedCannabisMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_PanaxiaLogisticsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Panaxia Logistics Ltd. entity.",
        "label": "Panaxia Logistics Ltd. [Member]",
        "terseLabel": "Panaxia transaction [Member]",
        "verboseLabel": "Panaxia Logistics Ltd. [Member]"
       }
      }
     },
     "localname": "PanaxiaLogisticsLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_PercentageOfAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about percentage of acquisition.",
        "label": "Percentage Of Acquisition",
        "terseLabel": "Percentage of acquisition"
       }
      }
     },
     "localname": "PercentageOfAcquisition",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfAwardsVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of awards vest.",
        "label": "Percentage Of Awards Vest",
        "terseLabel": "Awards vest"
       }
      }
     },
     "localname": "PercentageOfAwardsVest",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfIncomeTaxLiabilityOfKeyPersonnel": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of income tax liability of Key Personnel.",
        "label": "Percentage Of Income Tax Liability Of Key Personnel",
        "verboseLabel": "Percentage of income tax liability of key personnel"
       }
      }
     },
     "localname": "PercentageOfIncomeTaxLiabilityOfKeyPersonnel",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of options exercised.",
        "label": "Percentage Of Options Exercised",
        "verboseLabel": "Percentage of options exercised"
       }
      }
     },
     "localname": "PercentageOfOptionsExercised",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of outstanding share capital for Preferred Shares to be acquired.",
        "label": "Percentage Of Outstanding Share Capital For Preferred Shares To Be Acquired",
        "terseLabel": "Percentage of outstanding share capital for preferred shares to be acquired"
       }
      }
     },
     "localname": "PercentageOfOutstandingShareCapitalForPreferredSharesToBeAcquired",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfOutstandingSharesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage of outstanding shares acquired.",
        "label": "Percentage Of Outstanding Shares Acquired",
        "verboseLabel": "Percentage of outstanding shares acquired"
       }
      }
     },
     "localname": "PercentageOfOutstandingSharesAcquired",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfRestrictedSharesGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the percentage of restricted shares granted.",
        "label": "Percentage Of Restricted Shares Granted",
        "terseLabel": "Percentage of restricted shares granted"
       }
      }
     },
     "localname": "PercentageOfRestrictedSharesGranted",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfRightsHold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage of rights hold.",
        "label": "Percentage Of Rights Hold",
        "terseLabel": "Percentage of rights hold"
       }
      }
     },
     "localname": "PercentageOfRightsHold",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfSharesGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the percentage of shares granted.",
        "label": "Percentage Of Shares Granted",
        "terseLabel": "Percentage of shares granted"
       }
      }
     },
     "localname": "PercentageOfSharesGranted",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfWarrantsAndCompensationOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of warrants and Compensation options exercised.",
        "label": "Percentage Of Warrants And Compensation Options Exercised",
        "terseLabel": "Percentage of warrants and Compensation options exercised"
       }
      }
     },
     "localname": "PercentageOfWarrantsAndCompensationOptionsExercised",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage of warrants exercised.",
        "label": "Percentage Of Warrants Exercised",
        "verboseLabel": "Percentage of warrants exercised"
       }
      }
     },
     "localname": "PercentageOfWarrantsExercised",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfWithholdingTaxLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents percentage of withholding tax liabilities.",
        "label": "Percentage Of Withholding Tax Liabilities",
        "verboseLabel": "Percentage of withholding tax liabilities"
       }
      }
     },
     "localname": "PercentageOfWithholdingTaxLiabilities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents percentage of withholding tax liabilities of penalties and interest.",
        "label": "Percentage Of Withholding Tax Liabilities Of Penalties And Interest",
        "verboseLabel": "Percentage of withholding tax liabilities of penalties and interest"
       }
      }
     },
     "localname": "PercentageOfWithholdingTaxLiabilitiesOfPenaltiesAndInterest",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PeriodicPaymentInstallmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Periodic payment installment.",
        "label": "Periodic Payment Installment [Axis]"
       }
      }
     },
     "localname": "PeriodicPaymentInstallmentAxis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_PeriodicPaymentInstallmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Periodic payment installment.",
        "label": "Periodic Payment Installment [Domain]"
       }
      }
     },
     "localname": "PeriodicPaymentInstallmentDomain",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_PharmYarokPharmacyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Pharm Yarok pharmacy entity.",
        "label": "Pharm Yarok Pharmacy [Member]",
        "verboseLabel": "Pharm Yarok pharmacy [Member]"
       }
      }
     },
     "localname": "PharmYarokPharmacyMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_PlanAssetsAmountsDeposited": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of plan assets amount deposited.",
        "label": "Plan Assets Amounts Deposited",
        "verboseLabel": "Amounts deposited"
       }
      }
     },
     "localname": "PlanAssetsAmountsDeposited",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_PlanAssetsForeignCurrencyTranslationEffect": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of foreign currency translation effect.",
        "label": "Plan Assets Foreign Currency Translation Effect",
        "verboseLabel": "Foreign currency translation effect"
       }
      }
     },
     "localname": "PlanAssetsForeignCurrencyTranslationEffect",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_PreTaxDiscountRateOfCashFlows": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the pre tax discount rate of cash flows.",
        "label": "Pre Tax Discount Rate Of Cash Flows",
        "terseLabel": "Pre-tax discount rate of cash flows"
       }
      }
     },
     "localname": "PreTaxDiscountRateOfCashFlows",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_PreliminaryShelfProspectusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about preliminary shelf prospectus.",
        "label": "Preliminary Shelf Prospectus [Member]",
        "terseLabel": "Preliminary Shelf Prospectus [Member]"
       }
      }
     },
     "localname": "PreliminaryShelfProspectusMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_PrivatePlacementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about private placements.",
        "label": "Private Placements [Member]",
        "terseLabel": "2019 Private Placements [Member]"
       }
      }
     },
     "localname": "PrivatePlacementsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ProFormaAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported based on historical fact adjusted for potential activity. Includes, but is not limited to, information expected to be reported in future period for effect on historical fact. Excludes forecast information.",
        "label": "Pro Forma Adjustments [Member]"
       }
      }
     },
     "localname": "ProFormaAdjustmentsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ProceedsFromExerciseOfWarrantsAndCompensationOptions": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to proceeds from exercise of warrants and compensation options.",
        "label": "Proceeds From Exercise Of Warrants And Compensation Options",
        "terseLabel": "Proceeds from exercise of warrants and compensation options"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfWarrantsAndCompensationOptions",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ProceedsFromInvestmentInRestrictedDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 60.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents cash inflow from investments in restricted deposits.",
        "label": "Proceeds From Investment In Restricted Deposits",
        "terseLabel": "Proceeds from (investment in) restricted deposits"
       }
      }
     },
     "localname": "ProceedsFromInvestmentInRestrictedDeposits",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 0.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to proceeds from issuance of warrants measured at fair value.",
        "label": "Proceeds From Issuance Of Warrants Measured At Fair Value",
        "terseLabel": "Proceeds from issuance of warrants measured at fair value"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrantsMeasuredAtFairValue",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ProceedsFromWarrantsAndCompensationOptionsExercised": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Warrants and Compensation options exercised.",
        "label": "Proceeds From Warrants And Compensation Options Exercised",
        "terseLabel": "Proceeds from warrants and compensation options exercised"
       }
      }
     },
     "localname": "ProceedsFromWarrantsAndCompensationOptionsExercised",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ProductionCostsCapitalizedBiologicalAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of production costs capitalized on biological assets.",
        "label": "Production Costs Capitalized Biological Assets",
        "terseLabel": "Production costs capitalized"
       }
      }
     },
     "localname": "ProductionCostsCapitalizedBiologicalAssets",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent.",
        "label": "Profit Loss Attributable To Owners Of Parent Computation Of Diluted Net Earnings",
        "terseLabel": "For the computation of diluted net earnings, Net loss attributable to equity holders of the Company"
       }
      }
     },
     "localname": "ProfitLossAttributableToOwnersOfParentComputationOfDilutedNetEarnings",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/NETEARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents property, plant and equipment and right of use assets as of acquisition date.",
        "label": "Property Plant And Equipment And Right Of Use Assets As Of Acquisition Date",
        "verboseLabel": "Property, plant and equipment and right of use assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndRightOfUseAssetsAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_PurchaseOfTreasuryCommonShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of purchase of treasury common shares.",
        "label": "Purchase Of Treasury Common Shares",
        "verboseLabel": "Purchase of treasury common shares"
       }
      }
     },
     "localname": "PurchaseOfTreasuryCommonShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "imc_RayarokPharmLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for R.A. Yarok Pharm Ltd. (\u201cPharm Yarok\u201d).",
        "label": "Rayarok Pharm Ltd [Member]",
        "terseLabel": "R.A. Yarok Pharm Ltd. (\u201cPharm Yarok\u201d) [Member]"
       }
      }
     },
     "localname": "RayarokPharmLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_RealizedFairValueAdjustmentOnInventorySold": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME": {
       "order": 0.0,
       "parentTag": "ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized fair value adjustments on inventory sold in the period.",
        "label": "Realized Fair Value Adjustment On Inventory Sold",
        "negatedLabel": "Realized fair value adjustments on inventory sold in the period",
        "positiveTerseLabel": "Realized fair value adjustments on inventory sold in the year",
        "terseLabel": "Realized fair value adjustments on inventory sold in the period",
        "verboseLabel": "Fair value adjustment on sale of inventory"
       }
      }
     },
     "localname": "RealizedFairValueAdjustmentOnInventorySold",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFPROFITORLOSSANDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ReceivablesFromGovernmentAuthorities": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails": {
       "order": 30.0,
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount receivables from government authorities.",
        "label": "Receivables From Government Authorities",
        "terseLabel": "Government authorities"
       }
      }
     },
     "localname": "ReceivablesFromGovernmentAuthorities",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/OTHERACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ReductionOfSharePremiumCostAllocatedToOrdinaryShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction of share premium cost allocated to the Ordinary shares.",
        "label": "Reduction Of Share Premium Cost Allocated To Ordinary Shares",
        "terseLabel": "Reduction of share premium, cost allocated to Ordinary shares"
       }
      }
     },
     "localname": "ReductionOfSharePremiumCostAllocatedToOrdinaryShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_RemainingAmountOfCashPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents remaining amount of cash paid.",
        "label": "Remaining Amount Of Cash Paid",
        "verboseLabel": "Remaining amount of cash paid"
       }
      }
     },
     "localname": "RemainingAmountOfCashPaid",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_RemainingInstallmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining installment of payment.",
        "label": "Remaining Installment [Member]",
        "terseLabel": "Remaining installment [Member]"
       }
      }
     },
     "localname": "RemainingInstallmentMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_RestrictedShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Share Units [Member]"
       }
      }
     },
     "localname": "RestrictedShareUnitsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYNumberOfRestrictedShareUnitsRSUDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ReturnNetOfInterestIncomeReMeasurementGainLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information Return net of interest income re measurement gain loss.",
        "label": "Return Net Of Interest Income Re Measurement Gain Loss",
        "verboseLabel": "Return, net of interest income - remeasurement gain (loss)"
       }
      }
     },
     "localname": "ReturnNetOfInterestIncomeReMeasurementGainLoss",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EMPLOYEEBENEFITASSETSANDLIABILITIESDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_RevaluationOfExercisedWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the revaluation of exercised warrants.",
        "label": "Revaluation Of Exercised Warrants",
        "terseLabel": "Revaluation of exercised Warrants"
       }
      }
     },
     "localname": "RevaluationOfExercisedWarrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stand for revolving credit facility.",
        "label": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_RevolyTradingAndMarketingLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Revoly Trading and Marketing Ltd. (\u201cVironna\u201d).",
        "label": "Revoly Trading And Marketing Ltd [Member]",
        "terseLabel": "Revoly Trading and Marketing Ltd. (\u201cVironna\u201d) [Member]"
       }
      }
     },
     "localname": "RevolyTradingAndMarketingLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_RightOfUseAssetRecognizedWithCorrespondingLeaseLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to right-of-use asset recognized with corresponding lease liability.",
        "label": "Right Of Use Asset Recognized With Corresponding Lease Liability",
        "verboseLabel": "Right-of-use asset recognized with corresponding lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetRecognizedWithCorrespondingLeaseLiability",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_RightOfUseAssetsAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 90.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents right of use assets as of acquisition date.",
        "label": "Right Of Use Assets As Of Acquisition Date",
        "verboseLabel": "Right of use assets"
       }
      }
     },
     "localname": "RightOfUseAssetsAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_RiskFreeInterestRateOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk free interest rate of warrants.",
        "label": "Risk Free Interest Rate Of Warrants",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "RiskFreeInterestRateOfWarrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_RosenHighWayLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Rosen High Way Ltd. (\u201cRosen High Way\u201d).",
        "label": "Rosen High Way Ltd [Member]",
        "terseLabel": "Rosen High Way Ltd. (\u201cRosen High Way\u201d) [Member]"
       }
      }
     },
     "localname": "RosenHighWayLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to share based compensation.",
        "label": "Share Based Compensation",
        "terseLabel": "Expenses for share based compensation",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ShareIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about share incentive plan.",
        "label": "Share Incentive Plan [Member]",
        "terseLabel": "2018 Share Incentive Plan\" (the \"2018 Plan\") [Member]"
       }
      }
     },
     "localname": "ShareIncentivePlanMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_SharePurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share purchase agreement.",
        "label": "Share Purchase Agreement [Member]"
       }
      }
     },
     "localname": "SharePurchaseAgreementMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_ShareholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents member information related to Shareholders.",
        "label": "Shareholders [Member]"
       }
      }
     },
     "localname": "ShareholdersMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/RELATEDPARTYBALANCESANDTRANSACTIONSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Estimates And Assumptions Used In Preparation Of Financial Statement [Abstract]"
       }
      }
     },
     "localname": "SignificantAccountingEstimatesAndAssumptionsUsedInPreparationOfFinancialStatementAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "stringItemType"
    },
    "imc_SimpleAgreementForFutureEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Simple Agreement for Future Equity.",
        "label": "Simple Agreement For Future Equity [Member]"
       }
      }
     },
     "localname": "SimpleAgreementForFutureEquityMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_SublimecultureIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for SublimeCulture Inc.",
        "label": "Sublimeculture Inc [Member]",
        "terseLabel": "SublimeCulture Inc. [Member]"
       }
      }
     },
     "localname": "SublimecultureIncMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsequent event.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summarized Financial Information For Partly Owned Subsidiary [Abstract]"
       }
      }
     },
     "localname": "SummarizedFinancialInformationForPartlyOwnedSubsidiaryAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "stringItemType"
    },
    "imc_SupplementalDisclosureOfNonCashActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosure Of Non Cash Activities [Abstract]",
        "verboseLabel": "Supplemental disclosure of non-cash activities:"
       }
      }
     },
     "localname": "SupplementalDisclosureOfNonCashActivitiesAbstract",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 10.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of tax effect of adjustments in respect of current Income tax of previous years.",
        "label": "Tax Effect Of Adjustments In Respect Of Current Income Tax Of Previous Years",
        "terseLabel": "Adjustments in respect of current income tax of previous years"
       }
      }
     },
     "localname": "TaxEffectOfAdjustmentsInRespectOfCurrentIncomeTaxOfPreviousYears",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_TaxEffectOfDifferentTaxRateOfSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 20.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to different tax rates of subsidiaries.",
        "label": "Tax Effect Of Different Tax Rate Of Subsidiaries",
        "terseLabel": "Effect of different tax rate of subsidiaries"
       }
      }
     },
     "localname": "TaxEffectOfDifferentTaxRateOfSubsidiaries",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 70.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition of tax benefit in respect of losses of previous years.",
        "label": "Tax Effect Of Recognition Of Tax Benefit In Respect Of Losses Of Previous Years",
        "negatedLabel": "Recognition of tax benefit in respect of losses of previous years",
        "terseLabel": "Recognition (derecognition) of tax benefit in respect of losses of previous years"
       }
      }
     },
     "localname": "TaxEffectOfRecognitionOfTaxBenefitInRespectOfLossesOfPreviousYears",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 40.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax benefit in respect of loss for the year.",
        "label": "Tax Effect Of Unrecognized Tax Benefit In Respect Of Loss",
        "terseLabel": "Unrecognized tax benefit in respect of loss for the year"
       }
      }
     },
     "localname": "TaxEffectOfUnrecognizedTaxBenefitInRespectOfLoss",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_TermOfNonInterestBearingTradeReceivables": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents term of non interest bearing trade receivables .",
        "label": "Term Of Non Interest Bearing Trade Receivables",
        "verboseLabel": "Term of non interest bearing trade receivables"
       }
      }
     },
     "localname": "TermOfNonInterestBearingTradeReceivables",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_TermOfWarrantsFromDateOfIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of warrants from date of issuance.",
        "label": "Term Of Warrants From Date Of Issuance",
        "terseLabel": "Term of warrants from date of issuance",
        "verboseLabel": "Term of warrants"
       }
      }
     },
     "localname": "TermOfWarrantsFromDateOfIssuance",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "durationItemType"
    },
    "imc_TotalAcquisitionSubsidiary": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to acquisition of subsidiary.",
        "label": "Total Acquisition Subsidiary",
        "totalLabel": "Acquisition of a subsidiary"
       }
      }
     },
     "localname": "TotalAcquisitionSubsidiary",
     "nsuri": "http://www.imcannabis.com/20211231",
     "xbrltype": "monetaryItemType"
    },
    "imc_TotalAllocatedAmountTranslationTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total allocated amount translation transaction.",
        "label": "Total Allocated Amount Translation Transaction",
        "terseLabel": "Total allocated amount translation transaction"
       }
      }
     },
     "localname": "TotalAllocatedAmountTranslationTransaction",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails": {
       "order": 110.0,
       "parentTag": "imc_IdentifiableAssetsRecognisedAsOfAcquisitionDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for trade and other receivables acquired in a business combination.",
        "label": "Trade And Other Receivables Recognised As Of Acquisition Date",
        "terseLabel": "Trade and other receivables"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_TradeReceivablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Trade Receivables [Line Items]"
       }
      }
     },
     "localname": "TradeReceivablesLineItems",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_TradeReceivablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of trade receivables.",
        "label": "Trade Receivables [Table]"
       }
      }
     },
     "localname": "TradeReceivablesTable",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_TranslationDifferencesOfDefferedTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents translation differences of deffered taxes.",
        "label": "Translation Differences Of Deffered Taxes",
        "verboseLabel": "Translation differences"
       }
      }
     },
     "localname": "TranslationDifferencesOfDefferedTaxes",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_TrichomeAssetFundingCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trichome Asset Funding Corp.",
        "label": "Trichome Asset Funding Corp [Member]",
        "terseLabel": "Trichome Asset Funding Corp. [Member]"
       }
      }
     },
     "localname": "TrichomeAssetFundingCorpMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_TrichomeFinancialCannabisGpIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trichome Financial Cannabis GP Inc.",
        "label": "Trichome Financial Cannabis Gp Inc [Member]",
        "terseLabel": "Trichome Financial Cannabis GP Inc. [Member]"
       }
      }
     },
     "localname": "TrichomeFinancialCannabisGpIncMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_TrichomeFinancialCannabisManagerIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trichome Financial Cannabis Manager Inc.",
        "label": "Trichome Financial Cannabis Manager Inc [Member]",
        "terseLabel": "Trichome Financial Cannabis Manager Inc. [Member]"
       }
      }
     },
     "localname": "TrichomeFinancialCannabisManagerIncMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_TrichomeFinancialCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trichome Financial Corp. (\u201cTrichome\u201d).",
        "label": "Trichome Financial Corp [Member]",
        "terseLabel": "Trichome Financial Corp. (\u201cTrichome\u201d) [Member]",
        "verboseLabel": "Trichome transaction [Member]"
       }
      }
     },
     "localname": "TrichomeFinancialCorpMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/INTANGIBLEASSETSNETDetailTextuals",
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_TrichomeJwcAcquisitionCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trichome JWC Acquisition Corp. (\u201cTJAC\u201d).",
        "label": "Trichome Jwc Acquisition Corp [Member]",
        "terseLabel": "Trichome JWC Acquisition Corp. (\u201cTJAC\u201d) [Member]"
       }
      }
     },
     "localname": "TrichomeJwcAcquisitionCorpMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_TrichomeRetailCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trichome Retail Corp.",
        "label": "Trichome Retail Corp [Member]",
        "terseLabel": "Trichome Retail Corp. [Member]"
       }
      }
     },
     "localname": "TrichomeRetailCorpMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_TypeOfCannabisAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Type Of Cannabis [Axis]"
       }
      }
     },
     "localname": "TypeOfCannabisAxis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_TypeOfCannabisDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the type of cannabis.",
        "label": "Type Of Cannabis [Domain]"
       }
      }
     },
     "localname": "TypeOfCannabisDomain",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_UnobservableInputAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Unobservable Input [Axis]"
       }
      }
     },
     "localname": "UnobservableInputAxis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_UnobservableInputDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for unobservable input.",
        "label": "Unobservable Input [Domain]"
       }
      }
     },
     "localname": "UnobservableInputDomain",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_UtilizationOfLossesNotPreviouslyRecognized": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3": {
       "order": 50.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of utilization of losses not previously recognized.",
        "label": "Utilization Of Losses Not Previously Recognized",
        "verboseLabel": "Utilization of losses not previously recognized"
       }
      }
     },
     "localname": "UtilizationOfLossesNotPreviouslyRecognized",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of compensation units converted to ordinary shares and warrants.",
        "label": "Value Of Compensation Units Converted To Ordinary Shares And Warrants",
        "terseLabel": "Value of compensation units converted to ordinary shares and warrants"
       }
      }
     },
     "localname": "ValueOfCompensationUnitsConvertedToOrdinarySharesAndWarrants",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_ValueOfWarrantsConvertedToOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of warrants converted to Ordinary shares.",
        "label": "Value Of Warrants Converted To Ordinary Shares.",
        "terseLabel": "Value of warrants converted to ordinary shares"
       }
      }
     },
     "localname": "ValueOfWarrantsConvertedToOrdinaryShares",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for vest in eight equal installments upon lapse of each three month period thereafter.",
        "label": "Vest In Eight Equal Installments Upon Lapse Of Each Three Month Period Thereafter [Member]",
        "terseLabel": "Vest in eight equal installments upon the lapse of each three-month period thereafter [Member]"
       }
      }
     },
     "localname": "VestInEightEqualInstallmentsUponLapseOfEachThreeMonthPeriodThereafterMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_VestingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "imc_VestingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It's represents the vesting.",
        "label": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_VestingPercentageOfShareBasedArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The vesting percentage of share-based arrangement.",
        "label": "Vesting Percentage Of Share Based Arrangement",
        "verboseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "VestingPercentageOfShareBasedArrangement",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals"
     ],
     "xbrltype": "percentItemType"
    },
    "imc_VironnaPharmacyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Vironna pharmacy entity.",
        "label": "Vironna Pharmacy [Member]",
        "verboseLabel": "Vironna pharmacy [Member]"
       }
      }
     },
     "localname": "VironnaPharmacyMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails",
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSTables",
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation",
      "http://www.imcannabis.com/role/GENERALDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_Warrant2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information of 2021 Warrant.",
        "label": "Warrant 2021 [Member]",
        "terseLabel": "2021 Warrant [Member]"
       }
      }
     },
     "localname": "Warrant2021Member",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_WarrantPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents warrant price per share.",
        "label": "Warrant Price Per Share",
        "verboseLabel": "Warrant price per share"
       }
      }
     },
     "localname": "WarrantPricePerShare",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "perShareItemType"
    },
    "imc_Warrants2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Warrants.",
        "label": "Warrants 2018 [Member]",
        "terseLabel": "2018 Warrants [Member]"
       }
      }
     },
     "localname": "Warrants2018Member",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_Warrants2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2019 Warrants.",
        "label": "Warrants 2019 [Member]",
        "terseLabel": "2019 Warrants [Member]"
       }
      }
     },
     "localname": "Warrants2019Member",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_WarrantsAndCompensationOptions2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Warrants and Compensation Options",
        "label": "Warrants And Compensation Options 2019 [Member]",
        "verboseLabel": "2019 Warrants and Compensation Options [Member]"
       }
      }
     },
     "localname": "WarrantsAndCompensationOptions2019Member",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_WarrantsAndCompensationOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants and Compensation options.",
        "label": "Warrants And Compensation Options [Member]"
       }
      }
     },
     "localname": "WarrantsAndCompensationOptionsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_WarrantsMeasuredAtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": {
       "order": 0.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amounts of warrants measured at fair value.",
        "label": "Warrants Measured At Fair Value",
        "terseLabel": "Warrants measured at fair value",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsMeasuredAtFairValue",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION",
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information of the warrants.",
        "label": "Warrants [Member]",
        "terseLabel": "2018 Warrants [Member]"
       }
      }
     },
     "localname": "WarrantsMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetails3"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_WeightedAverageFairValueLessCostToSellOfBiologicalAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the weighted average fair value less cost to sell of biological assets.",
        "label": "Weighted Average Fair Value Less Cost To Sell Of Biological Assets",
        "terseLabel": "Weighted average fair value less cost to sell"
       }
      }
     },
     "localname": "WeightedAverageFairValueLessCostToSellOfBiologicalAssets",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BIOLOGICALASSETSDetailTextuals"
     ],
     "xbrltype": "decimalItemType"
    },
    "imc_WholesalesAndPharmaciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for wholesales and pharmacies.",
        "label": "Wholesales And Pharmacies [Member]",
        "verboseLabel": "Wholesalers and pharmacies [Member]"
       }
      }
     },
     "localname": "WholesalesAndPharmaciesMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/TRADERECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_WorkInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents member information related to work in progress.",
        "label": "Work In Progress [Member]",
        "verboseLabel": "Work in progress [Member]"
       }
      }
     },
     "localname": "WorkInProgressMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "imc_WorkingCapital": {
     "auth_ref": [],
     "calculation": {
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 0.0,
       "parentTag": "imc_TotalAcquisitionSubsidiary",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount related to working capital.",
        "label": "Working Capital",
        "terseLabel": "Working capital (excluding cash and cash equivalents)"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_WorkingCapitalOfBusinessAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents working capital of business acquisition.",
        "label": "Working Capital Of Business Acquisition",
        "verboseLabel": "Working capital of business acquisition"
       }
      }
     },
     "localname": "WorkingCapitalOfBusinessAcquisition",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDetailTextuals",
      "http://www.imcannabis.com/role/GENERALDetailTextuals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "imc_XintezaApiLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Xinteza API Ltd.",
        "label": "Xinteza Api Ltd [Member]"
       }
      }
     },
     "localname": "XintezaApiLtdMember",
     "nsuri": "http://www.imcannabis.com/20211231",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals",
      "http://www.imcannabis.com/role/SUBSEQUENTEVENTSDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.imcannabis.com/role/FINANCIALINSTRUMENTSDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProFormaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pro Forma [Member]"
       }
      }
     },
     "localname": "ProFormaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.imcannabis.com/role/TAXESONINCOMEDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.imcannabis.com/role/BUSINESSCOMBINATIONSDisclosureOfDetailedInformationAboutProformaAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.imcannabis.com/role/EQUITYDetailTextuals"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r1": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r10": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r100": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r101": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r102": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI",
   "URIDate": "2021-03-24"
  },
  "r103": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r104": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r105": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r106": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r107": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r108": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r109": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r11": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r110": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r111": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2021-03-24"
  },
  "r112": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_v&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r113": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r114": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r115": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r116": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r117": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r118": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r119": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r12": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r120": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r121": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r122": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r123": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r124": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2021-03-24"
  },
  "r125": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r126": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r127": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r128": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r129": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r13": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r130": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r131": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r132": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r133": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r134": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r135": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r136": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r137": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r138": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r139": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r14": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "51",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r140": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r141": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r142": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r143": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r144": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2021-03-24"
  },
  "r145": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r146": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r147": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r148": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "43",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_43&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r149": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r15": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r150": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r151": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r152": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r153": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r154": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "51",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r155": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r156": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Section": "Example 1 XYZ Dairy Ltd",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS41_IE_ex1__IAS41_IE_ex1_TI",
   "URIDate": "2021-03-24"
  },
  "r157": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r158": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r159": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r16": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r160": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r161": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r162": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r163": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r164": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r165": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r166": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r167": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r168": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r169": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r17": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r170": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r171": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r172": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r173": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r174": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r175": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r176": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r177": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r178": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r179": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r18": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r180": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r181": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r182": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44D",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r183": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r184": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "46",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r185": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r186": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI",
   "URIDate": "2021-03-24"
  },
  "r187": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C__IAS07_IE_C_TI",
   "URIDate": "2021-03-24"
  },
  "r188": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "Presentation of a statement of cash flows",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI",
   "URIDate": "2021-03-24"
  },
  "r189": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "30",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_30_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r19": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r190": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r191": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r192": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r193": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r194": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "10",
   "Paragraph": "22",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r195": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r196": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r197": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r198": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r199": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r2": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r20": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r200": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r201": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r202": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r203": {
   "Clause": "ix",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r204": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r205": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r206": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r207": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r208": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r209": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r21": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r210": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r211": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r212": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r213": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r214": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r215": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r216": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r217": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r218": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r219": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r22": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r220": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r221": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r222": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r223": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r224": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r225": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r226": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r227": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r228": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r229": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r23": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_r&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r230": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r231": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r232": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r233": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r234": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r235": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r236": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r237": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r238": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r239": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r24": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r240": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r241": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r242": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r243": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r244": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r245": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r246": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r247": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_g_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r248": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r249": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "m",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r25": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r250": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "o",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_o_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r251": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r252": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r253": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r254": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r255": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "IE72",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r256": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI",
   "URIDate": "2021-03-24"
  },
  "r257": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Section": "Disclosures application of paragraphs 59 and 61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67_TI",
   "URIDate": "2021-03-24"
  },
  "r258": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r259": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "21C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r26": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r260": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r261": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r262": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r263": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r264": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r265": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r266": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r267": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35K",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r268": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r269": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r27": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r270": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "36",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r271": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r272": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r273": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r274": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r275": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r276": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r277": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r278": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r279": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11D",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11D&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r28": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r280": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r281": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B8",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B8_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r282": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r283": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Defined terms",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2021-03-24"
  },
  "r284": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Scope",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2021-03-24"
  },
  "r285": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r286": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r287": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r288": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r289": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r29": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r290": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r291": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r292": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r293": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r294": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r295": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r296": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r297": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r298": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r299": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r3": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r30": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r300": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "IG4",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_IG4&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r301": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2021-03-24"
  },
  "r302": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "7.2.34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r303": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r304": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r305": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r306": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r307": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "124",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r308": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "125",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r309": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r31": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r310": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r311": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r312": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r313": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r314": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "C32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2021-03-24"
  },
  "r315": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "9",
   "Paragraph": "7.2.42",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r316": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r317": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r318": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r319": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_c&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r32": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "70",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r320": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r321": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r322": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r323": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r324": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r325": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r326": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r327": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r328": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r329": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r33": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r330": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r331": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r332": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r34": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r35": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r36": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r37": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r38": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r39": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r4": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r40": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r41": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r42": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r43": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r44": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r45": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r46": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r47": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r48": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r49": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r5": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r50": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r51": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r52": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r53": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r54": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r55": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r56": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r57": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "22",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r58": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2021-03-24"
  },
  "r59": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r6": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r60": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r61": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r62": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r63": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r64": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r65": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r66": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r67": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2021-03-24"
  },
  "r68": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r69": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r7": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r70": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r71": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r72": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r73": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r74": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r75": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r76": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r77": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r78": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r79": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r8": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r80": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r81": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r82": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r83": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r84": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r85": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r86": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r87": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r88": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r89": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r9": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r90": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r91": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "144",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r92": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r93": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r94": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "5",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r95": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r96": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "9",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r97": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Section": "Scope",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI",
   "URIDate": "2021-03-24"
  },
  "r98": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r99": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2021-03-24"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>153
<FILENAME>0001178913-22-001377-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-22-001377-xbrl.zip
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M2KX/QSYOS6G^'$;V!YR&?%'!O2FL".'5NQUE)0LK;SFFB$SX#%ZM\I\^MX:
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MWLCW^LP=A0YW(B?@',1=-MB:%%8R_'9XQ#POR1>$.(B^GIFVS6:LN.!E9<4
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M2*YGTB+K$G-=6-PH?EBGZ?:P%#,6,Y651#&VXJ>U =Q94V]#Z8$?A:$[8F'
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M8V'8[X-TRGC$?>ZQ$0^9;<>V Y<39S"R^ULL;/B&VXR50F:Z:Z \%PSR6<)
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M#H6L'U:"0 9*++646D@G-%6(0,85<2XD,Y'JH5@:K>*.XH;P7!L*%A"'&3!
MF6PXSO [TBM#$1XG[\R+UDL*R -%)>8)%5'#I::S5WJIA*)D$(+AS.G&O(R
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MB\(2JJ/J>J"A$:- U9R@ L;R/,]-\)%302$S1AW+@"868[4!W&Y,I\T8X#V
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M*7-F)M9X;^_DP_$YWCX]&^^='^X=3!Z#$-:8*#H4<UE]_O#-V008D)+F2+!
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M(GG""VE1 ZKG#>R>[PX)J[6GH)"%CZR7#U@WZ56O[9JCLGS+@<$O&98)!&T
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MIV]0%0):FN\ ,2VDKFO.^I&XYD.R'-=^%)8C[)(U61 !7"6\2RH+N05VT 5
M875F 705J4GA=NM&V2D5"IT-$A-DR,0_>+' H:96/B<ZW0A1-B-&1$4;^()U
M"D=:V_+@4QP=%>(E86*4 7!D_RX7\SD0B'(!UXU/2U:F!<; MC^2F+EZ#8P\
M&MG-DO JUB4=)M(N+&U0PNQ++\P,[08EWIZWQB<KD21,V$_'%ZC8KG6BPV'J
M)A'*Q+Q:<C  :AJ/4*:0$<"^HTDR>3UIA\P]$,)MQR"UOIN:X4@R\EW&LQ*%
MT'Z@+XH8J8T7W[R8^[TC192Q37+I>T6*K!,[*$QL=2S"(Q6:K*F*LX*JR*/8
M$EC_$,;*]VG"5<]R:HVP\W9\2CY'T<]01<0#/JTMT1I#+TFU@/:U"%W3@89(
MJ+#,Z?DKSZKTIVH*@ '%&?I1A32HC[+,QHCK@.6EH0@^J2Y^022K V8P?"@C
M]3N2.6AA#1(KH](>Q8I&N1J=Z"! %J9"ZM/KDY2Y3F+I6,H2#UI-0#NS773,
MXT_6R_05[OYUWLWL<"X*"2:7\-5S%C*0/]*/YL36QD?]]K*.9>H;)A.C[2[1
M U]_VD$=Y2[6$?*+=#8SV-#/L%BQVM7,G6 _60!KVQ$\]Z6 ^*M[JI+&$)^S
M5+AA3L(XGDZ_YP_].]8N''^PVK66>\0^20'C?FN$]VHNU+U44R:I/T/K[*(]
MJXG,D@RR"\J&9/@Z)UUS>Y&HU*I83-E""-\+<<Q4A._M4;,ZTL@XH(; (+58
M'>4A!S/.1H);R[77>^6)1:HE(Q2$3OEV_U11 ='Z9D:VQGJU*-M5N32TZN5B
M7$L!2OG_H -*!.9V?:X99$L!SC.$L'2CD6Y3P-2+.F$&4ZJFZ5\4DBN]'B5I
MVCH[3W@?S1W!+]&L<:X%9U.=5XB#F**S&;)!26_7,[5EPOI",;:D;*OS@VPA
M1@*,YA30#*>+:B'#-?A,3L, @X@-;K$-ANO')0*:((]ND6%-<WKB0)J2N,;G
M*M?".)=:>CZ[R"EVB4^EWIN6]Y4%'RF:]N$D05-&[18)&U[>QY4+UV;J=\_-
M,L,P[ZJ;]Z@^5-?>^E ?LYZ2:*"&-=LZ]07TGA'?7I(2ER3 M42B%=+R*9NQ
M3RFSWK.PU"FVHC5L)=1V^"H0370Q"@7\490KV6UNE7*E8&2(.[> R^T-/A]>
M9K[/LC37ZQ+GZ!UU6NC5AE3WV=-1 2Q4>A4OP _]5?O60U?UOV66@;$*^*:H
MDJPB7(NZ2[.L)T $'PTOHMB@&ZQG;C$^TN%Z-B6I^S0':(TL98VEN)C:)M-.
MVFK::%2U>/S[:]EK.IAS33N?F+WF2S)[UN?+GYO>^2WI\Q&[L0)%;\8@:Y)@
M7V<5&N<$I,XD51'>BMR(RL (""&O^[TUS*QT>%18,AE+4$:%^2K[2&&2@GI6
MJB<.2:X8_J>M-^X.Q19(B^TNB+* ^HT),T2QTA@,I7 Q>9ZBGF"%B^RCGF-/
MV&8P1J8@VY1:1 +#X/Q()2ERV06+JF])%T:]3JK3!VR['A3(%B9!"7N7(;D;
M%<6%*ZJ>^>.P(L0+60*QY5($0( L0E'1E["<#IQAM>J+IO*T$@P*]YG5:AR5
M(JNQ '[U!E+M7\_A0+2!+>W]HX"+JK Z09-Q:X"(W/\"RVT0QE'7Z%13RJ4E
M2E"10SD%-G?P8>?MD6DI77JC-IT*^[T>'@-Y&H%,38>X*P^K.DA=2KM2*77A
MA2=ODA0,O$72&IQ;^>:52+5LJ&W:D<HZ0K"1MJ-0N31P^2?K_UL4E"4M6#BS
MWD[#=^M;G=3;=\7UC3^EF&NIJA4"MMQ@Z#Y]3*CO5&80N!^(&)%,-X.;NT8M
M!SU3*4FA4 .KP/!KKL5)TYZ6MQR+WSZL29XWW&'O7EZ( Z07;PN4)2?H>H>E
MR/T!36#][:F':9<2NE=LASD;FFY')95EP^KM;I.>9LN: ..)K^7.5<24_'NJ
M'A&==&-Z*=E[@@$%U)3 M+ "+8C3F(?#E*$KD1U9>XHLU[[3!$UMTG4J?+*Z
M>!%.U^A\70&SU-%Y&(0'J"@Z:IL"JSF>\-,*+8.>UH*(8RMGS;DHT=)RUE#V
MD_+5+,$EYAG6M\(7C$AWG-/2OAF5=1J.&TTN5Y#&+C*ZJU;_0=^[[7NTTZP@
M"2+*%UG<.KSU 2"K!D5PDMJ( 1^J8!@J"TECJ#B-J3 .O:[,NECRB7K'%*D@
M*Q*EE@0CP3%$ZEH;ETB]$O2#XN"PFH7Q91U((QNLW[5^2O[A(EH%98@%)9LW
M5C9K#Z):!^_6(01Y"$1'A<;HDT.+D^7GEH6/E:<%V('  X1@R)5VV1S;P.9:
M"-2;;V3 U56*^"=*GB<)+!8*DC!DXT:0K*KV'M<=BTH19&8FX59MGTJSJD-^
MR@Z95XLIM2B+QX1*ERNAI.[X*?18^HR2WVE'9\V.(-]KFH;K;$V,7Y/7US&.
M'8JJY/E-7U@MM7U!*-,>&AWPC-<2U6&6YJ4U@0/+A23UR/ 8K80'6P&1+P'(
M&^1A'_,GL7+'[U)--=FJ%:Z[]2Q\5BI84FZ4M*MEIJ""VBV/*T%1^4]Q(/%T
M0S/H-1F]=J01OW]D,+K]+C!2X7RJ,&YE#%3]2\F*:VW/4-PI9WC1SKO4T=MM
M@"#D%&^H%62U2]V>W(8]A4 NV+H"I?S&RJI00@!$;) C 5]FVF)8KXI=L313
MSER0#8!9X"RO9?<WJGAU_F[/.G?M'YVNQ&$0@0I>1A@4_.T#5UMY!IHVH+AE
MO<?W+F@I;#[/,8Z88KH//O%H0;[PO4N6$AB;&_D(RUC'!/L QE_4(ME,]/KH
M&8$6VLYE"*$H6BVU:KBUWJ96TFMA/1?E9I2!S\A:$#U%T)2/3W8U#]#GB6KS
M)BA@%2E%H"8%3!0K!0L\IUGK( Z,L>8F/VQDV2I=506&X[F\Z:K^R\I:PK32
M.FT0G0PH!^/K:$W!Z/AB0:L=.#N.#8*1M587[HKK0/2C%$0KE%0GHNG!#?E>
M9&F*"=I.X4.&1T"E/]XCJN=0SJZ=4R'](Z;X+?/@IO.J#NHC=TEF7;%LP60>
MIW8@25H_D>OQ=_V7[)5"#FUD4TO4M?AN&V'XTGF%@R!LU,Q[JIB6K.$J*50"
M1UA%]>#T=#7=&BOHV9@+7:$N2DR)VCVM^?%/F)-IN77^A@3(?^FH(9F^811M
M-I-#A"*AO_I(1B)YO$7.U=+Y;MJQTZIF1TU/!^[[.>4'S?,R)5?(>0&?UB.M
MC7G[YWMMFY'\=E>)$PZK3&7RI4(=CH5[,1DD$K*_:@-;\JK*E%% B"/P,:7^
MBO;/C[ #'=V4FBG49A5#8::B<MK=[M&EKEE,]S]"8J=2=$4[I7L9XQJ9T4N5
M'!X5<FXGY&HF_AH+/UB3Z!(+C!29B)5[!T)2EEJO&3"82V6YHC.^"_]@1&2Q
MVW[GJ-Q5+S"J]!?+.K65;!^3:Z^<['6%N*G- 3A$HP&S0EFC>0TV/-K%XI)U
MKI@RJY=<K4F2J4:9=1Q\4F$I*N0/U5](_H2BHZFR6-TCQL1W"1$K"AAU%A:2
M1876+UG4 U+\L54:3+ !DG57AGV*+!S4 W/*BJ8C5^I#)>;Q'.PV[M9N\_6/
M1; &[VVY;ZC?A0SG[O3DO#T_,$)R[A?3C>]VY#]K.O9>I26<RMX:AG?T$NA0
M5" :".9TB1JA-HRK\W4OSD-+6>7PV;5.6]Z'YN.-."P9S(!/& 4"+RYW4&6]
M75D5E@[IEN@,(JX]%-8?1L($R98%%C]1+J:RD4>K]?KF]M-\A6D!>Z;P:PO[
M\UWDHKR(87P61>^ %>58@/:.L+&T$H4,=WB)]2MEJK:8=&T", U"-">Y\3MP
MCJYG-<1 DV'I3-J(&D"MBZ'HS-^W!;\!3@SH0E:RTFAXR^_A6GS[^LTR:B)X
MA:[U+[<.@C/!J8TTWP264DL:M]/G$49+6F\#0XV$"*S(-H7I2._'32,W8EVL
M%5OS^HUH5"Y];SB5.B4<Y)9TGLKMIL/3%8W43),0^DT[ ]1Q=?D2)7+$PL\F
MNY<0>FFAQ\ R^FR=WD'[:?H![^<VUDL[YTOI* +/FX_@@A$NPKO*S4.MK1K+
ME&79ZSJ0RW]4$:M3%D[23!9A@NU##UB!-=^0%J*F3AGY\#O/$MP$TIH7]R32
MI\;($QKI5(_45NATG(@A]U(4%-5WQ59'&D=@2*S79CQH1-NQ1769%[KN_#U[
MA-YO?9-Z!GOU5#NB#^(Z_D-:X%?L!= &M%#D*JX5829:LTJ3EVZ 8E2IPJJQ
MUIL=Q^[54)P 5M882]8FL^<FAIVF)9800L_OY*:$0>]A"?K'_J2]?PV")T./
M)4P5W6VH.4_C/*P(<UH5"G/\=N]^&((OM-WO2\3G0S=EZ7JW1U>19NOJ$2)@
MP%B)45  V9IBR+=Y"'I2>JESQ58FT$JG@1&9849ZZ%EHKK_*PZC[0=_FZ<!^
M6,K#0>P#5U]K@:E.]E=%HQXOLDIB5K?8KEIWW1W*?EZDT64^Y4KE36=U-1UD
MK4V%6*<@&D4DL6H*A2]A::T+TS:*GSUYO3=N[!@35ND43:(ZCD1C?>-4Y(:?
M1-7'N-]QT*N[I0!H#8)46&=++ +7ZD5R_H_Q7EW%O;/:GAY&U.F\55'IE&X:
MPOJ*^L]MEUE;[V@<Z*[5]T3EX,(R"JVV<4!4A%GYE"SZ0R;/5'L2[LFJZV]*
M]X'\4FMWVK&4VO1K[[J>[_JB!N)RTW7DPLUEB:+]NK<S&C N.48D\YL5*S(7
M+;)+95KI[? UDVGLGF-[O9'MM,Z16?1.[MPJ@/3JI1L%=>7VK'J)]DUVNV]$
M$>_: ^TJ$-.L.V&N9<U-ITC4Q7 B6$W6!:0TZ+I=GF/;O9$SN'W==8E[%E^E
M)1HN29P7O]Q@]*)Y,+KJ@';MP2.5Z^Z:2K<C#RTH:0*L$1V2=3*0<N.IV ]%
MSFMJ6K\8X5G'WG=&1L(I]B<,<"N/#RT?'5!N V^[14!=S]F828US9*N@/"S1
M%$8YJLR^4SHA3C*CNJ=F[:FOU] VN0*"XE1PF,G!_O@,<R]^6?QV?7V]"U23
M%;O ?[&FX6.R6>FEO[\ AT629$4#3&FD0G@RLVU).%I*2Y$RD@YQI;:=C?%$
M#"^&3\)68&BMJIY!'F 9Q*NY+/!K])5%]6.D;%(!-:E WXN&UY.Y2^1\_!(X
M3D]VU5VB(+<IC=TG!LE6]L"JZQL:\PZEM<T-:^VK4S&4DLCZ.EY#N;MOR75C
MP(D:<*72#>JB,()TKUNK<-W#&A4H%"B,/J54TEE&EW^8_-WUJ<2D*#.9"Y,9
MNO&O6(9# 5:(D%CAZT(-@WSX#<;54T6!*?:VHS1T#XYI6!DF@A[5)BZ_I(GK
MO]!@39D#]?8NZ?I4SNRFYI!U27[EW>\:1MK&L(\OBA_P;\_L7^/ZC52MVG:V
M8K?2LB[6(?.:1/)<5 ND,F!-%-LVFAC?OO_H.Q76L%('2<QX55>CEN9$[7<W
MK *IJ*>MQR0*+;5:P:&4+5(<['5.DS)U=- 2ZF&^(.N/6.5S<,WUMZZYKYD@
MIU/#5TL>P,N79 ]I[6B&R8J>09=PWIK5D.IQE=T_MO9.?C_<WW%&5L'F6)1V
M5J47V)L".Y%_3*M6<,"JN=61!2*)#P@I!H6VIXEE58%&%HV)RK#555,%]- E
M#9!#J_DNS;2NY*;= 00#63Q5YS%W6:2:"4%UY:;F%!^S!(5*[FL5/ZB#R[6I
MI2V8RDH;75V!&D-=4[J2*HT@WZK]EJ#N[$@!]09[%HH>YOD,9ZV =V,T,EHN
M+*J0A'H.K1&$*"N$2*WY'4Q !192EI&,!E9S 6E[5L'$[^=&$-\ ,DHV OR&
M=3*70:#+U0LO-5RH4I:T]PCA2V?0-6L<:LB8%?9T) [EO68=+8]$?$]&4@ZY
MLY.;SJ18W6#L<Y8MDRUA<B?SS@4OE5#5"ZL["PQ[KA2Y&DG-?W=[(WF=6OB6
MEP2FOWN]?GU92%YUK3^R''S62O8:T;MBI*7 /CKVTB:!EA4\+*+J]F>8M=27
M;[$W2K]L;<(5V;%N*^)N5<&09L6.58@7F;%;JO-#W,#5UC9W-X_]ZKV$'[P'
M[J-581AV1TZ:^TC&D1.CXXQA*QST[&#0&_D#XRF4V:5)MM&^!;0:?W<H&K@L
M/WV_]BTZDW7R][ZO%*7=1G UR\I<G9!^S_;Z/6\8-#^L&VO@MV>YZ9!NA-"3
ME;!+"V^ I@G#EJ$E!-:^ ^H&:-^8\ XJFVEUN==I;:#/6FU;QN)[JS._@8)(
M667W[>[I[H_C+$O)6O<VRT. QJF2<?"4GN64OR;JZ]=W=(H_6H.H+L0.-J*D
MQ1JY<@V0[:K!T /:LSZ\W[-$G6IF.#5H@+IUY%+.-(Y8AX8T5WJ'KZ%C_^1T
MI=V=;%4[6-U%E!GIX(M"96^&,XP<Q#BO^U  "+V!W_-==P4VZE*74S5=21QC
MV5.]'3W2M]7Z8U!05G3 P7@2K4(RE?8K:6SSZ&B;>K/BN!-@F2UYAEX7.<:/
MXBN<4AFQ*<U<S \3G*2]4()SA16KB0Q/MH219'8KHF^-B"WI<6N=_8)?Y=D5
MU0?#[@:5+F=P[_Z , POVK( 8L/?B0BJHO2J89CVYHGORO(M"E?4>-3PP33'
MRDH'=4P265*6(GWF$D]EV5"CBD<BVJ;*O'LX@V3OG5& &$(&HX+)G,4R=2PO
MJ& ">72PI/((&,4/%A5;IJ+#Y#3)BQP!NI]C?!=\G%JCP%JGHH4*<OU%:0UW
M^_8/ I^;*[3(.11JWI%P44=_U[-_(*9$4^S5?@ XW\4%%37%T !A2UK,J!HM
M.AA$RRC5&(--L<F[R*T@@UKK15:67&0@(H[0B5:N%QF0HCTQ=6->9ETL&!(%
MSC4!58N")>;6%#Y Y\R\(] 0]@4^#9)US-$&+P^D7KR64K G]$P9"46"/NTJ
M(RL6<0'!\]E,)(R@)>L:UG^I-PWP8Z904%AOI5U1:C-(1)EH=)/F!/.?'"K6
ML)0KZLBYIS/T'ROA#RW=E2*+>E-)-99?!;0 Z=U7WX\10547='U0Y1;4*GYC
MN# O"D$U4<D6"*2F\?_8>]/EMK%L3?3_C>AW0/N>ZF-'0#0G39F5=4.6[4S7
ML6R5I:R,[(Z.$R (DBB3  L@)2N?_JYQ#P!(4;)LTFEUG:ZR)!+8P]IKK_'[
M3,R--M_D !.[EV>_GYGW<+H78[VD^"@*1$S*Q%(IU?<S,:;(G4!T"T8'-+Q>
M1]YZR"LV6A=<BXYC$*V:A"\*#SR7[R"*V/_NHX@/LIGWO)-M$&FUY\(UV14*
MP 9G=Q7+=$/8QH946--@:3SH2<J6X'6&_$@)-KI2T8#VTPI"B].@KZ&JW31Z
M" #+9(_]0J@-*J?T#F@(XW$WGN#V-NQ@:*JU[.VX-JR 6I%1S;WJ,5?%KR@1
MP6_&G"\K[Q&NP:\W!V>4N=+2N_&MUVYAP,2O+3%U/^9Q+5;TI5N-Y8)PD4^,
M_%VA#UR?D_&DE?@FJG:5&AQ+#"QCX)W+P8)*.1BE__3.1-BW:V)+W[S>5;];
M\R[%*C56+]PC)QCQSA$U*T3>^BBXB',P/N^V V:PBKI4VPAL[$->O5ER"BN(
M1;QWFY)\>9,9O8VND#3P'\MDD,1W+)#FMZR8!F_S(A\GE/ UOE-M]G?+TZ*0
M69"E.I4KB\R*N =^>4WY6/NP%_9[AQ51GT2@"8A8SJ\AJQ?MV:,5-A:0X=\]
MWO7FPK'._LJJ,7]D3PVOWL%AV-D_"/N'QJ.N%)(UJY*5]65W*"+Y:OI=("R=
M',RI2[\%2B)+KD.NKX"UHFP"UF@A95Y)'(.2GG!P6NXD[V_-@T[I08U=ZV2L
M$JQN!547/<B,X&/$!HULF7=$6?-2.[TEE0AZ.,TL:0^?DR*9@_43C<4R('A>
M59HM7A0&12MM(4%UX )1CBWS1*:Q)&J4AO+N.)K#<Q7/K*36<LQ]4$MRM7+.
M?.O5$HV)**/B]$4ROF%[OC:*8;Y$^]S$P&JO'^7Y FY<N<&],W)4Q5T,P;$?
M%V" EMH-HA".(PO)QHE:%) ]1T LA6O ,#[L=Y0.[BG<4KAEN!XQ*DX!2\6(
M&FB9;2$Y;(K(OL*FN:70<!7>^MU2-,[7UY:%3YSZ=(W=^7@P*FXK'HFFQ[LW
M%\@L?;R"Y[:/:/OXEV=$Y\X&,WZGARYXXU<ZFBM[)EEP3%]E5TDIE']>(X"U
MV05 Q%/V\,;Z8CH= ,:OK38"\/&IN@,K5H&AC3,3TJ5PEQ1.*>XI :O -B<&
M:Z5TR,%6?,2F]$'03EK> ,CJPZAY<X)4<U]D$. 9-<3*TSR.%EZO!^EH1,VA
M-L ?"8<W8Y0I9+6C-_$S/"N2JG]9K=@P5!V_F,]QZ'_/9-*)$=UHJ3*?+FW<
MVH)**RL1?;P)PY2A\W_Y#=M;LF5$8\X4'B+3)LKJX(SECYN)<3J6>H^^5U=?
MKP*SJQ(>I_*!.:+8+)SWH[VB#]V,)8H2 U+$X>RSK2)V=]3?H>;6(-D:Z3(R
MSUY,TF)H$%9]_++ZYA':ABNHM8^,)1)F57[H[!!"0V1+^!M:U I67Q\EUF93
M%D_ NNGTK3]N:SA OZ,<[U=ET%F.,4S<:[S\*.TT&)Z]Q$11+-T "FH..R4!
M>PH4+QRS;8PAZ^JCW+YI'(6E2 BI<"1T.=B(Q5J@H&@ ;C^U(AR7LAU&Y=$G
MN0>/"G.,GL1'>>0M%#V%R]$B3(V"23*;[\$-0YTZIR]>2E8XV]/C,5\6\[R\
M'P#]%O:T<W"/,JMF,M\5;@^UZ'-#M%++_#,%8SB+V,@@I\LW/JC-XP+,SF9#
M0;?R/WIAKR?V@E>+@U_>MY71-2OC>%^^Y5;JW&J:.%^JM ZZ=382:'<3JG<S
MXG1QUAEP^IG4X054B\!<%X;=%,8'IV9N*FB:*[ (BD>^L;+L*G2,B(KUP.9\
M21A8(A&5(<FU0Q8 _E9+N>:<=7* '$Z*: !^SQP[T05#V[T??.M,%Z!AX1["
M0*M88OC^U6]JOIN^@SS'_G>?Y]BJ-K^%H7V#JEF$8WL%)A 8E\D5PON%^@^P
M7,!0FQ=@%2T+1!4)#5O[5/H97/;VV^MN*6AC[H]6[R^54+Q[>[AO^HPX?)U,
MOJ93W3>A%UD&Q\>M_8VHZEU/GF8GS;1IYL\\OR8EY]R9S4\UC;&FRL!5JNA3
M()"P5:JHT!M-=&L':8='Y=LW:[^+7_A[4BRQMGU&7!O4=-D<*:@O,0DA1V#\
MS9]'-[>4V9KPA'<+:\2AORKB<&PB#C3&<J'%B/7'M,/^RL"%B4*H?7 ?63O%
M+WIENDV9!QI+N-\X(V/G'*B5 PL7<2=W-3A]GP'>7D+,XKUR0J988!ZE'*"Y
MSMT"8\F![&/I#'X"J<>PS=<&5AKUD<IJD<S$+( G&) .60*)ME8"-74AY"G8
MH/Z:R9,)1P_7><&!B)>,3&RB_Q2ZDUH5?;LI7Y4(E8\1BK\4:$7J:L6?.WT#
MO#B$TR!E>FZ*8(YF"GU WF)@:M9/M?[[=;;)?2PBWAO-I#9'K+YVC#9H].0?
MP#O?(FBP4-9VUP(7_H[:_9>H*'),DX+07*7YL@3Y49A.P<#GD,8I?+5$YED3
MR'@IP*ITZDX5,0X;!;$C",L5P0#CC!QL]"R7[J$QU_R>3M)D%+Q%)YD- 2U\
M,!&V]XCDC^5FEO/<D?)6\ &;.H-7HP*47AT<?C%AY!U^CX6*EZ<*?80ME" (
M67G8OW*"E_9N8+G4N.8#\QD2G5AKIF\W"Z<(TB0(0ABDD'K^S=4[/@X^IM-\
M7$1<O>PC[@F\H*D76,$JR6#36N;EERS[;7<A15\8_UG&A%;?+)V"A8$6BQ]C
MY/"0D^UX<X:#H;>+H&H2*XV#G,(PA%,''R<,DSCB.IJQ%MRCNN/(O@-G.[',
M(F:=:I.T$(._G?S\[M6'"\LJ02-;!5R+$(B=;TQ:*MFI#Z;0^)0+C;4T@"]K
MJI<]2_\HHDEZQSY_>MN*,@MIB?<^@H:M*5UUV,JX!-.4%TCUK(-Z6'F,5[*(
MYBAR$=#%*?T'&;:'-(Z :WXU!F6(0@V%&YEGJT-)!_H7-N;X:890G&JD<3QY
M-LYQ/#0.^J1 &=J/"'0J93G$&#;M@RM'GV+I):A'AB'!B[Q69BVY,8WZYUZM
M>I=>S3-%T\TYZ6R0E%S1WZ:6 1Z"7P'KP* 0.TT177-ETXVTX'.=%J*X-&R<
M1(R<D*OTT]JF?RD[EAC;+(E**IHFY'71W[ 1A+?>N$1(LU+:BG*\+^1L<TVX
M^0N5A7?0X:ML<@\<U&>V]/OSN46^5DS (M\WF1%)-H[&K!6P5,(P<6.V%7:2
M"#DH'U<RX46*B#QG_UO3TG*N;Z\@^M\-78G4\N,,YC]+1_$W#"&RG(QN2?IL
MMLQ /?-G8,OPWM-T$IJQ'Y,;R0^46N1<?[0]*8*TZ-M:0YRS58,;S7AE#Y5S
M3>7U_5$F2>FL8-A!::Y89HMT:CNC=35X6PWVK('!H<H74@W:THI8^N1J)7*T
M_4R'P]L'&D/8J)F,A?1*CU4 'AK4KT6Z6,!293F\*ZFW3[E+$.)/GI\8:5/%
MKQ?_ 8H(]2J>+IJIM&<XZ/Z+Z!,FY2^\M(R)%KE]6NY;6;4T_)Y]2@8#9.["
MB!Z@Z9"FH\+8UAC>Q]?#X[B;L,J78?L8<3H4I3(X1X;L1-MA.&UUN]]X>O%*
M_^GXBQ:Q,F40_>KPG;UUUG*8EC$WH'#:VF)3XFOF.7PN75-?\R<*5Q\\AJNW
MVR_GMH>OKLY'#6AO!B?,6KJ>KO6(X52CU_X#/; A2Q.NK>;1N%-#\?\.6ON;
M):+NF6)U<ZN5\JV-$JLX" T*-F=8]02M2;2Z#ZG4:+TF&KY%6HZBV'4IZ5W^
M3'$MP"0GP%\:P.'^JN'W#ZIOOG?$DN.ZW<97F;AN_UC?Y]Z/\[Q<[%7BFDT;
M?:^L\JD\]R6,I.:B@0/9M*A\E:U<5??P2A*\?[0?]@ZJ;0QT0PYQR8;\0><:
M,]W_W5:W?>S<H-5=ZK:.VL==C/ _7&PV*H?1OTTBXRZAV:9E%9@PKQ8<[F']
M*/5^\O7LH*)0X^EX3(XZZ3V!*9OF\4<;WQ">'E<BO#?OGI;RHF]K>W0B 3RZ
MI7;$4=YA0T5</2$G.W_+8TW-HRTC1.HI)^SNQ,A- 'QMS28-Q);7UC73;36V
MJ(7N6V1[M#*]U;/IK8W4G*T4-MA6S>INH[I>?9T+K5MM'MFL^':5U1!1.=:
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M65^XT%TY4P. =\MU7DPMA!WGS;32?Y2@88 % =3+6"5:JQ#!H)$_Y*I9P?G
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M3F]^"/[S,IW!HK]+KH,/.1B<_QD&]!L$^2G2D1[?](]$U8)W/ER)Q+!%[9#
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M2!F4BW#A_1N7]]'!6%]5XXNA+)IC.GX]/T&.6? RT6Y%2L[N"7)Y(NWC!,-
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M4E:/#N.=7V%L=S]#G[5Q__'9NY8M9Y^EU"C)8%;J>&=7JGL0]OO'NZ"<OI+
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M^F&O[P^'; ?$,TC4XS?ZQ0VXC9RXEEREGJWO?3B.$3$LPE@U>H[IP@_..AR
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M-<(VW$(A=NF1.9+^>XEWMYY5UI6P-$4B62.B#V\,/)@F55*#ROJ[(PW!MD#
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M*?%YD:+/*R-P>%C0^C.)8Q)$TP$7$9VVD+1P6<)T12V-PR)AJE$Q=X#I0-+
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M$<,/DMW(YWF21GP9XZEJ"/R7_%+.7K%UR22P+!2H9V:D+_Z-Q@&7?%BQ,R?
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M728V0(:5[%SWQUQZ:KZL="L$8(9#7=4B5J=9YE88/T2J-O ;VID09,)':<S
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MT+!L<@5/Y*=Y1*T03I5 B=ZZH;3;2*0(68P+(1R954\![[=Q7D@1LBW!M1@
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MHH&KC>*9B8# @Y\4\_G0Q[[;S!T,6.+Q4%CP+5MN[U/"-8[_7,-U6R"WB5O
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MGU2<2L2'Q#,8;R-8'?-VR5UHY6\\3?S>*% \2V)W\-;5EE8,_+ =:V!9< ?
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M8X5I)*PCLPC)OUIJ)Z,FQ3( #>8L=!UZJ*$Y@TZPW)IFT]8U$UTA7T3H$$L
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MK)"RS+),>@LI&\A;Z0!].TJ'IH:G8(J\WU9$H,YN9]<!@L.O5Y2WI$*6$_N
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MJVKC6P<C4PP-;#9(PDTO55X,R).B-;(]V9@G@X%4*X(<J.I8]SEN*$+9, A
MJ? B;1[B&;LH00XK#,_MJL"BI+$9W9W]-="19ELSRO^:21/E3YIT3RQE6A!Q
M!@K?##C(QM91RO2.>=EJ8.)<HBF,M_>,\;TN\YYX(85[G3.H<!<,CJ<2)]\/
M;!(&(73.9^WQ<BK?*4C='+"ZR4 *0%%*TB>%-L(S;?1Q-2G2L[OKN#6CA67A
M%NI9DS#*?6!BR?^.!"]\D4ZC_,IO_*0-"B?9KPZK$/05\9CQD<:MY'6@N.96
MP:3P6W#&YW%C,;Z&UAN%Q7 8L#BV$LL*J;:16R4!0 (,#(GMG"IZ3Q@R" PP
MWZL!0+H 3U>S-<&E@_R$@FM9@ 0/LOM">Z%^E1N]C.L$%53DC#9LVJ8#PDP=
M5$9E6:X4VF1U5=H DES*CC<BOB?J]:H_)0_:. 862#4#W@2L1NA,,AC6C 4$
MN,=T,);)C*)*JX%BDZA@YV&(C[E#CW'?A'&.P"V3L,D40G&%=G9C=C821#=%
M*Q'A)F0J>FY8Q#+TK1Q@BF0JD^'K\OQ ONT'E!+*BI*LYU[4FVM0Q#[=*03-
MV.YS/1\ARMR1G)QA;[EVW>(_3+7HJ1@H^NRX7: 0IC=;\LW/?RNR;G?Q=&,S
M)\W(OG)32,M]R2B* @5QH83\\BA-(L& XTOE&?P=]"@Q@%=E1=,NWX7NJBO0
MS/66:R# &%@TO?NVFV-,N%//'_!9L I4S;%J4RAI,;$_"F?(8/-NCQ0V=8U>
MS5_[VKP2(P'N3UM75")[N'LQA@Q6?'-/6ES;:.(OP3([AT@%8/*M(HRC=@("
M.2TES\<1S,;\%79*6&92FDEG/V/]O=;,J>B[18JOC<)Z(#75]Q6>]U-#3^L$
M4,_Q*<03@3HQB#PWDU-9BE%K5*H'3D)[$N<-C&'](AZSJ'/1F/#.FP* W4P@
M?F89)#F/5.-MES4UX2 4D??7$*B?K8)"#6[1[206%JZTT1LQQ] G!E8H)Y4L
M'@>;W#[<!@W<#U%A=P1I9FRI1XVR7& V!3;")^:50YSM6E)N\Y(O^?IN$+,E
M4L577LHA57S;+<CJ!W,-+&56\*K/92T$V %F+4;773T*:WD,_,'O4_]^9-?0
MN2GV&@$D&>W<(*LY. <R,Z*K1JEK4YI#KK!$"P]XZ<]+*.6+4^DQ3 C\\0.
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MV$<C^8W$@NY_CP5]=8Q26H9UV'(ZSLXR])5D211J(DN\UYP"\"3&3Z(JCSH
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M'X<[XHF OXM:3MNWX!$S;C)^"/'40Q20Z'NH!W2'Q_4C?":]G>3)>AJ!<8I
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MX-BLR][DV*Y.-I_K5_.4\K[8DY'+Q#Q.+V+<-! K6&-K;+IV\0F(XMC84U2
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MX :W@< -ZB+J,[/E!J0&EW!O6'%S'^F?Z:?08N0RWCQFR'>);J)R;)-Z<W
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MD((D- ESD7]/0IS/4X@.U33]MM9_3%HZDZ5TM&E6!E@.BL\&YD9I 6CG4&)
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M8/@Z3A*=;.XF$1<E24OF,V$8\R!!65Z%-,4%P]3\2)%D12$M<D;X7\Q5: 9
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M\0.NBZ'<6G?!A&G),85@4M77:J@ CB?:>KVD.MA4/:L"T!*6_?CD<O^M"?8
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M177O(MY%M_U*0]I$DKA8L0D;FUN%"QY%@U%D#YS N;5*LC4)9IF@9!P:X9=
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M3NCS_LG_')Y]/#XY/3SX=G)T=G385S$D?F7!SZSF=\_+ET^NXL]DDN$K15)
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M4BO#PO;ZU6B\7_C;&2?<B4<L'>-,8C=$8S&- M^W4QM,R"T666LS&D'V/"2
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M%(2E)\('.BDX5\)N=G%=(WKL="#I8\[RHFX0T8B0!'%(H.E4Y66D7-3'S?\
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M@_"KK+[6F%3-0C&[(_+G#2$)DPEC><TRMY0<3OBYR-[T.)D4:E&A0O7FV))
MD%<4))0AFC>W@\3]^I__GQNX[^:XMW \:;&8GDLA^58GF,F?N<=-?V.+V;SG
MACI,"HLFSVZ\ENC/DP.RG33]P?L;G<Y+8#T:4X1B;'<8E-"GO%<,3Q!,+F;A
M :'QJL*Q+?CGX\8JX, 2@>)LR/:*-Z_P!'#VO3;*\T/<-W49ZJ%HN>#YM&=(
M3*]U\*9GF(2>"?14IW*WX11/P(G;GQ]P7_,#VX?=J>&@C[Z<'9X<GIX=?_R\
M_V7_U\//AU_.]K]\.#[K@8=6O[6./UK-KPGU\_CLM\.34^OH"WP!/SK:_V2=
MG>Q_.5T+!.@-\)DM;%>!EDE9Y+E"*V^P-,E<NPFI1D<FV\@Q>DK4_<>S2UA-
M.3.PK'0H2%0<UV9V7J+=DTB4_X[!1\7142B8**<-]Q>C"2^P%(17("(%SI3H
MC%3@V"2CR+IKQM8Z]I_T_$1"BEL!BFZB,$M ]4;(#>3H72;+F7@+'53=7[QN
MW;RO$(]@2TM0;G42X+*#A&:S"UUE2(XRI7TZX/*#GOT9B##Z-8X)5I#;YCRX
M9O"L& LG>HQT8%OVJL+_[WYD+WWD1/2F]X0^$NI-#G<3.M98ZL"2J!(Z[6 ,
M_!(CP#!M5@G[?.D[\_0VE>\#VLI%/DV2BK*?SZH<Y,J$FVCH'>Q_37%QR2I1
M4M#,C$!/V_J$SS\?R.I8Q6K@]N2PS:+>F*V&@Z>\!GK [=^HE0W5IK?:;1'^
M7#Q6CM&3XD/:+'JDQ/+\CMXW5@,,1 $O-2+2M0=LRM(<WJ'!C,;Y$[*UD0R6
M@46Q9QF2P2=,&6%.XVO+5DAXG8N\#;!]TU(0QV=1$]SCI.:%#H_)6F;I)NI?
M-^,45M^T-G9W9=W%2OXP=EN50M=BQIB<8[+BU&^:&M!:4NO MXU'/O_C\T/9
M [QW_/!TSO,I"*GSP8IW7LD%\.SA,N7K^RT3?ZO38A4/=-]H,^3?LXHNY=^-
MY.%&ZK57$GV+PA[$ ,VF$]D3( ".QQ"G!&<-)%4096.@=Q$72$T$S+E>2G\>
M.Y6,R(^')Q88FU_.-,+\T2E\L8DQ)1@M(AV=8:DAU1\+^A'UFI7FWO;0AYR:
M,68+'#."G\!92__V% Z5FC6.ILEP8!5EHM". \>VWB^J2G R.*I@T'A_J1<S
MM>BE3 ^^!*5[VBMOI=7J"8;CT*6KTK_\&>[V5^MC4>+TUM^! <L%F87OT9RK
M@1'+8C&)<V;]/CJPO/>1J OX-LV-6@ *5*.1N=?9E^64Z0$)<00C*N"R,ODN
M^ 8O$2'P,QP[VZAH8S,<V8ZC-\)^PIV87[1W O.3_RBK[_"O?Z!_:/M[3C!R
M=HEOM!=V</P%6.7@;',NF"R>I91Z9[*GE,BD93#)@+$743.J9NP(ZZZ<%H;-
MW]RLZTLUDPGD?!HQB(#0.>\L=@EOUW"\,M6W\S+K2+(DYDEJAQY/?)_[/$I8
MR!*XC(]<[L5;C$JUMBH2I*RCK\9$&0%S(;L]I7^HC,]) V4AJZ6TGZD@K%MS
M<O Z61:/S0*R-Z0):JQ_1LUS Q:^I*(4A_FQP[(13YGC1W$6.2DP6L"3\9C9
M;/S >;OKX*ZUE:2(EE-I);WRV-/PV(^DH6S@GC >)V/?=OUX'$=.$OBN-QJQ
MQ,T2?[R]/.2MDX>Z8\]Z&*B?/0:W-EB]\LRN\0QG?I2-DS"(X\1WPS%+O=CU
M?6\\=FS/3[882-=?)\\P<+^GYYUDL>2<)@6@T,B0$6H#T[U/$<GJ,(?82!2,
MJ=DM@]8,$S-HJ8.K7>\)7*$I;Q(;-T9B'\>BO_(I0<5]X)>\*&?FA+;W:AZJ
M8EGC-W4'O^:F<:C]UW^@X9&BRU(G;/[!664=]N=K.D)A4R#$NY&<]UZ3\\NG
MN:H?<T=E?9"Z-@OB(!GQT(_341A'G&?)V(WBR.?9%MM'P;;(^A9ZL=,GIP>-
MW"7)_H_/=Q+6G63$$]A2]Q#4W0)P:[LD]ZLY=V<6!X<G&V5)PL=Q[*=@UV5L
M'/E!-@YBU[-3=WM9?+1.%M\_Y]/D>LD'PN)8A:]$G+D__'7X=?CG_:+(*2OY
M:U'&.!-8-(.)>,%)29G*&3*>_F:]_'L'=EUF\1^;?Q^2IS@H9WG3)4X82'W)
M!AIM?,GR@D1$.>W-QI\>?M@_P7(>,29P;OUE\=>KJZMAS5-6#9-R@J7+NY1(
M6BH4/#W^>/A_OAZ>G)W>4"%XBB6"\F<[5FW^A4T$,1S^@7.U-U=KWB2>5$:J
MOW(.B_W$;%GJ'V4T]E) HO(9E4?@SU%V9CEU(=6JM0AQ';$ >]"@+E2(&R7G
M1C;RBPK5&G1SA@U-\(2!J -O%>XUWR%<BF)N@;#_Y<@*G#W'=CNU+%9*DD;>
M3A=>#WJJ]%87Z:%,AJVH:7I"!E)2U<<KH7F>4_6$JKU612D]NZ&W@%:D]H;@
M7S1,7Z=B\Y&YP5O2(2VO["&DQ$2J$RM:RB(76J_96+T%M2QA[-O>19I+G,+_
M*0FIJ8+O?V5Q#,I39.__A]4YT&&%U49R"#2R485= >(7_P W[5QJTX$HZ-<S
M9F4-!5G,,RQC2:@N"'$+I^>-SLAR+(RA)@SJ7C#I$J%%2%^7S>1F/%$Z^FGS
M:4,#5$-&;*[JD,3S1"8!7QFG-O8<V&[)M"-9 K5YN?94M$,$ .2,Y&#T[E^3
MJ#2IJJ\.32.U-;7 $\ZF<FHT_OEM>#JT3IOFC?UDKOI,%"E*!"BT!1#(KU9U
M0'IF$+78",''TG)F(LL>'NBNE:^"U-62]AL2/$8#CB8UO*<2OS>B[D86W#P3
M=MCS&!'[WSX<G5D'QY\_'YV='1Y:1U\^'I]\WL?6@*=]BZ=DFGUD?P,/_. "
MC'Q>;<X>2,0"5E7F=]>;=^<*W53R I:K@OB5GLJ^-..?F,Z>\H1P!PR8Z\X&
M;.:@[EOB*80/"CQ]8?<@4:3]Q@I0;M9[AN A5* 'VA..#+>S@D-[<X %T**'
M]/?\$K]]CVFSRSS)!]B!*_ 42E'=)(_8D)/RL >R,;SU<R7QY%7:;BBN<2 S
MUL<J($>1 $&X'EY-A,>4\HP@BD'.HOGG[CF.O8%2ZT/@@U7[J[9?-)<(6U7W
MN"BOL)'+LPJ; 6<H\JEF6/0^SY2-WF7+/C-K(*R.G/JDQ<5D_RJ+ X^!%=?_
MEBAE7!JDC1U$5F=%RJ??C*,J:/T(IOO#SV5TP< OQ%<$RPD>@H'/OO=L(<ZN
MVB$JLYXJCQEG,. B:)(9F/>P65.. [LQ!T9@Q7K9PD:[:3KV"P%2]%]S,1M%
M >C*A0M9- J,,"&R5;CJ"!BQ*#)$L$%XYF;L7AXC_FLN(# JKH8#XX"$RYSK
MV!RRRGEE8#/?368TG\K&"V(K*O67O->(!S4&Y9+WLMH[Q*FF+F:YI/H:7"^"
MJ>CR\=)/NXM%623]+C*V)>A(8PUCRW.[=Z,&<9.H:1+4KD%/)/%7BAIZ V)/
MH-]=(NNT]_%?H%+S3 TNTTV"C5J3D"D@!TGM-J@42\]\)Q=\P^WO=-_NYNC=
ME,^1HX[Z2 U=%'S<,C%UT897DXLXX%IG=OI?M26NZ5--V^^6Y?B[]CG2 ^1N
MS1?@H"EL3AD,D:0@AAG6JH>1H)J:KDU8?S+OQ%#?=3OY]?M=@04U+W@LHV&-
M3B'0P38KJC?O;N)@A>KG<]6:7Q7735ZNV1[93]0B4/SP.V^ACTHC0APO+*D@
M%VJ%R='PCC3IP4)L-2+OSY#0\C^>SQB_#_R&M T.#8,"-N P70C6V(2AW0^)
MVC6+UV]G4L=68Y:+%FXP]64<@&I^)%3HUP9:\!2#<HN)3B?MIY=YC2"BGSX=
M:'S26T&WY%TZ*.]#?7>!GE&3PBJOIE8BGT:1T[+Z+F)@0,D('0J/BMGTNV%S
MDF<@%G:-U[($-9@&ND")3OC?,S$Q7(6G98!%S[FI93,H<*X:FS 0_7:N[80H
MXD0M56<GJ?F-HMN'NNGS=YR!\940ZI$%]T26BF3QKR=2BN2RM<IZD\;,^K5B
M=5V5)6+ER@6]O?L&-U<O(>EG6%PI>P.%..:@Y@C!__QZH+=:3.PA72+[OY25
M )_!QI^K[")+0%\*UU9(.9HW(';&> FZ))5=DPLP[#G+C+I-\>('IX>_6 ??
M3O;?B@,VV^'1LQ =5FV(V6^G/X>!K8Y>@O4-<;"0F**->@]?MZ$M/+[Q\K'-
M*'^)9HAKRS[[O 7DTLC0@;2T\N):_D!-"LS_(+&8J.H*-"8H>ENC^ 9O%\S2
M]!SE[C2MZ3:7Z'RKGU%+<)V ON*%$MJI^/&PN^!D4554O*?>779=*MQWQ0#4
M=DLN^WXQS^>+5/7T"0>,=AX?O'_TV?KZZ0!/C?.IF+RJQ[[0Q(L%[*GU=_"N
M,$NQ)=C2K7##!J0HG(MXMI*@!^5>9@C14SY%0E0B%,CW_<>O,E!\4 XIMR"F
M4.P)=''L'\98,9QW<V^TNEJDJ<#&3=<9#QSI4-PN-^UM.?*E->8+:RW18^(6
M51,9*)-U.4,[)A<]C4E5UO6>\,4$A>*$9_C69,^ZM5Q:"L=$?S5'-/? MF]8
MR4 0N/+")]1X2>.XKO<(>!U]BVJ^MYC5<C1;>04/:0EN.<B#WDF]CA3@M3%_
M@WQ?8+H:[EEF\RNPW+4QGERC620BZ=?DP\QY<C&PXKP4_TA,9DCS<Y*3%YP5
M^,:RC1E3,R3Q%1QOKE(YJ5$ET;Q%:]MRV>'>0T:JUL)0Q0>@_9A9SV%=PKVQ
M(%W)<"0C"="B%.I44P>^TQ1<W_/K5J@&-[1->B"CZ<4^?7H/+X$%*0V2XF\<
M'/PK[+.E%,#\NGG"0/0U-BD2ZCV3#X^9>"U4Q<(WG%L+=9-<^HH(#UDNZB8O
M"J)\,1$"KISE24TG34 $Y@P[(7CU1<A/Z(WHU^TX?%IS"#=@2\1:-S*Z(<FF
M'J_@GZ?UHE H:.IXEN8#$LR\_!"H'DT?!$-7V&(2:[Z<2;P")B>5*GQZ&BZ(
M@(TH.W2,0A'5X:*"*X4^0O %UK'/6LO.M9-U55&XTG"@T'7'P.&<ULH:G-&"
M@8=YH7'<F@2=R/4R-41(H"N2;2%':7TTYEV"B8&;I/\*.TLC/ NJJU16]@<)
M@#!0PHQ<%_&Z>K.04;XLL/>=R3Y\9IV5%3R_E/JC>QQM[E9(=P25+\;/8ZYO
M?W8!#HFP!?9A$[J+;6Q:C7BQ/X'GU2P55I8:[B:M8U]8QSBY4)9X"  _.-7<
MF%R)PRH0!.)S/J6$.D)(S/#CWU@UPZF:[56@%KS$66:&U@/!TK;99E@#E=/8
M#&3]7(,'RVT:B/ %L,"_I=$FSC\UD&N-J)9JYS,B"W#;I94)(0DR,[D *4_R
M;A^C#[0AV*%OR$@\LZ]E/3^O6(ICG.#D9T4Y843F+2VI6X@:B?NIG*8E>8YE
M2;F/0^!*H,)$L,_7$H,(>/ZGB7: M5_46M\G=F7<UQ#A", A]NI%H/X%K\'L
MC>='N]$N75&PH=3H' 'R".T(K(A$S7*?3+B:2"OMF;N5? EQB] ]=(NT-1JW
M^^H@.)&?IQ*3#L4V!RN;S)KE^![-$6K7;% -QA;GPD^,VJ<#"2U]J"9R;JC8
MYZD/7"5D5+$,UGO1Y('K)JROWIAPF\$:00< QP2+<(<[] ?Z#V_HFG]X;]RW
MYM^^]F&:SP+S!R.+\'O4GR$NHLEQBQ$ZC4,FTLMH"B%UR:67 O[/6#:I#GT7
M,3";I[* $MT2J_.<[27)KQ7?VY>I&U*AB?)!ONH(_N:J:?I2,(KG=2IF9J[:
MR&4KE"<QU%N1\K2<[HETBC9P6OBC^71EE4U3JH-58T]B(SS7L1XJ:;DOI:4$
M9[ ^<GCA-R O#S#J"3;=VR<]W;LZ>>)@<3&[6MYHK:HEZ2JJ6LI5V5PLVI!E
M"JKI!J$RD2*O)6 2.S]'?Q'1[/' 9BRG N\9NZ8?(EA2H3/)2T^DH;&)/."!
M9H0[8JD2'RW!J=Z]>/JYH&'<GRQA2=ZCO4MT=SVNN:LZC]_8 PO_[^T[V<L5
MCU([2-W091'S[7 4VB[WW(1'W&=)Y#^PE\L#!>?]:443E;2BR7, 6]BB(O'V
MXM1OA,Q8\:.&CVYMZ<+U^,^_GN5&L)NJ7E>)F+OV^"F/Z88<TJJFJ2>$LWOC
MO!5X=K<V8&WL8-2/*NU_[>CQV9L\OE;_W-8(@1['&;]W;82Y\$+X?T&PB;,5
M=@'JO*<\+'<'>&T[S^/G,/*W>=?N(J&V=F]=+]I1\;$AP;!'A1A8%O#$ L+;
M>@&Q_AW?V][-V%;+Y/8MVTYVWE8)><;^>')6][>>U;?U-'YVQMN\:3MM"MQN
M9&VGY-B (8!];P3=\M22(=AZR;"-&FW+.7X;MVP[65G]2!4B[)0([9]+0L/
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M"H:AVP>(^=E%A0B3% [H](OBO6L.[+.8=S#L&P0)"N@T,ENT[\M"GR]'$LL
M"4< T;NNOQQ#D(MZ%G #'8@Q00@VSIOW[_GJ[0#Z<'1R>'!V?')J?=[_AW5R
M^+_?#D_/K,^'AV='7W[=UNZY?: [A1[7I4?,_B'M<HF6!D>6FS]Z$*0=WJ,+
M^0#$GA".B@EQVGX(11)A/:@6,'@W%\RG?U_)W&Q#(1W<!^0,C+1A9DAJ%^'X
M31-PX7 )=$.U%P/]Q!FQ:S[#(B954Z$>*T/X&$>#UY[QBI[6I'[Q9;>Z<7).
MND7VAH('C.'%*ZK=PO7+UZR7CT,T5\9<8,_JG#E\*$^OU:/?/:ZZN3X%GQP[
MTWHA6[KH'>O>R@>-%&H: 4_/3KX=G'T[.;3VOWRP]K^=_79\<G3VCTX_G71W
M7U);'4^C:.2/F#_BCI\E6<0Y3]F(9:,L"4;QFL*E:T48O)%B0-Y* (%M5X4M
M0'2QU7<%R3(FF8 XP%I*U"H5YPWD-YHXAD"0[$^=6P/*U\"U5Q<@)<0=J00F
MN\:KS/Q*<SO3FGJ3OVU,H'?P)_Q]L@#N"49VT&RFE'02V>AT7B;?%:X1_KJF
M*^6ECKV_Y[V)W[YQWDH;JVO:"/3R-_GE6W)J6(-^WD+H ^UUOLA%ODT$R;N&
MG<S]+-=L&SA< A])U=,M"B78K^%$\344DE<'R N1Q.NE#;@9S>OY\(GO2VDX
MD75"".,W:2D=T"BNX2YSK+SB T%MF4)H-^QC)BP,0:.(@B2>(.]W@1VRTMXQ
M*JC(T)?#*73\Q"A9X7_,4(347)H]0^O(R& **P,1X >W//H7(F70JTE3AT;W
MS@4<']!  X!O+$5BZ!OH^&;]E_Y61K(+^B65.*N?(2,ITD1CL3(?BU764X+7
MFI3H $EY)AUXV=XF2L):6('-#M0Y:"9F^%J22<UWDW!=8$S,D"%J"DP]V]L.
MS'>%!]9EJY6^?\'M%5.K/>>2/AAV,=6R;-8X^S9Z8D*LEXL2W:5%+:>-99T=
M4) LX-6Q/#RB%@)(7Z7N._P9B2CAR6*=^R53!$NO\<OCV7U'+97 XY&;NMSS
M_,Q/6!*"P'#M$?<2GZ7N*'Z,I1)XP^ Q$6HGO+.EDZ\3(91-A9JBPG/I#O3!
M-!G%I^UJ]EXJW;1EM*,$#-3*HHRE+!K;OFW'S/6#B+G9.!S;L9L\J@9\G02\
M5@JFT)J$-Q-@;QCFPD\E'9L-$S2.!9U;@XI[YCUVZLTES%V.T&(XW"I)*K!F
M#6 T*K1^I?H'IA4YB['=>Q0Z'OB9+'2=A(VB49"FGA=$CZK\6RO5KY7LM87:
M *<UQ@1:Q:RX_G?'KD!27CD,5<'I,0N3]>E<E J!><$+773!_Y!=%@9S4-S:
MF%G9: ^RC2HB2FGYF'=NW]"\2\*FYN3+F'<WP")S)YDW;;(LKY>:.&[!FVN;
MQ+W6:LM()I.REJ6#J8XN-G"JK_S_,/YWLB!QO= =!8'G)UD0>V-W',1C+^61
M[42/"C ]'_\CQU]NVE*[%6X5-=>VSA'8F2HG[[7*Z055.<6A%X9AYJ2V-_(C
MVV;!:,0<QOTQC\<!L[=3'"V9(QN73=VHJ(Z\;'T*N1W-#.C(>N.93?!2134Q
M!SDMYP-S-JYNW)9A(+ SP,1!EA!@?/7*F.C  ..EY@4%3=4J(C##[N2O-P"J
ME&E5?S6;B3?""/^BD,9B"@9/*0#Y]0,$SBT-N<?34[TI1OT#1:L7<9VG.:'Y
MMX+19&#%-#%,A5\SQ$41'7YD3,G8JO4&BR70EL)D A8*&8'>;I"^$S/OM.]^
M&YX.S0$,^&-]-6TK%=RU\LX5)])]VPVFW_:"0PLG(Y]C83)N&' 0EB3#>R\-
M1=7CC[/\#XRE3-!TKI51K>&$9;H *Y]ELH'FDUIOC'FK/.,5%J>8%[Z5R/9Y
MTW;2>+'J;;1Y#M39O#Z:#7!?JJN>RK\6S21ZJ[XH%T6*QTA=*M.B,S]5P3,;
M!"E#X*(<(>%([%W:V9Z$Q)?2ZO*P#-[C#G U.J/SCG1TY!3(V=>8%Q-\(V=P
MZ+9J<2HJ329GY!F9,G$N OHAGP _LBFGXE!UCK3_B'""W4)YU:Z84&$/%=20
M;X#E$;1\#0>&HF#:EBU/< @[JN!3-\K<C,<.!Z4^BH+("UPG\U@\B@/.'Q<F
MWM+A9#<EM/<;P$0DI!-.E27T9\,;GX6&VBW-O9+M#UG#+"ORD(*!9#GK##-\
M6!IC:MNAA>58J^XB1VV#'"\O56$A;2PE*TDB&T4SS<A+.:,*#AV1*[!&Q]#;
M"6(:R9 '6_GHQ0QE.?Q4%CW1CU>4C6V/*#[3VX!;!Y9"85VR!!U7,<VJ4U9\
M;0)]"@T#>G5Z7L^II'A*6.0"AE_<56PLW1=W7]S[VLHS63Q%]'V1SY;W$PR2
M0H24E;!O3D3K^J%U).JHKB[XE%^2(E?/$(_F?U!!1>=-Y'0O/A&S4%J&I"Y=
MQ<N%"4F5JU9=6D6)V51,'_]K45:+B;P%1;-%PG1[CO9T0>VM/7#GQM;?4! @
M3[I39")QQ0J)?'D[2^,$=KDW%L8N:4^M*;Q89V;[4GU%:X![M^8"O7T+85B
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MO#Y8=(%%EV3&+K%TY4P<VE2-W2?7\?H>X1#M:W^$+41:XW^/7'AP[#N;Z 3
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M 'N ?65L<P [@)U#VQM@"[ MOVW=\Z;8 =#&@W9O@,H*U%+:T !O@'?I;&4
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M]!4C=^'XQT 5L<8BU30=(A 0@>"1OHG8JSUI>K'LS6!CFEI=@SQ[-HU7" *
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MU6.,Q=#R<#H^;<+KGSOX^N<FP#8;&IR FM'YIBS"$,J;2D,0'LN;^!0<(\T
M_,"Q=YLSS#5RC1%4A53$C6!O,.-?P4+PK/B \1EU>LW]>*[/]C9R+,-Z=ND6
M8 _8Z5/GZ-A%JR?B5CV%WPSCN^)F?%=.%MX5/R@2U!!5IC"/A9'FA])[^;F2
MV%3%A"LWQS#]X/I-:DQO9+N,4WZF,YMUQI&Y>VN8"P^/8<F?W99!&AV3C87T
MDQ*8'L6EG]#:(U66-5FM:Q'I)]'N2JBMF7)8ZKD>D079**#M0-OQKNW.\N2.
M4X*E\.5 "<8P8]\%_&'K(DUMV+Q^N&M+E;;S^CW?+1#2OQ>N9TS><MKM=XH%
M-!H%N1AT3Q?+]LC=?AJ'Y6_P\NP@4Y@CQULF;A J^%74B)!%F!@6LD8&N<7U
MR <SXGNZ'PX.^]:?VW\<.QX1X[KYC)&)D4,Q/UWZP<0M]T=K^7>(^V  ?WA'
M+AFF'^Q_ZWO03XMJ"3-(E_ OAY]<?+X3+H7Z[D!'CO=&;^;H&5\.'8S^O$03
MTIDK9'Y';^X66W^>.LO;0[4>J N1*(>]$?5U/;T2JA11_,>G4$2T6CO0('\3
M_7_V54MXX4+X^#X\5K^&O_P0]"R\N(. [=[O<FZ;V#'2#F:XZ,254#A#VQQG
M H?.5^&FU>VVKCM]X:;W^'"84(QV EECP?!<P5T,76-L(,? [^T3=5!#[M,_
MR0C$*8^H,4"^;7'3Z_9[]YW;UJ!]VQ^0_WYM=P?]WMW-KZWNEW:_TVW_[[?.
MX ]R_T?T6<A@X#8;(*Q;(/3NA+ -0J<K!*W8'M#=26S-Y*,YN9]WM15+1 O/
M7G[@@RSX)% 8U%S!$8E;FS2/%O>9,V0^P+Y!%B)XMH1;VS21XY)9DLR+]L(E
MB'\7X9',W1-<M)T2^>F)ML<)#%M])4CL#&3M&[8C;)JA*;GZFUJ'R[\C1G@_
MZ4\(!ED(TOZV1;4))HJ_'1"O)Y^8)F^9;[N]B0CL;UX^%.*/V* D:(NL'[GP
MM_W&Q)9\; ..77B,>;_\SON3;+"3R#?8>/\AZZL@RONNG'"#Y@8]&X/.;','
MSXS%+)&#L=&WG&1_=L ;X,@R' ?$@G<7SIO0]^S1GX!!P&#^&'S$Y)<7+$P<
M>Q;4?5P.D8N)9D1O- H@> ZRW"!FE6Q_6( H0#1E-4D0:"(_:NP$< 4@ A#S
M!V)K-%K,%J8?,!WCB3$R/  B +$ C4C/]@/H ?3RA]YY9P< ' &.A6M"-GL2
M5->7G451.=F;S3TQB+N5$)%7T#9//N?:H:)T)@PH#"@,* PH#"@,* PH#&A5
M!S0C(WE=S$@LY-3RY#?>S.C69M?(1-8("\C?L^S_(6N!G#=!(GT4$^X7M26:
M4X"SE\N7]YXW[[8PBP8E1@M#]15GB_JHFHOZB2/[7C&%(DF:7)>:\L:Q57[I
MA"2)=5G3]<96C45#5%59$S5)WOU8T46UT8@X0"\X(WZ_H$)JTC**)WHCO8_N
M#FA;-)N\-PF^TGHUW-7ECNLN\#A,R/F*9T.:7GCV<5:R5FNJ20^PSH$9V<^T
MH%_VVP'ZY73]PM;()M)V346O*YDIJF6JEI]!Z)ZNJ?Z#'7N,W.G%Y\L(_50<
M?D"=Y3V*K).N3.HL1W-)(9HHHC(_'2T4)NOU)KX:\O/T'H(TO3-4TJ[Q5*LW
MP'8"90/*AGUEHS::S7KFRJ;].IHBZQG?&I,)=K UPF[/VDC*3$WU*(D/YLJ!
M,J!X0/%$-)!AQ?/N%ANI:1Y5TL1&/3-GZQ%[B A_M85'6@IFO2.'6I,;"F>Z
MABWB)-N3XVSB@(XL7M1ETI'YJ4A9;#:;$=L3I:,BPX\V3N@9V+WO%G;([0_$
M-[2\]!Q"M5:OBYPI2S#,0.F</I#\*AU9KF>G=+JVM9'ZWUEF_J>F::2:JH('
M"(H&% W[BD:IRXI\K*))PQJI'W%^>P[PYBKIJUCUQ5]VX<GTY3/O$ 0-@@9!
M@Z!!T"!H$#0(&@0-@@9!@Z!!T-QX^!4JZ^IB3S!M-Z>-9ZH9JLV3U!F'/)OU
MR)!GL['YL=B0ZJHB:0TE(JWNP;$GAD?/DWG_')F<"Z .EQ7P'AH%4G)&2K96
M>)*5#VF-AI83Z:&8")0$*(DL9FY%51MB/B3.I!8'YG&@:,DIJM;UIIHS1;.K
M8 '" F$9(FSR$I#W&1ND^FBBJFIU7=O[6-$TM2GM)0;5)5E2]C^.*QC)AO99
MEX_(>JW>U#DC/%M.&=2/@*)B45'%E6UDH:CR*^( U06J"U17V5573/%'%JHK
MXU*0M;Y2ZJ"K0%>!KBJ;KHJI'SE&5Z5L%C44%50-,ZHFEV29_1-/2I(;XQ^+
M(]C>%#L$G[.Y@Z?8<HT7+!ADWIYAX4>:.</HY)!$*IG.!2<=G93O9'!2$Y-.
M!HK8B)H,FJ*V%\Y7%467(L+Y/0J]FTWD=7S@0>9,Y#%+K,7K@8(949"M*3N)
M0B#LE\5&(12O3)X,J(0*JX0,9N6&HM4UK0C*EB0K!@@)A$R#D.N82:.NU,^+
MF<1N]YHCJW/;"K8IY[7C&%"]PE1/'!_-F>NQ^3)Y<#WK[!F%<6JSY:-!D*Y:
M*HE5C127&).]1LIQKU.]R;AN K,#.)XAQV,R2++G>.9;BXI ;" V7\36)%U2
MU:9&V!I1TW8Z)]-PS\LP3[*['P?4YK#0H)1SL0H>,O9F(1Y'$8 'P /@\3%D
M #P '@"/*3DSUR  '@ /@ ? 8V(4 7@ /  >'T/&512R5%5-O-4S57I?[L0+
M(I(>N2 B*;O)S9I&%S0BDINAVBA*E;$V/U::#6QEEB6L_FDT-25GME6F\ ?8
MR1 [LYBKZ#)^WNPI20T.<*.<W%AGK#4;\IG[B,36Q$ Y#+".?]8E+T_)EW:Q
MY2F<5Z;078#DO#9'A%(4T!#EU1!QY2(EJ139T!F-FBZ"S@"=P8W.8%9EQ%2?
M<%UX4L]K4T$PW!FB6+K3LE\(HI$;U-1L[I1GP(;*$LS+/ -"T0I320W,-0BR
M+ !X #P 'A.C", #X 'P^!@R !X #X#'E)R9:Q  #X 'P /@,3&* +SB@ =%
M*XG#O^U7[(P,%POV1/B.' =9GBL@:^S7L6#+]1/%!'M.?[BP6,K:2D[BA1PY
M>B%'WEWG/#K#450;C8AEGXXUHEGR^!8'/P=3POWGZ1)NO<GO(=B"14_F2F'V
M-NBKR9K$T"(2K)7FQ#"V5NN2%<7(JB9'9"H4QDDHF 'FIO2R8N;&L&!&:6B2
M*$<4S!3&+"BF =YPP!M=TE0IHB@:> .\ =X<XHW>B-I=N4#>I%7D F0!LA08
MN(BM "F,6CF>(P+1#*!=>G.4+*GUB -X"R-2ZC43,%4!9PJ=JI2ZK,@Y,*RJ
M4PN[50O<KRFRO'+(Y2(YCWD%B36H*D=KT.9^2:?2D/=496Z+E[T U:RO6NI*
M7G5OD%8$]#]_$F-H"541ZSH3FJ$R:Z>@0G(:11Y52/**];Q-"$63FTT6%$4F
M2UJQ1?6RS)EEP=8DQ.:^,\QH#^8:Q*Y#M S#-E51D]A21-GM/YE_1!:L$Z!S
MCG161;$A:Q$[QQ9!9WZ7_(&UP%K>HI*G9R:D3OT<4Q+(6(!.8)^"S#6(79VP
MFLFEIB9++-"Y!(D10%X@+W\3^JGY&XDU $S <2V$2O"D(4D_;'SIQXVWBK^9
MC%1"0EH2/:>ID7I.J>\;*8JF'Q%NV%MB\*-Z07/8RXJ _,U*TX6ME9^$Z0?U
M1M0AHL72L3*I"$!?ANB;XFRWMNJ;367_F(A,5_YSXF@.60"?E9JBY^4L !7+
M2<6EX2F)LJJRRZ(R+6$#E<I.I89:3[XY26Y4XG?Y&!A33L:D:0<>NUR;$^UR
M7+H%<Q 8F=H<)DEUB;DX9 D63H$XY21.NE/9<0N59[*OHE-/+L7F<S0>$U5U
M&33L2IZ_5JC^_,YV)I@(:\QV]7E:,LHT4\1VQMC9:*+@VJ8Q%FB[Q)I __V)
MF58?2"?)K!N)57E=BU3EJKJORE5B"S72+6V?C>*4^(HLO-2TYZ3N3V,G<W86
M:)DR:!D>E["):I+50A509=:K05>!KF)&5R4OU<_;)-I>L"]"(^5:HU\"2XFM
M>8_1HGW0FB70FBDJS54L72,*KU@7L)1Y%&!M@=XHM]ZH-W6E8+W!;]((J =0
M#V56#^17318+50]9)K> P@"%P4BK2Z,PM+JJ%ZHP2I#  UH"M$2YM4135K*)
MS@+!&4E+@I3#PE(.LU27K,TQ(&@0- @:! V"!D$7_C(0- @:! V"!D&#H*M7
M>*16JO#H&IG(&F$!N?3HRUL\\N/+@B*17HJRR$7ZV,D2RR\@2YHHC.W%T,1\
M1V13[4?2D*S:D/9#LFJS(49\+-?%C9K2,%(KBF)#$7<_UA1=;>B-_61<39/$
MAO9>?=*JU#3^J.+B2X^41DU4Q6+"P0EIR9Q5 .JE'.J%K4SL9!5(FJA($?LA
MI:-BJEI<!(H(%!'8.<GMG)A=0M-10GGL]JG5=+D)1@_H&M UK.L:M=%L1FR>
ME;*NR:Z69T?S2#49- ]HGBIJGL1%U&RH'E72Q$8]LW!.>N5 <;72BE(318E_
M7<.6F\Y'P33HR+.;#=;9^RHR;I_@=%1DCOO]2E)-;#;XUY5@EX'.*;O.D>5Z
M=CHG]:JJ/?]/DQ30,Z!G0,^PKF=B-HX^K&?24!%RK2Y59$D>*K12%2>D$(*@
M0= @:! T"!H$#8(&08.@0= @:! T"+K,%5K5*<?J8D\P;9?1XY]8B6\RUZ #
M ==,]ZK2]<B]JNJ-G>!H0U0D6=.E_7#G@V-/#.^>0"XBY"FM-J62"BAERG\_
M*RZ73UCA ',-2IF4;.4I)2PGTN6H[-HL2%^9XB)0$CF-(H]*(I.96].CRHZS
M('$FQ3DPCP-%2TY1PK)FWA0MT_DT0%@@; JG\R5EK*8U*?_DB$/[M+J^FRMT
M[)'T<84EV6B#K,M,I$:M4<\KI1%J2OP&@OX"_56<_HJK^LA"?^57 P(:#30:
M:+2*:K28FI(L-%K&%29K-=;0--!AH,- AU5$A\74JQRCPU*UHO2:)N5U7CMH
M(+^!Q6?B[)_X5)+$FX'M(5.PO2EV"#YG<P=/L>4:+U@PR'P^P\*/-"V'T3DC
MB52*/GRNZ#GBI"8FGB.:T7-$0]M;*U!5M:E$;/'9H]"[V41>QP<>I.5$'3/'
MW&( 4# C"K(U92=*NY'$AJQ%I-UD3_'*).& 2JBP2LAD5F[4E8@UN^PI6Y*4
M&R D$#(]0FI:D_S8V[5#"WA:SVB!/D>RY[@AK:+G%2<&'0 Z@!<=$+?(G8<.
MR"9EY[-<T&:PP'/@.;L\CUGZS9[G>6YO6E/%.I ?R,\=^0E%-;%>%XL@:-9[
M@1:T#R@P$AB9[G2L2;JDJDV-S+&I$C6EF:^@\U;2Y!F[NVA 10T+#4HY]ZG@
M(6-O>N)Q% %X #P 'A]#!L #X 'PF)(S<PT"X 'P '@ /"9&$8 'P /@\3%D
M7$4A2U4NQ%NA4*5WTTY\/ID8O5*BJWMKEYHB2U&U/%#&$Z7*6)L?*\T&'LMJ
MI$:]$5$!#14U*> 3V,D2.S.9J^J2'K%\#\4MP(WB7U8D-S2MJ8FBV(Q(0&TV
MY#/W[:"GTC:C]F"'.A.@8QGHF'@?'3;X&%O\Q67-Q_:FAJK,$ '9<C @'@.*
M(Z.*L9(4D6RHDGI-T1J@2D"5@"K)2)7$%*7Q7.ZRN3$IV"&@/$!Y-'=+:#1R
M@YJ:[Y&R]R#E5D=3==9"L0]3R2#,-0BR4P!X #P 'A.C", #X 'P^!@R !X
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M_-2WZ,)&9.AZ-'WU'>R8>+@,5'O]B33SW&=KA,XMSYU*[HS@?<Z3A-[29RL
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M&BRAEN2\A:*QFIRKM.LUN2,,>V'8[RG/8&:^TM"9,-OW;1D9N<-DM?4=YT)
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MVE76E)73^+4Q9I,@V)K.W=J%7HT=Z+4QVD,M.])4-/FGB<IX+1:QIWDN==6
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MR_1>?_:9W]&G"K<=3Y'&;."1&="XLAGCVA*252$=JO16:'GOWAH92M(<ZF^
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M[9P;,^I7@-:73I2R:/PD+L5ZST&$:GJL3:QNS1QS]E\2"T_!=8=:P.)E;=F
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MQ;'E+='D"L+(>%Y.\<P63ZHB['(K7?;O[OH?;QZDR_MO7R\*R,?#KQK3?*S
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M0#@DKD(3:6P1>X356&A"  >1AAQC9/@8;)6GB73M#N>^=,L__Y5X U_Z$HP
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MH/,J1D<I[)G/<QEKD<NX^?C/'<[1@5*GLWIA_+3(/_0+_:>W*QS1=9*A8B!
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M*!SW8XGZH(2_\\8L<KH!"3P>:QDR&V%'+:_K4%5?&\#'-E(T[&01^ M,$/_
M/DHTJ=6BG1#HV5Y_>Z#EYTF$0*N8,LEGB[Q@$8$?DSY@ _E!O*%%&^R@R>FY
M-JU.#\413YCRR)BR0#IE@+V<2@WF&TU6>0Q8]QS7MD:4WU+?+#!8GRQ*F;V@
M@% <BWYUSXKC\I"#(U,<67OT;E9Q([!#H" L%*$U'HR(?%@SK?&9(LMEKCO>
M'B9VI%%J^OSX*3'&AJF$/-:!'X7Q#1R*$\6_,P>)X"2:H8?)2DS-Q(S3\[!Q
M7,2TD[$4^NI(3XLC*?TD=Z*J8.K&,*)#53;F893"I=*J)_KFQU\OLT3&& B(
M^$-"B],P%,2G)C!F0]7=>#(6<LZ!!YNYD/Y@G <8EH=)_*&*Y!,V1LVC.?FH
MJU&+.0TANE#;!"!A$8 #0,8Y:$\N4ZS8#NAADBE."08IXH+<R^^UQQ:(6C..
M7S@GM&N8Y4\PPD17>U(JUX*D[>PSG#2V/#\(<3"42)Q*SG&>F1,C(YM;P$-]
M*7R-YTO)TF>/O$H?051C1C=6!=XXPW!$XRBFS(_7"<)$C(0/1TRS>R"S@"7/
M(J_8C)I"'STR#M#]IX"-?^'<-#["Q%"4[U1U+$IA;*\?KRE#"".9U*3" +9O
MT0YE8+Q8/.9&EY8[D2ATD_/)0XLU8JJV5!8VHJ5G$YX#SZ 5$FGTON@U[""3
MLU22W.I3M.1'L.'2<=_T9[@#W"C@*BM/3PQ0I)6>84NH%" PK@'?2]0BA/&4
M XQ4V#A/=],9#(U/[6V)U%Z1VBM2>T5JKTCM%:F]VZ?V;C.^2.3OIG]$_J[(
MWQ7YNQOG[PIO9M&OJMT<5Z9^<4!/8^065+4LO^#8LJD'<(;MEL&:QX1HVD.9
M9@*R/#E_0NPQ&L ^MF.9I]US7Q-??* W?HUN3'>VH!,0XYFT-(_6]UGW8VQ[
M#UB#_L?XCIS9TB!T:1=6;A]C,-)RH@90!,SS@#4NQX[;M!%X:L&)L;B7\1(2
MCA+6DS\YISOOT(:NYQ%_ANV=L1L0W3TLF@W:Q<"4'Y@!,]M=C+;#@5Z?JTI\
M' ^?+N6$W7^+;MCDZ HP[Z\L'^<W8NNKAU<?GA:Y=V[_>?40G7#*O4>"%QP!
MP#<?%J#_YECH'7K -:&WX'3\?>V]MF-.C"A59=;N*<I:B""_BFRRD0T[,=F;
MT>8U_<IZJLPF"8HXVR-Y<B'?DO<_A/=G+.33)>]3D;GR")6SGX<360=\WD*B
MHQAM<\T3]8MU$>ZU#+UE*.U=6^3J48M<?4T;P@0ZT$W'>RXM?5LS,I+HHS["
M+@L5Q)U;Z<@?VH6.1?6'M.LHLM1D0VQ9>C$]+%Q!]0HL]Z%GS?A,$-9I4(8%
M#H($5Y?I3A9F:3.,Y\CROQ@-&EO(JJ)OQ>P9W;FLMWF8/(R+PDDE4M87N9>7
MYG.[]+]RZ +'5VK&.?6>A@[BR N<@X!6(I(=3G>  QY;P]AI2WOQA:W58^:^
M!J4Q=8JY@>.PM4."N"-VZ!A/<GKL]Y<D?AJ\XPY[EK44?HMQD2(4S^DPBW'A
MSNA)A]L3 ?6U\H_MX- J:*MF*FA_].=\A@F'BQ5WV>'G.Y?FQ#D8^(H5FQMG
M&(>A[SY'4>B4Z('KT@-[:$80^;?LF$O6EV1ZE07 4.4<D<0N.&'!K31R&T;Q
MLA*2PD!2V$<SRF0BF4%EO(N-KY'HJTS:^7$V]WP,N>&GT2JB4&$J.2HZ2I^M
M$IDO?V#J/JR4<6A.X$,8H&;,$[=-P]<T?0#8POTP<*/(8>/U2,%=BGXUE[L8
M]> NV8DO0]8'-YSGD]<D,2*>-V?A+6>H;)P]7E^>O64SW5C*BCL/<)055X?9
M6) $PXE>P#2DF-=\3=#L$L>)OI50#F6JS@&A)7*F%YXN\8E(>7>!!*?'C"@.
M#"GPYHRPLQ?,E()7_J"(G;*><[#[0JJSJAM*HO1L.HPFP##-,3D'!JR%3V#*
MTTOWXSX#5?: DX0NK79+[**U8LR)L5*?5BZTEJ%ES.9 %3"E)=,<!.JR2$-/
M EV0H13]$./9$X+Z*'G- 5P2MA=2WV?5 #C\:R4:A:7+Q4;Y  @-U6AGS% )
M 7D38]*]%Q82<I#"!?@O\M1L,)8//'^323^J(JM*2^XIZKI1/R^L]S<E>TZQ
M>91"JQ?"E RYT!D;6DOI=C,LS-W/.-VD[B!GK,@]=>TLI84#3DR@8[,'>7]G
M]L>K-.9S:+.\*5EH+S03H9E\:-=",]%Z6]H]MV \T+HLZ8LY\'DWY\C_F_HP
MDM9(-&&CZB7C W:!U)B:R#R()CFSYB,++Z6I^2;VK;?H"-G@Q4T4^7._ #KH
M =,"](.$G]/$-I^:%JS%^J)AL? B86,(2LZGY$XM*%F/!BW^O[D'(/%)6#?Y
M>3KX-2+-\,-X(F!Z\M,B]2,IA=Y,GP0!\^$EN$&.W.,37&(+/T[SM[#"SJ;=
MC91T)4^XN)_9D!!0*UC0BSD?F-LPYE.1\I]>)4CCC*3AY!UF[#BAH[+#1M51
M@B^*ZC'QO+!",CK1I$\#33 ZL1KGXIJ'YP0B?W:O^;.&R)\5^;,B?U;DSXK\
M69$_*_)G1?ZLR)\5^;.+'^R</[LF?ZS3RJD7%5FVB1T<VD%0@?3J'G7# #[G
MCKLH5[DGL8'0HH.29Q/PRV'R $KTRXGEF'*..V& +34#4-A^O[DZ5WN29\XL
MC($%UA/!$:=^('VWL.DQ,)FHG4SNPL*&FQZA_5\6%P>7@8)@%<GEL=R'U[P%
MTN)^ZJH)E[BT.'10)'(QV!3.P+3L]!OJ76!? <^CKQ"<K.A7]\G)EAML'8R3
MK?B\R!W%[EGM7"NN[63NL,JN?[&#>47W%MK48P(VU.LY=G\;13T/DCTB,(,L
M[-@BQZU>1F1,(SG/"7:9+N@ (^V'92YGRS&>&G[,W-Y#,J<X(=TXHSDFD\$6
M>5<$VB0&>6/XC2\N)FU;P[!_3#(!>.'EF9E\X7,2,=[\Y)JE7:0/A'FA>6Z0
ME'@K30'"48LH&M$TC?OIL7F+Y^PBY_^OB9'W<A1V2^??T2[^+)G>233Q2W31
MB!Y&3SC9&0WEUW(4#[]M!A;K(4.#Y.ANAYT^T7%ZX8,!H88TE[A(>WJEHRF*
MHK:T=L:D09J9X]/T!FR6<6U:WN_8Y?!^_(B))9<X9WO$AU0_QG[]S P00U<*
M92=PH$18 TBSLJ=\.Y4+OSIW1^U>=%8DPV_84)X=7:O=-C(Z;M?UZ+8M(^AD
M=X&7Z5!SS\)^3YM@G*IT6KV,8[LT_4D3,*ESD9'GLA,BJ5AZTCW\B6Q=9R)W
M,\<$8 @3MD 986'TT)0V_+9\&*R0)DJ+BG('O=HBBJI>9*2<[80IFM8U.ADI
M9(<[G&UQIB5K>3B3SAG+T@=2+'0IZ[9/$V*71L7*83XP[3B*>#E,/0:[W\Y,
MBZ5G)F]ER^%YOPO?B1/:-K/]N,9:Z*:5)MQ:\ZQ</7JELE_D ?M2KS-4QT1E
ME ,+^ ]+F:">#IP [<M1:A-7V6A:;S"QO!&[XT+Z#0>/L-HMEAJ%A;JT<RH?
M)!XK\Q2#'+I]VF@:5?%(<>2:94"H/HQC3( 7S$"7S$Z6P':$"566EZ%A^VF^
M,IK682%^4FLAW#Q]5O@@:D/ 8\X_7WT--<ZP9LS$IL"LYS1+<*6::.#RJ$Q<
ML+*BVZZ\N$R)5QC&)DHF,8=+XBV'TPW44IM<Z$]]>_]KU)DZW,@3':G%XJ)1
MUVH_U?HV@S%@%2L9>'0V&*__UBZD+!2R'.I@]M.*?9Y5$6GY6?N^GR7M&9D_
M&HV0I#D 1S^+;!%J&R03^>(2(VX<9+[I:[@,?L3IS,'DD'OS-<P]HBTMI]B"
M%RM$33NTLC+@'Z;YA-7YD9V4'DO/>P#S(DI^> C2\(-1&@X<#%NPU:*,=?U-
M:V]9?T,A!\C6>89%'U-1G\LEFSLLE/,7&IWR[+69^\)X"^@/R!,]8#ROTM3\
M3BB_1.V E:6B8<OSS"8DF2B.U3@S*GZQ<;T+I,+[/B0DMCEPG^EJX%&4[8;U
M0 F[/,V*\5LTZ$ZIRAU0FQZ?&+7X'Q"'C*T@ZB&)66N9STODR(55SN$Q8%M_
M>![E()%?)T)_/]T:FS7!7KWRJ):(]K,,?\]P]X3LT?+CV^E&V&7Z+OX*5&C"
M)3(^X"\TVXZA$?4!*#QGL"#=B/Q>X?3>AB>I2GV\WM7XC&F&;V]MV2/545<6
M, *WN/W7K70WQ_( [M/U68$U?@,56\(8(]X6)'2@U-A3^&S1.ZN$RMO2RN#N
MG_V,+N$)#?%7H$$;%_#9<U_H<N14Z;,IS6R3J>;8A>*)29UP),!T9I-T574T
M]^62=TNFXJ4_I$K.1VR( (;@I6O/P?PU+^A>F7Q!$0:F0;A86:(]S).C*J0Q
MFW;'.Q2Q$O7WTL-\8 /0+N%&;.%#3Q0^_F)2-?5_YV1 ABS].FNO<&<?HX^N
M PN3I3M08*6'H1OPQ46JY=@VG^@(&%HR+D?/DI''PP'!VSWS/&P=SNK*V= >
M/L,F;J*4F'K(]I!;)+\ ;89__L*,'[R)&AX\C[R8VZ>KM[J]7NDUI)VHAK2C
M](K-(WR=IFD"X+))">EJMX=R 5M>5R:'DQ]O+R_C(M*D"X(?<68MZ *E;E@&
MBE!0.THKP_E60AEH^>>_:16HTM'EEIX1!;A,>7@RJD#Q7'G)=0K;W\0V6ZLG
M=Q5M 9#Q4\SE8D<.R+=U2QH0]0Y[K7=HBWH'4>\@ZAU$O8.H=Q#U#G6K=Q#%
M#0L?BN*&)1P1Q0WQ9_4H;A!E"SF'SG9PC'[/&DW(WCI*M8G^655*+FN@$+65
M2X6S%SHX9*;5)H+!B8#4*D\LWO/MHG\A_<OTW.\2[XX2C"YDVAK!H9X]Z0_S
M-4ZOC:X\3"QG;F8EUYZQY[!G?@;M;';&G;)QUF@ZE06=332-=O&+;$,LGQ&=
MBT4SN=2.9AA::V5^),^,N'3]P/]&ANZ3@W'@OO_I!PUZ7[M>PMT8W_! 9J9'
M\Z:P*W/B>??C/@UC]1UXB#^?SMC%+Y8YX)[:&R?#^;3.=:@5ZV!&CXZ>7!AQ
M7YE+MDFZE*K*O8Q\J4BWW"J=3.T8W4[;$! J)Z&MG9TE"_3-HJR%":>KJ:JB
M)GWAF F:2GJ['S<2C779*!V+-<5HMPR]SL>U+4ZILIZ9) F"@R6)\40=.AP
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M_9B85R>^_9&6=\(S^@\?SY9[O&\DEXI )P>7\AEZ32O45J$$A?3/?C8V9"
MSF #//(#; IHQ98H:!)K2/X0 #D]"<L1J^GR-/EOGAUW<H(V^6_,9RW'!^63
M$2SK5(A>H$B3QQFZ8]/RI&<<20ZL%@C^:8*](<=6@(%"V_67NQ$V178+ A<$
MOG*[C27PCQ;@U1.=QV32,10%B)M:[%0X!RX;5 M:')\#.7,MAXYKF9C>,_&#
MQI+\Z:CKH1;N2\0F0S[UEL.>P33%Q"4+]#9?FOM1J]ZY,PS'Z! V!$6:DF#B
MKO;B%%#5\J/^>6'\S(A[\9/?SA^D:2U%W\0?=)DPD"()^Q IQ,(WM/Q3LF^H
MZ7)M<,*.H,N-FVLU0LILT0V^"9Z 8@ZAH3N=>>C^SXTAT*YJFU16)M,NWE[@
M) +:M-WR)7,XL<@S5E!.B)/Z$GP($@PGTM&N)B@365=Y&67B,SR+\DN/!'//
M\5G;=HN.#WQV[6?6#C_J? \700$B+'".CZ*MW>E0KU<ZHW0\!G'+*SC#1X:&
M$SZ5M<Z/9A>$S[N0OKH8=,$#>J9C2</6]V&)*$Y<"+>'6IU/937\B5$6'(2'
MWPZB1O=X+FQ^0PPH+L]SP8'3%H@SC"<ML+;W#E<?A_%ILV;\J$3",1!GY+-U
M^?/$;4-BPBHW#?I0$JC N;:Z97P1RLUG'\U._NN)Y#^1_">2_T3RGTC^$\E_
MN_2"WT%XKQ3?I0CFC88I-\>$9C\K/UQK3H<WU3TWKU"&7B%;.6?'I5G,_/F'
M2=PKE+XG+3:@W\:JYMLL<-BKJ^[P9[7QGF]MLQM6\8X5=L':!O?\ON/U&_>I
M$7Y%AG3(8-CI&OY%V0"_*;(T-?\$LSFI\S#S-1YMMC!C#:T_F??1ME_1Y@9-
MFO\53G8GRTM/44>1A("-S< B?M]6MV>TUV2<QXGF-]1\I];SC9-L U:VNS=$
MPVV%7:$AA+F=EI3<3DO\BZO[+:F%^RV%FML.(G6+9DOLIRPAZKDOB)[_.-,6
MMMGN9%6-,G\ 5SNIMP T7(EZ;*2,C'P&D>Q;-I9*J=)C565>\"3DPVO9EMI>
MY=F*'GL5"2T&3D!,!DY] 9RZ=J'ULHJ 2X%E>(L7&CVEP7MEN?3^ ?N5>+@6
M' OKOCC$\R?64K/7@VDEV^K.:NM"[2[AQM0:C6QR0%*O&>A1_NV5EM/T>Z%4
M1[Y%8Y%Y^ -JY+*H*!%_3H:]H [;>':2K3G4!5<S>5VI:LU.Z\ND\_HL+YO4
M2UQ?,5(OOH>FHOFRGQ@_U906F+QZ%_XQC#UJT)4SOIN+VXO+"^E78+)@=/G2
M%SCM-__SMZZFJ>]O;B_Y;_MR !V";Q0!>(:+OQ+ ,-?#M6>RK+J4[T%56EI7
M4=2V:FAM;=GW\-5S:3D,)I[=ARHRK7DA?I!P.Q3P-/P;GXH/+>+#Z/^P_'];
MT^'-5\S_O*7_7M)_0Z0"G+JECJ,S:>Y8[+6Q/@_V$L 5MG(.FQJ1H34U;9^:
MQ6/7FYH![/%'\,Z93T=NP#\^^Z J2ICQ%Y[6AY]*\>Y6+0>V1;?F2X_&$9JN
M]KJ=<@E-B0A-.2E":ZHVL(MQ$SK^ZRO\Z;P4Z9:,:!' K\0;4 7@0GIS1C\Z
M>RO]GZ,6_77B-BU5Z_;J)]8I(G 4H1A2 9/IM)HJS(]34->)+ RMI==0"#>'
M+)HJ>D_1$)>N36_J\Q;TH2@&,YQ=/SMJ6=PTZ\#H]=16_>1URCJ@:,.P"9")
M?5)/ T%8XL(2SZ6UCJKK=50"&DIK3=4(CD[:_PX+FP.N)B5]>.VXA7V=F(NF
M=8QNS05YB!55<9:.T50A?IP"ND[TH;>[6;FNM1*^S:"/I@K>DS3%SQ<:!H9N
M\F@2^5? _OD37/G-L6;$]UWX]<O(/&:QW32[H:6W=*7FHCV%91S)0AP+42S&
M,$"PFEH5PH(7%GP^)1I B"4KV:4K$<="B4U5,XY(A>B/_IS/)J8WE3Y/![_R
MC#KE?73Y%/+J:L1^NM1?7S]%(,('P)+)YMRDM9*;])0+16NJ9#].J5TGDE!;
MG7;))%&&1-Z1)/35)*%="$/^= SY;Q?]"^E?IN=^E[Y28<S\[%P8LTOTXU,0
MQY6!/E7*E40&X\+(KPK.+=O>L$G93@BRDE-JBJX8BJ[IAJKK)3M RU >OIFO
MB+L4C0^5^7O@.LR]T\<1Z"#U\1PL-><Y7L%[3$+5]8DC_0HOE/XP7],B-?W9
M"4A5(3&S)&9+-]H=M882$]$3L1.04TA,4=%<.OW"GMH'8<IK^MR=?/."$S-\
M(^G\,+&<N9D6TK_^P2^?@'P65N_6,KREJFH-7>9<?#,,%D)<F+WEF;U"&=@,
M79NJ#!R1H/]&GEW[57KTS!$=WNZ,I%O3^T[H:)"4U/_=\ES'.069+^1YMCS7
M:YGFSC"8(W#?&47H6X%L-]13$NW'(+:%2-X,S9HJDBM1S_8.Y7O/=*RI]-6>
M^V' ^?%JS;B^1HM:85YO+X[;1J>&Y>,,A1&#MX\KK\[!,4!7/B4Q+"QL86%O
MBZY-%>?-$=7(Y(Y80 OAFS&^I=76VR L:RM\$2>%Z2M,7R$K-T&SILK*XS!]
M'SUK.'&G1+J.1D9?NMXL]C^'-YR  UI8Q5M;Q89J]&J8.!8B;X3<B-LB\BSL
M8F$7"UE_5'9QEAP/&YY\_BK=.,-C]F<+J9PME5MMI8;F\K)4YICZ&58Q%.)9
MF-!"K&Z$9DT5J\=K0H>B]]9T@&]YQRY_A>6\O8SN&&H-BY1S933':"&HA1TM
M[&@A\(_6CN[[/@FD:\!:3,FF/O$C%N!".&<)9T-1M$Z-#6B*HQQ%A6=;F,["
M=-X8S9HJ28_,=/[G'Y=2?_C7W/(MRHX78M#_[(N)UL**7B6H=46MX6SM$+__
M^3),8+<0U<)X%L:S$/G':SQ_(X%IV<)J7H3(B0AC0U=J+(P9<@HA+.QE82]O
MC&9-%9['82_?_NM6NIL'P%O(G)Z23R/+D:$,GPL[6=C)*T1S3VW5,$_[]G6:
M1FL17A86LK"0A9 _-@L9F)\-GUW.;1Q[>NQI84((9PIA5>WT:ICRQ7%SR'!3
M2&!A'@OS>%,T:ZKD/ [SF.:HPC_FR#QVT2ILX.W%;PM^ZB=^*?(.*?(*V2NL
M7V']"AE^;-8ONJ]3P[JECY[IC/QC%]9"$&<+XG;7T.LGB&]?IRDD93@J9+*P
MAX4]O"F:-566AK<P]#IJHQD'\]@X@.*SY[X<NR0^'%Q/0Z1K2J]MU$^DASB.
M*"X$>8V(J'*-@-T)2PPOT">\H^L-+\7+$V;U(56!%1_"E\V!3?*_OV:AJR3L
M^Z%-3 _Q9A(C9.&G):#ZY]P/K/%K:L)4%W#T(&#]/V\E9-ECUPT<-R",7]^%
MS90US=!U0^NVSZ0?4_L=\,:G?YP1Y_RWA[,/#X1(P/1<Z0Z_IP[>J&\I=PL?
ME8<IZQ%FQ8<A_[R;3V$OPYR;5NI):T'7!+ ]3H@TCOK(^($9$"K7)'<L!?#9
MI3N%VU[IQ#!^R4\(/,GTB#3SR S^.Y+,Z&L^"&1I! _SZ3=G\&)WY%](^#J0
MN)0=PJ>C['>G'CKWL2 >1"<*1,D<#H%+TK%E,WC($-<P@.79-CP7EXH7+(<N
M J3O?'8A)00W?!)X)C+:F30P 0N'?(%PU?&9)&47GDP+?G,]R79]'VX"Q6%N
MT]>./7>:?$[ZJ[!R8EM3V!7N#A:"JD.XH+4[WU85/@%$O7.=<]35/->V$0P6
MU^8HM%,H"8@#'\!QTC,G?\VMX'7I)F LDAD$GC684TXO2R/+(\/ ?D6@@XSD
M?\E2X$JFA*CH!!=2_BHXSN)[&>#YBWU$8X O/)AB3F)-R??C:Q(?35P;-(5%
M*KR00+$=6T&(EQ13$>U=)Z19$"K$H]<\,B&.;ST#*W:&6"2#*PQ?"4OD+TP2
M.%QR\C9X(7UAE+#\F-SO2.29@.9.]_#*20B/QI0<\F0&N#9.A;CT_,=DD4]$
M-/C5F)9F+JMY7$E)>>)B%F(HP_AW%'5#ZIGE"9*59$7M&/)C:,]'N=K$:NHM
MI!7$*D5(K:AQ(^V%?W/EF9/C*C5Q)VI=R0 ^7$OG$H>!IF1QM^3"!AXQOY^;
M8UC2NQF:2NL^G7C1ATEE7 %E?.E\WK7 BL!/N&JO*#^]Y\>.RCM3PO^FT)]E
M[9Q_<";]$JX[^>]J[TKVT5,G8%I![\+]"_-#=4.YT-?9[8M DAB4I!!,Z]:X
MQ@F0>AR[]X5]>0!,JU(Y *S!>?IP<RM=]N_N^A]O'J3+^V]?D=39)RO$9I,W
MC*S9 C:8%&"%]KPK4H8*P%Z%/=O6W?WCIP?I\1X@?/=P_^7FJO_XZ4JZOKGK
MWUW>]+](#X]PX?;3W>/#IM OMK^8EVS,%=XO&]Y)&C;G@1M>8*Y_>H6Q+#1)
MR/(#EAA-[>!%LZ L>,P52&_3XS+;G?L8RY(ED(!D%DC^A&H/S"+@?X$X-XMC
M<[XTW$9XK['CMQ7,3*,;$MN>F2-LEO2/,Y 5^#?L9QC^G7'@A9A/!+FD[$I@
M 6)9&E57NHY6ND@*Q$J6W&1&^Z(#B\N(E"1%W5[Y*#4@@*-(VKLU[J<"?J7%
M_5+RS=CM,F$6<.$E46[O1_1P\_GNYOH&I.NCU+^\O/_M[O'F[K/T%?COY0VP
MXS>7\-2+W4O]UA_S.N?="K_<2L?=.H]0J*E7;2QO:8'LP1DTLGRPH<"2 K/*
MC%6.5^#F9B"-7&X[)XTY:HK"[=QXDRRTP8?NDP-KHTXA4QI.3.>)Q&;QA?0;
M&*W4JLM]8>QR@:\MO$-.VJ[O-K;U*G2E-(;WKQ!?*TEOB?]Q+"\:7%GZOM:]
MT(VU N/0<8D--U6:4&#F6K5;OR(1O?II%^_KST"]V/71E]Y8#O)&I,<GUQV]
M6+;]EJIRMF4.+-L*P"K9+92_^I!7B80<(E\A"@2="CIM/IT.3<][18HTIQ@5
M6>E%%;0I:%/0YOYHTQSAXL* IN5'L4,:,+1-%DS,"G\B55LLM,*U94&Z@G0%
MZ5:U]6]IPAV;EB<]F_:<A.%7##Q:(^+1!'VT;8GU3$:"*@55"JH\#%5BQH)'
MIJ;E,!TWS,<5-"EH4M!DE31IF[YOC:W0 (V3CV8>>;;<N6^_)KV_EK,J)>D-
MNG7?2MP33),&!Z9OH<])>G'G]D@:$'@:*,&8"6@MY!^^2A-S%.=M,4<RB?(4
M/6+33"'NO\*<*>&I$HQ",(K]"F\FJL-0SL@:C\%2QI2_-_[<F]ES2IDC,K:&
M5O 6"1]3;\,,QZ:0:<Y2UF:9[Q!M^GOJT4OU45I/[1@]56VWNLOU45?$'WK6
MC!5(]:.4ZJ^84?UZ[7H?,>F:^/ZE.QU8K"[9[SNCS]SO_^G'S#;ALEND@.I,
M@I>9,XR6>G.2B9M_%^&TQ?2)IO.^=56=Q\S\0NI!G2<B'U95P EH9<2Z1FSM
M)"H+<L"%B6J,,V*Q!L@C+#.9S6P:;Z$.WL3\J"D))NXHK&_Q@U '3=X#:NV4
MF"#T4"<-"KF:J*L8Y"5^A2O)R2=B)KST8@43[G >L<M%<NGI8SQ"+J0;1R+F
M<"(-,HXAE68A#2>NBQ4 +Q-"5?K #3=$;RO\3M3QHPW! 21/(6>3</SLR.#.
M653<BY^P)$+^AN7S#-_YLR\Y)  I";8*F"]4JC##0-3<Y,<TJ&F5@@8B-R..
M1)2"6F7)>HS90ID*HL!PCF@L3COWM&\PERJ+"@$ $XL\,VO:QZIQS*@-ZYKR
MB(SF:Z&!/"#$D28$C>G7Y"U(299+R=@=!-R5%N9P(807N=4252;([65BV20R
M_&E(.J7(+Q;0,0,=OVN&/ LOL17%_KR0(3 F,.8GD5BHP*?\[I0N5>KQ%--2
M92$_+RC"@&FE6>C[X4E]<?"2<M*DAX46W*'X]$:TO(L*J9OK;P]2[T+"C@F
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MG9M? S9 US43K:D:\ :SUK!$_ )'LRNPUU=$/RFE0-:'= _)YWDFT9\/+,,
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MWDB"[/ :#JHJ3"MD\,HK@02B@D,WUMX2U\@CO05F:TNNB=[A@-(83?*22#K
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M@2(IU6AHU?:\$OL\4=AGA7U6V&>%?5;89X5]/DW;\_9[QF4XB'*\Q+DD 9O
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MPTLJT.-($'"@<(O+>V($*=IENS!-<S08F++K?$N%>_?SAX2__7[^=U@]=!!
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MJ@4#K6<GK[;PP7_'QKY)XC:(E]D;'EZZ#/AS4P+C/-GL[$RCVC/+Y =M*\^
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M$T$O\DU))3'SATMB5-$L/7/A>5GZ/;V Q?:E16SK<-ZJGN2?L,Y+%'$YRMH
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M4*VC]B5)J@(@M L0+IU/W5A$J+RH4^TH.M2- R@T$10NG$#==%"H:$(#;!H
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M]<L.FAC= : )H$F3T*2"'O9M09,2:VYV< 1\$D"11J%(%8WJ6P8CU;:LZ>H
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MRU&4G][%UH*V0HB<FC\KX7]Y;R?^X WZ-:$[_>=AOYR]])%OFXYSJWWR_9U
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M'M%P?(L^CXCI^SR:C.X>"P;DV _.BJWL1$IR,95#3FTAL95J^Y\  =G?1TA
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MS;6HRE\ZAQ.'+2;MI]LCCI[1[QJ'+2:CS^?PR5T'55G20[IS^/U#GQS;.!R
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M3OEO/A:_=]'[#P>2:T: %YX^JZB?Q;&8N27)+V\$PN66QAOFKDA0[*'A8'L
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MKFSS?:E]K:=;EMGO<WQ?WX%.KW_._7 1D(LP]&$%$1G_$S#HU@/U:C'#<1]
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M1PX?U?FH)'8< [,*-AWQL6,'.W9G\!@<*WA4G_&]M)&-SJ!O'#&"G)LE?=P
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M %)_T&^!MH2Z,\X-UHR[D'0*>@Y@8MBT*YZQ$R"VC!>C*)X'K"CT/9AYN'!
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M@+Y&?VPGI6-G3_0V9D) +8VO[6DU1UK;FOZ>^B!9 5KXD-8P=L+-Y7:QD>5
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M\JZ6$N]^<D7H"_2T\*^Q\U[J"IPO5C.^%\DM1SF=5KC%-/H9%^@!W++B\:R
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M9>.7:D]WE)+_/IJ20+&7(4^M2_E6^EJNJ3<)@\?M +.%&@4J)5EV@B4O>BT
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M[W,2_+XAAEW?'&2B=C6=$[Z^JT]#6*!MRV*2PD * [XP: 7/\>I!P_09JS(
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M 20/46S$@ZT^=DN*7O9EYD7Z3X[EM#5UYT^Q=ORG5$].!MB27]D'R\8TK?[
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M*YC$7).X/HX4,8EU-9U5<]@P9AK*%/1+F&S9B,.N]PQ):M0@+J?@8A@=@$Z
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M#SZ:/ELVP2PG[@[SZ%K>C+Y8]R*YR%]OG\_RSA&E/81H^TW8PT;LWG%LI9J
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ML;/[-BZ#VC.T\TOS$TL+P&6 C0DV)J'H7^>^Q$E/;,3)@,1%T;8A\#/.!$X
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M]N<1#R)3AJG%MAU#8=UU6/@SMZZ8NJ0;'%#OX.&->.)27CL-O2KM'$BZ;$C
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MGN?\U(NT,U]%#\(%G+[['1>NL(C7<C*#./3AFH,?HV 09*S?K[=_?X-7@&3
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M,*POY[]4/NM+_;RN:%%ZY)>(L$.HPCU5UU1C4 GP*8?% GP  6L"B0EP[2;
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MDJMBN!1Z!L7V&INO20==!I7(#/X=7/QEY4(*Q!R/('L0HQ37JR ZZ=@%-9S
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M0P?^06%I50H609[H=1!% 91=)@(8W"]6)HCX!U6@TI>4'P#.6EY(B@%UC2%
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MT-&:I+F[#FG.,PX*[<LV#@OW(<[5,2I;=GN)L',V-'N5Q9<<T_L=MDILELK
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MC&X,ZQ5>*ZQSV-6HS!YQ23Q9Q&><,<TWN!CPD1L.%T4P2F^0D2W2 Z"JPE@
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MQQOL- 8[)@/09+9*JRRF^=,)"9(<-?'[;ZPU^?'V/M5:Y?/7JE@'<>+S1 ]
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MT/RIE9EC*E.I*F-%:0&)T@&*A#3HK5;7_,SQC[9ME"[SA"ID[B58?M3A_#H
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M*'O])^_%H\U"]G<%AAH2#)J&^,F?3P7 ?S[K],XDN'\^<X9P?K'[\YD_!PQ
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MWX[^&Z!&7G 1Q2+2^SR9\%CYR9G[5^8G5%(DCUK!T%F8"M%OFP.[8TK10<L
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M/($@)%E,L@R/1!JXVZ/-H_4$=Y^Y)UAW--8NWA-W\3Z ->4O[L [O+8:0G;
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MTGJ:[S(,!>B<01^LZT'-FPYRW0;MJOG5>SWGG:'IB(2E7K=#BH^?5*W:I=P
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M@N8RH"ZO#B!Z@'41,9(MGLN@G6@F=56DOOO3U$R.KMKD*E<97M*GD G ^']
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M3.(#^<%0B%OP"G H(8P0)P0Y>LCF@>GQ:-*JZT</Z,2^LJ?Z0]E7=>L JPF
M)%L(-N7'QBP*/!XGM!?2.4E<,Y09_@+W)JE\RD.@Z@#X/*>R70A$@S. 4WD&
M.)0XOL7?*^-A)]9KT(*0.Z*D!B(!*I'LH;I"%B01/A/=J*4IT!"+<KD/+!>
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M'"0=^0O&8.VR6]+OE1\"M#@0WAGH>Z"1@G$:*S_$F*<W:)"7)C6-BX]OC-\
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M[-^5>&0*L+Y2J^W?)V?_8K[MB?I%CTQ6:3)ZQF1DM2SK1'L&'Q^V:5HX:5H
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M-KPHPZ[;%:)_3@Z@?4#DP??4'--J[S_-?ON(?2JZAR9A3<+;)>&..1CN_W*
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MH//-4;_\FPM1.V=I%OOI+2DD?L"5M/T54'>1TV) BF]0+-D0!0"C0O?,8$^
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M7.?-IA4QYU+"1I8;M\<DJS4E;,FO&4;^UB[9;=WHNP6005=.W!RMBB/XCUL
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M&\U3C<OP35;W6A*G"249'D[#*LVDUD-3QAA+-\RH=L.=M_3%>@7Y-[U[CN)
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M%LAY3H0X#F$6(6E<-2,MK^2Y+4T[40,VF7(;/]#?7*R7&"B [;MFK/D_4>G
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MXD+'8_ $A_R5<V+#:'7RPQ[V_UZC>\ZMY76/033T6MF\#(-8SQ3Q?\):ZYG
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MW\LY&G(:48''4=/G8KVB&O;*3>>BNY4<7S0]"-5S]:T/7:A!BOTT& [&8H#
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M&;UT?]K$+[!8<6M/6Y=_?+C^55IW1Z:VIJ"<N;P3-X-J>$\:BVN5A]W](U@
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M-[E_.S=]S=/) =VI]@_UU?#_ U!+ P04    "  @0814!/ZUOQ %  !;$
M$    &5X:&EB:71?.3DM-BYH=&W%6.M/XS@0_W[2_0]S1;<+4E.20CEH2Z5N
M6VZ1=BEJBW3[T8F=QG>IG;4=H/?7WSB/DKYNRSZT$0)[/)['S^.9,=W(+.+>
MK[\ ="-&:#;"L>$F9KWN:?ZW(/[F./"!!TQH1L'(-@1RD1"QS)>S;RB#=,&$
M@4 Q8I MU5S,833\LS\)>8QC#?>3,0X97#::#;?A5G8/9+)4?!X9\*ZN6N!
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M'0]4QBUPD)]\<1Z&PQH]..-\:8FVJ:#FN^"\:9%SOCHW<E.Q$._*4OQ@P.O
M^U89ZDOL;H!1<UAPYZASU%>92FP:@*(465M8]GPY#ZSLG,=>>OND=345PT_?
M"=X?[;SV@UEY/!ZW96X35\4'VC2YVAS*<&_[=H ;]I,7KT$#XYD\MS9EIY]>
MT.P#'&;+H;/EM.UT49O(I^\$W]&KS9?AYLO7G4IG;:>2VG@_?2?><#S:5,(H
MJHT=@/7 ]$;0,:(P",C@B3GN(RMEX^&@)M1314Q5?\@S*TH#0[(-88P6BB%_
M9X5/&+J>9[??#1/J)2;4Z1%F5--&)F;#/^:4PO04-CO8 DXG?AP-D^AK3Z*S
M(TRBIBU,S(3_,G*)I;?%I+;#/.HRCX0WHLHW:>I*U;P77)NR)Z0&AM0L[//%
M^)]W0*/QY[KK, TP:N:(_L>\-8LW9_W_Z)? ?^[MB,S)RGIF7V* ^>5-Y&VV
M/GF3?EM3LOKE#?#MY.S=V>GIV?O3?P&FWSUO_ P"6R\Q^?F>^M^%].'MV;MW
M[SF/J\1)^\V:L*DCM/+TGK5Q^N'#A[<,ZFV:Z D,P+?9V-^\/1).P(2V.)7Y
M9AQ&OGW?%B.H0GPCD8')WA:9ROHX-DH_O[6W6S0V\2?\"(*03V_VF_A\KP[L
M#?0Q<AR:$'>64&<-35R$ 6S23"?$L:7I%T;1=%5\- .V>R[[@!#_ZMX")S#2
MQ_MI$P8@V>AN IH$RH,W8"'C2SI._,N;%<A1Y  #!*2]T%VRJGB=S [B-TRW
MB+TXP;:O:9ALLV8]:.Z-%7B^CW<_?WD3PU"SEE(_SB]O'$I<+^;4$\B3C_DB
MC.+H*J3XB@B)(OAB^U<D>]Z14T(#^&"DW833]E"L77*OB?1T=1%N8*SL!%R!
M;Q6NB"H[.HF^"J(-*$U7BUP3':6CD.(D!RPA%5,PG61(%2G^57!:4L]9AQMR
ME;D%+D*Z_43PM+H&.64-CJ4;TQ/\*_K)#3>V%QB Z9+:0827D](Y)T5.!.K#
MJG-=-OAH&8)&N TC&,H<0PRFJ[N(C%C"B@*V6M"]0/O?R1:$P^9Z<[\6)JRL
MT+"YF0TQNB!A[?B+A>:-/XJ).TZC5V88O%+&0%)<Q0%&QZ3^ZPGX=)R_IE$Y
M(QZ4P[>B&3N"N0FC:!2#R+Y/8FQM&4Z? D)AVYK9F"%"1/J@QHQ9>RKUAB'*
MCJI 6;D%<6E'ZTD0$XQ#F[ 3J6EP$X(TG>=O-53)U+9V_^@R)WG,Y70UQ;.[
M9FJHZQA# [5<WJ/#IOXYJ/=NNLV&^>8ZYP>@R_ \B;P E%U0 KW4GJZC3N?F
M^D"XAP=*'@ ':#1":>$0XD9<F72HQV(!V5S8EO;S5K7Z1(;,,&0[QW25L;6@
MKDFHH%/)&"*H! G@PWZ/GKT2MTN?7]BF<..?7&^#<08A4S/T-M1LB)=,/9&,
M/2LP3)_)AO>K%Z^O0/4B5-#*ZD$,P\7W0P>EX0R4+_11/L!:8++S@M_8*.#4
M#"K1V1#R:WA<I,AM\$[=)6''U_A8ZQ@$7?A40*D.P)B%KY!^;.S3U85OH]3*
MFP>M"-.1N9?V!C@459'5J- 'IUF*RSC-$CRS/?=\-]IN?<^Q2WIV$V"/.,W4
M7X#ES93V+Q%A)7"/D)ZQ@"7;7R2>A*WE4E,FK@96*3_01\9R6NUJ_)^:\#UB
MZ(+$,2^8KG!W7(<^WA-<VL\W^YQ!(@4TJYDR!31D%^?=-:8N(ZX$X7)QCSC,
M?*/\[*G@)A4QK(/K$:J?0XQL&H/)$.\RMP0W(:B,IPW@/4+\5YYSC_&-9Z<
MY8GA=9F@=3%CHQ(IH%O/&%(T+N1E>$XNB>\] C?=*?R[)'0#R]?V292; 8)
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MR"6>Y_@D6$8*_DNE7^:1XM<^*]KSK_*5'NZD](#0BHHH=8"XT5X%<6'>5)<
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M!:KU.-HW[H2NK#VY)2MK7&JS*)!@F&.=2\V4>#4PA(\39[0=4!ZP_T)DC(?
MG<@L*/S1=D 9$)$HI'+#5Q?_0+09Y'1*Y(+P60B29)9SJ1GG6>.& 9,K^E'H
M>O]>II)/YR45!ZCL-42+"-/?94*95,!07\:Y F-$W 5:@5?Q)@'"ZZO[[P@/
ML$>8*<X\L>6>L@HXJBP "%^[^PCL@E(1) HI?'GK=+FTSYSB7!D8)^OLGJ5B
MT"@-U(:?R<1[?DR>AUS$$SXJK*& B-B-XR7RVN[")ZJU BT9XYTK,+5]S(Z$
M/:%P(SXC97EMPNJBP/<RX7^:D8_H!(-E$B=N2)CC\P:+Y):ZJ[ZR<PV'URXI
MX5>(Q!GH8C[+F.!<@U%='ES\S0V6B @H*81"7+8'.]>:YKA:B\A/$/+2A'=*
M9'*&^*=2/LNYUK2ZU7_B2BIA6LXT8P2EWZID@N@NYER#X?=;\5 ;0:^#J1"+
M;BCR=^NFC-C]LG-M0VW,]Y6:S:/LFW';#0+DW;SE+SB'/ZM,=:YM*) TQF<P
MS=>D=XY:]K,'P TGO"JALFG.-1C;+8.?L(^'+E=BK^)<@W'=K;8G;QTF;@V[
M/=CY ";B+0O]H:_TRGO8CN)$B QSAO/!6MC2#>4=94.L*&AI9[#S 8RH8<)&
M5X.H8_  3%SKZ\X'&[[)G!L_AGXB$"_9(YT/-GR%.5_-958:$K-M\^3 I#+5
M^6!#CV5@GVZE2(Y5F.9\L/$:W^,HCK>Y>$:7],,<X&33G \V7F&60M(-:;,$
M'*.Q^P-%+UR3@-)<YX,-YUZ9#OEE74L!;-\4UV"OOY3SP8:#<%.-':(8X1?D
MW458(O)(YSD?P;R8^9D0LE#D#3"-+Y!)Q$K*BY4O.1]MO-#K/++U@2H X1U'
MT1SG8Q/>:]5-J//5UH'!^0C&D"'&F)'[4RN%C;[G? 1G/"GC49P/"ZS(8%WG
MHPWYI\Q$MK^OP'>VIS@?P5C"U0^D(L$M7@&-+SH?P=168AU6I<NL?0645G4^
M@K'7T,3=,$94,-R!N.SRI7I,D?X@=L^8K.A\M"%LYANRDBED[( WW/ED(P:-
MZ 1NL'3S_.C5VA)3I'B2\PF,%X@IEZ/'T",$S6Y"ELJ88++=,?G_D1L42K'<
MFF2ZLO-)4WB4/BVM5Q=[,16C%!Z5]6#GDTU;2(9<Z\7U VJ*(4C?+9,E1O<J
M9FWQ9.<3&%%EZQ6Z<_W,V=9*OB*7)LGFH?"ZU;^J+.Q\@NK_&2(:3I9F"F27
M8>D&M% %D6W6;N0R1KIB@-$'G$^6O3F%74+=(,B9Y7RR83W:7EQB;^,-=S[9
ML!%MUBK)>CR&9/<2G]ST$2+_1Q-_LM_%?,NY[C+.)YO/=9E$^5,WCEH3HM9B
MK;W>G>Q\MAA.KF)>90UU/MLPM.R:Z%3@D<QR/I]K^YUK^]FJ[:=1O@%PZ3\=
M+'B44"OK +6TGB+T6\B+RT9 ;NFSKQT_5*&^P_,(4<6* U9CY/ "(;0*B$F+
M6,"Z^(8X[%Y_M?H8\#A!S?M]NM>^E)$@*[:Q]WJ3]IK[?>&CK59[ Q8[T(:>
MA[QF"0YX?&%?)^"$&<1NC9"]5U25,P(&D%PTUE5'@-UJ)HB[:%2J3'*<*%NN
M50*QNKC!"3YAIK1F^RI54_9>TEA'<E%"P C]=1T38+=>&_S=F\"NU])H/$ME
M8<"6R3='5%IS!FRY^^J;JU+%!FP9^\KH;Y;+.2"O5E R:F?6)_RFBTKY[+W$
MOI+*P0=7 ;5U<2!@KY8$V%W4!,6&CATUA:)%0)4)&V?SA)G1.H14JVJ2I+G%
M034-34S4";(N-@3LNJO!S$-4M<(29*MHW7M^YA"B4DXY53X!Y 8"J+F&\JU*
M3U!O^PZ<NR\>KV[4L:)4#.14D((HI%@[BB?;7=%>Y:J3(QT[1:A4^PJLN:EV
MBK J:(&U/M5/#5'YK=/ME6A2I.O<)[&VZEQ[USL/35J-HF![E\(!T$:E'EE.
ME\^G0A>SXF4YF;Z<')E8)=#6@N+)D8-;1*V@R<E(S\)2;@4Y3D]TWDL!MX*^
M)R.,\RO)%;0X&0E<HX)=09R3$;@5J^<5A#DE<5FE<E]!F%.2E94+!A;4.1F)
MN4)APH)8)R,WJ]9$7%L63X4R]55'+&AY2J*WM#AC096S!%YC,<:"RB<CA]==
MD+&@Z,E(\[:*-1:4.R517U8LLB#*R8CY]9>++&AZ,AJ"G6*2!=U.1G>H7FZR
MH-DIJ1"BDI=K+_P)$41><+,@R\DH ?9*<1:T.QE505@0M"#'R<CT6F5("_*<
MGH!>M4)I0;J3D="M%RTM2'@R\KQ:Q=2"+B<CDTNJMA8$.1EAV[!";$&H4Y2P
MY75IU^&=)T0>7GW<@A@G(V6K%><MZ,*1H/_^?DT6\K4?Z>\V?[5!*O0S041^
M+ZHJ;Q#K]?7U-P*7&X;NDQ__-HGF[U-:W70'O<%]M]WJM4:CSGATBQ(BQ<47
MO\*HBU[>H0PT:C.91GB>4K;U%"V3&S\*HF=_X@:M.$9)7.Q,#B2S('JEE1TP
M#<I,T$@3TZP3)T]W T*8;?!NWF@I6)H?),2</PTN:A3"KQO,3@FU]31=U-A%
MS%>\A98&SC/C6/!PAC:9O'F>674B/X;1$S799$%_BV7".]"\L8Z-_EP[*]]N
M9(W*X"CJS%IHYSI?$#UP$!9:]1B%*R---YQ@HF"C6Y3]W0UIE;<4 .'AK+(D
M(.K:.W,K[7N$@H F?J_$F'OLSLGC@'V:-)I=9PZ$RO.="QL='5:?>XCBY \7
MOZ XH>'6L0G(:FLX%S;89RM)<"K7#=V$U_%A8XQS8:,?T@K3/WT4> 2]E".+
MB;(QE)8;M'?",L/J/8Y>DYGD,)6'TLJ,!^]T82)#<@U?5>2OAG>VT"8'C\9"
M20]P#PLQW*K8;@A_4(L7B(%F*-ULN1)RG17KNWF$A56J7FF!K NO 8406@7$
M@#::D,"ZBUA%,1O@G;:SL4=5D\2&T*.K(9P@8=3UD*,H/F*+.-O:T%'4&K%[
M,G:4L:,H+&*9;6SK@I)R(7OQJPP[O=:X<_O0&H[_O&GU6OUV9]3JWXZ'K?ZH
MU1YW!WW(KI9R=.4-2EX1"C>[F^C[6-27A.E<D<*OYU516PZ.45S<)4>(MJ3!
M#A@4._)V/D(\%>;#058;.]CH[&/OC"SJ]:%\CT+R_ 5I&[XY>;OB!+NT-><J
M:EZ(KF2N\_'P]E2M]T+)D*K,<AMN056G X^J4HX.V'PJAYV'M1I_!V:6T86>
MASP0;"TV]JNXTT=EI['#3.6OAH08>]&\[KI]HFUU6[UN?S0>/G[M](NH-H":
M%JNCB[YR)5P%IC[% EE/A>*N $<LE;;]$2M.\J9!1X&H@ORMU O*0J0!DY))
M:TZ;&OPG*\PG# Y2GE\CM&N/R0Q'R^?9 XZF?C+ O2@6A]V9+N=H!IH<]S$#
MIN:5I9@"ZLP\VGJ*TS0H9>L+9[[S"0RR2XQ3!R!U=:2;(L9M9S@<5+9I+;QG
M0BRU5G(^0R' +4HK"Q+Y< L!\0//F^5\@8(8\T;EM6ZI=F%\+1F+V DN7/<K
M23-.O=(9XKP5@AEED YF'I))O$H6(9$$V7 CD!!UKMU'02"%;/I1 =\(=_#6
M'T7H=WVL.@+OB2"O)###[IM4]T4X*N.8\5.B)EJ#I8$B^%SL6<(W6!90#5==
M$;RI>RZ2SH\B],SN7>?(ZV IH87$[G,HT0G$=__0MG^(859GX__9^'\V_N_-
M^+_B7_3W0COYSKC3(K6]S&'J&)XDR/L6!41HH)V@UG7'.;0732F%)56'*2L<
MI@C-YF!=(S,3CJ$?_[C#"'7#!&$B00_3-FL2>,23=&V_0OK<^B^^1U[@-,)<
MF5"<6;K&6[8W+!<V'A!>+<QS=.V.M)-;7BPL)0ACY-EN>K:;GNVF)V(W9<D0
MH(/ESB;!"EQ2+K@T'>T="0FL$:0BPE(1["BR$"OL-%_$.XK<0P/,.>+D470E
MKX+NIN@JZ11^:/O>Y=F^!QOQQMGWOKK)$I-W7FK**P^$ W[K^1FC9YH#,":"
MXHT;>BH&).XL.(CUHZ1' ,3CF1L.0O0G<K$"8MQ9<!#;AJ\5>F6H[_R7]-<J
MVZBW%)P X%T(MR ?HU";!FIK.9J5[O9 !!-DMY"ZAH*4;78$+(R[1PL9E5RM
MXLW:&@PG]I50^,=-A''TZH?/\6/HD2<[6M)6)6TWGMT%T:NDO+)\OAU++?U0
M+W)#<J552"^><;;<GJKE=DMT VRDW8:4AY%(@(-JA17"S$-4)- U"E%M60ZL
M+;(:^LIB'%C39#7\=R2[O5LB=1P.U?E5HST*(EFPV0@KBHA@+W%%ZZM$#)7<
MZ4-;8:\ 6F&'B,BH$T+#52O8<L K]F-RRFB'X=56A<^M2>*_^&9%[JI_"J8]
MUQ@O/:-OM<\ ,M2IPBTU'6NM=(0$4+%<Z:T%APBC6803(IO-UZ^9 KK<67 0
MVWZ75#:1.477KBS);9:'],(SY1[PHD"SD*J";X<(< HE;)>[7Z64#9Z2K-MQ
MFE66=SV.@L%TM'R*?<]WTT0>G'9LO5F2$8@&8=DAXX%@@F/H?L#1!"$OIH#2
MALD49XI4YZ\E45I+XKR0C,JKV#%Z[S9.8&5Y#<(;-_;CP;1+E0(W:"T6@3]9
MB5S=N^'HXB.'BUI;WTY5BQR<U>'LHU>J.%6[ 1:6U6[,53]K*:%"_VF921BO
M;J=[&(=7I?V8XZR5KZTC8>,3Y6YEUL[^ZJH1=AQ'@>^EE\W*Z3=8V+G0[(*X
M]Z>U +JP*-7Z:E;XG'-A(^>) ]=**%YW=J_KGE3XD'-A(]F* ]<0+;*^WG4A
M;O !Y\)&%A<'GLYTBNB7BNCEFO V_XYS 48$Y,G 5(!KSV@?^)J%;9,/$72
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M53I*J].$3 X,O.&UP7*[D4RN $U> ,\"/-\C_*,;D@?@F8@.JPH0'$A80ZW
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M$IR8R<,=5WN5'SI$H<"$TKGG,QZB%Q0N$:_J W>\=C D$QRB4Z$<>PDDK*&
M(@M7( EW?34&4"P?+8OE)[THCJG1I& LK4GBO_BTN)80'^EL0*VN-FSZH5<V
M@JA4F91/!]&\2J@,BXR)<OVRX>%4?+RYCC^.W@HX;(H+LC*.X..!!!!S?7)<
MQ?;XD93HRF!=;@;;R-6>P7K,M+91HHZ#CF&RQG>.,#1)_V&1:>^0 XRDL/.0
MUE;@H?)F?41X).'K^<W'76 - !U3M*_S?U0A0UI:B<SHT$B,><8-L*)+=:6S
M9 PYBC =,RR53"1'$9YC:%I0LIM(@FWV$C71'O1'@U[WEG:F&HW)GVGHQ."N
MW1K]<=<;?!_EX6EN4.KBI153P32!EFF<!6H@;[M-V/K3>?6ZTHB>*&3"Z@=T
M RKJP9<;+V%M<3A^>E;DH]3[QYL$!ZTM88<%L+X3A;\*P*+E-B!Z<$/WI^_V
MHF<_3OQ)W$L\(3S<\;I!$TQHOK[-^\L$NQ.T3.@;$7?#B1 <_@0K$0_??!P1
M'O] B]ZZDS<A*,RQNC$.[#VB2_[IXNB'$B"\X8ZFGXL= X+=T)\KP<$:ZH#Q
M6NV;?=ASOWZ/\ \B_JU:F'*(OSF(=LZUT/1A,L%+Y.41T52O]+U4&*7O.Y&$
M D*+5CR8EE(5;OE%^$V7<RYLL)I>Y(;Q@_OFIK&XJC!+9CD7-K@.M_<J^3EM
M]CJ8/N;-7M5!K[BJ+5]]48)7'7+Q)&W_O00P0H[BL>V&<8*7QN"J+P7(G4_!
M#\GWWH9H$CV'?DQ; ROAKKD$(,<^]VZ8T\!L2>V:/,S#7"1SA]YVPH'Z,=9;
M1+N4#A-P<^ZFPL$N;:B>/9KC8?#:2><YEV!4JZY'SJD_]>DKM[WW%;B"Z:K.
M)9B [/Q2F%-!:07GTH8<<>.&/]H8>;X^&U.?[5R"">/N1R$-%<)10#[WG)K#
MR4/<#5.(,4(E/!*=+:NPKG-I0SCI1>'S&.'Y381Q]$I@T&",2G.=2S#BQQI.
M\SNFN(9S"48 (=HAPN2RC=V?^1OAHPH4,%C/N003^UV"S".0%5FZ@VFJ:&]H
MBFEKUPQ9(44,UW0NP82.%TUGB)!#1++!4^+Z(=7Q,]XTF)9;F@QP&NN3&R10
MG)8 (J\OW?M,0U&/T:WUR\Z5#;&LCY*R?+$2 C,&[96N /D/HH0QCXK^*L[5
M6F3;1[BN;4<,PXELS?G1G%!?JU3A^3@%_A; L< BJ'F8ZGA<CB1&28S#[B43
M.W4:BK3(<P0V'J<BSD+W%-BXG(I(\QQA8"-TJAYLOK\-;%!.190YKKV]U[O1
MB:JL]ZV"&DNY!Y%QU]5X@D2HXLR$]A#L@5P*?E1HS\4>J&+!10OMQ=D#U>3N
M86AUV/9*%#TG-+0Z;763RL!G+2G/UEP2F;NT<Y)]/A&2&;G/<R)].1TB*7KM
MU_+DZ9!&*5Z@(,RI2-IV@@D*LIV*Q*T??5"0Z(3$;XV(AX(\IR)GVPJ&* AW
M0K*X<@A&09R3D[XU(C8*(IV<_&T8U%$0[%2D;QLQ'P713D4:WU^PQ]K<>2*D
M-0LL*<C$D>WWDM!\\SCJ]CNC47OP]:;;;XV[@_Y(A58T99W^HLR.P!:09[EU
MBOT4A]FIK@*SC#P+9+U*\MP5X.0)G].?!7B>>OJSS81C&UF)U1..K20@6DHX
MMI$Q6#7AV$;\O;TD>3!A]D>1_DS1CW/\IV[\E.(?XR1%_3T*DIC^ZUV&Y<6[
MU9:17SFCA C\U#<QFJ"0B*H1A^5SQSH7!D^V*;"K[SZ&\0)-4NGY=B/V<AM@
MWGAMH'GYQW>I\%8TQ1(W>>".WR<-<R"XD.X.TLZ*!['%P!I,K$IPK2P/&"E5
M+U^/!I3XO"ZSI8@,:T(YJ?E@%;QEJ@C?PJ0HVC<GN%\?=:X)\QS!?X[@;S32
M0MT'6LQGO='LS8W>%RAST"(R:XUF;V[POD@[/4?P'U-9> TY1:CGPBL&+P:7
M@9I((X;U',O!95Q9D89]W.BQU7* ]=GM'4FHN4)V=4FFJM]LE'D& 8FLN!=/
M;N>?C]WQG_TE)<1@.D1Q0E28!'DC(O:@1_*E>#AZA.NCI?%3<2OTVE&8>>$)
MB5/0G]P8>0_N6YKJ@#'MMTY_[&G[;XV_ -.WJXN.GM_7:'4XSE-RLQ=12)_1
MP91F,21O4H\P>PH<E#*85'PVI8%6?*@L7B+T%_ G'#LY@=GF<VZ?QFAE@)8R
MP ;+)$Y<<G]I&*_H\@KQM_0-.)[1'*$R%DS<[@GPB:3JE.YB#IB*9.)][?PD
M.JL?9]D7-9T=Y6\X )JF5I$>E-PQIB]NPUTUQF3AT9S[S@-VXO!AYIK%-H4
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MYVDH>((<W.D%3Y 7K&9%R3=]SIFV*+H\%17 9E-1$ 6YRM,-HB#G6LWL2MF
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M/-L]6O3-2+ E1[,NPKK+]LJ[$3DQCJ</<F+\SA;E*+C3T8JRVWAVK^/83U]
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M2E\.E-(_KK2--\XT2T>8_"+G'H+A*$MR33--+C8,E'^M=>12^[.D#]&2Y)2
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MSLA!0:C%UQ842*VLKRXH" 4M@#@.[I6?'&].BWR7O81SZ<HP$>HZ $R$V@X
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M840FA5%,8:0PNBN,%$:]A9&">X ,PL%<9:L>EZX,$Z[\_<"$ZWTO,"&50 :
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M'@*).I"(\D#1ZM<;4+C>]044KH!? M+]A5F-@EA;-S_YJ@\#@VL@"AA<!4'
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M@ O,TB7S=8#Z A.9Q7N$B<STV35PWEF\NP^[!EU!#P:%S/TH4) SZW!02'V
M@4(JAM.'?/=QAIP-;SDU,NLWG!J2P34_6Z/?Y9.VM*3>_4)O=!3Q?=0/X;WV
M_?'LW(1^.#=3Y:>UXLI MAR.Z4 RO!PZ$"600P>B&-G\6;$>5J@PTMYX=JT]
M0N3S+6/KP$S-2OG4IH:%XR@,'J(L1P(/.6]^-/ 0I5J$OHZ4G[RZS!XH&5V3
M+:OZ,#"(6O4!#*)E?0"#*!U-\JKVYGCV23VI*(S5M0FF82U*MP$8,D0AAX4,
M4<%A(4.4SL0+WGC)]5[4<ZX,;1G"LO8,"*)52$ 0_0GM[WR63*U,K/PR%'N-
M:&K(^>^64T-R?[NI(=E];U1R1>O(!.24<OOSG? 4]F20D$S?-TA(UN\;)"3/
MTU1\R4<XMS1!=7HL:,HP(+F[.PQ(/NX. Y*%K8GU9?@EB,:S4<"UXD,N[/FR
MC9*7+>/9O2HO*]9D"(8-R=6#PX:<Q3X";(1&_)<)8OU/=;8R===?%K1D$ BU
MZ RBH1HLXG@5_>NWWSX_6O_/,Q4]_CFT\V\C&W_+T+[5?ASQWQ*@WWSW]IL,
M*OUHDA92GFY*=A,=-F%P#56@ SC*(]=<K+\TA*\;,<"&"M !X/U4!\J:\'/
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M7EE=ZMUEG,5!W#9\DVMY-+37OIK7P.0F@^,+@O7A78K+8IQ)RS>YIF^X[>"
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MM/E#LCU9U1U(Q'XZO3O4PK#;[%*HIWY-MP5=);B"S3:P3^69QV99/&?[J:2
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MMIBG@,$0-\K+Z,=B_5 D>6$)*E5ZXJFEN%J&*W( M87N9(O]?<]$%XB6" 9
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MC)+L)E=EGALAF+-''2SST6/4T>$LS[Z@NY9 8NM@5%0'RGST>'I01] ]:RF
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M%<GD$>,92;BGANV1).]4Y/9<E&( R_3YH?8>OIR+NF"VHN.L&)B]Z&PV'?O
M=9*]$YC.19S<9<:Z2W61B?$2W<C1VN6>SV79US+#EEKRK/:/QHO9HTSFGFK8
MYS''G5BD3PIC17]&*O*6E'"X?BR=$,.=CPW0L\ @\QK=N0CX43U"?^2%.L;+
MMW/!( I_G,MDU_)"GTR(XU+AGI'$2QH5*T@T=,UPI+FT9Q#A=Y197H@OH-&+
MFV_43\#.9NX[\\J0<LK"ACBI=L4Y>0M/]&6#V:HP@U[V<A15*?F@3&7$J.=B
M*VS<T&;H8]Y A  %Y'.2/%R-/;-M3/P0?6QX=HJLC/"@]#A^ 5Z^?<%/D"W_
M!B06J3]R-EKARBF=BCSU,N%<%&99X+[I Q$=1T,J,217E;-1"#,G]#DH.B#/
M0N#+_)I"CM(DHU V-L_ NBW6 _)/.H:O\(_ KU?U=Z"],5?EF3@:PQBH332S
M!SQ,S2F8.7O!BU7(BY4C#]@/[%]E$N,"F6=*(X@(FV<QW63).EGQO]H"7=M:
MU(S#\XC5GX-_-M]3&_(0LJ3]R1""92=AHC[2ML5$(]/:KYP#T"UPRB$=*MRU
MK;!&+J,L2F=06HRC7JSOZ?L3I$F.BKA<%%A8?EM0?K%KT*FD7*4Y1 , 8BJ^
M@5>;*U$\&C]#HN8[>,='WTDI/T7X=8?ZL4 MT^%,U.K4_.GJ;O'T_?&&+&[)
M_<VOY&DYN[^>/5X_D?D]6?Y\0QYN'N>+:_+ _O^1+!?PN_DCF5TO'I;SQ3WY
M+2P[=C";K$GCI].Y23//C^3A+SFD1H-GNN@C+?#/)9:LH?JZSK(G>:N[7HCP
MO9SWYC5XJ,_:N".PZJ9.TR, D7%Z[Y(U=145;T)2UB5P$=FQ:6,(I1H".JP>
MK>(+0%Q0QO:VH!1M#RTK>(OG*CCH2]:L,S<BK+=XBQ>T$%T1:U^T9=F.V52H
MZ?L%@1<3)6YQD&*2[AB9,CP94DS)D&;#@H'MF\CM3Y!"ZW,3UNQ3/A8L6E]!
M8/F49"3.TS0JE/#L27)E.,HC>:,WZS6%Y9YYVLR]JB!:0WEKL,CN=Y#6D]F2
M(DZR2&[ZS2*#YVP4QQ2NMARU]1J!V<\,!X9&N1A:G!#X]1P/8XO6IM;<V.85
MZPU>3BQ9M6AC)U_(K[AU@_2$OU)XG,GTIF'5=!QRT1CIPBW6VI=.[OY?S-RW
M),4<>6P7NQ$[TN=\5VG?@_EW\GJ@]YX&MM#KG[R%<O@W *KV$=OWI_G]S=,3
MN5I\NYS?SV"K\Q3"7J<'UQW[S;RB&Y<M\V#U960Q^P>C!XI^":FVIT!>P< !
M@(;#Q-LTA^UKY?:FI(4;#V'7K#]L1JO07HZXXM3[)BK.!EV-F!<LV$9%E7Z0
M_!TJHI2[YS*)$UBV?D/-">!(5N5!"H>;Y6*-B_)5M$VJ*!VP.JUX_V;[L^)#
M!+4,:4$.,6)FE$%9J^8LV+4^80=F<]A[NH*%1X XT#X94 9IHOK@:B^#%O?+
M^?W73K7&"_+U^^QQ=K^\@7\SC^/;?/F-M7DBL_MK<O7S[/'K36C.AY+,;ZB4
M8R6S7T#7Q2[@^I<>BVO1Q1W@FJ,IGS98MOLUX@(5L0WIH8+6,2%(>7,0\P;#
M#"!TL\,<:5.\GT,FH/7+E1=#)\00=H0X3X9S1;NAGB_N%E_G5[,[,GMZNEF&
MMYZYX3S6!GM?]D'YJZ[L.,:.6S,- MEN&[EP\.'9\!.(\[$,(X[;G)FCI+^
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M=Y?GB5<YQG9A8%./LR/'4++<T_HT<56/,[4KX:YS T%KC40-FI\.1!L(AD/
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M@6^ <N*K_%'+D(%TLW%II. ][ ;H<?-< O)8W%P5S8+O<Z[">?YZ35<5/&^
M;&+9*DD3/+2YI-4[I=F,$PR5/7"W-,OB;FTPBWRP"AC_ &; *5J?8'LR_(;D
M"I;)X'LRV ;H2HCYEO)Q&&;1C^;@S8]:/$3@O5IL-F\0@HEND:ICZ?S;E6=3
MQDC\!6+H'FB!@7@FCHI(.[:,\R@*7]3RP!*FVD@M/A6XRDTE0V1SG-G\60<^
M&""KW&_=$ L.G9K<4E&FF>_>,1,=)"OWZTM)$//LD99;9G$6ZR=:52D_9[^G
M5?L.J%UGVRZO!&X+<4R,VF]&O;!GO0RBH/AA?-&_NL"6< :53/D&UW'[?1A
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M-E&[[3S#DE7Q=;2!-,%.^^(ZEFL%@Q$1,/@"P\$!.8Y'8C[@Z>VS(U!#2FY
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M@9LI=WWGH.6]6ZB@'=/\G.1I_H)[+B&8]]=D]0JK!H9CK>HP^R2%_[(U9E=
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M[.#R)Z;Z,3]0OH+ 8:@SD:?)Z@-KT)8)P_3 !8(CW?R M%21\>(7O,6XG2,
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M!FB.^/&$QHMQ&,P7K4EH^ )9YB478" B1B)B*/]';8,1ZW=%JB;8Y?[;$B/
M0SAV4[#7U]@Z]X"[$751J &30@G,,+@&PI%H*DG)T;TJ_RAV],\%)4["X$(*
MA[,I:!;,[!C%DO[),E1# IT^^48:;>EU#YXNH!_-,,KN8U\9-%SP.UU<X#M,
M#T?X_N>""UX'W5?P-GNJDRJZJX2O:14E*8V58X09.#FS.$;ZHQ3RP]^F^;O2
MXB[)Z!P>-SFHOOP 40\J\!.D^09/D@]?:37[#3Y$\$M!6(,#F:6;*'?-0[$Z
M7KQY+Y9DJW07P^/83+Y8^P-9OK)631O0K5W)7ZG'G%@JXK=0T5K^:UGFS!,%
MMP5]&/FBC;^"P\_DC![FZV^B[(-$/V@I+YH]/50[E/LXV:964_S(^6HHYY%.
M.Y]6KS3>P3-)_@U8M@T)$J*&2U@38@U<4MI.HCI'8\\&HAW_CK^XBM+5#F$M
MLB>VG4U>7BN8I3Q*_(T6WTNZWJ5WR9I"2GZ9'H8_G'"*XFBM%;%4O/U]9J10
MQ9@JR2*0=%$0]B4%^R$>'3#:P!(PXDC*J-.FKPES!D_!_GZWQ#;G5=8W))%%
M1B11!$VW>/$ K.>$$:",%U^H62]>-H7DZ9Q4%/T>TY%G 2Q8?3,AT!V'23!@
MM]G&;,U--_O_VR+?*&^TCFIY<)W+^=?^6X*? WYC.>7FDT':DB%\.LA$((_$
MEPC_%(%OM9XNGL.4'\*Q@V;RRDFKSF2#U)-P8-CY@$7-7-(33*QEQS)A UC6
M,S/M>J9)=8"'3U,_53_*;!S I(,FHP.3SFR%5#@WT?QK3[4@ES\C$PY:Z\Q,
M.(=Y--&L.<,)LBTH'/^P7SPR']K9OW^C^#P:JI57'P\I+S4 -;:W0-91/<]8
MH9$4C#:#RT^,&]\W*AYF<W(O"%#':QE027*@4W=R\1QH!!31 (&#-\9O5"0'
MD*)!8M&=J<D]$^,RN:@.-%-NL\A\?.0RB\[,_$%H=%;2LBE'/,_4MYC-"TX4
MT3JI%L5=7H(#)B)4-XRKKVP,QIUYMLHWM,_T*:'(JI!$\#P0HY0XAM/WUJ/A
M=AC)%DF"LWD&E/MJ,N)5H0NN#!AA01JXB05PD'&3M"E%PN$VO_565WFDS*T8
MR&-1$*"17_B+@&M5'IS.L[!J$\OG((LV\7PY,U-V&R7%+U"@>+&>Q_ $=)U$
M]<DK'MT4&,FAYG0L2_9IMCYU\CH=U7M;,[I$Y60X<E5(J[>8@KB]O6;$Z8/5
MZ219L0XU9A.)X" C!C01) HO(%3VRY,CR?[N$9*@#?RX;NJUL[!=$XGC()LU
MS6PX,U,UWVRC5;7(% $M:?9 &3E9Q1:)@D8EO:;\O_/L)EJ]SK/M[KB[2DX$
M<+,MDY_^^%]@ <!O_[=8$ 'K"F5DL/\R.H(T/L=@ZD&61C"468NVS6%4$$$&
MD70020@X5$ *05K.PJP<@]$'V9 #-/?<# 4Z8LOHAW!#+VE&UPZ),=QUEGMZ
M<(\B/D'D-Z;6Q8/GNP-O#IO/_GASG'GJP*##YB%G$%R6B*T(^?3,/_+Y["8:
M+YHX^"6,A3U),V:8"Z8>\X%SIA[S3.:(E@<'30M%[F<V"_Z=?N &@*=&6.;?
MV (*[^6:A;YY,3C4$]WGT^_T@_OT(E]$E9,-_V!G79=/"H.<1>-X=M D8Y\D
MRC?),B?BJQW/4WF5&OY4',?(_IEZ!,4[LVDL4IL U_@O&ZQ'6]Q$0IL+9%8=
M2%^S-+ W.P=RZJ#9*M/AU!]IS=USF)F.7#IHT1RL3T%/0#A3%Z_!2\RW]0;D
M'_7XAI_;BPR')<^X]1;L>Q0'CAPVR9 ;\@.D^<)Y3+!^[APVN4RZ<F;S2E0C
M$.[ -7^@);:U ^),S3?0\K%9[0'(1V!B6^NWLL\T'#IHWHGO-2ZG^*0\*3EE
M2*Y+&I1I6'A8!'CS*'R(^IU)2+@QKH?]N_L\QC7O2I]*\B]J ZG@I_U'2&$E
M:3&Q$D(0LA43/_YJL6Y.]J"H0I/%!N_XCW9"W/XJOGQ5SOMD;4<UTS*/,0@]
M*'@T-P^REQUNPNV0<KR,Y4"4)$)[G S6@QG-S8-,9]&KF_MZ*<QF=1X>S]-N
MLXD*B.RIBRHH32!=5U14Z<?BG:T2D.0WB9.H^# _\![P>)GS'<.&&BJ4Q$UJ
M-\SPA920'$C!;,"<EB G_R%L/6C^*YQL"GVHS3!K'.<D?ITTGP_\3;W,6;HK
M"C;00_0!Q![CP*E)8\J'9IK&QPY-M?HY,%)WFKRU@@-R[-#7AGZ.C+3_1IT(
M=$?[E3GP1<O(\ BM_4HYKDXPX\ +'U079:6MH#.IE^LZ;T9PHG_6B$%UX7^Z
M<DIA^?M?:?Y21-O79#5+F<**B>.6.Z.K$'(D$M5#H5N40Y8E$6!'I[49[HK@
M!MM%^C7L9BBL@A)>C@E7U/UVT2CLH%,YZ/%#[8EL-]1;,'*@$,-Y=1#<D1Z@
MX7*X,]!Q'?(#M%S*.% ][ZYOYGRK\VR"1U9]5^ #T_4.>S<2R )S0A'TS^!]
MS\2>*WB>_<,\K3JA',9$@TPZ%<(T3HLM\Y;A4.R1EKNT*DT''KT7UM'S+HV*
MSJ5U+D=GS,3A;<=#P61!'L.3_FE?CTK$L-8#GK NR,9PI'\"#M..L"ZY#/?T
M [;LEIOXH/:D!J0CXCZ-B/UZYRX '::W*>PDM,MN%[BZN;M8_GSS2&975XOO
M]\LG\GAS=3/_979Y=\-F9EAKVI"+YGOJ])0.WB86+7U&4V5-_P _[:55O" 9
M]?MH[@#N],\">^X2[97[!6%?"<I+/8!#NHGS\+AXN'E<_I7QY&YVOR2S^VMR
M\Q_?YP_?;L1/\_OE[/[K'.;2[.GI9OG$>'*SG'Q>N6H,6_2K(H&RB9CS_7N6
M5"4NQCU5S%N:T0PB$MSC,(%ZQ0Z(^U/P%0UBGN)^ETU57WJ0>CN Z_?=].""
M%6>KGNV H,!*:_OS$ HAN^'K-]G=<L6!N2L6;#HM?;SYY>;QZ88L9_]^LV#_
M#,B(MG#<#:@1L2>AT H_=+"98TXZ,ZL2AP:MDYBF!D.5!SW-7&- ]L473O#&
M(Z0Y6ZR_EXX)^F_V;*$2)E1@>CMF''=E$/GT;> <Q(9HV#^^EZ=*43_4-%KP
M:6WC_.O/RR^+6_:#=#3#,8]F+,/B5WO$%EHR:$?<.G4U[TLU$W'RP]7CZ6Z(
M:CQ4K-JBHC=EE;!5#NNM*@_G& _8MO*AH-NH$!>DFA"88==\I5*+5 E\I9("
M'A&KO*K#$DD)SS:_;4B1Y8VT442AG-=/R^S^E<)0^+6F@ =S*\P&(N!:3R$#
MQM$&*(6UY$S+:MUL?YI_O9_?SJ_PY(0?/L[OOY*;I^7\VVQY\X0'*,P*?/_V
ML)PO[I\(LPIPHD*6/]^0A\>;A]GC#/Y %K?XJ]OY_>S^:CZ[(T]+UA_.8 (T
M'Y(]"LL>1,F\X][0U=-97XKW+.[K#N66PPRON=2:IO(C9W23=RBO^D^&#M&H
M,(^/%)[Q0 1(E)B70Y=DE2\B= #S&D+L0(!3R0AUX'01T2J841.@AG32[P)W
MH,9W)1O6M?6XUR[#=F '/6P)S%H>S"YMV<COW[[-'N?_+_-3&F]D?G^[>/S&
M717V+\+\EN7=7\GBUWO6[.G[Y=/\>CY[_&MXKLHH%MF//^^\5GV-\TW$ACZK
MXJ^'2L'!IA_T7"VP ^ME$<5T0"Q+V]XO]U1(.02M8.A0<K#8</:+''N?,I)E
MT-IMP]:_9G?%%,A"S;SD*(4DNL6&33*^:;Z#W+7&>R+LP7,+UWW@1][+XV2S
M0-&IGG(U%&W@8*'U %GB!,DI.-F/*0YYW%GV9PXTHR] 0(]"6G :U!![L(5E
M5\ Q$2P@'S0J_M*28(W,MP3+_;/:OJL]N_SP</I+OOXRU2W1<.GI,!K,HT%V
MODR%CG*[UNFO2$Y.O]! B*[*JJ3ZL ?.BM8\G S;^WS"VJ6]]:IA( S5@_('
MZ6:S3?,/*O-"ZRIK6I')_D3F>C)48O6/$% ]1!^L?3I;K8H=FQ)61!R#Z$%D
M%U]&V8:B9U'%U#S<,$-]K1H>'%1L!;Q(C"6V6&#AF,V(,'UQ\[JE_I4T\*N\
M]!779F.(S@[>6'%[%^MUPCQ2YL'B34K\EI3LG]]P'ZI5TOG>"Z9&KK$<BE_U
MB<%.OAMQ@:;3W$90=4=^C2:ZDM]XYTD,B;O:65#9U4\OGDE16<7TGSM8R,IR
M!P_@'HJ$_1\M,#Y4;QZQ/9$=+@AV@=HF/+K7VTRRX!AF(#G I :X18!;L'\P
MFB=S9X&G#3V/9 KKFG"_DF&;]JQDZS^X2C\2_=*KL6I<&%73V8,AT]*O-5V<
M6J4I\WM88V\G7WND7^,)IVUBMXCGS3W9I'VR77D^(=E.7!=1$?$2,J[,T+(L
MUE<IV_+.D,(G1K)+E*QBE.20,HM+_9<5#$L$\I(-?/KYX017*[L:%78EO"_L
M3[$WX=T)]/=T)>2&3;O@NTO,FY[^H,4J*?EJ4E=6<'H8(7J*M=%G>0X#"*VZ
M2:JYR]+4QO"SHNL)U^J2B=W^-&=+X070=?(&U1OCOR8TC9O:'/KU1?1A#C#O
M1#Z@EV?EL>/0:Y' (3L1[*666O&D3W8L>L72RL2W6MTE:^JJ32EK&X0.=8BV
MJ@ZT#49A.H1;]02Y_2G)\.R[_.Q;47[)4]8L90Z@J[J\U3V"4!HM *OJ-#V"
M42 M"*L:-5(X/>,9K"Q*KW9EE6\80IF1S* VO#6IF]?)UORIO@F 3FTT.VH)
M:55#FC13GH,6F0#I5:A+OB]!U#7)9O'?&"W0_)H6R1N-;XM\ Y$RZ0/[[FLD
M7+PF#5XWDP#FY5B^1MG7/(_?DS0U)J-H-A%*C;*H_CZ).0%DS2C "-R4; 4-
MPG=L\N==[*>H$,?\%2.%O A:3FX:I^2K;HHHU?*:+Q+Q20+?Q+"GE,BOBNW#
M3.'D?C4)GA0&/D[DU[W,KBFYJ9N?MP?K90#ZMLB>HA23UO$BGOK0,+WB+#("
MG7FZ/]$](!.U#\TX)_:D",<5  TSZ(GNO@(XG*!IWQ#2*.5%#'082P!9@R-E
MGC9OXY@.YY-LC<9,XGVP_W(>8!T.W9S@_NM!:AO4C)0^LRAV&L^JNMGP@"N]
M8\!X4-<Q%65.8Q)52NL0UGD[*]P7;V:#ZZJW<B0RJY3"N"%IM@VS^Q+;+^%P
M3)<-L<Z,&1'+@2YPK156[0(OUC7Y^ +0<'LPE5:;IXZ=&B-">UD&K;C*22(E
M!]G<Q1HR!].LQ-:8_<HLAKK\WDKI,V$B+R=%TB'H,8MPF:8BP$Y^]4B'HL?0
M:>7@40R-N>F;R&(?P!L', 44RDVI1=KUS\$=3.I.?LZ(]/3WZTR;=O]'18LU
M:CN$\=#8Y:*U+0J>:2_!WAZ57\70;WUXML?Y9$0/<;O:M/?KS]0,'Z@\UBN.
M-N7>;C9TY/8KB==[#!W).MW@02KUSN+3591%<1)EY#I/>3([-F?S7<G<SVFN
MQH:I>HVEQZ56M,6[CC_0PA:&HE -88V";'\ZKI#;H^,0'^LSVD1'LMW^_46E
M>4_9O5W]UD^0':+DF^?*WL.L361KU:8F.XR8=Q/M6OTY+<L':<P\8YO6'=^_
M5K--7E1P-GJ5EY5%AY:O22DR D"Z#V;:,8]-.S5:THP,9RX1CEV*!S)D%57T
MQ4=^%W?D=C54NL,Q6CT @1$"T<U>B#IM;9"LID8R7E-KT[U\+?+=RZM:$NG(
MBJML-RK^L4ZIHT!4V($E@S1:6:C%B-U26P$JN0,3M!;ZE^7#70BJGI2O-(;+
M9)L6*_MA0]H-.1)&+'A1T#T@!MWC9&+#2?GOLDW04&U8SA7F!J U15G-LBR!
MO-I1\;%8S[;;-%G!Z?XO\$8B>[G*-VR4%6;ENF8Z,MQ"KN$C)&J^@O54Z^^0
M-_XA.)"LOT1B]BD/NC>6'7H-!=S*<%@]M\$M1B3JD 3&]*_,8]F@4WGH 7=+
M?*'4J *^S'%0AS!F"RP949I"6^M."8 F35M,:!=]3';DVZO6^W2;=59IZWNA
MUE*NMZQ=COM7EQ]L02CR]^KUD:FOT_$T="$OV(<4?DQ@FVB]D@"5O!&!5IYT
MHTVI7BDZ_/2F"ZP-\PMB9N/2GYD%+N^JV&8^H#D1[0EV(*R'O],6,_E:!?%
M?K^^F#%H54>/X0_DTS_AG_[IL_=EV@Q(>T(=G$X5-'G)KB"J!)*@+-]SZXS
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M:5]^OU)OI#ZFF;BHQ,KM-/#7*(4_MR_P8+DS%VO]$F^Y2>I41Q4DC?E+) <
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MF^]"01GSX6B9Q+3./E5185VAP[TIN5SSC^H/1.T7HH\'KH([MJM,59"_(_W
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M1LL[EPU46K/GV6,/4#2(/%L$'AS5,( (8KUG.A\9X?Y>.&&)(9;#=B*+]@8
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MBU]?JY93E&3=7&]YMC))@9UQ+[4$O-%HO&2MM 2SE&BT!#_I>_IR8-V4HKG
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M)P"4:V3]X#0*G<^9VQHF&^EE(5;I9@57/TZ6RWP.D^I-'E#YM&'4)"J%QV?
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M:9F5O53AZ@E/XA'$_:,&Z%4"WA>:]Q8=O+,N7BJG'\:&.GCS-@9S:YI]F&"
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M.TV(Q-1'>&9CQOP'AK^7MZ^=4ZV_/3, KVY?.^=;?WMF 'Z\?>V<<?WM.0"
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M\CMF0$*C$ [T$%6N87/>#Q4< 102W[AI>,) PA(/#4L82#3AIB$-G+PPD"#
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MMA&0U;TW[F))B">QY.RZ7B5@\=(DEFR4X BFL)3%."T?V]:B#600?H&E)9[
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M"AN'""LCOQL7]0)@+HC>IP$WJ6"POO&[L=%L>^#(5G5LEG)>$.U,:1<V>OE
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MDR( 04T3=I0+"&J:H"/7+(H !(5+T)%M#KEUS.O^D.4.!)0=T)AMKN#$H5#
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M_8 [S/J])! 000D+GR,O"80#4'#'V( 7/Y1'FT=AQM7FCKP]%?H'W"$VQE<
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MR>2EAR&L<CK&E$QT>AC"JJ=K3.YAJ!_@GO.'93&>J=(B>,XKE:X[.M5KD'_
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M!/(Y<5$M  0+(:\3+Q#W"K#9?E7>94_+SS9!HXJ5PX)E3\"/F6 DG#=$Z]V
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M]HYK'#7' >U#\97,< !F*L4 ]%77< !FVL4 ]%7AB  2 >[ ^2JUWUDD-7?
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M8SD8U+S"N=%&BZFX/6/U:-6<W+D15(RPNJ<=S"+@QJ +LK]S2NP $N;Z'4A
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M>IJDF9TVFM"*6#F;ZMIP&+2WZ;FE)6176KR9)@R%4E5+((UJLJ<&2"49KB7
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M?/AUX O?"1]/\5M$.3_-)R<QAON(#,A4SN_<_*&_2M]6$I.&KJTDUE82TZY
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M8I,H(X1).@GH(CN#/,RYTT9![(?!4N!4.G[<N=/&\;(#/&]K$X.J^@JM6"\
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MB\)3ET5TX:@P0_D,+=<O@14M,%!94M'%H\2,,#2T@K\$5-(AB<K*_5\\A+A
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M0-&$*?)Z?(9'#/#A(0+";7P *FT5TL;ID]>$6RH<L9L'['RZ?$U"0@2;6*)
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M!DE<=*0H:/0SY,E+1G1B1YN^]E4NQF 6!C//]W)_3F>%EGAL!X=L]'YN?#=
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MJ8%>$@"0L*3YYDT,_U(('?$"P,C@K_K X>XLE-WW:[(S3W.0*+_W,#D82@U
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M/5]9QU%5 \M4$Q3SNPBC=;:D7\-MPJ^VUIKP A79NOPVU1_K9!MNT)OVK/'
M'CQ-^L/)9-0;3_ZTQCVM-E_/C0*4T%BDK7!M/-(@?93:0PIY+4K*.!UV( 5X
MXIE&9\D ^Y&PS?2*Z#5TGQTDSV092%2>L"-$C<?F&,IJA:!*(5:21-[K-D'2
M>E>]*4M+^1-JS_!4&2Y&Z<;MH1HY=,%28UY]K-&NYV\3[PWT%@LP2U#:65K=
MRDL[X.UR^8*R]N=>R2N&*Z_.U!7K5IOU@Q*:(!>)%Z0Y31NXW-.2O,+?WPYF
M_A:5#-K'B([G">EP[G4!WYK_:XL*7XA+)>I(-6'1) 'P(Z@@C;*2MDE>;CS%
M&<P'("D. E( M8JY*Z'6%Z7?D X4,[U#,@C5.WL,=1') %G[D#*JU;JJ17F*
M \JLZ)=:P+...F7-=B\6*H4G:F,->,]M7;=F]:GB(F1=69QS7*I;BY\] UQ<
MO>=1?_A7K_?0&_0>[:DUF?2F$VO0[=O6@]VWIZ(!2U@+I;?>^.$[  \@ %#X
MY=54@WFE7!9M>XG-H.E>VV= *A"),L<9]YKPU^';>%1>+_X"AV/;25SFM)L/
MOYBZD.P S'/Z1W A2>T_^C3Z>)JK-$.E<9_LLHI/^AEE8."?4DGE!9Z;WE&V
M0?-0%#QURJ[1Q5^FCQ-YKV;/+G@'K>5L6\LL"-9$^KAQJU1/0!![:9.!=PL>
M'>^Q%S^&D35+MFZ4E7S?KHO6E^*82,U><0>;<8HS)693![DQ" H)6V4.51/@
M;%*:F^5M;6;E<IP*RGRG)JQ7I<>(,E?KV2RDB?TTL!_MCC686IW.\&4PM0=/
MHV'?[DC6U&,HEQ#6B;<,O(4':4FLV0PUB_""Y2CTO1G;1A*?2$]3J4+Z7N>'
MR?8U]N:>2RW/5V]&?0PH'I)))>"$)]&'[>RN*TZ[IJ!57"&47$F,?[22/!Y[
M%'I!\IS^V4G_1!=VR$7;3^;4>F<<(]74*@QG6\CQ''YY_T]XO#,)(P]08C_O
M\?WH1NO8CB,7^/ MV?]P@T8<+&K?LNG\"O<*E!ZQ.)'XD:(F*)M".X!'8^!F
MIVK^]<J*$6&4;)>N_Q)X&Q#'H>OWYRX_"Y)3*PDF0G>XFQ7\T$_KUQ659,R3
M2FHJCMUW-PJ_C]#4K*V#?59)'<4QU,J#/[WEZIO[SJ0"]ZR26HKYI).5%VQ=
M%AGXAYTO*M  ;Z'_/HU<)"^A1OOL1M\!4FJ8T# '.C<J\FF&D1MXZY&_C;G6
M#>EQ-<4G\]G1S#Q4[)X3+KF(+Q4;>;-5N 9E3>Y.&&VHA%!&5.LHJB0I%V=/
M&SN8"=)V/-2Y42'>B6]ZAG;5$D32E!Z.=VZ45 3.7Y>:F8_;M/4G]Y?&#W)N
M5 CPXAW_WX]9VF@4&;"HY3,G::1ASHT*N5Z\99Q:D-Q$'3[NW*@0[\_OZ\$6
M&8-@FZ!#/F8M,?( YT:%G(=*N^^MP6SK(QV*10WA:6A@**G@"S</-)[<N<NB
M _>H<ZM"DD.\]Y2Q!RBQYSQ?B3;*N54AY=%I[\-YGZ+P!XL@[+/.K9:W4CQF
M<Y]65[K^K,ZMH!AL-.EC4_2*S"($5]XF75R0APKYS!0AOEFJG)_!@2KE1./S
MHPHXH<RHBUD?!A*N HXMPZ 4X9R$'H^;S##8N%@^OKWC<]@9=(-<%S"J(]&D
MNV&E*XOFU33KGE<I;$0_JZD),0HPDW?LFIHZ(P<JWO7<6$;,!2)$<HP7&!G5
MZU86(X+;OL#(J(ZVDA@1[Q0*D&IWGC4 )+Y+C@(QHQK,2B)&NW_9*:HM4/@K
MHA*A"V]A4A<<QK55"9,)?1K48X6_1BM!,R$FLS'0<#=Z)7+*8RXO&#GR/6,)
M5ZNN\]U]EH"UNCO]7K8$JE7@63?&)52M&D^]SBYQ:I5W\G7[SEG:@L03 U#B
MU;KD*2$*)4I&:?'*+V5K!3L8TA)3$1@DB(6B*"Z^0@5/_M5-FX"E//X)K3(0
M)>\H9S*Q@CFJ2K=!:U8LZXH^C3XY1V7E?R+!S$0KOBGT89E()D>2%6.L/DP^
M;+TL5H.#J8-GE61A/44 !*L0RMZ\?2L4C!Q \XU4DI>U>\\DB>!KX+;EI.O@
M>7VJBSR'\&5?P<J;^5PI@YCG]:D5DI5@!)'(]B2,$<W,:HZI/G!CL K]N;W>
M1.$;2)4A#L8HXT23OIIC;HRZ4C&/B_(IT<RHA@GG^0S5!_4A_R%,DG ]7*34
M\<C[X^?U868:;O@Y.7Q8.)GM9/TS.)C!CA#.B#NSEMP73@U@3R6<7M8@!@!:
M>C,OM?/&;@*(Q-/9YYVERKE1^0!,\\BP$&PQWDD(<EM:AJ''SS?-=T2WVPR#
MC(-A$E;'YN#58\-MEAH9Y5\3KV-S65E8_V6CQ+##3:K.I@(ELG'?6+6U"T6*
M[BU0%J>O5RZ#&A6KZITP[5INCS<J #L7AV%'_R%W1!T(ZR(Q,=>1%Q&<J\5(
M;8<7$**[QDCM1HUT%??[* -3$P$D@0 13!$O4@-R7(]0"%5M.MI "(G ':G*
M_&+S*KF-YBE$?KB=.JX_V_KPA_DP@":LBZ0]VI@/;NS%0RCT7V( F>M[;U3/
ME)J>%\T3=[)>(=8:!7'])_T%-QL+.*$-A4JP1"TYN5IEG)&<2D2 45Y[\:UK
MD,:L"EF==KQ)"OR)OT]#<J,QXT$/;:W _ZKT-3S]()Y%WB8+9SYXUSND)%L[
MBU'E^W <>+4F5:-J,4CHA$$,?YZCW5+F=4X@+9F7LCZ/_"\057F:#"M@?+=M
M#,5)''?"]:L7Y$VT@_E3&,Y_>+[/K88K>XT^,8\LGAZWP2R3H)TM%)[![%T5
M6M29]8FCI+(Q#>'Y!J(U_.SH>B4,T!89+CINO((?'OV%-(<WUT>_ET=+Z#5*
MZNBS/MYD!8_O*20)ZEEAS&X(6W-*?8(TF:NZ:!OU#%QT*'+8L*KF%FT<<$9Y
M[(5^N$3YO()=&^7G%>UG<#YPLH\+?X-LQ  2AO2].JC@)M0G8)5%O:QG2.D+
M- J,9;%CKS=03"#ZAXM!&"P*%4[M3N-^BTX!N R>QF 60O,E^_\Q@'MERTA8
MDYA0N$?&^?!(PR"4K9BCV81;<YQS9<3 C69(V>K"S^B'A7P 00Q4 <3[$JW"
MN>DL=4%4W0*E.6D'<1)M>0S6AEXEW,+D?!@>=.54!AAE7N$^*N=#9[)R(_ *
M)<M\Y+ZG=^B1&\1N:E@J@XKW)<(M7LZJ5;UYL4J0L#,*]YDYH]X4S,(UF+H_
ME:E(F F%V]R<4>ZX48"BV$<@6__*Y YY7N'..^=<+?NW$,-D!:+IR@U4^Q1%
M7J2F:1"+HJ?P#40!$H-/4 Q6K:3<605^)@_P==\E_4#<\PLW(CK?<IE&J0W^
MGJYX92*7.*M.O9%89RM8HD\]!FEMFF"I[,PFS^O<JFBWQ[Q'6:6!D'9P?!$V
M #]*_;0D</?8!.[XN1O-T=V!!9F8J[K9:8XBY_:#$1?7=>__VG@-&5B%KAR5
MQ5QHD7ZA/MY(Y1VE6?UC3HXUZX;3K%8SIX57]$K4K XT)Q3.C&M9D[K6G%Y
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M#:U&A>U0.X[86L"O4E9=RT+7:7J>@FGU4?ZJ/)#IE@GZY9KMC(&^:CXCE^^
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MTND/)R_CWO!QT/LVF5J#KC7N3NS!],_>J#>VA]T1_&,\'<)_VV.K.QQ-[>%
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M+,@9M(_]S!/-/';PR1G$3_W&J(P?B7$Y@_BY!U$*1!Q;<S'0>]"HFYTX"HA
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MB(LM.CE/"UA*T&H'7+*LK8/ CR'ZY&7R#;%/#R+K*N!?1;D]<;FPQDWQW+V
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MI2:?YD9J*'L@$(HKX=:3',.(:ZU QTY>\;&GH8^?*KE>-KG.AN1,4F3EYD0
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MB4),IN8P$5E>/S6'B4@M4ZDY3*0)J9N:PT1Z$'/I9#2"DY+S_K'VDN_9_I'
M--LZ?@6[-,'_]4N^2US]<I(9_=,EH&+A@PC9B3%CSV.V54VV44?6TV<?H^0
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M_2,$A'^^<YOH'A'1/1HR4C*:_^&Z^0&@O$O"1RQ,2/ 8<(N2@)"2X*8+P X
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M__)S^@__.=B1MTIVC4=W&F'=OY"UO%8VK_U6W#-)4D+#JZ.?U)H[2&#597*
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MG7B'T.=5[#-$%Y-"GDO.@'=JGLG/5^G7WWX9BZ]=FC9+RLPM0.<2T)>%[C'
M!+=YN8NQ.HG/\N8(9:QD$%I.W_D^]8! ]?LXPS</[Y_U'BXUS%LRI0E =$:K
M^:*5!D *+[5S3UBHSR.V\=2P8N752^M)[J,M)U5=TU='G_Q2MOP?]SECB<WK
MOG_M*T@XXKS>[04IX@ZR%%::^UN))R%&V-,2+];26BSH[E(<N7Z(S!5T]*KH
MUF,JPUN)NS\(4L A!S:+'?_;GN-3$[5_>H[_]Z#FXT,67)TD*5+Z+'LC&>$
MB*LZ2?/M[#QM#3CIZ,CH:#%M^5!FX!PV[=O^#.>GEKYIU$M/??_A63<H"P<8
M\+G*6WO25EUS9\/*R0J!AR<8S2<-P/IO )AD7%"7MO'ST4$]#WIC_UOR:@[O
M,1(MQ6].0%3]#;]0T"_$M=YE.W=H#=\7WY%:(=@QTUZFGCPH$]@7@S;= +CZ
M&3DN&^ZD!'P9WP_)"/4-CKPGMDRUI'35W:,NQD[LG8Y56L"EQ5'? .2,;]\
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MD1F#JOHN7Q0=/=H7D3G:LT@5FTK1B;5GD^4S"67OR)DQU#@5: *CR%:N7&\
M*A/[>"&?7&6'>5<V;GE@:X";*3N5G"%W#>M4QMM,$]-:VV2$B-0V78V_=!%D
M=TEF6KS[BWAP+@&5(_7O,_'(=1UJG;&M\1.8-+SZ<5MR&LR\BM+1MG"KW"'
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M7+\SM6^YQ&D<%U:W4=G+C&546"K+6ATXM;,'\YF!JU0CAJ;GKJJ3IS52%CT
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M3TK_@6A9*$/GIU,#UBDI_=(,IS Y?-K&.3$:4Z#>4#&R4=L0V54E])5&^4;
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MU@I.00<Y__MB>5W3@9ABI3J\SC7@WB-,P57XWV_(BAEA)8;_SO* 7P-N=N-
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M1G_&-'?X/T(*\HEZUIL7+[#B[??L9(W;4N;FPWP*$FN<*+ISRE18=4R.J5*
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MMD7O6%$$(M)K5+HTZ5*C\M*%" JAHZ*T4*1W(B"@M A(E]YK1 @U@'20WGN
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M&AEPVH1NZJ4,S?KP0G>N8\WR-%Q!PA_[7#*'A:>PYZ5]A4M#6QED]T#>U Q
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MOUIS_CX1,0NV3'Z^UV?S5'VQ8(J\O^"VH>D1]'8,M#M]Y= CHK*VSVN9G$Q
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M1%3($JKX+4%)Y:P)-QP03Q]A2G:V,96RJK\'%QP)#NRJ_FV(?\Q\L*X>*9;
M</_+]7"%![\\;EL./;]**RY^;%/H,O*]\#:2]//@FI6/2$H3M:F,:8)#4@[[
M'#1O+U7B$805YDIEE: 1DFUE8I: ?1K+JM(1ZM)]:Y;?4=UF AYLKG,F\I#=
M?**JF]6&M^E,M.9L#"+E4K5;9/?&^U<55[%4\'Z> %L@5X)2LW)6Y\%D:)2^
M35K!H;4[)*2,9R]1-$IW9 O%N^Y??HM>HV_#,\5J4XYUI2*!+HBMHM;!S$7X
MQFX*-VBNT.3Z!#@$M5Y/A6FKOC'68L[D0 W$G@/D4#/>6 U(/6N92C#D<7KI
M/OBV9;64;4U=(/!))2TQP"3L8WOQQT?O&917GC!TFYGQ4S<G\!A%<"@YG_PJ
MO G2AZ, H"R',PX"W YK]-BXP]OYZEHJYP!I*FN*_AIWMY;+U<V2)<91/Z("
M6?EML<EUQC>&[/&FNSFR+1XAIQL4?E'V^YF9T[\<JB_^T(A[_[M\B2K,FHV%
M):TE?@Y/!:ZK\__'W.6ZAP03?.%8,/FT4NZX<?L$[)LHQQ/*BK0#L17V )TW
MCW_VJ+3-&VY6A#B!J" "$<QA3N_("HL8)GXZ+^714+UX.E1?7F8@/9OV#+_U
MSOC]]#E OV9_5>^,I;_5/ZOMS8^CB.;NQ10%KKO>2JK]RRP/5%SJ M1?J)6/
M6+\K0X>JVW%A=#:WR-^!_8BRIMGM15F-(_CB@ZF;[)>BNIV8%X#&O'&$J'SQ
MQ#FFHAS8%.7ES7, #+GZLOBEP8K[-U9A\3.JH;)/@QU4:G%ZB@\#PN<NY/F:
M#_58_4'6_CY:V& U\-KG"R6/B>(<T+N;[\.%FV(%?<>A^GW9*7_(.X0^\OH"
MST-J:VO_H3O$YW:DK0@ J5;)\EERI5[(Q8A/_UJ:<W]^Z!A*ETY4K!A"JSAG
MM_O>W24U4!__=/+S' !N38 R0J4FUU]XFHM51J3O/L^)JX6RY18SS047QXKG
M9:A=M5\31];T\G:&SA_M&IW--*T;*J:<U(?H!^?P<N2R^]S29FWA#]TFZ>2H
M[0UEKWLSD1\H+!Q^H\D!#%I]*0H"(A%>-&1/[1Z< R"NRAV+>@97KZRN$G0.
M@X;-"0CL<SHA=]7BG+2>Z^ D)3@S_-:60+%UQN[LD"Z[^-N=R-"S.#$CM;H<
M<DORG<FI)][."_(99MJHJ&V[E32E;(_1+"_!4K_1)LKV2+Y8.K*![K+%0 C@
M]#I81!LM,=MAJW\.>(EGMU>Q]P!8J#2VUGJ,@@OT5Y.9\#K1YX ;P_T26L]H
M/74S,36./9X>@_5/ZMTM7(Z70_E%96&003-%=X$>">0?6N\?'6.K:2I4QMKN
M!X7M%!9Z+)7:R8#?>1<86%$ULU=5J)=LG61@4#8:MNG@31V^;HM?,[AB4<&C
M6;@4;WY;+4V*:/A@7'HPKWSO_U1>R5T A-_G<T!'*08^IC%Y#GB*_)5_JOTG
M.P_>PYN.DEOI?HO.FIZ^?[44BF ^D.XA_.I+9\+DY&#\YG,V8/'W#^GTLWH[
M;.R2JVR73R-6C4 ;)2=B,V?]QN+B PS6:/Z<V\=9QSAWR=NM\+J9U [D"/*&
M&U@1!PSB*Q,$6O99>F@G7 W&7 .8#B-T3*>2]YM,*-NK3*M:]*MSTJ>."N;L
MB%09<Z/^FZ]36K0,W3IUGM\Z*GZ-(NE_[CVWCTQS @6PWL#5YI8/>-U+'_MY
M_7+;VZ#]NPEKW@^%5(R?Y:MZEG9%ZW6L=?&K_32F&YYS0WJ)9$PK-BWI\9G*
M@DGQ\$\SW^&-D$^4W1SE"*X 9P:23M>,*@6=?:&4K\''M,$T*DIFW$/?7,P7
MX)O73A@(D[,R#E:>2I^(?!1@E/7SF(\NNQEG(*0JCN7G/(G_0+TG9R!OW-M
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MIR;UGEB*#C3=R2P57S4AQ)VD6)G<B$Y_WT>0;F;<'TXALM/UBP447'_YT6O
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M\A'&@\)MV;KKHFU%3Z"OSP'\F8 JD ( _K, ^RDM!JL\]YG1,NO59\9]%RX
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M<_;6TH1\U14M@Y7JT$$Q;;/$=IKP.2:"+-KXW*BE=^#+-5+VRK#TJ&P27>Y
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MY 660LZ[E3\%<XBW"*U@Y9A&TM/&;$;5 -5=,Z4=0UE$$[J(P^'[S>_GV:I
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M13>'I4W8AAY>4VAU*^  M+I\"TT!0NT#GC1CXP*>C8@UA%2762B\&;4M43P
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M=@C^=VC,Y6(45Z0GR:'T\^Y=G'=$E=.]<:NT*091,[& O$ZIORF"OWMRQ&-
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MDR"VI%71;)%]5+_4<)1)X@:SQ/[L2>URISUKTL<G_)"'Y6R>/4'M@\W*%S>
MX_)?HK% 5<RE&/KYG75Q-!GLKNXRL]0!4;#?R"T!W>LR>9=%NK.; ?+X\%(;
M3)4MOH79+W/CZZXUQ,:FS*Y&NRPKLN\KO0!&?.BS,_,/A@#%,%U3 ]V9?\Z"
M.X6,5&++12X);@! I'R.UP73469J&M"7G<7&-_GW060?X&B-Y4UKP_C<%.7
MKXJA9V@93H$O($^8[?R.=[7Y?8%GR\?K<E\NT+ CM-R+LU#HZQ !SS/0@PJ&
M%/;EA7B+B?D91::)YI\BZKSOQ)I4A4AM[-M(1UMD _G0N21=!_P=T%. ,$1X
M-%?<K=1;I.*H7U8^VE05-"B87@ 8 VM88!3K'XN[GVOMWF\XC(>9PG6Q,18?
M/[N0/ #Y3-\ F*E2"V$6Q:*E/F7!$9CHO(T2/C[V@ $9%-D"<^<%<6-Y )LQ
M/T5=UE"U4AUOR>^!YO&U"\.')YF0\,#"/D:O+1^VP^]&OG86>;DW@,H-<Z7<
M:$0EPZVX#PW%;B2=D[+76.]5[<4K7@%-1:L1L.KFXDN9AC%1=<L:1SLF,9;V
M.S$R*,94MGDD0N%QYY6UFL.\.H[$!,535R0:7RIYN<6_98*K2STU>/64^4=:
M)LZ0\"792^;V<)BC H[$>/Q)K%.+N!O[,NFH6HKY+'GQX9XN?'G3H]Y" D>8
MA64P92BOAP@+%50,W[6[NW29>4*H1?M)8L!URC+L.,>_J_X"%5'PF6LG[50,
MQW@Y=]W1G#L.+DV)S(%_S8^2 O]+_^)_@*R5J\ROJ-HZOR-IWDP%Q. *';(L
MDBRG06K-FQ:>'%3L-_SJ#6<=OON-WUV:GNL[F6&W!6&\28;+T?F[G+)25 X+
M RKOE!DQL EA:#SS</L(-S93"R@_L#C/>!9R+0#U P8AN@+>-6:TUXBTRV^C
MO4<39<KDOWJ5:VR;V4Q7_P+VOQ=K+.GW.U2".F;Q\\$7S'_16E=N\@Q?DC-G
MD(50MZ5XGTS[I.\F.]RM/B:"^EI&R6@P363:9YIQ,'&,1.#U6"BS=&DZ X?E
M'FVX&_F X"SQ]>JMAL-X(89\T1"4@Q(+E#HR0BM(2VT!+SGWC;)5E%$V 1WG
M:#ZB&3G.*@#B-13\>+?G9_A8%""OP*= $T<P,$.CDT$_S? 'CC<$=42_^[)H
M+MT9Y%83F:H69Y,XJ.Z1^\, @>^U?INY[_R?3O*4&A4F,*OECEF@D: KFPHK
MMRY$-9UL\MAN,WWBW/].\D@Y6;GOJ4OL3P/=&?I*Z$;]E&S2U)3*RLO"FLKQ
MM2@8]"SY+1KJ4\&/7E7M626^]^.R_-TGXN>&,/<VWK,0VT73"%B,I6,CIY *
M@W6_I>[>.PR]H<!9<Q>J8\ID-EJY^5D'@<Y+2W<5Q^K%'!.-8,7Z]E3Y9VL$
MGP58'TQLF:;OP:P@ IG/$Z1VF>+?8I[A*/6:$.$:HTY,(%/MY'X'0L*)(84-
MS4"B9;=V*H2ZK&F7PP./$G75#.;7RX^WD!>&WP-D)K!HF>>V565]3FUO(Z0I
MYG%PW>XY L0^)-FA=/+M9R#-[UQ[AIAM3?P; ,Q\/FQ97(H/.I-:-65FILQL
MM&A>(-O^IM$$S6]07:Q$9:"L\)^S$OG@)XH,Z]CE( H%.XE! %U%._E9*JKK
MY&#@PVX_Y7;@IHIL67$$'WBK5;EK(_:!5X)X!H_J'Z$;0&V,9[=SIPMU4TWG
MH]?W9_2I\)+'KSW)ILCSH[@>:BOA/_CAD0F0M8?[:V# #/.4YE-]10/,Z05.
MAF\;&% Z@0KP\#G(3ZO_.&[14'1ICRRX0R$O^1'V '-:_6+3;2+H:S#WAGV!
MU;O?RT&/-Y!2+J'C,Y_#?.F58IM*)&Y#\K4H1N>(%B!0M:&FT1S^C\G?G_XY
MT@DH?W81?;6H-8[^9]/KCA"4IZ>>MI*-=W8KE;8)Q.>_;NS8?P<PGFR]).09
MN 3C[MP -"=6$:,6HE$3\@&#WY/68HAW M1AQ>%'TLVK*REN]#< WR% $&*%
MQL_&FW1QRRM5.@NFO#TS2^7:!? A&HO)]D<G*B>8.'K? ,@"Y.6^Y-7.U&2X
MT+[5;8IQ2]ZZ%IV('_WF1_8I<'[#.(@=1] >YIDA\)$!=U 8.!OOF#/YN%FB
M3U2U10#'H]4\8:#ZOBF"5YA[Q0UE^:OY+].K:1WDK2Q1<2/QM+'JQ!W!B<E)
M-J^E["M%_X;550]^J(T(^+.3?02?5AW>]F1P>=HS::5X&G7LXK'IT!J=]FH=
MST>?6):*V*).6\N.NL]GJ,L;?6K0Q!$G7#KWX!PV*G)\<7Q9#H,#NYGOF_L=
M\/PU[1.Y>O>D=N>>1^*Z RKP36QER3S9V1V4L@?8\UU!Z8OSHO1E<JW\6AFU
M!0:2>\Z(0+D3$+/12*&<^J+QIT'9^-%$V*4OM,2H&#%!W:9E_/+Y+C :;34!
MUC#[*=L//-5ZGN239[VB7% R=&90*JQZ 0E9E'\H6QFB:XAV-G%+M1KH!PU2
M^2<;ULE'T(NUO@@C"?L<?+[F*B9XP9S2XU-@4#O>@E? 8'3=#V2:ZMEG?D5-
MQ"8;> .@G\+)0,@G1'SY.2"SA6'RB3!+I\(3+0*-A(JX>-UA$>FM2J&#T1%X
M42_9V5Q7W-SQ:NH%6?D5M/C,;G-.H5C!Q_8P*BFFK?'"ZQ0>O1@?:C''LE.^
MXM60SE++7IB3F(N]@*2LF_MP_M$.^MQ:1T_U-%0;8?BI (D<C3*'*CVSL^N(
MXF+G3N5TC*OPN?-)4C/2[RN-Q>,<XQ/S-S^MIKKDMH]I*UCPV=M8:R?J^!Q-
MP].?+JL]D=:+*Y"]ATWN,>FR$&M&C-0!@Y&:5'F0=8%^VB$)N=Q%PY9'8?),
M/@GONF:>YN-O?B<# DTX?O51.#+C(_>'PHZ!T?Z-_ *9I)$B:P2Z3?$!AO*+
MM' 9A0J'1QLOGB4Y).Y %@?5&9,FF0Y[*ZUL#<U>/"@N<592)$U!M R(&."Z
M>1[0Q+JJGI;H[*K(N_?L=H9 ")_C/P0,,7^!_FM;#C$U'>K^WNIX U8#H@@9
M,/0L:,)R0+W1N#[B_3?*8]%F-R#IU$XFU;=@Q(#O7J2,\6(@\X6I1)T1^/[P
MX@DK,<.8[&92H[:A.*B-5:E"8\6^*1"=QT&X9L46*U<1R)-7:SK/B]CJ7F4Y
MMR5>I%S7Y*AM$5W3N)5)O5*RU#8Z3T+=$N[][?(2??SE4M[[^^0,=&>RI3%5
M9\[A@WM!R-&%KM>ZN+5?"+K /X+M0Z44#UG9;[SB\L+H1A:?K8,$1U5) 68?
ML:UN2F,S8W5B-<<*F=+P7Y.E<DSKF>'A=?[1/&<C][("@DQMK.*"339+B@-Y
MY4"\U 171U*VWY#>!*GW>E9MS1)DW73'GD7RL_E M7 -W+_\*'38V!1PJ<E8
MX\*P'F\'"G=K,+?;IJSC4(2,[$<LD*7&HG2RV5V*)2/P7ID<R[Y<VF)6GW/%
MJ*:4TI1X_2O\<>+YLB E^WJ)+,VO4KS.;P]FS4JO"9/MKWAJ$(BHP2FN)UJ)
MK_.H5:SD$,\\@A^*\L XE4RS>!IVG/,#L9+WKM9W7_B-E)/:>&;LDGJT\4Z(
M3M,@XY7'+O>-Z#@38LC\\#"X"I=[ERJM&*BZ?PZWH77,D%,[ZZGD[1G9$TMA
M)Y/LIJE?N!I] 6-G?=,N7/*(5<9=LON#?9-<VD+^2=6,T%6-S@9C,:?L#]AN
M?K+C+L$W8;*L1A3\^3U+[$DW%9BIQ_Y?RN;^(ZYX(#AS=!-2S-4^M<UACCU3
M[1Y)73#YDCD9.51 E@!?43^:.ZG9/.S-6AZT(/LCHWZ@W+GH/8O7<49>C<IJ
MR< [LLU72G=X_Q&9K445#7 $81$C)%LI2*'<V; ^SHVH=C-4?( D&$LJ-UF1
M0KK3TO%ZYB7MKO"YKI**1Q*&H4O^(>*N.H]:Q5&OI2=(D(M,/@92+ K4VX\-
M#Q7QGCCNXT#OU5#H__G*[T?NMF=2;KTT7>'<7EU/=/;J<W"*?M/^N\I27TTL
MDX^:-6/6G(@9_I>MJ3J1/R-G+HN3(AH<#KO:UDTMP2)E\0VY'0A,4!T7<5D9
M63>^2Q6*\8HG!2<>SR>2;?Q':FZS!IF:B/I50/E)0Z6K]RSL[!!%X6,QO[U/
MP0%]>EE^*4B^Q^)WZ$)BO"'55IA&?PT]_'4#V/3*[IU<J/6C;\<*$/3EGV>&
MU9;#S[/P^S6%C*6SR0#=]O;!#XXJ*39*?:W+S6J2AS(>TLHO'<&H\V.I\^/U
MPD3BV%5_Z"F$D@Q;CS;*1V8Z84QD$3OYM;-&@S7?M5,E90GEB9NQ,!6#X:-^
MS>UH@9W[AO<Y%K.YF"''EEW78G*4H]MV30C#<7Y"C2;DKP8ZF;\&0/^,PCT/
MCNG.BZ'8RIV]@)?Y0YI?=Z.ZI:J/V>J!;5-47-JAVG5X8_@(_9%C5?  _]P%
M?OJJ^9]!5_\HI&+@_>1_,-1_[Y)[2W@_GXB)':I(%8#L8CNM+AAUEQ78G6)/
MC:@ECF0,^1:"B88636/?]HN=V26?<A>?J2C+K5WH,L7!TZB^!=5]]6 6G$!$
M^S].5J YY6,V"/PJ4KT$IVG)GS=K'P%'(,CK&?IAS<L&=JP?:^U:WPPM7AI
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MU.%SL7'!N=3KCV^/\A')'N2>;0WGJN63&T >MM$R.I/$>%ZQ_.4]]1@5,4*
MV_"U_&BKW-R&H7K4TIE,:)#4?B/L5@1SUJI %,O:/]-=2N<W;39]&W,Y9 2I
MIL>%8VB/]TQ-!$*<[<9U#7!,D^,":>F+U_>NY'OA)F.=XO./^-G11).>TP;N
M1*GMTA[S3)KO-/SD0O)("7]W89#BLR\P CEMG</:G-\+MUL&=#39CPL+VH_R
M:X2(G491+I3];!5N3W<_<@+(=1PF<K%,C, IOHDOJN\/TYBMMOWB9+GP.3!8
ML4C_4NA72NE?.]6,*@?"_BQ;YN)YC)^E,-E_+IEB%*);WQD_TWIU3[E;]\\X
M<NX%8I\PBR;>V69"E.LQ4"3C3T50:RO@N-S!4\3-G&Y=/I0Z=_$&4)_#,:=^
M+M/?]_AW,G[HT'Y\D9*]7JU8Q;_YR[V69K)9_$!4@,!_+D;1P-/I3O91ID1E
M:,;02UE''@9$>VW8"IY>HB+_;L/.^6TX $#^S7S (VV)@5U*%\-6_KBP]U9?
M%D/L\96C8,6;]2:MC9F_L-(1/4+6\MZR$>7RH0#\U64/)??,M"YU#?FN+RKJ
MQO#BF1(+F<"E:>J)PS]XEQM_>(>+O=#W7B;$IWF_/1GPF*-JP[BLM@7:6H<^
M\:#2[LGRMCYK[?:D:BYYZ_#G#5=>W)PF_OCH0UV.#+[%)$,)U>%&R:40L]R(
MEH_!Q6=?':2\4I&',J_TK#G$\><:*^F $!YS&OUQOIVZ:;7!#NJ01-2IBJ@C
M7VK^GSU2GR5CM(SY!_8,DT'<+$$9W@&7C"!,,Q+CX3AF[./5Y8O4168O24Q1
M!;2<0,^,%WWJIFDF. 41,P4?RA("4HY..'+@&R:K:4OW16<Y!F4U["*4JM.#
MMI<JM?6+!8NR4??SSLSF'#>;4#G6M@_M&C)=DH%>Q)IF&(= ^)FNUOX-X)+-
M:TR88YY_>ID32*8PA#E'VY4NY "[ZG<\O$LZP>7.M-7&+XW2QIB$33#M9+O@
M0/'72&N";PEA_L6A ,D3E.Z>QA>D@<.E&#IH=C$I[4$^=E#1A3WFI<3.T)JY
MGH>*S'LL.)%<63'Q',,9N+_Y^\S.G%,S92>FAK=2)E<P,5RCH_Y2N+ O;YU&
M[%%-2\(3 UO.NVLPN]]0T)C(>GY4TJO_Y#G1CD<-&PJP1$/;<9\WZ .>NP&)
MD[TEY=U:\8IT#*6"_0Y9Z!U2IS2C'IQ,=37I87Z1=#M6V'AQ3N,3MDJ'[!AY
MSY&,@4F-$9+:L=?R7BN1>E8OR.3JL*.,YC&Y>%O>-9:.],RE E,"3FVV6:6V
M1W)+XQ,"4<SL56VCMB.@W)W,F*3G>E]IB!6.CRMBR7^T/4U2[U>SNQY$).FN
MS3[_G7PX/=6\1^ZC\G;_M[33 J&[G,,*G9?\V'Z9U_-)2KE2E]M30?[3(YCS
M6T)'2.]6-CFZ$7P66NX(/W"08\Y<'6:\#Y68-<JE."9_:,YC8OF'KSZM13R+
M^+R%',MW)0%?ZVA[.@96E^#==E$:KWK9?*U3&-+CIM14-6W@D6;0QH=+I\&X
M<406(2^&88<-NU*9VTY.3C*"!14/=^IKD;H9M$LR[IJMED,RV*I+$#3G8\=4
M:--RW\IY-#+.,#M(7[PMXNLY)!QRQOG3X^PSP_26ADZ@N.<>?1TP5U1X)ZI\
M<?8-YJ<<QP3;7_;,V%^"<7<$L]>2MX&:+YO0 >:%&Q<&N0P.]#84(1Y>4<J'
M,^3!4(?9 )X1&*B8XV2E,J#84X#K;@ICMC5'76LLW%JIW!%"M.]Y0$N:,U?@
MTR,LH*<C]$XV"#%S*3_.?^Q"/#4S[^S;+^228-6T!C,X\_4$QQ,9MT[!?B?4
MHIKT9WQD?2O:J7Q2U_0G<I5&X-BZ.F1$G[=/0Y>CU">5XG?<WFS8X5UG..QH
MVC 5:[2S8%$C2)Q?/KW5!,8215W?I\HI</J$B0&FB8M=T-:8CI2M#W E,>1E
M%]P P"'+@:3 =0CI.)B@M5U#3IH5[<^7PN+>N\8B=."6_1%RY#[M=L!?<3P7
M6'N4WZAY=]/DUS0T#/F>5T=9D!J-1Q[WVY_%;W.3.>PM-Z2Z?&K=)"#-.\G7
MM5@F</6$VKVQ>9XH_J$E#(T0S.0:VG7*9W\:;R"K)A(6I[ZX,[$7&>#A#Y.J
M^;E299W[#?]4+^A.J](I")3=1C9SL105AT:3T-ZE&>$5?-X;^QB@EU'6Y(_O
M[:TBN/"7_.'&Z>/RBE]I#]]X=_5S8,-EI?P,-96H^2*;__&6Z-\-7,\-B6
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M:\_*YKUU)5<33&=6/TN5NNT#O]]>N'3(U-+*$/NR!VK1(D,]DZJ"6(-9O2!
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MSW/_XOK=]W41UPA!@Y''\S95.V2D.H>\ K-Y$5A4]?N@5>/U<D'UB]^!&]D
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M6S*P04FDVPZ6=+@;*8KXILIC2R0X\>O"!R<\![L3W3<N5Z6B[?JN$!2J(G7
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M2()#M%J$ !X;-=7A96GO5 *DCRP1#M2ZEWX)VU&^241O=+%W4WJK,2#8@/M
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M?X/T4)$-KYC%'//$#SOB,X%'>PMKXY$8&:%+ 3PY[%.5Q9[OI:ZLY%7]+Y8
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MD\^Z&EY/G]U_TR='Y+VZ _XP<@<8.;Q!7'7]B6[5H;C,G:2XDQGR]/6F]Q?
M)IQ']W8H8Q/8.8ZWZG_2GHP!)"YF4.G[K_>3+5?5:$DPL5Z%.T[-[G6QCY;K
ML9T#(_HF5AN/7J5-FH#'MB[UZV/-ZW0>-V4LL$V>^0F,ZE3&X6(FE"WO5WY=
MQ9D1+XD<]\7YH<)?+Y)K\,W]RZ\Z';6"M/5/0-! WIO(L;PBF\5GA]&1 \<!
MUCL\\AN2EJ_ZQ6-PR"^1A)]=$Z#=2*?%>+N3.;[*S<_Z@7-U<.M!<)&GH(D?
M2'=RKQRRGW]\/6/F"Q^EDG\/73<P)8)#R#1"?K+O^X^72"_/B?^8UYV-O6&=
M;%#8=(/BSV) 756&GV?&Y2U/!#.C0MI[T6S9&-T2H[E9^)=:#OPTYAE\[Y^
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MB[W2I'<V2ND)4_PFIOIYR>9T^X8Y)I!@79F."GS))^ = JM8W"9+!:7;O_G
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M0SBR  W&!^TMOB4-NO< AZEA<XD_USC6*5XN,3)']L=L62F/,BN7:,'7RCO
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M1>:HLM4O?\.)0XT5TJCO9D\V:A3 S,7G+WSY5!R"PQ+%][].U^U3V%[(18G
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MKQB:10;]:F:IPW)^0;H[[GR7B'(*YUVN+0M,AD(92WF)GU:\#J72O@? ^UF
M%O0A3B__\;<:RL/;FS'=A3&:=(GI&LB9)4Q,"G_H%?[^B[3STF[G0K"W0]*D
ML$Q[-[W:P!P-&X!LJ"FT[A9P'Z?$3-CM\3/(*R3,GC$.9WA2YI>6?LJC\:_Q
MBJRO&L^Z)PUIS+E1(CC7>V.C+!Z#73L 9>GES8O)+,>%O'>PDE8W6;Y+B3K^
M1R-I'C$G'_?RT]S'"Z<ODC_?Q7[LRLLVURINV?LT)#O;;E=_\9D97;]M4BB8
M=03/CX3-Y'0Y\?8U/P'5)Z8[0BTATJ!\4X@?NHUA'6_<74)B$*I\T+3#%G \
M:+ZL6?^;Z!OMJ]_K?Q@DPJ1FM1:^IXS5E0_JBP+&;O =/"\V&?AL^-8#;Z%E
MR<P@# ,7-$<>001R^$HN>XR6<GX=RY3<&U[J-[50]BC;<K;;I>WKN.+TZ01.
MRC* )'.2%PU04 )6L%7DY_2G]8CO33/&5:Q2V]#'WFI57L8&F+ZVA0&"FCTE
MY>70I.X,6@U.88P,[_6]BRG_OHJK$I;]:*F;P*H3$N8;JL%O;!KI!6A7ZD-J
M:X:GPWPY5'FW ,(NDU6+78C;X4%,,JON-VF7[6ONS5DX?XX4">>57;U^WN);
MZ0VTIHR6]OE$.3J[NB:T"TT/,_R@S?*:T4&&Q[S1P.R-YX8USK^#VIR^\E)_
M.[KT]VOM1+=CJJ%-.4J6B9-^B*C+U.+1$%[/;.0B)@M[NH!3E^:SUN9'ICDS
M%_6T=CI?9 9RA6$X$/"FJSBS68D,&V;ND <;9",&1;QVX,<E9NF9$8VJ[EG7
M?BC-$/9QP94I>O'SEP14F3FP$M-JK+0G4Q7TGRJ5%P_XHV8M=(3U&RU]_ODL
M._IF[ [^-Q)'-IL?9Q>88IR% :(J3AMK7WFC,"\4B18^FR(PRSE\9&SD7=R=
MYVF3<=(.FURZ7@_>*X,N-^O*$9&4W&7CD?3SL<O(PU(:UU?&GJF/ 1<TP]:\
M4K^>!?U<OIB$9H,?@J?-FDX:\!A*8G-P)K6B=-TZHI$%&;._<4GF8[O>XA<B
MGI#LY^=Q!0\06I].][?-4Z&$TS.*A#4&(GH$OXEU!00A<".^27*%F&AVA_PP
MDTOP[H)U7>AB.<FJ^"<?1XTMDCI*;46J?_[?BJX$:BN)\P<XC&O+6'8#RE[<
M;Z>#-@XO2S83N($@>=^N$D%W<<C[$=JP)B9L9,Z*3C4:TVC^6@A$#.S@J:\7
MGX.WAR6*%3NVJ/0?\7PIS@G >WR*"5T_;GED E^AX[_N8P31@$OMW*2L"N74
M-KAE'OQWE-H(Q>0EK)8'YS6FDTVM32<.L:^Z1:HPEDSQ!N&:\E*'R13=BHWA
M'V=_WRPM9JX:,O9'AF]XLQ7)5BPU$!494DA;R>V2MXJ6FULNR5%LRS*-6G[9
M0&VY_9,8ND::R[20KF&#E3UZBQ7-BZ\9!:$SK*=>%_#=(]/QU.[KPLS4;8H8
M0(-%N47@3":7+B;?@CY%^J>/GK&=3T0(ZM5,\KUOK(I6_\>?+4-^CRR+ZA\C
MA.*CM__#&DFA56.@21%\3!&$H;6-(O$?69[/+]/JFF=N& ^G"XQX%F98+>=J
M='?#\P^EE.N%JJ2V-G/68?E2BFJ1AVQ^C@Q@G/O9/FYB@1*6O=!6,S(H_7QX
MK24QID-B&!C7_FR0*06X-_@)FNLT2?B-REW&Z*'720$L25'KH6V2V(?=F,#W
MSE>D$O<B!.CH5!,C'M"KW@F]H+S1X+?!^:K[,"O75"?:U";3G,4V4'-$F3>5
MO,J55R*A[19MQ05UH$Q@F"&J"?Z=Q>!OSV('URA;YZH=-X0U>/T,I?JX3?8=
M^T[73TKA%AW3YM_ZDB9#_LES_\?RB'P[])7HT]T,_S*[FG1?Z@([Y,.2X-2"
M[P'J7HN3!,N['HTO8"U3DM6]G[N?3WUACU ^B_R\>3JHH_AT%MHQ_!"$,E?(
M,9\9:#8V?"'TD/C#!=[XNTF+)0O2*1Q4G=RX82 V4S0OKN2#@R_/*HTB I>7
M.V7>*VR\T);/W9?O?'ZZ1];D#C1+.K5/!=NR@QJ#.[Q^OTO3ERG5G>Y,>9I=
M)4R8,GPC^]?A74]4-//*1_'F(+>;<73TSUN1/.]TK*UHY['T[V-S_O\2R@ A
MKCN>H[> [3(\/2SB3]K%1Z?^ #FI/?[.=/A*C+3C%B ),@69]F+7(ZO+R3?X
M/]IR'8TY+#;"+))D;@%TQW!.K&!U@_HW.;X8-BL4VY5=4L"5%.G7K!FC2F61
MX)9&MY?N0A)R@6!S<;0HH;]=Y-W(>[()FN@*C1)C(O5NWVZ1A'[O-XUU50<1
MDU.O,QL_1BJ9%Z</;UZ,O>97DYR,%!#E18Y)"U.:F2/)7&\!?,MGP[@)YJ#G
MQJ#F)^,B!4JU$TIKB>>I4@=*BW+,0_6^>#.;#C#/61"$(5B/]H/VD;!5[-R1
M"?,[)(T%B!KK\\.W_YV_NXQ'I^$+!4U[LP?; =@<1O6N#'J4WHK2VM+YL<3Z
M8=GT&D;*UAPTRZ[R?,#SCJF<_Q%&[K'=Q3)Q*]F%:+/R]KFOY/=0F2'L=Z1$
M[A\I]:]5Z>>5_I(4E%KAD6Y+M)4$1?9=W#$!PEY;\Y3.3>(:[]>%3="'4/#'
MA#(4R]!^XCM/_XO/^B-[Z](WC*"GFTI-BO 3Z0:MR.4.&N!-\P'19;_8L^DI
MY.OM(:DO$A>3PMD;DFMU=J=H.[KY>:@,/-<AV6JV?-4\HL1;(G+Y;<;IL%ZJ
MRM'1>J[RJKWGR6,NN.7FZ=\ZA3?(/G]S!07]\73RN=BBQ7C,_M6VWN!X0H2$
MMRYFCLJ[_YJ0%FZU-%CU87F286(!!Z1[@-(8K?6YWJWY?,"LYM]A0<G_*3QQ
M^HV57B-1W&IXE_]XS.1!@:TD4S+F%D"LZ.YH8R^X9^7JD?.RP$V%(*HM(7$G
MU5WI^C2N %>BB7CQ+"Q8<RJG]W3SN S:)8N79#K!9R^RB5_\_+& L>9<Q>FO
M_=8N[@5249 !4<2]X]V6G^^+X1-Q$CU_-\C^_"<B06T.T]Y^H%4'Z1:5UO.H
MR91TZ ^$9H^_.L[FQR:</M6M(44X^NB%[X^RDCL.@,=X#(XWBHHV[M19(*K!
MAGT_/>*"<:_+<01_<Z[4R?^51NH$J7";U21 (EYUX4*-JH$,T<N>)F7-:U^U
M[2!M<X]2G);QB"COKM6KS-T(I\<:CW[1 "+#MF\!Z)*(L(CZ]*@@UVTH!<C1
M?'KO_I2! 4,1HSR<;OTSTR99#DX3S:T?:_P@9O2BB*NE6<B,2DL'6/7WB_TC
MKT)[L,HA<&_N=P)<)'QE,ZQ?M0;6:FCV#6-@X=O3W6$1G<W)SL'#"=8?PG?E
M41[#3/EEO#K9+G3F4:6P(//JR9.NR+9IU+K?@CBT6PZ-G.D&TLQD5YK)<V0H
M3P4?*GDZ3020M4TT1KF5EYJ;S<H)%*Z#3M<13K)\J<I5+4%:J-+7!M/>K64"
M3M*]S)<_4N <67GQ4;8W?.3#;PR8BI9]Z!7'F]N]7$8U"0;</@A6='+Z+T?P
M=DQ13S*9#6--!L1J'&=$!V9!IX?>!BD32Y&GO"60,_*>NL,;\YQ#1AD[/=<G
MRB;/$YLPZ9+;&)*(P8&!:4BXU^@R?L+L44Q46\,U34>*33";^\\&DR\Y:]KM
M9$YD=D?7ZLIAK3?/?R+&K&BTS9<'4'EF?<5:\P3(6P P'VOS^XJW3![^)U$5
M2?MR3(3;WSO9>W7-DQNG%*LZW9TW>K*I=QQA, -$O6M"0$;ZQ'M6/,O1908&
M%?X&$F2T,"O#"42$W%N4=0W)A[K7F>)S:7&H35V8<ALRY7.61PF8DF.HP$$L
M2C"[ -GD:BPC-6&FLP4VDUP#PU(\T&)"73F)GQQXZJHK3*>-CO89?=MXB\#W
MP$V:1GL8"P%;R#CR.X'5IN:!?1!IT]KV1:-'E3\OR+[]P2/P;.0M8-F$"?^@
MTF@#XE$$Y-VB(46I6+\TEJG;OQ'I]PV99NQ#P#MHQ!I:W"QC*?0N(GG.ZVD^
M!_$6@Q_B$FTF1#URPUX%:O$,M9$2#\@TR6@U\Y8?:(56EVQFJE6B\L=6(KQ;
MB<J49)RWW]HRDWRJOGZWQ2]L.LWK4>-VB!=\-#Q 9FI 3%*.,S1 ,_$+V0O8
MY_$)KF,X=)R/:9</<U1M#6(-!+<\-0I"F[G4;;QH$\?F47S%'=YS=HS /N;
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M<\4U0?URTEV[(T8SED\>^>"9D\GO">7W66"IC/*9DTU%7B<0KYC5^-/LJ%N
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M< HTR^I3^:SS>_,\<ZS!!PQ$'-QD\L_-9E')3[<LB"^2 9>N.*P@S $G&H9
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MI9J >P#]Q:]@95^9<[&EBFV@BL%!YS+ ZYOPM(MAKR=EI U<:]1QG4&\YN8
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MPO?:Y$)PR#106$JI[=@;)E>AGROROJQKF?( O![$-T=K1T)*W(1+63"ATAP
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M=AZ/MHC0X^\^VM7QA'BM^HBM&MX#"#$3AZLQJO%,QXKUC/2A<O#FE;XJF]Y
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M;%2X8+\5S,T.MSBXM7U&JNUMK#'V,?9#76,H],>!6\17%M^]WG^#=DH!=RH
M;GV&(.[C@4K9G->I7P %/@4$+=^XQ=-K(Y#E!-+($2%VZV0]$EHAFS'3C[X@
MU=$9UVM!<'Q:PNO9O%$U^AK"DE=V_Q*R_E>P%$&\< U.@%1&'J/>73$+2F#+
M5.990_>U0[O81@6CTY2P0G;2FI/^IW3*X;@GY=R8KT@8J\DT[Q(W:ZVWX*&
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M5A?9<QDN+U$$4IJ_@);!4VAM'RG1JI>J%\X7YCR0FTS3;QU>:%"7(?U'.1C
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MGI\>D_-1E'0LF#'.3713TCCNYPWT?/8F0-MO)$.Z>8L17,## 2[Y\*Y.1Q:
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M=[-L@3G;1(A])3G7>=3[,WWCQLFJ*7X]8WL^T' QYH-M261)<-[K#F"(]I1
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MM9SOY=)>)?[RO&[I]V+ WXT<X\XML$P)=8"^/'8.%\+%?3+*"6 Z<+H_NGP
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M8[4BFQ*!BD[RY? @.I\>$@W-M_\%H, P4Z^*TZZ&#GWJI$P%[0L+7P@,V3X
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M"80IQ21P"4ZTJB^:2)N#. <'RO%>X#4CWFFYPUG0!8/,&47Z##0+)FS)M/+
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M>%!)5^[,[$Z2_9LY#CTWKM^THD(!R7Z,4Y9O\N*Z^'.(1#:W?-7I7^?%!4P
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M^#DQ:U!7W7.X8E\6\?<##5D]EXEC65F?18KI6R07RC,HZ*]GOIX/I,JP.RN
M^ZKAF\Y[9WFPGAO@IQ,N_.Y^IA&;)A7# U,-.\L_OQFKYNS;%!_S**#_H; N
M>UC;-II5/G&+@[9N/ 9&U$),)_3[BOH9(SD7CMJ;61X3GP%A'F/V4RX[&MN'
M+MD.\4[Z"IMT=4FK4J1J*T9*=IQ[@V>)?:'JV+/Y,$U6[*,'@!J$O<O.BM<A
M9=& P<&/+J_,.PJEDK\;;Q=OETKNQO/D.QX>\&!:Q<(%D>)B_)*-^=W+WC7P
M8E$G.6$5.29&9'0<,KDG8&7RW4_CSY[0O$BI/V:&3^B?O*J*M])_LYTL B=&
M!3"V.*K;"KJABO)[-HQ->N<\2W=()M5"4B[Q2W?(R4Z&F:,0GUHV_U@$7W[>
M7ZQ,54KNS]TZTY!Y1_\_4[9K&3P _K$YP G];T;)W_^/UU\G^Z#L 7W'<N$,
M1T-A$GO?[4@^,=Z?0H,:30@['-%/5(RZDU2\Q!\ HD9.G2_%HU>OM9RDT"W'
MG6\+LH"*CF-TPRR%OM@_D0"*+3&=O:@KC52/%1.Z0[5;DG1WH WR4=YRG LH
MQ0S+.ZKSI.KHH*#F=[N27U<2L&'0JS:06Q%J[L;W[6@XB%JM':*GUW@_,IF=
MG_ M[N_]-=L)J WXIN$7T9PY'2.N(QE4[UDO^ "PG7#.L%1<(,^TV1U4'[W#
M9LJJVR@L6ZAHFA_EC5AS3GS*@/GX\G)?\TZ].DB-(.,!(  [<# 6)^(V0=79
M>&?(3HD;K-!R'2G<GD<-I@^J/DX[/$?9U]6'P&+-?LYR7N26FLA80#A3RD%)
MG#_=&#6CSP:]H+1'RBFB^?9-/2N3'@R7E*@7MW&^9J$GVUY4#&U9YA>4+UJ:
M0W:48J\E9#S<A3Y^JQL!NUV-V^;5\/WWK>Z\=QH%\[N&C%,I"-DAZRZ.X+E,
MWVE.-)!L)^#QV-F<PBL5V1W]-E"IT3JC!\4%_++P;Q5XE'OLE!*/[",=4&L2
MM$"*!=_[Z7 -E/0Y_)IJ8PY6O8+\*7>VKI?N%^,\#CG%1D*0/G#NG_>,U:/=
MJ8$?6R;/2_L6MS)?GF'=3!?_WJJ&A]D5+W%XY9'HB"&UJP[C%-N=G4E+-/ T
MWI/GQ+QA:TPI:;-TC8#K7]UVB<*:D1=)<I1$72R+LICT-5=Z4#N$U%'LMJ\G
MP@J\9D9)Q>HXDX5X5GR(<:.+"H<7'D%+T48BY&N3YKP_A?R3>O^HK:O;2^*W
M3_''X0MF %*8ZT[61#ID&1-1N]EC, -RTOFP;CJ)UN/"#(.?CK29BOZ_+4X#
M[-[N)]VKF!XM+(5Y+#VWTT)=Q/#>+#F .UV.)4?\+H9/829"70'X4Y4I/['3
M;R;%&W5Y-2S9?SK\<;L>A[=1)A\G%ZZGHYZFT?718/[Z ?WL-80EN1$%"]HU
MOT'""KQW;G;E4M1^&+]?VM*#"$F!TW./%M%J^-Y1&B,>V*16\<%T:D]05Y'=
MQ^1A'M02J@>;^C4-Z=@4UT)DEHY?;5Y^EI# UQF9EFY'M*?J3S'63/AW?&SX
MN0@X@/CT<*40A#5JF H57R',,G2#D/T:#5/FT<'AQ"#1V-\23WQ34IEAKN)S
M9XA:8_!C&[_ CHRB@.3,? MR:BKM?U.=JC]VF9=Q,?F4P&@[!PH188,0%BH%
M3]/HT8*6YVZ!= KETMY/LUV4DV2+'V>Z,[1/SS8LD=H;(J/0Y;M14;L9K%[$
M=M5*LMN_ X=;C2W<9*BA70P%[$UR'\P.>0 ![FW9RM.8-H4[P!?N^D,(3#ND
M(/Z3;LMRA1U%/;,2>\$ BM'N2\UO]5_>VY3SH##G,S5!U9R>'(L&TB6S*B 7
MJ"4QJYQIVM-&,V+[*2E"?V%'AU?Z&QFOGM4@U729ZUMXT!AH1Z'];4RC[K$?
MKWCZ7GK!<,O%_-9QW1Y[X8C)?T:G=C7(R96NT6$>3:(B#?E<X4WB1)397G3^
M7^_;5TR1(\ACBDAVF<^%SQX#'7PU:#1^4O50/8[Q9<,C_%4E_F[U=:V)8;]R
MZ&_XX4'XHS<SS[!W[+-FUED8[&IO?3@9ZY_+T1"5ZFJ_Y7T&)_QYLR9)T#CA
MSFFXVANY<-?OPW10< ;,O=L=B<,$YFS>19ZV1\&LG&F;HEX731Q@ &W-+U^X
M94\7OIB6%6[>&H+.H=*9SM&&<Z:0/"_A:ST 1*'X =#IF/L L,<7M^?)"/*,
MABPLIIW#B3NR"1S.!['VI\>48^A?T1,[=F+^ =_HF?@<S<ED2(.>T9,=2+HW
MWHYAT?853:@+$#-OD(W>OQ87O)XK-WKCKG%)#?0[!4R_AE)/6$3P2[S'->%E
MX$DXQ^Z=OUY=E]AM/<H.@O/'O#N7T+S:$8U08Z6F>>7GMZS'?>PTV%[/T.CS
M$<K-\,FP=XW7X_KSX=Q)F9KF^!0J?ZO)TE<R%62%!Q-71Y):N:5(Q>@WU07=
M+*PT1EB'A W$\N);7M%1?CR"IM>D\%Z_S.IZC)=).%4_DRS[TJJZXUP@6XNK
M^-M5CZ-4?6PRWOMI^;%<4&FN*DFOK(L4$1;:_K"+UN4WRC&/FCTT_=,TG<5S
M(N'>';[9W/HK9QB(*F1PJM0UI<I$D<YVXL &L(:Y;9J$']-:+1M)HBO?+=_A
M^MR=LLQ5ETM3@1@XS:\A8VT)-$U6TA_[-%7;WZQ ZN:2@?L1,]/%3<^.\JO]
M0#<@WXL%\[3X!4K6YTE[MXI<9Y.8[<9OPY,IV:A]7G=<J/!Y1>^=M(]+C;T6
MR*VGW"B.]S6S275OZV0@P:0$/+?$.[^'7.AX&[>\UN%]AW>L9$>FAS#IM)U7
M2@#7Y/JX_[N<GR"(#3 ]"AHU#4QA!\WEMH69YRZUP?)^F\J'T-D&\Z[&!PX%
MBC8=5XSN>>C*TH12DFZD<[8UKV($^EG!%(J->OCDG!_%)6'FW+C_ 1EU/@">
M,\QQ95<.TA85.]-'-Q_]L&B_OB@!52?%U/,)L"M5/KD:A9^IL(&B6,W_K+>\
M_,IX<8$BG?0V0[[Q3E?8'R V,)T[N3@E0#4\ "1VK<Z?,=0D'A=I.5(YVS$X
M1%M(R(#;"58R]"?JU(B-[]H=+6A8[SLD M]=:Y[3Q=A[/8V4PM-0MR;1N-'F
M69!FZNJD\=GNBSX"[\8^ $( *E?HFKIV(KLVNAC#^W5S[JS2R8QM0X:YZVDA
MF#>AVC$9G/NP(%VS[ 4]'NE;NMHQ*L$##W8_"<[#]4^<FMS\U33[2%]M4;I&
M.S2M!+?# I2,(_O-3TTQ*K2'5/B(D;WFEF]*S'UH+'V\<]^L,!8M2O& _X]H
MUX<:<RNG^OINGX'JV$P;\?%J54&N48-9EG .<1FG4WUC[.0WM&_7(7R& HS_
MJ#LPKM\Q+A,H[+$5993_WGW>4N]6,9K__7=20H(&:%9AFC\J@REK7[D\))%O
MY 9H81SWV8-_A(OI:"K7D3;FS$E1-"[%?.[XK$R^ !Y[\_^JR<N'65PA#).Z
MVFB;VB-Y&*L_DXM_28I.!\S\88^?;J,OBH-+9C_-9LZI*KI.)_Y%/%M=2T@+
M\J**FV$V4I&U@Z7;QM0_12+?"J\*2'511XE!6/0G#M;_XM93@TJJ=Z>O:5:W
MT\>_C<K.9;&$^=L5>:<-D!5I-^K,CRA_MZ*K:[YQ,Y;JZLW6G_2((U*B"''*
M_H50MG@F"F5O=+"9T*Y53HXE1JM%<#MP.=3N<^G&7C)OO,_<UYCY"[^VQ=EA
M0N'B4G8!6T0*&(LDX 87\+[QTU8KF'>@X:2'4C_3A'E+!-HHW.=$.]I%#!S+
M7GIEP#NXG/&FF%G04N1F4B(2M"#ZBXWR\&5]1XKWJ@ARRCSSQ@(F"@J'62SQ
ME^($^LKB2!D&\RJR5LLG(1ECIN2'C^E[_["+&1]SAH6NAE2NVVI:LX5H>;V*
MWQL4?*32^]. PCPY]!UIKST0EY_]=[K^:GK?]\U+P@Z&!M*1K:;U['!'PPVD
MFB 3Y.O^7.A9^0_Y*J2EE_ZH+'K !7#.?RX]:2MGAVLT5^#(H%+]/H)1BL\O
MW?'/F:C)MVDOPO6?.(?6%WG]ZG43"="I#;%O6D&C]>!S.);!\>2?J5*_@IA'
M8KWF6 .1NOV\L5X8VY%VQ@QDBX4+%FCN67$>MU+;^I/J6*N(@H8H#+XA\&*M
M/R;,_O[EN&7S1%ZDL)=C2()BS6UZ4@>L:.'*6FA\7W(0Q%?MY^5XY;"\*5&>
M+]\-+M'1D:$ X $DL H%!:<Z(]?\K5:+C@8GR%P,* ^L;W_(>Z+BE&^F]2NH
MD^G#;ED$Y R/_F2'5\3 SB0= CL[EDO/GR:.@V7[=GPF1OM7AXGFY#R+92;W
M1M[(B"BH"[H6EPC?[4ZDDUC+6LJZKQA\(Y(,K?(7689(=0EIFKP]57'91?@/
M-G\\>.*.R2)AZW1+H#F]\%3'ZF5T\$\\7D(8,V 9#V/NCM6V0*8S\O5% <:5
M=2.0C)#H >!DMUWHY"B2YK_00"%RC0 JZYF,V"!:S:]0/0E7<DI*^4#HB<)Z
M@0_2>S.]0/C J5ZDHV.8)'GH2@X9?U7/S&HCT1(N^:G+W69K<G2L[DM^]C%Y
MU*NC@\+".25<16Z:7*N=EN.;Z7=(M.@?[S)$NF-1+E,+XDV$Z<)=;T93G<'0
M@1KSEP4CZ71';I,DY)*C$(@L"@<MYKKD_:(7!?=+WV[2%DJ-US?L WNP=3VV
M<&MV?_3CC@^=$4AJM*#F2%W@,K@>M&!L(5;RHD:&1/.Y^E_D_ ;8&<$20S_]
MN!$7*\6"X:KZ<R#;YMHQLL+?CRYAK8 LP'J8R^HZ"WQ9<U<^PNN7J6/'?VM0
MR=#L_0)N85+*SF7P;H>UB/\VQ8CRI2<Z,3$E/BB2)]-OY,T"@9_Z4]6Z%0F6
M;J$7PX'6-?T4LQ29X$-#W8MC@[D"LF,.]9S.O*,G"C)B5=,?_V?#6O\UL/7?
M)76YI14/@-4=[LL09N&#V,C(UQ5#IZEYD>Q:P__;#3O^TR*$N05('F->!;X/
M9,B8*SKYB E?1<J-!(INLX<> ^YGK]+R](%I'*M"1%S"Y\ QV*N\.B%_ZI7)
MH\5@/,; @O[;_M#[TX0_[&[CV6.IG@>!HHH9"Y$W\Z__W<E).#!RR&K<O5E\
MQ8F;U(PN&+AJ1/?ZV#1[I959F_Q%GRO#R4H0+V648\<RQ-Z,U%N5D&QN[IWX
MH1-]T@ AQ=IQM(XCP\I!1-X BY*%FRN!_USHHIMN>C4HY>?1H7RJ_%%K0^:;
MQ@9KZ-L%G^T_[ 6%Z^W)'[V;>T:]9:D5&+_ Q:]Q]J)/ #OV7I8'@P=BZ3P[
M/G!5J4A3VL2) :<%"H^0^,,;G '$I+_!ZE,^NR )H/(0D4+8X,OSC5A=2:WV
MO ;VJ$-*;VV?2Q !XE/[KGAUJ,9N;-VTK>AZ<03_1&N-6W6;)NPR(4S=%OS)
MMOWO<?TGXSS]%T/JON;Q#S][C!5R=DAL5*%7;5D\GTQ R>K/E]^WLL_D0+4V
MCR(&LAZ'XJB^E5([@BFR+BD1'$R]-K 5]<QPOQ1, <_-RS=;N@/_47](VC\
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M#O-KT,JQ2JA:BA?C74&=NPJ)'I-!<'$!7=LLU CE2C+! V@79++XY$E+B-+
M).9"U4-N+\4:S/@)72#18W'":H["*[>O)"6M4RV%;]^F[=*5;CD;'G[;B/&X
M>HS/BPW] 5=T=&*]-"M1Y0<UYUEZ<[3+I%>6VH'K4@/2,(_B91UJ*&/QTM0Y
M"QD$XVL"1RF:=@P)>V-B;OT!M24]8>?D[3V>N !HR GY54?ZU[LF$'1V\E3C
M(TOKO]F3KMB=T2_?;C%&'+2[7+&>)$)+8<0%E_$P)^&R]V!I(Y%-?5@,1WEV
M)._S_\FYP^O/>3<&V?&4M$C-[!IR<]E%)QQD$A7R2OUB#<\] S\)N]"WPB;6
MPI[QHNH=/!*=8=;!M%SYWKE7@0?_*1V9O-:5J0C:Y^Q8>(;]S<,?FO2R+WP6
M2OK&?@WP&S\;@VT$K ,_$AYF?]FF"IAM%%%F?0F]LS]QQ36G?O2U1X"U;\@A
MP[)2;*'N\$8]0OX,J-$QN<UTZO9X^>;^ =+X?,$QSB^ LT=BM$J7><_D^;@*
ML@*#D97U1BSH,&DCVU^LWD!,MFM@!N8E8@C-T'A$7TZ!Z43)\&,V6 JM:[0K
M->ATI;J!%KM?'%&%TZ29;"]D-^SO:2#'LF+2"D]N3('Q_,9MQVXTT6%[9)(7
MC0#Y=!2D+?WFL)R6S'3_RD_7VR0#S'D?LPK\LI'IT3/OO9%A;^*E1YA8!4+(
MAVJ%*+QGK4=I50?83'!JU<QGG:Q(T&%)C-M/+Y;[X!%_^:$N1\B$AUV?847<
M^]:Y<7VA#S*XDB=CQB8JQ?RX)IXO_KC8><C90$Y>2X_;2(X@!"2BIU[E=,^[
MW__5]T.<LK7UOWTM[3M2#Y<\V2,!J_XF?Y*(N 1\=E^QD#V.<WO<$EA^6"H4
MO]\V2U4[Y^+F!^61LDDXCGMR#3!N_!6PLYNU>%_E>5Q)Q(R1:\$N@JHAAH//
M76ZN%5SIW6. &D$Y6&-VC;^UVA!"5@X?CI;2J@M]\'\#PZH\ T9W'4%'#BU<
M#"Y4=^<T1@0<!?GG)0TVHO&-E0XWSR-7Y7CR-N1E4X<V#=^ZS\CYZ+2]O-DG
MLQ1D88?H#"PH-'F1T$DU6+VVI+TQV]$0:[P+SB,K_VZC>C5N@MYGJ]^_([):
MZ68>A16B@E[1H")VZ&*%L=QO32LA YXW:A%*V-X<XR(H>'C&3G#:I)>>CGGO
MEJ+#78NL52]CX=V^FJ2ZWP+">\=5DD/,G0KN]T:&Y:2I4@]#TPL+NO)-YL*$
MZ5;DWYY9UTW(/[9]T.KD(Q&B6:2:*'EEL</>:1[ C<_/RC[YJ#SL\7@TYD/X
MU+R[67_"J,L4M9?5OIJ?O\3(FQ@$&U[@MZ>H\QO'FH--U6@!@0O:>>MA=^Q
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M!][BS(+$Q$Z'.H*B<VV@6:[IT4F>::\UMR:^7=,_A\!1=T6369'R0TVT&WH
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MZ#O^<F$V^5DK]HG<6G-W*J^Y;0E\_\N?JQ#RWV<( 2@V<*[KT?OVI+6M:R&
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M9WP"%HZYB@O@HC0N/(TX)LQS/LNKJ'Q<L"A;*S<AC1YBDULL>^A>B.K2P>Q
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M+MV^6CO*_NW?^/(HDOO[0SZAMD#&*CPX74"P)YLO@C)'+@Q!'/7=_L>3!ZH
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M7J)O\,H*Q(JG -HSMR%MQ3;LT&D0[W-\[GI?S?F*D#W/NLBL>5MZNCGSZ'O
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M39.V#.;1H 51-?WMGX?+#/)H-D=:#$&>_?6-P=U#:;*LD6_(5A7SW=U'4/M
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M.WRGVIZ2YM20B%E3O3%]8UIG^+MX%3$R]$5K*4\R5CC-V)Q.UK)H8]N5^#=
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MWP]9_G[K2LW.* @S8K[[?RQX9&WH>-G^Q892=/O?S(;Z*^@PPIHO&,D_"PR
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MYE"(T'%@OSFXN&P,%+\NI.$.9WP<M7/%M$S0(KBA+CID.J_%DO(,S/#<+\9
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M%\[ZT"I;2I1W4E#QI+]14+X9+?;NYNGIY$JJ7 ?G5&#"7*]6&N$]\XVHU#@
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M=YUXS2NOA<LEEK<+-:YL_/4C1E48LC? Z+'-LRA%YID[?XGPJD41D9'-I;O
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MI\#XJ&C\Q<"9W'I9NF$;F(A[?5M^K%  W2=SVM'#)9_-LX6,2A)];1!+.#O
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MWV4@Y]K,(?[ Z/YIAQ(DSKLKU9P&?C-FF^.?SL6^GI!=@,C9E 4-U^XR7W8
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M$@N2F J0]62*C]RYBNU[&/SHG&'^%A#K_0RE9*!L +R3TO>*S%4I@\32E2)
MO*GR]Z3HY9"N%,=(:_#8BL;-)!86=@M@\=+&B TAWOBXGP>'>>LUQ[EG2#9'
M"&_',<M'T_O!!&HNYXPN^ZKEH<^NC.!ZZR"25P1C5S4^A[RU]I.OB'IA7<V
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MX*^PJJ'.#'!VO4#%/6O3P9:ZG1+NI [_:<ZA1N#:/!3E0F_B8WXX2/2=(U%
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M[ANVT,ZF=TNF>,_""1)+?MO**H&XA(3A\[8-4 9U9!%6?V>VBK\W,=40859
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M-(3Z#<&W6X QI3::JDF6ZU+O(#O^YXAMLG%A0>*WP]V#T?,M>,E9L1SE@%^
MW,&\(IN),JXV59/HR0;M+4 6%'. #'5N>0WUM/&%*/ZZ^O-JA.Z"W$QC,1<5
MC[?3T)XN&BLHX49#1GO"2$Q(.SN^?PNX]M 3\TYP!+J:SK6G$Q>70W=4M#J+
MRF/^<;3XWA^.^X21^&=O1@/+QD[&HA[9(^%;3691;R8JXX?[#<_.6.^,F&)O
M =$%<(-+7@T^P56-R;=D%U^O54]$.W%:'?7F/*X><0@$40)2B+$&DCLK#W5,
M<S?L:X0[!%/#G'.?DS#M>3)>13LO/=T=<S4VMHBMM<'>SPJO+%*Q8MI[;<+
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M&_WZ>\$8!4>.0DN?9F1XOW@AO_68D7(/WBK5LY:4Z'@*)#G6(XKFI.]99&]
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MUD8=]ZU:?1JBZDPWI-K:_)E/0<SJ.K+-'_LKS"1PQ>FKO*H%:?X0%7(Z9E#
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MQ<:6Q-$GDRO/^SUPP^;M*MU/[P!$Z<$*AS]U&S3!J@)S7$,=;EX7'6.5P//
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MG;;1GBUHR!Q?80D]E\X:;C AP*AHH@G"2B"9Z]:F('YMY8]$.>_$O'0T5FX
M]W4A]HHI7%HM<R&<N[V1).FW1M\7))A'I1['A-$SHN^FE<I9OJ=?G-*B-XSM
M37*>MX1Y@E92>5J_BZ^:JRL9*DP'J.@HXIL^7^'^DG9.KS WLH/=]A0YO1A[
M^?6WY_STYT)D<P3Q;,?QVT5#*WP^^N\Z7S!%W;.(L K)D=PY8^;P>B)2<_&B
MB<RE(,^>27LJ:>X\ OB7/=6\0LE/6L_B%/*=0$3V DO?8(4UEB_N]>Y7?&!T
M--G/0E?4!5Q+Y28@3(6F_TEA[E\%\F*H5O;C@SU#][ 64]>K?'Z)N]RUVW;7
MU6_7GIR.-!0F]B0.5VQOTU!&UO/)V7^R= E\@*P0]RG>25:Q6XGB7WR:3M/?
MMLF_ PKF7>!I0+CB1ZEOM5FHKLI*E-745-?!H?&SXZ3UGT69S'!V3HMRV;=H
MSP.P',YY2N[%-N[XCJ6+P$6RS8!1=:Q\*I+[[M)7'(=W.6>G]U2>-9D4D;XH
M_U3V?-4T6'N#WT3-Q"#]3E8,?PP1QD&Y!HYCHV.L'E07ZD1YNH!9+]^4I)D4
MB'*2\.KBK!JDO '(U:AU^08BE$Q7%KC?-'CL<;X+=MMY6@D*]M2.WOV<A4BU
MEW8BP5KEAOO?_K]<ZO[OXF]$0^3/4+]B8R^$EAE8I=J>URL_OB>KL*_R3F((
M(*;1'J( K^"NX%OM")JV/+H")V# EJZ@L\)&5\I &W4'^>11^O8W@R&*:(HN
M1>OG%0ZR:06&"D?ZMJO9!\9A8#!=5#DYFD#FP3W$YAWMOM8X;HG-W/#X?UHF
M=K'FT'([\X8&1U+>B@VS:57<K^>],++U"*$P<4='06C!,"<7%PVY6MW+Y(DL
MJ,LB(3H>XR_"5?E(WZ;NEY[=7-3T-4-JA?HO%U%]UMZU76<9A3_55,@*[V0I
M_S8&TDR%@\S:+VIO?_]:_A]/;BNT#R8,KBL5V7M:TNI0'!YH3NU;M%=-+IN>
M.3<:2P43J"R<4ZXW&T^854KXF52V"I@6DOH%V^!?=L'++9MB^>0>4#TH[G^B
MD[J=1<H]'&0MD"!-]O.XCSDQX2F/B!:V/9$_A'+^%-@3OM%RIV1IAYY6<>&-
M&E-\,^ELVL?&[[]W04\3]5L5KSO_HDK\G.W?.'I'B&UT]"43N-:@7UNL9-=#
MQ)07-Q9KMR#BM'= &\ W=V/(IK!:CL@&Z/I$JG Y,9HLJ(R$:>C@6F#)6P#N
M2LC7^3-Y8"P_@>K)Y^BW5G(J([\0H)6%^[5 2K#[>9.G=-%<65^\O+"Q4[.U
MRP$YI VE8O=.7]JG,-FVM][VL]3.2:^?S2Q"G[I5.Z2 5TM]>) Z>A=28:"$
M7A5-#O\P)I/6_91"@T/H3G*ZV99A3PX?5KVI7E1K_BSS);U/[?=?X!%5.5Q$
MKG3NC,'"597=^TMK5>A'B@U?0/\YLF;.R3:OT2FOJ2%\>,H@;%Z.X(W1]!G9
M\X>.T:?&UT,"'%1[%DB1/-Y,4<O(B91TN][NO:<B;QWUC0PK7TT#B$\$W#O=
MK\G19"B5#V8.Y+DM7U=CP%>.HY/XH( +<?) P_D%)5:J%[)SO'OAQQ(O%C<N
M/4G,A&8VC@?FE'B_6P [5-9^396P5#5%ZH]>/+D!*(ODEUYXPT<L\1>DSKS\
M&^+%-PB$D>7:?^13?G^AE[31K+:)=E!8U0]&88&.[4P:M!NTF')MBC%">63Q
MDRV#C^!Y87#B\,[1V7IX^/BTWFPWX'V'0(\*U7FWXG\D.]TP>Y\%X#Y""@C(
M3/R)B>B=HB;KG2%FFN >P38;',=4MO)U7PM7C?$WCN,7;TSHN<G0RKE1G@L7
M08@ZJJQ$W[KS=3=K--+;CK=S-JZR2I3NO8_?-X>-1(FK$SB^3"5,3Z=BN@'H
MQ6P8 8.P+. 5 [='54G;QA9-OGJM90Z.$BH38QJ^W]>FI?=^!RU,?VD5Z[^Y
M.2S_/;0DP%IUHRZ-!Q713\/<:5TE/WF-WEF.],")T5_V99@G!&N/BXO9>_?/
MFG)U/'Q5V;XR@M*RJST@ANQ;3-+OG8A]H*R-%C^^'J/;*3BL#(!WUA@:#7U$
MS";^N%K[&1 K<<>DLP2\,+&)"Z;4?$DN<.O5YXY/8NIC,E(T_[0$VLKMR"BA
M3IZ[K<F/Z]D>'.V=D'Z?JJ!!XH[O4!>FK*19/_ I:1D,IEW!<]C!3%828N5,
MB+>73$/>9BCC\Z>%].%5%EAL)WF>Q:# K39S;Z[A_C)'R-GYTF6W/<U:SZ1:
MBZ70%D7K93&C%PMVQF"=GZ9FPJR G7UPS&]+6#D@2?,XF7YN#TN)_LYU3',#
M^-ZJ9*^[*;H4#AOTT3".XH1"E3&<"+SU\XHF.NH.A"IXNCPG?"V8(/SKLXQQ
M:FM:DTZ3ASOZ$E?SYUM<K37/QTA'&B,N$-EJ(U0;D6JJ?0D-_[TRC)S-'VK_
M4W^*<VB8P/P.-%'HZD3VA7L2941O#Z/CLK?JM=?O)(W+\H%F ;:.H_3?M4\)
M@]6II-F6_87YX=1-K-:B22D>5"%O&_RM<@"V]2+WV*\L-B7I:P[7RK_I]<+,
MG1D]5S.S/D'9*5T;U.2.2B^"2S[D=ZXO+LC9M,I]G7X6&T%&-CE!SD.U_TR>
MP;A:_N,=Q_-VDL?;&N"52RH!@XI,BW%&^NM3PLK/I]S$/^LSV5HLZ;1[< +5
M#K8P6LSS;<9K.S'AF<#@5V&<Y\+"7+BO*S?>QB#K/O4^/'_DAY"7K\B$*U;!
M5W2ANROA I2SC,#A#.:@\J4=KG=^Y[DFAWD++ N\IIB@E<%(W,D<O+%J]EE(
MLW2<?R'4ZJ?7?39[<;;<!>=GR38JM>_\V N$.I<>#M%P6*M6^(4IX*IE7\%S
M9/48'Y97A.2Q]8%""RI%6^ P4+"S3W6/@@ A$:@-%KN6B]=0<:PTP?";0G!S
M3;?P/?G A9@'%CP+'+/X<V*W</")/QNS>.A$5>^W(O6-S #ZDUNK"&.N27'W
ME0SE 1I9#W(7=@8J23VSHRS'WC4=KG*L'%*><8S*KM8 W^4^/QO+@5OT]+#'
M-6QVL=-A)8I%O1F^QQAM!.7C!'?RT.I$3[?4&.L96<,''2OZ]L3A-4%1FEE-
M"CL'N^ /%3V#B]-G0Q0RL,/K++J,5+NPNXIFZV;;/DI&V';ZQ"B6"/Y+(ZZ-
MU+,I@Z_(Q4-I5I%W(H!)AX>8\3F=<>-KM(;BZ]C<\G&"ZN5'?B;C-346WI5.
M&V$M4L#@\ISF5$;F^E3&V)B64EF^7U.)&1/Z4;7NY..<8_*2VAIQ)Q7 [DSA
MP\62@GGK'FN'MY\ =6'QY2)X($-MH@ L1?F\[OP; ?PA\E':;G(1/V^WHL'Y
M"BT[%<.Y^G3BTTH&--'GTS2Q?J[:'3^8[HAP8_!+D<\U?9*_.?(DQ@-U[TGT
M+X$H,Z&[1E4%/WH'[MZOV(<;PQV =G4Y=GQ9*PJR2M0Y8+H(GC!RRJY\JMO/
M=SU1J3ZT/H1DN#S_*G)X]-M<"/YG?UISNN<YTNGIG9P<;ZNUH@'BJ\\NA-TI
MT>G.9*T_K,BLD1>_3$DS)_^U-G<#0!A.M@>>CI 7-R-<V<I-$[Y4UR\'G0BP
M!)X8M!/;]'8UC=LZ_'*&F7:!9ZJ,EHY/2S&*36$!>1"*UZ,SYO4U>BS&"4K'
M0AAM].7,E=?EF(RB^]/S__3RN;^3U R6SQ#4U4^CEB8_^I2I=75E%2>=%73=
MM+<:]R1L+=%?CCK)@N537DD%R0^;:U:T; Y20>>*^L6[6KQ"T<?LN89J"[W4
M<SUQV;/%.:0XTP2_#Q&NOH8_4=4;P*D:(J><FP:\=!B-<=M>>_A<U^-CI4]O
M*P!&A3R@E%I)4P^],UP@U$]6[23MQN2ID[6D-V]])'L><"G7/1LVP$@W:%/4
M2-^ +=V]<,F\,V9[^J$Z01WQ/'BC*9U"WGF8=V?H>4KIO#1JB%MWTM2 ?,(N
M]/VJ'>K3_,G6.&QZAK'N,"8H][ M;2U@W?BMN^%;SZ23"^V#K3T]-N00N0+V
M<ZE^2EC/^)7*%,Q1]7QB:/'<]-KY7VH\?/G51EYZC-#^#JP<=4Q(:R_IWA\-
M>.G-XGN(M]>^$B(X[\M/0,("0^RBLWR\_68BBP6\"YQJZG]@K;18LBLH(8-=
M%_XHE</^4#_?M28-FDY?+C2.7Q=<.^9MO;UWF=0(/-PP9\!-R!,:%>T[Z8%+
MN=/VDH,<A90+X9S>G]!^ZS?"S*6Y)TFV^3$6P2&!S9CU( (%V<]"3.2J  9;
M26.H]J3[5U;G<OMYF7X1^L)]P;-G&_#!T DEM/P;OS$LJ%AE*['WI&)6#&)Z
M&2>;M9\-'"^8EY..&8]QX2;Y'(/46HC<GAT.$8@*3)?CH6([K2A20<O&E;(*
MSD8UQTON'Q8="12\*)BPH^VK[EG0?DGIJS5DXBUXN)_='142NY$QRFOH2VI%
MOR/ZX0JY=L]QNTB KKM+4-X8:;6LHD?)?5S!U48!K7& NS;O\,THFJO/8;F#
MUQT%ZTL,;7Z*LC%K1SRIYC^09(*X#877Y5>3[:RQV4!O /@FG5G'QR!$GP#,
M<L4'J*+ZS;IN&[#\A<!/O\%E3I#RDKD!>-KOUQ'C(@'/N $$%:P4_A :N@'X
M#H/Q.IO$C4%3![!6Y84"^,0OMUAY>4JZ&X"4T=QFJFU@C:X!'_#"/.]"JQ@E
M;T;<$Q[:[JKYCDNLX)L15^CNKEWMYFOM6#D'X+F9X8.TZ(SF,1G958D_)[7O
M[4/5CZ; 'B+16JS?+XC#D=XX/L]"2HPA[S$9H_%GU4"4<D/%=H-#F#RG0ZV$
MZ=U^TP;BVJ_7)-/7[1GJSR6BU\.%."-:@(G!*YB3/'3)/U<VA./B$<9ZX 48
MFZ*(@M4'2V0<<_79_'V9ZY>"-'9.*E6RS9V$!12.=M7M.=&$&C\H)*G!!@O&
MBVR<]$H)^.I.F8&I^R<CP9+ ).&*M_';JM\(@A5>-$C<O>-ZGO311MM)?_[I
M(&YV95)O\0V >@5UF!SFS<(9MC*WN<^INV]@$#=@.5YZ+K#>)(9/2*0\CL*W
MMKS3_E'KKI]HZR"1MR_9$$:N.QY<;:1G8N 3HUEKJ_AHLW-">V]ME=K[F5=)
M_"+9#E/([2(-+H?W23DK=D!M,^:I#-QQ>NBWV[[YVL]*#CNE&NH3=J>"Q]<T
MO\Z2,Z[CA"O> ,+UF6N#Q<P$\U@WDS;EL9N'&S&KDP(_BA:W]@IJPYJ(>+ C
M,89P':YG6H=$$5"S,=_.4I-RG;-J?MMZPN!>>[^1-WM<^]G-1J-*M(-7F],\
M5QQ1D]SBQ*4[&OHFO?8.I'O6>F_*@$J=K9Q+^'LYILXYV\Y;ZL2Q?6NCX6X-
M L[ULQ!D)/#-\D@G5$6-ZWD14BPD0Y;QR.EV9M=$)BE:9C&K!!3B+?V,FP)H
MV62?\'!^XBAAT"<:!104NU"]ZT''$88&1N\S3#Q,RS;@.ITW$3^(S+W5;P)]
M??W"CW(SF)!ZV7H6^<V4H(L 5:P.X?\E-S"\0U=<(>E _RS898Y06S!!.YUE
M]O;'N%44T[G -"IG9$4#_'@R\$_2'@5;Z6?YIV=_;+@+EVPI&3*ZR9^"@@<2
M/\MP[Y]G1 ,*Q0P33O(M'A1\+2U>31*^W1!1&?8[0H15AO!O"5#=ZDW?UN8]
M.%"[ 7105&#B6D8>;0_1LF15ZQ_R;EH7G[/)-?H98Z(^% W;\:_:F:C:DU.*
MR$BN:DD ?]1?K&>GUH?-O]DYEGI?M*KR]DJ"HW#,6Z 0X@ED[YADH)L_VL-,
M%1T7>=E*@FU9WHG=ZJW_HV.#M83QX[\6QOIKQ%]K-V2^!7&>&,]K8T7>[\ H
M !<]K'\[Z_%),U54:VI_Z8*[HMIWK(T2'I(LJ<;K##^4"<ZMT"'G^-WOG8_U
M3$QBA@QILTH1C)GA#JFJ"&/K;0*U#G^%[\8*P[P'AG?;4099!)A%^3<24YFC
M>4J/":H=SY/ABSDSI=Y*K7&!R=0J(<A?.CA$;&5K^U9Y\[Z-9?.88W51\DC'
M(D:+_8/L7E<\^&PS%*14/\[YKJ;.*.Y5 WW1CII5$U?FYW=)26H>:FP;XC5
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MWH%]2TEH7S!O<N^H2Z7X!%:C*(M<;_N"\&?/!5(F?'M6OD]'_64?5DS';N4
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M_W]0Y*?,*+(?WFY[+G3[WXE^.S9G]6$A<)S_-C)A;20HB0GL47%D NQLAN
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ML]H%^"]E9K]!@KD?[,;.2&7^UB_<7PWNZOR%G39.;*=R0O-KZ3NGAM<I4DQ
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M7]YHM#_P< VV\KNI=U\M027ZM8O(TI/OQI8!(0+1;Z_>2]E-DB(Y$T*VHS9
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MO:M,T"0TZ0U;U;&%ZAB!-%*UD0"87EVF2.,DDIP4;'-RHU?X+MVP:ONM CG
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MO953PX4+X9G^[R]<"/N^_\V':*&%BQ"_S1"2BHRT4(MX$_56? S_5/YN78*
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M5R@L0GD6LK!O'I0-IA(K\:"AYEDN<&I[)A>XFXM[@*3%^<9 ]P]9<@&>ZUQ
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M0O%Z""[ %V%F;HHPMS8V182A44>5$$'7+U[!A48@]!!H%!=S"C "P"PL?^-
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M&@_%C2;Q\%O(QXY@EG"<.;>50@P<"_^&&RSS=\XR_FUI'?]686HE&2WER9)
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M7VGGPO>NI6L!!GSF@53CLW]%O@QL::$I 9$!WWH^:#E<?0"7^5?<E?^AO^\
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M"=BHO00-[SG7$%5>)3A@%!NHO0'CL(B8GH/RGC>&B2IG1NYR4N+(C[Z<F-G
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MGG?,%I:<<2?XZ5U_<):E!&XTL[U07_#NX\%1!?!5.3IN&W)@YFU6YFEAD3'
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M*Z7):K40(VA0+^0@=B*)PM74RPZ3XE=$LF*;&%G$ OS('&PQF0B21S!DF I
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MH(X*?JN16@*T!&C1B.7$4)O-Y<LFS)>(*A%UW[#-1 ?$Q%?LS!VBWS@T_+1
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M538=MI$OK2D*'HFMH^OY\_BPF>_O>>+BX=_<L8O?[!6=/3/GG -X=%QKYIW
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M#A] G_Y08+RBPW<4@^?HQZ,\^N6[.EP+T/ X/0#? *%IU!NODY#TT;2/09C
M,4YYR(%.@*2RHPP[NF):W\6IL-\^77Y9*>3T!L]]H[ZA\OYK/]==3/5C%Z!?
MLRVWWI0CPD1+E1-K[-D _KMP\=A5@)?]:^]=SQ5+H0;M.-2 :CCDE]167YG!
MZXF_;4+_R?&WZ2]6_6/:6T@%N:F6F?Y E9>G3U9N6G';[8T]>P$_@-(Z']G_
M E!+ 0(4 Q0    ( "!!A%1>G"A]T<P! /5="P 0              "  0
M  !E>&AI8FET7SDY+3$N:'1M4$L! A0#%     @ ($&$5,.*!%^1:P( -EPQ
M !               ( !_\P! &5X:&EB:71?.3DM,BYH=&U02P$"% ,4
M"  @0814YX3AQ[Y# 0![TPL $               @ &^. 0 97AH:6)I=%\Y
M.2TS+FAT;5!+ 0(4 Q0    ( "!!A%0I<H43& @  .HM   0
M  "  :I\!0!E>&AI8FET7SDY+30N:'1M4$L! A0#%     @ ($&$5"$#![7Y
M!P  (RX  !               ( !\(0% &5X:&EB:71?.3DM-2YH=&U02P$"
M% ,4    "  @0814!/ZUOQ %  !;$   $               @ $7C04 97AH
M:6)I=%\Y.2TV+FAT;5!+ 0(4 Q0    ( "!!A%0(GA9R'P4  ) 0   0
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M              "  91$!@!I;6,M,C R,3$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( "!!A%1\/99C89$  (*4"@ 4              "  ?/D!P!I;6,M,C R
M,3$R,S%?<')E+GAM;%!+ 0(4 Q0    ( "!!A%3,Y8I9L$$$ *<>!0 -
M          "  89V" !I;6-?:6UG,#$N:G!G4$L! A0#%     @ ($&$5 4C
M ?R,#0  2 X   T              ( !8;@, &EM8U]I;6<P,BYJ<&=02P$"
M% ,4    "  @0814QI$LM6Q"  "C+P( #0              @ $8Q@P >FLR
@,C(W-30T+FAT;5!+!08     $  0 .<#  "O" T    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
